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Foot 81 mouth disease 
IK7/ The UK 2001 FMD outbreak 
P. Kitching 
Winnipeg, CAN 
The United Kingdom had been &ee of FMD since 1981, when there had 
been a single outbreak in a dairy herd on the Isle of Wight, off the coast of 
southern UK. On February 19th, this year, pigs waiting slaughter in an 
abattoir in southern Essex, to the north of London were idendfied by the on- 
duty veterinarian with feet lesions consistent with FMD, and this was 
confirmed positive the following day at the high security Institute for Animal 
Health laboratory, Pirbright. This laboratory is also the World Reference 
Laboratory for FMD, and apart from having the largest research group 
working on FMD, also maintains a library of FMD virus isolates collected 
&om around the world during the last 60years. The virus strain was quickly 
identified by nucleotide sequencing to be the PanAsia strain of serotype 0 
FMD virus, which was known to be present throughout most of Asia, and 
had recently caused new outbreaks in Japan (&ee since 1908), South Korea 
(fke since 1934) and South Africa (this was the first outbreak of serotype 
Streptococcus pyogenes new features of an old pathogen 
0 ever recorded), Mongolia and eastern Russia. The index farm contained 
over 500 adult, mostly cull sows and boars, and following clinical examination 
it was apparent that disease had probably been introduced as early as the 
beginning of February, as most ofthe pigs had lesions of approximately 10 days 
old. The firmer fed almost exclusively a diet of waste food (swi l l ) ,  collected 
from nearby schools, hospitals and restaurants. Regulations relating to s w i l l  
feeding make it compulsory to boil all waste food before feeding to pigs, but 
this is diflicult to enforce. Control of the outbreaks was taken over from 
MAFF by the Chief Scientist, supported by four teams of mathematical 
modellen and other involved groups, who reported directly to the Prime 
Minister’s Office. The slaughter policy was extended to all neighboring farms 
and those within a 3 km radius of the infected farm; slaughter of the infected 
farm was to be completed within 24 b of diagnosis, and neighbouring farms 
within 48 h, and this became the responsibility of the Army. The use of 
vaccination was considered, but would not have sigruficantly altered the 
disease distribution or the final outcome, and was likely to confuse subsequent 
re-establishment of disease kee status. The total cost of the outbreak has not 
been calculated, but including the effect on tourism, will exceed 15 billion 
pounds sterling. 
Pathogenesis and epidemiology of invasive 
Streptococcus pyogenes isolates 
C. Brandt 
Aachen, D 
During the last two decades, a remarkable change in the epidemiology of 
Streptococcus pyogenes infections with a marked increase in reporting of invasive 
diseases, such as bacteremia, necrotizing fasciitis, and myositis was observed 
worldwide. A substantial portion of these deep-seated infections was asso- 
ciated with the streptococcal toxic shock syndrome. It has been hypothesized 
that the emergence or re-emergence of more virulent strains, particularly 
those with type emml, emm3 or emm28 is related to the type distribution of 
the organism among superficial infections partially depending on an absence 
ofprotective immunity against these types in the population. Intense research 
on pathogenesis has investigated the role of the pyrogenic exotoxins SpeA 
through SpeJ some of which act as superantigens. Whde the distribution of 
Vaccination issues (Joint symposium ESCMID/ISID) 
emm-types among mvasive isolates parallels the distribution of em-types 
among isolates h m  supdcial infections ro some extent, a smng association 
between the Shepfococcuspyogm em-type and the presence of certain genes 
coding for pyrogenic exotoxins has been observed in invasive and in non- 
invasive isolates. Since neither factor can solely explain all the manifestations 
of streptococcal toxic shock syndmme so far, the genetic control of exotoxin 
production or expresion of other vmdence factors, such as the hyalumnic 
acid capsule, streptobase, streptolysin S and the mitogenic factor F, has 
become a major focus for pathogenesis research ofthis organism. Addiaondy, 
subtyping by sequencing of the sic-gene encodmg the streptococcal inhibitor 
of complement of isolates from invasive and noninvasive infections with 
emml has demonstrated a remarkably hetemgenous array ofsubclones. It has 
been postulated that sic-variants arise by natural selection on human mucosal 
surfaces, and that ths  process may sustain epidemic waves and contribute to 
the emergence and reemergence of Smptococruspyoptes. The overall impIica- 
nons of these aspects in the concept of invasive S!reptococmpyogenes infections 
will be reviewed. 
(5171 Introduction of MenC vaccine in UK 
E. Miller, R. Borrow, M. Ramsay, N. Andrews and E. Kaczmanki 
London, Mamhestq UK 
Objectives: To measure impact of MenC conjugate vaccines on age-specific 
incidence of invasive MenC disease, to derive age-specific efficacy estimates 
and to monitor impact on the phenotypic and genotypic characteristics ofthe 
organism. 
Methods: Vaccination history was obtained for all group C meningococcal 
cases confirmed in targeted age groups. Efficacies estimated for up to 
2lmonth.s of follow-up based on vaccine coverage data for the targeted 
age groups as at June 2001. Evidence of herd immunity was sought by 
comparing incidence of group C disease in unvaccinated individuah before 
and after the MCC campaign. To monitor evidence of capsular switching, all 
invasive isolates are phenotyped, 50% are porA sequenced and multilocus 
sequence typing performed on 10%. 
Results: Up to 31/9/01, 23 confirmed vaccine failures were identified. 
Efficacy estimates are 91.5 (64.9-98.0) for the routine 2/3/4months sche- 
dule, and 89.3 (72.7-95.8), 100 (84.9-100), 95.3 (88.3-98.6) and91.9 (73.3- 
98.4), respectively, for the 12-23months, 2-4years. 5-14years and 15- 
17 years catch-up cohorts, respectively. Percentage reduction in attack rates 
in unimmunized individuals are for 1-4years 50%, 5-$years 57%, 9-14years 
34% and 15-17years 61%. No changes suggestive of capsular switching are 
evident over the 48-month period. 
Conclusions: Based on the antibody persistence data from prelicensure clinical 
trials, serum bactericidal antibody levels in the youngest age groups are 
currently declining to near baseline so vaccinees wiIl be reliant on memory 
for protection. However, efficacy estimates remain high in toddlea. Reduc- 
tions in group C disease in unvaccinated individuals both in the cohorts 
targeted for immunization are consistent with herd immunity. There is no 
evidence of capsular switching to date. 
[ 519 I Is the MMR vaccination safe andlor necessary? 
H. Peltola 
Helsinki, FIN 
Objectives: To investigate the data on the safety and efficacy of measles- 
mumps-bella (=) vaccinaaon. 
Methods: hterature search of the epidemiology of MMR diseases, and the 
tmpact of M M R  vaccines. 
Results: Wherever the MMR diseases have been looked at, their high 
prevaccination incidence was common feature. Also the incidence of com- 
plicaaons has been rather similar, with some exceptions. Measles vaccinaaon 
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was introduced in the 1970s, while mumps and rubella components are still 
searching for their way to general use in many countries. The combined 
Mh4R vaccine was introduced in the 1970s, and thorough research has been 
carried out with this combination. Although the antigens vary in Merent 
MMR vaccines, especially in terms of the mumps component, the vaccine 
efficacy has been good - again with the exception of the mumps component 
whose efficacy has been the highest with the Jeryl Lynn and the lower with the 
Rubini strain. The reactogenicity of all MMR vaccines is low, the best data 
deriving h m  prospective double-blind studies on vaccine using the Moraten 
st ra in  for measles, Jeryl Lynn for mumps, an R A  27/3 for rubella. This is also 
the only vaccine from whch long-term data are available on the clinical efft- 
cacy and the (low) complication rates. Whatever MMR vaccine in question, 
a t  least two doses are necessary for the elimination of aIl sMMR diseases. 
Conclusions: MMR vaccines are, generally speaking, safe and efficaceous, but 
they are not identical. One should take into account no only the short-term 
but also the long-term eflects before large-scale vaccinations are introduced. 
Only few vaccine brands can show hard data on all these important issues. 
Bearing in mind the severity of Mh4R diseases, there is no doubt MMR 
vaccines are among the most necessary weapons we have in immunizations at 
hand. 
Management of central nervous system infections in risk populations 
1 s21 1 Parasitic infections of the central nervous system 
E. Scrimgeour 
AI-Khod, OM 
Parasitic involvement of the central nervous system (CNS) is integral in many 
protozoal and helminthic infections. Falciparum malaria, African and 
American trypanosomiasis, and toxoplasmosis involve millions of people, 
and produce distinctive, diagnostic clinical features. Immune evasion is 
exhibited by many protozoa, e.g. Toxoplasma gondii may remain silent for 
many decades, only becoming symptomatic when immunosuppression devel- 
ops. In helminthiasis, CNS invasion is less prominent, but trichinosis, 
angiostrongyliasis cantonensis, and cysticercosis produce well-recognized 
syndromes. In the case of the brain, meningoencephalitis or space-occuping 
lesions result, often with seizures as in cysticercosis and schistosomiasis 
japonicum. Myelopathy is caused by deposition of parasitic ova (e.g. in 
schistosomiasis), invasion by adults (e.g. in paragonimiasis), or indirectly as 
in diphyllobothriasis. Ophthalrmc involvement variously causes iritis (e.g. 
onchocerciasis), choroidoretinitis (e.g. angiostrongyliasis), or optic neuritis 
(e.g. trypanosomiasis). The AIDS pandendemic and the increasing use of 
immunosuppressive drugs have resulted in an unprecedented rise in the 
incidence of CNS parasite infection, notably toxoplasma brain abscess. Cases 
of meningoencephalitis in microsporidiosis, disseminated stronyloidmis, and 
trypanosomiasis cruzi have also increased. Idenhfication of CNS parasite 
invasion has improved with the development of investigations such as antigen 
detection in CSF, and magnetic resonance imaging. Although treatment in 
some conditions, e.g. falciparum malaria and trypanosomiasis gambiensehas, 
has improved sigdicantly, there has been little or no progress in control and 
prevention of the major parasitic zoonosis. 
CNS infections caused by viruses. Focus on 
herpesviruses and JC virus 
P: Cinque 
Milan, 1 
Viral infections of the central nevous system (CNS) still represent a major 
threat in immunocompronlised people, especially those mfected with the 
human immunodefiiency virus (HIV). These are mainly caused by herpes- 
viruses, including cytomegalovirus (CMV) and, to a lesser extent, herpes 
simplex viruses type 1 and 2, varicella-zoster virus and human herpesvirus 6, 
and by the papovavirus JC virus (JCV), the etiologic agent of the progressive 
multifocal leukoencephalopathy (PML). Over the last decade, the diagnosis of 
these infections has substantially been improved by the application of nucleic 
acid amplification techniques in the cerebrospinal fluid (CSF). Viral infections 
of the CNS can now be specifically identifed by detection of the respective 
genomes in CSF, thus reducing the time for diagnosis and the use of invasive 
procedures. More recently, quantitative amplification techniques have also 
been introduced in clinical practice, providing an estimate of microbial 
replication at the time of diagnosis and during follow-up. The prognosis 
ofthese diseases has benefited from advances not only in diagnostics but also in 
drug development. However, despite the large armamentarium of antiviral 
drugs, CNS infections caused by herpesviruses often fail to respond to specific 
therapy. This might be due to the severity of disease, limited access of certain 
drugs to the CNS or development of antiviral drug resistance. With respect to 
PML, a few drugs are known that are active agamst JCV invitro, but none of 
these bas so far been shown to be effective invivo. On the other hand, the 
kequency of these diseases among HIV-infected patients has drastically 
declined in the western world following the introduction of potent anti- 
HIV combination therapies, as in the case of CMVencephalitis. Furthermore, 
anti-HIV treatment may perse be effective in treating some of these infections, 
such as PML, by improvement of the host immune defences. 
Tuberculous meningitis: still a challenge to the 
clinician? 
J.-C. Garcia-Monco 
Galdacano, E 
Tuberculous involvement of the central nervous system is most fiequently 
caused by mycobacterium tuberculosis and s t i l l  represents a formidable 
diagnostic challenge. tuberculous meningitis, the most severe form of neu- 
rologic tuberculous infection, presents most frequently as a subacute syn- 
drome with fever, headache and abnormal sensorium. In children, 
hydrocephalus is particularly fiequent. The presence of human immunode- 
ficiency virus infection does not seem to modify significantly the clinical 
picture of tuberculous meningitis. Neuroimaging reveals enhancement of the 
basal cisterns and a variable degree of hydrocephalus. Cerebrospinal fluid 
(CSF) typically shows lymphocytic pleocytosis with low glucose levels, 
although initial polymorphonuclear predominance may occur. Cerebrospinal 
fluid culture is positive in approximately 60% of patients and takes several 
weeks for the bacilli to grow. Polymerase chain reaction of the CSF has 
improved the diagnosis but is not yet widely available. Empirical therapy is 
often initiated upon suspicion based on a clinically consistent picture and CSF 
findings. Most of the regimens contain three drugs that should include 
rifampin and isoniazid, although some experts advise four-drug regimens. 
To date, multiple-drug resistance has not been a problem in neurological 
tuberculosis, although the mortality rate of this infection remains at approxi- 
mately 25% of the patients. Parenchymal CNS involvement can occur in the 
form of tuberculomas or, more rarely, abscesses. Although surgery was initially 
advocated as the mainstay of therapy, more recent evidence suggests that they 
both can be cured with medical treatment alone. Also, damage of the spinal 
cord, roots and spine can occur in the form of spinal meningitis or radicu- 
lomyelitis, spondylitis or even spinal cord infarction. Less frequently, oppor- 
tunistic nontuberculous mycobacteria, especially Mycobacterium avium, can 
cause meningitis or meningoencephalitis, particularly in HIV-infected 
patients. Therapy in these cases includes a macrolide, ethambutol, and a 
third agent (rhbutine, rifampin, ciprofloxacin or clofazimine). Overall 
prognosis in nontuberculous mycobacterial infection is somber, with a 
mortality rate close to 70%. 
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Diagnostic methods: molecular 
1 025  1 Multicenter performance evaluation of NucliSens 
EasyQ HIV-1 
V. Soriano, H. Cuypers, M. Segondy, B. Montes, M. Koppelman, 
C. de Mendoza, T. Oosterlaken, B. Top and €! van de Wiel 
Madrid, E; Amsterdam, NL; Montpellier, F; Boxtel, NL 
Objectives: A HIV-1 viral load assay was developed based on NASBA 
amplification and real time detection with molecular beacon probes. Molec- 
ular beacons are oligonucleotides with a stem-loop structure and with 
quenching and fluorescent moieties on their 5’-and 3’-ends. Binding of 
the specific loop sequence with its complementary target RNA produced by 
the NASBA reaction results in unfolding of the stem and hence the emission 
of a fluorescent signal upon excitation at the appropriate wave length. In this 
study, the performance of this new test was evaluated in routine settings at 
three sites. 
Methods: The real-time NASBA assay (NucliSens EasyQ HIV-1) uses an 
HIV-1 gag-based primer set in combination with bioMerieux’s proprietary 
silica-based extraction technology to isolate HN-1 RNA from plasma. As a 
control for the entire procedure an internal cahbrator is added to the sample 
prior to nucleic acid extraction. Two distinct molecular beacons are added 
to the amplification mixture: one molecular beacon with a loop comple- 
mentary to a highly conserved region of the wild-type HIV-1 RNA and 
another complementary to the calibrator RNA. To obtain broad subtype 
reactivity, the HIV-1-specific beacon contiaim inosine nucleotides a t  positions 
known for sequence variation hot spots in the viral genome among HIV-1 
subtypes. 
Results: Linearity was investigated at each site by testing a dilution series with 
8-16 replicates at each concentration of a HN-I RNA reference material 
calibrated against the WHO standard. A linear doseresponse was observed in 
a range of 25-1 000 000 copies/mL plasma with SDs of about 0.10 log at 
concentrations above 1000 copies/mL and higher SDs at lower concentra- 
tions. Quantitations at all sites were very comparable, demonstrating a good 
interlab reproducibility. Of more than 50 non-B clades tested, representatives 
of group M subtypes A-J and the majority of the group 0 specimens were 
detected and correctly quantified in comparison to, e.g. hDNA 3.0 payer) 
and other commercially avadable assays. Parallel testing of 101 clinical samples 
showed good correlation with the FDA-approved NucliSens HN-1 QT 
(R=O.956, CI0.936-0.970). Average time to result for amplification and 
real-time detection was approximately 9Omin for 48 samples includmg 
30 min hands-on. 
Conclusions: This multicenter trial demonstrates excellent performance of a 
high throughput real-time NucliSens assay for HIV-1 viral load measurement 
in routine settings. 
/026/ A broadly reactive real-time NASBA assay for 
rapid detection of Norwalk-like virus RNA in stool samples 
S Greene, D Kowalslu, L Grosso, P van Aarle and P Hama 
Durham, USA, Boxtel, NL 
Norwakhke viruses are a genencally diverse group of vlruses now recog- 
mzed as the most common cause of vlral gastroenterlhs. RT-PCR has been 
the convennonal method for detecnng NLVs in stool samples We have 
prevlously reported the development of a rapid and Senslhve nucleic acid 
sequenced based ampkficatlon (NASBA) assay for the electrochermlurmnes- 
cent (ECL) detechon of the 8FIIb Genogoup (GG) I Norwalk VINS stram 
RNA uslng NuchSens@ Basic Ktt (bioM&eux, Durham, NC). Ths assay 
promded an altername means for detechon of NV RNA m stool samples. 
However, the two-step assay detected only a s m a l l  number of GGI smns  and 
detected no GGII smns A d d h o d  even though more rapid than RT- 
PCR analysis, the NLV NuckSens& Basic Kit amphficahon and ECL 
detecnon assay required 3 h to complete. 
Objective: We set out to develop a one-step accelerated broadly 
reachve NASBA assay using the NuchSens@ Baslc I t  assay and molecular 
beacons for red-tune detectlon of NLV GGI and GGII RNA m stool samples. 
Methods: A 10% stool suspemon of known NLV RT-PCR negahve and 
posihve stool samples &om various GGI and GGII NLV outbreaks was 
prepared in sterile nuclease-free water. The prepared stool suspension was 
centrifuged at 5000 x g for 15 min at room temperature. A 100 @L of the 
cleared stool suspension was added to 900 pl of NucliSens@ Basic Kit lysis 
buffer. Viral RNA was isolated using reagents su lied in the kit. NLV RNA 
amplification primer sets, and molecular beacons. 
Results: The one-step broadly reactive real-time NASBA assay detected NLV 
RNA in both RT-PCR positive and RT-PCR negative samples in 60 min. 
Conclusions: The results of our study indicate that the NucliSens@ Basic Kit 
using broadly reactive amplification primes and molecular beacons for real- 
time detection of viral RNA provides a more rapid method than ECL to 
detect NLVs in stool. 
was detected using the NASBA based NucliSens t x ? ”  Basic &t, broadly reactive 
10271 Clinical evaluation of a NucliSens Basic Kit 
application for the detection of enterovirus in cerebrospinal 
fluid (CSF) by nucleic acid sequence-based amplification 
(NASBA) 
C. Ginocchio, E Zhang and A. Mahotra 
Lake Success, New Jeney, USA 
Background Enteroviruses are a common cause of pediatric infections. The 
accurate, rapid merentiation of enteroviral illness f?om other bacterial and 
viral infections is important for therapeutic and prognostic reasons. Our 
laboratory previously determined the technical performance of a modified 
NucliSens Basic Kit NASBA assay (Fox et al.) for the detection ofenterovirus. 
This study evaluated the clinical performance of the assay using CSF samples 
collected during the 2001 enteroviral season. 
Methods: Nucleic acid isolation, amplification and detection were performed 
using the NucliSens Basic Kit reagents (Organon Teknika/bioMerieux, 
Boxtel, NL.). Nucleic acids kom CSF and an enterovirus-specific internal 
control (IC) were coextracted and coamplified with a single enterovirus 5’- 
NTR specific primer pair. Electrocheduminesence (ECL) detection ofboth 
enterovirus RNA and IC RNA were performed using target specific capture 
probes and ruthenium (Ru2f) labeled detection probes. Samples were 
reported as negative (ECL signal <350 units). indeterminant (ECL signal 
350-649 units) and positive (ECL signal >650 units). Negative results were 
reported as indeterminant due to amplification inhibition if the 1C ECL 
values were <50000 units. All the results were correlated with clinical 
presentation, CSF cell counts, bacterial, fungal and viral cultures, performed 
when indicated. 
Results: In total, 144 CSFs were tested by the NASBA assayofwhch 74 (51%) 
were positive (mean ECL signal of 630 000 units, range 1640-10 000 OOO 
units) and 68 (49%) were negative (mean ECL signal of 12 units, range 1 1 2 3  
units). CSF viral culture was performed on 95 of the samples submitted. 
Enterovirus RNAwas detected in 14 samples that were viral culture negahve. 
There were no CSFs culture positive and NASBA negative. For two samples, 
NASBA positive and culture negative, repeat analysis of additional CSF and 
stool were found to be NASBA positive also. The NASBA reaction was 
inhibited in two visibly bloody samples (1.4%). 
Conclusions: The NucliSens enterovirus assay demonstrated superior 
sensitivity over viral culture, excellent specificity. a clear delineation of 
positive samples and minimal amplification inhibition. Daily testing and 
the rapid turn-around-time for results greatly impacted patient care by 
reducing hospitahzation and the inappropriate use of antibiotics for viral 
infections. 
ml Use of internally controlled real-time NASBA 
for the detection of HBV DNA 
H. Niesters, S .  Pas, J. Voermans, R de Man and A. Osterhaus 
Rotterdam, NL 
Objectives: The detechon of HBV DNA has been mportant for the 
defimuon of climcally important thresholds, as well as to momtor the effect 
of anhvtd treatment and the detechon of resistant related variants. Nucleic 
acid amphficahon assays wth  real hme detechon enable the detecuon of HBV 
DNA in clinical samples over a very broad dynarmc range. The use of an 
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internally controlled real time assay based on NASBA amplification in 
combmation with detection using molecular beacons was evaluated for 
clinical performance. 
Methods: The performance of the NucliSensEasyQ HBV assay (Organon 
Tekmka/bioM&eux) assay was established using well-characterized reference 
samples ranging between 1 and 8.7log. WHO IU/mL. Furthermore, refer- 
ence panels &om quahty control studies were evaluated as well as samples 
containing different genotypes of HBV The clinical use of the assay was 
established using samples from patients under antiviral treatment. Compar- 
isons with commercially available assays (Roche Amplicor Monitor, and 
Digene Hybrid Capture 11) were performed to determine concordance on the 
standardization of results. 
Results: The real-time based assay, in combination with the NuchSens 
Extractor (Organon/bioMCrieux), could accurately measure HBV DNA 
between 2 and 8.71og WHO I U / d ,  depending on the amount of input 
material. Standard deviation was less than 0.25 log below 1000 WHO, andless 
than 0.15 log above 1000 WHO lU/mL. Both serum as well as plasma could 
be measured accurately within a 0.251og variation. The real time assay 
accurately compared with both the Digene Hybrid Capture I1 as well as 
the Roche monitor assay, and depending on the amount of internal standard 
or calibrator added, could be used for both high as well as low HBV DNA 
containing samples. This enables the monitoring of patients under antiviral 
treatment with a smgle assay. 
Conclusion: The real-time based assay enabled the amphfkation of HBV DNA 
within 60 min, which combined with automated extraction could detect and 
quannfy 48 samples in a single working day. The assay showed to be clinically 
useful in monitoringpatients under antiviral treatment. Furthermore, the uses of 
well-knownstandards enable the comparison with data generated with Merent 
assays. 
10291 Novel isothermal nucleic acid amplification 
technologies for the detection and discrimination of 
infectious diseases and genetic mutations 
J. Thomas, €? Marsh, E. Wright, G. Mock, C. Pereira, S. Ho. 
A. Bowden, A. Bennett and D. Cardy 
Banbury, UK 
Objectives: The development and evaluation of a novel isothermal nucleic 
acid amplification technology as a simple and robust molecular diagnostic 
assay suitable for rapid, accurate detection and discrimination of human 
infections and genetic mutations. 
Methods: The amplification system utilize DNA polymerase and/or RNA 
polymerase for the isothermal generation of a target-dependent signal. A 
unique target-dependent structure is formed by the hybridization of DNA 
probes that are partially complementary to each other and the target sequence, 
which can be DNA or RNA. The RNA polymerase promoter encoded 
within this structure is only functional in the presence of target, following 
which transcription ofa unique, short nontarget RNA sequence occurs. The 
transcribed RNA signal and end detection sequences are universal for all 
targets. A number of detection methods applicable to both manual and 
automated versions of the assay have been validated. These include end-point 
detection using an enzyme linked oligo-sorbent assay (ELOSA) detecting 
color or luminescence (m, HRP), fluorescence using molecular beacons for 
real-time quantitation and TRF and DeFRET. The systems have the advan- 
tage that they are isothermal and do not involve copying long tracts oftarget 
sequence to which specific probes are required. Moreover, they are quick and 
performed on standard low-tech laboratory equipment requiring no mole- 
cular expertise. 
Results: The assays can detect and discriminate between wild type and variant 
targets in several human, bacterial and viral pathogens. Complex genetic 
material has been successfdly used from pure nucleic acid extracts (E.  coli, 23s 
rRNA RSV, RNA) and simple crude cell lysates (C. trachomatis rRNA, 23s 
rRNA; MRSA gDNA, mecA/coa). Our results suggest numerous applica- 
tions, including the diagnosis of bacterial and viral pathogenic infections, 
antibiotic resistance genes, and food- and water-borne diseases. One version 
ofthe assay has additional benefits. Firstly, it can detect and discriminate single 
nucleotide polymorphism (SNPs), or three base deletion mutations such as in 
cystic fibrosis (delta 608). Secondly, the ability to detect RNA without the 
requirement for reverse transcriptase allows feasible gene expression analysis. 
Conclusions: When fully developed these novel isothermal assays will 
be sensitive, rapid, simple to perform, amenable to automation for 
HTS, and a realistic alternative to culture and PCR with numerous applica- 
tions. 
less than one hour real-time PCR detection 
of toxigenic enteric pathogens directly from faeces using 
the Smart Cycler@ 
S .  D. BBanger, M. Boissinot, F. J. Picard, C. Mknard and M. G. Bergeron 
Que'bec, CAN 
Objectives: Shiga toxin-producing Escherichiucoli (STEC) and cytotoxin-pro- 
ducing Cloxtridium d@le are important toxigenic fecal pathogens of clinical 
significance. The methods currently used in the chical microbiology 
laboratories for the detection of these two classes of pathogens require at 
least 48 h. We have developed two rapid real-time fluorescence-based PCR 
assays for the detection of the toxin genes responsible for the virulent 
manifestations of these two pathogens. 
Methods: We designed two pain of PCR primers targeting the shiga tox- 
in genes stxl  and stx2. Two molecular beacons bearing different 
fluorophores were used as internal probes specific for each amplicon. For 
the C. d@le assay, we also designed two pairs of PCR primes and two 
molecular beacons eugeting the cytotoxin genes tcdA and tcdB. Internal 
control DNA was incorporated into both assays to monitor potential PCR 
ihbition. 
Results: Using purified genomic DNA, we showed that the analytical sen- 
sitivity of both assays was around 10 genome copies for each target. The 
specificity was demonstrated by the absence of amplification with 1 ng of 
DNA (-lo5 genome copies) from 20 strains not producing shiga toxin for the 
STEC assay and fiom 15 non-C. d&le bacteria for the C. dijki le  assay. These 
assays, respectively, detected efficiently all STEC and C. d f i i l e  strains tested. 
Liquid or unformed feces samples obtained &om patients were processed by a 
rapid (IOmin) DNA extraction protocol and submitted to nucleic acid 
amphfication on the Smart Cycler@. The shiga toxin gene PCR assay was 
validated by testing 38 feces samples obtained from 27 patients. Twenty-six of 
these samples were positive with both the PCR assay and the culture-based 
assay. Of the 12 culture negative samples, there was one PCR positive sample 
which could be explained by the presence of shiga toxin-producing bacteria 
other than E .  coli 0157:H7. The C. d@le assay was performed on 58 
samples. Both tcdA and fcdB were efficiently ampwied h m  28 of 29 
C. d@cile cytotoxin-positive feces samples. There was no amplification 
observed with all 27 cytotoxin-negative feces samples. 
Conclusions: We have developed the first less than one hour real-time PCR 
assays for the sensitive and specific detection of toxigenic C. d@cile and shiga 
toxin-producing bacteria directly from stools. 
Rapid detection of methicillin-resistant 
Staphylococcus a u w s  (MRSA) by a novel 
isothermal amplification assay (CytAMP) 
K. Levi, C. Bailey, I? Marsh, D. Cardy and K. Towner 
Nottingham, Banbury, UK 
Objectives: Specific and rapid identification of methicillin-resistant Staphy- 
lococnrs aureus (MRSA) in patient specimens is essential for the effective control 
of MRSA nosocomial infection. This study evaluated the specificity and 
sensitivity of a novel isothermal amplification assay (CytAMP) for detection of 
MRSA in comparison with conventional culture and PCR-based identifica- 
tion methods. 
Methods: The CytAMP assay is based on the formation of a three-way 
junction (3WJ) structure between the target DNA sequence and two target- 
speafic ohgonucleotide probes. For detection of MRSA. two sets of probes 
were designed to simultaneously detect the methicillin resiitance (mecA) and 
coagulase (coa) genes found in MRSA isolates. Following formation of the 
3WJ, an isothermal RNA amplification reaction occurs in a single tubel 
microtiter well and is detected by an enzyme-linked oligosorbent assay 
(ELOSA). The assay takes approximately 4 h to complete fiom initial cell 
lysis to detection. 
Results: In a survey of436 clinical isolates, comprising 359 staphylococci and 
77 otherorganism, CytAMP recognized 116 (98.3%) of118 MRSAisolates 
identified by the 'gold standard' of PCR, compared with 98 (83%) identified 
by conventional culture. In addition, CytAMP identifed as MRSA five 
S.aurerrs isolates which were PCR-negative for m e d ,  but whch were 
recognized as MRSA by latex agglutination tests for the PBP2' product of 
me&. CytAMP incorrectly identified three (0.7%) of the 436 isolates as 
MRSA in comparison with 13 (3%) misidentified by conventional culture. In 
addtion to culture confirmation, the CytAMP assay has also been used 
successfidy to iden* MRSA from patient screening swabs which have been 
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incubated overnight in Brain Heart Infusion broth >2 pg/mL oxacillin. In 
this application, results from patient MRSA screening swabs arriving in the 
laboratory by late afternoon are available to the infection control team by 
lunchtime the next day. 
Conclusion: The CytAMP assay is a user-fkiendly and specific molecular 
method for the direct detection of MRSA in patient specimens and is a 
promising alternative to PCR and culture for the rapid identification of 
patients with MRSA colonization or infection. 
Identification of Leishmania to the species level was obtained by PCR-RFLP 
analysis of a Leishmania-specific nuclear repetitive genomic sequence. Leish- 
mania stocks isolated invitro were characterized by means of starch-gel 
electrophoretic analysis of 15 isoenzymes. 
Results: Tbirty-four patients (14 with AIDS and 20 immunocompetent) were 
diagnosed as having VL; four patients, two ICT adults and two with AIDS) 
had CL. Comparative results are reported in the table. 
10321 The role of PCR in the diagnosis of visceral 
and cutaneous leishmaniasis: a Cyear prospective study 
in Italy 
S. Antinori, M. Galazzi, S. Calattini, A. Cascio, C. Colomba, V. Frasca 
Polara, C. Scalamogna, M. Gramiccia and M. Corbellino 
Pdermo, Milan, Rome, I 
Bone- Skm biopsy or scraping 
marmw PCR 
Category Diagnosis Micros vs Culture PB BMA Ahc Culmre PCR 
16 ICT chldren VL 15/16 11/13 16/16 14/14 1/1 ND ND 
14AIDSaddts VL 12/13 4/6 14/14 13/13 ND ND ND 
4ICTadulh VL 2/2  ND 4/4 2/2 ND ND N D  
2 ICTadulh CL N D  ND 0 / 2  N D  2/2 ND 2/2 
2 AIDS adults 1 CL, 012 012 012 012 2 /2  ND 2/2 
1 PKDL 
Objective: To compare polymerase cham reaction (PCR) employed 
on penpheral blood, bone-marrow aspmte and slun scrapmg w t h  tra&hod 
methods for the dlagnosri of visceral (VL) and cutaneous l e i s h a s i s  
Methods: A &year prospechve study was carried out from September 1996 to 
October 2001 142 pahents hving in Wan (82.4%) and Palermo presentmg 
wth  chmcal signs of either VL or CL were included The PCR assay was 
compared to mcroscopy and inntro cultivaaon for prunary dagnoss ofVL 
and to mcroscopy only for primary and follow-up dmgnosls of CL The DNA 
extracted from peripheral blood (PB) and bone-marrow aspuate PIMA) was 
assayed by means of Leishmama-spec& PCR. Prnners R223 and R333 
whch amphfy a 359-bp fkgment of the 18s rRNA gene were employed. 
(CL) 
Post-therapeutic follow-up was performed by PCR on peripheral blood for 
patients with VL (1 19 samples for ICT patients and 187 for AIDS patients) and 
allowed detection of all cases ofrelapse (1 ICT children and 13 AIDS patients). 
By means of PCR-REP analysis we identified L. infanhtm as the responsible 
species in all but 2 subjects which were infected with L. donovani. Molecular 
identification was confirmed by isoenzyme analysis in all cases. 
Conclusions: PCR is at least as sensitive as traditional methods in the primary 
diagnosis of VL and CL. Post-therapeutic monitoring by PCR in peripheral 
blood is a reliable method to detect clinical disease relapse and allows precise 
and noninvasive follow-up of patients. 
Nosocomial infections 
] 033 I Risk factors for nosocomial infections: results from 
the Lombardy prevalence study 
A. Lizioli, L. Panceri, A. Porretta, F. Vegni and G. Privitera 
Milan, Lecco, Pisa, i; London, UK 
Objective: To describe site-specific risk factors for nosocomial infections (NI) 
using data from a prevalence survey of NI in Lombardy. 
Methods: A descriptive study by one-day point prevalence survey. The survey 
involved 88 out of the 113 public hospitals of Lombardy, voluntarily 
participating. AU adult patients (>15yean) admitted in the 24 h preceding 
the survey in any department, excluding psychiatric ones, were investigated. 
The survey was conducted by local teams trained by Prevention Unit of 
Regione Lombardia. NI infections were defined according to CDC criteria. 
Data analysis was performed on separate models for the four main types of NI: 
primary bloodstream infection (PBI), pneumonia, urinary tract infection 
(UTI) and surgical wound infection (SWI). 
Results: In multivariate analysis, vascular catheter (OR. 6.3), immunocom- 
promission (OR. 3.5), alterations of consciousness (2.6), parented feeding 
(2.6) emerged as independent clinical predictors of n o s o c o d  PBI. Risk 
facton significantly associated with nosocomial pneumonia were: age (OR 
t . O t ) ,  male sex (OR. t.6), previous admission (OR. 1.6), chronic respiratory 
disease (OR: 2.3), immunocompromission (OR 1.8), alterations of con- 
sciousness (OR 4.2). mechanical ventilation (OR 5.1). parenteral feeding 
(OR 3.4), surgical procedure (OR 1.5). For nosocornid UTI, age (OR 
l.Ol), previous admission (OR 2.8), diabetes (OR. 2.8), chronic renal fdure 
(OR 2.8), trauma, alterations of consciousness (OR: 2.8), urinary catheter 
(OR 2.8) were found to be sigdcant risk factors in both univariate and 
multivariate analysis. Only two factors significantly increased, in the multi- 
variate analysis, the risk for SWI: parenteral feeding (OR 3.2) and CDC 
classification of surgical procedures. Time-span fiom the occurrence of 
infection to surveillance day was not longer in infected patients than in 
norinfected (P< 0.005). 
Conclusions: This study provides useful data to identify concttions or patients 
groups at increased risk of acquiring nosocomial infections, which might be 
target for NI control measures. Logistic regression allowed to determine that 
most of the factors influencing the occurrence of NI were those modifable 
factors associated with treatment received by the patients during the stay in 
hospital. Many NI are avoidable ifsuitable precautions are taken when treating 
patients who must undergo instrumental diagnosis or treatment. 
10341 Risk factors for nosocomial Stenoftophornonas 
maltophilia acquisition: does carbapenem treatment make a 
difference? 
L. Mooney, G. Smith, P. Turner and K. Kerx 
Leeds, Alderley Edge, UK 
Objectives: To conduct a prospective study of risk factors for acquisition ofthe 
emerging nosocomial pathogen Stenotrophomonar maltophilia (Sm): in parti- 
cular, to investigate the relative importance of antecedent therapy with 
carbapenems, to which Sm is inherently resistant. 
Methods: Patients admitted to an adult hematology unit over a one year 
period were enrolled into this prospective controlled study. Specimens were 
obtained on admission and twice weekly thereafter until discharge. These 
included feces, sputum, urine, blood, and swabs h m  vascular catheters. 
Specimens were plated onto a selective/differential agar and putative isolates 
identified using the API 20NE system. Conconlitantly, epidemiological data, 
including parameters previously suggested as risk factors for acquisition of Sm 
were collected. These included; indwelling vascdar catheters, previous 
hospitalization and antibiotic therapy, Neutrogena, duration ofhospitalization 
and of antimicrobial therapy, in particular carbapenems. Data from Sm- 
positive patients were compared with Sm-negative controls using wivariate 
analysis. Those variables found to be sigdcant (P< 0.05) were analyzed 
using fornard stepwise logistic regression analysis. Environmental samples 
were taken tiom handwash basins, cleaning items, baths, lavatories, etc., 
throughout the study. Isolates were typed using ERIC-PCR and CHEF- 
PFGE and profiles analyzed using Bionumerics software. 
Results: S m  was isolated from 7/71 patienn. 280/693 environmental sites 
yielded Sm. Univariate analysis indicated 10 variables associated with Sm 
acquisition. Significantly more Sm-positive patients (57%) had mucositis 
compared with controls (19%). In addition, 86% of Sm-positive patients 
6 Absfracfs 
received vancomycin and aztreonam therapy compared with controls (45 and 
44%, respectively). Logistic regression analysis indicated that the flucloxacillin 
therapy was sigdcantly associated with Sm acquisition. 4/7 Sm-positive 
patients and 20/64 Sm-negative patients received meropenem during the 
hospital admission in which Sm was cultured this was not statistically 
significant. 
Conclusions: There have been codicting repom &om retrospective studies as 
to whether carbapenem therapy is a risk factor for Sm acquisition. Although 
the number of patients examined was small, our prospective study indicates no 
statistically significant association between antecedent or contemporaneous 
carbapenem therapy and Sm acquisition. 
10351 Trends in mimaganisms isolated in bloodstream 
infections after the implementation of an infection control 
program 
L. Cabral, E Antunes, 0. Neto, E Serralheiro, E Ferreira and A. Vaz 
Lisbon, P 
Introduction: The continuous surveillance of bloodstream infections is 
important to detect the etiologic agents in an Institution, in order to establish 
protocols for empiric therapy and to improve infection control strategy. 
Objective: Trend evaluation of clinically significant isolates from blood 
cultures over a 3-year, 6-month period. 
Setting: SAMS Hospital, a Private Community Acute-Care Hospital with 
121 beds in Lisbon. 
Methods: Retrospective analysis of 3507 blood cultures performed in Bactec 
9050 (Becton Dickinson, USA) during the study period (1 November 1997 
through 30 April 2001). 
Results: Of the 3507 blood cultures performed, 395 (11.2%) were positive 
corresponding to 185 bloodstream infections (10.9% ofthe 1691 hypotheses 
of bloodstream infection) and 186 micro-organisms were detected. The 
leading pathogens were coagulase-negative staphylococci, Staphylococcus QUY- 
eus, enteric Gram-negative rods, in particular Escherichia coli, Enterocoms 
faeralis and Pseudomonus aemginosa. Since 1997, a MRSA endemic problem 
had been observed in S A M S  Hospital. An intensive infection control program 
was initiated in the end of 1998 to prevent and control these nosocomial 
infections. We observed that the Gram-positive bacteria decreased in relative 
frequency (77% in 1997 to 50% in 2000), the Gram-negative increased 
significantly (23% in 1997 to 50% in 2001) and yeasts did not have significant 
alteration in their trend. MRSA nosocomial bloodstream infections decreased 
substantially with no single case registered until November 2001. Eschm'chia 
coli isolates increased in 2000. 
Conclusions: The control measures adopted in order to control the MRSA 
endemic problem, were the major factor for the decrease in Gram-positive. 
The increase in Gram-negative, specially Escherichia coli isolates (genitourinary 
tract source), was probably due to guideline implementation for blood culture 
collection in upper urinary tract infections, at hospital entrance. 
ml Clinical relevance of the three major K/ebsie/fa 
pneumoniae phylogenetic subgroups: unequal distribution 
in clinical sources and different levels of antimicrobial 
resistance of blood isolates 
S. Brisse, K. Kusters and J. Verhoef 
Utrecht, NL 
Objectives: Based on the nucleotide sequences of genes gyrA and pa&, three 
Hebsiellapneumoniae and two K .  oxytoca phylogenetic subgroups were pre- 
viously identified (Brisse and Verhoef, 2001, Int. J. Syst. Evol. Micmbiol. 51: 
915-921). These subgroups are separated by considerable evolutionary dis- 
tance (e.g. higher than the distance among Escherichia coli subgroups A, B1, B2 
and D) and each contains extensive serain diversity. The aim of the present 
study was to determine the distribution of the K. pneumoniue subgroups (KpI, 
KpII and KpIII) in clinical samples. 
Methods: C h c a l  isolates of K. pneumoniae were collected h m  hospitals of 
13 European countries during the years 1997-2001. Only one isolate per 
patient was included. 141 blood isolates, 35 urinary tract infection (UTI) 
isolates, 45 respiratory tract infection (RTI) isolates and 19 wound isolates 
were included. Identifcation at the Klebsiella genus level was performed using 
the VITEK apparatus (BioMerieux) and conventional biochemical tests. 
Species idenhficaaon and phylogenetlc subgroup assignment of the 
isolates was acheved by charactenzahon of the g d  gene. MICs of 16 
anmcroblals were determed by the nucrodduaon method (NCCLS 
guidehnes) 
Results: Out of 201 randomly selected stmns, 180 (90%) belonged to 
subgroup KpI, 12 (6%) to KpII, and 9 (4%) to KpIII. Based on a negahve 
adomtol fermentaaon test, 39 adhhonal KpII (5 s t r a m )  and KpIII (34 stclins) 
were added to the stucty. The percentages ofsubgroups KpI, Q I I  and KpIII m 
the total sample of 240 isolates were, respechvely, 69, 8.5 and 23% 111 blood 
isolates, 94,6 and 0% 111 UTI isolates, 78,4 and 18% in RTI isolates, and 79.5 
and 16% 111 wound isolates The absence of KpIII subgroup m UTI was 
strdung Each subgroup was geographcally widely dmributed across Europe 
Anamcrobial remtance of the three subgroups was compared for 98 blood 
isolates The kequency of resistant isolates was generally decreasing (for most 
agents) &om subgroup KpI to KpIII For example, 34% of 61 smns  of 
subgroup KpI, 23% of 14 KpII stram, and only 6% of 23 stram of KpIII were 
resistant to ceftazidime, the hallmark of ESBL producuon. 
Conclusion: These results mhcate important chca l ,  epideuuologcal and/or 
ecologcal hfferences between the three major phylogeneac subgroups of thls 
genehcdy heterogeneous species known as K pneumonine 
10371 Surveillance of antibiotic-resistance of 
staphylococci in a large teaching hospital in Rome 
M. C. Ghezzi, C. Mancini, G. L a d e a n d  G. Raponi 
Rome, I 
Objective: To control the resistance of strains of staphylococci consecutively 
isolated from c h c a l  specimens at the University Hospital "Policlinico 
Umberto I" of Rome from Janu;uy 2000 until June 2001. 
Methods: Strains were considered only if representative of a single infective 
episode occurring in various body sites: respiratory tract, urinary tract, blood 
and central venous catheters, cutaneous wounds, vaginal tract, pus and others. 
Idendfcation and susceptibility tats were performed by automated method 
(Vitek2, Bio-Merieux). Oxaclllin and vancomycin sensitivity was screened by 
commercially available agar and resistance confirmed by broth dilution 
method according to NCCLS guidelines. All the results were repeatedly 
validated using S. aureus 29213ATCC as quality control strain. 
Results: A total of 826 strains were considered. S.aums was the most 
frequently isolated strain (42.98%), whereas S. epidermidis (31.84%). and 
S. haemolyticus (10.77%) were the most representative among CoNS. Oxacillin 
resistance ranged from 55% of S. ~ureus to 7 1 and 72% of S.  epidermidis and 
S. haemolyticus, respectively. Most of the staphylococci showed resistance to 
penicillin ( h m  84% of S. haemolyticus to 100% of S. wartlm). No resistance or 
intermediate resistance to vancomycin was observed. Some strains of S. hae- 
molyticus (6.7%) showed reduced sensitivity to teicoplanin (MIC90 = 16 mg/L) 
and up to 19% were completely resistant to the drug (MIC90 > 16 mg/L). All 
the teicoplanin-resistant S. haemolyticus were isolated h m  blood stream 
infections mostly occurring in the I.C.U. Further to vancomycin, netilrmcin 
was the most &ctive drug since resistance was limited to 25% of S. a u r m  and 
19% of S. epidermidis. 
Conclusions: Data of the present study evidenced high frequency of isolation 
of oxadin-resistant staphylococci. Furthermore, the appearance of relatively 
high kequency of isolation of teicoplanin-resistant S. haemolytints was 
observed. As compared to our previous investigation performed during 
1997-1998, the results of &s study showed decreased oxacillin-resistance 
of S. aureus during the observation period and, simultaneously, increased 
oxacillin-resistance of CoNS. Finally, our results showed that all the isolates 
were sensitive to vancomycin. 
1 038 I Determining the significance of coagulase-negative 
staphylococci isolated from paired blood cultures of 
neonates by species identification and strain clonalii 
Y C. Huang, T. Y. Lin, L. H. Su, Y H. Chou and R. I. Lien 
Kweijhan, Taoyuan, TW 
Object: Coagulase-negative staphylococci (CONS) are the most common 
pathogens isolated from neonates with nosocomial infections. However, 
discriminating true infection &om contamination is usually a challenge 
to the physician. One criterion is the isolation from sequential blood cul- 
tures or from separate sites, which is based on the assumption that the 
isolates are the same. Using reference methods to obtain species identifica- 
tion and molecular methods to perform strain genotype, we sought to 
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understand better and possibly to improve the interpretation of CONS blood 
isolates. 
Methods: During July 1999 and November 2000, infants hospitalized in 
NICUs at Chang Gung Children’s Hospital with clmically suspected noso- 
comial sepsis were included in this study and two blood culture sets were 
obtained simultaneously from different peripheral sites. Both blood culture 
sets positive for CONS were hrther analyzed for species identification with 
ID 32-Staph gallery and saain clonality with two genotyping methods 
(tnfrequent restriction site polymerase ch in  reaction and pulse held gel 
electrophoresis). 
Results Two blood culture sets were obtained in 142 episodes. No bacterial 
organism was isolated fiom either sample in 73 episodes (51%). One bacteria 
was isolated firom one of the two blood cultures in 14 episodes (10%) and 
CONS encountered in seven episodes. Two Herent bacterial organism 
isolated &om either sample were noted in three episodes (2.1%) and CONS 
were involved in each episode. Bacterial organisms isolated &om both blood 
cultures were same in 52 episodes (37%), among which CONS were isolated 
in 26 episodes. Only 13 pairs of CONS strains were available for assessment. A 
consistent CONS species was noted in all 13 pairs. (S. epidennidis 9; S. hominis 
3; S. i n t m d i u s  1) Both genotyping results were concordant and a consistent 
genotype was also noted in all 13 pairs. However, eight genotypes h m  nine 
S. epidemidis strains and two genotypes from three S. hominis strains were 
idensled, respectively. 
Conclusion: CONS were not only the most common pathogens of 
nosocomial bacteremia in NICU but also the most common blood cul- 
ture contaminants. CONS isolated from two blood cultures obtained simul- 
taneously from separate sites in infants at NICU usually represent true 
infection. 
I 039 I Impact and changes in Enterococcal bloodstream 
infections in a teaching hospital: a 5-year study 
C. Tampe, E. Arroyo, G. Gonzalez, S. Saavedra and C. Ramirez-Ronda 
SanJuan, USA 
Objective: To assess the impact of enterococcal bloodstream infections (BSI) 
in a teaching hospital, and identifj trends in patient morbibity and antibiotic 
susceptibility over time. 
Methods: All patients with enterococcal BSI with bacteriology collected &om 
1996 to 2000 were studied and compared for morbidity and microbial 
susceptibllity. 
Results: A total of 115 cases were studied. The number of cases per year was 
stable over time. Most cases were EnterococMs faecalis (79), the rest were 
E.fnen’um (31) and E. auium (5). Most infections were nosocomial (65.2%), 
those with E. faeciurn significantly more so than with the other two species 
(90.3% vs. 56%, P< 0.0006). The fiaction of cases by vancomycin-resistant 
enterococci (VFS) dropped (32-20.8%), but not sigdcantly. Patients with 
E.Jbeciurn BSI (vs. E.faecalis) were sigmficantly more likely to have a VRE 
(71% vs. 11.4%. P<0.001, OR 19). had longer hospitalizations (51.8 vs. 
25.4days, P< 0.001), used the ICU more often (58.1% vs. 34.2% P=0.04), 
and had a higher mortality (71% vs. 20%, P=0.004). Patients with VRE 
BSI (vs. non-VRE) had significantly longer hospitalizations (48.1 vs. 
27.7days, P=0.004), and a higher moaahty (65.5% vs. 38.6%. P=0.02). 
Length of stay in these patients dropped (56-35 days) and moaahty increased 
(62.5 to 80%) over time, but not sigmficantly. E. faecium’s resistance to 
vancomycin, penicillin. gentamicin, and ciprofloxacin increased, but not 
significantly. E. faecdis showed a agmficant drop in gentamicin resistance 
(61.1% to 6.3%. P=0.0002) and a trend to decreased vancomycin and 
increased penicillin resistance. 
Conclusion: The rate of VRE and non-VRE BSI at this teaching institu- 
tion has remained stable in the last 5years. E.fecium BSI were over- 
whelnungly nosocomial, VRE, and trending to increased antibiotic 
resistance. E.faecium and VIUE BSI were associated with a wone prognosis, 
unchanged over time. E.fdwllis was found to be increasingly gentamicin 
sensitive. It is unclear, whether newer antibiotics can change the impact of 
enterococcal BSI. 
(o401 Gastroenteritis outbreak in a university hospital 
due to Nomalk-like virus 
A. Widmer, P. Graber, M. Dangel, E Dudly, D. Goldenberger and 
R. Frei 
Basel, Zurich, CH 
Nomak-like viruses (NLVs) are the most common cause of outbreaks of 
nonbacterial gastroenteritis worldwide. These outbreaks are fi-equently diag- 
nosed in semi-closed communities such as educational institutions and 
hospitals. Infection caused by NLVs is commonly manifested by a short 
and self-limiting diarrhea. However, severe disease may occur. We report an 
outbreak ofacute gastroenteritis in a tertiary care center between 28 February 
and 20 March 2001. 
Objectives: To describe the epidemiological features and infection control 
measures of the outbreak. 
Methods: case definition: Rapid onset of vomiting, diarrhea without fever, 
and spontaneous rapid recovery within 48 h. NLVs were detected by use of 
reverse tranxriptase PCR targeting a 334-bp-long conserved hgment of the 
RNA polymerase gene. 
Resultr: Sixty-two patients met the case definition. 27 (42%) were patients, 
36 (58%) healthcare workers. Microbiologd diagnosis was made within 
3 days after the onset of the first case. Twelve (38%) out of 32 fecal speci- 
mens examined were positive for NLV. Nine of these 12 specimens had 
a 100% identical nucleotide sequence of about 300bp. Phylogenetic analysis 
of this genotype indicated clustering within genogroup I1 near Bristol 
Virus (92% nucleotide similarity). The outbreak started in the Department 
of Dermatology and rapidly spread through the Department of Internal 
Medicine. Only dedicated healthcare workers were allowed to take care 
of case patients. Routine disinfection of the innate environment including 
floors was enforced. None of the applied techniques stopped the outbreak, 
but spreadmg to the Bone Marrow Transpknt Unit was prevented. The 
most likely source was an infected patient who introduced SLV into 
the hospital. 
Conclusions: Rapid identification can limit spread of SLV, but the impact of 
applying published guidelines appears limited. To our knowledge, this is 
the first reported, microbiologically documented outbreak of acute gastro- 
enteritis in a large hospital associated with NLVs in Switzerland. 
Antibiotic resistance of anaerobic bacteria (Organized by the European Working Party on Antimicrobial Resistance 
in Anaerobic Bacteria (EWPARAB)) 
(5761 Epidemiology of resistance in Sacternides ftagilis 
and related species 
E Nagy 
Szeged, HUN 
ffacterordesfiagrlis and related species of the genus Bucferotdes are the most 
prevalent pathogens involved m human ctseases. Bacterotdes are the predo- 
mnant orgamsms in the fecal flora as well, m h g  up nearly 30% of the 
mdgenous mcrobial popdahon of the mteshnd tract. It is considered an 
extremely stable commumty, however, many transient orgarusms passmg 
through for short penods may gve  the opportumaes for fiequent genetx 
exchange. Ths  has an lmportant lmphcahon in the &sseminahon of anhbiohc 
resistance genes. The phylogenetic position of M m i d e s  together with the 
frequent opportunities for direct contact with diverse species is likely related 
to the wide variety of genetic elements (plasmids, hzmsposons, IS elements) 
found in Borteroides spp. and may explain the spread of resistance genes among 
them. 
Besides chomosomally mediated 8-lactamase production tetracyclin resis- 
tance is the most prevalent among Baaeroides strains worldwide. Conjugative 
transposons carry the tetQ gene which can be found with broad host range 
within Bacferoidec and species of related genus. Clindamycin resistance in the 
Bacteroides is mediated by a macrolide-lincornyciaepto-gTarmn (MLS) 
mechanism. The gene can be found in transpowns on plasmids or on 
chmmosal conjugative elements. The frequency of the spread of chdamycin 
resistance differs in Werent countries in Europe and worldwide. The 
occurrence and spread of resistance to imipenem and metronidazole among 
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Bmteroides strains merit special clinical importance. It has been shown by us 
and by other investigators that the presence of the $A gene is much more 
prevalent than the expression of the imipenem resistance. The spread of the 
CfiA gene among species other than B.fragilis is still very rare. A series of CfiA 
positive B.jagdis strains (some of them with hgh MICs for imipenem) were 
investigated in our laboratory for the presence of IS elements. Known and 
new IS elements can be involved as active promoters of the gene. Our recent 
results looking for the genetic background of metronidazole resistance among 
Bacteroides strains obtained from ditferent parts ofthe world, indicate that well- 
described carriers, like plP417, account for the majority of nimA-D genes, 
but nimA, C, D, E genes could also be chromosomally coded. 
The epidemiology of antibiotic resistance of Bacreroides strains: this ubiquitous, 
host-associated organism shows the need of parallel presence of three critical 
components required for the spread of annbiotic resistance: the presence of 
the antibiotic resistance gene, the ability to express the gene and the 
mechanism for widespread dissemination. 
Carbapenem resistance in Bacteroides fragik much 
mechanism, little resistance 
I. Podglajen, D. Vingadassalom, T. R y b h e ,  J. Breuil and E. Collatz 
Paris, F 
The species Bartemidesfragilis is divided into two DNA homology groups, I 
and II, which comprise, respectively, >95 and <5% of the B.&& strains 
Fluoroquinolones 
isolated in medical practice. Group I strains typically contain the chromo- 
some-borne cepA gene encoding a class A/group 2e 8-lactamase (which does 
not confer carbapenem resistance), while the group I1 strains contain the @ 
gene encoding a carbapenemase of class B/group 3. Overall carbapenem 
resistance rates in B.3agilis vary, accordng to most studies, between <1 and 
2% and only exceptionally exceed 5%. There are currently no data indicative 
of a trend toward increase. 
Expression of carbapenem resistance (MIC of imipenem = or >16 mg/L) 
requires activation of the otherwise silent &l gene. This activation is brought 
about by mobile promoters carried by insertion sequence (IS) elements which 
target a ca. 100 bp stretch immediately upstream of the @ gene. Five such IS 
elements (and isoforms thereof) are currently known, IS942, IS1 186, IS1 187, 
IS1 188 and IS4351. They occur preferentially, but not exclusively, in the @- 
positive group. The transcriptional start sites of rfiA on the IS elements have 
been mapped. All were found downstream from a promoter region typical of 
B.fragilis as previoudy characterized by Bayley ef al. (FEMS h4icrobiol. Lett. 
2000; 193: 149-154) and different from that recognized by the principal sigma 
factor of Gram-negative bacteria. The relative strengths of the individual IS- 
borne promoters vary by a factor of ca. 5 in B.fragiilis and are fairly well 
correlated with the carbapenem resistance levels. Preliminary data indicate 
that they are functional also in Porphyromow distaronis but not in Escherichia coli 
or Pseudomonas uemginosa. 
1088) Effects of fluoroquinolones on the development of 
fluoroquinolone-resistant Salmonella 
J. M. Ling, E. W. ChanandM. L. KO 
Hong Kong, CHN 
Objectives: (1) To study the in vitro deTelopment of fluoroquinolone- 
resistant (FqR) Salmonella enferica serotype Typhimurium. (2) To detect the 
presence of mutations in the topoisomerase gene of FqR mutants. 
Methods: Thirty clinical isolates and one standard strain (ATCC13311) of S. 
Typhimurium were subjected to daily passage in Mueller-Hinton broth 
containing increasing serial two-fold dilutions starting at 0 . 5 ~  MICs and 
up to 128 mg/L of pefloxacin, nodoxacin, ofloxacin, ciprofloxacin, levo- 
floxacin, gemifloxacin and moxifloxacin. The overnight cultures were tested 
for their susceptibihty to the NCCLS recommended sensitive breakpoint 
concentrations of these fluoroquinolones (Fqs) (except gemifloxacin) by the 
NCCLS agar dilution method. Mutations in the topoisomerase gene gyrA 
were detected by amplifjmg DNA from the tested strains using primers 
specific for the quinolone resistance-determining region of the gene followed 
by single-strand conformational polymorphism analysis and DNA sequen- 
cing. 
Results: The tested strains were sensitive to all the Fqs tested (MIC range: 
0.03-1 mg/L). Ciprofloxacin and levofloxacin were most efficient in selecting 
resistance (resistance developed at the lowest concentration range of 0.5- 
4 mg/L), and pefloxacin the least efficient (4-8 mg/L). However, pefloxacin 
was the first to which isolates became resistant regardless of the Fq used in the 
selection procedure whiie levofloxacin was the last to which isolates became 
resistant when a Fq other than itself was used in the selection procedure. 
Although gedoxacin and moxifloxacin were quite efficient in selectmg 
resistance, eradication ofstrains could be observed at the lowest concentration 
(0.12-0.25 mg/L) in contrast to %16 mg/L for the other Fqs. Two mutations 
ingyrA that were present in clinical isolates were detected in resistant mutants: 
TCC + TTC resulting in Ser83 + Phe and GAC 3 GGC resulting in 
Asp87 + Gly. 
Conclusions: (1) Resistance to pefloxacin developed most rapidly regardless of 
the Fq used for selection. (2) Levofloxacin and ciprofloxacin were most 
effective in selecting for resistance to Fqs. (3) Gemifloxacin and moxiiloxacin 
were most efficient in eradicating strains. (4) Mutations i n g y r A  identical to 
those found in clinical isolates were detected in resistant mutants. (5) The 
selection potentials of Fqs besides their activities are important factors in the 
choice of therapy 
loss] In vitro killing effect of moxifloxacin on 
multidrug-resistant Stenotrophomonas maltophilia 
L. Karnesis, E. J. Giamarellos-Bourbods, M. Tzivras, 
Z .  Chryssouli and H. Giamarellou 
Afhens, GR 
Objective: The limited number of atimicrobial agents active on nosocomial 
Stenotrophomonas maltophilia led to the study of the in vitro time-kill effect of 
the novel methoxyfhoroquinolone moxifloxacin on that species. 
Methods: Twenty isolates &om different patients with nosocomial infections 
resistant to ampicilli/sulbactam, cotrimoxazole and ciprofloxacin and suscep- 
tible to moxiiloxacin (MIC < 1 pg/mL) were applied. They were exposed 
over time to concentrations equal to 1 and 4~ MIC. Moxifloxacin was added 
with a 6 log-phase inoculum of each isoIate in MueUer-Hinton broth and 
bacterial growth was determined at standard time-intervals during incubation 
at 37 "C. Kdmg effect was determined as any equal or more than a 3 log 10 
decrease of viabIe cell countS from the baseline. 
Results. Bactericidal activity of 1 x MIC of moxifloxacin was found in four 
(20%), eight (40%) and five (25%) isolates after 4, 6 and 24 h of growth, 
respectively, and of 4X MIC of moxifloxacin in seven (35%), nine (45%), 14 
(70%) and 12 (60%) isolates after 2,4,6 and 24 h ofgrowth, respectively Mean 
(fSD) decreases of viable cells were 0.85 f 0.24, 1.89 z t  0.38, 2.39 i 0.41 
and 0.73 f 0.47 after 2 ,4 ,6  and 24 h of growth, respectively, in the presence 
of1 x MIC and 1.35 zk 0.49,1.58 f 0.52,2.84 * 0.79 and 1.03 f 0.82 after 2, 
4, 6 and 24 h of growth, respectively, in the presence of 4X MIC. 
Conclusions: Based on its early time-kill effect on S. mattophifia, moxiftoxacin 
might be considered as a promising alternative for the therapeutic manage- 
ment of nosocomial infections by that species. 
lntracellular accumulation and bactericidal activity 
of moxifloxacin and ciprofloxacin in primary respiratory 
epithelial cells 
M. Ulrich, H. Stass, J.-G. Moeller and G. Doering 
Tuebingen, Wupperfal, D 
Due to their chemical structures, fluoroquinolones may penetrate and 
accumulate in human cells, thereby increasing their potential to protect 
man against bacterial pathogens. Therefore, we investigated the intracellular 
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concentration of moxifloxacin and ciprofloxacin in human primary respira- 
tory epithelial cells (vesicles). Additionally. we determined the antimicrobial 
activity of moxifloxacin against Staphylouicrus aureus and S. pneumoniae and 
ciprofloxacin against Haemophilur intuenzae and Pseudomonas aeruginosa. Vesi- 
cles were incubated for 30 min with 5 pg/mL moxifloxacin or ciprofloxacin. 
Then, washed or unwashed vesicles were incubated with 107 cfdmL of the 
various pathogens for 5-18 h. Bacterial viability was determined by plate 
counting and survival of vesicles using light and electron microscopy. Intra- 
ceUular fluoroquinolone concentrations were determined using HPLC. 
Intracellularly, 51.1 pg/mL moxifloxacin and 36.9 pg/mL ciprofloxacin were 
found afier a 30-min incubation in washed cells, corresponding to a -10- and 
7-fold drug accumulation, respectively. In unwashed cell cultures, 100% of ail 
pathogens were Wed by the fluoroquinolones. In washed cells, the intra- 
cellular drug concentrations led to the lulling of 85% S. aureus, 95% S. pneu- 
monine, 100% H .  iny’luenzne, and 91% P awuginosa. Conversely, after bacterial 
challenge, 48-94% of unwashed vesicles and 42-76% of washed vesicles 
preincubated with drugs were rescued, compared to the survival of O-38% of 
vesicles without drugs. The intracellular accumulation offluoroquinolones in 
respiratory epithelial cells and the high activity against sensitive bacterial 
pathogens provide an excellent rational for their use in human respiratory tract 
infections. 
1 091 1 Anti-anaerobic activity of BMS 284756 0-3811) a 
new des-F(6)quinolone antibiotic compared with those of 
moxifloxacin. levofloxacin, ciprofloxacin, metronidazole and 
three 8-lactams 
L. Dubreuil, J. Behra-Miellet and L. Calvet 
O’lle, F 
Objectives: MICs were determined on BMS 284756 (BMS) moxifloxacin 
(MOX), levofloxacin (LEV), ciprofloxacin (CIP), coamoxycIav (AMC), 
piperacillin-tazobactam (PTZ), imipenem (IMI), clindamycin (CLN) and 
metronidazole (MOL) against 330 anaerobes isolated &om human clinical 
samples. 
Methods: Reference agar dilution (standard M11 A5, NCCLS). 
Results: BMS, MOX, LEVand CIP, inhibited at 4 mg/L, respectively, 100,97, 
80 and 47% ofthe Bacteroidexjagilis group strains whereas resistance rates were, 
respectively: AMC 5.4%. PTZ and IMI 0.8%, CLN 30%, MOL 0.8%. 
Considering the three fluoroquinolones,the M I C ~ O , ~ ~  (mg/L) were: 
Microogranisms (N) BMS MOX LEV CIP 
B.f.gilis group (129) 0.25/1 0.5/2 2 /6  6/64 
Other Gram-negative bacilli (74) 0.125/0.5 0.125/2 0.5/4 1/6 
Clostridia (34) 0.125/1 0.25/2 0.5/16 0.5/32 
Non-sporulated Gram+ rods (27) 0.25/1 0.25/1 0.25/2 0 3 4  
Peptostreptococcus spp. (66) 0.125/1 0.25/1 1/4 1 /4 
AU Gram+ (127) 0.125/1 0.25/2 0.5/4 1/16 
All anaerobes (330) 0.12511 0 . 2 ~ 2  i/8 2/32 
BMS 284756 and MOX unlike other fluoroquinolones demonstrated high 
activity against the B.jngilir group and clostridia but BMS 284756 was the 
more potent fluoroquinolone. Only one strain of B.j?ngilis was resistant to 
AMC,PTZ, IMI. Another strain of B.jngilis was resistant to metronidazole 
(MIC=64mg/L). BMS 284756 was also more potent than LEV and CIP 
against gram positive rods and anaerobic cocci. At concentration of 1 mg/L, 
BMS 284756 inhibited all strains of Fusobucterium, Porphyromow, Pro- 
pionibucteriurn and Gram-positive cocci. At concentration of 2mg/L, BMS 
284756 inhibited all Gram-positive anaerobes (127 strains) and 199 out of203 
Gram-negative anaerobes. Overall 330 anaerobes,BMS 284756inhibited95,99 
and 100% of the strains investigated at concentrations of 1, 2, and 4 mg/L, 
respectively. Comparatively, at the same concentrations, moxifloxacin inhibited 
73,93and97,5%ofthewholeanaerobes. Overallc~damycinresistanceratewas 
18.5%. 
Conclusions: The broad anaerobic spectrum ofBMS 284756 demonstrated in 
vitro is very promsing to treat anaerobic or mured infections; further chnical 
evaluation is needed. 
In vitro assessment of alternatives to penicillin in 
the treatment of invasive pneumococcal disease 
P. Clarke, H. Humphreys and E. Smyth 
Dublin, IRL 
Objective: The prevalence of penicillin-resistant pneumococci from blood 
and cerebrospinal fluid in Ireland is high as previously demonstrated by data 
€-om the European Antimicrobial Resistance Surveillance System (EARS). 
We assessed the invitro activity of two recently launched antibiotics that might 
be useful in alternatives treatment. 
Methods: Minimum inhibitory concentrations (MIC) to benzylpenicdlin, 
cefotaxime, moxifloxacin and linezolid using E-test strips were carried out on 
all pneumococcal isolates isolated fiom Irish laboratories as part ofthe EARSS 
study, i.e. blood and cerebrospinal fluid. The participating laboratories in 
E A R S  in Ireland cover about 80-90% of the population. 
Results: A total of317 isolates were received during 1999 and 2000 ofwhich 
16% were fully resistant (MIC * 2mg/mL) or less susceptible to penicillin 
(MIC * 0.1 mg/mL). The MIC,, for cefotaxime, moxifloxacin and linezolid 
were 0.08, 0.064 and 0.25 mg/mL., respectively. For the 51 isolates that were 
moderately susceptible or f d y  resistant to penicillin, the MICw to the three 
agents were 0.4, 0.05 and 0.30 mg/mL, respectively. 
Conclusion: Whilst the prevalence of pneumococcal isolates resistant 
to penicillin is quite hgh in Ireland, all isolates to date are sensitive to 
cefotaxime, moxifloxacin and linezolid. Therefore, as well as cefotaxime, 
modoxacin and linezolid are potential options for the treatment of invasive 
infection. 
(0931 Levofloxacin-resistant streptococcus pneumoniae 
continue to exhibit cross-resistance to other 
fluoroquinolones 
R. S. Blosser-Middleton, I. A. Critchley, J. Yamakita, M. Akasalu, 
C. Thornsberry, D. E Sahm and M. E. Jones 
Hemdon, USA;  Tokyo, JP; Franklin, U S A ;  Hiluerrum, NL 
Objectives: Antimicrobial resistance among S.pneumoniae (SP) is a worldwide 
concern. As fiuoroquinolones are more frequently prescribed for respiratory 
tract mfections, concerns arise regarding the prevalence of fluoroquinolone- 
resistant mutants and the effects of mutations conferring resistance to one 
fluoroquinolone on the activities of other fluoroquinolones. We examined 40 
levofloxacin (LEV)-resistant (R) SP collected during a 1999-2000 surveil- 
lance study for concurrent resistance to other fluoroquinolones, indudmg 
gatifloxacin (GAT) and modoxacin (MXF). 
Methods: During 1999-2000.5015 SP were collected h m  13 countries in 
Europe, Asia, and South America. Isolates were submitted to our central 
laboratory (Focus Technologies, Hemdon, Virginii) and tested by NCCLS 
broth microdilution against levofloxacin and comparator agents. 40 LEV-R 
SP were identified and tested on a second broth microdilution panel 
against LEV, ciprofloxacin (CIP), GAT, MXF, norfloxacin (NOR), and 
trovafloxacin (TRO). In addition, the quinolone-resistance-determining 
regioils (QRDRs) of gyrA, n B ,  parC, and yarE of these isolates were 
sequenced. 
Results: Overall, 0.8% of the isolates collected were LEV-R. The MICg0 of 
LEV was 1 mg/L in all countries, irrespective of the prevalence of LEV 
resistance. AU the 40 LEV-R SP had GyrA (Ser81- or Glu85-) alterations and 
37 had ParC (Ser79Phe, Asp83Asn, or Lysl37Asn) alterations. Two isolates 
had a LEV MIC of 32mg/L and possessed GyrA (Glu85Lys) and ParC 
(Ser79Phe/Tyr) alterations. Among the 40 LEV-R SP tested, all were 
nonsusceptible to GAT (10 intermediate, MIC = 2 mg/L; 30 resistant, 
MICZ4mg/L), 39 were nonsusceptible to MXF (31 intermediate, 
MIC = 2 mg/L; 8 resistant, MIC 3 4 mg/L), 38 had TRO MICs 3 2 mg/ 
L, and 39 had CIP MICs>Smg/L. No isolates had a NOR MIC< 16 
mg/L. 
Conclusions: The LEV resistance remained rare in a 1999-2000 lbcouncry 
surveillance study with a prevalence of <1% overall. Irrespective of the 
QRDR sequences, when LEV resistance was detected, most isolates were also 
nonsusceptible to other marketed fluomquinolones. 
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1 094 1 Comparative in vitro activity of BMS-284756, a 
novel Des-fluoro (6) quinolone, and other antichlamydial 
agents against respiratory, vascular, and cerebral strains 
of Chlamydia pneumoniae 
M. Maw, J. Rupp and J. Gieffers 
Lubeck, D 
Objective: The obligate intracellular bacterium Chlamydia pneumoniae is a 
fiequent cause of respiratory infections and can be cultured &om athero- 
sclerotic vascular lesions. Less than 60 strains of this fiequent but fastidious 
pathogen are available worldwide, and data on their susceptibihty profiles are 
scanty. BMS-284756 is a novel Des-fluoro (6) quinolone proposed to be 
efficient against a broad range of fastidious bacteria. Thus, we evaluated its in 
vitro efficiency to inhibit growth of 20 C. pneumoniae strains in comparison to 
established anticblamydial agents using a recently proposed system of stan- 
dardized MIC determination for Chlamydiae. This system monitors activity 
against actively replicating cblamydlae and is an in vitro model for drug 
efficiency in acute chlamydial infection. 
Infections in the immunocompromised host 
Methods: Standardized testing of C. pneumonia MICswas done using HEp-2 
cell monolayers, serum-fiee conditions, and a seed of 500 inclusion forming 
units per well. Inclusion formation was monitored by immunofluorescence 
microscopy. MICs were determined for 20 C. pneumoniae strains from the US 
and Europe (nine respiratory isolates, 10 vascular isolates, and one fiom 
cerebrospinal fluid) in parallel for BMS-284756, moxifloxacin, levofloxacin, 
azithromycin, and doxycycline. 
Results: MIC90s were: BMS-284756 0.0025 mg/L; moxjfloxacim 0.05 mg/L; 
levofloxacin. 0.4 mg/L; azithromycin: 0.08 mg/L; doxycyche: 0.1 mg/L. Thus, 
on a weight base, BMS-284756 was the most efficient substance to eliminate 
chlamydial growth in cell cultures. The origin of the isolates had no impact on 
their susceptibility profiles as respimtory, vascular, and cerebral strains showed 
nearly identical patterns. 
Conclusion: Actively replicating C .  gneumoniae can be eliminated with con- 
siderable efficiency by a variety of drugs. BMS-284756 was the most effective 
substance overall when compared to moxifloxacin, levofloxacin, azithromy- 
cin, and doxycydine. Resistance was not observed. All C. pneumonia strains 
tested so far had comparahle susceptibility patterns. An anunal model and 
clinical studies are needed to establish the in vivo activity of BMS-284756 
against the chlamydial infections. 
F) Viral dynamics in cytomegalovirus infection in 
solid organ transplantation 
V. Ghisetti, A. Barbui, S. Varetto, 1. Franchi and G. Marchiaro 
Turin, I 
Objective: To study the dynamics of CMV replication in patients undergoing 
solid organ transplantation. 
Methods: CMV viral load w a s  studied in 25 patients (median follow-up 
82 days) on anti-CMV therapy (i.v. GCV, 10 mg/kg/day for 21 days) and in 
eight patients with CMV reactivation not requiring GCV (median follow-up 
89days). Viral load was measured in sequential blood leukocytes by a 
quantitative polymerase chain reaction (PCR, Cobas Amplicor CMV Moni- 
tor, Roche), lowest detection limit 100 genome per 106 cells. Samples were 
taken from patients on GCVat day +4, +7, +12, +14, +18, +20, +21 and 
after GCV w a s  dismissed (day 4.7, 14 and 21). Two hundred and sixty-four 
samples were analyzed. 
Results: In patients on GCV baseline viral load was 4.37 log genome per 106 
cells, significantly higher than the one in patients not on GCV (3.11og. 
P < 0.0001). By day 21, GCV treated patients showed a 1.86 log reduction of 
pretreatment level corresponding to 83% of baseline load. CMV-DNA 
cleared by 1.51og during the first 13days of therapy and 0.31og by day 
21. Being symptomless, the patients’ therapy was discontinued (the mean end- 
of-treatment viral level: 3.01 logs). At days 4, 7, 14 and 21 after GCV w a s  
dsmissed, CMV level ranged &om 2.51 to 3.151ogs in 21/25 patients. Four 
patients (16%) experienced a CMV relapse 4-34days after GCV treatment. 
Vial load picked to 4.72 logs. A second 21-day GCV course was administered 
at the end ofwhich the CMV-DNA= below the PCR detection limit. The 
relapse was not related either to the pre-transplantation CMV serum status (all 
the four recipients were CMV seropositive before transplantation) or to 
changes in immunosuppressive drug regimen. 
Conclusions: Our findings show that CMV replication and clearance are 
dynamic processes whose knowledge during the GCV therapy may have 
important implications for the efficacy of antiviral regimen and controlling 
CMV In transplanted patients who are at high risk of CMV infection, viral  
clearance can be a slow process in which dosage and duration of the antiviral 
treatment as well as the availability of sensitive methods to detect CMV 
reactivation are important to prevent CMV disease. 
Cytomegalovirus (CMV) infection in kidney 
recipients: are CMV genotypes and other herpes viruses 
(HHV-6, 7, 8) associated with clinical manifestations? 
S. Pacsa, A. Voevodin, H. Kazak, N. Gadallah and 
Kuwait, K W T  
Objectives: CMV is one of the most important major causes of clinical 
manifestations in kidney transplant patients. Symptom may vary according to 
Al-Nakib 
the genotypes of the virus or co-infection with other herpes viruses. This 
study aimed at investigating: (a) the possible association of CMVgB genotypes 
with c h c a l  manifestations, and (b) the role of other herpes viruses in the 
outcome of CMV infection. 
Methods: In the present study 42 symptomatic and 87 asymptomatic kidney 
transplant patients were involved. For diagnosing a CMV infection/disease, 
the antigenemia assay (detecting the pp65 antigen in leukocytes) was 
used. Genotypes of CMV were identified by the combination of a PCR- 
RFLP assay. Genomes of HHV-6,7 and 8 were detected by nested PCK tests. 
Results: The four CMV B genotypes were determined in symptomatic 
(n = 28) and asymptomatic patients. There was no association between any 
particular genotype and the clinical symptoms. DNA of HHV-6 could be 
detected at a relatively low incidence (7%), and there was no ditrerence 
between symptomatic and asymptomatic patients. Distribution of HHV-7 
DNA showed an interesting picture. While it could be detected in 37 of 87 
(43%) asymptomatic patients, it was detectable only in 7 of 42 (17%) 
symptomatic patients. HHV-8 DNA was found only in 3 of 129 patients 
tested (2%). 
Conclusions: The results suggest that there is no association between geno- 
types of CMVand disease ndestations. The pathogenic role of HHV-6 and 
HHV-7 remains unclear. The low prevalence of HHV-7 DNA in sympto- 
matic patients may be explained be the impact of ganciclovir therapy. The 
importance of HHV-8 requires further studies in larger number of transplant 
patients. 
(097/ Cobas Amplicor CMV monitor compared to 
Antigenemia or rapid quantitative culture in CMV 
monitoring in solid organ transplant patients 
P. R. A. Meylan, R. Sahli, M. Weitz, D. Garzoni, W. Wunderli, L. Kaiser, 
M. Gorgievski, T. Klimkait, H. Hirsch and W Bossart 
Swiss Working Groupfor Clinical v i ro log~ CH 
Objective: To evaluate Cobas Amplicor CMV Monitor (CACM) in compar- 
ison with tests used currently used in Swiss centers to monitor CMV in a 
preemptive approach in solid or&an transplant (SOT) patients. 
Methods: CMV viral load was monitored weekly after transplantation in 36 
SOT recipients. CMV antigenemia @p65 leukocyte assays, n = 17) or mfec- 
tivity by the shell vial assay (a  = 19) in PBL was used to monitor and guide 
preemptive treatment. Using stored plasma samples, we compared the 
kinetics of CMV viral load appearance in the blood by routine assays 
(RA) or CACM. 
Results Samples of 36 patients aged 23-72 (rnedian=51, 26 males, 10 
females) with a documented CMV viremialantigenemia (27 ludneys, 6 hearts, 
3 livers) Corn four centers were analyzed. The patients had from 1 to 13 
samples (median = 5) assayed before peak viral load or treatment initiation. 
The median (range) time &om transplantation to detection of CMV in the 
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blood by R A  was 35.5 days (7-74), but 39 days (747) to reach the thresholds 
for preemptive R,, P= 0.008, Wilcoxon’s signed-rank test when compared to 
RA detectable): the time to CACM detectable was 35 days (7-61, P =  0.36), 
CACM >lo00 copies/mL: 39 days (9-61, P= 0.42), CACM > 5000 copies/ 
mL: 43days (1747, P= 0.03). Eight patients did not require treatment, two 
were treated prophylactically, 14 preemptively and 12 therapeutically (after 
developing CMV disease). Of the latter, three had not been treated pre- 
emptively earlier despite having met a threshold for treatment by the RA. 
Using a threshold for preemptive action of 1000 copies/mL., CACM would 
have met this trigger point before RA using the usual thresholds in 12 patients, 
offering the potential to prevent the occurrence of CMV disease in four 
patients. 
Conclusion: The CMV-DNA monitoring in the plasma using Cobas Ampli- 
cor offers a standardized, commercially available method with a sensitivity 
similar to currently used RA. In our experience, 1000 copies/mL plasma 
appears as a potential threshold for preemptive action corresponding to those 
defined with in-house assays. This is of interest for the future organization of 
multicenter studies with preemptive treatment arms. 
Acknowledgement: Supported by Roche Diagnostics and Roche Pharma 
(Switzerland). 
Are CMV-seronegative donors a risk factor for CMV 
seropositive stem cell transplant recipients? 
M. Eibl, W. Zinke-Cerwenka, U. Apfelbeck, S. Sormann and 
W. Linkesch 
Graz, A 
Objectives: In h s  retrospective analysis, we evaluated the incidence of CMV 
reactivation, CMV disease and death from CMV infection in CMV sero- 
positive allogenic stem cell transplant recipients depending on the CMV status 
of the donor. 
Patients and methods: Sixty-two consecutive patients (male : female = 37 : 25) 
aged &om 19 to 64years (median: 42) were dografted using either bone marrow 
(n = 26) or peripheral blood progenitor cells (a= 36) from related (n = 34) or 
unrelated (n = 28) donors. The underlying hematological malignancies were: 
a n =  24, CML: n =  15,ALL: n = 5, NHL: n =  13, MM: n =  3, SAA:  n =  1 
and MDS: n = 1. Conventional dose conditioning was performed in 51 patients 
and reduced conditioning in 11 patients. Antithymocyte globulin (ATG) for 
GVHDprophylaxiswasadminkteredinallrecipientsofunrelatedgrafts andin6/ 
34 patients with related donors. The lugh-dose acyclovir was given for CMV 
prophylaxis, and PCR-based preemptive therapy was carried out using either 
ganciclovir, foscarnet or cidofoe. The following CMV donor/recipient status 
could be found: positive/positive: n = 18, negative/negative: n = 19, positive/ 
negative: n = 8 and negative/positive: n = 17. 
Results: At least two positive CMV-PCR results requiring preemptive 
therapy could be detected in 14 patients, 12 of them developed CMV disease 
(interstitial pneumonia: n = 9, encephalitis: n = 1, hepatitis: n = 1, gastro- 
intestinal manifestation: n = 1). Seven patients died &om CMV dlsease; they 
were all CMV-seropositive pre-transplant, and six of them had CMV- 
seronegative donors. Among the CMV-positive patients with negative donors 
11/17 (64.7%) showed at least two positive PCR results, whereas in only 
35.3% there was no evidence of CMV reactivation. Among the CMV-positive 
patients with positive donors in 3/18 (16.7%) at least two positive PCR results 
could be detected and the majority (83.3%) didn’t show any sign of CMV 
reactivation. 
Conclusion: Regarding the incidence of CMV reactivation, CMV disease and 
especially death &om CMV disease the subgroup of seropositive patients with 
seronegative donors had the worst outcome. Therefore, the question arises, 
whether CMV-positive donors should be preferred for CMV-positive stem 
cell transplant recipients. 
One-year analysis of CMV-PCR surveillance data in 
heart transplant recipients: a safe strategy to prevent 
CMV disease? 
A. Krause, J. S. Harwood, A. W. Berrmgton, G. Parry, J. H. Dark, 
A. Hasan, J. Forty, A. J. L. Turner and E K Gould 
Nmcastle upon Tyne, UK 
Description: Cytomegalovirus (CMV) infection can cause severe disease in 
transplant pahents. Numerous protocols emt  to prevent the (re-)occurrence 
of CMV-disease, but there is no consensus as to which of these strategm is 
ophmal In January 2000, we introduced qUanhtahVe CMV-PCR (QPCR) 
monitoring of CMV-IgG+ve and CMV- status nusmatched patlents (CMV- 
MM) post-transplantahon (Tx). The QPCR was performed m c e  weekly on 
In-pahents and weekly thereafter, or for 3 months post-therapy lf the pahent 
received gancdow (GCV). AU pahents received oral aciclow for 3 months 
Purpose: (1) To estabhh whether QPCR results can be used as early 
predictors of CMV &ease. (2) To remew the uality of a cut-off value above 
whch preemptive GCV therapy should be started (3) To assess the necessity 
of QPCR survedance of CMV-IgG+ve pahents 
Methods: We conducted a retrospechve survey of QPCR results of patlents 
who underwent cardrac Tx between January 2000 and January 2001. Twenty 
pahents (15 adults and 5 children) who s m v e d  3months were included. 
Results Four pahents were CMV-MM: one pahent remamed QPCR-ve, 
whde three became QPCR+ve, among whch one was asymptornaac 
(QPCR load lo5 GO ie$/mL). Two pahents became symptomahc (QPCR 
load 105-106 and 10 -lo5 copies/mL) and both were treated wth GCV. Of 
the 16 pahents who were C M V - [ e v e  at the tune ofTx, seven remamed 
negahve and rune became POSlhVe by QPCR Two of these became sympto- 
mahc but dld not requre specific therapy Among these, there was no obvlous 
correlaaon between QPCR load and the development of symptoms. 
Conclusions: (1) The number of CMV-MM pahents was too s m a l l  to permt 
any conclusion about the value of QPCR as an early predxtor ofdsease. (2) It  
may not be worthwhde to momtor the asymptomahc CkfV-IgG+ve pahents 
by QPCR, but thu area requres further study QPCR should be mcluded in 
the magnosac work-up of symptomahc patients, where appropnate. 
s 
m( Prevention of ChW disease: cost evaluation of two 
regimes in heart and lung transplantation 
J. S. Harwood, A. Krause, J. H. Dark, €? A. Corris, A. Hasan, G. Parry, 
A. J. L. Turner and E K. Gould 
Newcastle upon qne,  UK 
Description: Optimal strategy for prevention of CMV disease following solid 
organ transplantation is unknown. Several studies have demonstrated the 
beneficial effects of prophylaxis with i.v. immunoglobulin, ganciclovir and 
valacidovir, or preemptive treatment based on viral load measurements. Few 
studies have assessed the cost-effectiveness of different regimes. In January 
2000, we introduced a CMV surveillance protocol based on weekly quanti- 
tative PCR viral load measurements in addition to selective ganciclovir 
prophylaxis to replace i.v. immunoglobulin for all CMV-mismatched patients 
and oral ganciclovir for CMV-IgG-positive lung transplant recipients. We 
compared the costs of the new protocol with the previous for patients 
transplanted between January 2000 and January 2001. 
Methods: Patients records were reviewed and cost-calculations were made 
based on the two protocols. 
Results: A total of 78 ~ a r d i ~ p u l m ~ ~ r y  transplants (32 lungs, 43 hearts, 3 
heart/lung) were performed at this center between the dates specified. Forty- 
one recipients W e d  our surveillance criteria. The comparison of costs 
between the old and the new protocols are shown below: 
Htx reflpientr: Old protocol U S  8547; new protocol US$11567; Werence: 
+US$3020. 
Lrx redpients: Old protocol USt85930; new protocol USS41939; difference: 
Conclusions: We can conclude h m  these results that the preemptive therapy 
strategy in heart transplant recipients is slightly more expensive than pm- 
phylaxis. However, in lung transplantation considerable saving can be made. 
-US$43991. 
ml BKV-associated nephropathy after kidney 
transplantation: a single-center analysis in a pediatric cohort 
A. Azzi, R. De Santis, €? Comoli, C. Rossi and F. Ginevri 
Florence, Padua, GEWOA, I 
0bjectives:BKV reactivation is known as cause ofureteral stenosis in the renal 
transplant recipients and ofhemorrhagic cystitis, particularly in bone marrow 
transplantation patients. Recurrent BKV reactivation occurs tiequently in 
immunocompetent individuals resulting in asymptomatic viral urinary shed- 
ding. Recently, the human polyomavirus BK has been recognized as a possible 
cause of interstitial nephritis in kidney transplantation recipients, a complica- 
tion which may lead to graft failure in as many as 45% of affected patients. 
Moreover, it has been even more recently observed that the human poly- 
omavirus JC also could be involved in post transplant intentitid nephropathy. 
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We have performed a retrospective analysis on pediatric ludney-allograft 
recipients with the aim of evaluating the incidence and clinical relevance of 
BKV and or JCV mfection under new immunosuppressive drugs. 
Methods: Serum and urine samples &om 100 pediatric kidney allograft 
recipients, referred to G. G a s h  Institute in the last 5 years, were analyzed 
by PCR assays for BKV-DNA presence. In a group of BKV-DNA positive 
samples and in a group of BKV-DNA negative samples, a PCR for the JCV 
DNA was also carried out. Moreover, the BKV viral load was measured by a 
quantitative PCR. 
Results: BKV viruria was observed in 26 out of the 100 patients (26%), while 
BKV viremia was concomitantly demonstrated in 5 out of 26 patients with 
viruria (19%). All five children with viremia showed renal damage consistent 
with interstitial nephropathy and increase of serum creatinine levels. The 
damage stabilized after immunosuppression reduction in four patients, 
while the remaining recipient lost the graft owing to a histologically 
confirmed interstitial BKV nephritis. JCV sequences were shown in 15 
out of 26 (58%) urine samples BKV DNA positive and in only 1 out of 
20 urine samples BKV DNA negative. JCV sequences were not detected in 
serum samples. 
Conclusions: These data indicate that BKV viremia and high viral unnary 
shedding are closely related to kidney grdt damage. Our clinical data also 
indicate that the BKV-related kidney-graft damage is becoming a relevant 
complication after renal transplantation possibly owing to the use of new, 
more potent, and immunosuppressive regimens. 
F] Bacterernia coincides with impaired gut integrity 
in HSCT recipients 
N. M. A. Blijlevens, B. van't Land, J. E Donnelly and B. E. De Pauw 
Nijmegen, Wageningen, NL 
Introduction: Mucosal barrier injury (MBI) of the oral cavity and gut is a 
severe and dose-limiting complication of ablative regimens used to prepare for 
hematopoietic stem cell transplant (HSCT). Gut M B I  results in increased 
permeability and decreased absorption. Here we describe the onset of 
bacteremia in relation to changes in gut permeability and absorption as 
measured by a multisugar test. 
Study population: Sixteen add& received a regimen consisting of idarubicin 
42 mg/M2 given by continuous infusion for 48 h on HSCT day 13 followed 
by cyclophosphamide 60 mg/kg i.v. on days 6 and 5 and total body irradiation 
with 4.5 Gy on days 2 and 1 in preparation for an HLA-matched, MLC- 
negative T-cell depleted sibling HSCT. All were managed throughout the 
study period with a triple-lumen central venous catheter (CVC) that was 
inserted on HSCT day -13 
Methods: Beginning on day 12 before HSCT, after an overnight fast, subjects 
emptied their bladders and then drank an isotonic solution consisting of 5 g 
lactulose, 1 g r-rhamnose, 0.2 g 3-O-methylglucose, 0.5 g D-xylose in 
1OOmL. Urine was then collected over 5h, the total output was recorded 
and an aliquot was stored at 80 "C. The test was repeated on HSCT days -7, 
0, f7,  +14, +21. The sugars were detected using high-performance liquid 
chromatography and the fluorescence label 9-fluorenylmethyl chloroformate 
hydrazine. Lactulose/rhamnose &/R) ratios were used as an index of gut 
integrity. Blood was drawn through each lumen of the CVC for culture twice 
weekly and also peripherally at the onset of fever. Bacteremia was considered 
present when any organism was recovered &om a single blood culture except 
coagulase-negative staphylococci and micrococci for which two cultures 
yieldmg the same species were required. Antimicrobial prophylaxis consisted 
of oral ciprofloxacin 500mgql2h fiom admission. seven patients received 
meropenem 1 gq8h from HSCT day +1 onwards, whereas eight patients 
were given cefepime empirically and only one patient continued taking 
ciprofloxacin. 
Results: Mean L/R ratio was significantly higher on HSCT days 0 (3.00), 7 
(6.17) and 14 (4.87) than on days -7 (0.06)and 21 (2.59) (P< 0.05) with 
respect to the baseline HSCT day -12 (0.07). and bacteremia occurred 
predominantly on these days (0.7,14) involving mainly the coagulase-negative 
staphylococci (23/27 [85%] episodes). 
Conclusion: Gram-positive bacteremia OCCUIS when gut integrity is perturbed 
in allogenic HSCT-transplant recipients. 
Antimicrobial needs and options: the importance of using the best in class for appropriate empiric therapy 
(Symposium arranged by Bayer) 
wl Variability of antibiotic use and resistance in 
Europe 
G. Gialdroni Grassi 
Pavia, I 
Across Europe, there is a range of both antimicrobial preferences and 
consequent resistant patterns. The first line choices of physicians in Italy 
and Spain tend to be macrolide agents, such as erythromycin and clarithro- 
mycin, while the UK and Germany prefer /?-lactams, such as the amoxicillin 
and the cephalosporins. There are several swceptibdity systems in place which 
monitor either point prevalence or continuous surveillance. These surveys 
include the Alexander Project, PROTEKT, EARSS, SENTRY, MRL/Focus 
and others, which include most European counaies, whereas specific country 
surveys include the SEPRA in Italy. There are clear patterns of resistance to 
macrolides, with the highest rates being observed in Southern European 
countries with Streptococcus pneurnoniae (>2540%), whereas Northern and 
Central European countries, such as the UK and Germany, have correspond- 
ing resistance rates of <8%. /?-Lactam resistance for the Pneurnocccnrs is highest 
in Spain, Italy, France and Greece with rates >30%. Ifdemophilux infuenzae 
also has resistance issues, particularly with /?-lactamase-producing strains. 
Repons suggest that these are 1540% across Europe. Other pathogens noted 
to have gmwing resistance issues include Escherichiacoli, KlebsieUa species and 
Pseudornonas aenrginosa. The outcome of the combination of this geographic 
variability and increased travel is the need for an empirical antimicrobial 
which is active against all the possible resistant st ra ins  currently encountered 
in Europe. The new 8-methoxyquinolone, m d o x a c i n  covers many 
community respiratory species, while ciprofloxacin would be the drug of 
choice for the Gram-negative pathogens. 
I 5107 I Preserving the efficacy of an antibiotic class 
E-J. Schmitz 
DGsselda6 D 
The introduction ofnew members ofan antimicrobial class, although exciting, 
may also carry some risksunless the potential for resistance emergence to the new 
agent andother classmembersis fulyappreciated. Itis hypothesizedthat use ofless 
pharmacodynamically potent class members may enrich a population for fmt- 
step mutants, thus setting the stage for resistance developing to the new agents 
with possible loss of activity. Fluoroquinolones, an expanding class, exert their 
action at two sites in the bacterial cell: DNA gyrase and DNA topoisomeme IV 
Diftitrent agents have varying attinity for the two sites in different species. The 
structure ofthe quinolones affects the binding ofthe drug to these enzymes, with 
poor-binding encouraging the selection of resistant mutants. The impact of a 
poor-binding drug usedextensively in a population encourages rapidemergence 
of resistance. To prevent this high-dhity, compounds should be used in 
preference. Analysis ofthe C7 and C8 moieties on the quinolone molecule have 
an impact on binding. The C8 methoxy improves binding to DNA gyrase, while 
large, bulky C7 molecules block efflux pumps. Both of these structures are 
foundwithmmoxiaoxacin; thisaffordsalowerpropensityfor resistanceselection 
compared with agents such as levofloxacin. The sigfllficance of molecular 
structure and resistance emergence will be discussed. 
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I S108 1 Pharmacokinetic predictors for clinical outcome 
A. MacGowan 
Bristol, UK 
The basic pharmacodynamics of fluoroquinolones is well understood. The 
principle pharmacodynamic predictor of efficacy is the AVC/MIC ratio, 
though C,/MIC also has an important role. The magnitude of the AVC/ 
MIC, which predicts the clinical eficacy of fluoroquinolones has been 
estimated for &ee drug &actions and Streptococnrs pneumoniae. These values 
are for levofloxacin 24-48; gatilloxacin 35-70; gemifloxacin 75-300 and 
moxifloxacin 18Ck375. A number offactors, such as bacterial species, bacterial 
inoculum, host status and the end point chosen are known to have an impact 
on the size of the AVC/MIC required to ensure optimal outcomes. One size 
does not fit all, as this ratio magnitude will not predict outcome in all 
situations. Pharmacodynamics can also be applied to predict emergence of 
resistance. It has also been suggested that these ratios may be an indicator of 
rate of response. The relevance of pharmacodynamics to eficacy and resis- 
tance will be highlighted. 
1 5109 1 Moxifloxacin IV-anovel parenteral therapyfor CAP 
J. Garau 
Barcelona, E 
Moxifloxacin has been administered orally to over 10 million patients world- 
wide with respiratory tract infections. Moxifloxacin i.v. has been approved in 
the US and other countries for the treatment of CAP in the hospital, and is 
awaiting approval in Europe. Data d be presented ftom two multicenter 
studies that assess the safety and eficacy of intravenous moxifloxacin in 
hospitalized CAP patients. The sequential therapy approach of l.v./p.o. 
modoxacin was evaluated against the ERS standard of coamoxiclavulanate 
Impact on human health of non-human use of antibiotics 
and/or clarithromycin in a European setting. Over 500 evaluable patients 
showed moxifloxacin i.v. to be statistically superior to the ERS combination 
in terms of clinical response, 93% versus 85% (95% C 1 ~ 2 . 9 ,  13.2%). 
Furthermore, the patients treated with modoxacin defervesced sigmfkantly 
sooner. This has marked implications for both patient and health-care setting. 
The rate of bacterial eradication was also si&icantly hgher with moxi- 
floxacin, 94% versus 82% (95% CI = 1.2, 22.9%). In the second study, 
conducted in North America, moxifloxacin i.v. was found to be equivalent 
to trovafloxacin or levofloxacin therapy Moreover, adverse events were 
s& in both treatment groups. The main adverse events, hke diarrhea, 
transiently elevated LFTs and nausea, were mild. Together, these studies 
demonstrate that moxifloxacin i.v. as monotherapy is as effective or event 
superior to standard combination therapy, is well tolerated, and is convenient 
to use with a once-daily dosage. 
1 s110 1 Providing complete coverage for rapid resolution 
H. Lode 
Berlin, D 
The convergence of emerging mistance, newly recognized pathogens, an 
altering healthcare system, and an evolving patient type yields a more complex 
situation for today’s prescriber. The need to treat more resistant pathogens in a 
more rapid manner reduces the empiric options available. The recognition of 
mixed infections has added to this management dilemma. Clearly, no single 
antimicrobial can cover all these variables and use of one agent, to try to do this 
is fraught with d&culties. Moxifloxacin and ciprofloxacin are two fluor- 
oquinolones with complimentary activities and PO can be used as initial 
antimicrobial therapy to provide rapid and reliable coverage in both parented 
and oral forms. These drugs have a good to excellent safety record. As the 
dectious presentations evolve these two agents, in particular, i.v. moxiflox- 
acin will meet many of the clinician’s expectations. 
antmcrobial agents in animal production has an overall negligble negative 
effect on human health, limited primarily to only a few types of foodborne 
bacteria (e.g. Sdmonella and Campylobacter). Not all antimicrobial agents used 
ml Impact on human health of non-human use of 
antibiotics 
T. Shryock 
Greenjeld, USA 
Antimicrobial agents are approved for use by competent regulatory authorities 
to prevent, control, and treat disease in food animals, and to increase efficiency 
of feed utilization. The beneficial effects of these uses in food animals include 
(1) improved human health (e.g. improved immune response to infection) by 
assuring the supply of healthy animals into the food chain, so that adequate, 
affordable nutrition can be maintained; (2) increased feed efficiency and lower 
manure production that fosters good land stewardship and environmental 
protection; and (3) improved animal health and welfare. Many reviews, 
committees and meetings have used a variety of indirect evidence to condude 
that antimicrobial use in food animals might negatively impact human health 
through the selection of bacterial pathogens resistant to antibiotics used in 
human mehcine followed by the subsequent transfer of the pathogens to 
humans via food. The facts of the matter actually suggest that the use of 
in animals-are or d be used extensively in humans (e.g. ionophores, 
orthosomycins, bacitracin), and of those that are used in animals, most are 
of classes for which there is already a high prevalence of resistance in some 
genera ofhuman-isolated bacteria (e.g. tetracycline and macrolide resistance). 
Moreover, alternate treatment options are available to physicians. The 
magnitude and extent of exposure of humans to viable foodborne bacteria, 
some of which may have resistance genes, is minimized by processing 
interventions and cooking. Finally, the magnitude and medical consequence 
of resistance gene transfer and selection among bacteria within the human 
intestinal tract remains unclear. Aproportionate response to address the 
potential risk to human health should include (1) risk assessment to appro- 
priately guide the most effective interventions throughout the entire food 
chain; (2) continued application ofjudicious use guidelines for antimicrobial 
use by producers, veterinarians and physicians; (3) national antimicrobial 
resistance monitoring programs; and (4) continued support for science-based 
regulatory processes for drug evaluations. 
Antifungal susceptibility testing 
m1 sensititre Yeastone colorimetric antifungal panel 
for testing voriconazole against isolates of Candida spp.: a 
comparison with the NCCLS M27-A microdilution 
reference method 
A. Espmel-Ingroff, C. Knapp, N Holl~day and S Iwkan 
Rtchmond, Westlake, USA 
Objectives: The purpose of h s  study was to evaluate the commercial 
Sensihtre YeastOne Colonmetric Andungal Panel for susceptibhty teshng 
of yeast to the new rnazole voriconazole The adab le  Nahonal Co-ttee 
for Chnical Laboratory Standards (NCCLS) mcrodlluhon method for the 
anufungal suscephbhty testmg of Candlda spp and Crypfocouus neofmans 
(M27-A document) may not be the most efficient and convement procedure 
for use m the cluucal laboratory. It has been demonstrated that the Sensiatre 
YeastOne panel provides comparable MICs to those obtamed by the NCCLS 
method for testmg reference agents agatnst yeast 
Methods: We compared MIC values obtamed smdtaneoudy by Sensiatre 
YeastOne Colorlmetrlc Anafungal Panel and NCCLS M27-A broth nucro- 
dduhon methods after 24- and 48-h of incubahon for reference agents 
amphotericin B, fluconazole, flucytosme, and ltraconazole and the 
novel triazole voriconazole The 100 c h c a l  isolates evaluated included 38 
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C. albicdns, 24 C.glabmta, 7 C. kncrei, 5 C. Iusitaniae, 10 C.parapsilosis, and 16 
C. tropicalis. Colorimetric MICs of amphotericin B corresponded to the first 
blue well (no growth) and MICs of the other agents to the fmt purple or blue 
well. 
Results: Three comparisons ofMIC pairs by the two methods were evaluated 
to obtain percentages of agreement (+2 dilution range): 24- and 48-h 
colorimetric versus correspondmg 24- and 48h NCCLS MICs md 24-h 
colorimetric versus 48-h reference MICs. The agreement between the 
methods for voriconazole MICs was 95.9% when both 24- and 48-h 
colorimetric MICs were compared to 24- and 48-h NCCLS MICs. The 
agreement was slightly lower (92.7%) when 24-h colorimetric values were 
Results: For most of the other agents were similar (91.7-98%). Comparison of 
amphotericin B MICs provide excellent levels of agreement (96.9-100% by 
all comparisons). 
Conclusion: These data suggest the potential value of the YeastOne panel for 
use in the clinical laboratory to test the susceptibilities of common Candidu 
isolates to voriconazole. 
compared ta 48-h NCCLS MICS. 
101261 In vitro antifungal activity of voriconazole against 
clinical isolates of Candida and Arpefgihis species 
L. Polonelli, S. Conti, E Fanti, M. Drago, M. Turrini, 
M. Scaltrito and G. Morace 
Parma, Milun, I 
Objectives: Voriconazole is a new triazole, derived &om fluconazole, with a 
broad spectrum of annfungal activity against Candida spp., including fluco- 
m o l e  resistant strains, and fungicidal activity against Aspegillus spp. Vor- 
iconazole is considered to be an ideal anrifungal agent for therapy of 
persistently neutropenic patients in whom Candida and Asper@llus spp. have 
become a major cause of invasive infections. We tested voriconazole against 
clinical isolates of Candida and Aspergillus spp. with the purpose ofverlfying its 
inhibitory and hngicidal activity in vim. 
Methods: Voriconazole (concentrations ranging from 0.008 to 8 mg/L) 
susceptibility was tested with 200 clinical Candida isolates (105 C. albicam) 
and two ATCC control strains with the broth microdilution method NCCLS 
M27A, and 37 clinical &ergillus isolates (22 A.furnigatus) with the broth 
microdilution method NCCLS M38P Microplates were read spectrophoto- 
metrically (540 nm) for the yeast (MIC = reduced turbidity equal or greater 
than 80??) and visually for Aspergillus spp. (MICo = absence of visible growth, 
and MIC,=prominent reduction in growth). MFCs were obtained inocu- 
lating (0.01 mL) weh with voriconazole concentrations greater than the MIC 
values. With the aim of reducing clinical reporting of susceptibility data, 20 
Aspergillus isolates were tested contemporaneously with inocula made from 
48-h and 7-day-old cultures. 
Results: The MICw value for the Candida isolates was 0.25 mg/L, while the 
value for MFCw was greater than 8 mg/L. The most susceptible species was 
C. albicans (MICgo O.O3mg/L). For the Aspergillur isolates the results were: 
MICz-so (OSmg/L), MIC0-% (2mg/L), and MFCw (4mg/L). No differ- 
ences were demonstrated in the susceptibility results to voriconazole of the 20 
AspergiNus isolates tested with inocula made h m  48-h-old cultures in 
comparison with inocula made, according to M38P protocol, &om 7-day- 
old cultures. 
Conclusions: Voriconazole showed very effective inhibitory activity against 
both Candida ulbicans and the non C. albicans isolates, including C. knrsei. 
Significant fungicidal activity was demonstrated against Aspergillus isolates. 
Moreover, the use of inocula made h m  48-h-old cultures permitted timely 
reporting of susceptibility results for Aspergillus clinical isolates. Owing to its 
excellent bioavailability, voriconazole is free of the main drawbacks encoun- 
tered with fluconazole and itraconazole, viz. a narrow spectrum and poor 
delivery, respectively. 
101271 Quality control limits for disk susceptibility tests 
of fluconazole and voriconazole 
S .  Brown, A. Bany and M. Traczewski 
Wilsonville, USA 
Objective: Methods for performing yeast disk susceptibihty testing of F using 
Mueller-Hinton agar (MHA) supplemented with gIucose (G) and methylene 
blue (MB) dye have been proposed earher. Ths  study was undertaken to 
estabhsh quality control ranges for both F and V disk tests using the standard 
NCCLS QC yeast stralns. 
Methods: MHAwas supplemented either durmg production or post produc- 
tlonmth G to a final concentranon of2% and MB dye to a final concentration 
of 0.5 mg/L Ten replicates of each QC strain were tested on three lots of 
MHA usmg two lots of 25 pg F or 1 pg V disks at eght internaaod 
laboratories. Zones of inhlblhon were read at 24 and 48 h of incubahon at 
35°C. 
Results: The results are presented in Table 1. 
Table1 Results 
Prepared plates Supplemented plates 
(mm at 24 or 48 h) (nun at 24 or 48 h) 
QC stram F-24 F-48 F-24 V-48 F-24 F48 V-24 V-48 
C albtcans 28-39 3 W 1  32-42 32-43 30-41 3 W 1  3 M l  31-42 
C krusei NR NR 16-25 12-21 NR NR 1&25 12-21 
Cparapsilosis 22-23 20-31 28-37 27-38 23-33 26-31 29-38 2&38 
C tropicalis 26-37 20-31 NR NR 2 6 3 7  NR R NR 
NR = not recommended. 
Conclusions: Q C  ranges for disk difision tests of F and V using MHA 
containing G and h4B are proposed. 
101281 Antifungal susceptibility testing by the National 
Committee for Clinical Laboratory Standards of Candida 
species isolates from blood cultures in hospitalized patients 
C. A. Venturelli, G. Bedini, C. Guaraldi, A. Casolari, M. La Regina, 
L. Codeluppi, C. Piccinini, R. Mussini, E Esposito and I. Rumpianesi 
Modena, I 
Objective: The aim of the study was to institute a prospective surveillance 
program for Candida species isolated h m  blood cultures of patients adrmtted 
at the University Hospital of Modena and to determine the invitro activity of 
four antifungal agents against the yeast isolates. 
Materials and method: Data were collected between January 2000 and 
October 2001. The susceptibility testing was performed by a broth micro- 
dduition method following the recommendations ofthe National Committee 
for Clinical Laboratory Standards (document M27-A) guidelines; the anti- 
fungal agents tested were fluconazole, itraconazole, amphotericin B and 
flucytosine. One reference strain, C. krusei ATCC 6258, was included to 
ensure quality control. 
Results: During the study period the distribution of the species was as follows: 
17 (57%) C. albicans, five (17%) C .  parupsilosic, three (10%) C. tropicalis, two 
(7%) C.glabrata, one (3%) C.pelliculosu, one (3%) C.guillennondi, and one 
(3%) C. h s e i .  Resistance to fluconazole (>64 pg/mL) and itraconazole 
(>1 pg/mL) was observed in 10% (two C. albirans, one C. tropicalis) and 
17% (two C. tropicah, one C.pelliculosa, one C.glubrutu, one C. krusei), 
respectively. The resistance to fluconazole was correlated with antifungal 
prophylaxis (fluconazole 100 mgper day). Only, 3% (one C. tropicalis) of these 
isolates were found to be resistant to flucytosine (> 32 pg/mL) in a patient 
with hematological neoplasia. In our series, there were not Candidu species 
resistant to amphotericin B. 
Conclusion: Results in this study, consistent with those obtained by others’ 
studies, suggest the prominent role of C. albicum, but also the importance of 
non-C.albicans species in bloodstream infections and the emergence of 
anhfungal resistance among the Candida spp. For this reason, it has become 
prominent for &agnostic laboratories to perform susceptibility testing of yeast 
and to monitor trends, although adjustments regarding methodology and 
interpretation are s t i l l  proposed with a relevant impact on the frequency 
of resistance reported. Continued monitoring of these trends is important as 
we strive to control and optimize therapy of BSI attributable to Candidu 
species. 
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Molecular diagnostic methods of tuberculosis 
The DNA extraction method critically affects PCR 
sensitivity for the diagnosis of tuberculosis 
D. Houhoula, J. Papaparaskevas, S. Nlkolaou, E. Vogiatzakis, 
N. J. Legakis and L. Zerva 
Athens, GR 
Objectives: Rapid diagnosis of Myrobactm’um tubercufosk is of extreme clinical 
importance, however, culture techniques have a very long turnaround time 
and acid-fast stains (AFS) are not sensitive. PCR techniques provide fast and 
accurate results but are reported to lack sensitivity in AFS-negative specimens. 
A critical factor influencing PCR performance is the DNA extraction 
protocol applied. The purpose of the study was to evaluate three Merent 
methods of DNA extaction in culture-positive, AFS-negative clinical speci- 
mens. 
Methods: Out of 1480 consecutive clinical specimens, 38 from 30 patients (31 
sputum, 2 bronchoalveolar lavage and five gastric aspirate samples) were found 
to be culture-positive but AFS-negative, and were retrospectively tested using 
an in-house PCR protocol. This protocol amphfies a 123-bp sequence of the 
IS6110 segment of the M. tuberculosis complex and its analyhcal sensitivity 
corresponded to 89 fg DNA. Extraction was performed using two commer- 
cial kits, the QIAamp DNA Mini Kit, Qiagen, Germany with some 
modtfications and IsoQuick, Orca, USA, as well as a modified in-house 
developed method, Boom’s protocol. All DNA samples were additionally 
tested diluted 1/10 to detect PCR inhibition. The amplification products 
were electrophoresed in a 2% agarose gel and visualized under UV illumina- 
tion. 
Results: Thirty-two out of 38 samples were PCR-positive using the QIAamp 
method, 25 using the IsoQuick method and 22 with the Boom’s protocol 
corresponding to assay sensitivities of 84.2, 65.8 and 57.9%, respectively. 
Testing the samples diluted 1/10 increased sensitivity with all methods; 1, 1 
and 3 additional samples were found positive, respectively. All three methods 
evaluated were easy to perform but turn-around time was 1 h longer with 
QIAamp in comparison to IsoQuick and Boom (45 min only), owing to an 
additional enzymatic incubation step. Finally, the costs of the respective 
protocols corresponded to € 3.52, 2.06 and 1.08 per test. 
Conclusions: Even in samples with low bacillary counts as characteristically 
are culture-positive and AFS-negative samples, molecular diagnosis of tuber- 
culosis by PCR can provide very sensitive results. It appears that the DNA 
extraction method critically affects assay sensitivity. The modified QIAamp 
DNA Mini Kit proved to be the most sensitive of all methods. 
[0130] Comparison of the molecular identification of 
mycobacteria by use of the RIDOM, MicroSeq, GenBank and 
RDP-II databases 
C. Y. Turenne, D. Harmsen, T. Pfeuffer, E. Richter, J. Albert, A. Kabani, 
K. C. Carroll and J. L. Cloud 
Winnipeg, CAN; Wurz6uq, Borsfel, 0; Salt Loke City, USA 
Objectives: Molecular identification of mycobacteria provides two primary 
advantages to phenotypic identification: rapid turn-around time and 
improved accuraq. The information content of the 5’-end of the 16s rRNA 
gene is sufficient for identification of most mycobacterial species. The 
RIDOM service (http://www.ridom.de/) is in the process of making freely 
available a comprehensive database much like that of the high-quality 
commercial database McroSeq. 
Methods: An evaluation was performed to demonstrate the qualzty and 
accuracy of results provided by two specialised databases (RIDOM version 
1 .O and MicroSeq 500 vs. 1.4.1) and the more general GenBank and RDP-I1 
databases. The newly determined sequences h m  the ATCC Mycobacterium- 
type strains (n = 79) and &om clinical isolates (n = 94) were analyzed by these 
databases. 
Results: AU of the type strain sequences analyzed hy RIDOM were correct 
with 100% similarity. MicroSeq does not include all sequences of established 
species, such as M. lent@wm as well as many of the most recently described 
species. Consequently, a few type strains were misidentified. In contrast, only 
23 and 25% of species had a prefect match with sequences from GenBank and 
RDP-11, respectively. An overwhelming 39 and 34% of the type s t r a i n  
sequences were not given-top scotes against GenBank and RDP-11, respec- 
tively. Therefore, these strains would have not been correctly identified. 
Querymg the dtfferent databases wlth the 94 cltmcal isolate sequences, 
RIDOM gave in 92.5% a perfect match, whereas WcroSeq ylelded this 
result only m 73.4% of aU cases. Only, 4.3% of all RIDOM results had a 
sidarity equal or below 99%, whch we regard as the threshold for the 
reporang criteria of a ‘duhnct spenes’ McroSeq fded  in 12.8% to surpass 
t h  threshold GenBank and RDP-I1 agam deltvered results insufficient for 
rehble dngnoss of Mycobactmum species 
Conclusion: Whereas both the McroSeq and RIDOM databases provlde 
(espeually m comparlson to GenBank and RDP-11) excellent resub for the 
majority of mycobacterd isolates, RIDOM is not only fieelpr accessible but 
also is sigmficantly more exhaustwe Therefore, the RIDOM service IS an 
excellent tool for all laboratories wlth sequencmg capacihes 
101311 Use of real-time PCR for detection in clinical 
samples genetic polymorphism causing resistance to 
isoniazid and rifampin in M y w b c t ~ i u m  tubeKuloris 
M Espasa, J. M. G o d e z ,  F. Alcade, J. Lonca, X.-M. Manterola, 
E Verdir and €? Call 
i3arcelana, Hospitakt de Llobregat, Badalona, E 
Objectives: Development of a detechon system in c h c d  samples of genehc 
mutahons causing r e s m c e  (r) to isomand (€3) and h p b m  (R) m Myrc- 
bacterium tuberculosrs (MTC). 
Methods: From 1999 to 2001, we collected samples from pahents mth MTC 
isolates and stuhedthe suscephbhty pattern to first line anhtuberculous drugs 
(radlomeaic method). Based on a prevlous s t u d y  describbmg the most 
common genehc mutatlons causlng resistance to H and R m our geognphc 
area, we designed probes mth fluorescence molecules (Taqman probes) to 
detect pomt mUMhOIlS m c315 ofthe katG gene, ribosome-bmdmgsite ( R B S )  
ofrnhA locus and ~ 4 3 2 4 5 8  ofrpoBgene. Aprobe homologous to IS61 lowas 
designed as amphfIcahon control. We used a real-hme PCR detechon system 
(ABIPRISM 7700). 
Standsrdiition: To detemune the specificity of the method we used 61 
SWS wlth known mutahons bm the studied genes. The semhvlty was 
analyzed preparing samples unth known moculum of MTC. 
Detection in clinical samples: The DNA of c h c d  samples was extracted and 
each gene was amphfied. Target genes were sequenced m resstant stmns. 
Results: The study of previously typed strams showed that thts method had 
100% specificity 111 detechon of known point mutahons m each gene. The 
threshold of detechon was about lOOOcfu/mL. 
Detection in clinical samples: We analyzed 91 samples (52 pahents) mth a 
H-r stram, 27 samples (11 pahents) with a R-r stram and 126 samples (126 
patients) wlth a SenBhve stram used as a control group. The overall detectlon 
senslhvlty in poslllve Ziehl-Nielssen chmcal samples was of 97%. bemg 400/0 
m negahve smn samples. This method detected directly from chnical samples: 
78%(14/18)stra~nsmthc315 katGgenemutahon, 68%(13/19)mthanRBS 
inhA locus mutahon and 67% (10/15) H-r stmns wthout mutahons m these 
posihons, and 100% (1 1/11) strams mth mutahon m c432-458 of y o B  gene. 
These results were corroborated mth sequenciahon of studled genes. T h  
study detected 52% of H-r-mutated smns  and 1OOOh of R-r-mutated strams. 
Conclusions: Development of a methodology able to rapidly (48 h) detect in 
chmcal samples the presence of the most fiequent mutahons causmg H-r and/ 
or R-r (detechon of 60% of the possible mutated resutant strams) This 
methodology may thereby allow moddicahon of anhtuberculous treatment to 
avoid relapses, transmion of resistant strains and improvement m the prog- 
noss of pahen& 
1 01 32 1 Use of multiple genetic markers to study evolution 
of the Mycobacterium Fubercu/osis Beijing family in 
North-western Russia 
I Mokrousov, 0 Narvskaya, E Limeschenko, A Vyazovaya, 
T Otten and B Vishnevsky 
St Petersbuq, RUS 
Objective: To study genehcd polymorphsm and evoluhon of the Mycobacter- 
rum tuberculosis Beqng f d y  in North-western Russia, where ths genotype IS 
prevalent in up to 50% of c h c a l  st rams 
16 Abstracts 
Methods: PCR, PCR-RFLP and hybridization analysis of the direct repeat 
(DR) locus, IS61 IO.IS1.547, katC463, Rv3 135-PPE, and my40 sequences. 
Results: A total 195 of the 394 strains stumed in 199&2001 were of the 
Beijing genotype as defined by spoligotyping (signals 35-43). A total of 98% 
of these Beijing strains (typical) were closely related by IS6 1 1  0-RFLP 
(DR > 0.8), five strains (two distinct profiles, 'atypical') were more distant 
&om the rest (DR 0.6). The IS61 10-RFLF-based NJ-tree showed the 
branchs' lengths considerably longer for the atypical strains.T*ical strains 
had two IS1547 copies, one of them with forward left-arm IS61 10 insertion, 
and I-kb Rv3135gene. Atypical strains had a single intact 151547 copy, and 
1.9-kb Rv3135 gene. The IS1547 copies (both in typical and atypical strains) 
differed fiom the published IS1547 sequences of H37Rv, CDC1551 and the 
Beijing strains &om Thailand. All the strains had kafC463Leu allele and intact 
mfp40. 
New drugs 
Conclusions: AU the Bei j ing fdy  M. tuberculosis strainscurrently circulating 
in the North-west ofRussia are relatively ancient, and may present a particular 
separate subgroup within this genotype endemic for this region since the very 
evolutionary time. Atypical Beijing strains (2% of s&) are evolutionary 
older, but do not seem to be the ancestral; they might have a common 
(unknown) predecessor with typical Beijing strains. The DR locus structure 
of the Beijing-type is extremly conserved since the evolutionary distant time. 
Sequence changes in IS1547, Rv3135 and mtp40 are too deply rooted to 
correlate with recent evolution events in this genetic family. Recent and 
ongoing clonal dissemination of the drug-resistant Beijing strains with high 
copy number of IS61 10 could be owing to the IS61 ICLmediated genome 
rearrangements and could reflect one specific course of adaptation to the 
host. 
[ 01 33 1 Multivalent drug design: synthesis and in vitro 
analysis of an array of vancomycin dimers 
J. Griffin, M. Linsell, M. Nodwell, Q. Q. Chen, J. Pace, K. Quast, 
K. Krause, L. Farrington, T. Wu, D. Higgins, T. Jenkins and J. K. Judice 
South San Francisco, USA 
Objectives: The design, synthesis, and in vitro microbiological analysis of an 
array of 40 covalently linked vancomycin dimers is reported. This work was 
undertaken to systematically probe the impact of linkage orientation and 
linker length on biological activity against drug-resistant and drug-sensitive 
Gram-positive pathogens. 
Methods: To prepare the array, monomeric vancomycin synthons were linked 
through four distinct positions of the glycopeptide (C-terminus (C), N- 
terminus (N), vancosamine residue 0, and resorcinol ring (R)) in 10 unique 
pairwise combinations. Peptide-basedlinkers offour different lengths (1 1,19. 
27, and 43 atoms) were employed. 
Results: The in vitro susceptibility studies revealed several key results. First, 
both linkage orientation and linker-length substantially impact antibacterial 
potency in vitro. Second, the effects oflinkage orientation are not monotonic; 
i.e. no linkage series displays activity that is either uniformly superior or 
inferior to that ofvancomycin against all test organisms. For example, whereas 
all series have at least one compound that displays enhanced activity against 
enterococci and penicillin-resistant Sfreprocom pneumoniae, only compounds 
in the V-V Linkage series display even modestly enhanced potency against 
glycopeptide-intermediate-resistant S. aurew. Third, the C-C, C-V, and 
V-R series display the most promising broad-pectmm activity among those 
studied, whereas the N-N series is the least potent overall. Fourth, three 
categories of linker length effects on activity were observed-no effect, 
maximal potency at shorter lengths, or maximal potency at intermediate 
lengths. 
Discussion: The results are interpreted in terms of a mechanistic model in 
which covalent dimeriation can provide both gains and losses of function 
relative to vancomycin itself. Gains of function may accrue as a result of 
enhanced afijnity for target (depsi)peptide ligands, while losses of function 
may result fiom disruption of antibacterial effects that do not involve 
association with these ligands. 
I 01 34 1 Antibacterial activity of two dimeric vancomycin 
analogues, AM1 462 and AM1 905: lack of correlation 
between MIC and bactericidal activity 
J. Pace, K. Quast, Q. Chen, M. Linsell, K. Krause, L. Farrington, 
M. Nodwell, M. Leadbetter, T. Wu, D. Schmidt, E. Mayberry, 
E. Soriano, P. Fatheree, B. Bazzini, J. Combs, M. O'Keefe, K. Kaniga, 
B. Phi, J. Bao, D. Gao, D. Higgins, J. Griffin, B. Christensen, 
D. Karr and K. Judice 
Soufh San Francisco, USA 
Objective: To evaluate and compare the antimicrobd activity of two dimeric 
vancomycin analogues with clinically utilized compantor agents against both 
vancomycin-susceptible and -resistant bacteria. 
Methods: Minimal inhibitory concentration (MIC) and minimal bactericidal 
concentration were determined utilizing the broth microddution method as 
per NCCLS guidelines against Staphylococcur spp., Sfreptococcus spp., and 
Enteroco~u5 spp. Studies of resistance induction in VanB enterococci were 
performed by preincubation of bacteria with subinhibitory concentrations of 
vancomycin or the agent under study before determination of the MIC. 
Bactericidal activity was also determined by time-kill method. Post-antibiotic 
effect (PAE) following exposure for one hour at MIC was also determined. 
Results: AM1 462 was more active against the staphylococci with lower MICs 
than vancomycin, however, it did not exhibit activity against the enterococci. 
AM1 905, while exhibiting similar to slightly higher MICs than vancomycin 
against the staphylococci and streptococci, was active against even VanA 
enterococci. Utihzing induction studies, the reason for the difference was 
partially elucidated. Growth of VanB enterococci in the presence of sub-MIC 
vancomycin or AM1 462 itselfinduced resistance to AM1 462 but not to AM1 
905. It was also observed that while MICs ofAMI 462 were lower against the 
staphylococci as compared to AM1 905, AM1 462 was bacteriostatic in 
contrast to the bactericidal AM1 905. Interestingly, M I  905, while bacter- 
iostatic against the VanA enterococci, exerted a substantial PAE. 
Conclusion: Through a multivalent approach, introduction of a substituent 
group into an inhibitor molecule which may also bind to the same site or 
concomitantly another target, greater affinity, and thus the inhibitory activity 
might be expected. In the case of antibacterials, one may consider applying 
this principle to salvage agents to which resistance has developed. Our findings 
with AM1 462 and AM1 905 strongly suggest that antibacterials with novel 
properties can be created ftomknown compounds and utility may be regained 
or improved. 
Equivalence of shorter course therapy with 
oritavancin compared to vancomycinkephalexin in 
complicated skinlskin structure infections (CSSI) 
M. Wasilewski, D. Disch, J. McGill, H. Harris, W. O'Riordan, 
M. Zeckel and J. Loutit 
Indianapolis, San Frunci'q LJolka, Brisbane, USA 
Objective: To determine the efficacy of oritavancin (0), an investigational 
semisynthetic glycopeptide with bactericidal activity in vim against the 
Gram-positive pathogens, as compared with vancomycidcephalexin in 
the treatment of complicated skin, soft-tissue infections. 
Methods: Phase 3, double-blind, randomized study of 517 patients with CSSI 
caused by Gram-positive pathogens. Patients received 0 1.5 or 3mg/kg (3- 
7 days i.v., then oral placebo) or vancomycin 0 15 mg/kg/dose (3-7 days 
i.v., then oral cephalexin) for total therapy of 10-14 days. Signs/symptoms of 
infection, blood and local culture specimens, and safety assessments (vitals, 
ECG, labs, adveme went (AE) monitoring) were assessed at baseline, on- 
therapy, and at early and Iate follow-up. 
Results: Efficacy was equivalent between the two 0 doses in all analyzes. In an 
intent-to-treat analysis of dosed patients (N=480), 63% 0 and 65% V 
patients had successful clinical outcome (cure or improvement), 95% CI 
(-0.115, 0.076). Of the clinically evaluable patients (N=384), cellulitis, 
major abscess, or wound/burn/other was the diagnosis in 160 (42%), 143 
(37%), and 81 (21%) patients, respectively. Of these 384 patients 76% 0 and 
80% V patients were clinically successful, 95% C1 (-0.139, 0.048). Of 
clinically evaluable patients with MRSA (N=33), 74% of 0 and 80% of 
V patients were clinically successful. In bacteriologically evaluable patients 
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(N= 25-16), 74% 0 and 76% V patients had successful bacteriologic outcome, 
95% CI (-0.144, 0.097). S. aureus was the most common organism isolated, 
identified as the sole pathogen in 100 (39%) ofbaseline cultures. Relapse rates 
ofqualifiedpatientsatlate follow-upwerel0, 4,andS%forO 1.5,O 3,andV, 
respectively. The AE profile was sixxdar between treatment groups. The mean 
total therapy length for 0 1.5, 0 3, and V was 5.3, 5.7, and 11.5days, 
respectively. 
Conclusion: Oritavancin i.v. therapy for 3-7 days was equivalent to vanco- 
mycin/cephalexin therapy for 10-14 days in a phase 3 study of CSSI caused by 
Gram-positive pathogens, including MRSA. 
Combination studies of shortshain cecropin 
A-melitin hybrid peptides with different antibiotics against 
multiresistant Acinetobacter spp. by killing curves 
T. Alarcon, J. Saugar, L. Rivas, D. Andreu, L. Perez and M. Lopez-Brea 
Madrid, Barcelona, E 
Objectives: To study the combination of difFerent peptides with antibiotics 
against Acinetobacter baumanrtii by using killing curves. 
Material and methods: Two A. baumnnnii strains, a susceptible (ATCC 
19606). and a multiresistant strain were studied. CA(1-8)M(1-18), a synthetic 
cecropin A-melittin hybrid peptide (KWKLFKKIGIGAVLKVLTTGLPA- 
LIS-NH2), and three short-chain peptides: CRIS2 (KWIUFKKEKVL), 
CRIS3 (KWKLLKKIGAVLKVL) and CRIS7 (WKLLKKILKIL) were tested 
in combination with tobramycin (TOB), imipenem (IMP), fosfomycin (FOS) 
or colistin (CT). Peptides and antibiotics were tested alone and in combina- 
tion at the following concentrations: 1 p~ for CA(1-8)M(1-18) and CRIS2, 
0.5pMn for CRIS3 and CRIS7,8 mg/L for TOB, 40 mg/L for IMP, 130 mg/ 
L for FOS and 8 mg/L for CT. Antibiotic concentrations were chosen as the 
peak concentration found in human serum after normal doses. Tube controls 
and tubes with one or two agents were inoculated simultaneously to achieve a 
final concentration of 10(5) to lO(6) cfu/mL.. Viable colony counting was 
performed at 0,1,2,6,  and 24 h. Synergy was defined as a 1 2  log 10 c f u / m L  
decrease of combination compared with the most active single. 
Results: Indifference was observed with CA(l-8)M(1-18) combined with 
TOB, IMP, CTand FOS in the susceptible strain. The same peptide studied in 
the resistant strains showed synergy in the combination with TOB and 
indifference with the others combination. CRIS2 showed indifference 
associated with TOB, IMP and CT in both susceptible and resistant strains. 
When associated with FOS antagonisms were observed in both strains. 
CRIS3 showed indifference associated with TOB, IMP, CT and FOS in 
the susceptible strain. The combination with TOB, W, CT showed synergy 
in the resistant strain. The combination with FOS was indifferent. CRIS7 
showed indif€erence associated with TOB, IMP, and CT, but showed 
antagonism when associated with FOS in the susceptible strain. The combi- 
nation with TOB, IMP, CT showed synergy in the resistant strain but the 
combination with FOS was indifferent. 
Conclusions: By using killing curves, CA(1-8)M(1-18) showed synergy 
when combined with tobramycin in a rnultiresistant A. baumannii strains. 
Two short-chain derivatives (CRIS3 and CRIS7) showed synergy in the 
resistant strain when combined with tobramycin, imipenem and colisM, 
suggesting a future potential use for these peptides. 
Linezolid 
101371 Susceptibility of Gram-positive bacteria from ICU 
patients in UK hospitals to linezolid and other antimicrobial 
agents 
A. P. Johnson, S. Mushtaq, D. James, C. J. Henwood and 
D. M. Livermore 
London, UK 
Objectives: To determine the prevalence of resistance to antimicrobial agents, 
including linezolid, among clinically significant Gram-positive cocci f h m  
ICU patients in the UK hospitals. 
Methods: Microbiologists in 25 sentinel laboratories in the UK were 
asked to refer up to 100 consecutive, clinically significant, Gram- 
positive cocci isolated fiom ICU patients. Isolates were identified and 
subjected to MIC determinations by the British Society for Antimicrobial 
Chemotherapy method for a range of antimicrobial agents including 
linezolid. 
Results. A total of 161 3 isolates were collected, comprising predominantly 
S. uurem (47.6%), coagulase-negative staphylococci (CNS) (30.6%), entero- 
cocci (14.4%). streptococci (3.5%) and pneumococci (2.7%). The remainder 
comprised diptheroids, Bacillus spp. and a Nocardia. Among the S. aureuj 
isolates, 60% were oxacillin-resistant, as where 81% ofthe CNS. Vancomycin- 
resistant S.aureus were not detected although three isolates (0.4%) were 
resistant to teicoplanin (MICs 8 mg/L). In contrast, 14% of the CNS were 
resistant to teicoplanin (MICs 8-32 mg/L), with 1% resistant to vancomycin. 
Among the enterococci, 72% were E.f;tccalis and 25% were E.faecium, the 
remainder comprising E .  carselfivus or E.gullinarum; 18% of the E.faen'urn 
were vancomycin-resistant compared to only 3% of the E.faecalis. Rates of 
high-level gentamicin resistance in E.frtecalis E.faecium were 25 and 40%, 
respectively. Among the streptococci and pneumococci, 11 and 9%, respec- 
tively, were resistant to penicillin, whdst 13 and 7% were resistant to 
erythromycin. None of the isolates showed resistance to linezolid, with 
the MICs for the entire study population falhng in the range 0.5-4 mg/L. 
Conclusions: Resistance to first-line antimicrobial agents is a major 
problem among Gram-positive bacteria occurring in the UK ICUs. The 
dominance of methicillin-resistant staphylococci is, especially st rdung,  as is 
the fkequent vancomycin resistance in E.faecium. Although resistance to 
linezolid has been reported in enterococci and in one MASA isolate, these 
data indicate that such resistance is s t i l l  extremely rare in the UK, and that the 
drug is a potentially useful option for Gram-positive infections in ICU 
patients. 
101381 Linezolid in the treatment of methicillin-resistant 
5. aureus infection 
L. Ferrer, J. de Otero, S. Elia, M. Sandiumenge, E. M o n d  and 
F. Ferrer-Ruscalleda 
Barcelona, E 
MRSA infection is a serious problem associated with big epidemiological and 
economical impact. The development of new drugs like linezolid give new 
chances in MEGA infection management. 
Objective: To analyze the effect of linezolid in the treatment of MRSA 
infection compared to glycopeptides and its influence on mortality rate, 
number of admissions and length of stay. 
Meth0ds:Prospectivestudyincludingpatient~Ainfectiona~~edto 
our hospital between January 2000 and October 2001. Assiptomatic carriers 
and patients prematurely dead were not included. Periodical clinical and control 
cultureswere performed during follow-up. We collected baseline characteristics, 
length of stay (from MRSA dugnosis to &charge), m o d t y  rate and number 
of persistant carriers. Dsrences between patients receiving hezolid 01 
glycopeptides were analyzed using ANOVA tests and bivariate correlation. 
Resufts: Thirty-six patients were included, median age 73.9yean (48-95), 19 
(52.7%) were female, site of mfection: 66% soft tissues, 11% respiratory 
tract, 11%cardiovascularand8%surgicalwound.Ninepatientsreceivedlinezolid 
that was well tolerated. Few adverse events were observed. In this group, median 
length of stay was 10.3 days, and during the follow-up five patienk were read- 
mitted, four were found to be persistent carriers, none died and three needed 
social support. Linezolidreduced length ofstay: 10.3 day versus 23.8 (P= 0.01); 
reduced number of persistent carriers: 4 versus 12 ( P =  0.045); and showed a 
tendency to reduce mortality rate (P=0.079) compared to glycopeptides. 
Multivariate analysis disclosed that linezolid had an independent effect on the 
reduction oflength of stay (P= 0.008). 
Conclusions: Linezolid reduced length of stay in MRSA infected patients, 
reduced the number of persistent carriers and showed advantage in the 
treatment of this infection compared to glycopeptides. Linezolid was well 
tolerated with few adverse events. 
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vj Linezolid vs. vancomycin in nosocomial 
pneumonia: prospective surveillance for appearance of 
vancomycin-resistant enterococci in stool 
S. K. Cammarata and T. H. Oliphant 
Kalarnezoo, USA 
Objective: The emergence of vancomycin-resistant enterococci (VRE) has 
been associated with the use of vancomycin (vanco). To monitor for the 
appearance ofVRE during vanco use, we prospectively cultured rectal swabs 
during a comparison of vanco versus linezolid (LZD) in the treatment of 
nosocomial pneumonia (NP). 
Methods: Patients with NP were randomized to treatment with LZD 
600 mg/12 h every day or vancomycin 1 g/12 h every day for up to 21 days. 
Patients could receive aztreonam for Gram-negative coverage. Rectal swabs 
were obtained at baseline and at EOT and were cultured for the presence of 
VRE. 
Results: A total of 623 patients (321 LZD, 302 vanco) were treated; 585 (304 
LZD, 281 vanco) had rectal swabs collected at both baseline and EOT. The 
incidence of VRE at EOT in prospectively cultured patients without VRE at 
baseline was 1/288 (0.3%) for LZD compared with 15/267 (5.6%) for vanco 
(P<0.001). Average length of therapy in all treated patients was 9.5 and 
9.4 days for LZD and vanco, respectively. The LZD-treated patient newly 
colonized with VRE at EOT was treated for 4days. The 15 vancomycin- 
treated patients who became colonized with VRE were treated for an average 
of 11 days (range 6-21 days). 
Conclusion: During h s  prospective Np study, rectal swabs collected before 
and after treatment revealed one LZD-treated patient who became colonized 
with VRE during treatment, while the conversion rate was significantly 
higher (5.6%) for vanco-treated patients. Conversion in the vanco group was 
associated with a longer duration of therapy. 
/0140j Comparison of hospital resource use between 
linezolid and teicoplanin for the treatment of Gram-positive 
bacterial infections: results of a multicentre trial 
J. Li, D. Balan, R. Willke, E. MozafTari, B. Rittenhouse, B. Hafh  and 
D. Nathwani 
Kalamazoo, Peapack, USA; Dundee, UK 
Background: Linezolid (LZD), a novel oxazolidinone antibiotic available in 
intravenous (i.v.) and 100% bioavdable oral forms, is as eEective as standard 
therapies, including vancomycin, in the treatment of Gram-positive infec- 
tions. LZD has been shown to reduce hospital resource use when compared to 
vancomycin (Pharmacotherapy 2001; 21: 263-74). 
Objective: Compare i.v. days of study medications (i.v. duration), length of 
hospital stay (LOS) and hospital-discharge rate (HDR) between LZD and 
teicoplanin (TEI), a widely used alternative to vancomycin, for the treatment 
of Gram-positive infections in an open-label, multicenter randomized trial, 
which showed that LZD had sigmficantly better eficacy, especially in 
bacteremia (ICAAC 2001; poster L-1481). 
Methods: In this trial, 430 hospitalized patients with pneumonia, complicated 
skidsoft tissue infection, or bacteremia caused by Gram-positive bacteria 
were treated with LZD (i.v. followed by optional oral) or TEI (i.v. followed 
by optional intramuscular). Patients received up to 4weeks of treatment 
followed by up to 3 weeks of observation. Anthmetic mean, Kaplan-Meier 
survival function adjusted mean and median, and proportion were used for 
i.v. days, LOS, and HDR, respectively. Between-treatment differences in 
these measurements were tested with Student’s f-, Wilcoxon’s, and X2-test, 
respectively. 
Results: See Table 1 below for the total intent-to-treat sample results. Though 
not shown in the table, bacteremia patients (n = 32 + 33) treatedwith LZD had 
much shorter LOS (KM mean: 18.8 vs. 23.7; KM median: 17 vs. 25) though 
the difference was not statistically sigdcant owing to limited sample size. 
Table 1 The total intent-to-treat sample results 
LOS Patienu dischugcd dap (%) 
Study i.v.&y m m e m  KMmedian 
Median N nim (*sE) (95% CI) 7 14 21 28 
LZD 215 6.2 13.3 (0.83) 9 (8-10) 35 67 80 87 
TEI 215 9.4 14.7 (0.87) 10 (Gll)  27 63 74 83 
P-value 0.000 0.20 0.08 0.31 0.14 0.22 
Conclusion: LZD patients tended to have shorter LOS and hgher HDR in 
the first week, especially for bacteremia, possibly due to LZD group’s 
significantly shorter i.v. duration. 
Experimental infections 
(01411 Rifampin + ceftriaxone decrease lipoteichoic acid 
CSF concentrations and reduce neuronal damage compared 
to ceftriaxone alone in experimental S. pneumoniae 
meningitis 
J. Gerber, V. Sander, S. Bunkowski and R. Nau 
cd%lingen, D 
Objectives: Rifampin @IF) releases smaller quantities of lipoteichoic acids 
(LTA) &om S.pneumoniae than cefmaxone (CRO). Owing to the rapid 
development of resistance, RIF cannot be used as a single agent for therapy 
ofbacterial meningitis. For this reason, we studied the effect of an initial FUF 
therapy followed by the combination RIF + CRO in the rabbit model of 
meningitis. 
Methods: NZW Rabbits were infected intracisternally with a S.pneumoniae 
type 3 strain. At 12h after infection, treatment was started with RIF 
(10mg/kg bolus, 5 mg/kg/h maintenance dose), 6 h  later CRO was added 
(20 mg/kg followed by lOmg/kg/h). Controls received CRO (20 mg/kg 
followed by lOmg/kg/h). Bacterial titen, leukocyte densities (WBC), LTA, 
lactate and protein concentrations were determined at 12, 14, 18, 20, and 
24 h. Density ofneuronal apoptosedmm’ were quantified in the granule layer 
of the dentate g y m s  by in situ-tahg. 
Results: Bacterial titers were effectively reduced in both p u p s  
(Alogcfu/mL/h f SD =0.64 f 0.16 [CRO] vs. 0.42 zk 0.15 m). Release 
of LTA was lower in rifampin-pretreated animals. Median of A12-14h 
(ng/mL) was -0.1 (&om -6.8 to 3.6) vs. 0.7 (from -0.2 to 35) 
(P=O.Ol).  When CRO was added 18 h after mfection, LTA concentrations 
in CSF did not increase (median of A 18-20h: 0.1 [from -1.6 to 3.21). 
Density of neuronal apoptoses was laver after combination therapy (median: 
37.8/mm2 [9.9-90.21 VS. 67.3/mm2 [32.7-183.71 P=0.03). The CSF lac- 
tate/protein concentrations and WBC increased during the course of the 
experiment (no Werences between treatment groups). 
Conclusion: Initial therapy with RIF followed by a combination of 
RIF + CRO, which is suitable to prevent rapid development of resistance, 
is capable of reducing the release of proidammatory compounds and 
neuronal damage in bacterial meningitis. 
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/0142) In vivo foreign body infection induces an 
exponential decrease of protein synthesis in Staphylococcus 
epidennidis 
S. J. Vandecasteele, W. E. Peetermans, R. Merckx and J. Van Eldere 
Leuuen, B 
Objectives: Coagulase-negative staphylococci (CNS) can cause persistent 
infections in association with foreign bodies. The exact cause of this persistent 
nature remains unclear, but a state of bacterial dormancy is hypothesised as a 
contributing factor. The aim of this study was to evaluate overall bacterial 
metabolical activity during in vivo foreign body infection. Therefore the 
expression of the 16s gene, which is known to be the rate-limiting step in 
bacterial protein synthesis, was followed. 
Methods: Catheter segments (n= 175) were inoculated in vitro with S. epi- 
dermidis in exponential growth phase and immediately implanted subcuta- 
neouslyin rats. The catheters were removed after 15 min, 1 ,2 ,4 ,6 ,12  h and 1, 
2, 7 and 14days. Directly after explantation, an instant RNA and DNA 
isolation was performed using a Fastprep=-based protocol. RNA (translated in 
cDNA) and genomic DNA (gDNA) were quantified with Taqman quanti- 
tative PCR to determine the expression ofthe 16s gene given by the cDNA/ 
gDNA quotient. 
Results: 16s expression decreased rapidly after implantation of the catheters 
in vivo (one-way ANOVA: P<O.0001). The decrease in expression was 
ex onentially and given by the formula: expression = 525 x time-' 7883, with 
R = 0.96. Average expression was 48.4 (15 min), 27.4 (1 h), 20.1 (2 h), 4.2 
(3 h), 6.5 (6 h), 2.7 (12 h), 1.09 (1 day), 1.3 (2 days) and 0.3 (I and 2 weeks). 
Differences between early and late expression levels were sigmfkant (Bon- 
ferroni test: P <  0.001). 
Conclusion: In vitro, early adhesion to foreign bodies provokes a significant 
increase in 16s expression [ICAAC 2001 abstract 957. In vivo, f6S expres- 
sion in CNS attached to foreign bodies declines e x p o n e n d y  dxectly after 
implantation of the foreign body. Thus, the in vivo environment induces a 
rapid decline in protein synthesis in CNS attached on foreign bodies, and very 
low levels are reached within 1 day. These findings add strong evidence to the 
hypothesis that during the in vivo foreign body infection the majority of 
adherent CNS enter a state of metabolical dormancy. This may explain the 
limited benefit of antibiotics that act on cell wall and protein synthesis for the 
eradication of long-standing CNS foreign body infections. 
P 
jo143/ Studying the role of Staphylococcus aureus 
coagulase in experimental endocarditis (EE) by transfer and 
expression in Lactococcus lactis 
Y. A. Que, J. A. HaeAiger, J. M. Entenza, J. Vouillamoz, P. Francioli and 
€? Moreillon 
Lausanne, CH 
Background: Studies with Coa-inactivated S.  aureus failed to identie a role for 
t h s  factor in EE. In these experiments, redundant S.  aureus virulence factors 
could have masked the Coa defect. Here, we studed the intrinsic role of Coa 
by expressing it in the low pathogenic L. factis. Coa + L. l a d s  were tested in 
vim and in rats with EE, and compared both to the parent, and to L. factis 
expressing the S.  aureus fibronectin binding protein A (FnBPA). 
Methods: The coa andfnbA genes were constitutively expressed in L. lads 
using the pOri23 vector (Infect. Imniun. 2000; 68:3516). Parent and 
Molecular diagnostics (Symposium organized by ESGMD) 
js145) Clinical virology in real time 
H. Niesters 
Rotterdam, NL 
The abhty to detect nucleic acids has had and shU has a maJor lmpact on 
diagnoshcs m wology. Both quanhtahve and quahtahve techruques, whether 
signal or target amphficahon based systems, are currently used routmely in 
most If not all wology laboratories. Technological ~mprovements, &om 
automated sample isolahon to real m e  amphficahon technology, has given 
recombinants were inoculated to rats with aortic EE. The minimal inoculum 
infecting >SOYA ofrats (ID80) and the vegetation (Vg) bacterial densities were 
followed for 48h. Platelet-induced bacterial killing was determined by 
exposing L. ktis to platelet-rich or platelet-depleted rat plasma. 
Results: The ID80 (in CFU) were 107 (parent), >109(Coa+) and 105 
(FnBPA +). After inoculation, parent-infected Vgs maintained a low-grade 
infection (3 logcfu/g Vgs) over 48 h. In contrast, Coa + Vgs became rapidly 
sterile within 24 h, whereas FnBPA + Vgs became more heady infected 
(>8 log CFU/g Vg). In in vim, Coa + lactococci triggered plasma coagula- 
tionandIost>5 logcfd24 hinplatelet-richplasma,comparedto<210gcfu/24h 
in platelet-depleted plasma ( P <  0.0001). 
Conclusion: Constitutive Coa production in L. l a d s  triggered spontaneous 
eradication from the Vgs. The in vitro results suggest Coa-induced platelet- 
activation and consequent release of platelet microbicidal proteins. Thus, 
while FnBPA increased infectivity, Coa ws potentially delaerious for the 
microorganism. In S. aureur, this effect might be circumvented by the tight 
regulation ofthe cod gene, which is expressed only in during the early phase of 
bacterial growth. 
vl A murine model of Chlamydia pneumoniae 
infection 
M Mueller, S Poshus, I Muehldorfer, T Hartung and 
C. Hermann 
Consram, D 
Objective: Chlamydaa pneumoniae (Cp) represents an emergmg pathogen 
identhed only 12years ago. It occurs throughout the world and sero- 
prevalence in the adult popdahon is about 70% mth presumed persstence 
of the mtracellular pathogen in 80% of these. Increasmgly, aSSOCiahON of Cp 
m t h  chromc and degenerahve Asease such as asthma, m d h p k  sclerosis and 
atherosclerosis are reported The a m  of &IS study was to estabhh and 
characterize a m u m e  model of Cp infechon, m order to study pathophy- 
siology and putahve treatment regimens. 
Methods: Mice were infected intranaSay durlng anesthesia by ethylether w t h  
106 Cp/mouse At various tune-pomts after infeChOn, the bacterd burden in 
Merent  organs was determned by a novel quanhtauve red-hme PCR with a 
SenSihnty of 0 1 genome equivalents per PCR sample The development of 
anh-Cp anhbomes was followed by mcrounmunofluorescence test, wtuch 
was adapted for mce. Levels of TNF-a, IL-6 and IL-10 in bronchoalveolar 
lavage @At) and lung, as well as serum amyloid A (SAA) were determined by 
ELISA. 
Results: Intranasal apphcahon of 106 Cp resulted in an asymptomaac 
lnfechon charactenzed by a maximal bacterial burden 111 BAL on the day 
of lnfechon and rn the lung two days after infechon. No bactenal load was 
detected 11i a variety of other organs SUggeShng no systemc spread. By day 95, 
Cp were completely eramcated from BAT, and lung Notably, the course of the 
estabhshed infechon was very rmld wlth no apparent symptoms, lack of acute 
phase response (SAA) and no mduchon ofTNF-a, IL-6 and IL-10 in BAL and 
lung In serum of all dec ted  mce, anh-Cp IgG was detectable at day 18, 
indlcahng actwahon of the m u n e  system 
Conclusions: So far, there is no ewdence of persistent lnfechon of m c e  
fo l lomg smgle infechon by Cp PCR detecaon ofbacteria allows to monitor 
closely e h m a h o n  of bacterial burden. The model is currently bemg 
employed to study the anhbiohc and immunomodulatory treatment 
strategles 
the ability to develop and introduce test systems for most viruses of clinical 
interest, and to obtain clinically reIevant information needed for optimal 
antiviral treatment options. Both PCR- and NASBA-based amplification 
technologies in combination with real time detection can be used currently to 
generate results in a short turn-around time and to determine whether 
variants relevant for antiviral resistance are present. These new technologies 
now enable the introduction of the individual patient disease management 
concept. Within our clinical setting, we have introduced this, e.g. for the 
quantitative detection of Epstein Barr Virus (EBV) in T-cell depleted 
allogeneic stem cell transplant patients. This enabled us to develop models 
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for pre-emptive anti B-cell immunotherapy for EBV reactivation, thereby 
effectively reducing not only the incidence of EBV-lymphoproliferative 
disease (EBV-LPD) but the virus-related mortality. Furthermore, additional 
clinically relevant viruses can now easily be detected. It also becomes more 
feasible to introduce molecular testing for those viruses that can be easily 
detected using more classical virological methods. Prospective studies are 
needed to evaluate the meaning of additional positive samples, for which it 
seemed that these classical testing already had full clinical relevance. It should, 
however, be made clear that a complete exchange oftechnologies are unlikely 
to occur, and that some complementary technologies should stay operational. 
The implementation of these molecular diagnostics technologies furthermore 
Warrants the use and introduction of standardized materials as well as 
participation in international quality control programs. The use of an internal 
control not only ensures the accuracy of the results generated, but also is 
necessary to enable precise quantification of these results and to determine 
detection thresholds. Since so many targets do have clinical implications, 
laboratories have to use more universal internal controls before the in-house 
developed assays should be introduced in clinical virology. 
A polyphasic approach for identification of 
bacteria: the Burkholderia cepacia example 
l? Vandamme 
Ghent, B 
Polyphasic taxonomy is not a new, nor a recent development in bacterial 
classification. It arose in the early 1970s and aimed at the integration of 
d&erent kinds of data and information on microorganisms. Nowadays, it 
comprises three major elements. First, specaes demarcation is based on 
DNA-DNA hybridization experiments as described by Wayne et al. 
(1987). Second, bacterial phylogeny can be deduced h m  comparative 
sequence analysis of conserved macromolecules such as 16s rDNA. Third, 
it recognizes and uses the value of these and various other methods for 
distinguishing and describing bacteria at different taxonomic levels. The 
application of a polyphasic approach to unravel the taxonomic structure and 
relationships of Burkholderia cepacia exemphfies the strengths and weaknesses of 
a classification based on polyphasic taxonomy. It  illustrates how and why 
different techniques were used to reveal the identity over 3000 B.  repacia-like 
isolates. Simultaneously, it highhghts a painful consequence of a classification 
based on multiple parameters: identification of new or unusual isolates has 
become polyphasic too. B. cepacia is an extremely versatile organism that is 
truly considered friend and foe to humans. It is a genuinely ubiquitous 
organism that is now recognized as the most useful bacterium with a range of 
biotechnological applications including biocontrol, bioremediation and plant 
growth promotion. However, it has also become notorious as a naturally 
multiresistant and life-threatening pathogen in immune suppressed hosts such 
as cystic fibrosis patients. A polyphasic analysis including comparative 16s 
rDNA and RecA sequence analysis, DNA-DNA hybridization experiments, 
whole-cell protein and fatty acid andyses. various DNA fingerprinting 
methods, DNA base ratio determination, and biochemical characterization, 
was performed on over 3000 isolates. This study revealed the presence of 
various novel organisms that are regularly misidentified as B. cepucia. It also 
demonstrated that B. cepm'a is a complex of at least nine closely related 
organisms each representing a distinct species. Most of these nine species 
occur in the environment and are associated with human infections. Potential 
candidates for biotechnological applications OCCUI in all of these species. 
However, salient characteristics U e r  strongly between them. A thorough 
evaluation of cystic fibrosis related isolates demonstrated that correct species 
level identification is essential for patient management and infection control. 
Old and new hot topics in infection control (Symposium organized by ESGNI) 
FI Infection control and modeling 
H. Grundmann 
Nottingham, UK 
Little is known about the amount of cross-transmission, the risk factors 
involved and the relative effectiveness of infection control procedures 
when nosocomial pathogens like methicillin-resistant Staphylococcus aurew 
(MRSA) have become endemic in settings like intensive care units. 
Descriptive epidemiological tools such as molecular epidemiology and cluster 
statistics provide answers towards the amount of transmission that occurs in a 
given unit, whereas analytical approaches such as case-control and cohort 
studies address the risk factors involved. The success of interventions can be 
determined by caremy designed cross-over trials if ethical approval can 
be obtained. A fourth genre of epidemiological investigations consists 
of mathematical modeling. Models can be used as a conceptional framework 
for estimating the relative contribution of various factors involved in the 
dissemination of pathogens among susceptible hosts. Alternatively, mathe- 
matical models can be utilized to predict the success of interventions 
when parameters have been carefully ascertained during analytical 
and observational studies. Using observed parameters with only limited 
parameter estimation, the models provide further insights into the underlying 
epidemiology of nosocomial pathogens via estimation of the effective case 
reproductive number, %. Usiig cohort data from an adult intensive care 
unit in the UK the merits of various epidemiological approaches will be 
discussed. 
Inhibitors of pumps and beta-ladamases in Gram-negative bacteria (Joint ESCMID/ICAAC symposium) 
Multidrug efflux in Gram-negative bacteria 
K. Poole 
Kitlgstofl, CAN 
Efflux mediated resistance to antimicrobials in Gram-negative bacteria has 
been known for two decades. More recently, however, efflux systems of 
broad substrate specificity, accommodating and, thus, providing resistance to 
a variety of structurally unrelated antimicrobials have been described in a 
number ofGram-negative organisms. The most significant ofthese pumps are 
tripartite, comprised of an inner membrane proton-drug antiporter, an 
outer membrane- and periplasm-spanning channel-tunnel and a periplasmic 
membrane fusion protein that apparently links the membrane-associated 
components Homologous 3-component multidrug efflux systems have 
been described in Escherichia cofi, Salmonella enteiica serovar Typhimurium, 
Neisseria gonowhoeae, Pseudomonas aenrginosn, Pseudomonas putda, Burkholderia 
cepacia, Sfenotrophomonas malfophilia and Acinetobacm baumannii. These 
systems can accommodate most classes of antimicrobials as well as biocides, 
organic solvents, dyes, detergents, and inhibitors of fatty acid biosynthesis. 
In organisms such as l? aetuginosa, several ofthese multidrug efflux systems have 
been described where they play a role in intrinsic and acquired resistance to 
multiple agents. Five such tripartite multidmg efflux systems have 
been described to date in this organism. collectively providing resistance 
to most known classes of antimicrobials and expressed constitutively 
(MexAB-OprM), in response to antimicrobials (MexXY-OprM), or 
hyperexpressed as a result of mutation (MexCD-OplJ, MexEF-OprN, 
Me=-OprM, as well as the other two). The corresponding efflux genes 
are organized in operons and linked to regulatory genes that are responsible 
for controlling efflux gene expression and are, in many instances, the target 
for mutations leading to efflux gene hyperexpression and acquired multidrug 
resistance. Despite their significance vis-&is antimicrobial resistance, 
the multiplicity of these multidrug efflux systems in a given organism and 
their broad distribution in Gram-negative bacteria raises questions about 
antimicrobial export as their intended or natural function. Indeed, it has 
recently been shown that MexAl3-OprM operation is important for 
the pathogenesis of l? aeruginora, possibly as a result of its export of v d e n c e  
factor(s). Still, whatever the intended function, it is clear that targeting 
these efflux mechanisms therapeutically would be usefd in countering 
intrinsic and acquired antimicrobial resistance in many Gram-negative 
pathogens. 
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Quality improvement in antibiotic prescription (Symposium organized by ESGAP & BSAC) 
1 5162 1 Practice guidelines: different strategies, same goals 
W. E. Peetermans 
Leuven, B 
The goals of practice guidelines are to improve the quality of care and the 
appropriateness of antibiotic prescription, to optimize cost-effectiveness and 
to serve as an educational tool. They are not a substitute for clinical judgment. 
The quality standards of guideline development must be followed to ensure 
scientific validity. Guidelines based upon c l i~ca l  experience of experts or a 
consensus conference have their weaknesses. A systematic review of scientific 
evidence must be evaluated by the development group and translated into a 
clinical guidelme. Specific issues concerning the topic and the purpose of the 
guideline, its target population and its target professional groups must be 
determined. The strength of the recommendations must be clearly linked to 
the grade of evidence. The AGREE instrument allows to assess the quality of 
the guideline and its recommendations. 
The applicabhty can be tested in pilot hospitals. Effective and eficient 
dissemination and implementation strategies must be explored to induce 
changes in clinical practice and prescribing behaviour. Implementation is 
essentially a local activity and the multidisciplinary antimicrobial management 
team is the best forum to adapt the guideline and to organize its implementa- 
tion and follow-up. Understanding patient, system and physician barriers to 
adherence may provide a fkunework of improvement. 
(51641 Antimicrobial drug list in countries with limited 
resources: a tool to promote rational use of antimicrobials 
and to contain the emergence of antimicrobials resistance 
W Gardjito and E Kolopahng 
Surubaya, ID 
The need for anmcrobials ( U s )  is driven by the hgh incidence of 
infectious diseases Death ftom acute respiratory tract lnfechons (ARI), 
diarrhoeal diseases, measles, AIDS, malaria, and tuberculosis account for more 
than 85% of the mortality of infection worldwide (WHO, 2001). In Indo- 
nesia, the leading causes of infant and child mortality were infectious diseases: 
diarrhoea, ARI, neonatal tetanus, and measles. Anti-microbial resistance 
(AMR) is directly linked to the use of antimicrobial agents, and is common 
in the general community as well as in hospitals. The emerging problems of 
Ah4R cause a significant burden mainly of the poor population. AMR costs 
money, livelihoods and lives, as well as threatens the effectiveness of health 
delivery programmes especially in developing countries. Complex political, 
socio economical and behavioral factors are associated with the emergence of 
AMR which include overuse, misuse, and also underuse of AMS by health 
professionals, unskilled practitioners, patientshy persons. Action to opdmise 
prescribing patterns and to reduce inappropriate A M s  use is thus crucial. 
Effective interventions must address the underlying causes of current systems, 
practice, and barriers to change. Limiting A M s  choice by adopting the WHO 
essential drug concept can be implemented, however, antimicrobial drug list 
alone will not be effective in containing the emergence of AMR and on 
opportunities for improving economic efficiency. At community level, health 
centers are provided with basic or essential A M s  against common infectious 
diseases, tuberculosis, leprosy based on morbidity pattern, standard diagnostic 
and treatment guidelines. In the hospital setting, limitation of AMs is 
formulated via the Formulary System based on the standard diagnostic and 
treatment guidelines, antibiotic guidelines, including the antibiotic policy A 
strong Hospital Pharmacy and Therapeutics Committee is regarded impor- 
tant, and an active 'antimicrobial agent team' consisting of infectious disease 
specialists, infection control practitioners, clinical microbiologists, and clinical 
pharmacists has been found extremely important in implementing rational 
antimicrobial policies. Education should be considered as the cornerstone of 
the programme. Integrated interventions through multidisciplinary approach 
to reduce A M s  use in the health centers and hospitals being proposed, as a 
solution will be presented. 
Sepsis pathogenesis 
Late immunoneutralization of procalcitonin 
(ProcT) in septic pigs is as therapeutically effective as early 
therapy 
K Becker, M Edwards, J Marhnez, E Nylen, R Smder, B Muller 
and J White 
Wahrngtorr, USA, Basel, CH 
Objectives and methods: A model of hghly vmlent sepsis was developed m 
pigs (cecotomy followed by mtraperitoneal mallation of 1 g/kg cecal con- 
tents plus 1012 c h  E coli] Sepsls was induced m25 castrated male Yorkshire 
pigs (25-30kg), after whch three treatment arms were s t u d l e d  (1) early 
therapy pvlth a 1-h muavenous mfusion of rabbit anhporclne PmCT IgG 
gwen simultaneously wtth the inducaon of sepsls, (2) late therapy wth the 
same pephde a-tered after the 3rd hour, when the aruIllals were 
moribund, and (3) sephc controls whch received nommmune rabbit IgG, 
mther at the early (n = 8) or the late (tg = 5) hme penod 
Results: The sephc controls all &ed by t 1 h They exhbited progressive 
hypotension, ohguria, decreased cardmc output, and lachc acidema. In 
contrast, 86% of anunals receivmg early therapy and 80% of those receivlng 
late therapy survived until euthanasia at 15 h. Prior to the time of sacrifice 
(t = 15 h), arterial blood pressure (ABP), cardiac index (CI), serum creatinine 
(Cr), urine output (UOP), pH and lactic acid (LA) were measured (Table 1). 
Number ABP' CI' CR' UOP' LA' 
animals (mmHg) (L/m/mz) (mg/dL) (mL/h) pH' (mg/dL) 
Early Rx 8 6 4 f 3 0  2.81&0.70 1.2f0.4 58&94 7.31f0.11 3.0f1.4 
LateRx 5 6 5 f 1 7  2.25f0.72 1.1f0.2 5 1 f 3 8  7.36f0.02 2 . 7 f l . I  
N o h  12 t t t t t i 
*Mean f SEM, not statistically significant by f-test at P C  0.05. 
TAU animals died. 
Conclusion: There were no sigtufhnt difFerences in any parameters measured 
between those treated early versus late. Furthermore, there was a minor trend 
toward improvement in some parameters (Cr, pH and LA) in animals which 
underwent late therapy in comparison to those having early therapy. These 
findings further support the potential efficacy of such therapy in humans, even 
if sepsis is recognized late in the course of this disease, when physiologic and 
metabolic parametem begin to deteriorate. 
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I 01 67 I Bioartificial extracorporeal phagocytosis 
assistance in a pig-model of Gram-positive sepsis 
M. Sauer, S. Noh, M. Suraj, J. Altrichter, J. Stange, R. Schmidt 
and S. Mitmer 
Rostock, D 
Objectives: One major reason for the development of a systemic bacterial or 
fungal infection is the impairment of the host immune system especially 
phagocytosis. Therefore, we investigated the possibility to establish an 
extracorporeal phagocytosis assistance system for the treatment of sepsis. 
The presented study shows results of bioartificial phagocytosis assistance in a 
pig-model of Gram-positive sepsis. 
Methods: Human hematopoetic precursor cells have been expanded and 
stimulated to differentiate towards functional granulocytic cells. After stimu- 
lation the cells showed increased chemiluminesence, active intracellular 
killing and a high reduction rate of E.coli, Staphylococcus airreus, Candida 
albicans and Picornavirus. In an animal-model of sepsis, S i r  to the one 
described by Lee et al. (Crit Care Med, 1998, 26 : 73&737), 21 female 
immature landscape swines (7.5-12kg) were given 8 x 109cfu/kg living 
S.aureuc i.v. and for 7 days clinical parameters and survival time were 
monitored. After a I-h infusion of bacteria 14 pigs were treated for 4 h by 
an extracorporeal plasmaperfusion model containing a membrane-based 
bioreactor (Nylon) with in mean 6.2 X lo9 cells. Plasmaseperation was carried 
out hy centrifugation, plasma reflux to the anunal was done through a 0.2 pm 
pore-size plasmafiiter (PF 1000,GAMBRO AI3). Group I was treated without 
cells (untreated-group = UG, n = 71, group I1 with cells (treated- 
group = TG, n = 7). Group 111 were given the bacteria without extracorpor- 
eal treatment after inoculation (septic control group = SCG, n = 7). 
Results: AU animals of the SCG died (between 31, 75 and 156 h, in mean: 
70 h). Two out of seven pigs of the UG, hut six out of seven pigs of the TG 
survived the whole observation time (survival-time TG between 165 and 
168 h, in mean: 167.57 h; survival-time UG between 1.08 and 168 h, in mean: 
75.19 h). Statistic significance (log rank test) were seen between UG and TG 
(P= 0.0019) and between SCG and TG (P=  0.0001) hut which was not seen 
between UG and SCG (P=O.43). The plasmaperfusion model showed a 
good compatibility (no great differences between SCG and UG in the course 
of disease). The other clinical parameters showed benefit for the cell-treated 
animals (TG) compared with the UG (see Table 1). 
Table1 Clinical parameters showing benefit for the cell-treated animals (TG) 
compared with the UG 
Clrmcal parameter Untreated group (UC) Treated group (TG) Septic control group 
(expressed a mean) (n = 7) (n=7) (SCG) (n = 7 )  
Sumval nme (h) 
(obrwmtion rime 
168b) 
Bacterial count in 
blood (chdmL) 
after 168h or death 
bctat  after IhX h or 
death ( m / L )  
Creatirune after I68 h 
or death (w/L) 
Urea after 168 h or 
death ( m / L )  
AT III ahcr 168 h or 
death (“A) 
Quick alier 168 h or 
death (%) 
Thrombocyter aher 
168 h or death ($L) 
75.19 
5.5.3 T 7.13 
110.3F 50.6 
9.4 =F 4.7 
587U 
8 1 ~ 2 6  
163.000~ 107.000 
167.57 
1.54T 0.93 
m.nT47.5 
3.0 f 2.9 
75712  
105T-8 
314.000 T 259.000 
70 
10.6$10.6 
86.3T18.8 
10.2FZ.O 
84 7 .34 
96 50 
115.000~57.000 
Conclusion: The cell-based extracorporeal immune support improves the 
outcome in a pig model ofsepsis. Bioartificial phagocytosis assistance may be a 
new tool in the treatment of severe infection. 
1 0168 I Synergistic effect of muramyldipeptide with 
lipopolysaccharide and nonendotoxin-stimuli 
S. Traub, N. Kuhasch, S. Morath, R. R. Schmidt and T. Hartung 
Constance, D 
Objectives: The bacterial components serving for pattern recognition by the 
innate immune qystem are increasingly identified. However, little is known 
about the interplay of these components. Here, muramyldqJeptide (h4DP; 
N-Acetylmuramyl-L-~yl-D-iso~u~e),  i.e. a part of the peptidoglycan 
with a strong adjuvant effect, was characterized as to its synergistic effect with 
lipopolysaccharide (LPS) in monocytes and macrophages. Further, we inves- 
tigated the structural requirements and besides LPS also other nonendotoxin- 
stimuli. We considered the receptor- and signalling-systems of MDP which 
are not yet completely known. 
Methods: Employing a human whole blood cytokine release model or 
murine primary macrophages, 15 synthetic muropeptide-derivatives were 
tested as to their immunomodulatory effects. 
Results: A number of these derivatives were potent synergists of lipopoly- 
saccharide (LPS) and induced cytokine release, but did not induce an immune 
response on their own. MDP was the minimal bioactive structure of 
peptidoglycan. Further we observed a stereoselective recognition, i.e. other 
stereoisomers were not active. The LPS (Salmonella abortus equi) concentra- 
tion-response curve with respect to TNF-a-release was shifted by a factor of 
1000 when 2 0 p ~  MDP was added. In combination with nonendotoxin- 
stimuli like CpG-oligonucleotides or MALP-2 &om mycoplasm we also 
observed synergistic effects ofMDP, but not together with lipoteichoic acid 
(LTA) from Staphylococcus aurars or its exotoxin (SEB). Since receptor- and 
signahng-cascades have not yet been ideneified, toll-like receptor 2 (TLR-2) 
knock-out or C3H/HeJ LPS-nonresponder mice carrying a mutated TLR-4 
were employed. In different macrophages f b m  both mice, synergy of MDP 
with dfierent immune stimuli was found. These findings suggest that MDP 
does not require TLR-2 or TLR-4. 
Conclusions: MDP bas a priming effect on the immune system. The results 
indicate that breakdown products of naturally occurring peptidoglycan 
components, which are ubiquitous in all bacteria, cause in the host stronger 
effects with other bacterial components than the substances alone. This potent 
synergy has implications for pyrogen testing, putative therapeutic strategies in 
infection and sepsis as well as for the development of novel immunostimu- 
lators. 
Lipoteichoic acid from Staphy/ococcus aureus 
is a strong stimulus for neutrophil recruitment 
S .  von Aulock, S. Morath, A. Pfeiffer and T. Hartung 
Constance, Regemburg, D 
Objectives: Staphylocornrs aureus infections are often associated with pus 
formation. This implies that a major immune response to these bacteria is 
the recruitment and activation of neutrophils. Where lipopolysaccharide 
(LPS) is the major immunostimulatory principle of Gram-negative bacteria, 
lipoteichoic acid (LTA) is the equivalent molecule of the Gram-positive 
bacteria. Effects of highly pure bioactive LTA on neutrophil functions and 
chemokine induction were investigated. 
Methods: The expression of tlr-2 on human neutrophils was investigated by 
meam of flow cytomeq. Isolated human neutrophils or human whole blood 
were incubated with LPS or LTA and release of degranulation products, 
cytokines or chemokines were measured hy ELISA. Oxidative burst was 
measured by luminol-enhanced chemiluminescence induced by LPS, LTA or 
PMA alone or in combination. 
Results: Neutrophils express the key receptors for LTA signaling, CDI4 and 
tlr-2, however, LTA did not induce or prime for oxidative burst in whole 
blood or human neutrophils. Further, LTA did not induce degranulation of 
bactericidal permeability increasing protein (BPI) in whole blood at con- 
centrations up to 10 pg/mL. LTA did not stimulate the release of sigmficant 
amounts of TNF-a or leukotriene-B4 (LTB4) in purified neutrophils. 
However, LTA induced a very fast release of LTB4 in whole blood which 
could be attributed to the monocytes. The maximum of LTB4 release was 
similar to that induced by the same concentration of LPS from S. abortus equi. 
Four LPS (E. coli, K. pneumoniae, B. pertu~sis, F! amginosa) with different 
potencies were titrated to induce the same amount of T N F a  as 10 p g / d  
LTA (S. aureus) in whole blood. All stimuli also induced equal amounts of IL-6. 
However, LTA induced more of the chemokine IL-8 than any of the LPS and 
induced comparable amounts of the chemoattractants MCP-1 and MIP-la. 
LTA also induced more granulocyte colony-stimulating factor (G-CSF) 
release than the LPS. 
Conclusions: Although LTA does not seem to activate neutrophils directly, it 
is a strong stimulus for the recruitment of neutrophils &om the hone marrow 
via G-CSF induction and attraction of neutrophits to the site of infection via 
stimulation of chemokine release. 
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101701 Generation of fully human monoclonal antibodies 
specific to bacterial and fungal pathogens in a human/ 
mouse radiation chimera: the Trimera system 
Z. Rosenthal-Galili, S. Priel, S. Shavit, S. GreenfeId, D. Terkieltaub, 
M. Zohar, E. Ilan, 0. Ben-Moshe, A. Kischitzky, R. Eren and S. Dagan 
Rehovot, IL 
The emergence of drug resistant pathogens is becoming a global concern, 
which requires new therapeutic approaches. Antibody therapies for treating 
and preventing bacterial or fungal infections constitute about 25% of the 
current drugs in development. 
Objectives: Generation of HmAbs for treating and presenting GNB and 
Candidu albicuns infection. 
Methods: We have taken that approach to generate fully human monoclonal 
antibodies (HmAbs) directed against different pathogens such as C. albicans, 
Gram-negative bacteria (GNB) and Staphyloroaus uureus (Staph A). These 
antibodies are being produced in the Trimera mouse system, which was 
shown previously to be a powelful tool to generate HmAbs against hepatitis B 
and hepatitis C viruses. This system consists of normal strains of mice that 
were rendered permissive for engrafrment of human cells and tissues by lethal 
total body irradiation and radioprotectioii with SCID mouse bone marrow 
cells. 
Results: We have employed the Trimera system to generate KmAbs against 
Bagellin from GNB and against glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) h m  C. albicuns. Flagellin has a role in mucosal attachment and 
invasion and induces pro-idammatory gene expression ultimately causing 
shock and mortality. GAPDH is a glycolytic enzyme. I t  is expressed on a 
fungal cell wall and has a role in C. albicum attachment to fibronectin and 
laminin adhesion molecules. These properties make these two molecules 
good candidates for immunotherapy. In order to produce HmAbs against 
GNB flagellin, Trimera mice were transplanted with lymphocytes from 
donors positive for antitlagellin antibodies. Immunization of these Trimera 
mice with the N-terminal part of flagellm presented on autologous dendritic 
cells resulted in amplification of the human specific immune response to GNB 
flagellin, np to 60-fold over the response of the donor. Similarly, immuniza- 
tion of Trimera mice with C. albicans GAPDH resulted in amplification of the 
human specific immune response to GAPDH, up to 40-fold over the response 
of the donor. 
Conclusions: Hybridoma clones were generated fiom human B cells har- 
vested h m  the spleens of the responding mice. These hybridomas secrete 
human anti-flagellin IgG and anti-GAPDH IgG. The properties of these 
mAbs are currently being investigated. Thus, the Trimera mouse system is an 
effective tool to ampli6 human immune responses in mice, leading to the 
generation of therapeutic human monoclonal antibodies. 
I 0171 1 Curliated fscherichia coli and the sudden infant 
death syndrome 
P Goldwater and K. A Bettelhem 
Adelaide, Melbourne, A U S  
Objectives: To explore the role of curhated E. coli and soluble curhn m the 
pathogenem of SIDS. 
Methods: CurLm produchon of a random selecaon of E. cola stram solated 
tiom the InteSMeS of 94 SIDS babies and 17 dead controls as well as 92 healthy 
baby stools was exammed by culture on Congo red agar (CRA). Sera 
these groups of babies were examined by dot-unmunoblot and Western blot 
for soluble curh (CsgA) usmg &mty purlfied rabbit ana-CsgA antibody. 
Results: 100% of SIDS E. coh isolates (94 of 94 mdmdual babies' isolates) 
produced curh when grown at 26" C for 48 h on CRA. Control isolates tiom 
non-SIDS deaths (13 of 17 mdmdual isolates) had a ngmficantly lower rate of 
curh pmducaon (P= 0 00002) than SIDS strains 74 of 92 (80 4%) healthy 
baby fiolates produced curh (P= 0 00005). The 15 kDa bands (matching 
CsgA control ma ted )  were seen on immunoblots of SIDS sera but not dead 
or healthy conrtol sera 
Conclusion: Curhated E coli and soluble curlm may be mvolved 
m the pathogenem of SIDS. Physiological effects of curhn support tlus 
hypothesis 
Alteration of numbers of circulating and 
lung-derived lymphocyte subsets after endotoxin challenge 
M. Holub and D. A. Lawrence 
Albany, U S A  
Objectives: A sigmficant morbidity and mortality of intensive care patients is 
caused by secondary bacterial infections with bacterial pneumonia beimg the 
leadmg bacterial complication. The development of secondary dections has 
been associated with alterations of cell-mediated immunity including reduc- 
tions of CD4+ Tand NK cells in peripheral blood (PB). The aim of our study 
was to evaluate whether similar reductions of immune cells during sepsis also 
occur with lung-resident lymphocyte subsets. 
Methods: Experimental sepsis-like condition was initiated in BALB/C mice 
with 10 pg of endotoxin given intraperitoneally; 24 h after the initial chal- 
lenge animals were sacrificed by COz anesthesia, exsanquinated, and circula- 
tion was perfused with 35 mL of cold physiologic solution. Lung-derived 
lymphocyte subsets were obtained by enzymatic digestion of lung tissue with 
collagenase and DNAse (both Sigma, Saint Luise, USA). The PB and lung- 
derived lymphocyte subsets were quantified with monoclonal antibodies 
purchased &om Pharmingen (San Jose, USA) using Tru-Count TubesTM 
(Becton-Dickinson, San Jose, USA). Analysis was performed with three-color 
flow cytometer (FACScan, BD, San Jose, USA). 
Results: The results are shown in the table. 
Peripheral blood (cells/m3) Lung (ceUs/lobe x 103 
Lymphocyte 
subsets 
CDJf cells 
CD4+ T cells 
B cells 
NK cells 
C D ~ +  T ceh 
Conml Endotoxh Control Endotom 
(n = 8) (n=6) (n=8) (n = 6) 
2845f232 819f286' 151.1f29.2 76.3f17.7' 
22V4f 181 6763Z205* 120.63~ 18.3 58 .4f  15.7" 
7 4 8 f 5 2  192f52* 47.4f14.6 25.9f7.1 
943 f 136 322 f 123' 75.4 f 27.2 50.1 f 13.7 
3 4 6 f 7 2  184+75 59.9f23.7 413114.4  
*P< 0.01. 
#PS 0.05 (stahshcd analyses employed SNdent's t-test). Data are presented as 
mean f SE. 
Conclusion: Our results demonstrate that experimental endotoxemia signifi- 
cantly reduced numbers of CD4+ T cells, CD*+ T cells, and B cells in PB as 
well as CD4+ T cells resident in the lungs. This suggests that an inflammatory 
response could establish an important predisposing condition for secondary 
bacterial pneumonia. 
Acknowledgements: The study is supported by the grant no. 
3D43TW00915 h m  the Fogarty International Center, NIH, Bethesda, 
USA. 
1 0173 I Monocyte and lymphocyte apoptosis resistance in 
patients affected by brucellae infection 
M. Tolomeo, P Di Carlo, V Abbadessa, L. Txtone, G C a m z o ,  
E. Barbusca and F Scarlata 
Palemzo, I 
Objective: Brucellosis is endemc m southern Italy and its Islands. Although 
anabioac therapy qwckly induces a c h c a l  Improvement, in several paaents 
the infechon persists and, after several months, induces relapses and become 
chromc. The bactena mfect monocytes and macrophages developmg w~tlun 
these mononudear cells. Recent data have shown that monocytes lnfected in 
vmo wth brucellae become resfitant to Fas-hgand-mduced apoptoss We 
sturlled the senslhvlty of penpheral blood mononucleated cells (PBMC) to 
apoptosis and the expresslon of Merent ~mmunolqpc and apoptohc marken 
in PBMC in 10 infected panents (two m chromc phase and eight m acute 
Methods: Apoptosis in monocytes and lymphocytes was evaluated in vltm 
after 24 h ofCHl l  (Fas-agomhc) treatment by flow cytometry uwga  three- 
color panel of fluorescent agents: annemne-V, propidIum iodIde and anh- 
CD6' or anh-CD3 Moreover, the expression of Fas (CD") in CD4+ and 
Phase). 
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CD8+ lymphocytes and the percentage of CD4+, CD8+ and CD38+ lym- 
phocytes were also determined. 
Results: Before the star t  of therapy, monocytes of all patients showed a high 
level of resistance to CHI 1-induced apoptosis. T h  resistance persisted 10- 
20 days afcer the Start of therapy and then quickly decreased. Interestingly 
lymphocytes were also more resistant to CH1 1-induced apoptosis compared 
with lymphocytes of healthy donors, although their resistance was lower than 
that observed in monocytes. The number of CD4+ and CD8+ cells was 
normal in all patients while the percentage of CD4+ lymphocytes expressing 
CD9’ was increased in 50% of patients. No modification in CD95 expression 
was observed in monocytes. At the time of diagnosis all patients showed a high 
percentage of CD8+ lymphocytes expressing CD38 T h  percentage 
decreased w i h  one month fiom the start of therapy. 
Conclusionr: We demonstrated that PBMC of patients affected by brucellae 
infechon were resistant to apoptosls despite the mcrease in CD95 and CD3* 
expression on lymphocytes Our data indxate that the extrinsic apOptOhC 
pathway (Fas/Fas-L) is not involved m CHll-resistance Considermg that 
lymphocytes are not infected by brucellae, ther apoptosis resistance may be 
due to a soluble factor released by dected monocytes The evldence of 
apoptosis resutance m PBMC of chroruc pahents suggesa that the evaluahon 
of sensihvlty to CH11-induced apoptosis ~fl monocytes may be used to test 
the effechveness of therapy 
Pharmacokinetics of quinolones 
I 0 1  74 Kill kinetics of fluoroquinolones (FQ) in in vitro 
pharmacodynamic models of infection 
A. Dalhoff, S. Schubert and U. Ullmann 
Wuppertul, Kid, D 
Background Models that interpret both pharmacokinetics and bacterial 
response provide information about the bactericidal activity of the agents 
studied under clinically relevant experimental conditions. The aim of this 
study was to assess the speed of kilhng of various fluoroquinolones (FQ) 
against Gram-negative (GN) and Gram-positive (GP) bacteria. 
Materiels and methods: A one-compartment model was used. Serum 
concentrations following different oral doses of ciprofloxacin, moxifloxacin, 
ofloxacin, levofloxacin and gatifloxacin were simulated. Ciprofloxacin and 
ofloxacin were dosed twice, the others once daily. Three strains (varying in 
FQ susceptibility) ofthe following species were studied E.  cofi, K. pneumoniae, 
I? uemginosa, S. aureus, and S. pnerrmoniae. The antibacterial effect was yuanti- 
tated by calculating the area under the c h / d  curve and the time to 99.9% 
killing. 
Results: 
1 All FQs exhibited a dose-dependent effect against GNs however, only 
moxifloxacin and gadtloxacin exhibited a dose-dependent effect against GP. 
2 Ciprofloxacin was the most active FQ against GN and reduced viable 
counts most rapidly. 
3 I? amginosa exposed to ciprofloxacin was sigdcantly aftected and resis- 
tance did not develop. However, exposure to levofloxacin resulted in 
regrowth and resistance development. 
4 Against K.pneumoniue both ciprofloxacin and moxifloxacin were sigrufi- 
candy more active and reduced viable counts more rapidly than any other 
yuinolones studied. 
5 The speed of bactericidal kill against GP was greatest for modoxacin. 
6 S. pnarmoniae strains with gatifloxacin MICs of 0.25 and 0.5 mg/L regrew; 
postexposure isolates had gatifloxacin MICs of 0.5-2 nlg/L 
7 In contrast, moxifloxacin reduced cfu even of the borderline susceptible 
S. pneumoniae strain below the limit of detectability within 12 h and no 
resistance developed. 
Conclusions: Amongst the yuinolones tested, ciprofloxacin and modoxacin 
showed an enhanced rate of killing. Ciprofloxacin was the most active 
quinolone against GN and moxifloxacin the most active one against GP. 
Modoxacin demonstrated superior activity against borderline susceptible 
S. pneumoniae with no resistance development. 
101751 Population pharmacokinetics of moxifloxacin 
intravenous in healthy subjects and patients with 
community-acquired pneumonia 
H. Stass, H. Stab and F. Kruesmann 
West Haven, USA; Wuppettal, D 
Background: Modoxacin (MXF) is an 8-methoxy-quinolone with excel- 
lent in vim activity against a variety of respiratory pathogens. 
Methods: The PK data obtained from a subgroup of patients with commu- 
nity-acquired pneumonia (Cm, 60 + 18 years and 76 + 22.5 kg, N= 307) 
participating in two multicentered, randomized c h c a l  trials were compared 
with those &om healthy subject (HV) studies (N= 65). An amount of 400 mg 
MXF was given once daily to the patients as intravenous (i.v.) drip infusion 
(median 60min, range 45-137min), whereas the HV received controlled 
short infusions (30 or 60min) in the dose range of 100-400mg SD and 
400 mg once daily For the CAP patients sparse plasma samphg was applied, 
whereas rich data sampling was obtained &om the HV. Conventional and 
population PK (PPK) evaluations were used to analyze the data. 
Results: PK ofpatients and HV were comparable. Mean peak concentrations 
were slightly higher for patients after the first dose (5.01 mg/L vs. 3.5 mg/L), 
whereas they were comparable to those ofthe HVat steady-state (4.5 mg/L vs. 
4.1 mg/L). This effect was probably caused by a disease-induced reduction of 
the distribution volume ( e g  altered blood flow), which returned to normal 
upon recovery of the patient. Owing to the application of drip infusion the 
variability of C,, in the patients was -50% relative to -23% in HV. The 
dominant terminal half lives were comparable for patients and Hv. Earlier 
findings in HVof a slight, but not clinically relevant gender effect on the PK of 
MXF were confirmed in patients (e.g. mean C, 4.5 + 4.1 mg/L males: 
5.6 + 2.8 mg/L females). PPK calculations estimated similar AUC for padents 
and HV; the patients’ PPK estimates were biased owing to the complexity of 
the structural PK model and the necessity of sparse data sampling. 
Conclusion: Overall, the PK data for MXF fiom CAP patients and those &om 
healthy subjects were comparable and there was no evidence that any patient 
subset might require dose adjustments. 
(0176jI Different potentials of fluoroquinolones to prevent 
bacterial resistance: can they be distinguished using in vitro 
dynamic models? 
A. Firsov, S. Vostrov, S .  Zinner, I. Lubenko, Y. Portnoy, X. Zhao 
and K. Drlica 
Moscow, RUS; Cambridge, New York, USA 
Objectives: To examine the ability of moxifloxacin (MXF) and levofloxacin 
(LVF) to prevent the selection of resistant mutants of Stuphylococnrs aureus, 
multiple dose simulations were performed over a wide range of the ratio of 
area under the curve (AUC) to MIC. 
Methods: A clinical isolate of methicillin-resistant strain of S. aureus was 
selected for the study. The MICs of MXF and LVF determined by multiple 
serial dilutions were 0.09 and 0.5 mg/L, respectively. The ‘mutant prevention 
concentrations’ (MPC) of MXF and LVF were 0.33 and 1.75 mg/L, respec- 
tively A series of monoexponential pharmacokinetic profiles that mimic 
once-daily administration ofMXF (half-life 12 h) and LVX (half-life 6.8 h) for 
3days were simulated in vitro. With each yuinolone, these profiles were 
designed to provide peak concentration at levels equal to the MIC, between 
the MIC and MPC, i.e. within the ‘mutant selection window’, and above the 
MPC. The respective AUCT/MIC ratios varied from 12 to 15-222-242 h, 
where Tis the 24-h dosing interval, and the starting inoculum was 108 c h /  
mL. Changes in S. UWRUS susceptibility were examined daily with repeated 
MIC determinations. 
Results: No MIC increase was seen at the peak concentrations equal to the 
MICs, i.e. at the lowest simulated AUCT/MIC ratios (13-15 h). Within the 
‘window’ (AUCT/MICs of 27-29 and 53-58 h), significant increases in 
MICs were observed following treatment. With both yuinolones, only 
minimal MIC increases were observed at AUCT/MICs of 107-1 16 h, and 
no MIC changes were seen at AUCT/MICs of MXF of 222 h and LFX of 
242 h (trough levels above MPC). These ‘protective’ AUCT/MIC ratios 
correspond to 65% of the usual clinical dose of MXF and 220% of the clinical 
dose of LVF (Fig. 1). 
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Figure 1 Ratio of final MIC to initial MIC for S. aureux exposed to different AUC,,/ 
MICs of modoxacin (0) and levofloxacin @. 
Conclusion: These data suggest that (1) in vim dynamic models can be used to 
predict relative ability ofquinolones to prevent mutant selection and (2) in t h i s  
model MFX protects against resistance development at subtherapeutic doses 
whereas LFX provides a similar effect only at doses that exceed its clinical 
dose. 
1 01 77 I Levofloxacin compensates with pharmacokinetics 
for less favourable pharmacodynamics towards 
P. aeruginosa compared to ciprofloxacin 
B. Wiedemann 
E o m ,  D 
Objective: Ciprofloxacin has been regarded as the gold standard for the 
antimicrobial activity for infections with P aeruginosa. Levofloxacin is less 
active ifMICs are the measure of activity. However, Ievofloxacin has a more 
favourable pharmacokinetic. In an in vitm model, we simulated the phar- 
macokinetics of levofloxacin and ciprofloxacin after intravenous injection to 
follow the kill kinetics of f? aetugitzoxu wild type (5087 mL) and a low level 
resistant mutant (5087M1). Furthermore, the capacity of the drugs to select 
for resistant mutants was of interest. 
Methods: We used an in vitro model according to Grassso, simulating the intra 
venous injection of400 and 800mg ciprofloxacin or 500,750, and l O O O m g  
levofloxacin. The dimination ofthe drug out ofthe central compartment was 
regulated by a peristaltic pump, which added fresh Miiler-Hinton broth. The 
samples were taken after 0.5, 1-68. 10.12, and 24 h, to measure the bacterial 
count on nutrient agar NI and the concentration of antibiotics by bioassay 
with K. pneumoniae as a test organism. 
Results: The effect of levofloxacin on i? aenrginosa 5087tnL.. the wdd type 
strain, after the simulation of 500-mg i.v. dosage was less effective than a 400- 
mg dosage of ciprofloxacin for the first 6 h, when the reduction in cfus with 
both drugs was equal. Thereafter, ciprofloxacin allowed a slow regrowth, 
whereas levofloxacin kept a bacteriostatic activity. Doubling the ciprofloxacin 
dosage did not result in a marked increase of the effect, whereas a doubling of 
the levofloxacin dosage resulted in a further reduction of the bacterial count to 
nearly six orders of magnitude. With the efflux mutant M1 results were 
similar, however, regrowth occurred earlier. With none of the drug dosing, 
we saw a pronounced selection of resistant mutants. All isolates picked after 
the regrowth were sensitive. Resistant mutants always were a minor portion of 
the total count. 
Conclusion: The favourable pharmacokmetic properties of levofloxacin seem 
to outweigh the less pronounced pharniacodynamics of ths drug, as com- 
pared to ciprofloxacin. Because of the higher prolonged concentration of 
levofloxacin during the experiments, the overall effect of levofloxacin was 
slightly better than that of ciprofloxacin. 
101781 Concentrations of moxifloxacin at the focus of 
infection of patients suffering from erysipelas after a 
400-mg single dose 
H. Stass, H. Stab, C. Joukhadar, J. Moller and M. Muller 
Wuppettal, 0; Vienna, A 
Objective: The techruque of mcrod~alysrs offers a powerful h o d  to get 
more detalled PK informahon &om infectedlesions than 'classical' methods so 
far applied to pahents. The aun of thts study was therefore to apply t h ~ s  
techmque to determme modoxacm (MXF) concentranons at the focus of 
infection of in-pahents suffering &om sofc-hssue mfechons and to compare 
them with those observed in noninfected ussue. 
Methods: SIX pahents who were hospitalxed for the treatment of soft tissue 
mfechons (erysipelas; mean age = 53.8 years) received a concomitant single 
400 mg intravenous 1 h infusion. Blood samples were taken over 96 h to assess 
the pharmacokmetlcs of MXF. In addition microcka$%te was collected for 
8 h, m 0.5 h fiachons after start of infusion m the lnfected and the n o d e c t e d  
ussue (contralateral extremtty) to determine the unbound mterstitd drug 
concentranom Drug concentrauons were measured using validated HPLC 
wth fluorescence detechon. The non-compartmental PK data were calcu- 
lated; stahstical assessment was done with ANOVA. To evaluate safety and 
tolerablltty, physical exarinnation, haematology, chnical chemistry, urinalysis, 
and ECG were assessed, A& were recorded. 
Results: There were no serious adverse events in the study, the treatments 
were well tolerated. PK of MXF in plasma were comparable to those known 
h m  prevlous studies in healthy subjects. In the mterstitial fluid of the nssues, 
geo. mean AUC,,,, and C,,, were mcreased by 133 and 161% comparing 
the mfected mth  the not mfected body site ( A U C W ~ , ~  6.84/2.5mgh/L vs. 
2.94/2.43mgh/L, C,-, 1 78/2.7Smg/T. vs. 0.68/2.45mg/L, geo. mean/ 
SD), with a within subject vanabhty of about 12W0 for both parameters. 
Conclusion: MXF was well tolerated m the study. The kinetic data related to 
the ussue mhcate that MXF seems to accumulate in infected areas. Th15 can 
be e x p h e d  by the dmribution characteristln of MXF itself and the 
pathophysiological changes at the focus of mfection. The results of this study 
indxate that MXF has favorable ckstnbuhon characterxtm supporting its use 
to treat slnn and sot3 tissue infecaons 
1 01 79 I Penetration of moxifloxadn into the infected 
tissues of patients Suffering from diabetic foot infections 
determined by microdialysis 
H Stass, H Stab, C Joukhadar, J. Moller and M Muller 
Wuppettal, 0; Vmrra, A 
Objective: M~crodIalysa has advantages compared to the 'classical' Samphng 
techruques for lunehc stuckes. In the present study, mcroddysis was used to 
compare the concentrahons of moxdoxacm (MXF) at the focus of lnfection 
wth those at the noninfected contralateral site m 'habetic foot' pahents. 
Methds: SIX hospitaked pabents treated for mabehc foot mfechons (mean 
age = 64.3 years) received a concomttant smgle 400mg 1.v. 1 h &on of 
MXE Blood samples were collected up to 96 h after start of mfkion to 
determme the PK of MXE Ulcroddysate was sampled for 8 h after start of 
&ion m 0.5 h hctmns to de t e rme  the unbound intersuhd drug con- 
Centrahom m the dected and the n o d e c t e d  tissue (conaalateral extre- 
mty). Drug concentrahons were measured mth  a vahdated HPLC method 
and fluorescence detecuon. The non-compartmental methods were applled 
for the PK evaluaaon; for staust~cal analysis ANOVA was used Physical 
examinahon, haematology, chmcal chemtry, urmalysis, and ECG were 
assessed and AEs were recorded to evaluate safety and tolerabhty 
Results: There were no serious AEs in the study, the treatments were well 
tolerated PK of MXF in plasma were comparable to those known from 
previous studies in healthy subjects. At the focus of mfecnon the AUCO-~," 
and C, were decreased by 38 and 24% compared to the not d e a e d  body 
site (AUCoau 3 77/1.92mg/h/L vs. 6 07/1.88mg/h/L, C-,+ 0.83/ 
2.38 mg/L vs 1.10/1 81 rng/L, geo. mean f SD) The wthm-subject varia- 
bhty was -74% for AUC,,., and 96% for C,, , The half-lives were 4.851 
01 17 and 6.06/01.22 h (mfited vs. not dected, geo mean & SD). 
Conclusion: MXF was well toleratedm the study. The assuePK data for MXF 
reflect the pathophysiological changes a t  the focus of infechon of the habehc 
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foot patients. Owing to the deterioration of perfUsion caused by the disease 
related microangiopathies MXF concentrations in the infected area are lower 
than in the noninfected tissues. The results of this study are in line with 
previous findings for other anti-infectives studied in this population. 
io18oJ Pharmacodynamics of levoxacin in the treatment 
of infective endocarditis 
B. Cadeo, P. Villani, P. Viale, M. Regazzi, L. Pagani, E Marchetti 
and G. Carosi 
Brescia, Pavia, Udine, Bolzano, Verona, I 
Objective: Infective endocarditis (IE) is a severe and life-threatening infection, 
where standard treatments often failed. Levofloxacin (L) has been reported as 
an attractive option in animal models, but clinical data are lacking. Our aim is 
to evaluate the clincal outcome of therapeutic regimens includmg high dose 
levofloxacin, whose pharmacodynamics (PD) was investigated. 
Methods: Five patients with uncomplicated community-acquired left-sided 
and two patient with ‘late’ prosthetic valve IE received L500mg/day i.v., 
Ceftriaxone (CX) 2 g/day i.v. and netilmicin (N) 300mg/day i.v. At the end 
of the 2nd week of therapy, CX and N were suspended and L switched to oral 
administration. For each patient, eight blood samples were collected &om 0 to 
12 h post-dosing after the 6th i.v. and oral administration, to compare L serum 
levels, measured through standard HPLC technique. Blood cultures were 
taken at baseline, 5th and 28th day. Because, L had been given twice daiiy, in 
the PD analysis we only correlated the 24 h-area under the curve (AUCZ4) 
with the L minimum inibitory concentration (MIC) of the isolate. 
Results Viridans Streptococci with respective L-MIC of 1,0.5 and 0.5 mg/L 
were isolated in three patients, oxacillin-sensible S. mrem with L-MIC of 
0.125 mg/L in 3, K. oqroca with L-MIC of 1 mg/L in one. Overall, the 
duration of treatments was 28 days. No treatment-related side effect has been 
recorded. All patients had a favourable outcome, confirmed at 90-days follow- 
up. The serum values and pharmacokinetic profiles of L (i.v. and per 0s) were 
as expected, and overlapped in all patients evaluated. The AUIC (ratio 
AUCZ4/MIC) were markedly over 220 in all cases. 
Conclusion: Our findings, although very preliminary, suggest that L may have 
a role in the treatment of IE, providing an AUK greater than 220. Should 
those findings be confirmed by larger trials, the equivalence of the intravenous 
and oral administration of L may be useful for both early switch programs and 
discharge. 
ml Efficacy and pharmacodynamia of human-like 
treatment with moxifloxacin (MOX) compared to 
levofloxacin (LEV) on experimental pneumonia due to 
penicillin-resistant pneumococci (PRSP) with decreasing 
susceptibilities to fluoroquinolones (FQ) 
C. Lequeu, E. Jobez, C. Delaq C. Newirth, L. Piroth, M. Buisson, 
P. A r v i s  and H. Portier 
Dijon, F 
Background The increasing frequency of PRSP with reduced susceptibility 
to ciprofloxacin (CIP) raises the question of the therapeutic efficacy of the 
new FQ on infections due to such strains. 
Objectives: To investigate the in vivo efficacy of MOX and LEV on ex- 
perimental pneumonia due to strains with various levels of susceptibility to 
Methods: 1-PRSP pneumonia in rabbits treated with hum-like treatment 
of MOX 400 mg/day, LEV 500 mg/day for 48 h; 2-pharmacokinetic data was 
obtained for each animal; 3-bacterial content (logcfu/g) in lung and spleen. 
The susceptibiltty profiles of the strains for CIP/LEV/MOX were (MIC, 
mg/L; genotype): strain S S S  0.5/0.5/0.125, strain RSS: 8/1.75/0.25 (pa& 
mutation), strain RRS: 64/16/0.5 (parC mutation), strain RRR: 64/16/4 
(parC and gyrA mutations), respectively. 
Results: 6-12 animals per group were tested. Lung bacterial reductions 
(logcfdg) for LEV and MOX were: strain SSS 4 . 2 f 2  vs. 4.83~2; strain 
RSS: 2.4+2 vs. 1 . 3 f 2  (P=O.l); strain RRS: 0.9f0.9 vs. 3.1+0.7 
(P< 0.01); strain RRR: 0.3 i 2 vs. 0.8 f 0.3. MOX was more effective in 
spleen than LEV (P< 0.01). Mutants were detected in lungs for RSS and 
RRS strains for both antibiotics. C-/MIC, AUC/MIC and T> MIC were 
strongly correlated and associated to in vivo antibacterial efficacy. A CART 
analysis identified discriminant PK-PD values for >2 log cfu bacterial reduc- 
tion on MOX. Cm/MIC * 6.4, AUCIMIC * 32 and T>MIC * 30 
(P=0.04). When MICs are normahzed, in vivo mutants appeared when 
AUC/MIC, were between 7 and 31 for both antibiotics (P=O.03). 
Conclusion: In t h s  in vivo pneumococcal pneumonia model with human 
adapted treatment, MOX is (i) effective against CIP- and LEV-resistant PSDP, 
(ii) mutants appear in vivo when PRSP harbor parC mutation for both LEV 
and MOX; (iii) mutan& did not appear invivo for AUC on normalized MIC 
ratio >31. 
FQ. 
Surgical infections: solutions to the emergence of antibiotic resistance (Symposium arranged by Pfizer) 
[m Definitions related to surgical infections 
E. Patchen Dellinger 
Seattle, USA 
A surgical infection is generally regarded as one that requires anatomic 
(“surgical“) intervention to ensure its resolution, and which normally will 
not resolve upon antimicrobial intervention alone. The intervention may be 
as simple as opening a recent incision to drain a surgical-site infection or 
placing a percutaneous catheter in an abscess, or as complex and invasive as the 
debridement of infected retroperitoneal necrosis associated with pancreatitis. 
Thus surgical infections encompass a wide range of infections. Many terms 
have been applied to postoperative infections. To simplify communication, 
the Centers for Disease Control and Prevention in the United States of 
America, in collaboration with the Society for Healthcare Epidemiology of 
America and the Surgical Infection Society, has recommended that all such 
infections be called surgical-site infections (SSIs). These can be divided into 
supeficial incisional mfections, which occur above the muscular fascia and 
involve skm and subcutaneous tissues only, deep incisional infections, which 
penetrate as far as the muscular fascia, and “organ space” infections, which 
involve the body cavity or organ space of the operation away from the site of 
incision (peritoneal cavity, pleural space, mediastinum, joint space, etc.). All 
SSIs are, by definition, postoperative. The risk of an SSI is often estimated 
using the National Nosocomial Infections Surveillance risk index. Organ- 
space infections may occur without prior surgical intervention, and are 
variously termed peritonitis, inm-abdominal abscess, emphysema, pericar- 
ditis, septic arthritis, etc. Peritonitis can be divided into primary (usually not 
surgical), secondary, and tertiary forms. In some instances, the words sepsis 
and infection have been used interchangeably. However, we usually reserve 
the term sepsis to indicate a particular systemic response to infection. Many 
patients have a systemic inf3ammatory response that cannot be attributed to 
infection. This condition is called systemic inflammatory response syndrome 
(SIRS). When a systemic idammatory response is caused by infection, the 
condition is termed sepsis or SIRS with infection. Two other terms, severe 
sepsis and septic shock, refer to sepsis associated with organ failure or 
hypotension, respectively. Severe sepsis and septic shock can occur in response 
to infections due to any pathogen and are not defined by Gram-negative, 
Gram-positive, fungal, or other pathogen characteristics, although certain 
pathogens (such as Streptococcuspyogenes and Clostridium spp.) are more likely to 
cause sepsis than others. 
[s1861 The increasing threat of resistance in surgical 
infections 
F de Lalla 
Mcenra, I 
Despite developments m surgical techniques and anhbiotlc pmphylaxls, 
pOStOperahVe mfechon remans a considerable cause of morbidq and mor- 
tahty among s u r g d  pahents. It IS also responsible for considerable mcreases rn 
the durahon and cost ofhospital stay Indeed, it has been esnmated that a single 
surgcal wound infechon accounts, on average, for 7 days of additlonal 
hospitalizahon and an mcrease of more than US$ 3000 m hospital charges 
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Overall, in the USA, the annual dwect cost of postoperative infection is 
probably well in excess of US$ 1.5 billion. The choice of appropriate 
antimicrobial agents for prophylaxis and treatment of postoperative infections 
requires an understanding of the microbiology of surgical infections, available 
antimicrobial agents, susceptibility and resistance patterns among likely 
pathogens, and individual risk factols for infection. The organisms most 
fiequently associated with superficial (incision) wound infection are Gram- 
positive cocci, in particular Stagkylococrus aurt-us. In the case of infectious 
complications, following clean surgical procedures that involve the implanta- 
tion of prosthetic devices, it is coagulase-negative staphylococci and S.  aureus 
(quite often methicih-resistant strains) that predominate. Intra-abdominal 
and pelvic postoperative infections are most often characterized by a mixture 
of aerobic and anaerobic flora. The most common aerobes are Enterobacter- 
iaceae (Escherichia coli, Proteus spp., and others) and enterococci, whde among 
anaerobes Bacteroides jagilk group species prevail. The involvement of fungi 
(such as Candida spp.) also needs to be considered. Infections in patients who 
have been hospitalwed for a long time or who have received antibiotics 
previously are more likely to involve resistant bacterial strains. Adequate 
drainage, surgical control of the source of infection, and effective adjunctive 
antimicrobial therapy are important factors in the successful treatment of 
postoperative infections. In the case of intra-abdominal and pelvic infections, 
antimicrobial therapy should be directed against both Gram-negative enteric 
and anaerobic bacteria. Combinations of aminoglycosides with clindamycin 
or metronidazole have been widely used with great success. In recent yean, 
monotherapy with either a carbapenem or a 8-lactadb-lactamase inhibitor 
combination has proved effective in both clinical trials and clinical practice. 
Furthermore, p-lactam/P-lactamase inhibitor combinations have been shown 
to be effective options for perioperative prophylaxis during abdominal and 
pelvic surgery. 
General principles in surgical prophylaxis 
S. Geroulanos 
Athens, GR 
Antimicrobial prophylaxis can decrease the incidence ofinfection, pamcularly 
wound infection, after certain operations, but this benefit must be weighed 
against the risks of toxic or allergic reactions, the emergence of resistant 
bacteria, drug interactions, the selection of bacteria, and superinfection. 
Antimicrobial prophylaxis is recommended only for procedures with high 
infection rates, i.e. those involving the implantation ofprosthetic material and 
those for whch the consequences of infection are especially serious. An 
effective prophylactic regimen should be directed against the most likely 
infecting organisms but need not be active against every potential pathogen. 
Regimens that decrease the total number of endogenous and exogenous 
bacteria generally permit host defenses to resist clinical mfection. Infection is 
prevented when therapeutically effective concentrations of an antibiotic are 
present in the blood and the tissue during and after the procedure, when the 
risk of contamination is maximal. Therefore, antimicrobial prophylaxis should 
commence just before the operation. The initiation of prophylaxis earlier is 
less effective, and its initiation after the operation is meaningless. A s q l e  dose 
given just after the induction of anesthesia is s&cient to achieve therapeutic 
drug levels at the time of maxjmal endogenous or exogenous contamination 
without selecting bacterral strains resistant to the drug. If the surgical 
procedure is delayed or prolonged (more than 3 h), or if major blood loss 
occm, a second dose might be advisable, especially if the chosen agent has a 
short elimination half-life. For this reason, the use of a long-acting antibiotic 
agent in long-lasting procedures is to be preferred. The postoperative 
admitllstration of prophylactic drugs is usually unnecessary (except in the 
case of heavy bleeding associated with the development af new hematomas) 
and, furthermore, is considered harmful. Prophylaxis that continues for more 
than 24 h will result in the selection of bacterial sh;lins and the emergence of 
drug-resistant bacteria. Despite the existence of several consensus guidelines, 
the selection of an antibiotic prophylaxis regimen must take into considera- 
tion the local resistance patterns, the time of preoperative hospitalization, and, 
in particular, the presence ofrisk factors for infection, including those related 
to antibiotic use, the surgical procedure, and the environment. These factors 
are associated with sigruficant increases in morbidity and mortality, and may 
indicate the need to modlfy an antimicrobial prophylaxis scheme in high-risk 
patients. 
The role of beta-lactamlbeta-lactamase inhibitor 
combinations in surgical infections 
I. Sayek 
Ankara, TR 
Many surgical infections are characterized by synergistic polymicmbial 
mixed infection, for which broad-spectrum andmicrobial therapy is 
usually administered on an empiric basis. Until relatively recently, standard 
empiric therapeutic regimens have involved the use of two or more antibiotics 
in combination, such as an aminoglyfoside and an antianaerobic agent 
(clindamycin or metronidazole), to achieve adequate aerobic and anaerobic 
coverage. Evidence from a number of clinical studies suggests that singleagent 
therapy with a fi-lactam//?-lactamase inhibitor combination is a clinically 
effective and cost-effective alternative to multidrug regimens, as well as to 
monotherapy with cephalosporins or carbapenems, in the treatment of mixed 
mfections. It has been shown that p-lactamlj-lactamase inbibitor combina- 
tions can be used effectively in the treatment of intra-abdominal infections, 
gynecological pelvic, diabetic foot, and other mixed infections. The 
P-lactam/j-lactamase inhibitor combinations are also suitable for use in 
perioperative prophylaxis, and may offer benefits over other agents in terms 
of reduced incidence of surgical wound infections and lower costs. A 
p-lactam/#Llactamase inhibitor combination has been shown to be a cost- 
effective alternative for the prophylaxis of intra-abdominal infections. 
Treat the infection or follow the protocol? An interactive debate 
151931 Follow the protocol: keep a fallback choice in the 
therapy of infections in the critically ill 
M. Niederman 
Mineola, USA 
Infections in the critically ill are a major source ofmorbidity and mortality, but 
are increasingly due to multiresistant organisms. These include resistant 
Gram-negative bacteria (I? aeruginosa, Adnetobacter species) and resistant 
Gram-positive organisms (methicillin-resistant S. aureus, vancomycin-resis- 
tant enterococcus). Although data show that initially adequate empiric 
therapy can lead to improved outcomes, the exact method for achieving 
such therapy is uncertain. One argument is that the uncontrolled and empiric 
use ofbroad-spectrum antibiotics in the intensive care unit can only add to the 
problem of resistance and have the end result of making initial therapy even 
more likely to be ineffective. In order to treat patients with effective antibiotic 
therapy it is necessary to have tight control over the use of antibiotics. This 
means no unrestricted use, and u s i n g  the appropriate drug for each specific 
patient. Thus, we need protocols for empiric therapy of the critically ill that 
define the likely organisms, and take into account local susceptibility patterns. 
In ths context, we should use the most focused therapy regimen possible, 
while shU covering all likely etiologies. The use of a more broad-spectrum 
approach has no added clinical benefit and can only provide more selection 
pressure for anhbiouc resistance. In addition to empuic therapy being 
focused, it is necessary to stop antibiohcs or narrow the spectrum of therapy, 
once bacteriologd and chmcal response data become avadable. In this way, 
we d not use our most potent anabiotics excessively, and wdl have active 
agents, such as the carbapenems, the oxazolidinones, and advanced fl-lactams 
as fallback choices for pahentS who redy need them. 
1 5194 1 Cover all possibilities - eliminate the risk of 
resistance 
J. Mouton 
Nijmegan, NL 
Patients suspected of hawng an infection are usually treated according to a 
standard protocol that follows the hospital formulary or other guidelines; &IS 
usually includes guidance on the choice ofantibtotic as well as dosingregimen 
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that should be used. However, guidelines are usually based on antibiotic 
efficacy and coverage of whatever microorganisms most frequently cause 
infections in a particular setting. Until now, few dosing regimens have been 
aimed at decreasing the chance ofemergence ofresistance (resistance counter- 
selection) and only a few studies, most of them involving the use of 
fluoroquinolones, have been designed to elucidate the underlying mechan- 
isms of resistance. The simplest approach to study the risk of resistance 
developing is to determine the mutation prevention concenmtion (MPC) of 
a drug in vitro; the MPC is defined as the lowest concentration of an antibiotic 
that is needed to prevent the growth of resistant mutants using a high 
inoculum. It appears that the MPC is not the same for all fluoroquinolones. 
In admtion, it has been shown that the emergence of resistance is dependent 
on the magnitude of the pharmacodynamic indices AUC/MIC and peak 
MIC, and may be Werent across various quinolones and causative species. 
Thus, both tbe choice of drug as well as the dosing regimen should be d o r e d  
for each bacterial species and in some cases even specific strains, not only for 
improved efficacy but also to decrease the risk of the emergence of resistance. 
151951 Follow the protocol - save powerful antibiotics for 
targeted use 
J. Cohen 
Brighton, U K  
Antibiotic guidelines are nationally, or internationally agreed strategies for the 
treatment of a specific infection, or infectious dlsease syndrome, using a 
standardized approach based on evidence-based criteria, epidemiological data 
and/or consensus-derived opinion. Protocols are local recommendations that 
are derived fiom these guidelines. The purposes of protocols are twofold: to 
ensure that the individual patient receives the most appropriate care, and that 
any consequential effects at a population level are minimized, i.e. that the same 
best treatment option remains available for the next patient. Protocols are 
developed for several reasons (a) to apply evidence-based criteria to guide 
practice (b) to assist in the management of complicated cases, and (c) to 
control antimicrobial use and to h i t  the development of resistance. There are 
a number of examples of protocol/guidelines in common use 
Pneumonia 
Endocarditis 
0 Febnle neutropenia 
VRE management 
HAAFLT 
Meningococcal meningitis 
Tuberculosis 
Antifungal therapy 
Malaria 
Helicobacter infection 
Despite the widespread acceptance of these protocols, there are surprisingly 
few data that show how well they are adhered to, or the consequences of 
avoidance. Within Europe, the Copenhagen declaration made important 
statements in respect of the threat of emerging resistance, and t h ~ s  remains an 
important justification for protocols and one argument in favor of reserving 
certain antibiotics for specific use. In addition, examples wiU be discussed in 
which protocols can have a beneficial effect on patient outcome. In my 
opinion, protocols should be followed, rather than the choice being left to 
individual clinicians, as th is  is an evidence-based approach that maximizes the 
chance of clinical success and thus reduces the risk of antibiotic resistance 
development. 
Js19kJ Cover all possibilities - right first time saves lives 
D. Paterson 
Pittsburgh, USA 
The cornerstone of any antibiotic management program is the optimization of 
antibiotic therapy so that patient outcome is improwd. Optimization of 
therapy requires knowledge of local antibiotic susceptibility data. Hospital- 
wide antibiograms may be insuficient for this purpose, but antibiograms 
specific to the particular intensive care unit (ICU) involved are more usehl. 
Unfortunately, in many ICUs, antibiotic resistance is so widespread that high 
percentages of antibiotics are resistant to many commonly used ‘workhorse’ 
antibiotics (such as extended-spectrum cephalosporins or fi-lactam/p-lacta- 
mase inhibitor combinations). What is the impact of the incorrect choice of 
empiric antibiotic therapy? Several studies have now demonstrated that if 
empiric therapy does not cover the infecting organism, patient mortality rises. 
Inadequate empiric coverage is largely because of antibiotic resistance. In 
Gram-negative bacilli this resistance may be mediated by extended-spectrum 
8-lactamases; enzymes that inactivate extended-spectrum cephalosporins. 
Additionally, Gram-negative bacilli may produce multiple 8-lactamases, 
thereby overcoming the effects of B-lactamase inhibitors. The carbapenems 
are not inactivated by extended-spectrum 8-lactamases and AmpC 8-lacta- 
mases. Because Gram-negative bacilli are such common causes of serious 
infection in ICUs, it is necessary for clinicians to be aware of the antibiotic 
susceptibfity profile of these organisms in their units. The Empiric therapy 
should be chosen so as to maximize the likelihood that such therapy will cover 
the probable pathogens infecting their ICU patients, and not be based on 
national guidelines or cost considerations. 
Electronic communication of microbial typing data: feasibility and added value? (Symposium organized by ESGEM) 
wl The gene project: construction and use of on-line 
databases based on automated ribotyping 
S. Brisse 
Utrecht, NL 
Objectives: Among the available methods for genetic fingerprinting, ribo- 
typing (ribosomal RNA restriction fiagment length polymorpbm) is the 
only one that is fdly automated, using instruments called RiboPrinters 
(DuPont-Qualicon, Wilmington, DE, USA). It remains to be fully evaluated. 
Methods: A network of 18 (mostly European) laboratories, eight of which 
use a RiboPrinter and 10 of which use other fingerprinting techtuques 
(including PFGE, AFLE MLST and manual ribotyping), is currently (i) 
standardzing ribotyping procedures (restriction enzyme choice) and evalu- 
ating the interlaboratory reproducibility of automated ribotyping; (ii) 
creating an on-line database of electronic fingerprints; and (iii) 
evaluating the performance (discriminatory power, identification capacity) 
of automated ribotyping for 15 bacterial species of public health importance, 
includmg the major nosocomial, food-borne and community-acquired 
pathogens. 
Results: Reproducibhty of automated ribotyping was found to be higher 
than 95% in all species tested when the automated analysis of the fingerprints 
(categorization into ‘ribotypes’) is manually refined after visual inspection of 
the patterns. Comparative studies show that ribotyping can generally dis- 
criminate a high proportion of ‘epidemic’ clones previously identified based 
on other techniques (for example, 14 out ofthe 16 major multidrug resistant 
Strqptococruspneumoniae international clones have &tinct PvuII ribotypes), but 
the ability of ribotyping to discriminatc these clones fiom closely related, 
nonepidemic strains varies among species. Automated ribotyping was so far 
found to be useful for the identification of epidemic clones of An’netobacter 
baumannii, Pseudomonus aeruginosa, vancomycin-resistant Enterocoms faecium, 
and the Burkholdm’a cepacia complex. A database of electronic fingerprints 
built using the software BioNumerics (Applied Maths, Belgium) has been 
made adab le  on the Internet (see http://www.ewi.med.uu.nl/gene), allow- 
ing remote pattern matching and identification using BioNumerics or a web 
browser. 
Conclusions: Automated ribotyping proves to he a powerful and reliable 
technology for international networks for the exchange of bacterial fmger- 
print data. However, automated ribotyping analysis generally needs to be 
complemented by other typing techniques, and its wider applicability to 
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clirucal microbiology and molecular epidemiology is currently lirmted by its 
relatively high cost. 
Problems and solutions for electronic 
communication of DNA fingerprint -the ENEMTI experience 
K. Towner 
Nottingharn, UK 
Rapid molecular typing techniques are becoming essential tools for monitor- 
ing the geographical spread of particular virulent, epidemic or antibiotic- 
resistant bacteria. However, in many cases, such techniques either lack 
standardization and reproducibility, or their use is restricted to central 
reference laboratories. The European Network for Exchange of Microbial 
Typing Information (ENEMTI) is fimded by the European Science Founda- 
tion (ESF) to provide a forum in whcb to evaluate initiatives designed to 
allow local strain analysis and identification, combined with centralized data 
comparison and exchange. Central to this approach is the concept of highly 
standardized typing protocols used in conjunction with a central interactive 
database. Advanced software for the construction of databases is now available, 
and various difTerent typing approaches (AFLP, PFGE, RAPD, REP-PCR 
and molecillar serotyping) have been evaluated by ENEMTI for their 
reproducibility between a e r e n t  participating laboratories with four groups 
of organisms: An'nerobacter, Eschaichia coli, Legionella and Sraphylocoms aureus. 
To date, PFGE and AFLP have shown the most promise, but there are also the 
most time-consunling of the techniques examined. Rapid PCR-based 
fingerprinting techniques had shown promise in preliminary experiments 
using standardized reagents, but recent problems in the manufacturing process 
have illustrated the dangers of relying on quality control procedures at a single 
commercial supplier. To allow easier comparison between fingerprints gen- 
erated in =rent laboratories with different eIectrophoresis equipment, it 
may be advantageous to base the comparison on the extrapolated molecular 
sizes offmgerprints. However, once again there are problems with the lack of 
precision found with some commercial molecular size markers. It is clear that 
rigorous standarktion is absolutely mandatory if interIaboratory exchange 
ofelectronic typing data is to be achieved. Further, ifsuch typing databases are 
to be used widely in Europe and elsewhere in the future, a mechanism will 
probably be required to allow some form of practical training in the 
standardized protocols for members of participating laboratories. Detads of 
all the protocols and activities of ENEMTI can be found at the ENEMTI 
website (http://www.rivm.nl/enemti/). 
Pregnant women and neonatal infections (Joint symposium with IDSA) 
(s216; Towards elimination of perinatal HIV - an 
incomplete success story 
C. Rudin 
Bad,  CH 
Since the time when AIDS was fmt reported in 1981, more than 50 million 
people, includingat least 23 &on women and 5 million children, have been 
infected with HIV across the globe according to the 1999 estimates of the 
World Health Organization. With the development of a test for H N  infection 
in 1985, transfusion-mediated disease was almost completely eliminated, 
leaving mother-to-child transmission the main mode of acquisition of 
pediatric HIV infection. Before preventive interventions became avadable, 
transmission rates of 14-33% and of 40-50% were reported by prospective 
studies from industrialized and developing countries, respectively. However, 
in 1994, the completion of the AIDS Clinical Trial Group 076 trial initiated a 
new era ofhope and progress in the pediatric AIDS epidemic. The widespread 
introduction of this three phase regimen with ZDV into clinical practice 
Malaria: selected aspects 
152231 Modern diagnostic strategies to avoid 
misdiagnosis of malaria 
T Hanscheid 
Lubon, P 
In most endemc counmes h t e d  economc resources mean that malaria 1s 
usually hagnosed on c h c a l  grounds alone However, mcroscopy may be 
valuable as it could also be used in the hagnosis of other dseases, hke 
resulted in a two third reduction of vertical HIV transmission in the 
industrialzed world. Vertical msmission rates have steadily continued to 
decrease since due ro the introduction of additional interventions like elective 
cesarean section delivery and reftlining from breast-feeding. The application 
of a combination of these three interventions is now widespread and 
transmission rates as low as 1% have been acfueved. More recently, complete 
suppression of m a t e d  viremia by means of HAART ha5 also been shown to 
result in similarly low transmission rates. Although many questions s t i l l  remain 
partly unanswered, a more than 90% reduction in vertical transmission rates 
has been acheved over a period of less than l0years in the industrialized 
world. Nevertheless, due to the enormous costs and infnstructural needs, we 
have not managed to translate this success story to those countries who would 
need such interventions to reduce vertical HIV transmission most desperately. 
Even though recent trials have demonstrated benefits from more abbreviated 
and less costly interventions and thus raised hopes that transmission rates can 
also be ameliorated in relatively impoverished countries in the future, our 
globe is stdl left with at least 1500 new pediatric HIV infections, which occur 
every single day, mostly in such countries. 
tuberculosis. In counmes with imported malaria the judicious use of the 
rapidly performed RDTs may especially help places with, and/or times of 
h t e d  expertise in microscopy, like durtng on-call-hours. PCR methods are 
unlikely to find a widespread use in the routine diagnosis of maarid due to 
long turn-around-times. They may be useful in selected cases, mainly in 
confirming positive cases. Yet, as many as 50% of imported malaria cases may 
be missed at first presentation. The detection of hemozoin, during routinely 
requested full-blood-count, is a novel way to diagnose malaria even in the 
absence of clinical suspicion. 
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Antibiotic treatment of intra-abdominal infections Antibiotic prescribing policies 
102241 ~xc-5 mortality associated with inappropriate 
initial empiric antibiotic therapy in patients undergoing 
surgery for intra-abdominal infection 
M. Bare, X. Castells, A. Garcia, 0. Geling, A. Coma and D. Yin 
Sabadell, l3amlona, E; Piscataway, Whitehouse Station, USA 
Objective: To assess the effect of inappropriate initial empiric antibiotic 
therapy on the risk of in-hospital death among patients undergoing surgery 
for intra-abdominal infections (W). 
Methods: Retrospective analysis of patient records from two acute-care 
hospitals in Spain. The initial empiric therapy is classified as inappropriate 
if one or more baseline pathogens are resistant to all antibiotics in the i n i d  
regimen in case of positive culture or not according to guidelines in case of 
negative/missing culture. Multivariate logistic regression was performed to 
estimate the effect of inappropriate therapy on the risk of in-hospital death 
while adjusting for patient age, gender, infection site and type, and comorbid 
conditions. 
Results A total of 365 adult patients who underwent surgery for IAI between 
1998 and 2000 were retrospectively identified. Mean age was 56.7years; 41% 
were female. The most common sites ofinfection were appendix (39.7%) and 
upper GI (29.6%). A total of293 patients (80.3%) bad peritonitis; 93 patients 
(25%) received inappropriate initial empiric antibiotic therapy. A total of52 of 
the 365 patients (14.2%) died; 18 (4.9%) required re-operation to resolve 
index infection; 58 (15.9%) required additional parented antibiotics to 
resolve index infection. The rate of in-hospital death among patients who 
received inappropriate initial empiric therapy was higher (30.0% vs. 9.6%, 
P= 0.001) compared with patients who received appropriate initial empiric 
therapy In multivariate logistic regression, the risk of death was independently 
associated with inadequate initial empiric therapy (Odd's ratio (OR) = 3.7; 
95% CI: 1.7-8.1). Other risk factors included age 2 65 (OR = 8.9; CI: 3.4- 
23.4), peritonitis from duodenal, gastric, biliary, or pancreatic source (2.3; 
1.0-5.4, relative to appendicitis with peritoneal abscess), neoplasm (3.4; 1.3- 
9.0). diseases of the respiratory system (5.3; 2.4-11.4), diseases of the 
genitourinary system (2.6; 1.14.4). and infectious and parasitic diseases 
Conclusions: Among patients undergoing surgery for IAI, the OR of in- 
hospital death are 3.7 times higher in patients who received inappropriate 
initial empiric antibiotic compared to those who received appropriate initial 
empiric therapy. Age265, peritonitis &om duodenal, gastric, biliary, or 
pancreatic source and certain comorbid conditions are also associated with 
hgher risk of death. However, other unobserved confounding factors may 
st i l l  exist. 
(4.6; 1.8-11.9). 
10225] Association between inappropriate initial empiric 
antibiotic therapy and the need for re-operation and 
second-line therapy among German patients undergoing 
surgery for community-acquired intra-abdominal infections 
W. Sendt, A. Altendorf-Hofinann, J. Scheele, Q. Zhang, K. Krobot, 
A. Spannheimer, F. Eichmann and D. Yin 
/ m a ,  D; U'hitehouse Station, USA; Munich, D 
Objective: To assess the association between inappropriate initial empiric 
antibiotic therapy and need for re-operation and second-he therapy among 
patients undergoing surgery for community-acquired intra-abdominal infec- 
tions (W). 
Methods: Patients who underwent surgery for community-acquired IAI after 
January 1999 were retrospectively identified at 20 German hospitals. Medical 
records were reviewed to confirm IAI and to collect data. Initial empiric 
therapy is classified as inappropriate if at least one pathogen is resistant to all 
antibiotics in initial regimen in case of positive culture or not according to 
guidelines in case of negative/missing culture. Multivariate logistic regressions 
were performed to estimate associations between inappropriate therapy and 
need for re-operation and second-line therapy while adjusting for age, gender 
and comorbid conditions such as neoplasm, congestive heart failure, diabetes, 
and cardiovascular, renal and respiratory diseases. 
Results: A total of 423 eligible patients were included. Mean patient age was 
56.4 k 18.6 years; 42.8% were female. Most common sites of IAI included 
appendix (133 patients) and colon (94). IAI processes included perforation 
(117), abscess (59), and other secondary peritonitis (169). Pathogens were 
documented in 199 patients (47.6%); most kquendy identified pathogens 
included E. coli (147 isolates), Bacteroides species (26) and Streptococci (19). A 
total of21 patients died (5%); 12 due to infection and nine due to other causes. 
Sixteen patienB (3.8%) required re-operation and 59 (14.0%) required 
second-line parented antibiotics to resolve infections. Flfoj-one patients 
received inappropriate initial therapy. Compared with patients who resolved 
their index infection with initial therapy, those requiring re-operation and 
second-line therapy and those who died due to infection were more likely to 
receive inappropriate initial therapy (8.9?? vs. 37.5, 23.7, and 16.7%, respec- 
tively). After controlling for covariates, patients who received inappropriate 
initial therapy were more likely to undergo re-operations (OR= 4.8, 95% 
CI = 1.7-13.9) and to require second-line parented antibiotic therapy (2.9, 
1.4-5.8). The association between inappropriate therapy and infection- 
related death was not statistically significant. 
Conclusion: Among patients undergoing surgery for community-acquired 
IAI, inappropriate initial antibiotic therapy increases the use of re-operation 
and second-line parented antibiotic therapy. 
-1 Outcomes of initial empiric antibiotic therapy and 
hospital resource use in patients undergoing surgery for 
community-acquired intra-abdominal infections in three 
Swiss hospitals 
S. Ess, D. Yin, R. Lyu and T. Szucs 
Zurich, CH; Whitehouse Station, Piscataway, USA 
Objectives: To estimate outcomes and resources use in patients undergoing 
surgery for community-acquired intra-abdominal infections (IAI) and to 
assess the relationship between outcomes and resources use. 
Methods: Patients with community-acquired IAIs were retrospectively iden- 
tified at three hospitals in Switzerland using ICDlO codes. Medical 
records were reviewed to confirm dqnosis and to collect data. AN 
patients had surgical control of infection in addition to parented antibiotic 
therapy. Patients with nosocomial infections were excluded. Empiric 
therapy was defined as successful if the index infection was resolved without 
addltional surgical intervention or second-line parented antibiotic therapy. 
Multivariate linear regressions were performed to estimate the association 
between outcomes of initial empiric antibiotic therapy and total 
parenteral antibiotic days and hospital length of stay (logarithmic scale) 
while adjusting for patient age, gender, APACHE I1 score and comorbid 
conditions. 
Results: A total of 370 patients had confirmed, community-acquired IAIs 
without exclusion criteria or missing data. Mean patient age was 
51 & 18 years; 48% were female. The most common sites of infection were 
appendix (45%), colon (34%) and biliary tract (10%). The infection processes 
included abscess (52%), perforations (9%). and other secondary peritonitis 
(36%). A total of 284 patients (77%) resolved the index infection with the 
initial empiric antibiotic therapy without additional surgery or second-line 
antibiotics, 33 (8.9%) required additional surgical intervention and 38 (10.3%) 
required second-line therapy to resolve infection, nine patients relapsed 
after discharge and six (1.6%) died in hospital due to IAI. The results of 
multivariate linear regressions indicate that patients who required additional 
surgery or second-line antibiotic therapy to resolve the index infection 
had sigdcantly longer duration of parented antibiotic therapy (12.5 and 
9.9daysvs. 6.5days, P<0.05) andhospitallengthofstay (24.1 and 15.ldays 
vs. 10.7days, P <  0.05) compared to patients who resolved their infection 
with the initial empiric antibiotic therapy. Higher APACHE I1 score, infec- 
tion of the colon and cardlovascular disease were also associated with longer 
LOS. 
Conclusion: In patients undergoing surgery for community-acquired intra- 
abdominal infection, the need for re-operation or second-line antibiotic 
therapy results in significant increases in hospital resource use. 
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Treatment outcomes, hospital resource use and 
cost of care for patients undergoing surgery for 
intra-abdominal infections in Northern Italy 
E de Lalla, L. Timillero, E. Pignattari and C. Roda 
Italian PharmacoEconomic Group for Anfimicrobiul Therapy 
Objectives: To describe the treatment outcomes, detailed hospital resources 
use and cost of care among patients hospitalized for intra-abdominal infection 
(IAI). 
Methods: A prospective observational study was conducted in five hospitals in 
Northern Italy Adult patients hospitalized for IAI between January 2000 and 
September 2001 were enrolled. Patients with nosocomial infections were 
excluded. Clinical evaluation was done on day 3 and at discharge. Direct 
medical costs were assessed from the hospital perspective: antibiotic acquisi- 
tion and administmion (including materials and nursing time estimated by 
time-motion methods), laboratory and radiological procedures and hospita- 
lization. 
Results: A total of 112 patients were included in this preliminary analysis. 
Mean age was 57.1(SD 18.3) years; 42 were female. The most common types 
of infections were perforated appendicitis (32.1%), secondary peritonitis 
(25.9%) and cholecystitis with abscess (15.2%). S i - seven  strains were 
isolated &om 97 cultures from blood, abdominal cavity, or other intra- 
abdominal sites. Escherichiu coli (17) and Enferocouusfaecalis (10) were the 
most frequently isolated organisms. The average simplified acute physiology 
score ( S A P S  11) at baseline was 18.7 (10.6). At discharge, 95 (84.8%) patients 
were cured, 10 (8.9%) had improvement and seven (6.3%) failed (six died). 
The most commonly used parented antibiotics included metronidazole (573 
patient-days), cefiziaxone (346) and cefotetan (232). Average number of 
parented antibiotic days and length of stay were 7.3 (15.5) and 15.3 
(21.3) days, respectively. Average time to defervescence was 3.3 (2.6days). 
The most frequently performed laboratory tests included blood cell count (2.6 
per patient), serum chemistry (2.5), ECG (1.2) and cultures of blood and 
other sites (0.87). X-ray, ultrasonogram and CTwereperformed 1.2,0.2,0.14 
times per patient, respectively. For each i.v. infusion, the average cost of 
materials and nursing time estimated by time-motion studies were 0.84 and 
4.21 Euros, respectively. Average cost ofantibiotic acquisition, adrmnistration, 
laboratory and radiology examinations, and hospitalization were 355.5,125.7, 
206.3, and 4575.2 Euros per patient per hospitalization, respectively 
Conclusion: Patients undergoing surgery for IAI result in significant resources 
use and cost. It is important to understand treatment outcomes, resources use 
and cost in order to improve the cost-effectiveness of patient management. 
102281 Antimicrobial drug use and resistance pattern in 
5. pneurnoniae: a correlation study in Italy 
M. L. Moro, A. Pantosti, G. Traversa, S. Spila Alegiani, D. Boccia and 
s. salmaso 
Bologna, Rome, I 
Objectives: We compared regional data on antibiotic consumption with 
patterns of antibiotic resistance of S.prreumoniae as obtained within the 
EARSS project in 1999-2000 (European Antimicrobial Resistance Surveil- 
lance System), in order to evaluate the relationship between antibiotic use and 
resistance prevalence. 
Methods: The Italian EARSS network comprised 64 laboratories, serving 70 
hospitals. Participating labs were asked to collect and test for antimicrobial 
susceptibility all first isolates of S.  pnuemoniue from blood and CSE All isolates 
were sent to the Reference Laboratory, where confirmatory susceptibility 
testing were performed. Data on antibiotic use in 2000 were obtained from 
the Ministry of Health. National and regional level of antibiotic use were 
expressed both in terms of defined daily doses (DDDs) prescribed per 1000 
inhabitants per day, and expenditure. The geographic relationship between 
resistance to macrolides and penicillins, and consumption of macrolides and 
8-lactams, was assessed by linear regression analysis (SPSS 10.0). 
Results: A total of 322 strains were obtained f b m  50 participating labora- 
tories. A total of 72.7% of the isolates were collected &om blood and 27.3% 
from CSE The level of resistance was 12.1% for penicillin, and 28.6% for 
erythromycin, with a marked geographic trend. Penicillin resistance was 
higher in southern than in northern Italy (21.4% v5.9.5%, P< 0.05). a similar 
difference was observed for erythromycin (45.7% vs. 23.8%; P<O.O5). 
Macrolides and 8-lactams represented 22.7 and 40.9%. respectively, of 
the overall level of antibiotic use (22 DDD/1000 inhabitants die), with 
large regional variation. A geographic correlation was found between total 
macrohdes consumption and erythromycin resistance (R’ = 0.55; P <  0.05), 
and between total 8-lactams consumption and penicillin nonsusceptibility 
(R2 = 0.68; P <  0.05). 
Conclusions: In Italy, the resistance of S. pneumoniae to penicillin and macro- 
lides follows a geographic trend, with higher level of resistance in southern 
Italy. A similar trend is observed for antibiotic consumption, which suggests 
that resistance pattern of S. pneumoniae could depend, at least in part, on the 
use of antibiotics. Further analysis is requested for a better understanding of 
these results. 
102291 Influence of an infectious disease consulting 
service on quality and costs of antibiotic prescriptions at a 
university hospital 
S .  Lemmen, A. Bauer, S. Kotterik, H. Ngyen, C. Breuer and H. Heinm 
Aachen, D 
Background An infectious disease consulting service was established at 
the Department of Internal Medicine at the University Hospital Aachen, 
Germany in September 1999 in order to assess and optimize the quality of 
antibiotic usage. 
Methods: Written guidelines relating to the most common community- 
acquired and nosocomial infectious ckseases were implemented. Instructions 
on signs, symptoms and diagnosis ofinfectious diseases was given to physicians 
by infectious disease specialists. All patients admitted to the hospital via the 
emergency ward were enrolled the study. 
Results: During the 8-month intervention period (September 1999 to April 
2000) 20.7% (155/748) of the patients received antibiotics in comparison to 
28.5% (146/513) during the 6-month control period (November 1998 to 
April 1999) without an infectious disease service. Demographic data of the 
patients and distribution of infections were comparable. In both groups, 
therapy was started in the emergency ward in about 85% of cases; the major 
indication for treatment were lower respiratory infections (69%). Inadequate 
prescriptions could be reduced sigmficantly h m  30% (44/146) to 17% 
(271155). The route of administration was changed from i.v. to p.0. after 
6.7 and 4.5 days, respectively. The mean length oftherapy and mean length of 
stayinthehospitaldecreasedform11.6to9.3daysandfiom16.4to 14.2days. 
respectively. There was no sigmficant difference in mortality rates: 3.4% 
(5/146) in the control group and 5.8% (9/155) in the intervention group. 
Costs per patient on antibiotics could be reduced by 32% &om 159 to 109 
Euro, thus resulting in a total saving of about 10.500 Euro. The cost of the 
infectious disease specialist with an average weekly workload of about 4 h was 
approximately 4000 Euro. 
Conclusions: (1) Establishing an infectious disease service improved the 
prescription behavior significantly and decreased the duration of therapy 
and of hospitalization without interfering with the quality of medical care. (2) 
Hospitals with limited financial and personal resources are advised to focus on 
the admittingunit. (3) The total cost saving of 65OO Euro for the intervention 
period shows that this service is indeed cost-effective. 
1-1 Antibiotics prescribing in the emergency 
depamnent a prospective study in 34 French EDs 
D. War ra t ,  D. Brun-Ney, B. Cordier, J. M. Viso, M. Zarka, Y. Pean, 
M. Pecking, A. Scheimberg 
Ed f i e  Vigiil’Roc Group, Park, F 
Background: In the ED the prevalence of infectious diseases (ID) is high 
and their antibiotic treatment (AB) unknown. Our purpose is to identify AB 
prescribing, defined as a de novo introduction (ABN), an interruption (ABI), 
a modification (ABM) or the pursuit (ABP) of an AE3 previously prescribed. 
Methods: Consecutive patients aged 18years or more are included if (1) 
ABN, ABI, ABM or ABP are decided by, or with the agreement of, the 
attending physician (2) they consent to be followed up by telephone for at least 
3days. They are classified in five classes according to pretest evaluation 
of acuteness of illness (PTA): I = no test required, I I = I  + tests ordered, 
111 = functional prognosis unstable, IV = vital prognosis involved but no CPR 
needed, V = IV + CPR required. 
Results: From December 11 through 24,2000,33 EDs reported 38 859 Visits 
(97 &37/ED/day). Of 21 909 non-trauma patients. A total of 2468 (11.2%) 
were potentially ID, 80% of whom received an AB. All 34 participating EDs 
included 1981 patients (4.74 & 0.96/center/day 11-21]) aged 52 f 2 4 y w s .  
sex ratio 52%M with ABN 77.3%, ABI 3.2%, ABM 14.5%, and ABP 5%. 
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Main IDS are respiratory (37.4%), urinary (20.4%) and skininfections (18.6%) 
and AB classes used are penicillins (57.2%). 3GC (10.4%) and fluoroquino- 
lones (20.8%). Patients' PTA is similar to that of the common French ED- 
patient: I, 19.8% I1,45.8%; 111, 22.3%; IV, 11.156; V, 0.9% 1089 (55%) were 
hospitalized. A 3-day follow-up was obtained for 1829 (93%), ofwhorn 1.4% 
were reported dead, 3.9% did not observe AB and 23.2% had an AB change. 
Conclusions: IDS are a motive for consultation in 10-20% of non-trauma ED 
patients. As our study population is fairly representative of French EDs, we 
would expect that ofthe 6 000 000 non-trauma patients seen in 2000,672 000 
had an ID and 537 000 were treated with at least one AB. The adequacy ofAB 
with current guidelines is unknown. 
102311 Modeling the temporal relationship between 
hospital use of rnacrolides, third generation cephalosporins 
and fluoroquinolones (FQ), and the percentage of 
methicillin-resistant staphylococcus aureus isolates: a time 
series analysis 
E M. MacKenzie, J. M. Lopez-Lozano, A. Beyaert, D. L. Monnet, 
M. Camacho, D. Stuart, R. Wilson and I. M. Gould 
Aberdeen, UK: Orihuela-Aiirante, Murcia, E; Copenhagen, DK 
Objective: To study the temporal relationship between hospital use of 
antimicrobials and %MRSA of all S. aureus isolates. 
Methods: The study was performed in a Scottish 1200-bed tertiary referral, 
teaching hospital during the period January 1996 to December 2000. 
Monthly hospital data were obtained on the percentage nonduplicate, non- 
surveillance MRSA, and the use of antimicrobials in Defhed Daily Doses 
(DDD) per 1000 patient-days. An Autoregressive Integrated Moving Average 
Fungal infections 
(ARIMA) model was adjusted to each of the series. A dynamic model with 
polynomial distributed lags was then adjusted to assess the relationship 
between %MRSA and use of various antimicrobials. 
Results: The average monthly %=A was 14.9% but: showed large varia- 
tions from 0 to 41.5%. Examination of the %MRSA series showed a global 
increasing trend but included three seasonal cycles in April to July 1998, April 
to October 1999, and February to September 2000 (maximum to minimum 
level). The monthly no. of S. aureus isolates overall, i.e. susceptible +resistant 
isolates, did not show this seasonal pattern. The average monthly use ofMAC, 
3GC and FQ was 90.2.62.5, and 51.9 DDD/lOM) patient-days, respectively. 
However, there were also large variations during the study period, e.g. for 
MAC &om 32.7 to 177.9. Examination ofthe series showed: (1) for MAC, a 
sustained increase over the whole study period and a seasonal pattern with 
maximum levels of use during winter months (November 1995, December 
1996, December 1997, December 1998 toFebruary 1999, December 1999 to 
January 2000, December 2000) (2) for 3GC, an increase for the overall period 
with a sharper increase from mid-1999 to December 2000 and a seasonal 
pattern with peaks in December months (3) for FQ, a less marked increase 
without an evident seasonal pattern. When adjusting the dynamic model to 
capture the relationships between these series, we found that the monthly 
%MRSA was explained by: (1) the %MRSA observed 3 and 6 months before 
(2) use ofMAC up to 3 months before (3) use of 3GC 4 months before and (4) 
use of FQ between 3 and 9 months before. This model explained 93% of the 
variations in the %MRSA observed during the study period. 
Conclusion: By using time series analysis, we demonstrated a dynamic 
relationship between the use of MAC, 3GC and FQ, and the %MRSA in 
our hospital. These results confirm previous hypotheses that the %MRSA 
observed in a hospital is related not only to the MRSA colonizing pressure, 
but also, and with a certain delay, to the use of several antimicrobial classes to 
which the Aberdeen MRSA are resistant. 
102321 Antifungal drug susceptibility of Aspeqillus spp. 
isolated from nosocomial departments with 
high-risk patients 
J. Filioti, E. Pavlidou, E. Farmaki, I? Panagopoulou, J. Dotis, 
C. Panteliadis and E. Roilides 
Thessaloniki, GR 
Objectives: Invasive aspergillosis (IA) causes increased morbidity and mor- 
tality in immunocornpromised hosts. Nosocomid transmission of airborne 
conidia has been considered as an important mode of hngal acquisition. We 
aimed to study antifungal drug susceptibility of aspergdh h m  hospital 
departments having patients with increased risk for IA. 
Methods: Fifty-four Aspergillus isolates (19 Afumigatus, 17 A . f i u u s  and 18 A. 
niger) were evaluated for minimal inhibitory concentrations (MIC) of two 
current and two newer antifungal agents. The strains studied were randomly 
chosen from a total of 470 isolates collected from four units (Solid Organ 
Transplantation, Hematology, Paediatric Oncology, Paediatric Intensive 
Care) at 12-monthly air samphgs during 2000. The invitro susceptibilities 
to amphotericin B (AmB), itraconazole (ITC), voriconazole (VRC) and 
posaconazole (PSC) were tested by NCCLS M38-P micromethod. The 
endpoints for MIC (mg/L, no growth) were read visually. 
Results: 
SPP. AmEl ITC VRC PSC 
A.jirmigafus MICSo 0.5 2 0.5 0.125 
A..flavur MICS0 1 2 0.5 0.25 
A.  niger MICSo 0.125 2 0.5 0.5 
Range 0 . 6 2  0.06-16 0.25-1 <0.015-0.5 
Range 0.125-4 0.06-4 0.25-2 0.031 
Range 0.6-0.25 0 .254 0.254 0.061 
Conclusions: Aspergillus spp. isolated &om hospital departments mth  high- 
nsk paaents were found to have low MIC for currently used antifungal drugs. 
Suscephbhty to AmB was A. niger> A .  fumigatus>A. Javus. All three 
Aspergillus spp. were gene* more susceptible to the newer azoles than 
ITC. Although Aspergillus spp. can be fiequently isolated in nosocomial 
environments and pose a significant threat to immunocompromised patients, 
they do not appear to possess unusual patterns of drug resistance. 
Acknowledgement: Supported by PENED99 
102331 Multicentre evaluation of inoculum preparation 
methodologies for antifungal susceptibility testing (AST) of 
Aspergillus species 
E. Petrikkou, J. Mosquera, E. Chryssanthou, M. Cuenca-Estrella 
and J. Rodriguez-Tudela 
Majadahonda, E; Manchester, UK; Stockholm, S 
Objectives: The procedure of NCCLS M38-P recommends inoculum pre- 
paration by a spectrophotometric method. However, color and size of 
spores can have an influence on the optical density (OD) values. Alternatives 
as spore enumeration with a hematocytometer could be a more reliable 
procedure for inoculum preparation (JCM 39: 1345-47, 2001). We have 
evaluated the interlaboratory reproducibility of a microscopic spore enumera- 
tion method. 
Methods: Three labs participated in the study. A total of 40 Aspergihs strains 
including 10 each ofrl.fum&atus (AF), A.fipavus (M), A .  terreus (AT), A. niger 
(AN) were tested. Inoculum size were adjusted between 1 x lo6 and 
5 x lo6 cfu/mL by spore enumeration with a Neubauer improved chamber 
(NB), and quantified by plating aliquots onto Potato Dextrose agar (colony 
counting, CC). OD at 530nm of each inoculum suspension was also 
measured by spectrophotometrical reading (SP). Analysis: (i) agreement 
(AGR):% ofCC within 1 x to 5 x 1 o 6 c ~ / r n l ;  (ii) correlation: intraclass 
correlation coefficient (ICC), over a maximum value of 1. 
Results: The total AGR for the three labs was 89.2%. By species the AGR 
were: (i) AF, 96.7%; (ii) M, 80% ( i )  AT, 90%, (iv) AN, 90%. For all 
participants, the average ICCs between CC versus NB and CC versus SP were 
as follows:(i) M, 0.37 and -0.19, respectively; (ii) Afl, 0.69 and 0.39; (iii) AT, 
0.52 and 0.44; (iv) AN, 0.81 and 0.58; (v) total, 0.73 and 0.15, respectively. 
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Conclusions: (i) The inoculum preparation by spore enumeration is a 
reproducible method with high interlab AGR, >90%, with the exception 
of Afl (AGR of 80%). (ii) The spore enumeration exhibits significant higher 
correlation with colony counting than that of SP procedure. (iii) Inoculum 
size has a great influence on the MICs for filamentous fungi and a reliable 
procedure for inoculum preparation is mandatory. 
1 0234 1 A retrospective observational study of nosocomial 
candidemia 
A. Bedini, C. Venturelli, V Borghi, C. Mussini, G. Guaraldi, 
M. Codeluppi, E Rumpianesi and R. Esposito 
Modena, f 
Objective: Aim ofthe present study was to evaluate, in an Italian tertiary care 
hospital, the incidence of nosocomial candidemia together with causative 
pathogens, treatment, and risk factors for death. 
Materials and methods: A retrospective. observational study was conducted 
in an Italian tertiary care hospital. Data were collected between January 1998 
and August 2001. Candtdemia diagnosis was defined as the detection of at 
least two positive blood cultures yielding Candida spp. during the same 
hospital admission. 
Results: During the study period a total of 55 episodes of candidemia 
occurred in 52 patients, accounting for a global incidence of 4.17/10000 
in-patients. Median age was 55 years and both sexes were equally represented. 
Fungemia occurred a mean of 30 days after admission. The most common 
reasons for hospitalization were solid neoplasia (27%), abdominal surgery 
(19%), trauma (11%) and hematologic neoplasia (8%). Twenty-four (46%) 
patients were hospitalized in medical wards, 17 (33%) patients in surgical 
wards and 11 (21%) patients in intensive care units (four patients in neonatal 
intensive care units). C. albicans was the most frequently isolated pathogen, 
accounting for 50% of fungal isolates, followed by C.parapsilosb (14%). 
C. tropicalis (13%), C.gZabratu (ll%), C. reylanoides (4%). C. lusitaniue (2%)). 
C.pseudorropicak (2%). C.gwilkmrondi (2%) and C. sake (2%). Thuty-three 
(63%) patients received adequate antifungal therapy. Eighteen, adults (43%) of 
the 42 patients, with central venous catheters underwent line removal; five of 
them had catheter-related candidemia. Neonatal fimgemia episodes were 
observed only until 1998 and patients neither underwent central line removal 
nor died. The 30-day crude mortality rate was 31%. Hematologic neoplasia, 
inadequate antifungal therapy and retention of central h e s  were sigruficantly 
associated with poor outcome. 
Conclusions: Candidemia is s t i l l  a frequent and life-threatning complication 
in patients hospitalized and with a severe underlying disease. Adequate 
antifungal therapy and central h e  removal independently reduced the high 
mortality of the disease. In our case-record, no neonatal case was detected after 
1998 indicating that there could be an improuvement in the patient care. 
Moreover, neonatal patients, a s m a l l  sample size, showed a favourable out- 
come despite the persistence of the central-line. 
102351 Ninety-four cases of candidemia in a Belgian 
hospital: a retrospective study on outcome 
E. Vlieghe, T. Moreels, D. Schepens, F! Zachee, R. Lins, R. Daelemans 
and B. De Keulenaer 
Antwerp, B 
Objectives: To describe the epidemiology of candtdemia in our hospital, and 
its prognostic determinants. 
Methods: A retrospective study of 94 patients with a proven candidemia 
between January 1993 and October 2001 in Stuivenberg Hospital Antwerp, 
Belgium. 
Results: The average age was 62.3years, ranging between 8 and 95 years and 
the male/female ratio was 1.35. We measured an average candidemia-related 
mordty  of 44.6% without any specific trend during the study period. C. 
albicans was isolated in 53% of the cases, followed by C. glabrutu in nearly 30% 
and C.parapsilosis in 7% of the patients. We noticed a decrease of the absolute 
number of candidemias with a shift towards the non-C. albicans species from 
1/3 to 1/2 of the isolates. Among all the Cundida species, C. albirans had the 
highest mortality (54%). Eighty-five percent of our patients were colonised 
with Candido spp. prior to candidernia (sputum (40%). urine (35%) and 
catheter (23%)). There was a poor outcome ifpatients were colonised with 
Candida spp. in urine (P<0.0001, RR=3.8), skin swabs (P<O.OOOl, 
R = 2.8) or catheters (P< 0.0001. R = 2.75). The number of colonised sites 
was correlated with an adverse outcome as well ( P =  0.037). Patients receiving 
antibiotics or a combination of antibiotics with steroids or TPN did not 
influence the outcome, whereas the combination of antibiotics, steroids and 
TPN would wonen the outcome with a factor 2.2 (P< 0.0001). The SOFA 
score on the fint day of sepsis correlated well with the outcome (P=  0.034), 
were the APACHE I1 score didn’t on admission. There was no sigmtkant 
correlation with age or immunodeficiency. 
Conclusion: Candidemia in our patients was associated with a high mortality. 
This was related to: the species, the prior colonisation and the number of 
colonisation sites, the combination of antibiotics, steroids and TPN and the 
SOFA score on the onset of the sepsis. These may be important parameters 
and could guide decisions on treatment. 
/02361 Caspofungin treatment of candidal esophagitis in 
HIV-infected patients 
M. DiNubile, R. Lupinacci, R. Berman and C. Sable 
West Point, U S A  
Objectives: Caspohngin is a new broad-spectrum antifimgal drug of the 
novel echinocandin class. We analyzed the clinical efficacy of caspofungin 
50mg/day in the treatment of HIV-infected adults with endoscopically 
proven Candida esophagitis from four Phase II/III trials. 
Methods: Symptoms were assessed daily; a favorable outcome required 
complete resolution of all esophageal symptoms assessed at the time of 
discontinuation oftherapy Relapse was defined as recurrent symptoms during 
the subsequent 2 weeks. A multivariate logistic regression model was devel- 
oped to identify potential factors [including severity of presenting symptoms, 
CD4 count on entry, extent of disease assessed endoscopically at baseline, 
causative Cundida species, duration of therapy (total and afier resolution of 
symptoms), time on treatment prior to symptom resolution, and antifungal 
prophylaxis] that might predict symptomatic relapse in the 2 weeks following 
completion of caspofungin therapy 
Results: The 95/123 evaluable patients (77%) were men. Median CD4 count 
was 31/mm3. C. albicans was isolated from 109/110 cases where a pathogen 
was cultured and constituted the sole isolate in 77% of these cases, 55% had 
extensive esophageal disease at the time ofpretreatment endoscopy. Duration 
of therapy ranged from 7 to 20days (mediax12days). At the completion of 
therapy, symptoms had completely resolved in 117/123 patients [95%; 95% 
confidence interval: 90-98%]; median time to resolution of symptoms was 
-4 days. Response rates were 43/46 (93%) and 70/73 (96%) for patients with 
more or less than 50CD4 cells/mm3, and 80185 (94%) and 23/24 (96%) in 
infections caused by C. albicuns alone or in association with non-C. albicanr 
isolates. Symptoms recurred within 2 weeks of stopping caspofungin in 19/ 
115 evaluable patients (17%), including 3/16 (19%) receiving antifungal 
prophylaxis. Rela se rates were similar for patients with more or less than 
50 CD4 cells/mm . In dus small number of patients, only symptom severity 
and extent of disease judged endoscopically at baseline were significantly 
(P< 0.10) associated with early relapse in the multivariate model. 
Conclusions: Caspofungin 50mg/day appeared to be rapidly effective in 
eradicating symptoms of Candidu esophagitis in HIV-dected patients. As 
expected, symptomatic relapse occurred commonly in the 2weeks after 
discontinuation of therapy. Res onse and relapse rates were similar in patients 
with more or less than 50 CD ceiE/mm3. 
9 .  
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102371 Caspofungin (CAS) versus a Amphotericin 
B deoxycholate (Am61 in the treatment (Rx) of invasive 
candidiasis (IC) in neutropenic (N) and non-neutropenic (NN) 
patients (Pts): a multicentre, randomized, double-blind study 
J. Mora-Duarte, R. Betts, C. Rotstein, A. Lopes-Colombo, 
L. Thompson-Moya, J. Smietana, R .  Lupinacci, C. Sable, 
N. Kartsonis and J. Perfect 
San Jose, C R ;  Rochester, USA;  Hamilton, CAN; San Paulo, BR; 
Santiago, CL; West Point, Durham, U S A  
Objectives: AmB remains the gold standard for the R x  ofIC, but toxicity and 
lack of efficacy often limits its use. Although well tolerated, fluconazole (F) is 
often limited to N N  pts, and non-C. albiarnr. Candida infections are relatively 
more resistant to F. CAS, an echinocandm fungicidal against Candida, was 
compared to AmB for primary Rx of IC. 
34 Abstracts 
Methods: Patients with IC were randomized to CAS ( 7 O m g  x 1 ,  then 
50 mg/day) or AmB (0.6-1.0 mg/kg/day). Inclusion required a (+) blood 
culture or culture boom a sterile invasive site witbin 4 days of study entry (SE) 
and evidence of infection (fever/hypothermia, hypotension, or local signs of 
infection) within 2 days of SE. Patients were stratified by Apache I1 & N status. 
Patients were treated for 14day~ after the last (+) culture but could be 
switched to F &er lodays IV Rx. The primary analysis was the MITT 
assmment (met major entry criteria & received > 1 day IV Rx) at the end of 
IV Rx. A predefined secondary analysis was the evaluable (EP) assessment 
(met MITT & received at least 5 days IV Rx). Success required both symptom 
resolution & microbiological clearance. A blinded clinician assessed eligibdity 
& response. 
Results: Of 239 pts enrolled, 224 (CAS 109; AmB 115) met MITT. Baseline 
characteristics, including percentage of N pts (CAS 13%; A d 3  9%, P =  0.32) 
& Apache I1 scores (mean CAS 14.8; AmB 15.4, P=0.46), were sunilar. 
Infections were primarily candldemia (83%; CAS 92; AmB 94) & Condida 
peritonitis (10%; CAS 12; AmB 10). Infections were caused by C.albicam 
(45%), C.paropsiIosis (19%), C. fropicolts (16%). & Cgtabrarn (11%). Success at 
end of IV Rx in MlTTwas 73.4% in the CAS group and 61.7% in the AmB 
group. For EP, success was 80.7% in CAS and 64.Yh in AmB. A summary of 
the results for both MITT and EP is in the table below. 
CAS Ams 
n/m % n/m % for swam (%) 
Dserence adjusted 
MIlT 80/109 73.4 71/115 61.7 12.7 
FJ 71/88 80.7 63/97 64.9 15.4 
(65.1, 81.7) (52.8, 70.7) (-0.7, 26.0) 
(72.4, 89.0) (55.4, 74.5) (1.1. 29.7) 
Values in parenthem are at 95% CI. 
At 6-8 week follow-up, there was no dif5erence in relapse or survival between 
p u p s .  Fewer pts in the CAS group had drug-related (DR) clinical A E s  (CAS 
29%; AmB 54%) or lab AEs (CAS 24% AmB 54%); one (1%) CAS & 16 
(13%) A d  pts had D R  SAEs. Three (3%) CAS & 29 (23%) AmB pts were 
discontinued (DC) for a D R  AE. Nephrotoxicity (CAS 4 %  AmB 23%) was 
also less 6equent in CAS pts. 
Conclusions: In the primary analysis (MITT), CAS was equivalent to AmB in 
the Rx ofIC. In a predefmed secondary analysis (EP), CAS was more effective 
than AmB. CAS was better tolerated than AmB as assessed by D R  clinical 
AEs, lab AEs, SAEs, & AEs leading to DC. 
)02381 Bactericidal and fungicidal activity of 
Nchlorotaurine, a product of human leukocytes 
M. Nagl, C. Lass-Florl, R. Wunner and W. Gottardi 
Innsbruck, A 
Objectives: N-chlorotaunne (ClHN-CHZCH2-S03-) is a long-lived oxi- 
dant produced by neutrophilic and esinophilic granulocytes as well as 
monocytes during the oxidative burst. 
Methods and results: By quantitative suspension tests, a 1% aqueous solution 
( 5 5 m )  of the synthetic sodium salt demonstrated strong killing activity 
against gram-positive and gram-negative bacteria (e.g. Staphylocoms auras  
including methicillin-resistant strains, Streptococcus pyogenes, Eschm’cbia coli, 
Proteus mirabzlis, Pseudomonos aeruginosa) w i t h  10-30min as well as against 
yeasts (Candida spp.) and moulds (AspergiuuS spp., Alternaria alfernnfo, F ~ ~ o r i ~ m  
monilifome, Penicillium commune) within 1 4 h .  As a special feature, the 
microbicidal activity can be increased significantly in the presence of organic 
material leading to killing of fungi within minutes. This phenomenon is 
explained by transhalogenation, i.e. m f e r  of the active chlorine to other 
amino compounds, especially to ammonia generating monochloramine. 
Conclusions: Since 1% N-chlorotaurine sodium proved to be very well 
tolerated by application to the human eye, urinary bladder, ear and paranasal 
sinuses, it is a promising new antimicrubial agent for topical treatment of 
infections in different body regions. 
102391 Use of real-time PCR and ELISA for rapid diagnosis 
of invasive fungal infections in immunocompromised 
hematology patients 
B. L. Jones, N. E. Jordanides, M. Copland, L. McLintock, E. Allan, 
M. Devaney, C. Nugent, A. Parker and T. L. Holyoake 
Glqow, Edinburgh, UK 
The early diagnosis of invasive fungal infection (IFI) remains a sigmficant 
clinical problem in immunocompromised hematology patients. This pro- 
spective blinded study aimed to validate the use of real-time PCR and new 
generation ELISAs to detect IF1 in patients with hematological malignancy 
undergoing intensive cfiemotherapy/stem cell transplantation. A total of 56 
patients (86 neutropenic episodes) recruited between December 2000 and 
August 2001 are currently evaluable. Peripheral blood samples taken on 
admmion and twice weekly to hospital discharge or until immunosuppression 
discontinued, have been analyzed using PCR to detect 18s ribosomal DNA 
and by ELISA for mannan (Candido spp.) or ga lac toman  ( A s p e ~ d h  spp.). 
In addition, standard clinical and laboratory data have been collected. A total 
of 39/56 patients had positive PCR results: of these, 13 were positive on a 
single occasion, 12 were intermittently positive and 14 (four high risk and 
ten high-intermediate risk) had sequential positive results (two or more). A 
total of 20/56 patients had positive ELISA results: 15 were positive on a single 
occasion, one was intermittently positive and four were sequentially positive. 
Correlating clinical and standard laboratory data for 86 neutropenic episodes, 
there were one proven, four probable, four possible and 77 episodes with no 
evidence of IFI, based on EORTC criteria. For the 14 patients with 
sequential positive PCR results, seven had clinically proven, probable or 
possible IF1 based on EORTC criteria and of these, 6/7 were PCR positive 
1-55 days (mean 22 days) prior to commencing empiric antifungaI therapy. 
The remaining seven patients had no evidence of IF1 and did not receive 
empiric antifungal therapy. Of these patients, 5/7 showed resolution of PCR 
positivity coincident with neutrophil recovery. There were no cases of 
proven/probable IF1 in the 17 patients consistently PCR negative. One 
patient with intermittent positive PCR results had probable IFI. The ELISA 
results showed poor correlation both with PCR and clinical criteria. These 
early results provide evidence that molecular techniques are likely to become 
important diagnostic tools for the early detection of IFI. 
Appropriate use of antibiotics and its impact on development of resistance (LIBRA symposium supported by an 
educational grant from Bayer) 
Globalization of antimicrobial 
epidemiological challenges 
resistance - 
P. M. Tulkens 
Brussels, B 
The steady increase in antimicrobial resistance among many common bacter- 
ial pathogens has markedy reduced the initial empiric options ofthe primary 
care physician. Taking Spneumonine as an example, macrolides, tetracyclines, 
and cotrimoxazole can no longer be considered as first line antibiotics for 
most respiratory tract infections in many European countries. Likewise, the 
dosages of b-lactams need to be readjusted. Thus, prescribers can no longer 
confidently reach for their “tried and trusted” agents choice, since many 
conclusions of the clinical trials which support their choice may simply no 
longer be valid if older than a few years. Even recent agents are losing their 
momentum (e.g. the recent repom from Hong Kong highhghting resistance 
rates to so-called “new fluoquinolones” of >lo% [Ho et al. JAC 20011). 
Similarly, difficult situations may arise for many other important pathogens. It 
is, therefore, essential 
for the prescriber to remain informed about the true level of sensitivity of 
the organism causing the infections she/he wants to treat within her/his local 
environment, and to act accordingly; 
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for the Health Authorihes to collect sensihnty data, to pubkh them on a 
regular basls, and to review regularly naaonal and local guidehes accordmg to 
these surveys; 
for both Industry and Pubhc Health authoriaes to promote the approprlate 
use of anabiotics by agreemg on COnQhOns of usage (as specfied ~fl the SPC 
and other official documentanon) that wdl reduce the risk ofrapid emergence 
ofresistance These rules should not only apply to new drugs but also to older 
ones, includmg generics, whch need to be regularly re-evaluated m new of 
the changes in patterns and extent of resistance 
/s241\ infectious diseaselpopulation dynamics 
perspective: consequences of action and inaction 
E. Rubinstein 
21-Aviq IR 
Recognition and acceptance of a problem is the most important step in 
changing the situation. The crisis in antimicrobial resistance has now reached 
epidemic proportions in some countries with respect to certain key bacterial 
pathogens. The ability of physicians to empirically prescribe is diminishing 
dady but unfortunately it seems only the “authorities and experts” recognize 
the situation rarely do primary care physicians acknowledge the new circum- 
stances of treating infection. The consequences of positive action may be the 
slowing or reversal of antimicrobial resistance, conversely the continuity ofthe 
status quo in terms of today’s prescribing d only serve to exacerbate the 
problem. Previous attempts to control macrolide resistance in Finkand 
(Seppala NEJM 1995) is a good example of how effective antimicrobial 
control can reverse the growing situation. However there are many examples 
of continued use, especially with poorly active class agents, has driven the 
resistance growth. The use of different dosage regimen, shorter durations of 
therapy, combination treatment or just less antimicrobials have all been 
suggested as ways of taking action, but the most important step is convincing 
the GP and others that there is a problem and it needs action. The 
consequences ofnonacceptance will be catastrophic as resistant clones become 
globally disseminated and fewer agents are viable. 
v( PWPD perspective: does dose matter? 
R GarraEo 
Pam, F 
The recent advances m the uuderstandmg of drug dosing and fkquency have 
unproved the use of some anhrmcrobial5, e.g qumolones. However the 
implementahon of specific pharmaccdynmc rahos such as AUCMIC or 
C,,.MIC have usually been to the least amount of drug needed to ensure an 
outcome such as clinical cure in a specific patient type or bacteriological 
eradication with a certain pathogen. However to date the use of such ratios to 
prevent bacterial resistance emergence has not been effectively developed. 
The fluoroquinolones, pamcularly the newer class members have been 
designed to achieve minimum levels to not only achieve clinical cure but 
also exceed the MIC of most common pathogens such as pneumococci 
thereby endeavoring to slow or prevent resistance emergence. However, the 
application of these approaches to other commonly used classes has been 
inconsistent and clearly requires expansion ifclasses such as the macrolides and 
8-lactams are to maintain reliable levels of activity. As recommended by the 
World Health Organization in 2000 one of the most rationale approach is the 
“use of the most PD potent member of a class in order to maintain efficacy”. 
The specific PD ratio used to measure PD potency is essentially dictated by the 
mode of antibiotic bactericidal activity (concentration or time dependent), 
but it is now admitted that use of less active class members or even misuse of 
highly active antibiotics could contribute to emergence of resistance which 
although not immediately clear and obvious to fronthe prescribers must 
dictate their future use ifwe are to keep what we currently possess. Dose does 
matter as does kquency and duration, it is now essential that this is explained 
and promoted ro d antimicrobial users. 
Physicians’ perspective: life at the sharp end of 
prescribing 
W Holmes 
Nottingham, UK 
Although most patients who present with acute respiratory infection are 
previously well and have uncomplicated disease, many primary care physicians 
nonetheless find the management of such problems ditficult. With only a few 
minutes to assess their patients’ complaint, provide treatment and informa- 
tion, consultations are always full, and often rushed. Professional and govem- 
ment pressure to limit unnecessary prescribing, to use drugs deemed 
“cost-effective”, and to deal with rising microbial resistance adds fhrther 
to the primary care doctor’s problem. In UK primary care, as in most 
countries, access to investigations is limited, and patients demands and 
litigation are rising steadily. Faced with this mix of &culties, many doctors 
struggle with this common clinical problem. Yet the key features of respiratory 
infection: cough, chest pain, sputum and breathlessness, can be quickly 
evaluated and appropriate clinical decisions made. Research into the manage- 
ment of acute cough in primary care has provided usem information to help 
primary care physicians provide better care-identifymg those patients who 
can be reassured, and those who require treatment. Primary care doctors need 
to understand the natural hstory of acute respiratory infection, and develop 
confidence in its management. 
Controversies in the management of LRTls (Symposium arranged by Pfizer) 
Chlamydia and Mycoplasma: do they matter? 
F. Blasi 
Milan, 1 
The term “atypical pathogens” is used to describe a number of microorgu- 
isms that can cause so called “atypical pneumonia”, and other respiratory 
and probably nonrespiratory diseases. For the past decade, the fi-equency 
of pneumonia due to atypical pathogens has varied considerably in Merent 
clinical series, but these pathogens as a group have become accepted as 
relatively common causes of pneumonia in both outpatient and 
inpatient settings. The most important bacteria included in this group 
are Myqlasma pneumoniae, Chlamydia pnatmoniae and Legionella species. 
M. pneumoniae infection OCCUTS worldwide throughout the year, without 
sigruficant seasonal fluctuations and is both endemic and epidemic. Peaks 
of incidence occur every 5-7 years and epidemics of Mycupfasma infection last 
&8 months. Children and young adults are most often involved in M.pneu- 
moniae infections, and this agent is the most common cause of CAP in the 5 
2Oyears age groups. C.pneumomae is considered the most common nonviral 
intracellular human respiratory pathogen. It is involved in a wide specmm of 
infections of the upper (pharyngitis, sinusitis and otitis media) and lower 
respiratory tract (acute bronchitis, exacerbations of chronic bronchitis, 
asthma, and CAP) in both immunocompetent and immunocompmmised 
hosts. Recently, evidence of Mycoplasma and C. pneumoniae invoivement in 
asthma attacks has been reported. These pathogens are also involved in 
chronic asthma, and both in vitro and animal model studies indicate that 
atypical agents may play a role in the pathogenesis of the disease. The finding 
of a relationship between wheezing episodes and acute M. pneumoniae or 
C.pneumoniae infection is intriguing and suggests a potential role for these 
pathogens in the exacerbation of childhood asthma. It is likely that M. pneu- 
moniae and C. pneumoniae can trigger the ‘‘wheezing process” in subjects who 
are predisposed either by their genetic background or by events that have 
“primed” their immune systems and lungs. Persistent C. pneumoniae infection 
is conmon in chronic bronchitis. It is thought to contribute to disease 
progression by increasing the level of chronic inflammation through pm- 
inflammatory cytokine production and by its toxic effect on bronchial 
epithelial cells, The preliminary data on C.pneumoniae chronic infection in 
COPD patients and its interaction with host cells indicates that this agent is a 
plausible candidate for the modulation of the natural history of chronic 
bronchitis, emphysema and asthma. There is also convincing evidence that 
C. pneumoniae is associated with atherosclerosis and acute cardiovascular 
events. 
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vl What is the impact of pneumococcal resistance? 
Pharmacological evidence 
G. W. Amsden 
New York, USA 
Based on theories that have historically been utihzed with B-lactams and 
aminoglycosides, the serum concentrations of some of the macrolides suggest 
that not only should some of them be ineffective against infections caused by 
sensitive pneumococcal strains, but they should also breed resistant strains of 
these pathogens. While the increasing volume of in vim pneumococcal 
resistance reports appears to bear out these thoughts, the complete lack of 
reports of concurrent clinical failures does not. This stark contrast between 
plentiful in vitm data and absent in vivo data forces us to remember that not all 
drugs are pharmacokinetically and pharmacodynamically similar, and, though 
helpfid, data &om a test tube cannot always explain what will happen in a 
human. Although extracellular, tissue site concentrations ofthe B-lactams and 
aminoglycosides are in relative equilibrium with those measured in serum, 
those of the macrolides and quinolones are not. Extracellular, tissue site 
concentrations of macrolides and quinolones are always higher than those 
measured in serum and are even higher at sites of idammation. Highest 
concentrations are measured within the acute reactant cells that will actually 
be clearing the bacteria, regardless ofwhether the pathogen is in the blood or 
at the infection site. The concentrations within neutrophils and monocytes are 
at least a log-fold higher than those demonstrated at the tissue site. It is this 
high intracellular level of drug that not only allows them to be bactericidal 
rather than static in some situations, but is also the explanation for the lack of 
clinical failures due to resistance. Speculation as to whether the intracellular 
activity of these drugs is only applicable to intracellular pathogens has been 
dismissed by a recent report by Mandell et al. [l] which showed good 
intracellular activity of macrolides against intracellular pneumococci. The 
concepts discussed above also suggest that drugs with relatively lower or less 
sustained intracellular concentrations will become clinically ineffective much 
sooner than compounds like azithromycin, that concentrate to a high degree 
and maintain these high white blood cell concentrations for prolonged 
periods. 
Reference 
I .  MandeU GL. Coleman EJ. Activities of mnmicrobid agenrr against inrraceU&r pneumococct 
A n t i m i d  Agents Chmothn 2000; 4 4  2561-3. 
15246) What is the impact of pneumococcal resistance? 
Clinical evidence 
M. S. Niederman 
MineoIa, USA 
Antibiotic resistance is increasingly prevalent among the common bacteria 
causes of LRTl’s, the pneumococcus, Haemophilus infuenzae, and Moraxella 
ratanhalis. In patients with C M ,  pneumococcus is the most common 
pathogen, and multiple drug resistance is present in up to 40% of all isolates, 
although most is intermediate and not high level resistance. Drug resistant 
pneumococcus (DRSP) is more likely in certain at-risk populations including 
those >age 65 years, and those with a history of alcoholism, multiple medical 
comorbihties, therapy with a j3-lactam in the past 3months, immune 
suppression, and exposure to a child in day care. The many guidelines for 
management of CAP a l l  deal with DRSP differently, but the ATS guidelines 
advise modlhcation of empiric therapy in at-risk populations in an effort to 
keep current levels of resistance from increasing. DRSP includes not only 
penicillin resistance, but also multidrug resistance, including to macrolides. 
For this reason, macrolide monotherapy of CAP should be limited to 
inpatients and outpatients with none of the risk factors for infections with 
DRSP or gram-negative bacteria. However, in this population, use of a 
focused therapy (macrolides) may help to prevent selection pressure for 
resistance that could emerge if broad-spectrum agents were used. The 
paradigm for CAP therapy in at-risk populations is to use a selected j-lactam 
with a macrolide, or alternatively to use monotherapy with a new quinolone. 
If a quinolone is used, the most active agents are gatifloxacin, moxifloxacin or 
gemifloxacin, and these may have advantages now that there are reports of 
levofloxacin resistant pneumococci, especially in COPD patients. There are 
some data indicating that the higher levels of penicdlin resistance (MIC 
of= 4mg/L) are associated with increased mortality, but fortunately few 
Datients have this level ofresistance present. For the time being, it is important 
;o identif 
highly ef 
hture, u 
factors. 
(5247 
H. Lode 
Berlin, D 
- 
patients at-risk for infection with DRSP and to target them with 
ctive therapy to prevent the selection of more resistance in the 
ile using focused and targeted therapy in patients without risk 
RTI guidelines - Europe versus North America 
Guidelines for respiratory tract infections have been published or endorsed by 
a number of learned societies around the world. The intention of these 
documents is to guide and educate physicians, so that antibiotic prescribing is 
both clinically effective and cost effective, and antibiotics are used in a rational 
way. The information should further ensure that patients receive optimai 
disease management and that society benefits by making the best possible use 
of all resources within the healthcare system. Guidelines are most usefully 
viewed as a hypothesis that physicians should m o w  based on the collection 
of local data, such as epidemiology and susceptibility of potential pathogens. 
For community-acquired pneumonia (CAP) in Europe, early national guide- 
lines published in France, the United Kingdom, Italy, and Spain have been 
followed by guidehes from the European Respiratory Society, and in 2001 
updated guidelines from the British Thoracic Society. In North America, the 
first guidelines were published by a Canadian Conference Consensus Group 
and the American Thoracic Society (ATS), to be followed by guidelines f h m  
the Infectious Disease Society of America (IDSA). More recently, the 
Canadian Infectious Disease Society and Canadian Thoracic Society 
(CIDWCTS) jointly released guidelines and the IDSA and ATS issued 
updates, all of which were evidence-based documents. The Centers for 
Disease Control and Prevention (CDCP) published recommendations for 
antimicrobial therapy but not disease management per se. There are fewer 
published guidelines for h e  treatment of acute exacerbations of chronic 
bronchitis (AECB). The Asia Pacific Region Consensus Group made 
recommendations for empiric AECB therapy in 1998, the same year as 
the European Thoracic Society published guidelines for recommended 
treatments. Therapy recommendations for both CAP and AECB vary 
between the guidelines and these differences will be &cussed in more 
detail. 
Emerging challenges in the treatment of resistant Gram-positive infections: new therapeutic options 
(Symposium arranged by Gilead) 
negative staphylococci as medical advances produced an increasing pool of 
vulnerable patients. Hospital infection control and antibiotic prescribing 
policies were largely developed in response to the dXiculties posed by these 
organisms. Resistance to glycopeptides, quinolones, streptogramins, and 
linezolid (the last two still relatively uncommon) has occurred among these 
staphylococci, giving rise to increased multidrug resistance. Meanwhile, 
threatening these same patients, glycopeptide-resistant enterococci have 
appeared, perhaps selected by the increased use of cephalosporins and 
quinolones in general and of glycopeptides in specific for staphylococcal 
I 5248 I Antibiotic resistance in Gram-positive pathogens: 
the European experience 
I .  Phillips 
Malaga, E 
During the first decades of the antibiotic era, multiple-resistant Staphylococcus 
aureus (the hospital Staphylococcus) ravaged our hospitals, being succeeded by 
methicillin-resistant Staphylococcus aureux and multiple-resistant coagulase- 
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and Clostridium d@le infections. Staphylococci can abso acquire resistance to 
streptogramins and linezolid. Initially, Streptocouw pyogenes seemed likely to 
m i m i c  the staphylococci as tetracycline and macrolide resistance developed. 
However, while these resistances have waxed and waned, perhaps in relation 
to the patterns of use of the drug and to clonal spread of different strains, 
resistance to /?-lactams has never developed in any of the B-haemolytic 
streptococci. Streptococcus pneumoniae has behaved similarly to S. pyogews until 
recently; over the past 2 decades it has developed low-level resistance to /?- 
iactams, which, although low-level, has considerable clinical importance. 
Largely in the background, alpha-haeniolytic streptococci in the normal 
respiratory flora have provided a ready store of transferable genes mediating 
resistance, particularly to /?-lactams and macrolides. Of note, hmever, is that 
these organisms have become increasingly prevalent in bacteremias in immu- 
nocompromised patients. Thus, although there have been periods during 
which the Gram-positive pathogens have been eclipsed in importance by the 
Gram-negative bacteria, and although the geographic distribution of resis- 
tance in Europe has been uneven, often affecting southern more than 
northern Europe. the development of multiple antibiotic resistance in 
virtually all the important Gram-positive pathogens has been inexorable. 
Furthermore, many of these multiple-resistant bacteria infect the 
most vulnerable patients - the very young, the old, and the immunocom- 
promised. 
1-1 Serious Gram-positive infections: clinical 
challenges of the new millennium 
P. Munoz 
Madrid, E 
Gram-positive infections have, for the first time, outnumbered Gram-nega- 
tive infections in clinical microbiology laboratories. Their increase in number 
and the relentless development of antimicrobial resistance have focused the 
attention of clinicians and the pharmaceutical industry towards finding new 
therapeutic tools. Staphylococcus aureus and coagulase-negative staphylococci 
account for the vast majority of infections related to prosthetic materials 
including intravascular catheters, heart valves, articular prosthesis, etc. Their 
related morbidity and mortality is hgh and therapy usually requires the 
parenteral administration of glycopeptides. Streptocow pneumoniae remains 
the most common cause of pneumonia and severe meningitis, and has also 
become an important nosocomial pathogen. The reduced susceptibility of this 
microorganism to penicillin has greatly complicated the management of 
central nervous system infections in which its participation is suspected. 
Enterococcus spp. is the second-leading cause of nosocomial urinary tract 
infections and is also commonly implicated in wound infections, bacteremia, 
and endocarditis. The widespread ditfusion of multiresistant Enterococci 
occasionally leaves the clinician without well-established bactericidal tbera- 
pies. Group A Streptococcus has caused significant social alarm due to the 
increasing number of cases of necrotizing fascitis in previously healthy 
patienu. Group B Smptococcus is associated with severe episodes ofbacteremia 
and endocarditis, as well as urinary tract infections and osteomyelitis. Strepto- 
corms uiriduns has become a significant cause of bloodstream infections in 
hematologic patients with neutropenia and mucositis, as well as empyema and 
other purulent collections in critically ill patients. Other Gram-positive 
microorganisms that are becoming a cause of concern include Clostridium 
d@cile, Listm’a monocytogenes, Nocurdia farcinica, and different species of 
Corynebacterium. Due to the increasing number of clinical challenges, there 
is a pressing need for effective new bactericidal therapies for the treatment 
of serious Gram-positive infections. 
(52501 Emerging challenges in the treatment of resistant 
Gram-positive infections: new therapeutic options 
H. Giamarellou 
Athens, GR 
MRSA, MRSE, VRE, PRSP, and, to a much lesser extent, GISA, represent 
the majority of pathogens currently Implicated in serious Gram-positive 
infections for which therapeutic decisions are increasingly difficult. Vanco- 
mycin, although active invitro against multiresistant staphylococci 
and pneumococci, possesses pharmacokinetic and pharmacodynamic 
disadvantages necessitating drug monitoring and the addition of rifampicin 
and/or gentamicin to overcome its slow bactericidal activity. Furthermore, 
variable kmetics are responsible either for subtherapeutic antibiotic levels or 
for potential vancomycin toxicities. Teicoplanin lacks extensive use in 
“difficult to treat” infections such as staphylococcal endocarditis and osteo- 
myelitis, and dosage schedules are difficult to manage. On the other 
hand, inappropriate extensive empirical use of vancomycin, particularly in 
ICU settings and in febrile neutropenic patients, has led to the emerging 
threat of increased W infections. PRSP in lower respiratory tract 
infections appears to respond to high-dose IV penicillin G; however, PRSP 
meningitis is a potentially lethal infection necessitating intrathecal vancomy- 
cin. New therapeutic modalities active against Gram-positive pathogens 
include linezolid, quinupristiddalfopristin (Q/D), daptomycin, oritavancin, 
and glycylcyclines, with the newer ketolides and “respiratory” quinolones 
being principaily active against PRSP Only linezolid and Q/D are on the 
market, and the invivo data appear promising. However, there are several 
considerations: (1) Iinezolid is not bactericidal against staphylococci, and 
prolonged therapy is limited by concerns for anemia and thrombocytopenia; 
and (2) Q/D requires central venous routes, it is not bactericidal against 
Enterococcusfaecium and MRSA with e r d  resistance phenotypes, and several 
adverse drug interactions have been described. Despite the dserent 
site of action and the promising invitro activity and kinetic profiles of these 
2 new compounds, the invivo emergence of resistance during therapy is 
already a fact, signaling the necessity for prudent prescribing practices by 
clinicians. 
I 5251 I Daptomycin: a new agent to treat serious 
Gram-positive infections 
J. Verhoef 
Utrecht, NL 
Daptomycin is a novel lipopeptide antibiotic with rapid, concentration- 
dependent bactericidal activity against ail clinically relevant Gram-positive 
bacteria, including multiresistant strains of Staphylococcus, Enterococm, 
and Streptococcur pneumoniae. Spontaneous acquisition of resistance OCCUR 
rarely. The mechanism of action appears to be at least partly due to bacterial 
membrane depolarization. Daptomycin exhibits linear phannacokinetic 
disposition, has a prolonged elimination half-life (.-9h), and is largely 
excreted unchanged in urine. Efficacy has been demonstrated in a variety 
of preclinical animal models including bacteremia, soft tissue/tbigh infection, 
endocardtis, pfieumonia, and osteomyelitis. Preclinical toxicology has iden- 
tltied skeletal muscle as the primary organ for toxicity; there are no effects on 
cardiac or smooth muscle. Daptomycin-induced myopathy w a s  characterized 
by minimal degeneration with regeneration in the absence of fibrosis. The 
myopathy is easily monitored with creatinine phosphokinase (CPK) levels and 
is minimized by once-daily dosing. Preliminary phase I1 data suggested 
efficacy in bacteremia and in skin and soft tissue infections. Phase 111 data 
available to date include 2 large prospective, randomized evaluator-blinded 
studies of the efficacy and safety of daptomycin vs. standard therapy (semi- 
synthetic penicillin or vancomycin) in the treatment of complicated skin and 
soft tissue infection. Results demonstrate that daptomycin is as egective as 
standard therapy based on clinical and microbiologic endpoints. However, 
patients receiving daptomycin required sigruficantly shorter duration of 
therapy than patients receiving comparator agents. Based on clinical trials 
to date, daptomycin appears to have a safety profile comparable to conven- 
tional therapy. Adverse effects such as local venous irritation, hypersensitivity, 
and gastrointestinal toxicity have been uncommonly observed with dapto- 
mycin, without evidence of nephrotoxicity, ototoxicity, or hepatotoxicity. 
Overall incidence and severity ofCPKelevations have been similar to standard 
therapy. Ongoing studies include the treatment of moderate to severe 
community-acquired pneumonia, staphylococcal endocarditidbacteremia 
and infections due to vancomycin-resistant enterococci. Daptomycin appears 
to be a promising new agent for the treatment of serious Gram-positive 
infections. 
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Interactive grand rounds: braving the storms of hospital infection (Symposium arranged by AstraZeneca) 
[m] Hospital-acquired pneumonia: a complex killer 
N. Vetter and E. Hauer 
Vienna, A 
Hospital-acquired pneumonia (HAP), defined as a pneumonia that develops 
at least 48 h after hospital admission, is the second most fiequent nosocomial 
infection (after urinary tract dection) and the one with the highest death rate. 
Diagnosis and treatment of patients with HAP remains a &cult and complex 
undertaking, Diagnosis is difficult due to the absence of typical symptoms like 
fever, purulent tracheal secretions or cough - this is particularly true for older 
patients or patients with immune deficiency. Effective treatment relies on 
rapid identification ofinfected patients and accurate selection of antimicrobial 
agents for initial treatment. The selection of initial antibiotic therapy, how- 
ever, is based on the presumed causative pathogens and their patterns of 
antimicrobial susceptibility. The decision malung process is complicated by 
the diversity of pathogens responsible for HAP; these are selected by local or 
systemic host factors, including the underlying disease of the hospitalized 
patient, the virulence of the organism, and prior exposure to antimicrobials. 
Of particular importance are the Gram-negative organisms (Escherichchia mli, 
Mebsiella spp.. Smatia spp., Proteus mirabilis, Pseudomows spp.) and Staphylo- 
coccus uureus. To add to the complexity ofdmgnosis and treatment, other factors 
to be considered are prior duration of hospitalization, previous usage of 
antimicrobial agents, and intrinsic activities ofantimicrobial agents. This case 
study will address the challenge of diagnosing and treating a patient with 
HAP. 
m1 Suspected intra-abdominal infection: approaching 
the unresponsive patient 
U. Schoeffel 
Frt-ibutg, D 
Suspected intra-abdominal infection consistent with laboratory data but 
without localizing signs at abdominal examination is a typical surgical 
problem. The clinical presentation of unresponsive patient$ is often non- 
characteristic and leaves the clinician in a dilemma of how best to proceed. 
With no clear-cut signs of M u s e  peritomtis or other intestinal catastrophe, 
questions arise over which diagnostic tests to pedorm and/or which therapy 
to begin. A stepwise approach to some key questions is imperative and should 
Chlamydia and H. pyiori in vascular diseases 
ensure the most appropriate course of action is taken. Firstly, does an 
intra-abdominal infection seem probable? There may be clues such as bowel 
paralysis, distension, some reaction to palpation, or the occurrence of intra- 
abdominal fluid. Secondly, should a directed or a more wide-ranging search 
for the presence of infection be adopted? If, in turn, a suspected intra- 
abdominal infection is  confirmed, the third question should address the 
urgency and approach to source control. In parallel to this stepwise approach, 
empirical anti-infective therapy should be initiated as soon as severe bacterial 
infection is suspected. If there is no obvious source of contamination, then 
therapy should be directed against indigenous enteric bacteria. The case study 
presented will tackle the problem of an unresponsive patient and suggest how 
best to address the treatment of intra-abdominal infection. 
[ 5254 1 Candidaemia: diagnosis and treatment challenges 
T. Calandra 
Lausanne, CH 
Candida is a kequent cause of nosocomial infections with sigmfkant mor- 
bidity and mortality. Along with an increasing incidence, these infections 
remain dificult to dtagnose. Chical symptoms and signs are usually non- 
specific, and standard culture techniques and serological methods lack sensi- 
tivity. Amplification of genornic DNA sequences by polymerase chain 
reaction may improve our diagnostic abiliv, but is not available on a routine 
basis. The most fiequent clinical manifatations of Candida are candidaemia, 
intra-abdominal candidiasis, candidal urinary tract infections, and dissemi- 
nated candidiasis. Candidaemia, associated with a high crude and attributable 
mortality, wdl be examined in this case study. Most episodes are caused by 
Candida albicans, however, nonalbicans Candida infections are increasing and 
may predominate in some institutions. Risk factors for candidaemia include 
treatment with antibiotics, use of intravascular devices, parented nutrition, 
surgery, and colonization with Candida at multiple sites. In light of this, 
intravascular devices should be removed or exchanged whenever possible in 
patients with candidaemia. Regarding treatment, studies of non-neutropenic 
patients with candidaemia have shown that azoles are as effective but less toxic 
than amphotericin B. New antlfungal agents, such as the echinocandins, look 
promising for the treatment of patients with candtlasis, including blood- 
stream infections, and are currently being evaluated for candidaemia. This case 
study will highlight some of the issues faced when treating patients with this 
serious infection. 
152591 ff. pylori: a headhache for the third millenium? 
M. R. Gismondo 
Milan, I 
Despite our current understanding that H.pylori is confined to gastric mucosa, 
new interest is generated by the link between H.pyloti and disorder outside the 
alimentary tract. An increasing number of extra-digestive conditions have been 
reported to bear association with H.pylOn: coronary heart disease, vascular 
disorders, inflammatory and immune-mediated disorders, etc. Our results, 
accordmg to those of other AA., shown that H.pyloti infection is common in 
patients with headache and with migraine without aura. We have carried out two 
studies: an epidemiological investigation and a clinical study. Epidemiological 
results have shownthat42%ofinectedpatientss~erftPrfiromirnigraineorheadache. 
The number ofpositive CagA strains was significantly hlgher than those oNacA 
positive strains. Patients treated by using “Lactobacillus” significantly reduced 
symptoms. These results encourage futher investigations to undestand the 
“poliedric” role of H. pylori in human disease. 
Clostrium diffirile (Symposium organised by ESGCD) 
Is261/ Diagnostic methods and testing protocols for 
Clostridium difficile infections in Europe: an overview 
contributed to the development of a large number of tests for the diagnosis 
of C. d&Ze-associated diseases (CDAD). These tests indude fecal culture on 
selective media, detection of toxins A and/or B with “classic” or “rapid” 
enzyme immunoassays, or detection of the glutamate dehydrogenase (GDH), 
a marker antigen of C. d f i l e .  The lack ofguidelines in Europe can make the 
choice of testing protocols di&cult. 
Under the auspices of the ESCMID Study Group on C. d@n’le (ESGCD), 
we undertook a European-wide survey aimed at obtaining an overview on the 
current practices in bacteriology laboratories. A standardized questionnaire 
F. Barbut and M. Delmee 
Paris, F; Brussek, B 
In recent decades, Clmtridium d&le has emerged as an important enter- 
opathogen responsible for antibiotic-associated diarrhea and/or colitis. The 
recognition of C. d@ik as a leading cause of nosocomial diarrhea also 
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about diagnostic methods and testing protocols was sent to one co-ordinator 
in each country participating in this survey. This co-ordinator was in charge of 
forwarding the questionnaire to hospital laboratories arbitrarily selected on 
the basis of 1 lab per 10000 beds of hospitalization. This questionnaire 
covered dif€erent fields about CDAD diagnosis: circumstances of request, 
criteria used for undertaking C. d w l e  investigations, methods used for the 
diagnosis (culture, toxin detection, GDH detection) . . . antimicrobial sus- 
ceptibility testing and experience in typing C. d@cile strains were also 
evaluated. The questionnaire also focussed on the strategies that are currently 
used in labs for CDAD diagnosis. Data about the number of C. dficile cases 
detected in 2000, the size of hospital (number of beds and number of 
admissions) were also collected in order to approximately estimate the 
incidence CDAD in Merent care settings. Global results and Werencies 
among countries will be discussed. 
Community-acquired pneumonia 
102641 Severity of airflow obstruction and bacterial 
etiology of acute exacerbation in COPD - data from a 
prospective study 
S. Balk, M. Mewelt, H. Stetzelberg, H. Mauch and H. Lode 
Berlin, D 
Introduction: Retrospective data from a previous analysis of our study-group 
suggests a relationship between severity of airway obstruction in COPD, and 
the pattern of causative bacterial pathogens in acute exacerbations (AECB) 
[Eller et al. Chest (1998)l. Ths  hypothesis was tested in a prospective 
study. 
Methods: From January 1997 to April 2001, patients with COPD and 
worsening of respiratory symptoms were evaluated for inclusion into this 
investigation. Radiographic and other procedures were performed as required 
to exclude other conditions but AECB as cause ofrespiratory distress. Sputum 
samples were obtained whenever possible, and semiquantitative microscopic 
and cultural bacteriologic testing was performed. For all subjects, spiromehic 
data from an infection-f?ee interval was required. Patients were classified into 
three stages ofseverity of airflow obstruction, according to ATS criteria. Stage 
I, FEV1" 50% predicted; stage 11, FEVl 3550% predicted; and stage 111, 
FEVl *35% predicted. Bacteria were divided into three groups. Group 1 
included Streptococcus pneumoniae, Staphylococcus aureus, and other Gram- 
positive cocci, group 2 consisted of Haemophilus infuenzae and Moraella 
catarrhah, and group 3 included Gram-negative enteric bacteria and Pseudo- 
m o m  aeruginosa. 
Results: A total of 292 subjects were evaluated for inclusion. Sixty-seven 
patients were treated as outpatients, 225 subjects were inpatients. In 76 
individuals, bronchectasis or conditions other than AECB (e.g. pneumonia, 
carcinoma) disqualified &om inclusion. In 115 patients, an increase of 
purulent sputum was present (Type Winnipeg I or 11), and relevant bacteria 
were isolated &om valid sputum samples (AMS-criteria). Sq-e ight  subjects 
(59.1%) were male, mean age was 62yean (range 54-68years). Half of the 
individuals were present smokers (n = 57, 49.6%), 18 were never-smokers 
(15.7%). Thirty-two (27.8%) isolated bacteria belonged to group l-organ- 
isms, 48 (41.7%) were group 2-bacteria, and 35 bacteria (30.4%) belonged to 
group 3. There was a significant relationship between extent of airway 
obstruction prior to onset of AECB and the pattern of isolated bacterial 
pathogens in an acute exacerbation (P=  0.01). 
Bacteria, n @) 
COPD Group 1 Group 2 Group 3 n 
Stage I 19 (40.4) 22 (46.8) 6 (12.8) 47 
Stage I1 10 (27.0) 16 (43.2) 11  (29.7) 37 
Stage 111 3 (9.7) 10 (32.3) 18 (58.1) 31 
n 32 48 35 115 
Conclusion: These findmgs confirm OUI prewous results fiom retmspechve 
analysis. They rmght be valuable m guidmg mhd anhbiotrc therapy m 
pahents presentmg mth  AECB presumptwely caused by bacteria (Type 
W m p e g  I or 11) 
-1 Efficacy and safety of rnoxifloxacin versus 
ceftriaxone in the treatment of AECB (SMART) 
C. Grassi, L. Casali, S. Mannelli, E. Curti and M. Tellarini 
Pavia, Pmgla, Genoa, Milan, I 
Objective: Mox33oxacin is a broad spectrum 8-methoxy-fluoroquinolone 
that covers all the common community-acquired Gram-positive and Gram- 
negative respiratory tract pathogens. The aim ofthis study was to compare the 
eficacy and safety of moxilloxacin (MXF) orally given for Sdays, to cef- 
triaxone (CFX), intramuscularly given for 7 days in the treatment of patients 
suffering from AECB. 
Methods: A total of 476 patients suf€ering &om AECB (Anthonisen I and 11) 
were enrolled in a nonblinded, randomised, multicenter Italian c!inical trial 
comparing modoxacin (400mg OD p.0.) to ceftriaxone (1 g OD im.). A 
total of 423 patients were valid for efficacy (PP), 213 (MXF) versus 210 
(CFX). The two groups were comparable in terms of demography and clinical 
S t a t u s .  
Results: The c h c a l  success rate at the test-of-cure visit (Day 10 post-therapy) 
for MXF (90.6%) was statistically equivalent to that of CFX (89.5%) [95% CI 
0.60; -2.1581. However, in the MXF group, patients experienced a lower 
percentage of relapses compared to those in the CFX group (71.3% vs. 
76.7%). Relapse was recorded for patients successfXy treated at the test-of- 
cure visit and followed for up to a 6-month period. The incidence of adverse 
events (AEs) was similar in both groups. 
Conclusions: Five-day oral MXF is as effective and safe as 7-day intramuscular 
CFX in patients with AECB. In addition, MXF may have a potential benefit 
in prolonging the exacerbation-&ee period. 
102661 Risk factors for adverse outcome in hospitalized 
patients with pneumocaccal pneumonia 
A. K. Zacharof, C. Petrogianopoulos, C. Flevaris, G. Karachalios, 
R. Koutri, M. Mouroutsou, E. Vartzioti, K. Gourgouli, L. Kandili and 
K. Mpethimouti 
Athens, Halandri-Athens, GR 
Objective: To idenhfy the risk factors for death and respiratory failure in 
hospitalized patients with pneumococcal bacteremia and pneumonia, we 
study retrospectively all the available data fhm our patients medical charts. 
Patients and methods: During the last 18months 204 adults (mean age 
59 & 6 STD years) admitted to our Department for treatment of pneumo- 
coccal pneumonia with bacteremia. 
Results From these patients, 25 (12.5%; 95% confidence interval [CI], 12- 
28%) died and 34 (16%; 95% CI, 1631%) survived after short mechanical 
vendation for acute respiratory failure. In univariate analyzes, patients with 
various pre-existing lung dlseases (relative risk [RR], 2.5; 95% CI, 1.8-4.4), 
initial body temperature >39 "C (RR, 2.0; 95% CI, 1.6-4.6). or n o s o c o d  
infections (RR, 2.2; 95% CI, 1.9-3.9) or who were 355 yean old (RR, 2.8; 
95% CI, 1.8-5.9) were at greater risk for adverse outcomes than patients 
without these risk factors. From 75 patients without these risk facton, only 
three (4%. 95% CI, 0.62.0%) died, and the remaining 72 patientl did not 
require adnussion to the Intensive Care Unit (ICU). Calculating these I& 
facton with a multivariate logistic model, death or acute respiratory failure 
would have been predicted in 55% of patients. Better outcome was accurately 
predicted in 79% of our patients. In multivariate analysis, nosocomial infec- 
tion was the greatest risk factor (adjusted odds ratio, 16.6; 95% CI, 2.9-8.9). 
Conclusions: In hospitahzed patients with pneumococcal pneumonia and 
bacteremia, risk factors determined at hospital admission can easily predict the 
final outcome. If we were able to identify in time these risk facton ICU or 
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more aggressive medical treatments would benefited these patients. In- 
dependent of age, patients who acquired nosocomial infections, during their 
hospitalization, were at the greatest risk factor for death or respiratory failure. 
(02671 Community-acquired pneumonia guidelines: 
evaluation of antibiotics, outcomes and costs 
D. Goff and S. Sierawski 
Westewilk, U S A  
Introduction: The most appropriate empiric antibiotic choice will depend 
upon local antibiotic resistance patterns, patient demographics, epidemiolo- 
gical data, and cost. The Ohio State University Medical Center (OSUMC) 
developed a practice guideline for CAP. Azithromycin !c ampicillin/sulbac- 
tam was recommended for empiric coverage unless the patient was critically ill 
or had modifylng factors such as suspected or documented penicillin resistant 
streptococcus pneumonia (PRSP) . 
Objective: To assess the cluucal and economic outcome of patients who 
receive azithromycin for CAP, with a secondary goal to determine the 
appropriateness of the guidelines. 
Methods: This was a retrospective analysis of all patients who received 
azithromycin between September 1999 and May 2000, for the treatment 
Erta penem 
of CAP. Demographic and epidemiologic data included age, gender, and 
environment of the patient prior to hospitahtion. Prior antibiotic use was 
recorded. Clinical and microbiological outcomes were recorded Adverse 
drug reactions (ADR) and discharge antibiotics were identified. Hospital 
length of stay (LOS) and total cost of care were calculated. 
Results: Azithromycin was administered to 124 hospitalized patients with 
CAP; 40 as monotherapy, 41 in combination with ampicWsdbactarn, 35 in 
combination with antipseudomonal antibiotics, and eight in combination 
with others. Mean age = 63.9, 53% male. Environment prior to hospitaliza- 
tion was 80% kom home, 9% transfer &om other hospital, 5% nursing home, 
and 6% prison. Prior to hospidzation, 21% patients failed or had intolerance 
to oral outpatient antihiotics. Microbiologically evaluable patients included 
5/109 with hacteremia; two Streptococcuj pneumoniae (1 PRSP), one 
p-hemolytic streptococcus, one Enterocorcusfaecalis, one Staphylocorcus aureus, 
and 22/77 with a positive sputum culture (1 PRSP). Microbiologic success 
was 98%. Clinical success was 98%. Mortality was < 1%. ADR's were diarrhea 
(1%). Most patients (91%) were discharged on an oral antibiotic; 38% 
azithromycin, 33% amoxicillin/clawlanate, 20?? others. Mean hospital 
LOS = 4.6 days. Mean cost = US$ 4850. 
Conclusion: Compliance to the OSUMC practice guideline for CAP show 
that patients have successful clinical outcomes with an acceptable LOS and 
cost. The low rate of PRSP (<2%) supports the use of azithromycin as the 
preferred antibiotic unless moddpng factors are present. 
102681 Ertapenem is highly active against common clinical 
bacterial pathogens 
I. Friedland, A. Majumdar, M. Motyl, L. Mixson and G. Woods 
West Poinf, U S A  
Objectives: Determine the in vitro activity of ertapenem, a new once a day 
parented 8-lactam, against common clinical bacterial pathogens and relate 
MICg, values to plasma ertapenem concentrations. 
Methods: Isolates were obtained &om adults enrolled in Phase I1 and I11 
clinical trials of ertapenem therapy. These studies enrolled patients with 
community-acquired and mixed infections, including complicated intra- 
abdominal, skin and skin structure, and urinary tract infections, acute pelvic 
infections, and community-acquired pneumonia at 425 sites worldwide. A 
total of 3221 aerobes and anaerobes were tested at Merck Research Labora- 
tories for susceptibility to ertapenem by microtiter dilution. In separate 
studies, ertapenem concentrations in plasma and urine were measured for 
up to 24h following I-g dose in 68 healthy adult volunteers. 
Results: Ertapenem MICgo values (mcg/mL) for the most common patho- 
gens isolated during clinical trials were: Escherichia coli (n = 759), 0.016; 
Klebsiella spp. (n = 149), 0.03; Enterobacter spp. (n = 56), 0.25; other Enter- 
obacferiaceae (n = 124), 0.06; Staphylococcuspneumoniae (n = 113), 0.25; methi- 
cillin-susceptible S. aureus (n = 187), 0.25; S. pyogenes (n = 37), 0.03; 
S.  aguluctiae (n = 48). 0.125; Hoemophilir injuenzae (n 59), 0.125; Moraxella 
cufonhalis (n = 9). 0.01 6; B.fragilis group (n = 479). 1; all other anaerobes 
(n = 805). 1; methicillin-resistant S. aureus (n = 27), 16; enterococci (n = 169), 
16; Paemginosa (ti=%), 16. The mean plasma ertapenem concentrations 
after a 1-g dose were 9-11 pg/mL at 12h and 1.2-1.9pg/mL at 24 h. 
Conclusions: Following 1-g dose, ertapenem plasma concentrations exceed 
MIC9" values for common clinical isolates, except enterococci, E aeruginosa, 
and methicdhn-resistant S. aureus for at least 24 h. These data suggest that 
ertapenem, 1 g once a day, is likely to be highly effective against most aerobic 
and anaerobic bacteria responsible for community-acquired and mixed 
infections. 
Efficacy of ertapenem in the treatment of 
community-acquired pneumococcal pneumonia 
R. Isaacs, I. Friedland, K. McCarroll, J. Geib and J. Moll 
West Point, U S A  
Objectives: Dete rme  the efficacy of ertapenem, a new once a day parented 
8-lactam, for treatment of adults with serious CAPP and compare it with 
ceftrlaxone (CRO) therapy. 
Methods: A prospective, double-blind (with in-house blinding), multicenter 
study was conducted in aduIts with comunity-acquired pneumonia requir- 
ing initial parented therapy. Patients were stratified based on Pneumonia 
Severity Index (PSI 1-3 or >3) and age (65year or less or >65year) and 
randomized in a 1 : 1 ratio to intravenous (i-v.) ertapenem, 1 g once a day, or 
i.v. CRO, 1 g once a day. Patients whose sputum or blood cultures grew 
Streptococcus pneumonia were included in this subgroup analysis. Switch to 
oral amoxicillin-clavulanate was allowed after at least 3 days of i.v. therapy. 
Clinical and microbiologic efficacy were assessed 7-1 4 days post-therapy 
(i.v. + oral). 
Results Serious CAPP was diagnosed in 48 (26%) of the clinically evaluable 
patients in the ertapenem group and 60 (30%) in the CRO group. Baseline 
demographm were similar in the two treatment groups. In the ertapenem and 
CRO groups, respectively, 19 and 32% of patients had a PSI > 3 and 38 and 
43% were >65year of age. Of patients who received ertapenem, six were 
bacteremic, as were 17 of those treated with CRO. Median duration of total 
therapy was 10.5 days in the ertapenem group and 13 days in the CRO group; 
98% of the patients in the ertapenem group and 92% in the CRO group 
received oral therapy. Ertapenem versus CRO clinical cure rates were 92% 
(44/48) versus 93% (56/60) overall, and by penicillin (pen) susceptibility (S, 
susceptible; NS, nonsusceptible; UNK, unknown; R,  resistant) were: pen-S, 
88% (28/32) versus 91% (32/35); pen-NS, 100% (11/11) versus 92% (12/13); 
pen-UNK, 100% (5/5) versus 100% (12112); pen-R, 100% (111) versus 100% 
(3/3). Bacterial eradication rates were 98% for ertapenem and 98% for CRO; 
rates were not afCected by penicillin susceptibility. Both ertapenem and CRO 
were generally well tolerated. 
Conclusions: In this subgroup analysis, ertapenem 1 g once a day, with an oral 
switch option, was highly effective for treatment of serious CAPE including 
infections with pen-NS isolates, and was as effective as CRO 1 g once a day. 
The outcome of CAPP treated with ertapenem or CRO was not influenced 
by the degree of penicillin susceptihihty. Ertapenem had a safety and toler- 
abihty profile similar to CRO. 
/02701 Ertapenem versus ceftriaxone (CRO) for treatment 
of community-acquired pneumonia (CAP): the European 
experience 
R. Isaacs, K. McCarroll, I. Friedland, T. Oliveria and J. Geib 
West Point, U S A  
Objectives: Determine the efficacy of ertapenem, a new once a day parented 
B-lactam with the potential to be used for community-acquired infections, for 
treatment of adults with serious CAP and compare it with CRO. We report 
here on the clinical experience of 188 patients kom six European countries. 
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Methods: In two prospective, double-bhnd (wth in-house bhndmg), multi- 
center studies conducted worldwde, mcludmg SIX European countries, adults 
with serious CAP were strahfied based on Pneumoma Severity Index (PSI 1- 
3 or >3) and age (65 year or less or >65 year) and randomed to ertapenem, 
1 g once a day, or CRO, 1 g once a day, both gwen I.V. or 1 m Switch to oral 
amomcillm-clavulanate was allowed after at least 3 days of 1.v. therapy and 
c h c a l  mprovement Respuatory specimens were collected for culture and 
susceptlbihty tesnng ofisolated pathogens Clmical and microbiologic efficacy 
was assessed 7-1 4 days post-therapy (1.v + ophond oral). 
Results: Of the 866 panents randomzed worldwde, 118 (14%) were from 
European sites, 90 (76%) were cluucally evaluable; 52 (44%) were rmcro- 
biologdly evaluable The two treatment groups were u d a r  with respect to 
age, gender, and ethtllcity. Medm total therapy was 10 days m both treatment 
groups; 67% of pahents in the ertapenem group and 69% m the CRO group 
received oral therapy. C h c a l  cure rates overall and by stratum are shown 111 
the table below. 
Drug PSI>3 PSI 1-3 >65years 165years Overall 
Ertapenem 94% (15/16) 90% (38/42) 91%, (21/23) 91% (32135) 91% (53/58) 
CRO 82% (9/11) 86% (18/21) 80%1 (12/15) 88% (15/17) 84% (27/32) 
Eradcanon rates for Streptomaus pneumoniae, the most common pathogen, 
were 92% for ertapenem and 100% for CRO and were not duenced  by 
suscephbhty to p e m c h .  Both ertapenem and CRO were generally well 
tolerated. 
Conclusions: In t h l s  subgroup analysis of European pahents, ertapenem 1 g 
once a day, with an oral s w t h  option, was lughly effechve for senous CM, 
includmg elderly pauents and pahents wdi concmtant &eases, and was as 
effective as CRO. The safety and tolerabhty profile of ertapenem was simlar 
to CRO. 
Safety and tolerability of ertapenem administered 
intramuscularly (i.m.) 
I. Friedland, J. Moll, Q. Jiang and G. Woods 
West Point, USA 
Objectives: Ertapenem is a new once a day j?-lactam antimicrobial agent that 
can be administered by intravenous (i.v.) infusion or i.m. injection. The 
objective of this study was to evaluate the local tolerability and safety of i.m. 
ertapenem, which in human subjects is >90% bioavailable, compared with 
i.m. ceftriaxone. 
Methods: In a prospective, double-blind (also with sponsor blinding), multi- 
center study, adults (n = 117) with lower respiratory tract infection, skin 
infection, or urinary tract infection requiring initial parented therapy were 
randomized in a 3 :  1 ratio to i.m. ertapenem, 1 g once a day, or i.m. 
ceftriaxone, 1 g once a day. Both agents were reconstituted in 1% lidocaine 
without adrendme. Patients who improved clinically could be switched to 
oral amoxicillin-clavulanate after at least 2 days of i.m. therapy. Tolerability 
and safety were evaluated in the treated population; efficacywas assessed in the 
modified-intent-to-treat population. 
Results: Eighty-seven patients received i.m. ertapenem therapy for a mean 
of 4.1 days, and 30 patients received i.m. ceftriaxone for a mean of 3.8 days. 
31/87 patients (36%) treated with ertapenem and 13/30 (43%) treated with 
ceftriaxone experienced one or more symptom at the local injection site; the 
most common were tenderness or pain. Local symptom were generally mild, 
and were judged to be moderate to severe in only one (1%) patient in the 
ertapenem group and three (10%) in the ceftriaxone group. Clinical drug- 
related adverse experiences were reported during i.m. therapy in 14 (16%) 
patients in the ertapenem group, most commonly mild gastrointestinal 
symptoms, and five (17%) patients in the ceftriaxone group. The efficacy 
of i.m. ertapenem appeared comparable to that of i.m. ceftriaxone. 
Conclusion: An i.m. ertapenem therapy, 1 g once a day, was generally well 
tolerated. The safety and tolerabdity profile of i.m. ertapenem therapy was 
comparable to those of i.m. ceftriaxone therapy. 
Epidemiological resistance of Gram-negative bacteria 
(02721 Chromosomal, plasmid and &lactamare gene 
heterogeneity among Salmonella enterica enteriditis PT4 
isolated in southern Italy 
L Villa, C Mammma, V. Mynagou, L S. Tzouvelelus, P. T. Tassios, 
A NastasiandA Carattoh 
Rome, Palermo, 1, Athens, GR, Florence, I 
Objectives: The a m  of this study was to de t e rme  the mechatllsms and 
vectors of resistance to expanded spectrum 8-lacrams observed among SIX 
Salmonella entenca ssp enterica serotype Enteritidls isolates kom southern Italy 
during 199G-1998 
Methods: Isolahon, specles characterizaaon. serotypmg and phage typing 
were pe6ormed accordmg to standard procedures Suscepnbhty to 15 
anubiohcs was determmed by a dlsk &sion method and evaluated usmg 
NCCLS gwdehnes Resistance plasmds were tansferred by conjuganon to 
an Escherichkra colt recrpient stram, isolated and mgested urlth EcoRI prlor to 
agarose gel electrophoresls P-Lactamase content was detenmned by iso- 
electric focusing &om salmonella and tram-conjugant cell lysates, PCR and 
DNA-DNA hybridizauon with SHV and ampC pruners and probes, and 
nucleonde sequenang Genomc DNA fingqmnts were generated by XbaI 
xesmctlon and pulsed field gel electrophoxs1s 
Results: Ofthe 1889 S. Enteriuks isolates charactenzed durmg 1990-1998 at 
the Centre for Enteric Pathogens of southern Italy, only sm-five of whch 
were of phage type P T b w e r e  reslstant to expanded spectrum cephalospor- 
m Of these, one, of PFGE type A, harbored a nontransferable ampC gene, 
whtlst the remammg five, of PFGE type B, Lontanied a transfenbk, plasrmd- 
borne SHVZ2 gene However, two dstmct types of SHVIZ-bearmg plasm& 
were observed, one of whtch also contuned a type 1 integron includmg 
aacC4, aadAl and u#B2 gene cassettes 
Conclusions: Resistance to expanded spectrum cephalosporlns in food-borne 
S. Entenuh PT4 strams CoflShtutes a potenhal chmcal problem. An unusual 
heterogeneity with respect to plasrmd and gene content, as well as genomc 
background, was observed among such stram from southern Italy. 
1 0273 [ Population structure and antibiotic resistance of 
Acinetobacter DNA group 2 and 13TU isolates causing 
nosocomial infections in United Kingdom hospitals 
R. Spence, K. Towner, C. Henwood, D. James, N. Woodford and 
D. Livermore 
Nottingham, London, UK 
Objectives: To examine the population structure of isolates of Acinetobacter 
DNA groups 2 (Acinetobacter baunrannir) and 13TU (unnamed) obtained from 
clinical specimens in UK hospitals. These are the two DNA groups of 
Acinetobacter associated most frequently with outbreaks of nosocomid 
infection. A subsequent aim was to determine whether resistance to particular 
antibiotics could be correlated with the ability of individud genotypes to 
cause outbreaks of mfection. 
Methods: A total of 595 Acinetobacter isolates, conected consecutively &om 
54 hospitals in UK, Wales and Scotland, were identified to the DNA group 
level by D N A  fingerprinting. Of these, 287 consecutive isolates belonging to 
DNA groups 2 and 13TU obtained &om 46 hospitals throughout 
the UK were analyzed by RAPD-PCR using primers DAF-4 and ERIC- 
2. lsolates with RAPD fingerprints showing >72% similarity with both 
primers were considered to be closely related and to belong to the same 
genotype. Antibiotic susceptibility testing was pedormed on all isolates 
examined. 
Results: In contrast to previous European studies which have suggested a 
limited number of circulating genotypes, RAPD typing indicated a hetero- 
geneous population, with 37 genotypes of Acinetobacter DNA groups 2 and 
13TU circulatingwihn and between UK hospitals. However, 42% ofisolates 
belonged to four predominant genotypes found in 15, 12, 12 and eight 
different hospitals, respectively. Resistance was widespread to most of the 
major antibiotic classes, except carbapenems and polymyxins. However, in 
general, sporadic isolates were more susceptible than outbreak isolates, and 
possession of multiple antibiotic resistance was associated with the ability of 
strains to cause outbreaks. 
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1 0274 1 Evolution of TEM E S B k  in Polish hospitals 
1995-2000 
A. Baraniak, J. Fiett, E. Sadowy and M. Gniadkowski 
Warsaw, PL 
Objectives: To follow the evolution ofTEM extended-spectrum fi-lactames 
(ESBLs) in Poland. 
Methods: Seventeen ESBL-producing Mebsiellm and Escherickia mli isolates 
recovered in 1998-2000 in five hospitals were investigated. The isolates were 
subjected to mating, and, together with the trans-conjugants, to the IEF 
analysis of fi-lactamases. ESBL activity was detected by the bioassay approach. 
ESBL-encoding genes were amplified by PCR and sequenced together with 
their promoters. Some of the isolates were compared by PFGE and plasmid 
fingerprinting with 10 K.  pneumoniae and E. coli isolates from 1995 to 96 fiom 
4 other centres, identified before as producers of TEM-47, -48, -49 or -68 
ESBLs. 
Results: Apart fiom other fl-lactamases the isolates were found to produce 
enzymes with PIS of 5.5 or 6.0, which showed the ceftazidime- and 
cefotaxime-hydrolysing activity invitro. All these enzymes were identified 
as TEM fi-lactamases and in the majority of the isolates their genes were 
located on transmissible plasmids. Sequencinghas revealed that seven different 
TEM ESBLs, TEM-4, -29, -47, -85, -86, -93 and -94, were expressed by the 
isolates, out of which the TEM-85, -86 and -94 are novel variants ofESBLs, 
and TEM-4, -29 and -93 were identified for the fint time in Poland. The 
sequence analysis of bla7Eit4 genes and their promoters suggested that the 
evolutionary tree of TEM ESBLs in Poland consists of at least two separate 
branches, one ofwhich. with the single bla7EM-93 gene, originates from the 
b l a E M -  1 A precursor gene. The second branch, containing all the remaining 
variant genes, originates &om the bla?TEM- IF gene and is highly structured 
with at least three major and several minor subbranches. The PFGE and 
plasmid fingerprinting analyzes revealed a remarkable diversity of K .  pneu- 
moniae clones and plasmids containing the related blaTEM genes. The only 
similarities were observed among T E M - 4 7  producers from 1995 to 96 fiom 
three different centres. 
Conclusions: Ten dtfferent variants of TEM ESBLs identified between 1995 
and 2000 in Poland, including seven unique types, indicate that Polish 
hospitals have been a place of rapid evolution of this family of p-lactamases. 
Identification of the Same or closely related blaTEM gene variants in 
numerous hospitals together with typing data suggest that both convergent 
evolution as well as spread of ESBL producers between different centres may 
have contributed to the situation observed nowadays. 
Influenza and other viruses 
R. Ramphal, J. Bille, H. Yigit, L. Valera, P. Pierce, P. Poundstone and 
J. Fung-Tomc 
Cainesville, USA; Lutanne, CH; Wallingford, USA 
Objectives: The NCCLS currently recommends that Microbiology Labora- 
tories and Clinicians consider that organisms carrying an ESBL to be resistant 
to all cephalosporins. However, the susceptibilityofsuch strains to 3rd and 4th 
generation cephalosporins has been reported to be between 40 and 90%, 
depending on the source of the strains and the agent stuched. Among the 
cephalosporins, FEP, a 4th generation agent with increased stability against 
most betalactamases, shows very high susceptibilities using the conventional 
break point of 8 mg/L but clinical data on outcomes with the use this agent 
have been lacking. 
Methods: In order to obtain such data, case report forms were provided to 
selected clirucians in six countries to obtain information on patients with 
ESBL E .  coli/Klebsielhe treated with FEP before susceptibilities were available. 
They were also asked to provide the strains that were considered to be ESBL 
producers for verification ofthe MICs against cephalosporins. AU strains were 
retested by tube dilutions to obtain their MIC for cefepime and other 
agents. 
Results. Sixty-eight cases were collected. Twelve patients were excluded for 
a varieiy of reasons. Forty-four FEP treated patients had isolates confirmed as 
ESBL bearing strains of E.  coli/Klebsiellae. Twelve patients treated with 
imipenem also had isolates confirmed as ESBL E. coli/l(lebsiellne. Of the 44 
patients receiving FEP as initial empiric therapy, six also received an ami- 
noglycoside. 68% of the 44 isolates had an MIC of * 8 mg/L of FEP whereas 
97% of those tested had MICs of * 8 mg/L of ceftazidime. Of the FEP invitro 
susceptible isolates, 80% (24/30) were eradicated or presumably eradtcated 
with FEP therapy. Of the invitro resistant isolates, 35.7% (5/14) were 
eradicated or presumably eradicated with FEP therapy. Cure rates by site 
of infection were: urinary tract 90%, lower respiratory tract 76%, bacteremia 
45% (60% for strains with MICP of* 8 mg/L). Ofthesepatients, 12 case report 
forms were obtained from a study of empiric imipenem versus FEP 
for nosocomial pneumonia in which an additional 12 patients with ESBL 
E. coli/Klebsiellae were also treated with imipenem. The bacterial eradication 
rates were 83 and 70% for FEP and imipenem, respectively. 
Conclusion: These data suggest that FEP may be effective therapy for ESBL 
producing strains of E. coli/MebsielJae which fall within the conventional 
susceptibility range. Such idormation may be used in designing empiric 
therapy in institutions where the susceptibilities of the resident ESBL clones 
are known. 
102761 The development of a new national surveillance 
system in the UK for ‘influenza-like illness’ 
D.L. Cooper, G.E. Smith, C. Joseph, V Hollyoak, J. Dickens 
Birmingham, London, LPeds, Wnk$2d, U K  
NHS Direct is a nurse led national telephone helpline for health advice. 
Objectives: To describe the evolution of a new surveillance system designed 
to detect ‘influenza like illness’. Assess the usefulness of this surveillance 
system for early detection of ‘influenza like illness’ in the community. 
Report the results of the surveillance undertaken during three winters 
(1 999-2002). 
Methods: NHS Direct is open 24 h a day, 365 days a year, organized into 23 
c d  centres and takes over 5 million calk a year. During the first winter of the 
surveillance (1999/2000), call data relating to respiratory symptoms were 
received fiom three NHS Direct sites (population 6.6 million). The surveil- 
lance has been extended to all 23 sites (population 52 million) during the 
winter of 2001/2002. Age-spec& data are received every weekday and 
disseminated to public health colleagues in UK and Wales. Nurses at all NHS 
Direct sites use the Clinical Assessment System (CAS) to handle calls. The 
CAS is based around 200 computerized clinical algorithms. For surveillance 
during 2001/2002 the ‘cold/flu’, cough and fever algorithms were used to 
monitor respiratory symptoms in the community. 
Results: The data are accurate indicators of influenza activity during Enghsh 
wintea characterized by both high (1999/200Gpredominantly Influenza A 
H3N2) and low influenza activity (2000/2001-predominantly Influenza B). 
However, analysis of data is complicated by seasonal trends in other respiratory 
viruses and the availability of other primary care services. The proportion of 
NHS Direct calls for which the ‘cold/flu’ algorithm is used usually fluctuates 
between 1 and 3% but peaks over Christmas (when other primary care 
services are less available), as well as during periods when respiratory viruses 
are known to be circulating in the community. During periods of peak 
influenza activity NHS Direct data reflects the age distribution of influenza 
shown by laboratory data. This paper wiU be updated with NHS Direct 
surveillance data &om the winter of 2001/2002. 
Conclusions: The benefits of the NHS Direct based survedlance system 
compared to currently used routine s u r v e h c e  system for influenza are its 
national coverage and timely nature. The complex and flexible nature of CAS 
provides an opportunity to improve the specificity of the definition of 
influenza like illness and to detect syndromes rather than primary symptoms. 
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10277/ The incidence of influenzwmociated 
hospitalizations in children in Germany 
J. Weigl, W. Puppe and H. Schmitt 
Kiel, Mainz, D 
Objectives: Since new vaccines and antiviral drugs for influenza have become 
available, collation of actual and country-specific epidemiological data is 
essential. Since respiratory syncytial virus (RSV) is a well-known pediatric 
airway pathogen and some epidemiologic data exist already, a comparison 
between influenza and RSV is performed. 
Methods: FromJuly 1996 to June 2001, the naso-pharyngeal aspirates (MA)  
ofchddren fiom birth to 16 years ofage, Admitted to one ofthe two pediatric 
hospitals in Kiel, Germany, were investigated by a 9-valent multiplex reverse 
transcriptase PCR assay. 
Results: NPA were investigated in 60.5% of 3469 children adrmtted with an 
acute respiratory tract infection. Community-acquired (nosocomial) mfec- 
tions due to influenza Awere dugnosed in 122 (lo), due to d u e n z a  B in 14 
(2) and due to RSV in 329 (14) cases. Patients with influenza A (median 
752 days) and influenza B (median 966 days) were older than patients with 
RSV (median 168 days). The specunm ofdisease presentation was broader in 
influenza than in RSV. In each winter, admissions with d u e n z a  were less 
common than with RSV. Influenza B only occurred in 2 years. The cumu- 
lative, population-based incidences per 100OOO children 0-16 (0-5; >5- 
16) years of age were 53 (123; 22) for influenza A, 16 (30; 9) for influenza B 
and 165 (453; 4) for RSV. Cardlac conditions and asthma were the major risk 
factors in influenza A (RR 9.8; 4.1) and in RSV (8.5; 2.1) idections. 
Underlying conditions were most common in influenza B. Low gestational 
age doubled the risk for influenza A infection, but did not show a dose-effect 
relationship as in RSV. 
Conclusions: The importance of influenza-positive hospitalizations is about 
one third that of RSV. The incidence is similar to reports f b m  the USA. 
Targeting children with underlying conditions, especially cardiac conditions 
and asthma in the German immunization program is appropriate, as long as no 
policy for vaccination of the general pediatric population exists. 
wl Persistence of Picornaviridae in human neural 
stem cells: an in vitro model for central nervous system 
damages and viral etiologies 
V. Legay, C. D&Eage, J. J. Chomel, M. Aymard and B. Lina 
Lyon, F 
Background: Multiple invivo and invim studies suggest that persistent 
infections due to Picomaviridae are not uncommon. It has now been pmved 
that Poliovirus can persist in human central nervous system (CNS), and it is 
now hypothesized that this enternviral persistence may be related to neuro- 
logical diseases. 
Objectives: To investigate the possible links between Picornaviridae persistent 
infections and CNS damages using an invitro model developed with human 
neural and glial cells. 
Material and methods: The human cell line Dev, established &om a primitive 
nenroectodermic tumor is similar to neural precursors and retains the capacity 
to differentiate towards astrocytes. A total of 25 000 cells were inoculatedwith 
calibrated suspensions of three TClD5,/25 pL of each virus strain: Cytome- 
galovirus, Herpes Simplex Virus, Adenovirus, Mumps virus, Measle vim, 
Enterovirus type 70, Cowackievirus B3, Poliovirus type three sabin strain, 
ECHOvirus type 6 and 7, and Human Parechovirus type 1. After a contact 
period of 1 h 30 min, the inoculum was discarded and cells cultivated with 
5 mL Dulbeccos MEM supplementedwith 10% Fetal Calfserum at 37 "C in a 
5% C02 incubator. Cytopathic effect was observed daily, culture passages 
perfiormed each 72 h. When no CPE was observed, total DNA or RNA was 
extracted horn the monolayer and tested with the respective speclfic PCR. 
Eventually, when a persistent infection was suspected, supernatants of the cell 
monolayers were inoculated onto sensitive cells and titrated according to the 
Reed and Muench method. 
Results: A cytopathc effect was observed with all viruses except human 
parechovirus type 1. Aher cytopathic effect, the monolayer was spontaneously 
restored in ECHOvirus 6 and ECHOvirus 7 infected cells only. Despite the 
lack of cytopathic effect, human parechovirus type 1 established a persistent 
infection in Dev cells, as confirmed by a specific RT-PCR. Supernatants fbm 
HPEVI, E6 and E7 persistently infectedDev cells titrated 104 TCIDs0/25 pL 
on HRT cells, 105 TCID5,/25 pL on MRC-5 diploid cells and 104 TCIDm/ 
25 pL on MRC-5 diploid cells, respectively. 
Conclusion: This invim model confirms that several Picornaviridae can be 
responsible for persistent infections in neural and glial human cells. In 
agreement with the results described with poliovirus, this invitro model 
may be helpful to investigate the role of Picornaviridae in CNS damages and 
in neurodegenerative diseases. 
1 02791 Epidemiology of varicella infection to assess the 
burden of disease in Germany 
S. Wagenpfeil, A. Neiss, H. Bisanz, €? Wutzler, J. Vollmar and A. Goertz 
Munich, Jena, D 
Objectives: Varicella is a common but not always benign disease which may 
place a great economic burden. To provide baseline estimates of varicella 
epidemiology in Germany, a retrospective study was conducted. 
Methods: A representative nationwide sample of 1334 unvaccinated varicella 
cases was obtained f b m  randomly selected pediatricians and general practi- 
tionerdinternists. Each physician contributed five randomly selected varicella 
cases occurring in 1999. Epidemiological data and data on resource utilization 
were collected h o r n  patient files via telephone interviews. Because pedia- 
tricians were over-represented in the sample, results were weighted according 
to the true relationship of diagnoses by pediatricians (0.6) and general 
practitioners (0.4) on the basis of the German prescription index for 
1999. 
Results: Mean age was 7.4 (median 5years) with 90% of cases younger than 
12years. Highest incidence was in 5-6-year-olds. The treating physician 
assessed for 16.3% of varicella cases a severe come. Overall incidence of 
complications was estimated to be 5.7%. Complications accounted for an 
avenge of 0.09 hospital days per case. Certificates of sick leave were issued for 
1.31 days per case. Of these, 0.63 days were paid by sickness funds for parents 
caring for their sick children. Using the incidence of 760000 cases in 1999 
according to the German prescription index, we estimatedhost one million 
days of work loss. The overall costs for society were about 150 million Euro, 
thereof 81% for indirect costs. 
Conclusion: The findings of the s t u d y  indicate that varicella is a serious 
disease, especially for adults resulting in substantial medical and societal costs 
in Germany. The most important economic indicator is work loss. Costs could 
be saved essentially by introducing universal varicella vaccination. 
AIDS and HIV infection 
Ritonavir boosted protease inhibitor (PI) regimens 
show superior virological efficacy compared to single PI 
regimens 
M. Lichterfeld, A. Wohrmann, N. Schmelsser, B. Salzberger, 
G. Fatkenheuer and J. Rockstroh 
Bonn, Cologne, Regensbug, D 
Background: Low dose ritonavir boosting of a further PI can result in 
beneficial pharmacokinetic interactions that allow BID dosing while 
maintaining higher drug trough concentrations. These regimens are, there- 
fore, a promising strategy to improve both HAART-associated tolerabilityand 
efficacy. We retrospectively analyzed the virological responses of HN patients 
receiving either single PI- or boosted PI-based HAAKT as first PI-containing 
treatment in the CologneBonn patient cohort. 
Methods: Data of 387 patients were available for short-term virological 
response analysis (6 months). A total of 327 of these patients had been started 
on single PI regimens: hard-gel saquinavir (HG-SQV): 22%, indinavir (IDV): 
32%, ritonavir (RTV): 23%, nelfimavir (NFV): 23%. Sixty patients had 
received boosted PI: SQV-RTV (1000-1250 mg/100 BID): 1296, IDV/ 
RTV (800/200mg or (800/100mg BID): 63%. Lopinavir (LPV)/RTV 
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(400/100 BID): 25%. Long-term virological responses (12 months) were 
evaluable in 193 patients treated with single PIS (HG-SQV 15%, IDV: 
35%, RTV 2396, NFV 27%) and in 37 patients on boosted-PI-therapy 
(SQV-RTV 8%, IDV/RTV: 68%. LPV/RTV: 25%). 
Results: Patients receiving single PI-treatment with HG-SQV had less 
favorable treatment reponses when compared to single IDV-, RTV- or 
NFV-treated patients, both in the short term analysis (25% vs. 75, 67, 
70.6%, respectively; P< 0.05) and the long-term analysis (25.5% vs. 80.6, 
71.1, 69.8%. respectively; P<0.05). To avoid HG-SQV induced 
effects, patients treated with this PI were excluded &om hrther analysis. 
Initial viral suppression below the limit of detection (<400 copies/mL) 
w a s  achieved in 61.7% of patients on single PI therapy and in 83.3% 
of patients treated with boosted PIS (P<0.05). Durable viral control 
(<400 copies/mL) over 12months was found in 67% of patients &om the 
single PI group and 91.8% of patients receiving boosted PI-treatment 
(P< 0.05). 
Conclusion: Boosted protease inhibitor therapy with SQV/RTV, IDV/RTV 
and LPV/RTV seems to induce higher rates of virological suppression both in 
short- and long-term follow-up, compared to conventional single PI treat- 
ment. 
ml HIV quasispecies evolution and profile of 
cellderived membrane proteins acquired by virions in the 
plasma and spinal fluid of AIDS patients 
I. Abbate, G. Cappiello, R. Longo, A. Ursitti, S. Calcaterra, 
A. Spanb and M. R.  Capobianchi 
Rome, I 
Objective: Cell-derived membrane proteins (CMP) acquired by HIV provide 
information of the cellular source of circulating virus. CMP profile of HIV 
present in the plasma and in the spinal fluid of AIDS patients as well gp120 
hypervariable region (V3 loop) quasispecies heterogeneity were established in 
order to analyze relationships with coreceptor usage and compartmentahza- 
tion of viral replication in these body sites. 
Methods: CMP profde was established by immunocapture of purified virions 
from plasma and spinal fluid with monoclonal antibodies to cell membrane 
markers includmg: CD26, CD45R0, CD36, CD58, N-CAM, VCAM-1, 
ELAM-I, CD44 and glutamate receptor. Viral quasispecies were analyzed by 
V3 loop cloning and sequencing. 
Results: Seven patients were included in the study. Direct comparison 
between plasma and spinal fluid was possible on five paired specimens. 
Incorporation of CMP in viral envelope was lower for HIV from spinal fluid 
as compared to plasma virions. CD44 was the most represented CMP in 
virions from spinal fluid, while the monocyte marker CD36 was the 
most prominent CMP on plasma virions. V3 loop sequences in HIV from 
both body compartments were compatible with a predominant usage of 
CCR-5 as coreceptor. Virion heterogeneity in V3 loop was generally lower in 
spinal fluid. Viral quasispecies evolution in two patients indicated a distinct 
clusterization of clones derived from the two body fluids, while in 
the remaining patients spinal fluid and plasma V3 loop clones were not 
separated. 
Conclusions: Our data indicate that in AIDS patients HIV present in the 
spinal fluid and plasma may evolve separately. Accordingly, CMP 
profde of virions derived from the two body compartments may be quite 
different, suggesting distinct cellular source of the HIV, although a similar 
pattern of coreceptor usage is suggested by the V3 loop aminoacid 
pattern. The comparative analysis of CMP profie and quasispecies hetero- 
geneity may help in understanding the evolution of HIV during the 
natural history of the infection and may be usefix1 in the study of its cellular 
reservoirs. 
1 0282 1 Correlation between human immunodeficiency 
virus type 1 levels and cytokine profile into the 
cervicovaginal secretions of a female cohort 
F. Zara, R .  E. Nappi, R. Brerra, R .  Mighavacca, E. Nucleo, 
M. Spalla, C. Bergante, A. Smeraldi, L. Pagani and A. Spinillo 
Pavia, I 
Objectives: To evaluate the role of cytokines on human immunodeficiency 
virus type 1 (HIV-1) replication and shedding into the cenricovaginal secretions 
(CVS) and their relationshp with clinical parameters of HIV-1 disease. 
Methods: Sixty paired cervicovaginal and blood samples were collected &om 
HIV-infected women followed at colposcopic unit of Department of Obste- 
trics Gynaecology, Pavia. F&y-one out of 60 were in active anhretroviral 
treatment (ART). CVS specimens were analyzed for cytokines levels (inter- 
leukin-IL-1-j?, tumor necrosis factor TNF-a, IL-6) by ELISA (Chemicon, 
Italy), for presence and load of HW-RNA and HIV-DNA by RT-PCR, and 
for detection and type of human papillomavirus (HPV) by PCR-RFLP. 
Plasma HIV-RNA viral load was determined by RT-PCR. 
Results: The prevalence of HIV-RNA viremia was 45%. HIV-DNA, cell- 
associated and cell-free HIV-RNA were detected in 76.7, 70 and 71.7% of 
CVS specimens, respectively. The median levels of TNF-a, E-1-p and IL-6 
in CVS were 27.8, 30, and 4.15pg/mL, respectively. There w a s  a dnect 
correlation between the CVS concentration of IL-1-j?, plasma HrV-RNA 
viral load, HIV-DNA and cell-associated HIV-RNA in CVS. Fifty-one 
women in active ART had sigtllficantly higher concentration of IL-6 and 
lower concentration of TNF-a in CVS than the nine untreated subjects. 
Conclusion: These results suggest that local immune activation is associated 
with presence and load of HIV-1 in the CVS and local concentration of 
proinflammatory cytokines may influence the risk of HIV transmission. 
/0283[ Influence of HIV infection in the evolution of 
Legionnaires' disease 
M. L. Pedro-Botet, N. Sopena, D. Garcia-Pares, M. J. Dominguez, 
Z. Vilaseca, E. Reynaga, M. A. Garcia-Nuiiez and M. Sabria 
Badalona, E 
Objectives: Although Legionnaires' disease (LD) is rarely described in AIDS 
patients, the incidence of this infection is similar to that in those without HIV 
infection. Since 1983, 15 cases ofAIDS with LD have been seen in HUGTiP. 
A previous descriptive analysis demonstrated that mortality and morbidity 
were high in this subset. Clinical features and complications of LD were 
compared between HIV and non-HIV patients. 
Methods: Data related to HIVand LD were retrospectively collected. Fifteen 
HIV patients (group A) and 64 non-HIV patients (group B) with LD were 
included in the study. Patiens in group B had not received previous immu- 
nosuppressive therapy. 
R ~ l t s :  No statistical Merences were observed between the two groups in 
the origin (community, nosocomial), delay in treatment (>3days), or anti- 
biotic therapy (erythromycin, fluoroquinolones). Fine score >3 was not 
sigmficant in either group (P=  0.1 1). Most patients in the two groups were 
males with a mean age of37.8 (group A) and 57.4 (group B). Among intrinsic 
risk factors, liver disease (P=O.00019) and smoking (P=O.Ol) were sig- 
dicardy more frequent in HIV patients. Previous b-lactam treatment was 
also more frequent (P= 0.03) in HIV patients. Respiratory symptomatology 
was present in 12 (80%) versus 42 (65.6%) of groups A and B, respectively 
(P= 0.22) with dyspnea being ofnote in group A (P= 0.01). Extrarespiratory 
symptoms were present in seven (46.6%) versus 32 (50%) patients in groups A 
and B, respectively ( P =  0.95). Hyponatremia (P= 0.004) and an increase in 
AST (I" 0.01) were sigmticantly more frequent in group A. Radiologically, 
HIV patients showed more bilateral pulmonary infiltration (P=0.006). 
Complications (P= 0.04) and specially respiratory failure (P= 0.07) were 
also more frequent in t h  group. Lastly, mortality was slgfuficantly greater 
(P=  0.02) in HIV patients. 
Conclusions: Morbidity and mortality of LD are significantly higher in HIV 
Venus non-HIV patients. 
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Rickettsia1 diseases 2002: an update (Symposium organized by EUWOG) 
Ehrlichiosis: trends in Europe 
A. BjoersdorfT 
Kalmar, S 
Ehrlichiosis in humans and animals in Europe is caused by intracellukr 
organism of the families Ehrlichia and Amplasma. As the order Rickettsdes 
currently is reorganized with new species combinations being used, the 
nomenclature is stiU unfamiliar. Ehrlichioses are named as granulocytic or 
monocytic depending on which cell lineage is predominantly infected. 
Human monocytic ehrlichosis is caused by Ehrlichia chaffeeensis. The principal 
tick vector for E. chaffeensis is Amblyomrna amerimnum. Based on serology, 
sporadic cases of monocytic ehrlichiosis have been reported tiom a small 
number of European countries. The ehrlichiosis of considerable c h c a l  im- 
portance in Europe is granulocytic ehrlichiosis caused by Ehrlichiaphagocytophila 
(proposednew name; Annphmaphagqtophila) . The vector ofE. phagqtophilain 
Europe is the common tick Ixodes ricinus. Clinical cases of human granulocytic 
ehrlichiosis have been described in several European countries. and serological 
evidence of human infection is being reported from countries all over Europe. 
Related seroprevalence rates in tick-exposed populations varies between 1 and 
25%. The most common clinical manifesrations ofgranulocyhc ehrlichimis are 
fever, headache, and myalgia. Additional nonspecific symptoms may include 
rigors, malaise, and arthralgia. However, several studies assert that the infection 
often is mdd and self-resolving. 
Resistant staphylococci (Joint ESCMIDIICAAC symposium) 
w\ Alternative therapies for staphylococci and their 
problems 
B. Murray 
Houston, USA 
Staphylococci remain important causes of morbidity and mortality, both in 
and out ofthe hospital setting. W e  modalities to prevent infections caused 
by these organisms, as well as to ameliorate the consequences of a systemic 
inflammatory response that may occur, are being pursued, the mainstay of 
management remains antimicrobial agents. The resistance of staphylococci to 
@-lactams and to alternatives, some ofwhich have excellent bioauailability, is 
well known and helped spur studies of other therapies. Two such therapies 
have been approved for use in recent years in many parts ofthe world. The first 
of these, quinupristin/daEopristin (Q/D). is a combination of streptogramins 
that together show enhanced, and even irreversible, binding to ribosomes; 
binding, and the bactericidal effect, is decreased in the presence of the 
cMLS-B (constitutive) phenotype, encoded by em genes, which results 
in ribosomal methylation. Q/D is administered intravenously (long line 
Viral respiratory infections (Joint ESCMID/ESCV symposium) 
preferred) and produces considerable myalgias, arthralgias and interactions 
with other drugs. Combinations of Q/D with other antimicrobials generally 
appear to be beneficial or indifferent, although results can vary in Werent 
assays. Linezolid, an oxazolidinone, is used either IV or PO, with excellent 
bioavailability. It is a generally bacteriostatic, protein synthesis inhibitor, 
but some kdhg may be observed in vitro and in animal modes. Reversible 
anemia and thronibocytopenia are seen, usually after prolonged exposure. 
Newer fluoroquinolones with enhanced Gm f activity include gdtdloxacin, 
m o d o x w i n  and g e d o x a c k  however, MICs ate increased, often into the 
resistant range, with MRSA. Another new antibiotic with Gm +activity is 
telithromycin (a ketolide more potent than macrolides and a poor inducer of 
the iMLS phenotype), which is active against most MSSA but not MRSA 
(which usually &splay the cMLS phenotype). Agents in comparative 
clinical trials include oritavancin (LY333328) and daptomycin (both have 
completed phase 111 trials for complicated skin and soft tissue infections), 
tigecycline (GAR936, a glycylcycline), MB1226 (an antimicrobial peptide in 
phase 111 for prevention of bloodstream infections), and ABT733, a ketolide. 
A rapidly bactericidal antistaphylococcal agent that is bioavailable is still 
needed. 
Seasonal influence on the epidemiology of viral 
respiratory infections 
B. Lina 
Lyon, F 
Respiratory infections are major causes of illness observed in all age groups 
and all year round. These infections are mainly caused by respiratory viruses 
(influenza A and B; respiratory syncytial virus; parainfluenza viruses I, I1 and 
111; adenovirus; enterovirus; rhinovirus; coronavirus). These viruses have 
diaerent characteristics such as clinical presentations, seasonal patterns and age 
distribution. By combining diagnostic procedures (antigenic detection plus 
culture plus P C R  plus serodiagnosis), viral etiology can be assessed in 7040% 
of patients presenting with acute respiratory tract infections. This high rate of 
diagnosis allows a clear characterization ofthe epidemiology of these viruses in 
the Herent  regions ofthe world. When comparable, the studies conducted in 
different countries are in agreement. Common cold is the most h-equent 
upper respiratory tract disease. It is mainly due to rhinoviruses and corona- 
viruses, and occurs during early fall and spring. Influenza and RSV are 
responsible for the severe acute lower respiratory tract infections mainly 
observed during winter. The age distribution diffen for these two viruses 
since RSV is observed in wry young children (age below five) and in 
the elderly while influenza is mainly observed in older children (more than 
5-year-old) and young adults. RSV is responsible for severe bronchiolitis 
leading to admission to the hospitahzation, while para I and 11, observed also 
during the winter period, can be responsible for mild bronchiolitis. Para I11 
infections are mainly recorded during summer. Adenovirus has no obvious 
seasonal pattern, but seems to be responsible for small located epidemics 
(serotype 4 and 7) that are observed in young adults. This virus is a h  observed 
in very young upper respiratory tract infections that resemble influenza 
presentations, Even if the seasonal pattern and the epidemiology of these 
respiratory viruses is better understood, it remains a real challenge to assess for 
each individual case that the virus responsible for the clinical presentation 
observed is the one supposed to be circulating at that time of the year. Since, 
efficient techniques for the diagnosis of infections due to respiratory viruses 
are now available and e&cient in numerous laboratories, this hagnosis should 
be carried out, particularly in the age of development of specific antiviral 
agents. 
A newly discovered human pneurnovirus isolated 
from young children with respiratory tract disease 
3. G. van den H0ogen.J. C. de jong, J. Groen, T. Kurken, R de Groot, 
R. A. M. Foucher and A. D. M. E. Osterhaus 
Rotterdam, N L  
From 28 young children m the Netherlands, a paramyxovuus was isolated that 
was identified as a tentative new member of the Meclpneumovuvs genus 
based on vlrological data, sequence homology and gene constellation. So far, 
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avian pneumovirus was the sole member of thls recently assigned 
genus, hence the provisional name for the newly discovered virus: human 
metapneumovirus. The clinical symptoms of the children fiom whom the 
virus was isolated were reminiscent of those caused by human respiratory 
syncyaal virus infection, ranging from upper respiratory tract disease to 
severe bronchiohtis and pneumonia. Serological studies showed that by 
the age of 5 years, virtually all children in The Netherlands have been exposed 
to human metapneumovirus and that the vints has been circulating in 
humans for at least half a century. We have generated sequences for al l  
hMPVopen reading frames (ORFs) and intergenic sequences as well as partial 
sequences of the genomic termini. The overall percentage amino acid 
sequence identity between APV and hh4PV N, P, M, F, M2-1, M2-2 and 
L ORFs was 5648%. Some nucleotide sequence identity was also 
found between the noncodmg regions of the APV and hMPV genomes. 
Although no discernible amino acid sequence identity was found between 
two of the ORFs of hMPV and 0% of other paramyxoviruses, the amino 
acid content, hydrophilicity profiles and location of these ORFs in the viral 
genome suggest that they represent SH and G proteins. The high percentage 
sequence identity between APVand hMPV, their similar genomic organiza- 
tion (3’-N-P-M-F-M2-SH-G-L-5’) as well as phylogenetic analyzes provide 
evidence for the proposed classification of hMPV as the first mammalian 
metapneumovirus. 
Quinolone and macrolide resistance 
I 031 5 1 Topoisomerase mutations associated with in vitro 
selection of resistance to moxifloxacin in Streptococcus 
pneumoniae 
E. Varon, S. Houssaye and L. Gutmann 
Paris, F 
Modoxacin (MOW is an 8-methoxyquinolone very active against Strepto- 
c o w  pneumoniae. In a previous study [I], we showed, using isogenic tran- 
formants with different mutations in the QRDR of ParC or GyrA, that a 
similar low level of resistance was obtained for MOX, although it did not 
indicate if a preferential target existed. In this work, we demonstrated the 
order of acquisition and the mutations selected on MOX in two wild-type 
pneumococcal strains, R6 and 5714. Selection of first-step mutants was 
performed by plating lo9 to 10“ cells on MH blood agar plates containing 
MOX or levofloxacin (LEV) incubated for 72 h, while the second selection 
step was done on MOX. Selection occurred only at 2 and 4x MIC and 
fiequencies of selection of first- and second-step mutants did not differ 
significantly whatever was the fluoroquinolone ( F Q  used, ranging &om 
10-7 to 10-9. Analysis of R6- and 5714-derived first-step mutants (n= 19) 
selected on MOX (2x MIC) revealed two main types ofmutants. First, 10 
derivatives showed only two-fold increased MICs of the FQs tested, but no 
mutation in the QRDR of GyrA, GyrB, ParC or ParE. Since no decrease in 
MICs were observed with reserpine, the resistance mechanism has still to be 
determined. The other eight mutants showed a single GyrA mutation at 
position 81, associated with two- to four-fold increased MICs of MOX and 
sparlloxacin and at most a two-fold increase in MICs of LEV, ciprofloxacin, 
and pefloxacin, consistent with the GyrA phenotype [l]. As expected, when 
LEV was used fmt as selecting agent QX MIC), only mutants with the ParC 
phenotype [l] were selected showing four-fold increased MOX MICs. All the 
second-step mutants selected on MOX from first-step mutants (GyrA S81F, 
selected on MOX) had a second mutation either in ParC at position 79 or 83, 
or in ParE at position 435. Similarly, all the second-step mutants selected from 
ParC mutants (S79Y, selected on LEV) had a second mutation in GyrA at  
position 81 or 85. This work indicates GyrA as the primary target of MOX. 
Since a single mutation in GyrA or Par€ similarly affects its MICs, MOX 
could belong to the FQs which target preferentially GyrA, although probably 
acting through both gyrase and topoisomerase W. Since a two-step mutation 
process modifying GyrA and ParC or ParE is necessary to MOX resistance, 
any other FQ able to select fiat-step ParC mutants will favor the emergence of 
MOX resistance. 
Reference 
1. Vuon, E el 01. Anfimimh &mrS Chimoth  1999 43: 3026. 
)03161 Patterns of mutations in target genes in 
septicaemia isolates of Escherichia coli and 
Klebsiellapneumoniae with resistance or reduced 
Susceptibility to quninolones 
F. Fendukly 1. Karlsson, K. Dornbusch and G. Kronvall 
Stockholm, S 
Objectives: To describe mutations m QRDR in E. coli and K .  pneumoniae, of 
subunits of topoisomerase I1 and IV in septicemia isolates with reduced 
susceptibility to ciprofloxacin (CIP), and to correlate mutations to the degree 
of resistance. 
Methods: DNA probes were used as primers to amplify and sequence QRDR 
ofgyrA, gyrB, parCandparE in blood isolates of E. coli and K.pneumoniae. The 
strains were selected on the basis of reduced susceptibility to CIP as deter- 
mined by the disc test and MIC determinations. The strains were also tested 
for susceptibility to nalidixic acid (NA). 
Results: In E. coli, mutations in thegyrA gene were seen at codom 83 and 87, 
leadmgto amino acid substitutions Ser + Leu (TCG + TTG) and Asp + Asn 
(GAC --t AAC), together with single ot  double mutations in parC leading to 
Sera0 + Ile (ACG -+ ATC),Glu84 + Gly (GAA --f AAA) or Gly78 -+ Cys 
(GGC + TCG) in all CIP resistant strains (MIC > 8 mg/L). Mutations in 
parE were uncommon and no mutations were seen in gyrB. Strains with 
reduced susceptibility (MIC 0.1251 mg/L) showed a single mutation ingyrA 
(Ser83 +Leu) and also in parC (Gly78 -+ Cys or Ser80 --t Ile). No parC 
mutations were found in the absence of gyrA mutations. All s t r a i n s  were 
resistant to NA (MIC > 8 mg/L). In K. pneumoniae, only one resistant strain 
with resistance to CIP (MIC 8 mg/L) was found with a double mutation in 
gyrA in codon 83, leading to Thre + Phe (ACT --t TCC) and in codon 87 to 
Asp -+ Gly (GAC -+ GGC), whereas strains with reduced susceptibility (MIC 
0.25-2 mg/L) harbored a slngle mutation ingyrA, leading to Thre83 -+ Ser or 
Tyt (ACT + TCC or TAC). Resistance to NA (MIC 8 -+ 256 m g / L )  was 
present in al l  strains. The same mutation in codon 83 with Thre + Ser was 
also observed in six  CIP susceptible strains (MIC 0.016-0.064 mg/L). In two 
wild-type strains the MICs were 0.008-0.01 6 mg/L. These eight strains were 
susceptible to NA (MIC 24mg/L).  
Conclusion: E. coli and Mebsielh blood isolates with high-level CIP resistance 
harbor double mutations in gyrA and E. coli also in parC. Strains with single 
mutation ingyrA remained susceptible, but the MICs were increased. All the 
strains were resistant to NA. CIP-susceptible strains of K .  pneumonia with one 
mutation in gyrA, leadmg to Thre83 + Ser and with susceptibility to NA 
might be the Erst step towards reduced susceptibility. Additional mutations in 
parC and efflux mechanisms have to be tested in K.pneumoniue. NA resistance 
was predictive of reduced susceptibility to fluoroquinolones. 
I 0317 I Different contribution of efflux to 
fluoroquinolone (FQ) resistance in clinical isolates and 
laboratory-created mutants of Streptococcus pneumoniae 
W N )  
H. Smith, K. Nichol, A. Walkty, D. Hoban and G. Zhanel 
Winnipeg, CAN 
Objectives: The reserpine-sensitive efflux pump PmrA has recently been 
shown to confer FQ resistance in SPN. The aim of this study was to compare 
the contribution of efflux to ciprofloxacin (cipro)-resistant (MIC 2 4 pg/mL) 
clinical isolates (CLIN) and lab-created mutants (LAB) resistant to cipro, 
gatifloxacin (gati), gedoxacin (gemi), levofloxacin (levo), and moxifloxacin 
( m o ~ ) .  
Methods: A total of 34 cipro-resistant CLIN were collected as part of an 
ongoing national respiratory organism surveillance program and their MICs 
were determined by broth microdilution (NCCLS, M7-A4,1997). A total of 
39 single-step LAB were created from three susceptible SPN isolates at 1-16x 
MIC of cipro, gati, gemi, levo or moxi. The Quinolone Resistance Deter- 
mining Regions (QRDRS) of GyrA and ParC were sequenced in all the 
CLIN and LAB. The role of efflux was evaluated via reserpine studies for all 
isolates. 
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Results: QRDR changes were observed in 14/34 (41%) and 32/34 (94%) of 
CLIN for GyrA and ParC, respectively. Ciprofloxacin-positive efflux (a four- 
fold or greater decrease in MIC in the presence of reserpine) was observed 
in 12/34 (35%) of the CLIN. Conversely, QRDR changes were observed in 
6/39 (15%) of GyrA and 4/39 (10%) of ParC in the LAB and 100% of the 
ciprofloxacin-resistant mutants were efflux-positive. The 20% of gati, 44% of 
gemi, 67% oflevo, and22% ofmoxi-resistant mutants were able to efflux cipro 
but none were positive for efflux of the FQ with which they were selected. 
Conclusions: The clinical isolates predominately showed QRDR changes 
(94% in ParC and 41% in GyrA), but only 35% were positive for efflux. 
Alternatively, efflux of cipro contributed to 100% of cipro-resistant laboratory 
mutants whereas only 15 and 10% had GyrA and ParC changes, respectively. 
Resistance in clinical isolates was primarily due to QRDR changes whereas 
resistance in laboratory mutants was predominately a result of efflux. 
I 0318 I Macrolide resistance (Macr) by ribosomal mutation 
detected in clinical isolates of Streptococcus pneumoniae 
isolated from PROTEKT 2000 
D. J. Farrell, I. Morrissey, S. Bakker, D. Felmingham, 
J. Poehlsgaard and S. Douthwaite 
London, UK; Odeme, DK 
Objectives: PROTEKT is a global, longitudinal study of the antimicrobial 
susceptibility of bacterial pathogens associated with community-acquired 
lower respiratory tract infections. We have been screening c h c a l  isolates 
from PROTEKT 2000 for the genetic determinants of Macr (total of 1047 
isolates) and have discovered 17 isolates negative for known efflux or rRNA 
methylase mechanisms. The aim of this study was to determine the molecular 
basis of Macr in these strains. 
Methods: Segments of the L4 and L22 riboprotein genes and the four copies 
of the 23s rRNA (domains V and 11) gene were amplified, sequenced and 
mutations determined. RT-PCR and primer extension was performed at the 
region of the 23s mutations to determine the relative proportion of RNA 
having the mutation. SPN R6 and macrolide resistant strains negative for 
erm(A), erm(A) subclass erm(TR), erm(B), m ( C )  and mtf(A) genes were 
tested. 
Results: Three isolates carried an A2058C; mutation in three alleles of the 23s 
rRNA gene (erythromycin A FRY MIC 64-128mg/L). Five isoktes had 
AZ059G mutations in all four 23s rRNA copies (ERY MIC 16-128mg/L). 
Three German isolates had A2059G mutations in 1, 2, and 3 of the 23s 
rRNA copies, respectively (for isolates 1, 2, 3: ERY MIC 1, 8, 64mg/L; 
Clarythromycin[CLA] 1,2,16mg/L,Azithromycin[AzI]0.5,128,128mg/L). 
One Canadian isolates had an A2059Gmutation in two alleles (ERY MIC 32, 
CLA 8, AZI 128 mg/L). One isolate from the USA had a C2611G mutation 
in three 23s rRNA alleles (ERY MIC 128, CLA 32, AZI 8mg/L). An L22 
riboprotein G95D amino-acid substitution combined with AZ059G muta- 
tion in all four copies was found in three Japanese isolates (ERY MIC 64- 
128mg/L). L4 riboprotein gene mutations were not found in any isolates. 
The telithromycin MIC range for the 17 isolates was 0.015-0.25mg/L. 
Conclusions: This study shows that a s m a l l  number of Macr S.pnnrmoniae 
have ribosomal alterations as the mechanisms for macrolide resistance. The 
isolates are global in distribution. The data suggest a dosage effect for 
resistance; as the number of alleles with the mutation increases so does the 
MIC. The data also suggest that some macrolides may be more affected than 
others by these mutations. Ofparticular interest is the large increase in MIC to 
azithromycin when the A2059G mutation is present in one compared to two 
copies. Telithromycin MIC values remain low for all 17 isolates suggesting 
that these mutations do not have a major effect on this new ketolide 
antimicrobial. 
Macrolide resistance (Macr) mechanisms in 
Streptococcus pyogenes (SPY) isolated in the 
PROTEKT 2000 study 
D J Farrell, I Momssey, S Bakker and D Felrmngham 
London, UK 
Background PROTEKT is a global, longltudmal study of the anhmcrobd 
suscephbhty of bacterial pathogens aswciated mth community-acquired 
lower respiratory tract mfechons. The objechve ofthls study was to compare 
Macr mechamsms m SPY isolates fiom counmes parhcipahng in PROTEKT 
2000. 
Methods: The presence of Macr genes (em@), erm(A) subclass mn(TR), 
em@), erm(C) and m$(A)) were deterrmned in 143 Macr lsolates collected 
fimm 19 countries (total sample sze 1485 isolates) using a novel rapid-cycle 
multlplex PCR assay w t h  microwell-format gene specific probe detection 
Results. Overall, 46.3% of the isolates tested were &(A), 31.3% were em@)), 
20.9% were m(A) subclass ermm) and no isolates were negative for al l  the 
genehc markers tested. The m ( A )  or m(C) gene was not found III any isolate 
and none showed more than one Macr mechamm. The majonty of the 
countries surveyed showed low levels (<lo isolates) of Macr (thm being 
Argenhna, Austral~a, Brazil, France, Gmmany, Hong Kong, Poland, Hungary, 
Sweden, Switzerland, Turkey and USA), and therefore, it was not possible to 
obtain meaningful data regarding distribuhon of resistance types from these 
sites. However, Italy, Japan, South Korea, Canada, Mexico, Portugal and 
S p a  could be analyzed. For Italy, Portugal and South Korea at least 70?? were 
em@), but the reverse was true for Japan, Mexico and Spain where at least 
70% were d(A) .  No m(B) were found m Canadian isolates (58.3% m(A)  
subclass e n n o ,  41.7% m.f(A)) 
Conclusions: The dutribution ofMacr mechaiusms was found to vary widely 
between countries and a e r e n t  geographical regions and further d y s i s  is 
required to try to explain t h  phenomenon. The low number ofMacr isolates 
(N= 143) is a reflection of the overall low level ofmacrolide resistance m SW 
rather than the sample m e  (14311485, 9.6%). 
PI. 
Reference 
1 F m l l  DJ d nl J. A m m d  Chemothn mi. 48 541 
1 0320 [ Activity of the ketolide antibiotic teliiromycin is 
refractory to e m  monomethylation of bacterial rRNA 
M. Liu and S Douthmte 
Odeme, DK 
Objectives: Methylahon of speclfic nucleohdes m ribosomal RNA is one of 
the means by whch bacteria achieve resBtance to macrohddincosamide- 
streptogramm (MLS) anhbiodcs. The degree of resistance IS determined by 
how effechvely the rRNA IS methylated. We have unplemented a bactend 
system in whch the rRNA methyhhons are defined, and invesagated what 
effect em mono- and hethylahon of the rRNA has on the activity of 
representahve MLS, mcludmg ketohde, anhbiohcs. 
Methods: The methyltransferase gene, mnA, was mactwated m Eschmkhta coli 
AS19, a hyperpermeable srrain. This stram (AS19-d-negative) was then 
transformed wth  plasnuds c o n w n g  either the monomethyltransferase 
ermN, or the kmethyltransferase emtE, or w t h  a control plasnud 
wthout an em gene. MICs were d e t e m e d  for the AS19-nmA-negative 
strams by usmg the agar ddution method accordmg to the NCCLS guidehes. 
For each stram, approxlmately 10 000 cells were applied to surface of Luna- 
Be- agar plates contammg senal two-fold ddutions of chdamycm, 
clarithromycin, erythrumycm, hcomycm, prlstmamycin IA, tehthromycin 
(HMR 3647) or HMR 3004. The levels of methylahon at A2058 were 
measured by reverse transcriptase extermon of a pruner complementary to 
nucleohdes 2061-2078 of the 23s RNA, in the presence of dTTP and 
ddCTF? Pruner extension products were analyzed by potyacrylarmde gel 
electrophoresis, and the degree ofmethylahon was calculated by scannmg the 
rehhve intensihes of the unmethylated and dunethylared bands w t h  a 
PhosphorImager. 
Resuftr: In the test system, >80% of the rRNA molecules are monomethy- 
lated by ermN (TlrD) or dtmethylated by emE. The mnE dunethylahon 
confers hgh reslstance to all MLS and ketohde drugs. The m N  
monomethylaaon predlctably confers hgh resstance to the hcosamides 
chdamycm and h c o m y m ,  mtermedtate resBtance to the macrohdes clar- 
ithromynn and erythromycin, and low resistance to the streptograrmn B 
pnshnamycm IA. In contrast to the macrohdes, monomethylation only mildly 
affects the antmucrobial aChVlUeS of the ketohdes tehthromyctn and HMR 
3004, and these drugs re- 16-250~ as potent as clarithromym and 
erythromycin. 
Conclusions: These dtfferences in the macrohde and ketohde a~avlties could 
explain the recent reports of variahon III the MICs of telithromym for 
streptococcal strams that have conshtutwe-enn MLS reslatance, and whch are 
hghly resistant to erythromycin 
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)0321) Association of genes responsible for erythromycin 
and tetracycline resistance in Streptococcus pyogenes and 
their expression 
M. Santagati, C. Cascone, G. Pozzi and S. Stefani 
Cofanja, Siena, I 
Objectives: The presence of more than one gene responsible for erythro- 
mycin resistance associated or not with tetracycline resistance determinants in 
the same isolate of S. pyogener, was investigated in a sample ofstrains in order to 
(i) determine their genetic linkage (ii) evaluate their ability to be cotransferred 
and (iii) study the expression of these determinants. 
Methods: In a previous PCR screening for erythromycin-resistant S. pyogenes. 
13 strains with associated genes, enn(77Z), m$(A), em@), tet(0) were found. 
The genetic linkage of genes was determined by PFGE restricted with SmaI 
followed by hybridization with rrm(TR), m$(A), erm(B) and tet(0) probes. 
Conjugation experiments were performed using erythromycin-resistant 
S. pyogrnes as donor and E. f.ecaZis JH2-2 as recipient. Studies of expression 
of associated genes were performed by RT-PCR. 
Results: ALl S. pyogenes showed an MLSB phenotype. Among 11 tetracycline 
resistant strains no. 7 carried e r m w ) ,  erm(B), and tetf0) genes while no. 4 
carried rrm(7’R) and tet(0) genes. Only two tetracycline susceptible strains 
carried both erm(TR) and mtf(A) genes. Southern blot analysis with the probes 
for each gene revealed that erm(TR) and tet(0) genes hybridized in the same 
SmaI fragment (242kb), while the erm(B) probe hybridized in a 97-kb 
fragment, except for two strains in which erm(TI2) and tet(0) hybridized 
in a 291-kb Smal fragment. No association in the erythromycin-resistant 
tetracycline-susceptible strains was found between erm(TR) and m$(A) genes. 
Preliminary conjugation experiments showed that it was possible to transfer 
the erythromycin and tetracycline resistance to a recipient strain. RT-PCR 
experiments demonstrated the expression ofall genes with the only exception 
of five S.pyogenes, carrying erm(B), enn(TR) and tet(0) genes, in which erm(B) 
was not expressed. 
Conclusion: Our study demonstrated that e r t n p ) ,  in spite of its recent origin 
in Spyogenes, is a quite &se gene in this species and it is always functional, 
even if associated with other erythromycin-resistance determinants. In our 
sample it is fiequently associated and localized in the same fiagment of the 
ret(0)  gene, instead of erm(B) or nzef(A)). The erm(B) gene was not expressed in 
five strains, demonstrating that the erm(TR) gene alone is responsible for the 
MLSB phenotype. Our results demonstrated that a single phenotype of 
resistance can be determined by different genes with different levels of 
expression and mobility. 
m3q Efflux-mediated quinolone resistance in 
Bacteroides fragilis group strains 
H. Oh, M. Hedberg and C. Edlund 
Stockholm, S 
Objectives: In the present study, the possible efflux of quinolones were 
investigated in 35 Baaeroides fiagilis group isolates with moderate to high 
levels of resistance to quinolones (ciprofloxacin, levofloxacin, modoxacin 
and clinafloxacin) and compared to five ATCC strains by determining: (i) the 
impact of a known efflux inhibitor, carbonyl cyanide m-chlorophenylhy- 
drazone (CCCP), on the intracellular ciprofloxacin accumulation, and (ii) the 
CCCP and/or reserpine-induced growth idubition in the presence of 
moxifloxacin. 
Methods: The accumulation of ciprofloxacin by 35 B.fiagik group strains, 
isolated from fecal samples or clinical specimens, was measured by a silicon oil 
based fluorescence method. These strains had previously been characterized 
according to mutations in their GyrA QRDR and antimicrobial suscept- 
ibilities. Strains were incubated in lOpg/mL ciprofloxacin with and without 
the addition ofCCCI? The cells were separatedhm the extracellular solution 
by centrifugation through a silicon oil barrier. The entire pellet was placed in 
glycine-HCl buffer to obtain cell-lysis. After centrifugation, the amount of 
ciprofloxacin in the supernatant was determined by specmfluoromeay. The 
possible presence ofefflux was furrher examined using growth inhibition assay 
by studying the effect of reserpine and CCCP on the growth of the same 
strains in various concentrations of modoxacin. Samples were removed after 
24 and 48 h in order to determine the amount ofviable cells per ml by 10-fold 
dilution to 10-7, inoculation on blood agar plates, incubation and colony 
counting. 
Results: The CCCP-mediated ciprofloxacin accumulation was expressed as 
ratio between the accumulation with and without CCCP The ratio varied 
between 0.9 and 4.9. Eleven of the 35 isolates had a ratio of >2 indicating an 
increased efflux activig Accordingly, all of these were highly quinolone 
resistant with MICs of 8-256 pg/mL. In most of these strains efflux inhibitors 
mediated an  increased susceptibility to moxifloxacin. 
Conclusion: In 11 of the 35 studied isolates, the presence of CCCP 
produced marked increases in the amount of intracellular ciprofloxacin. In 
the majority of these strains, inhibition of the efflux-pump led to growth 
suppression when cultured in the presence of moxifloxacin. These results 
indicate overexpression of efflux-pumps in quinolone resistant B.f.gilis group 
isolates. 
Time to re-evaluate antimicrobial agents in an era of increasing resistance (Symposium arranged by Roche) 
I 5329 I Is antimicrobial resistance also subject to 
globalization? 
G. C. Schito 
Genoa, I 
In recent years, one of the more alarming aspects of clinical microbiology has 
been the dramatic increase in the incidence of antibacterial resistance among 
pathogens causing nosocomial as well as community-acquired infections. 
Resistance to antimicrobial drugs is known to vary profoundly depending on 
geographic location, probably depending also on a different use of antibiotics. 
With regard to the major respiratory tract pathogens and in particular to 
S. pneumoniae, the most common cause of CAP, macrolide resistance (erm/ 
met) prevails in fi-kctam-refractory strains but may be high (>3@-50%) 
independently and in Italy it reaches 40%, whereas fluoroquinolone resistance 
is rare but increasing. While the problem bas attained pandemic proportions, 
the prevalence ofpenicdhn resistance and multiple resistance is highly variable 
depending on site, e.g. the Netherlands percentage: ?; India: <5%; Italy: 5- 
15%: South Afiica: 30-40%; Spain, France: 50%, Japan, Korea: 7040%. In 
terms of clinical consequences, penicillin resistance (MIC 4mg/L) may not 
represent a threat in nonmeningeal infections if only crude mortality rates are 
considered. On the contrary, both low-level macrolide resistance and fluor- 
oquinolone resistance may lead to clinical failures in CAP. With regard to 
Haemophilur injuenzae, a major cause of CAP in COPD patients, the 
prevailing mechanism of resistance is represented by p-lactamase synthesis 
for which considerable variations (from 10 to 40??) have been reported: in 
Italy, resistance to amoxicillin has progressed sharply (contrary to the situation 
prevahng in S.pneumoniae) h m  5% in 1997 to 16% in 1999. The important 
differences in terms of prevalence of resistance observed when comparing 
Italy to other countries, and especially those belonging to the European 
Union, may be tentatively attributed to different habits in the usage of drugs, 
both in terms of antibiotic classes and of route of administration. In Italy, the 
preference of physicians and patients alike goes towards the adoption of 
parenteral antibiotics in the treatment of severe infections, with third gen- 
eration cephalosporins displaying a long serum half life being the most 
fiequent choice. The distinctive microbiological and pharmacokinetic advan- 
tages of these drugs dowing for a rapid bactericidal activity and sustained 
MBCs in tissues, the easier compliance obtained over most compounds 
administered by the oral route may all have contributed to abate the rates 
of resistance in S. pneumortiue and other RTI pathogens. 
Bacterial resistance: the clinical challenge 
R .  G. Finch 
Noftingham, UK 
Antibiotic resistance leads to treatment failure, prolonged morbidity and 
occasional mortality. The costs of antibiotic resistance are poorly defined but 
include prolonged hospitalization, increased laboratory investigations, alter- 
native management approaches and a greater economic burden. The relation- 
ship between antibiotic use and resistance is complex. In many developed 
countries prescribing is professionally controlled but varies markedly in 
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indications, choice, dose and duration of therapy. Thus it is not surprising that 
prescribing strategies to date have had iittle impact on the increasing rates of 
resistance among hospital and community pathogens. Professional concern 
has stimulated action from governments, international agencies and, in 
Europe, the EU. Strategies for controlling resistance have emphasized the 
importance of antibiotic resistance surveillance, monitoring antibiotic use, 
education of professionals and the public, prudent prescribing, improved 
hygiene, and the development of new anti-infective drugs and vaccines. 
Prudent prescribing is essential and yet the majority of drug administration, 
especially withm the community, remains empirical. The clinician can seek 
prescribing guidance from several sources, including government and profes- 
sional societies, and, increasingly, management guidelines, which may be 
based on consensus after a critical analysis of the literature. Guidelines are now 
available in abundance but are often not accessible in an easily digestible form 
at the point of prescribing. CD-ROMs and web-based sources provide 
Secretory immunity - a major adaptive defense system 
additional prescribing support. Prescribing information must take account 
of changing patterns of antibiotic resistance. Surveillance systems are now 
available in abundance at local, national and international levels, but the data 
are often selective or lack robustness and are rarely presented in a timely 
manner to aid the prescriber. Drug licensing authorities, e.g. the E m ,  are 
placing greater emphasis on the need to include regional susceptibility data in 
the SPCs of anti-infective drugs. However, such data are rarely helpful for 
individual prescribing events, especially when this remains empirical and 
without a microbiological diagnosis. In summary, the prescribing clinician is 
in a dilemma. He feels responsible for the problem of resistance and yet is 
rarely presented with robust tools to bring about its control. It is therefore 
essential that strategies to control resistance be integrated and tested scien- 
tifically to ensure that prescribing is better supported. The goal must be cost- 
effective prescribing whilst minimizing the risks of adding to the burden of 
antibiotic resistance. 
wj Mucosal immunity - a major adaptive defense 
system 
P. Brandtzaeg 
Oslo, N 
The mucosal surface area of an adult indi\+dual amounts to some 400 m2. This 
extensive and generally quite vulnerable epithelial barrier is protected by 
numerous innate defense mechanisms that cooperate intimately with a local 
adaptive immune system. Its most prominent feature is an abundance of 
supepithelial plasma cells and B-cell blasts (collectively called immunocytes), 
constituting at least 80% of all antibody-farming cells ofthe body. These local 
immunocytes produce mainly dimeric IgA (dIgA) with incorporated J chain. 
Facing the large host of environmental challenges, specific mucosal immunity 
has developed two strategies: (i) immune exclusion performed by secretory 
antibodies (SigA and SIgM), mainly to inhibit colonization of pathogenic 
microorganisms and penetration of harinful antigens; and (ii) immunosup- 
pression to avoid local and peripheral hypersensitivity towards innocuous 
substances bombarding the mucosal surfaces. In the gut, the latter phenom- 
enon is called oral tolerance; it apparently involves several down-regulatory 
mechanisms and explains why most individuals show no adverse immune 
reactions against persistent contact with food proteins and the normal 
microbial flora. Immune exclusion depends on an ingenious cooperation 
between the enormous niucosal B-cell system and a transmembrane epithelial 
glycoprotein called secretory component (SC), or the polymeric Ig receptor 
@IgR). This is quantitatively the most important receptor of the immune 
system because it is responsible for external transport of large amounts of 
locally produced dIgA and pentameric IgM. The pIgR shows high and 
selective a€finity for these two ligands because of their incorporated J chain. 
Role and mechanisms of toxins in pathogenesis 
(K3421 Bacterial toxins: from infectious diseases to 
cellular microbiology 
P. Boquet 
Nice, F 
Toxins have been the first v d e n c e  factors of pathogenic bacteria discovered. 
Diphtheria toxin (DT). shown in 1888 by R o w  and Yersin at the Pasteur 
Institute to be the only protein of Corytlebdm’um diphtheriae required for the 
death caused by an infection with this bacteria, was the microbial toxin which 
opened a prodigious way of investigations. Currently, studies on bacterial 
toxins, together with those on virulence factors translocated directly fiom the 
microbes to the host cells, has given rise to the emergence of a new discipline 
which has been named ‘Cellular Microbiology’. Toxins, like DT, may 
represent the critical and unique virulence factor of a microbe which renders 
a bacteria highly harmful for the infected patient. Like DT, tetanus, botulinum 
or cholera toxins are the virulence factors of Closhidium tefani, Clostridium 
The eplthehal receptor belongs to the Ig supergene farmly and can be 
up-regulated by various cytolunes, parhcularly mtederon-y and mterleu- 
km-4 (IL-4) derived from achvated T cells as well as IL-1 and TNF-a from 
macrophages In ths way, the secretory -une system can be modulated 
accordmg to the intensity oflocal m u n e  responses Durlng a varlable period 
after buth, both Mmune exclusion and oral tolerance are poorly developed; 
appropnate generanon of the underlymg network of regulatory mechmsms 
depends both on the e s t a b k k n t  of a normal rmcrobzal flora and on the 
introduchon of dietary anhgenS (hrmng and dose). Breast-feedmg IS m u -  
nologdly important durlng thu; vulnerable penod, not only as a natural 
‘subshtuhon therapy’ for the lacking secretory anhbodm but apparently also 
for its Immune-modulahng propemes The dant’s secretory immune 
responses are imhally dommated by SIgM, but afler 1-2 months SIgA usually 
predommates, although there are large mdmdual varshons in the develop- 
ment of mucosal immumty Mucosal defense promded by dIgA/SIgA is more 
favorable than that promded by pentameric IgM/SIgM because (a) dIgA more 
easdy plllns access to the basolaterally expressed epithehl pIgR and IS 
therefore eficiently transported to the lumen, (b) SIgA 1s a pamcularly stable 
anhbody class and 1s therefore well suited to pefiorm m u n e  exclusion; (c) 
dIgA generally funcfions in a nodammatory  manner and may be mvolved 
m epithelial clearance of soluble antigens from the mucosa as well as in- 
traepithehal virus neutdzation w t h  no cytolyhc side-effect; (d) dIgA avidly 
binds to Fc-a R on phagocytes and may normally dampen thew proidam- 
matory potenhd but enhance phagocytosis, and (e) dIgA and especdy SIgA 
(and SC on a sohd phase) can eficiently achvate eosmophds and thus enhance 
their prodammatory potenhd m situahons where immune exclusion fails, 
such as in parasihc infestahons The recent construcnon of pIgWSC knock- 
out mice has substanhated the mportance ofsecretory U M I U N ~ ~  for mucod 
homeostasis and defense agamst tom-producing pathogens. 
botulinum or Vibbtio cholera, respectively, which determine entirely the patho- 
genic power of these bacteria. Other toxins do work only in cooperation with 
additional virulence factors made by the infecting bacteria. For instance toxins 
from Bacillus anthracir are only harmful ifthe producing bacteria is able to make 
a capsule. Also the vacuolating cytotoxin VacA from Helicobacrerpylori appears 
to be an additional virulence factor which becomes M y  eflicient for 
pathogenicity when acting in cooperation with proteins encoded by the 
pathogenicity island termed ‘Cag’. Finally many pathogenic bacteria may also 
produce toxins but their precise roles in the virulence of the producing 
microbes are not evident or still unknown. For instance uropathogenic E. coli 
strains produce a toxin named cytotoxic necrotizing factor-1 (CNF-1) whose 
roles in the urinary infections are still under debate. On the molecular and cell 
biology side, bacterial toxins are sophisticated tools for the biologist which 
allow the precise dissection of cellular signaling cascades or complicated 
processes such as endocytosis and intracellular traEicking. Finally, it is worth to 
note that recent scientific breakthroughs have been made by studies and 
uhlizations of bacterial toxins. 
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Infection in cancer patients (Joint symposium with EORTUIATG) 
(5344) Etiology of bacterial infections in cancer patients in 
Europe: an ever changing scenario 
M. Akova 
Ankara, TR 
Bacterial infections are s t i l l  the most common cause of morbidity and 
mortality in patients with cancer. The past two decades have witnessed 
dramatic changes related to the characteristics of these infections which 
include changes in the spectrum and in antimicrobial susceptibility ofisolates. 
Microbiological data from the studies performed by International Antimi- 
crobial Therapy Cooperative Group (IATCG) of the European Organization 
for Research and Treatment of Cancer (EORTC) provided comprehensive 
evidence on the patterns and trends ofbacterial infections. Starting from mid- 
1980s there was a shft in infecting organism with increasing predominance of 
Gram-positive bacteria. Coagulase-negative staphylococci emerged as the 
leading cause ofinfection being responsible at least one t h d  of all bacteremias 
and streptococci mainly viridans type closely followed. Penicillin, third 
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generation cephalosporin and mawlide resistance has become prevalent 
among streptococcal isolates. In 1994, tATCG/EORTC T d  XI revealed 
that 69% of single-pathogen bacteremias were due to a Gram-positive agent. 
However, recent evidence indicates that the trend is revesing again. A 
comparison of data fium two IATCG trials in 1993 and 2000 found that 
there was a significant increase in overall incidence of Gram-negative 
bacteremia and also single agent Gram-negative bacteremia (6.5% vs. 12%. 
P <  0.001). Incidence ofbacteremias due to MebsieZla spp. and Enterobarterspp. 
also increased. Fluoroquinolone prophylaxis was used less frequently during 
Trial XIV (33% vs. 52%, P<O.0001). Ths  has led fewer isolation of 
Escherichia coli resistant to quinolones (200h vs. 38%). Increasing overall 
infection rate for Gram-negatives has also been reported 6om Merent 
centers in Europe and elsewhere. An alarming increase in the incidence of 
type1 beta-lactamase producing Enterobacter spp. and unusual but more 
resistant pathogens such as Acinetobactu spp. and Sfenotrophornonus maltophilia 
may be challenging. It is imperative more than ever for physicians to be aware 
of changing trends in infecting microorganisms and their antimicrobial 
susceptibhty patterns in cancer patients. 
[ s348 I Epidemiology of BSE in Italy and Europe 
M. Caramelli, G. Ru, C. Gagna, E Ingravalle and C. Maurella 
Turin, I 
Objectives: Bovine Spongdorm Encephalopathy (BSE) is a fatal disease of 
cattle. Strong evidence indicates that BSE agent is responsible of the variant of 
Creutzfeldt-Jakob disease in human beings. Passive surveillance was the only 
way to detect BSE until rapid test became available. The public health concern 
along with pitfalls ofthe passive surveillance ofBSE led to the implementation 
of a EU-wide active survedance based on rapid tests. This paper describes the 
epidemiological situation regarding BSE after the set up of the active 
surveillance. 
Methods: Since January 2001, all cattle for human consumption and a random 
sample of dead-on-farm cattle have been tested for BSE. From July 2001 the 
test has been extended to all dead-on-farm and emergency slaughtered cattle 
over 24 months. 
Results and conclusions: The introduction of such a system allowed the 
identification of the disease in indigenous cows in Italy and in another 
countries as Germany, Spain, Austria, Finland. As of November, there have 
been about 1500 cases throughout Europe. In Italy, as of 4 December 2001 
confirmed cases totaled 42 h m  409060 tests performed up to this date. 
Three of the animals had been imported h m  another country (2 from 
Germany, 1 from Switzerland). On the basis ofthe estimated size ofthe bovine 
population older than 24months the raw incidence excluded the nonau- 
tochthonous cases is 12.5 cases per million animals. The geographc dis- 
tribution of outbreaks partly reflects distribution of the national bovine 
population. Collectively, the northern Italian regions where most cases of 
BSE were identified (Aosta Valley, Piedmont, Lombardy, Veneto, Friuli 
Venezia Giulia, the province of Bolzano, Emilia-Romagna) represent 
65.7% of the entire Italian bovine population. In the five regions where 
the observed cases are concentrated (Lombardy, Emilia-Romagna, Piedmont, 
Frid-Venezia-Gida with 36 of 42 cases), the incidence varies h m  31.2 to 
7.5 cases per million animals. The distribution of cases by breed shows an- 
alogies with what has been observed in other countries with a predominance 
of high mJk production races. The incidence is: Frisian (24 observed cases; 
16.6perrmllionanimals over24months),BrownSwiss (11;27.5permdion), 
Italian Sirnmenthal(4; 43.0 per million) and Herens (1; 62.9 per million). The 
lower incidence in Frisian breed is not easily explained. Collectively, 36 of the 
41 identified cases were born after the meat and bone meal has been banned in 
feeding stuffi for ruminants. Prelimmary results of the data analysis indicate 
that in dl the outbreaks, during the period ofpresumed exposure, commercial 
animal feed or raw material had been purchased. 
Advances in invasive fungal infection 
153521 Trends in cryptococcosis in Europe 
M. Viviani 
Milan, I 
Cryptococcosis (CR) is a life-threatening fungal infection, usually presenting 
as meningo-encephaltis. C R  may occur in apparently healthy hosts but it 
mainly affects patients with significant underlying predisposing factors, 
particularly advanced HIV disease. Data on its incidence are s t i l l  limited as 
CR is a nonreportable disease and few prospective epidemiological s a t d m  
have been carried out. The C R  trend has been monitored in France since 
1985 by the National Reference Centre which provided evidence of the 
unchanged occurrence of cases in HIV-negative patients over the years, the 
progressive increase in number of cases associated with the AIDS epidemic 
and the impact of the highly active antiretroviral therapy (HAART) in the 
19961998 when it reduced the annual incidence by >SO%. The levelling 
trend observed after 1998, reported also in other studies, was thought to be 
related to the diminished effect of HAAFCT because of side-effects, poor 
patient compliance with therapy and development of resistant HIV strains. To 
investigate the epidemiology of CR in Europe, a prospective survey was 
started by the European Confederation of Medical Mycology (ECMM) in 
July 1997. A standard questionnaire was used for each case to report basic 
information concerning the patient, underlying disease, cluucal presentation 
and diagnostic and treatment approach. As ofDecember 1999,655 cases were 
notified and 56.5 evaluated. Most of the cases were reported by 8 of the 17 
participating countries. CR was associated with HIV infection in 435 patients 
(77%, range 59-94% according to country) and was AIDS-defining in 57.5% 
(range 2480%). CR was clearly under-reported, also where an active 
reporting network was present. The annnal incidence could be estimated 
in Lombardia (Italy) where it was 0.85/100 AIDS population. The number of 
cases diagnosed on the basis of CSF-positive cultures (410/531, 77%) 
suggested late diagnoses. Treatment was started with amphotericin B in 
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50% of cases, combined with flucytosine in half of them, and Buconazole in 
22% of cases. Various combination therapies were used for the remaining 
patients. The determination of the sero-genotype ofthe isolate provided new 
insights into the European distribution of the infecting strains. Continued 
monitoring of the C R  trend is essential to evaluate the effectiveness of 
HAART, to provide more data on the unusual manifestations of the “immune 
recovery syndrome” associated with the use of HAART, and to verlfy the 
possibility of safe discontinuation of suppressive therapy after sterilization of 
cultures and rise of CD4 cell count have been achieved. The aim ofECMM is 
also to increase the number of reporting centers extending the network 
throughout Europe, to develop diagnostic skills, to raise awareness of cryp- 
tococcal infection also in non HIV-infected at risk patients, in whom C R  is 
often diagnosed too late or overlooked, and finally to start drawing the 
European distribution map of Cryptococcus neofDrmans sero-genotypes. 
Pneumococcus - ever increasing resistance (Joint symposium with IWFESCI) 
Macrolide resistance: from pumps to ribosomes 
R. Leclercq 
Caen, F 
Resistance to macrolides and lincosamides is increasingly reported in clinical 
isolates of Gram-positive bacteria, including pneumococci. Three ways have 
been used by bacteria to resist macrolides--target site modification by 
methylation or mutation that prevents the binding of the antibiotic to its 
ribosomal target, efflux of the antibiotic and drug inactivation. In pneumo- 
cocci, drug inactivation has still not been reported and the impact of the two 
other mechanisms in terms ofincidence is unequal accordmg to the countries. 
Modifcation ofthe ribosomal target confers cross resistance to macrolides and 
related antibiotics which have overlapping binding sites, the lincosamides, 
whereas efflux afTects only some of these molecules and confers a lower level 
of resistance. Target modification is mostly related to the synthesis of 
ribosomal methylases encoded by erm(Ei) or erm(TR) (subset of erm(A) 
class) genes. The erm(B) genes are usually borne by conjugative transposons 
and the spread of macrohde resistance m pneumococci mght result both from 
dssemmanon of clonal smm, horizontal transfer of the conjugatxve dement 
and possibiy &om DNA exchange between strams by transformahon followed 
by recombinahon Efflux is due to the synthesu of pumps b e l o w  to the 
MFS f a d y  and encoded by large transposable elements. Recently, laboratory 
strains and chmcal isolates of pneumococci harborrng ribosomal mutaaons 
have been reported. In survey studles, these smns represent generally <2% of 
erythromycm-resistant pneumococci. Various mutations of nbosomal struc- 
tures, mcludmg 23s rRNA, L44 and L22 proteins have been charactenzed. 
Every mutahon is charactenzed by a spec& phenotype. Huge geographc 
differences, fiom 3 to 74%. are observed m the macrohde remtance fre- 
quencies accordmg to countries. In general, hgher IS the rate of p e m c h  
resistance, hgher IS the rate of macrohde resistance. Epidenuologc surveys 
have shown that the major mechamsm of mustance of pneumococci to 
macrolides m Europe IS target modlficaaon due to the presence of em@) 
genes, whle in other countries, mcludmg USA, the efflux mechanism 
appears prevalent. The reasons for these epidenuologcal Merences are 
unknown 
Update on parasitic infections 
17 Alveolar and cystic Echinococcosis: new trends 
B. Gottstein 
Bern, CH 
Infection with E. multilocularis encounters either constitutional resistance, late 
resistance or full susceptibhty to alveolar echinococcosis (AE). Dissection of 
humoral, cell- and cytokine-mediated immune responses in susceptible and 
resistant humans showed differences partially dependent on host MHC class 11 
polymorphism. A murine AE model (C57BL/6) was used to document 
susceptibility to disease upon a marked nitric oxide-mediated immunosup- 
pression phenomenon, including high inflammatory cytokine transcripts for 
IL-1, TNF-a. Concomitantly, genetic NOS-deficiency resulted in a relative 
resistance to AE. Furthermore, the encapsulating parasitic laminated l a y e r a  
carbohydrate-rich envelope of the parasitewas identified to function as the 
key factor within the parasite survival strategy. This occurred by modulating 
the host immune response upon the T-cell independent nature the major 
carbohydrate anhgen Em2(G1 l), a mum-type hghly glycosylated protem. 
S i d a r  observations about the key role of carbohydrate molecules haw been 
acheved wth  E.granulosus (qshc echmococcosis, CE). Thus, the major 
Kglycans &om the E.granulosus LL were found to be noncharged smctures 
havmg complex-type antennae and core fuCOSyhhon. Chcally, new tools are 
presently investigated to assess the viabihty status of treated and nontreated 
parasites rn human AE and CE patients. Thus, the wabhty m FNABs can be 
tested upon 14-3-3-gene expression on the protein level or by RT-PCR. 
Thus, nonwable parasites are mcreasmgly idendied not only m successfidy 
treated AE patients, but also 111 persons exposed to mfeChOn wth a subsequent 
abortwe asymptomahc course of AE. Spontaneous dymg-out of hydatid cysts 
has also been described in CE pahents and associated to nnmunological, 
predomnantly Thl-hnked phenomena, whereas Th2 cell aChvahOn appear to 
associate w t h  suscephbhty to &ease. Taken together, there I an accumula- 
tion of facts that contribute to OUT understandmg of how the parasite can 
develop m certam paQents suffermg from AE and how, m other mfected 
mdiwduals, the parasite cLes out wthout causing dlsease 
Pertussis: the hidden epidemic 
(53711 The hidden high endemicity of infections with 
Bordetella pertussis in highly vaccinated populations 
J. Schellekens 
BiWovm, NL 
Symptomatic infections with B. pertussis in elder children, adolescents and 
adults often may be subclinical and in cases in which a physician is consulted 
often pertussis is not considered in the Merential diagnosis. Moreover, in 
countries in which pertussis-serology is not available or, when available, 
reliable criteria for positivity (for recent or actual infection) of values in a 
single serum are absent, laboratory-confirmation of pertussis in individuals 
>15 years is rarely achieved because most cases consult a physician at the (late) 
stage of disease in which culture for B.pertursir and pertussis-PCR have little 
or no solving power and in which the dynamic phase of the immunorespons 
already has taken place. In the Netherlands we used the seroprevalence of IgG 
antibodies to pertussis toxin (IgG-PT) in the population (N=7800) to 
calculate the incidence of infection with B.pertusric in that population in 
the year before blood samphg (1995-1996). This couldbe done because we 
have established the rate of decline of IgG-PT after symptomatic natural 
infection in multiple follow-up sera (during 2-10ycars) of 57 patients with 
pertussis which resulted in a formula for the functional relationship between 
time since infection and I&-PT concentration. Applying this formula to the 
seroprevalence data of the population of 3-79 years (individuals <3 years were 
excluded because of possible interference of maternal IgG-PT or IgG-PT 
induced by vaccination) we estimated an incidence of infection with B. per- 
tussis in the year before blood-sampling of 3900/100000 (3.9%). The age- 
specific incidence per year was lowest for 3-4-year-olds (1.2%) and increased 
with age to 3.3% (5-9years), 3.4% (10-14). 4.0% (15-19) and, maximally, 
6.0% (20-24). Among individuals 2540years of age the incidence varied 
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between 3.5 and 5% per year. Among individuals of 60 years and older the 
incidence varied between 2 and 3% per year. In contrast, in the Netherlands 
the incidence of pertussis according to nodfications in the study period 1994- 
1996 was highest among 3-9 years olds (75/100 OOO/year, i.e. 0.075%) and 
lowest among individuals >15years (< 4/100000/year, i.e. <0.004%)! The 
occurrence of B. pertussis infections in elder children, adolescents and adults is 
severely underestimated. These data are of importance not only for daily 
practice but also for determining optimal strategies for booster vaccination at 
later ages to duninish morbimty and, perhaps more importantly, to diminish 
transmission of B.pertussis to unimmunized infants. 
Nosocornial infections of MRSA 
/03731 Improvement of perioperative antibiotic 
prophylaxis in prolonged cardiac surgery by automated 
alerts in the operating room 
G. Zanetti, H. Flanagan, L. Cohn, R. Giardina and R. Platt 
Luanne, CH; Boston, USA 
Objective: The efficacy of perioperative antibiotic prophylaxis diminishes 
during the long procedures. This observation has prompted recommenda- 
tions to re-dose the antibiotic during procedures of prolonged duration. 
Despite these recommendations, intraoperative re-dosing is often omitted. 
We aimed at assessing the impact of an automated intraoperative alert to re- 
dose the prophyiactic antibiotics in prolonged cardiac operations. 
Methods: We conducted a randomized, controlled, evaluator-blinded trial in 
a university-affiliated hospital. We included patients undergoing cardiac 
surgery that lasted more than 4 h  after the preoperative administration of 
cefazolin, unless they were receiving therapeutic antibiotics at the time of 
surgery. Patients were randomized to an audible and visual reminder on the 
operating-room computer console at 225 min after the administration of 
preoperative antibiotic (reminder group, n = 137). or control (n = 136). After 
another 30min, the circulating nurse was required to indicate whether a 
follow-up dose of antibiotic had been administered. 
Results Intraoperative reclosing was significantly more fiequent in the 
reminder group (93/137, 68%) than in the control group (551136, 40%) 
(adjusted OR. 3.31; 95% CI 1.97-5.56; P<O.OOl). The impact of the 
reminder was even larger when compared with the 6months preceding 
the study period (129 re-dosed480, 27%, P <  0.001), suggesting some spil- 
lover effect on the control group. Re-dosing was formally declined in 18 of 
the 44 patients in the reminder group without re-dosing. The rate of surgical 
site dection in the reminder group (5/137, 4%) was similar to the one 
observed in the control group (8/136, 6%, P=O.4), but significantly lower 
than in the pre-study period (48/480, 10%; P=0.02). 
Conclusion: The use of an automated reminder system in the operating room 
improved compliance with guidelines on perioperative antibiotic prophylaxis. 
1 0374 1 Modeling therapeutic decision-making for 
antimicrobial therapy: an application to Gram-positive 
infections using vancomycin 
0 .  Ergonul, A. Gundlapalli, E. MozaEari, K. Lofgren, J. Lloyd, R. Evans, 
W. Stockdale and M. Samore 
Salt Lake City, Peapack, USA 
Objectives: To examine variations in therapeutic antimicrobial decision- 
making in hospitalized patients @ts) with well-defmed infectious syndromes. 
Methods: The study population consisted of adult inpatients admitted to 
either of two tertiary care hospitals between January 1999 and December 
2000, who (1) had one of the following diagnoses: (a) nosocomial primary or 
catheter-related blood-stream infection owing to Gram-positive organisms 
(noso-BSI); (b) celluhtis/soft-tissue infection (skin infl; (c) osteomyelitis 
(osteo); and (2) received at least one dose of intravenous (i.v.) vancomycin 
(vanco). The primary outcome measure in the analysis presented here was the 
length of stay (LOS). 
Results: The cohort &om hospital A consisted of  260 pts and from hospital B 
41 1 pts (671 total). A total of333 pts had noso-BSI, 229 had sktn infand 107 
pts had osteo. The most common organisms associated with noso-BSI were: 
Sfaphylococcus coagulase-negative (51%). S. uureur (25%), and Enterocoms 
(22%). In hospitals A and B, vancomycin was part of the initial antibiotic 
regimen in 40 and 43% ofsubjects with noso-BSI, 48 and 66% of subjects with 
cellulitis, and 75 and 65% of subjects with osteomyelitis, respectively. Overall, 
only 10% of subjects received vanco as their single i.v. antibiotic; pts received 
an average offour different antibiotics. The median duration 0fi.v. antibiotics 
was 13 days and i.v. vancomycin 6 days. The percent of pts with noso-BSI, 
skin-inf, and osteo receiving at least 5days of vanco was 53, 21, 25%, 
respectively; the correspondmg figures for receipt of at least lodays of vanco 
were 34,10, and 11%. The percent ofpts switchedfioman i.v. to a completely 
oral antimicrobial regimen prior to discharge was low (8%). Pts with noso-BSI 
had the highest mean LOS (noso-BSI: 36days; skin inE 14days; osteo: 
14 days). For pts with skin i d ,  subjects started on vanco initially had shorter 
length of stay than subjects not started on vanco initially (hospital A 10 vs. 
22 days; hospital B: 10 vs. 21 days). 
Conclusion: Vanco prescribing practices in pts with Gram-positive noso-BSI, 
skin inf, and osteo were comparable across these two hospitals. Lengths of stay 
were prolonged. particularly in pts with noso-BSI, and may have been affected 
by the initial antibiotic selection. Oral step-down regimens were inconsis- 
tently used. An analysis of the clinical factors that drive frequent modifications 
of antimicrobial therapy is in progress. 
103751 Cost-effectiveness of an antiseptic-impregnated 
central venous catheter in intensive care patients 
T. Chojnacki, U. Frank, M. Dettenkofer and E D. Daschner 
Freibux, D 
Objectives: A case-control study to estimate the economic outcome asso- 
ciated with the use of an antiseptic-impregnated Arrow Gt-uard BlueTM 
versus standard catheter in the ICU unit. 
Methods: Data of intensive care patients (n = 138) with central venous 
catheter were prospectively recorded over a 15-month period. Altogether 
30 (21.7%) patients developed catheter-related bacteremia, of whch 20 
(14.5%) met the criteria for inclusion in the study. Pair-matched controls 
without catheter-related infection were assigned and the marginal costs were 
calculated. The cost of medication, blood products, examinations and medical 
equipment was calculated on the basis of consumption, whereas all remaining 
costs were calculated from data provided by the hospital administration. 
Results: Marginal costs averaged € 85.52/day per case. Based on the direct 
comparison of the mean values, prolongation of the length of stay in the 
hospital was estimated at 10.8 days or, on the basis of  transitional probabilities, 
at 2.8 days. The higher purchase cost of the antiseptic impregnated catheter of 
€ ZUcatheter, as against € 18/catheter for a normal, uncoated double-lumen 
central venous catheter (although other, more expensive models, can cost up 
to € 59.3), is offset by the addtional cost ensuing through catheter-associated 
infection of € 82.5Iday x 2.8 days = € 231. With an infection rate of 0.28- 
7.5% for conventional catheters and 04.25% for antiseptic-impregnated 
catheters, on average, the difference per 1000 catheters is € 2434.8 in favor 
of the antiseptic-impregnated catheter (conventional catheters: € 9098.1 
antiseptic-impregnated catheters: € 6663.3). 
Conclusion: The use of antiseptic-impregnated catheters appears to be cost- 
effective for intensive care patients in a university-hospital setting. 
jo3761 ~uccess rate of conservative treatment of totally 
implantable device-related bacteremia 
S .  Cherifi, B. Byl, H. Strale, M. J. Struelens and F. Jacobs 
Brussels, B 
Introduction: Totally implantable venous-access device (TIVAD) represents a 
convenient approach for patients requiring long-term intravenous therapy but 
infection is an important complication. Its optimal treatment remains poorly 
defined. 
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Objectives: To review the outcome of TIVAD-related bacteremia in patients 
treated without the removal of the catheter and to determine the predictive 
factors of favorable outcome. 
Methods: All patients with TIVAD-idated bacteremia occurring h m  
1996 to 2000 in our 858-bed academic hospital were retrospectively 
reviewed. 
Results: A total of 67 patients developed 92 episodes of infection. Isolated 
pathogens were Gram-positive cocci in 78.4% (coagulase-negative Staphy- 
lococci (CNS) 55.9%, Staphylococcus auras (14.4%), Gram-negative bacilli 
(9.0%) and h g i  (6.3%)). Early decision for catheter removal was taken in 32 
episodes (35%), associated with the following etiologic agents or conditions: 
fungi (5), S. aurew (9), Pseudomonars (l), sepsis (14),localsigns (lo), orEvlureof 
a previous conservative treatment (8). Among the 57 evaluable episodes (62%) 
treated with antibiotics given for 1&14 days trough the infected TWAD left 
in place (conservative treatment), we observed 32 successes (56%). 16 failures 
(28%) and 9 relapses (16%). Only one ofthese 57 patients (1.8%) died from 
TWAD infection. The following conditions were associated with an increased 
risk of failure: local signs ofinfection (RR: 1.94, CI: 1.1C-3.42; P=O.029), 
sepsis (RR: 2.27, CI: 1.09-4.74, P=0.097) and organism other than 
CNS (RR. 2.70; GI: 1.11659; P=0.021). The rate of success for con- 
servative treatment of CNS infections in the absence oflocal signs ofinfection 
or septic signs achieved 74% (25/34 episodes). The following conditions 
did not influence the risk of failure of conservative treatment: delay between 
insertion and infection, site of insertion, indication (parenteral nutrition 
vs. chemotherapy), neutropenia, polymicrobial versus monomicrobial 
infection. 
Conclusion: In our study, treatment was conservative in 62% of TIVAD- 
related bacteremia. The cure rate in these episodes was 56%, but increased up 
to 74% for the subset of patients with CNS infections without local signs or 
sepsis. Because of limited vascular access in these patients, we favor the 
conservative treatment in the latter indlcation. 
wl Establishment of the HARMONY IUMS MRSA 
Global Database: a progress report 
B D Cookson 
On behalj of the HARMONY Typtng Prtyect partrapants and the IUMS 
Staphylococal Sub Committee 
Objectives: In a DGXII-funded HARMONY project to estabhh an EU 
MRSA database 
Methods: Exchange scienmts have performed mecRIA (S Salmenftnna/W 
Witte) and binary typing ( W Vanleeuwen/A van Belkm) and nbotypmg (A 
LynchN Fussmg) The Bath (Wellcome Centre) has performed MLST (M 
Enright) Thls has informed the underlying geneac backound ofthe vanous 
MRSA EU clones. Internet data transfer protocols (wlth the ENEMTI 
project) are nearing completion. FAFLP is also completed Most importantly 
the relevant aspects of PFGE (the urnvenal typmg method currently adopted 
by typing laboratories) that need to be standardzed were identified The 
group had analyzed MRSA rn a blinded fashon with their own PFGE 
protocols and wth  an agreed protocol that standarbed the run parameters 
The group had been reluctant to standardze other parameters as they had each 
developed these over many years and It was felt to so do mght hmder rather 
than help standarhahon 
Results: HARMONY, established as the InternahOnd Sub-Comttee of 
Staphylococci’s global database. PFGE results. There were clonal trends, but 
there were many Werences between the centers The group met and felt that, 
in mew of the results, many parameters (e.g. volume of agarose, posihon and 
type ofstandards) should now be standardwed The prevlous standard protocol 
took too long S Murchan vlsited A Deplano/M Struelens and others at the 
Belgian Centre to agree the finer technical details and a new pulsing protocol 
that would produce ophmal separahori of the bands in <24 h Ths  new 
protocol resulted m almost perfect concordance between the two centers and 
five others have now subrmtted near-perfect results. To our knowledge, this is 
the first hme this has been achieved We put our success down to mehcdous 
attentlon to detad and Joint ways ofworhng (ksprit de corps) There d be a 
brief overnew of the nomenclature for MRSA (there are currently 36 stram 
types in the database)and the clonahty ofspread W I ~  the EU (there are four 
internahondy spreadng clones whlch have even spread during the project 
over the last 2 years). 
Conclusions: T h  database bodes well for the EU. Plans are undemy to 
interact it with DG SANCO’s HELICS and EARS networks The lessons 
can be extended to other pathogens such as enterococci 
103781 Methicillin-resistant Staphylococcus aureus 
(MRSA) clones identified at four health institutions in Italy 
R. Mato, I. Santos Sanches, E Campanile, S. Stefani, M. Vendetti, 
P. Villari, C. Cocuzza and H. De Lencastre 
Oeiras, B; Catania, Rome, Milan, I ;  New York, U S A  
Objectives: To evaluate the prevalence and epidemiology of MRSA clones 
collected at four health institutions in Italy. 
Methods: A total of 204 MRSA were recovered during two collection 
periods, 1997 and 1998, from four hospitals located in three Italian cities: 
Naples (63 strains), Milan (45 strains), Rome (93 strains). All strains were 
characterized according to the antimicrobial susceptibility patterns and 
genotypic profiles defmed by PFGE and hybridization with the me& and 
Tn554 probes. Susceptibility patterns were performed against 12 antimicro- 
bials: ampicilltn (Amp), chloramphenicol (C), ciprofloxacin (Cip), clinda- 
mycin (Da), erythromycin (E), gentamicin (Gen), oxacillin (Oxa), rifampin 
(MJ, tetracycline (Te), trimethoprim-sulfamethoxazole (Sxt), teicoplanin 
(Teic), and vancomycin (Va). MICs were evaluated for quinupristin-dalfo- 
pristin (synenid) at the concentrations of 0.5, 1, 2, 4mg/L. 
Results: The 204 MRSA were clustered into four main clonal types: two of 
them already documented as widely disseminated in Europe - the Iberian 
MRSA (38 isolates, 18.6%) and the Brazilian MRSA (25 isolates, 12.2%); two 
new clones were detected in this sample - the ‘Italian’ clone comprising 90 
isolates (44.1%) present in he four health institutions and the ‘Rome’ clone 
with 32 strains (15.6%) identified in Rome only. The remaining 19 MRSA 
were included into 11 minor clonal types. By ribotyping, all strains had a 
similar profile with the exception of isolates belonging to the Italian clone. 
Each clod type could be associated with an antibiotype: 84% of the Iberian 
MRSA isolates were susceptible only to C and Sxt; 72% of the Brazdian 
MRSA were susceptible to C; 69% ofthe Ital~an clone strains were susceptible 
to C, Rif, Te, and Sxt, and 78% ofthe Rome-clone isolates were susceptible to 
C, Da, E and Sxt. In addition all the strains were susceptible to teicoplanin, 
and vancomycin. MICs to synercid of most strains were <0.5 mg/L (suscep- 
tible) except for 73 MRSA isolates, 62 out of which belonged to the Italian 
clone that shared an MIC > 0.5 mg/L. 
Conclusions: The present study showed that the MRSA clones responsible for 
infection particularly at hgh-risk areas of Italian hospitals includes not only 
geographically spreading clones but also r eg tad  or local clones. This data will 
be useful for further epidemiological surveys and for the reinforcement of 
mfection control measures to prevent their dissemination inside the hospital 
and at the community. 
103791 Prevalence of methicillin-resistant Staphy/ococcus 
aureus and small colony variants 5. aureus in Belgian cystic 
fibrosis patients 
A. Vergison, 0. Denis, C. h o o p ,  H. Franckx, T. Calliuw, P. Lebecque, 
J. Gigi, E De Baets, G. Claeys, K. De Boeck, J. Van Eldere, A. M o t ,  
D. Pierard, G. Casimir, N. Douat, K. Desager, M. Ieven and M. J. Struelens 
Brussels, De Haan, Ghent, Latven, Antwerp, B 
Objectives: To study the prevalence of methicillin resistance and SCV 
phenotype among Belgian CF population colonized with S. aureus. 
Methods: S. a u r m  strains were collected &om six Belgian CF clinics and one 
re-validation Centre during a 6-month period. One or more S. QUWW strain 
per patient were characterized by phenotypic methods (coagulase, latex test 
and Oxacillin Screen Agar) and a triplex PCR ampl$mg nuc, medl and 16s 
rRNA genes. MRSA was defined by the presence of m e d  gene. 
Resultx A total of 179 strains from 162 patients were analyzed. The m e d  gene 
was present in 21 strains from 20 patients (12%). A total ofseven patients were 
carqhg both MRSA and MSSA. MRSA prevalence ranged from 0% in two 
centers to 19-24% in three centers. Median age of the patients was sig- 
nificantly higher (23years vs. 15.5years) in the three centers with higher 
prevalence ofMRSA (P< 0.001). Twenty-four percent (5/21) ofthe MRSA 
strains failed to grow on Oxacillin Screen Agar plate; 3/5 of these showed the 
SCV phenotype. 22 patients presented a SCV phenotype of S. a u r m  (14%). 
12 patients carried both normal and SCV strains. Ten patients (6%) harbored 
the SCV phenotype only. SCV carriage ranged &om 0% in three centers to 
2430% in two centers. A number of 21/22 SCV strains were found in one 
laboratory testing primary cultures from two centers. 
Conclusions: (1) The overall prevalence ofMRSA in Belgian CF centers was 
low (12% of S. aureus colonized patients). (2) MRSA prevalence by Centre 
was very heterogeneous. (3) Older CF patients were more likely to be 
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colonized with MRSA (P< 0.001). (4) 35% of MRSA carriers also carried 
MSSA. (5) The prevalence of SCV phenotype was much lower than described 
in a previous study and was mostly detected in one laboratory. (6) MSSA and 
MRSA prevalence could be undereshmated due to use of laboratory methods 
that may be inadequate for detection of S. aureus SCV phenotype. 
Dissemination of epidemic strains in Central 
Europe and changes of resistance patterns in MRSA 
W. Witte, C. Cuny and C. Braulke 
Wemigerode, D 
Objective: To follow emergence and spread of epidemic MRSA by means of 
molecular typing and computer-assisted comparison of typing patterns. 
Methodology: Molecular typing by Sma-I-macrorestriction patterns and 
PCR detected genomic polymorphism, PCR demonstration of resistance 
determinants; computerized pattern analysis and comparison by use of the 
HARMONY MRSA collection. 
Resub. From 1991 to 1994, three clonal groups of MRSA with epidemic 
interhospital spread were predominant in Germany: the Northern German 
p-laaamases and carbapenemase 
Epidemic MRSA (corresponding to the Iberic clone widely spread in several 
European countries), the Southern German MRSA (corresponding to epi- 
demic strains from Belgium, Slovenia, Bulgaria, and UK [EMRSA]). and the 
Hannover area MRSA. These groups exhibited a broad pattern of multi- 
resistance including aac6'-aph2''-based aminoglycosid resistance. After 1995, 
the prevalence of these clonal groups declined f b m  20 to 30% for each to 
about 3-1%, whereas that of newly emerging groups with less broad multi- 
resistance as A: the Berlin epidemic strain with med,  grM (also in Sweden and 
in Belgium); B: the Barnim epidemic strain with med, ermC, grM (identical 
to EMRSAl5 &om UK, also occurring in Sweden); and C: the h e - H e s s e  
epidemic strain with m e d ,  e m C  (also in Belgium and Finland) has increased 
( A  199411%. 2000-26,7%; B: until 1996-0,2000-19,8%; C: until 1998-0, 
2000-6%). Besides an outbreak of GISA belonging to North German 
Epidemic MRSA, one of the other epidemic MRSA had exhibited this 
phenotype or acquired resistance to quinupristin-dalfopristin and to linezolid. 
Conclusion: Increasing spread of newly emerging epidemic MRSA with less 
broad resistance patterns has led to decrease in MRSA of resistance to 
gentamicin (now 4.1%), to oxyteaacycline (now 9.2%), to rifampicin 
(now 4.1%), and to trimethoprim (now 9.7%). Epidemic MRSA prevalent 
in Central Europe ohviously have also been disseminated in other European 
countries. 
I 0381 I Comparative study of the development of 
resistance to imipenem and meropenem in Acinetobacter 
baumannii clinical isolates 
S. Lopez-Hernandez, T. Alarcon, L. Perez and M. Lopez-Brea 
Madrid, E 
Objectives: To compare the development of resistance to imipenem (IMP) 
and meropenem (MEP) in Acinetobacter baumannii (Ab) clinical isolates, 
studymg the mutation frequency for both antibiotics, and the stability of 
resistance in the mutants obtained. 
Methods: Six strains of Ab were selected &om 156 clinical isolates previously 
characterized by rep-PCR and having different resistance patterns to B- 
lactams. The MICs of IMP and MEP were studied by agar dilution following 
the 1998 NCCLS recommendations. The mutation frequency was studied by 
culturing each strain in Mueller-Hinton agar plates (MHA) with IMP 
and MEP concentrations eight-, four- and two-fold greater than their 
respective MICs. The colonies present in the plates with the higher con- 
centration were subcultured in plates containing twice the MIC of MEP or 
IMP dependmg on the antibiotic used. The mutation frequency was calcu- 
lated by dividing the number of mutants growing at concentrations eight-fold 
the original MIC or higher into the initial inoculum. A mutant was 
considered to be stable when there were no changes in the MIC after five 
subcultures in MHA. 
Results: Sixteen mutants selected with MEP (M-MEP) were obtained in all 
six strains, but seven mutants selected with IMP (M-IMP) were obtained in 
only two strains. The M-MEP showed MICs ofMEP that were 2-32-fold the 
original MIC, and remained susceptible to IMP In the M-IW, the MICs 
increased one- or two-fold, and a l l  strains remained susceptible to IW. The 
mutation fiequency was higher for MEP than for IW, h m  4 x lo-'' to 
2.8 x lo-*. A total of86.9% of the mutants were stable in their resistance to 
carbapenenls . 
Conclusions: 
1 MEP-selected mutants more often than IMP, and a stable, high-level 
resistance to MEP was obtained in most of them. 
2 Selection of resistance to MEP does not appear to affect resistance to IMP. 
Therefore, the mechanism of resistance involved could be different. 
I 0382 1 Insertion sequence lSEcp7 as a genetic tool for 
expression and integration of the clavulanic acid inhibited 
extended-spectrum p-lactamases of the CTX-M type 
L. Poirel, J. Decousser and P. Nordmann 
Le-Kremlin-Bice^tre, F 
Objectives: The Ambler class A clavulanic acid inhibited extended-spectrum 
B-lactamase (ESBL) CTX-M-18 has been characterized h m  a KIebsiella 
pneumoniae isolate h m  Vietnam. The genetic environment of thts gene 
was characterized since several CTX-M-type genes are associated with 
insertion sequence ISEcpl. The ISEcpl as a vector for blaCTX-A4 gene 
expression and mobility has been also assessed. The natural reservoir of ISEcpl 
has been searched among constituent of bacterial flora in humans since the 
progenitors of several plasmid-mediated CTX-M-type 8-lactamases are 
Enterobacteriaceae such as KZuyuera sp. 
Methods: Shotgun cloning of BamHI- or Sau3AI restricted plasmid DNA of 
the p K.pneumoniue isolate was performed into pBK-CMV followed by 
selection in Escherichia coli DHlOB. DNA sequencing was performed with 
inserts of several recombinant plasmids. Additional plasmid constructs were 
performed consistingin subclonings (i) in the low copy vector pACYC184 to 
study the fl-lactamase expression with or without the 3'-end of the insertion 
sequence ISEcpl, (i) of parts of the sequence located upstream and down- 
stream of blaCTX-M-18. A transposition assay using the conjugate plasmid 
pox38 as recipient in E. coli was used to analyze ISEcpl transposition. A 
series of bacterial species that are component of the enteric flora in humans 
were screened for ISEcpl . Hybridization were performed by the Southern 
technique with an internal probe for ISEcpl and genomic DNAs of strains of 
enterobacterial species, Pseudomonas sp., Aeromom sp., Clorhidium sp., Entero- 
coccus sp., Stuphylococrus sp., Bijdobacterium sp., Campylobacter sp. . . . 
Results: Sequencing of the surrounding sequences of blaCTx-M-18 identi- 
fied in the immediate upstream and downstream DNA region, ISEcpl and 
another insertion sequence, IS903B, respectively. Deletion experiments and 
primer extension analysis identified -35 and -10 promoter sequences in the 
3'-end of ISEcpl for driving expression of blaCTX-M-18. ISEcpl = active 
for transposition of the blaCTX-M-18 gene without IS903B. None of the 
studied bacterial species of the human fecal flora was found to be the natural 
reservoir of ISEcpl. ISEcpl-like sequences were identified in one Shigella 
ronnei strain and one Clostridium pefingerrs s t r a i n  without B-lactamase 
gene. 
Conclusion: ISEcpl has a still unknown natural reservoir and is a driving 
force for expression and mobilization of the ESBL genes of the CTX-M- 
type. 
1 0383 I Comparison of the kinetics parameters of the 
ceftazidime-hydrolyzing CTX-M-15 8-lactamase to those of 
its progenitor CTX-MJ, and analysis of surrounding DNA 
sequences of these B-lactamase genes 
L. Poirel, M. Gniadkowslu and P Nordmann 
Le-Ketdtn-BtCi'tw, F; Warsaw, PL 
Objectives: The extended-spectrum B-lactamase CTX-M-15 had been 
identified premously from New D e h  enterobacterial isolates It Mered 
fiom CTXM-3 (idenafied from enterobacterial isolates from Poland) by an 
aspartate to glycine substltutlon m poslhon ABL238. Biochemcal properties 
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of CTX-M-15 and of CTX-M-3 against /3-lactams were compared. 
Additionally, the DNA sequences surroundmg these 8-lactamase genes were 
compared. 
Methods: From whole-cell DNAs of clinical enterobacterial isolates, the 
blaCTX-M- 25 and blaCTX-M-3 genes were amplified by PCR and cloned 
into the same pCRScript cloning vector in Escherichia colt DHlOB. Purified 
enzymes were obtained from p-lactamase extracts of cultures of E.coli 
DHlOB-harboring recombinant plasmidq that were purified by ion-exchange 
chromatography, and isoelectric focusing analysis and kinetic parameters were 
determined. Using PCR experiments and primers located in the /?-lactanme 
genes and in insertion sequence ISEcpl identified upstream of bluC7X-M- 25, 
the 5'-upstream-located DNA sequences of blaCTX-M- 15 and btaC1Ix-M-3 
were compared. 
Results: The specific activities of the purified e es CTX-M-3 and CTX- 
M-15 /3-lactamases were 22.5 and 6 1 . 2 m ~  T g  ofprotein, respectively, 
when 100 m~ cefotaxime was used as the substrate. Both enzymes, with an 
identical p l  value of 8.4, conferred a same level of resistance to /?-lactams 
except to ceftazidime. The catalytic activity of CTX-M-15 was weaker than 
that of CTX-M-3 against penicillins (although identical for piperacillin 
whereas it was higher against cephalosporins (identical for cefotaxime) 
including ceftazidime. Finally, an insertion sequence ISEcpl with putative 
-35 and - 10 promoter sequences driving /?-lactamase expression was found 
upstream of both blaCTX-M-type genes. However, an additional 79-bp 
sequence was found immediately upstream of blaCTX-M-3 only. 
Conclusion: This report further underlines that the clavulanic acid inhibited 
CTX-M-type extended-spectrum enzymes that usually hydrolyze c e f o h e  
and not ceftaddime may indeed hydrolyze ceftazidime through a single amino 
acid substitution. Thus, ceftazidime-containing treatment for curing 
mfections due to CTX-M-type enterobacterial producers should be contra- 
indtcated. Finally, this work gives additional evidence for ISEcpl-mediated 
spread and/or expression of blaCTX-M-type enzymes, as evidenced in 
distantly related enterobacterial isolates such as those from India and 
Poland. 
103841 OXA-~O, a novel oxacillinase with carbapenemase 
activity from an Acinetobacterbaumanni clinical strain 
L. Poirel, C. Heritier and I? Nordmann 
L-Krmlin-Bu&e, F 
Objectives: A clinical strain of Acinefobacter baurnannii (AbZZ) was isolated in 
the hospital Bicetre (Le-Kremlin-Bicetre, France) from a broncheal lavage of a 
Portugese patient who had been directly transferred from Portugal to France. 
The aim of this work was to analyze the /l-lactamase content of AbZZ s t r a i n  
that was resistant to all /?-lactams including carbapenems. 
Methods: Shotgun cloning of Hind111 fragments of genomic DNA of AbZZ 
was followed by selection onto amoxicillin (50 mg/mL)-containing trypticase 
soy agar of recombinant Escherichiu coli clones and 8-lactamase expression in 
E. coli. Purified /3-lactamase was performed from E. coli DHlOB cultures 
harboring one of the recombinant plasnlids with ion-exchange chromato- 
graphy followed by determination of kinetic parameters by spectrophoto- 
metry analysis. MICs were determined by an agar dilution method accordmg 
to the NCCLS guidelines. The molecular biology techniques included those 
for plasmid extractions and analyzes, I-Ceu-I digests for determination of 
chromosomal location of B-lactamase gene associated with hybridization by 
the Southern technique with probes for the identifted B-lattamase gene and 
for 16s RNA, and determination of integron-location of the gene using 
sequencing and PCR amplifications experiments with primers located in the 
5'- and 3'-conserved regions for class 1 integron. 
Results: Shotgun cloning identified a novel oxacillinase gene bluOXA-40. 
OXA-40 mered from OXA-24/-25/-26 by one or two amino acid 
substitutions. These oxacillinases had been identified mostly from the same 
geographc region in southern Europe, i.e. Spain, and conferred a decreased 
susceptibility to carbapenems. Detailed kinetic parameters (&at, &J of the 
purified OXA-40 enzyme from cultures of E.mli DHlOB harboring a 
recombinant plasmid pOXA-40 indtcated that this clavulanic-acid resistant 
enzyme has a sigdcant carbapenemase activity. Plasmid analysis, I-Ceu-I 
digestion following by hybridization with 16s RNA and blaOXA-40 internal 
probes and sequence analysis of the neighboring regions of blaOXA-40 
indicated that bluOX4-40 was chromosomally located and, on the contrary 
to most of the oxacillinase genes, integron-free. 
Conclusion: This report provides further evidence that multiple-antibiotic 
resistant Ab strains may carry carbapenemase genes that are undetectable 
clinically. 
(03851 The active insertion sequence 151999 enhances 
expression of the integron-located blaVEB-1 encoding an 
extended spectrum 19-lactamase in Pseudomonas aeruginosa 
D Aubert, T Naas and P. Nordmann 
Le-Kremlin-Btcetre, F 
The mtegron-borne blaVEB-1 gene encodes an extended spectrum 
B-lactamase that was m h d y  found in an Eschhra col~ Isolate from Vietnam 
and subsequently m two Pseudmno~s aenrgnosu isolates fcom Thadand In the 
latter two s t ram,  blaP'EB-2 was associated wth  either one or two merhon 
sequences (IS1999 and IS2000) that were merted upstream of blaVEB-I. 
Epidermologd surveys have idenhfied blaVEB- 2 m up to 48 and 94% of 
unrelated ceftaudme-resistant enterobacterral and P m g r n o s a  isolates &om 
Thdand, respechvely. 
Objectives: The rn of t h ~ ~  work was (1) to study the dstribuhon of IS1999 
and IS2000 111 blaVEB-1 posihve enterobacterral and Paetugtnosa chmcal 
isolates from Thadand (n) to analyze theu contribuhon in /?-lactamase 
expression and to determne hanSposihOn abhty of IS1999 
Methods: PCR analym and dot blot expenments were used to study 
dtstribuhon of ISs To d e t e m e  whether IS1999 may d u e n c e  MaVEB-1 
expression, several recombmant plasmds contammg bla VE&I alone, asso- 
clated wth IS1999 orland IS2000, were mtroduced mto E cob and B m- 
grnosa reference strams Specific 8-lactamase acnwues and MICs of 8-lactam 
anhbiohcs were deterrmned for these stram. Pruner extenson experments 
were used to charactem funchod promoters. 
Result% IS1999 was present HI 90% of the blaP'ER I-contmng P amgtnosa 
shams and among these latter strams 7% possessed an adhhonal IS2000 
inserted urlthrn the IS1999 sequence. In Enterobacterweae, out of 18 
blaVEB-1 positive Isolates, none of them contamed either IS1999 or 
IS2000 except one Mebsielh pmwrnoniae s t m n  that has a bhvEB-1 gene 
assoclated wth  IS1999. In Famgimsa, the B-lactamase expression was 
enhanced in the construct w t h  IS1999 upstream of btaVEB-1 leadmg to a 
4-8 fold increase of MIC values for 8-lactams Pruner extenslon idenufied 
two achve promoters located m the left mverted repeat of IS1999 m 
P aerugimsu whde only one of them was funchod m E colt. Addthondy, 
a transpositton assay m E coli charactenzed IS1999 nansposaon and revealed 
that the 5'-upstream located sequence of bla VE&1 IS not a hot spot for IS1999 
transposihon. 
Conclusion: The bla VEB-I expression 1s enhanced m P omgiosa by an 
upstream insemon of IS1999. Ths may explam the h~gh prevalence of the 
assocratlon between IS1999 and blaVEB-1 UI these cefbmhe-resistant 
I? aerugima isolates 
Detection of extended spectrum p-lactamase 
production amongst Acinetobacter species 
U. G. Ulkar, T. Demiray, 0. A. Gurbuz, Z. Dansuk, 
N. Apaydin and A. Mert 
Ankara, TR 
Objectives: To investigate extended spectrum B-lactamase (ESBL) frequency 
amongst Acinetobacter species with two Merent methods. 
Methods: Eight-one non-duplicate Acinetobacter strains isolated fcom clinical 
specimens were enrolled in the study. Double disk synergy (DDS) test and 
OXOID combination disks [ceftazidme (CDo2, 30/10pg) and cefotaxime 
(CDo3, 30/10 pg) with clavulanic acid] were used to detect ESBL frequency. 
Thuty microgram cefotaxime, ceftazidime, cefepime, aztreonam and cef- 
triaxone (OXOID) disks were placed 25 mm (center-to-center) from a 20/ 
10-pg amoxicillin-clavulanate disk for the conventional DDS test. A clear 
extension of the edge of the inhibition zone of any of the antibiotics towards 
the disk containing clavulanate was interpreted as positive for ESBL produc- 
tion. For the strains having very small zone sizes around the dtsks, the test was 
repeated decreasing the distance between the disks. For the OXOID combi- 
nation disks, the zone sizes of ceftazidime and cefotaxime disks were measured 
and compared with the zone sizes measured with the combination disks. Five 
milluneter or above enhancement of the zone sizes with the combination disks 
were detected as having ESBLs. 
Results: A number of79 (97.5%) ofthe st ra ins  were identified as A. buummni, 
two (2.5%) as A. junii. With the conventional DDS test 29 (35.5.8.h) of the  
strains were detected as producing ESBLs, with the OXOID combinahon 
disks the number was 28 (34.6%). While testingthe strainswith DDS test, the 
differences between the disks were lowered even to 15- in the strains 
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having very small zone sizes. There were additional strains detected as 
producing ESBLs at that distance. 
Conclusions: To visualize the ESBL production, DDS test may have to be run 
several times to get the best distance between the disks for detecting 
enhancement. OXOLD combination disks seem sensitive and easy for routine 
chicaI application in the detection of ESBLs. 
10387) Decreased production of AmpC /l-lactamases by 
ciprofloxacin, salicylate and 2.4-dinitrophenol in Citrobacter 
freundii strains 
M. M. Tavio, M. Perilli, P. Becerro, L. Bueno and G. Amicosante 
Ihs Palmac de Gran Canaria, E; L'Aquila, I 
Objectives: Quinolone-resistance in C.freundii strains has been associated 
with a decreased production of chromosomal AmpC j3-lactamasest and with 
the expression of marA in Escherichia cdi. Likewise, hypesusceptibility of the 
Pseudomnnas nenrginosa nfxB mutants to /?-lactams is owing to reduced 
expression of the AmpC fl-lactamase. The objective of the present study 
was to compare the effect of subinhibitory concentrations of ciprofloxacin 
(CPX) and two induces of marRAB expression, salicylate (SL) and 2,4- 
dinitrophenol (DNT), on chromosomal AmpC 8-lactamase expression in 
two C.freundii strains. 
Methods: Two chromosomal AmpC 8-lactamase overproducing C.freundii 
strains (DM 1 and DM2) were used. Their j3-lactamase crude extracts (j3-CE) 
were obtained after growing in presence of CPX (0,0.03,0.06 and 0.12 mg/ 
L), SL (0, 3, 5 and l o r n ) ,  DNT (0, 0.5, 1 and 2 m ) ,  with and without 
10mg/L cefoxitin (FOX) as an inducer of AmpC j3-lactamase production. 
Their specific activities were determined using 0.1 m~ cephaloridine (CR) as 
substrate. The effect of CPX (0.12 mg/L), SL (10 rn) and DNT (2 m ~ )  in the 
outer membrane proteins (OMP) was analyzed by electrophoresis in urea- 
SDSPAGE. 
Results: The specific activity (SA) of non-induced fl-CE horn the DM1 and 
DM2 strains on 0.1 m~ C R  decreased progressively with the increment of 
CPX, SL or DNT concentrations in the culture medium. SA decreased 24- 
93% with CPX, 6590% with SL and 22-81% with D N T  in the DM1 strain 
fi-CE and 3>84% with CPX, 77-99% with SL and 46-95% with D N T  in the 
DM2 strain /?-CE. B-CE obtained in the presence of CPX, SL or D N T  and 
FOX hydrolyzed C R  1.5-12 times faster than non-induced j3-CE. Only the 
exposure to SL or DNT resulted in changes in OMP expression (a 44-kDa 
protein did not express). The diminution of SA in 8-CE from the DMl and 
DM2 strains by the exposure to CPX, SL, or DNT was concomitant with 
decreased FOX ( 2 4  times), cefotaxime (2-16 times), ceftazidime (2-8 times), 
ceftriaxone (2-64 times) and imipenem (2-4 times) MICs. 
Conclusions: The exposure of the DM1 and DM2 strains to subinhibitory 
concentrations of CPX, SL or DNT resulted in a decreased production of 
Non-molecular diagnostic methods I 
AmpC j3-lactamases and an mcreased suscepnbhty to cephalosportns and 
irmpenem Only the presence of SL and DNT repressed the expression of 
OMP in the DMl and DM2 st~jllfls 
Reference 
1 Tavlo-Perez MM, Amcosante G, Fanceschuu. N et cll Mtmb Drug Resur 19YY 5 23-40 
I 0388 I Effect of ceftizoxime and piperarillin/tazobactam 
dosing on efficacy and mutation frequency of Bacteroides 
fragilis and Enterobacter cloacae in mixed infection 
murine abscesses 
L. E. T. Stearne, N. Lemmens, W. H. E Goessens, 
J. W. Mouton and I. C. Gyssens 
Rotterdam, NL 
Objectives: Emergence of resistance may occur when microorganisms are 
exposed to sustained low dosing of fl-lactam antibiotics. Little or no data are 
available for BE Using a murine abscess model (Antimicrob. Agents Che- 
mother., 45, 1394-1401). we studied the effect ofdosing increases on efficacy 
and frequency of resistance to CZX and PT in mixed infections of BF and 
EC. 
Methods: Mice received a dady dosing of 6-1536 mg/kg (q2) CZX or 24- 
6144 mg/kg (q2) PT starting 30 min before inoculation with 7 log 10 cfu BF 
ATCC 23745 andEC 22491 (cefoxitin-resistant) clinical isolate (MICs 1,0.25 
(CZX) and 1, 4 (PT) mg/L, respectively). After 24 h, abscesses were homo- 
genized and 20 pL of 1 0-fold dilutions plated onto agar plates containing 0, 
1 x , 2  x , 4 x ,  8 x  or 16 x MICs of CZX or PT. MFs were calculated from total 
bacterial counts and mutant stability assessed by multiple subculture on 
antibiotic-free media. 
Results: The respective ED50 ofBF/EC were 555/422mg/kg/day for CZX 
and 84/528mg/kg/day for PT. CZX-resistant BF and EC mutants were 
isolated from untreated controls at a MF of 0.0014.000001 on up to 
16 x MIC plates and PT-resistant EC at a MF of 0.000014.000001 on up 
to 4 X MIC plates. No PT-resistant BF were isolated on plates containing 
>1  x MIC PT. With CZX dosing 12-384mg/kg/day, the MF of EC 
increased to 0.14.01. Isolated mutants with a ,256-fold MlC increase 
produced high levels of a stably depressed cephalosporinase. The MFs of 
CZX-resistant BF were unchanged with increasing CZX dosing. No CZX- 
resistant mutants were isolated at >768 mg/kg/day. Increasing PT dosing had 
little effect on the MFs of PT-resistant EC with no mutants isolated at 
>384 mg/kg/day. 
Conclusions: Sustained exposure of BF/EC mixed infections to low dosing 
CZX could select stably derepressed CZX-resistant EC mutants in early 
abscess developmenr. PTefficacy is similar (EC) or superior (BF) to CZX but 
PT is more efficient in the suppression of EC and BF mutants. 
(p389/ Usefulness of selective broth media for the 
detection of group B streptococci (GBS) in pregnant women 
A. Menasalvas, C. Guerrero, R. Cesteros, A. Miranda, 
T. Rodriguez and M. Segovia 
Murcfa, E 
Objective: To confirm the usefulness of selective broth mema for detecting 
group B streptococci (GBS) in pregnant women in order to include its use in 
our procedures. 
Methods: From March to July 2001, all samples fiom pregnant women were 
included in a prospective study. Vaginal and anorectal swabs were inoculated 
onto Columbia with colistin and n a l i h c  acid (CNA) and Todd Hewitt broth 
supplemented with 5% blood, gentamicin and nalidixic acid (SBM). All 
culture media were incubated at 35 "C in 5% CO1. After 24 h of incubation 
SBM broths were subcultured onto CNA plates and all negative cultures were 
incubated for additional 24 h. 
Results: A total of 694 samples from 370 patients were evaluated (368 vaginal 
and 326 anorectal). GBS was found in 113 (16%) sampls from 64 (17.2%) 
women. Of the 113 positive specimens GBS was recovered from 100 (49 
vaginal and 5 1 anorectal) samples in CNA (88.4%). SBM recovered GBS in 13 
additional samples from 12 women. Evaluating paired samples of these 
women, in .six (9.3%) was the diagnostic method. Of 113 positive samples 
there were 17 that were isolated in direct CNA plates but were not detected in 
SMB subcultures. Of these 17 samples 12 (70%) were anorectal samples. 
Conclusions: SBM broth improves the recovery of GBS in pregnant women. 
Nearly 10% of our patients were misdiagnosed without the use of this 
medium. These data support the routine use of a selective broth media for 
the detection of GBS in pregnant women. 
/p390) Growth of Burkholderia cepacia complex and other 
organisms on B. cepacia selective agar (BCSA) 
S. Mihaylova and M. Sredkova 
Pleven, B 
Objective: To evaluate the growth on BCSA of isolates belongmg to the 
Burkhdderia cepacia complex and organisms other than Burkholderio cepacia 
complex. 
Methods: A total of 127 B. cepacia complex isolates were included in the study: 
two horn cystic fibrosis (CF) patients, 119 h m  non-CF patients, and six &om 
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hospital environment. The following organisms other than B. cepocia complex 
were tested 23 S. maltophilia, 12 A.  baumannii, 10 I? amginosa, one Pputida; 
10 S. marcescens, nine E.  coli, nine Kpneurnoniae, eight E. cloacae; 22 Staphy- 
lococcus spp., and 14 Enterococcus spp. The identification ofthese 245 strains was 
performed using conventional biochemical analysis and/or commercial sys- 
tems. The testing of the e6cacy of BCSA was conducted in two phases. In 
phase 1 polymyxin and gentamicin were included in BCA-base. In phase 2 
vancomycin was added to this formulation. BCSA plates were inoculated with 
standardzed bacterial suspensions and were incubated at 32 "C up to 72 h. 
Results: A total of 226 of 245 strains grew on BCSA-base. For 19 Sfaphy- 
lococcus spp, this base had ihbitory effect. All B. cepacia complex isolates, six of 
23 S. maltophilia, and seven of 14 Enterococcus spp. grew on BCSA phase 1. 
None of the tested organisms of family Enterobacteriaceae, Pseudomonas spp., 
A. baumannii, and Staphylocom spp. showed growth on BCSA with poly- 
myxin and gentamicin. The addition of vancomycin to BlCSA phase 1 
inhibited two of seven enterococci but had no effect on the growth of the 
nonfermentative Gram-negative isolates. 
Conclusions: BCSA demonstrates high sensitivity for isolation of the 
B. cepacia complex organisms. This medium inhibits most of the non-B. cepucia 
complex strains but it is not enough selective for S. maltophilia. This organismis 
particularly problematic species since, it has simdar to the B. cepacia 
complex biochemical properties and can be found in specimens of CF 
patients. Our data show that BCSA is eEective medium for identification 
of putative B. repacia complex organisms and should be included in primary 
culture protocols. 
Evaluation of two different selective solid media 
for detection of group 6 streptococci (GBS) in pregnant 
women 
R. Cesteros, A. Menasahas, A. Miranda, C. Guerrero, 
T. Rodriguez and M. Segovia 
Murcia, E 
Objective: To evaluate Granada agar plate and Columbia with colistin and 
nalidixic acid agar (CNA) for the detection of GBS in pregnant women. 
Methods: From March to July 2001, 694 (368 vaginal and 326 anorectal) 
samples from 370 pregnant women were processed in our laboratory for the 
detection of GBS. All samples were inoculated onto GM and CNA plates. 
After 24h of incubation in 5% CO, a t  37 "C all culture negative plates were 
reincubated for additional 24 h. 
Results: GBS was isolated from 115 of694 samples (16.5%) from 68 (18.4%) 
patients. Fifty-five (15%) of 368 vaginal swabs and 60 (18.4%) of anorectal 
swabs were positive. GBS was recovered fiom 109 specimens in GM and 
from 100 specimens in CNA giving sensitivities of94.7 and 8696, respectively. 
GBS grew only in Granada agar in 15 cases (six vaginal and nine anorecd 
samples) and in CNA agar in six cases (three vaginal and three anorectal 
samples). The 15 samples only positive in GM were from 13 women, 
evaluating these cases in 10 of them GUS was isolated in CNA of paired 
sample (anorectal or vaginal). Only in three (4.4%) patients GBS was detected 
exclusively in GM. GBS was detected in two (3%) patients only in CNA 
media. 
Conclusions: There were no sigruficant differences between both culture 
meda. GM because of characteristics colored colonies is an easier and faster 
method for detecting GBS in pregnant women. 
LP392 1 Staphychrom 2, a new specific staphylocoagulase 
test using a chromogenic substrate 
A -M Freydlere, M -A Charveriat, M Bes, A. Carricajo and C Ploton 
Lyon, Saint Ebenne, F 
Objectives: Tested wth  297 SiaphyZococcus strams, Staphychrom 1 (Interna- 
h o d  M~crobio, France), a 2-h fluorogemc test using human prothrombin 
and protease uhbitors for the detechon of staphylocoagulase has been shown 
to be more specific, and as sensinve as the reference tube coagulase test (TCT), 
and more speclfic and more sensihve than the latex agglutmanon test (LAT) 
Pastorex Staph Plus (Blo-Rad) Staphychrom 2, a new verslon of Staphy- 
chrom 1, uses a chromogemc substrate and a snnphfied methodology. Thls 
study compared Staphychrom 2 to (I) Staphychrom 1 (n) a reference TCTand 
(iii) the LAT Slidex Staph Plus (bioMiriew, France) for the rapid identifica- 
tion of Staphylococcus aureus. 
Methods: A total of 113 clinical isolates including 92 S. aureus (78 methicillin 
sensitive and 14 methicillin resistant), and 21 non-S.uureus, were tested. 
Moreover, 15 collection strains: four S. aureus (two of which with a negative 
reference TCT) and 11 non-S. aureux, selected for their ability to give false- 
positive results either with the TCT or a LAX were tested. 
Results: With the c l i~ca l  isolates, Staphychrom 2, Staphychrom 1 and the 
TCT yielded a positive-coagulase test with 91 of 92 S. uuws strains 
(sensitivity 98.9%) then a negative coagulase-test with the 21 of 21 non- 
S. aureus and one S. aureus strains (specificity 100%). The LAT yielded a 
negative-agglutination with 18 of 21 non-S. aureus and three S. aureus strains 
(one methicillin sensitive and two methicillin resistant) and a positive- 
agglutination with three non-S. aureux strains (sensitivity 96.7% and specificity 
85.7%). With the collection strains, Staphychrom 2 and Staphychrom 1 
yielded a positive-coagulase test with two of four S. aureus and a negative- 
coagulase test with the 11 non-S. aureus and the two S. a u m s  known to be 
negative with the reference TCT. The TCT yielded a positive test with two of 
four S. uureus and eight of 11 non-S. aureus strains (three S. srhleiiri subsp 
coagulans and four S. in tmed ius  and one S. hyicus). The LAT yielded a 
positive-agglutination test with three of four S. aurm and seven non-S. aurew 
strains (two S. xhlegeri subsp coagulans, three S. intmedius,  one S.  hyicus and 
one S.  delphini]. 
Conclusions: Staphychrom 2 yields the same results as Staphychrom 1. 
This test is as sensitive and more spec& than the TCT, and more sensitive 
and more specific than the LAT Slidex Staph Plus. This rapid, accurate and 
easy-to-use coagdase test seems to be a good substitute for the conventional 
TCT. 
I P393 1 Evaluation of a new commercial selective medium 
for recovery of Burkholderia cepada complex from 
respiratory secretions of patients with cystic fibrosis 
M L Garlaschl, E Scarazatu, L. Cariani, G Clariua, P Russo. 
M L Belh,M. L FenuandG.Manno 
Milan, Genoa, I 
Objectives: Burkholdena cepacia complex, is an important pathogen, causing 
respuatory-tract demons  m pahents w th  cystlc fibrosis. Because several 
orgamsms rmsldenufied as B. cepma grew on commendy available agars 
mtended to be selective for B. cepana, we beheved a me&um that was mare 
inh~bitory et that was enriched to support the grow of B cepana was requxed. 
The am of our study IS to verify a new selechve agar mehum B q a a a  
Selecave Agar (BCSA) in an effort to improve the speed and accuracy of the 
isohhon of the B cepucia complex 
Methods: In two Itahan c h c a l  mcrobiology laboratones ( I S t i t u h  C h c i  dl 
Perfezionamento o f h  and G. Gash Insntute ofGenova) was carried out 
a prospecuve comparahve eduahon (&om 7 July to 10 September 2001 .) of 
two commercial prepared media m the rouhne setup procedures for respm- 
tory specmens from CF pauents The PXhcqahng laboratones were allowed 
to lncorporate the addaonal selecnw agars mto their exlshng CF respuatory 
protocok as best sulted the mdmdual laboratory5 procedures. We compared 
BCSA (manufactured by BioMeneux Itaha S p A) to Oxtdaaon-Fermata- 
uon Agar Polympn Bacitracin Lactose agar (OFPBL) (&om BBL, Cock- 
eyswlle) Bacterial strams were identified at species level by convenaonal 
biochermcal method, the B. cepma complex status was assesed by genus and 
species-spechc polymerase cham reachon assays (Ago& JCM 2001, Bevlvino 
JCM in press). 
Results: A total of 333 respiratory specnnens from CF paaents were processed 
The 21 1 of 333 (63 4%) cultures had no growth of any orgamsms on any 
selecuve agar for B cepucia complex, 25 of 333 (7 5%) cultures grew 5 ~ e p ~ ~ t a  
complex on both meha, 43 of333 (13%) grew other thm B tqaaa compJex 
on BCSA agar and 122 of 333 (36 6%) on OFPBL agar Other orgalllsms 
that grew on BCSA and OFPBL agar included 74 staphylococncr aureus (one 
on both me&a, 73 on OFPBL only), 37 moulds (13 on both medla, 24 on 
OFPBL only), 15 Achromobacter xylosoxidans (11 on both me&a, fouron 
OFPBL only); 57 yeasts (two on both medla. 55 on OFPBL only), 
m e  Dseudomonus aeruginosa (eight on both medla, one on OFPBL 
Conclusions: We conclude that (1) BCSA and OFPBL was slrmlarly 
m their abkty to support the growth of 5.cepma complex (II) BCSA IS 
superior to OFPBL m suppressing growth of orgamsms other than B. cepana 
complex 
only) 
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Conclusions: Selective chromogenic agar has much improved specii5city for 
salmonella idennfication and will have a sigruficant impact in reducing 
laboratory workload and costs. 
Evaluation of two different paediatric blood 
culture bottles of BacT/Alert system for the detection of 
Neisseria meningitidis 
M. Rosell6, D. Fontanals, A. Gene and A. Godez-Cuevas 
Subadell, Barcelona, E 
Objectives: To evaluate the performance of the new BacT/Alert pediatric 
aerobic bottle with activated carbon (FAN) in comDarison with the old BacT/ 
[p3961 Synthesis and evaluation of a new chromogenic 
substrate for detection Of 8-flbosidase . ,  
Alert pediatric aerobic bottle (STD), to support the growth of Neisseria 
meningitidis (N. meningitidis) . 
Methods: We studied 30 frozen strains. sensitive and moderatelv sensitive to 
L. Butterworth, J. Perry, J. Procter, M. Burton and K. Gould 
Newcastle upon uK 
p e n i c h  and belonging to serogroups B and C, isolated &om patients with 
sepsis and/or meningitis. We prepared two dilutions of each strain of 1 : lo5 
and 1 : lo6 UFC/mL. Of each dilution one bottle STD (vented) and two 
bottles FAN (one vented and one nonvented) were inoculated with 0.4 mL of 
inoculum and 1 mL ofhuman blood. Bodes were vented prior to loading into 
the BacT/Alert system and were incubated for 5 days or until the instrument 
signaled that they were positive. Before inoculating bottles we made a 
quantitative inoculum control. 
Results: There were no s i d c a n t  difFerences in the capacity of recovering 
strains of N. meningitidis between both types of bottles, with average inocula 
between 174 and 1497 UFC/mL. There were no significant Merences in 
detection time (in hours) related to serogroup or penicillin sensitivity. There 
were statistically sigrufcant Merence in detection time between STD bottles 
and FAN bottles in favor of STD. There were statistically significant differ- 
ences in detection time between FAN vented and FAN nonvented, in favor of 
FAN vented. 
Conclusions: The FAN bottles were comparable with STD bottles in their 
ability to recover N. meninxiridis, although they needed more incubation time. 
According to our results, we suggest venting the bottles before incubation 
when sepsis and/or meningitis are suspected, in order to obtain the results 
early. 
Objectives: To synthesize a chromogenic substrate which allowed visualiza- 
tion of 8-ribosidase activity in agar media and to evaluate the diagnostic 
potential of this substrate for the differentiation of pathogenic bacteria. 
Methods: 3’,4’-dihydroxytlavone is a molecule which chelate iron to form a 
black insoluble precipitate. This molecule was chemically derivatized to form 
a nonchelating /?-riboside and this substrate was incorporated with iron into 
an agar-based culture medium. A total of 158 bacterial strains were inoculated 
onto t h ~ s  medurn and incubated overnight. When the riboside substrate was 
hydrolyzed by bacterial enzyme activity the 3‘, 4’-&hydroxyflavone was 
released and reacted with iron to form black bacterial colonies. 
Results: Among the Gram-negative bacteria tested 8-ribosidase activity was 
widespread but not universal. Most strains ofEnterobacteriaceae were positive 
for this activity but Ersinia enterocolitiur and Vibrio chokrae were negative. 
8-ribosidase activity was also hghly useful for the differentiation of Shigella 
spp. (positive) and Proteus spp. (negative). Among Gram-positive bacteria 
there were also usell findings. For example, Corynebucterium diphrhetiae was a 
strong producer of fi-ribosidase whereas most streptococci were negative. 
This could be of diagnostic importance for the isolation of C .  diphtheriae from 
throat swabs. 
Conclusions: This is the first microbiology report of the diagnostic utility of a 
P-ribosidase substrate. The substrate allowed for the clear recognition of 
bacteria producing 8-ribosidase due to the formation of black colonies. We 
conclude that this substrate could be applied in new chromogenic media for 
the rapid detection of bacterial pathogens. 
(p395/ ~n assessment of the cost effectiveness of a 
chromogenic agar (ABC medium) for the selective isolation 
of salmonellae from routine stool samples 
v1 Early detection of Listeria monocytogenes with 
selective CHROMagar Listeria medium 
L. Mereghetti, C. Beuzelin, N. Marquet-van der Mee, l? Laudat 
and R. Quentin W. O’NeiU, H. Plumb, P. Kennedy and R. Cooke 
Eastbourne, Worthing, UK Tours, F 
Objectives: To investigate whether a novel chromogenic agar (a-8-chromo- 
genic (ABC)) medium, Lab M, Bury, England) was more efficient in terms of 
workload (Welcan units) and cost than commonly used selective enteric 
media. 
Methods: ABC medium exploiu the fact that salmonellae may be distin- 
guished &om other members of the Enterobacteriacae by the presence of 
a-galactosidase (a-gal) activity in the absence of b-galactosidase @-gal) 
activity. Salmonellae produce a characteristic green colony (a-gal positive, 
b-gal negative) whereas non-Salmonella strains are either clear (a-gal and p-gal 
negative) or black @-gal positive). The study was performed in two district 
general hospitals, A and B. A11 stool samples were subcultured Lom selenite 
broth onto ABC medium and either desoxycholate lactose agar (DCLS) or 
xylose lactose desoxycholate (XLD) agars. Hospital A routinely used DCLS 
and XLD agars whilst hospital B used XLD only. Costing and Welcan units 
were calculated for each medium. 
Results: A total of 866 stool samples were processed from which 14 
salmonellae (1.6%) were isolated. The 620 samples were cultured onto 
XLD and 246 onto DCLS. XLD/DCLS media produced a greater number 
ofsuspect colonies (227) that required further investigation compared to ABC 
medium (31 suspect colonies). In hospital A, one salmonella was detected by 
AEiC medium only. Overall, the sensitivity and specificity was superior for 
ABC medium (100&45.2%, respectively) than for XLD/DCLS media 
(92.3 & 5%. respectively). Comparative specificities for ABC medium were 
sigdcantly different at the two hospital sites (hospital A 100% and hospital B 
50%). T h  was probably due to hospital A’s previous experience with this 
medium. The difference in Welcan units between XLD/DCLS and ABC was 
2197 units. Using half-plates for ABC medium, consumable costs were 
comparable with XLD/DCLS media. 
Background: Listeriosis is a major public health problem in developed 
countries, where expansion of the agro-food industry has resulted in the 
possibjhty of a wide variety of food becoming contaminated with Listerin 
monocytogenes, which may cause large food-borne outbreaks. Rapid detection 
of the bacterium in food products is thus essential for industrial 
food producers. Various selective chromogenic media Merentiating L. mono- 
cytogenes Lorn the other species of Listeria on the basis of metabolic 
reactions (color of the colonies, opaque halo around colonies) are now 
available. 
Methods: We compared the time required for the s ecific detection of 
L. monocytogenes with the most recent CHROMagar& Listeria medium 
(CHROMagarTM) with that on ALOA@ medium (AES Laboratoires). We 
tested 194 strains of Listeria sp. (152 L. monocyfogenes, 25 L. ivanovii, eight 
L. innocua, nine other Listeria sp.). The interpretation criteria were: the color 
ofthe colonies, the presence or absence of an opaque halo, the diameter of the 
halo measured after various times of incubation at 37 “C (18, 24 and 48 h). 
Statistical analysis was performed with EpiInfo6. 
Results: Halos were observed for L. molnocytogenes and L. ivanovii strains 
only, on both media. At 18h, the halo was significantly larger with 
CHROMagarTM Listeria medium than with ALOA@ medium in 75% of 
cases. At 24 h, the halo was still sigtllficantly larger with CHROMagarTM 
Listeria medium. At 48h, there was no significant difference in halo size 
between the two media. 
Conclusions: The use of chromogenic media can sigdcantly reduce the time 
required to detect of L. monocytogenes in food products b m  that required for 
detection with the reference method (IS0 11290-1). Our results suggest 
that the opaque halo appears earlier on some chromogenic media than on 
others. 
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Evaluation of Burkholderia cepecia selective agar 
(BCSA) on supporting growth of B. cepacia complex bacteria 
from clinical and environmental sources in Italy 
S. Piana, M. L. Belli, S. Ottolino, C. Dalmastri, A. M. Bevivino, 
L. Chiarini, S. Tabbacchioni and G. Manno 
Genon, Rome, I 
Background: Burkholderia cqm'a (BC) complex is an opportunistic pathogen 
present in the environment that cause pulmonary infections in cystic fibrosis 
(CF) patients (pts). There are now nine established species or genomovars 
(gvr) in the BC complex. The most frequent gvr recovered in CF pts is BC gvr 
111, but a careful and continuous microbiological monitoring in airways 
specimens for recovery BC complex belonging species, is important to 
completely understand the epidemiology of these pathogens. 
Objective: We evaluated a new selective medlum, B. cepacia Selective Agar 
(BCSA) (BioMerieux Italy), with others commercial prepared selective media 
in their ability to support the growth ofBC complex strains from clinical (CF) 
and environmental sources. 
Methods: We studied a collection of 68 strains isolated fiom sputa of 53 pts 
from a e r e n t  Italian regions attending the CF center of Genova and 75 strains 
isolated from the maize rhizosphere in three Italian regions. Strains were 
assigned to the BC complex by polyphasic analysis employing (i) conventional 
tests: API 20 E, API NE Systems (BioMerieux), OF basal medium (Difco) for 
six sugars, oxidase test, growth at 42 "C, pigment and hemolysis production: 
(i) genus and species-specific polymerase chain reaction assays (Bevivino 
JCM in press). BCSA plates were compared mth OFPBL and Cepacia 
Medium (CM) (both from BBL, Cockeysville). Growth study was carried 
out by a subculture of strains on blood agar for 24-48 h and aliquots of a 
bacterial suspension (1 x lo3 to 1 x 104rfu/mL) placed on BCSA, OFPBL 
and CM. Recovery efficiency for strains was determined after incubation at 
30 and 35 "C for 72 h. 
Results: BC complex status of studied strains was: 2% gvr I, 68% gvr 111, 3.5% 
B. stabilis, 19.6% B. ambijaria, 5.6% B. pyrroci'nia. Conventional tests were able 
to recognize B. slabilis but failed to discriminate BC gvr I to BC gvr 111 and to 
B. ambijiria. The 100% of studied strains grown on BCSA and OFPBL and 
97% on CM (three CF strains of BC gvr IIIA and one CF gvr I11 failed to 
growth on CM). All strains displayed good growth on BCSA and OFPBL 
after 48 h at 35 "C but on 24 h incubated BCSA plates the colony growth was 
yet detectable. CM needed an increased incubation time for 72 h to improve 
the optimum growth rate. 
Conclusions: Our results show that BCSA is superior to OFPBL and CM for 
rapidity and quality of growth of Italian BC complex strains of CF and 
environmental origins. 
(p3991 Blood cultures: time required for recovery of 
bacteria and yeasts with BacTlAlert system 
A. Gogho, M. Arosio, M. Facheris, C. Farina, A. Manisco, 
F. Moioli and F. Vailati 
Beyamo, I 
Objectives: Prompt detection of bacteraemia and fungaemia impacts posi- 
tively on patient management and continues to be one of the most important 
responsabilities of clinical microbiologist. The aim of this study is to evaluate 
the time of grow of bacteria and yeasts in blood cultures of the automated 
BacT/Alert system (Biomkieux). 
Methods: Blood cultures, FAN aerobic and anaerobic, obtained &om hospi- 
talized patients between 19 June 1998 and 15 December 2091 were studied. 
Bodes were incubated for a standard 7-day protocol or until the insttument 
signaled that they were positive. In this study, the rime of growth is defined by 
number of days between the collection and the detection of growth by the 
technician (cultures are examined daily, 7/7days, at 08.00and 15.00h) and 
matches with the days required to report the positive result and Gram stain to 
the clinician. 
Results: A total 87 785 bottles for blood cultures were performed. Positive 
cultures were found in 10 851 cases (12.4%). The microorganisms isolated 
were 11921. The time required for recovery of microorganisms was as 
follows: Odays (i.e. the same day of the collection, 0.6%), 1 day (61.1%), 
2days (28.1%). 3days (5.6%). 4days (1.8%), 5days (l.l%), 6days (0.9%), 
7days (0.7%). 
Detection of gmwth (days) 
Mcro-orgamsms 0 1 2 3 4 5 
Envrnbacteriaceace 43 2656 297 78 21 13 
Aerobic Gram-neg 1 273 87 28 3 4 
AernbIcGram-pos b o d  3 90 68 17 5 2 
Aerobic Gm-por coca 23 4076 2642 474 142 55 
Yeast 96 116 21 7 1 
Total (fl) 72 7287 3344 673 215 127 
Total (%) 0 6  61.1 281 565 1 6  107 
b o d  (others) 
Aemlnc Gnm-oeg coca 4 3 1  
Roplontbamum spp 5 3  3 3 5  
6 7 Total 
5 5 3118 
1 402 
6 2 143 
8 
57 55 158 
2 243 
112 91 11921 
B n 7467 
0.94 0.76 
Conclusion: Based on thts study, the c h u a u  can expect the results of positive 
blood cultures and Gram s t a m  the day &er in 61.7% and 2 days after m 89.8% 
of the bacteriemc pahent. The identlficauon and susceptibility of dxect 
mocdahon from posihve culture can provlde an in te rn  find results mthm 
3 days nearly in 90% 
I P a 0  I Evaluation of Agar blood-neomycin-nalidixic acid 
and Agar Columbibcolistin-nalidixic acid in the isolation of 
group B Streptococcus, in pregnant women 
S. Benites Casdo, M. Chavez Casdo and C. Romero Goicochea 
Tijalfo, PE 
Objective: Group B S t r e p t o m  (GBS) is a major cause of neonatal morbi* 
and mortahty worldwide. We study 442 cervtcovagmal specimens of pregnant 
women mth 25-26weeks gestation, in Trujillo City, Peru horn main 
Hospitals and Centers of Health, to de t e rme  the presence of (GBS) and 
to compare the quality of isolation of media. 
Methods: We evaluated 442 cemcovaginal specmens. A swab was cultured in 
a selecnve isolauon Agar blood-neomycin-n&&c acid (ASNA) and Agar 
Columbla-colisnna-nalidixic acid (ACCA), the idennficatlon of GBS w a s  
carried out by means of the catalasa tests, Bacitracm, CAMP test and serology 
for Aggluhnaaon mth  antisera Lancefield DIFCO. 
Results: We compare ASNA and ACCA, determining the effwuveness of 
each one, and then to be able to use it like routine media. We deterrmned that 
15.84% are carriers of GBS. Obsenrlng that in ASNA GBS grows more 
quickly than in ACCA. Also in ASNA grow lw contaminants than in ACCA. 
Condwion: We concluded that the medium more appropriate for the 
lsolation of SGB m pregnancy women is the ASNA medmm in comparison 
with the ACCA. 
w1 Evaluation of the performance of bioMerieux 
campylosel agar 
E Montigon, M. Fouilloux and E Villeval 
Cruponne, F 
Campylobacter cause diarrhea with abdominal pains and fever. Campylobdev 
jqmi is the species most kquently isolated by bacteriology laboratories. 
Campylosel agar is a selective medium, enabling isolation of these pathogenic 
intestinal bacteria from polycontaminated specimens (liquid stools). The 
growth of contaminant bacteria can, in the event of low or insAcient 
inhibition, lead to incorrect results due to the relatively slow growth of 
Campylobactev stains. 
Purposeof study: The purpose ofthis study was to compare the performance 
of the bioM&eux preplated medium, in terms of nutrient capacity and 
selectivity, with the main competitor media available: Oxoid and Becton 
Dickinson. 
Materials and methods: 25 C. jejuni strains and other Campylobacter species 
were tested. They were obtained both from internal strain and ATCC 
collections. For selectivity, 25 interfering strains were used, including Entero- 
bacteriaceae, nonfernienting Gram-negative bacilli, Gram-positive bacteria, 
yeasts and anaerobes. For each strain, a two MCF sterile physiological 
saline solution suspension was produced. Inoculation was performed for 
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the three isolation media to be compared using a 10-pL calibrated loop. 
Columbia agar with 5% sheep blood inoculated in parallel was used as a 
nonselective reference. The plates were incubated under microaerophilic 
conditions for 72 h at 37 "C. A growth intensity and colony size reading was 
performed simultaneously for all the media after 24, 48 and 72 h of incuba- 
tion. 
Results: The C. jejuni strains studied were used to classify the culture media in 
order of nutrient capacity. The Oxoid medium was found to have the richest 
growth after 48 h, followed by those of Becton Dickinson and bioMCrienx. 
However, overall, for all the strains tested, only the bioMCrieux medium 
enabled visible colony growth after just 24 h of incubation. In the same way, 
the media were classified in order of selectivity according to the growth of 
interfering strains. The bioM6rieux medtum proved to be the most selective, 
followed by those of Becton Dickinson and Oxoid. 
Conclusions: The bioMCrieux Campylosel agar has a nutrient capacity similar 
to those of its main competitors with a better performance in terms of 
selectivity. This culture medmm is a reliable product, well adapted to the needs 
of Campylobacfer, whch is dacul t  to isolate due to the generally very 
abundant accompanying flora. 
wl CPS ID3. an advanced chromogenic medium for 
diagnosis of urinary tract infections 
L. Barbaux, L. Butterworth, S. Mailler, S. Orenga, J. Perry, D. Robichon 
and C. Roger-Dalbert 
La Balme-les-Groffes, F; Newcastle-upon-Tyne, UK 
Objective: CPS ID was the first Chromogenic Medium designed for easy 
diagnosis of urinary tract infections, enabling the enumeration of 
microorganisms, the identification of Escherichia coli and the preliminary 
idendfcation of enterococci, Proteeae, and the Klebsiella-Enterobacter- 
Serratia group (KES). CPS ID2 included a new chomogenic substrate for 
easier identification of E. coli, especdy in multimicrobial cultures. CPS ID3 
is an evolution of this medium incorporating an innovative chromogenic 
substrate for the detection of deaminase in bacteria of the tribe Proteeae 
(patent pending). 
Methods: This new medium was compared to CPS ID2 using a collection of 
350 microorganisms commonly encountered in urine. A preliminary com- 
parison was also made using urine specimens. 
Results: All the microorganisms grow on CPS ID3, and the colonies of Gran- 
positive cocci and yeasts are larger. The sensitivity of E. coli identification is 
slightly better on CPS ID3 and the specificity is 1 W ?  on both media, as this 
identification is based on the highly specific glucuronidase activity. The 
sensitivity of Proteeae detection is higher on the new medtum; deep brown 
colonies are produced without the addttion of any reagent and there is no 
diffision in the agar. On CPS ID3. colonies of Citrobacterare similar to those 
ofKES. The detection of enterococci is 100% sensitive on both media, but the 
specificity is higher on CPS ID3 with better dtscrimination between enter- 
ococci and group B streptococci. These results are confirmed with urine 
specimens: the growth of staphylococci is better and the detection of Proteeae 
is easier than with CPS ID2. 
Conclusion: CPS ID3 enables easy detection and enumeration of Proteeae 
even in mixed cultures. The growth of Gram-positive cocci and yeasts has 
been improved and other parameters have been optimized. CPS ID3 is the 
chromogenic medium perfectly adapted to the diagnosis of urinary infections, 
even with the most complex specimens. 
[ P a 3  1 New Oxoid Dryspot tests for detecting important 
non-0157 E. coli serotypes isolated from difiemt culture 
media 
A. Parker, 0. Sidnell, C. Harvey, T. Hartman and M. Metcafe 
Basingstoke, UK 
Objectives: To evaluate the new range of Dryspot Serocheck tests with non- 
0157 E. coli and other Gram-negative lactose fermenting organisms &om 
different culture media. 
Methods: Oxoid Ltd. has developed a range of latex agglutination kits for the 
individual identification of somatic antigen &om six of the most common 
verotoxigenic non-0157 E.coli serotypes (026, 091, 0103, 0 1 1 1 ,  0128 
and 0145). A total of 112 strains of Escherichia coli and other lactose- 
fermenting Gram-negative bacteria were grown overnight (18-24 h) at 
37°C on MacConkey, Enterohaemolysin and Nutrient agars (all manufac- 
tured by Oxoid Ltd) and tested with each Semcheck kit. 
Results All serotypes (026,091,0103,0111,0128,0145) ofE. colitested 
were positive with the appropriate E .  coli Serocheck h t ,  regardless of agar type 
used. With the exception of a single bacterium (Edwardsiella tarda) that 
agglutinated weakly with all E. coli Serocheck test latex reagents, there were 
no false positive reactions with other serotypes of E. coli or other Gram- 
negative bacteria regardless of agar type used. Edwardsielh tardo can be 
differentiated b o r n  E. coli by its production of hydrogen sulphide. 
Conclusions: Excellent sensitivity (100%) and specifcity (99%) was demon- 
strated for each of the Serocheck kits with strains grown on the three different 
agar types. Dryspot E. coli Serocheck kits can be stored for two yean at room 
temperature. The tests provide fast and simple screening procedures for non- 
0157 serotypes implicated in human disease. 
v] The influence of the presence of albumin in the 
growth andlor motility of Gram-positive and -negative 
bacteria 
H. Akel 
Znrqa, JOR 
Objectives: Little attention has been given to the role of albumin play in 
determining the growth and motility ofbacteria. The data presents the growth 
and motility of motile and nonmotile bacteria in laboratory cultures. Firstly, 
the &ect oftype ofbacteria on their growth for 6 days. Secondly, the effect of 
different degrees of temperature on the growth of motile and nonmotile 
bacteria. Finally, the effect of albumin at different concentrations on the 
growth and motihty of motile and nonmotile bacteria at different degrees of 
temperature and at Merent environmental conditions. 
Methods: The organisms used for the determination the effect of albumin 
were: Pseudomonos aeruginosa (ATCC 27853), Escherichio coli (ATCC 25922), 
KIebsiella pneumonia (ATCC 13883) and Staphylococcus aureus (ATCC 25923). 
Growth of microorganisms in the presence of albumin was determined 
by culturing in duplicate in order to incubate at 37°C and 43°C 
under aerobic condition. The radius of bacterial spread &om the central 
inoculum was measured (in nun) daily for up to 6 days of incubation. Motility 
of bacteria was observed under a phase contrast microscope, using a flat 
capillary tubes ofpath 0.2 mm, called microslides under aerobic and anaerobic 
conditions. 
Results and conclusions: Culture media with the Werent levels of albumin 
which inoculated with one strain of bacteria: I? aeruginosa (ATCC 27853), 
E. coli (ATCC 25922), K.pneumonia (ATCC 13883) and S. aums (ATCC 
25923). Samples were incubated at either 37 'C or 43 "C and viable counts 
were made a t  24, 48, 72, 96 and 144 h. At 37 "C, I? amginosa and S. aureus 
grew well in hU strength at the presence of high concentration of albumin, 
whereas, E. coli shaved little growth. The failure of K. pneumonia to grow can 
be attributed to high osmolarity of the albumin. No increase in growth of all 
used organisms at 43 "C, except for I! aeruginosa which reflects the tolerance of 
this organism to unusual growth conditions. The results ofthe study show that 
the bacteria survive and may highly multiply even at high concentration of 
albumin and at both used temperature. 
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Antibiotic usage 
I P405 I Assessment of antibiotic therapy after 72 h: impact 
of a questionnaire on the use of antibiotics 
L. Senn, B. Burnand, I? Francioli and G. Zanetti 
Lausanne, CH 
Objective: Antibiotic therapy (AB) can be reassessed after 48-72 h, based 
on clinical evolution, and microbiological and laboratory results. 
Such assessment may lead to a more appropriate use of antibiotics. A 
questionnaire was developed for this purpose and evaluated in a randomized 
study. 
Methods: Patients hospitahed in the surgical and memcal wards of a 
university hospital were screened for inclusion by daily chart review. The 
eligible patients were those receiving an i.v. antibiotic for 72-96 h. They were 
randomly allocated to either no intervention (n = 125) or mailing of a 
questionnaire to the resident in charge (n = 126). The questionnaire asked 
three questions about continuation of AB and, in case of continuation, 
indication and possible adjustment. The primary outcome was time until 
modification of AB (interruption, adjustment, switch to oral therapy). The 
results in the two groups were compared by Cox-proportional hazard ratio 
modeling. Comparison was also made with 151 patients treated during the 
2 months preceding the study. A sample of 50 (20%) patients was randomly 
selected to evaluate the appropriateness of AB within the 48 h following 
inclusion (clinical evaluation sample). 
Results: There was a nonsignificant trend towards shorter time to 
modification of AB in the intervention group (adjusted hazard ratio 1.2; 
95% CI 0.93-1.56). Time to modification was significantly shorter in the 
intervention group than during the pre-study period (adjusted hazard ratio 
1.15; 95% CI 1.02-1.31). According to this latter result, the questionnaire 
would infer 15% less days until modification of AB in the intervention group. 
In the chical evaluation sample, the management of AB within 48h 
following the inclusion was considered inappropriate in 44% of patients in 
each group. However, no withdrawal of antibiotics was considered inap- 
propriate, suggesting that the questionnaire did not induce hazardous 
decisions. 
Conclusion: The present study failed to demonstrate a sigdcant reduction in 
time until modification of AEI by use of a questionnaire aimed at assessing 
antibiotic treatment after 72-96 h. However, ths may be an underestimate of 
the impact ofthe intervention by a contamination effect to the control group, 
as the study was randomized at the patient level. Although some benefit may 
arise from this simple and easily automatable approach, multiple strategies are 
probably needed to improve antibiotics use. 
1 P406 1 First evaluation of the impact of an antibiotic 
management team on the antibiotic consumption in a 
general hospital 
C. Rossi, E G. Moonens, J.-P. Duhne, B. Turpin, A. Boulanger and 
J.-I? Sabot 
Baudour, B 
Objective: To evaluate the impact of an antibiotic management team (AMT) 
on AB consumption in a general hospital (H). 
Methods: Three hospitals (HA, HB, HC) were united in a 755-beds 
general hospital in 1999. After providing a single AB formulary, an AMT 
composed of an infectious diseases specialist (IDS), a pharmacist, a micro- 
biologist, an internal medicine specialist and a computer-analyst was created 
in December 2000. AB controlled were “Broad spectrum AB” (piperacil- 
lin 41 tazobactam, ceftazidim, cefepim, ceftriaxon, aztreonam and carbape- 
nem), glycopeptides and quinolones. Period I (PI) (1 Janruary to 30 
September 2000) and period I1 (PII) (1 Janruary to 30 September 2001) 
were compared. In HA, an AB policy existed from 1996 co-ordinated by the 
microbiologist and the pharmacist. On PII, the IDS and microbiologist made 
advised consultations in all services with educational programs on AB use 
twice a week. In HB and HC, no AB policy existed before AMT intervention 
(PI). In HB, during PII, the AMT initiated the same AB policy as in HA. In 
HC, controlled AB prescription was not notified. The IDS made advised 
consultations without direct control on AB prescription. Data of AB 
consumption were expressed in Defined Daily Dose per 1000 hospitalization 
days (DDD/1000J). 
Results: The H global AB consumpdon was 261.1 1 DDD/1000 J in period I 
and 201.32 in period I1 (-23%). HA decreased from 296.38 in PI to 230.32 in 
PI1 (-22%), HB f?om 269.01 in PI to 202.79 in PI1 (-24.6%) and HC from 
193.42 in PI to 145.54 in PI1 (-24.7%). The H Glycopeptides consumption 
was 10.44 DDD/lM)O J in PI and 8.43 in PI1 (-19.2%) with decrease of27.3 
and 39.6%, respectively, for HA and HB, and increase of 25% for HC. The H 
‘Broad spectrum AB’ consumption was 34.98 DDD/1000 J in PI and 23 in 
PI1 (-34.25%) with decrease of 26.3 and 50.20%, respectively, for HA and 
HB, and increase of22% for HC. The H Parented Quinolones consumption 
was 5.05 DDD/1000 J in PI and 4.29 in PI1 (-15%) with decrease of 14.6, 
12.1 and 32% for, respectively, HA, HB and HC. The H oral Ciprofloxacin 
consumption was 18.17 DDD/1000 J in PI and 14.5 in PI1 (-20%) with 
increase of 41% for HA and decrease of27.5 and 32%, respectively, for HB and 
HC. 
Conclusions: The AMT succeeded in reducing H global AB use through 
advised consultations, educational programs and particularly daily notification 
ofcontrolled AB prescription. The results ofthe AB consumption decrease on 
patient clinical outcome, hospital epidemiology and cost should be eduated 
further. 
An infectious diseases (ID) day-hospital (DH) 
service in a tertiary care center in the third millennium: a 12- 
month survey of patients according to the spectrum of 
diagnoses, length of stay, and diagnosis-related group 
(DRG) parameters 
R. Manhedi, A. Gramegna, L. Calza and F. Chiodo 
Bologna, I 
Objective: To perform a survey of patients hospitalized at the day-hospital 
(DH) of an infectious diseases (ID) department of a teaching hospital in the 
year 2000. 
Methods: All DH hospitalizations were analyzed according to the discharge 
diagnosis, mean number of dady admissions, and DRG parameters, in order to 
assess the performance of our service, and plan fixture needs and tsource 
allocation. 
Results: In 1-year period, 304 patients were hospitalized in 302 working days 
using the four available DH beds: the overall 2478 days of admission led to a 
mean 8.1 5 daily admission rate, responsible for a 205% occupancy ofDH beds. 
As noticed since 1998, liver diseases accounted for the majority of main 
diagnoses (135 cases: 44.4%), followed by HIV disease (107 patients: 35.2%), 
neoplasms (eight patients), fever of unknown origin and viral diseases (seven 
each), CNS infections (6), respiratory tract, genito-urinary-tract, and bone/ 
joint diseases (four patients each), and skin/soft tissue infection (3) were the 
remaining diagnoses, together with miscellaneous ID (19 patients). Although 
an overall 8.15 daily DH admissions per patient was calculated, a sigmfkant 
dserence was found bemeen HIV-infected patients (10.5 & 3.2) and patients 
withliverdisease (5.4f 1.9; P<O.OOl). These figure substantiallyovetlap the 
trimmed mean length of admissions of other ID DH of Emilia-Romagna 
region for the same DRG groups, when excludmg a slightly more prolonged 
stay for uncomplicated HIVand liver disease, balanced by a shorter length of 
hospitalization for ADS and complicated hepatic disorders. An overall mean 
1.03 DRG weight was calculated for our DH patients, but a significantly 
greater index was recognized for HIV-related admissions (1.47 f 0.39; 
Discussion: HIV-related DH admissions largely overcame those owing to 
other illnesses until 1997 (with a maximum rate of 90.7% in the year 15196). 
but as a result of the changed natural history of HIV disease, the majority of 
DH hospitalizations now regards non-HIV-infected patients (53.4 to 64. I%, 
1998-2001). Concurrently, with shortage of inpatients beds, a notably 
reduced mean time ofDH stay, and the increased need ofDH hospitahzation 
for other diseases, significant issues are emerging about the changing referral 
to our DH, modified epidemiology and delivery of care of ID, and eventual 
needs for patients isolation, when potentially transmissible diseases are of 
concern. A continued monitoring of DH adrmssions and their features is 
strongly advisable to adjust standards of care to the moving target represented 
by ID patients in the third millennium, and to optimize patients care in the 
next future. 
P<O.001). 
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v] A protocol for medical audit and peer review in 
infedous diseases - experiences with the method 
M. Erntell, H. Beckman, B. Elgefors, B. M. Eriksson, A. Fry&n, 
!I. Hallgirde, M. Karlsson, I. Vig and T. Vikerfors 
On beha!fofthe M e d U  Audit Croup ofthe Swedish Society Oflnfectious Diseasa 
Objectiver: Since 1993, the Swedish Society of Infectious Diseases has 
developed indicators of medical quality in the diagnoses endocarditis, pneu- 
monia, bacterial meningitis, HIV, malaria, the follow-up of nosocomial 
infections and the use of antibiotics. A national quality register for treatment 
of endocarditis has been established. In collaboration with the Swedish 
Medical Association and The Swedish Society of Medicine we have devel- 
oped protocols for medical audit and peer review ofdepartments ofinfectious 
diseases in Sweden. 
Methods: The medical audit group has developed two protocols; one 
describing structure and process quality data of the department reviewed, 
and one describing the medical quality using the indicators for each diagnosis 
and for nosocomial infection asessment and antibiotic use. The department 
carries out the self-assessment of the medical audit. Two experienced con- 
sultants perform the peer review during 3days. which includes audit of 
protocols and medical records, interviews of hospital management staff and 
colleagues in other departments. 
Results: Eleven audits using the peer-review method have been performed. 
The chosen indicaton ofmedical quality have been accepted and successively 
integrated in the infectious diseases departments in Sweden. The register of 
endocarditis is the largest of its kind indudmg more than 1400 episodes. The 
experience is that the self-performed medical audit is very interesting and not 
too time-consuming. The peer review has been very appreciated among the 
colleagues. 
Conc1usions:The peer-review method hasgiven fkrtherinsightsinto the medical 
quality ofthe reviewed departments not detectable just by medical indicators of 
quality. Audit of medical records is essential for peer review. Some deficits of 
medical quality can only be detected by study ofrecords andinterviews ofexternal 
persons. Colleagues find the method very well suited for quality assurance in 
clinical practice. (Protocols available at http://www.infektion.net) 
vl Experience of a specialized infectious diseases 
home-care service from 1995 to 2001 
J. P. Horcajada, N. Benito, J. M. Min5, L. Garcia, M. Sala, R. Buira, 
N. Borris, C.  Tortajada, A. Soriano and J. M. Gatell 
Barcelona, E 
Objective: In 1995, a specialized dectious diseases (ID) home-care service 
was created in our institution in order to improve the quality of life ofpatients 
with prolonged parented antimicrobial therapy requirements and to reduce 
their hospital stay. Clinically stable patients with infections that required i.v. 
antimicrobial therapy were considered for inclusion in the service. We review 
the experience of this service between 1995 and 2001. 
Methods: Analysis of the number of included patients per year, number of 
patients with HIV infection, ID Diagnosis and administered antimicrobial 
treatment. 
Rer~lts: The number of patients included each year during the period 1995 
through 2001 were: 54,57,86,232,213,321 and 280, respectively. In 1995, 
50 (92.5%) were HIV patients; in 1996, 53 (93%); in 1997, 65 (75.6%); in 
1998.95 (41%); in 1999,64 (30%); in 2000.90 (28%) and in 2001,68 (20%). 
The main ID and antimicrobial treatment per year are shown in Tables 1 and 
2. In the case of endocarditis, parented outpatient therapy reduced 504days 
per year of hospital stay since 1998. 
Table 1 
Diagnosis Number of patients included per year 
Citomegalovirus 
Other HN-related 
Fungal infection 
Bacterial endocarditis 
Osteomielitis 
Celnlitis 
Pneumonia 
Urinary-tract infection 
1995 
21 
13 
3 
5 
2 
0 
0 
0 
1996 
39 
3 
9 
3 
1 
0 
0 
0 
1997 1998 
26 
28 
8 
26 
14 
15 
47 
41 
1999 2000 2001 
15 
25 
2 
22 
15 
8 
49 
26 
6 
44 
2 
20 
27 
33 
89 
78 
6 
24 
7 
29 
31 
21 
57 
64 
Table 2 
Treatment Number of daily antimicrobials given per year 
1995 1996 1997 1998 1999 2000 2001 
Antiviral 285 123 892 442 130 86 46 
Antibionc 53 179 420 1002 1270 1736 1285 
Annhngal 3 17 164 225 158 93 188 
GSF 210 498 253 48 14 25 10 
Conclusions: The number of patients included in our specialized ID home- 
care service have been increasing in the last years. The percentage of 
HIV-patients included with respect to non-HIV-patients have decreased 
since 1996, probably, in relation to the introduction of highly active anti- 
retmviral therapy and a better control of opportunistic infections. Urinary- 
tract infection, pneumonia, osteomielitis and endocarditis are actually the 
more fiequent infections treated in this service, with reduction of the hospital 
stay. 
The evaluation of rational antibiotic use in a 
teaching hospital in Turkey 
A. Erbay, A. Colpan, H. Bodur, M. Samore and 0. Ergonul 
Ankara, TR; Salt Lake City, USA 
Objective: To evaluate rational antibiotic use in relation to diagnosis and 
bacteriological findings in an 11 00-bed teaching hospital in Turkey 
Methods: An antibiotic restriction poIicy for ceftazidime, cefepime, imipe- 
nem, meropenem, ticarnllin-cladamte, piperacillin-tazobact, vancomy- 
cin, teicoplanin and intravenous formulations of quinolones was initiated in 
Ankara Numune Hospital in January 1999. In July 2001, a point prevalence 
study of the hospitalized patients who received antibiotics was performed. 
Two infectious diseases specialists assessed the prescribed antibiotics according 
to published guidelines. 
Results. Of the 713 patients hospitalized, 281 (39.4%) patients received 377 
antibiotics. F&y-eight (20.6%) patients received antibiotics for the treatment 
of hospital-acquired infections. Among 30 merent antibiotics the most 
kequently prescribed were first generation cephalosporins (19.9%). ampicil- 
lin-sulbactam (19.1%), aminoglycosides (11.7%), quinolones (1 1.1%) and 
carbapenems (7.2%). Most ofthe antibiotics (75.99'0) were given in parented 
form. The dosage of 35 (8.9%) antibiotics was out of standards. Eighty-six 
antibiotics were administered to 75 (26.9%) patients who had no evidence of 
an infection or indxation ofprophylaxis. Unnecessary antibiotic use was 30% 
in surgical wards, 14% in intensive care units and 8% in medical wards. 
Ampicilh-sulbactam and first generation cephdosporins were the most 
frequently unnecessarily used antibiotics (35 and 31%, respectively). Bacter- 
iological samples had been taken before the antibiotic prescription in 114 
(40.6%) patients. Antibiotic prescriptions were switched to another antibiotic 
in 43 (15.3%) patients; the main reason was susceptibility test result (44.62%). 
Antibiotic use was appropriate in 67%. Rational antibiotic use was highest 
when the results of bacteriological samples were positive. 
Conclusions: Irrational antibiotic use was high for ampicillin-sulbactam and 
first generation cephalosporins. Antibiotic use was inappropriate particularly 
in surgical wards. Additional interventions such as postgraduate training 
programs and elaboration of local guidelines could be beneficial. 
w\ Glycopeptlde overuse and the impact of a 
restriction policy 
M. Lelekis, M. Chini, A. Ioakimidou, A. Mysdkos, J. Perdios, 
0. Kalogeropoulou and P. Gargalianos 
Athens, CR 
Glycopeptide (G) overuse is considered as a risk factor for the emergence of 
glycopeptide resistant enterococci (GRE). The isolation ofsuch strains in OUF 
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hospital in late 1999 and during 2000 correlated well with the increasing 
G consumption during the last years. As a result, a restriction policy has 
been implemented since April 2001. According to this policy every G 
prescription has to be authorized by an infectious diseases physician. ICU 
was not included (a merent policy exists there). The main target was to 
effectively reduce the inappropriate use of G in cases where another anti- 
staphylococcal agent could be used. We present the results of an interim 
evaluation of our policy (for the period 1 April to 30 September 2001). A 
s id icant  decrease in G consumption was recordedin our hospital during this 
six-month period, in comparison with the same period of year 2000. With 
ICU data not included, vancomycin (V) use was reduced from 20.6 to 15.25 
DDDs/1000 patient-days (-26%) and that of teicoplanin (T) from 17 to 8.6 
DDDs/1000 patieut-days (-50%). In contrast an impressive rise in cloxacillin 
and fusidic acid use was observed (+800 and +400%, respectively). An 
increase was also recorded for clindamycin (&om 23.8 to 31.3 DDDs/ 
1000 patient-days, + 31.5%). When ICU data were included, the reduction 
for Vuse was sdl26%, but only 3.5% for T, because ofincreased consumption 
of this agent in the ICU. In the same period, the mean length of stay in our 
hospital showed a slight decrease (&om 4.87 to 4.6days) and so did the 
mortality &om all causes(&om 2.52 to 2.47%) (excluding ICU in both 
measurements). W e  the increase in cloxacillin and fusidic acid use is most 
welcomed, this is not the case for clindamycin since its overuse is also a risk 
factor for GRE emergence. 
Conclusions: It is encouraging that, at least in the shoa-term, our policy 
seems to effectively decrease G consumption without adversely a6eceing 
length of stay or mortality. The impact on GRE problem in our hospital is 
being evaluated and d be presented in a future publication. Lastly, a 
restriction policy is probably needed for the ICU as well. 
(p4121 Distribution, trends and seasonal behavior of 
antimicrobials used in five Spanish sanitary districts 
P. Campillos, M.-V. Tarazona, A. Burgos, J. Aznar, M. G o d e z ,  
M. Ah, C. Borrell and J.-M. L6pez-Lozano 
Orihuela, Valencia, Elche, Castelldn, E 
[ P413 I Antimicrobials use control at a teaching hospital, 
Surabaya, Indonesia 
E. Kolopaking 
Surabaya, ID 
Inappropriate use of antimicrobials (AM) is the key driver of AM resistance. 
Therefore, since 1984 Dr Soetomo Hospital has conducted a comprehensive 
program to promote rational use of AM. Starting with AM use reviews, it was 
found that there were huge problems in using AM. For example, the resul& of 
review on using AM for surgical prophylaxis in surgery wards in 1986 showed 
that irrational use according to the indication: 76.5% for clean and 27.5% for 
clean contaminated operations. Indications were correct, but inappropriate 
according to (a) timing: 57.2% for clean and 26.3% for clean contaminated (b) 
route of administration: 42.8% for dean and 10.6% for clean contaminated (c) 
duration: 10096 for both categories. As results of these efforts, a guideline for 
AM usage was developed in 1990. The guideline was not only a list ofAM, but 
also a policy on regulation and an educational tool. However, it was obvious 
that regulations and education alone were not effective in changing behavior. 
Regulations and educational measured should be supported by managerial 
steps. Unfortunately the roles of microbiological laboratory were not devel- 
oped yet. Continual AM utilization studies provided feedback, among others 
were: peer reviews, focused group discussions, retraining, providmg reliable 
literatures, etc. which in turn would bring awareness regarding the need for 
rational management and use of AM. The AM utilization studies and feed- 
backs also stimulated the need to revise the guideline periodidly Therefore, 
the second edition guideline was published in 1992. Although the results of 
the review was promising, i.e. the number of rational use of AM had been 
increasing steadily, 2040%, it also showed that the lack of microbiological 
information was the key factor in preventing the progress. Since the devel- 
opment of the guideline was not fully supported by systematic and standar- 
dized microbiological surveillance, this caused de-motivation in the 
adherence towards the guideline. Now with the support from The Royal 
Netherlands Academy of Arts and Sciences, Dr Soetomo Hospital together 
with Dr Kariadi Hospital, Leiden UMC, Erasmus UMC, and Nijmegen 
UMC are conducting study on Antimicrobial Resistance in Indonesia: 
prevalence and prevention (Ah4FUN Study). It is expected that the results 
wdl enhance the rational use of AM since microbiological laboratory is 
involved. 
Objective: To describe the outpatient antibiotic use in five sanitary districts in 
Comunidad Valenciana (Spain), its trends, relative distribution and sesonal 
behavior. 
Methods: The study was performed in five sanitary districts (2nd, 4th. 9th, 
19th and 20th - 1300000 inhabitants) in the ComunidadValenciana (Spain). 
Monthly DDD per 1000 inhabitants-day (DDH) of d antimicrobial used in 
community were obtained from prescriptions fmanced by the National 
Health System. From January 1996 to August 2000 in districts 2nd, 4th, 
9th and 19th, and from January 1994 to August 2000 in district ZOth, time 
series were performed using such data. In order to asses trends and seasonal 
behavior, A R M  models were adjusted. Multiplicative seasonal factors 
where estimated using Season SPSS procedure. 
Results: We observed a seasonal distribution with the highest overall use of 
antibiotics during winter months (e.g. in terms o fDDH January 1996: 29.4; 
January 1997: 33.3; January 1998: 30.4, January 1999: 32.9; January 2000 
26.9). Figures for summer months are nearly halfof those of winter months. 
Highest January seasonal factors correspond to macrolides (1.62), followed by 
penicillins with extended spectrum (1.61), third-generation cephalosporins 
(1.49), second-generation cephalosporins (1.43) and combinations of peni- 
cillins (incl- 8-lactamase inhibitors) (1.39). Trends of each antimicrobial 
group are presented. 
Conclusions: Upper respiratory-tract infections are the most frequent 
community infections in winter months. This fact can explain seasonal 
pattern in antimicrobial use, despite the frequently unknown infection 
aetiology. Intervention studies, guidelines and educational programs to reduce 
the prescription of antibiotics for respiratory-tract infectiom are necesaxy 
Time Series Analysis techniques are useful tools in order to improve 
knowledge ahout elements that can help to control of bacterial resistance 
problems. 
Acknowledgments This project is supported by Grant no. 00/0002 of Fondo 
de Investigacih Sanitaria, Mnisterio de Sanidad, Spain. 
P414 I Antibiotic prescribing patterns in outpatients with 
bacterial infedom. A questionnaire study of general 
practitioners in Denmark, Norway and Sweden 
I Odenholt, N. Frmodt-MoUer, K. Rokstad, A. Bylander-Groth and 
S. Molstad 
Malmo, S,  Copenhagen, OK, Tmndham, N 
Objectives: To mveshgate the anhbiohc prescriphon patterns for common 
bactenal infections among general practitioners (GF”s) in Denmark, Norway 
and Sweden, and to compare these patterns wlth the officlal guldehes for the 
respechve counmes. 
Methods: A queshonnvre concerxung how to handle eight cases of 
common bacterial infechons (urmary-tract decaon  0, SinuSihs, ouhs 
me&a, shn infechon, acute and relapsmg tonsfihs, acute exacerbahon 
of chromc bronchhs (AECB) and pneumoma) was sent to lo00 GPs m 
each country From the questionnares returned, answers were recorded 
accordmg to country, age and sex of the GP Anhbiohc treatment guidehes 
from the three countries were collected and compared to the answes 
recorded 
Results: The queshonnawes were answered and returned h m  46.8% (D), 
34.2% (N) and 38 8% (S), respechvely, of the GPs The malelfemale raho was 
2 5 (D), 2 7 (N) and 1.5 (S), respechvely, and the age me&an between 50 and 
60 years in D and S, 6 5 0  in N, reflechng the sex and age distnbuaon among 
GP’s in the three counmes. There were major d&krences in treatment of 
UTI, AECB, relapslng tonslllttls and skm mfections wMe treatment r e p e n s  
were quite sinular for the other mfechons. For ohhs me&, GPs m D and N 
awated symptoms before anhbiohc treahnent in contrast to Swedish GPs, 
who were more prone to treat at once The treatment modahha reftected the 
gmdehes for the three countnes 
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Conclusion: The questionnaire study was a relatively easy method to unravel 
the attitudes among GPs in the three countries, and the answers concurred 
with the antibiotic treatment guidelines for the individual countries. Changes 
in antibiotic treatment among GPs in the three countries could probably be 
accomplished by changing the treatment guidelines, which seem to be 
followed closely. 
The time and costs required for the intravenous 
administration of antibiotics: an activity-based costing 
approach 
A. R. H. van Zanten, P. M. Engelfkiet, J. Kosa and M. J. C. Nuijten 
Ede, Jisp, NL 
Objectives: To assess the true costs ofintravenous antibiotics administration by 
an activity-based costing approach. 
Methods: Core of this study was a time and motion analysis conducted in a 
large peripheral hospital in the Netherlands. A total of 100 routine acts of 
preparing and administering intravenous antibiotics were observed and timed 
by two research nurses. An extensive inventory and workflow chart was made 
of the whole process of intravenous antibiotics administration. This preli- 
minary analysis was used firstly to develop appropriate data transcription forms 
and secondly to be able to determine personnel costs and additional costs 
attributable to i.v. antibiotic therapy, such as overhead costs. The average costs 
per administration were calculated for each of the ditferent administration 
methods used in the hospital. 
Results: Four different methods ofintravenous drug administration were used 
in the study hospital: administration by volumetric pump, by syringe pump, 
'unaided' infusion bag administration, and direct intravenous injection. 
Average times per procedure, including preparation and adminismtion of 
the drug, were 4:  49 (SD 2 : 37). 4 :  56 (2 : 03), 5 :  51 (3: 33) and 9 :  23 
(minutes : seconds). When these times were related to personnel salaries, 
and the costs ofmaterials used were added (excluding drug costs), t h s  resulted 
in average costs of resp. EUR 5.65, 7.28, 5.36, 3.83 per administration. The 
insertion of an intravenous catheter, necessary for a first time administration to 
patients without an intravenous site, w a s  measured separately, and was found 
to be 10 : 15 (6 : 31) on average, associated with a cost of EUR 9.17. A few 
typical examples are given of how these data can be used to calculate the total 
personnel and material costs due to the preparation and administration of 
intravenous antibiotics for a full treatment of a particular patient. In addition, 
an attempt was made to estimate the overhead, storage and other miscella- 
neous costs attributable to intravenous antibiotics therapy. Although a reason- 
ably accurate estimate of those costs proved difficult, it seemed unlikely that 
such 'hidden' costs d add significantly to personnel and material costs. 
Conclusion: The true costs ofintravenous antibiotics administration consist of 
personnel time, material costs and overhead in addition to the costs of the 
drugs themselves. In our analysis, the nursing time required and materials used 
were identified as the main cost drivers. 
Ip4161 Comparison of hospital resource use between 
linezolid and teicoplanin for Gram-positive bacterial 
infections including skin and soft tissue infections: results 
from European Cohort of a multicentre trial 
M. Tavakoli, D. Nathwani, D. Balan and J. Z .  Li 
St Andrews, Dundee, UK; Kalamazoo, USA 
Background Linezolid (LZD) is a new synthetic oxazolidinone antibacterial 
agent, which is active against multiresistant Gram-positive organisms. It is 
available in both i.v. and oral forms with 100% bioavailability. It is as effective 
as standard therapies including flucloxacillin and vancomycin for a range of 
infections. In a randomised multicentre trial, LZD was compared to Teico- 
planin (TEI), a commonly used glycopeptide agent in Europe, for clinical 
eficacy and hospital resource utilization. The latter data are presented here. 
Objective: Compare length of hospital (LOS) and i.v. days of study medica- 
tions and discharge rate (DR) between Linezolid and Teicoplanin for the 
treatment of Gram-positive infections with special reference to skin and soft 
tissue infections. 
Methods: From a randomised inulticentre trial, 227 hospitalized patients from 
the UK, Germany, Sweden, Italy and Spain caused by Gram-positive bacteria, 
including complicated skin/soft tissue infection (SSTI) subset, were treated 
with Linezolid (i.v. followed by oral) or Teicoplanin (i.v. followed by optional 
intramuscular (im.)) for a minimum of 6 days and up to 28 days. This was 
followed by a further 21 days follow-up observation. The analytic sample 
consists of 210 patients after excluding 17 deaths not related to treatment. 
Kaplan-Meier survival analysis and t-test were used to estimate mean and 
medun LOS and i.v. days, respectively. The hospital discharge rates are also 
reported. Discharge dates, were confirmed for 88% of the sample (185/210) 
while the remaining LOS data were censored. 
Results: Results for the total intent-to-heat (ITT) and the subgroup of S k i d  
Soft Tissue Infection (SSTI) are shown below. 
LOS % Patients ducharged by 
iu. Day KM KM 
mean mean me& ? znd 3rd 4rh Srudy sample 
and medicahon N (days) (SE) (95% Cl) week week week week 
ALL (LZD) 108 5.8 15 (1) 9 (7-11) 35 61 75 82 
102 9.3 17 (2) 9 (7-11) 29 58 69 75 ALL (TEr) 
P d u e  0.ooO 0.5 0.5 
SSTI (LZD) 65 5.3 14 (2) 8 (&lo) 42 65 75 82 
53 8.9 16 (2) 8 (7-9) 36 60 74 79 SSTI (TEI) 
P d u e  0.0002 0.82 0.82 
0.37 0.63 0.3 0.16 
0.53 0.64 0.82 0.75 
Conclusion: Linezolid patients tend to have shorter LOS, higher DR and 
sigdcantly shorter i.v. days. 
p17/ A 10-year study of the consumption of quinolones, 
trimethoprirn and mecillinarn in relation to the development 
of antimicrobial resistance in a large number of bacterial 
species 
vaq.0; s 
A. Runehagen and G. Kahlmeter 
Objective: The correlation between the use of antibiotics and resistance is not 
always evident. In Kronoberg county, Sweden, we have more than 10 years of 
quantitative data on antimicrobial susceptibility and on outpatient antibiotic 
consumption. This study attempts to relate resistance to consumption during 
t h i s  period. 
Methods: In a stable population of 176000 during 199C2001, all suscept- 
ibility tests were performed according to the Swedish Reference Group of 
Antibiotics. All inhibition zone diameters were measured and yearly zone 
diameter distributions were analyzed. The mean and SD of the wild-type 
populations were calculated. Resistance was measured using epidemiological 
breakpoints, and defined as the proportion of isolates outside -3 SD. In 
Sweden sales of drugs are registered centrally which allows the analysis of 
yearly drug consumption by outpatients. Data were analyzed as defined daily 
doses per 1000 inhabitants and year (DDD). Three classes of antibiotics were 
studied, each representing Merent  trends in consumption. 
Results: The consumption of trimethoprim was stable over 10 years (0.54- 
0.66 DDD/1000 IY). Resistance increased in E.fuealis (8-28%) and 
decreased in S. agulactiae (104%). In Staphylococci, E. coli, Kfebisella and 
Prooreus rnirabiiis the resistance levels were stable between 5 and 15%. The 
consumption of meciUinam more than doubled (0.54-1.22 DDD/1000 IY). 
Resistance levels were stable in E. coli (9-10%), Kfebsieflapneurnoniae (10-9%), 
Klebisella oxytoca (16-16%), and decreasedin Proteur rnirabilis (156%). The use 
of fluoroquinolones increased from 0.55 DDD/1000 IY to a maximum 1.47 
DDD/1000 IY in 1994 after w h c h  a gradual decrease to 0.98 DDD/1000 IY 
was recorded in 2000. Increasing resistance levels were recorded in Campy- 
lobarter (742%) and P~eudomonas amginosa (1622%). In E.  coli, with more 
than 3000 isolates analyzed per year, quinolone resistance has been slowly 
increasing to a level of 5% over the last 6years. 
Conclusion: The relation between consumption of and resistance to anti- 
microbial agents is not always immediately evident. In the present study, we 
were able to analyze high quality data over 10 years for large number ofisolates 
in a stable catchment population for three antibiotics showing different 
consumption trends. There was no clearcut simple correlation between 
consumption and resistance development. 
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Ip4181 European surveillance of antimicrobial 
consumption (ESAC): availability and accessibility of 
antibiotic utilization data in European countries 
M. M. Elseviers, R. Vander Stichele, I. Vanhaeren, M. Van Looveren, 
I. Bauraind, E. Hendrickx and H. Goossens 
Edegem, Chent, Brussels, B 
Objectives: ESAC (granted by DG/SANCO of the EC for the period 
November 2001actober 2003) is an international network of national 
surveillance systems, aiming to collect comparable and reliable antibiotic 
use data in all European countries. In order to obtain insight in the starting 
position of all participating countries, a preparatory questionnaire was dis- 
tributed among all national representatives. 
Methods: The questionnaire was sent to 26 national representatives, all 
returned the completed forms. Sales status of antibiotics, reimbursement 
system, availability of consumption data and details about the structure of 
existing databases for community care and hospitals were questioned. 
Results: In 21 out of 26 countries, antibiotics are prescription only, OTC is 
still possible in the remaining 5. In 15 countries, an identical reimbursement 
system is used for all antibiotics with a percentage of reimbursement ranging 
h m  0 to 100%. In most countries, government (Ministery of Health 
Medicines Agency) as well as other organisations (Health Insurance Company, 
Pharmacists, Marketing Research Company) are capable of data collection. 
For ambulatory care, in most countries (n= 18) census data are available, per 
county (n= 16) and on a quarterly (n= 8) or monthly (n=6) base. For 
hospitals, it seems that the availability of data is more limited. Anatomical 
Therapeutic Chemical (ATC) classification of antibiotics is used in all 
countries except 2 and volume can be expressed in defined dady dose 
(DDD) in most of them. An increasing number of countries have antibiotic 
consumption data available in recent years ranging from 16 in 1997 to 21 in 
2000 for ambulatory care and from 10 in 1997 to 16 in 2000 for hospitals. Data 
of 2001 will be available between March and October of 2002. 
Conclusion: It is the intention of the ESAC project to create a dynamic and 
up-to-date databank covering all aspects of antibiotic use. At the end of the 
pilot period, databases of continuing surveillance of antibiotic use, containing 
retrospective annual data for the period 1997-2001 and detailed prospective 
data for 2002, WIII be accessible for scientists and health authorities in order to 
link utilization data to resistance patterns and to assess the impact of inter- 
vention strategies at the community and hospital level. 
Consumption of 26 parenteral antimicrobial agents 
in 50 Northern France hospitals. Data from the ARECUN 
Hospital Pharmacists Study Group 
S .  Alfandari, C. Bonenfant, L. Depretere and G. Beaucaire 
Tourcoing, Armentiera, Saint Omer, F 
Objectives: Little data is available on hospital antibiotic (AB) consumption in 
France. ARECLIN is a network of infectious diseases and infection control 
professionals in North France hospitals. It covers approximately 7% of the 
French population, i.e. 4 million individuals A project to record AB con- 
sumption was initiated in 1998. 
Methods: Annual data were collected retrospectively since 1995 and pro- 
spectively after 1998. Simultaneously, ARECLIN promoted the use of 
automatic stop orders for hospital AB. Data collected included consumption 
of 23 AB (amikacin, aztreonam, cefepim, cefotaxime, cefpirome, ceftazidime, 
ceftriaxone, ciprofloxacine, fosfomycine, fusidic acid, lwofloxacin, imipe- 
nem, isepamicin, ofloxacine, pefloxacine, piperacillin, quinupristin/dalfo- 
pristin, sulbactam, tazocillin, teicoplanin, ticarcillin, ticarch-clavulanic 
acid, vancomyciue) and three antifungals (amphotericin B lipid formulations 
and fluconazole), total hospitals AB spending and activity data. AB con- 
sumption was compared using WHO defined daily doses per 100 hospitaliza- 
tion days (DDD/HD). 
Results: Participation in the study varied by hospital size: 100% for hospitals 
with >400 acute care beds (n = 9), 80?? for 200-400 beds (n = 12) and 27% 
for <200 beds (n= 128). P <  10-7. The non-participating hospitals had a 
mean bed number of 68 compared to 241 for participating hospitals. Thus, 50 
hospitak (40 publics, 10 private) were enrolled in 2000. AB consumption was 
hgher in hospitals with >400 beds (16.3 k3.5 DDD/HD) than in 2-400 
bedshospitals(l0.2f4DDD/HD)or<200bedshospids(10.5~ 13DDD/ 
HD). A difference in per-admission AB cost was also noted 23.9 +L 7 € (>400 
beds), 14.6 f 5.1 e (2-400 beds), 15.2 f 15 € (<200 beds). Over 6yem. 
overall evolution of AB consumption was marked by a non sigdcant increase 
(fiom 14.4 DDD/HD in 1995 to 17.2 DDD/HD in 2000, P=0.88). The 
only sigdcant diffmnce observed in AB class consumption was a dramatic 
decrease of aminoglycoside consumption (2.4 DDD/HD in 1995 to 1.5 
DDD/HD in 2000, P < 0.002). Conversely, the mean AB cost per admission 
decreased from 33.5 23 to 16.8 =t 12 € (P< 0.02). 
Conclusions: This study provides interesting information on the wide varia- 
tion of AB consumption among hospitals in the same geographcal setting as 
well as among hospitals with similar size and activity. It will help us target 
hospital specific AB control strategies. 
ml Use of antibiotics and development of resistance at 
a university hospital 
A. C. Rodloff, B. Chiistiansen, Ch. Eckhardt and J. Beer 
hip+ ,  D 
Objective: The de-escalation approach in treatment of severe infections is 
generally accepted at our university hospital. Several antibiotic agents are used 
in parallel for this purpose. The study was done to assess the impact of this 
approach on resistance development in nosocomial pathogens. 
Methods: Data were collected on antibiotic use since 1997. MlCs were 
established for al l  pathogens isolated from relevant specimens of infected 
patients of the university hospital. 
Results: The following overall use of selected antibiotics was made: 
%/patient days 
Agent 1997 1998 1999 2000 
Imipenem 19 29 35 29 
PIP/TAz 177 257 214 181 
Cetiazihme 45 45 51 51 
Gentamicin 19 19 15 8 
Ciprofloxacin 4 4 7 5 
During the time period studied, no changes in resistance patterns, i.e. for 
Pseudomonas uetuginosa were observed (MIC distributlons will be shown). 
Conclusions Employing several antibiotic agents for de-escalation therapy in 
parallel seem to be at least as effective in reducing selective pressure as 
scheduled changes of antibiotic classes. 
ml Antibiotic consumption in hospitals of Clalit Health 
Services in Israel, 1995-1999 
R. Kitzes-Cohen, A. Wasrennan, D. Koos, N. Bar-Joseph, 
A. Goldschmid and N. Liebermann 
Ha@, “2-Aviv, IL 
Objectives: This study was performed with the intent to obtain information 
about the pattern of antibiotic consumption in eight Clalit Health Services 
general hospitals. An antibiotic control policy under the supervision of 
infectious diseases physicians exists in all the Clalit Health Services hospitals, 
except one. The most expensive antibiotics, with broad-spectrum activity and 
a major impact on bacterial resistance, are restricted (vancomycin. ureido- 
penicillins, ceftazidime, carbapenems, amikacin, quinolones) . 
Methods: The data presented are based on the antibiotics supplied to all the 
hospitals during the years 1995-1999, which represent the actual hospital 
antibiotic consumption. The ATC/DDD 2000 methodology was used. The 
data are expressed as Defined Daily Dose (DDDs) per 100 bed days and is 
statistically analyzed for each year, for each hospital and, in adcltion, according 
to hospital type (tertiary or community). 
Resuhs: The total DDDs for each hospital were around 120 without 
significant variation over time. The DDDs of restricted antibiotics varied 
fiom 6.6 to 7.9 during the study period. Use ofbroad-spectrum penicilIins - 
JOlCA was the highest (57 DDDs) followed by cephalosporins - JOlDA 
(27.5 DDDs). The patterns of DDDs Mered during the Syeas, like 
coamoxiclav, which increased from 14 to 27 ( P < O . O l )  and amoxicillin, 
which decreased from 24 to 16 DDDs (P<O.OOl). The patterns of con- 
sumption differed between tertiary and community hospitals. Penidin G was 
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hghly used in community hospitals (P< 0.001) and amikacin, carbapenems, 
vancomycin and tazocin were highly used m tertiary hospitals (P< 0.001). 
Conclusions: The positive mpact ofinfection control units is reflected by the 
low DDDs of restricted antibiotics. However, more than 120 DDDs/year in 
each hospital reflect high consumption of antibiotics in general and control 
measures should be directed to decrease the consumption of nonrestricted 
antibiotics, as well. 
Keywords antibiotics, ConSumphOn, DDDs 
w1 Prevalence of antibiotic use in nosocomial 
infections 
S. Rugina and C. S. Cambrea 
Constanta, RO 
Background: To h o w  the prevalence of antibiotic utilization is important for 
correct appreciation of antibiotic use and for estimation of medical expenses. 
Objectives: To obtain information on antibiotic utilization in nosocomial 
infections (NI) in a county hospital. 
Methods: The study was carried out in the County Hospital Constanta, 
Romania (1875 beds), in 1997, in the departments with a high epidemiologic 
risk of transmission of N I  normal and pathologic obstetrics, newly born, 
pediatrics, general surgery, intensive care unit, hemodialysis and plastic 
surgery. The study is based on cross-sectional surveys. The prevalence of 
NI was calculated for patients with one or more NI, and the use of antibiotics 
for each episode was taken into consideration. 
Results: A total of 26 NI were detecced in 502 surveyed patients in the studied 
departments. This represent a prevalence of NI of about 5.17%, and in a 
patients with one or more NI, of about 4.78% (SD = 15.07). The prevalence 
of antibiotics use was 46.2% with highest values in intensive care unit (90.47), 
plastic surgery (89.5%). pediaaics (70.49%) and general surgery (54%). The 
most fiequent antibiotics used in NI treatment were: Penicillin G (38.46%). 
Gentamycine (69.23%), Ampicillin (30.76%). Norfloxacine (11.53%), 
Cephalosporines of third generation (19.23%), and Metronidazol 
(15.38%). There were used next associations of antibiotics: Ampicil- 
lin + Gentamycine + Metronidazol in four cases, Penicillin G + Gentamycine 
in 14 cases. Monotherapy was performed with Cephalosporines of third 
generation in five cases, with Fluorquinolons in three cases and with 
Imipenem in one case. The supplementary expenditures on NI were esti- 
mated. 
Conclusions: We found an antibiotic abuse in surgery departments, pediatrics 
and intensive care unit. Optimization of antibiotics use require a good 
collaboration between clinician, pathologist, pharmacist and pharmaceutical 
companies for the best policy in antibiotic use. The results obtained in this 
study show the need for another national multicenter study, based on the same 
methodology. 
were clean-contammated and cephazoh was used in 16/25 (64%) of pts. In 
general ward AP varied between each categories of SP (34/56 clean-con- 
tarmnated, 13/56 contaminated and 1/56 dirty). Cephazolin was used in 
28.6% of pts; cefaiaxone and cefepime in 17.8% of cases, respectively. The 
5.3% of pa received metronidazole + gentarmcin for colorectal SP. AP was 
mcorrect for timing 111 37.5% of cases and for dosage m 34.4% AP became 
therapy m 75% of cases. 
Conclusion: Apphcahon of GD for correct AP was started in orthopedic and 
mdo-facial  wards. A major goals are to standadze the correct use ofAP by 
international GD in all wards and to control the incidence of SSI with a 
surveiIlance system. 
lp424/ Laboratory physicians: an alternative resource for 
implementing organization-wide quality systems 
T. M. S. Barkham and R. C. Hawkins 
Singapore, S C P  
Objective: To raise ayviveness ofin-house expertise for the implementation of 
organisation-wide quality systems. 
Comment Healthcare institutions are introducing quahty improvement 
program that have been in use in indusq for over 30years. These program 
cost money, much of it spent on external consultants and middle management 
hired to implement them. Pathology physicians in diagnostic laboratories are 
well versed in quality issues and for many years have been subjected to 
accreditation which addresses administration, personnel, safety, the physical 
environment, test procedures, quality arsurance and quality improvement. 
Laboratories have existing safety committees with skills re. vaccination, 
control of and exposure to dangerous chemical and biological agents, their 
safe disposal and systems for the reporting and recording of injuries. These 
skills can be put to use across organisations implementing standards such as 
IS0  9000 (Quality systems), I S 0  14000 (Environmental Management) and 
OHSAS 18000 (Occupational Health and Safety Assessment Series) as well as 
IS0  17000 (caboratory Systems). In addition, under pressure h m  the threat 
of ‘league tables’ and other forms of comparison, organisations are imple- 
menting Quality Improvement Programs similar to those used in laboratories. 
Aspects of care can be tracked mathematically with statistical process controls 
in routine use in chemistry and serology laboratories, e.g. run charts and 
control charts. These methods can and should be applied to processes to 
identify abnormal or unexpected outcomes, e.g. unscheduled returns to the 
operating theatre, implant infection rates, caesarian section rates. There is an 
opportunity for Pathology physicians to apply their expertise and share their 
experience in areas beyond the laboratory. 
Conclusion: Healthcare Institutions can make use of in-house Pathology 
expertise that can be harnessed to address Quality Control and Improvement 
throughout the Institution. 
Perioperative antibiotic prophylaxis (AP) in five 
Italian hospitals 
D. Tomasoni, G. Gattuso, G. Fibbia, D. Confalonieri, B. Morandini, 
G. Perboni, I? Costa and A. Scalzini 
Mantua, I 
Objectives: To evaluate the AP for prevention surgical site infections (SSI) in 
five Italian hospitals. To assay the degree of knowledge and use ofAP. To study 
the effectiveness of guidelines (GD) for rational use of antibiotics. 
Methods: A retrospective study was conducted to determine AP use accord- 
ing to surgical procedures (SP) in maxillo-facial, thoracic, urologic, gyne- 
cological, orthopedic and general wards. The review included the 
classification of the SP and the types of antibiotics used, route, timing and 
additional doses. In general ward the SP were divided by category and each 
one including a set of similar procedures. 
Results: The review of 162/306 (52.9%) patients (pts) undergoing SP revealed 
a SSI rate of 1.6%. AP was received by 150/162 (92.6%) pts. AP was not 
indicated in 6.2% of cases and in 1.2% was not performed. Cephalosporim 
were adninistrated in 117/150 (78.0%) pts and penicdines in 15/150 
(10.0%). Cephazolin was somminsndted in 39.4% of cases, particularly in 
al l  SP of thoracic, rnaxillo and urologic wards. Cefniaxone was used in 26.0% 
ofcases and in orthopedic surgeries was administrated in 22/59 (44.1%) cases. 
56/59 (94.9%) of the orthopedic SP were clean (prosthesis 26/56, 46.4%); 
teicoplanin (30.8%) and cephazoh (26.9%) were used. AU gynecological SP 
I P425 I Public health and public pharmacy 
M. Voitcu, E. Carausu, R. Streit, N. Balan, G. Sarbu and R. Balica 
Iasi, RO 
The community pharmacy roles in the public health are:the epidemic diseases 
control, the nonepidemic diseases control, the use ofthe psychodisleptic drugs 
control, the prevention of illness, the sanitary education of the public, the 
protection of mother and ctuld, the f d y  planning and the reproduction 
health, the stomatological prevention, the education b r  healthy nourishment, 
the protection of the environment, the prevention of alcoholism, the control 
of the medicine abuse and self-medication (automedication). Within the 
present work, we determine the importance of the self-medication with 
antibiotics and the role of the pharmacist in the automekcation control. We 
use the method of the specific questionnaire and the study of the pharma- 
ceutical services with in the community pharmacy, during a period of 60 days. 
The list of the compensated medicines from our country has 2092 products, 
containing 260 active ingredients. The antibiotics represent 380 products 
(18%) based upon 23 active ingredients (8.8%), the list containing also 154 
antimicrobial products (7.3%), meaning that the antibiotic products have an 
important role as therapeutic agents. Between the most prescribed antibiotics 
upon the compensated receipts during the 2000yean, we find amoxicillin 
(2.7%), ampicillin (2.5%) and cephalexin (1.5%). This means the antibiotic 
products are frequently prescribed in our country, because of the specific 
morbidity. A research of the most prescribed medicines upon noncompen- 
sated receipts during the 2000yean, gave the following results for the 
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antibiotics: amoxicillinum (1.4%), ampiciUinum (1.4%), nystatinum (1.13%), 
erytromycinum (0.95%), phenoxymethtlmethydini (0.8%), gentamicynum 
(0.7%), doxyciclinum (0.7%). The conclusion of our study: the pharmacist is 
able and has the prestige to conarol the antibiotic abuse and the self-medica- 
tion, explaining the consequences to the patients. All these represent a part of 
the pharmaceutical services offered by the pharmacist in the community 
pharmacy. 
vl Outpatient parenteral antibiotic therapy (OPAT): 
the Italian registry 
S. Esposito, S. Noviello, A. Tice, A. Maiello, E de Lalla, C. Girmenia, 
E Marranconi, G. Serrentino, A. Iaccarino and E. Di Cianni 
Naples, I; Seattle, USA; Turin, Vkenza, Rome, Schio, I 
Objectives: In the early eighties, in the US the advantages (reduced costs, no 
hospitalization trauma in children, no immobilization syndrome in elderly, 
reduction of nosocomial and acquired infections by multiresistant organisms) 
of OPAT were identified and suitable therapeutic programs were established 
Following the US experience, other countries set up their own OPAT 
programs which vary considerably from country to country because of 
different ways in which infections diseases are managed in Merent parts 
of the world and because of different reimbursement systems. In order to 
Resistance in Gram-negative bacilli 
understand the ways of managing OPAT and its results, a national OPAT 
registry was set up in 1999 in Italy belonging to a wider International OPAT 
database, which collects data also from USA, Canada, Spain, Uruguay and 
Argentina. 
Methods: Up to now 400 patients and as many antibiotic counes have been 
included in the national registry by eight different centen. The analysis of data 
permits to get information about the criteria of patient’s selection, treatment 
(route of administration, site of care, choice of antibiotic, dosage and 
duration), outcomes and possible side-effects. 
Results: Italian results offer a quite peculiar picture of OPAT in this country 
when comparing data with those of other countries. In contrast with other 
countries where soft tissue infections and osteomyelitis are the most frequent 
diagnoses for including patients in OPAT programs, in Italy pneumonia and 
bronchitis are the top two amenable infections. Ceftriaxone, Teicoplanin and 
Amikacin are absolutely the top three antibiotics selected for OPAT in Italy 
which confirm that a single daily dose regimen represents a great advantage in 
terms of compliance. FinaUy a large percentage of antibiotic courses (50%) are 
carried out by using the i.m. administration route which is very unusual in 
other countries. 
Conclusions: OPAT registry is still ongoing and it will gwe us more detailed 
information in the future about the management of infections in the out- 
patient setting, but it already permits to define an actual picture of OPAT in 
our country and/or to compare and cordate data and information from 
different countries. 
v1 Infections due to 8-lactamase producers among 
critically ill hospitalized patients and their susceptibility to 
cefoperazone-sulbactam 
A. Shahani 
Cochin, IND 
The problem of infections owing to the /?-lactamase-producing organjsms i s  
increasing globally at an alarming rate. Most laboratories in developing 
countries do not employ tests for detection of 8-lactamase owing to the 
high cost of such testing. In h s  study, sigdicant pathogens hke Enferococcus 
fecalis, coagulase-negative Staphyfocouus and Staphylococcus aurew were tested 
for 8-lactamase production by nitrocefin disc test (BBL, Difco) and the 
multidrug-resistant Gram-negative organisms with suspicious antibiogram 
were tested for ESBL production by a simple disc approximation test using 
cefotaxime and cefotaxime-clavulanic acid discs. A total of 49 Enterococcus 
$curis, 60 coagulase-negative Staphylococcus and 48 S. aureus strains were tested 
by nitrocefin test, and 71 E. coli, 120 Klebsiella spp., 21 Citrobacter spp., 7 
Enterobacter spp.. 32 Protars spp., 85 F? aemginosa and 93 nonfermenter Gram- 
negative bacih were tested for ESBL production. These were obtained from 
the critically ill hospitalized patients from sounes, like urine (17%), respiratory 
(20%), wound (20%), blood (27%) and other sterile body sites (16%). Of the 
157 Gram-positive isolates tested, 76 were fl-lactamase producers ofwhich 32 
(42%) were susceptible to cefoperazone-sulbact. Of the 429 Gram-nega- 
tive isolates, 283 multidrug-resistant isolates were tested for ESBL production. 
A total of 217 isolates were found to be ESBL producers ofwhich 158 (72%) 
were susceptible to cefoperazone-sulbactam. Cefoperazone-sulbactam can be 
used emperically for treatment of infections in critically ill in-patients in 
hospitals with a high prevalence of infections owing to the ESBL-producing 
Gram-negative organisms. 
jp4281 Epidemiology of Enterobacfer aerogenes in 
Belgium: preliminary results of a multicenter survey 
Y. De Gheldre, Y. Glupczynslu, C. Berlun, M. J. Struelens and 
l? De Mol, Gdepih-Gospiz 
Yvoir, Lkssels, L&e, B 
Objectives: A M h O d  prospechve study was conducted in 2000-2001 to 
characterize the epidemology of E aerogenes cltn~cal isolates from hospitalued 
pahents in Belgnn hospitals 
Methods: Propomon rates and inndence data for E. aerogenes clinical isolates 
recovered from routine culturef during the second semester 2000 
were evaluated usmg a queshonnaxe. E. aerogenes stratns were defined as 
mdhreslstant (MREA) if they were resistant to at least one of the thd 
generahon cephalosporms. Anhmcmbid suscephbhty (MICs of 10 anti- 
rmcrobials determmed by agar dUhOn) and ESBL produchon (detected using 
the double-dxsk synergy test and Oxoid combmation disks) were d e t e m e d  
on s h a m s  collected h m  hospitahed pahents (five consecuhve nonduplicate 
MREA strains for each center) 60m May 2000 to May 2001. 
Results: Forty per cent (n = 50) of the centen answered the questionme 
The regonal dlstribuhon showed 21 parhcipants &om Walloma, 22 of 
Flanders and 7 from the Brussels regmn MREA represented 51% (range 
0-98) of the smns and mean mcidence of MREA among hospitalwed 
pahents was evaluated at 5/1000 ( w e  0-17) adrmssions; 78% (range 0- 
100) of the MREA strams were nosocornally acqulred 65 centers sent 313 
strams isolated from pahents (mean age 72years) hospitahed mostly m 
medxcal (35%), long-ame care (20%), mtemve care (18%) and surgical 
(15%) wts. Shams origmated m n l y  ham the u a r y  (44%) and respuatory 
(32%) tracts, from wounds swabs (13%) and blood cultures (5%). More than 
85% of the stmns were resistant to ceftaadme and ciprofloxaan, less than 
15% to armnoglycosides, l a  than 8% PO cefepnne and mpenem. No 
meropenem-resistant strains were recovered ESBL producaon was detected 
by the two methods m 65% of the strams, all being resistant to both 
ceftazidlme and ciprofloxacin 
Conclusions: T h s  study strongly confirms the wdespread &ssermnanon of 
ESBL-producmg MREA strams among pahents adrmtted to alarge number of 
Beban hospitals and their dismbuhon m almost all types of wards. 
vl Molecular typing of extended spectrum 
plactatnase-producing K/ebsiella pneumoniae isolates in a 
neonatal intensive-care unit in Greece 
E Lebessi, H Dellagrammahcas, P T Tasslos, L S. Tzouvelelus, 
S l o m d o u ,  M Foustoukou and N. J Legalas 
Athens, GR 
Objectives: The m of &IS study was to deterrmne clonal relations among 
extended-spectrum /?-lactamase-producing KlebrreUa pneumonrue (EPKP) iso- 
lated 60m neonates. 
Methods: Isolanon and species charactenzanon were performed accordmg to 
standard procedures. Suscephbhty to anhbiotics was deterrmned by a disk 
dxhsion method and evaluated usmg NCCLS gurdehes. Genomc DNA 
fingerprints were generated by XbaI restrichon and pulsed field gel electro- 
phoresis (PFGE) 
Results: During the period 1997-1998, 21 infechons and 23 ColonIZahOns 
with EPKP were recorded in the NICU of a chtldren’s hospital m Athens. 
Seventeen of the mfected and 12 of the colomzed neonates had been referred 
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fhm other hospitals. The remaining infections and colonizations occurred 
during hospitalization in OUT hospital PFGE typing showed that the latter 
cases were owing to an outbreak st ra in  that persisted in the unit, whereas the 
repeated introduction of EPKP-carriers was mostly owing to the clonal 
outbreaks in two maternity hospitals. 
Condusions: Extended-spectrum 8-lactamase-producing K.  pneumoniae 
(EPKP) strains are frequently implicated in outbreaks in neonatal inten- 
sive-care unia. Past studies have documented the high prevalence of EPKP in 
various Greek hospitals. The data presented here indicate that these micro- 
organism have ako been spread in pediatric and maternity hospitals in the 
Athens area. 
suscephble (64.3% vs. 77.0%); nahondy, greater suscepabhty was seen for 
cefmidune (88 1%; n = 159 066) versus cefepme (78.4%. n = 10 052). a 
Merence present mthm each regon. For S. marcescens, 94.4% of isolates 
natlonally were suscephble to c e h o n e  (n = 16 960). compared mth  87.6% 
to cefiazldme (n = 9799), also seen m North-central (94.8% vs. 89 2%) and 
South-east (93.7% vs. 85.0%); a Merence was noted between cefrrlaxone and 
cefotmme in North-east (97 3% vs 92 3%) and North-central (94.8% vs. 
90.6%). 
Conclusions: A greater percentage of Gram-negahve orgamms r e m  
suscephble to extended-spec- cephalosponn than to fluoroquinolone 
antibiohcs, a difference vahdated nanonally and regonally w x t h  the US. 
First detection of CTX-Md-like /I-lactamase- 
producing E. coli in Europe 
Ip432) Epidemiology of ciprofloxacin resistance and its 
relationship to ESBL-producing Klebsiellapneumoniae 
I. Schneider, E. Keuleyan, R. Markovska and A. Bauernfeind 
Munich, D; Sofia, BG 
A. Dashti, S. Amyes, R. Miles and R. Paton 
Edinburgh, UK 
Objectives: Surveillance of the epidemiology of extended-spectrum 1-lacta- 
mase (ESBL)-producing Enterobacteriaceae in Bulgaria and screening for 
uncommon enzymes. 
Methods: Enterobacteriaceae isolated h m  clinical specimens between 1997 
and 2001 were screened for the production of ESBL by their MICs for 
oxyiminocephalosporins and aztreonam together with combinations includ- 
ing sulbactam. Strains supposed to produce ESBLs were further analyzed to 
identify their enzymes. 
Results: An E. coli strain &om urine of a female patient demonstrated MIC 
of >512 and 256mg/L for cefotaxime and ceftazidime, indicating the 
production of a cefotaximase. The p l  of the enzyme was slightly above that 
ofCTX-M-3. The gene encoding this enzyme was transferrable and could be 
amplified with CTX-M group specific primers. Sequencing of the amplificate 
and deduction of the amino acid sequence demonstrated identity with 
CTX-M-3 except for one amino acid substitution at position 240 &om 
aspartate to glycine. Therefore the enzyme was identified as CTX-M-3 hke 
p-lactamase previously descibed by Karim, A et al. (FEMS Microbiol Lett 201 
Conclusion: Bulgaria is the first place in Europe where CTX-M-3 hke 
/Llactamase was detected after it had been isolated h m  patients in Japan 
and in India in 2000. Continuing surveillance can show whether this 8- 
lactamase gene may spread among patients in Bulgaria. 
(2001) 237-241). 
National and regional susceptibility of Gram- 
negative organisms to extended-spectrum cephalosporin 
and fluoroquinolone antibiotics: results of the Antimicrobial 
Resistance Management (ARM) Program 
J. Gums 
Gainesville, USA 
Objectives: The ongoing ARM program was developed to document 
susceptibility patterns, including for Gram-negative organisms, in both in- 
and out-patient isolates. Since 1987, more than 10 million isolates have been 
collected on 19 organisms and 46 antibiotics h m  103 US hospitals in the 
North-east, North-central, South-east, South-central, and South-west. 
Methods: Antibiograms and sensitivity reports of isolates for Escherichiu coli, 
Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aarginosa, and Senaria 
marcescem were reviewed for susceptibility to extended-spectrum cephalos- 
porin (cefuroxime, cefoxitin, cefotetan, cefotaxime, ceftazidime, cefhiaxone, 
and cefepime) and fluoroquinolone (ciprofloxacin, levofloxacin, ofloxacin, 
and trovafloxacin) antibiotics. 
Results: The total number of isolates and percentage of isolates susceptible to 
the antibiotics were determined for each organism. Nationally, E. co[i isolates 
had greater susceptibility to ceftriaxone (n = 318 802) than fluoroquinolones 
(n = 571 551). This was also seen for K .  pneumoniue, except in South-west, 
where isolate susceptibility to ciprofloxacin (98.5%) dtered fiom ceftriaxone 
(98.0%). Isolate susceptibility of ciprofloxacin and levofloxacin to I? mirabilis 
was suppressed, specifically for ciprofloxacin in South-cend (70.6%); cross- 
resistance is suggested by similar increases and decreases in susceptihility to 
these agents within regions. Isolate susceptibility differed nationaliy between 
cefuiaxone (99.4%. n = 58 422) and ceftazidime (96.5%, n= 29 344); espe- 
cially in the North-east (98.9% vs. 86.8%). For I? aenrginosa, national suscept- 
ibility to ciprofloxacin (73.6%, n =  141 034) and levofloxacin (67.3%, 
n = 41 673) was similar, except in South-west, where levofloxacin was more 
Objectives: To examine the epidemiology of ciprofloxacin resistant ESBL- 
producing Mebsiella pneumoniae strains. 
Methods: Sixty-nine unique patient isolates of K. pneumoniae isolated fiom a 
variety of clinical specimens submitted to the clirucal bacteriology laboratories 
of the Royal Infirmary of Edinburgh and associated GP practices were 
identified and susceptibility testing performed with the Vitek system. Strains 
that flagged as extended spectrum B-lactamase (ESBL) positive by the Vitek 
system were subjected to isoelectric focusing. 
Results: The results suggested that all 69 isolates harboured at least one ESBL. 
Of the 69 isolates, 32 (46.6%) were found to be resistant to ciprofloxacin, 11 
(16%) were intermediate and 26 (37.6%) were sensitive. To investigate the 
epidemiological relationship between the ciprofloxacin resistant/ESBL posi- 
tive strains, pulse-field gel electrophoresis (PFGE) was performed. Rapid- 
dest@ software was used to calculate the genetic distance by the Nei distance 
method. PFGE analysis indicated that the clinical isolates belonged to four 
distinct genotype cluster groups (A, B, C and D), each group or cluster was 
homogenous or compact with respect to certain characteristics. Group A 
consisted of 25 isolates, Group B three isolates and Groups C and D, two 
isolates each. PCR was used to amplifj~ thegyrA gene h m  genomic DNA of 
the ciprofloxacin resistant isolates. The amplified product was sent for analysis 
by automated DNA sequencing and the resulting DNA sequences compared 
with the gyrA gene of K .  pneumoniae. 
Conclusions: These results indicate that the spread of fluoroquinolone 
resistance is largely as a result of the dissemination of a single clonal strain. 
The sequencing results demonstrated that alteration of the GyrA subunit 
DNA gyme at amino acid 83 and/or amino acid 87 played a central role in 
conferring high-level fluoroquinolone resistance in K. pneumoniae possessing 
ESBLs. 
I P433 1 Extended spectrum &lactamases-producing 
Klebsiella pneumoniae in a Spanish hospital (1993-1 999) 
C. Ardanuy, M. A. Dominguez, J. Lhres, C. Peiia, J. Ayats, M. Pujol, 
X. A r k  and R. Martin 
Hospitalet de Llobregat, E 
From January I993 to December 1999,487 extended-spectrum B-lactamase- 
producing Hebsiella pneumoniae (ESBL-Kp) were isolated fiom clinical sam- 
ples of223 patients admitted in our hospital (isolates h m  25 patients were not 
available for further studies). 
Objectives: To characterize the clonal relationship between these strains and 
to study the ESBL. 
Methods: Antibiotic resistance pattern analysis, pulsed-field gel electmphor- 
esis (PFGE) and isoelectric focusing of 8-lactamases were performed. 
Results. Eight antibiotypes, 28 PFGE clones and 8 ESBL-production patterns 
of pls were found during the study period. A dominant epidemic clone by 
PFGE was found from January 1993 to June 1995 in clinical samples from 132 
patients. These isolates showed five ESBL-production patterns of pls (N): (a) 
7.6(41); @)8.2(68); (c) 7.6+8.2(20);(d)7.6+5.4(2);and(e)8.2+5.4(1). 
All ESBL production patterns were transferred by conjugation to Escherichia 
cali J-53-2. This epidemic clone was only found in four isolates between 
December 1997 and January 1998. The remaining 62 isolates were classified 
in 38 different clones by PFGE, of them, 91.9% produced an ESBL of pI7.6. 
Among these isolates six clones were found in clinical samples from more than 
one patient. 
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Conclusions: The ESBL-Kp isolated in our hospital during the study period 
were mainly owing to the spread of an epidemic clone until June 1995. After 
this date, small outbreaks caused by other ESBL-Kp clones were detected. The 
ESBL phenotype in Kp is mainly owmg to the enzymes belonging to the SHV 
family. 
vl Drug resistance and molecular epidemiology of 
extended-spectrum 8-lactamase-producing Klebsiel/a 
pneumoniae isolated from an intensive-care unit in a clinical 
hospital in Szuecin, Poland 
J. Julsa, I. Maczynska and S. Giedrys-Kalemba 
Szczecin, PL 
Endemic and epidemic nosocomial infections caused by extended-spectrum 
8-lactamase-producing (ESBL+) KlebsieZla pneumoniae (K. pn.) represent a 
persistent problem in intensive-care units (ICU). Epidemic strains of 
ESBL 1- K. pn. have been associated with increased morbidity and mortality 
in hospitalized patients. 
Objectives: The aims of the present study were to analyze occurence and 
antibiotic resistance ESBL+ strains of K. pn. and to delineate the clonal 
diversity and transmission patterns of these strains by genome macrorestriction 
analysis. 
Materials and methods: During the period h m  1999 to 2001, 70 strains of 
K. pn. ESBLf were isolated From various materials &om patients hospitalized 
in ICU in Clinical Hospital No. 2 in Szczecin. Susceptibility to antimicrobial 
agents was tested by the disc diffusion method (according to NCCLS 
standards) and the double-disc test for detection ESBL expression. Genome 
macrorestriction analysis by pulsed-field gel electrophoresis (PFGE) was 
obtained by using Xbal. Patterns were visually compared into clonal groups 
and clonal variants. 
Results: 55% of ESBL+ s t r a i n s  of K. pn. was susceptible to piperacillinl 
tazobactam, but only 7% to amoxicillin/clavulanic acid; 12 strains were 
intermediate susceptible to ce fokme  and 5 to ceftazidime. They were 
distinguished by different susceptibility to fluoroquinolones (62%) and to 
aminoglycosides (40%). All strains were susceptible to imipenem. Chromo- 
somal DNA digested with XbaI produced an average of 20 hgments ranging 
in size from less than 50 kb to approximately 700 kb. TypA was dominant-35 
strains identical; clonal variants: typAl-20 strains closely related, typ A2-7 
strains less related; 8 strains genetically unrelated. 
Conclusion: High percent of K. pn. ESBL +isolates were observed. Most 
strains belong to the same clone. Time of isolations suggest that the patients 
hospitalized for long periods in ICU have been acted as a reservoir for cross 
infections. An increase in the number of ESBL + K. pn. isolates in ICU is 
ownd mainly to dissemination of resistant plasmids or mutations in existing 
plasmid mediated 8-lactamases under the selective pressure produced by the 
overuse of the third-generation cephalosporin. 
[p4351 Molecular identification of Escherichia coli and 
Klebsiella with suspected extended spectrum and AmpC 
/I-lactamases 
K. J. Shemood, I. Wiegand, K. Westphal, J. Wagner and B. Wiedemann 
Bonn, Berlin, D 
Objectives: Resistance to cephalosporins is mediated not only by the &e- 
quently reported extended-spectrum /?-lactamases (ESBLs) but also by plas- 
mid-mediated and hyperproduced chromosomal AmpC 8-lactamases 
(AmpCs). Little is known about the contributions of AmpCs to extended- 
spectrum p-lactam resistance in Germany. Therefore, we investigated the 
frequency of ESBL- and AmpC-mediated resistance in a group of E. coli and 
Klebsiella strains. 
Methods: Between February 2000 and January 2001,24 E. coli, 12 K.pneu- 
moniae and 3 K.oxyfoca strains fiom five Berlin hospitals were submitted 
because of reduced susceptibility to third generation cephalosporins. For these 
strains, minimum inhibitory concentrations (MICs) of seven 8-lactams were 
determined. Based on these MICs, the strains were divided into those with a 
suspected ESBL and those with a suspected AmpC. The fi-lactamases were 
then identified at the molecular level by PCR and subsequent sequencing of 
the /?-lactamase genes. 
Results: Of these 39 strains, 55% derived their resistance from the production 
of AmpCs, 40% showed ESBL production, 2.5% hyperproduced a TEM-1 
enzyme and 2.5% produced an mhibitor-resistant j-lactamase (IRBL). At the 
species level, 74% of the E. colt and only 27% of the Mehsiella derived their 
resistance &om the producnon of AmpCs. Of the E cola AmpC producers, 
76% hyperproduced the chromosomal AmpC are because of a combmation of 
promoter mutaaons and 24% possessed plasmid-medmted AmpCs. 
Conclusions: There IS a hgh percentage of extended-spec- /?-lactam 
resistance whch is due not to ESBLs but to AmpCs. Ths  percentage varies 
w t h  the species Therefore, it is imperame to idendfy the specles and these 
enzymes so that an appropnate therapy can be demed. Plasmd-medmted 
AmpCs are of epidermolog~cal unportance because the mobdity could lead to 
a rue m resistance. 
I P436 I Trend of vancomycin (VAN)-resistant enterococci, 
and third generation cephalosporin, imipenem (IMP)- and 
fluoroquinolone (FQNkresistant Gram-negative bacilli (GNB) 
in Korea 
K. Lee, A. J. Park, Y. J. Park, J. H. Shin, H. C. Cho, J. H. Cho and 
Y. Chong 
On behalf of the KONSAR Group Korea 
Objectives: Increasing trends ofVAN-resistant E.faecium, and IMP- or FQN- 
resistant GNB were noted in the previous surveillance by KONSAR (Korean 
Nationwide Surveillance ofAntirnicrobial Resistance) group. The aim ofthis 
study was to determine that the increased resistance was a transient phenom- 
enon 
Methods: The susceptibility test data in 2000 were collected f b m  32 of 68 
KONSAR hospitals. Excluding hospitals with lower quality control perfor- 
mance, the data h m  23 hospitals were analyzed and the trend was compared 
to the previous data. 
Results: Seventy per cent of S. aureus and 20% of E.faeaum were resistant to 
oxacfin and vancomycin, respectively. Relatively high resistance rates in 
GNB were: 27% of E.coli and 70% of A.baumannii to FQN; 25% of 
K.pneumoniae, 43% of E. cloarae and 68% of A. baumannii to ceftazidime; 
9% of E. coli and 16% of K .  pneumoniae to cefoxitin, and 5% of A. baumannii 
and 20% of I! ae~ginosa to imipenem (Table 1). 
Table 1 Antimicrobial reslstance rates of GNB isolated in 2000 
___ ~~ 
Resistance rate (%) 
Species (no. of 
isolates tested) Cefotaxime Ceftazidime Cefoxitin Imipenem Fluoroquinolone 
E. coli (21268) 7 6 9 0 27 
K. pneumoniae 15 25 16 0 9 
E. doacae (4536) 35 43 
(1 1051) 
10 
A. bnumannii 68 68 NA 5 70 
Paemginma NT 19 NA 20 42 
NA <1 
(9836) 
(17204) 
The rates at different size or location of hospitals did not differ significantly, 
even in the VAN-resistant E.faecium and IMP-resistant i? amgitiosa. Com- 
pared to the previous data, gradual rise of resistance rates were noted in 
ceftazidime (17% in 1998 to 19% in 2000) and IMP-resistant (17% in 1998 to 
20% in 2000) E! aeruginora, and FQN-resistant A .  baumannii (56% in 1997 to 
70% in 2000). A previous study showed that approximately 1/2 and 10% of 
IMP-resistant A. baumannii and F! aeruginosa, respectively, had VIM2 metallo- 
8-lactamase gene on mobile integrons. 
Conclusion: VAN-resistant E.foecium, and IMP-resistant A. baumannii and 
I? aemginosa, besides already problematic MRSAs and ESBL-producing 
K. pneumoniae, have become new threat in al l  levels of hospitals in Korea. 
I P437 1 High prevalence of PER-1-extended spectrum 8- 
lactamase-producing Acinetobacter baumannii in Korea 
D. Yong, J. H. Shin, S. I m ,  J. Yum, K. Lee and Y. Chong 
Seoul, Kwangju, KOR 
Objectives: PER-1 extended spectrum B-lactamase (ESBL), first reported in 
1993, was prevalent in Acinetobacter baumannii and Pseudomonas aemginosa 
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isolated from Turkey. As far as we know, it has not been reported in regions 
outside Europe. In &IS study, we examined the presence and prevalence of 
PER-1-producing A. baumannii and l? aeruginosa isolated in Korean hospitals. 
Methods: In an initial study, 5 ESBL-positive A. baumannii isolates were 
collected &om a tertiary care Korean hospital. In a subsequent study, 97 and 
100 consecutive A. baumannii and I? aerugirrora isolates, respectively, were 
collected hpm another hospital. Double dsk synergy was tested by placing 
amoxicillin-clavulanate disks and cefcazidime, cefotaxime and cefepime disks 
at an edge to edge &stance of 1.5, 1.0 or 0.5cm. PCR was used to detect 
presence ofblaTEM, blaSHv blaOXA and blaPER-1 in the initial study. In the 
sebsequent study, all ofthe isolates were tested to detect presence ofblaPEK-1, 
and the results were compared to DDS. Representative blaPER-2 PCR 
products were used to determine the nucleotide sequence by dideoxy chain 
termination method. 
Results: In the initial study, blaPER- 1 was detected from all of the five A.  
baumannii isolates with positive DDS, but blaTEM, bkzSHVand blaOXA were 
not detected from any of them. In the srbsequent study, blaPER-f was 
detected from 53 of 97 A. bnurnannii isolates, but none of the I? amginora. 
Analysis showed that the nucleotide sequences of blaPER- 1 of the isolates 
were identical to that reported by Nordmaim et al. All of the isolates with 
blaPER- 1 were resistant to cefotaxime, ceftazidime, aztreonam and cefepime. 
Only 14 of 53 of blaPER-1-positive isolates were DDS positive when the disk 
distance was 1.5 cm. Additional 12 and 16 positive isolates were detected 
when the distances were 1.0 and 0.5 cm, respectively. Cefepime disk gave 
more positive results. 
Conclusions: Prevalence of PER-1-producing A. baumannii s t r a i n s  in Korean 
hospitals revealed that the resistance was also present in Far Eastern region. 
The blaPER-I sequence was identical to that reported in Europe. All of the 
blaPER-1-positive isolates were resistant to cefepime. It was difficult to detect 
PER-1-producer by DDS, but cefepime disk was more useful. Further studies 
are required to improve detection method and to determine clinical sig- 
nificance of the PER-1-producing isolates. 
Prevalence and phenotypic characteristics of 
extended spectrum p-lactamases (ESBL) in a medical center, 
Tel Aviv, Israel 
S. Navon-Venezia, D. Turner, D. Schwartz and Y. Carmeli 
El Aviv, IL 
Objectives: The occurrence ofESBL producers and the common phenotype 
may vary across geographical areas. We examined the prevalence and phe- 
notypic characteristics of ESBL producers among cefuroxime-resistant (Cefu- 
R) Enterobacteriaceae in Tel Aviv. 
Methods: The MIC of nonurine clinical isolates to cefuroxime, cefotaxime 
(CTX) and ceftazidime (CTZ) was determined using automated microdilu- 
tion system (MicroScan). Production ofESBL was confirmed among Cefu-R 
isolates by disk diasion using cefpodoxime (CPD), CTX, and CTZ with and 
without clavulanate (Clav); a difference of 5 mm in zone of ihbit ion was 
considered as ESBL phenotype. 
Results: Cefu-R rate was 60% among E. coli, 46% among Idebriek spp., and 
23% among Proteus spp. 432 Ceh-R isolates were examined for ESBL 
phenotype (51 blood isolates). Out of the 432 isolates tested 186 (43%) were 
confirmed as ESBL producers. Number of isolates tested and rate of ESBL 
producers among various species were: Khbsiella spp. (81) 79%, Proteus spp. 
(58) 62%. E. coli (64) 53%, Enterobacter spp. (69) 42%, Senrrtia spp. (70) 14%, 
Citrobacter spp. (25) 24%, Providem'a spp. (21) 24%, Morganella spp. (41) 5%, 
and Muyvera spp. (3) 0%. Among Cefu-R isolates 242 (56%) had MIC 2 2 for 
CTZ, and 70 (16%) for CTX. OfESBL producers 39 (21%) hadMIC < 2 for 
CTZ and 9 (4.8%) for CTX. Six  of the ESBL-producing strains (3.2%) had 
MIC < 2 for both CTZ and CTX (E. coli 2, Senaria marcescem 2, Citrobacter 
koseri, MoiorganeUa morganii). The overall sensitivity of confirmatory tests were 
CPD/Clav, 79% CTZ/Clav, 66% CTX/Clav, 91% (compared to all three 
combined). Sensitivity of CTZ/Clav confxmatory test for Mebsiella spp., 
Roteus spp., E.  coli, and Enterobacterspp. were 84,22,76, and 62%. respectively, 
and of CTX/Clav 95,97,94, and 83%, respectively. Sensitivities of combina- 
tion of two tests were: CPD/Clav + CTZ/Clav 90%, CPD/Clav + CTX/ 
Clav 95%. and CTZ/Clav+ CTX/Clav 100%. 
Conclusions: ESBL production is prevalent among Enterobacteriaceae in our 
institution. CTWClav was superior to CTZ/Clav in confirming ESBL 
producers, sensitivity varied between species. Combination of testing with 
CTZ/Clav + CTX/Clav detected all these strains, with no additional benefit 
from CPD/Chv. Screening isolates with elevated MIC to CTX+ CTZ, 
would have resulted in missing 3% ofthe ESBL producers. Using Cefu-R as a 
criterion for ESBL screening is simple to apply and may improve the 
sensitivity of the test. 
vl Extended-spectrum j?-Iactamases (ESBL) production 
in clinical isolates of Enterobacteriaceae rods 
Z. Muszyiidci, I. MirsBa and A. Sekaradkiewicz 
Poznati, PL 
Objectives: The aim of this study was to determine the prevalence of ESBL- 
activity among isolates from various body sites of intensive-care units (ICUs) 
patients during the last years (1997-2000) in Pomai, Poland. 
Methods: The analysis included 120 resistant to oxyimino-~-laCtams strains 
belonging to Enterobacteriaceae family. ESBL profile of strains was detected 
using double-disc tests. The susceptibility of the isolates to 16 drug (beta- 
lactams, aminoglycosides and quinolones) were determined by the disc- 
difision tests according to the recommendations of NCCLS. 
Results: The results showed that ESBL-producing strains were dissemineted 
in ICUs (62% of strains demonstrated ESBL-activity), and K.pnarmoniae (49 
strains) and E. coli (12 srains) were the most common hosts of their expression. 
ESBL were found in strains of wide range of Enterobacteriaceae (Senafia 
marcescens, Enterobacrer cloaceae, Proteus mirabilis, Morgunella mqunic,  Rotm 
penneri?. 
Many of ESBL-producing isolates were not resistant to oxyimino-b- 
lactams in susceptibility testing invitro and this have been asociated with 
clinical failures. 
Conclusion: Our results confirmed the need of monitoring of ESBL-activity 
in Enterobacteriaceae isolates to prevent and control their dissemination and 
to avoid therapeutic failures. 
ml SHV ESBLs in the Klebsiella pneumoniae 
population in a regional hospital in Slovenia 
B. Jutersek, A. Baraniak, A. Mruwka, T. Zohar-Cretnik, A. Storman and 
M. Gniadkowski 
Celje, SLO; Wanaw, PL 
Objectives: To reveal the epidemiology of ESBL-producing Klebsielta pneu- 
moniae in a large regional hospital in Slovenia. 
Methods: Forty ESBL-producing K. pneumoniae isolates h r n  a hospital in 
Celje were studied. They constituted a randomised sample of all 152 ESBL- 
producing isolates of the species collected fiom Werent patiena in the center 
between January 1997 and May 2001. The isolates were typed by PFGE and 
subjected to the ESBL gene conjugative transfer experiment. Protein extracts 
of the isolates and the transconjugants were analyzed by IEF to visualise their 
b-lactamases, and ESBL activity was detected by the bioassay approach. 
ESBL-encoding genes were amplified by PCR with the use of plasmids 
purified from the transconjugants. 
Results: Seven Werent PFGE types were discerned among the K. pneumoniae 
isolates analyzed. One ofthe types, split hrther into nine subtypes, was clearly 
predominant, being represented by 22 isolates. Each of the other PFGE types 
with multiple isolates was diferentiated into several subtypes too. No 
correlation between the PFGE type and the hospital ward was observed. 
Thirty-four isolates of all PFGE types were characterised by a smgle 
fi-lactamase IEF band with a p l  of 7.6, which was also the case of all 15 
transconjugants produced by these isolates. The bioassay revealed that this 
band contained an enzyme with cefotaxime- hut not ceftazidime-hydrolysing 
activity. PCR revealed that the j3-lactamase belonged to the S H V  famiy. The 
remaining six isolates (all of the major PFGE type) expressed multiple 
8-lactamases with PIS of 8.2, 7.6, 6.8 and 5.4, and genes for the p l  8.2, 
6.8 and 5.4 enzymes were located in uansmissible plasmids. Only, the pl8.2 
8-lactamases demonstrated ESBL activity, hyddysiug cefotaxime and ceh-  
zidime, and, according to PCR, these enzymes were classified into the SHV 
Conclusions: This work revealed a complicated epidemiology of ESBL- 
producing K .  pneumoniae in the center. The remarkable representation of 
isolates of a single PFGE type indicated the clonal outbreak of a strain, which 
expressed either the p l  7.6 or pl  8.2 SHV-type ESBL. The presence of 
numerous other PFGE types and subtypes suggested the possibility of the 
transmission ofthe pI7.6 ESBL gene-carryingplasmids among distinct strains. 
It could also indicate occurrences of the independent acquisition of the ESBL 
by the strains and/or the gradual evolution of the outbreak into a complex 
endemic situation. 
family too. 
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wl Antibiotic resistance of Gram-negative rods 
isolated from hospitalized children 
J. Ruczkowska, I. Doha, B. Kowdska-Krochmal and I. Choroszy-Krd 
Wroclaw, PL 
Objectives: Survedance on antibiotic (n = 9-18) resistance of Gram-negative 
rods isolated fiom children hospitahzed in Clinics ofpaediatric (P.)Surgery (S) 
and P. Nephrology (N) in 1998-2000. 
Material and methods: By the disc &sion method (NCCLS) antibiograms 
for 1583 Gram-negative rods (61 1 from S and 972 from N) were performed. 
Results: Strains isolated fcom children showed low level of resistance to 
fluoroquinolones (5% S 81 N), carbapenems (I-2% N) and piperadin/ 
tazobactam (9% N). High level resistance (> 50%) for S straimi was found to 
cejiriaaxone (56%). aztreonam (57%), cefotaxime (57%). piperacillin (60%), c&r- 
oxime (61%), cephalotin (70%) and ampicillin (79%) while for N only to ampicillin 
(64%). In 4 groups of Gram-negative rods highly resistant to majority of 
antibiotics were Klebsiella (S & N) and I? aeruginosa (S). The last was also more 
resistant to imipenem - IPM (31%) and meropenem - MEM (43%); the most 
frequent pattern for carbapenem-resistant strains was simultaneous resistance 
to piperacillin/tazobactam, cefoperazone, gentamicin, netilmicin with - 
susceptibility to ceftazidune, amikacin and fluoroquinolones. Between 
1998 and 2000 a great increase in resistance of I? aeruginosa to carbapenems 
(IPM h m  9 to 55%, MEM - 1642%) was noticed in S. ESBL(+) 
strains were more often isolated from S than N (32 81 12%). among them 
there were mainly Hebsiella (56 & 47%), E .  coli (27 & 31%), Enterobarter (16 & 
14%). The increase of ESBL(+) isolates was noticed in S among Klebsiella 
(7&85%) and E. coli (1440%). while in N there was a decrease - Klebsiella 
(55-45%), E. coli (2&5%), Enterobacter (31-22%). ESBL(+) strains from S 
were a little more resistant to amoxicilldclawlanic acid, piperacillin/tazo- 
bactam and netilimicin, while strains from N to gentamicin and cotrimox- 
azole. 
Conclusions: (1) Increasing antibiotic resistance of Gram-negative rods 
isolated &om S & N may be explained by higher number of ESBL(+) strains 
in S. (2) Because of increasing trend in ESBL(+) frequency cephalosporins 
usage should be limited. (3) Cross-resistance of ESBL(+) strains to amino- 
glycosides excludes them fiom antibacterial therapy. (4) Appearing and 
spreading of carbapenem-resistant Paenrginosa in S may be the result of 
carbapenems overusage in hospital. (5) Low level resistance to fluoroquino- 
lones is probably connected with limited use of those drugs in the treatment of 
children. 
LP442 1 Uropathogens and their susceptibilities to 
antibiotics 
A. M. Khalil, E. M. ELSawy and M. A. Ghoneim 
Mansoura, EGY 
Objectives: To analyze the frequency structure of urinary tract infection 
(UTI) and antimicrobial resistance of the most common important 
urinary pathogen isolated from in-patients in urology and nephrology 
center. 
Methods: Au urine isolates fiom urine cultures were collected fiom in- 
patients in Urology and Nephrology Center in Mansoura University. The 
analysis was based on the microbiology laboratory data. Urine cultures were 
done in laboratory accordmg to the standard techniques. The identification of 
isolates and antimicrobial susceptibility tests were performed using the 
MicroScan WakAway40 dried MICAD panels for Gram negative/positive. 
Results: A total of 235 consecutive isolates collected from urine cultures were 
analyzed. There were 89.4% Gram-negative pathogens among them and 9.4% 
were Gram-positive pathogens. The most common isolates was Esckerichia coli 
represented 29.4% of the isolates. The isolates that followed were Klebsieila 
spp. 19.6%, Pseudomuttas aouginosa 11.9%. Enterobacter spp. 8.9%, Sewatia spp. 
8.5%, Citrobader spp. 5.5% and coagulase negative staphylococci 4.7%. These 
seven pathogens accounted (98.8%) of the isolates. 
The resistance for E .  coli was as follows; trimethoprim/sulphamethoxazole 
73.9%, gentamicin 52.2%, nodoxacin 49.3%. cephalothin 43.5% and tobra- 
micin 42%. 
Conclusions: E.coli was identified as the commonest pathogen of UTI. 
There is a high degree resistance of trimethoprim/sulphamethoxazole, 
gentamicin and norfloxacin that can be caused by complicated UTIs cases. 
Amoxicillin/ckvulanate or nitrofbntoin can be used for empyric treatment 
of UTI 
I P443 I Antimicrobial resistance patterns in a military 
medical academy, Turkey 
H. Aydogan, A. Basustaoglu, M. Baysallar, A. Kucukkaraaslan and 
L. Doganci 
Ankara, TR 
Objectives: Here in we report antibiotic susceptibility pattern of different 
isolates from various clinical sampIes, sent h m  different departments to our 
bacteriology laboratory through January to December in 2000. 
Methods: The antibiotic susceptibility tests have been made by disc a s i o n  
method, according to the NCCLS criteria. 
Results: Totally 29 374 specimens were received and 6395 pathogens were 
isolated. The frequency of specimens were as follows: 42.2% genitourinary 
system, 29.9% respiratory system, 11.8% body fluids and wound, 9.7% blood, 
4.6% gastrointestinal system, and 0.7% CSF. Overall, the most important 
bacteria isolated were Staphylocows aureus (24%). Escherichia coli (22%). 
Pseudomonos mgz'twsa (9%), Klebsiella pneumoniae (Y?), Adnetobacter spp. 
(5%). Forty-eight percent of S a u w s  isolates were resistant to oxacillin. 
All S .  aureus isolates were fdly susceptible to teicoplanin and vancomycin. 
E. coli was the most common isolate of all Gram-negative isolates (38%) h m  
Department of Urology. For E. coli, the most active antimicrobial tested were 
imipenem and meropenem (99%) and the most resistant antimicrobials were 
ampicillin, trimethophrim-suthox~ole, and medocillin with 60, 51, 
and 47%, respectively. For K. pneumoniae, the most active antimicrobial tested 
were imipenem and meropenem (100%) and the most resistant antimicrobials 
were ampicillin (Two). I? aerugiaosa was the most kequently isolated pathogen 
fiom wound specimens. For F? aenrginosa, the most active antimicrobial tested 
were amikacin (32%) and the most resistant antimicrobials were ampicdhn, 
trimetophrim-sdfimethoxazole, and medocillin with 60, 51, and 47%, 
respectively. The antimicrobial agents most resistant against isolates were 
ticarcillin/davnlanic acid mezlocillm, and netilrmcin with 76,75, and 61% of 
isolates being resjstant, respectively. imipenem- and meropenem-resistance 
rates were high (39.41%). For Adnetobackr spp almost all antimicrobial 
resistance rates were higher than 50% and for this isolate imipenem and 
meropenem-resistance rates were 51.53%. 
Conclusion: Here, there are s t i l l  sufficient treatment options for patients 
infected with the most important bacteria species. However, the situation for 
patients with Acinetobacter spp. infections is still critical. 
[p444) Bacteremia involving antibiatic-msktant Gram- 
negative bacilli in critically ill patients: clinical outcome and 
length of hosp'mlization in comparison with bacteraemia 
involving antibiotic-susceptible isolates 
S. I. Blot, K. H. Vandewoude and F. A. Colardyn 
Ghent, B 
Objective: To evaluate the clinical impact of antibiotic-resistance in Gram- 
negative bacteremia in critically ill patients. 
Methods: Retrospective, single-center cohort study @muary 1992-Decem- 
ber 2000). An outcome comparison was performed between ICU patients 
with bacteremia involving antibiotic-resistant (AB-R) (n = 120) and anti- 
biotic-susceptible (AB-S) (n = 208) bacilli. Bacilli were defined AB-R by 
invitm resistance to ceftazidm. I? aenrginosa isolates were considered AB-R 
when resistant to one of the following antibiotics: piperacillin, ciprofioxacin. 
ceftazidim, imipenem. In all patients only the first episode of Gram-negative 
bacteremia was taken into account. 
Results: Between patients with AB-R and AB-S bacteremia no important 
differences were found in age (resp. 52 =t 16.9 vs. 54 f 17.4 years; P= 0.303), 
APACHE I1 score (resp. 23 f8 .6  vs. 23f9.0; P=O.814), APACHE I1 
related expectedmortality (44127.3 vs. 41 f28 .2% P=0.305),  acute renal 
failure (resp. 27% vs. 25%. P =  0.431), hemodynamic instability (resp. 85% vs. 
78% P =  0.117) and acute respiratory failure (resp. 96% vs. 92%; P=0.227). 
Patients with AB-R bacteremia were mechanically ventilated for a more 
extended period (29f25.9 vs. 20 f 18.6days; P< 0.001). They also had a 
longer duration of stay in the hospital (88dz83.8 vs. 70f71.1 days; 
P=O.O07). This seems to be the consequence of a longer duration of 
hospitalization prior to the onset of the bacteremia (3Oic30.3 vs. 
18 f 27.5 days; P <  0.001) whereas duration of hospitalization after onset 
of the bacteremia did not differ (55 f60 .3  vs. 50k62.4days; P=0.333). 
Also, when length of ICU stay was compared, patients with AB-R bacteremia 
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were found to have a longer 1CU stay prior to the onset of the bacteremia 
(24f20.5 vs. 13& 14.0days; P<O.O01) whereas legh of ICU-stay after 
onset of the bacteremia did not d8er (17 5 19.7 vs. 16 & 17.9 days; 
P =  0.321). No difference was noted between patients with AB-R and 
AB-S bacteremia in 14-day mortality (resp. 27% vs. 26%; P=O.550), 28-day 
mortahty (resp. 36% vs. 34%; P= 0.756) and in hospital mortahty (45% vs. 
42%; P=0.576). 
Conclusion: Antibiotic-resistance in Gram-negative bacteremia did neitherot 
adversely affect the outcome in our ICU population, nor does it increase the 
duration of stay in the ICU and the hospital. 
S. pneumoniae 
(p44zl Macrolide-resistance in pneumococci in the North- 
east of England 
C. Graham 
Newcastle upon ljne, UK 
Objectives: To determine the mechanism of macrolide resistance amongst 
Streplococcu~pneumonia~ isolated in the North-east ofEngland and to assess the 
activity of a range of antibiotics agamst these resistant strains. 
Methods: There are two principle types of macrolide resistance seen in 
pneumococci, resistance ofthe M phenotype (low level resistance to 14-, 15- 
member macrolides) is mediated by an efflux pump encoded by the MefE 
gene. The M L S  phenotype results in high level macrolide resistance (and 
resistance to clindamycin and steptogramins) and is due to methylation of 
ribosomal RNA peptidyl transferase encoded by the em B gene. MICs were 
performed on 61 isolates from the North-east ofEngland using the NCCLS 
agar breakpoint method. Erythromycin and clindamycin were tested along 
with clarithromycin, azithromycin, penicillin, cefotaxime, josamycin, spir- 
amycin, telithrornycin, linezolid and rnodoxacin. All macrolide-resistant 
strains were further analyzed by PCR to determine genotype. 
Results: Thuty-seven erythromycin-resistant strains were detected (MIC 
ranged fiom 4 to >128mg/L). Nine of these (24%) were resistant to 
clindamycin (MLS phenotype), the remaining 28 were susceptible to clin- 
damycin (M phenotype). All ofthe MLS isolates displayed highlevel resistance 
(MIC > 128mg/L) to erythromycin. All showed reduced susceptibility to 
penicillin, four having MICs > 1 mg/L. Pneumococci of the M phenotype 
had MICs to erythromycin in the range o f 6 3 2  mg/L, of note, only five were 
penicillin resistant, and a further two were of intermediate sensitivity. 
Resistance to telithromycin, linezolid and moxifloxacin was uncommon. 
Of the M phenotype, 27/28 isolates were positive by MefE gene PCR; the 
em B gene was detected in 7/9 isolates displaying the h4LS phenotype. 
Conclusions: In Europe, resistance in >90% of cases is ofthe h4L.S phenotype 
and is due to the em B gene whereas in USA and Canada, 5643% of isolates 
carry the MefE gene. No data on mechanisms of resistance is available in the 
UK. In this study we found 76% ofthe macrolide-resistantpneurnococci to be 
of the M phenotype owing to the presence of the MefE gene. Isolates of the 
M L S  phenotype were more frequently penicillin resistant. 
lp4461 Genotypes of invasive pneumococcal isolates 
recently recovered from Italian patients 
G. Dicuonzo, G. Gherardi, B. Gertz, G. Lorino, F. D'Ambrosio, 
A. Goglto, G. Orefici, A. Pantosti and B. Beall 
Rome, I; Atlanfa, USA; Bergamo, I 
Objectives: To assess serotype variability, antibiotic resistance, and genetic 
relatedness among recent clinical isolates of invasive Srr~tococcuspneumoniae 
recovered in different areas of Italy. 
Methods: Pneumococcal isolates were subjected to antibiotic-resistance 
testing and serotyping. Isolates were genotyped using pulsed-field gel elec- 
trophoresis (PFGE), multilocus-sequence typing (MLST), and restriction 
fragment length polymorphism (RFLP) analysis of penicillin-binding protein 
(PBP) genes and pspA. 
Results: Nine genetically related sets of isolates, defined by PFGE and/or 
MLST, were identified among the 22 penicillin non-susceptible isolates 
(PNSP), and five of these sets were represented by two to seven isolates. 
Twenty-six genetically related sets were represented among the 59 penicillin 
susceptible pneurnococci (PSP), six ofwhich were represented by two to five 
isolates. In general, restriction kagment length polymorphism profdes of 
pbpZb, pbp2x. and pspA were conserved within isolates shown to be related 
through PFGE and/or MLST. Three of the genetically related sets were 
represented by nidtiple serotypes (9 A + 9 V + 14 + 24E 19 A + 15 A, and 
18Cf4) .  In addlhon, one geXIehCdy mhstmgwhable set of 3 type 24F 
PNSP shared a rnultilocus sequence type, only seen prevlously 111 mterme- 
diately resistant type 14 lsolates Three new PNSP rnultrlocus sequence types 
and three new alleles were deposited mto the pneumococcal MLST database. 
Conclusions: Th~s work reports new pemcdlm non-suscephble strains, and 
evidence of capsular mtchmg to serotypes not prevlously reported to arise 
through horizontal recombinahon events The h4LST database at http // 
wwwmlst.net IS a useful resource for trackmg the epidemology of pneu- 
mococcal strains worldwde 
fi-Lactarn-macrolide resistance and multiresistance 
of Streptococcus pneumoniae in severe infections 
T. Turcu, V. Luca, C. Luca and R. Fantanaru 
h i ,  RO 
Objectives: Study of antibiotics registance and sensibility of invasive S. pneu- 
moniae isolated between 1991 and 2000 in the Clinic of Infections Diseases of 
Iasi in order to adaptive the fmt-line antibiotherapy. 
Methods: The study included 136 patients with severe Pneumocoms infec- 
tions: 72.7% meningitis, 6.6% septicemia's and 20.5% infections ofthe inferior 
respiratory tracts. S. pneumoniae isolated and identified through conventional 
methods, were tested by the djflizsionmethod (NCCLS Standards) using disks 
of oxacillin (1 p), ampicillin, amoxicillin/clavulanic acid, ceftriaxone, cefo- 
taxime, imipenem, vancomycyn, erythromycin, rifampin, chloramphenicol, 
tetracycline and ofloxacin. A part of the strains were tested through the 
dilution method for the MIC of penicillin. 
Results: S. pneumoniae was isolated from cerebrospinal fluid (65.4% cases), 
hemocultures (13.2%), sputum (1 9.8%) pleural and pericardic liquid (0.7% 
cases). Our study showed a medium resistance to penicillin of 22.8% with 
yearly variation. The resistance to rifampin, ampicdin, chloramphenicol and 
erythromycin was oE 4.4,5.1,7.8 and 8.0%, respectively. About 11.8% strains 
were multiresistant (more or equal to three antibiotics). Resistance was 
unconmion to cephalosporines, imipenem, vancomycin and 63.4% strains 
were susceptible to all anti-Pneumococcus antibiotics. There were 15 different 
antibiotypes evident. 
Conclusions: The prevalence of 22.8% strains of invasive Spneumoniae 
resistant to penicillin, 8.0% resistant to erythromycin and 11.3% multiresistant 
with 15 antibiotypes of resistance and with yearly and regional variations, 
determine the adaptability of antibiotherapy of severe pneumococcae infec- 
tions to the actual reality. 
1 P448 I Antimicrobial susceptibility pattern and serotype 
distribution of nasopharyngeal Streptococcus pneurnoniae 
isolates from children with respiratory tract infections 
A. Yagci, C. Akbenlioglu, A. I h ,  N. Ulger, G. Soyletir and M. Bakir 
Istanbul, 7'R 
Objective: Because there is little information on the epidemiology of infec- 
tions due to Strepfococcuspneumonpiae in Turkish children, most cases ofbacterial 
pneumonia and meningitis are treated empirically. Conjugatedpneumococcal 
vaccine coverage has not been evaluated with large scale studies in Turkey. As 
the pharynx is the primary reservoir for potentially invasive pneumococci, we 
performed a pharyngeal culture surveillance in 322 children with respiratory 
tract infections. 
Methods: The swab samples obtained from lower nasopharynx were imme- 
diately put into Stuart transport medlum and transferred to laboratory within 
2 h. Each swab sample was inoculated onto blood agar medium and incubated 
overnight at 35 "C under 5% CO,. Pneumococci were initially identifed on 
the basis of alpha hemolysis and colony morphology, identification was 
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confirmed by optochm susceptibility and bile solubility. Minimal inhibitory 
concentrations (MIC) to penicillin were determined by the E-test. Suscept- 
ibihty to other antimicrobial drugs was determined by disk a s i o n  test. 
Serotyping was performed by the Quellurig reaction, with the use of antisera 
fiom the Statens Serum Institute, Copenhagen. 
Results: S. pneumoniae was isolated &om 92(28.7%) of the patients. Overall, 25 
(27.1%) were resistant to penicillin G, 24(26.1%) with intermemate resistance 
(MIC 0.12-1 mg/L) and 1(1%) with high level resistance (MIC 2mg/L). 
Percentages of resistance to other tested antimicrobials were as follows: 
erythromycine (9.6), clindamycin (3.2), chloramphenicol (6.4), ceftriaxone 
(l), trimethoprim-sulfametho-xazole (30.9). rifampin (0). The first three 
mostly isolated serotypes were 19F, 6B, 3 and 7, 9 and 11-valent conjugate 
pneumococcal vaccines covered 34.8, 38.1 and 42.4%. respectively, of our 
S. pneumoniae isolates. 
Conclusion: Although penich-resistance rate was relatively high compared 
to majority of Western Europe, high level resistance was 1% only. Conjugate 
pneumococcal vaccine coverage is lower in Turkey than it is in Europe and is 
consistent with most Asian countries. 
Nationwide surveillance of antimicrobial resistance 
in Streptococcus pneumoniae in Slovenia 
I. Strumbelj, H. Ribic, T. Franko-Kancler, V: Bozanic, I. Grmek Kosnik, 
L. Merljak, M. Kavcic and T. Harlander 
Munka Sobota, Ljubljana, Maribor, Celje, Kranj, Nova Gorica, Kopes Novo 
Mesto, SLO 
Objectives: To determine rates of resistance to selected antimicrobial agents 
and phenotypes of resistance to macrolides and lincosamides. 
Methods: Eight microbiology laboratories from all regions of Slovenia 
isolated 666 non-replicated strains of Streptoco~u~pneurnoniae b tween January 
and September 2001, mostly from respiratory tract. Strains were isolated from 
outpatients and patients from general, but not from tertiary care hospitals. 
S. pneumoniae was identified by colony morphology and positive optochine or 
bile solubility test. Oxacillin screening test and susceptibility to five non-b- 
lactam antimicrobials (vancomycin, tetracycline, trimethoprime-sulfa- 
methoxasole-SXT, erythromycin and clindamycin) was determined by stan- 
dard d isk-as ion  procedure according to NCCLS. Intermediate and 
resistant category (non-B-lactams) was interpreted as resistant. This procedure 
was used for all 666 strains. MICs for penicillin and cefotaxime of strains with 
oxacillin inhbition zone less than 20mm were determined by E-test (AB 
Biodisk, S o h ) .  Penicillin or erythromycin-resistant strains were tested with 
moxifloxacin (disk-dilfusion, NCCLS). Phenotype of resistance to macrolides 
and lincosamides was determined by double disk induction method with disks 
of erythromycin and clindamycin. 
Results: All strains were susceptible to vancomycin. Resistance to penicillin: 
16% of strains were intermediate (MIC 0.12-1 mg/L), 1% resistant 
(MIC 2 2 mg/L). Resistance to cefotaxime: 4% of strains were intermediate 
(MIC 1 mg/L), 0.1% resistant (MIC >2mg/L). Resisance rate to SXTwas 
28%, to tetracycline 14%, to erythromycin 12% and to clindamycin 8%. Two 
phenotypes were found in 77 erythromycin-resistant isolates: 70% constitu- 
tive MLSB phenotype and 30% M-phenotype. One hundred strains were 
tested with moxifloxacin, all strains were susceptible. 
Conclusions: Rates of resistance to antinucrobials tested in S. pneurnoniae is a 
cause of concern. Surveillance d continue. Erythromycin-resistant strains 
were fiozen and should be studied further. Detailed epidemiological analysis 
of collected data is also necessary. 
jP450/ Macrolide-resistant Streptococcus pneumoniae in 
Poland - molecular analysis 
K. Betlejewska-Kielak, E. Sadowy and W. Hryniewicz 
Warsaw, PL 
Objectives: To investigate molecular determinants of niacrolide-resistance 
among pneumococci isolated in Poland and to study the clonal structure of 
this population. 
Methods: Among 726 isolates of pneumococci collected in 1994-1999, 96 
(13%) showed resistance to erythromycin. For these strains, minimal inhibi- 
tory concentrations (MIC) for penicillin, erythromycin, clindamycin and 
spiramycin were determined by broth microdilution method according to 
NCCLS. Serotypes of strains were determined at the Statens Serum Institute, 
Copenhagen, Denmark by the Quellung reaction. Pulsed-field gel 
electrophoresis (PFGE) of SmaI restriction fragments of bacterial chromo- 
some was used to study the population structure of macrolide-resistant 
S t r e p t o w m  pneumoniae and the strains were considered related when they 
shared at least 80% of bands in their PFGE patterns. The presence of e m B  and 
mefA resistance genes, encoding ribosomal methylase and efflux pump, 
respectively, was tested by PCR with specific primers. Sequencing of the 
L4 protein gene rplD was performed in the case of isolates lacking any of the 
two resistance genes. 
Results: The most prevalent serotypes among macrolide-resistant pneumo- 
cocci were 23F and 6B (55 and 17 isolates, respectively). PFGE analysis 
revealed the presence of 34 clonal groups among analyzed strains. Different 
mechanisms were identified to be responsible for the resistance phenotype: 
rRNA methylation (both constitutive and inducible) by the ermB gene 
product, mutations in the tplD gene and drug efflux associated with the 
presence of mefA. The most prevalent mechanism was associated with the 
constitutive expression of the ermB gene. 
Conclusion: Dissemination of macrolide resistance among S. pneumoniae in 
Poland is a result of independent acquisition of different resistance genes 
(mainly em@, which is followed by successful expansion of some clones 
harboring the resistance genes. 
Surveillance of pneumococcal resistance in Belgium 
during winter 2000-2001 
R. S. Vanhoof, I. Damhe, E. Mans, Van Bossuyt, and the SP Multicentre 
Study Group, B 
A total of 318 pneumococcal isolates, collected by 10 labs, were tested for 
their susceptibllity to penicillin (PEN), ampicillin (AMP), amoxkillin 
(AMX), amoxicillin/davulanate (AMC), cefaclor (CFC), cefuroxkne 
(CRX), cefotaxime (CTX), imipenem (IMI), ciprofloxacin (CIP)', gemi- 
floxacin (GEM), levofloxacin (LEV), erythromycin (ERY), clarithromycin 
(CLA), Azithromycin (AZI), miocamycin (MIO), clindamycin (CLI) and 
tetracycline (TET) using NCCLS standardized microdilution. Insusceptibilicy 
rates (IR; following NCCLS) were as follows: PEN 22.0% [of which 11.3% 
high-level (HL)], AMP24.2% (HL 14.l%),AMx2.2%(HLO%), AMC 1.9% 
(HL O%), CFC 20.7% (HL 18.2%). CRX 17.9% (HL 16.3%). CRX-axed 
16.3% (HL 14.4%)**, CTX 8.5% (HL 4.4%), IMI 4.4% (HL 0%). CIP 11.3% 
(HL 2.8%), GEM 0%, LEV 2.5% (HL O%), ERY 30.8% (HL 27.3%). CLA 
28.3% (HL27.0%), AZI 28.3% (HL25.2%), M I 0  33% (HL21.1%), CLI 11% 
(HL 10.4%), TET 39% (HL 38.1%). Overall, GEM was the most active 
compound with EvuCso, MIC90 and IR of 0.015mg/L, O.O3mg/L and O%, 
respectively, followed by AMC, AMX and IMI: 0.015 and 1 mg/L, 1.9%/ 
0.015 and 1 mg/L, 2.2%/0.015 and 0.12mg/L, 4.4%, respectively, In PEN- 
non-susceptible isolates, MICs of the p-lactams rose with those of PEN. 
However, IMI, CTX, AMX and AMC were generally 4,2,1 and I-doubling 
dutions, respectively, more active on these isolates than PEN. AMP was 
equally active, whereas CRX and CFC were generally 2- and 3-doubling 
dilutions respectively, less potent. Furthermore, cross-resistance between 
PEN and other B-lactams in the PEN-non-susceptible isolates was not 
absolute. Indeed, most of the PEN-non-susceptible isolates remained fully 
susceptible to IMI (97.0%), AMC (91.4%) and AMX (90.0%). Compared to 
former survedance studies we have noted the following variations in IR: 
PEN 12.5% (1995), 12.3% (1997). 16.2% (1999) and 22.0% (2001); AMX 
and AMC: 0% (1995 and 1997). 1.0% (1999), and 2.2 and 1.9%, respectively, 
(2001); C T X  6.2% (1995), 7.6% (1997), 12.7% (1999) and 8.5% (2001); IMI: 
3.4% (1995), 3.3% (1997), 0.5% (1999) and 4.4% (2001); CIP: not tested in 
1995 and 1997, 15.6% (1999) and 11.3% (2001); ERY 21.6% (1995), 31.1% 
(1997), 36.1% (1999) and 30.8% (2001); T E T  27.3% (1995). 31.1% (1997). 
22.9 (1999) and 39.0% (2001). 
*: Pneumococcal infections not indicated; and **: breakpoints based on 
250 mg. 
W] Mathematical modeling of the progression of 
bacterial resistance to penicillin G by decreased affinity in 
penicillin binding proteins 
L. Temime, P. Y. Boelle and D. Guillemot 
Paris, F 
Objectives: Streptwocurs pneurnoniae and Neissm'a meningitidis share a very 
similar penicillin G-resistance mechanism medmted by decreased affinity in 
penicillin binding proteins. However, epidemiological studies report that 
whereas resistance is now common in S.pneumonioe. it is stdl rare in 
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N. meningifidis. The objectives of this study were to investigate the factors that 
may account for this difference and to anticipate trends in the meningococcal 
resistance to penicillin. 
Methods: A mathematical model is presented for the emergence and spread 
of bacterial resistance to penicillin in the community, through intra-indivi- 
dd-resistance selection and inter-individual transmission. It is assumed 
that antibiotic exposure is unrelated to bacterial carriage. The resistance 
levels of bacterial strains are described by the MIC. The model depends 
on several parameters, which were estimated b n 1  the literature: the 
duration of carriage (2.2months for S.pneumoniae and lomonths for 
N.meningitIdis); the frequency of antibiotic treatment in the concerned 
population, mostly composed of children for S. pnoumoniue and of young 
adults for iV meningifidis (from once a year to once every 2 years); the contact 
rates, etc. 
Res~l t r .  Used with parameters reflecting the natural hisrory of colonization of 
S. pneumoniae, the model forecasts the emergence of resistant bacteria in an all 
sensitive population (MIC < 0.06) afcer approximately 20years. The pre- 
dicted repartition of resistance levels then becomes bimodal with amajority of 
resistant strains a few years after emergence. In the case of N. meningitidis, the 
model also predicts an evolution towards a bimodal repartition of resistance 
levels, but much slower. 
Conclusion: The predictions concerning the emergence of pneumococcal 
resistance are consistent with what has been observed. Moreover, yearly data 
from the French National Reference Center of Pneumococci exhibit an 
evolution towards a bimodal repartition of MIC in agreement with the 
predictions. The model accounts for the ditfermg epidemiology of resistance 
of S. pneumoniae and N. meningitidis: when introduced as model parameters, 
the Merent characteristics ofpneumococcal and meningococcal colonization 
in terms of transmissibility, of carriage duration or of antibiotic use produce 
widely different outcomes. Finally, the model predicts that even if antibiotic 
use remains constant, meningococcal resistance is bound to increase in the 
next decades. 
jp453- 5. pneumoniae antimicrobial resistance and 
serotypes of isolates in adult patients with bacteremic 
pneumonia 
A. Fleites, I. Cahue, P. Venero, G. Sierra and M. J. Santos 
Oviedo, E 
Objectives: During 1989-1993 we detected an incidence rate of 9.3 bac- 
teremic pneumococcal pneumonia per 100 000 persons/year in Oviedo 
(Austria, Spain). Resistance to antibiotics and serotyping have been 
monitored since 1989. We analyzed data over a 12-year period (1989- 
2001). 
Methods: The strains and the patients were identified by computerized 
micmbiological and clinical records. The serotyping was performed in a 
Reference Center. The oxacfin disk screening test, the broth microdilution 
method (NCCLS M100-S10) and the Chi-square test were used. 
Results: We identify 254 isolates, in blood cultures of adult patients (196 
males, 58 females). 132 (51.9%) patients were 265years old. The most 
common serotypes (%) were: 3 (22.8), 14 (11.4), 9 (8.5), 8 (8.5), 4 (7.7) 
and 19 (7.3); 95.4 and 96.0% were related to the 23-valent vaccine for all 
patients and the older patients (265 years), respectively. Resistance rate (%) 
were: penicillin 27.1 (20.4 intermediate, 6.7 resistant), erythromycin, 12.0, 
clindamycin 11.2 (2 strains had the M phenotype), chloramphenicol 15.2, 
tetracycline, 28.0, cotrimoxazol 36.2, ciprofloxacin 1.9, vancomycin 0. 
Penicillin-non-susceptible strains were 85.5 and 52.1% susceptible to amox- 
icillin and cefotaxime, respectively. Relevant trends (%) between 1989 and 94 
(n= 149) and 1995-2001 (n= 105) were: resistance to eFjthromycin, 6.8 
versus 19.4 (P=0.003), resistance to tetracycline, 31.0 versus 23.8 
(P= 0.209), resistance to chloramphenicol, 21.3 versus 6.6 (P= 0.004). 
No sigmficance was found in resistance to penicillin (26.1 vs. 28.5, 
P=O.672). The global mortality was 19.7 and 23.2% for the older patients 
(P=O.170). No significant increase in mortality was detected in the peni- 
cillin-non-susceptible group (22.4% vs. 18.6%, P =  0.542). 
Conclusions: Relevant data for treatment and preventive strategies are 
documented. Resistance to penicillin remain stable in our geographic area. 
For macrolides, studies of sensitivity invitro are imperative. 
vl Antibiotic resistance in Croatian Streptococcus 
pneumoniae isolates 
S. Andrasevic, A. Tambic Andrasevic, M. Payer1 Pal and S. Plesko 
Zagreb, Cukovec, HR 
Objectives: Most respiratory tract infections are treated empirically and we 
wanted to investigate the resistance rate in Strqrorocn*cpneumoniae so to be able 
to recommend adequate therapy for community acquired respiratory tract 
infections. 
Methods: We analyzed 174 pneumococcal isolates conected in two Croatian 
hospitals University Hospital for Infectious Diseases in Zagreb and General 
Hospital in Cakovec. Isolates were obtained h m  blood cultures (ll), 
cerebrospinal fluid (6), bronchoalveolar lavage (l), tracheal aspirate (27), 
pleural aspirate (2), wound swab (l), eye swab (7) and nasopharynged swab 
(37). Sensitivity to penicillin, amoxicillin and erythromycin was determined 
by detecting minimal inhtbitory concentrations (MICs) using microdilution 
method. 
Results: Sensitivity to penicillin was 63%; 20% ofisolates were moderately and 
17% highly resistant to penicillin. Sensitivity to amoxidin was 99% and to 
erythromycin 85%. The macrolide-resistant strains showed M type (5%) and 
MLS-B type (10%) of resistance. Macrolide-resistant isolates were more 
fiequent among penicillin moderately resistant (38%) and highly resistant 
(20%) isolates than among penicillin sensitive (7%) isolates. 
Conclusions: In comparison with previous results, we have noted an increase 
in penicillin resistance, especially on the account of the shifr towards highly 
resistant isolates. 
(p455( Penicillin-resistant streptococcus pneumoniae 
isolated from infected children in Athens, Greece: resistance 
patterns, serotyping and penicillin-binding protein 26 
mutation characterization by PCR 
S. Chatzipanagiotou, E. Papavasileiou, T. Panagea, A. Makri, 
I. Paxaskaki, C. Nicolaou, A. Ioannidis and N. J. Legakis 
Athens, GR 
Streptococcus pneumoniue remains a major cause of community acquired infec- 
tions. Over recent years, the increasing emergence of penicillin-resistant 
S. pneumoniae (PRSP) is causing serious clinical problems worldwide. We 
report the experience gamed in the Penteli Chddren Hospital ofkhens, with 
respect to PRSP isolated b m  infected children, in terms of their resistance 
patterns to other antibiotics, serotyping and characterization of penicillin- 
binding protein 28 genes @bp 2b) mutation by PCR, throughout 1 year 
(September 1999 to October 2000). From a total of 207 S. pneumoniap s d n s  
isolated &om nasopharynx, mastoid pus, middle ear, sputum, conjunctiva and 
blood, 27 (13%) were resist+ to penicillin (PRSP). The MICs of penicillin 
were for all PRSP A* 0.25 Ilg/mL. Significant resistance rates were found to 
cephalosporins and ciprofloxacin. All strains were susceptible to vancomycin 
and rifampicin and sparfloxacin. The multidrug-resistance rates were 25 out of 
27 PRSP (92.6%). The27 PRSP belonged to six Merent serotypeo: 0:23 (9), 
0:19 (9), 0:9 (4), 0:15 (2). 0:14 (2) and 0 :6  (1). There was no link between 
serotype and a certain resistance phenotype. All strains were pbp 2b class B 
mutants. Our results support the general concept, that special preventive and 
therapeutic strategies should be implemented for the management of pneu- 
mococcal infections. These should include vaccination programs, as well as 
therapeutic options offered by strategies concerning newer quinolone deri- 
vatives, as well as other antimicrobd agents like ketolides, oxazolidinones and 
streptogramins. 
Vancornycin status DIOC5(3)* Bisoxonol' Rhodamine-lW** 
Suscepnble 4.60 f 1.55 1.60 f 0.12 1.47 f 1.17 
Heterogeneous GISA 1.72 f0.67 1.07f0.15 0.66f0.20 
Homogeneous GISA 1.10 =& 0.60 1.06 k 0.26 0.77 f 0.60 
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[p4561 Tracking Streptococcus pneumoniae isolates with 
decreased antimiuobial susceptibility by MIC distribution 
analysis: SENTRY, Europe 1997-2000 
R. Canton, E. Loza, M.I. Morosini, J. Verhoef, R .  Jones 
On behalf of the SENTRY Putticipants Group 
Objective: To study the evolution of antimicrobial resistance of Streptom- 
cuspneumoniue isolates obtained in Europe during the SENTRY Antimicrobial 
Survedance Program over a 4-year period (1997-2000). 
Methods: A total of 1600 S.pneumoniae isolates causing respiratory tract 
infections were obtained in 16 (1997), 18 (1998), 8 (1999), 15 (2000) 
laboratories &om 15 European countries. Susceptibility (NCCLS) 
testing was centralized (Eijkman-Winkler Institute and The Jones 
Group). 
Results: MIC ranges (pg/mL) and resistance rates (intermediate +resistant; 
NCCLS breakpoints) were: yearly dserences in fl-lactams and erythromycin 
resistance were owing to the inclusion ofsites with widely Werent resistance 
rates 6.e. penicillin <3-55%). As expected, erythromycin resistance was 
hlgher among penicillin resistant isolates (53% during 1999 and 2000) 
and linked (>75%) to Erm phenotype. Decreased quinolone susceptibility 
was scarcely observed (0.3 in 1998 and 0.5 in 1999). Only four isolats 
(two from Spain) displayed levofloxacin MICs of 2 2  pg/mL during 1999 and 
2000. AU these four isolates were inhibited by 0.12-0.5pg/mL of 
BMS284756. 
Conclusion: MIC distribution analysis was usell to detect isolates with 
decreased antimicrobial susceptibilities (Table 1). 
Table 1 MIC distriboaon analysis (Abstract P456) 
1997 (n=316) 1998 (n=535) 1999 (n=213) 2wO (n=536) 
Range %R Ranp Y' Range %I< Range %R 
Peru& 50.03 to 4 26.2 50.03 to 4 269 50.03 to 4 41.4 50.03 to 4 34.0 
Cefotaxhe 50008  to 8 6.6 20.008 to 2 8 5 50.008 to 4 20.6 - - 
- -  - 50008 to 8 21.1 Ceftrlaxonc ~ 
Cefepime 50.06 to >8 10.4 50.06 co 8 10.0 50 06 to 2 18.8 50.06 to 2 19.1 
Erythrurnycin 50.25 to >32 18.3 50.25 co >32 23.7 50.25 to >32 19.7 50.25 to >32 29.9 
Qumu./dJio. 50.25 to 2 6.0 50.25 to 2 0 7  50.25 to 1 0 50.25 to 2 0.4 
Chloramphenicol 5 2  to 16 8.5 5 2  to 16 8.9 52 to >I6 12.7 5 2  to >16 11.7 
Teolcydine 5 2  to 216 25.9 52 to >16 24.6 52 to >16 20.7 5 2  to >16 31.8 
Le~floxacm 50.5 to 2 0 50.5 to >4 0 3  50.5 to >4 0.5 50.5 to 2 0 
- -  
C O - W Z O I ~  50.5 to >4 24.6 50.5 to >4 27 1 50.5 to >4 35.7 50.5 co >4 39.4 
BMS284756. ~ - -  - 20.03 to 0.5 0 50.03 to I 0 
'The levogloxacin criteria was used (I + R > 2 pg/mL). 
I P457 I Different properties of streptococcus pneumoniae 
isolates carrying macrolide efflux genes mef(A) or mef(a 
M. Del Grosso, A. Scotto d'Abusco, E Iannelli, M. Santagati, G. Pozzi 
and A. Pantosti 
Rome, Sienu, Cufaniu, I 
Objectives: One of the main determinants of maclolide resistance in Strepto- 
cocnrspneumoniae is the mefgene which encodes for a drug efflux pump. The 
characteristics of the mef-containing elements and the properties of strains 
carrying the two Werent mefgenes, m&4) and mejEJ, were studied in a large 
series of erythromycin-resistant isolates. 
Methods: The mefgene was detected by PCR. mejA)  and mejEJ were 
distinguished by PCR-RFLP and sequencing. Molecular typing was obtained 
by pulsed-field gel electrophoresis (PFGE). Multilocus sequence typing 
(MLST) of a mef(tl) isolate was performed. Transformation assays and mating 
experiments were performed. 
Results: Out of 187 erythromycin-resistant strains, 40 (21%) showed an M 
phenotype and carried mt$ 33 carried m&4) and seven m&E). All isolates 
carrying m&d) belonged to serotype 14 and were susceptible to the anti- 
biotics tested, except erythromycin. 17 m&d)-positive strains were examined 
by PFGE. All shared very similar profiles suggesting they belong to the same 
clone. The allelic profile of one isolate, obtained by MLST fST 9) corresponds 
to that of clone England 14-9, a major antimicrobial-resistant clone. The 
m 4 E )  strams belonged to SIX Merent serotypes, the majority were resistant to 
other annbioncs besides erythromycm, mcludmg p e m c h  Three rneJE) 
strams exmned  by PFGE &d not appear to be c l o d y  rdated. The 
sequences of a & w e n t  of the element, mcludmg mefand msr(A) homologue. 
were, respecnvely, idenhcal in three mgA) strams and in three m&E) strams, 
although there were dtfferences at 168 posinons between the two 
groups. In all the m&A) isdates, the mfelement was inserted m celB, that  
led to mparment of rhe competence for transformanon of the strains. The 
mflE) element was merted at dd&rent chromosomal sites, therefore, the 
competence abhty of the m@E) stram was mamtamed Transfer of ery- 
thromycin resistance by conjuganon was obtained h m  two out of three 
m&A) strams, whereas no transfer was seen from the three meJE) strains 
studed. 
Conclusions: In Italy, erythromycm resistance 111 S pneumonia is conferred by 
mefgenes m 21% of the remtant isolates and the m@) gene 1s p r e h g .  Thls 
situation is Merent horn that in North Amenca, where m&E) 1s the most 
common erychromycm-remtance determmant Owmg to the mportant 
lfferent characterisncs of the s m s  carrylng meJA) or meJE), we suggest 
to mantam the dtsnncnon between these two genes 
Ip4581 in vitro activity of plactam antibiotics against 
respiratory tract pathogens isolated in France during 
2000-2001 
H. Drugeon, N. Momor-Vdle, A Bensalah and M E Juvln 
Nantes, Pans, Levallois Pewer, F 
Objectives: The objecnve of this study was to evaluate the m vitro acnvtty of 
oral fi-lactam antibiohcs (BL) commonly used m France dgamst recent 
respiratory tract pathogens. 
Methods: A total of 1694 French c h c a l  stram of adult respmtory tract 
infecnons were isolated fiom November 2000 to Aprd 2001 m 30 French 
parncipant centers MICs ofpem& (PEN), a m o m c h  (AMX), amomclav 
(AMC), cefpodoxlme (CPD) and cefuroxlme (CXM) were determmed by 
the agar dunon  method rn a central laboratory Suscepnbdq rates were 
calculated accordmg to the recommendatlons of the Cormti de l'hnbio- 
gramme de la Sociite Franwse de Miuobmlope. 
Results: Streptococcus pneumonia (SP): 49% of the s t r a m  were suscepnble 
(PSS), 28 3% mtermedate (PIS) and 22.7% reslstant (PRS) to PEN. MICs 
50% (mg/L)/MICs 90% (mg/L) ofBL were the followmg: O v e d  SP s t r a m s  
(n = 675): CPD: 0.0614; AMX. 0 0612; CXM: 0.2514, PSS (n= 331): CPD 
0.03/0.06; AMX: 0.015/0.03; CXM: 0.03/0.12; PIS (n = 191): CPD: 0.5/2, 
AMX: 0.5/1; CXPVI 2/4; PRS (n= 153): CPD: 2/4; AMX 2/4; CXM: 4/ 
16.4% of the smns were ofhgh level of resstance (MICs> =4mg/L) to 
AMX. Haemophdus injwenzae (I-II) 33.2% ofthe s t r m s  were /Mactamase @la) 
producers MICs 50% (mg/L)/MICs 90% (mg/L)/percentages of suscept- 
ibhty were the followmg: overall HI stratns (n= 751): CPD: 0.12/0.25/99.9; 
AMC. 0.5/2/98.8; CXM: 1/4/66, non-blaproducers (n = 493): CPD: 0.121 
0.25/99 8; AMC. 0.5/2/98.4; CXM: 1/4/66.7; bla producers (n=245). 
CPD: 0.12/0.25/100; AMC: 1/2/99.6, CXM: 1/8/64.5. Moraxella curunhaf~s 
(MC) (n = 268): 92.1% of the strams were fl-lactamase @la) producers. MICs 
50% (mg/L)/MICs 90% (mg/L)/percentages of suscephbhty were the 
follaymg. CPD: 0 5/1/99.3; AMC: 0.03/0.12/100; CXM: 0.5/1/91.4. 
Conclusions The results of th s  study show that a hgh rate of pernullin 
resistance 1s found among French SP; AMX and CPD have a better achvlty 
than CXM agamst SP, especdy agamst PIS and PRSCPD has the best 
acnwty agamst HI, followed by AMC ant CXM whch bas a lower percentage 
of suscepnbdity - AMC has lower MICs agamt MC than cephalosporms 
although most smns  are suscepnble to the three compounds. O v e d ,  CPD 
and AMC appear to be the best canrlldates for the treatment of comumty 
acqumd respiratory-tract infecnons 
vl Antimicrobial susceptibilities and serotypes (STs) of 
364 Streptococcw pneumoniae isolates in the Comunidad 
Valenciana (Spain) 
M. Montaner, E. Canton, R. Moreno, J. P e w ,  S. Cuellar and 
M Gobernado 
I/alemta, C&-llon, E 
Objectives The lmportance of plondmg vaccinanon programs has 
mcreased wlth the emergence of annbionc-resistant s t r a m s  of S pneumontue 
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Surveillance for drug resistance and ST distribution and its variation along 
time in the different geographical areas is critical for evaluating the coverage of 
pneumococcal vaccines. 
Methods: We evaluated 364 strains of S. pneumoniae, isolated from the in- and 
out-patients of two hospitals of the Comunidad Valenciana. STs were 
determined by Quellung reaction, with reagents provided by the Statum 
Serum Institute. MICs of penicillin (PV), ampicillin (AM), amoxycillin/ 
cladanic acid (XL.), cefuroxime (XM), cefotaxime (CT), erythromycin 
(EM), clindamycin (CM), rifmpicin (RI), vancomycin (VA) andlevofloxacin 
(LE) were determined by E-test method, and the breakpoints applied were 
NCCLS 2000 (M7-A5). 
Results: From our 364 strains, 70 (19.2%) were invasive (INV) (mainly blood, 
CSF and pleural) and 294 (80.8%) were non-invasive (NON-INV). The most 
frequent STs were: 19 (22.5%). 6 (14.0%). 3 (11.8%). 23 (11.8%), 14 (9.1%) 
and 9 (6.9%). The prevalence of highly resistant strains (INV/Non-INV) 
were: PV 8.6% (9.4%/8.5%), AM 0.9%( 0%/1.2%), XL 0%. XM 3.4% (7.7%/ 
2.3%), CT 1.9% (1.5%/1.9%), EM 47.7% (38.1%/50.0%), CM 40.0% 
(23.8%/43.6%), RI 0%. VA 0% and LE 0.3% (0%/0.4%). For PV 36.1 
and 69.0% of non-susceptible (NS) strains were NS to XM and EM, 
respectively; and 0.8 and 21.5% of susceptible (S) strains were NS to XM 
and EM, respectively. There were 83 (27.3%) strains S to all the antibiotics 
studied. Their ST (no) were: three (14), six (10). 19 (lo), 23 (nine), 11 (six), 9 
(five), 4 (four), 22 (three), 33 (three), non-rypable (NT) (three), 14 (two), 16 
(two), 17 (two), 18 (two), 24 (two), and one each ofthe following STs: 5,10, 
15,21,34and41. We found77 (25.3%)strainsNStoonlyoneantibiotic. The 
ST (no) were 19 (19). three (12), 6 (12), 23 (seven), 9 (three), 11 (three), 29 
(three), NT (three), 4 (two), 14 (two), 18 (two) and one each ofthe following 
ST. 5, 7, 8, 10, 16, 20, 24, 33 and 35. There were six (2%) strains NS to five 
antibiotics, belonging to STs, 9, 14 and 19. 
Conclusions: The levels of resistance to PV, EM and XM found are higher 
than other similar studies reported in our country. The heptavalent conjugated 
vaccine covers 73.3% of invasive strains &om children <2 years and the 23- 
d e n t  pneumococcal polysaccharide vaccine covers >90% in all the p u p s  
older than 2years. 
Ip4601 Effectiveness of the 23-valent pneumococcal 
polysaccharide vaccine (PPV) in COPD-patients on steroids 
N. Schmidt, A. de Row, M. W. Pletz, N. Stmad, P. Zielen and H. Lode 
Berlin, Frankfurt/M., Bonn, D 
Objectives: The efEcacy of the PPV is still unclear especially in patients with 
COPD. There are no valid data concerning time-dependent antibody 
production after vaccination and the effect of often concomitant steroid 
therapy. To evaluate the efficacy of the PPV the antibody production in 
patients with steroid therapy-dependent COPD was compared with that in 
healthy volunteers. 
Methods: Patients with COPD on inhalative steroids (n=29, mean age 
62years) or on systemic steroids (receiving >10 mg prednisolone/d; n = 17, 
mean age 63 years) and a control group of healthy volunteers (n = 23, mean 
age 64years) were vaccinated with PPV (0.5mL Pneumopur@). Antibody 
titers against the serotypes 4,6,9,12, 14,18,19 and 23 were measured by the 
CovaLink NH ELISA technique@ before and 3 and 12 months after vaccina- 
tion, respectively. An antibody concentration of >1.0 pg/mL was considered 
to be protective. 
Results: We found a sigdcant (P< 0.05) rise of antibodies in all groups 
3 months post vaccination. Twelve months after PPV the COPD-patients on 
systemic steroids had a lower mean antibody titers (not statistically sigmfkant) 
than the patients on inhalative steroids and control patients. 
Conclusion: Until 12 months after the vaccination with the 23-valent pneu- 
mococcal polysaccharide vaccine the COPD-patients on systemic and inha- 
lative steroids exhibit sufficient antibody concentrations. 
(p4611 The carriage of stmptococc~ pneumoniae in 
nasopharynx of infants and young children 
A. Sulikowska, I? Grzesiowski, M. Taraszkiewicz and W. Hryniewicz 
Warsaw, PL 
Objectives: To determine the rate and risk factors of nasopharyngeal carriage 
of Stnptocomspnarmonia~ and its susceptibility to antibiotics in children under 
4years of age in Warsaw. 
Methods: Two hundred children were examined between November 2000 
and May 2001 in selected settings in Warsaw (orphanage, 107; crkche, 56; and 
the family children, 37). The collection of demographic data, previous 
antibiotic therapy, respiratory tract infections and vaccination was performed 
on a special questionnaire. Nasopharynx swabs were taken and they were 
cultured on blood agar plates and incubated at 37 "C in 5% of COZ overnight. 
S. pneumoniae was identified by colony morphology, optochin susceptibility 
and bile solubility. The MICs of 13 antibiotics for S.pneumoniae 
were determined by bmth microdilution method according to NCCLS 
guidelines. 
Results: Altogether, 110 strains of S. pneumoniae were isolated 63 strains from 
orphanage children, 36 &om creche, and 11 from the family children, thus the 
carrier rate of Spneumoniae was 58.9, 64.3 and 29.7%, respectively. Suscept- 
ibility testing revealed that 34 strains (30.9%) were intermedate (orphanage 
24 strains, creche 10) and 7 strains (6.4%) were f d y  resistant to penicillin 
(orphanage six strains, creche one). No single penicillin non-susceptible strain 
(PNSP) was found among isolates from the farmly children. Susceptibility 
to other antibiotics in orphanage/creche was as follows: amoxicillin 
90.5%/97.2%, cefuroxime 90.5%/97.2%, cefotaxime 90.5%/97.2%, cefepime 
90.5%/97.2%, imipenem 92.1%/97.2%, erythromycin 46.0%/66.7%, 
clindanycin 46.0%/66.7%, cotrimoxazole 9.5%/13.9%, doxycycline 
47.6%/50%, chloramphenicol87.3%/55.6%, rifampin 96.8%/100.0%. van- 
comycin 100.0%/100.0%. Pneumococci isolated f k m  the fimily children 
were fully susceptible to majority of antibiotics tested with the exception of 
cotrimoxazole, chloramphenicol and doxycycline; to which susceptibdity was 
63.6, 81.8, and 90.9%, respectively. 
Conclusions: The genera1 rate of carriage was high (55%) and significantly 
higher in closed communities. Among 41 (37.2%) PNSP 7 strains (6.4%) were 
highly resistant to penicdh and most of them were isolated born orphanage 
children (six strains). In the orphanage and creche, high resistance to 
erythromycin and clindamycin as well as to cotrimoxazole was observed. 
Clonal spread of resistant strains within a closed community could have taken 
place and its confirmation requires further molecular studies. 
I P462 1 Utility of urinary antigen detection in the diagnosis 
of pneumococcal pneumonia in children 
J. Dominguez, M. Azuara, S. Blanco, N. Gali, A. Mainou, C. Prat, 
C. Rodrigo and V Ausina 
atdalona, E 
Objectives: (1) To establish the utility of the urinary antigen detection by a 
new immuuochromatographic membrane test (ICT) (Binax Inc., Portland, 
Maine) in the pneumococcal pneumonia diagnosis in pediatric patients. (2) 
Assessment of the ICT usefulness in healthy nasopharyngeal carrier children. 
Methods: Twelve urine samples from children with pneumococcal pneu- 
monia dngnosed by hemoculture and pneumococcal polysaccharide capsular 
antigen detection by counter-immunoelectrophoresis in urine were studied. 
We also evaluated urine samples fiom 34 pediatric patients with Mycoplasma 
pneumoniae pneumonia. Urine samples were studed both non-concentrated 
and concentrated by selective ultrafiltration. We included urine samples from 
healthy children but with pneumococcal nasopharyngeal carriage. The ICT 
was performed accordiug to the manufacturer's instructions. 
Results: S. pneumoniae antigen was detected in 11 out of 12 non-concentrated 
urine born patients with pneumococcal pneumonia (91.7%), and in 11 of the 
11 concentrated urines (100%). The ICT specificity was 58.8% using non- 
concentrated urine and 6.1% using concentrated urine. Pneumococcal anti- 
gen was also detected in six non-concentnted urine from the 11 nasophar- 
yngeal carriers and in eight cases out of the 10 concentrated urines. 
Conclusions: (1) The ICT assay is a simple, sensitive, but a very nonspecific 
test for the pneumococcal pneumonia in children. (2) The use of the 
concentrated urine increases the sensitivity but decreases significantly the 
specificity. (3) The S.pneumaniae urinary antigen could be detected in 
nasopharyngeal carriers. 
1 P463 1 streptococcus pneumoniae (sp) in community- 
acquired pneumonia (CAP): multicentre study 
B. Sarachan, L. Mhehan and C. Baxovanos 
Buenos Awes, AR 
Streptocomspneumoniae (Sp) is one of the pathogens whch is manly respon- 
sible for respmtory tract InfeChOns in both, chddren and adults. The level of 
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prevalence of Sp resistant to penicillin (pe), is well-documented worldwde in 
the literature. The aim of the present study is to determine: (a) the incidence 
of Sp in C W ,  in adults and children; 0.) the usefulness of the Sp antigen- 
detection test as a tool in presumptive lower respiratory tract infections; and 
(c) the prevalence of Sp resistant to Pe. Between April 2000 and October 2001 
(two Winter seasons), we studied 179 patients with CAP, documented by 
clinical sings, symptoms and X-ray Out ofthe total 179, 157 were adults and 
22 children, aged between 1- and 2-year-olds. The specimens analyzed were 
expectorated sputum in adults, and laver respiratory tract aspiration in kids. 
Both samples were cultured between the 3 h post sample collection. Quanti- 
tative cuIture was performed on chocolate and sheep blood agar plates 
incubated at 35°C in 5-10% COz atmosphere for 48-72h. At the same 
time Gram- and Ziehl-Neelsen stains was done. In 170/179 patients blood 
cultures were taken. The presumptive identifications of &a-hemolytic colo- 
nies was done by conventional biochemical methods (optoquin susceptibility 
and bile solubihty tests). Sp. antigen detection was done in each patients using 
Binax (in 109 urine samples) and Murex (70 urine, 70 serum and 21 sputum 
samples) according with the manufacturer's recommendations. The results 
obtain were: 
Total of Sp isolated (respiratory samples plus blood) 37/179 = 20.7%. 
0 Ag-positive by binax: 44%. 
Ag-positive by murex: 41.6%; 
0 PPV for binax: 86.2%; 
0 NPV for binax: 82.3%; 
PPV for murex: 80%; 
0 NPV for murex: 58.3%. 
Pe-sensibhty results were: 
0 81.1% 5 0.06 pg/mL (30/37); 
5.4% 2 2.0 pg/mL (2/37). 
Conclusions: 
1. The incidence of Sp as etiologic agent inn CAP in Argentina is within the 
international levels. 
2. In our experience Sp antigen detection, could be used only as a pre- 
sumptive rapid method. 
3. The majority of the strains isolated in ths  study were hghly sensitive and 
the prevalence of resistance tp Pe ohtained was mainly of intermediate 
level. 
4. The spread of Pe-resistant strains is irkcreasing in the community world- 
wide, these makes the need to be determine the epidemiological situation 
in each country. 
13.5% 0.12-1.0 pg/mL (5137); 
1 P464 I Telithromycin is highly active against isolates of 
5. pneumoniae collected from patients with community- 
acquired respiratory tract infections in Italy (CARTls; 
PROTEKT 1999-2001) 
G. Schito, G. Russo, G. Fadda, A. Cavallero and G. Pozzi 
Genoa, Catania, Rome, Milan, Siena, I 
Objectives: PROTEKT is a global longitudmal surveillance study designed to 
track the spread of antibacterial resistance among bacterial pathogens fiom 
CARTIs. Data are now available for isolates collected in Italy during two 
consecutive winter seasons: 1999-2000 (2000) and 2000-2001 (2001; pre- 
liminary data). 
Methods: Isolates were collected from two centers in 2000 and five centres in 
2001. MICs of antibacterial were determined centrally by NCCLS broth 
microdilution methods and interpreted using available NCCLS breakpoints. 
Results: Prevalence of resistance to penicillin G and erythromycin A 
among isolates of S.pneumoniae during 2000 ( n =  119) was as follows: 
penicilhn G intermediate (PenI, MIC 0.12-1mg/L), 6 (5%); penicillin 
G resistant (PenR, MIC>or=2mg/L), 12 (10.1%); erythromycin A 
resistant (EryR, MIC > or = 1 mg/L), 51 (42.9%). Corresponding data for 
2001 (n=69) were: PenI, 2 (2.9%); P e a ,  6 (8.7%); EryR, 20 (29%). 
Mode MIC, MIC9,, and susceptibility data for a selection of the antibacterials 
tested against S. pneumoniae are presented in Table 1. Telithromycin was 
the most potent of the oral agents tested, having a mode MIC, MIC50 
and MIC,, of 0.015, 0.015 and 0.25 mg/L, respectively, in both study years. 
Importantly, telithromycin retained potent activity against pneumococci 
resistant to other antibacterials. Telithromycin was also highly active against 
isolates of H .  influenzae (2090: mode MIC, 1 mg/L; MIC,", 2mg/L; 2001: 
mode MIC. 2 mg/L; MIC90, 2 mg/L) and M .  catarrhah (2000: mode MIC, 
0.12mg/L; MICPo. 0.12mgIL; 2001: mode MIC, O.O6mg/L, MICw, 
0.06 mg/L). 
Table 1 Invitro activity of test antibacterials against Spneumoniae (2000) 
Mode MIC MICso 90 
Antibacterial (m%/L) (&L) suscepclbdity 
Telithomycin 0.15 0.35 - 
Penicillin G 0.03 2 84.9 
Cefuroxime 0.06 4 88.9 
Erythromycin A 0.06 >64 57.1 
Arithmmycin 0.12 >64 57.1 
Clarithmmycin 0.03 >32 57.1 
Coaimoxazale 0.23 4 47.1 
Levofloxacin 1 1 100 
Linezolid 1 2 1M) 
0.06 0.12 100 
0.3 1 99.2 
Conclusions: PROTEKT 1999-2001 confirms the high prevalence ofmacro- 
hde resutance amongst pneumococci m Italy and the potent activlty of 
tehthromycin awnst tsolates of the major bacterial pathogens imphcated 
in CARTIs, irrespecave of resistance phenotype. 
lp465] Breakthrough pneumococcal bacteremia in 
patients being treated with clarithromycin or amoxicillinl 
cClavulanate 
D. Van Kerkhoven, W E. Peetermans and J. Verhaegen 
Leuwn, B 
Objective: To evaluate the correlation between failure of antibiotic treatment 
and resistance of S. pneumoniae isolated Gom blood cultures. 
Patients and methods: The patient population was selected using 
three criteria: >18years, pneumococcal bacteremia and hospitalization at 
the University Hospitals Leuven. The tecords were retrospectively 
reviewed by means of stmdardized protocol. The identification of S. pneu- 
moniae and the susceptibility testing was performed using conventional 
methods. 
Results: 136 pneumococcal bacteremia (39% women and 61% men) were 
diagnosed in the period 1998-2000 (age group 18-50 21%; 51-70: 34%. 71- 
80: 21%; and >81: 24%). Seventy-eight per cent had a pneumonia. The others 
had upper-respiratory tract infections (6%), bronchitis (5%), abdominal 
infections (3%) or catheter-related infections (2%). There was one case of 
cellulitis and OPSI and for 5% the source of infection was unknown. The 
susceptibility for penicillin was intermediate for 11 isolates and two were 
resistant (MICpeni 1.5 and 3mg/L). 21% was resistant to erythromycin. 31 
patients died (23%). 
Thirteen patients took antibiotics a few days before admission to the 
hospital where pneumococcal bacteremia was clagnosed. Pre-hospitalization 
antibiotic therapy was clarithromycin (4x), amoxicillm/clavulanate (5 X), 
cefadroxil (2x), cefaclor ( l x )  and amoxicfin ( Ix) .  Four patienu received 
clarithromycin (2 x 500mg/day) for 3-14days. S. pneumoniae fiom these 
patients were sensitive to penicillm but resistant to erythromycin. Four 
patients received amoxicillm/cla&te (2 X 500 mg/day) for 3-18 days 
and one patient amoxiciUln for 7 days. All S. pneumoniae &om these patients 
were sensitive to penicillin. 
Conclusions: The four patients with breakthrough bacteremia under clari- 
thromycin treatment showed erythromycin-resistant S. pneumoniae. In Bel- 
gium, >90% of the erythromycin-resistant pneumococci have the ermA.44 
gene and express the MLSB-phenotype resistance (MICs erythromycin 
>256 mg/L). The pre-hospitalization therapy with amoxicdh ik clavulanate 
could not avoid a breakthrough bacteremia in s i x  patients, but there was no 
association with penicihn resistance. 
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Resistance mechanisms in S. pneumoniae 
lp466) A preliminary comparison of the Macrolide 
resistance (Macr) mechanism distribution in streptococcus 
pneumniae (SPN) isolated from PROTEKT 2000 and 
PROTEKT 2001 
D. J. Farrell, I. Morrissey, S. Bakker, C. Turner and D. Felmingham 
London, UK 
Objectives: PROTEKT is a global, longitudinal study of the antimicrobial 
susceptibility of bactenal pathogens associated with community-acquired 
lower respiratory tract infections. The program is currently completing its 
second year of investigation (year 1 = 2000, year 2 =2001). The objective of 
this study was to compare the Macr mechanism distribution for SPN testedso 
far h m  countries with sufficient isolates tested so far in the PROTEKT 2001 
study with isolates &om the same counmes in PROTEKT 2001. 
Methods: The presence of Macr genes [erm(A), m ( A )  subclass erm(TR), 
erm(B), erm(Cj and m&4)] was determined using a rapid-cycle multiplex 
PCR assay with microwell-format gene specific probe detection as previously 
described [l] 
Results: Comparative data is shown in Table 1. 
Table 1 Comparaave data 
GeztotyQpc ("/. of Man isohur) 
Irohtn t w e d  (e) M$(A) Em (B) M.f (A) & m (!3) Negative' 
Countq 2000 2001 2000 2001 2000 2001 2000 2001 2000 2001 
F~~~ 106 43 2.8 o 97.2 iw o o o n 
ldY 53 57 41.5 36.8 58.5 63.2 o o o n 
spun 38 128 5.3 5.5 94.7 93.7 o o o n 
Gemmy 50 40 50 47.5 40 52.5 0 0 10 0 
C d  57 46 52.6 69.8 35.1 28.3 3.5 2.2 8.8 4.3 
USA 105 58 63.8 61 2 22.9 17.2 12.4 15 5 1 0 
Japan 242 467 43 34.3 52.1 63.4 3.3 1.9 1.7 0.4 
'Negative for all the mechanisms tested, resistance owing to 23s r R N A  and/or 
riboprotein mutations. 
Discussion: The distribution of Macr genes has remained relatively 
unchanged in France, Italy and Spain. A significant increase in the percentage 
of ern(@ occurred in Japan. Conversely, data &om the USA and Canada 
suggests an increase in m@) distribution and the USA still shows a sigtllfcant 
percentage of isolates with dual mechanisms. Interestingly, the number of 
isolates negative for the mechanisms tested has decreased. 
Reference 
1 .  F m l l  DJ ct d. J. Antimimob Chemother 2001 48541 
lp4671 Activities of 16-membered macrolides on Italian 
streptococcus pneumoniae isolates with different levels of 
erythromycin susceptibility 
A. Mazzariol, J. Zuliani and G. Cornagha 
Verona, I 
Macrolide resistance among pneumococci is a major cause of concern in Italy, 
always affecting erythromycin, the new macrolide compounds, namely 
clarithromycin and roxithromycin, as well as the azalide azithromycin. More 
ofren than not, the resistance affects also the 16-membered compounds and 
the lincosamides, too. A total of 375 S.pneumoniue isolated from Merent 
Xtalian geographic areas were tested for their susceptibility to the 16-mem- 
bered macrolides, the 14-membered macrolides etythromycin, clarithromy- 
cin and roxithromycin, the azalide azithromycin and other reference 
antibiotics. The presence of either the erm(A) or the mef(A) gene was 
investigated by PCR on all erythromycin-resistant strains. A total of 38.7% 
of the isolates proved erythromycin-resistant. All the erythromycin-resistant 
strains were also resistant to the other 14-membered macrolides tested and to 
azithromycin. Of all the erythromycin-resistant isolates, 600/0 revealed a MLS 
B constitutive resistance (MLS B CR), 21.4% a MLS B inducible resistance 
(IVlLS B IR), and a 18.6% an M-type resistance. The MLS B C R  isolates 
showed the widest MIC range of 16-membered macrolides (all 50.06 to 
>256mg/mL.), h o s t  90% of these st ra ins  proving highly resistant to 
spiramycin, josamycin and midecamycin. Indeed Rokitamycin showed 
high-level resistance only in the 50% of strains. MLS B IR isolates showed 
a greater susceptibility to 16-membered macrolides: spiramycin (MIC50 
8 mg/mL, Micw country 256mg/mL, range: <0.06->256 mg/mL.) being 
the least effective, whilst josamycin and midecamicine (MICSO = 1 mg/mL 
and 0.5 mg/mL, respectively, MI% = 8 mg/mL, range: 50.06-32 mg/mL) 
and rokytamycin (MICso = 5 O.O6mg/mL, MICw = 0.5 mg/mL, range: 
- <0.06-4mg/mL) were definitely more active. Virtually all the M isolates 
proved susceptible to 16-membered macrolides. Thus, different phenotypes 
of erythromycin resistance show a different pattern of resistance to 16- 
membered compound macrolides, which in turn proved endowed 
with Merent levels of activity even on isolates sharing the same 
phenotype. Intrinsic potency and inducing capability might account for such 
differences. 
] P468 I Multicentre evaluation and genotypic analysis of 
macrolide and ketolide activities on Italian Streptococcus 
pneumoniae isolates 
A. Mazzariol, J. Zuliani, E Luzzaro, G. Manno, R. Rescddani, 
M. P. Ronchetti, S. Cresti, D. Savoia, G. Ravizzola, R. Fontana and 
G. Cornagha 
Verona, Kmse, Genoa, Monza, Rome, Siena, Turin, Brescia, I 
Macrolide resistance among pneumococci is a major cause of concern in Italy, 
where high rates of pneumococci that are highly resistant to macrolides have 
been reported, even in the absence ofthe high rates ofpenicillin resistance that 
are usually found at the same time. The activities of the novel ketolide 
telithromycin and of other reference antibiotics were assayed on 427 Strepto- 
cocnls pneumoniae isolated fiom 12 different Italian centers over the period 
1999-2001. The genotypes of all erythromycin-resistant strains were inves- 
tigated by PCR. A total of 38% of the isolates proved erythromycin-resistant, 
whereas 17% were not susceptible to penicillin (5.3% resistant and 11.7% 
intermediate). AU the erythromycin-resistant serains were also resistant to 
azithromycin, clarithromycin and roxithromycin. Genotype analysis revealed 
the presence of the erm(A) gene in 90.2% and of the m#) gene in 9.8% of 
the erythromycin-resistant isolates, respectively. According to the break- 
points, 98.4 of the isolates were susceptible to telithromycin, with MICs 
ranging Gom 0.002 to >32 pg/mL (MICSO = 0.012 pg/mL, MIC9o = 
O.O64pg/mL. Telithromycin was uniformly active on s t r a i n s  with either 
the Mef or the MLSB phenotype, including the constitutively resistant MLSB 
isolates whose erythromycin MICs exceeded 256 p g / d .  Telithromycin 
proved very active on al l  Italian S. pneumoniae isolates examined in the present 
study. No cross-resistance with erythromycin or other macrolides was 
detected; thus telithromycin deserves further attention as a potential therapy 
for S.pneumoniae infections (Tables 1 to 3). 
Table 1 MIC, (pg/mL) of Spneumonim (427 isolates) 
Antibiotics MIC9a Range 
Erythromycin 
Telithromycin 
Azithromycin 
Clarithromycin 
Roxythromycin 
Clindamycin 
Penicillin G 
Lewfloxacin 
0.064 
0.012 
0.19 
0.047 
0.125 
0.064 
0.023 
- 
>256 
0.064 
>256 
>256 
>256 
>256 
0.5 
- 
<0.01&>256 
<0.002->32 
<0.016->256 
10.016->256 
<0.01&>256 
<0.016->256 
40.002-> 12 
- 
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Table 2 Susceptibilities (%) of Spneumoniae (427 isolates) 
Antibiotics Susceptible Intermediate Resistant 
Erythromycin 62 0 38 
Azithromyctn 55 7 38 
Clarithromycin 61.4 0.4 38.2 
Clindamycin 69.6 0.2 30.2 
Penicillin G 83 11.7 5.3 
Levoflaxacin - - 
Telithromycin 98.4 1.4 0.2 
- 
MLSB (CR) - 
MLSB (IR) - 
M 
Macrolide resistance mechanisms among 
streptococcus pneumniae nasopharyngeal strains isolated 
from children in Athens, Greece: a preliminary report 
1. Galani, M. Souli, D. Katsianou and H. Giamarellou 
Athens, GR 
Objectives: In Greece, macrolide-resistant pneumococci have been isolated at 
a rate of 25% in 2000. Knowledge of the prevalence and type of macrotide 
resistance mechanism may have important therapeutic implications as it m y  
guide empirical antimicrobial treatment for common community acquired 
infections. 
Methods: A total of 409 S.pneumonim isolates were obtained during a 
surveillance study involving 1000 children (age 1-5 years) attending day-care 
centen of Athens metropolitan area fiom February to April 2000. These 
strains were characterized by in vitro susceptibihty testing that was carried out 
by disk difision and E-test. The strains found to be erythromycin resistant, 
accordtng to the NCCLS guidelines have been phenotypically and genoty- 
pically characterized. Fifty-one out of 101 erythromycin-resistant isolates 
have already been studied for the resistance phenotype by disk dif€usion using 
2 pg clindamycin, 15 pg erythromycin and 7.5 pg quinopristin disks aohnston 
et al. 1998, AAC, 42: 2425-26) and for the presence of macrolide resistance 
genes (ermAM and mefE) by PCR (Sutcliffe et al. 1996, AAC, 4 0  2562-6). 
Resistance mechanisms in Streptococcus Pyogenes 
Results: Twenty-four lsolates (47%) were assigned to the consntunve macro- 
hde, lmcosanude and s t rep togrm B rmstance (MLSB) phenotype and ;ill 
camed the m A M  gene. Twenty-seven isolates (53%) were resistant to 
erythromycm but suscepnble to chndamycin (M-phenotype) and all possessed 
the me& gene 
Conclusions: Although the study 1s sd ongoing mefE and &Mseem to be 
equally cfistnbuted m our commumty. Recommendatlons for the empmc 
treatment of pneumococcal mfectlons based on these data cannot be made 
v] Pneumococcel strains containing an eMa 
methylase can show heterogeneous resistance to kmlide 
antibiotics 
A. Tat-Kamradt, T. Dougherty, D. Girard, A. Giovanis, A. Marra, 
L. Brennan, J. Duignan andJ. SutcHe 
Groton, Nnu Haven, USA 
Ketolide antibiotics are a new macrolide-related class of compounds which 
have activity against strains inducibly resistant to erythromycin. In particular, 
these compounds have activity invim against isolates of S.pneumoniae 
containing the ern(@ methylase. Further stu@ shows that some S. pneumoniae 
strains contain sigtllficant subpopulations which are able to form colonies on 
agar plates with amounts of telithromycin that are at least 10-fold higher than 
the MIC to this drug. Seventy clinic2 isolates of m(B) pneumococci were 
tested for resistance to telithromycin and 29 gave this heterogeneous resistance 
response. Additionally, a smaller subpopulation ofhighly resistant clones h r n  
these strains could be selected on higher concentrations of telithromycin, 
which had an elevated MIC to ketolides. These isolates retained their 
resistance to ketolides even after repeated passage in the absence of drug. 
Strains which are heterogeneous to telithromycin give a comparable response 
to other ketolide antibiotics. Sequencing of the ermB gene and its immediate 
upstream region does not show any sequence that is consistently correlated 
with heterogeneity. However, heterogeneity is clearly linked to the m(B) 
gene, because 21 of 21 erm(B) +transformants using donor DNA from five 
heterogeneous st ra ins  were heterogeneous. The transformants using donor 
DNA h m  nonheterogeneous (homogeneous) strains a l l  were homogeneous 
in their response to telithromycin. Further DNA sequencing is in progress. 
Northern blot analysis showed that heterogeneous m(B) strains produce 
more mRNA than homogeneous strains do, even without induction. In 
adcfition, they produce multiple erm(B)-hybridizing transcripts, implying that 
the heterogeneity determinant is located upstream of and that alters the 
transcription ofthe m ( B )  locus. Invivo, heterogeneity has been shown to be 
important in murine infection models. Drug treatment enhances the recovery 
of resistant strains from both lung and blood. Furthermore, combining 
heterogeneous em(@ genes with a mutation in ribosomal protein L4 leads 
to very high MICs to ketolides. This combination has recently been identified 
in a clinical isolate. Use ofketolides in the clinic may lead to rapid emergence 
of resistance. 
(1 A novel efflux mechanism in 
Streptococcus Pyogenes strains inducibly resistant to 
erythromycin 
E. Giovauetti, A. Brenciani, R. Buriom, M. P. Montanari and 
P. E. Varaldo 
Atuona, I 
Objectives: Streptoccuus pyogenes s t r a m  induclbly rwtant to MLS antlbiotlcs 
can be subdmded mto three phenotypes ih4L.S-A, &US-B, and MLS-C. 
Although W S - A  isolates carry the methylase gene ermAM, both MIS-B 
ollghez-level resistant) and A4LS-C (lower-level resistant) isolates carry the 
methylase gene em7R The me@ gene, associated wlth the efflux-mehated 
erythromycm resistance typlcal ofthe M phenotype, IS also detectable by PCR 
m most iMLS-B and IMLS-C isolates 
Methods: Erythromycin efflux was established by determining the intracellular 
accumulation of 14C-erythromycin in the absence and presence of an energy 
uncoupler (CCCP). Erythromycin-resistance genes were detected by PCR using 
specific primer pairs. The expression of mefA was determined by RT-PCR. 
Results: Unlike control isolates of the M phenotype, none of the eight 
inducibly resistant st ra ins  tested with identical genotype (em77Z mefA). but 
different phenotype (four W S - B  and four iMLS-C) expressed the mefA 
gene. Other macrolide efflux genes described in Grampositive cocci (mreA 
and msrA) were not detected in the eight isolates. However, erythromycin 
efflux was recorded in all WS-B,  but in no iMLS-C isolates. In conjugation 
experiments using an W S - B  (ermTR m$A) isolate as a donor and a RtjR 
FusR mutant of an iMLS-C (m7X) isolate as a recipient, mefA-negative 
ermTR-positive transconjugants were obtained which had the novel eEBux 
pump and showed the W S - B  phenotype. 
Conclusions: An efflux system other than that mediated by Me$A 
contributes to MLS resistance in iMLS-B, but not iMLS-C, isolates of 
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erythromycin-resistant S. pyogenes. The lower-levek resistance of the iMLS-C 
phenotype is apparently owing to ermTR-mednted methylase activity, 
whereas the higher-level resistance of the MLS-B phenotype appears to 
depend on the same methylase activity plus the new efflux pump. 
) P472 1 Close association of e m ( @  with tet(M) and of 
e m ( 4  and mef(A) with tet(0) in erythromycin- and 
tetracydine-resistant isolates of Streptococcus pyogenes 
E. Giovanetti, A. Brenciani, R. Lupidi, M. C. Roberts and I? E. Varaldo 
Ancona, 1; Seattle, USA 
Objectives: In Streprococnrspyogenes, erythromycin resistance is owing to either 
methylase em(A), erm(B), or efflux mef(A) genes. Tetracycline resistance is 
found in c. 70?? of the em(@-positive isolates with constitutive erythromycin 
resistance (those with inducible erythromycin resistance are usually suscep- 
tible to tetracycline); in >90% ofthe errn(A)-positive isolates: and in c. 70% of 
the meJ(A)-positive isolates with efflux-mediated erythromycin resistance (M 
phenotype). The ret(M) is so far the most common tetracycline resistance 
gene found in ths species. 
Methods: Sixty-one, recent and independent Italian clinical strains of S. pyo- 
genes resistant to both erythromycin (MIC > 1 pg/mL) and tetracycline (MIC, 
>8pg/mL) were tested. Resistance genes were detected by PCR using 
specific primer pairs. 
Results: All erm(B)-positive isolates (n = 16) had the tetfM) gene. All erm(A)- 
positive isolates (n=27) had the t e t ( 0 )  gene [two were also positive for 
ret(M)]. All isolates carrying the m&4) gene as the only erythromycin 
resistance gene ( n  = 18) had the tet(0) determinant. 
Conclusions: We found the association between tet(M) and erm(B) in this 
species. However, also tet(0) was found to be extensively involved in 
tetracycline resistance among erythromycin-resistant isolates of S. p y o p m s .  
The tef (0) gene was associated (i) with &(A) in the tetracycline-resistant 
isolates with efflux-mediated erythromycin resistance: and (ii) with erm(A) in 
the tetracycline-resistant isolates carrying this gene, which mediates an 
inducible type of erythromycin resistance. This is the first time that the 
tet (0) gene has been found in association with any other antibiotic resistance 
genes. 
FI Telithromycin activity is reduced by efflux in 
Streptococcus pyogenes 
G. Cornagha, A. Mazzariol, J. Zuliani, R. Canton, M. I. Morosini, 
J. C .  Galan and F. Baquero 
Vnona, I;  Madrid, E 
Telithromycin, a ketolide antibiotic, is active on many Streptocorns strains that 
are resistant to erythromycin by virtue of em genes, encoding an 23s rRNA 
methylase. Differences in binding of the two antibiotics to the H35 helm of 
the domain I1 probably do not account for their different activities (Schlunzen 
et al., Nature 413 : 814, October 2001), whchmaybe also related to different 
inducing activities. It has been also claimed that eaux mechanisms (namely 
mefA in S.pyogenes, producing an M phenotype) were not active on teli- 
thromycin. In an Italian collection of 269 S.pyogenes strains, genetically 
characterized by PCR, the range MIC for telithromycin in erythromycin 
susceptible strains was 0.004-0.06 pg/mL, and 0.19-0.5 pg/mL for strains 
endowed with the M phenotype and expressing the mefA gene. Those results 
were l l l y  confirmed in a Spanish series of 152 genetically characterized 
erythromycin-susceptible (mefA minus) S. pyogenes (telithromycin MIC range 
0.004-0.12; mode 0.03 pg/mL) and 40 strains containing the mefA gene 
(MIC range 0.06-4; mode 1 pg/mL). In summary, the MICs of strains with 
the mefA efflux gene were on average 15 times higher than those of fully 
susceptible strains. The effect ofthe mefA pump was then investigated by using 
radiolabeled telithromycin in strains with different resistance genotypes. A 
clear telithromycin efflux could be demonstrated in the strains expressing the 
mefA gene, but not in those expressing an em gene nor in the susceptible 
strains (in which no mefor em gene could be found). The efflux revenibility 
by addition of an inhibiting compound, namely sodium anenate, could be also 
demonstrated. 
jp474/ Phenotypes and genotypes of erythromycin- 
resistant Streptococcus pyogenes strains isolated in Poland 
K. Szczypa, B. Chmylak, A. Skoczynska and W Hryniewicz 
Warsaw, PL 
Objectives: The antibiotic resistance patterns and the distribution of ery- 
thromycin resistance genes of Streptococcus pyogetzes with merent resistance 
phenotypes were investigated 
Methods: Fourteen local microbiology laboratories in Poland collected 69 
isolates oferythromycin-resistant S. pyogenes h m  1997 to October 2001. The 
isolates were recovered h m  throat swabs (43%), pus samples (53%) and blood 
(4%). Identification was performed by routine laboratory techniques includ- 
ing latex agglutination test. MICs were determined by the standard micro- 
dilution procedure and interpreted according to NCCLS criteria. The 
following antimicrobial drugs were tested: penicillin G, erythromycin, clar- 
ithromycin, roxithromycin, azithromycin, spiramycin, clindamycin, quino- 
pristin/daKopristin, telithromycin, linezolid, moxifloxacin and tetracycline. 
The erythromycin and clindamycin double-dw test was performed in order 
to class* the erythromycin resistance phenotype. The presence of 
the erythromycin resistance genes ermB, m T R  and mefA was detected by 
PCR. 
Results: According to the double-disc test, 52 isolates (75%) exhibited the 
inducible and 14 (20%) the constitutive MLSB phenotype. The M-phenotype 
was presented by only three (5%) isolates. The PCR amplification showed that 
all the isolates with inducible MLSB and M phenotypes harbored the emTR 
and mefA genes, respectively. Ofthe 14 constitutive phenotype isolates, eight 
were positive with primers specific for emTR gene and the remaining isolates 
were positive with primers specific for the emB gene. AU the strains were 
susceptible to penicillin (MlC90 < 0.003mg/L), linezolid (MICg0 = 1 mg/L), 
quinopristin/dalfopristin (MIGO = 1 rng/L), moxilloxacin (MICw = 
0.12 mg/L) and telithromycin (MIC90 = 0.06mg/L). All constitutive MLS 
phenotype isolates were resistant to spiramycin but 44 (85%) of the inducible 
phenotype isolates were susceptible to 16-membered macrolide. Tetracycline 
resistance was observed in 67 (97.1%) strains. 
Conclusions: All S. pyogenes were fully susceptible to penicillin with very low 
MICs. The great majority ofresistant strains (85%) had the MLSB phenotype 
conferred by the presence of emTR gene. The novel drugs such linezolid, 
quinopristin/da&opristin, moxifloxacin and telithromycin retained good 
activity against erythromycin-resistant strains. 
In vitro susceptibility of p-hemolytic streptococci 
to penicillin. erythromycin, clindamycin and tetracycline: a 
2-year study 
S. Karavelioglu and G. Soyletir 
Istanbul, TR 
We studied the susceptibility of P-hemolytic streptococci isolated in our 
hospital from January 2000 to November 2001. Of 583 total P-hemolytic 
streptococci, 87.4% were group A; 11.2% group B and 4.1% were groups C 
and G. Most of group A streptococci were isolated from throat (94.9%) and 
most group B (69.4%) were 6om urine. Similar to group A, most ofgroups C 
and G (85.2%) were from throat cultures. 
Methods: Susceptibility to penicillin was determined by E-test technique; and 
to other antibiotics by NCCLS disc a s i o n  method. 
Results: Penicillin MICs against Herent  serogroups of B-hemolytic strep- 
tococci demonstrated that all serogroups are sti l l  susceptible to penicillin. 
MI& andMIC900fgroupsA,B andC-G were0.008-0.012pg/mL, 0.047- 
0.064 pg/mL and 0.012-0.016 pg/mL, respectively. The highest MIC9" 
(0.064 pg/nlL) was observed for group B streptococci. In group A strepto- 
cocci, 13.6, 2, and 0.8% of the strains were intermediately susceptible or 
resistant to tetracycline, erythromycin and clindamycin correspondingly. In 
group B, these rates were 80, 9.2, and 9.2%. Erythromycin resistance (27%) 
was relatively higher in group G, whereas none ofthe group C was resistant to 
t h i s  antibiotic. 
Conclusion: This study exhibits that penicillin should still be the first choice 
of treatment against 8-hemolytic streptococci. However, detection of 
one group A isolate with borderline penicillin MIC (0.125pg/tnL,) and 
relatively higher MIC against group B streptococci indicate that routine 
laboratories must continuously perform susceptibility testing in order 
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to identlfj possible changes in penicillin susceptibility of fi-hemolpc 
streptococci. 
vl Telithromycin activity is reduced by efflux in 
Streptococcus pyogenes 
A. Mazzariol, J. Zuliani, R. Cant&, M. I. Morosini, J. C. Galin, 
E Banquero and G. Cornagha 
Verona, I; Madrid, E 
Telithromycin, a ketolide antibiotic, is active on many Streptococcus strains 
that are resistant to erythromycin by virtue of erm genes, encoding a 23s 
rRNA methylase. Differences in binding of the two antibiotics to the H35 
helix of the domain I1 probably do not entirely account for their different 
activities, which may be also related to different inducing activities. It has been 
also claimed that efflux mechanisms (namely mefA in S. pyogenes, producing an 
M phenotype) were not active on telithromycin. In an Itahan collection of 
269 S.pyogenes strains, genetically characterized by PCR, the range MIC for 
telithromycin in erythromycin susceptible strains was 0.004-0.06 pg/mL, and 
0 .1945 pg/mL for strains endowed with the M phenotype and expressing 
the m.fA gene. Those results were fully confirmed in a Spanish series of 152 
genetically characterized erythromycin-susceptible (m$A minus) S. pyogenes 
(telithromycin MIC range 0.004-0.12; mode O.O3pg/mL) and 40 s t r a i n s  
containing the mefA gene (MIC range 0.06-4; mode 1 pg/mL). In summary, 
the MICs ofstrains with the mefA efflux gene were on average 15 times higher 
than those of fully susceptible strains. The effect of the mefA pump was then 
investigated by using rad~olabeled telithromycin in strains with different 
resistance genotypes. A clear telithromycin efflux could be demonstrated 
in the strains expressing the mefA gene, but not in those expressing an erm gene 
nor in the susceptible strains (in which no mef or em gene could be found). 
The efflux reversibility by addition of an inhibiting compound, namely 
sodium arsenate, could be also demonstrated. 
m] Evaluation of 16-membered macrolides on Italian 
Streptococcus pyogenes isolates with different levels of 
sensitivity to erythromycin 
A. Mazzariol, J. Zuliani and G. Cornagha 
Verona, I 
Half a decade after the dramatic increase of erythromycin-resistant Sfrepfo- 
coccus pyogenes in Italy, the resistance levels observed in this country are still 
among the highest ever measured world-wide. Unlike the experience in other 
countries, in Italy the resistance is often not confined to the 14- and 15- 
membered macrolides only, but aEects the 16-membered compounds and the 
hcosamides, too. Thus, the resistance would not appear to depend on the 
active efflux of antibiotic h m  the bacterial cell (the so-called 'M' phenotype) 
in the majority of cases. 
A total of 495 cases &om Werent Iralian geogaphic areas were tested for 
their susceptibility to the 16-membered macrolides, the 14-membered 
macrolides erythromycin, clatithromycin and dthromycin,  the azaIide 
azithromycin and other reference antibiotics. The presence of either the 
erm(A) or the m&4) gene was investigated by PCR on all erythromycin- 
resistant strains. 
AU the erythromycin-resistant strains (namely 33.1% of the total isolates) 
were also resistant to all other macrolides tested. 25% of the erythromycin- 
resistant isolates revealed a MLSB constitutive resistance (MLSB CR), 43.7% a 
MLSB-inducible resistance (MLSB IR) and a 31.3% an M (&ux-related) 
resistance. 
Resistance to 16-membered macrolides was high among virmally all the 
MLSB CR isolates, whilst the MLSB IR isolates showed different pattern of 
susceptibility. On the latter isolates, spiramycin and josamycin showed the 
lowest activity (MICSD and MICgo 2 256mg/mL, range: 50.06 to >256 mg/ 
mL); midecamycin (MIC50 = 8 mg/mL, MIC9o 2 256 mg/mL, range: 50.06 
to >256 mg/mL) and rokitamycin (MICSo = 0.5 mg/mL., MICgo 2256 mg/ 
mL, range: 50.06 to >256mg/mL) were more dective. Virtually, all the M 
isolates proved susceptibility to all six-membered macrolides. 
Thus, different 16-membered macrolides are endowed with different levels 
of activity against erythromycin-resistant S. p y o g m s  isolates. Such differences 
clearly relates with the Werent phenotypes of erythromycin resistance, 
too. 
1 P477 I A 2-year multicenter evaluation of telithromycin 
activity on Italian Streptococcus pyogenes isolates with 
different genotypes of erythromycin resistance 
A. Mazzariol, J. Zuliani, S.  Esposito, A. Giammanco, A. Mosca, 
E. Muresu, P. Nicoletti, M. Li Bergoli, R. Fontana and G. Cornagha 
Verona, Naples, Palerrno, Bari, Sassari, Florence, San Giovanni, I 
The activities of the novel ketolide telithromycin, of the 14-membered 
macrolides erythromycin, clindamycin and roxithromycin, of the azalide 
azithromycin and of other reference antibiotics were assayed on 495 S. pyo- 
genes isolated in 12 different Italian centers over the period 1999-2001. The 
presence of either the erm(A) or the mef(A) gene was investigated by PCR on 
all erythromycin-resistant strains. 
A total of 32.1% ofthe isolates proved resistant to erythromycin as well as to 
the other 14-membered macrolides tested and to azithromycin. The geno- 
typic analysis revealed the presence of an erm gene in 68.7%, and of the mef(A) 
gene in 31.3% ofthe erythromycin-resistant isolates, respectively. The erm and 
the mef(A) gene did not coexist in any strain of S. pyogenes. According to the 
breakpoints, 94.1% of the isolates were susceptible to telithromycin 
(MIC5(] = 0.012 p g / d ;  MIC90 = 0.38 pg/mL). Telithromycin was evenly 
active on strains with either the M or the MLSB phenotype, included 
constitutively resistant M L S  B isolates whose erythromycin MICs exceeded 
256 pg/mL. 
Telithromycin proved very active on most S. pyogenes isolates examined 
in the present study, including most strains resistant to erythromycin or 
other macrolides. It may represent a suitable alternative to the first-choice 
penicillin treatment of S. pyogmes infections when an alternative therapy is 
needed. 
I P479 I Short course treatment 5days clarithromycin 
versus 5 days cefuroxime axetil and amoxicillin/clavulanate 
in patients with streptococcal tonsillopharyngitis 
H. Scholz, D. Adam and M. Helmerking 
Berlin, Munich, D 
Objectives: In order to investigate eficacy and s a f q  of short come therapy 
in streptococcal tonsillopharyngitis a large clinical trial has been conducted to 
investigate 5-day treatment with various antibiotics in comparison to lO-day 
penicillin V. In the following evaluation results of the different short coune 
treatment options were compared. 
Methods: In this prospective, randomized, multicenter study in chddren aged 
1-18years with acute tonsillopharyngitis and positive culture for group A 
8-hemolytic streptococci (GABHS) efficacy and safety of clarithromycin 
(CLA a=511, 15mg/kg/day, bid), cefuroxime axed (CAE: n=498, 
20 mg/kg/day, bid) and amoxicillin/clavulanate (AC: n = 515, 37.5 mg/ 
kg/day, tid) were compared. AU patients were treated for 5 days. 
Results: A total of 1524 patients were evaluated for intent-to-treat analysis. 
Microbiological testing demonstrated susceptibility of 100% for CAE 
and AC, whereas susceptibility for CLA was only 88.9%. Microbiological 
eradication 2-4 days after end of therapy was sigtllficantly higher ( P  < 0.001) 
for both CAE (89.9%) and AC (92.9%) in comparison with CLA 
(82.6%). Clinical efficacy 2-4days after end of therapy was 97.2% (CAE), 
96.9% (AC) and 94.1% (CLA); 7-9 days after end oftreahnent 89.9% (CAE), 
92.9% (AC) and 82.6% (CLA), P-value 0.0077 and <0.001, respectively. 
The clinical and bacteriological response was sqpficantly better in 
children with CLA-sensitive strains than in strains with CLA-resistant 
streptococci. 
Conclusion: Regarding patients' compliance, analysis demonstrated that after 
5-days treatment, compliance decreased dramatically. CAE and AC offer 
reliable options of successful short course therapy for tonsil lopmgitk of 
5 days. Owing to the inferior efficacy of CLA it cannot be recommended as a 
first-line-treatment of GABHS tonsdlopharyngitis. 
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vl Investigation of methicillin-resistant 
Staphylococcus aureus hand and nasal carriage among 
patients’ helpers and visitors 
A.S. Kantarcioglu and A. Yucel 
Btanbul, TR 
Hand and nasal carriage of Staphylococcus aureus is an important risk factor for 
infection by this organism in both community and hospital settings. Methi- 
cillin-resistant S. aureu (MRSA), is a major nosocomial pathogen. Regarding 
the recent reports, strains of MRSA, which had been largely confined to 
hospitals and long-term care facilities, are also emerging in the community. 
Several stuhes of S. aureus carriage have been performed among dif5erent 
groups of health care worken or among healthy individuals. However, other 
close relatives of the patients may act as a reservoir in S. aureus transmission to 
others. In this study, we investigated the hand and nasal carriage of MRSA 
among patients’ accomplices and visitors to determine the role in the 
epidemiology ofinfection. The study group is apparently healthy, nonhospital 
workers who have temporarily been in the hospital somehow in relation with 
patients at risk. A total of280 hand and nose cultures of 140 individuals were 
performed. Methicillin resistance of S. aureus strains were determined with 
disk difksion assay according to the National Committee for Clinical 
Laboratory Standards Guidelines S. aureus ATCC25923 (29213) strain was 
used for control. S. aureu was found in 30 (21.4%) ofnose and 19 (13.6%) of 
hand samples. Therefore, nasal carriage was found in 30 (21.4%) of nose and 
hand carriage was found in 19 (19/149; 13.6%) of these 140 subjects. Eight 
(16.3%) ofthe total (30 + 19) 49 strains were found resistant to methican in 
disk diffusion method. Three of the eight MRSA strains isolated from 140 
individuals were obtained &om nose and five of them were obtained from 
hands. Therefore, MRSA nasal-carriage rate was determined as 2.1% (3/140) 
and hand carriage was defined 3.6% (5/140). These results may be epide- 
mically si@icant in spreading of MRSA both among hospitalized patients 
and in community. 
Ip481] Prevalence of methicillin-resistant Staphylococcus 
aureus in different regions of Russia: results of multicentre 
study 
A. Narezkina, I. Edelstein, A. Dekhnich, L. Stratchounski, M. Pimkin 
and 1. Palagin 
Smolensk, RUS 
Objectives: MethiciUin-resistant Sfuphylococruc aureus (MRSA) is one of the 
most important nosocomial pathogens. The spread of methicillix-resistant 
staphylococci has become an alarming problem throughout the world, but no 
data concerning the prevalence of MRSA in Russia have been published yet. 
The aim of this study was to determine the kequency and distribution of 
MRSA in Merent regions of Russia. 
Methods: A total of 879 c h c a l  strains of S. aureus isolated in 2000-2001 from 
patients hospitalized in 17 hospitals in Merent parts of Russia - four in 
Central region (Moscow, Ryazan, Smolensk), two in North-West region (St. 
Petersburg), three in South region (Krasnodar, Stavropol), two in Volga 
region (N. Novgorod, Kasan), three in Ural region (Ekaterinburg, Ufa), 
three in Siberian region (Krasnoyarsk, Novosibirsk, Tomsk), were included in 
the study. Antimicrobial susceptibility testing was performed by agar ddution 
method. The susceptibility testing and interpretation of the results were 
performed according to the NCCLS guidelines. S. aureus ATCC29213 strain 
was used for quality control. 
Results: Among 879 S. QUEU strains 295 (33.6%) have been found to be 
methicillin resistant. The prevalence of MRSA varied significantly between 
different hospitals - h m  0 to 89.5%. No association between geographic 
location of hospital and rates of resistance to methicillin was found. The 
highest rates of resistance to methicillin (36.6495%) were found in hospitals 
where patients with infected burns and orthopedic infections were predo- 
minant. No or much lower resistance rates to methicillin (@27.3%) were 
found in the general service hospitals and pediatric hospitals. The highest 
percentage of MRSA was observed in burn, orthopedic and intensive care 
units of all hospitals included in this survey. 
Conclusions: The prevalence of MRSA in hospitalized patiencs in Russia was 
found to be more dependent on the profile of clinical ward than on the 
geographical location of a hospital. 
Epidemiology of MRSA-resistance phenotypes in a 
Greek tertiary care hospital 
A. Pantazatou, E. Demertzi, J. Papanicolas, I. Stefanou, S. Smilakou and 
A. Avlamis 
Athens, GR 
Objectives: To investigate the distribution of resistance phenotypes of methi- 
cillin-resistant S. aureus (MRSA) in our hospital during the period 1994- 
2001. 
Materials and methods: A total of 1212 nonreplicate MRSA strains out of a 
total of 3178 Saureus, isolated from 1994 to 2001 in ‘Laikon’ General 
Hospital, a tertiary care hospital, in Athens, Greece, were included in the 
study. Identification was based on standard methodology. Susceptibility to 
gentamicin (G), erythromycin (E), vancomycin 0, cotrimoxazole (S), 
ciprofloxacin (C), rifampicin (A), fusidic acid (F), clindamycin (L) and 
chloramphenicol (H) was performed with the Kirby-Bauer disk di&sion 
method according to NCCLS. A total of 127 MRSA strains, isolated during 
the last 2 years were investigated by the agar-screening test (4 pg/mLJ for 
Vancomycin Intermediate Staphylococcus aureus (VISA). Resistant phenotypes 
were analyzed with the WHONET software. 
Results The incidence of MRSA increased f b m  33% in 1994, to 50% in 
2001. MRSA strains, susceptible to all antibiotics tested, decreased &om 40% 
in 1994 to 13.5% in 2001. Two multiresistant phenotypes were the most 
common in 2001, representing 48.3% of MRSA isolates. Phenotype 
GE-SCRFL, (resistant to all antibiotics, except vancomycin and chloran- 
phenicol) had a rate of 40.7%, and phenotype GE-SCRFLH (resistant to all 
antibiotics, except vancomycin) had a rate of 7.6%. These two phenotypes 
were found increased in comparison to 1994 (rates of 1 and 0%, respectively). 
Phenotype GE-SCRFL- was mainly detected in ICU and surgical depart- 
ment (38% of the phenotype’s isolates), whilst phenotype GE-SCRFLH was 
detected mainly in two of the three medical departments (55% of the 
phenotype’s isolates). No Merences were detected with respect to the 
distribution ofsusceptible MRSA isolates, with 11, 11.6 and 13.2%, among 
ICU, medical and surgical wards, respectively. No VISA strains were detected. 
Only one isolate was confirmed by E-test to have MIC 3 pg/mL. 
Conclusions: (1) No VISA strain was isolated in our hospital. (2) A progressive 
increase in the MRSA isolation rate was documented. (3) Two main multi- 
resistant phenotypes emerged and predominated in the hospital. (4) Differ- 
ences were detected with respect to the dstribution ofthese two phenotypes 
among different departments. (5) These phenotypic results suggest a possible 
clonal dmemination of multiresistant strains among wards of the hospital, 
which needs hrther evaluation with genotypic techniques. 
Fl Investigation of slime factor (production) and 
methicillin resistance in coagulase-negative staphylococci 
isolated from patients’ helpers and visitors 
AS.  Kantarciogh and A. Yucel 
Istanbul, TR 
Increased incidence ofcoagulase-negative staphylococcal infections due to the 
progeess of invasive medical methods become a major clinical problem since 
they have an ecological niche on human skin from which they are &cult to 
eradicate, and they have aEo adapted themselves to survive on inert devices. 
Slime production is considered useful as a marker for clinically sigdcant 
infections with coagulase-negative staphylococci (CNS). The two major 
clinical importances of CNS are, either the resistance against many antibiotics 
used for therapy and particularly transfer of antibiotic resistance to the other 
more pathogen bacteria via plasmids (conjugation). Methicillin resistance in 
staphylococci are resisfant to many other antibiotics and have being recog- 
nized increasingIy among immunocompromised patients. In this study, we 
investigated methicillin resistance and s h e  production in CNS isolated &om 
patients’ accomplices and visitors considering their close relationship between 
patients at risk. Slime production of CNS strains was investigated using 
Congo-red agar method. Methicillin-resistance of CNS isolates was deter- 
mined with disk diffusion assay recording to the National Committee for 
Clinical Laboratory Standards guidelines. A total of 137 strains were isolated 
6om 280 hand and nose cultures of 140 individuals. Slime factor was found 
positive in about 66 (48.1%) ofthe isolates. Forty-three (31.4%) of the strains 
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showed resistance to methicillin. Of these 38 (88.3%) produced slime. The 
amount of slime positive strains (38/43) were more than slime negative ones 
(5/43). Slime-positive CNS isoIates were found more resistant to methicillin 
than slime negative-ones. The incidence-of resistance to oxacillin and slime 
positivity detected in the strains &om patients' accomplices and visitors was 
found epidemiologically remarkable. 
lp4841 Characterization of MRSA isolates involved in 
outbreaks by conventional and molecular typing 
I. Montesinos, T. Delgado, N. Batista, C:. Revert, M. Cuervo, 
M. Lecuona, A. Torres and A. Sierra 
LA LAguna, S/C Zneriie, E 
Objectives: Characterization of MRSA isolates involved in outbreaks by 
different epidemiological typing and to determine the contribution of the 
typing method7 based on PCR. 
Methods: We studied the four MRSA outbreaks originated at the Hospital 
Universitario de Canarias h m  1997 to 2000. We studied 26 MRSA isolates 
&om nasal carriage and clinical samples of 15 patients and 7 MRSA isolates 
&om health-care workers. Also we stuhed four MRSA isolates &om three 
patients and one staff involved in an outbreak at the Hospital Universitario 
Nuestra Sefiora de La Candelaria placed also in Tenerife. The typing methods 
used were antibiogram, macrorestriction (SmaI) and pulsed-field gel electro- 
phoresis (CHEF 11). and protein A gene and coagulase gene polymorphism. 
Results: The molecular typing methods used anable us to identlfy the 
epidemic strain in all the outbreaks. W e  PGFE is time consuming (7 days) 
and laborious, the techniqum based on PCR are rapid (24-48 h) and simple to 
carry out. The antibiogram anable us to idenafy the epidemic strain except for 
one patient. However, the molecular markers results and the epidemiological 
data, for this patient, related it with the outbreak. The two hospitals shared the 
same epidemic strain. 
Conclusions: The molecular markers based in PCR were a good method in 
detecting outbreak-related strains and are useful in the preliminary studies of 
outbreaks because of their easy and rapid accomplishment. 
vl Epidemiologic typing of methicillin-resistant 
Staphylococcus aureus (MRSA) by pulsed-field gel 
electrophoresis (PFGE) and the association with the intra- or 
extra-hospital origin of the isolates 
I Montesinos, T. Delgado, M J Ramos, M Cuervo, M L~CUOM, 
A Torres and A Sierra 
LA Laguna, E 
Objectives: Epidermologic typing of MRSA isolates by pulsed-field gel 
electrophoresis (PFGE) and the aSSOnahOn of the restrichon patterns obtamed 
wlth the intra- or extra-hospitaary ongn of the isolates. 
Methods: We studed 128 MRSA isolates obtamed from the Hospital 
Umversitario de Canarias between 1997 and 2000, correspondng to both 
mtra- (n = 95) and extra-hospitalary (n = 33) lnfechons and COlOrU7ahOnS. We 
also stumed eight MRSA isolates from health-care worker that we consider 
intra-hospitalary acquued. Cnteria fix mfectlons were as defined by 
Center for Disease Control and Preventron (CDC) gwdehes Isolates not 
associated wlth infechon were classified as colomzmg. MRSA was defined 
as nosocomial if the isolate was obtained after 48h of a s s o n .  The 
methlcfin resistance was confirmed by an o x a c h  d x  ( 5 ~ )  and the 
amphfication by PCR of the me& gene Macrorestllchon mth  SmaI and 
PFGE (Chef 11, Bio-Rad) was performed For statistical analysis we used x2 
and Fisher's correchon 
Results: We detected three pulsotype5: pulsotype A (12 subtypes), B (2 
subtypes) and C, accordmg to Tenover's criteria and the fingerprmtlng 
analysls of the PFGE profiles. The 89% of the lsolates were pulsotype A, 
the 10% pulsotype B and the 0.8% pulsotype C The pulsotype A (81.6%) was 
stansacally more frequent among mtra-l~ospitalarly acqulred isolates and was 
the pulsotype that caused outbreaks whde B (84 6%) and C (100%) pulsotypes 
dormnated the extra-hospitalary isolate> (P< 0 001) 
Conclusions: In our expenence, the PFGE IS a good molecular typing to 
ascertam the mtra- or extra-hospitalary origm of the isolates 
I P486 ] Economic evaluation of linezolid for the treatment 
of infections caused by MRSA in Spain 
J Soto and E Montull 
Madrid, Barcelona, E 
Lmezohd is a new anhbiohc agent, acave agamst Gram-posihves mcludmg 
MRSAwth mtravenous and oral presentanons It has demonstrated a sirmlar 
c h c a l  eficacy compared to that ofVancomycm for the treatment of dfferent 
infechons produced by MRSA. 
Objective: To carry out an econormc eduahon of using hnezohd versus 
vancomycin in the treatment of MRSA mfechons. 
Methods: A cost-rmmuzahon analysis was performed by bwldmg a decrslon 
analyhc model Health resources uhhzaaon, after the use of both anhbiotics 
was obtamed h m  pubhhed arhcles and only direct medcal costs were 
mcluded In the analysis. Cast arqulsihon of both products was obtamed from 
official sources wWe the cost of each day of hospitalmition @days for 
hezohd and lZdays for vancomycin), andyacal tests and a b t r a h O n  
of both drugs were taken hom a nahond database of health-care costs 
(Soikos).The perspecave selected for t h ~ s  analysls was hospital asslstance 
and the tune honzon chosen was for 12days. the maxlmum tune that 
&chargeable pahents are hospitalzed m c h c a l  nab. 
Results: In the table, all the resources consumed after the ~dmmstrahon of 
linezohd or vancomycm and the total cost/pahent are shown (m Euros) 
cost3 Lmezohd Vmcomycm 
Drug acquisluon 1 524 E 422 E 
Days of hospitalmuon 2 308 E 3.462 E 
Admustmuon i v 16 E 78 E 
Plasmatic levels OE 30 E 
Analyncal tests 6 E  12 E 
Total cost/pabent 3 854 E 4.004 E 
Conclusions: The use of linezolid instead of vancomycin in the treatment of 
infections caused by MRSA will save resources for the Spanish National 
Health Service producing sunilar clinical results with lower associated costs. In 
addition, linezolid will increase the quality of life of patients as it will permit 
them finalize their treatment at home. 
Agar dilution MIC and time kill assays on 
Staphylococcus aureus focusing on nonmultiresistant MRSA 
strains 
I. Gosbell, L. Fernandes and C. Fernandes 
Liverpool, St. Leonards, AUS 
Objectives: To assess the antibacterial activity of various antibacterial agents 
with reference to their MICs and time-kill assays on Staphylcmw raw, 
particularly, non-multiresistant MRSA sttains. 
Methods: Agar dilution MICs (NCCLS) were pesormed on 27 isolates of 
methicillin-susceptible S. a u m ,  34 isolates of non-multiresistant MRSA 
(susceptible to 0-2 non-8-lams) and 24 isolates of multiresistant MRSA. 
The following antibiotics were tested chloramphenicol, ciprofloxacin, clin- 
damycin, erythromycin, fusidic acid, gatifloxacin, gentamicin, linezolid, 
oritavancin, mupirocin, oxacillin a t  35 "C, oxacillin at 30 "C, quinupristin/ 
dalfopristin, rifanipicin, teicoplanin and vancomycin. Time kill assays were 
performed with a nonmultiresistant Western Samoan Phage Pattern-2 and 
ATCC25923 (fully sensitive S. aureus) strains. Ciprofloxacin, galifloxacin, 
clindamycin, rifampicin, fusidic acid, trimethoprim and vancomycin were 
tested alone and in various combinations. 
Results: Ciprofloxacin and gatifloxacin were the most bactericidal com- 
pounds tested; dampicin and vancomycin were only bactericidal at 24 h. 
Resistance emerged readily in vitro to ciprofloxacin, r&mpicin, hsidic acid 
and trimethoprim. No combination tested exhibited synergy. The combina- 
tions of rifampicin/fusidic acid, rifampicin/cipmfloxacin, rifampicin/ 
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clindamycin and ciprofloxacidtrimethoprim exhlbited indifFerence. The 
combinations of ciprofloxacidchdamycin, ciprofloxacin/hidic acid, cipro- 
floxacin/trimethoprim and rifampicin/trimethoprim were antagonistic. 
Conclusion: Selection of antibiotics to treat nonmulnresistant MRSA remains 
problematic. 
m] Utility of the automated VITEK system in detection 
of methiclflin-resistant sraphylococr~s aureus (MRSA) in a 
general hospital 
V. Figueroa, R. Labat, J. Aguilar, E Bascaran, L. Sevi, L. Guelfand and 
S. Kaufinan 
Bwenos Aires, AR 
Staphylococcus aureus (SA) is one ofthe most common pathogens in community 
and hospital acquire infections. The prompt investigation of the methicillin 
resistance is a challenge for microbiologists. Detection of mecA gene is the 
gold standard method but it is ditKcult and time consuming. To find a reliable 
and quick method, easy to perform daily in a health care center, we studied 
the utility of the automated VITEK system (bioMerieux), for detection of 
MRSA in clinical isolates in comparison to disk f i s i o n  and oxacillin agar 
screening. 
Methods: A total of 748 SA strains of hospitalized patients, isolated from skin 
and soft tissue, respiratory samples, body fluids, bone and blood., obtained 
from 01 January 1997 to 31 October 2001 were tested. We compared disk 
diffusion (following NCCLS recommendations) results with those obtained 
with GPS-SA card to 31 December 2000 and GPS-102 h m  01 January 
2001(bioMirieux). The strains were confirmed with the oxacillin agar 
screening. 
Results: We found 49% of SAMR and 51% of susceptible strains. Only one 
strain was susceptible to oxacillin for VITEK and resistant by disk diffusion, 
the agar screening result was positive. Ten strains were resistant with VITEK 
but susceptible with disk difision and the agar screening negative. Seven 
strains were susceptible with VITEK and resistant with disk ditfusion, with the 
agar screening negative and finally only two strains were found resistant with 
VITEK but susceptible with disk &sion and the screening result was 
positive. 
Conclusions: According to our results, the automated VITEK system is avery 
useful, quick and reliable tool for routine labor for detection of MRSA. We 
suggest to follow-up of the Expert System and the confkmation of suspicious 
strains by oxacillin agar screening. 
1 P489 1 Patterns of susceptibility of methicillin-resistant 
Staphylococcus aureus in Beirut, Lebanon 
Z. Daoud, J. Mokhbat and N. Hakime 
Beirut, LEN 
Objective: In many countries, oxacillin (methicillin)-resistant Staphylocom 
aureuc (MRSA) has become a significant nosocomial pathogen. Changes in 
susceptibility of MRSA were recorded during last years where more suscept- 
ibility is observed to gentamycin, erythromycin and clindamysin. The aim of 
this study is to analyze the patterns of susceptibility of the clinical isolates of 
methicih-resistant Staphylococcus aureus to other antimicrobial agents in two 
general hospitals in Beirut. 
Material and methods: This study was conducted firom 01 January 1998 till 
01 January 2001 (3years). All reported antibiotic susceptibility data were 
derived from the routine clinical laboratory database at two general hospitals 
located in the area of Beirut. The antibiotic susceptibility testing was 
determined using Kirby-Bauer technique or flooding technique. A total 
number of 3 16 strains 0 s  MRSA were isolated in hospital 1 and 260 strains in 
hospital 2. 
Resuits: The results are shown in Tables 1-3. 
Table 1 Percentages of suscepnbdity of MRSA at the studied hospitals 
~ 
MR Gen Eryr Clin 0 8  Pef Van Tei 
Hospital 1 14.5% 41.9 39.4 57.6 45.5 45.5 1001 100 
Hospital 2 14.2 54.0 51.4 62.2 - - 100 100 
Gen: gentamycin; Ery: erythromycin; Clin: clindamycin; On: ofloxacin; Pef: 
pefloxacin; Van: vacomycin; Tei: teicoplenin. 
Table 2 D s a e n t  resistance phenorypes represented ar number of strains (correspond- 
ing percentage) 
Eryth R/chda R Erytb S/Clind S Eryth R/Clind S 
Hospital 1 (N=46) 19 (41.3%) 23 (50.0%) 4 (8.7%) 
Hospital 2 (N= 37) 14 (37 8%) 19 (51.4%) 4 (10.8%) 
Table 3 Evolution of the percentages of susceptibility to gentamycin between 1995 and 
2000 
1995 2001 
Hospital 1 
Hospital 2 
31.6% 
- 
41.9% 
54.0% 
Discussion: The emergence of new epidemic MRSA strains more susceptible 
to antibiotics has been recently reportedby several authors. A marked decrease 
in use of gentamicin was suspected to be a factor contributing to the 
emergence of gentamycin-susceptible W S A .  In our resdts, we can note 
an increase in the susceptibility to gentamicin between 1995 and 2000, as well 
as high prevalence of erythromycin-clindcin-susceptible strains. These 
results show similar patterns in both hospitals. This is most probably due to the 
fact that the population is the same. AU MRSA were susceptible to glycopep- 
tides and showed a relatively low susceptibility to Buoroquinolones (45%). 
Resistance of methicillin- and ciprofloxacin- 
resistant Stapbylococcus aumu to the newer quinolones 
levofloxacin, moxifloxacin and to linezolid, quinupristin/ 
dalfopristin, vancornycin and teicoplanin 
A. Grisold, G. Feierl, U. Wagner, B. Si, E. Daghofer and H. Kesslex 
MRSA Working Group, Gar, A 
Objectives: S. aureus resistant to methicillin (MRSA) are not only resistant to 
all the B-lactam antibiotics, but are also often resistant to other classes of 
antibiotics, limiting therapeutical possibihties in case of necessary treatment. 
In order to determine the efficacy of vancomycin, teicoplanin and the newer 
antibiotics levofloxacin, moxifloxacin, linezolid and quinupristin/dalfopris- 
tin, each agent was tested to 112 strains of clinical MRSA. 
Methods: A total of 112 non-repeat clinical saains of MRSA were tested to 
the glycopeptide antibiotics vancomycin and teicoplanin, as well as to the 
newer quinolones levofloxacin and moxifloxacin, further to linezolid, an 
oxazolidinon and to quinuprisddalfopristin, an antibiotic of the macrolid/ 
streptogramin-pup. The m i d  inhibitory concentrations (MICs) of the 
drugs were determined according to the guidelines of the National Com- 
mittee for Clinical Laboratory Standards (NCCLS). 
Results: MICs for the glycopeptide antibiotics vancomycin and teicoplanin 
ranged h m  0.5 to 4 mg/L and from 0.75 to 8 mg/L, respectively. Linezolid 
and quinupristin/daKopristin exhibited MIC levels ranging from 0.125 to 
2 mg/L. The MICs for the newer quinolones exhibited from 2.0 mg/L to 
232  mg/L for levofloxacin and &om 0.5 to 8 mg/L for moxifloxacin. 
Conclusions: Both glycopeptides, vancomycin and teicoplanin remain uni- 
formly susceptible to the tested strains. Linezolid and quinnpristin/dalfopris- 
tin also show excelient activity to the tested MRSA strains, and may be 
alternatives in therapy or may be used in combination. AU MRSA strains 
included in this study have been tested resistant to ciprofloxacin with 
MICs 2.16 mg/L. Even if the results for the newer quinolones show better 
in vitro results compared to ciprofloxacin, treatment of such strains with 
levofloxacin or rnoxifloxacin should be considered with care. 
Dramatic increase in methicillin-resistant 
Staphylococcus aumus (MRSA) due to a predominant clone 
in county jails between 1996 and 2001 
E. Pan, N. Moss, B. Haller, E. Charlebois and F. Perdreau-Remington 
San Francisco, USA 
Objective: To describe the prevalence and distribution of MRSA genotypes 
among clinical isolates h m  San Francisco (SF) County jail inmates. 
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Methods: A total of 244 clinical isolates of S. aureus cultured h m  inmates in 
one hospital jail ward and five county jails were evaluated between January 
1996 and October 2001. Isolates were characterized using antimicrobial 
susceptibility patterns and MRSA were analyzed using pulsed-field gel 
electrophoresis (PFGE) following SmaI digestion. Clinical information h m  
the inmates hospitalized at San Francisco General Hospital (SFGH) was 
obtained from a computerized clinical record database. 
Results: Ofthe 233 unique individuals, 70% were male, 23% were female, and 
7% were unidentified. One hundred and one (41%) of all 244 isolates were 
resistant to methicdlin. MRSA rates increased &om 12% in 1996 to 68% 
through October 2001 (Fig. 1). Antimicrobial resistance among MRSA 
isolates from the jails versus the hospital jail ward were: gentamicin (3%/ 
6%), ciprofloxacin (10%/1 l%), clindamycin (7??/11%), tetracycline (lo%/ 
17%), trimethoprim-sulEvnethoxazole (4%/1 l%), and erythromycin (55%/ 
50%). Over 80% of MRSA isolates originated &om wound or soft tissue 
cultures. Among the 17 hospitalized inmates, 14 (82%) had prior admissions. 
Admitting diagnoses were primarily soft tissue infections (65%), followed by 
pneumonia (15%) and osteomyelitis (5%). MRSA isolates &om 74 individuals 
were available for genotyping. Of the eight clonotypes identified, two clones 
(1 and 8) were present in all jads and the jail ward since 1996. Clone 8 initially 
prevalent at <15% in 1996-1997 accounted for >80% in 200(b2001 (Fig. 2). 
Only one ofthe five clones found in the inpatientjail ward was not seen in the 
county jails. 
Figure 1 Percentage of MRSA over time. 
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Figure 2 Clone &mibution by year 
Conclusion: We found a hgh MRSA prevalence beyond nosocomal rates 
among c h c a l  S aureu isolates from county J&. The mcrease in MRSA 
prevalence between 1996 and 2001 w a  associated mth  the emergence of a 
predomnant clone. suscephbhty patterns were consistent mth  commumty- 
a c q m d  (CA) MRSA. Ths  report idenhfied a potenhally aggressive CA- 
MRSA clone mth enhanced s u d  in the community. Furthermore, jads 
may represent a srgtllficant reservos for mdespread transmssion of CA- 
MRSA. 
vl Less than 1-h detection of methicillin-resistant 
Staphy/ococcus JUEUS directly from nasal swabs by real- 
time PCR using the Smart Cycler@ 
A Huletsky, F Gagnon, V. Rossbach, K. Truchon, EJ Picard 
and M.G. Bergeron 
Que%ec City, CAN 
Objectives: Metluch-reststant Staphylococrus aureus (MRSA) is one of the 
most s id icant  pathogens, being responsible for signtficant pahent rnorbidty, 
mortahty and healthcare costs. Current control strategm to hmt  the emer- 
gence and rapid spread of h s  organism rely on the rapid and SeIlSlhve 
detecnon of MRSA carriers, so that appropriate barrier preCaUhOn may be 
used to reduce transmion. The objective ofths study was to develop a real- 
hme fluorescence-based assay whch allows the detechon of MRSA duectly 
from nasal swabs m less than 1 h. 
Methods: Prmers speclfic to the rlght extremtles of the staphylococcal 
cassette chromosome mec (SCCmec) sequences identlfied in the major 
epidemc clones of MRSA were used in a mdhpkx PCR assay m combina- 
hon m t h  a pruner speclfic to the o f l  gene sequence of the Saureuc 
chromosome located to the right extremty of the SCCmec lntegrahon site. 
A molecular beacon probe targehng the amphfied regon of o@ was 
integrated mto the mulhplex assay for real-hme detechon of MRSA usmg 
the Smart Cycler@. Nasal samples obtamed &om volunteers were splked wth  
MRSA cultures. Splked samples were prepared by usmg a rapid DNA 
extrachon protocol. A ready-to-use assay (AMPLIMRSA) has been designed 
(InfechO Diagnostic) for the routine detechon of MRSA 
Results: There was a 96 7% correlanon between the PCR results and the 
idenhficahon of MRSA Two of 205 (1%) MRSA strams tested were not 
detected by PCR whde 13 of 252 (5 2%) MSSA strains were rmsldentlfied as 
MRSA The PCR assay allowed detechon ofless than 10 copies ofMRSA per 
PCR reachon based on teshng with splked nasal samples. None of the 10 
methcfin-resistant or 14 methcfin-sensihve coagulase-negatwe staphylo- 
coccal specles tested were detected umg the real-tune PCR assay 
Conclusions: Ths  mdhpkx PCR assay represents a rapid and powerfd 
method for the specific detechon of MRSA duectly fiom nasal swabs. 
vl Determination of nasal carriage of methicillin- 
resistant Staphylococcus JU~WS among hospital staff and 
outpatients 
S. Cesur and E Cokca 
Ankara, TR 
Introduction: The a m  of this study was to determine the carriage rates of 
nasal MRSA in hospital staff and outpatients. 
Material and methods: The study included 500 hospital staff and 500 
outpatients. Nasal samples cultured onto 5% sheep blood agar Gram-staining, 
catalyze and coagulation activihes were evaluated in samples showmg typical 
colonial morphology. These colonies were also cultured onto DNAase and 
Mannitol salt agar. The protein profiles of the isolated strains were idenhfied 
on polyacrylamide gel electrophoresis (SDS-PAGE). 
Results: Nasal-carriage rate of MRSA was 6.6% (331500) among hospital 
s td ,  while the same rate was 2.6% (13/500) among outpatients. The 
difference was stahstidy signtfcant (P< 0.001). MRSA carrier staff were 
mainly working in the surgcal wards where hospital infections due to MRSA 
were frequently detected. The protein profiles of the tsolated M R S A  strains 
h m  both hospital staE and outpatients were similar by SDS-PAGE. 
Conclusion: MRSA nasal carriage rate among hospital staff was hgher than 
the rate among outpahents (P< 0,001). The s d a r i t y  between the protein 
profdes of these strvns suggested that nasal MRSA strains of the outpatients 
nught have been origmated &om the hospital. 
Staphylococcal scalded skin syndrome in an adult 
due to methicillin-resistant Staphylococcus aureus 
Y. Ito, M.E Yoh, K. Toda, M. Shimazaki, T. Nakamura and E. Morita 
Gfk J p  
Objectives: Staphylococcal scalded skin syndrome (SSSS) is a generalized 
exfoliative dermatosis, caused by exfoliative toxin (ET) producing strains of 
Staphylococcus aureus. SSSS usually ai3ect.s mfants and children, but rarely occurs 
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in adults. SSSS in adults is usually associated with immunosupression and/or 
renal insufticiency, and mortality rate is high We report a case of SSSS in an 
adult due to ET producing methicillin resistant S.aureus (MRSA); the 
immunocompromised patient was successfully recovered. 
A 71-year-old man, with a chronic history of diabetes mellitus, was 
admitted to our hospital with lumbago on July 17th, 2000. He was diagnosed 
as renal cell carcinoma with bone metastasis. In hospital, he had a sudden onset 
of high fever and erythema, followed by formation of flaccid bullae and 
exfoliation with a positive Nikolsky sign. Methicillin-resistant S. aureus 
(MRSA), producing exfoliative toxin B, was isolated f h m  blood and bile 
cultures, and Aeromom hydrophila was isolated from bile culture. Skin biopsy 
specimen showed a cleavage of the epidermis at the level of the granular layer. 
Soon after, the patient was recognized to have SSSS and cholecystitis, was 
treated with intravenous vancomycin and teicoplanin, and underwent per- 
cutaneous transhepatic gall bladder drainage, which led to recovery. SSSS in 
adults is usually seen in the host of immunosuppression. A. hydrophila is 
recognized as opportunistic pathogen. 
Conclusions: SSSS should be considered in the differential diagnosis of 
immunocompromised adult patients with sudden onset of high fever and 
erythema. Rapid microbiological examination is necessary for appropriate 
antimicrobial therapy, because it is possible that SSSS in adults is caused by 
MRSA and complicated by opportunistic infection. 
Fl Effective control measures for preventing 
transmission of methicillin-resistant Staphylococcus aureus 
in a medical intensive care unit 
1. Mdovic, M. Jereb, L. Vidmar and A. Trampuz 
Ljub&za, SLO 
Objective: Programs for controlling methicillin-resistant Staphylococcus aureus 
(MRSA) in hospitals with a high endemic level have not universally been 
accepted. Main concerns are hgh costs and low anticipated medical benefits 
ofsuch programs. Goal ofthis study w a s  to evaluate a strategy to prevent cross- 
transmission of MRSA in a 10-bed medical intensive care unit (ICU) of a 
university hospital with a high level of endemic MRSA. 
Methods. The incidence of ICU-acquired MRSA cases was compared 
between a &month period before and a 6-month period after implementa- 
tion of control measures at November 1,2000. Routine screening for MRSA 
carriage (nose, throat, wounds, tracheal aspirate) was performed in all patients 
admitted during both periods. Control measures in the second period 
included (1) strict use of alcoholic hand rub by health care workers before 
and after each patient contact, before manipulating catheters, after contact 
with body fluids, and after removing gloves (2) preemptive skin and throat 
decolonization with chlorhexidine in the first 5 days after admission, and (3) 
barrier precautions and decolonization of patients with MRSA (includmg 
nasal mupirocin). 
Results: Of 133 patients, admitted during the first 6-month period, MRSA 
was recovered from 23 patients, of which 14 cases (60.9%) were ICU- 
acquired. After implementation of infection control measures, 149 patients 
were admitted to the ICU in the following 6 months. MRSA was detected in 
24 patients, ofwhich 3 cases (12.5%) were ICU-acquired. The incidence of 
ICU-acquired cases decreased after implementation of control measures f?om 
10.5 to 2.0% (P= 0.003), whereas the rate of imported cases increased in the 
same period from 6.8 to 14.0% (P=0.05). 
Conclusions: Infection control measures can si&icantky decrease the inci- 
dence of transmission of MRSA in an ICU with a high level of endemic 
MRSA in spite of increased rate of imported cases. 
I P496 1 Cost resulting from applying the German 
guidelines on hospital hygiene measures in patients 
carrying methicillin-resistant Staphy/ococcus aureus (MRSA) 
C.E.W. Herr, T.H. Heckrodt, R. Schnettler and T.E Eikmann 
Giessen, D 
Objectives: In 1999, the German health authorities-Robert Koch Institute 
(RK1)-published a guideline on hospital hygiene measures in patients 
carrying MRSA (MRSA-pat.). Aim was to estimate surplus costs when 
carrying for MRSA-pat. according to these guidelines. 
Methods: Records of all MRSA-pat. treated in a ward for septic surgery (daily 
costs for inpatients: 398.41q during 1 year were assessed. For each measure’s 
costs were eshmated considemg informauon h m :  medrcal, budget and 
house cleanmg personnel. For each MRSA-pat. these costs were collected for 
the tune spent rn the ward. Costs concermng each measure durlng the year 
were then added together and dmded by the total number of MRSA- 
Hospital-Day (MHD) assessed. 
Results: 20 MRSA-pat. -80% male, age m e b .  74.5 years, mean 70.7years, 
80% w t h  first m e  MRSA-ponhve mcrobiologcal swabs durmg the present 
hospital stay (MRSA-new) were assesbed, resultmg in a total of 4%-MHD, 
65% of these m MRSA-new pat. 
0 For each category of measure costs of one h4HD were calculated. 
0 Tnne for Informahon and tratmg of personnel: on ward 0.25€, hygiene 
0 Isolanon of MRSA-pat. (costs for ‘barred’ beds): 305.74€. 
0 Protectwe measures (tune and matenal): 36.02&. 
0 Desmfechon and cleanmg (hme and mated):  2.006 
0 Refusal (mated): 2.44 € 
Mxrobiological screerung (exclusive tune of sample talung). 12.918 
0 Eradzcahon @reparahons): 7 5 5 e  
0 Measures upon drscharge from hospital (tune). 0.388. 
0 Transportanon concertung dmgnosacs ( m e  and material): 1.268. 
Total costs for one MHD were 371.958. Dunng 1 year cost for MRSA-new 
paclents were about 120 000.W, m those prewously known to be MRSA 
posihve (MRSA-old) about 65 OOO.OO€, assumtng that costs for barred beds 
dld not M e r  between MRSA-new and MRSA-old pat. 
Conclusions: 
0 Most of the surplus costs concerning h4RSA hygene measures accordmg 
to German gwdehes arose firom pat. wlthout prewously known M A  
posiuve status. 
0 D d y  surplus costs ln carmg for MRSA-pat alone were about as lugh as the 
total amount the ward recewed for one day of inpatient stay. 
0 Much &cussed measures, e.g. wearmg a cap, amounted only to mnute 
costs but can be usem in relnforcmg h a p h e  rn paaent care. 
0 The most expensive measure per day was a separate mom for these pahents 
This is catego&ed as DB (recommended) by nanonal authorlties and 
therefore of lugh importance as far as legally correct hospital hygene is 
concerned 
department: 3 178. 
[p497] Computerized surveillance of methicillin-resistant 
Staphylococcus aureus 
C. Ezpeleta, I. Atutxa, 6. Busto, J. Martinez, E. G h e z ,  J. Unzaga and 
R. Cistema 
Bilbao, E 
Objectives: The aim of this study is to asses the usehlness of a software 
designed to detect MRSA colonized or infected patients and to send this 
information to the infection control unit. 
Methods: The hospital de Basurto is an 800-bed general teaching hospital that 
gives care to the urban area of Bilbao. A software was implemented for 
surveillance of MRSA. When a patient previously colonized/infected with 
MRSA is admitted to the hospital or a new case is diagnosed in the 
Microbiology Laboratory an alarm is displayed in the Infection Control 
Unit. So if it is judged to be or epidemiological significance contact 
precautions are started and nasal and axilar swabs are cultured. If MRSA is 
recovered nasal mupirocine and clorhexidine soap are started. Microbiological 
methods for MRSA study include: agar screen, disk ditbion, BBL Crystal, 
Gen. mec detection, and molecular typing by means of PCR for epidemio- 
logical purposes. 
Results: Since 1 January 1999 to 31 October 2001, 193 colonized/infected 
patients with MRSA have been diagnosed in our hospital. The software has 
found 106 previously infected and 87 newly diagnosed cases during present 
admission. MRSA have been recovered &om wounds in 76 patients, h m  
blood in 41, fiom respiratory tract in 28 and from urine in 18 cases. A total of 
191 patients have been studied to find nasal and/or axilar colonization. 
22.64% of previously infected patients and 48.27% of newly diagnosed were 
colonized with MRSA in nasal and/or axilar cultures so decontamination 
with nasal mupirocine and clorhexidine soap was carried out. Twenty-four 
(12.43%) out of 193 patients were admitted to the hospital from a nursing 
home and 16 of them (66.6%) were MRSA carriers. Of the 167 remaining 
patients only 30% were MRSA carriers. An outbreak (five patients) was 
detected in ICU in December 2000; 66 health-care workers were studied, no 
one of them was a MRSA carrier. Cross infection was dragnosed by molecular 
typing methods. This outbreak was finished with strict adherence to contact 
precautions, nasal mupirocin and clorhexidine soap. 
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Conclusions: The s o h e  has been useful to detect MRSA mfected/ 
colonized patients and outbreaks. Nasal carriers are more kequent 
among newly dtagnosed cases and among panents a h t t e d  &om nuning 
homes. 
1 P498 1 Nasal carriage of methicillin-resistant 
Staphy/ococcus aureus (MRSA) in health care workers 
(HCWs) in an Iranian hospital 
M. Rahbar, M. Kermiyar, R. Grah-Agaji, H. Va!d~ and Y. JShaW. Rajai 
Urmia, IR 
Background and objectives: The carriers of Sraphylococcus aureus are a major 
source of infections for hospitalized patients. Several studies have reported that 
the rate of nasal carrying is ranging fiom 16.8 to 50.1% in HCWs. The 
mortality rate of infections caused by MRSA is very high. It is estimated to be 
2%84%. The aim of this study was to determine frequency ofnasal carriage of 
S. aureux in HCWs of Imam Khomeini Hospital of Urmia, West Azarbayjan, 
Iran. 
Methods: Hospital staff (n=230; 115 male and 115 female; average age 
30years) were randomly selected. Cultures were obtained &om the anterior 
nares of HCWs. Specimens for detection of MRSA were planted onto 
mannitolsalt agar and incubated at 35 “C for up to 48 h. Organism with 
a yellow color (mannitol fermenters) were identifed as S~aghyJococcus aureus by 
standard methods, includmg Gram stain, catalase, DNAse and tube coagulase 
test. Agar screen test was used to detect MRSA by inoculating 104 colony 
forming units onto Muller-Hintons agar supplemented with 4% NaCl 
containing 6rng of oxacillin per mL. Strains resistant to oxaciilin were 
confirmed as rnethicilh-resistant. No changes in the method of idenhfylng 
MRSA occurred during the course of the study. Antibiogram typing was 
performed by using d isk-as ion  method according to the National Com- 
mittee for Clinical Laboratory (NCCL) standards. In addition, resistance of 
S. aureus to penicillin, co-trimoxazole, vancomycin, ciprofloxacin, erythto- 
mycin, clindamycin and gentamicin were tested using the disk-diffusion 
method. 
Results: A total of90 (40%) of the 230 HCWs were positive for nasal carriage 
of S. aureus (53 male and 39 female). The frequency of MRSA in the staff of 
Merent wards in increasing order was as follows: physicians 8%, nurses 
31.81%, service workers 33.3%, staff of emergency ward 42.9%, operation 
room technicians 83.3%, anesthesia technicians lOO?h. Resistance rate of 
S. aureux isolated from nose of HCWs to commonly used antibiotics was as 
follows: penicillin 67.4%, co-trimoxazol41.3%, gentamycin 25%, clindamy- 
cin 18.3%, ciprofloxacin 14.1%, erythromycin 8.7%, and vancomycin (0%). 
Conclusion: Our study indicated that the rate of MRSA nasal carriage is high 
in HCWs and that the rate of resistance to other antibiotic is increasing which 
may be a serious problem for the treatment hospitalued patients. 
(p4991 Methicillin-resistant Staphylococcus aureus 
differentiation by bacteriophage typing and by pulsed-field 
gel electrophoresis 
C Wildemauwe, C Godard, E Van Bossuyt, S. Damke, R. Vanhoof and 
H De Beenhouwer 
Brussels, Aalst, B 
Objectives: Dete rme  the dlvenity of bacteriophage types and pulsed-field 
gel electrophoresls types among methlch-resistant Staphylococcus QUWUS 
strains recovered in a general Belgmn hospital 
Methods: Durmg the year 2000,138 methch-resfitant Staphylococcus sums 
strains, collected in a 500-bed general Belgnn hospital, were charactenzed 
wrth the tradmonal bacteriophage typing method and by a pulsed-field gel 
electrophoresls usmg the SmaI enzyme All strains were checked for coagulase, 
o x a c h  resfitance and the mecA gene. 
Results: All strams were coagulase poslhve. They were all me& posihve except 
four, whch have been excluded from ths study. The o x a c h  MIC varied 
between 16 mg/L and more than 256 mg/L, except for one s m n  s h m n g  a 
MIC of 4 mg/L and two s a n s  w t h  a MIC ofless than 1 mg/L. Nevertheless, 
the two latter strayls, being m d  posinve, produced the correspondmg 
protem PBP 2’ (detected by a serologd method) With the bacteriophage 
techmque, only two strains were not typable. On the other hand, 110 s a n s  
(80%) were only sensihve at RTDXl00 The majority of the strans belonged 
to a [O] type (61%), followed by a m type (12%) A total of”% ofthe strains 
had the same pulsotype Nearly all strains of the [O] and u] phage type 
belonged to thu pulsotype. A Merent band profile was found for the two not 
typable strams The phage type 54/81 (RTDXlOO) corresponded also to a 
speccfic pulsotype 
Conclusions: Bactenophage qpng IS the standard method for typmg S our- 
eus. Analysis of the cell DNA by pulsed-field gel electrophoresis after 
macrOreSUichon is increasingly recogrnzed as an improved method Yet it 
1s techcally and financially more exachng. Among the 134 s a n s ,  we 
exarmned two mam phage patterns were observed whereas only one pulso- 
type was domant .  Both phage types belonged to thu pulsotype. So, it 
appears that a subdvtsion ofpulsotypes by a method Iike phage typmg can 
provide supplementary mfomanon. As to the Beban stmns phage typing 
rematns hlghly semhve, at least at the 100-fold concentration 
I P500 I Molecular epidemiology of MRSA isolates in 
intensive care unit during a 4-year period 
B. Aksu, A. Yagci, A. I k i  and G. Soyletir 
Istanbut, TR 
Objective: Nosocomial infections caused by methicillin-resistant Staphylococ- 
CUS aureus (MRSA) pose a serious problem in many countries. Padents 
admitted to intensive care unit ( 1 0  are especially prone to develop 
infections caused by common nosocomial pathogens like MRSA due to 
special risk factors (ivasive procedures, antibiotic use, age, chronic disease, 
etc.). We analyzed 56 MRSA strains isolated from ICU patients between 1998 
and 2001 by arbitrarily primed (AP)-PCR in order to evaluate strain 
relatedness. 
Methods: MRSA isolates were identified by standard methods. DNA extrac- 
tion was performed by Nuclespin DNA extraction kit (Macherey-Nagel, 
Germany). AP-PCR analysis was performed with M13 and ERIC 2 primers. 
Amplicons were analyzed by electrophoresis through agarose gels. On the 
basis of different amplified DNA band patterns strains could be divided into 
various PCR groups by visual inspection. 
Results: Evaluation of band patterns revealed that there was an evidence of 
transmission of strains between patients and, during whole study period there 
were 11 incidences of two or more Merent patients with isolates having 
identical fingerprints. Fortunately, a given genotype affected four patients at 
most and the longest persistence period was 2 months. 
Conclusion: AP-PCR method can be applied as a part of routine laboratory 
procedures for e d e r  detection of epidemics in ICU in order for immediate 
determination of common source and take infection control measures. 
I P501 I isoigtes of methiciltin-resistant ~taphy/ococcus 
aureus (MRSA) from stool of patients with acute 
gastroenterocolitis (AGEO often produce enterotoxinr 
I. Grmek Kosnik, R .  Frei, M. Dolenc, B. Virnik, M. Seljak 
and A.. Trampuz 
Kranj, SLO; Basel, CH; Jesenim, SLO 
Background: Enterotoxins are important virulence factors of S r a p h y l o c o ~  
aunus. We studied the fkquency of enterotoxin positive isolates of S. a u m  
isolated from patients with AGEC. 
Methods: In the period fiom January 2000 to August 2001, 3877 stool 
specimens of patients with AGEC or diarrhea, were analyzed for pathogenic 
bacteria. We did not routinely examine stools for C. d @ k  Isolates of 
S.aureus were tested for staphylococcal enterotoxin (SE) A, B, C and D 
production using SET-RPLA (Staphylococcal enterotoxin test kit, OXOID). 
In all primoisolates of S. aureus antimicrobial Susceptibility testing was per- 
formed by use of disk-difision method. We determined m e d  gene by PCR 
and performed molecular typing by pulsed-field gel electrophoresis. 
Results: In 6.5% out of 3877 stool samples, we isolated Cmpylobacter spp.; in 
4.7% Salmonella serogroup B, C, and D; in 0.3% Yersinia enteracolitira; in 0.1% 
Shigellu spp. S. aureus was found in 27 (0.7%) stool specimens. Eleven isolates 
were MRSA and belonged to six patients hospitalized in two regional 
hospitals. AU MRSA isolates produced SE A. One isolate of MSSA produced 
SE B, other MSSAwere SE negative. Although MRSA isolates were sporadic, 
they were identical morphologically, according to biochemical tests, and 
susceptibility to antibiotics. All MRSA were mecA gene positive. PFGE 
confirmed the same genotype. For that reason we suppose they represent 
the same strain. 
Conclusions: More than half of S. aureus isolates obtained from stool of 
patients with AGEC produced SE. All MRSA produced SE. All MRSA 
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posinve stool samples were sent f b m  two hospitals. Four out of six MRSA 
were isolated within 2 months and could be epidemologically connected. 
As SE is an important virulence factor of S. aurelrs, we think that detection 
ofSE production in connection with the clinical picture argues for the clinical 
importance of the isolate. In addition, the pattern of SE production may 
contribute to the epidemiological analysis of MRSA epidemics. 
1 P502 I An outbreak of methicillin-resistant 
Staphylococcus aureus (MRSA) with a strain that is negative 
in latex agglutination tests (LAT) and does not express 
capsular polysaccharide 
C Potel, C Lopez, M. Alvarez and J C Lee 
Vgo, E, Boston, USA 
Objectives: Clonal study of LAT negahve MRSA s t r m s  and its reIatronshp 
w t h  capsular polysaccharides 
Methods: Eighteen MRSA were isolated &om 16 panents and two nasal 
carriers in the Fitima Chnic between 1999 and 2000 All the MRSA were 
Nosocomial infections: epidemiology 
identified by tube coagulase test, amplification of the me& and nucA genes, 
API-STAPH (bioMCrieux), and oxacillin disc d f i i o n .  Four LAT were 
tested Slidex-Staph Plus and Staph-Kit @ioM&ieux), Dryspot Staphytect 
Plus (OXOID). Pastorex Staph-Plus STAPH (Sanofi-Pasteur). Capsule ser- 
otyping was performed by immunodifhion assays. The epidemiological 
relatedness was studied by repetitive element sequence-based PCR, random- 
amplified polymorphc DNA, coa gene restriction kagment length poly- 
morphism and spa gene polymorphism analysis. 
Results: All 18 of the isolates represented a single epidemic clone and were 
LAT neganve. Three representative strains did not react with antibodies (Ab) 
to any ofthe known CP serotypes (1,2,5, or 8), although they did react with 
Ab to ribitol teichoic acid. PCR amplification ofthe cap8-specific genes, but 
not the cap5-specific genes, suggests that the strains do not carry a new capsule 
locus. The three strains were positive in a biofilm assay. 
Conclusion: Nomeactivity of these MRSA in the LAT is not likely due to the 
production of capsule, but it may be related to b i o f h  production. Alter- 
natively, these strains may be regulatory mutants whose expression ofsurface 
antigens is down regulated. The development ofany new LAT should include 
Abs to consitutively expressed staphylococcal antigens like ribitol teichoic acid 
in order to avoid false negative results. 
(p503( Prevalence of infections in i a  intensive care units 
in an Italian region (Piemonte) 
A. Gramoni, R. Raiteri, B. Barberis, E. Manno, S. Cardellino, 
P Donadio and G. Di Perri 
Turin, Rivoli, Asti, I 
Objectives: The aims of the study were to determine in our region the 
prevalence of infections among patients in the intensive care units (ICUs), the 
setting where infections were acquired (community, hospital, ICU), the most 
frequently reported infections and their relationship with specific risk 
factors. 
Methods: A number of 18 of the 33 nonspeciahzed lCUs in Piemonte took 
part into the study. The patient population was defined as all patients 
occupying a bed over a 24-h period in Zdays: 27 June and 18 July 2001. 
For each patient, the investigator collected a comprehensive case report with 
demographics data, clinical status on admission (Simplified Acute Physiologic 
Score, SAPS II), diagnostic and therapeutic interventions up to 1 week 
preceding the study day. The definitions of infections followed the 1988 
statements of the CDC. Patient outcome was messed up to 3 weeks after the 
study day. 
Results: Ofthe 183 participants, 126 were men and 57 female. The mean age 
was 61 years. Eighty-four (45.9%) patients had one or more mfections. Out of 
the 109 total infections, 26 (23.9%) were community-acquired infections, 29 
(26.6%) hospital-acquired and 54 (49.5%) ICU-acquired infections. Most 
frequent infections involved low respiratory tract and urinary tract (see 
Table 1). 
Table 1 
Type of infection n 
Pneumonia 
Lower respiratory tract 
Urinary tract 
Gastrointestinal 
C h c a l  sepsis 
Bloodstream 
Wound 
Central nervous system 
Skin and soft rissue 
>2 ICU-acquired 
- >2 Hospital-acquired 
2 2  Community-acquired 
40 
20 
16 
11 
9 
8 
2 
2 
1 
11 
4 
3 
36.7 
18.3 
14.7 
10.1 
8.3 
7.3 
1.8 
1.8 
0.9 
27.5 
16.0 
13.0 
Increasing length of ICU stay (more than 8 days), tracheotomy, S A P S  and total 
parented nutnnon have been idenhfied as risk factors for ICU-acqmred 
infechon on bivariate analp=, whereas only the length of ICU stay was yet 
significant on 1ogIshC regression analysn. 
Conclusions: Infechve problems are of great mportance in the ICU setting 
and almost 50% of pahents in ICUs has one or more infecaons. O v e d ,  
infectlon rates are s& to findmgs of other European reports (e g. EPIC 
study) but ICU-acquired infections are less frequent than those prevlously 
reported in other Itahan stukes 
A real-time computer-based nosocomial infection 
surveillance program (Infhos) 
P. L6pez, C. Ezpeleta, R. Herrero and R. Cisterna 
Bilbao, E 
Objectives: The aim of this study is to asses the effectiveness of a computer- 
based nosocomial infection (NI) surveillance program called INFHOS to 
detect NI by comparing it's results with the results of a prevalence survey 
(EPINE) carried out in our hospital in 2001. 
Methods: The INFHOS program detects patients with NI by means of an 
expert software that merges data h m  microbiology, pharmacy, and 
admission. Patients are classified in four groups: without NI, IN possible, 
IN probably, NI certain. In the case of patients with NI, criteria for NI 
diagnosis (positive cultures, antibiotics, or clinic) and date ofdragnosis are also 
displayed. This pmgram has been built in our hospital. In this study we wish to 
compare the results ofour annual prevalence survey (excludmg psychiatry and 
short time admission ward were we didn't flnd any NI) with the results of the 
INFHOS. 
Results: A total of 497 patients were studied by the two methods-130 in 
surgery, 30 in the ICU and 337 in other wards. In the prevalence 
survey we found 31 NI, 28 out of them were also classifted by INFHOS 
as IN certain. In the other hand, the INFHOS program find 28 NI among 
the patients without nosocomial infection in the prevalence survey. When 
these 28 cases were analyzed, only three were active NI the day when the 
prevalence survey was carried out. Two of this three cases were classified as 
community-acquired infections in the prevalence survey and the other was a 
positive blood culture with coagulase-negative Staphylococcus in only one out 
of six blood culture bottles that we interpret as a contaminant. After this 
comparison we decided to change some d e s  to adjust the NI definition 
criteria. 
Conclusions: The computer system allows all inpatients to be screened for 
either infection control or antibiotic management interventions on a daily 
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basis with minimal time being expend on data collection. The main advantage 
of this program is to move infection control surveillance to a real-time mode. 
main microorganisms implicated. NUTI increase the hospitalization but not 
the mortality. 
(p5051 Nosocomial infection after acute stroke 
M. Zabalza, J. R. Blanco, J. D. Mosquela, I. Hernando, M. Vallejo 
and E. Ramalle 
hgraCa, E 
Introduction: Despite the efforts to decreasing stroke incidence and mortality, 
nosocomial infection are an important problem after acute stroke. 
Objective: To know the incidence, etioloh.y, localization and factors associated 
with nosocomial infection during acute stroke. 
Methods: Prospective study (from June 2000 to May 2001) of alI patients 
adrmtted to the hospital because ofnonhemorrhagic acute smoke. Diagnosis of 
nosocomial infection, after the h t  72 h after admission, was based on the 
clinical madestations, supported by hematological, microbiological and 
imaging findings. 
Results: During this period, 201 patients were included. In 17.4% there was 
an infectious complication, 54.3% urinary tract infection (UTI) and 45.7% 
pneumonia (owing to aspiration). Diagnosis of stroke (vs. transient ischemic 
attack) increase the infectious risk (PO.01) as well as a Canadan Neurological 
score <7 at admission ( P  0.004) (a lower value increase the seventy of the 
stroke). Infection happened a median of 6.8 day after admission (range, 3- 
15). The presence offever and indwelling bladder catheter were associated to a 
higher infectious risk (P= 0,001). Statistical analysis (P< 0.05) showed that 
age >75yean, male, diabetes, Charlson score for co-morbidity >1, and a 
d u e  at admission of glucose >126 mg/dL, iron <50 pg/dL, CFW > 10 mg/ 
L, leukocyte count > 10 x 103/pL. and fibrinogen >350 mg/dL where 
associated to a higher infectious risk. Gram-negatives accounted for 76.5% 
of the episodes (mainly E. colr), and 11 3% were polymicrobial. Antimicrobial 
therapy was considered adequate in 61.5% of cases. The overall mortality is 
increased by the presence of an infection (P=O.OOl). 
Conclusions: After acute nonhemorrhagic stroke, 17.4% of patients present 
some infectious complication. The main etiology is UTI followed by 
pneumonia. Gram-negatives are the main microorganism implicated. 
IP506j Nosocomial urinary tract infection (Nuti) in the 
elderly admitted to internal medicine services 
L. Metola, M. Rivero, J. R. Blanco, C. Urdanoz, A. Rivera 
and J. A. Oteo 
LqroCo, Navawa, E 
Introduction: NUT1 increase the morbidity and mortality of elderly patients 
admitted at hospital. 
Objective: To assess the incidence, etiolog and risk factors associated with 
NUTI in elderly. 
Methods: Prospective study Oune 2000 through May 2001) of patients older 
than 65years admitted in Internal Medicvle Services. We analyzed demo- 
graphic characteristics, clinical data, associated factors, urinary drainage 
methods, type of catheter bladder, predisposing factors, and complications 
(including m o d t y ) .  Urinary culture was realized in symptomatic patients 
(dysuria, hequency or urgency), including fever of unknown localization. A 
urine culture was considered to be positive ifa quantitative culture growing a 
single organism in concentrations of >105cfu/ml of urine, and no more 
than two isolated present (with exception of Enterococcus and Candida infec- 
tions). 
Results: During this period, 1342 elderly patients were admitted, 52% 
women, and a median age (SD) of 78.5 (7.4)years. The global incidence 
of NUTI was 3.8%; 60.4% women, and a median age (SD) of 80.3 (6) years. 
Risk factors associated to NUTI were: previous hospitalization (P<  0.05), 
nursing home resident ( P  < 0.001), higher severity ofthe McCabe 81 Jackcon 
( P <  0.005), presence of exogenous risk factors (>2) ( D  0.001), bedridden 
(P< 0.001), urinary incontinence (P< O.OOl), and indwelling bladder cathe- 
ter (P<O.OOl)  (in special Foley catheter; P<O.OOl). Gram-negatives 
accounted for 54.7% of the episodes (mainly E.  coh), and 7.5% were poly- 
microbial. Among patients with NUTI, bacteremia was present in 5.6%. 
NUTI increased the days of hospitalization (P< 0.005) but not the overall 
mortahty. 
Conclusions: Concomitant illness or risk factors, previous admission at 
hospital or nursing home resident, and a urinary incontinence or bladder 
catheter are risk factors associated to NUTI in elderly. Gram-negatives are the 
1 P507 1 Prevalence of nosocomial infections in ~ta~y:  results 
from the Lombardy survey in 2000 
A. Lizioli, L. Panceri, A. Porretta, M. Santini and G. Privitera 
Milan, Lecco, f i a ,  I 
Objectives: To obtain prevalence rates of nosocomial infections (NI) in 
Lombardx to determine distribution of hospital acquired infections by 
hospital department and to identifjr the pathogens more fiequently involved. 
Methods: A descriptive study by point prevalence survey. The survey involved 
88 out of the 113 public hospital of Lombardy voluntarily participating. All 
adult patients (older than 15 years) admitted in the 24 h precedmg the survey 
in any department, excluding those in psychiatric departments, were inves- 
tigated. All patients in the same ward had to be investigated on the same day. 
The survey was conducted by local teams trained by Prevention Unit of 
Region Lombardia. NI infections were defined according to CDC criteria. 
Results: A total of 18 667 patients was surveyed, representing 72% average 
dady total of occupied beds in public hospitals in Lombardy. A total of916 NI 
were observed, thus the overall prevalence was 4.9%. Prevalence of blood- 
stream infections (BSI) was 0.6% of pneumonia was 1.1%; of urinary tract 
infections (UTI) was 1.6% and of gastrointestinal infections (GI) was 0.4%. 
surgical wound infections (SW) occurred in 2.7% of surgical patients. The 
highest rate of BSl and pneumonia was in intensive care unit (ICU), 
respectively, 7.0% and 17.2%. With respect to urinary tract infections 
(UTI), high prevalence was observed in spinal unit (20.0%), ICU (8.3%) 
and rehabfitation (6.4%).0perated patients had an increase of SWI. BSI and 
pneumonia directly related to increased surgical contamination. The pre- 
valence rates of all sites of NI increased with ASA score. Microbiological 
confirmation was obtained for 50 cases ofBSI (45.9%), for 87 ofpneumonia 
(42.0%), for 209 of UTI (67.9%), for 23 of GI (33.8%) and for 50 of SWI 
(36.5%). MRSA accounted for the 23% of all isolated S. aureus; in intensive 
care units patients the proportion of MRSA represented 44% of S. aureus 
isolations. In BSI coagulase-negative staphylococci accounted for 22%. The 
proportion of methicillin resistance between coagulase-negative staphylo- 
cocci was 38% in all isolates, and 43% between isolates fiom BSI. 
Conclusions: The high participation in this study suggest that the method is 
suitable. The results are of undoubted descriptive interest for understanding 
the general dimension and features of the problem of NI in Lombardy, and 
provides baseline data for rational priorities in allocation of resources, for 
further studies and for infection control activities. 
1 P508 I The first national prevalence study of hospital 
infections 
N. Milic, D. Drndarevic, K. Bukumirovic and L. Markovic-Denic 
Belgrade, W 
Objectives: The hospital infections are for a long time very well-known 
public health problem with a certain of consequences like medical, econorn- 
ics, ethic, statutory, etc. The number of countries, which recognize the need 
ofscientific cognition’s repose on collecting data about the liequency ofthese 
infections by organized epidemiological surveillance. increase. The study of 
prevalence is the first necessary stage in insight ofhospital infection frequency. 
This study enrolls hospital infection among the all patients present in hospital 
in the moment ofstudy (usually 1 day). The aim ofthis study is to insight status 
and the size of the hospital infection problem in Republic of Serbia. 
Methods: 
The type of study (prevalence study); 
0 The studied population; 
0 The infection and variable observe definition; 
0 The data collecting; 
0 The validity of data; 
0 The facing of data. 
Result% Twenty-seven (27) hospitals took part with 71 15 patients. Therehm 
21 (21) General Hospitals with 4131 (58.1%) patients and six (6) University 
Hospitals with 2984 (41.9%) patients. Study included 3107 (43.7%) men and 
3107 (43.7%) women. The prevalence of the patients with the hospital 
infection was 6.3%, whereas the prevalence of hospital infections was 
7.5%. Highest prevalence level of hospital infection was determined in 
university hospitals (9.9%). whereas that level in general hospitals was little 
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less (5.7%). The highest prevalence level was confirmed in neonatology 
(14.6%) than orthopedic and traumatology departments (10.4%). According 
to anatomic localiiation mainly there were infections of operating field, 
urinary system, respiratory system and mfections of skin and soft tissues. 
Microbiological confirmation had only 50.8% of hospital infections. The 
main causes were Pseudomonas aeruginosa, Staphylococcus aureus, Klebziella spp. 
and Escherirhia coli. During the study antibiotics has been &en from 35.4% of 
hospitalized patients. Antibiotics in prophylaxis has been taken &om 36.3% of 
patients that was operated and among them 37.8% patients with uninfected 
operating field. 
Conclusion: The study of prevalence pointed out the importance of epide- 
miological surveiIlance initiation at hospital infections. 
I P509 Three prevalence surveys of hospital-acquired 
infections in a Greek hospital 
S. Doukakis, L. Tzimis, G. Perogambrakis, D. Koutsoumba, 
V. Petroulakis, I? Korkonikitas, E. Lionaki, I. Tzanakis, A. Papadaki, 
S. Kazoulis. M. Kaloniatou, D. Athanasopoulos, A. Galis and S. Kastanakis 
Chania, GR 
As it is well known. survedlance of hospital-acquired infections (HAIS) is an 
important component of an effective nosocomial infection control program. 
Prevalence surveillance is a rapid and inexpensive way to estimate the problem 
of HAIs. To study the problem of nosocomial infections in our hospital, three 
prevalence studies were made &om our team during the years 1994-1999. 
The 6rst study included 288 patients, the second 288 too and the third 265 
(the total number of hospitalized patients at the time of the study). In the first 
study a nosocomial infection was found in 20 patients, in the second in 15 
patiena and in the third study in 13 patients. The overall prevalence of HAIs 
was 6.9, 5.2 and 4.9% for the three studies, respectively. In the first study, 
amongHAIs, urinary tract infections were 12 (60.0%), lower respiratory tract 
infections were six (30.0%) and surgical site infections were two (10.0%). In 
the second study, urinary tract infections were four (26.7%). lower respiratory 
tract infections were two (13.3%). surgical site infections were 5 (33.3%) and 
bloodstream infections were four (26.7%). In the thud study, urinary tract 
infections were six (46.1%), lower respiratory tract infections were three 
(23.0%), surgical site infections were three (23.0%), and bloodstream infec- 
tions was one (7.7%). The use of antibiotics among the hospitalized patients 
was found to be 47.2, 60.1 and 58.5% for the three studies, respectively. The 
incidence of multi-resistant bacteria was primarily Enterococnrs spp. and 
secondary Pseudomonas aemginosa, Enterobarter spp., Ktebsiella pneumoniae, 
Escherirchia coli, Staphylococcus aureus, Staphylococcus epidemidis. Regarding 
age the highest incidence of HAIs occurred in the third age group. Unjustified 
prescription of prophylactic chemotherapy was found despite the suggestions 
ofthe infection control committee. Repeated prevalence surveillance is avahd 
way to estimate the problem of HAIs. 
NRTIs was found in the adult ICU (31.1%). Mechanical ventilation, as well 
as, the presence of inm-tracheal tube or tracheostomy were the main risk 
factors for NRTIs (P< 0.0001). Responsible microorganism was found in 80 
out of 197 (40.6%) cases and 102 strains were isolated. The majority of them 
were Gram-negative bacteria (66.7%). The most frequently isolated micro- 
organisms were: I? aemginosa (21.6%), Staphylococcus spp. (21.6%), Acinetobacter 
spp. (19.6%) and Kpneumoniue (11 3%). With the exception of K.pneumoniae 
(17.2% in 1999’s study and 4.5% in 20004, there was no Werence in the 
frequency of microorganisms’ isolation between the two prevalence studies. 
Conclusion: Our data suggested that HARTIs are the most common HA1 in 
Greek hospitals. Gram-negative microorganisms are the most frequently 
isolated pathogen. No substantial epidemiological differences in the two- 
point prevalence studies were noted. 
1 P511 1 Microbiology of nosocomial infections and 
susceptibility to antibiotics in an intensive care unit in 
Greece 
E. Chinou, Z. Chiolou, A. Georgouli, N. Trobouki and P. Golemati 
Braeus, GR 
Objectives: To determine microbial flora of nosocomial infections in ICU. To 
determine antimicrobial resistance patterns among aerobic Gram-positive and 
-negative microorganisms isolated fiom patients on a seven-bed ICU over a 3- 
year period. 
Methods: During 1998-2000,913 cultures horn 1098 patienu with various 
clinical manifestations of nosocomial infections were isolated. Disc difhion 
method and breakpoint MICs were employed to detect the in vitro activity of 
antibiotics. 
Results: A total number of 913 isolates were evaluated &om respiratory tract 
(34.6%), blood (29%), intravascular catheters (13.8%). wounds (12.4%) and 
urinary tract (10.2%). The isolated microflora was Gram-positive cocci: CNS 
(34.7%), S. aweus (16%), Enterococd (5.8%) and Gram-negative rods: l?aenr- 
ginosa (17.3%), A. baumannii (10.4%). Ktebsiella sp. (5%). E. coli (4%) and 
Entnobacter sp. (2.8%). The sensitivity of Gram-positive microorganisms 
was tested to ampicillin, amoxicillin/clavulanic acid, oxacillin, vancomycin, 
teicoplanin, gentamicin, ciprofloxacin, erythromycin and clindamycin. The 
high level of methiciIlin resistance among CNS (80%) was obtained. The 
sensitivity of Gram-negative microorganisms was tested to ampicdhdsulbac- 
tame, gentamicin, piperacillin/tazobactarn, ceftriaxone, ceftazidime, cefe- 
pime, ciprofloxacin, imipenem and meropenem. The solated 
Enterobacteriaceae had good susceptibility to imipenem (95%) instead of 
l? aenrginosa and A.  baumannii susceptibility to the same drug (30%) and (50%), 
respectively. 
Conclusions: In the ICU ofour hospital j-lactam antibiotics are not the drugs 
of choice for empirical treatment in nosocomial CNS infections. For the 
treatment ofinfections caused by Gram-negative microbes the drugs of choice 
would be carbapenems and piperaciIlin/tazobactarn. 
I P510 I Two point prevalence studies of hospital-acquired 
respiratory tract infections in 14 Greek hospitals 
P. Nikolaides, D. Kofieridis, J. Papadakk, G. Kioumis, E. Maltezos, 
S. Levidiotou, J. Pediaditis, M. Lazanas, E. Anevlavis, M. Roubelaki, 
J. Staralas, S. Kastanakk, A. Gikas and Y. Tselentis 
Greek hfirtion Confml NeIumrk- University Hospital of Herklion, GR 
Objectives: Hospital acquired respiratory tract infections (HARTIs) are 
associated with significant morbidity and mortality. The aim of this study 
was to investigate the epidemiological feature of HARTIs in Greek hospitals. 
Methods: Two point prevalence studies ofhospital-acquired infections (HAIs) 
were carried out in 14 Greek hospitals, scattered in all Greek territory, during 
the years 1999 and 2000. Respiratory-tract infections were recorded accord- 
ing to the CDC definitions. 
Results: A total of 7120 hospitalized patients were registered during the 
studies. A number of 3767 (52.9%) were men. Their median age was 62yean 
(range: 0-99). During the study 610 (8.6%) patients of HA1 were identified. 
Among them 197 (32.3%) were HARTIs [I18 out of 366 (32.2%) HAIS, in 
1999s study and 79 out of 244 (32.4%), in 2000 s]. One hundred and eleven 
out of 193 patients (56.3%) had a lower respintory tract infection (LRTI), 67 
(34.0%) patients had a pneumonia and 19 (9.7%) had an upper respiratory tract 
infection (URTI). Five out of 197 (2.5%) patients had a concomitant 
nosocomial surgical site infection (SSI), and four out of 197 (2%) had a 
nosocomial urinary tract infection (UTI). The greatest prevalence rate of 
m] Control and temporal evolution of a multi-resistant 
Acinetobacter baumannii outbreak in an intensive care unit 
J. J. Camarena, R. Zaragoza, R. Gonzalez, J. C. Navarro, A. Artero, 
S. Sancho and J. M. Nogueira 
Valem’a, E 
Objectives: In 1997, Acinetobacter baumannii became the most common cause 
of intensive-care bacteremia (ICU) in our hospital. The aims of this study 
were to describe the genotypic characteristics of these isolates, the temporal 
evolution of a detected multi-resistant cluster, and analyze the influence of 
control measures on the evolution of the outbreak. 
Methods Prospective study of all strains of A. baumannii isolated in bactere- 
mic patients of an ICU in a teaching hospital, during the last 6 years. Analysis 
of genomic DNA, by PFGE and RFLP-PCR, and susceptibility study of the 
isolates. Clustering of the genotypic patterns obtained and analysis of their 
temporal evolution. Analysis of preventive and control measures adopted 
during the multi-resistant outbreak, including architectonic changes in the 
ICU. 
Results: During the study period 312 blood and other samples from 72 
patients with A. baumannii bacteremia were analyzed. Six clusters were 
obtained The multi-resistant outbreak was caused by the a cluster (C3), 
which grouped the 66.6% of cases. In this cluster, all the antibiotics tested, 
including carbapenems, were resistant, except polimixine and colimicine. 
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Mula-resistant-C3 caused the 100% of isolates in 1997. Despite prevenhve 
measures, mcludmg archtectural changes XI ICU, the C3 cluster remamed as 
the mam group of A. baurnannii (67% of cases) m 1998. However others 
clusters that grouped suscephble-straw were emergmg. F d y ,  from Feb- 
ruary 2001 the only present cluster was semble-C5, and multi-resistant-C3 
was eradicated. 
Conclusions: The common prevenhve measures adopted for the control of a 
multi-resistant outbreak of A. baumannii m ICU were not enough effechve. 
Only the archtectornc changes had a remote effect m the outbreak eradxa- 
hon. 
/p5131 Computer keyboards and nosocomial pathogens in 
a children's hospital 
A. Kara, G. Kanra, D. Giir, A. B. Cengiz and M. Apis 
Ankara, TR 
Introduction: Nosocomial infections are important adverse events that com- 
plicate the hospihation of patients and result in considerable morbidity and 
mortality, increased length of stay and increased health care cost. The role of 
the hospital environment as a reservoir of nasocomial pathogens is contro- 
versial and has not been thoroughly investigated. Computers are a relatively 
recent addition in hospital environment with fiequently used keyboards. This 
study was undertaken to investigate the potential role of keyboards in the 
transmission of nosocomial pathogens 
Methods: Sampling occurred on the same day &om 156 computer keyboards. 
Forty-four out of 156 keyboards were located in the inpatient services, and 
from neonatal and pediatric intensive care units. Two keyboard samples from 
bone marrow transplantation unit and, 32 keyboard samples Gom doctors' 
stations were taken. In total 78 samples Gom in patient unit were collected. 
The other 78 were taken from doctor offices (46), secretary unit (28), 
parenteral nutrition unit (1) cardiac catheterization unit (2) and one from 
information desk. A sterile cotton tipped swab moistened with sterile saline 
solution was moved over the letter keys A, K, L, M (most commonly used 
letters in Turkish), space bar and enter key. After the collection, thioglycol- 
lacte broth medium and blood-agar medium was inoculated. 
Results: A total of 24 environmental isolates were obtained with two sample 
sites yielding multiple organisms. Staphylocornrs aums was the most common 
pathogen identified. Seven out of 19 S. aureus isolates were MRSA. Other 
isolates were Enterobacter (5) and E. coli (2). Five of the MRSA was isolated 
&om the outpatient units and two multiple organism isolated sites &om the 
intensive care unit. 
Conclusion: As a result of these findings, hand washing before and after the 
keyboards contact must be encouraged. ALSO plastic keyboard cover and daily 
cleaning procedures for keyboard must be installed in both services and 
outpatient units. 
(p5141 Microbiological control of airborne contamination 
in hospitals with the use of an airlDEAL sampler 
M. Fleischer U. Nawrot and 0. Bortkiewicz 
Wroclaw, PL 
Objectives: The aim of the study was to compare different methods for 
microbiological control of hospital air and to assess the utility of the airIDEAL 
impactor sampler (bioMerieux) in controlling air contamination in the 
hospitals environment. 
Methods: Air samples were collected from 12 conventionally ventilated 
operating rooms (n-LAW and fhrnl0 rooms of the hematology wards 
equipped with HEPA fdtration system (LAF). Air contamination was mea- 
sured by the sedimentation method, i.e. by 30-min exposure ofplates spread 
with nutrient agar (TSA; TSA witb neutralizing agents, and Sabouraud 
dextrose chloramphenicol), and by the airIDEAL sampler involving the same 
agar plates. Air samples Gom each of the investigated rooms were taken 
simultaneously by both the methods. Statistical analysis was performed using 
the Statistica PL. 
Results According to the measuring method applied, air contamination in 
n-LAF room varied from 68.1 to 1655.8ch/m3 (sedimentation method), 
ranged between 342.4 and 9895.6 cfu/m3 (air IDEAL sampler + TSA), or fell 
between 463.6 and 10314.6cfk/m3 (air DEAL sampler+TSA with neu- 
tralizingagents). InLAF roomsaircontamimtionvariedh-omOto 74.7 cfdm3, 
h m  5 to 33.3cfu/m3 and h-om 5 to 121.3cfu/m3 for the three methods, 
respectively. The investigations show that the cfu/m3 values obtained with the 
sedimentation method averaged lower than those achieved with the impactor 
sampler. This Werence was found to be statistically sigtllficant (P= 0.03) for 
n-LAF rooms. When use was made of TSA with neutralizmg agents, the 
number of detected airborne microorganisms was greater (P=O.01). The 
most commonly isolated pathogenic species were S. aureus, Enmocornrs spp., 
Srrepfococcus spp., P aenrginosa, A. lwo@i and A.  fmalis.  Penicillium spp. and 
Cladospon'um spp. 
Conclusions: (1) Microbiological control of air contamination in hospitals 
with the use ofthe airDEALimpact sampler detected bgher cfu/m3 values as 
compared to those measured by the sedimentation method; for rooms with 
conventional ventilation this difference was of statistical sigdcance. (2) The 
application of TSA witb neu&g agents increased the detectability of 
airborne microorganisms. 
I P515 I A comparative study of the frequency and 
resistance of Gram-negative bacteria isolated from intensive 
care unit and the rest wards in a Greek hospital within 
a 3-year period 
V Karabassi, M Pouyiouka, M Toutouza, V Scandarm, A. Xanthak~, 
E Kandri and C Kontou-Castellanou 
Athens, GR 
Objectives: The recordmg of the hnds of Gram(-) bacteria whch were 
lsolated h-om Intensive care umt (ICU) and the rest wards of a Greek hosptal 
wthm a 3-year period as well as a comparison of thew kequency and 
remtance to anhbiohcs. 
Materialsand methods:Durmgthe 3-year penod from 1998 to 2000, a total of 
4279 c h c a l  isolates of Gram-) bacteria were collected h m  pattents treated m 
ourhospital Ofthese610(14 3%) denvedfromICUand3669 (85.7%)h-omthe 
rest ofthe hospital. The most commonmaterials were in ICU. bronchd secretton 
69%, catheter ups 11%, blood cultures 7.5% and m the rest: unne 45%, blood 
cultures 13%, wounds6% C u l ~ s a n d i d e n t l f i c a h o n o ~ ~ e n a ~ r e ~ ~ o r m ~  
by convenhod methods Suscephbhty to anabiohcs was detected by the 
&&ion method according to NCCLS gtu&nes 
Results: Of the s t r a m s  tested the most frequent bacteria were m frequency 
order m ICU P aeruginosa 35%, A baumannir 33%, E aerogenes 10%. K. pneu- 
moniae 8% and in the regular wards E cob 44 5%, I? aetupnora 18%, K.pneu- 
rnoniae 8 4%, Proreus spp. 7 5% The percentage of resistance to anhbmtm for 
Gram(-) bacteria derived from ICU and the regular wards were, respechvely, 
for P aeruginosa: ucarcdhn 78-33%. impenem 75-18%, ceftandnne 64-21%, 
tobramycin 73-31%. ciprofloxacm 72-20%, for A .  buumannii: mpenem 12- 
7%, cefizidxne 9446%. ciprotloxacm 88-75%, tobramyan 66-49%,for 
E cob ampicfin 71-49%, amoxlch-clavulamc acid 4524%, cefotaxlme 
247%. ciprofloxacin 19-7%, gentarman 19-7%. As regards the sensitmty of 
the bacteria lsolated, it IS worth nothmg that: The resistance of I? aencginosa to 
armnoglycosides and Ceftavdime has mcreased durmg the 3-year period 
(tobramycm: in ICU h-om 7009 m 1998 to 76% m 2000, in the rest from 22 to 
32% c&idnne m ICU &om 52 to 63%) A baumannrr was mulareslstant 
wth  mcreasing resistance to mpenem 
Conclusions: Gram(-) bacterra lsolated from ICU were much more resstant 
to anhbiohcs than these of the rest wards of the hospital The resistance of the 
majority of Gram(-) bacteria has mcreased sigrufcantly during the 3-year 
study period. The ConMud observahon of bacteria and the pohcy of the 
restnchon m the use of anhbiohcs can have beneficd effects 
Emergence of multi-resistant Acinetobacter 
baumannii in the Leiden University Medical Center 
T. van der Reijden, K. van der Kouwe, S. Bernards, T. Berbee, 
H. Verbakel, L. Dijkshoorn and l? van den Broek 
Leiden, NL 
Multiresistant strains of the genus Aciner~bacter have been reported to cause 
outbreaks in many hospitals worldwide. In the Leiden University Medical 
Center (LUMC), these organisms have been isolated only sporadically h-om 
clinical specimens. in November 2000, a sudden increase in the incidence of 
multiresistant Acinetobacter was noticed in patients on the 1CU of the Internal 
Medicine Department (ICIG). Species identification by amplhed ribosomal 
DNA restriction analysis (ARDRA), and strain identification (typing) by 
RAF'D-PCR and AFLP showed &at one single ArirPetobacfer baurnannn& 
was involved. The problems gave rise to several successive interventions in the 
period of November 200GMarch 2001, including limited admissian and 
strict isolation of patients, and an prevention of admission followed by 
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cleaning and duidecting. Although these measures ininally resulted in a 
decrease of cases, the organism was later found to have spread to the surgical 
ICU and was again - albeit at a lower rate - found in patients on the ICIG. 
Because its fiat manifestation, a total of 97 isolates were cultured &om 23 
patients on the two ICUs, mostly &om respiratory tract specimens. Many 
environmental specimens were analyzed for presence of the epidemic organ- 
ism, although it was recovered flom a few of these - the sources and mode of 
transmission could not be elucidated. The AFLP fingerprint of the organism 
was compared to hundreds of Acinefobarter isolates of the AFLP lib-. It 
appeared that the LUMC strain was genetically neither closely related to 
A. baumannii strains &om other European outbreaks, nor to the strains causing 
outbreaks in several Dutch hospitals in the same period. The fact that the 
strain persisted in the LUMC over a period ofup to 10-month indicated that 
after an initial epidemic episode, it had become endemic in the hospital. 
v] Phenotyping and genotyping methods for 
epidemiological control of Acinetobacter baumannii hospital 
infections 
E. Stefaniuk, J. Saelczyk and W. Hryniewicz 
Warsaw, PL 
Objectives: Acinetobacter baumannii is Gram-negative bacillus that is respon- 
sible for an increasing number of nosocomial infections. It is diflicult to 
control A .  baumannii outbreaks, because usually they are caused by multi- 
resistant strains. The aim of this study was to evaluate usefulness of dfierent 
methods used for of An'netobacfer spp. typing. 
Methods: Sixty Acinetobacrer spp. isolates were recovered between January 
1999 and December 2000 in different wards of the Regional Hospital in 
Czestochowa. The strains were identified to the species level using the ATB 
and Vitek systems (bioMeriCux) and the molecular ARDRA method. 
Susceptibility to a broad panel of antimicrobial agents was determined by 
the agar dhtion method according to NCCLS. Sunilarity among the isolates 
was studied by the PCR-based approaches with RAPD-7, RAPD-1283 and 
ERIC1 primers. 
Results. Using the ATB ID32GN test 88% of Acinetobacter isolates were 
identified as A. baumannii, one isolate as A. haemofytinrs and only one isolate as 
A. junii. The seven remaining isolates were identified using the Vitek test as 
A. calcoacetinrs bio. anifratus, and by the ARDRA method as A. baumannii, 
genospecies 4 and genospecies 5. Analysis of the biochemic profdes, the 
resistance and genetic patterns revealed similarity between A. baumannii strains 
which were collected in different wards of hospital. 
Conclusion: The results suggested that A. baumannii infections that occurred 
in the hospital from January 1999 to December 2000 were caused by multi- 
resistant strains. AU of them were sensitive to carbapenems and 88% of strains 
were sensitive to netilmicin. The ARDRA method is more discriminatory 
than biochemical tests. Typing results revealed the homogenous structure of 
the population of A. baumannii in analyzed wards of hospital and this could 
have resulted from the patients transfer between these wards. 
1 P518-] PER-type 1-lactamase-producing Proteus mirabilis 
strains causing outbreaks in a general hospital in northern 
Italy 
R.  Mighavacca. L. Pallecchi, C. Matti, R. Daturi, E Zara, M. Spalla, 
E. Nucleo, G. M. Rossolini and L. Pagani 
Pavio, Siena, I 
Introduction: An increase of b-lactam resistance rates, mostly owing to the 
acquired /l-lactamases of TEM-type, has occurred in R mirabibs, especially in 
nosocomial settings. Recently, also extended-spectrum b-lactamases @She- 
taLs) have started spreading in these species. 
Objectives: the aims were to investigate the production of ESbetaLs and the 
epidemiological correlations in R mirabilis isolates from an Italian hospital 
where increased resistance rates to expanded-spectrum cephalosporins have 
recently been observed. 
Methods: we studied 294 f? mirabilis obtained h m  inpatients of the Uni- 
versity Hospital ofpavia during the periods February 1997-January 1998 and 
January-November 2001. Isolates were identified by GNI cards and tested for 
antimicrobial susceptibility by GNS cards (Vitek System-BioMtrieux). 
B-lactam susceptibilities were also determined by broth macrodilution pro- 
cedure. Ampicillin resistant isolates were screened for ESbetaL production by 
the clavulanate sinergy test. Isoelectric focusing, activity on substrates, PCR 
amplification of bla alleles and sequencing were performed. Genotypic 
analysis of ESbetaL producers was carried out by pulsed field gel elecpo- 
phoresis (PFGE) of genomic DNA and plasmid analyzes. 
Resuk: A total of 294 1? mirabilis were collected &om patients in medical and 
surgical wards and in a general 1CU. 158 of the above strains resulted 
intermedate or resistant to ampic& and 81 isolates produced an ESbetaL. 
Enzyme assays and molecular analysis revealed the presence of a determinant 
encoding PER-type ESbetaLs in 63 isolates, 52 strains were obtained in the 
fxst period, whereas 11 strains in the latter period, respectively. Genotyping 
by PFGE showed that all the PER-type producers isolated in the first period 
were clonally related, notwithstandmg their origin fiom Werent wards, so a 
dissemination of s t r a i n s  had occurred. The isolates of the latter period 
harbored a conjugate plasmid co- for a PER-type ESbetaL, so in this 
case, horizontal transfer of the resistance determinant could have played a 
relevant role in its dissemination. Analysis of digested genomic DNA by 
PFGE of I! mirabilis isolates unambiguously identified Merent bacterial 
clones responsible for the two epidemics. 
Conclusions: The long persistence of PER-type producing R mirabilis and 
their circulation in Werent hospital wards suggest their possible role as a long- 
term reservoir for further epidemic spread. 
I P519 I Comparison of efficacy of alcohol-based hand 
antiseptics on reduction of release of skin flora 
I. Mirska, K. Matuska, M. Moulis and Z. Muszyiiski 
Poznara; PL 
Objectives: In the dismfection ofthe hand skin the most often used antiseptics 
are alcohol-based preparations. They are frequently combined with chlor- 
hexidine (CH) because of their antimicrobial spectrum and residual activity. 
Recently there has been an increasing number of reporu on allergic reactions 
to CH among the medical sta f f  and the emergence of CH-resistant noso- 
comial bacteria. Therefore, the following question emerges: is it possible to 
reduce the application ofantiseptics containing CH? The aim ofthe study was 
to compare in vivo the efficacy of selected alcohol-based antiseptics without 
and with CH. 
Methods: We used three antiseptics containing: ethanol 52 g + 2-propanol 
10 g (E); 2-propanol 36 g + I-propanol 28 g (P); 2-propanol 30 g + I-pro- 
pan0125 g + ethanol 20 g + CH 0.5 g (PCH). The tests were performed on 23 
volunteers. According to EN 12791/97 the mean reduction factor (RF) of 
bacteria counts released tiom the fingertips before hand-wash and immedi- 
ately after the hand-disinfection (2 x 3 mL, 3 min) as well as after wearing 
gloves for 3 h (sustained effect) were determined. The fingertips were rubbed 
for 1 min on the base of a petridish Containing 10 mL of tryptone soya broth 
with neutralizer (3% polisorbate 80 + 2% lecitine L + 3% lubrol) to asses the 
release ofskin bacteria. Statistical analysis was performed using Wilcoxon test. 
Results: The immediate effect of rubbing of PCH (log RF = 1.2; SD = 0.8) 
and P (0.9; 0.9) was equal, in contrast to the E (0.4; 0.7). which was 
significantly less effective (P< 0.05). There were no sigmficant differences 
in reduction ofskm flora assessed for PCH (1.1; 0.3) and P (0.9; 0.2) after 3 h 
of wearing gloves and both antiseptics showed sustained effect. In contrast 
activity of E against skin bacteria was significantly less evident (- 0.02; 0.8) 
and there was no sustained effect. 
Conclusions: The propanon-based antiseptics demonstrate the rapid and 
strong effect on reduction of the release of skm flora fiom the hands and 
the sigmficantly better efficacy than antiseptics containing ethanol. Antiseptics 
like P and PCH could be replaced one by another in contrast to ethanol-based 
antiseptics. It may give an argument for the limitation in application of 
antiseptics containing CH for hands disinfection. 
wl What is the medical staffs' knowledge and 
behavior for hand-washing in intensive care units? 
S. Esen, H. Kumcagiz, M. Sunbul, C Eroglu and H. Leblebicioglu 
Samsun, TR 
Objectives: Hand hygene is considered the most lmportant measure to 
reduce the transrmssion of nosocormal pathogens m healthcare semngs. The 
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aim of this study is to investigate the hand-washmg compliance of health care 
workers which workmg in neonatal unit and intensive care unit, and to 
compare their hand washing behavior with their answers in questionnaire. 
Methods: Between February 1 and March 31, 2001 medical personals 
behavior was observed in intensive care and newborn units without telling 
any one by an infection control nurse. The observer recorded the patient 
contacts and activities for each participant during 3-h observation periods. 
After inspection of each person, a questionnaire form was requested and filled 
by all persons in second part of the study. 
Results: The study group consists of 50 physicians, 38 nurses, 34 medical 
students and 19 nursing assistants. Hand-washing ratio was 7.8% before 
any application and 64.5% after application. Hand washing or rubbing 
occurred after 64.5% of total contacts. Nurses, physicians, students and 
nursing stuff washed their hands after any contam 64.9, 68.0, 61.8 and 
63.2%, respectively. Nurses had a sigmficantly higher hand washing frequency 
before contact than the other groups (Pi 0.0001). Liquid soap and water 76 
(74.5%) was the most preferred hand washing method. None of the men 
washed their hands before any application, all of the hand washed persons 
before application were female (P<O.(X)Ol). 52.0% of the hand washed 
people dried their hands, 13.2% of them with disposable towel. About 82.3% 
of the group believes that hand washing or disinfection is very important to 
reduce nosocomial infection and 86.5% of the s t a f i i  believes that theirs and 
medical personnel’s hand-washing fiequency is poor. The most important 
reason for poor hand-washing was inadequate hand washing and drying 
equipment. 
Conclusions: The participants in this survey were well aware of this sig- 
nificance, but there is st i l l  a discrepancy between theory and practice. To 
increase hand-washing fiequency education programs about this topic should 
be made. 
I P521 I Choosing an optimal preservation system for some 
ointments 
I. Olta, T. Oita, I. Wpescu, D. Grigore and P. Fiterman 
h i ,  RO 
Objectives: Ointments need protectlon agamst nucrobd spodage, first of all 
m order to insure the consumer agaulst potennal danger arsmg Gom 
pathogemc germs contarmnahng the product, and second to guarantee 
long-term stabhty (shelf Me) of the formula, even under use condmons 
On the other hand, preservauves are often nted (lust after perfumes) as the 
cosmetic ingredents responsible for slun irritation, allerges, and atopic 
reactions To guarantee mcrobially ‘clean’ omtments, with long shelf hfe, 
and reduced amounts of preservauve levels, i s  therefore the wlsh of every 
formulator. 
Microbiological studies: To deterrmne the efficacy of a preservahve system, 
the so-called ‘challenge tests’ are carried out on the omtment formula: the 
product is a r a f c d y  contammated wth  a known amount (-1.105-1.106 
rmcroorganmdg), and the decrease in total germ count wtth nme (3, 5 or 
7days, 14 and up to 28days) is measured. Unfortunately, no standard 
umveaally accepted method of challenge testmg IS agreed upon for cosmehc 
products (USE BF’, CTFA guidehes M e r  greatly from each other m scope 
and mterpretahon). Our own stuhes were 
followng way the product to be tested (a 
inoculated with, respectwely 
I a mixture of E coh (IP52166). S QIVPUS (ATCC 9144), Paerugrnosa 
(IP5842) and B subtrlrs (ATCC 6633) ‘is representahves of Gram-poslhve 
and Gram-negatwe bacteria; 
2 a rmxture of C albrcans (IP 4872) and S cereutsiae (ATCC 2601) to stand for 
yeasts, and 
3 Aspegl lus  n i p  (ATCC 16604) as a member of the mold genus 
After 3, 5 or 7days, 14 and up to 28days, the total germ count of 
each contammated product IS deterlmned by standard plate-count 
methods 
Conclusion: Mastering the risk of mcrob~ological contammatfon of oint- 
ments durmg manufacturmg, filling and over the tune of storage and use IS a 
tough challenge for the formulator and mcroblologst Even though It mght 
be &fficult today to estabhh a demonstratlon oflllness contracted through the 
use of a contaminated off the shelf ointment, recalls (voluntary or forced by 
the authorities) owing to unacceptable levels of microbial loads, occur on a 
regular basis. 
1 P522 Microbial contamination of oxygen manometers in 
selected hospitals of Tehran 
P. Owlia, M. Jalali, M. Mohammadian and A. Momenizadeh 
Tehran, IR 
Objectives: Oxygen is used as an acceptable therapeutic option. One of the 
oxygen-therapy methods is application of humidifier, hut unfortunately 
microbial contamination of these manometen may be leaded to patient’s 
infection. 
Methods: A total of 130 samples of water in humidifiers of three general 
hospitals in Tehran were studied. Incidence of microbial contamination was 
determined and its severity was assessed by colony count. These samples take 
&om internal, ICU and CCU wards. AU samples were inoculated on Brain- 
Heart Infusion agar and colony count were performed. The pure colonies 
were subcultured and isolated strains were determined by microbiological 
methods. 
Results Microbial contamination was 91.7%. Mixed microbial contamina- 
tion was evident in 61.1%. The contamination rate is varied fi-om 63.6 to 
100% in Herent wards. Colony counts were changed in the range of 
100 to More than 1OOOOOcfu/mL. There are more than 1OOOOOcfU/mL 
in 38.2’A samples. Frequently isolated strain were E. coli, Pseudomonac aeru- 
ginosa, Acinetobacter, Staphytococcus sapphy t ims ,  Proteus, Dipthemid and 
Fungi. 
Conclusions: Accordmg to the high incidence of contamination in 
humidifiers, especial attention to infection transmission by these objects is 
necessary. 
jp523 lntegrons as tools for epidemiological studies 
P. Severino and V. M a w e s  
SJo Paulo, BR 
Objectives Integrons, defined as genetic elements involved in the site-spec& 
incorporation and excision of gene cassettes, are widespread among clinical 
isolates. T h  prevalence, coupled with the reported stability of entire 
structures over extended periods of time, brings to mind the potential use 
of integron detection as an epidemiological tool. In order to evaluate this 
contribution, we examined integron content of Gram-negative snains impli- 
cated in three distinct episodes ofsuspected cross-infection among inpatients. 
Methods: Ribotyping of isolates and PCR directed to the conserved regions 
of integrons together with restriction-pattern analysis of amplification pro- 
ducts were the adopted techniques. 
Resub In the fmt episode, ribotyping identified a strain of Acinetoboaer 
sp., isolated several times over a 3-month period, as responsible for an 
outbreak correlated with the use of m e c h c a l  ventilation in the intensive 
care unit. Sixteen patients and 18 isoktes, including controls, were enrolled in 
this study. The second event concerned simultaneous isolations of Pseudo- 
monas amginosa and Serratia marcescens &om 13 patients submitted to 
bronchoscopic procedures. Molecular typing was able to characterize a 
pseudo-outbreak related to the inappropriate disinfection of the equipment. 
In both events, results obtained with integron detection and ribotyping were 
in agreement and correctly identified epidemiologically related strains. In the 
third episode, several isolates of Acinetobarter sp. were collected from distinct 
patients in the Intensive Care Unit over a %month period. The isolates 
belonged to the same genotype, as determined by ribotyping and PFGE. 
However, integron content was mostly distinct, indicating that no cross- 
infection had occurred. 
Conclusion: The present results strongly suggest that integron detection can 
be considered an important tool for molecular epidemiology in hospital 
environments, helping in the quick elucidation of possible cross-infection 
cases, especially in critical wards such as intensive care units. 
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r H ]  Molecular basis of isoniazid resistance in 
Mycobacterfum tuberculosis strains from the St. Petersburg 
area of Russia 
I. Mokrousov, T. Otten, E. Limeschenko, A. Vyazovaya, B. Visbnevsky 
and 0. Narvskaya 
St. Petenbug, RUS 
Objective: To study the prevalence of isoniazid (INH) resistance associated 
mutation katG AGC(Ser)315 -+ ACC(Thr) in Mycobactm'um tuberculosic clin- 
ical isolates h m  unrelated patients in St. Petersburg area of Russia in 1998- 
2001. 
Methods: Susceptibility testing and katC315 PCR-RFLP assay to detect 
phenotypically and genotypically INH resistance; IS6110-RFLP and spoli- 
gotyping to assess genetic relatedness of the strains. 
Results: We revealed 95.2% prevalence of katG315ACC allele among 174 
INH-resistant isolates. This mutation was not found among 39 INH-suscep- 
tible cases. The Beijing genotype was identified in 63% of INH-resistant 
strains. The katG 315AGC -t ACC shift was more prevalent among the 
Beijing f d y  strains versus strains of other genotypes: 100% versus 84.5% for 
new cases, 98% versus 86% for all cases. 
Conclusions: High prevalence of this katC325 mutation makes it useful 
genetical marker for detection of INH resistant tuberculosis (TB) in St. 
Petersburg area of Russia. Current TB epidemic in this region is due to the 
clonal dissemination of the MDR strains of the Beijing family. The ongoing 
transmission of these strains is likely to be the driving force of such a high 
prevalence of h s  mutation in katG3 15. 
Characterization of rp06 mutations by line probe 
assay and DNA sequencing in rifampin-resistant clinical 
Mycobacterium tuberculosis isolates from Kuwait and Dubai 
S. Ahmad, E. Mokaddas and E. Fares 
Safar, K W ;  Dubai, AE 
Objectives: To identie mutations in rifampin-resistance-determining region 
(RRDR) of the rpoB gene in rifampin-resistant clinical isolates of Mycobarter- 
ium tuberculosis recovered from tuberculosis (TB) patients in Kuwait and 
Dubai. 
Methods: A line probe assay and direct DNA sequencing of PCR-amplified 
RRDR were used to identlfy mutations in rpoB gene in clinical isolates of 
M. tuberculosis. A total of 29 rifmpin-resistant and 12 rifmpin-susceptible 
isolates were analyzed, recovered h m  TB patients fiom Kuwait and 
Dubai. The genotyping was performed by double-repetitive-element 
PCR (DRE-PCR) on the isolates which contained the s d a r  kind of 
mutation. 
Results: The line probe assay identified 28 resistant isolates as rifampin- 
resistant with specific detection ofmutation in 22 isolates including one isolate 
that exhibited hetro-resistance containing both the wild-type as well as 
H526D mutation in RRDR while one of the isolate was identified as 
rif'impin-susceptible. All the susceptible isolates were correctly identified. 
The DNA sequencing confirmed these results and led to further identification 
of five other mutations in the RRDR. These analyzes identified eight 
Merent mutations within RRDR with majority (14 of 29 or 48%) carrying 
mutations at codon 526 and one novel mutation (S522W) that has not been 
reported so far. The genotyping performed by DRE-PCR on the isolates 
carrying similar mutations showed that majority of these isolates exhibited 
variable DNA banding patterns. 
Conclusions: The concordance of the line probe assay and DNA sequencing 
with phenotypic drug susceptibility testing was 96.5% (28 of29). Mutations at 
codon 526 were most prevalent (14 of 29 or 48%), the highest reported so far. 
One new allele (S522W) of the rpoB gene was idenhfied. The majority of 
isolates carrying similar mutations were genotypically Merent as they 
exhibited variable DNA banding patterns in DFW-PCR. 
Acknowledgements: Supported by Kuwait University Research Adminis- 
tration grant MDI 301. 
lp5261 Clinical and experimental reduction of 
mycobacteria resistance to TB drugs 
I. Belyanin and E. Shmelev 
Moscow, RUS 
Objectives: To study possibilities to reduce resistance of mycobacteria to TB 
drugs. We treated a clinical strain resistant to streptomycin (S), rifampicin (R), 
isoniazid (H) and kanamycin (K) with dissolved ozone (PO3) (0.5-4.0pg/ 
mL) during 1 h and inoculated it onto solid media containing fierent 
concentrations of TB drugs. After 3weeks. we treated mycobacteria 
with PO3 again; the cycle was repeated three times. After each treatment 
with PO3 mycobacteria resistance to H was reduced and after the third 
treatment susceptibility to H was completely restored. Resistance to R was 
also reduced after each treatment, however, it remained high (640 p g / d  R). 
After the second treatment resistance to S was reduced, however, it was 
restored after the thud treatment. Resistance was reduced due to eliminated 
hydrophobic properties of the external membrane and activation of intra- 
cellular catalase peroxidase complex. A total of 68 mice were infected with 
mycobacteria resistant to S, H, R, K and divided into five groups: 1 and 2- 
controls; group +treated with H; group +treated with H and PO3 (0.5- 
4.0 pg/mL); group 5-treated with POJ. The first mouse died in the fourth 
month of infection. Inoculation of the mycobacteria collected in the lungs 
of the mice treated with PO3 resulted in growth of mycobacteria, susceptible 
to H. A total of 36 out of 56 sputum-positive patients with pulmonary 
TB, resistant to S, H, R, K received treatment with TB drugs plus intravenous 
injections of 400 mL PO3 (0.5-4.0 pg/mL) every 5-7 days, 12-55 infusions. 
Within 4months susceptibility to H and/or R was restored in 59.5% 
cases. By the fourth month susceptibility to H, R, K was restored in 
47.2% cases. Out of 20 controls, resistance to one drug was reduced in 
15% cases. Sputum conversion occurred in 76.7% cases, treated with H and/ 
or R plus PO3. 
I P528 1 Molecular mechanisms of isoniazid and rifampin 
resistance in Myco&acterium tuberculosis from Barcelona 
M. E. VerdG, F. March, P Cortk, E Alcaide, M. Espasa, J. Gonzilez, 
J. Lonca, J. M. Manternla, M. SaIvadi, and l? Coll 
Barcelona, L'Hospitalet de Uobregat, Badalona, E 
Objectives: To establish the presence and frequency of molecular mechanism 
for Mycobactetium tuberculosis resistance to isoniazid (INH) and rifampin (RIF) 
in the urban area of Barcelona. 
Methods: A sample of 53 INH-resistant strains of M .  tubemlosir from 
Barcelona, 17 ofwhich were also resistant to RIF, was analyzed by polymerase 
chain reaction (PCR) and direct sequencing analysis of the entire katG 
gene, inhA regulatory region, oxyR-ahpC intergenic region and rpoB 
core region. Each of these strains displayed a unique RFLP-IS6110 RFLP 
pattern. 
Results Of 53 INH-resistant strains, 29 (55%) had hatC alterations consisting 
ofsmall deletions (3-14 nucleotids) (n = 3) or nucleotid substitutions (n = 26) 
resulting in either aminmid replacement or stop mutation. All strains but two 
had a single alteration. Although the nucleotid substitutions were detected all 
along the gene (codons 94, 172,189,204,234,315,463,560,592,678 and 
728), the most common deduced alteration was a Ser-to-Thr (Arg) or (Am) at 
postion 315 (n = 17). Seventeen (32%) ofthose 53 INH-resistant strains had a 
C to T (n = 14), T to C (n =2) or G to T (n = 1) substitutions flanking the 5' 
side of the presumed ribosome binding site, located in the region upstream of 
the inhA locus. In the intergenic region q R - a h p C ,  eight (15%) of those 53 
INH-resistant strains had simple nucleotide substitutions (positions -6, -12, 
-37, -39) or insertions (one or two nucleotids, positions -38/-39 and 
-45/-46).Mutationsinthecore regionofrpoBgeneweredetectedforalll7 
RIF-resistant strains but one. Six Merent rpoB mutations were identified at 
codons 441,451,456. The most common nucleotide variation was a Ser-to- 
Leu at position 456 (n = 7). 
Conclusions: The fin- that 64% of INH-resistant isolates have sequence 
alterations in either codon 315 of katG or ink4 upstream region and that 94% 
RIF-resistant isolates have mutations in the core region of rpoB indicates the 
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need to develop assays to screen for the emergence of INH and RIF resistance 
in our area. Thus, diagnostic PCR-based methods using three target 
sequences spanning codon 315 of katG, upstream region of inhA and core 
region of rpoB would facilitate the rapid adjustment of treatment regimens in 
our area, in time to reduce the chance of developing further drug resistance 
and of transmitting resistant strains. 
)p5291 The relationship between the isoniazid-resistant 
molecular mechanisms with minimum inhibitory 
concentration and the catalase activity in Mycobacterium 
tuberculosis 
J. Lonca, J. -M. Manterola, E Alcaide, M. Espasa, J. G o d e z ,  E. VerdG 
and I? Coll 
Badalona, L’Hospitalet de Llobregat, Barcelona, E 
Objectives: To study in the strains resistant to isoniazid the relationship 
between the minimum inhibitory concentrations (MIC), the catalase and 
peroxidase activity and the molecular m e c h s m s  of resistance. 
Methods: Fifty-three isoniazid-resistant strains of Mycobaderium tuberculosis 
were studied in the area ofBarcelona. All ofthem were resistant to 0.1 pg/mL 
of isoniazid by radiometric system. The isoniazid MICs were obtained in the 
Mddlebrook 7H10 medium. The catalase and peroxidase activities were 
determined with the Bogen reactive. The mutations were determined by 
PCR and were sequenced with ABI Prism (A.B.) Each of these strains 
displayed a dilferent RFLP-IS6110 pattern. 
Results: MICs of isoniazid were lower or equal than 2 pg/mL in 33 strains 
(62%), between 4 and 16 p g / d  in 17 (32%) and upper or equal than 32 pg/ 
mL in three (6%). MICs of the 17 strains with mutation in the regulatory 
region of inhA ranged between 0.25 and 2 pg/mL, 71% of them having an 
MIC between 0.25 and 0.5 pg/mL. The MIC of the strains with mutation at 
codon 315 ofgene katGwas between 4 and 16 pg/mL. In nine ofthe 30 (30%) 
strains with MIC lower than 2 pg/mL and one of the three strains with MIC 
upper than 16 pg/mL no mutations were found. The three strains with MIC 
upper than 16 pg/mL lacked catalase and peroxidase activity. The presence of 
catalase activity was detected in 71% ofthe strains with mutation at codon 315 
of katG but, however, the peroxidase at 1 h was negative in the 65% of these 
strains. Ninety percent ofthe strains with MIC lower than 2 pg/mL conserved 
the catalase and peroxidase activities. 
Conclusions: The strains with MIC upper than 16 pg/mL lacked catalase and 
peroxidase activities. The strains with mutation at codon 315 of gen katG had 
a high level of resistance but the majority conserved the catalase. All the strains 
with MIC between 4 and 16 pg/mL had a mutation at the 315 codon of katG. 
The strains with mutations in the regulatory region of inhA had a low level of 
resistance and the majority conserved the catalase activity. The absence of 
catalase activity or the presence of a mutation at codon 315 of gene katG 
permits the rapid detection of the 96% of the M. tuberculosis strains with high 
level resistance. 
Acknowledgements: This study was supported by the Grant 99/0049-01 
from the FIS, Ministerio de Sanidad y Consumo, Madnd, Spain. 
vl Detection of mutations linked to rifampin- and 
isoniazid-resistance in Mycobacterium tubercdosis strains 
by molecular assays 
A. Piana, M. Or&, I. Maida, G. Sotgiu, N. Castigha and G. Cherchi 
Sassari, I 
Objectives: Anti-Mycobacterium tuberculosis drug-resistance, mainly multidrug 
resistance (MDR-TB), represents an important public health problem in 
several countries. Recently, the World Health Organization and Center for 
Diseases Control and Prevention have elaborated anti-TB treatment guide- 
lines: suggested regimens include primary (isoniazid, ethambutol, rifampin, 
streptomycin-capreomycin) and alternative drugs (cycloserine-terizidone, 
WI;lzinamide-morfazinamide, kanamycin, pamino salicylic acid). Rifampin 
and isoniazid resistance is related to mutations of tpoB and kutG genes, 
respectively. Aim of our study is to identltjr the presence of these mutations 
in M. tubenulosic isoniazid- and rifampin-resistant strains, isolated in our 
Institute; to evaluate linkage between type of mutation and level of resistance; 
usefulness of easy molecular techques for rapid detection of such mutations 
on body specimens. 
Methods: Isoniazid- and rifampin-resistance was tested on 50 M .  fuberculosis 
strains by single-strand conformation polymorphism (SSCP) and polymerase 
chain reaction-restriction fragment length polymorphism (PCR-RFLP) 
assays, using HaeIII, PstuI, BsteII, BstuI enzymes. Drug-resistance of control 
strains was determined by cdtural techniques (fluorimetry-BACTEC 9120). 
Results: Cultural assay showed isoniazid- and rifampin-resistance in 6.12 and 
2%, respectively (data confirmed by SSCP assay). Mutation of katG, linked to 
isonkid resistance, was detected using BstuI enzyme, and mutation of rpoB, 
expression ofreduced sensitivity to rifampin, using HaeIII. A total of 15 body 
specimens, M. tuberculosis-positive to conventional assays, were tested by SSCP 
techmque. Si& results were found only where the mycobacterial load was 
elevated. 
Conclusions: Epidemiologic reports of numerous case5 of tuberculosis due to 
MLX strains induce to detect quickly both Mycobacteria and drug-resis- 
tance, in order to start rapidly an effective theram. On this basis, molecular 
assays are useful for a rapid therapeutic decision. 
17 Activity of 11 antimicrobial agents against 
multidrug-resistant strains of Myrobaaepum tubeKulosis 
isolated during the 199811999 National Survey in Italy 
L Fattonm, E. Iona, G. B Wghori, €? Vaccarmo, V. Penah, G. Besom, 
E Maghano, A. Cassone and G Orefici 
The SMLRA Study Group (Italian Multlcentre Study on Resislance to 
Antituberculous Dvugs) 
Objectives: Deternunahon of the m vim achvlty to first- and second-ltne 
anhtuberculous agents of mdhdrug-resistant (MDR) strams (resistant to at 
least ~somazid, INH, and nfampicm, RMP) of M htbercuIons (MTB) isolated 
durlng the 1998/1999 Ital~an Survey. 
Methods: A network of 20 laboratories M i g  the WHO/IUATLD quahty 
criteria for deterrmmg the suscephinhty to anhtuberculous agents isolated 
MTB strams from March 1998 to March 1999 and d e t e m e d  drug 
suscephbhty to fiat-hne agents. The s t r a m  were sent to the Nahonal 
Reference Laboratory of Vdla Marelh, Milan, for re-teshng drug suscept- 
ibhty; MDR strans were then sent to the WHO Supranahond Reference 
Laboratory ofthe Ishtuto Superiore & Sat; ,  Rome, for deterrmnation ofthe 
MICs of INH, Iuw, streptomycm (SM), ethambutol (Em) (fmt-he 
drugs), and ciprofloxacm (CIP), ofloxacln (OFL), spdaxacm (SPA), mom- 
floxacm (MOX), rlfabutln (RFE), rlfapenhne (RFP), armkacm (AK) (second- 
hne drugs), in Mddlebrook 7Hll  agar. MIC was defined as the lowest drug 
concentration &biting >99% of the moculum. Recommended cnhcal 
concentrahons (pg/mL) for separahng suscepable fbm resstant stcuns were: 
INH, 0.2; RMP, 1; EMB, 8, SM, 2, tentahve cnhcd concentrahons were 
CP, OFL, 2; SPA, MOX, RFB, RFP, 0.5; AK, 8 
Results: Out of810 isolates, 649 were fully suscepable and 161 were resistance 
to at least one drug. Out of a total of51 h4DR strum, 18 s t r m  were testedfor 
MICs All strans were resstant to INH (MIC range 1 to >64pg/d) and 
RMP (MIC range 2 to 264 pg/mL). Sxteen stram (89%) were rwstmt to 
SM (MIC range 4 to 264 pg/mL) and four (22%) to EMB (MIC 16 vg/mL). 
Three strams (17%) were resistant to CIP (MIC range 4 to >16pg/mL) 
and SPA (1-4pg/mL) and two (11%) to OFL (MIC range &16pg/mL) 
and MOX (2-4pg/mL). All stnuns were resistant to RFB (MIC range 
2-32 pg/mL) and 17 (94%) to RFP (MIC range 2 to 20.64 pg/mL). Only 
one stratn was resistant to AK (MIC 2 64 pg/mL). Although all drugs 
&splayed a rather conhnuous MIC dmribuhon, more than 50% of the s w n s  
remtant to W, RFP and AK showed MICs of 264 pg/mL. 
Conclusions: These data showed that, among ht-lme drugs, EMB is actlve 
agamt most MDR s ~ n s  tested. Among second-he drugs, all fluoroqui- 
nolones, but not rfamycins, were shIl achve agamt most of these strams wth 
none or low resstance levels. These observahons can be of mportance for 
treatment of MDR tuberculosis ln Italy 
(p5321 In vitro resistance of Mycobacterium tuberculosis 
drugs in Bilbao. Spain 
C. Aspichueta, M. J. Unzaga, F? Velasco, B. Amezua, M. P. Barrio, 
A. Martinez, C. Ezpeleta and R. Cisterna 
Bilbao, E 
Objectives: The aim of this study w a s  to evaluate the current stahts of 
resistance of Mycobacterium tubtmlosis to antituberculous drug in OUT hospital. 
Methods: The in vitro sensitivity of 224 strains of M. tubemlosic isolated from 
1977 to 2001 in 37 (16.5%) HIV (+) patients and 187 (83.5%) patients of 
general population against isoniazid (0.2 mg/L), streptomycin (6mg/L), 
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ethambutol (7.5 mg/L) rifampicin (2 mg/L) and PAS (0.5 mg/L) w a s  studied 
by the Canetti's proportions method. 
Rwuk. A total of 78 (35%) out of the 224 strains studied were resistant to at 
least one of the drugs tested. Among them, 74 (33%) showed resistance to 
streptomycin, 15 (6.7%) isoniazid, two (0.9%) PAS, 0 ethambutol(7.5 mg/L) 
and 0 rifampicin. Smgle drug resistance was observedin 66 (29.5%) strain with 
the following distribution: 62 (27.7%) to streptomycin, three (1.3%) to 
isoniazid and one (0.5%) to PAS. Resistance to two or three drugs was found 
in 12 (5.4%) strains with the following distribution: 11 (4.9%) were resistant to 
streptomycin + isoniazid, and one strain to streptomycin + isoniazid + PAS. 
Conclusions: (1) The rate ofresistance to INH was higher than 4%. (2) There 
was not multirresistance to the INH + RIF so combined therapy is useful. (3) 
There were no Werences between both seropositives and seronegatives 
patients. 
(p5331 Molecular epidemiology study of isoniazid- 
resistant tuberculosis in Barcelona, Spain 
M. E. VerdG, F. March, F. Alcaide, M. Espasa, J. Gonzilez, J. Lonca, 
J. M. Manterola, M. Salvad6 and P. Coll 
Barcelona, L'Hospitalet de Llobregat, Badalona, E 
Objective: To determine the diversity of DNA fingerprint patterns of 
isoniazid (1NH)-resistant Mycobarterium tuberculosis strains from Barcelona 
and to evaluate their community transmission. 
Methods: Between October 1995 and September 1997, a survey of drug- 
resistant tuberculosis in Barcelona area found a rate of 5.7% primary and 
20.5% acquired drug resistance, 3.8 and 17.3% of which was to I N H .  One 
M. tuberculosis isolate was available for RFLP-IS6110 analysis fiom 61 (64%) 
1NH-resistant strains. A 'cluster' is defined as two or more M .  tuberculosis 
isolates with completely identical RFLP patterns when six or more bands are 
present. 
Resultr: Of the 61 INH-resistant strains, 46 (75%) had a unique IS61 10 RFLP 
pattern and 15 (25%) matched at least one other isolate, forming seven 
clusters. All clusters contained RFLP patterns with six bands or more. Twelve 
of fifteen clustered patients were in small clusters of two and the rest were in a 
cluster of three. Epidemiological relatedness was demonstrated in only two 
patients paired by RFLP. 
Conclusion: RFLP analysis indicated that transmission ofINH-resistant strains 
contributes substantially to the emergence of INH-resistant tuberculosis in 
Barcelona through short transmission chains. Therefore, in addition to the 
effective control tuberculosis programs adopted in our area, further improve- 
ment in early identification and treatment might prevent the development and 
transmission of INH resistance. 
FI Molecular fingerprinting of isoniazid-resistant 
clinical Mycobacterium tuberculosis isolates from Kuwait 
S. Ahamd, E. Mokaddas and A. Abal 
Safat, KWT 
Objectives: To determine genotypic relatedness among isoniazid-resistant 
clinical isolates of Mycobarterium tuberculosis recovered from tuberculosis (TB) 
patients in Kuwait during a 3-year period (1998-2000). 
Methods: Touchdown double-repetitive-element PCR @RE-PCR), a rapid 
typing method based on specific amplification of segments of DNA located 
between two repetitive elements (insertion sequence, IS6110 and poly GC- 
rich sequences, PGRS) on the M .  tuberculosis genome, was carried out for 
molecular fingerprinting of 53 isoniazid-resistant clinical isolates. The po€y- 
morphisni at codon 463 in the ka tC  gene was also determined and correlated 
with genotypic relationships among the isolates. 
Results The DRE-PCR classified 53 isoniazid-resistant M .  tuberculosis isolates 
as having 28 distinct patterns with 24 being unique patterns. Majority of 
isolates (17 of 25) yielding a single DNA fhgment in DRl-PCR were 
recovered from patients of South Asian origin. Two isolates recovered from 
some of the patients within a span of 2months yielded the same typing 
pattern. Most ofthe isolates (7&90%) from South Asian and South-east Asian 
patients contained L463 in the ka tC  gene. Nearly 85% of the isolates 
recovered from patients of Middle Eastern origin also contained L463 instead 
of R463 in the kutC gene. 
Conclusions: Nearly half of the isoniazid-resistant M .  tuberculosis isolates 
recovered h m  TB patients in Kuwait yielded unique DNA bandingpatterns. 
The presence of a single DNA Gagment of the same size in DRE-PCR from 
majority of isolates recovered from South Asian patients, known to carry <2 
copies oflS6110 element, was most likely due to low copy number of IS6110 
rather than any specific relationship among these isolates. The prevalence of 
L463 in the katG gene was higher than expected in isolates from Middle 
Eastern (mostly Kuwaiti) patients. The genotypic relatedness of two isolates, 
recovered from a Kuwaiti patient and a Filipino patient, was strongly 
indicated. 
Acknowledgement: Supported by Kuwait University Research Administra- 
tion Grant MI 116. 
(p5351 Comparative evaluation of different molecular 
typing methods for multidrug-resistant Mycobacterium 
tubemdosis isolated in Italy 
E Pittaluga, A. Cassone, D. M .  Ciriio, A. degh Esposti, L. Fattorini, 
L. Gazzola, E Mandler, G. B. Mighori, C. Piersimoni, C. Scarparo 
and A. Gori 
Tctrin, Rome, Milan, Tradute, Anmna, Vicenza, I 
The resurgence of tuberculosis and the emergence of mdtidrug-resistant 
(MDR) strains of Mycobadmiurn tuberculosis has stimulated the development of 
improved molecular typing methods, valuable instruments for tuberculosis 
surveillance, control and prevention. The insertion sequence (IS) IS6110 is 
the strain-specific marker of choice for the epidemiological typing of 
M .  tuberculosis isolates, and the IS61 10 restriction fragment length polymorph- 
ism (RFLP) analysis is the "gold standard" for M. tuberculosis fingerprinting. 
For strains with few insertional sequences pulse field gel electrophoresis is the 
technique ofchoice. Both techniques are labor-intensive and time consuming 
and require large amount of high molecular weight chromosomal DNA. The 
aim of this study is to compare a rapid and easy to perform PCR-based typing 
strategy (Heminested Inverse PCR) to conventional methods for molecular 
characterization of MDR M. tuberculosis strains. We typed 61 strains (53 
patients) isolated in Italy in a 2 years time frame (1998-2000 SMIRA Project) 
by Heminested Inverse PCR (HIP) of IS6110, IS6110 R E P  analysis and 
Pulsed Field Gel Electrophoresis (PFGE). HIP typing was 100% reproducible, 
showing identical patterns h m  the same isolate in Merent experiments. A 
total of 40 easily distinguishable fingerprints consisting in 2-10 fkagrnents 
were identified by HIP. One strain gave only one fragment and was considered 
not typeable by this method. Among the 61 strains examined, only three s m a l l  
clusters of two, two and three patients were recognized. Multiple strains Gom 
the same patient gave identical pattern indicaring short-term treatment failure. 
These results were confirmed by PFGE and IS6110 RFLP showing that 
sensitivity between the three methods was comparable. The strain not type- 
able by HIP was well characterized by the other two techniques. No evidence 
of predominant MDR strain circulating in Italy was found by any of the three 
typing methods. In conclusion, Heminested Inverse PCR is a reproducible, 
easy to perform method for molecular typing of MDR M .  tuberculosis strains 
with high potential for rapid identification and monitoring of outbreaks. 
/p5361 Drug resistance in Mycobacterium tuberculosis in 
Turkey: a retrospective study by BACTEC TB system 
0. Kisa, A. Albay, M. A. Saracli and L. Doganci 
Ankara, 7l7 
Objectives: With the recent evolution of multidrug-resistant strains of 
Mycobarterium tuberculosis, the need for prompt and accurate antimicrobial 
susceptibility testing has become a real necessity. So, we retrospectively 
evaluated the rate of drug susceptibility of M. tuberculosis to four primary 
antituberculosis drugs in Giihane Military Medical Academy between Jan- 
uary 1998 and October 2001. 
Methods: Drug susceptibility tests to isoniazid (INH), streptomycin ( S ) ,  
ethambutol (E), and rifampin (R) were performed by using the radiometric 
BACTEC 460 TB system and the records of the laboratory were evaluated. 
Results: The drug susceptibility tests of 1032 M. tuberculosis complex isolates 
of 454 patients were evaluated. We found that 85.3% of isolates were 
susceptible to all four major drugs, whereas 14.8% were resistant to at least 
one drug. Mono resistance rate was 10.8% and three strains (0.7%) were 
resistant to all four drugs. Multidrug resistance (MDR) was accounted for 
1.6% ofisolates while polyresistance rate other than MDR was observed in 15 
(3.3%) isolates. 
Conclusions: Although our results don't represent the drug resistance ofentire 
country, the present s t u d y  is one of the few retrospective studies about the 
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prevelance of the drug resistance of M .  tuberculosis in Turkey, but gives good 
information about antimycobacterial drug resistance rates in our country. 
Continuous monitoring of drug resistance in M .  ruberrubsis is essential in 
order to support national tuberculosis control programs although our resis- 
tance rates are below the dangerous zone. 
w( Multidrug-resistant tuberculosis in Portugal: 
molecular characterization 
I. Portugal and L. Brum 
Lisbon, P 
Objectives: An alarming increase in multidrug-resistant tuberculosis (MDR- 
TB) has been reported in several countries including Portugal, particularly 
among patients infected with human immunodeficiency virus (HIV). In 
Portugal, nosocomial outbreaks ofMDR-TB related to HIV-infected patients 
have been described. A particular MDR-TB cluster (cluster A) including 76% 
of the analyzed strains was identified in 1998. These isolates had been 
collected in several hospital units all over the country. Although strains 
isolated in hospital and public health laboratories are currently notified to 
Portuguese authorities, the true magnitude of the problem is unknown. Our 
objectives were to evaluate the prevalence and clustering of MDR-TB strains 
isolated in Portuguese laboratories, in particular cluster A, and to set up a 
national database of MDR-TB strains genotypes. 
Methods: MDR-TB strains were collected in several hospital and public 
health laboratories a l l  over the coun&y, in the year 2000. We included all the 
strains (susceptible and resistant strains) from two hospital units in Lisbon. We 
performed Restriction Fragment Length Polymorphism analysis using IS61 10 
as a probe (REP-IS6110) to all the isolated strains. 
Results: RFLP-IS6110 analysis revealed that cluster A strains are s t i l l  respon- 
sible for 49% ofall the multidrug resistance tuberculosis analyzed in this study. 
We have also found 12 new RFLP patterns corresponding to 12 never 
detected strains. We also found for the first time the existence of cluster A 
patterns in susceptible strains (19% of cluster A strains). 
Conclusion: In view of the above findings, we can conclude that cluster A 
strains are still spread all over the country and continues to be responsible for 
the main resistant tuberculosis. FWLP-IS6110 analysis is not sufficient to 
Candida 
molecularly define MDR-TB strains in Portugal, as we have found Identical 
patterns in susceptible and resistant strains. The new detected patterns may 
correspond to new cases of MDR-TB and epidemiological investigation must 
be conducted in order to evaluate this situation. 
lp5381 Genotypic and phenotypic characterization of 
rifampin-resistant Mycobacterium tubefruknis strains 
M. S. Diaz, D. Garcia De Viedma, M. Marin. L. Mc&, M. J. Ruiz 
and E. Bouza 
Madrid, E 
Objectives: The characterization of Mycobartenurn tuberculosis strains resistant 
to antituberculous drugs k a relevant issue. Detection of resistance to rifampin 
(RMP) is of particular importance, as it is a marker for multidrug-resistant 
MTB strains. 
Methods: A total of 11 RMP-resistant and I1 FUW-susceptible strains (as 
determined by the agar proportion method) were selected for analysis. The 
genotypic characterization of the rpobeta core region was performed by DNA 
sequencing and single-stranded codormation polymorphism (SSCP). For the 
phenotypic characterization, the RMP minimal inhibitory concentrations 
(MICs) were obtained by E-test. 
Results All resistant strains showed a single mutation and all susceptible 
control strains showed no mutation in the rpobeta core region. A high 
mutation variability was detected, seven different mutations recorded among 
the 11 resistant strains. The mutations were located at the three codons more 
frequently associated with rifampin resistance: 516 (two strains), 526 (four 
strains), 531 (five strains). The sensitivity and specificity of genotypic screen- 
ing by SSCP was 54 and 100%. SSCP allowed mutations to be detected at 
codon 526 but not all at 531 or 516. The phenotypic characterization 
indicated a great difference in rifampin MICs for resistant (12 to 
>256 pg/mL.) and susceptible (<0.05 pg/mL) strains.  The highest MIC 
values were not linked to mutations in any specific codon. 
Conclusions: (1) All RMP-resistant MTB strains showed single mutations in 
the rpobeta core region. (2) A high variability of mutations was recorded. (3) 
SSCP has a high specificity but lacks sensitivity, requiring additional DNA 
sequencing. (4) E-test showed a good correlation with DNA sequencing. 
ml Enzymatic properties of Candida spp. strains 
isolated from various clinical specimens 
E. Krzemikka-Jacekowiak and Z. Cybulski 
Poznan, PL 
Objectives: The aim of this study was to examine enzymatic properties of 
Candida spp. strains which were isolated from various clinical specimens. 
Methods: A total of 420 yeast strains belonging to Cundida spp. were 
examined. These strains were isolated from the following clinical specimens: 
vaginal swabs, oral and throat swabs, urine samples, tissue samples 
from patients after surgery for larynx carcinoma, from peritoneal fluids, 
from large intestine samples, from nail samples, from sputum, bile, sperm 
and pus samples, and from groin swabs. The yeasts were identified on the 
basis of their morphological characteristics and according to their 
biochemical properties examined by means of API 20C AUX kits (bioM6r- 
ieux). The abhty to release lipases and proteases was examined as well. The 
release of lipases was examined after incubation of 30 and 37°C. The 
proteases release was examined using media with human albumin and bovine 
caseine. 
Results: Among the 420 Candida spp. strains examined, the foUowing were 
most commonly observed C.albicans, 317 strains (75.5%) and the next: 
C. krusei, 52 strains (12.4%), and C. tfipicafis, 33 strains (7.8%). However, 
the species: C .  parapsihis, C. pseudotropicalis. C .  stelfaloidea, C. pelficulosa, 
C.gulliermondii, C .  h u m i d  were less frequently observed. All strains of 
Candida spp. were divided into 13 biotypes according to their lipolytic 
and proteolytic activity. The s t r a i n s  of C. albicans were divided in eight 
different biotypes. Biotype I was dominant among C. albicans and it included 
150 suains examined. Ths biotypewas characterized by lipolytic activity both 
in 30 and 37 "C and proteolytic in the presence of albumin and caseine. Other 
strains were assigned to e e r e n t  biotypes. 
Conclusions: The enzymatic examination of yeasts may be helpful in diag- 
nosing C. albicans and in epidemiological characterization of candidosis. 
Mechanisms of antifungal activity of vaginal 
diamines on Candida species 
A. Gonplaves Rodtigues, C. Pina-Vaz, S. Costa-de-Oliveira, C. Tames, 
J. Martinez-de-Oliveira and I?-A. Mardh 
Porto, P; Lund, S 
Putrescine and cadaverine are bacterial diamines that are produced in sig- 
nificant amounts by the overgrowing bacterial population found in the vaginal 
fluid of women with BV [l]. Both W e s  showed a dosedependent 
lnhibition of germ tube formation by C.afbicans as well on budding of 
non-albicans strains [2]. 
Objectives: To evaluate the mechanisms of antifungal activity of putrescine 
and cadaverine, estimated as the minimal inhibitory concentration (MIC) and 
minimal lethal concentration (MLC) on the most commonly pathogenic 
Cundida species. 
Methods: Seven clinical vaginal isolates of Candida were tested at serial 
concentrations of putrescine and cadaverine (Sigma-AIdrich), in RPMI- 
1640 medmm (Sigma). The fhgistatie activity was studied with the fluor- 
escent probe FUN-1 and observation under epifluorescence microscopy and 
flow cytometry; MIC was also determined according the NCCLS protocol M 
27-A. The fungicidal activity was assayed by h4LC and viability counts (cfu). 
Membrane alterations induced in the yeast cells were evaluated by staining 
with propidium iodide (PI) followed by flow cytometry. 
Results: MIC ranged from 15.6 to 62.5 pg/mL and h4LC was 14-fold higher 
the corresponding MIC for cadaverine; MIC ranged fiom 62.5 to 250 pg/nL 
and MLC was &%fold higher the MIC for putrescine. No correlation was 
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found between MIC and MLC to amines and the susceptibility pattern to 
antifungals. The concentrations associated to an extensive rate of killing 
induced an extensive permeation to PI, related to a direct damage of the 
cytoplasmic membrane. Lower concentrations induced a marked metabolic 
impairment. 
Conclusions: Both putrescine and cadaverine, at concentrations commonly 
found in the vaginal fluid of women with BV, showed a marked antifungal 
effect, pamcularly fungistatic, on vaginal isolates of Candida. Our results 
fmdy support the hypothesis that the presence of these and possibly other 
bacterial amines produced by anaerobes in the vaginal flora seen in BV may 
explain why candidosis is rarely seen in such instances. 
References 
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(p5411 Candida spp. and Aspetgillus spp. emerging cause 
of nosocomial breakthrough fungemia in hospitalized 
patients 
E. Raise, I? Bechi, P. Chmello, E. Narne, V. Mamnes, R .  Sancetta and 
M. Bergamasco 
Venice, I 
Objectives: Invasive Candida spp. and Aspergillw spp. are the emerging causes 
of nosoconlid infections in patients (pts) with cancer, bone marrow transplant 
recipients (BMT) and intensive care unit (ICU). The authors want to 
determine the causes of nosocomial mycosis infections and the efficacy of 
the therapy in patients with haematological disorders and risk device factors. 
Methods: A retrospective study &om 1998 to 2001 for the invasive Candida 
spp. and Aspergillus spp. was evaluated in 26 pts (14 males and 12 females), 
62 f 9 years old; 7 pts had Aspergdlus pneumonia (AP) with LLC, NHD, HD, 
neutrophils <500/cm2 (3 pts), corticosteroids and chemotherapy (4 pts) and 
airborne infection (1 pt). In 19 pts were isolated from blood culture C. albicans 
(13/19 pts), C.sake (1/19), C.glabraia (1/19), C. tropicalis (3/19), C.para- 
psilosis (1/19). Seventeen patients (17/19) were admitted in ICU and they had 
nosocomial disseminated mycosis caused by Candida spp. (12117 C. albicans, 
C.glabrata 1/17, C. tropicalis3/17, C.parapsilosic 1/17); in theurine therewere 
Merent strains of Candida ( C .  albicans 4/17, C. tropicalis 1/17). 
Results: The risk device factors (1 or 2 devices contemporary) were: central 
venous catheters (CVC) in 19 pts, pulmonary arterial catheters (2 pts), 
nutritional parentheral therapy (NPT, 2 pts), PEG (1 pt), urinary tract 
catheters (UTC, 3 pts). The treatment in AP was with amphotericin B 
(AMB, 5/7 pts) and itraconazole (217 pts), the exitus rate was 117 (14%). In 
patients with candidemia, the treatment was with fluconazole (7/17) or 
amphotericinB (8/17) and 2 pts (2/17) died before the therapy. The mortality 
rate for canmdemia was 10/17 (58%) with less mortality in the AMB group. 
Conclusions: Nosoconual infection in ICU and in patients with haemato- 
logical disorders are very frequent, severe with a high mortality rate. High 
dose chemotherapy, BMT and airborne infection are the factors for emerging 
AP; the CVC is the most common risk device factor for disseminated 
Candida spp. in ICU and the treatment with AMl3 had better r d t s  than 
fluconazole. 
v1 Prophylaxis and treatment of Candida infection in 
patients with infected pancreatic necrosis 
G. Farkas, J. Mirton, L. Leindler and E. Nagy 
Sxeged, HUN 
Objectives: The incidence of fungal infection ha5 increased during recent 
decades. The purpose of this review was to determine the incidence of 
Candida infection in cases with infected pancreatic necrosis (TPN), to deter- 
mine the most &equent risk factors, and to assess the best treatment approach 
for dsseminated candidal infection and the role of prophylactic fluconazole 
medication. 
Methods: Between 1986 and 1995, 30 (21%) of the 145 cases of IPN 
idenafied were infected with Candida albicans. Risk factors determined in 
patients with Candida infection included the presence of necrotic tissue, and 
the use of broad-spemum antibiotics, intravascular catheters and parented 
nueition. In the last 5 years prophylactic fluconazole medication was applied 
in all 50 patients with IPN. 
Result A total of 29 of the 30 Candidu-infected cases involved mixed bacterial 
and fungal infections. A total of 16 of the 30 patients displayed fungal 
colonization, while the other 14 patients had disseminated fungal infection. 
There were two deaths in the disseminated group, but no mortality occurred 
in the colonization group. In both fatal cases, flucytosine was applied. When 
fluconozole was used against disseminated fungal infection, no mortality was 
noted. Following prophylactic fluconozole medication, Candida albicans 
colonization appeared in three patients, without any mortality, but one 
patient suffered fluconazole-resistant Candida h s e i  disseminated infection 
with a fatal outcome in spite of amphotericin-B medication. In 46 of the 50 
patients with IPN, there was no evidence of fungal infection postoperatively. 
Conclusion: The combination of adequate surgical treatment with effective 
antibiotics and early antifungal therapy is the ideal management approach for 
IPN with Candidu infection, and fluconazole may be regarded as an efficient 
drug for the prophylaxis of candidiasis. 
Evaluation of Candida ID, a chromogenic medium 
for presumptive identification of Candida species 
C.D. Cirdenes, M.I? Arkvalo, A. Torres-Lana, A. Arias, C. Rodriguez, 
J. Salgado and A. Sierra 
Ln faguna, Sanfa Cmz de Tern@, E 
Objective: Due to the increasing number of human severe mfections caused 
ky Candida ulbicans and other species of this genus, it is now mandatory to 
identify them correctly. Our purpose is to evaluate the ability of a chromo- 
genic medium, Candida ID (bioMkrieux, Spain) to Merentiate Candida 
albicans h m  other species belonging to this genus. 
Methods: We have studied 351 Merent clinical isolated from Hospital 
Universitario de Canarias, a 670-bedded tertiary setting. The samples 
included 113 urines, 52 vaginal swabs, 43 &m blood cultures, 29 &om 
nails, 25 from wounds, 20 catheters, 14 stools and 55 from miscellaneous 
origin. Distribution of the microorganisms were: 150 Candida albicans, 67 
C. tropicalis, 61 C.parupsilosis, 37 C,glubrara, 5 C. h e i  and 31 other species. 
All yeasts were isolated following standard proceedings using Sabouraud as 
primary medium. The isolates were stored in distilled water until the assay was 
performed. Then they were subcultures in blood plate 24h at 35°C and 
subsequently cultured in Candida ID where they were inspected after 24 and 
48 h. Colony color was judged according manufacturer’s instructions. Our 
reference identification method was API ID 32C (bioMiriew, Spain). 
Results: Results are reported after the 48 h inspection. Plates were read by at 
least two of the authors independently Of the 150 C. albicans, 138 showed 
blue colonies (sensitivity was 92%). Nine no-albicans yeasts also appeared 
blue, including three C. tropicalis, two C.glabratn, one C.guilZiemMndii, one 
C. luurentii and the only two Trichosporon cutaneum found in the study 
(specificity was 95.5%). The positive predictive value for presumptive iden- 
tification of C .  albicanswas 93.9% and the negative predictive value was 94.1%. 
A total of 81 pink colonies were observed, mainly for C .  tropicalis (n = 58), but 
also for other 23, including C.famata (five out ofsix found), C.glabrata (n = 4), 
C. a lb icm (n = 3). We found 123 white colonies: all isolates of C. parapsilosis 
(n =61), 31 out of 37 Cglabrata and 31 &om other species. 
Conclusions: Candida ID is a simple and easy-to-read medium and is able to 
support the growth of all the yeast tested in this assay. We estimate adequate its 
sensitivity and specificity and appears to be as a valuable tool in accelerating the 
discrimination between C. albicans and C. no-albicans species. 
(p5441 Effect of slime production of Candida species on in 
vitro antifungal susceptibility test of fluconazole 
N Cerikcioglu, U Over, T. San, E Sahk and G SOykhr 
htanbul, TR 
We searched for the effect of s h e  produchon on m vltro fluconazole 
suscepabhty of blood isolates of Candrda spp. and if ever, changes in MIC 
and b i o f h  producbon of subsequent subcultures of these smns Addmon- 
ally, we looked for any effect of 8% glucose, whch s suggested to induce 
b i o f h  formahon on suscephbhty test results 
Methods: Each Candida stmn was stumed at three occasions i.e, after 
removal of blood cells, duectly h m  blood culture bottles when Bactec 
9240 system gave growth signal (denoted as “a”) and two subsequent 
subcultures wltb 1 week mtervds (denoted as “b” and “c”) 
(1) Fluconazole MIC determmaoons were performed on ‘a’, ‘b‘, and ‘c’ of 
each strain by macrodunon method usmg RPMI-1640 mehum accordmg 
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to NCCLS M 27-A guidelines and modified form of this guideline by adding 
8% glucose to the medium. 
(2) S h e  production ofeach strain was determined at three occasions (a, b, c) 
by using 8% glucose containing Sabouraud Dextrose Broth. 
(3) Slime layer of each strain (a, b, c) was also investigated by means of 
transmission electron microscopy (TEM). 
Results: Of the seven Candida isolates, two were C. albicans, three C.para- 
psilosis, and two C. pelliculosa. Non-slime producer two strains showed no 
polysaccharide projections on TEM; however, three strains with 2+ and 3+ 
slime production displayed markedly thck polysaccharide layer on TEM 
which showed gradual decline and, even vanished in subcultures. 
Conclusions: Fluconazole MICs were completely similar indicating that 
thickness or presence of s h e  layer had no effect on susceptibility results 
of initial isolates and subcultures. Addition of 8% of glucose also did not cause 
any change in fluconazole MICs of either initial isolates or their subcultures 
with or without slime layer. 
lp545) The genotypic and proteolytic diversity of Candida 
spp. isolates from children with bone marrow 
transplantation and adult patients with haernatological 
malignancies 
U. Nawrot, J. Skala and M. Bartoszewicz-Potyrala 
Wroclaw, PL 
The purpose of this study was to determine the genotypes and proteolytic 
activity of C. albicans strains spread in the haematological units of two distinct 
hospitals ofthe same town. The strains (58 C. albicans isolates &om 35 children 
with bone marrow transplantation and 32 C. albicans and 4 C .  dubliniensis &om 
27 adult patients of haematology unit) were identified by the germ tube test, 
growth on Chromagar-Candida medium and by biochemical test ID-32C 
(bioMirieux, France). Genomic DNA was extracted &om each isolate and 
PCRs were performed using CA-INT-L and CA-INT-R primers that 
detected the presence ofthe transposable intron in the 25s [DNA. Genotypes 
A, B, D resulted in a single PCR product (450,840 and 1080 bp, respectively), 
and genotype C had two (450 and 840 bp). Activity of secretory proteinase 
was determined on the basis of clarification around the yeasts colony on agar 
medium containing 0.2% bovine serum albumin. 
Genotype A was prevalent in chlldren as well as in adult patients, but the 
percentage of genotype A isolates was higher in children (77.6%) than in 
adults (58.3%). Genotype B ranked second in prevalence (12 and 16.7% in 
children and adults, respectively) and genotype C ranked third (10.4 and 
13.9%, respectively). Four strains isolated &om adult patients were classified as 
genotype D identical to that of C. dubliniensis. We did not find sigmficant 
aerences  in the percentage of genotype A, B, C, and D between the isolates 
from respiratory tract (69, 12.7, 14.6, and 3.7%. respectively) and the isolates 
&om digestive tract (64, 16, 12, and 8%), respectively). In the genitourinary 
tract, we found only genotype A (85.7%) and B (14.3%). Multiple isolates 
&om different body sites of the same patients revealed that most patients (16) 
were colonized by strains ofthe same genotype (A, C or D), and some patients 
(6) by two genotypes. 
Examinations of the proteolytic activity of C. albicans and C. dubliniensis 
revealed no difference in the proteolytic activity ofgenotypes A, B and C, but 
C. dubliniensis showed a lower activity than C. albicans. 
jP5461 The influence of antiretroviral therapy on oral 
rnucosa candidiasis in HIV patients 
A.B. Macura, A. Bort and B. Postawa-Klosinska 
Cracow, PL 
Objective: Oral mucosa candidasis is the most common one among the 
numerous HIV infection manifestations. It may be the earliest sign of the 
disease. Long lasting observations give evidence that antiretroviral therapy is 
beneficial also in the cases of this opportunistic infection because it reduces 
both the number and severity of relapses, however, the prolongation of the 
patients’survival time creates the need of antifungal therapy prolongation, and 
thorough observation ofits effectiveness and methods. We decided to analyze 
the efficacy of antifungal therapy on the development of oral mucosa 
candimasis in the inpatients of the Jagiellonian University Medical College 
Hospital in Cracow. 
Methods: The drug susceptibility was tested with nine antifungds. The 
susceptibility to 5-fluorocytosine, amphotericin B, nystatin. Miconazole and 
ketoconazole was tested by using ATB Fungus dilution test (bioM6rieux) 
accordmg to the procedures worked out by the manufacturer. The suscept- 
ibility to fluconazole, itraconazole, clotrimazole and tioconazole was eval- 
uated by the disk-diffusion method (DHN Ltd., Poland). The study was 
carried out in 75 patients with confirmed HIV infection. The antiretroviral 
therapy was administered 34 patients (group I) and was not in 41 patients 
(group 11). The set of antiretroviral drugs consisted of two inverse transcriptase 
inhibitors and one HIV protease inhibitor. 
Results: Fungi were isolated &om 69 out of 75 HIV patients. However, the 
s i p  of oral mycosis were found only in 50 patients, most often the 
pseudomembranaceous (21 patients) and atrophc (20 patients) types. The 
least common were the hypertrophic (seven patients) and angular (two 
patients) types. The signs of candidiasis were found in 23 out of 34 patients 
(67.3%) in the group treated with antiretroviral agents. In the untreated group, 
the signs were found in 27 persons (65.9??). We have shown a decrease in the 
number of fungi present in the oral cavity in patients under antiretroviral 
treatment as well as higher susceptibility to fluconazole. 
Conclusions: 
1 The susceptibihty of fungal s t r a i n s  isolated &om patients under antiretro- 
viral therapy to fluconazole was hgher than that of the straim from untreated 
patients. 
2 The antiretroviral therapy of HIV patients did not influence the prevalence 
of oral mucosa mycosis manifestations, however, sigruficantly reduced the 
number of fungi present in the oral cavity. 
ml Oral amphotericin B prophylaxis against 
candidemia in very low birth weight infants 
A. Mayan, S. Ashkenazi, I .  Shalit, N. Linder and L. Sirota 
Petah Tiqwa, IL 
Objective: To evaluate the efficacy of oral amphotericin B solution for the 
prevention of CBSI in high-risk K B W  infants. 
Methods: A prospective study with historic control comparing oral ampho- 
tericin B solution ( O M )  vs. no prophylaxis for the highest risk neonates in 
the neonatal intensive care unit (NICU) of a major children medical center in 
Israel. All VLBW infants who were born between Jan- and December 
2000 and had one of the following inclusion criteria: required mechanical 
ventilation, had central venous catheters (CVC), received total parenteral 
nutrition (TPN), required antibiotic or comcosteroid therapy were included 
in the study group and received OAMB as long as the above parameters 
persisted. The historic control group of patients included all VLBW infants 
who were born between January and December of 1998 and had the same 
inclusion criteria as above. Demographic and clinical data were retrieved f b m  
the patient’s medical records retrospectively and prospectively for the control 
and the study group, respectively. All patients were evaluated for the devel- 
opment of CBSI and adverse side-effect of the treatment. 
Results: Two hundred and seventy-eight patients were included, 151 patients 
in the study group and 127 patients in the control group. There were no 
significant statistical Merences between the two groups regarding age, sex, 
gestational age, birth weight, mechanical ventilation, presence of CVCs, 
antibiotic and com’costeroid therapy, deveIopment of necrotizing enteroco- 
litis (NEC), bronchopulmonary dysplasia (BPD) and breast feeding. In the 
study group, 5 patients (3.3%) developed CBSI compared to 28 (22%) in the 
historic control group ofpatients ( P <  0.001). The crude mortality was 15 and 
18% in the study group and in the control group, respectively. The main 
Candida species were C. ghbrata, C. albicans and C. parapsihis. No serious 
adverse events occurred in the study group. 
Conclusions: Oral amphotericin B solution is safe and may be effective in the 
prevention of CBSI in high-risk VLBW infants. Larger prospective rando- 
mized studies to evaluate the eficacy of OAMB solution on CBSI in VLBW 
are warranted before it can be recommended for routine use in this high-risk 
population. 
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Antifungal drug susceptibility of Candida spp. in a 
neonatal intensive care unit (NICU) 
J. Filioti, E. Pavlidou, E. Farmaki, J. Evdoridou, P. Panagopoulou, 
M. Tsivitanidou, G. Kremenopoulos and E. Rollides 
Thessaloniki, CR 
Objectives: Antifungal drug resistance has been demonstrated as an important 
medical problem among Candida spp. worldwide. C. non-albicuns spp. have 
emerged as frequent causes ofneonatal candidiasis with potential implications 
on antifungal management in the NICU. 
Methods: A total of91 isolates (21 obtained &om blood in 1998-2000 and 70 
obtained fkom mouth or perineum in 1999) were studied. Minimal inhibitory 
(MIC) and fungicidal (MFC) concentrations of amphotericin B (AMB), 
flucytocine (5FC), fluconazole (FLU) and itraconazole (ITRA) were eval- 
uated by NCCLS micromethod. No antifungals are used in the NICU 
prophylactically. Dose-dependent susceptibility (S-DD) was considered as 
16-32 for FLU or 0.254.5mg/L for ITRA. 
Results: MIC and MFC for the most fiequent Candida spp. isolated are 
presented in Table 1 (R: resistant). 
Table 1 
C m d i d a  spp. (8 )  AmB 5FC FLU ITRA 
C. dbiarnr (39) 
MIC 
MFC 
MIC 
MFC 
MIC 
MFC 
MIC 
MFC 
MIC 
MFC 
C. mpirtrlir (22) 
c. kmsd (7) 
C. parapsiloris (7) 
C.gla6ratl (6) 
<O.OHJ.~  <0.25->128 <0.25-4 <0.06<0.25 
0.060.5 (I-R) 0.2+>128 4->m (2 S-DO) 4->32 
n . i zw.5  <o.z5-z 0.25->128 0.06->32 
< n . m . 5  a z s . 4  0.544 < n . o ~ 1 6  
0.25-1 <0.25-16 (4 S-DD, 1 R) 4->128 (6 S-DO, 9 R) 32->32 
0.12Fo.5 0 5-128 (1 S-DO, 1 R) &>I28 (2 R) 0.25->32 
0.064.25 <0.254.5 0.25-2 <O.IMl 
0.1254.25 n z5->128 4-64 (1 S-OD, 1 R) 0.25-32 
o.iz5-0.5 < o . i z ~ o . i 2 5  a.25-8 0.061 
0.12sw1.5 < o . i z w s  i z a > m  (2 >DO, 2 R) 32->32 
Conclusions: NICU isolates of most kequent Candida spp. remain completely 
susceptible to Ax&. C. albicans also remains highly susceptible to azoles. In 
contrast, non-albicans spp. exhibit decreased susceptibility especially to 
ITRA. Only 32% of C. tropicalis, 33% of C.glabrata and 57% of each C. kmsei 
and C. parapsilosis were susceptible to ITRA. The decreased susceptibility of 
certain non-albicans spp. to azoles, particularly ITRA, needs continuous 
monitoring in the NICU and fuaher studies of its causes. 
Acknowledgement Partially supported by PENED’99. 
1 P549 1 Interaction of sertraline with Candida albicanr 
selectively attenuates fungal virulence in vitro 
C. Lass-Florl, M. Ledochowski, M. Dierich, D. Fuchs and R. Wiirzner 
Innsbruck, A 
Objectives: Selective serotonin reuptake inhibitors (SSRIs) are used as firs- 
line therapy for premenstrual syndrome and antidepressants. Recently we 
found, that sertraline (SSRI, Tresleen, Vienna, Austria) has in vim and vitro 
antifungal activity against Candida spp. In t h s  study, we investigated whether 
the interaction between sertraline and Candida ulbicans affects the virulence 
properties of this fungal pathogen in vim. 
Methods: The morphology of C. ulbicuns was investigated by assessing hyphal 
elongation, and the extracellular phospholipase activity was measured by the 
egg yolk agar method. In addition, an assay for Candida secreted aspartyl 
proteinases (Saps) was investigated. The ability of macrophages to inhibit 
germination ofblastoconida treated with and without semaline was examined 
by a microbiological assay. 
Results. Sertraline treatment of C. albicans sigrn6cantly ( P <  0.01) aEected 
hyphal elongation, phospholipase activity, production of secreted proteinases 
and fungal viability. Monocyte derived macrophages (MDMS) treated with 
sertraline reduced irhbition ofgermination ofblastoconidia in comparison to 
MDMs alone. 
Conclusions: Our fin+ suggest that the interaction between sertraline and 
C. albicans diminish the virulence properties of this fungal pathogen. 
vl Susceptibility patterns of clinical isolates of 
Candida krusei isolated from hematological patients 
E. Swoboda-Kopec, M. Wroblewska, E. Stelmach, E. Krawczyk 
and M. Luczak 
Warsaw, PL 
Objectives: Estimation of Gequency of C. kmsei isolation from specimens 
obtained Gom hematological patients and assessment oftheir susceptibility to 
antifungal agents. 
Methods: Specimens sent for culture comprised stool, sputum, blood, urine, 
as well as swabs of the throat, mouth, wound and peritoneum. The isolation 
and identification of cultured fungi was done according to standard myco- 
logical procedures and commercially available tests @ioMirieux, Sanofi 
Diagnostics Pasteur). Patterns of susceptibility to antifungal agents were 
assayed using Fungitest (Sanofi Diagnostics Pasteur). 
Results: In a total of342 specimens, 402 strains ofyeast-like fungi and moulds 
were isolated. The most commonly isolated species were C. albicans, 172 
strains (42.78%), C.glubrafa, 93 strains (23.3%) and C.kmse i ,  34 strains 
(8.45%). Most fungal strains were isolatediiom stools, 235 (58.45%), sputum, 
58 (14.42%) and blood, 24 (5.97%). Among 34 strains of C. krusei, 24 were 
cultured from stools, 3 Gom blood, 4 Gom sputum, 1 fiom urine and 2 from 
throat swabs. All isolates of C.kmsei were resistant to 5-fluorocytosine, 
miconazole, and fluconazole. A total of 33 strains (97.05%) were resistant 
to ketoconazole and 28 strains (82.35%). to itnconazole. All were susceptible 
to amphotericin B. 
Conclusion: 1. C. h e i  comprises 8.45% of all fungal isolates cultured from 
hematological patients. 2. The strains are characterized by resistance to many 
commonly used antihngal agents, while remaining susceptible to amphoter- 
icin B. 3. Emergence of multidrug resistant Cundidn spp. warrants modifica- 
tion of anhfungal therapy and prophylaxis, particularly in hematological 
patients. 
Error associated with the phenotypic identification 
of Candida species 
R. McMullan, J. Xu, C. War, J. Moore, R. McClurg, J. Evans 
and S. Heddenvick 
Beljiit, UK 
Objective: To assess the reliability of phenotypic methods in routine use for 
speciation of Cundida isolates Gom blood. 
Methods: FQ-nine isolates of Candida spp. were obtained kom the blood 
cultures ofinpatients at Belfast City Hospital during 1994-2000. These were 
identified phenotypically at the time of isolation using the bioM6rieux API 
32C (R) scheme. Total gnomic fungal DNAwas extracted and PCR carried 
out initially using the s m a l l  internal transcribed spacer (ITS) region primers, 
ITS3 and ITS4. Sequences obtained were compared with those stored in 
Gedank using BLAST (R) alignment sohare.  When the phenotypic and 
genotypic findings ditrered a further PCR reaction was set up amplifjmg the 
large ITS region (ITS1-5.8s-ITS2) to corroborate the initial molecular 
identification. 
Results: PCR sequence homology >98% was acheved in all cases. Five 
species differed when the genotype was compared to the phenotype of both 
albicam and non-dbicans species; this represents an error rate of 8.5% in 
phenotypic identification. The errors correlated with both false-positive and 
false-negative results in the detection of acid production Gom galactose 
and saccharose in the API scheme. Two of the misidentifications were 
C. dubliniensis; these had both been phenotypically identified as C. albicans 
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and represent the first two reports of bloodstream infection PSI) caused by 
this organism in northern Ireland. Interestingly, both occurred in patients 
with gynaecological malignancy who had none of the typical characteristics 
(HIV-seropositivity, neutropenia, transplantation or advanced liver disease) of 
C. dubliniensis BSI thus far described in the literature. 
Conclusion: Given the importance of correct identification of organisms 
causing BSI for both epidemiological reporting and appropriate patient 
management there is evidence of need to improve current methods of 
candid speciation. Ths  might be achieved either by use of more discrim- 
nating phenotypic testing or by incorporating molecular methods into 
routine practice. 
(p5521 Evaluation of the combined measurement of 
circulating Candida mannan and antimannan antibody levels 
by an enzyme immunoassay (EIA) in patients with proven 
invasive candidiasis 
C. Maes, j. Maertens, E. Van Wijngaerden, C. Verwaest and J. Verhaegen 
huven ,  B 
Objectives: Because of the low sensitivity of cultures and the lack ofspecifkity 
ofclinical symptoms, diagnosis ofsystemic candidiasis remains d8icult. In this 
study, we evaluated two recently developed EIAs for diagnosis of invasive 
candidiasis. 
Methods: During a 10-month period, we prospectively collected 118 serum 
samples from 29 patients with proven candidemia. Patients were hospitalized 
in intensive care (n = 9), surgical (n = 7), haenlatological (n = 5), and other 
units (n = 8). For each patient, serial samples were taken within 3 weeks after 
Candida isolation from blood cultures. Forty-five control sera were included: 
40 fiom 40 healthy blood donors and 5 &om 5 hospitalized patients with 
Candida colonization without evidence of invasive candidiasis. Candida 
mannan and antimannan antibodm were determined in all 163 sera using 
a one-stage sandwich EIA for the detection ofmannan (Platelia@ Candida Ag, 
Sanofi Pasteur), and a two-stage EIA for the detection of antimannan 
antibodies (Platelia@ Candida Ab, Sanofi Pasteur). A mannan threshold 
concentration of 0.5ng/mL was used as the limit for antigenemia; a titer 
of lOAU or more was considered to be a positive result by the antimannan 
antibody test. 
Results: Sixty-six (56%) of the 118 sera had antibody titers that exceeded 
10 AU and 60 (51%) displayed positive antigenemia values. Antigenenlia was 
present in 38% of samples with and in 67% of samples without a positive 
antibody test. Only 25 specimens (21%) had both circulating m ~ a n  and 
significant antimannan antibodies. Positive antibody titers and positive anti- 
genemia values were obtained in 7.5%, respectively, 5% of healthy blood 
donors and in one of five colonized patients. Sensitivity, specificity, and 
positive and negative predictive values, calculated per patient, for the antigen 
and antibody EIA and for the combined use ofboth EIAs are shown in Table 1. 
No difference in results could be demonstrated between C. albicans (n = 18) 
and other Candida species (C.glabrata, n = 7;  C. tropicalis, n = 3; C. parapsilosis, 
n = 1). 
Table 1 Sensitivity, specificity, and predictive values for the detection of antigen and 
anti-mannan antibodies 
StatiStiCS 
Mannanemia Anti-mannan combination 
EIA antibody EL4 of ElAs 
~~ 
Sensitivity (%) 79 59 93 
Specificity (%) 93 91 87 
Positive predictive value (%) 92 87 87 
Negative predictive value (%) 82 69 93 
Conclusions: The combined Use of E M  detectton of mannanemta and 
antmaman annbodies allowed the detection of93% of mycologdly proven 
canddermas mth  a specficity of 87%, irrespective of species type, patlent 
unmune status, and hospital ward. 
)p553/ In vivo efficacy ~f PLD-I~S in mice models of 
systemic Candida infection 
W. Schoenfeld, J. Mittendorf, A. Schmidt, U. Geschke and K. Oreskovic 
Zugreb, HR; Wuppertal, D 
Background PLD-118 is a novel oral antifungal identified at Bayer AG as 
BAY 10-8888 and licensed to PLIVA. In vitro, PLD-118 has activity against 
various Candida species including azole-resistant strains. 
Objective: To assess the in vivo eacacy of PLD-118 in mice with systemic 
dection caused by different Candida species. 
Methods: Clinical isolates of Candida spp. were identified by standard 
methods and evaluated for pathogenicity in mice. Male CFWl mice were 
used in C. albicans studies and DBA mice in experiments with C.glabrata or 
C. krusei. All animals were infected via lateral tail vein. C. albicans strains were 
fluconazole-susceptible (MIC < 4 mg/L, n = 27) or fluconazole-resistant 
(MIC> 64mg/L, n=27). All C.albimns strains caused lethal infection in 
mice. PLD-118 was given orally, twice daily for 4 days, starting 30 min after 
infection. Control groups received vehicle or fiuconazole. Survival uras 
monitored for lodays. None of tested non-albiurns strains caused 
lethal infection in nGve mice, and efficacy was assessed by du counts from 
kidneys. Animals received a single dose ofPLD-118 or vehicle, 30min after 
infection. Kidneys were removed and processed 1, 8, 24 and 48h after 
infection. 
Resufts: PLD-118 was highly effective in mice with lethal systemic C. albicum 
infection. Doses of 5 and 10 mg/kg bid resulted in survival rates of 80 and 
1 OO%, respectively In contrast to fluconazole, PLD-118 was effective in vim 
against fluconazole-resistant C. albicans strains. Animals infected with C. glab- 
rata or C. krusei developed kidney infection that spontaneously cleared within 
following 2days. In both infection models, PLD-118 caused a sigdcant 
reduction of cfu as compared to controls. 
Conclusion: PLD-118 is active in vim against Candida species, including 
fluconazole-resistant and non-albicans strains, and warrants further develop- 
ment as an alternative treatment option for azoles and/or other andfungals for 
systemic use. 
(p554( Trends in antifungal use and susceptibility profile 
of nosocomial Candida spp. in a pediatric hospital, Italy 
G. Manno, M.L. Be&, A. Coppini, M. Cmciani, E. Ugolotti, S. Piana, 
M.L. Fenu and R.  Rossi 
Genoa, Vmona, I 
Objective: Surveillance on antifungal agents use and emergence of nosoco- 
mial resistant Candida (Ca) spp. strains is useful tool to guide local 
antimicmbial therapy. Therefore, we studied annfimgal consumption, Ca 
spp. occDlTence and andfungal susceptibility profile of strains isolated from 
01/01/1995 to 31/12/2000 in a pediatric hospital. 
Methods: We analyzed data of 234 Ca spp.: 182 (77%) albuans and 52 non- 
albicans (including 24 C.glabrata, 16 C.purapsilosis, 4 C. lusitaniae, 4 C. m- 
picalis). Strains were isolated with conventional methods from various speci- 
mens (mucocutaneous 32%, urine 3077, sputum 22%, blood 16%) collected in 
Werent wards (NICU and PICU 23%, surgery 24%. infections disease 23%. 
pulmonology 19% and pediatrics 11%). Species identification was obtained by 
API 20 C Candida (bioM6rieux) system. Antifungal susceptibility to ampho- 
tericin B (AM), flucytosine (SFC), fiuconazole (FZ), itraconazole (IZ). and 
ketoconazole (Rz) was determined with E-test (AB Biodisks) performed 
according to the manufacture, NCCLS proposed breakpoint (h427.A) were 
applied and ATCC C. krusei and C. parapsilosis QC strains were used. The use 
of antifungal agents was calculated ( h m  1996) as defined dally doses/1000 
pts-days (DDDs). 
Results: The rate ofsusceptible strains was: 91% AM, 98% 5FC, 47% FZ, 24% 
IZ and 66% KZ for C. albicans and 65% AM, 88% 5FC, 48% FZ, 27% I 2  and 
90% KZ for Ca non-albicans. Rates of susceptibility to azoles among isolates 
h m  HIV-infected patients were signtficantly lower (FZ 22%, IZ 12%, KZ 
59%). Comparing 1995-2000, we found (i) among C. albicanr an increase 
rateofsusceptiblestrains toFZfkom32%(14/44) to80% (8110) (P=0.0019); 
(ii) an increase rate of Ca non-dlbisanr h m  9.8% (5/51 t o d  strains.) to 67% 
(20/30 strains) (P=0.0018). The most prescribed drugs (DDDs) were AM 
8.2 and FZ 8.1 comparedwith 5FC 1.06 and I2 4.4. The use ofAM, FZ and 
IZ remained constant over the years while the use of 5FC decreased from 0.24 
in 1996 to 0.125 in 2000. 
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Conclusions: 5FC was the most active agent against our series of isolates; FZ 
and IZ resistance in of C. albicans and non-albicans isolates is exceedingly high. 
The increased rate of non-albicans found is worrisome and requires strict 
monitoring and better control of antifungal agents use. New active antifuIlgal 
compound are needed. 
4 Reading ofthe inhibition zone diameter became more cI&cult at 48 h than 
at 24 h. 
Fl The role of 1.25-dihidroxycalciferol on the 
candidacidal of human macrophage 
N. Rintiswati 
Egyakarta, ID 
Objectives: To investigated the candidacidal activation of macrophage 
induced by 1,25-dhidroxycalciferol (calcitriol). 
Methods: Seven days cultures of human macrophages which isolates &om 
tonsil donors of tonsilectomy patients were growth on medium content of 
1,25-dihidmxycalciferol at gradual concentration and medium fiee of 1,25- 
dihidroxycalciferol. All of the culture then induced by Candida albicam. The 
activation of macrophages measured by potency of phagocytosis, content of 
Candida intracell, count of viable Candida culture on Sabouroud agar medium 
and nitric oxid (NO) secretion. 
Results: The results showed that the hghest of percentage phagocytosis 
achieved by macrophages population treated by 10-7 1,25-dihIdrOxycalci- 
ferol. The count of Candida reduced which isolated from macrophages was 
got on treat with calcitriol10-7. While the NO secretion among all ofgroup 
of macrophages population were almost the same value. 
Conclusion: The result clearly that 1,25-dihIdroxycalciferol gave an effect on 
increased ofphagocytosis and killing effect to Candida, but not gave an effect 
on NO secretion. 
[p5561 Disk diffusion method for determining 
susceptibility of Candida spp. to voriconazole 
C. Serrano, D. Morilla, R. Claro, M. Ramirez, A. Valverde, M. Chivez, 
S. Bemal and E. Martin-Mazuelos 
Seville, E 
Objective: The purpose was to evaluate the disk-&sion test for determining 
susceptibility of Candida spp. to voriconazole(V) in comparison with the 
reference method (NCCLS, M27A document). 
Material and methods: We studied 203 Candidu spp. (168 C. albicam, 126 
C.glabrata, 9 C. tropicalis) isolated from clinical specimens. Susceptibility test 
was carried out by the agar &&usion method using disk with 1 pg of V 
(Beckton Dickinson) on Mueller-Hinton agar with 2% glucose and 0.5 pg/ 
mL of methylene blue. The test was read after 24 and 48 h of incubation at 
35°C. The MICs (mg/L) obtained by the reference broth microdilution 
method (NCCLS, M27A document) (MDB) were dehed  as the lowest 
concentration ofV that inhibited the 50% of growth, they were read at 24 and 
48 h of incubation at 35 “C. 
Results. At 24 h, 197 of the 203 strains (97%) showed and inhibition zone 
&meter of major or equal to 18 mm2 for Vand 194 of these (98%) showed 
MICs values minor or equal to 2 pg/mL. for V by MDB read at 24 h. All the 
strains with the inhibition zone diameter <18 mz had also MIC values of V 
less than or equal 2 pg/mL being resistant to fluconazole. At 48 h, 181 of the 
203 strains (89%) showed an inhibition zone diameter of greater than or equal 
to 18 nunz for Vand 178 ofthese (98%) showed MIC values less than or equal 
to 2 pg/mL for V by MDB read at 48 h. Nineteen of the 22 strains (86%) with 
inhibition zone hameter <18 mz had MICs values to Vat 48 h less than or 
equal to 2 p g / d  and only 3 (14%) had MICs values > 2 p g l d .  Sixteen of 
the 22 strains were resistant to fluconazole. 
Conclusions: 
1 Better correlation between disk difision and the reference broth micro- 
dilution method at 24 h/24 h than 48 h/48 h. 
2 Good correlation was observed between h b i t i o n  zone greater than or 
equal 18 mm2 and the MICs values less than or equal to 2 p /mL. 
3 Most of the strains with inhibition zone diameter <18mm were resistant 
to fluconazole. 
B 
[ P557 I Candidaemia in a tertiary care hospital: in vitro 
susceptibility of Candida isolates to five antifungal agents 
S.  Maraki, A. Christidou, M. Dialynas and Y. Tselentis 
Heraklion, GR 
Background: Nosocomialfungemia occurs with increasing rates in patients with 
severe underlying disease or immunosuppression. Candida species are the 
main cause of fungal bloodstream infections. 
Objective: To determine the in vitro susceptibility of five antifungal agents 
against yeast strains isolated from blood cultures in the University Hospital of 
Crete, Greece. 
Methods: A total of 82 yeast strains isolated h m  blood cultures were included 
in the study. The isolates were identified by API 20 C AUX system 
(bioM6rieux) and conventional methods. The susceptibdity to antifungals 
was performed by E-test (Ai3 Biodisk} for amphotericin-B (AP), 5-fluor- 
ocytosine (FC), ketoconazole (KE), fluconazole (FL), and itraconazole (IT). 
Results. Candidu ahicam was the most common species isolated (34 strains; 
41.5%), followed by C. tropicalis (20 strains; 24.4%). C.parapsiZosis (11 strains; 
13.4%). C.glabrafa (8 strains; 9.8%), C.lusi*miae (5 strains; 6.1%), 
C.famata, C. humicola, C. incospicua, and C. nowegimis (1 strain each; 1.2% 
each). The MI% (and MIC range, mg/L) determined for each antlfungal 
agent against C. albicans were: AP 0.25 (0,012-l), FC > 32 (0.032->32), KE 
0.125 (0,004-16), FL 8 (0.01%32), and IT 1 (0.016-1.5), while against 
Candida non-albicaru were: AP 0.75 (0.016-12), FC 0.5 (0,004->32), KE 1 
(0.004>32), FL 48 (0.19->256), and IT>32 (0.016->32). Of C. albicam 
isolates 11.8% showed resistance to FC and IT, and only 2.9% to AF’ and KE. 
All C .  albicans isolates were sensitive to FL. Ofnon-albicans isolates resistance 
rates to IT, AF’, KE, FL and FC were 37.5, 20.8, 12.5, 10.4 and 6.25%, 
respectively. 
Conclusions: C. albicans predominates among Candida species isolated fiom 
bloodstream fungal infections in our hospital, with quiet low resistance rates to 
antifungals. However, susceptibility to antifungal agents can help to determine 
optimum therapy. 
lp558) In vitro susceptibility of 65 Candida spp. oral 
isolates to fluconazole 
F. Alecu, D. Alecu, C. Defta and S. Dumitriu 
Bucharest, RO 
Objective: To assess for the fluconazole susceptibility among Candida spp. oral 
isolates recovered fiom Romanian individuals included in a study between 
June 2000 and September 2001. 
Methods: A total of 65 Candidu spp. isolates were collected from 
53 oropharyngeal samples. For identification, the colony appearance on 
chromagar-Candida medium, chlamidospores production and substrate 
assimilation profiles with API 20 C AUX system were used. The flucona- 
zole-susceptibility assessment was conducted using E-test method. 
Results: From 65 Candida spp. isolates 63% (41) were identified as Candida 
albicans and 13.8% (9) were C. krusei. Other Candida spp. represented less than 
25% ofthe isolates (4 C. kehr, 3 C.glabrata, 2 C. dubliniensis, 2 C. nowgemis, 1 
C. inconspicud, 1 C. lusitaniae, 1 C .  magnoliae, 1 C. tropicalis). A total of 40 from 
41 C. albicans isolates were susceptible (MIC < 8 mg/L) and 1 C. albicans 
isolates was susceptible dose-dependent S-DD (MIC = 16mg/L) to fluco- 
mole.  Concerning the fluconazole susceptibility of the 24 non-albicans 
isolates, the results are: 4 C .  knrsei isolates were resistant (MIC = 64mg/L); 
4 C .  knrsei, 2 C. nowegemis and 1 C.gldrata isolates were S-DD to flu- 
conazole. The other Candida spp. isolates were susceptible to fluconazole 
(MIC < 8 mg/L). 
Conclusions: 
1. The majority (97.5%) of C. albicans isolates were susceptible to fluconazole 
and no resistant isolate was recovered in this study. 
2 Despite the fact that C. knrsei is considered an intrinsic resistant species to 
fluconazole, in chis study, four isolates were S-DD and one isolate was 
susceptible to fluconazole 
3 The two C. dubliniensis isolates were susceptible to fluconazole. 
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Typing and antifungal susceptibility testing of 
Candida strains isolated from the blood cultures of 
candidemia patients 
0. Kurt, H. Kurt, B. Bayar, K. 0. Memikoglu, A. h a p  and E. Tekeli 
Ankara, TR 
Objectives: Fungal infections have dramatically increased in recent years along 
with the occurrence of drug-resistant isolates especially in immunocompro- 
mised patients. These infections cause high morbidity, mortality and the 
antifungal drug choices are limited. Some Candida species are intrinsically 
resistant to some antifungal drugs and this makes the treatment choices more 
difticult. The typing procedures and antifungal susceptibility testing of 
Candida species are not routinely pedorined in many microbiology labora- 
tories. The aim of this study is to type and determine the andfungal 
susceptibilities of Candida strains isolated h m  blood cultures of candidemic 
patients. 
Methods: A total of 50 Candida strains isolated h m  candidemic patients were 
typed by the help of classical mycologic methods and API 20C AUX 
identification luts. The germ tube test positive strains were typed as C. albicans 
and the germ test tube negative strains were identified by inoculating onto the 
corn meal agar and API 20C AUX system. Antifungal susceptibility testing 
was performed according to the standard NCCLS M27A procedure by 
microdilution. The four drugs stumed were amphotericin B, fluconazole, 
ketoconazole, flucytosine. 
Results: Thirty of the isolates (60%) were C. albicans, 9 (18%) were C.para- 
psilosis, 5 (10%) were C. tropicalis, 2 (4%) were C. knrsei, 1 (2%) was C. keflr, 1 
(2%) was Cglabrata, 1 (2%) was C. lusitaniae, 1 (2%) was C. &and 1 (2%) 
was C.famata. In recent years, an increasing incidence of non-albicans 
candidal infections has been reported and this study shows similar results; 
40% were non-albicans strains. None of the Candida isolates were resistant to 
fluconazole besides the two C. knrsei strains which are known to be intrinsi- 
cally resistant. All the strains were found to he susceptible to amphotericin 3, 
ketoconazole, flucytosine. 
Conclusion: Typing and determining antifungal susceptibility patterns of the 
Candida strains are helpful in the management of candidemic patients. 
(p560 Evaluation of the in vitro activity of caspofungin 
against invasive Candida from cancer patients: comparison 
of €-test and NCCLS methods 
M. Laverdikre, C. Restieri and E Hahel 
Montreal, C A N  
Background: Emerging non-albicatu Candida infections and azoles resistance 
have changed the pattern of invasive hngal infections in cancer patients. 
Objective: To compare the in vim activity of caspofungin (Cas), fluconazole 
(F), itraconazole (I) and amphotericin B (AMB) against 178 hngemic yeasts 
recovered between 1997 and 2001 6om cancer patients using two Werent 
susceptibility testing methods. 
Methods: Susceptibility testing were performed using the E-test and the 
broth microdilution reference NCCLS M27-A method. 
Results: The comparative MIC90 (mg/L) were given in Table 1. 
The percentages of agreement within two dilutions between NCCLS 
reference method and E-test for I, F, CAS and Ah4B were 81,82,84, and 97%, 
respectively. 
Conclusions: Overall caspohngin is very active against invasive Candida in 
cancer patients. The E-test results correlated well with reference MICs. 
Pathogenesis of infection 
Table 1 Comparative MICgo (mg/L) 
NCCLS E-test 
Species (i%) 
C A S F  I A M B C A S F  1 AMB 
Allorganisms (178) 1 32 1 1 1 16 2 1 
C.albicans (92) 0.25 4 0.25 0.5 0.25 1 0.25 0.5 
C.glabruta (26) 0.5 16 2 1 0.19 16 64 1 
C. tropicalis (22) 0.25 8 1 0.5 0.5 1 0.5 1 
C.paraprifosis (20) 2 2 0.25 0.5 2 0.7 0.06 0.7 
F-resistant (21) 0.5 512 16 1 1 512 64 1.5 
I-resistant (21) 1 512 16 1 0.5 512 64 1 
vl Expression of an alternative respiratory pathway in 
Candida spp. 
S. Costa-de-Oliveira, C. Pina Vaz, A. Gonplves Rodrigues and 
C. Tavares 
Porto, P 
Introduction: The alternative respiratory pathway (cyanine-resistant) of 
mitochondrial respiration occurs in all higher plants, many hngi and some 
protozoa. Such a pathway uses electrons h m  the ubiquinone pool to reduce 
oxygen to water, bypassing the complex 111 and the cytochrome oxidase, two 
sites of energy conservation in the main respiratory chain. An alternative 
oxidase, sensitive to salicylhydroxamic acid (SHAM), is responsible for this 
alternative pathway (1). The cyanide-resistant respiration has been found in a 
few yeast of the genera Candida, such as Candida knrsei (2) and C. parapsihis 
(3). The effect of sodium azide was overided by the expression of an 
alternative respiratory pathway (4). 
Objective: To evaluate the presence of an alternative pathway to citochrome 
oxidase, resistant to sodium azide but susceptible to salicylhydroxamic 
acid. 
Materials and methods: Thuty-four clirucal isolates of Candida were studied 
to determine the presence of an alternative respiratory pathway including 14 
C. krusei, 3 C .  parapsilosis, 6 C. albirans, 5 C. glabrata, 2 C. lwitaniae, 1 C. rugosa. 
We used as control strains Debaryomyces hansenii PYCC 2968 (known to 
express an alternative pathway) and Saaharomyces cereuisiae PYCC 4072 as a 
negative control. The oxygen consumption was measured with a Clark-type 
electrode in the presence ofrespiratory inhibitors (3.2 rn ofsodium azide and 
SHAM), after addition of glucose. 
Results: Following the inhibition of cytochrome oxidase pathway (with 
sodium azide), the consumption of 0 2  stopped in a l l  strains except in the 
14 s t r a i n s  of C. knrsei, one s t r a i n  of C. parapsdosis and D. hansenii. 
Conclusions: C.Lnrsei, a pathogen with wide resistance to andfungals, 
invariably possesses an alternative metabolic pathway that could justify its 
promoted pathogenicity and resistance to adverse conditions. Interestingly, 
such a pathway was expressed in only one strain of C .  parapsilosis 
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-1 Virulence characteristic of Escherichia coli strains 
causing asymptomatic bacteriuria 
J. Vranes, D. Drenjancevic, V Kruzic and S Schoenwald 
Osbek, Zagreb, HR 
Objectives: Unne colomhon ofien occurs m the absence of chnical 
symptoms and IS called asymptomahc bactenuria (ABU). Physicms have 
hale knowledge of the potenual for urmrulence of the ABU-assoaated 
bacterial s t r a m .  Usually, the strain is allowed to pemt  untd that, or another 
invadmg s m ,  produces symptomaac urunary tract Infechon (UTI) A better 
understandmg of the virulence potenhal of the ABU-associated orgatmm 
would reduce the uncertainty III the treatment decisions. In the present study, 
we compared the prevalence of dterent virulence characterishc among 
Ekchenchra coh strains lsolated h m  a group of women in whom ABU was 
detected at the follow-up, and a group of chddren m whom ABU was 
detected durmg the screenmg. 
Methods: Eschenchra coli isolates were collected h m  19 women and 17 
chddren in whom ABU was detected. AU lsolates were serotyped usmg 17 
Merent 0-anhsera The miCrOhter hemolysm assay was used to qUanhtate 
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the hemolytic activity of bacteria. Serum-sensitivity testing was performed 
according to a m o ~ c a t i o n  of the method described by Schiller and Hatch. 
The expression of adhesins was defined by hemagglutination (HA) and 
inhibition ofHA in microtiter plates. Buffalo green monkey kidney (BGMK) 
cell line was used for the adhesion assay. 
Resultt: There were no s d i c a n t  differences in the prevalence of most 
virulence characteristics between the strains detected in the two groups. The 
strains were equally often non-typeable, expressed low amounts of capsular 
polysaccharide, and were mostly sensitive to the bactericidal action of the 
serum. In addition, P-fimbriated strains were not detected, and most strains 
were non-adherent or adhered very poorly to the BGMK cell line. The 
prevalence of hemoloysin production was 23 and 26% among strains isolated 
&om patients with and without a history of recurrent UTls, respectively. The 
only statistically significant difTerence observed was a more common HA 
abllity detected among the strains isolated Gom children without a hstory of 
UTI than among the strains isolated fbm women with recurrent U T I s  
Conclusions: More virulent E.coli strains were detected in the group of 
children without a history of previous UTI in whom ABU was detected 
during the screening. As ABU is associated with an increased risk of 
symptomatic UTI a prospective study is needed to evaluate whether the 
HA ability is the predlctor of subsequent symptomatic UTI. 
(P<0.01). 
(p5631 Adherence ability to cellular and inert substrata 
and other virulence factors in opportunistic enterobacteria 
with different origins 
V. Lazar, M. Balotescu, D. Bulai, R. Cernat, C. Dinu, M. Ionescu, 
D. Tam and V. Herlea 
Budarest, RO 
The versatility of opportunistic bacteria is owing to the fact that 
different strains have acquired different sets of virulence genes, without 
species barrier. Attachment to epithelial cells is the first step of bac- 
terial pathogenicity. Most of pathogenic and opportunistic bacteria possess 
adhesins, which mediate their adhesion to susceptible host cells and promote 
several outcomes, including colonization, cell damage, interdzation, dls- 
turbances of regulatory cell mechanisms and intracellular proliferation/ 
persistence. 
The aim of the present study was to investigate the adherence capacity to 
different substrata and other virulence features as invasion and cytotoxicity of 
some opportunistic enterobacteria strains with different sources ofisolation. A 
set of 120 strains of opportunistic enterobacteria were preluninardy screened 
for their adhesion capacity to HEp-2 cells using Cravioto's qualitative method. 
We selected 16 strains which were tested for adhesion+invasion to the 
intestinal Caco-2 cell line by the Cravioto's adapted method and FAS method 
(using DAPI and FITC fluorochromes). We also studied the cytotoxic effect 
on Caco-2 cells after releasing the cytotoxins using polymixin B and a rapid 
colorimetric assay of MTT salts reduction as a measure of cellular viability. 
The strains exhibiting intensive adhesion and invasion features were tested by 
TEM. 
One strain of Enterobacter cloacae exhibited high adherence and invasion 
potential. This strain was also tested for its adhesion and biofilm-forming 
ability to an inert substratum - an urinary catheter Gagment inserted in a 
bacterial culture flow system using a peristaltic pump. Internal catether surface 
was examined by SEM. The presence of adherent single cells as well as cells 
embedded in a biofilm matrix was observed. This strain proved also the 
highest cytotoxic effect. The TEM examination showed the presence ofA/E 
lesions. In our knowledge, this last aspect, signaled for EPEC, some Citrobacter 
sp. and Hafnia sp. strains, has not yet been mentioned for Enterobactergenus. 
Our results showed that some opportunistic bacteria could exhlbit multiple 
virulence factors: adherence to inert substratum, adherence + invasion to the 
cellular substratum, cytotoxic effect and also the capacity to induce actin 
rearrangements and A/E lesions. Our results are proving that the virulence 
features determine the pathogenicity of opportunistic enterobacteria, not 
their species and genus designation. 
I P564 1 Bacterial translocation following acute edematous 
pancreatitis: any correlation to the advent of an infection? 
l? Grecka, G. C. Nikou, CH. Toumpanakis, E. J. Giamarellos- 
Bourbouhs, G. Giannikopoulos, TH. Arnaoutis and N. Katsilambros 
Athens, GR 
Objective: To define whether advent of fever in acute edematous pancreatitis 
is attributed to subsequent endotoxemia or infection. 
Methods: Thirty-three patients with signs of acute edematous pancreatitis 
diagnosed with an upper abdomen CT scan of less than 12 h before admission 
were enrolled. Eighteen were male and 15 female aged 61.5 & 17.3years with 
APACHE I1 score 5.82 f 4.21. Blood was sampled by venipuncture before 
insertion of a nasogastric tube, past three and six hours and on the second and 
third days for determination of endotoxins (LPS) and of C-reactive protein 
(CRP) and for culture. LPS were measured by the QCL-1000 LAL assay and 
CRP by nephelometry. Results were correlated to the presence or absence of 
fever (T> 38 "C) and were expressed as mean f SE. 
Results: Twenty-one patients presented afebrile with LPS 2.11 f 0.88 EU/ 
mL and CRE' 65.2 dz23.8 mg/L. Concentrations of LPS past 3 and 6 h were 
4.01 f 1.36 and 2.42 f 0.95 EU/mL., respectively. Fourteen of them (66.7%) 
remained afebrile on the second day with LPS 1.72 f 0.57 EU/mL and CRP 
16.3 f 3.4 mg/L. Ten of these patients remained also afebrile on the third day 
with LPS 0.44f0.01 EU/mL and C W  10.3f2.3mg/L whereas four 
became febrile on the 3rd day with LPS 1.31 & 0.91 EU/mL and CRP 
208.5 f 11.5mg/L. From the patient admitted afebrile, seven (33.3%) 
became febrile on the 2nd day with LPS 3.70f 1.56EU/mL and CRP 
56.9f24.1 mg/L. Fever also persisted on the third day with LPS 
3.96 f 2.39 EU/mL and CRP 183.7 f 20.3 mg/L. From the total number 
of enrolled patients 12 were adrmtted febrile and remained febrile on both the 
2nd and 3rd days. Concentrations ofLPS ofthese patients on admission, past 3 
and 6 h and on the 2nd and 3rd days were 3.54 f 1.25, 3.03 f 1.14, 
5.84 + 2.28, 2.98 f0.88 and 2.94 f 1.88 EU/mL, respectively. Respective 
CRP values of these patients on admission and on the second and third days 
were 80.0f40.1, 80.6f37.2 and 105.8&96.8mg/L. Blood cultures of a l l  
patienb were sterile. 
Conclusions: Fever in the field of acute edematous pancreatitis is accom- 
panied by systemic endotoxemia and subsequent increase of CRP in the 
absence of bacteremia. As a consequence the need for the administration of 
antimicrobials in acute edematous pancreatitis is doubtful. 
lp5651 Production of extracellular enzymes by strains of 
Stenotrophomonas maltophilia of both clinical and 
environmental origin 
L. Mooney, L. Macfarlane and K. Kerr 
Lxeds, UK 
Background Virulence factors of the nosocomial pathogen Stenotrophomonas 
maltophilia (Sm) are ill understood. Ecthyma gangrenorum (EG) is a recognized 
complication of Sm bacteremia. In EG associated with Z? aenrginosa septice- 
mia, enzymes such as protease and elastase are deemed important virulence 
factors. It is possible that exoenzymes may also play a role in pathogenesis of 
EG and other manifestations of Sm infection. Earlier studies of Srn exoen- 
zymes examined only very small numbers of strains.  We investigated a much 
larger number of isolates of clinical and environmental origin. As suscept- 
ibility of Sm to some antimicrobials is temperature-dependent, we also studied 
the influence of temperature on enzyme production. 
Methods: A total of 130 isolates of Sm from clinical (61) and environmental 
(69) sources were studled. Agar *ion assays were used for DNAse, 
RNAse, esterases, elastase, mucinase, gelatinase, protease, lecithinase, lipase, 
chondroitinase, hyaluronidase and haemolysin. Elastase was detected with a 
Congo Red assay. Assays were at 30 and 37 "C. 
Results: All strains produced DNAse, RNAse, esterases and gelatinase at 
either temperature. Lipase and lecithinase were produced by significantly 
more isolates at 30 "C compared with 37 "C ( P  < 0.05). Ninety-two percen- 
tage of strains were hemolytic on horse blood agar (HBA) at both tempera- 
tures. Fewer strains were hemolytic on human blood agar irrespective of 
temperature compared with HBA, but blood culture isolates were sigrufi- 
cantly more likely to be hemolytic at 37 "C than other clinical or envimn- 
mental isolates. Chondmitinase and hyaluronidase were produced by most 
strains with the exception of cystic fibrosis isolates which, when grown at 
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either temperature, were statistically signhcantly less likely to elaborate these 
enzymes. Clinical isolates were signtfcantly more likely (P<  0.05) to produce 
protease and mucinase at 37°C compared with environmental strains. All 
strains produced elastase at either temperature, but quantitative dfierences in 
production were apparent. 
Conclusions: This is the largest study to date of exoenzyme activity of Sm and 
is the first report of chondroitinase production by Sm. Although a range of 
enzymes were produced by most strains, clinical isolates were more likely to 
produce particula enzymes when grown at 37 "C, suggesting that these may 
be important in the pathogenesis of Sm infection. 
I P566 I Prosthetic valve endocarditii due to polyclonal 
coagulase-negative StaphvJocorcus infection 
W. G. L. L A t ,  H. De Beenhouwer and J. Van Eldere 
Koitnjk, Aalst, Leuven, B 
Objectives: Coagulase-negative Staphylococruc (CNS) endocarditis is generally 
believed to be monoclonal. Research in this field always started fiom blood 
cultures yielding CNS. Only a handful of researchers have investigated the 
hypothesis of polyclonality in foreign-device related CNS infection. In our 
laboratory, we have cultured the valve of a man who was diagnosed with 
prosthetic valve endocardltis peri-operatively. The aim of our study was to 
investigate the possible polyclonality on the infected valve. 
Methods: After surgical valvular repair, the prosthetic valve was cultured in 
our laboratory. After 24 h of incubation at 37 "C at least four different types of 
colonies could be distinguished visually on chocolate agar. Ditferent colonies 
were subsequently isolated on blood and rnannitol salt agar (MSA). Species 
identification was performed by the API Staph Idem System (API) and 
susceptibility testing by ATB anti-biogramme @ioM&rieux, Marcy l'Etoile, 
France). At the university hospital of Leuven, genomic macrorestriction was 
performed using Sma I digestion of chromosomal DNA (Gibco BRL, 
Gaithesburg, MD) and separation by pulsed-field gel electrophoresis (PFGE) 
(CHEF Mapper system, Bio-Rad, Hercules, CA). 
Results: On chocolate agar, four visually different types were identified: 
strains A, B, C and D. Strain B showed no growth on MSA and was not 
hemolytic. Strains A, C, D were mannitol negative and faintly hemolytic. All 
types were cataldse positive and coagulase negative. Identifeation with API 
gave Sfaphy!ococcus epidermidis for all strains. Strains B, C and D matched with 
the5505113analyticalprofile, strainAwith5305113. StrainsB, CandDwere 
susceptible to all antibiotics tested except to oxacillin. Strain A was resistant to 
erythromycin and susceptible to the other antibiotics tested. PFGE revealed 
that only strain A was genetically merent. 
Conclusions: Traditionally, foreign device related bacteremia and in particular 
infective endocarditis were thought to be monoclonal. These findings suggest 
that positive blood cultures yielding Meicnt types of CNS can be the result of 
Cytokines and immune resistance 
I P568 1 Antibody response elicited by Fscbericbia coli 
bladder infection in primates 
M Soderhall, L Guldevall, P. Colque-Navarro and R. Mollby 
Stockholm, S 
Introduction: Symptomatic urlnary tract dechons (mi) are one of the most 
common lnfecnous dseases m chmcal prachce and uropathogemc Eschahia  
coh is the major causative agent. C h c a l  observahons suggest that cystIhs 
induces a protective immune response but the mechamms are shll unclear. 
Objectives: To study anhbody response following expermental E. c011 bladder 
infecnons m pnmates, the d u e n c e  of the PapG class I1 adhesm, and to 
correlate the systermc and local immune response to the protective effect. 
Methods: Cyshtls were estabhhed in primates through moculation of a 
bactenal suspension of E. colt (1 nL, 107 c W m L )  ma an urethral catheter 
Blood samples and suprapubic bladder urine aspirahons were performed m c e  
a true infection. These findings also remind us ofthe fact that susceptibility to 
antibiotics can be Werent for diflerent strains. Theoretically, the most 
resistant strain should guide clinical therapy. 
lp5671 Identification of membrane receptors for 
hydroxsamate-type siderophores in Staphylococcus aureus 
P. Wysocki, I? Lisiecki and J. Mikuclu 
Lodz,  PL 
Objectives: Sraphylocom aurew strain B47 has produced an endogenous 
siderophore called sraphylobactin which belongs to hydroxamic class 
chelaton. Ths  strain utilize five egzogenous chelators as Fe(II1) sources: 
schizokinen, 2,3-dihydroxybemylglycine, 2,3-dihydroxybenzoyIserine, 
aerobactin, and acinetoferrin. 2,3-Dihydroxybenzoic acid, rhodotorulic acid 
and desferrioxamine B were not utilized Fe(II1) carriers by this strain. Little is 
known about membrane protein receptors for endo- and egzogenous side- 
rophores utilized by staphylococci. The aim of this studies was to establish of 
membrane protein, which serve as siderophore receptors and correlation 
between particular siderophores and detected proteins. 
Methods: The strain was cultured in synthetic Fe(III)-deficient medium 
(1 x ~ M M )  and in medium containing excess of Fe(II1) iron (1 x 10-4~). 
After lysis of protoplasts and differential centrihgation, the membrane 
protein bction was obtained. The photoreactive pazidobenzoil analog 
of 59Fe-labeled ferrioxamine B, [59Fe]rhodotorulic acid and [59Fe]acineto- 
ferrin was used to photolabeling of membrane proteins. After 
photolysis, membrane fiaction was subjected to gel electrophoresis (SDS- 
PAGE). For the '%e-labeIed chelaton detection gels were subjected to 
autoradiography. 
Results: Six iron-regulated proteins have been idenafied in the cytoplasmic 
membranes of s t r a i n  B47 cells harvested from synthetic Fe(III)-deficient 
medium. They occurred in the 96-14 kDa region. No new proteins were 
found in cell membranes harvested from medium with excess of iron. One 
protein (14kDa) has been linked to 59Fe-labeled acinetoferrin. Using 59Fe- 
labeled ferrioxamine Bit was demonstrated that this chelator has bound to the 
43kDa membrane protein. F e r r i d n e  B has not stimulated growth of 
strain B47. The complex of5'Fe-siderophor was not transported into the cell, 
because it was not detected in cytoplasm fiaction. No radioactive bands 
occurred on autoradiograms of membranes with 59Fe-labeled rhodotorulic 
acid. 
Conclusion: Staphylococcus aureus strain 347 has produced six iron-regulated 
proteins witch may bind not only the currently synthesized siderophores. In 
the condition of lvnted Fe(II1) availability this provides the possibihty of 
interchange of siderophores among various microorganisms, and of utilization 
of siderophore-Fe(1IIf complexes f h m  other bacteria present in the envir- 
onment. 
a week until two negative urine cultures had been obtained. The monkeys 
were then challenged with a second intravesical inoculation. Both a wild-type 
PapG class 11 P-fimbriated E. coli strain and two non PapG class I1 E. coli 
mutants were used as in the experimental model. Levels of IgA, secretory IgA 
and IgG against LPS derived from E. coli were detected in urine and serum 
samples from the monkeys by an indirect ELISA. 
Resultr: The wild type E.  coli strain and the two isogenic mutants induced 
primary bladder infections equally well. Protective immunity was induced by 
the wild type E. coli strain but not by the non PapG class I1 mutants. The 
protective effect was correlated to local secretory IgA response against the 
surface lipopolysaccharide in urine. 
Conclusions: The E.  coli PapG class I1 adhesin is required to induce protection 
against subsequent bacterial challenge. Protection against urinary cract infec- 
tions is correlated to the production of secretory IgA and infections in the 
urinary tract of monkeys may or may not induce a protective immune 
response, depending upon properties of the infecting strain. 
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lp569) Macrophage Inflammation Protein-3a (Mip-3a) in 
cerebrospinal fluid of patients with meningitis 
S. Bonora, P. Scappini, R. Raiteri, A. Rossati, I. Meoli, K. SciolG, 
M. Boffito, A. Sinicco, M. A. Cassatella and G. Di Perri 
Turin, Verona, I 
Objectives: The inflammatory response observed in infections of the sub- 
arachnoid space is mediated by chemokines. Among those interleukin-8 (IL- 
8) is known to play a pivotal role. Macrophage inflammatory protein-3a 
(MIP-3a) is a recently discovered CC chemokine involved in the regulation of 
humoral immunity and leukocyte homeostasis. The objective ofthis study was 
to evaluate the cerebrospinal fluid (CSF) MIP-3a concentrations in patients 
with meningitis and the relationship between MIP-3a and CSF inflammatory 
parameters. 
Methods: We studied 54 CSF samples obtained &om 21 patients affected by 
pyogenic meningitis (PM) (n = 14: five cases S.pneumoniae, three N. meningi- 
tidis, one R muginma, five of unknowu etiology) or aseptic meningitis (AM) 
(n =7: three tuberculous, four viral), and eight CSF samples of non-idam- 
matory CNS diseases as the controls. MIP-3a was measured by an ELISA test 
developed with specific antibodies purchased h m  R&D Systems (Minnea- 
polis, USA) with a detection limit of 10 pg/mL. IL-8 levels were determined 
by means of a commercial kit (R&D Systems, Minneapolis, USA). Differ- 
ences in chemokine levels between the two groups of patients were calculated 
with M a - m m e y  test, while correlations of MIP-3a with CSF cells 
count, protein level and CSF/blood glucose ratio were evaluated by means of 
Pearson test. 
Results: At admission, median MIP-3a was 1595 pg/mL (range 117-4500) in 
PM patients and 39pg/mL (k192) in A M  (P=O.OOO). Median IL-8 was 
3036pg/rnL (1217-8000) in the formers and 468 in the latters (P=0.014). 
MIP-3a and IL-8 were undetectable in all noninflammatory CSF samples. A 
correlation between MIP-3a levels and neutrophil counts was observed when 
considering the 21 admission measures (r= 0.66, P= 0.01) and all the 54 CSF 
samples (r= 0.68, P=O.Ol). MIP-3a did not show any correlation with CSF 
protein level and CSF blood/glucose ratio. 
Conclusion: This is the fiat report showing the presence ofMIP-3a in CSF of 
patients aEected by meningitis. MIP-3a was found to be lower than IG8 
levels. However, MIP-3a levels were sigdicantly higher in PM rather than in 
AM and correlated with CSF neutrophil counts. These data suggest a possible 
role of MIP-3a as a chemotactic factor in pyogenic meningitis. Further 
studies are needed to elucidate the precise role of this chemokine in 
pathogenesis ofPM and the potential application in the differential diagnosis 
of meningitis. 
Macrophage migration inhibitory factor (MIF) is 
elevated in cerebrospinal fluid (CSF) from patients with 
septic meningitis 
C. 0stergaard, T. Benfield and J. D. Lundgren 
Copenhagen, Hvidovre, DK 
Objectives: MIF has an essential role in the pathogenesis of outcome induced 
by sepsis (Calandra, T. Nature Med. 2000; 6: 164-70). However, its role in 
meningitis remains to be defined. 
Methods: MIF was determined by ELISA in CSF samples taken on 
admission from 101 patients suspected of having meningitis. Based on 
clinical, microbiological and biochemical characterization the patients were 
divided into four groups: 43 with septic meningitis (I), 42 with aseptic 
meningitis (11), four with encephalitis (III), and 12 without evidence of 
meningitis (IV). 
Results Data are shown as medians (min-max). Sigmficant dXerences in CSF 
MIF levels @g/mL) were detected among groups (I: 5006 (457-12746), II: 
1832 (0-12746), 111: 6433 (2037-8353), and IW 2365 (0-6991), Kruskal- 
Wallis, P< 0.005), with significantly higher CSF MIF levels in patients with 
septic meningitis than in patients with aseptic meningitis (IvhwWutney 
with Bonferonis correction, P= 0.01). CSF MIF levels were associated with 
severity of disease (number of days of hospitalization, Spearman, P < 0.001). 
CSF MIF levels correlated sigtllficantly with CSF protein levels, CSF/blood 
glucose ratio, CSF IL-8 levels, and with number ofleukocytes (lymphocytes, 
monocytes, and neumphils) in the CSF, as well as with number of leukocytes 
(neutrophils) in blood (P< 0.05). 
Conclusions: MIF may have an important role in the pathogenesis/patho- 
physiology of septic meningitis. 
[p5711 Detection of opsonic antibodies in patient sera 
after staphylococcal infections 
Boston, USA 
Objectives: Staphylococcal infections are among the leading causes of mor- 
tality in hospitalized neonates and infants. To better understand the immune 
response associated with these infections, we studied 16 sera from neonates 
and older children with Staphylocouus aureus infection and 10 normal sera. 
Methods: Specific antibodies against native and deacetylated extracellular 
staphylococcal polysaccharide (PNAG) were studied. In addition, the PNAG- 
specific opsonic killing ability of these sera was measured to determine if a 
potential protective immune response was generated. 
Results: The difference between titers against native and deacetylated antigen 
in patients was not statistically sigrufcant. The titers in n o d  sera against 
both antigens were higher than inpatients sera but again the difference was not 
statistically sigNficant. However, complement-mediated, PNAG-specific 
killing in patients sera was considerably higher (between 11.6 and 80.Ph) 
as compared to normal human sera wherein no sigmficant kdhg was 
observed. Opsonic lulling thus showed a statistically sigrufcant difference. 
Patients as well as healthy controls possess specific antibodies against PNAG, 
although these antibodies in healthy controls are not opsonic. Patient sera 
showed mean killing levels of about 50% while there was no opsonic activity 
in the control sera. 
Conclusions: Patients as well as healthy conmls possess antibodies specific for 
PNAG and these antibodies are directed against the native and deacetylated 
form of PNAG. Although anti-PNAG antibodies are present in healthy 
controls, these antibodies are not opsonic. 
A. Kropec, C. Kelly Quintos and G. Pier 
(p572] The influence of methicillin-resistant Staphy/moca/ 
septicemia on the sizes of T lymphocyte subpopulations 
and CD25+ cells in full-term eutrophic neonates 
J. Behrendt, J. Karpe, B. Mazur, M. Stojewska, G. Mikusz and 
U. Godula-Stughk 
Zabrze, PL 
Objectives: Severe bacterial septicemia (BS) may change natural immunity 
system in neonates. Variety of results of those investigations was the cause to 
undertake research aimed to evaluation how methicillin-resistant staphyllo- 
coccd septicemia influence the sizes of T lymphocytes subpopulations and 
CD25+ cells in full-term eutrophic neonates. 
Methods: The analysis comprised 46 neonates aged h m  2 to 10 days of life 
with birth weight from 3100 to 4500g, with gestational age from 39 to 
41 weeks, among them 24 (14 boys, 10 girls) septic and 22 (12 boys, 10 girls) 
healthy, born vaginally, with Apgar score >9 points, without perinatal risk 
factors (control group). In 67% (16 cases), early onset and in 33% (eight cases) 
late-onset BS were stated. Most frequently (79%) S. epidermidis was isolated 
from the blood, both in early (13 cases) and late-onset (six cases) infections. 
Other staphylococcal strains (S. sciuri, varneri, hominis) in five cases were found. 
Two early death ofseptic neonates were associated with severe birth asphyxia 
and multiorgan insufficiency. Flow cytometric immunophenoryping using 
lysed whole vein blood and monoclonal antibodies anti CD3+, CD4+, 
CD8+, HLA-DR + and CD25+ (l3ecton Dickinson) was performed to 
determine these cells. 
Results: In septic neonates, the mean relative size o fCD8t  (18.9 f 4.5%) was 
si&tcantly (P< 0.008) lower than in control (23.6 i 6.6%). Sigdtcant 
(P < 0.03) increase ofthe mean relative size ofCD25f cells in septic neonates 
(8.1 i 2.3%) in comparison to the control (6.6 k 1.3%) was noted. The mean 
relative sizes of CD3+ (67.2*5.9%), CD4+ (49.9&1&0.7%) and 
=A-DR + (1.8 f 0.9%) did not differ fiom the control. The mean absolute 
sizes of CD3+ (3.642~t1.299 G/L), CD4+ (2.743+1.199), CD8+ 
(1.005 & 0.298), HLA-DR + (0.091 f 0.042) and CD25+ (0.446 z!= 0.169) 
were similar to the mean values in conml one. CD4+/CD8+ ratio ranged 
from 1.5 to 4.9 (mean 2.94 f 1.38) in septic neonates and did not differ 
sigmfkantly from the control group (2.29 & 1.29, 1.2-6.3). 
Conclusion: Methicillin-resistant staphylococcal septicemia in fd-term neo- 
nates may lead to decrease of mean relative size of CD8+ T lymphocytes and 
to increase of CD25+ cells. 
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Expression of Fc receptors for IgG on peripheral 
blood phagocytic cells in bacteriemic patients 
P. Ruiz, E J. Molina, J. B. Lopez-Saez, B. Sainz. M. Cousinou, 
M. Herran, M. Escobar, C. Rivera and E Gomez 
Cadir, E 
Background Early markers of bacteriemia are usell for prognosis and, in 
decision making for i.v. antibiotic therapy. 
Objectives: To assess the diagnostic power of the surface expression of Fc 
receptors for IgG (FcgFb) for the prediction ofbacteriemia in febrile patients. 
Methods: We performed a prospective case-control study on 75 consecutive 
patients @ts) with an episode of bacteriemia as compared to 83 randomly 
selected concurrent febrile pts with negative blood cultures (control). Demo- 
graphic and clinical data were collected by chart review and/or questioning 
their attending physicians. Plasma levels of C-reactive protein (CRP), TNFq 
IL-lB, IL-6, IL-8 and IL-10 were determined. The surface expression of Fc 
receptors for IgG (Few): FcgRI, FcgRII and FcgRIII on peripheral blood 
monocytes (M) and granulocytes (G) was assessed by flow cytometry. These 
studies were done concomitantly with blood cultures. 
Results: Both groups were not diEerent for age, sex, previous administration 
of immunosupressants or antibiotics, clinical severity index or comorbid 
conditions. In univariate analysis, cases had significantly higher levels of CRP 
(P<0.001), TNFa (P<0.001), IL-la (P<O.O01) and IL-6 (P<0.01) than 
controls. The expression of FcgRIII on M (PBM-FcgRIII) and FcgRI on G 
(G-FcgRI) was si&icantly enhanced (P< 0.001) in bacteriemic pts as 
compared to culture-negative febrile pts; while the expression of the other 
FcgR-type, FcgRII by either M or G was sigtliftcantly decreased (P< 0.03). 
Setting a cut-off value 225% oftbe mean fluorescence intensity over controls 
for M-FcgRII, M-FcgRIII, G-FcgRI or G-FcgRII surface expression and, 
assuming a prevalence of bacteriemia of 5-10% among hospitalized pts 
undergoing blood cultures, results in a sensitivity, specificity, positive and, 
negative predictive values oE 77,95,74, and 98%. respectively, for M-FcgRII, 
73, 96, 74 and 97%, respectively, for M-FcgRIII, 58, 91, 49 and 96%. 
respectively, for G-FcgRI and, 72, 93, 57 and 93%, respectively, for 
G-FcgRII. 
Conclurionc Our results suggest that the surface expression ofFc receptors for 
IgG on peripheral blood monocytes and granulocytes may help clinicians to 
rule out bacteriemia in febrile patients. 
(p5751 Effects of Pseudomonas aentginosa experimental 
endocarditis in rabbits on granulocyte and monocyte 
phagocytosis and respiratory burst 
P Fanourgalus, M Nikolopoulou, S Hatzianastasiou, K. Psarra, 
A Vasdeh, E. Vadahs, V. Kapsunalt, C. Papasterlades and G Saroglou 
Athens, GR 
Introduction: Pmdomonas uencgrnozu (PA) left-sided endocardhs has a 
low mehcal cure rate. Poor penetraaon of anhbiotics m the vegetaaons, 
8-lactamase produchon, resistance to ammogkycosides, lack of postanhbiohc 
effect of @-lactam and algtnate production are the man known reasons 
Vegetations are also sxtes of Impaxed host rewtance where the inhltrauon of 
phagocyhc cells IS decreased. In addmon, rmcrobe cell-assomated surface 
structures protect the orgatllun and extracellular products further mpau host 
defense. 
Objective: To evaluate the d u e n c e  of PA endocarbhs on the phagocyhc 
achnty and the respiratory burst ofgranulocytes and monocytes m the model 
of experimental endocardm in rabbits. 
Materials and methods: Flfteen New Zealand male rabbits were used. One 
day after cathetervzahon, 108 Cfu of a PA mucoid stram were mjected ' h o  
days after bacterial challenge, ammals were randormzed to treatment (ceh- 
n h e  plus tobramycm, n=lO), or no treatment ( n = 5 )  groups. fight 
arumals horn the treatment group and only one from the no treatment 
sumved and all where sad iced  on day 8. Leucocyte phagocytx achvlty and 
respuatory burst deterrmnaaon was performed twxe (before catheterlzaaon 
and just before sacnfice). Commerd  t a t  luts PHAGO-test and PHAGO- 
BURST-test of Orpegen Pharma were used. Cells were analyzed usmg the 
flow cytometer FACS Cahbur (Becton Diclunson). 
Results: (1) The results concerning the rabbits sumvmg from the treatment 
group are (Phagocytosis (% monocytes): before treatment: 60.1 f 19 4. after 
treatment 40.8 f 6.4, P= 0.043. Phagocytosls (% granulocytes). before 
treatment: 75.0 f 8.4; after treatment: 56 0 !c 6.8, P= 0.018. Burst (% 
monocytes): before treatment: 18.4 & 9.0; after treatment: 4.5 zk 2.8, 
P=O.O18. Burst (% granulocytes): before treatment: 83.1 f6.7;  after treat- 
ment: 37 4 f 9 2, P =  0.018. Wdcaxon Signed ranks test for related samples 
was used for the stahshcd analysis (2) The one survived control wthout 
treatment showed sindar values. 
Conclusions: Leucocyte phagocyhc ablllty and oxidaave burst are attenuated 
durmg the course of PA experimental endocardias m rabbits Ths decreased 
funchon of monocytes and granulocytes may be a conmbutmg factor in the 
hgh rate ofrefractoriuess to anhbiohc therapy ofleft-sided PA endocadus in 
humans. 
1 P574 I Haemophilus influenzae porin contributes to 
signalling of the inflammatory cascade in rat brain 
M Galhero, M D'lsanto, M Viaello and A Tortora 
Naples, I 
In the present study we observed that the Haemophdus intumzae type b (Hib) 
porm, among the Merent surface bacterlal components, ls mvolved in the 
pathophysiology ofbacterial menmgitis. Hib porin (or P2 or protem BLC) is 
the most dommant band in SDS-PAGE outer membrane protem (OMP) 
preparanons accordmg to Nurmmem method, its molecular ma.ss varies 
between 36 and 42kDa Ths  protem emsts as a trimer and function as a 
porin Hlb porin has also been reported to be an lmportant munoprotec- 
tion target TNF-a and IL-I were shown to play an lmportant role in the 
host's response to bacteria and their products Astrocytes and mcroghal 
cells produce IL-1 and TNF-a w t h n  the central nervous system (CNS) 
The evohhon of the inflammatory process in the CNS depends on the set 
of cytokmes released during the first steps of the mfechon We analyzed by 
PCR the pattern of cytohes release after samulaaon vclth K b  porm to 
estabhsh the exact pathogemc mechamsms by whch Wb contributes to 
signalhng of the inflammatory cascade. Ths  study demonstrates that mom- 
laaon of f ib  porn mto the fourth cerebral ventricle causes the simultaneous 
expression of mterleulun-la +la), tumor necrosls factor-a (TNF-a) 
and macrophage inflammatory protem 2 (MIP-2) at 6 h aker mocdahon 
At 24 h tune-pomt the MIP-2 expression decreases, whde expression of IL-1% 
and TNF-a mcreases. The mRNA expreuslon of IL-la, TNF-a and MIP-2 
is correlated w t h  the bran blood barrier '"Jury as demonstrated by 
the appearance of serum protem and leukocytes m CSF and by the increase 
in bram wafer content In conclusion, the mterplay between bac- 
tenal components and host inflammatory cells is hkely to be a major 
detemnant of the expenmental presentation and outcome of bacterial bram 
edema. 
(p5761 Effect of TNF-a on uropathogenic E. coli adherence 
to human endothelial cells 
A. Szkaradkiewicz, M. Wal and Z .  Musqiisk 
Pornat, PL 
Objectives: The polyfunctional effect of tumor necrosis factor (TNF-a) on 
endothelial cells has already been well documented. Present study aimed at 
analysing effects of TNF-a on adherence of uropathogenic E. coli to human 
endothelial cells. 
Methods: The studies were performed using E.coli strains, which were 
isolated from urine of adult patients. The st ra ins  were identitied as belonging 
to E. coli species using API ID 32 GN strip and the ATB system (bioMerieux). 
All the strains were assayed by agglutination using the latex reagent for 
detection of P fimbriae (P-fimbriae particle agglutination test). Adherence 
of bacterial celIs to human umbilical vein endothelial cells (HUVEC) was 
studied after labeling of the bacteria with BrdU. Bacterial adherence w a s  
detected by immunoenzymatic assay with peroxidase-labeled monoclonal 
anti-BrdU antibodies. HUVEC were preincubated for 30 min in PBS con- 
taining r(h)TNF-a (Amersham) at 5, 10, 25, 50, 75 and lOOpg/mL or 
containing no r(h)TNF-a (control). 
Results: Mean value of absorbance for the E. coli strains was 0.42 f 0.05. As 
compared to the control values, bacterial adherence to HUVEC sigmficantly 
increased following preincubation with r(h)TNF-a at 25pg/mL (P< 0.05). 
Higher doses of r(h)TNF-a did not significantly alter the bacterial adherence 
to host cells. 
Conclusion: TNF-a may promote bacterial adherence to endothelial cells, 
which requires, however, specific concentration of the cytokine. 
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m) Ex-vivo activation of autologous BKV-spedfic 
cytotoxic T cells for the treatment of BKV-associated 
interstitial nephritis after kidney transplantation 
P. Comoli, A. Azzi, M. Labirio, R. De Santis, A. Nocera, C. Rossi, 
F. Perfurno, S. Basso, E Locatelli, R. Maccario and F. Ginevri 
Pavia. Florence, Genoa, I 
Polyoma BK virus (BKV)-associated interstitial nephritis is a recently 
described complication that affects with increased frequency renal dograft 
recipients. The infection leads to graft failure in as many as 45% of the aec ted  
patients. Currently, no established antiviral treatment is available, and control 
of viral repkation is tentatively obtained by means of reduction of immu- 
nosuppression. However, most patients with nephropathy due to BKV slip 
into a disheartening cycle, alternating between viral interstitial nephritis and 
rejection, precipitated by lowering immunosuppressive drug dosage. Thus, 
there is a need to develop alternative therapeutic tools able to control the 
infection. Adoptive cellular immunotherapy has proven to be a successful 
approach for prevention and/or treatment of Epstein-Bar virus- and cyto- 
megalovirus-related complications in the immunocompromised host. To 
assess the feasibhty of translating this strategy to the prevention of BKV- 
associated intentitial nephritis, we established a system for generating and 
expanding BKV-specific cytotoxic T c& (CTL) from peripheral blood 
lymphocytes (PBL) of renal transplant recipients with evidence of active virus 
replication. In detail, we optimized a procedure for the in vitro reactivation of 
virus-spec& CTLs using dendritic cells as BKV antigen-presenting cells. 
lmmunophenotyping showed that the CTLs thus obtained were >90% 
CD3+, >50% CD8+ , 2@-30% CD4+ , and contained 5-10% cells of 
NK phenotype, 10-20% CD3+/CD8+/CD56+ cells and variable numbers 
of gamma/delta + CTLs. BKV specificity of the lines was indicated by an 
efficient lysis of BKV-infected targets, with little or no reactivity observed 
against noninfected autologous or HLA-mismatched targets. The CTLs 
successfully generated with our method could be expanded in vim to reach 
s a c i e n t  numbers for infusion requirements. Overall, our p r e h n a r y  data 
hold promise for defining a CTL-based immunotherapy approach to BKV- 
related complications in kidney transplant recipients. 
I P578 I Plasmid pVM of Yersinia pseudotuberculosis has 
considerable immunosuppressive properties 
A. Voropaev, 1. Shurygina, 1. Malov, E. f i d e y  and V. KJimov 
Irkutsk, RUS 
We investigated the role of PVM (82 MDa) plasmid in pseudotuberculosis 
pathogenesis. In ths  study, two different sh-ains of Ypserrdotuberculosis (Yp.) 
(both pYV+ (47 MDa) and pVM+virulence plasmids strain and p W + -  
strain) and pYV + k: enterocolitica we.) were studied. Each strain was incubated 
for 24 h with the whole blood of healthy volunteers at a ratio of 1 &on 
microbial cells per 1 mL of blood. Blood without strain w a s  used as control 
and with lipopolysaccharide of Yp. (LPS) and superantigen of Yp. (YPMa) as 
positives controls. Concentrations of interferon4 (IFN-a), tumor necrosis 
factor-a (TNF-a), interleuh-1 (LL-I), interleukin-2 (IL-2) and interleukin- 
6 (IL-6) were measured by ELISA. Also we investigated the levels of the same 
cytokines in patients with pseudotuberculosis induced by pVM + pYV + and 
pYV +strains. In experiment, YPMa induced higher levels of IFN-a, TNF- 
a ,  K-1 and IL-6 that LPS and much more that any strain. Yp. pVM + pYV + 
induced significantly lower IFN-a, TNF-a, IL-1 and IL-6 levels that 
p W  + Yp. and pYV + Ye. (Fig. 1). Levels of IL-2 were unchanged. In the 
patients clinical course of pseudotuberculosis caused by pVM + pYV + Yp. 
were more severe than that pYV + Yp. Levels of cytokines production in the 
patients with pVM + pYV + Yp. were less insigatficant than that provoked by 
pYV + Yp. The fust week of &ease levels of all cytokines were si&icantly 
dimmished comparing with their levels in the healthy volunteers. Levels of 
IFN-z, IL-1 and IL-2 rose on the third week ofdisease but the level ofTNF-a 
remained unchanged and levels of IL-6 continued to decrease. These data 
show that Yp. has significant immunosuppressive properties F d  diminishes 
the cytokine production both in vitro and in vivo. Plasmid 82 Ida exacerbates 
immunosuppression. 
Figure 1 TNF-a production in vitro. 
Infections in transplant patients 
m] Do the positive donor blood cultures influence the 
success of organ transplantation? 
2. G W ,  D. Gorog, Z. Gerlei and F. Perner 
Budupest, HUN 
Objectives: Organs transplanted fmm bacteremic donors do not transmit 
bacterial infections. The aim of our study was to evaluate the impact of 
positive donor blood culture on the 30-day graft and patient survival after 
organ transplantation. 
Methods: Periferic blood samples were taken for blood cultures in BACTEC 
PLUS aeroblanaerob bottles. Bottles were incubated in BACTEC 9120 
systems. (Becton Dickinson). Positive samples were cultured in blood, 
chocolate and EMB agar produced by NOVAMED LTD. (Jerusalem, Israel), 
bacteria were identified using VITEC systems (bioM6rieux). 
Results: Between 1998 and 2001,132 kidney and 25 liver organ donors were 
examined. Total 40% of the kidney organ donon as well as 48% of liver organ 
donors were found to be bacteremic. The authors assessed the distribution of 
bacteria in donor blood cultures. The coagulase-negative Staphylococcus had 
the largest distribution ratio in 79% kidney and 66% liver donors. Gram- 
negative bacteria and Candidu sp. were found to be only 1%. UTI was 
observed to be 10.7% in kidney recipients. Wound infections occured in 3.9% 
ofkidney and in 16.6% ofliver recipients. There was no death and no graft lost 
from infectious complications in recipients that received organs fmm bac- 
teremic donors. 
Conclusions: From the results of these examinations, it has been assumed 
that organs transplantedfmm bacteremic donors do not result in poor outcomes. 
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[=I lnvasive Aspergi//osis in solid-organ 
transplantation: report of eight cases 
E Ergin, H. Arslan, E. Kuru Inci, B. Demirhan, H. Karakayali 
and M. Haberal 
Ankara, TR 
Objective: We retrospectively evaluated the clinical and laboratory findings in 
eight patients who were solid-organ transplant recipients and treated for 
invasive aspergdlosis (IA) at our center. Between 1998 and 2001,8 (4 liver and 
4 kidney recipients) of207 transplant recipients (27 liver and 180 hdney) were 
diagnosed with IA. AU the aEected patients were male, and their mean age was 
38 years (range: 22-55 years). The recipients' immunosuppressive protocols 
included various combinations of predtllsolone, cyclosporine, mycopheno- 
late-mofetil, azathioprine, and tacrolimus. The mean time from transplanta- 
don to IA diagnosis was 24 days (range: 15-34 days). The risk factors for the 
development of the disease were acute rejection (n=4),  long-term 
antibiotic therapy (n = 4), OKT3 treatment (n = 3), thrombocytopenia 
(n=3), and re-transplantation (n=l). The chical symptoms in the 
group were fever in 6 (75%) cases, productive cough with sputum and 
dyspnea in 5 (62.5%) cases, and unexplained diarrhea in 1 case (12.5%). 
All the patients' chest X-rays showed pneumonic inliltration or nodular 
involvement. Thoracic computed tomography (CT) revealed bronchopneu- 
monia, nodular, and nodular and cavitation patterns. Definitive diagnosis was 
based on isolation of Aspergillus jizmigatw from cultures of bronchoalveolar 
lavage fluid and sputum in two patients, bronchial biopsy in one patient, and 
autopsy findings in five cases. The four patients who were diagnosed with 
aspergillosis premortem were treated with liposomal amphotericin B (5 mg/ 
kglday). Two patients with clinical and laboratory findings that were highly 
suggestive of IA were empirically treated uith amphotericin B (3 mg/kg/day), 
and the diagnosis was confirmed postmortem. Two of the five pa- 
tients who were diagnosed at autopsy did not receive premortem antlfungal 
therapy. Six (75%) of the eight patients died. One of the remaining two 
patients was discharged after 21 days of amphotericin B and 14days of 
itraconazole therapy. The other indwidual received 21 days of amphotericin 
B therapy only. 
Conclusion: The hgh mortality rate in patients with IA underlines the 
importance of prompt diagnosis and treatment. This disease should always 
be considered a potential threat in high-risk transplant recipients, and therapy 
should be initiated as soon as specimens have been obtained for microbio- 
logical testing. 
/p5811 Cryptosporidiosis in renal transplanted and 
hemodialysis patients in Imam Hospital, Urmia 
K. Hazratti Tappeh, K. H. Makhdoumi, M. Rahbar and A. Taghizadeh 
Afihari 
Unnia, JR 
Background and Objectives: Some intestinal parasitic infections caused by 
parasites such as Cryptosporidium spp. are frequently seen in renal transplant and 
hemodialysis patients. 
Methods: Our study of infection by Cryptiqmidium spp. were determined in 
three groups. First group consisted of 87 renal-transplanted patients and the 
second group of 103 hemodialysis and other control cases. For every patient 
and control case, at least two fecal specimens were examined. 
Results: The frequencies of Cr)rptosporidium spp. infection in renal-trans- 
planted, hemodialysis patients and control groups were 11.5 and 3.88%, 
respectively. AIl control groups were negative for Cryptosporidium spp. Sta- 
tistical analysis showed significant differences among the renal-transplanted 
and control group ( P <  0.0239). But significant differences were not found 
among the hemodialysis patients and control group ( P <  0.0418). 
Conclusion: The frequencies of Cryptosporidium spp. infecton in renal- 
transplanted patients was higher in comparison to hemodialysis patients. 
It is concluded that renal-transplanted patients are at  high risk for infec- 
tions of Cryptosporidium spp. because of their immunocompromised 
state. 
[ P582 1 Infectious agents causing urinary tract infections in 
renal transplant recipients and their antimicrobial 
susceptibilities 
F. Ergin, H. Arslan, G. Yapar, H. Karakayah and M. Haberal 
Ankara, TR 
Introduction: Urinary tract infections (UTI) are the most common bacterial 
infections affecting renal transplant recipients. The most common pathogens 
causing UTI in this group of patient include Enterobactericeae. Enterococci, 
Staphylococci and Pseudomonas spp. 
Objectives: To determine the bacterial agents causing UTI and their anti- 
biotic susceptibiities in renal transplant recipients. 
Methods: Baskent University Hospital is a 300-bed, tertiary care hospital at 
whlch approximately 80 kidney transplantations are performed annually. Total 
1050 renal transplant recipients are included in follow-up program in our 
hospital. Thirty-one UTI episodes in 25 of these 1050 renal transplant 
recipients were evaluated. Industion criteria ofUTI: fever (238 "C), positive 
mid-stream urine culture (2 100.000 ch/mL), pyuria (> 25/pL.). Antibiotic 
susceptibdity testing was performed by Kirby-Bauer disk diffusion method. 
Results: The incidence of UTI was 0.3%. Twelve (38.7%) of the 31 isolates 
were Escherkhia coli, six (19.3%] were Klebsielh pnmmoniae, three (9.6%) were 
Enterobader aerogmes, three (9.6%) were Aciraefobacter baumanii, two (6.4%) 
were methlcillin resistant S~ophylocoms sums and one (3.2%) methicillin 
sensitive Stqby l -  epidmidis.  Seven (30.4%) of 23 Enterobacteriaceae 
were resistant to cipmfloxacin and 17 (73.9%) were resistant to uimethoprim- 
sulfomethoxazole. Five of the episodes have occured in the first month after 
transplantation, four in the period from the second through the sixth month 
and 22 beyond the sixth month. 
Conclusion: The incidence of UTI in renal transplant recipients who are 
included in follow-up program in our hospital is found to be low (31 episodes 
in 1050 recipients). Enterobacteriaceae are still the most frequently isolated 
agents in UTI among renal transplant recipients. Cipmfloxacin resistance 
should be considered when empirical therapy wtll be initiated. 
v] Tuberculosis in renal transplantation recipients 
H. Arslan, F. Ergin, F. Oner Eyuboglu, S .  Akcay, H. Karakayali 
and M. Haberal 
Ankara, TR 
Background: Immunosuppressed patients after renal transplantation (RT) are 
at increased risk of developing tuberculosis (TB). It is a serious inf'sious 
problem, especially for the patients living in the countries where this infection 
is endemic. In the present study, we retrospectively evaluated RT patients with 
tuberculosis of different organs with respect to clinical outcome, diagnostic 
procedure and response to antituberculosis therapy. 
Methods: We evaluated the side of infection, clinical manifestations, diag- 
nostic procedures, and response to the antituberculosis therapy in eight RT 
patients who developed TB after transplantation during a 5-year period. 
Results: The mean age of patients was 38. A total of 62% of them received the 
graft from a living donor. The infection was limited to the thoracic cavity in 
37.5% of the cases, a single extrapulmonary site in 37.5%. and it was 
disseminated in 25% of the patients. TB developed h m  6months to 
90 months (a median of 28 months) after transplantation. Fever was the most 
common symptom (observed in seven patients). In four cases (one thorasic 
and three extrathorasic), the disease appeared as fever of undetermined 
etiology. None of the patients responded to PPD skin test. M. tuberculosis 
culture were positive in five cases and microscopy revealed AFB in five 
patients. The diagnosis was performed with only histopathological evaluation 
in one patient. All of the patients were treated with four drug regiment 
(INH + ethambutol + rifampin + pyrazinamide). One allograft rejection epi- 
sode occurred during therapy. Hepatotoxicity developed in two patients 
during treatment. Seven patient completed 12 months therapy. One patient 
who was under antituberculosis therapy died following the diagnosis of 
disseminated TB. 
Conclusion: In RT patients, we have found that: 
0 extrapulmoner involvement was more frequent; 
TB might be considered seriously in patients who have prolonged fever of 
0 most of the cases were encountered later than the first transplantation year; 
0 rbpin-containing antituberculosis therapy was effective and did not 
undetermined etiology; 
cause graft failure. 
110 Abstracts 
P584 I Disscminatd Nocanlia iistemiije5 and coinfection 
with Trichophyton rubrum in a renal transplant recipient 
A. h a p ,  H. Arslan, E Ergin, H. Karakayali and M. ffaberal 
Ankara, TR 
A 45-year-old male patient who had undergone renal transplantation 16 years 
ago was admitted to hospital with a mass in his left groin and blurred vision 
and orbital pain in the left eye. At the time of admission, the patient was &ng 
tacrolimus, prednisolone, and cyclosporine-A. Pathological examination of 
the lesion revealed invasive fungal infection. A fundoscopic examination 
showed plaques suggestive of h g a l  infection, and Trichophyton tubnrm was 
isolated from material obtained from the left groin. On  the basis of these 
findings, immunosuppressive therapy was stopped, the patient was given an 
intravitreal injection of 0.1 mg amphotericin B and was started on antifungal 
treatment with amphotericin B (3mg/kg/day). On the third day of 
hospitalization, the patient became acutely febrile. A chest X-ray showed 
nodular iniiltration in the left lower lung lobe. Computed tomography (CT) 
demonstrated a solid, lobulated mass in the lateral lower basal segment of the 
left lung. Since the patient developed right-sided weakness, magnetic reso- 
nance imaging (MRI) of the brain was also perfiormed and showed multiple 
abscesses. A vitreal specimen was obtained by fine-needle aspiration and a 
positive growth signal was noted on the fourth day of blood culture incuba- 
tion. Modified acid-fast staining of both the vitreal specimen and the growth 
on the blood cultures showed acid-fast, delicate, branching filaments, which 
are characteristic of Nocurdia spp. Further investigations revealed the bacteria 
as Nocardia asteroides. Due to the patient’s deterioration and the diagnosis of 
nocardialsepsis, the treatment was changed to amphotericinB (3 mg/kg/day), 
TMP-SMX (2 X 160/8OOmg/day), amikacin (1 x 1 g/day) and cefotaxlme 
(3 x 1 g/day). At the end of the fust week on this new regimen, the patient’s 
fever subsided and overall condition improved dramatically. Two weeks later, 
the patient was discharged from hospital. He continued treatment with 
amikacin (1 X 1 g/day), TMP-SMX (2 x 2 ds tabledday), and imipenem 
(4 x 500 mglday) for 28 days. Subsequently, ototoxicity developed and 
Corynebacteria 
y-glutamyl transferase levels elevated. The treatment was changed to mer- 
openem 3 x 1 g/day. After 6 months of therapy, cranial MRI demonstrated 
almost complete resolution of the abscesses. We plan to stop the meropenem 
treatment at the end of 12 months. 
F\ Necrotizing fasciitis in a renal transplant recipient 
E E r p ,  H. Arslan, I. Turker, G. Yaps, M. Haberal and H. Karakayali 
Ankara, TR 
Invasive group A Streptococcal infection (GAS) is characterized by signs of 
shock, multiorgan failure and destructive soft tissue infection like necrotizing 
fasciitis. Necrotizing fasciitis is rarely seen after renal transplantation, with a 
few cases cited in literature, and survival is infrequent. A 51-year-old male 
renal transplantation recipient who had diabetes mellitus for 5years was 
admitted to hospital with fever, sore throat and localized pain erythema 
and edema without crepitation over his right elbow. His nasopharynx was 
hiperemic with hypertrophic tons&. Since the patient was in shock, a 
presumptive diagnosis of necrotizing fasciitis was made. Therapy consists 
of penicillin G 24 d o n  units/day plus clindamicin 1800mg/day was 
initiated and urgent debridement was carried out. Gram-positive cocci were 
seen in Gram stain of tissue specimen. GAS grew in throat, tissue, and blood 
cultures. Anaerobic cultures yielded no bacteria. Histopathologic examina- 
tions revealed subcutaneous and muscle necrosis. Muftiorgan failure, DIC and 
superinfections with methicillin-resistant S. aureus and Acinetobacter spp. 
developed in postoperative period despite intensive and appropriate anti- 
microbial and surgical intervention. Following progressive worsening, patient 
died on the 22nd day of admission. No postmortem biopsy was obtained 
because of the disagreement of his f d y .  In conclusion, for renal transplanta- 
tion patients, necrotizing fasciitis is a life-threatening disorder that requires 
early recognition and aggressive treatment, including surgical intervention. 
In this case report, isolation of GAS in throat culture was an interesting 
finding. 
Jp586j The European Commission DG RTD lNCO 
Copernicus program: an example of successful collaboration 
between countries of Eastern and Western Europe 
R. S. Kozlov, C. Andronescu, S. A. Gabrielian, T. G. Glushkevich, 
I? A. D. Grimont, V. E. Kim, I. K. Mazurova, I. Selga, L. P. Titov, 
G. Ya. Tseneva and A. Efstratiou 
Smolensk, RUS; Bucharest, RO; Yerevan, ARM; Kiw, UkX; Paris, F; 
Almafy, KAZ; Moscow, RUS; Rip,  LK Minsk, BLR; Saint Petenburg, 
RUS; London, UK 
The European Commission DG RTD INCO Copernicus programme 
lC15.CT.98.0302 commenced in September 1998 with the following objec- 
tives: to improve microbiological surveillance of potentially toxigenic cor- 
ynebacteria, to organize a network of Reference Laboratories within Eastern 
Europe @E) and to stimulate information and technology exchange between 
countries of Eastern and Western Europe (WE). Eleven partners &om nine 
counaies of EE and WE participated in this program, including the UK, 
France, Armenia, Belarus, Kazakhstan, Latvia, Romania, Russian Federation 
and the Ukraine. The total duration of the project was 40monrhs. Meth- 
odologies were focused upon the organization of an effectively functioning 
network, harmonization of methods for laboratory diagnosis of diphtheria, 
development of rapid techniques for determination of toxigenicity of cor- 
ynebacteria and the implementation of a surveillance database with regular 
data submission. An international quality assurance program was also devel- 
oped to allow improvements in microbiological surveillance and standadza- 
tion of laboratory methodologies. In addition, specific research activities, 
involving the training of partners in laboratories situated within WE (UK and 
France), were essential for successful collaboration ofpartners. New National 
Diphtheria Reference Centres were organized in Armenia, Belarus, Kazakh- 
stan, Latvia and the Ukraine. Microbiological surveillance was established 
snccessfdly by the implementation of specialized diagnostic methods and also 
the development and introduction ofnew, rapid methods for determination of 
toxigenicity (e.g. EL4 and immunochromatographic strip test) used in several 
field evaluations. A survedlance database was designed using Microsoft@ 
Access, which currently includes data on 1649 strains. This project can be 
considered as an example o f  successful collaboration between countries of EE 
and WE. It has not only led to improvements in laboratory diagnosis by 
harmonization of methodologies, and implementation of new diagnostic 
methods, but has also helped in strengthening surveillance and establishment 
of sciendfic collaboration, information exchange and transfer of technology 
(via visiting scientists program) between participating countries. In addition, 
available funds have allowed countries to acquire necessary reagents and 
equipment which overall stimulated the establishment of a reliable surveil- 
lance system for diphtheria. 
(p5871 Epidemiological surveillance of Coryt~ebiscterium 
diphtheriae and C. ulcerans infections in Europe 
S. Lai, €? A. D. Grimont, C. von Hunolstein, J. Vuopio-Varkila, 
J. Douboyas, K. H. Engler, H. Beattie, J. Blayer and A. Efstratiou 
London, UK; Paris, F; Rome, 
Objective: An epidemiological database for the surveillance of Corynebucterium 
diphtheria and C. ulceram infections has been established within the remit of 
the European Commission BioMed2 BMH4.CT.98.3793 Programme to 
monitor all laboratory-confirmed diphtheria cases in Europe. 
Methods: A database (DipEpi) for epidemiological surveillance of  C. dipkther- 
iae and C. ulceram isolates was established at the Resource Centre, PHLS, 
London. Clinical and epidemiological data accompanying, where possible, 
Helsinki, FIN; Thessaloniki, GR 
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each laboratory-confirmed case of diphtheria was collected. Each partner 
(Finland, France, Greece and Italy) submitted retrospective data on the isolates 
received and characterized by their laboratory. From 1998, data were 
submitted every 6months for enuy onto the database. UK data held on 
the Oracle database system was integrated within the DipEpi database for 
analysis. 
Results: The database contains 1945 entries, >95% ofthese are represented by 
UK data and the remainder are data submitted by partners. This 
includes information on 107 toxigenic strains, 1754 nontoxigenic strains 
and 84 others. Among the toxigenic strains, there is a predominance of 
C. ulceram (43), and a significant number is represented by C. diphthm'ae 
var mitis; of the nontoxigenic strains, C. diphtherioe var g r a ~  predominate, 
whilst C. diphthen'ae var mitu and C.psertdodiphtheriticum are also sigdicant. 
Other species include C. diphtheriae var beyanti, C. ukerans, C. striaturn and 
C. urealyticurn. 
Conclusion: Preliminary analysis highlights the prevalence of nontoxigenic 
C. diphtheriae, the sigdicance of 'toxigenic C. ulceram associated diphtheria' 
and the successhl centralization of epidemiological data of laboratory-con- 
firmed diphtheria cases in Western Europe. The global incidence ofiiections 
caused by nontoxigenic C. diphtheria and C. ulceram is unknown and their 
monitoring within the surveillance h i e w o r k  for diphtheria is warranted. 
Continued monitoring oflaboratory-confirmed cases of diphtheria in Europe 
is one of the objectives of the new DGSANCO European Diphtheria 
Surveillance Network programme, providing the basis for effective investiga- 
tion and control. 
I P588 1 Nontoxigenic Corynebacterium diphtheriae in 
England and Wales: genetic and biological characterization 
studies 
A. De Zoysa, G. Mann, J. White and A. Efstratiou 
London, UK 
Objectives: Since 1990, there has been a marked increase in the number of 
nontoxigenic C. diphthen'ue isolates referred to the PHLs/WHO Streptoco- 
ccus and Diphtheria Reference Unit (SDRLJ). SDRU and the Communic- 
able Disease Surveillance Centre (CDSC) enhanced surveillance of all 
nontoxigenic C. diphthm'ae infections in England and Wales during 1995 
and 1996. Since then, the number ofreferrals have continued to increase, from 
51 in 1993 to >3M) in 2000. It has been proposed that nontoxigenic 
C. diphtheriue could become toxigenic by acquiring the tox gene if their 
chromosomal gene (diphtheria toxin repressor gene, dtxR) is bctional. 
Hence, naturally occurring nontoxigenic strains could constitute a potential 
reservoir for toxigenicity by phage conversion. Ribotyping has revealed that 
several genotypes are circulating in the UK and a predominant genotype 
(provisionally designated as 'A) had disseminated widely within England and 
Wales. This bas highhghted the importance of performing studies to deter- 
mine whether the strains possessed functional d txR genes and their distribu- 
tion amongt clinical isolates. Sequence analysis of the amplified product was 
also undertaken, and to determine whether or not these were functional 
genes, production of siderophores in varying concentrations of iron was also 
demonstrated. 
Methods: A total of 140 C. diphthm'ue isolates were ribotyped. PCR ampli- 
fication of the d t x R  gene was camed out on a selection of 40 isolates and 
sequencing of the PCR products was performed by dye terminator cycle 
sequencing using a CEQ 2000 capillary sequencer. Siderophore production 
was determined using a modified Chrome Azurol S assay. 
Results. Results obtained have shown that these strains possessed the d t x R  
gene and they produced siderophores when grown in an iron-limiting 
environment. Sequence data detected 45 point mutations amongst the UK 
isolates with three amino acid substitutions. 
Conclusions: PCR amphfication showed that all strains possessed the d txR 
gene and sequence data detected considerable heterogeneity within the OW 
of the dtxR gene. However, none of the amino acid substitutions appeared to 
have inactivated the d t x R  gene. Detection of siderophore production showed 
that the d t x R  gene is fidly functional. 
lp589( Prevalence of corpllebaaerium urea/yticum in 
adult urinary tract infections in &year period (1998-2001) 
M. Kanellopoulou, N. Skarmoutsou, M. Martsoukou, E. Mylona, 
M. Katopodi, A. Charalambopoulou and E. Papahgas 
Athens, GR 
Objectives: To study (a) the prevalence of Cotynebucteriurn urealytinrrn in adult 
urinary tract infecuons in a penod of 4yem (1998-2001). (b) the= suscept- 
ibhty to antibiotics. 
Methods: Urine samples were plated in blood agar and incubated in ambient 
air, 35 "C for 4&72 h. MI Coryne System (BioMerieux) was used for 
identification. Sensitivities to antibiotics were tested by uucroduhon 
method, accordmg to NCCLS guidelines. 
Results: C. urealyticurn waslsolatedma total of24/19482 (0.12%) patients (13 
men, 1 1 women; mean age 66 years) during the study period. The underlying 
diseases of these patlents were: urologc manipulation 9/24; previous urologic 
diseases 5/24; mdwelling catheter 6/24; diabetes mehtus 2/24; hematologic 
malignacy 1/24; lung cancer 1/24. The majority (18/24) presented urologic 
symptoms (hematuria, dysuria frequency). The urine were akaline (PH > 8) 
in 8W?. Hematuria (mcroscopic/gross) and pyuria were fbund in 75 and 70%, 
respectively. The resistence to antibiotics was: penicfin 100%, gentamicin 
85%, erythromycin, clindamycin, cotrimmole 80?h each, quinolones 72%. 
temcyche 35%, rifampin 30%. smce all the isolates were sensitive to 
GI ycopeptides. 
Condusionr: (1) The prevalence of C. urealyticum in urinary tract infections is 
0.12% ma* in patients suffering from urologic diseases. (2) C. urealyrinrrn 
isolates were h a y  resistant to many antimicrobial agents including quino- 
lones and cotrimoxazole. (3) C. ureulyticum isolatesappearedhghly sensihve to 
glycopepades. (4) rfampin may be an alternauve antimicrobial agent for 
C. ureulyticum urinary tract infections. 
Corymbacterium mucifaciem bacteriaemia: 
two case reports 
A. Enriquez, C. Tom, P. Alvarez, R de J&&, N. Canuno and 
M. Baquero 
Madnd, E 
C mmfmm sp. nov. is an unusual species recently descnbed, isolated from 
human clnucal specmens. The morphologes of colomes are shghdy yellow- 
ish, h te r ing  and markedly mucoid. We describe the isolahon of C mun- 
faciens &om blood 111 two paaents. 
Case 1: A 36-year-old man i e c t e d  w t h  HIV-1 +osed 3 years ago. He 
came at emergency ward of our hospital complaimg of fever, thoracic pam 
and malase of 2days durahon. He had clintcal records of recurrent pneu- 
moma during the last year Chest radlograph was normal. He was dlagnosed of 
upper respiratory tract mfectlon, and treated wlth anthromycine Blood and 
sputum cultures were performed before antmicrobial therapy, but no patho- 
gen was recovered. Seven days later, he remained febrile but the respuatory 
symptoms were resolved. A new blood culture was peabrmed and one ofthe 
three botdes ylelded growth of a Gram-posxtive, coryneformed bactena 
idenhfied as C. mun@ciens. 
Case 2: A 52-year-old woman w a s  admttted at our hospital wlth an acute 
episode of hgh €ever, dyspnoea and malaise. She had a history of artenal 
hypertenslon and a record of pigeon contact. A chest radiograph revealed 
&se bdateral infiltrates suggesave of atypical pneumonia She was treated 
wlth macrohdes and dlscharged. After 48h. she had another episode of 
s d  chactenstics. The treatment ofmacrohdes and predmsonewas started 
agam, wlth complete improvement. C rnucifMens grew in one of the 
three blood cultures performed. In both the cases, the isolates presented 
in sheep blood agar a colomes of 1-1.5mm dameter, cucular, convex, 
ghtering, slightly yellomsh and markedly mucoid. Gram-stam revealed 
typical mphteroids Gram-positive cells in clusters with a mucous sheath 
around them 
Conclusions: Recently, a new species named C. rnuci@-wm obtamed &om 
buman clinical specmens has been descnbed. Although at present, blood 
culture is the most common source where th~s bacterium has been recovered, 
there is no data about its c h c d  sigruficance. In our pahena, the isohhon was 
in bloodstream too, but it: was not clearly associated to hs chmcal symptom 
and could be a colomzer of s h  or contartunant of sterlle body sites hke other 
corynebacteria However, a potenhd pathogenic role cannot be rejmed and 
more reports are necessary 
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[ P591 I Prospective study of bacteremia in children during 
a 7-year period 
A. Pkez, M. G n h e z ,  C. Rodngo, C. Prat, A. Pallares and 
G. Fernsldez 
Bum-lona, E 
Objectives: To analyze the etiology of pediatric bacteremia in a tertiary 
medical center and the relationship with age, source, risk factors, antibiotic 
susceptibility and mortahty. 
Patients and methods: We conducted a 7-year prospective study of bacter- 
emia episodes with clinical significance in children. A single blood culture was 
obtained and inoculated into aerobic bottle. Anaerobic bottle was inoculated 
only in clinical settings associated with anaerobic infection. 
R e d t ~  A total of 213 episodes of bacteremia were studied for 7 years. AfCer 
the neonatal period, 169 episodes were diagnosed. Among this group of 
chddren, community-acquired accounted for 85%. and 53% of the patients 
were younger than 2 years old. The most fiequent isolates were Streptococcur 
pnerrmoniae (18%). Neisseria meningifidis (16%), Staphylococnrs aureus (12%), 
Escherirhia cofi (1 1%) and coagulase-negative Sfaphylorows (10%). The main 
sources of bacteremia were pneumonia (14%). indwelling vascular catheters 
(14%), gastrointestinal and abdominal infections (lo%), urinary tract infec- 
tions (7%) and bone and joint infections (7%). In 35%, the source of 
bacteremia could not be established (occult bacteremia accounted for 
10%). Fifiy episodes were diagnosed in children with underlying diseases 
(50% malignant neoplasms). In the neonatal period, 44 episodes were studied. 
The main etiologic agent in early neonatal sepsis was Sfreptocorns agalucfide 
(55%) and in late onset sepsis was E. coli (31%). Some degree of penicillin 
resistance was observed in 45% ofpneumococcal strains (MIC > 0.06 pg/mL) 
and in 46% of the meningococcal strains (MIC>O.l2pg/mL). Of the 
pneumococcal isolates, 19% were also nonsusceptible to third generation 
cephalosporins (MIC > 0.5 pg/mL.). Four deaths attributed directly to the 
bacteremia were observed all in newborn infants. 
Conclusions: After the neonatal period, bacteremias were mainly commu- 
nity-acquired episodes in patients younger than 2-year-old and the most 
frequent causative agent was S.pneumoniae. No deaths attributed to bacter- 
emia occurred in children older than 1 month. Although our study is hospital 
based, it represents more closely a community-based study and may be 
applicable to most of the pediatric emergency departments. 
Acute mastoiditis in children - Pseudomonas 
aeruginosa as a leading pathogen in older patients 
Y. Butbul, D. Miron, R. Halevy, A. Koren and W. Sakran 
Afirla, IL 
Objectives: To assess the chnical features, pathogens, management, and 
outcome of acute mastoiditis (AM) in children in northern Israel. 
Methods: A systematic review of medical records of all children who were 
admitted with acute mastoiditis between January 1990 and December 2000 to 
the Pediatric Wards at Ha'Emek Memcal Center, M a ,  Israel. 
Results: During the study period, 57 children with acute mastoiditis were 
admitted. The median age was 34.5 months (range: 4months to 13years). In 
26 (45.6%) patients, acute mastoiditis complicated a first episode ofacute otitis 
media. Twenty-five (44%) children received antibiotic treatment before 
admission. Frequent symptoms on admission included erythema over the 
mastoid area (94.5%), proptosis ofthe auricle (91.2%), fever (75.8%). Middle 
ear, subperiostal, and mastoid aspirates yielded growth of pathogen in 35 
(78%) of the 45 children. The most frequent pathogens were: Pseudomonas 
aemginosa (26.6%). Streptococcw pneumoniae (17.7%) and group A Sfreptococcus 
(1 1.1%). A hgher incidence of S. pneumoniae on culture was found in children 
who did not suffer from AOM as compared to those who had AOM during 
the last week before admission (35% vs. 5%) and in children younger than 
2 years. Seventeen children underwent computed tomography ofthe mastoid 
for suspected surgical complication. Bone destruction of the mastoid was 
demonstrated in five children, subperiostal abscess was found in eight 
children. Flfry-two (91%) children were treated by antibiotics alone. Simple 
mastoidectomy was successfully performed in five children. The median 
duration of hospitalization was 7 days (range 1-%days). 
Conclusions: The diagnosis of AM could be made on clinical basis and CT is 
needed only in those children in which surgical complication is suspected. 
Half of the children admitted with AM have no previous history of recurrent 
AOM. In those children, S.pneumoniae was the leading pathogen, while 
I? aemginosa was more prevalent in children with recurrent AOM. The great 
majority of the patients recovered with medical therapy, and did not require 
surgical intervention. 
I P593 1 Nontyphoidal Salmonella bacteremia in childhood 
A. Christidou, M. Bitsori, E. Galanakis, S. Maraki, C.  Giannakopoulou 
and Y. Tselentis 
Heraklion, GR 
Objectives: To study the incidence, clinical and bacteriologic characteristics 
and outcome of nontyphoidal SalmOnrNo (NTS) hacteremia in children. 
Methods (population): All the children with culture-proven NTS infection 
hospitalized in the Department of Paediatrics and Neonatal Intensive Care 
Unit, University Hospital of Crete during the 9-year period h m  January 
1993 to September 2001 were included. The medical and microbiologic 
records of the children were retrospectively reviewed, and demographic, 
clinical and laboratory characteristics, serotype and susceptibihty of the strains, 
treatment and outcome were analyzed. 
Results: During the study period, the total number of children with NTS 
infection was 337 (mean annual number = 37.2). NTS infection was the cause 
of 0.015% of adrmssions. Among the 337 children with NTS infection, 
bacteremia was found in 13 children (0.04%). Most of the bacteremic cases 
presented between July and September (9/13). The mean age of the chddren 
was 1.8years (range: 5 months to 7.5years) and 9/13 were infants of <1 year. 
All children but one presented with fever >39 "C, one with febrile seizures, 
two with a rnascular rash and two with extraintestinal focal infections 
(prevertebral and rectal abscess). None of the children had meningitis or 
urinary tract infection. Two of the cases presented without gastroenteritis. 
None of the children had a predisposing underlying disease, such as sickle cell 
disease. The mean blood white cell count was 11 300/mm3 (range: 7800- 
15 700/mm3) and none of the children had leucopenia. S. enteritidis was the 
most common serotype isolated (6/13), followed by S.virchow (4/13), 
S. agona, S. newport, and S.  typhimurium (one case each). All strains were 
sensitive to all /Llactamic antibiotics and to cotrimoxazole. Repeat blood 
cultures were obtained in all patients and were all sterile. The median duration 
of hospitalization was 11 days and all children received antibiotics inuave- 
nously for a minimnm of 7days (range: 7-3Odays). Fever subsided after a 
mean time of 3 days after initiation of antibiotics. All the children had a full 
recovery and no NTS infection was manifested during a mean follow-up 
period of 3.45years (range: Zmonths to 9years). 
Conclusion: NTS bacteremia, although currently uncommon, may still cause 
considerable morbidity in healthy children, especially in the very young. The 
risk of focal infection is small and the outcome is favorable with appropriate 
antibiotic treatment. 
Efficacy of 54ay cefprozil versus l0-day 
amoxicillin/clavulanate for acute otitis media in children 
P. Marchisio, N. Principi and L. Lambertini 
The Italian Ce&mzif Otitis Media Study Group 
Objective: To compare the efficacy and safety of 5-day ce$rozil (CEFP) 
versus 10-day amoxicillin/clavulanate (AMX/CL) suspensions for acute otitis 
media (AOM) in children. 
Methods: In this prospective, open-label, multicenter study children aged 
6 months to 12 years with AOM (either first AOM or recurrent AOM) were 
randomized to receive CEFP (30 mg/kg/day BID) for 5 days or AMX/CL 
(50 mg/kg/day of AMX TID) for 10 days. Follow-up otoscopic and tympa- 
nometric controls were scheduled at the end of treatment and at day 28-32. 
Outcome was defined as satisfactory (cure, complete resolution of signs and 
symptoms and absence of effusion +improvement, partial resolution of signs 
and symptoms and persistence of e e i o n )  or unsatisfactory (failure by the end 
of therapy; recurrence by day 28-32). 
Results: Out of the 140 enrolled children, 73 (44M, mean age 4.3years) 
received AMX/CL and 67 (42M. mean age 4.1 years) CEFP By the end of 
therapy, a satisfactory outcome was observed in 67/67 (100%) children treated 
with CEFP and in 67/73 (90.4%) children treated with AMX/CL (P=O.OZ) 
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(cure: CEFP 37.3% vs. AMX/CL 42.4%; improvement: CEFP 62.7% vs. 
AMX/CL 48.0%). By day 28-32, a satisfactory outcome was observed in 
61/64 (95.3%) children treated with CEFP and in 56/61 (91.8%) children 
treated with AMX/CL (P=  0.48) (cure: CEFP 64.1% vs. AMX/CL 43.9%; 
improvement: CEFP 26.9% vs. M / C L  40.9%). Mild drug-related advene 
events (mainly gastrointestinal) were observed in 8/67 (11.9%) children 
treated with CEFP compared with 17/73 (23.3%) children treated with 
Conclusions: Shortened, effective, antibiotic therapies for community- 
acquired upper respiratory infections are desirable especially in children. 
Our data suggest that treatment with CEFP given for 5 days is as effective 
and well tolerated as the conventional treatment with AMx/CL for 
10days and may offer a valid alternative regimen with potential for better 
compliance. 
AMX/CL (P=0.12). 
(p5951 Epidemiology of invasive Streptococcus 
pneumoniae infections in children in an area of Barcelona, 
Spain 
H. Larramona, D. Fontanals, M. Domingo, J. Rivera and F. Segura 
Sabadell, E 
Background: Streptococ~s pnarmoniae remains a leading cause of serious 
community-acquired dections among young children, With the advent 
of conjugate vaccines, it is becoming possihle to prevent disease caused by t h i s  
organism. 
Objectives: To determine the incidence and the clinical and microbiologic 
characteristics of this disease in children resident in Sabadell, an industrial area 
with 371 663 inhabitants in the province of Barcelona, Spain. 
Methods: From January 1990 to December 2000, case records of children 
with pneumococcal invasive disease at Sabadell Hospital were retrospectively 
(1990-1996) reviewed and prospectively (1997-2000) collected. 
Results: A total of 112 children, 54% less than 24 months of age and 93% less 
than 6yean of age with invasive pneumococcal disease were diagnosed in 
a period of 11 years. The incidence was 76 per 100000 for children aged 
0-24months. 45 for children aged 0-48 nionths, and 16.6 for children aged 
O-14yean old. Occult bacteremia was the most common madestation 
observed (66 cases), pneumoniawas the second form (34 cases) and meningitis 
(10 cases) and arthritis (2 cases) were the other clinical d e s t a t i o n s .  Of 
the 105 strains tested, 8.6% were highly penicillin-resistant, 37.1% were 
intermediately penicillin-resistant, 16.2% were intermediately cefotaxime- 
resistant and 32.4% were erythromycin-resistant. Pneumococci of semgmups 
6,14,18,19,1,5,4,9,23and33wereisolatedmostl?equently(92%)butonly 
6,9, 14, 19 and 23 were resistant to penicillin, cefotaxime or erythromycin. 
Conclusions: The pneumococcus is the second cause of invasive bacterial 
infection in children in Sabadell, behind the meningococcus infection. Our 
incidence is greater than the incidence reported previo+ in Spain and 
Europe, perhaps due to the number of occult bacteremia cases in our study. 
Penicih-resistance levels in our area are very high, but the trend towards 
increasing penicillin resistance may have ended over the last f%w years. The 
currently licensed seven-valent pneumococcal conjugate vaccine representing 
serogroups 4, 6, 9, 14, 18, 19 and 23 would cover 78% of cases of invasive 
pneumococcal in children aged O-l4years, 80% in children aged 0- 
24months and 1W/o of cases of invasive pneumococcal &ease penicillin 
or cefotaxime-resistant in children resident in Sabadell. 
lp596; Phenotype and genotype diversity of the HMW 
adhesins in nonencapsulated Haemophilus influenzae 
isolates from invasive disease 
M. Cerquetti, E? Splgagha, G. Renna, R. Brunetti, R. Cardines 
and I? Mastrantonio 
Rome, I 
Among surface antigens of nonencapsulated Huemophifus inzuenzae, the 
HMWl and HMW2 proteins are the major adhesins responsible for attach- 
ment to human epithelial cells. These high molecular weight proteins were 
originally idenafied as the predominant target of the host nnmune response 
during host otitis media and were proposed as vaccine components. In 
H.  inyuenzae strain 12, both the HMWl and HMW2 proteins are present; 
the hmwlA and the hmwZA genes, which encode for the HMWl and HMW2 
structural proteins, are identical in the sequence of the first 1259 bp, but 
thereafter partially diverge (overall identity 80%). In the present study, 62 
nonencapsulated H. intuenzae strains isolated &om invasive disease were 
studed. The presence of the hmwA genes was determined by PCR using 
primers recognizing a sequence in the conserved region ofthe hmwlA and the 
hrnw2A genes h m  the strain 12. Western blotting with polyclonal rabbit 
antiserum and with HMW-specific monoclonal antibodies (Mabs) was per- 
formed to assess the presence of HMWl and HMW2 proteins. To hrther 
characterize the HMW type expressed by the different strains, a PCR-RFLP 
analysis was performed. A 21 15-bp sequence, located in the divergent region 
of hmwIA and hmw2A in strain 12, was amplified by PCR and sequentially 
digested with specific restriction enzymes. PCR demonstrated the presence 
of hmwA genes in 38 out of the 62 (61%) strains studied. Western blotting 
with polyclonal rabbit antiserum showed the presence ofHMW proteins in 30 
out of the 38 hmwA-positive strains (78.9%). Contrary to the prototype 
H. intuenzae strain 12, the majority of the strains exhibited only one HMW 
protein band. A large variability in the molecular mass of the proteins was 
observed (ranging fiom 110 to 160 ma). Using the HMW-specific Mabs, six 
different patterns were found. The expected PCR product of 2115bp was 
amplified in all the 38 strains tested. Several different RFLP profiles were 
obtained with each restriction enzyme. Our results demonstrate that the 
HMW adhesins are expressed by the large majority of nonencapsulated 
H. inzuenzae isolates fiom invasive disease. A large heterogenicity was found 
among the different strains studied, suggesting the presence of several variants 
of the HMWl and HMW2 proteins compared to those detected in the 
prototype strain 12. 
[ ~ 5 9 7  I tmmunogenicity of anti-/+aemophi/us influenlee 
type B CRM197 conjugate following mucosal vaccination 
with oligodeoxynucleotide containing immunostimulatory 
sequences as adjuvant 
S. Mariotti, C.  von Hunolstein, R. Teloni, G. Orefici, R. Nisini 
and G. Romagnoli 
Rome, I 
Objectives: Most vaccines are delivered by injection. Mucosal vaccination 
would increase compliance and decrease the risk of spread of infectious 
diseases due to a reduction of mucosal colonization and of contaminated 
syringes. However, most vaccines are unable to induce immune responses 
when administered mucody, and require the use of strong adjuvant or 
effective delivery systems. Synthetic oligodeoxynucleotides containing CpG 
immunostimulatory sequences (ISS) have been shown to act as potent 
adjuvants of type-1 immune responses also when mucosally coadministered 
with protein or peptide vaccines. We have shown that ISS can increase the 
antipolysaccharide (CHO) antibody titers and antidiphtheria toxin-neutraliz- 
ing antibody, if used as adjuvant of anti-Haemophiiuc inpUenzoe type b (HIB) 
CHO vaccine conjugated with cross-reacting material (CRM) of diphtheria 
toxin in mice. 
Methods: BAL.B/c mice were immunized by intranasal (i.n.) inhalation of 
2.5 pg CHO/mouse of HIB-CRM alone or in combination with 0.5 pg/ 
mouse of CT, 1G20 Fg/mouse of ISS or M-ODN in a total volume of 66 pL 
(33 kL/naris). HIB-CRM conjugate vaccine was administered in a three-dose 
schedule (0, 10 and 20days). Adjuvants were administered in the fint 
inoculum only, or in three inocula of vaccine. The antibody response to 
HIB-CHO in sera was determined by enzyme-linked immunosorbent assay 
(ELISA). Diphtheria toxin-neuuahzing activity of anti-CRh4 antibodies in 
sera of mice immunized with HIB-CFUvl alone or in combination with one 
or three doses of ISS (10 pg/mouse) was determined in vitm according to the 
Miyamura assay with Vero cell line. 
Resultr. Here we show that ISS have the potential to increase host local and 
systemic antibody response against both the CHO and the protein component 
of a conjugated vaccine when mucosally administered in mice. Mucosal 
administration of HIB-CRM vaccine induced anti-CHO and neutralizing 
antidiphtheria toxin antibodies of all the IgG subclasses, with a predominance 
of type-1 immune response-associated IgG2a and IgG3. At odds with 
systemic administration, the mucosal delivery of HIB-CRM induced anti- 
CHO and antidiphtheria toxin mucosal IgA. 
114 Abstracts 
Conclusions: Our data envisage the feasibility of a mucosal vaccination with 
an already licensed HIB-CRM vaccine and encourage the investigation to 
idennfy strategies of vaccination with schedules aimed at the valuation of 
protein carriers as protective immunogens. 
vl The introduction of HI6 vaccination in the Czech 
Republic 
I? Krizova, V. Lebedova and C. Benes 
&'rape, CZ 
Objectives: Active survehnce was introduced in the Czech Republic to 
estimate the incidence and case fatality rate of invasive disease caused by 
Haemophilus injuenzae b (HIB) and to assess the impact of routine HIB 
vaccination of infants. 
Methods: Active surveillance was introduced nation-wide in January 1999 
and case definition of invasive HIB disease included meningitis, epiglotitis, 
bacteremia and/or sepsis and pneumonia. According to the laboratory results, 
HIB cases were defined as confirmed, probable or suspected. Routine 
HIB vaccination of infants was introduced in July 2001 using tetravalent 
DiTePe + HIB vaccine. 
Results: The results of active surveillance of HIB invasive disease showed a 
total incidence of 1.0/100000 population in 1999 and 1.1/100000 in 2000. 
The hghest incidence, in both years, was in age group G11  months (17.1/ 
100000 and 15.6/100000, respectively) and 14years (17.4/100000 and 
20.9/100 000, respectively). The most kequent clinical form, in both years, 
was meningitis (53.5 and 59%, respectively) followed by epiglotitk (35.6 and 
27.3%, respectively). Total case fatality rate was 1% in 1999 and 2.6% in 2000. 
The data of active surveillance for 2001 indicate the decrease of HIB invasive 
disease after the introduction ofroutine HIB vaccination. The nunlberofHIB 
invasive cases in the period after the introduction ofroutine vaccination Quly- 
October 2001) decreased to 59.2% of the cases found by active surveillance in 
the same months in the previous Zyears (27 cases in July-October 1999, 27 
cases in July-October 2000 and 16 cases in July-October 2001). The 
introduction of active surveillance of HIE3 invasive disease 2years before 
the start of routine HIB vaccination of infants gives a possibility to assess the 
etlicacy of this mass vaccination and to follow eventual vaccine failure 
according to the rules of the EU project. 
Conclusion: Routine HIB vaccination ofidants was introduced in the Czech 
Republic in July 2001. The results of active surveillance indicate decrease. of 
HIB invasive disease under the influence of this mass vaccination. 
Acknowledgments: This study was supported by research grant N1/6803-3 
of the Internal Grant Agency of the Ministry of Health of the Czech 
Republic. We thank Dr. K. Jolley (University of Oxford, UK) for kind 
editing of the text. 
Neo-natal infection 
p] Distribution of Burkholderia cepacfa complex 
isolates from patients with cystic fibrosis 
G. Golini and R. Fontana 
Verona, I 
Objectives: To confirm all isolates obtained from patients with cystic fibrosis 
(CF) as Burkholderia cepaau (Bc) Complex and to iden@ the genomovar ofBc 
isolates. 
Methods: Sixty-nine isolates, identified by Api 20NE as Bc, were subjected to 
a PCR-based identification by amplification of the 16s rDNA gene and by 
amplification of the R e d  gene, and the profile obtained from RFLP analysis 
of these genes were analyzed. 
Results: Sixty isolates (86.9%) were identified as Bc Complex. Four (6.7%) 
isolates were found to be Bc genomovar I, 27 (45%) isolates to be Bc 
genomovar 111-A, 28 (46.7%) isolates to be Bc genomovar 111-B and 1 
(1.6%) isolate to be Bc genomovar V. Nine (13%) isolates, misidentified 
by biochemical tests were found to be Pseudarnonas aeruginosa (three isolates, 
33.3%), Alcaligeenes xilosoxidam (three isolates, 33.3%), Stenotrophomonnr mal- 
tophilia (two isolates, 22.2%) and Ralstonia pickettii or Cornmomonas acidworans 
(one isolate, 11.1%). 
Conclusion: All isolates obtained from patients CF, identified by commercial 
test, are to be further confirmed by using genotyping methods. 
/p6001 Characteristics of bacterial pathogens isolated 
from cystic fibrosis patients. Typing of Staphy/ococcus 
aureus isolates by use of PFGE method 
K. Semczuk, H. Dmenska, U. Lopaciuk and D. Dzierzanowska 
Warsaw, PI. 
Objectives: The aim of the study was the determination of the h-equency of 
isolation of various bacterial species from respiratory tract of cystic fibrosis 
(CF) patients treated in the Children's Memorial Health Institute in Warsaw, 
Poland. 
Methods: A total of 49 children with cystic fibrosis hospitalized between 
January 1999 and November 2001 were investigated. Clinical specimens used 
for bacteriological examination were: sputum, deep throat swabs and epi- 
pharynx swabs. 
Results: Total 446 samples were taken h m  49 children. Sfaphylococc~c aureus 
was the most tiequently isolated pathogen (167 isolates). Fifteen S. aureus 
strains were resistant to metbicillin. The second most frequent pathogen was 
Pseudomonac aemginosa (61 isolates). Other isolated bacterial species were: 
Haemophilw injuenzae (24), Moraxella cutanhalis (21). Gram-negative rods of 
Enterobacteriaceae family (1 9). Streptococcus pneumoniae (1 2). Stenotrophomonas 
maltophiliu (5), Streptocoaus pyqenes (5), B-hemolytic Streptoco~us non-A (4), 
and other nonfiermenting rods (3). It was ascertained, that in spite of antibiotic 
treatment and regression of clinical symptoms, the CUINI~S were still positive 
for S. aureus and I! amginma. Phenotype of S. aureus was based on antibiotic 
resistance profile. PFGE was used for clonal characteristics of isolates. 
Conclurions: CF children hospitalized in our Institute were colonized/ 
infected mainly by S. aueus and P aenrginosa. Persistence of these pathogens 
was observed in spite of antibiotic therapy. 
Ip6011 Nosocomial enterococcal infection in neonates 
G. Kovacicova. J. Koprnova, B. Mahdi Hafed, E. Bilikova, V. Krcmery, 
R. Babela, D. Chovancova and M. Huttova 
Bratislava, SK 
Detfinitions: Enteromms spp. is the third commonest cause of nosocomial 
infection in adults and the fourth in children. Therefore, we decided to 
perform retrospective surveillance of enterococcal infections in neonates in 
tertiary neonatal center in Bratislava, from January 1999 to December 2000. 
Methods: We investigated all enterococcal mfections within 2years, among 
246 neonates hospitalized for infections in the neonatal intensive care unit. 
We used univariate analysis to assess risk factor for neonatal infections caused 
by Enferococcus spp. (99) versus those neonates causedbyother organisms (147). 
Results: Within 246 neonates, in 99 cases Enfewcow spp. was isolated fiom 
various samples, in 21 cases fiom blood cultures (bacteremia) (P< 0.0016), in 
29 cases &om urine culture (P< 0.0063), in 39 cases &om umbilical swabs 
(omphalitis), and in 28 cases &om gastric aspiration. The only risk factors for 
enterococcal infection was isolated from colonization (a positive skin swab 
P <  0.01). Early markers of enterococcal infections in comparison to other 
infection were: higher procalcitonin level (PCT) (P< 0.0037). positive septic 
score (P< 0.018) and leucopenia defined as <lo00 ( P <  0.0013). Bacteremia 
(P < 0.0055) was significantly more frequently observed among neonates with 
enterococcal infections than among neonates with other infections. Klebsiella/ 
Enterobmfer (58.59% vs. 36.05%, P< 0.0008) and Candida spp. (25.25% vs. 
13.61%. P< 0.031) as copathogenes were significantly more fkequently 
observed in neonatal infections caused by EnterococMs spp. Outcome (both 
attributable and overall m o d t y )  was similar to other infections. However, 
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neurological sequel such as intraventricular hemorrhage (III/IV) (P  < 0.018) 
was significantly more kequently observed in cases with enterococcal mfec- 
tions than in neonates with other infections. 
Conclusion: Overall and attributable mortalities were (both) very low 
(2.02%) which is in contrast to adults, where mortality on enterococcal 
infections exceeds 15%. This is probably because early, empiric, anti-infectis 
therapy in neonates with fever contained in our center anti-enterococcal 
antibiotics, such as ampicillin/sulbactam, or ampicillin (55.56%) plus genta- 
micin (45.45% vs. 23.81%, P< 0.00063). Such therapy may be a protective 
factor against inferior outcome of enterococcal infections in neonates, where 
mortality (2%) was much lower than reported from bacteremia studies in 
adults. 
(p602; Nosocomial infections in pediatric intensive 
care units 
T. Delgado M e h ,  I. Montesinos, A. Mkndez, A. Meliin, 
M. Cuervo, M. Lecuona, A. Torres and A. Sierra 
La Laguna, E 
Objectives: To determine the incidence, the site and bacterial epidemiology 
of nosocomial infections among patients admitted to pediatric and neonatal 
intensive care units of an university hospital (650 beds). 
Methods: A prospective study as a part of hospital infection control program 
was performed for 4-month with periodic chart review during hospitalization 
using an uniform prospective questionnaire in each unit. Infants admitted at 
the pediatric intensive care units (PICU) or the neonatal intensive care units 
(NICU) at least 24 h were included in the study. 
Results: During the 4-month period, 121 patients were studied (31 in PICU 
and 90 in NICU). In these units, mechanical ventilators were used in 32% 
PICU patients and in 30% NICU patients, urinary catheters in 65% PICU 
patients and in 20% NICU patients and central intravascular catheter in 42% 
PICU patients and in 36% NICU patients. Ths study showed a devices 
utilization ratios comparable with that of NNIS data. The incidence of 
nosocomial infection was 6.45% in PICU and 22.22% in NICU. In both, 
the most frequent nosocomial infection was bacteremia (PICU-lOO% and 
NICU-51.28%). In NICU, the highest nosocomial infection incidence was 
observed for very low birth weight infants. In PICU, the microorganism 
isolated was S. epidermidis. In NICU, the most common pathogens were 
E. cloacae (29.6%), C. albicanr (18.5%) and S. epidermidis (14.8%), but there was 
a outbreak of E. cloacae in this unit in October. 
Conclusions: There is a high prevalence of invasive devices and procedures in 
these settings and improving infection control practices when these devices 
are used should be an important measure to reduce infections. PICU and 
NICU (specially NICU) provide care for patient populations at the greatest 
risk for nosocomial infection, for that, surveillance of these units should be 
included in the infection control program all the year, because it is funda- 
mental to develop intervention strategies for the prevention of nosocomial 
infectiom in this population. Also, observe the evolution of nosocomial 
infection in the same unit should be observed to have epidemiological validity 
that can be used to evaluate the efficacy of prophylactic measures. 
v] Nosocomial infections (Nls) In a neonatal and 
pediatric intensive care unites (ICU): a prospective analysis 
E. Mantero, S. Ferrando, €? Tuo, G. OttoneUo, M. L. Beh, S. Rovida and 
G. Manno 
Genoa, I 
Objectives: The assessment of NIs incidence and of related risk factors (RFs) 
in an individual institution is an effective tool to design local guidelines. 
Methods: We performed a prospective study in the period January 15, to July 
15, 2000 in a 25-bed intensive care unit (ICU). Eighty-one newborns (N) 
and 144 children (C) were studied. The RFs chosen were: birth weight, 
hospitalization days, invasive procedures, surgery and antibiotics use. Data 
were collected on standardized forms and statistically analyzed. 
Results: The incidence of NIs was 20.9% (47 infections): 33.3% in N and 
13.8% in C. bloodstream infections PSIS) were the most kequent infections 
(55% in N and 60% in C) followed by pneumonias (PNE) (22% in N and 40% 
in C). Pathogens involved in NIs were Coagulase-negative Staphylococci 
(CNS) (48%), Gram-negative (26.4%). S.  aurew (13%) and Candida spp. 
(7.5%). The isolation rate (%) in BSIs and PNE was, respectively: CNS 69 
and 25, Gram-negatives 20 and 43, S. aurew 11 and 18, Candida 0 and 14. The 
oxacillin resistance rate was: 94.7 in CNS and 7.6 in S. aureus; 66% ofKlebsiella 
were resistant to th~rd generation cephalosporins. All Candida PNE were 
caused by non-albicanr strains.  ForBSIs the most sigmficant RF was prolonged 
total parenteral nutrition (TPN) (P< 0.0001) and for PNE were prolonged 
mechanical ventilation, arterial catheter and TPN ( P <  0.0001). RFs related 
to CNS infections were CVC, TPN, arterial catheter (P=0.0012); to 
Klebsiefh infections were low birth weight, hospitalization days, CVC/days, 
NPT, arterial and bladder catheter (P=O.OOOl). Antibiotic therapy was 
prescribed in 21 1/225 (93.7%) patients; 97 patients were empirically treated 
with a first-line therapy aminoglycoside + glycopeptide. The mortality rate, 
only due to BSIs, was 1.7 (3.7 in N and 0.7 in C). 
Conclusions: Our results show a hgh incidence of BSIs caused by resistant 
CNS, the related RFs stress the need to improve educational measures on 
management of invasive procedures, particularly CVC. A careful antimicro- 
bial policy is mandatory concerning the use of glycopeptides and thrd 
generation cephalosporins as first-line therapy. 
[ P6041 Therapeutic effect of imipenem/cilastatin against 
severe neonatal infections 
G. Mkusz, A. Genge, J. Behrendt, J. Karpe, G. Szirer and 
U. Godula-Stughk 
Zabrze, PL 
Objectives: Severe bacterial infections remain the most important cause of 
mortality and cost for neonates hospitalized in neonatal intensive care 
unite (NICU). The clinical efficacy of imipenem/cilastatin has been assessed 
in the management of severe early onset and nosocomial infections in 
neonates. 
Methods: A total of 42 (23 boys and 19 girls) neonates with birth weight 83C- 
3900 g (31 prematures and 11 full-term) admitted to the NICU in a university 
hospital &om January 1, 2000 to September 30, 2001 because of acute 
respiratory disorders. 
Results: Septicemia was documented in 33 babies (early onset in 21, 
nosocomial in 12) by clinical findings (pneumonia, NEC, shock), hemato- 
logical disorders (thrombocytopenia, anaemia, DIC) and the presence of 
Klebsiella pneumoniae (1 5), Pseudomonas amcginosa (5). Adnorobaacr bcrumani? 
(Z), Serratia marcescens (l), E.  coli (I), S. hamolyticus (4), S. epidennidis (4) and 
S.  hominis (1) in blood cultures. AU Gram-negadve strains were sensitive to 
imipenem. Pyuria (Klebsiella 10.5 in urine culture) in one full-term neonates 
with congenital defect of urinary tract, bilateral purulent coxitis in one baby 
and severe pneumonia in seven prematures (early onset in three andventilator- 
associated in four cases) were diagnosed. In five pneumonic mechanically 
ventilated neonates Gram-negative bacteria (Klebsiella: 3, Pseudomonas: 2) 
susceptible to imipenem in tracheal aspirates were noted. Twelve neonates 
obtained imipenem as alone antibiotic therapy &om the beginning of idec- 
tion, 28 babies were treated earlier by aminoglicosides, cephalosporins or 
amoxicillin/clavulanic acid, one by vancomycine and one by meropenem 
without satisfactory results. Imipenem was administered in dose 50-60 mg/kg 
every 6 h during 10-16 days (in case of coxitis: 28 days): in 16 neonates as 
alone antibiotic, in 25 with vancomycine and in one with ceftazidim. This 
therapy produced satisfactory clinical response in 34 (81%) patients (complete 
in 42%, partial in 39%). The bacteremia, Gram-positive (2) and Gram- 
negative (2) persisted despite ofimipenem administration in four prematures. 
The pneumonic prematures died: one because of massive intracranial hemor- 
rhage and one of bronchopulmonary dysplasia. 
Conclusion: Clinical efficacy of imipenem/cilastatin confirms its usellness in 
the treatment of severe neonatal infections in the intensive care unit. 
Ip6os] An outbreak of neonatal sepsis caused by 
Klebsiella pneumoniae ESBL 
K. Dobrovic, M. Morovic, B. Stankovic, V. Gilic and 
V. Lukac-Medic 
Zadar, HR 
Objectives: Klebsiella pneumoniae is an unusual cause of sepsis in healthy 
newborns. In our hospital, there had been no infections caused by K. pneu- 
moniae ESBL until January 2001 when five neonates had clinical and 
laboratory confirmed sepsis. We describe the results of our investigation as 
well as infection control measures that stopped the outbreak. 
Methods: AU neonates were oflow birth weight and low gestational age. They 
had been given breast milk by tube plus parenteral feeding (mdtidose vials). 
Mothers stayed long in the hospital, they were treated by cefalosporins 
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perinatally and became colonized by nosocomial pathogenes. Strains were 
identified by conventional biochemical tests. Antibiotic susceptibitity was 
evaluated by disk-diasion test according to NCCLS. ESBL production 
was detected by the double-disk synergy test and ESBL E-test (AB 
biodisk). 
Results: Shortly after birth all affected neonates had been given cefurox- 
imefgeutamicin. Between the 10th and 15th day of life (few days after 
therapy had finished) they developed sepsis. K .  pneumoniae ESBL was isolated 
from blood culture in five neonates and from stool of two more neonates 
(colonization).All strains had the same susceptibility pattern (resistant to a l l  
cephalosporins, gentamicin, and susceptible to amikacin, imipenem and 
ciproflnxacin).The result of additional cultures: HCW-hands - nurseA 
K. pneumoniae ESBL, nurseB Enterococrus; breast milk - motherA K. pneu- 
moniae ESBL, motherB Serraria marcescens, Pseudomonac aenrginosa; Salviarrin 
(multidose vial): Senatia marcescens. 
Conclusion: Excessive usage of antibiotics especially cephalosporins selected 
resistant K.pneumoniae. One of the possible ways of colonization was 
obviously contaminated breast milk that was given to newborns by tube. 
Poor compliance regarding infection control procedures as well as over- 
crowding and understaffing led to the outbreak. The outbreak was terminated 
after all affected neonates were cohorted and requirement for infection 
control procedures was stressed increase hand antisepsis and reinforcement 
of single dose vials. In order to restrict the resistance, modification of early 
empiric antibiotic regimen (exclusion of cefalosporins) was also recom- 
mended. Surveillance cultures 10 months after the outbreak showed suscep- 
tible Escherichia coli as predominate bacteria in NICU. In that period, neither 
case of neonatal sepsis nor isolation of resistant K. pneumoniae was registered in 
this unit. 
Enteropathogenic E. coli 
I P606 I Reliability of polymorphanuclear elastase for the 
diagnosis of neonatal sepsis 
I. Wojsyk-Banaszak, J. Szczapa and J. Gadziiowsh 
Poznan, PL 
Infections are a major problem in neonatalintensive care units throughout the 
world, and early diagnosis and therapy would certainly reduce associated 
morbidity and mortality as well as decrease unnecessary antibiotic treatment. 
Objectives: To evaluate the usefulness of polymorphonuclear elastase (PMN- 
E) serum concentration as an early indicator of neonatal sepsis in comparison 
with routinely used infection markers. 
Methods: PMN-E was measured in 76 newborns with suspicion of systemic 
bacterial d e a i o n  treated in a tertiary intensive care unit. The measurements 
were performed with commercially available enzyme immunoassay (Milenia). 
Results: Mean PMN-E-value in n o d e c t e d  newborns was 38.85 ng/mL, 
and for infected 184.12ng/mL. ( P <  0.05) (Student’s t-test). The sensitivity to 
the diagnosis of culture-proven bacterial systemic infection was 68% for 
PMN-E, 60% for C-reactive protein, 59% for the immature to total neu- 
trophil ratio and 56% for the total white blood cell count. The corresponding 
specifcity amounted to 92, 86, 100 and 80%, respectively. 
Conclusion: Serum PMN-E level determination yields diagnostic advantages 
in comparison with infection markers routinely used in sepsis screen and may 
serve as a valuable early indicator of neonatal systemic bacterial infection. 
Acknowledgements: This work was carried out as a part of the research 
project no. 6 W5E 049 21 sponsored by the Polish State Committee for 
Scientific Research. 
[p6071 Diarrhea in Danish children under 5years of age: a 
case-control study 
B. Olesen, l? Schiellerup, M. Helms, J. Neimann, E Scheutz and 
P. Gerner-Smidt 
Copenhagen, D K  
Objectives: To clarlfy the most important etiologies of bacterial diarrhea in 
Danish chddren under 5 years of age. 
Methods: Stools fiom 219 cases with diarrhea from all over the country and 
416 healthy controls were examined for Salmonella, Campylobacter, Yminia, 
Shigplla and Mbrio spp. using standard methods. Stools were also examined for 
verocytotoxin-producing Echerichia coli (VTEC), attaching and effacing E. coli 
(A/EEC) including enteropathogenic E. coli (EPEC), enterotoxigenic E. coli 
(ETEC), enteroinvasive E. coli (EIEC), and enteroaggregative E. coli (EAg- 
gEC) by colony hybridization of virulence genes and serotyping. 
Resuk Overall, a bacterial cause was found in 18% of the cases. The 
following pathogens were associated with disease (P < 0.05 when comparing 
isolation rates between patients and controls, Fisher’s exact test): Campylobacter 
coli/jguni: 11/219 (5%) patients versus 3/416 (<l%) controls; Salmonella: 8/ 
219 (4%) versus 01416 (0%); EPEC: 7/219 (3%) versus 2/416 (<1%); VTEC: 
6/219 (3%) versus 2/416 (<1%); and Yeninia: 61219 (3%) versus 0/416 (0%). 
EAggEC, A/EEC (eae positive nonclassical EPEC serotypes) and ETEC hy- 
bridizing with the EAST1 gene-probe were found with equal Gequencies in 
patients and controls. No Shigella, Vibn‘o, EIEC or ETEC hybridmngwith gene 
probes for heat-labile or heat-stable enterotoxin (CT and ST) were isolated. 
Conclusions: E. coli (VTEC and EPEC) seems to be a major cause (6%) of 
diarrhea in children under 5years of age. We recommend that routine 
examinations of stool cultures from children of this age group should include 
tests for VTEC and EPEC. 
lp6081 Antimicrobial resistance of coliform bacteria from 
hospital sewage and the environment in Bangladesh 
M. Rahman, 1. Kubn, M. Rahman and R. Mollby 
Stockholm, S; Dhaka, B D  
Objectives: The extensive use of antibiotics and other chemotherapeutics in 
hospitals as well as in animal production and fish farming has resulted in drug- 
resistant bacteria in the environment all over the world, particularly in 
developing countries. The object of the study is to investigate the spread 
of antibiotic-resistant coliform bacteria h m  hospital to the environment in 
Bangladesh. 
Methods: The sampling site was a model system of duckweed-aquaculture- 
based hospital sewage treatment plant. Total 132 samples were collected from 
various stages of a treatment plant, from feces of hospitalized diarrheal 
patients, from fish culture pond and fiom cultured fsh as well as Gom a 
control treatment plant. Coliform bacterial isolates were biochemically typed 
by the PhP system and one representative from each PhP type (strain) were 
tested for susceptibility to eight different antibiotics at four concentrations by 
minimal inhibitory concentration method (MIC). 
Results. A total of 1009 coliform bacteria were typed by the PhP-RS system 
and 125 common PhP types were found altogether. Within the common 
types, 29 major types were identified, which were found at several sites and on 
several occasions. The overall antimiclobial resistance among the 125 com- 
mon strains was as follows: sulphamethoxazole (98%), ampicillin (74%), 
tetracycline (37%), erythromycine (42%), chloramphenicol (43%), nahdixic 
acid (78%). cephalothin (56%), streptomycin (38%). 
Conclusions: Our data indicate that the percentage of antibiotic-resistant 
bacteria in the hospital sewage, in most cases, are higher than fiom other 
sources. Our results suggest that the discharge/use of hospital sewage in 
commuriity/environment might constitute a public health hazard through the 
spread of antibiotic resistance. The pathogenic properties of these (resistant) 
isolates are presently being characterized. 
] P609 I Antibacterial activity of Thai medicinal plants 
against enterohemorrhagic Escherirhia coli 01 57: H7 
S. Voravuthikunchai, A. Lortheeranuwat, T. Ninprom, W Popaya, 
S. Phongpaichit and T. Supawita 
Hatyai, Songkfa, TH 
Objectives: The stimulating effect of subinhibitory concentrations of anti- 
biotics on the production of verocytotoxin by enterohemorrhagic Escherichia 
coli 0157: H7 has been claimed. The purpose of t h ~ s  tudy was to find an 
alternative, but effective me&cinal plant for the treatment of thn organism. 
Methods: Fifty-five preparations of the exmacts of 38 kinds of Thai herbs were 
tested for their antibacterd activity against Merent strains ofE. coli, including 
three strains ofE. coli 0157: H7, E. coli 0 2 6  H11, E. coli 0111: NM, E. coli 
022, five strains of E. coli isolated Gom bovine and E. coli ATCC 25922. 
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Inhibition of growth was tested by the paper disc agar diffusion method. 
Antibiotic susceptibility discs were used as control. Minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) were 
determined by agar microdilution method and agar dilution method in 
petridishes with millipore filter. 
Results: Seventeen extracts showed some antibacterial activity against E. coli 
0157: H7 and most strains. Quercus in&ctoria Olivier, Punica grantum Linn. 
Peltophorum dasyrarhis (Mid Kurz ex Baker, Walsura orbusta Roxb showed the 
greatest inhibition zones, rauging from 12.30 to 7.05mm. Pgranatum and 
I? dasyrachis were demonstrated to be highly effective against E. coli 0157: H7 
with the MIC values of 0.39 and 0.78mg/mL and the MBC values of 1.56 
and 3.12 mg/mL, respectively. 
Conclusions: As both Pgranotum and I? dasyrachis were proved to be active 
against E. coli 0157: H7, they should be fbrther examined for their efTect on 
verocytotoxin production in order to provide an alternative treatment of 
E. coli 0157: H7 infection. 
18 (83 3%) ammals and had a hgher rate of anhgen-specific response than the 
ammals receivmg soluble CFA/I anhgen and conaols Spec& Peyer's patches 
(PP), lymph nodes (LN) and spleen (SPL) lymphocyte prohferaaon response 
rose to the hghest value by the s x  posbmmumzahon week. However, lower 
PP, LN and SPL prohferahon was observed in young rabbits i m m m e d  wlth 
soluble CFA/I anhgen, Gee hposomes and L case1 cells The results concern- 
ing the 3H-leucme-labeled E colt H10407 cells adhesion to the lntesonal 
mucosa showed (I) PrOteChOn of rabbit intesnnal mucosa apsn t  d e n t  
E. colt H10407 s m n ;  (u) mbhihon of ETEC bacteria adhesion to intestinal 
mucosa, especially m the anunals from batch C and (ui) significant faster 
release of3H-leucine-labeled E. cob H10407 s t r a m  &om the mtesanal tract of 
a d s  m u m z e d  mth  CFMI anngen entrapped in hposomes combined 
with L. m e i  cells The htopathologcal and electron rmcroscopy findings 
confirm the above results. Sumnungup, the results of thls study point out the 
possibhty of prondmg an efficient protecaon awnst infecnon wth  E. co11 
s m n s  (ETEC) after mucosal mmulllzahon wth  CFA/I anhgen entrapped in 
hposomes associated wlth L Laset cells 
1 P610 1 Detection of a possible adhesion of 67 kDa from 
diarrheagenic enteropathogenic Escherichia coli (EPEC) 
S.  Gavilanes, A. Manjarrez, E. Chavez, L. Leon and A. Cravioto 
Mexico City, MEX 
EPEC strains are a worldwide cause of severe infantile diarrhea. Essential for 
pathogenicity is their ability to adhere to the smal l  intestinal mucosa and to 
produce a characteristic attachmg and efficing (A/E) lesion in the enterocyte 
brush border membrane. Very little information is available about the nature 
of the specific bacterial surface appendages or surface components (adhesins) 
of EPEC responsible for the epithelial cell attachment. The aim of the present 
study is to identify the adhesins responsible for the adherence ofEPEC to the 
intestinal mucosa. In this study, we have detected a putative adhesin of 67 kDa 
h m  an EPEC strain. To obtain the adhesin tiaction, EPEC strain (E2348/69) 
was disrupted by brief sonication and the cell extract containing surface 
proteins and fimbriae were obtained by ultracentrifugation. The extract was 
partially dissociated into h b r i a e  and an adhesin-enriched fraction by heating 
to 70°C. The adhesins released &om the fimbriae were collected in the 
supernatant after centrifugation. Partially purified adhesin was able to bind to 
human intestinal mucosa and tissue-cultured HEp-2 cells. A specific rabbit 
antiserum raised against the 67kDa procein inhibited EPEC adhesions to 
HEp-2 cells by 80%. Immunoprecipitation assay showed that 94-96 kDa and 
the 67 kDa establish a fimbriaeadhesins complex. Expression of the 67 kDa 
protein was diminished sigtllficantly when the bacteria was grown at 25 "C in 
broth medium. Growing the bacteria at this temperature also diminished the 
bacterial binding to HEp-2 cells. This protein was detected in other adherent 
EPEC strains in contrast to nonadherent E. coli isolates that did not produce 
this putative adhesin. These results suggest that the 67 kDa protein might be an 
adhesin that participates in the initial stages ofEPEC adhesion. The adhesins 
detected in the present study may be useful in the development of future 
vaccines. 
I P611 I Mucosal immunization of young rabbits against 
enterotoxigenic Fscherichia coli cells by CFAll antigen 
entrapped in liposomes associated with factobacillur casei 
V Dima, M Ionescu, M. Balotescu, G. Becheanu and S. Dima 
Bucharest, R O ;  Rome, I 
In hs work, a mucosal vaccine contammg ColonI?ahon factor anhgen (CFA/ 
I) entrapped in hposomes associated wth  Lactobadus cask has been tested for 
safety and unmunogenicity m young rabbits. S x  anunal groups were used. 
Two houn after mehdme  admmistrahon, the young rabbits (500-8M)g) 
were gwen three oral doses (7-10 days apart): CFA/I anhgen (5 mgldose) 
entrapped in hposomes (batch A), soluble CFA/I anagen (batch B); CFA/I 
antigen entrapped m hposomes (CFNI-L) associated w t h  L m e !  
(1 x 109cells/dose) (batch C) and control batches: L. c a m  (batch D); h e  
hposomes only (batch E) and Hank's balanced salt solution (HBSS) (batch F) 
Experunental paranleten (a) serologcal and (b) lymphocyte proliferaaon 
assays; (c) adhesion of 3H-leucme-labeled Eschercchra colt (H10407 stram) to 
the mteshnal mucosa; (d) hstopathologd and (e) transrmssion electron 
rmcroscopy (TEM) evaluahon The results showed that three mucosal doses of 
hposomes contaumd CFtVI, and L. met were protechve apns t  oral chal- 
lenge mth 5 x lo9 E. coh cells (H10407 \train). The a d  fiom batch C 
ehbi ted  increased hten of spenfic anhbohes to CFMI antigen m 15 of the 
(p6121 Epidemiology of antibiotic resistance in commensal 
Fscherichia coli of cattle 
D. Hoyle, C. Yates, M. Pearce, H. Knight, G. Gunn, M. Woolhouse, 
C. Low and S. Amyes 
Wellcome Tmst International Partnership Research Award in Veterinary 
Epidemiology 
Objective: To examine the genetic diversity of commensal Escherichiacoli 
isolates in a cohort of newborn calves and follow changes in E. coli populations 
resistant to ampicillin, apramycin and nahdixic acid with age. 
Methods: Fecal samples were collected weekly for 3 months fiom a cohort of 
46 beef suckler calves on a Scotdsh farm. Fecal samples were screened for 
resistant E. coli by plating onto selective agar containing 16 mg/L ampicilltn, 
16 mg/L apramycin or 8mg/L nalidixic acid. The genetic diversity of E. coli 
across the cohort and within individual fecal samples was examined by pulsed- 
field gel electrophoresis (PFGE). The proportion of resistant E. coli in fecal 
samples fiom a selection of the cohort was examined over time using a viable 
count method. 
Results: To date 27 calves have been sampled weekly from birth for 4 weeks. 
E. coli resistant to ampicillin, apramycin or nalidixic acid were detected in 96, 
1 1 and 56% of 1-week-old calves and in 81,7 and 33% of calves by 1 month of 
age. Resistance to two or more antibiotics was found in 59 and3756 of animals 
at lweek and lmonth of age, respectively. Ampicillin-, apramycin- and 
nalidixic acid-resistant bacteria were isolated from 16, 4 and 4% of dams 
sampled post-partum, respectively. Considerable variation in PFGE types 
were found in E. coli isolated horn nonselective media both within a single 
fecal sample and between calves. Diversity of nalidixic acid-resistant E. coli 
isolates was low and only two PFGE types have been distinguished to date 
across the cohort. The total E. coli counts ranged fiom 105 to 108 &/g feces. 
Resistant E. coli constituted a minority of the total population. 
Conclusion: The cohort studied carried a genetically diverse population of 
commensal E. coli. Calves were colonized within days of birth by resistant 
bacteria, and carriage of resistant bacteria by calves was greater than that by 
their dams. Ths  suggests that calves acquired antibiotic-resistant bacteria 
either from the environment or directly h m  other cohort animals. Pre- 
liminary PFGE results provide evidence for the c l o d  spread of nalidixic acid- 
resistant E. coli through the cohort. 
I P613 I Hemolytic uremic syndrome associated with 
consumption of unpasteurized cow's milk 
E Allerberger, A. W. Friedrich, K. Grif, M. P. Dierich, M. Wagner, 
A. Capnoh and H. Karch 
Innsbruck, A; Munster, 0; Vienna, A; Rome, I 
Objdives: Acute hemolyac urermc syndrome (HUS) 1s often assouated with 
enterohemorrhaglc Erdserich~u coli (EHEC) mfechons. In addiuon to EHEC 
0157, pamcular 11011-0157 EHEC seropups, especially 026, have 
emerged as sigtuficant causes of HUS. The source and the vehicle of 
contarmnahon w t h  EHEC 0 2 6  are not often identified. We report two 
Austrian cases of HUS due to E. colt 026:H- aechng an 11-month-old boy 
and a 28-month-old girl in whch transmssion through unpasteurized cow's 
mdk was posihvely idenhfed. 
Methods and results: The isolates were m&s&gwshable fiom each other 
usmg automated ribotypmg and ylelded the wrulence genes stx2, eae, and hly 
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An epidemiological investigation revealed that the children had stayed in the 
Same hotel. Both patients had consumed unpasteurized cow’s milk from the 
breakfast butfe. Fecal samples were taken fbm the cows of the farm 
producing the incriminating milk and in one of three cattle EHEC 
026:H-isolates had a PFGE pattern indistinguishable h m  the patients’ 
strains. Austrian law does not allow delivery of raw cow’s milk to hotels; 
for the few exceptions allowing delivery of untreated milk, labeling with ‘raw 
milk, boil before consumption’ is mandatory. The manager of the hotel 
catering to babies and young children justified the use ofuntreatedmdk with a 
perceived ‘general trend towards biological products.’ 
Conclusions: These two cases illustrate the hazards associated with the 
consumption of raw milk and underline the importance of microbiological 
diagnostic approaches able to detect sorbitol fermenting, non-0157 EHEC. 
Sorbitol fermenting EHEC, like EHEC 026, would be missed by diagnostic 
methods purely relying on Sorbitol-MacConkey agar plates. Stool specimens 
&om patients with HUS should at least be tested for the presence of Shiga 
toxin. 
1 P614 1 Escherichia enterotoxins genes are detectable 
among clinical isolates of Klebsiella spp. and Proteus spp. 
A. Mavzioutov, V. Bondarenko, A. N. Baymiev and A. Baymiev 
Ufa, Moscow, RUS 
Objectives: We studied the prevalence of virulence-associated genes by 
examining total DNA of clinical isolates klebsiella spp. (59 saains) and Proreus 
spp. (42 strains), which were isolated from different clinical searches. 
Methods: The three virulence determinants examined were heat-stable 
enterotoldn a (STa), heat-stable enterotoxin b (STb) and heat-labile entero- 
toxin h (LTh) Escherickia coli. Three sets of primers for amplification of 
sequences of the sta, stb, lth genes in polymerase chain reaction (PCR) were 
used to screen strains for the presence of these virulence determinants. 
Results: The PCR products specific for the sequences of the STa, S7% and 
L7k genes were found in 12 out of the 101 tested strains (ll.Yh), Ki‘ebsiella 
spp. were positive in 15.3%. As a result ofinvestigation, four s t r a i m  ofklebsiella 
spp. s t a t  (6.8%), three strains Klebsiellapneumoniae stb+ (5.1%), one strain of 
K.pneumoniae lth+ (1.7%) and one isolate of Ki’ebsiefla spp. stb+, Ith+ (1%). 
Among tested strains of Protm spp.. only three (7.1%) were lth-positive in 
PCR, two Proreus vulgaris (11%) and one Pmirabilis (4.2%). 
Conclusions: Our experiments indicate that ST- and LT-enterotoxins are 
necessary for klebsiell~ and I? vinrlence, and suggest that a similar mechanism is 
responsible for the dissemination and acquisition of ‘pathogenicity islands’ in 
Enterobacteriaceae. 
v1 The frequency of E. coli 0157:H7 in the Zagreb 
area, Croatia 
B. Matica, N. Brkljacic, A. Mlinaric-Dzepina, N. Jma-Dada, 
A. Baucic, I. Kovacek and N. Jonic-Knezevic 
Zigreb, HR 
Objectives: To determine the prevalence of E.coli 0157:H7 in Zagreb, 
Croatia. 
Methods: In our laboratory, EHEC detection was introduced in 1995. Since 
1996, it has been used routinely. During 1996, we investigated 10588 stool 
specimens &om outpatients with acute diarrhea. All samples were inoculated 
on  Sorbitol-McConkey agar at 37 “C. Sorbitol-negative colonies were 
agglutinated with E.coli 0157:H7 antiserum. EHEC was not found in 
any of the samples. We also tested 82 food samples (veal) and all were 
negative. In 1997, we analyzed 11 449 samples with negative outcome. In 
1998, seven stools tested positive out of 11 578 samples examined. In 1999, 
only one stool tested positive out of 12832 samples. In 2000, we examined 
13 612 stools and only two were positive. In 2001, we found no EHEC- 
positive stools in 13512 samples. All nine cases with proven EHEC were 
children aged 7 months to 7 years. They all had diarrhea, one of them also 
vomited. Five of the children had fever and blood in the stool. There were no 
clinical sequelae. 
Conclusions: Incidence of E .  coli 0156H7 in Zagreb area was very low. 
Virulence markers of entero-aggregated 
Escherichia coli isolated from children and adult diarrhea 
L. G. Giugliano, I. C. Piva, A. L. Pereira and R. Giugliano 
Bratilia, BR 
Enteroaggregative Escherichia coli (EAEC) have been associated with cases of 
acute and persistent diarrhea. The mechanisms by which these organisms 
cause diarrhea are not well understood, however, several virdence-related 
markers have been described, such as the pAA plasmid which encodes for the 
aggregative adherence fmbrias AAF/I and AAF/II and also the enterntoxins 
EAST1 and Pet. A serine protease (Pic), encoded by a chmmosod gene, has 
also been associated with EAEC strains. 
Objectives: This study examined the presence ofpAA plasmid in E. cofi strains 
isolated fiom sporadic cases of acute diarrhea in children and adults, and 
asymptomatic children controls. The strains hosting the pAA plasmid were 
hrther analyzed for the presence of sequences homologous to virulence 
markers associated with EAEC pathotype and extraintestinal E. coIi virulence 
factors. 
Methods and results: Initially 586 strains isolated from 143 chddren with 
diarrhea, 173 strains isolated from 37 asymptomatic controls and 435 strains 
isolated fiom 145 adults with diarrhea were investigated by colony hybridiza- 
tion to detect the presence ofpAA. Positive strains were found in, respectively, 
19.6,lO.S and 11.7% ofthe cases of children diarrhea, asymptomadc controls 
and adults diarrhea. The incidence of pAA+ strains was not signhcandy 
different in the groups studied. The pAA+ strains were analyzed for the 
presence of AAF/I, AAF/Ii, EAST1, Pet and Pic  using PCR assay. The 
fkequency of EAST2 and Pic genes were si@cantly higher in strains isolated 
from children diarrhea than 6om adults or asymptomatic conmls. Only 
34.1% of the pAA+ strains showed A A F / I  or AAF/U. The frequency of 
extraintestinal markers AFA and SFA were significantly higher in strains 
isolated 6om adults than 60m children diarrhea. More than one extraintest- 
inal virulence marker was found in 58% of the strains &om adults and in only 
7% of the strains fiom children diarrhea. 
Conclusions: Our results indicate that E. coli strains harboring pAA plasmid 
isolated &om children diarrhea, adults diarrhea or asymptomatic controls 
present distintive profiles of virulence markers. 
Ip617/ Infant diarrhea caused by enteropathogenic 
Escherichia coli 
S. Osugui, C. Oplustil and C. Mendes 
Sao Paulo, BR 
Introduction: Enteropathogenic Escherichia roli (EPEC) is a widespread 
bacteria and was associated for the first time with gastrointestinal infection 
in 1940. After ths period, s m a l l  outbreaks or isolated cases were reported in all 
the continents. This pathogen is described as the major etiologic agent of 
infant diarrhea in developing countries. In Brazil they are responsible for 
almost 30% of infant bacteria-related diarrhea. 
Objective: Venfy the prevalence of diarrhea caused by EPEC and the main 
serogroups in children under 4 years old. 
Material and methods: From J a n u q  1998 to April 2001, a total of 5276 stool 
samples h o r n  children of >4yean with suspicion of gastrointestinal infection 
were analyzed. The samples were collected in Cary-Blair transport media, 
plated in MacConkey agar and incubated at 35-37 “C for 18-24 h. AU strains 
of E.coli with biochemical merences were submitted to agglutination 
(PROBAC) against the following serogroups: 026, 055, 0111, 0119, 0114, 
0125, 0142, 0158, 086,0126, 0127 and 0128. 
Results: Out ofthe total of 5276 samples, 4727 (89.6%) cultures were negative 
for enteropathogens and 549 (10.4%) were positive. Of these, 215 (39.1%) 
were positive for EPEC. The serogroups found and their prevalence were: 
026, 44 (20.5%) cases; 0125, 32 (14.9%); 0126, 23 (10.7%); 0128, 21 (9.8%); 
055, 18 (8.45); 0111, 16 (7.4%); 0142, 14 (6.5%); 0199, 13 (6.0%); 0127, 11 
(5.1%); 0868  (3.7%); 0158,5 (2.3%). There were 12 (2.2%) cases ofinfection 
of EPEC associated with other organisms. Other etiologic agents isolated 
were 142 (25.9%) Campylocbacter spp., 138 (25.1%) Salmondln spp., 34 (6.2%) 
Shigefluspp., 5 (0.Yh) enteroinvasive E. coli, 2 (0.4%) simultaneous infection of 
Salmonella spp. and Campylobacter spp., and 1 (0.2%) Aeromonas spp. The 
prevalence of EPEC with age distribution was: 0-1 year: 33.5%; >1-2yem: 
41.Y? >2-3yeats: 19?? and >Wyears: 5.6%. 
Condusion:The major gastrointestinal infections during the first 2 years oflife 
were caused by EPEC. 0 2 6  serogroup was the more prevalent among the 
EPEC analyzed. 
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Salmonella, Shigella, Vibrio and other enteropathogens 
vl Antibiotic resistance of Shigella and Salmonella 
strains isolated from stool cultures over a 12-month period 
in Bucharest 
M. Podani, V. Arama, C. Ionescu, A. A. Iancu, C. Sanda, A. M. Briot, 
V Molagic and A. Streinu-Cercel 
Bucharest, RO 
Objective: To define the resistance rates to commonly used antibiotics (AB) of 
all strains of Salmonella and Shigella spp. isolated h m  stool specimens between 
December 2000 and November 2001 from patients admitted at our institute 
with a diagnosis of diarrhea. 
Methods: Review ofthe results of antibiograrns of Salmonella and Shigella spp. 
obtained &om stools. The identification of the species was done by conven- 
tional microbiological methods; the antibiograms were performed by the disk 
difFusion method with respect to 1999 NCCLS standards with results 
expressed as: resistant (R), intermediate (I), and sensitive (S). The AB taken 
in to study were: tetracycline (T), cloramphenycol (CL), co-trimomole 
(CTX), ampicillin (A), nalidhc acid (NA), ciprofloxacin (CP), colimycin 
(CO), 3rd generation cephalosporins (3GC). 
Results: From 1253 stool cultures, 900 (72%) were positive for Shigelh spp. 
(97% S.&nm’, 3% S. sonnet] and 77 (6%) positive for Salmonella spp. (94.8% 
group BO, 5.2% group CO and DO). The AB-resistance study of S.Jexneri 
showed practically the absence ofresistance to CP and 3GC, low rates o fR  to 
CO (7%) and NA (4%), moderate rates to CTX (22%) and high rates to CL 
(77.3%), T (78%), A (84.7%). The four strains of S. sonnei were also 100% 
sensitive to CP and 3GC. For Salmonella group, BO strains were recorded the 
following R rates: no resistance to CP, 4.8% to 3GC, 7% to CO, 10% to NA, 
32.8% to CTX, 58.2% to T, 69% to CL .and 70% to A. For the fay strains of 
group CO and DO there was no AB resistance noted, except one inter- 
mediate resistance to 3GC. 
Conclusions: In our geographic region, the most frequent pathogen recovered 
from stools belong to Shigella spp. They showed a very good sensitivity to 
ciproflofloxacin, third generation cephalosporins, nalidixic acid and colimy- 
cin. The Salmonella group BO, seldom isolated, showed higher resistance rates 
to all AB tested, but still preserved a very good sensitivity to ciproflofloxacin 
and third generation cephalosporins that remains the antibiotics of choice in 
cases of diarrhea necessitating treatment 
1 P619 I Increase in antibiotic resistance in Salmonella 
enteritidis strains from humans in a 3-year period in Bosnia 
and Herzegovina 
S .  Uzunovic-Kamberovic 
Zenica, BIH 
Objective: Salmonella enteritidis was the predominant Salmonella serotype in 
Zenica-Doboj Canton, Bosnia and Herzegovina, in the period 1998-2000, 
and accounted 79.6% of all Salmonella spp. isolates. It provided an opportunity 
to carry out its antibiotic resistance pattern. 
Methods: A total number of 238 Salmonella enteritidis (SE) strains were isolated 
from human stools during 1998-2000, 164 of which were sporadic and 74 
isolated from 27 outbreaks. The strains idendied and serogrouped by 
conventional methods. Antimicrobial susceptibility tests were performed 
by disk-diffusion method, according NCCLS recommendations to 16 anti- 
microbials: ampicillin, ampicillin-clamlanic acid, cefalothin, cefumxime, 
cefotaxime, azithromycin, gentamicin, tetracycline, doxycycline, trimetho- 
primsulfamethoxasole (SXT), chloramphenicol, nalidixic acid, pefloxacin, 
ofloxacin, ciprofloxacin and nitrofurane. 
Results The overall resistance rate of the S. enteritidis strains in the 3-year 
period was as follows: 34.5,39.7, and 50.9%. respectively. The resistance rate 
to only one antimicrobial in this period was 53.8, and 46.2% to more than 
one, respectively. The occurrence of ampican resistance increased from 10.6 
to 17.6%. Nalidixic acid resistance rate was 6.7% in the 3-year period. Stel, all 
of the SE isolates were susceptible to pefloxacin, ofloxacin and ciprofloxacin 
during &s period. Doxycicline showed the b h e s t  resistance rate, 28.8%. 
Increasing trend, but stel relatively low resistance rate showed SXT and 
chloramphenicol. There no were di6erences in the rates of the overall 
antimicrobial resistance between sporadic and outbreak isolates as well as 
between in- and out-patients isolates. 
Conclusion: Genedy, the resistance to antomicrobial drugs in SE is rare in 
many European countries. The percentage of resistance in this region has 
shown increasing trend and higher values even compared in some Mehter- 
ranean countries. Although the resistance rate to nalidixic acid is s t i l l  low, its 
increase in resistance draws our attention to the possible appearance of the 
resistance to the fluoroquinolones in the near future. Monitoring of S. enter- 
ifidis strains for antimicrobial resistance is also important fmm an individual 
perspective, because the outcome is worse in persons with resistant Salmonella 
infections. 
Ip6201 Infectious diarrhea: review of etiology, and 
antimicrobial resistance in patients at a university hospital 
in South-eastern United States 
A. Safdar, R. Talwani, J. A. Horvath, C. S. Bryan and B. Postic 
Columbia, USA 
Objectives: Infectious diarrhea is the Ieading cause of mortality in the under- 
developed world. Patients in western countries may suffer serious morbidity 
owing to infectious enterocolitis. This study was undertaken to determine 
the microbiologic profile of bacteria associated with diarrheal illness in 
patients at a large community teaching hospital in the South-eastem United 
states. 
Methods: Review of microorganisms from patients with diarrhea fmm 
January 01, 1997 to December 31, 2000 at Richland Memorial Hospital 
was performed retrospectively. 
Results: During 36months, 131 patients presented with diarrheal illness. 
Among 31 adults (15 male, single HIV+) and 100 pediatric (50 d e s )  
patients’ median age was 37f 16.4 and 3fl2years. respectiveIy. Shigella 
sonnei ‘group D ( 5 W !  was the most common pathogen (66 eases, 51 in 
children and 15 in adults), followed by Salmonella typhimurium ‘groupB (1Wo) 
(25 cases, 17 in children and 8 in adults). Salmonella meunchen ‘ p u p  C’ 
accounted for a single case in adults, whereas 11 pediatric patients developed 
diarrheal illness. Among adults, a single case of Yminia enterocolitica, Salmonella 
‘group C2’, Catnpylobacter jejuni, Sh@lla j7exnen’ (group B), PIesiomonas 
shigelloides was noticed. In children, four each had E.coli 0157537, and 
PshigeNoides isolated; five Y enterocolitica, three C. jguni, and two each had 
EdmrdsieUa tarda, and Salmonella ‘group D’ infection. The in vim antimi- 
crobial susceptibility (MICso & MIC90pg/mL) of Shigella sonnei to cipro- 
floxacin (<0.5 and <0.5), uimethoprim-sulfamethoxazole (TMP-SMX) 
(<lo and <lo) was within susceptible range, whereas for ampicillin (2.0 
and >32.0) an increased resistance was observed. Similarly, among Salmonella 
typhimurium isolates no resistance was noticed for ciprofloxacin (<0.5 and 
<0.5) and TMP-SMX (<lo and <lo), whereas a high level resistance for 
ampicillin (>32 and >32) in US was concerning. 
Conclusions: During last 3years, ‘group D’ Shigella sonnei was the most 
common cause of infectious diarrhea among both adults and pediatric 
population in our region. infections due to E. coli 0157:H7, Kcholerae, 
C.jejuni, and Pshigelloides were dominant pathogens in younger 
patients. A high level of ampicillin resistance among S.typhimurium was 
consistent with reports fmm South-east Asia. Cirpoflaxacin and TMP- 
SMX appears to have retained in vitro effect against most bacterial pathogens 
in this s e w .  
Ip6211 What can a national telephone help line for health 
advice tell us about the epidemiology of gastrointestinal 
infections in the community? 
D. L. Cooper, G. Smith, S. J. O’Brien, V. Hollyoak and S. Long 
Birmingham, London, Leeds, UK 
Objectives: To determine the level of community-based gastrointestinal 
infection symptoms reported to NHS Direct, in order to establish national, 
regional and subregional baselines. To describe the outcomes of these calls in 
terms of the advice or further care recommended. NHS Direct is a fiee nurse 
led national telephone help-line for health advice in the UK. 
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Methods: NHS Direct is open 24h, 365days of the year. The service is 
organized into 23 separate sites (call centers) and answers over 5 million calls a 
year. Call data presented w i t h  this paper have been collected fiom three 
NHS Direct call centers over a 12-month period. On receipt of a call, a n m e  
uses hidher judgement to select the most appropriate computerized clinical 
algorithm. The algorithm, along with the nurse's chical knowledge, is used 
to advise the caller or refer them to appropriate medical care (call outcome). 
The algorithms chosen to describe NHS Direct calls about gastrointestinal 
infection symptoms are vomiting, diarrhea and food poisoning. Calls are also 
categorized by the call outcome (e.g. self-care, routine doctors appointment, 
further immediate care). 
Results: Symptoms of gastrointestinal infection are common reasons for 
telephoning NHS Direct, comprising 10% of all calls. The rate of gastro- 
intestinal infection symptoms reported is particularly high for children (25.3 
calls per 100000/week compared to 3.3 for adults, ratio children:- 
adults = 7 : 1). The proportion of calls made about children with gastroin- 
testinal infection symptoms, that are referred to further immediate care is 
twice that of adults (0-4 year-olds = 42% (95% CI 41-43), 5-14 = 40% (37- 
44); all adults = 22% (20-23)). There is a seasonal rise in February-April in all 
gastrointestinal infection symptoms, which is most marked for calls about 
vomiting and for all gastrointestinal infection symptom in 1-4 year-olds. This 
may be owing to the viral rather than bacterial pathogens. 
Conclusions: NHS Direct data offer new opportunities to explore the 
epidemiology of gastrointestinal infection within the community and to 
detect cases with symptoms of gastrointestinal infection that are not ascer- 
tained by existing surveillance systems. Examining the age distrihution and 
outcome of calls provides insight into how the age-specific distribution of 
gastrointestinal pathogens detected by laboratories may be influenced by 
patient and doctor behavior. 
1 P622 1 Antimicrobial resistance in 743 patients with acute 
gastroenteritis: prevalence and clinical implications 
G. Tositti, I? Fabris, A. Tramarin, L. Lazzarini, E. Pignattari, 
M. Scagnelli and E de Lalla 
Vicenza, I 
Owing to the inappropriate use of antibiotics in the clinical practice as well as 
their extensive use in agriculture, the antibiotic resistance of the most 
common etiological agents of acute gastroenteritis is increasing. However, 
in developed countries the prevalence and the clinical relevance of antibiotic 
resistance in patients with acute gastroenteritis have not extensively been 
studied yet. 
Objectives: To evaluate the prevalence and the clinical impact of antibiotic 
resistance in the semng of acute gastroenteritis in adults patients. 
Materials and methods: Clinical, microbiological and therapeutic data of743 
cases with acute gastroenteritis hospitalized between 1995 and 2000 were 
analyzed. 
Resub The diagnosis of infective gastroenteritis was performed in 259 
(34.8%) cases: Salmonella spp. 129 (49.8%); Campylobacter spp. 58 (22.3%); 
others 72 (27.7%). Out ofthe 129 strains ofSalmonella spp., 31% were resistant 
to one or more antibiotics, as follows: ampicdin 35%; amoxicillin 25%; 
cotrimoxazole 7.5%. Interestingly, only one strain of Salmonella spp. isolated 
was found to be resistant to fluorchinolones, whereas 6.2% strains displayed 
intermediate sensitivity. Among Salmonella spp., the rate of antibiotic resis- 
tance was higher for S. fyphimurium (62%) compared either to S. enteritidis 
(10.6%) or other subtypes (33%). The antibiotic resistance of Salmonella spp. 
increased fiom 28% in 1995 to 39% in 2000. Seventy-nine percent of 
Campylobacter spp. isolated had one ore more antibiotic resistance (C. laridis 
100%; C. jejuni 69%). The rate ofantibiotic resistance was 50,23.9,48.7 (22/ 
46), and 3.9% to ampicfin, fluoquinolones, cotrimoxazole and macrolides, 
respectively. The rate of fluoroquinolones resistance increased &om 26.5% in 
1995 to 85.7% in 2000. This behaviour was not observed for other antibiotics 
tested. Despite the non negligible increase of antibiotic resistance, no sig- 
nificant variations were found in term of duration of symptoms (6.2 -f 3.3 
days vs. 5.8 f 2.6 days), duration of hospitalization (6.9 f 4.9 days vs. 
5.7 f 2.5 days) and the clinical course of the gastroenteritis. 
Conclusions: Our data confirm a progressive increase of antibiotic resistance 
of Salmonella and Camyfobafer spp. The antibiotic resistance appears to be very 
important for Campylobarter spp. which is particularly resistant to fluoroqui- 
nolones and arninopenicihn derivatives. However, at the moment, antimi- 
crobial resistance has not a clinical impact. 
lp623/ Efficacy of live recombinant Sa/me/ /a therapeutic 
vaccine against Helicobacter py/ori colonization in mice is 
influenced by the immune responses induced by the 
attenuated carrier 
K. Kaniga, M. Spears, M. Campbell and D. Sizemore 
South Son Franciico, St. Louis, USA 
Objectives: Helicobacter pylori is a human pathogen that persistently colonizes 
the gastric mucosa. Although H.pylori elicits local and systemic antibody 
responses, it still evades elimination by the host immune responses partly due 
to its surface antigens mimicking those of the host. Therefore, a cellular 
immunity might be needed for effective protection against H.pylori carrier 
state. In this study, we aimed to compare the immunogenicity and therapeutic 
efficacy of two attenuated live S.typhimurium carriers, delta-phoPQ and 
delta-phoPQ overproducing PhoP global regulator in H .  pylon' mouse 
model. 
Methods: S.typkimurium phoP was expressed h r n  the trc promoter on 
a pl5A-based plasmid that was introduced into a delta-phoPQ strain. 
This strain overproduced PhoP response regulator without the cognate 
histidine kinase and was referred to as PhoPOVER. H.pylori urease A 
and B subunits were cloned under the lambda promoter right on a 
pBR322-based plasmid that was introduced into both delta-phoPQ and 
PhoPOVER backgrounds. Mice were infected with H.pylori prior to intra- 
nasal vaccination with the delta-phoPQ and PhoPOVER vaccine constructs. 
The efficacy of the vaccination was assessed by viable count of H.pylori 
recovered fiom the gastric tissues. The humoral and cellular immune 
responses were measured. 
Results: The recombinant delta-phoPQ strain reduced the H.pylori coloni- 
zation only by 1 log as compared to challenged but untreated mice. However, 
the PhoPOVER was able to reduce H.pylori colonization in the gastric 
tissues by 2.5logs. Both delta-phoPQ and PhoPOVER carriers elicited a 
balanced Th-1/Th-2 systemic antibody responses against Salmonella total 
membrane. However, cellular immune responses against both Salmonella and 
H.pyIori were dominated by a Th-I response in PhoPOVER strain and 
undetectable in the delta-phoPQ carrier, correlating with the degree of 
protection. 
Conclusions: The efficacy of H.pylori urease A and B subunits in protecting 
against mouse-adapted H.pylori strains has only been assessed in the context of 
prophylactic vaccination. Our findings suggest that high efficacy against 
H .  pylori colonization in the gastric mucosa can be achieved in therapeutic 
vaccination using live attenuated Salmonella-vectored vaccine. The success 
ofsuch a vaccination is dependent upon the nature ofthe H .  pyloriantigen and 
the ability of the carrier to induce cellular immune responses in the host. 
I P624 I A study of Salmonella spp. isolates from 1990 to 
2000, Lakonia, Greece 
M. Kalkani, P. Andriopoulos, M. Rebelou, K. Dimopoulou, 
M. Kafentzi, E. Kallcani and M. Dionisopoulou 
Sparfa, GR 
Objectives: To study and determine the Salmonella spp. strains during 1990- 
2000 and their susceptibility to antibiotics. 
Methods: During an 1 1-year period, 109 Salmonella spp. were isolated fiom 
1145 stool and blood cultures (16.5% positive tests) in our hospital. Their 
antibiotic resistance was assessed with the Kirby-Bauer disk dif5sion test, and 
their serotype was determined by the National School ofpublic Health in the 
University of Athens. 
Results The serotype results were: 66% S. enteritidis, 6% S. typhi, 3.6% 
S. blokley, 3.6% S. agona. Various others strains (Bovismor-bfians, Virchow, 
Newport, Oranienbury, Typhimurium and others in two or less isolates). A 
complete year and season incidence is described as well as antigen serotyping 
of the strains. Antibiotic resistance was found to be 23.8% for ampicdin, 
1 1.9% for amoxicillin + clavulanic acid, 3.6% for commoxazole whereas the 
strains were fully susceptible to ciprofloxacin and third generation cephalos- 
porins. 
Conclusions: We recorded an increasing incidence of Salmonella infections 
during this 11-year period. Salmonella enteritidis is still the most common 
serotype isolated, though there is a growing appearance of various other 
isolates, probably owing to changes in dietary habits and population exchange. 
Antibiotic resistance seems to make the use of ampicillin inapropriate, 
whereas susceptibility to ciprofloxacin and third generation cephalosporins 
is still complete. 
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lp625 Serotype distribution of Salmonella enterica 
subspecies enterica isolated from humans in Turkey 
between 1987 and 2000 
B Erdem 
Ankara, TR 
Objectives: To deternune the serotype distribuhon of Salmonella strams &om 
humans m Turkey 
Methods: Total of 1334 cultures (1 167 stool, 100 blood, 24 urine, 22 abscess, 
13 wound, 1 bone marrow, 1 bde, 1 prritoned fluid) were performed by 
standard methods All Salmonella spp isolates were serotyped by using 0 and 
H annsera accordmg to K a u h n - W h i t e  scheme. 
Results: Serotype dlstribuhon of Salmonella entertca subsp entenca isolated &om 
humans in Turkey between 1987 and 2000 is summarized in the Table 1 
grown, but one animal died shortly after the baby became ill. The isolation 
of t h s  species of Salmonella suggests the iguanas as source of the baby's 
infection. Since the end of the 19%, there have been several publications 
demonstrating an increase in the number of salmonellosis cases associated 
with pet ownership of reptiles (iguanas, turtles, snakes, . . .), especially in 
young infants and immunocompromised patients. We believe inquiring 
into pet ownership of exotic animals to be appropriate $Salmonella is cultured 
in CSF or blood cultures &om patients with meningitis. In cases of 
Salmonella meningitis relapse or recrudescence of disease are often obsenred, 
as was the case in this patient. Close follow up after appropriate antibiotic 
therapy and discharge &om hospital are therefore needed. Last but not the 
least, owners of exotic pets should be informed about handling and infection 
risks. 
Table 1 Serotype dutribuhon of S. e subrp. enfenca 
Years 
1987-1989 1992-1994 1995-1997 1998-2000 
Serotype n=360 (%) n ~ 3 5 3  (?A) n=339 (%) n=282 (%) 
Typhimurium 68.1 62.3 48.1 23.0 
Enteritidis 14.7 22.9 41.0 64.9 
4.4 6.8 1.8 2.1 
Typhi 
2.2 1.1 3.2 2.5 
Paratyphi B 
Haifa 
2.5' - 
- 1.4" - - 
- - 
CONaS 
- - - 2.1 
Hadar 
Other serotypes 8.1 5.4 6.0 5.4 
'All strains isolated horn an outbreak in 1987. 
All strains isolated from an outbreak in 1994. I* 
Conclusion: The total of Typhmurium and Enterihms account for about 
85% of Salmonella isolates Incidence of Typhlmurium has dechned cons~s- 
tently from 1987 to 2000 In contrast, n h e a r  increase ln the incidence of 
Ehterihdes has observed in the same period. These changes are stanshcdy 
sigdcant by Ch-square test, and are s d a r  to many European countries and 
USA. 
I P626 1 Salmonella enterica subspecies houtenae as a rare 
cause of meningitis 
D. Potters, K. Plaskie, L. Covens, I. Wybo and S. Lauwers 
Brusselr, B 
A 2.5-month-old male baby was hospitalized with high fever. He was 
pale, irritable, groaning and rehsed to eat. His medical history was unre- 
markable but his parents had iguanas as pets. On physical examination some 
petechiae were noted and bulging of the fontanel. A clinical diagnosis of 
bacterial meningitis was made, blood cultures were obtained, a lumbar 
punctiou was performed and ceftriaxone and ampicillin were started. A 
Salmonella species, susceptible to ceftriaxone and ampicillin (MIC by E-test 
0.064 and 1 mg/L, respectively) was isolated from the cerebrospinal fluid. 
Blood cultures (Bact/Alert 3 4  Organon Teknika Corp.) remained negative. 
The baby recovered and was discharged after 4 weeks of intravenous antibiotic 
therapy with ceftriaxone. Two weeks later the baby presented a relapse and 
a Salmonella species was again cultured from the cerebrospinal fluid. Intra- 
venous antibiotic therapy was restarted for 6 weeks. The baby was last seen 
4months later and was doing fine. The Belgian reference laboratory for 
Salmonella and Shigella serotyped the Salmonella strain. It was identified as 
Snlmonella entm'ca subspecies houtenae (S IV 4 4  z4z23), a species of cold- 
blooded animals. Feces of the iguanas were cultured on selective media 
direct and after enrichment in broth containing selenite. No pathogens were 
I P627 1 Surveillance data of Salmonella infection during 
1996-2001 in Ban, Italy 
D De Vito, C. h o ,  R Monno, M Bamsta, E Coma and G. h z z o  
Bari, I 
Objective: The Salmonellae COIUhtute a threat to our health and welfare. The 
prevalence of Salmonellosls in the world IS steady mcreased. In Europe is 
achvated a S u r v e b c e  Program of Salmonella infecaons. T h  Program 
mvolve 19 European country and 1s under the control of Commurucable 
Disease Sunredance Cenm ofthe PHLS London. We report data on Isolahon 
of Salmonella strams in Bari, Italy. 
Materials and methods: Stram of Salmonella were isolated horn vanous 
clrrncal samples accordmg to standard protocols. Data regarding serotypmg 
and annbiohc resistance were analyzed by software Epi-Info 6.4. 
Results: Durmg 1996-2001 253 stra~ns of Salmonella were isolated. S. fyphi- 
munutn (30.4%), S. ententidrs (25.3%), S.  typhi (1 1.9%) were the most common 
serotypes isolated. We have also observed the presence of S. hidalgo, 
S Limuewa and other semtypes that are rare in our area. Resistance to 
ampicfin and trmethopnmsulfamethoxazole occurred m the 36.8 and 
17.4%, respecavely No smns  resistant to qumolones, mcludmg ciprofloxacin 
were detected 
Conclusion: In our area no increase of mcidence of human Salmmlla 
infecnon has been demonstrated in the course of the years under study. 
The prevalence (23 3%) ofserotypes ofSalmonefia uncommon m our area, but 
reported m developmg countries, suggest a possible mtroduchon of these 
stra~ns as the result of presence of -grants, mternaaonal travel and 
lncreased consumptlon of imported food 
jp6281 Effect of different temperatures on the plasmid 
profile and antibiotic susceptibilities of Salmonella strains 
D. Tordiiney-Akbulut, E. J. Threlfall, H. Chart and M. Ang-Kiisiiker 
Istanbul, TR; London, UK 
After the incubation at 5, 37 and 45 "C for 18 h of Salmonella enteritidis and 
Salmonella typhimurium strains, plasmid profile analysis w a s  carried out by the 
method described by &do and Lui. It was found that three S. typhimurium DT 
104 strain was found to carry serovar specific plasmid (SSP) of 60 m a ;  one 
S. typhimurium DT 204b strain contained SSP of the 60 and a 1 lOMDa 
plasmid, S. typhimuriwm U302 s t r a i n  contained 100 MDa plasmid. Among the 
S. enteritidis strains, three S. entenlidis PT4 and one S. entetitidis PT21 strains 
contained the 38 MDa plasmid which was serovar specific, one S. enteritidis FT 
6a strain contained the serwar specific plasmid of 38 and a 30 MDa plasmid. 
According to plasmid profile anal sis after 3 days incubation at 5 "C, it was 
found that the S. typhimurium Us stram lost the 100MDa plasmid, at the 
same time it lost the chloramphenicol resistance also. After 3 days incubation 
at 45"C, except S. typhimurium DT 204b strain, all the Strains lost their 
plasmids. At the same time, it was found that the S. typhimurium DT 104 strain 
lost chloramphenicol resistance and the S.  typhimurium Uso2 strain lost 
chloramphenicol and gentamicin resistance. After 3days incubation at 5 
and 45 "C, all strains were incubated at 37 "C and plasmid profile analysis 
was performed and it was found that all strains gained their plasmids and 
antibiotic resistance again. After incubation at 5 "C ofthe S. typhimurium W3M 
strain integron PCR was performed. I t  was found that the plasmid which is 
B 
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100MDa was not lost completely, in fact it was integrated to bacterial 
chromosome. 
Distribution and antibiotic susceptibility of human 
isolates from nontyphoidal Salmonella serotypes, other than 
Enteritidis and Typhimurium, in Greece 
A. MarkogiaMakis, E. Velonakis, L. Kondyli, D. Chadzopoulou, 
P. Pandazi, N. Vakalis and A. Bethimouti 
Athens, GR 
Objective: The aim ofthe present study was to determine the dlstribution and 
the levels of antibiotic resistance of various nontyphoidal Salmonella serotypes 
other than Enteritidis and Typhimurium. Concise data describing the inci- 
dence and the patterns of antimicrobial resistance for each one of these 
serotypes have not been published until now. 
Materials and methods: A total of 219 human isolates were randomly 
selected from the collection of Greece's National Reference Centre for 
Salmonella and Shigella, originated from various parts of the country for an 
8-year period (1990-1997). They were almost evenly distributed every 
2years, with 1997 as the last year of the study. The susceptibilities to 10 
antimicrobials of various class lines were determined, using the MICs broth 
microdilution automated method. 
Results: A great variation in the antibiotic resistance rates has been noticed 
among the serotypes. In particular, S.  virhowand S. hadarhave proved the most 
resistant among the examined serotypes, with S. virhow to be additionally the 
most multiresistant one. The vast majority ofthe isolates, belonging to the rest 
of the serotypes, were completely sensitive to the examined antibiotics. All 
isolates were sensitive to third generation cephalosporins (ceftriaxone) and to 
quinolones (ciprofloxacin) tested. Some of the results are summarized in the 
following Table 1. 
Table 1 Incidence of antibiotic resistance in the main nontyphoidal Salmonella 
serotypes from humans 
No. of isolates No. of the 
Serotype referred to NRCSS' isolates tested % DR u/n M R  
S. infontis 83 
55 
S. virhow 
s. newpon 52 
S. hodar 13 
Other serotypes 293 
S.  bredeney 33 
53 1.2 0 
51 33.3 11.8 
27 0 0 
15 6.7 0 
12 33.3 8.3 
61 1.6 0 
Total 529 219 11.4 2.7 
'During the studied years: 1990, 1992, 1994, 1996 and 1997; DR, drug-resistant 
(resistant to 1 or more antimicrobial); M R ,  multiresistant (resistant to three or more 
antimicrobials). 
(p6301 DNA fingerprinting for food-related salmonellosis: 
a European collaboration 
T. Peters and E. J. Threlfall 
London, UK 
Objectives: Much salmonellosis prevention and control depends on early 
outbreak recognition through a suitable s u r v e k c e  system. The value of 
phenotypic typing methods as surveillance tools is well established and gene- 
printing is used as an adjunct in outbreak investigations in which enhanced 
strain discrimination is needed. Our study, involving nine national reference 
laboratories w i t h  Europe, investigates the potential for improvement in the 
current surveillance system when gene-prjnting is used to routinely subtype 
Salmonella isolates. The aim was to develop standard laboratory operating 
procedures for pulsed-field gel electrophoresis (PFGE) and for computer 
recognition of the results. 
Methods: Initially each participating Cenae received a set of 16 S. entmica 
strains to be used for quality assurance of the methods. Each laboratory then 
selected 500 strains of S. enterica representing currently defined serotypes of 
epidemiological importance within their country. An agreed protocol for 
rapid PFGE was used which involved proteinase K. lysis of cells, a series of 
washes at 50 "C followed by digestion with XbuI. Gel images were exchanged 
in tag image file format (tiff files) for comparison between centers. 
Results: We have harmonized a method for PFGE that gives reproducible 
results and is currently being applied in selected European reference labora- 
tories. By using defined parameters for electrophoresis the gel images 
produced were comparable between each Centre despite slight variations 
in DNA preparation. Electronic recording and transmission of data between 
laboratories bas enabled the formation of an international database of gel 
profiles. 
Conclusions: For the control of Salmonella, precise identification of the 
organism is an essential prerequisite. We used a harmonized PFGE protocol 
that takes into account some of the Merences between different European 
centers. Although standardization ofDNA preparation and digestion were not 
considered to be essential, standardization of the parameters for electrophor- 
esis was considered to be an absolute requirement. We are compfing a 
searchable database of gene-print information that will allow us to describe 
the range and incidence of subtypes for the major salmonella serotypes within 
Europe. The use of internationally agreed methods for DNA fingerprinting 
allows countries in the EU to rapidly compare subtypes of Salmonella 
organisms responsible for international food-related outbreaks. 
v1 High prevalence of antibiotic resistant 
nontyphoidal Sa/monel/a strains isolated from hospitalized 
Italian children 
E. Chiappini, S .  Campanile, L. Galli, T. Simonetti and M. de Martino 
Florence, I 
Salmonellosis is usually a self-limiting infection and does not require antibiotic 
treatment. However, systemic infections occur in 5-10% of cases; mainly 
among children, elders and immunocompromised patients. For these patients 
an effective antibiotic therapy may be lifesaving. In children, since fluor- 
oquinolones have not been approved for use, few drugs are available for the 
empirical treatment. Antibiotic resistance among Salmonella isolates is increas- 
ing world-wide. Epidemiological data about Salmonella strain susceptibility 
should be considered by pediatricians when starting an empirical antibiotic 
treatment. 
Methods: Over the period November 1999-November 2001, 491 children 
with diarrhea were admitted to our Division. Salmonella spp. was isolated h m  
stool cultures in 53/491 (10.8%) patients (median age: 2.2years; range: 
2 month-lo yean). All strains were identified and serotyped by standard 
tests. Susceptibility to ampicillin, ceftriaxon, ciprofloxacin, chloramphenicol, 
neomicin, tetracycline and trimethoprim was performed using the Kirby- 
Bauer method. 
Results: Among 53 Salmonella spp. strains, S.  thyphimurium was isolated in 27 
cases; S. enteritidis in 10; S. coeln in 2; S.  kimuenza; S. bredeney; S. mom; 
S .  movunjurn; S. thompson; S .  bareilly and S. israel in 1 case each; 7 Salmonella 
strains could not be serotyped. 75.5% strains showed resistance to at least one 
antibiotic. In particular, 85.2% S. typhimurium and 50% S. enteritidis strains 
were resistant to at least one antibiotic. Twelve strains were multiresistant (>3 
dmgs). Twenty-nine (55%) strains were resistant to ampicillin, two (3.8%) to 
ceftriaxon, four (7.5%) to ciprofloxacin, eight (15.1%) to chloramphenicol, 
two (3.8%) to neomicin, 34 (64%) to tetracycline, three (5.7%) to trimetho- 
prim. 
Conclusion: This study provides evidence for high prevalence of drug- 
resistant Salmonella spp. strains in Italy. Resistance to ampicillin was particu- 
larly fi-equent. We found 50% of S.entm'tidis isolates to be antimicrobial 
resistant, which is a high rate with compare to previously reported 2.2% in 
centralsouthern Italy Our data support evidence for increasing resistance 
among S.entetitidis strains which were previously thought to be usually 
antibiotic sensitive. Resistance to ceftriaxone has been reported to range 
&om 0.5% in the United States to 32% in Turkey We disclose an intermediate 
resistance rate of 3.8%. 
1-1 Epidemiological investigation of human 
campylobacteriosis by PCR-RFLP 
S. Botella, M. A. Feds ,  M. Hernindez and J. Hernindez 
Valentia, E 
Objectives: Campylobmter enteritis is predominantly caused by the two closely 
related species C.jejuni and C. coli, but C.jguni  accounts for about 90% of all 
human infechonr. We have developed a method for identification and 
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subtyping Cumpy~obacter isolates based on the restriction fragment length 
polymorphism (RFLP) of polymerase chain reaction (PCR) products of the 
JaA andJaB genes. T h  subtyping technique was optimized for detection of 
Campylobacter jejwni and the potential value of this PCR-REP typing was 
established. 
Methods: A total of 32 unrelated isolates including four NCTC reference 
strains were analyzed. Extraction of DNA was performed using the cetyl- 
trimethylammonium bromide (CTAB) method. Primers for PCR were 
designed from the nucleotide sequence of the flagellin gene sequences of 
C. jejuni: jaA: 5'-ATGGGATTTCGTATTAACAC-3' and j a B  5'- 
CTATTGTAATAATCTTAAAA-3'. The PCR product was digested with 
the restriction endonucleases Dral and DdeI in separate reactions. Molecular 
size of fragments generated by the genotypic methods was estimated by 
comparison with the molecular size marker, and computed similarities among 
strains was tested using Dice coefkient. Clustering of strains was based on the 
nonweighed average pair group method (WGMA) to facilitate the plotting of a 
dendrogram. All computations were performed using the NTSYS-PC pro- 
g-. 
Results and conclusions: The PCR-REP typing technique was highly 
discriminative between strains. In our work with 32 isolates, a total of seven 
different DdeI profdes were yielded. DruI was less discriminatory grouping 
only in four profiles. Using both endonucleases together, the number of DruI- 
DdeI profiles was increased to 12, indicating a high discrimination level. The 
use of RFLP-PCR-DruI-DdeI on the f i A  and ~ Q B  genes is a suitable 
technique for identification of campylobacters and a practical typing scheme 
for clinical and epidemiological investigation. 
/p633] Electrolyte and mixed acid-base disturbances in 
cholera 
I. Nabipour, M. Resoulinejat and K. Vahdat 
Bushehr, Tehran, IR 
Objectives: The presence of metabolic acidosis with an increased anion gap 
during the diarrheal phase of cholera has been documented but there is no 
notification on mixed acid-base disturbances in cholera. 
Methods: Acid-base dlsturbances in 56 patients with Vibrio cholerae serotype 
Ogawa) who were adrmtted in emergency ward of Imam-Khomeini hospital, 
Tehran, in the summer of 1998 were studied. At time of admission and 24 h 
after rehydration, electrolytes, renal function teso, PO,, pCO2, pH and serum 
bicarbonate were measured. 
Results: At time of admission, the mean serum concentrations ofsomum was 
136.6meq/L, that of potassium was 3.47meq/L, and that of BUN was 
58.1 meq/dL. All of the patients had metabolic acidosis with a mean serum 
bicarbonate value of 1 1 . 3 3 1 3 . 1 3 ~  and pH of 7.19f0.08 which were 
changed to 14 f2 .7  flul~ and 7.28f0.06, respectively (P< 0.05). Thirty- 
three (58.9%) of patients had mixed respiratory acidosis and metabolic 
acidosis. In comparison, the severity of acidosis and the mean of logpCOz 
of those with mixed acidosis were more than the patients with pure metabolic 
acidosis (P< 0.05). 
Conclusions: Acid-base disturbance in cholera is mixed respiratory and 
metabolic acidosis and the paradox of the presence of severe acidosis and 
low bicarbonate loss in diarrhea of patients with cholera is due to respiratory 
acidosis. 
lp6341 The determinants of cholera epidemic in Tehran 
in 1998 
K Holakouie, M Younessian and M. Noorae 
Ehrun, IR 
Objectives: A case-control study was conducted in Tehran m 1998 for 
determuzlng factors related to Contracttng cholera dtsease in the capital of 
Iran. Ths study was conducted in the peak of the epidenuc 
Methods: Thmy cases and 52 controls nlatched for age and sex were entered 
m thls hospital based study. Data about exposures durmg 72 h prior to cases 
onset of Asease were obtamed by quesaomes  that were filled by four 
trained interwewen. Data were analyzed by STATA sofbare and OR, 95% 
confidence mterval for each mdependent variable was calculated afler adjust- 
ment of possble confounders. 
Results. History of eatrng dad food (OR = 0.15,95% CI = 0.04-0.54) and 
w a s h  hands behre eahng (OR = 0.17, 95% CI = 0.04-0.65) were asso- 
ciated unth lower chance and hstory of travelmg out of Tehran (OR = 7.3, 
95% C1= 1.4-37.6) and consumptlon of arnfclal Ice (OR =4.08, 95% 
CI = 1.02-16 2) were associated with hgher chance Of COntrachng cholera. 
Conclusion: Although for dete-ng the cause of cholera epldemc such a 
study should be conducted early m epidemc, we were able to show 
the probable role of hand washmg and consummg salad (probably because 
of its low pH level) as protective factors and travel (probably because 
of drmkmg contammated water or contact unth mfected people) and con- 
sumphon of amfiaal ice, whch purchases 6om the shops, as rtsk factors of 
cholera 
1 P635 I Molecular epidemiology of Vibrio cholerae strains 
in Iran during 1998-2000 
M. Saifi, M. Pourshafie, S. Aghaie, M. Lo&, M. Sedaghat, M. Parzadeh 
and M. Kouhestani 
Tehran, IR 
Objectives: Cholera remains an important public health problem in many 
developing countries. Several investigations indicated that the best way of 
study about the history of cholera in geographic area, requires the information 
about epidemiological patterns of infection and the disease with molecular 
analysis of the different strains of Vcholerae prevalent in the area. 
Methods: A total of 506 stool samples of patients from d&erent cities of Iran 
had been analyzed and a total of 318 Vibrio cholerae 01 isolated from these 
specimens. 
Results: Resistance degree of strains to the following antibiotics which was 
tested by the agar dilution method, were: 83.3, 73, 43.7, 41.4, 5.4, 1.2 and 
1.2% for Co-trimoxazoleole, oxytetracycline, tetracycline, furazolidone, 
chloramphenicol, erythromycin and doxycycline, respectively. The plasmid 
profile detection and polymerase chain reaction (PCR) for the genes encod- 
ing the A subunit of choleratoxin (CTX A), zonnuk occludens toxin (ZOT), 
accessory cholera entrotoxin (ACE), toxin coregulated pillus (TCP) and 
restriction Gagnent length polymorphism (RFLP) on the PCR product 
and their phmids has been done, the existence of CTX, ZOT, ACE and TCP 
genes in all sh;lins was 84.4, 66.8, 72.9 and 65.4%, respectively. In RFLP of 
PCR products, we had no polymorphism. 70.7% of these strains had a 100-kb 
plasmid. 
Conclusions: This study provides evidence that Vibrio dtolerae have significant 
public health implications and we are objected to changing the new antibiotic 
resistance pattern. 
lp636/ Characterization of viable but nonculturable 
halophilic noncholera vibrios 
G. Sbaragha and D. Ottaviani 
Penigia, Anconu, I 
Objectives: The viable-but-nonculturable (VBNC) physiological state of 
bacteria was first described by environmental microbiologist. Cells in this 
state appear dormant and cannot be cultured, but are able ofreturning to the 
actively m e t a b o m  state. The VBNC state has been found in numerous 
human pathogens. The aim of present work is to analyze this state of 
dormancy in halophilic noncholera vibrios (NCVs), recognized as human 
pathogens. 
Methods: Vibrio v u l n q h ,  Valginolyticus, Khuweyi, Kdamsela, Kmediterranei 
obtained from fresh and frozen seafood were used. The microcosm water 
method described by Rollins and Colwell (Appl. Environ. Microbiol. 1986; 
58 : 531-38) was used to obtain nonculturable cells. The effects offacton such 
as temperature, pH and NaCl concentration on VBNC state were studied by 
staining preparations with CTC-DAPI in order to detect and enumerate 
VBNC cells (Cappelier et al. Vet. Res. 1997; 28 : 547-55). The culturabilityof 
cells was determined by spread plate counting on Columbia agar containing 
5%lysed horse blood (Federighi et al. Food Microbiol. 1998; 15 : 539-50). To 
examine both entry to and resuscitation from the VBNC state in the natural 
environment, we employed the membrane diffusion chambers described by 
McFeters and Stuart (Appl. Microbiol. 1972; 24: 805-1 I). The virulence and 
the cytotoxicity of NCVs were determined as described by Omviani et al. 
(Appl. Microbiol. Lett. 2001; 33:61-4). Measurements were obtained for 
late-log-phase cell suspensions and for VBNC cell suspensions ofNCV cells 
afker 10,20, 30 and 40days of starvation in microcosm water. 
Results: The VBNC state was documented in Kuulni jk ,  Ka&ndytirus and 
K hatveyi. NCVs showed ditferent morphological and physiological characters 
during starvation state (environmental conditions, time and bacterial cells 
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required to entry into VBNC state; seasonal msappearance). NCVs cells 
undergo a variety of metabolic changes on entering the VBNC state. 
Vwln@ and Clalginolyticus are able to retain virulence during enhy into 
and resuscitation from the VBNC state. 
Conclusions: The environmental conditions which induce the VBNC state 
differ from bacterium to bacterium, and it is likely that the physiology 
involved varies among Merent cells. 
I P637 I Evaluation of five commercial systems in the 
identification of a new emerging pathogen: Vibrio vuinificus 
biotype 3 
R. Colodner, L. Lerner, J. Kopelowitz, 1. Meir, Z. Lazarovich, 
Y. Keness and R. Raz 
Afula, Jenrsalem, Ha+, Zrijin, It 
Background: In the mid summer of 1996 we reported the first isolation of a 
new human pathogen, Vibrio vuln@us biotype 3, that causes septicemia and 
severe soft tissue infections following contact with fish from artificial fresh 
water ponds. Because then, the identification of this new emerging pathogen 
has become a challenge for cltnical laboratories. Our laboratory maintains a 
unique collection of this new biotype strains, all of them isolated in Israel. In 
this study, the ability of five commercial systems in identifying this new species 
has been evaluated. 
Methods: Fdty-one documented Kvulnijms biotype, three isolated during 
the first known outbreak during 1996-97, were processed by five commercial 
identlfication systems: API 20 NE, Vitek 1, Vitek 2 (BioMerieux, France), 
Microscan (Dade-Boering, USA) and Phoenix (Beckton Dickinson, USA). 
Results: The number of strains correctly identified by Phoenix, Vitek 2 and 
Vitek 1 were: 50 (98.0%), 46 (90.2%) and 7 (13.7%), respectively. Microscan 
and APl20 NE were unable to correctly identify any of the strains of this new 
emerging pathogen and mostly misidenafy them as other species of the 
Vibrionaceae farmly. 
Conclusions: Phoenix and Vitek 2 proved to be the best systems in order to 
idennfy the new biotype of Koulniji~us correctly. Microscan, API 20 NE and 
Vitek 1 failed to do so. However, since all of them presented a consistent 
phenotypic pattern, the ability ofthese systems to correctly idennfy the strains 
could be easily improved by supplementing their software with the data 
presented in this study. 
Isolation of the major clinical Vibrio species from 
water and plankton of the Persian Gulf 
L. Haghighi, I. Nabipour, S. M. Jafari, E. Ageron and M. Haghshenase 
Shiraz, Bushehr, rR; Paris, F 
Objectives: Vibrios are one of the dominant bacteria on plankton. Plankton 
have also been studied extensively as a potential aquatic zoological micro- 
habitat for Ycholerae. An environmental study was done to isolate the major 
clinical vibrios from the Persian Gulf. 
Methods: Sixteen coastal sites h m  Bushehr P o a  in the north-west of the 
Persian Gulfwere sampled at 1 m below the surface. A total of 30 water and 12 
plankton samples were collected. Water subsamples were filtered through 
0.22 pn membrane filter. Collected plankton samples were added to alkaline 
peptone water, after homogenization. 
Results: A total of 56 strains, 34 vibrios h m  water samples and 22 vibrios 
h m  plankton samples were characterized. Twelve isolates of Kbrio olgino- 
lyticux and 11 isolates of Vpurahaernolytinrs from plankton and water samples 
were identified. Clcholerae was not isolated from water (salinity: 37-42 ppt) 
and plankton samples. 
Conclusions: The pattern ofhigh salinity observed was that Vcholerae was not 
detected in regions of the study. But, the occurrence of Kulginolytincc and 
Vparahaemolyticus in the Persian Gulfsuggest that these bacteria are a potentd 
public health hazard in this geographcal area. 
vl Aspects pleading for relationships between 
hemagglutinins and other virulence factors in V. cholerae 
01 strains 
A. Israil and M. Balotescu 
Bucharest, RO 
Objectives: The present work was performed on 166 Kcholerae 0 1  strains 
isolated from clinical cases (161) and environment (five water sources) 
during the cholera epidemics of Romania between 1987 and 1995, in the 
purpose to detect any relationship between HA patterns and other virulence 
factors. 
Methods: All strains were simultaneously investigated for: HA aspects, 
adhesion ability (by slime test) and the presence of nine enzymatic virulence 
factors (spot, CAMP and Kanagawa hemolysis, esculin hydrolysis, mucinase, 
amylase, lecithinase, lipase and DNAse production). 
Results: Out of 166 Vcholerae strains, 95% exhibited HA activities with 
chicken erythrocytes, i.e. 81% MSHA, 8% FSHA, 65% MSFRHA; 21% 
exhibited atypical HAwith human (0 group) erythrocytes, these atypical HA 
aspects (accompanied by a great phage type diversity) being concentrated in 
strains isolated in 1993. Out of 166 Kcholerae strains, 87,86, 85,83,75 and 
60% were positive for lipase, amylase, lecitbinase, DNAse, Kanagawa hemo- 
lysin and caseinase, respectively; 41,12,7.8% were positive in spot hemolysis, 
esculin and mucinase, respectively; 48% showed adherence ability to abiotic 
(borosilicate) surfaces evidenced in slime test, but only 19% of them exhibited 
a surface pellicle. 
Conclusion: Our results demonstrated a high correspondence of62% between 
MSHA and caseinase activity, 48% between slime agglutinin and caseinase and 
44% between the same MSHA and slime agglutinins. All the five Wdtolerae 
strains isolated in water sources showed Kanagawa and lecithinase positivity, 
but their adhesion aspects were poorly represented suggesting that in the 
external medium, Kcholerae 01 strains can preserve a high potential of 
toxigenicity (Kanagawa toxin), but scant adhesion ability to abiotic surfaces 
( t h ~ s  aspect probably explaining the lower resistance in the external medium of 
Kcholerae 0 1  as compared to non-01 strains). It is to be mentioned that one 
strain isolated in a child with acute diarrhea exhibiting MSHA was negative 
for all the other investigated vimlence factors. The low correlation (8.5%) 
between caseinase and mucinase suggests the existence of two distinct 
enzymes, our results being Merent &om data cited by Finkelstein et al. 
1992. Our results versus other data from the literature (Ingole et al. 1998) 
proved to be similar for caseinase (69% vs. 60%) and lipase (87% vs. 65.38%), 
but showed discordances especially for lecithinase (85% vs. Wh) and DNAse 
(83% vs. 19.23%). 
Ip6401 Epidemiological considerations on Vibrio cholerae 
infection in Romania in the last 25years 
V. Florea, I. Dumitru, E. Muja and M. Codarcea 
Constantu, RO 
Background: For the past century and a half, cholera has remained endemic in 
the delta of Ganges, with annual epidemics in major population centers in 
West Bengal and Bangladesh. The disease has made periodic incursions into 
other portions of Southern and South-east Asia, and it has given rise to seven 
major pandemics since 1817. Since then, until early in the 1960s the disease 
contracted in extent across the globe remaining regularly present only in 
Southern Asia. 
Objective: To study the epidemiological aspects regarding Vibrio cholerae 
infection in Romania in the last 25 years. 
Materials and methods: We performed a retrospective study on 2279 
patients with Vibrio cholerae infection who were diagnosed in the 
Departments of Infectious Diseases between 1975 and 2000 in Romania. 
The etiologic agent was isolated from the stools by cultures on TCBS agar. 
Final identifications required agglutination with group- and type-spec& 
antiserums. 
Results. In Romania, after 1975, seven epidemics spread across the country: 
115 cases in September 1997, 746 cases in August-September 1981,745 cases 
in 1987,298 cases in 1990,247 cases in 1991,20 cases in 1993 and 100 cases in 
1994. Only five, respectively, three imported cases were registered in 1984 and 
1992 (contact with persons from southern Asia). Most of the cases were 
noticed in Constanta and Tulcea County and in the Danube Delta Area. In all 
cases Vibrio cholerae 0 : 1, El Tor biotype, Ogawa serotype was identified. 
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Water, fresh fish and sea fruit plays a major role in the transmission of 
Vibrio cholerae in endemic areas. During major epidemics, the direct con- 
tamination of food with infected excreta was also important. Mild and 
moderate clinical forms predominated; lethality was ranged between 1.5 
and 2%. 
Conclusions: In Romania, in the last 25yean, during seven epidemics, a great 
number of cases were registered, especially in south-east of the country and 
Danube Delta Area (contaminated water and fish). Despite the treatment, a 
high lethality was noticed in severe cases. 
v] Evaluation of different methods for detecting the 
toxin profile and other virulence factors in Vibrio cholerae 
strains 
M. Balotescu, A. Israil, C. Dinu and M. Damian 
Bucharest, RO 
The purpose of this work was to evaluate by comparison the efficiency of 
PCR, Reversed Passive Latex Agglutination (RPLA) and NAD degradation 
(as a marker for ADP-ribosylating toxin) methods for detecting the toxin 
protile of 13 Kcholerae 0 1  (1 1 clinical/2 waters) and six non-01 (4 clinical/2 
waters) strains. There were also used additional tests (cytotoxicity on VeroE6 
cells, adherence to HEp-2 cells, slime test and 10 enzymatic assays) to 
investigate the presence of other virulence features. The results showed a 
concordance between PCR-RPLA (84%>), PCR-NAD degradation (73%) 
and RPLA-NAD degradation (84%). The sensitivity of RPLA and NAD 
degradation methods was comparable to that of PCR in detecting 
CT + Kcholerae 01  strains. In case of one Kcholerae strain isolated in a patient 
with diarrhea RPLA positive (up to the titer of 10-6) and PCR negative for 
toxin box (crx, ace, zot), the NAD degradation method confirmed the RPLA 
positive result, this aspect pleading for the presence of a new cholera toxin 
(NCT) in llcholerae 01  strains with diflerent genetic sequences from classical 
CT, but similar to CT Erom immunologic and biologic point of view. The 
negative result in RPLA and positive in PCR concerning one Kcholerae strain 
isolated in a contact, could be explained by the repression of the phenotypic 
expressing of ctx gene, the NAD degradation being probably determined by 
another toxin with ADP ribosylating activity. The two Kcholerue 01  
CT +water strains, positive in PCR, RF’LA and NAD degradation as well 
as all 6 Kcholerae non-01 strains negative in PCR and RPLA, but positive in 
NAD degradation (even in the absence of CT) are pleading for the existence 
of a reservoir of toxigenic strains in the aquatic medium. The NAD reaction 
could not be ascribed exclusively to CT, hut can be attributed to any other 
factor with ADP ribosylating activity, being very useful in detecting certain 
virulent clones of Vcholerae. NAD degradation and biofilm-forming (slime 
test) abilities might offer to the bacterial cell advantages in surviving and 
dissemination in natural ecosystems. The highest positivity of cytotoxicity on 
Vero E6 cells and of the enzymatic tests (Kanagawa, sheep erythrocytes 
hemolysis, lecithinase, caseinase, esculin hydrolysis) in Kcholerue non-01 
CT- by comparison to Vcholerae 0 1  CT+strains, suggests that these 
virulence features could act as substitutes for CT in Kcholerae non-01 
CT-strains. 
The antimicrobial susceptibility test among clinical 
isolates of Shigella sonnei in Ankara, summer 2001 
C Ustun, A Arslanturk and A Karaderrm 
Ankara, TR 
During the summer of 2001 an outbreak of Shgella ronm was observed m 
Ankara Among the pahents admtted with gastroenterias dunng March to 
October 2001, the ones wth dysenteric rllarrhea increased. Ofthe 14% total 
stools were exarmned, there were 289 mucus and bloody stools (19.3%) 
Shge lk  sonnet was isolated in 54 patlents (18.7%). The results of these pahents 
stools were examned a t  Baymdu Hospid, Ankara. Speclmens were cultured 
for Shrgella and other entenc pathogens usmg standard mcrobiologd 
techmques The incidence of Shqella sonnet related dlarrhea had mcreased 
smce July 2001. Anarmcrobial suscepabhty test were performed usmg the 
=by-Bauer rllsk a s i o n  method in accordance mth the standard of 
NCCLS guidelmes All Shgella sonnei lsolates were susceptlble to ampicfin, 
chloramphemcol, aprofloxom and broad spectrum cephalosporm Tri- 
methoprm-sulfamethoxazole (TMP-SXT) resistance was observed m all 
strains of Shigella sonnei. As a result, especially in children with mucus and 
bloody diarrhea, the use of TMP/SXT in prophylaxis of shigellosis, needs to 
be questioned. 
lp643) Antimicrobial resistance of Shigella, 19944000 
A. Jamsheer, G. A. Botta, N. A. Al-Baloosh and A. Arzese 
Manama, BH;  Udine, I 
Objectives: It is estimated that shigellosis is responsible for 600 000 deaths 
each year, mostly in children. S. sonnei and S.flexneri are reported as the two 
commonest species. Resistance has been reported to ampicillin (AMP), 
chloramphenicol (CAF), cotrimoxazole (SXT) and tetracycline (TET). 
Recently beta lactamase production has been observed leading to cefotaxime 
resistance. Shigenosis represents a diarrheal disease for which antimicrobial 
therapy is indicated. We decided to investigate resistance to several antibiotics 
during the period. Our aim was to assess resistance profile of strains isolated 
during a 7-year period. 
Methods: Here we report antibiotic resistance on 1198 Shigella isolates 
collected during the period 1994-2000 in Bahrein including Sfi&e!h sonnei 
(N: 620), S . J e m ’  (N: 403) S. boydii (N: 108) S. dyxenreriae (N: 67). Testing 
was performed by agar disk difliusion method on strains isolated according 
classical identification tests using home made reagenb. 
Results: S. sonnei, the most common isolate, was highly resistant to SXTwith 
constant percentage during the observation period (88.4 in 1994 and 85.7 in 
2000). Resistance to AMP was maximal in 1997 (28.1%) declining to 5.1% in 
2000, the lowest value in the in the 7-year period. One strain was found 
resistant to cefot-e and one to cefuroxime. S.jkneri was highly resistant 
to both SXT (max 82% in 1997, min 52.8% in 2000) and AMP (max 95% in 
1996, min 52.6% in 1999). CAF resistance also markedly decreased in the last 
3 yeaa (down to 38% fiom 90% in 1996). No resistance was found for all the 
species tested to ciprofloxacin (CIP) and cefbiaxone. 
Conclusions: Contrary to general feeling and commonly reported data we 
observed a sometimes very siwicant decrease in resistance to ‘old’ antibiotics 
likely linked to their restricted use and consequent limited selective pressure. 
In some cases (such as SXT) this apparent advantage is impaired ;by the sickle 
cell trait/disease pment in our patients. The persistent exceptional activity of 
CIP is hampered by the side-effects in children, the most exposed population. 
A carefid rotational use of antibiotics might be the best policy to make old 
drugs again active Limiting the vicious spiral of continuos research for use (and 
abuse) of new molecules. 
Acknowledgement: This study was supported by a research grant h m  AGU 
to GAB. 
Ip6441 Yerslnia enteracolitlca hfection in children in 
Crete, Greece 
S. Maraki, E. Giannowi, I. Maniadaki, A. Georgdadalas, E. Galanakis 
and Y. Tselentis 
Heruklion, CR 
Background: Yeninin enterocolifiu, can cause illness ranging h m  self-limited 
enteritis to life-threatening systemic infection. The aim of the present study 
was to review the epidemiolagy clinical course and outcome of Y enteromlitica 
enteritis in chddren seen at the University General Hospital of Crete, Greece. 
Methods: Medtcal and microbiologic records of all chddren with stool 
cultures positive for k: enterocolitica were retrospectively reviewed during 
the 7-year period, 1995 through 2001. 
Results: The review included 41 patients aged less than 14yeaa with 
Y entemolifira enteritis. Most patients (71%) presented during the cold months 
November to April. A clear history of exposure to any potential source of 
contamination was not elicited. Y entmmlitira accounted for 6% of bacterial 
intestinal pathogens isolated during the study period. Of 43 isolates tested 
almost all were resistant to ampicillin, amoxycillin-clavulanic, cephalothin, 
cefuroxime, ceftazidime, aztreonam, and imipenem. The majority were 
susceptible to trimethoprim-s&amethoxazole, gentamicin, anlikacin, tetra- 
cycline, chloramphenicol, and the quinolones. Anintermediate resistance was 
commonly shown for rifampin. A total of 13 children were hospitalized and 
28 were treated as out-patients. Among the 13 hospitalized children 7 were 
aged less than 2years. Blood cultures were obtained for the hospitalized 
children and all were negative. Children commonly presented with fever and 
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enteritis. Bloody stools were observed in 23% and abdominal distension and 
pain mimicking acute abdomen in 38% of the hospitalized patients. No chdd 
had sickle-cell disease or thalassaemia and no one presented with extra- 
intestinal manifestations. Only seven children received antibiotics and all had 
an excellent outcome. 
Conclusions: Yenterocolifica was a considerable cause of enteritis in the 
children in Crete, especially during the winter months. A certain risk factor 
was not demonstrated. Young children were more prone to severe manifesta- 
tions. Acute abdomen was often the presenting manifestation. The role of 
antibiotics needs hrther evaluation. 
lp6451 Clonal dissemination of a Yersinia enterocolitica 
strain, with different susceptibility to nalidixic acid 
J. Sinchez-Chspedes, M. M. Navia, R. Martinez, B. Orden, 
R. Miuin, J. Ruiz and J. Vila 
Barcelona, Madrid, E 
Objective: To study the epidemiological relationship among 10 clinical 
isolates of Yersinia enterocolitica either susceptible or resistant to nalidixic acid 
as well as the mechanisms of nalidixic acid resistance. 
Materials and methods: Ten strains of Y enterocolitica collected from diar- 
rhoeagenic patients in different towns in the area of Madrid (Spain), were 
studied from July 2000 to March 2001. In order to perform the epidemio- 
logical analysis, two methods were used (1) Digestion of chromosomal DNA 
with low frequency restriction enzymes and pulsed-field gel electrophoresis 
(PFGE) and (2) REP-PCR. The susceptibility to nalidixic acid and cipro- 
floxacin was evaluated by a microdilution method. Moreover, the presence of 
mutations in thegyrA andparcgenes were analyzed by PCR amplification of 
the quinolone resistance-determining region (QRDR) of these genes and 
theix subsequent DNA sequencing. 
Results: These strains showed the same PFGE and REP-PCR patterns, 
despite their different geographical and temporary origin. Six strains were 
nalidixic acid-resistant (NalR), exhibiting a MIC of ciprofloxacin ranging 
between 0.25 and 1 mg/L. These strains showed mutations in the QRDR 
region of the ZyrA gene; four strains with one mutation in the amino acid 
codon Ser-83 that changed to Arg; one strain with a change from Ser-83 to 
Ile; and one strain with a change &om Asp-87 to Tyr. Mutations in the parC 
genes were not found in any of the studted strains. 
Conclusions: The nalidixic acid-resistance shown by these strains is due to the 
presence of mutations in the gyrA gene. These results showed a clonal 
dissemination of a nalidixic acid-resistant L: enterocolitica strain derived from 
a susceptible strain in the area ofMadrid (Spain), probably because ofselective 
pressure with Auoroquinolones. 
I P646 I The microflora of the small bowel in health and 
disease 
A. Sullivan, H. Tornblom, G. Lindberg, B. Hammarlund, 
A.-C. Palmgren, C. Einarsson and C. E. Nord 
Stockholm, S 
Objectives: To compare the microflora in the proximal jejunum in healthy 
volunteers with the microflora in patients with gastrointestinal symptoms 
suggestive of spontaneous bacterial overgrowth (diarrhea, abdominal pain, 
bloating) in the small bowel. 
Methods: Twenty healthy subjects with no gastrointestinal complaints were 
included in the study. Eighteen patients with gastrointestinal complaints 
suggestive of spontaneous bacterial overgrowth in the small bowel were 
recruited h m  the out-patient clinic at Center of Gastroenterology, Huddinge 
University Hospital. The pdcipants had not taken any antimicrobial agents 
within 1 month preceding the study. Biopsies from the proximal jejunum 
were taken with a Watson capsule. In order to prevent bacterial contamination 
from the gastrointestinal tract proximal to the small bowel, the capsule was 
flushed with 5 m L  sterile 0.9% saline solution, 5min before releasing the 
spring-loaded cutting device. During retraction, the biopsies were protected 
&om bacterial contamination within the capsule. The biopsies wem t rans-  
ported to the microbiological department in Brain Heart Infusion @HI) 
medium. The samples were weighed, homogenized and diluted in pre- 
reduced media and inoculated on nonselective and selective agar. The plates 
were incubated aerobically and anaerobically. All isolates were identified to 
genus level. 
Results: Seven ofthe patients sutfered from irritable bowel syndrome, six from 
chronic intestinal pseudo-obstruction, two from mitochondrial myopathia 
with diarrhea and the remaining three patients from malabsorption, diabetes 
mellitus with diarrhea and functional dyspepsia, respectively. The small bowel 
microflora in both healthy subjects and in patients was similar to the 
oropharyngeal microflora. Sfrepromam intnmedius and Haentophitus parahae- 
molytias were only found in the microtlora of healthy subjects. Lactobacillus 
spp. was detected in samples of 2 of 20 healthy subjects and in samples of 9 of 
18 patients (P<0.05). The numbers of Willonella were slightly higher in 
patients than in healthy subjects. No other statistically si@cant Uerences 
between numbers of species or of total numbers of aerobic and anaerobic 
microorganisms were found. 
Conclusions: The jejunum microflora in health and disease resembles the 
oropharyngeal microflora. There were no major differences in numbers of 
most species but some species were only isolated in healthy persons whereas 
others were mainly found in patients. 
Changes in the infant intestinal micro flora 
associated with an anthroposophic lifestyle 
J. Ah, J. Swartz, B. Bjorkst&, L. Engstrand, J. Engstrijm, I. Kiihn, 
G. Ldja, R. Mollby, E. Norin, G. Pershagen, C. Reinders, 
K. Wreiber and A. Scheynius 
On behalfoffhe Jarna group (S) 
Objectives: Children with an anthroposophic Me style have been shown to 
develop atopic allergy more seldom than contml children with a Western 
lifestyle. The intestinal flora is supposed to have an impact on the development 
of the immune system. In the anthroposophic life style a vegetarian diet 
comprising vegetables spontaneously fermented by lactobacilli, and a restric- 
tive use of antibiotics, antipyretics and vaccinations is typical. The aim of this 
s t u d y  was to assess the gut flora in infants in relation to certain life style 
Characteristics associated with anthmposophy. 
Methods: Fecal samples from 69 children below 2yem of age with an 
anthroposophic life style and 59 similarly aged infants with a traditional life 
style were analyzed by bacterial enumeration (cfu) and bacteria typing 
through biochemical fingerprinting (The PhenePlate (TM) method) of 
coliform bacteria, enterococci and lactic acid bacteria; eight isolates per 
group and Sample, i.e. >3000 isolates were typed. 
Results: The numbers of enterococci and lactic acid bacteria were si@- 
candy higher in children who bad never been exposed to antibiotics. The 
number of enterococci was significantly higher in breastfed and vegetarian 
idants (P< 0.01). The diversity (Simpson’s diversity index) oflactobacilli was 
higher in infants born at home, than in infants born in hospital and in 
vegetarians (P< 0.01). The diversity of coliform bacteria and of lactobacilli 
did not change with age in the anthroposophic group. The data were 
interpreted as to indicate an earlier establishment of a ‘mature’ flora in 
anthroposophic children than in control children. This linding could not 
have been obtained without fingerprinting methods. 
Conclusion: In conclusion, life style factors related to the anthroposophic way 
oflife influenced the composition of the gut flora in the infants, which in turn 
indicates that the modern Western lifestyle has influenced the colonization of 
the intestinal tract of the newborn. These differences may contribute to the 
lower prevalence of atopic msease previously observed in children in anthro- 
posophic families. 
Ip6481 Gastroenteritis outbreaks due to infections with 
‘Norwalk-like viruses’ in Switzerland 2001 
R. Fretz, l?. Svoboda, T. M. Liithi and A. Baumgartner 
Liestal, Wadensdl, Bern, CH 
‘Norwalk-like viruses’ (NLVs) are a genus belonging to the f d y  of 
Caliciviridae. These viruses are mainly transmitted by the fecal-oral route 
and by aerosols. They are one of the most common causes of outbreaks of 
nonbacterial gastroenteritis. In the US, NLVs are thought to be responsible for 
an estimated 67% offoodborne infections and for 96% of nonbacterial cases of 
gastroenteritis. By outbreak investigation in the German part of Switzerland, 
an attempt has been made for the Gst time to assess and describe the epidemic 
potential of NIVs in our country. In cooperation with different Cantonal 
Laboratories and public health speciabsts, outbreaks with NLVs as possible 
causative agent, were recorded, analyzed and classified during the year 2001. 
In total, seven NLVoutbreaks could be documented. In five cases, NLVs were 
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detected by RT-PCR in stool samples, in one case the PCR product could not 
be confirmed by sequencmg and in another case, no samples were 
provlded The chmcal symptoms were typtcal and in accordance wlth the 
d e h n o n  of the NLV-infection The outbreaks occurred in four Merent 
semngs four outbreaks concerned hfferent school and boy scout's camps 
(158 paaents), one was a mumcipal outbreak (a few hundred panents 
estmated), one occurred in a health resort (approx 40 panents) and one 
was a f d y  and-&lends outbreak (25 pahents). The described outbreaks - 
except the mumclpal outbreak, which was thought to be waterborne - 
pomted out clearly the relevance of person-to-penon transnmslon m the 
eptdemtology of the NLVs. Furthermore, one outbreak m a school camp was 
prolonged and showed the importance of dumfecnon of contarmnated 
enwronments (eg. beds, todets) atter a NLV-outbreak to prevent further 
mfecaons. 
Tissue heiminths and lice 
1 P649 1 Electroencephalographic findings in cerebral 
cysticercosis patients 
V Turkulov, N. Samardzija Made, G. Canak, J. Vukadinov, V Ivetic, 
R. Doder and S. Sevic 
Novi Sad, W 
During the last 5years (from 1997 to 2001), 13 patients with the diagnosis 
of brain cysticercosis have been treated in the Clinic for Infectious Diseases. 
Headache existed in eight patienu (61.54%), while faintness occurred in five 
patients (38.46%). In most ofthe patients, the disease was clinically manifested 
by the presence offocal centers. Eight pahents (61.54%) had epileptic seizures, 
seven patients (53.85%) felt malaise and numbness in one-half of the body, 
while talk disorders occurred in two patients (15.38%). In eight patients 
(61.54%) neurological finding were pathological. Besides computerized 
tomography and nuclear magnetic resonance, 11 patients were subjected 
to electroencephalography (EEG). EEG findings were changed in 10 patients 
(90.91%), while only 1 patient (9.094a) exhibited normal bioelectrical brain 
activity. In five patients (45.45%). the sigm of mild unspecific cerebral 
dysfunction existed (difhse in one patient, over the cenaoparietal, frond 
or temporal regions in four of them). One patient expressed cerebral 
dysfunction more heavily, over the bnta l  and temporal regions. In four 
patients (36.36%), the EEG was specifically changed, with actually present 
epileptic activity in the form of isolated spikes. AU four patients with 
specifically changed EEG clinically manifested epileptic seizures. The anti- 
epileptic therapy was administered to 10 patients (76.92%) and yielded 
favorable results. 
Ip6501 Inflammatory reaction in neurocysticercosis 
patients 
N.. Sanlardzija Made, V. Turkulov, J. Vukadmov, G. Canak, 
R. Doder and S. Sevic 
Novi Sad, W 
During the period from 1997 to 2001, 13 patients with the diagnosis of 
neurocysticircosis have been treated in our clinic. Besides the routine 
laboratory and other additional findings (computerized tomography (CT) 
and magnetic resonance), 11 patients were subjected to lumbar puncture and 
cytological and biochemical analyzes of cerebrospinal fluid (CSF) were carried 
out. In five patients (45.45%) cytobiochemical finding of CSF were normal, 
while in six patients (54.55%), it was pathologically changed, showing the 
signs of inflammatory reaction. Pleocytosis was gresent in six patients 
(54.55%), the number of elements reaching 3 x 10 to 215 x lo6&. Lym- 
phocytes dominated in the CSF concentrate, while very s m a l l  numbers of 
granulocytes, eosinophils and monocytes existed. CSF protein values were 
increased in five patients (45.45%). being about 0.64-1.52g/L. Values of 
glycorachia were normal in four patients (36.36%), while in two patients 
(18.18%) they were decreased. The presence of inflammation signs in CSF 
correlated with the findings of active cysticercosis forms, as found by CT in 
four patients (66.67%) (in addition to calcific forms). The presence of 
Iymphomonocytic pleocytosis and mild proteinorachia was established in 
four patients (66.67??), who exhibited hydrocephalus as well. According to 
our results, the occurrence of inflammatory reaction was ascertained in the 
patients who had active brain cysticercosis, as well as hydrocephalus as a 
neurocysticercosis complication. 
Ip651 incidence of parasitic infections in an 
onchocerciasis-endemic village in northern Nigeria 
0. Ojurongbe, AX Beyioku-Fagbenro, B.N. Thomas, O.A. Adeyeba and 
F.O. Olamiju 
Osogbo, Lgos, Jalingo, NG 
Objectives: To determine the prevalence of intestinal parasitic infection in an 
onchocerciasis endemic area and to mvestigate the possible association 
between the intensity of parasitic infections. 
Methods: Cross-sectional study of 235 adults in Gongon Maliki village in 
Northern part ofNigeria was undertaken for this study. A total of 116 people 
were found positive for onchocerciasis by the skin snip method. All the 116 
subjects was screened for the presence of intestinal parasites using the formol 
ether faecal concentration techque. The cht-square test was used to 
compare the propomon of positive indiwduals between groups. Disease 
intensity among Merent age groups and sex was compared to determne 
If the Mmnces  were sut i sWy sigmfican~ 
Result: Entamoeba coli, Hookworm, SchiFtosoma mummi, Shmgyioidies stetror- 
alis, Enterobius vemrblmis and Taerra sag~naki eggs and OM were seen in the 
stool sample of the 116 (49%) dimduals positive for onchocerciasis. While 
the preVaLence of E. di (6.03%) E. vertnincIaris (1.72%) and T.Zagnutfi (0.86%) 
were negligible those OfHOokworm (31 .Wo) and S. m m m *  (37.93%) were of 
sigdicant importance. Hookworm and S.nransoni occur togaher more 
frequently as a multiple infection than as a mgle specie infection and also 
as triple species infection with E.co& but very rare. Then i s  no direct 
correlation between the intensity of the infectious. 
Conclusion: The result reflect the poor hygiene level of the community. It also 
imply thatjoint m m e n t  of Hookworm and schistosomiasis infection would 
be beneficial to the cornunity along with the ongoing onchocerciasiis 
control program in the area. 
[p652] A particular case of eosinophiiic pneumonia 
Toxocara canis IgGlM positiw 
G. Casngliom, M. Maioli, S. Vernocch, B. Nardo, C. Incarbone and 
A. Rema 
Tradate, I 
We describe a case of a young woman 26-year-old with bilateral interstitial 
recidwan- pneumonia. The patient had a history of intrinsic asthma &om 
2 years rn treatment with lnhalatory drugs (low dose of inhalatory steroid and 
fiz agonist), she lived In a small town and she had got a dog. She presented 
fever, cough, dyspnea, chest pain, artromialgies, polipnea, 4 saturation 93%, 
tachycardia lOO/min, b h t e d  crepitaat rala, 
losus rash at the %re limbs. Labomtory dam 
tosis 37 X 109/L witla peripheral blaod eosiwphilia 193 X VES 62, 
IgE 6 9 1 1 I U / d  (normal values 0-150). AU other laboratory tindinps, 
including auto-antibodm, rheumatoid factor level. serology for CMV, Chla- 
myma, Laegionella, Mycoplasma, HIV, Rubella, Hepatitis ABC, tuberculin 
skm test results were neganve. Blood cultures and also sputum, urine, 
bronchoaspirate cultures were negahve. Stools examinanon was negative, 
the stools were checked for evidence of ova or parasites and appropriate 
exarmnations and cultures excluded deep h g a l  infections. The patient w a s  
treated empirically, full-dose. consecunvely wth many types of anbbiotin (ev 
cefinaxone, ev netilmiclne, ev teicoplanine, oral claritromicine) without any 
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resolution. She had a complete resolution in a few days with oral 50 mg/die 
metilprednisolone. Biopsy of a skin lesion was made with evidence of 
vasculitis. The histological examination showed necrotizing vasculitis and 
necrotizing granuloma with a prominent eosinophil infitrate compatible with 
Churg-Straws Syndrome. Siemlogy for Toxocara canis was positive: IgG/M 
ELISA 1.042 (positive >0.300). Churg-Strauss Syndrome is a rare systemic 
vasculitis occurring in patients with asthma and blood eosinophilia; lungs, 
skin, are the’most common sites of involvement, but many other organs are 
afTected frequently. The diagnosis often in established &om clinical findings or 
biopsy of extrapulmonary sites. The prognosis is good, with remission 
occurring in the majority of treated patients. Toxocara canis pneumonia 
may resolve spontaneously. Today, after 2years. she is in health. The question 
is unresolved: our patient was really affected by Churg-Strauss Syndrome? 
Keywords: Toxocara canis, ChurgStrauss Syndrome, eosinophilic pneumonia 
I P653 I Tunga penetrans 
R. Binazzi, E Riccardo, M. Bavastrelli and S. Sanguigni 
Rome, I 
Tungu penefram, also known as “sand flea, jigger flea, chigoe, chique” causes a 
particular infection ofthe cutaneous tissue, called Tungiasis. Adult fleas can be 
found in sand and soil and are free-living. After copulation females look for a 
host (humans and other animals such as pigs and poultry) and find their way in 
cracks of the skin, typically on the feet between the toes and under the 
toenails. They burrow in the hosts skin between the stratum corneum and the 
stratum granulosum leaving only their breathing organs (spiracles) uncovered. 
The fleas then grow in size remaining attached to the host with their mouth 
parts und  they resemble a small white pea with a black spot in the middle. The 
growth ofthe jiggers causes skin irritation and itching in the host that through 
scratching determines the dispersion of the eggs. Tunga penetrans (Fig. 1) was 
o r igd ly  discovered in Central and South America, however, now it has 
spread to the African continent and to India (Fig. 2) 
From 1990 to 2001, we observed 18 cases of T h g a  penetnrnr infection in 
patients coming 6om Tanzania, Zanzibar, Gabon, Guinea Bissau and the 
Ivory Coast. All the patients showed characteristic lesions located around the 
toen& and under the feet, particularly in the crevices of the skin between the 
toes, which contained the fecund female jiggers. The sizes ofthe injuries were 
Merent, all were painful and some showed signs of bacterial super-infection, 
especially the ones located around the toenails. Diagnosis was suspected while 
examining the lesions, and was confirmed by identifjmg a s m a l l  black point 
on the summit of the “ s m a l l  white pea” lesion, which corresponds to the 
posterior respiratory spiracles of the flea. The mature female jiggers were 
carefully removed and the sores were disinfected. 
v] Subcutaneous myasis 
R. Binazzi, E Riccardo, M. Bavastrelli and S. Sanguigni 
Rome, I 
From January 1990 to September 2001, in our department we have diagnosed 
and treated 27 cases of Subcutaneous myasis. The patients we observed 
came h m  Afkica, Central and South America and for the most part were 
tourists. At presentation, the patients showed a bullous lesion, that was 
described as itching and painful. Some also developed low grade fever and 
general malaise. Most patient could not remember being in close contact with 
flies or maggots, but all had slept and lived in poor hygienic conditions. The 
sores started as a smal l  vesicle, painless and un-itching, that grew in size 
becoming painful in 1-2 weeks. During physical examination, we found a 
characteristic 1-3 mm dark-line on top of the lesion. This corresponds to the 
respiratory spiracles of the maggot. Once the skin surface was covered with 
vaseline or oil, oxygen bubbles appeared c o n f i i g  our diagnosis. Patients 
who presented with early manifestations were advised to wait for the larva to 
develop, abstaining from any kmd of treatment, and to return afler 1-2 weeks. 
Treatment of the !%&grown lesion consisted in covering the spiracles with a 
thin film of p a d i n  oil to stop the maggot f b m  breathing and exerting firm 
digital pressure on each side of the b a a  to remove it. We observed and 
identifiedeach maggot analyzing its peculiar morphological features under an 
optic microscope. The larvae belonged to two species, Dermatobia hominis and 
Cordylobia anthropophago, both known agents of Subcutaneous myasis. Once 
the maggots were removed the lesions healed spontaneously in a few days. 
Local application of antibiotics may be useful to avoid bacterial super- 
infection. 
Ip6551 Confirmation of Tatera indica (Rodentia: 
Gerbillideae) as the main reservoir host of zoonotic 
cutaneous leishmaniasis in west Iran 
M. Dehestani, E. Javadian and Z. Sheikh 
Tehran, IR 
Introduction: During the Iran-Iraq war, ZCL was one of the most important 
infectious diseases in the area of our study. 
Methods: During our study (summer of 1994) 22 Tatera indica were collected 
and two out of them (9.09%) were ~ t u d y  infected with amastigote. 
Parasites were cultured in N” + LIT medium and isolated promastigotes 
were sent to the Medical University of Montpellier in France for identifica- 
tion. 
Results: The result of isoenzyme test showed, the parasite is Leishmania major 
zymodem MON 26-(LON 1). 
Conclusion: Therefore, Tatera indica was known as the main reservoir host of 
zoonotic Cutaneous Leishmaniasis in the west of Iran. This is the first report 
on the isolation and idencification of L. major zymodem MON 26-(LON 1) 
h m  t h i s  species of rodent mean time. Rhombomys opimw was absent in these 
areas. 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 129 
lp6561 A study of seven echinococciasis cases in adult 
patients during 2000-2001 
A. Karaitianou, M. Zoumberi, K. Kosiavelou, E. Anagnostou and 
G. Kouppari 
Melissia, GR 
Objective: To study seven echinococciasir cases in adult patients during2000- 
2001. 
Methods: Samples of serum from patients were examined for echinococcus 
antibodies by indirect hemagglutination test (IHA). The magnosis w a s  based 
also on imaging procedures. 
Cases report During the study period, echinoccociasis was diagnosed in 
seven cases. The common causes of admission were persistent epigastric pain 
(5/7), nausea/vomiting (2/7), cholestasis/cholangitis (1/7), weight loss (1/7), 
suppurative liver echinococcus cyst (117) and fever (317). All patients had 
hydatid cysts in the liver and all had positive echinococcus antibodies by IHA 
test. In 5/7 patients, the title of antibodies was 1:3200. Primary disease was 
found in 6/7 patients and recurrence in 117. AU patients were treated by 
surgery 
Conclusions: Echinococciasis is s t i l l  being a health problem in Greece. I H A  
test is a sensitive and specific method for diagnosis of echinococciasis. 
/p6577 Evaluation of IgG-ELISA and IHA and their 
correlation with ultrasound appearance in the long-term 
follow-up of cystic echinococcosis of the liver 
L. Maiocchi, 11. Maserati, A. Garlaschelli, C. Filice and E. Brunetti 
Pavia, I 
Objectives: Cystic echinococcosis (CE) poses important diagnostic and 
follow-up problems. Diagnosis of relapse may be diflicult, especially after 
medical treatment. The lack of serological patterns predictive of the patient’s 
post-treatment response is a contributing factor. This is due to the short of 
follow-up in most studies published so far. 
Methods: Since usefidness of serology in follow-up of CE is questioned by 
some for the reasons aforementioned, we evaluated retrospectively 42 patients 
with abdominal CE (23 male and 19 female), with a follow-up ranging &om 
12 to 48 months. IgG-ELISA and IHA are routinely used in our parasitology 
laboratory both for diagnosis and follow-up; their values were plotted in 
graphs together with ultrasound (US) appearance at the time of blood 
drawings. Fluid in the cysts at US (Gharbi types I, 11, 111) was a marker of 
viabdity. Solid cysts (Gharbi types N, V) were rated non-viable. 
Results: The graphs obtained showed four d8erent patterns. 
(1) ELISA and IHA run parallel, increasing or decreasing in accordance with 
(2) ELISAvalues decrease months before IHA while cysts become nonviable. 
(3) ELISA values are steady while IHA increases indicating relapse (reappear- 
(4) Both I&-ELISA and IHA fluctuate against a stable US appearance; these 
Conclusions: IgG-ELISA and IHA are useful in follow-up after medical 
treatment if combined with US examination. Further study of the patterns 
described and comparison with other serological markers of relapse (IgG 
subclasses, IgE, Cytochines) are needed to define reliable indexes of relapses 
and to help in clinical decision-making with these patient. 
US appearance. 
ance of fluid). 
fluctuations seem to have no clinical importance. 
lp658/ Hydatid disease: ruptured cyst 
A. Argyropoulou, Z. Psaroudaki, J. Kalomenidis, E. Perivoliotis, 
M. Lignos, G. Margariris, M. Anagnosropoulou, C. Roussos and 
0. Paniara 
Athens, GR 
Hydatid disease is a parasitic infection, most frequently caused by Echinococcus 
granulosus. The geographic distribution of the disease is cosmopolitan, in 
temperate climate countries. A 38-year-old man appeared in the emergency 
department with dyspnea, fever, cough, hemoptysis and left-sided pleuritic 
pain. The symptoms began 5 days ago with no response to the treatment of 
second generation cephalosporins. A chest X-ray revealed cavitary lesion in 
the left lower lobe and bilateral b a s h  acinar infiltrates in lower lobes. Full 
Blood Count showed Hct 45.5%. WBC 15.000/mm3 (PMN 87%. LYM 5%. 
M 4%, EOS 4%). Plt 195.000/mm3 and ESR was 56 mm. A gastropscopy was 
performed, but no potential site ofbleeding was found in the upper digestive 
tract. Bronchoscopy revealed the characteristic endobronchial whitish-yellow 
membranes, considered specific for ruptured hydatid disease, with an abnor- 
mal orifice in a subsegmental &vision of the posterior of the left lower 
bronchus, that correspond to the fistula between the cavity and the bronchian 
tree. O n  nzicroscopical examination (wet and stained preparations) of bron- 
chial washmg the pathogenomonic hooklets of Echinocouus granulosus were 
found. The diagnosis w a  also confirmed by serology. Investigation of the 
upper abdomen (CT scan) revealed a liver hydatid cyst. Albendazole was 
introduced and patient was referred for surgical treatment ofboth the lung and 
the hepatic cysts. 
Condusions: 
1. In lung infections, protoscolices or hooklets may sometimes be demon- 
strated in bronchial h a g e  fluid or sputum although the absence does not 
rule out the possibility of hydatid disease. 
2. Eosinophilia is present in fewer than 25% of cases. 
3. Surgical excision of the cyst is the treatment of choice for hydatid disease. 
Long-term treatment with Mebendazole is mainly recommended. 
lp6591 A new experimental approach to form the 
unilocular liver cystic echinococcosis in rabbits 
M. Hokelek, H. Guven, U. Belet, K. Erzurumlu and A. Guvenli 
Samsun, TR 
Objectives: Cystic echinococcosis is s t i l l  endemic in developing countries and 
remains to be an important cause of morbidity especially in Turkey. Beside 
surgical and percutaneous radiological methods new experimental therapeutic 
modalities with the use of antiparasitic drugs are undergoing. Therefore, to 
constitute an effective model of cystic echinococcosis is gaining importance. 
The aim of this study is to present a new practical and time saving experi- 
mental model for treatment of cystic echinococcosis. 
Methods: Seven New Zealand rabbits were used in this study. Naturally 
infected cystic cattle liver obtained &om slaughterhouse, explored under 
sterile conditions. Appropriate cysts opened and protoscoleces examined 
under light microscope with 0.1% eosin. Approximately 0.5an in diameter 
daughter cysts were taken &om big cysts, which has hgh viability rates of 
protoscoleces. Suitable cavities were performed in anterior surfaces of right 
lobes of rabbits’ livers under general anesthesia. Daughter cysts put into these 
cavities and after the liver capsule sutured separately. 
Results: Livers were evaluated with computerized tomography and ultra- 
sound monthly for 3 months postoperatively. Settled cysts were observed in dl 
livers at the end of the first month. Mean diameter was 8.8 f 0.8 mm. Five 
cysts diameters were increased, mean diameter was 9.8-f 1.0- while only 
two cysts diameter was decreased at the end of the third month. 
Conclusions: The main advantage of this method is to form a successful 
unilocular liver cyst surgically, then classical intraperitonedly protoscoleces 
injection methods. As a conclusion, this method is found an applicable 
approach with the decrease of the cyst development time and high inoculation 
rate of cysts into the liver. 
jP6601 An unusual case of hydatid disease in the thigh 
E Albayrak, S. Cesur, E. Karadeniz, 0. Memikoglu, 0. Kurt, H. Kurt and 
E. Tekeli 
Ankara, TR 
Objective: Hydatid cyst disease (Echinoccosis) is a zoonotic disease caused by 
the tapeworm Echimcocnrz which have the ability of implanting in any organ of 
the body but mostly in the liver producing a cystic mass. It rarely involves soft 
tissues with a kequency ranging between 2.4 and 5.3% of all hydatid disease 
cases. This is a very rare case initially presenting with a soft tissue mass in her 
thlgh with unusual localization of echinococcosis. In the literature not more 
than 10 cases with unusual localization of echinococcosis is reported. 
Case: A 57-year-old female admitted with the complaints of pain and 
increasing size of her left leg. A plain X-ray showed water density mass in 
the left thigh. It was learned 6om the history that 30yem ago she was 
operated &om the same region for the same complaints. We performed an 
M R I  test to left thgh region. A cystic multiloculated mass was identified on 
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MR images. Albendazole was started to the patient in order to prevent 
anaphylactic reaction due to rupture ofthe cyst during the operation. She was 
submitted to surgery again and a hydatid cyst was extirpated fiom the thigh. 
Histopathological examination revealed typical hydatid sand whch is com- 
patible witb the dragnosis hydatosis. The patient continued the treatment for 
45 days after surgical procedure. Blood eosinophils elevated initially returned 
to n o d  and no more complaint was present after treatment. 
Conclusion: Patients with musculoskeletal lesions of cystic structure as soft 
tissue masses should be evaluated by physicians especially in areas where 
echinococcosis is endemic. These cystic structures resemble abscesses mor- 
phologicw. Essentially ultxasonography, was suggestive of the diagnosis. 
Magnetic Resonance Imaging (h4RI) provides more precise information 
about the localization, number and morphologic structure of the lesion also 
helps to digerentiate the mass from neoplastic diseases. Surgical excision ofthe 
cysts and he-needle aspiration biopsy usually lead to the definitive dugnosis. 
Since puncture of these cysts may cause an anaphylactic reaction due to 
spillage of hydatid fluid and/or dissemination of infection, the use of fine- 
needle aspiration biopsy is not preferred but this procedure may represent a 
real aid in the definitive diagnose of clinically unsuspected hydatid cysts. 
Jp6611 Pulmonary hydatid disease: clinical presentation 
and outcome 
Y.N. Akhtar, A. Jan, A. Afaq, A.S. Khokar, M.A. Bangash and S. Fatimi 
Karachi, PAK; London, UK 
Introduction: Echinococcusgranulosis causes hydatid disease and is an increasing 
public health problem in parts of Asia. The lung is the most common site of 
cyst formation after the liver. 
Objectives: Ascertain demographics, clinical features, treatment and out- 
comes of patients with pulmonary hydatid disease. 
Methods: Retrospective descriptive case series using data-extraction sheets 
for patients presenting in a Karachi Tertiary Care Hospital, between January 
1995 and August 2001. 
Results: A total of 19 patients had pulmonary hydatid cysts out of a total of 100 
patients with hydatid disease. Demographics of the 19 patients: male (68%), 
female (32%). mean age; 21 years, Pakistanis (63%), Afghanis (37%). 
Clinical features: Productive cough (84%), fever (73%), haemoptysis (52%), 
dyspnoea (42%). chest pain (42%), coexisting liver cysts (11%). 
Treatment Albendazole (12%), Albendazole and surgical removal (88%). 
Outcomes: Mean length of admission; 1 week. No intraoperative cyst rup- 
ture, mord ty  or recurrence of cysts were documented. 
Discussion: Presentation is more common in young males with symptoms of 
cough, fever and haemoptysis. Surgical removal with Albendazole cover is the 
treatment of choice, and this carries low mortality and recurrence rates. Early 
clinical detection, sterilization of the source and interrupting transmission of 
HIV I 
the parasite should be comblned with increased awareness as necessary 
prevention strategies to combat hydatid disease in Pakistan and other parts 
of Asia. 
Ip6621 Do healthcare professionals contribute to 
ineffective control of head lice? 
B Olowokvre, H. J e b o n ,  M Beaumont and H.V. Duggal 
St&ord, UK 
Objectives: Myths and shgma surmundmg head hce have generated con- 
troversy over treatment and prevenhonmethods. In 1998. the Public Health 
Medcme Enwonment Group, UK produced gtudance on the treatment and 
prevenhon of head hce. Thu was adapted for local use m South Staffordshe, 
an English health &strict, and dssermnated among local healthcare profes- 
sionals (HCP). The aun of thu study was to examme healthcare professlonals 
use and awareness of the local pohcy and their knowledge ofthe treatment and 
prevenhon of head hce 18 months after dmemnanon 
Methods: Printed copies of the pohcy were posted to primary healthcare 
professionals (general PraChhonerS and prachce nurses), commuruty health- 
care professionals (commuruty pedatrinans, health clsitors and school nurses) 
and pharmacists m February 1999. A self-a-tered qUeShonnam was then 
sent to all HCP m September 2000 to gather data on their use ofthe guidehnes 
and their knowledge of the treatment and prevenhon of head hce. Responses 
were classified as ‘W, ‘some’ or ‘no’ knowledge of treatment and prevention 
methods. 
Resultr. The pohcy was well dssermnatedunth 76% (173/228) ofrespondents 
indlcatmg that they referred to It A sigtllficantly greater propomon of CHCP 
would refer to the guidelmes when asked about head hce by a pahent or parent 
(P< 0.001) compared to primary healthcare professionals (PHCP) or phar- 
macists. When describmg prevenhve measures for head lice, all HCP groups 
appeared to have s d a r  ‘full knowledge’. However, sigtllficant dfferences 
between the groups m the category ‘no knowledge’ (P< 0.00001) were seen 
w t h  PHCP accounhng for most respondents. Overall, treatment for head hce 
was poorly descnbed wth sigrufcant Merences seen between the groups 
(P= 0 0096). Most of those wth ‘no’ knowledge of how to treat head lice 
were PHCP Altogether, respondents were significantly more hkely to have 
‘full knowledge’ of prevenaon methods (53.8%, 95% CI 47.2-60.2%) 
( P i  0.0001) than they were of appropriate treatment methods (4.6, 2.3- 
8.1%) 
Conclusions: Our results suggest that HCPs lack of knowledge of approprlate 
treatment and prevenhon methods conmbutes to meffectrve control of head 
hce mfeChonS. Ths  lack of knowledge was most marked ln PHCP and to a 
lesser extent 111 pharmacists These results deserve further invesugahon in 
other popdahons. 
1 P663 1 Trends in the costs of HIV management 1996-2001 
F. Gomez, J. Bernal, S. P. Romero, A. A. Garcia-Egido, E J. Fernandez, 
F. M. Orihuela and B. Sainz 
Cadiz, E 
Background Increased use of protease inhibitors (PIS) has been associated 
with declines in AIDS mortality and opportunistic infections (01s). These 
benefits have been obtained at the expense of an enhanced cost for the oral 
antiretrovirals, specially PIS. 
Objective: We have retrospectively evaluated a cohort of 100 H N  patients 
before and after the start of HAART including PIS (HAART-PI) to assess the 
effects on healthcare costs of HAART-PI in a 450-bed teachmg hospital. 
Methods: Costs were obtained fiom the medical records, the Office for 
Control and Management, Central Laboratories Service and Pharmacy of the 
Hospital. Other costs were estimated &om the standards of the Andalusian 
Health Service and the Spanish Ministry of Health. Mean costs per patient per 
month were compared by semester since July 1996 to July2001. Mortality and 
the incidence of opportunistic infections were correlated with the use of PIS. 
Results: Hospital admissions and length of stay decreased by 47 and 21%, 
respectively. In-hospital cost per day decreased by 9%. pardally due to a 33% 
decline of adrmssions with 2 1 major HIV-associated diseases. Admission costs 
per patient per year declined by US$2823. Outpatient visits per year increased 
by 67%, with a cost increase of USf339 per patient per year. The cost of 
laboratory tests increased by USf2341 per outpatient per year. Cost of 
pharmacy per patient per year increased by US$3578. Estimated saving 
per patient per year was US$1597 during the year 1997, US$779 in 1998, 
US$419 in 1999, USf234 in 2000, and USJl2l in 2001. 
Conclusions: HIV patients on HAARTwith PIS not only had considerably less 
admissions to hospitals and milder HIV-associated complications but, an 
important global general management cost reduction in the short term 
(1-3years) after initiation of HAART-PI. Although, clinical benefits persist 
after 3 yean of therapy, global healthcare saving tend to decrease afterwards 
due to enhanced costs of pharmacy and laboratory tests. 
186641 Quality of life and use of complementary medicine 
among H N  positives 
P. Nasta, E ChaifFarino, F. Parazzini, K. Kokkas, G. Weiler and 
V. Agnoletto 
ELECTHIV 2 Study Group 
Introduction: In the pre-HAART period, 43% of individuals wth HIV in 
Europe had had the opportwty or expressed thelr intention of using 
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complementary therapies (CT). Since 1996, HAART changed the use of CT 
among HN-positive people. 
Objectives: ELECTHnT2 is a casecontrol study, sponsored by European 
Commission and Italian Institute ofHeath, comparing the characteristics and 
the quality of life of CT  users and non-CT usen, HN-infected subjects. 
Methods: In seven European countries (Italy, Belgium, France, Germany, 
Greece, Spain, UK), anonymous, self-administered questionnaires were 
distributed which included sociodemographic information, clinical, immu- 
nological, therapeutical and side-effect data. The Hat-Qol Questionnaire was 
chosen to compare the quality of Me of CT users and non-CT users. 
Results: Total 1066 self-administered, anonymous questionnaires were col- 
lected. Total 632 were CTusers and 434 non-CT users. Slightly better scores 
on the quality of life were obtained by those who use CT compared to non- 
CT users. CT  users speak more easily about themselves and their illness to 
others, hide less and are less ah id  that colleagues or family, may learn of their 
seropositive condition, compared to non-CT users (f-test P <  0.05, covar- 
iance analysis (CA) P< 0.05). Those using CTaccept their dlness more easily 
than those who do not use CT (t-test D< 0.05; CA P< 0.05). The quality of 
life is more satisfactory for CT users than for nonusers. The significance 
appears statistically correlated to the asymptomatic clmical status (t-test 
P <  0.05; CA P< 0.05). The analysis shows that those using CT perceive 
the use of antiretroviral therapies as more &&cult than those who do not use 
nonconventional therapies. The antiretroviral therapy seems to be accepted 
less by CTusers. The statistical sigruficance appears correlated with the clinical 
status (P=O.O3) and, in particular, with the definition of the AIDS case 
( P <  0.05). It is probable that the diagnosis of AIDS corresponds to a longer 
illness and therefore more difFicult therapeutic regimes. 
Conclusions: The level of quality of life seems to increase with the level of 
education of NATC users, whilst amongst nonusers it appears to remain 
constant. From the scores of the Hat QoL, it is also possible to notice a more 
problematic relationship between NATC users and their doctor, especially if 
the former has long-term side-eEects (in particular peripheral neuropathy). 
This is one more reason to seek refuge in nonconventional therapies. 
jP6651 Seroprevalence study of HIV HTLV-1/11 HBV and 
HCV infections among immigrant prostitutes in Madrid, 
Spain 
M. GutiCrrez, M. Martinez-Padial, M. ])el Alamo, D. Cuevas 
and M. Baquero 
Madrid, E 
Objectives: To evaluate the seroprevalence of the HTV-1/2 HTLV-1/11 HBV 
and HCV mfections among immigrant prostitutes in Madnd. 
Methods: We analyzed 391 samples &om women who had recently arrived in 
Spain to work as prostitutes (aged 1&41 years). Total 360 came fiom sub- 
Saharan Africa: Sierra Leona (185), Nigeria (123), Liberia (30). Sudan (19), 
and 31 from Latin American countries. Most of them fiom Ecuador 28/31. 
Their sera, collected &om January 1998 to November 2001 during their first 
2months in Spain were brought to OUT laboratory by 'Medicus Mund? 
screening tests were determined by detection of antibodies using EIAs (Axsym 
Abbott, Ortho) and confirmatory tests by lineal immunoassays (RIBA Inno- 
LIA Pepti-LAV) and Western blot. 
Results: Nineteen (4.9%) were dected with HIV-1 (8/185 from Sierra 
Leona, 6/123 from Nigeria, 4/30 from Liberia, and 1/28 from Ecuador), 14 
(3.6%) with HBV (HBsAg-positive). One in 154 was infected with HTLV- 
1/11, No cases of HCV infection were identdied. Total 150 (38%) had 
serologic markers of past infection with HBV. 
Conclusions: In this study, it is worthy to note the high prevalence of HIV-1 
among the women &om Liberia (13%). None of the women tested were 
dected with HCV despite the high prevalence of the HCV in these Afiican 
countries. In addition, one woman kom Sierra Leona was infected with 
HTLVWII (relatively rare). 
lp6661 Comparison of two RNA extraction methods prior 
to HIV genotypic resistance testing 
C. Labayru, J. M. Eiros, B. Hernindez, M. Ortega, R. Oraz de Lejarazu 
and A. Rodriguez 
Elladolid, E 
Objectives: A crihcal point in the development and performance ofmolecular 
dxagnosis techniques is the extraenon of genehC material in the purist 
conditions. We evaluated the use of two RNA extraction methods prior 
to the genotypic detection of HIV-I resistance by line probe assay (LiPA). 
Methods F&y plasma samples were tested for the determination of viral load 
(VL) by means of Cobas Arnpltcor HW-1 MonitorTM (Roche Diagnostics, 
Branchburg, NJ, USA), preserving the obtained RNA extracts. RNA 
extraction by means of SV Total RNA Isolation System (Promega Corpora- 
tion, Madison, WI, USA) was also carried out. Both RNA extracts were 
processed in parallel for the detection of HIV resistance by LiPA, and bands 
were recorded comparatively. 
Results: Findings obtained by Roche extraction method were superior in all 
the studied parameters: proportion of amplified samples (66.0% by Promega 
vs. 98.0% by Roche for LiPA RT and 76.0% vs. 100.0% for LiPA P). 
percentage of mutated samples (32.0% vs. 58.0% for LiPA RT and 30.0% 
vs. 42.0% for LiPA P) and band intensity, this being superior in 66.7% of the 
samples for LiPA RT and in 18.4% for LiPA €? 
Conclusions: The outcome obtained by LipA after RNA extraction by 
Roche methodology was remarkably superior to that of Promega. More 
studies focused on the optimization of extraction methods prior to genotypic 
detection of HIV resistance are needed. 
I P667 I Testing of HIV-1 viral load with the bDNA assay 
using low volumes of plasma 
E. Lopez-Cernada, R. Alonso, A. Marnn, L. Alcala, M. Rodnguez- 
Crerxems and E. Bouza 
Madrid, E 
Introduction a d  objectives: The branched DNA way has proved to be one 
of the most used systems for quannficatlon of HIV plasmatic viral loads and it 
is probably the most reproducible one. The main &sadvantage of the test may 
be the hgh plasma volumes needed (I mL.), which makes it unsuitable for 
pediatric tests. We assayed two smaller volumes and have compared their 
results m t h  those of the standard procedure 
Methods: Eighty samples &om W-pcmtive patients ranging h o r n  300 to 
300 OOOcopies/mL were included. All the samples were run with the standard 
recommended volume (1 mL) as well as wth  0.5 and 0.2mL. All r m n m g  
procedures were those recommended by the manufacturer. In both cases of 
reduced volumes, results were converted to a volume of 1 mL. All results were 
compared and analyzed. 
Results: Average viral loads for all three volumes were 4.21 log (52 430 C/mL.) 
for 1 mL, 4.321og (58 308 C/mL) for 0.5 d, and 4.39 log (72 316 C/mL) for 
0.2mL. Analysis of pared volumes showed the followmg correhhon coeffi- 
cients (R2): 0.95, 0.95 and 0.99 for the paus 110.5, 110.2 and 5/0.2rnL, 
respechvely. 
Conclusions: Average qUanhfiCatiOn was qute similar among all three tested 
volumes, since dttFerences were under accepted reproducibility d u e s  of the 
techque  (0.2 log). An almost perfect comlation was achieved with lower 
volumes, although the remaimng pars also produced very high correlation 
coefficients. Although standard protocol must be used whenever possible, we 
thmk lower volumes may be used wthout considerably affeChng the results of 
the assays 
Ip6c81 Interpretation of genotype methods for testing 
antiretroviral resistance 
F. Garcia Jr., N. M. Martinez, S. Suirez, M. Alvarez, R. Daza, F Garcia, 
M C Bernal, J Hernindez and M C Maroto 
Cranada, E 
Objective: To compare dfierent algorithms for interpretanon of resistance 
mutahom in the sequence of protease and reverse transcriptase genes. 
Methods: A total of 43 pahents suffermg HIV-I infeCtIOn have been 
genotyped for HIV protease and reverse transcriptase (Trugene HIV-1 
genotypmg lut, Visible Geneacs) Total 23% of them were studied for first 
fallure, 32% second fdure, and 37% thrd fdure. The remammg 8% were 
pregnant women AU sequences were subjected to 11 interpretanon systems 
usmg as reference the software fiom Visible Genehcs 
Results: The 11 algorithms tested for the 15 Merent drugs gave the same 
results in more than 80% of the cases for AZT, 3TC, NW, DLV, Em SQV, 
RTV, NFVand LPV, 54% for ddI; 55% for ddC, 59% for d4T, 53% for ABC; 
79% for IDV and 71% for APV The most s d a r  algorithm to Vmble 
Genehc's was Retrogcun w t h  a 82 02% concordance, and the lesser was 
ADRA Wlth 53%. 
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COM~USionS: There are important differences in interpretation to resistance to 
ddI, ddC, d4T, ABC and APX likely because the mutations that give 
resistance to these drugs may not be yet well established. In general, there 
is not a good matching between algorithms and Visible Genetic’s. Inter- 
pretation is still the main problem for the genotypic tests of resistance. 
w] Prevalence of genotypic resistance in HIV-na-ive 
patients 
C. Labayru, J. M. Eiros, B. Hernindez, M. Ortega, R .  Or& de Lejarazu 
and A. Rodriguez 
Valladolid, E 
Objectives: The aim of this retrospective study is to asses the prevalence of 
primary resistance to antiretroviral drugs, both nucleoside analogs and 
protease inhibitors in untreated patients h m  Spain, and to determine their 
possible relation with several epidemiological variables. 
Patients and methods: One hundred and twelve samples belonging to the 
same number of patients were processed by means of the genotypic technique 
line probe assay (LiPATM) in order to study the presence of mutations at 
codons 41, 69, 70, 74, 184 and 215 of reverse transcriptase gene (LiPA 
RTTM) and at codons 30,46,48, SO, 54.82.84 and 90 ofprotease gene (LiPA 
PTM). Patient’s epidemiological variables, which are relevant in HIV infec- 
tion, were also analyzed. 
Results: The successN amplification rate was 79.5% for LiPA RTTM and 
89.3% for LiPA PTM. In case of LiPA RTTM, statistical sigruficance 
(P<O.O5) was observed when successful amplification was related to sex 
(P=0.04) and to viral load level (P=O.OOS). Global prevalence of primary 
resistance was 12.5%. Primary mutations in reverse transcriptase gene were 
found in two samples (2.2%). being M41L, K70R and M184V in one ofthem 
and K70R in the other. With LiPA PTM, primary mutations weredetected in 
12.0% of cases, V82A being the most 6equently detected mutation (11112, 
91.6%). In one case (8.3%), mutation M46I was detected. Primary mutation 
V82A was found alone in eight samples (66.6%) and together with the 
secondary mutation I84V in three samples (25.0%). No statistical sigdcance 
was found for any of the epidemiological variables. 
Conclusions: As for amplification, the profitability ofthis technique should be 
improved, because problems were found in a high percentage of samples. The 
prevalence of resistance detected is around the mean of that found by other 
authors. 
m] Selective genotype mutations elicited by nelfinavir 
(“)-based antiretroviral therapy (ART): frequency, 
relationship with other codon mutations, and consequences 
on subsequent treatment options 
Bologna, z 
R. Made&, L. Calza and E Chodo 
Objective: To assess the fkequency, ART background, and outcome of the 
occurrence of the specific protease gene mutations at codons 30 & 88 among 
HIV-infected patients @) receiving the protease inhbitor (PI) NFV 
Methods: Among 1017p treated with ART since January 2000,233~ who 
received NFV for >6 months ensuring a >90% adherence were considered. 
Virologic or immunological failure prompted viral genotypization in 68 cases 
(29.2%): the protease gene mutations were assessed according to eventual 
previous ART, subsequent ART modifcation, and laboratory follow-up. 
Results: Of 233 p treated with NFV, 36 started NFV when nalive to AKT, 41 
were nake to PI and non-nucleoside reverse transcriptase inhibiton 
(NNRTI), 84 at their h t  switch of PI- or NNRTI-based ART, and 72 p 
afrer two or more ART changes. On the whole, only 3 p  of 233 (1.3%) 
developed the isolated D30N mutation (with or without the NSSD), con- 
currently with virologic failure (as expressed by a rise of >1 loglo of HIV- 
RNA levels). All cases occurred among the 77 ART- and PI- or =TI- 
ndive P, and prompted an ART change, including a different PI in 2p, a 
NNRTI in 1 p, and concurrent switch of 21 nucleoside analog: the 6-15- 
month follow-up showed a favorable virologic response (undetectable 
viremia in 2p, and a 1.81ogl0 drop of HIV-RNA in the remaining p). On 
the other hand, all the 156p with one or more failures of triple ART had a 
broad and varied resistance spectrum, including multiple cross-mutations 
impairing the activity of most PI, but failed to present the D30N 
mutation (P  < 0.04 compared with the 77 p who never received PI and/ 
or NNRTI) . 
Discussion: In ourseries, the spec& pnmary genotypic mutanons conferring 
resistance to NFV had a very low fkequency, and were M t e d  to p who were 
never exposed to PI- or NNRTI-based ART before starhng NFV, whde 
&lure ofsecond or rescue NFV-based ARTwas due to a growing spectrum of 
PI cmss-resistance, excludmg those at codons 30/88. The specific prmary 
NFV-reslstance profile @30N f N88D) d~~gu lshes  NFV h m  other PI, 
and allows ~ t s  use in either first-he or subsequent ART, although NFV 
efficacy IS often reduced when salvage therapy of p treated for a long time mth  
PI is of concern (and a broad spectrum of protease mutauon are expected, 
such as those mvolvmg codons 90, 36, 46, 48, 71,77,82,84). Since most of 
the shared PI-evoked mutaQons are absent when NFV IS used as first-he PI, 
the hnited cross-resistance kquently allows successful second-he or salvage 
PI-based ART. 
/p671] Comparison of Organon Tekknica nucleic acid 
sequence-based amplification and Roche Monitor assay for 
HIV-1 viral load quantification 
C. Martinez, C. Guerrero, B. Mom, T. Rodriguez and M. Segovia 
Murcia, E 
Objective: To compare the performance of Organon Teknika nucleic acid 
sequence-based amplification (NASBA-QT) and the Roche Amplicor Moni- 
tor assay (AMPLICOR HIV-1) for monitoring HIV-1 RNA levels. 
Methods: Plasma samples were obtained &om adult patients. Plasma was 
separated f b m  anticoagulated blood within 2 h of collection in EDTA and 
stored at -70 “C until analyzed. All samples were tested in the first thaw. Both 
the NASBA-QT and AMPLICOR HIV-1 assays were performed following 
the manufacturers’ instructions. For the correlation analysis, the Spearman’s 
correlation coefficient was calculated. 
ResuIts: Quantitative HIV-1 R N A  analysis was peerformed on plasma samples 
&om 70 HIV-seropositive patients. Log-transformed HW-1 RNA values that 
were above the levels of detection limit ofboth assay (N= 65) were compared. 
There were 52 and 54 positive samples in AMPLICOR HIV-1 and NASBA- 
QT, respectively. There were 41 samples positive by both methods, 11 samples 
were positive only by AMPLICOR HIV-1 and 13 were positive only by 
NASBA-QT. The quantification values obtained in the 41 positive samples by 
both assays were significantly correlated with one another (Spearman’s 
correlation coefficient of 0.741). 
Conclusion: This study showed a good correlation between the results 
obtained with the two assays. 
1 P672 I The trend of plasmatic HIV-1 viral loads: a way to 
assess evolution of efficacy of antiretroviral therapy in a 
large population 
R .  Alonso, E. Lopez-Cernada, A. Martin, l? Murioz, 
M. Rodriguez-Creixems and E. Bouza 
Madrid, E 
Introduction and objectives: HAART was introduced and generalized in 
Spain in early 1997. Since then, our patients have benefited clinically f b m  
these regimens. New and simple methods to estimate the evolution of large 
populations with HIV infection in the era of HAARTare now necessary. Our 
aim was the evaluation of HIV-1 viral load trends since 1996, just before the 
introduction of HAAKT, to the present. 
Methods: We included data f h m  22970 viral load tests. Plasmatic viral loads 
were determined by the QUANTIPLEX H N  bDNA system payer, Ger- 
many), according to the manufacturer’s insrmcdons. Six different viral load 
segments were established in order to analyze chronological trends (<500, 
50&10 000, 10000-30000, 30000-100000, 100000-500000, and 
>500000 copies/mL). Additionally frequency of poor evolutions (rise in 
more than 0.5 log or maintenance over 20 000 copies/mL) was also consid- 
ered for followed-up patients. 
Results: During 1996, fiequencies fkom all viral load levels, with the excep- 
tion of the highest (>SO0 000 copies/mL, 2.7%), were homogeneously 
distributed from 13 to 25%. From 1997 to the present, the most represented 
segment was the lowest (<SO0 copies/ml) with frequencies ranging from 
45% to almost 60%, followed by the second level (5W10000copies/niL), 
with around 20%. The remaining segments always accounted for less than 
10% each. The only segment whose 6equency increased over time was the 
first one (<SO0 copies/ml), while kcpencia  for all remaining levels were 
clearly decreasing. When considering follow up of treated patients, 
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poor evolution rate was kept almost constant throughout the period (average 
23%) 
Conclusion: Virema has been much reduced m our HIV-posinve pauents 
smce the mtroduchon of HAAR.T. T h  response has been globally mam- 
tamed over the last 5 years and values are sltghtly tendmg to the lowest viral 
load level The mennoned approach w t h  easy-to-measure parameters has 
perrmtted a rapid eshmate of the efficacy of HAART 111 a large HIV 
populahon. 
(nhal undetectable wal load rate of 82.4% vs final undetectable vlral load 
rate of 92.9%) and endocem (mnal undetectable wal load rate of58.8% vs. 
final undetectable viral load rate of 78.6%) Cesarean was the mam delivery 
way and only one pahent had a vagmal dehvery wth  an undetectable vlral load 
in M ~ I M  and endocervix. There were no permatal transrmssion 
Conclusions: The d load in blood does not prehct the vlral load m 
cemcovagmal secrehons. T b  situahon has an important sigmficance when 
the wal load 111 cemcovagmal6ecrehons is detected m pregnant women wth  
undetectable wal load m blood. 
P673 ] HIV-1 plasma virus load is increased in HIV-infected 
women with vulvovaginal candidiasis and C. trachomatis 
cervical infection 
A. Beltrame, A. Maatteelli, A. C. Carvalho, C. Casalini, S. Tedoldi, 
C. Pizzocolo, N. Saleri, A. Forleo, A. Patroni and G. Carosi 
Bresn'a, I 
Background: Sexually transmitted infections (STIs) increase transmissibility to 
HIV-1 and are associated to increased HIV-1 viral loads in genital (semen and 
cervicovaginal fluid) specimens. There is s t i l l  unproven association between 
STI and increase in plasma viral loads of HIV-1. Plasma virus load is a major 
risk factor for progression to AIDS and death. 
Objective: To define biological variables associated to increased prevalence 
and incidence of vulvovaginal candidiasis (WC) and Chlamydia hachomatis 
(CT) mfection among women with HIV infection. 
Methods: Prospective study of HIV-infected women at the Infectious and 
Tropical Diseases Clinic in Brescia, basehe prevalence and cohort incidence 
o f W C  and CT have been assessed. C W  was diagnosed by direct observation 
of Gram-stain preparations and culture fiomvaginal samples. CTwas searched 
in cervical swabs by the LCR technique. Incidence rates were calculated using 
the person/month method. Association between C W  and CTwith demo- 
graphic and biological variables was performed using multivariate logistic 
regression, and a Cox regression model. 
Results: From January 1998 to July 2001, 192 women were enrolled. The 
median age was 35.6years (SD+6.1years), 14.6% were immigrants from 
Africa. The route of acquisition of HIV was drug addition (IVDU) and 
heterosexual intercourse in 44.8 and 42.2%, respectively. Total 28.6% had 
CD4 cell count below 200, and in 20.4% HIV-RNA levels were over 
1OOOOcopies. A diagnosis of AIDS had been done in 25%. The baseline 
prevalence of C W  and CT was 14.6 and 9.6%, respectively. Among 106 
women who were followed for a mean period of 19.3months, the incidence 
of C W  was 12/100women/year (29 new episodes). Among 86 women 
who were followed for a mean period of 18.5 months, the incidence of CT 
was 5/100 women/year (seven new cases). In the multivariate logistic regres- 
sion model, incidence of CWand  CTwas not related to age, clinical stage or 
CD4 cell counts. However, the probability of HIV-RNA to be above 
10 000 copies was sigruficantly higher among women with C W  at baseline 
(OR=2.63; 95% CI, 1.03-6.68; P=0.04) and with new C W  episodes 
(RR=3.16; 95% CI, 1.31-7.61; P=O.Ol) and new CT infections 
(RR= 11.8; 95% CI, 1.33-104; P=0.02). 
Comments: We report a sigdcant association between incidence of CWand 
CT and plasma HIV-viral loads. Whether CW and CT are the cause or a 
consequence of increased viral loads need to be further investigated. 
1 P674 1 HIV viral load in blood and cervicovaginal 
secretions in pregnant women 
G RUE, R Diazaraque, S. Garcia-Bujalance, I Bates, J. M PeAa and 
C Ladr6n de Guevara 
Madnd, E 
Objective: To relate viral load in blood with vlral load m cervlcovaginal 
secrehons in pregnant women 
Methods: The walload m blood and cemcovagnal secretions was stumed m 
33 HIV-idected pregnant women at then first vlsit (initial wal load) and at 
38th week of pregnancy (final wal load) wth  Monitor HIV System 
(Roche@). If an dublaon  of reachon occurred the wal load was detected 
by bDNA (Quantlplex System 340 Bayera). We consldered as undetectable 
an H N  wal load <100copies/mL 
Results: Pregnant women that showed a final vlral load of <I00 coples/mL., 
the v w a l  and cemcal vlral load was undetectable too Only one panent had 
a final v a g d  load of220 copies/mL Pregnant women w t h  final vlralload of 
>tOOcopies/mL showed hghest rates of undetectable wal load m vagma 
lp6751 Treatment of pregnant women infected with 
HIV-1: study on treatment interruption during the first 
trimester of pregnancy 
S. C o d ,  C. D e j m  and A. Berrebi 
Toulouse, F 
One oEthe treatment recommendations for pregnant HIV-1-infected women 
is the mamtenance of eecave annretroviral drugs when pregnancy occurs. 
The maternal benefit is indlsputable, the risk of perinatal HIV-1 transrmssion 
is m u m  but what about the towcity for the newborn? The purpose d o u r  
study is to analyze another option chosen by Toulouse Umversity Hospital m 
France. If a climcal, mununolog~c and virologic status ofwoman is good when 
pregnancy occurs, any antlretrowal therapy is stopped durmg the first 
trimester (we avoid the period of embryo-fetal toxicity). The ZDV and 
3TC IS introduced at 24th, 28th or 32nd week of gestanon. The method used 
conslsted ofrepomng the Afferent therapeutic regimen before and during the 
pregnancy and to note the rate of CD4 and the viral load in the beginning of 
pregnancy and at the &very. Data have been analyzed on Excel tab computer 
to extract the results. A total of 40 women had an andretroviral therapy in 
early pregnancy. A total of 38 patients stopped thew treatment during the first 
trmester then followed this therapeutic repmen (23 women had 
ZDV + 3TC, 4 ZDV, and 11 ZDV + 3TC f NVP). At the delivery, the rate 
of CD4 of 27 patients had increased and the wal load of 31 women had 
decreased, including28 to a signifcant degree (1 e. aMTlahOn with >0.5 log). 
A total of 22 pahents had their CD4 count mcreased and their d load 
decreased at the same tme. T h  study shows that stopping of the therapy 
during the first trimester of pregnancy mmtained the viral load of 
<10 000 copies/mL (i.e. nsk of perinatal HIV-1 transrmssion reduced) in 
32 cases over 38. Further, this intermption treatment had no -act on the 
health of the mother during the pregnancy but its necessary to supervize the 
Immunovlrological marker for a long durahon. The lack of data on antl- 
retromral fetal toxiaty should incite us to minimize the exposure of the 
embryo and fetus to these molecules. The treatment mterruptlon pro- 
grammed m the fm trimester could be one of the strategies. But, d its 
impossible to stop the therapy because of the bad health of the mother, that 
would be interesting to proportion m the placenta and the cord the anh- 
r e t r o d  drug to have data on the human passage placenta. 
Kaletra treatment in patients from a Neapolitan 
area who failed previous HAARTs 
P. Fhppm, C. scolashco, C. Nacca, M. Battagha, N. Coppola, G. Rossi, 
F. Scarano, M Onofno, F. D'Amello, €2. Pisapia, C Marrocco, 
M. Imparato, E. Sagnelh and E Piccuvno 
Naples, Caserta, I 
Background: HAART- mtroduced m Italy 5years ago, unal today many 
pahents (pts.) faded prevlous PI- or NNRTI-based treatments Lopinam/ 
ritonaw (Kaletra) is a new PI combmanon that has shown to be effecuve in 
experienced and naive HIV-infected pahents. 
Aim: To evaluate the safety, tolerabdity and the efficacy of combmanons 
contammg Kaletra m mulnexperienced anh-HIV-posihve pahents 
Methods: We enrolled m an early access program 33 consecuhve ann-HN- 
posihve panents, who faded at least two prevlous HAARTS observed, as 
outpatients h m  December 2000. The medmn observation p e n 4  was 
32 weeks (range 4-38). Ofthe 33 enrolled pahents, 26 were male; the median 
age was 36years (range 31-63). All CDC c h c a l  groups were represented 
(Al: 4pts; B2. 12pts.; B 3  5pts.; C2. lpt., C3: llpts.). Twenty-eight 
pahents received Kaletra + 2 NRTI and five patients received Kale- + 1 
NRTI + 1 NNRTI. In all the patients, the foll-g were performed every 
4 week  c h c a l  exammanon, vlral load, CD4 cell count, he r ,  panmas and 
hdney function tests, hematology, cholesterolemia and triglycendema. The 
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efficacy of Kaletra was evaluated using 'on-treatment' analysis. Adherence to 
treatment was evaluated at the fourth week of treatment using a standardized 
questionnaire (QL0721 modified). 
Resulti: No new AIDS defining event has been observed during the 
treatment. Thuty-one patients but two well tolerated the Kaletra-based 
regimens. One anti-HCV-positive patient who received an =TI-contain- 
ing regimen discontinued treatment for hypertransaminasemia. A hypersen- 
sitivity syndrome probably due to abacavir occurred in the second patient. 
Abnormalities ofkidney and pancreatic function tests were not observed. The 
adherence to treatments was high (88%). No sigmfkant modification in 
cholesterol, triglycerides and glucose levels were observed during treatment. 
The mean&SD CD4 cells number raised &om 233f201 at baseline to 
584 f 380 at 32nd week. A 3 log decrease of HIV viral load was observed &om 
baseline to 28th week (5.17f2 and 2.01 f 1.05, respectively). The pre- 
valence ofpatients with undetectable viral load was 55% at the 4th week, 78% 
at the 16th week and 89% at the 28th week. 
Conclusions: Our ongoing data show that the Kaletra-containing regimens 
are effective, tolerated and safe in niultiexperienced patients. Adherence to 
treatments has been high. Thus, we suggest to extend the use ofKaletra in PI 
naive patients. 
1 P677 1 Correlations between HIV subtypes and 
antiretroviral treatment failure 
C. S. Cambrea, B. Gazzard and A. Pozniak 
Constanta, RO; London, UK 
Objective: To correlate genotype with response to antiretroviral treatment. 
Methods: Study was performed on outpatients in Chelsea & Westminster 
Hospital, London, UK. Genotype with quantitative phenotypic analysis and 
subtyping were performed in patients who had experienced ART failure. 
Treatment history (antiretroviral combinations, length and switches) and 
demographic parameters were recorded for each patient. 
Results: We analyzed 45 patients (15 November 2000-15 March 2001), who 
presented antiretroviral resistance for the clinical, immunologic and virologic 
point of view. The average age of patients studied was 34.5 (range from 28 to 
58years). Forty-one of 45 patients were men, out of which 38 were men 
having sex with men. For the studied patients, the average length of 
antiremviral treatment was 7.13 (range from 1 to 11 years). The duration 
and composition of antiretroviral treatment that had been used were similar 
among the subtypes. We found next subtypes B (n = 35), A (n = 5), C (n = 4), 
and D (n= 1). After analysis of genotyping and phenotyping assays, we 
observed that most of the patients (26) had NRTIs and " R T I s  resistance 
and only 10 patients presented resistance to all three classes of antiremvirals. 
We found only one patient with virus resistance to all drugs from all three 
classes. We noticed that there are some mutations that are sigruftcantly more 
prevalent in non-B subtype, comparative with subtype B (in RT: VlMA, 
P=O.O16, G190A/I, P=0057). Conversely, some other mutations are more 
frequent in B subtype comparative with non-B subtype (in PR: L90M, 
P30.004. M361, P=0.006, V771, P= 0.0001; in RT Y181C. P=O.O007, 
M41L, P=O.OOOl, T215Y/F, P=O.Ol). Some specific cluster was more 
prevalent in patients with B subtype comparative with non-B subtype (in P R  
M36I+W7I+L%M, P=O.O04). 
Conclusions: To interpret the different mutations correctly, it is necessary to 
consult an expert in viral resistance and/or continuously acmalized databases, 
e.g. Stanford University, AlamosResistanceDB and VircoDB in daily routine. 
The presence of &tinct genetic patterns among HIV subtypes in patients who 
experienced antiretroviral failure emphasizes the clinical need to advance our 
understanding of drug resistance in Merent subtypes and further clinical 
investigation is warranted. 
[=I HIV-subtypes analysis in the pol gene sequence 
E, Garcla Jr., S Suirez, N. M. M d n e z ,  M Alvarez, R. Daza, 
M C Bernal, E Garcia, J. Hernindez, G. PiCdrola and M. C Maroto 
Granada, E 
Objective: To know the HIV-circulatmg subtype using the pol gene sequence 
and to compare the results with three dlfferent ahgnment systems 
Methods: We have studled 43 pahents wth HIV-1 mfectlon fiom the 
Infecuous Diseases Umt m our hospltal. A hgment of 1.3 kb from the pol 
gene was transcribed andamphfed by PCR. In the amphfication product, the 
protease gene (codons 10-99) was sequenced and a part of the reverse 
transcriptase (codons 41-239) by b ihcuonal  sequencmg mth  primers 
labeled mth Cy5 5 and Cy5.0 in a sermautomatx sequencer (Visible Genencs 
Inc, Opengene System). The protease and revene transmptase sequences 
were analyzed m a new subtypmg method that compares the obtvned 
sequence mth the reference sequences for the subtypes, usmg BLAST 
algorithm (Basic Local Ahgnment Search Tool) and phylogenehe analysls 
(L.os Alamos Database) Two other methods for knowng the subtype f h m  the 
pol gene sequence were used (&om ABL Networks and Stanford database 
algorithms). 
Results: Subtype B was found in 68% of pahents wlth the Los 
Alamos Database and m 95% of them usmg the databases from AF3L and 
Stanford. Los Alamos Database showed w e d  subtypes in 21% of the 
samples. One pahent idenclfed as a CRF 02 A-G (circulating recombmant 
form) by two systems was identified as a B/F/K m u r e  by Los Alamos 
Database. 
Conclusion: The B subtype is the most prevalent as shown by pol gene 
sequencmg. This method may be useful to search for CRE but t h s  must be 
confirmed for sequencing longer genomc regzons 
CMV, EBV and herpes viruses 
lp6791 Seroprevalence of cytornegalovirus antibodies 
among various age groups in Konya, Turkey 
D. Findik, 0. Ural, U. Arslan and I. Tuncer 
Konya, TR 
Objective: Although cytomegalovirus rarely causes disease in immunocom- 
potent individuals, it can cause severe morbidity and mortality in congenitally 
infected newborns and immunocompromised patients. Cytomegalovirus 
infections which are endemic throughout the world are especially more 
common in the developing countries and in the areas of low socioeconomic 
conditions. This study was designed to show the prevalence of CMV 
antibodies (CMV IgM and IgG) among children aged lday to 15yem 
and in adults upper than 15 years of age. 
Methods: The antibodies to CMV (IgG and IgM) were analyzed in serum 
samples of 713 children (357 female, 346 male) and 585 aduit (349 females 
and 236 males) by means of Enzyme-Linked Fluorescent Assay (ELFA) 
technique (bioMerieux sa, France). 
Results: For the overall study population, we found that 2.38% were 
seropositive for CMV IgM, and 95.9?/0 for CMV IgG antibodies. The 
seropositivity of CMV IgM antibodies was 3.13% among children aged 0- 
15years and 1.78% among individuals over 15years of age (no statistically 
sigruficant difference P >  0.05). The seropositivity of CMV [gG antibdes 
was 86.2% among chddren aged (F-15 years and 97.6% among the individuals 
over 15 years of age and there was statistically significant difference between 
the age groups (P < 0.05) hut no difference between males and females 
(P> 0.05). 
Conclusion: Although symptomatic infection is rare most of the children are 
infected before puberty because the seropositivity rates of CMV IgG anti- 
bodies rise to 97.6% after the age of 15. Our findings confirm that CMV is 
highly endemic in our population. 
Ip6801 Prevalence of cytomegalovitus, herpes simplex 1, 
and herpes simplex 2 in cancer patients with infection 
C. Petrochilou, S. Karachalios, B. Karatnpasi, M. Pouylouka, A. Tsiriga, 
S. Kastellanos, I? Tsoukalas and C. Kontou-Castellanou 
Athens, GR 
Objectives: The purpose of this study was determinate in serum of the cancer 
panents for antibodies IgM, IgG, gBIgG against CMVas well as for IgG, IgM 
against HSVl and HSV2. 
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Materials and methods: Sera &om 65 cancer m-pahents of the S m t s  
Anargyri Oncologtcal Hospital who showed fever and leukopenia (Group 
A) as well sera f b m  15 cancer out-patients of ‘Nppokrateion’ General 
Hospital Without symptoms of infechon (Group B) were tested for the 
detechon of anhbodles. gBIgG agamst CMV and IgM, IgG a g u t  HSVl 
and HSV2 by the mcro-ELISA m plates method @lotest)-ALPHADIA 
SA/NN. IgG and IgM of CMV were tested by the ELISA method (AXSYM- 
ABBOTT) 
Result% Of the 65 cancer pahents wth  symptmm of ifecnon, 62 (95.3%) 
were posihve for IgG CMV anhbodles, Ten of these panents (15 3%) 
were posihve for IgM CMV In Group B, all were found to be poshve 
for IgG CVM, whde they all were negahve for IgM CMV. The gBIgG CMV 
were posihve m all the pahents wth IgG posinve anhbohes m both Groups A 
and B. Of the 65 pahents of Group A, 13 (20%) were posihve for the 
IgG HSVl anhbomes and one pahent (1 5%) were POSitlVe for the Igh4 
HSVl Ofthe 15 patlents m Group B, 2 (13 3%) were posihve for IgG HSVl 
and 1 pahent (6.6%) were posihve for I g M  HSVl As regards HSV2 m 
Group A, one pahent (1 5%) tested posihve for IgG HSV2, in Group 
B, all were negahve, and the IgM HSV2 were negahve for both Groups A 
and B 
Conclusion: Thls study showed that there is a htgh frequency of CMV m 
cancer pahents (84%) wth  a great deFee of relapse (15.3%) m pahents mth  
symptoms of infectlon. The eequency of HSVl IgG m cancer pauents was 
found to be hgh  (19%) whereas the frequency of HSV2 IgG was very low 
(1 5%) 
[ P681 1 Mononucleosis-syndrome: cytomegalovirus (CMV) 
infection in immunocompetent adults 
C. Schiefentein, A. Kapaun and T. Junghanss 
Heidelbeg, D 
Objective: Cytomegalovims (CMV) seroprevalence rates in adults range f b m  
50 to 90%. While CMV may cause severe disease in immunosuppressed 
patients (e.g. AIDS, organ transplant recipients), most CMV infections in 
immunocompetent individuals remain subclinical. However, about 0.1% of 
CMV infections in immunocompetent adults cause a prolonged mononu- 
cleosis-like illness which is often &cult to diagnose and which can easily be 
missed. This problem has rarely been addressed in a few case series in the 
literatux. 
Methods: We describe the clinical course and the diqpostic features of a 
nonimmunocompromised patient with acute CMV infection who presented 
to our tropical medicine outpatient clinic. 
Results: A 63-year-old lady presented with a 3-weeks history of recurrent 
fever with night sweats and general fatigue. On presentation she already 
started to feel better hut was still weak and had night meats. The clinical 
examination showed no abnormalities. The patient did not have weight loss. 
The symptoms had started 1 week after she had returned from a holiday in 
Tunisia. 
CMV serology was positive for IgM and IgG antibodies. CMV was isolated 
f b m  the urine while plasma PCR and antigenaemia assay were negative. The 
patient had an abnormal liver function with increased liver enzymes, as well as 
increased atypical lymphocytes in the blood. Other causes for the elevation of 
liver enzymes were excluded. The patient made an uneventful recovery 
within 7 weeks. 
We diagnosed five other patients with ‘mononucleosis-syndrome’ suffering 
from an acute CMV infection this year. They all presented with a prolonged 
period of fever (2-6 weeks), elevatedliver enzymes and atypical lymphocytes. 
Besides the c h c a l  findings, diagnosis was based on the presence of CMV IgM 
and IgG antibodies; virus isolation or PCR have not been performed. They all 
recovered after a mean period of 50 days, 
Conclusion: CMV infection may cause relevant clinical disease (‘mononu- 
cleosis-syndrome’) in immunocompetent adults. It should be con- 
sidered in patients presenting with a prolonged febrile dhm, atypkal 
lymphocytes and increased liver enzymes. The diagnosis is w t f o n v a r d  
(serology), so that laborious, unpleasant and expensive workup can be 
avoided. Further investigations are rarely needed. Careful follow-up is 
important to detect complications (pneumonitis, thrombocytopenia, menin- 
goencephalitis). In immunocompetent patients treatment is usually sympto- 
matic. 
Ip682j Primary CMV infection in an outpatient setting 
S. Korn, W Preiser, C. Stephan, R. Wigand and G. Just-Nubling 
Frankfurt am Main, D 
Objective: Despite being common throughout the world, CMV dection is 
rarely a cause of clinical illness. CMV-related morbidity mostly afTects 
immunocompromised patients (e.g. transplant recipients and HIV-infected 
individuals) and is probably related to insufficient immunological control of 
persistent infection. However, primary CMV infection may give rise to severe 
clinical illness in immunocompetent adults. We retrospectively analyzed cases 
of acute CMV infection in medical outpatients. 
Methods: During a 6-year period, we identified a total of 17 patients who 
were diagnosed as suffering from primary CMV infection in our medid  
outpatient c h c .  This was diagnosed on the basis of a strongly positive CMV 
IgM antibody test result, with or without detectable I& antibodies, together 
with a febrile illness accompanied by hepatitis. From the medical records we 
evaluated the presenting signs and symptoms as well as some relevant 
laboratory results. 
Results: At first consultation, all patients (6 female, 11 male; aged between 26 
and 58 years) had m a h e  and fever higher than 38 “C. Cephalgia was present 
in 10 out of 13 cases (four not known). In seven o u t  of nine patients who 
underwent abdominal ultrasound investigation, there was a mild enlargement 
of the spleen. None of the 17 patients had a palpable splenomegaly. Five 
patients had a mild leukocytosis but all 17 had a relative or absolute 
lymphocytosis. C-reactive protein was within normal limits in 4 patients 
and only slightly elevated in the remaining 13. All patients showed elevated 
levels of AST and y-GT to varying degrees. In all 15 patients whose LDH 
levels were determined these were markedly elevated. Seven patients reported 
travel to areas outside Europe, mostly to tropical areas, within the preceding 
2 weeks. 
Conclusions: CMV is a relevant differential diagnosis in feverish illnesses 
accompanied by hepatitis in adults. A substantial propomon of our patients 
seem to have acquired their CMV infection abroad, so that a diagnosis of 
CMV infection needs to be taken into account in travelers, in addition to 
infectious illnesses more commonly considered in this context such as dengue 
or hepatitis. 
(p6831 Hemorrhagic perisaiditis due to cytomegalovirus 
(CMV) presenting as cardiac tamponade in a 
noncompromised patient 
A Safdar. S.H Humphery, S.A Hardmg and TP. Close 
Columbia, USA 
Background Isolated CMV infechon of the pericardium is extremely rare m 
patlents mth  an intact immune system. 
Results: A 45-year-old black woman presented with progressive dyspnea, 
cough, and fangue for weeks. Adult-onset habetes mefitus and hypertension 
were well controlled. An ex teme  pencarhal effusion was noted on spiral 
chest computed tomography scan. Echocar&ography revealed normal left 
ventricular systohc Eunchon and diastohc collapse of the right ventricular free 
wall, cardlac tamponade. She was afebrde, and had &tant heart sounds on 
exarmnatlon. Laboratory studm showed the followng: WBC 8.7 WpL, 
CD3+4+ (42.6%) 760 ceUs/pL, platelets 574 K/pL, AST 44 U/L, CMV 
IgG 102 IU, and ESR 61 mm/h. An emergent permdocentem revealed 
1300 cc of blood colored pericardial fluid wth RBC 34001Wmm2, WBC 
999/mm2, neutrophds 64%, lymphocytes 13%, monocytes 21%, and glucose 
11 1 mg/dL She underwent locahed pericardectomy 4 days later due to 
reaccumulahon. A negahve workup mcluded HIV I and I1 anhbodm 
(Ab), HTLV I and I1 Ab, antinuclear Ab, nahve DNA Ab, anh-SM Ab, 
rheumatoid factor, CMV IgM, and urme H. capsulatum anngen. Her 
complement levels were normal (C3, C4, CH50) Pertcardd Rwd and blood 
cultures re-ed sterde, and negahve €w CMVand M. tubentrlosu by DNA 
amphfkahon a d y w .  H[lstalagicdy, organumg hemorrhage, p m m e n t  
lymphocyhc stromd mfiltranon, and charactenshc CMV mtranuclear and 
cytophsunc mclusions were abundant mthm the leaCtlVe fibroblasts through- 
out the pericardml thckness. Her lnfechon resolved after ganciclovlr 5 mg/kg 
every 12 h for 2 weeks, than every 24h for another 2 weeks. On 12-month 
follow-up no recurrence was nohced 
Conclusions: Cytomegalovlrus reactlvahon and end-organ infectlon is rare m 
indlvlduals w th  mtact cellular immumty In contrast, to the common mral 
(enterowuses) pertcardd infechon, CMV pencadas t~ often subacute and 
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may be considered as a potentially treatable cause of life-threatening com- 
plication in this setting. 
vl Mononucleosis infectious-bacterial super infections 
R. Petkovska. B. Petkovski, D. Ristevska and V. Malevska 
Bitola, MK 
Introduction: Infectious mononucleosis is a common expression Epstein-Barr 
virus infection. Clinical manifestation includes the classic tread of fever, 
pharyngitis and cervical lymphadenopathy as well as lymphocitosis with a 
predominance of a typical lymphocytes. The diagnosis is based on the clinical, 
hematological and serological data. The EBV infection with a clinical 
expression is usudy associated with the group of adolescent population, 
but with a signlficant increase of the fkequency in young children. 
Material and methods: The 4year long period reporting (1997-2000) 
includes 38 patients with infectious mononucleosis. The bacterial super 
infections were the subject of our interest. Membranous tonsillitis occurred 
in 34 patients (91.9%), peritonsiuar abscess in 6 (16.2%). otitis media 5 
(13.5%), pharyngotracheitis 11 (29.7%), bronchitis 9 (24.3%) and pneumonia 
7 (18.9%). Bacterial super infection was evident and in 31 of the cases 
confirmed with the most fiequent isolation of Sheptocom beta haemoliticus- 
23 isolates (71.3%), Pneumococrus-5 (16.3%), Staphylococrus aureus-3 (9.4%). 
From the thought swab/sputum sample. 
Conclusion: Infectious mononucleosis is a frequent expression of the primary 
EBV infection in the childhood and adolescence, especially among patients 
with a chronicaVrecidivant tonsillitis. All patients were commonly treated for 
the basic illness with a complementation of antibiotics ifnecessary based on 
the antibiogram. 
Evaluation of the Platelia Epstein-Barr virus viral 
capsid antigen (VCA) IgM, VCA IgG, nuclear antigen-1 
(EBNA-1) IgG, and early antigen diffuse (EA-D) Igt ELISA 
assays 
A. Demedemeester, A. De Koninck, C. Maes, J. Frans, E. Wollants, 
M.-H. Guindre and M. Van Ranst 
Leuven, B 
Commercial enzyme-linked immunosorbent assays (ELISA) for the specific 
serological diagnosis of Epstein-Barr virus (EBV) were developed based on 
affinity-purifed viral capsid antigen (VCA; gpl25), or recombinant polypep- 
tides consisting of the carboxyterminal 200 amino acids of EBV nuclear 
antigen-1 (EBNA-I) or early antigen (ddlbse-type) (EA-D). We evaluated the 
performance of the Platelia EBV VCA IgM, VCA I&, EBNA-1 IgG, and 
EA-D I& ELISA assays on a panel of 160 clinical samples (33 EBV 
nonimmune samples, 43 acute or late infection EBV samples, 40 EBV- 
reactivations or chronic, persistent EBV infections, and 44 EBV-immune 
samples). For the Platelia EBV VCA IgM assay, a sensitivity of 97.0% was 
obtained and a specificity of 100%. For the Platelia EBV VCA IgG assay, 
sensitivity was 100% and specificity was 97.4%. The Platelia EBNA-I assay 
showed a sensitivity of 93.8% and a specificity of 98.8%. The Platelia EA-D 
assay had a sensitivity of 81.7%. and a specificity of 90.7%. 
Conclusion: The Platelia EBV assays provide the means to classify EBV- 
samples into clinically relevant categories, allowing for standardization and 
automation of EBV-specific serology. 
(p686j Studies on association of Epstein-Barr virus (EBV) 
and human papilloma virus (HPII) with tongue carcinoma 
A. Szkaradkiewicz, M. Wal, A. Jopek, A. Kruk-Zagajewska, 
M. Wierzbicka and A. Kuch 
Pornati, PL 
Objectives: At present, not only HPV but also EBVare thought to oncogen- 
esis in epithelioid malignancies. The aim of this s t u d y  was to evaluate whether 
EBV or HPV might he involved in cases of cancers of the tongue. 
Methods: The studies were performed on 14 patients, aged 43-66 yean, with 
histopathological diagnosis of squamous epithelial cancer of the tongue. Sera 
of the patients were tested for IgG-anti-EA antibodies (ETI-EA-G Dia- 
Sorin), I&-anti-VCA antibodies (ETI-VCA-G, DiaSorin) and I&-anti- 
EBNA (ETI-EBNA-G; DiaSorin). In parallel, DNA extracted from cancer 
material was tested for the presence of EBV DNA and HPV DNA (Sharp 
Signal System; Digene). In addition another technique for HF'V 16 and HPV 
18 detection by PCR amplification was employed. 
Results: Basing on serological markers, in 13 patients an earlier experienced 
EBV infection was documented (serum IgG-anti-VCA, IgG-anti-EBNA 
antibodies). In 12 of the patients, presence of EBV DNA was identified 
and, among the latter patients, two exhibited a mixedEBV/HPV mfection. In 
no case could HPV genotypes: 16,18,31,33,35,39,45,51,52,56 or 58 be 
idendled. 
Conclusion: The results indicate that EBV may be involved in tongue cancer 
aetiopathogenesis. 
1 P687 I EBV hepatitis: clinical aspects 
V Nikolova and N. Naidenva 
Sofia, BG 
Objectives: To investigate the clinical presentation, laboratory data and course 
of hepatitis with EBV etiology. 
Methods: A total of 30 patients (26 males, 4 females) hospitalized in the 
Infectious Diseases Hospital during the period 199&2001 were included in 
the study. The clinical signs and symptom, liver disorders biochemical 
markers and serological data were analyzed. The diagnosis was confirmed 
on the presence of anti-EBV VCA IgM. 
Results: The age of the patients ranged fiom 5 to 40years, mean 19.60. 
Greater than 21 years were 26.6%. A great variety of symptoms was find fever, 
headache, pharyngitis, mialgia, anorexia, nausea, vomitings, malaise, lym- 
phadenopathy, periorbital edema, papular red and petechial rash, jaundice, 
hepatosplenomegaly. The course with moderate severity was with 
86.66%,with levels of bilirubinemia from 17 to 2 7 2 ~ / L ,  increased serum 
aminotransferases activities (ASAT 60-1159 p/L, ALAT 94-1140 p/L) and 
high levels of GGT (147-1419)r/L and AP/207-2007p/L). The complete 
blood count and diftierential showed atypical lymfocps with all persons. 
Thrombocytopenia was with 10%. Antibody test indicated with all perions 
recent infection with EBV. An anicteric course was registered with 12 
persons. Continuous subfebnlity, extreme splenomegaly and lymphadeno- 
pathy was with 1 p and diagnosis was performed by lymph node biopsy. 
Protracted course was registered with 3 p. The patients were treated f b m  7 to 
42 days. Hepatoprotective drugs, antibiotics, corticosteroides were adminis- 
tered. Clinical and laboratory checks 1 and 3 months after the acute phase 
revealed normal aminotransferases activities. 
Conclusions: EBV hepatitis is diseases with moderate severity, with no 
transition to chronic hepatitis, but the versatiltty and variabhty of the 
EBV infection is a challenge for the ditferential diagnosis. 
Anti-herpetic action of the interferon inducing 
yeast RNA-tilorone molecular complex 
N. Marchenko, A.V. Karpov, N.M. Zholobak, S.V. Antonenko, 
A.M. Shctherbinskaya and N.Y. Spivak 
Kim, UKR 
Antiviral effect of a yeast RNA-tilorone molecular complex (MC) has been 
studied in mice infected by herpes simplex virus type I (HSV-1). A specAc 
antiviral MC effect has been estimated from the animal survival rate, the HSV- 
1 level being determined by a CPR approach. The MC has been found to 
prolong the animal Me duration, the levels of HSV-1 reproduction in serum 
and brain tissue having become lover on the second day p.i. by 1.75 Ig & 0.07 
and 1.08 lg& 0.02, respectively, and by 2.08 lg f 0.05 and 1.47 lg f 0.02, 
respectively, on the 5th day p.i. The others conclude tbe MC to be a promising 
antiviral compound possessing antiherpetic action. 
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lp689 Detection of Epstein-Barr virus (EBV) by PCR assay 
in biopsy samples from pediatric patients with Hodgkin's 
disease in Spain 
C. Frias, E Almazin, A. Oriol, J. L. Mate, A. Hernandez and A. Perez 
Badalona, E 
Background: Epstein-Barr virus @BV) is associated with some cases of 
Hodgkin's hsease (HD). EBV has a pathogenic role in HD by inhibiting 
apoptosis or allowing cells to escape &om cytotoxic T lymphocytes response. 
Detection and typing of EBV in patients diagnosed with HD has epidemio- 
logic relevance. 
Objectives: To analyze biopsy samples from HD pediatric patients for EBV 
DNA by PCR assay and immunohistochemisuy (IH) techniques. To carry out 
EBV typing in EBV-positive samples. To investigate the presence of several 
proteins related to the cellular cycle and apoptosis. To correlate results with 
epidemiological features. 
Patients and methods: Seventeen pediatric patients (aged up to 21 years) 
diagnosed with HD between 1989 and 2000 were included in the study. 
Detection ofEBV was performed in DNA extracted &om para&-embedded 
biopsies by PCR assay (BamHI L region). EBV typing was carried out by 
nested-PCR (BamHI WYH region) and subsequent 2% agarose gel electro- 
phoresis. Detection of LMP-1, EBNA-1, p53, p21CIPAKrAF1, p27KIP1, 
bcl-2 and Ki-67 (MIB-1) was performed in neoplastic cells (Hodgkin and 
Reed-Sternberg) by IH using specific monoclod antibodies. 
Resultx The mean age ofpatients was 14.5 years (range 5-21 years), nine were 
male and eight female. The HD histiotypes found were: nodular sclerosis (12), 
mixed cellularity (2), interfolicular (1) and unknown (2). EBV was detected in 
8/17 patients (47.05%). Six patients carried EBV-A and in two patients EBV 
was untypable. Distribution of EBV positivity according to clinical HD stage 
at the time of diagnosis was: I (loo%), I1 (O%), 111 (66.6%) and IV (75%). 
Distribution of EBV positivity according to age was: 0-7years (loo%), 
7-14yean (50%) and 14-21years (28.5%). Mortality occurred in 1/9 
EBV-negative and in 0/8  EBV-positive cases, respectively. p21CIP/WAFl 
and p53 proteins were more often detected in EBV-negative than in EBV- 
positive HD cases. 
Conclusions: Overall, EBV was detected in 47.05% ofpediatric HD patients. 
EBV-A was the only subtype found. The highest rate of EBV positivity was 
found in patients under 7years of age. The different patterns of protein 
expression and EBV status found are discussed. The differences in EBV 
positivity found in the hfferent age groups should support the hypothesis of 
the multifactorial etiology of HD. 
lp6901 Herpes simplex virus as agent of central nervous 
system infections 
Thessalontkl, GR 
Herpes sunplexvlrus (HSV) 1s one of the most c o m o n  agents of encephallhs 
in othemse healthy older chddren and adults HSVencephallm (HSVE) is a 
severe hsease associated wth  sigmtkant morbihty and m o d t y  The a m  of 
t h s  study was the evduahon of PCR for detection of HSV DNA m 
cerebrosplnal fluid (CSF) samples, in parallel ulth serological analyzes of 
simultaneous drawn serum and CSF samples in the dagnosis of suspected 
encephahtis or memngoencephahs cases 
Methods: Fifty-two pared samples (serum and CSF) from 48 pahents (29 
males, 19 females) w t h  suspected encephahhs or memngoencephahtu aged 
2 months to 65 years old (24 chddren, 24 adults) were stuhed. All pahents 
were admitted to the hospital wth  neurologcal symptoms between June 1998 
and November 2001 (appmumately 3.5 years). CSF analysls &om all patients 
revealed leukocyte count and protein levels mild elevated PCR assay was used 
to detect HSV DNA in CSF samples. Pruners &om the thyrmdme h e  gene 
were used yeldmg a 320-bp amphcon. Serum and CSF samples obmned fiom 
the pahents were exanuned for IgM and IgG anhbockes apns t  HSV by 
enzyme-hkd munosorbent assay 
Results Nine cases of HSVE (seven adults, two chddren) were dlagnosed by 
posihve CSF-PCR (rate 18.8%) and eight of them by serum and CSF 
serology; one had HSV IgM and IgG m serum and IgG m CSF, one had 
I g M  and IgG only m serum, three had only IgG m serum and CSF and three 
had IgG only m serum. In one patient (mfant 4.5 month) CSF was posihve by 
PCR, but both serum and CSF were HSV anhbody-negahve. In three 
pahenu, PCR faded to detect HSV DNA m the CSF samples, but IgM 
and IgG anhbohes were detected only in the serum. Thus, in nine pahents, 
D Karabaxoglou, S Mitka, E Chadouli and A Kansouvdou 
the hagnosis of HSV encephahhs was confirmed, whereas m the other three 
pahents, the HSV encephahtis was suspected but it was not confirmed. 
Conclusions: Specific ckagnasa of HSVE was possible by a combinahon of 
PCR and detechon OfHSVauhbockes m serum and CSF samples, smce most 
forms of vmral encephahm shows& c h c a l  findings However, serial CSF 
samples should be exarmned &om pahents wth chmcally suspected HSVE for 
both PCR and mtrathecal HSV anhbody analysls. 
Ip6911 Diagnosis of herpes virus and enterovirus central 
nervous system infections in cerebrospinal fluid samples 
using genetic amplification techniques 
C. Frias, X. Ferrk, S. Mad. A. Hernandez and D. Quesada 
Badalona, E 
Background: Herpesvlruses are associated with central nervous system infec- 
hons, being herpes smplex m s  the most common cause of sporahc acute 
encephahhs Early hagnosis of herpeswus mfemons allows accurate therapy 
and reduces m o d t y  Enteroviruses are also involved in sporahc vlral 
memghs  and menmgoencephahhs. 
Objectives: To inveshgate the role of herpesviruses and enteroviruses in 
central nervous system infechons in phents from OUT geopphlcd area. 
Patients and methods: One hundred and SIX cerebrospinal fluid samples 
(CSF) from 101 pahents wth suspected herpesvlrus encephahhs (HE) were 
collected between February 1998 and Aprd2001 Sxty-seven were male and 
34 female; their mean age was 45 6years (range 6-87yem). Seventyane 
were immunocompetent pahents and 30 were known to be infected w t h  
HIV HE was suspected on cl~mcal findings, magmg techmques (EEG, CT 
scan, MRI) and CSF analysa. CSF samples were tested €or herpeswus DNA 
(herpes smplex virus (HSV), varicella zoster w u s  0,cytomegalovicus 
(CMV), human herpesvlrus 6 (HHV6) and Epstem-Barr v v u s  (EBV) by 
mdhplex nested-PCR (Radar-REAL, Spam). Enterowus Inveshgahon was 
carried out usmg the NuchSens Baslc G t  system (Organon Tekmka, Boxtel, 
Results: H e r p e s b e  DNA were detected m 25/101 patients (24 75%) 
Fourteen of them were immunocompetent pauents: HSV (n=9), 
HSV+EBV (n= 3). CMV (n= 1). VZV ( n =  1); and 11 weremfectedmth 
HIV HSV (n=5), EBV (n=4), CMV (n=1), VZV (n= 1). Herpesvlrus 
posihvity rates were: 14/71 (19.7%) for munocompetent pahents and 
11/30 (3666%) for HIV-posihve pahents On adnnsslon, fever and/or 
decreased level of consciousness were present m15/25 patients Imaging 
techmques supported EH dtagnosis m 5/25 patients. AbnormalIhes m 
CSF protems, glucose or leukocyte count were found in 15/25 pauents. 
Mortality occurred m 6/25 pahents (20%) Thrty-four out of 69 CSFsamples 
negahve for herpesviruses were fkrther screened for enterowruses Enter- 
o m s e s  were detected m 2/34 samples. 
Conclusions: Although HSV and EBV were the herpesvlruses most often 
found, other herpesviruses (CMV and VZV) have a role in herpesvmrus 
encephahhs Enteromses teshng in CSF samples negahve for herpesvlruses 
may allow assessing the involvement of these viruses in CNS lnfeChOnS m our 
area 
NL) 
lp6921 A PCR-assay for detection and species 
identification of five human herpes viruses 
A. Kruglova, N. Nikolaeva and V Demlun 
Moscow, RUS 
Objectives: To develop a method for simultaneous detecuon and species 
idenhficahon of five human herpesviruses (Herpes simplex wus (HSV) types 1 
and 2, Epstein-Barr virus (EBV), cytomegalovmrus (CMV), human herpes- 
virus type 8 (HHVS)). 
Methods: PCR-based ampl6cahon was used for detechon ofthe vlral DNAs. 
DNAs were isolated from virus-mfected cell cultures. Speaes idenhficanon 
was accomphhed by restnchon endonuclease @stion of amplicons 
obtamed after a secand round of PCR mth enzymes BqI or RsaI. Resmchon 
fragment patterns were analyzed by a p s e  gel electrophoresis. 
Results. Three highly conserved repons w i h n  the DNA polymerase gene 
were idennfied accordmg to a mdhple ahgnment of DNA sequences of 
human herpeswuses generated by the MACAW program. Three consensus 
primers targeted to each of the three conserved regons were designed. Ths 
primer set enables specific amphficahon of HSVl, HSV2, CMV, EBV, and 
HHV8 hphficahon with P1 and P3 primers yielded an approximately 
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870 bp long DNA merit that was used as a template for a second round of 
PCR with primers P1 and P2. The generation of the final PCR products of 
expected size (531 bp for HSVl and 2, 537 bp for EBV, 603 bp for CMV, 
517 bp for HHV8) attested to the specificity of the PCR assay. No amplifica- 
tion was found with HHV6 under the given conditions. VZV and HSV7 
templates were not tested in the PCR assay, since analysis of the correspondmg 
nucleotide sequences allowed us to make a conclusion that they should not be 
amplified with Pl/P2/P3 primer set. The sensitivity of the penta-specific 
PCR assay was assessed using serial dilutions of plasmid DNA containing the 
cloned P1/P3 amplified products of each herpesvirus. For all herpesviruses, 
the sensitivity of the assay was 1-10 genome copies. Clinical specimens of 
saliva, serum, blood, endocardial biopsies, urogenial scrabs obtained h m  
public health institutions of Merent profile will be used for validation of the 
assay in clinical application. 
Conclusions: A herpesvirus penta-specific consensus PCR assay coupled with 
restriction enzyme digestion, which allows one to idennfy five human 
herpesviruses, was developed. This PCR assay is a specific, sensitive, and 
cost-effective method for the evaluation of patients with different herpesvirus 
induced disorders. 
I P693 1 Detection of human herpes virus 6 late mRNA 
using NucliSens (TM) Basic Kit NASBA 
J. D. Fox, L. Perschky, G. Thacker, R. Stephens, B. Darke and 
D. Westmoreland 
Cad$ UK 
Objectives: The aim of this study was to develop an assay based on NucliSens 
(TM) Basic Kit NASBA for identification of clinically relevant human 
herpesvirus 6 (HHV6) infection in immunocompromised individuals. Such 
an assay would be useful in the management of post-transplant infections and 
enhance our understandmg of HHV6 pathogenesis. 
Methods: Kit-based reagents were utihzed for extraction, amplification and 
detection of amplified products (NucliSens (TM) Basic Kit, bioMirieux 
(Ltd.). The primers and probe were designed to amphtj~ and detect the 
HHV6-specific late gp 105 mRNA. Detection of amplified products was by 
electrochemiluminescence (ECL). Titrated HHV6 variant A (U1102) and B 
Hemorrhagic fevers 
(229) reference wuses, synthehc RNA (prepared by clorung of the target and 
m vltro tEanscnphOn) and a range ofblood and respiratory specunens (n = 100 
to date) were u h d  to evaluate the assv. 
Results: The assay proved to be very Sensihve and spec&. Less than or e q d  
to 100 HHV6 synthehc RNA copies were detectable 111 the assay wlth no 
amphfkahon h m  purlfied HHV6 DNA Vanant A and B vlruses were 
picked up wth  equal efficiency and there was no cross-reachon wlth closely 
related herpesvlruses. Extracts prepared for the cytomegalowus pp67 assay 
were suitable for HHV6 NASBA allowmg sigmficant infechon with either or 
both wuses to be assessed in a mgle sample 
Conclusion: The HHV6 N A S B A d  prove useful m identlftcaoon ofpahents 
w t h  actlve mfectlon and WIII help in studies of the association ofthis common 
betaherpesvirus w~th  s id i can t  msease. 
[p694] Incidence of Herpeszosterophthalmicus 1996-2000 
B. Petkovski and R. Petkovska 
Bifola, MK 
Aim: To present the clinical expression of t h ~ s  disease in its Werent forms, the 
possible complications on the eye which may led to serious and lasting 
damaging of the function of seeing as well as the therapy of this diseases. 
Material and methods: A total of 55 patients have been examined and treated 
within a period of 5 years in 1995-2000. 
Methods of examination: Anamnesias, clinical expression, blood test, der- 
matology examination, examination of the anterior segment of the eye with 
and d i h e  light, biomicroscopic examination, ophthalmological examination 
of the fundus of the eye. 
Results: In 23 cases, the disease went on with symptoms as blepharocon- 
junctivitis, photophobia, epiphora. a more expressed, mixed injection of the 
eye, but without recidives or serious complications. In 18 cases, keratitis 
developed which was cured with the therapy that was applied. There were 
nine cases of recidivent keratoconjunctivitis, and in five cases a inflammation 
of the optic nerve developed (neuritis nervi optici). 
Conclusion: This is a serious disease with possible very difficult complication 
on the eyesight. The patients are u s d y  at the age of 50-7Oyears with equal 
distribution of the sexes. 
ml Immunological characteristics of eye lesion in 
hemorrhagic fever with renal syndrome 
G. Sakhautdinova and D. Valishin 
U J ,  RUS 
The pathogenesis of hemorrhagic fever with renal syndrome (HFRS) suggests 
the possibility of involvement of the optical analyzer into the pathological 
process, about which testifies often revealed symptoms such as: optic weak- 
ness, eye pains sclera vessels and conjunctive injections. In 25 patients with 
HFRS, serious and grave condition was observed. In all cases, HFRS diagnosis 
was confirmed in MFA reactions by increasing titers of specific antibodies to 
four and more times. All observed patients were men aged 18-45 years. In this 
condition, we carried out the analysis of subpopulation of peripheral blood 
lymphocytes and the presence of tisue-specific humoral and cellular response 
to basic antigens of cornea (bovine corneal protein-54), lens (L-crystalline) 
and retina (S-antigen). Immunotypation was performed by indirect immuno- 
fluorescent method with monoclonal antibodies usage. Antibodies to antigens 
were revealed in steady phase UFA, using highly purified antigens as 
immunosorbents. Cellular response was evaluated in 5 days ’RBTL’ addmg 
the antigens in (lOmko/mL culture) dose. During acute period (5-14days of 
disease), we revealed the reduction ofthe general number o f T  cells (CD3+), 
the increase in CDSf lymphocyte number (suppressors (STA)) and the shift of 
imrnunoregularor factor to reduction. The number of mature B-cells (CD’”) 
and NK-cells (CDI6+) was also increased. None of patients had specific tissue 
antigens. In 50% of the patients were the signs of cellular sensibktion to 
BCR-54, in 17% patients to L-crystalline lens. Cellular response S-antigens 
were not discovered. Within the period of reconvalescence (15-26days of 
disease), all revealed disturbances were normalized. Described changes in 
lymphocyte population were typical for ‘acute phase’ of virus infections. As 
for cellular sensibilization to BCR-54 and L-crystallme lens, it can cemfy the 
possibility of similar antigen determinants of cornea and other tissues @dneys, 
myocardium) which are involved in the pathological process or modifications 
of antigen of cornea by HFRS vim.  
Prostaglandins metabolism in acute renal 
insufficiency in patients with hemorrhagic fever with 
renal syndrome 
G. Mirsaeva, R. Fazlyeva and G. Mavzioutova 
Ufa, RUS 
Renal pathology occupies a specific place in the clinical course and outcome 
of hemorrhagic fever with renal syndrome (HFRS), its clinical manifestation 
being acute renal insufficiency (ARI). However, the causes of ARI remain 
unclear. The purpose of our study was to investigate the character of 
prostaglandm metabolism in A N  in patients suffering fiom HFRS. The 
results of our study revealed a sigtllftcant reduction in the activity of 
prostaglandms depressive series in the initial period of HFRS: prostaglandins 
EZ value (PGE,) was 23.67 & 0.98 pg/mL (P< 0.001); 6-keto-prostaglandin 
Fla value (6-keto-PG Flu) was 26.83&3.74pg/mL. At the same time, 
increase of thromboxane BZ (TXB2 345 f 9.8 pg/mL, P < 0.001) which 
possesses vasoconstrictive and aggregation action was recorded. In oligoanuric 
period, the obsewed ctsturbances went on aggravating: levels of PGE2 and 6- 
keto-PG Fla were 7.8 and 7.1 times, respectively, lower compared to control 
values of these prostaglandins were increased, but still their levels remained 2.3 
and 2.0 times lower in comparison with control ones even in the period of 
clinical convalescence. While studying TXB2 content, it was determined that 
its value was six times higher in oligoanuric period, the trend towards its 
reduction was marked in the period ofrestored diuresis. The correlation index 
of TXB2/6-keto-PG Fla testified to the prevalence of vasoconstrictive 
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prostaglandins in blood serum (31.79 f 0.54 compared to control value of 
0.78f0.07). Thus, the obtained data point out to the participation of 
vasoactiw prostaglandins in the pathogenesis of ARI in patients with HFRS. 
It is disbalance in their correlation that plays a significant role. The results of 
our study can be regarded as pathogenetic evidence for the use of medicines 
possessing corrective effect on prostaglandins metabolism in the treatment of 
ARI  in patients suffering from HFRS. 
1 P697 1 Crime-Congo hemorrhagic fever (CCHF) in Kosova 
during the period 19954001 
A. Kalaveshi, L. Gashi, I. Humolli, N. Ramadani, I. Dedushaj and 
G. Mulliqi 
Dristina, W 
Objectives: Presentation of CCHF cases, Kosova (period 1995-2001), ana- 
lysis done for above-mentioned time Game, with special emphasis during the 
years 1995,1996 and 2001 when this disease appeared as outbreak in Kosova. 
Methods: Descriptive-retrospective analysis of the data taken from official 
surveillance system of the Institute of Public Health, Department of Epide- 
miology, Pristina, h m  the Clinic of Communicable Diseases, Medical 
Fakulty of Pristina; and serology data taken !?om the Mikrobiology Institute, 
Medical Fakdty, Ljubljana, Slovenia. 
Results: The first case of CCHF in Kosova was registered in the village of 
Nishor of Suhareka municipality in 1954. During 1995-2001 period, 129 
confirmed cases were registered, with 21 death cases resulting with fatality rate 
of 16.2%. CCHF occurred as outbreak during the year 1995 with 65 cases or 
incidence 3.07/100.000 and seven death cases with fatality rate of 10.7% 
during the year 1996 with 23 cases, or incidence 1.06/100.000 and five death 
cases with 21.7% fatality rate. After a quiet period for 4 yean with few sporadic 
cases in the year 2001, this disease appeared again in epidemic form with 31 
cases or incidence 1.44/100.000 and seven death cases with fatahty rate of 
22.5%. Out of 129 cases of disease in this period, in 74 cases or 57.3% the 
mode of transmission was tick bite, in 14 cases or 10.8% contact between 
people was the mode of transmission, and the way of contracting the virus is 
unknown in 14 cases or 31.7% - scientific explanation is available. The largest 
number of the confirmed 129 cases in t h s  period is in the age group of 
1545yean with 79 cases or 61.2%. During the time period 1995-2001, 
61.2% of the cases were male and 38.8% were female. The largest number of 
cases as anticipated in all time periods was in the group of farmers 52 cases or 
40.5%, housewives 39 or 30.2%. 
Conclusions: The territory ofKosova, dating from year 1954, when first cases 
were registered is endemic zone for this disease. Takmg into consideration that 
Kosova is an endemic-epidemic and epizootic area with CCHE also with 
enormous population of HP ticks, permanent surveillance of disease and 
appropriate prophylactic and epidemic prevention measures were taken. 
Despite that we can conclude that epidemiological situation in Kosova is 
uncertain and in the future, we can expect new cases of disease or outbreaks. 
Serosurvey of arbovirus among Bedouins in the 
Sinai in Egypt 
A Solman 
New York, USA 
Introduction: Recent outbreaks ofWest Nlle (WN) in humans in Israel stress 
the need to determne the current impact of ths mrus and other arbowuses m 
the Smai that shares a border w th  Israel. 
Objective: The objechve of this study was to determne the prevalence ofWN 
and other arbomruses among Bedoms (nomadlc w t h  h t e d  mobhty 
populahon) of north (El-Arish) and southeast (Nuweiba) S m ,  where there 
is a lack ofinformation about arboviral aChWty among ths umque popdahon 
Materials and methods: T h  study was estabhshed in collaboraaon wth  the 
Egyphan Mintsay of Health and Popdahon Eight-hundred and s~ny-slx 
(866) serum samples collected m 2001 fhm Bedoums hving in El-Ansh 
(n = 197) and Nuweiba (n = 669) were tested for IgG by ELISA usng anhgens 
for WN, Smddbs (SIN), sandfly fever Schan (SFS) and sandfly fever Naples 
(SFN) viruses using standard methods 
Results: The overall seroprevalence rate (SPR) of WN was 10% (n = 19) and 
4% (n = 24) m El-Ansh and Nuweiba, respechvely Intereshngly, SPR ofWN 
in both sites was not age dependent as premously reported in other governor- 
ates of Egypt. The SPR of WN was 5% (2/43) and 4% (5/136) m chddren 
(410  years) m El-Ansh and Nuweiba, IESpechvely, and peaked to 15% (8153) 
and 6% (8/143) among ages 21-3Oyears m these same areas, then dechned. 
The overall SPR of SIN was 7% (n= 14) and 3% (n =21) in El-Ansh and 
Nuweiba, respechvely No SIN antibodes were detected in ages of >6O yean 
(n = 34) for either site Antlbodtes to SFS w u s  were detected inEL-Ansh and 
Nuweiba ulth rehhvely low SPR [3% (n = 5) and 2% (n = 12), respechvely] 
Sipficant SFN achvity was noted through all age groups M both El-Arish 
and Nuweiba with an overall SPR of 9% (n = 17) and 8% (n = 54), respec- 
hvely, and a peak of 55% (6/11) in ages 61 to >70 m E l - h h  and 14% 
(20/143) in ages 21-30 in Nuweiba 
Conclusion: To our knowledge, ths study 1s the first to report the aChVlheS of 
the studled vm~ses,  parhcularly WN and SFN among Bedoluns tn the Sma~ 
Further invesugaaons are required to study the epidemology and ecology of 
the above vituses in the Sma. 
1 P699 I Epidemiological characteristics of dengue in 
Trujillo, Peru 
S. Bemtes Cashllo, C. Romero Goicochea, R Guzman V h  and 
M Chavez Cashllo 
Tnrjdlo, PE 
Objective: From January to August 2001, an epidermc of dengue fever was 
presented for the first tune in Trydlo aty in the North of Peru. In ths 
epidemc, we determned the prmcipal epidemologd characteristics of 
dengue 
Methods: To determme the epidermologd characteristics of dengue, we 
studled 360 cases of the 6152 presented wth an epidemiologcal and 
standardized questionnawe to ask the prmcipal risk factors to the &ease. 
Thls were confirmed wth  serologcal studles by the National Insntute of 
Health 
Results: Sera that had been collected premously by the Peruvlan Mimstry of 
Health were tested by enzyme-hnked munoabsorbent assay (ELISA) by 
DEN v m  type I and 11. The major morbidtty was in Florencia de Mora (FM) 
district w th  22.41 X 100Oha The positive tncLces in FM was 25.4%. There 
was no statishcal diflerence by sex The age wth  more cases was horn 40 to 
60years old. The fever symptom was 94.4%, muscle and J O ~  pain 60 8%, 
headache 51.9%. bone aches 39.4%, skm hemorrhages 27.2%. rashes 0.8%, 
echos i s  0.2%. nasal bleedmg 0.8%. hematuna 0.3%, etc. 
Conclusion: We concluded that the characterisacs of dengue m T~~~jlllo city,
Peru were the same as tn other dlstticts of the counq. 
v] Development of DNA vaccines against dengue 
infection and evaluation of their protective mechanisms by 
transgenic mice 
Y. Huang, K Hsieh, Y Liu and H Syrwu 
Kaohsslung, Taipn, TW 
To develop a saft. and effectwe DEN vaccme becomes a hgh pnority of the 
World Health Organtzahon, health m s t r i e s  m some aEected countries 
Since the phenomenon of anhbody-dependent enhancement of mfechon by 
anhwion anhbodles has been unphcated m the development of severe 
dengue hemorrhwc feverldengue shock syndrome (DHF/DSS), NSl has 
been considered as a po tend  candldate for DEN vaccme. The laboratory of 
Prof Sytwu prevloudy demonstrated DNA m u n m a o n  wth DEN2 virus 
NSl ehcited protecave m u m t y  m C3H mce agamst subsequent wal 
challenge Intravenously challenged wth  lethal DEN2, mce vaccmated mth  
NSl DNA ehbi ted  a delay onset of paralysis, a marked decrease of 
morbidq and a sigdcant enhancement of surwval. Despite h a w  a weak 
NS1-specific anhbody hter measured by ELISA, no anh-NS1 anabody 
response w a s  detected m NS1-vaccmated mce by radloimmunoprecipitaaon 
or m u n o b l o t  analysis. In contrast to h u m d  immune response, DNA 
immunizahon ehcits strong cellular m u n e  response, an NS1-spechc T-cell 
pmMerahon To further dssect the mechanisms and components mvoIved tn 
t h ~ s  protecuon, we wl perform the NS1-specdc cytotoxlc T-lymphocyte 
(CTL) assay and adoptive transfer expenments Sera, CD4 T cells, CD8 
T cells, or B cells from DNA-immumzed mce  d be indlvldually or 
comblnatorially transferred into renpients and the protechon in subsequent 
v d  challenge wl l  then be evaluated We d inveshgate the host defense 
mecharusms agamst dengue vms by using transgemc and knockout mce 
Dengue-mfected Th1/2 double transgemc C3H mce or IL-12 knockout 
C3H mce  d promde the best models to duectly dlssect the role of Thl or 
Th2 &fferenhahon and the regulahon of 1L-12 dunng the host-nrus 
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interacaons It has been reported that the efficacy of a DNA vaccine can be 
greatly improved by snnultaneous expression of interleulun-2 (IL-2) or other 
cytokmes. Therefore, m the future, we wdl construct new DEN 2 DNA 
vaccines by a bicistromc vector separately encodmg the NS1 and IL-2 (or 
other cytokme genes, e.g. GM-CSF, IL-4, IL-12), B7, CD4", CD4' hgand or 
heat shock protem (HSP), etc The m u n e  responses and protechve 
efficacy ehcited by these immunomodulatory DNA vactlfles wdl be further 
evaluated 
Automated methods 
[m] Evaluation of the VITEK 2 system for routine 
identification of clinical isolates in a university hospital 
laboratory 
M. Weber, M. Baudoin, E. Choquert and X. Haristoy 
Nanq, F 
Objective: The objective of the study was to assess the performance of the 
fully automated VITEK 2 system, dedicated to identification and suscept- 
ibility testing in the context of the hospital microbiology laboratory. 
Methods: Over a period o f 3  months, 255 Gram-negative rods (Gnr) and 185 
Gram-positive cocci (Gpc) were tested using the VITEK 2 ID-GNB and ID- 
GPC cards. The sealed cards, which ensure user safety, contain phenotypic 
fluorescence tests for the identification ofchnical strains in 3 h maximum. The 
strains tested belonged to Enterobacteriaceae (n = 207), non-Enterobacter- 
iaceae (n = 48), Micrococcaceae (n = 124). and Streptococcaceae (n = 61). 
The Gnr were mainly cultured overnight on BCP agar (58%) and CPS ID 2 
agar (35%), and the Gpc on TSA blood agar (94%). The strains were collected 
by primo isolation (85% for Gnr and 48% for Gpc) or after subculture (15% for 
Gnr and 52% for Gpc). The comparison was performed using ID 32 E and ID 
32 GN strips for Gnr, and rapid ID 32 STREP and ID 32 STAPH strips for 
Gpc. 
Results: Of the 255 strains of Gnr, 239 (93.7%), including low discrimina- 
tions, were correctly identified. Ten strains (3.9%) were not identified and six 
(2.4%) were misidentified. The strains not identified belonged to Klebsiella 
pneumoniae (2), Enferobacrer (3), Salmonella (l), Proteus mirabilis (1) Shigella (1). 
The system generated misidentifications for: Enterobacter cloacae (l), Morganella 
morganii (1). Escherichia coli (1). Klebsiellupneumoniae (2). Proteus vulgaris (1). For 
non-Enterobacteriaceae, only one strain of Pseudomonas aeruginosa was not 
identified. O f  the 185 Gpc strains, 171 (92.4%), including low discrimina- 
tions, were correctly identified. Two strains (1.1%) were not identified and 12 
(6.5%) were misidentified. The two strains which were not identified 
belonged to the Sfreplococcus genus (one S. anginosus, one S. pneumoniae). 
The misidentified strains belonged to the Enterocoocrtri and Staphylococnrs genera 
(one E.  avium, one E .  faecium, one E.galfinamm, five S. epidmidis,  one 
S. haemolyricus, one S.  hominis, one S. warneri, one S. xylosus). 
Conclusion: This study shows that VITEK 2 is an accurate system for the 
routine identification of clinical bacteria. Identification of S. epidermidis 
should be improved with the next database version. Identification in 2-3 h 
and the level of automation of the VITEK 2 system improve the laboratory 
work flow, and consequently meet the physician's requirements. 
I P702 1 Preincubation at 35°C gives false negative results 
in BACTEC 9240 blood culture system 
L. Lemming, H. M. Holt, I. S. Petersen, C. Gstergaard and B. Brnun 
Copeahaxen, DK 
Objectives: Concern about the performance ofBACTEC 9240 blood culture 
system arose when about 10% of 69 bottles indicated as negative in the 
BACTEC instrument were positive on terminal subculturing when used for 
educational purposes. Oficial recommendations &om the manufacturer are 
not clear regarding the advisability of preincubation at 35"C, but at our 
hospitals the bottles have traditionally been preincubated at 35 "C, and are not 
seldom more than 20 h delayed. Therefore, we wanted to determine the 
influence of preincubation time and temperature on the performance of 
BACTEC 9240. 
Methods: Blood culture sets (two BACTEC 9240 Plus Aerobic/F and one 
AnaerobicIF bottles) from two hospitals were preincubated at 35 "C and from 
one hospital kept at room temperature before entering the BACTEC 
instrument. Preincubation time in hours was registered. On arrival the bottles 
were visually inspected for signs of growth. Bottles seen to be positive were 
subcultured. One aerobic bottle from visually negative sets was also sub- 
cultured to detect growth not yet visible. All bottles whether visually positive 
or negative were incubated in BACTEC for 5 days or until detected positive. 
Bottles not detected positive after 5 days were removed h m  the instrument 
and subcultured. Positive bottles were defined as bottles giving growth 
detected by any of the above means. 
Results: During the first 4months (July-October 2001) 535 bottles were 
culture positive. Of these, 261 (49%) had been kept at room temperature and 
274 (51%) had been preincubated at 35 OC before entry into the BACTEC 
instrument. Ofthe 38 (7%) culture positive bottles not detected by BACTEC, 
three, visually negative, had been kept at mom temperature before entry, 
while the remaining 35 had been preincubated at 35 "C. Of these 35,20 were 
visually negative prior to entry into BACTEC, and 15 were visually positive; 
12 of the latter had been preincubated for more than 20 h. 
Conclusions: Preincubation of blood cultures at 35 "C reduced the positive 
yield by approximately 10% when only instrunient detection w a s  ublized. 
Careful visual inspection of bottles is mandatory when prolonged preincuba- 
tion at 35 "C is employed. 
1 P703 1 Comparison of Phoenix to Vitekz with a diverse 
group of bacteria which are found in clinical microbiology 
labs 
R. Gross, U. Horling and G. Peters 
Munster, D 
Objectives: Two rapid automated identification (ID) and susceptibility test 
systems, Phoenix and Vitek2, were evaluated for the identification of Gram- 
negative bacilli, Staphylococcus, and Enterococcu. 
Methods: A total of 176 Gram-negative ba&, 121 Enterocom and 400 
Staphylococcal strains were tested, composing a sample of species that are 
c o m o n l y  seen in clinical microbiology. This included: S.aureus (172). 
Staphylococms coagulase-negative species (228), E. faeralis (51), E. fmcium 
(56), other Enterococrur spp. (13), E .  coli (20), Enterobacter/Cilrobat~ (54), 
Klebsielta (35), Roteus/MorganeJia (23), Serratia (9), I? aenrginosa (22), Hafnia 
(5), and Acinetobacter (8). All isolates were tested in both systems following 
normal procedures recommended for each product. This included recom- 
mendations for supplemental tests. When needed the results of the supple- 
mental tests were used to select a final result. Phoenix and Vitek2 ID results 
were compared and when discordant, the strains were retested and the ID 
result arbitrated by a third method. Arbitration used API 20E for Gram- 
negatives, API 32s for Staphylocom, and API StrepRapid for Enterococcus. 
Results: Phoenix ID results were equal to ViteM ID results in 96% of the tests. 
The comparability by organism group were 95% for Gram-negative Barillus, 
95% for Sraphylococcur, and 97% for Enterococcus. Arbitration tests of the few 
discordant results were in favor of Phoenix = 8 x , ViteM = 8x times, and 
neither system 5 ~ .  Overall, supplemental manual ID tests were required for 
6.7% of the Vitek2 tests and 1.4% of the Phoenix tests. With Gram-negative 
bacteria the requirement for supplemental tests was 20.6% for VitekZ and 
1.1% for Phoenix. 
Conclusions: The Phoenix system is highly equivalent to Vitek2 in the 
identification of common Gram-positive and -negative strains. Vitek2 fre- 
quently requires supplemental testing with Gram-negative bacteria whereas 
with Phoenix supplemental testing is only occasionally required. 
v1 Comparison of Phoenix to Vitek2 antimicrobial 
susceptibility test performance with a diverse group of 
bacteria which are found in clinical microbiology labs 
R Gross, U. Horhng and G. Peters 
Munsfer, D 
Objectives: Two rapd automated idenbficahon and anhmcrobial 
suscepabihty test (AST) systems, Phoemx (BD Diagnosacs), and Vitek2 
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(BioMirieux), were evaluated for the AST performance using a challenge set 
of Gram-negative bacdh and Gram-positive Cocci. 
Methods: Standard commercially available Phoenix panels and Vitek2 cards 
were used with appropriate panel types for Gram-negative and Gram-positive 
organisms. A total of 165 Gram-negative bacilli, 102 Enrerococcus (34 VRE) 
and 340 Staphylococcal strains (158 S. aureuf and 49 MRSA), were tested 
composing a sample of species that are commonly seen in clinical micro- 
biology All antibiotics evaluated were clinically relevant for organism being 
tested and included 10 antibiotics for Gnm negatives, 11 for Staphylococci, 
and eight for Enterococcus. Isolates were tested in both systems following 
normal procedures recommended for each product. Individual MICs were 
interpreted following DIN standards except for agents where there were no 
interpretive standard, in which case SFM or NCCLS standards were used. 
Phoenix and Vitek2 ASTresults were compared and major discrepancies were 
retested and the AST result arbitrated by microddution MIC testing (Biotest 
AG, Dreieich, Germany). Overall performance by organism group and by 
significant resistance mechanisms were compared. 
Results: Overall, Phoenix AST results were comparable to Vitek2 in 94% of 
the tests. The comparability by organism group were 92% for Gram-negative 
Bacillus, 96% for S~Q~~$OCOCCUS, and 88% for Enterococm. MRSA was detected 
in 49 strains in both systems with two strains being resistant in Phoenix and 
susceptible in Vitek2, and two strains susceptible in Phoenix and resistant in 
Vitek2. VRE was detected in both systems 32 times, and in Vitek but not 
Phoenix two times, and in Phoenix but not Vitek one time. Arbitration 
testingwas in favor ofPhoenix in the two cases where Phoenix was susceptible 
and Vitek2 was resistant. 
Conclusions: The Phoenix system is generally equivalent to Vitek2 in the 
AST testing of common Gram-positive and -negative strains. 
P706 I Detection of glycopeptide resistance in 
Enterococcus faecium using Phoenix Automated 
Microbiology System 
A Butterworth, B. Turng, M. Votta, T Wiles, J Salomon and J Reuben 
sparks, USA 
Objective: Glycopeptide (vancomycm and teicoplanm, VA and TEC) resis- 
tance in Enterococcus faeaum (GR-EF) has become a worldwtde concern, 
especially 111 nosocomal mfechons. The purpose of t h s  study was to evaluate 
the performance of PhoemxTM Automated Microbiology System m the 
identlfrcahon and detection of GR in EF 
Methods: The Phoemx System was compared to mdhplex PCR, standard 
broth mcrodduhon (SBM) and dsk *ion methods (DD) per NCCLS 
recommended procedures. A total of 86 isolates were idenafied using 
convenhond biochermcal tests as a reference method A mdhplex PCR test 
was then used to deterrmne the dycopephdes resistance genotypes ( V Q ~  or 
van@. Suay-eight smns  of GR-EF (46 vanA and 22 van@ and 18 strams of 
glycopephde suscephble EF (GS-EF) were tested in Phoem, SBM and d d  
d&sion methods for the= suscephbhty to VA and TEC. 
Results: The Phoemx ldenhficahon results of the test strillfls were 96 5% 
correlated wth the reference idennficanon results. All 18 strams of GS-EF 
were correctly detected m Phoenur, SBM and DD. Phoenut detected all 68 
strams of GR-EF wth VA resistance. However, of the 46 V Q ~ A  S~~~IIIS tested, 
Phoem gave (1/46-2%) suscephble TEC results. Also, 2% of vanA strains 
showed susceptible result to TEC in a l l  three AST methods tested. Of the 22 
vanB strams tested, five strams showed resistant results to TEC wth both 
Phoemx and SBM whle the other 17 s t r a m  were detectedas suscephble mall 
three AST methods to TEC. The average tune to results for idenhficahon m 
Phoem was 2 h. The average tune to detechon for VA and TEC were 7 and 
9 h by Phoenut, respectwely. 
Conclusion:These results mhcate that idenaficahon and glycopephde 
resutance 111 EF may be reliably and rapidly detected in the Phoemx 
system 
m/ The BD Phoenix automated identification and 
susceptibility testing system in a clinical microbiology 
laboratory 
E. Stefaniuk, A. Baraniak and W. Hrynicwicz 
Warsaw, PL 
Objectives: PhoenixTM Automated Microbiology System (BD Bioscences) is 
a new fully automated system for rapid idenafication and antimicrobial 
susceptibility testing of Gram-positive and Gram-negative bacteria. The 
objective of this study was to evaluate the quality of performance of 
PhoenixTM panels used for identification and antimicrobial susceptibility 
testing. 
Methods: Two hundred and sw-one  Gram-negative (n = 175) and Gram- 
positive (n = 86) isolates collected &om Polish hospitals in recent years were 
used in the study. Two PhoenixTM ID/AST panel types, NMIC/ID-5 for 
Gram-negative rods and PMIC/iD4 for Gram-positive cocci, were used in 
the analysis according to manufacturer’s reconunendatioils. Results of this 
Ftudy were compared with data obtained by standard or conventional 
microbiological methods. 
Results: A high rate of agreement between PhoenixTM identification and the 
conventional methods was observed. It ranged b o r n  97.3% for Gram-positive 
cocci to 96.0% for Gram-negative nonfermenters, and 91.0% for Entero- 
bacteriaceae isolates. A high Ievel of agreement was demonstrated by the 
susceptibility data obtained with PhoenixTM and the standard agar dilution 
method. For staphylococci, enterococci and Enterobacteriaceae isolates the 
100% concordance of the isolate susceptibility categorization was observed 
with the majority of antimicrobials tested. The category agreement value of 
below 90% was found only in the case of ciprofloxacin susceptibihty in 
enterococci (84.6%) and Gram-negative nonfermenting rods (88.5%). There 
were no major’ (false resistance) or very major‘ (false susceptibihty) errors in 
the detection of methicih-resistance in staphylococci and resistance to 
glycopeptides and high concentrations of aminoglycosides in positive for 
ESBL by ‘double-disc’ method. 
Conclusion: The PhoenixTM system is a reliable system for clinical micro- 
biology diagnostic. 
VI Controlled clinical comparison of New BacTlALERT 
FN versus standard anaerobic blood culture bottles 
B. Reller, S. Mirrett, C. Petti, C. Woods, R. Magadia and M. Weinstein 
Durham, New Bnmswick, USA 
Objectives: To determine the optimal anaerobic companion bottle to pair 
with the BacT/ALERT (bioMkieux, Durham, NC, USA) nonvented 
aerobic FA (FA) medium for recovery of pathogenic microorganisms fivm 
adult patients with bacteremia and hngemia, we compared BacT/ALERT 
FN (FN) bottles with standard BacT/ALERT SN (SN) anaerobic bottles. 
Methods: Each bottle, FA, FN, and SN, was filled with 8-12 mL of blood. 
Results Of 11 498 blood culture setS received in the clinical microbiology 
laboratory, 7945 sets had all three bottles filled adequately and 8569 had both 
anaerobic bottles fded adequately. Of 683 clinically important (based on 
previously published criteria) isolates detected in one or both adequately fdled 
anaerobic bottles, dgnificantly more staphylococci (P < 0.001). includ~ng 
Sraphylocomj QUMS ( P <  0.01); Enterobacteriaceae (P< 0.001); and all 
microorganisms combined (P<O.001) were detected in FN bottles. In 
contrast, sigdicantly more Pseudomom amginma ( P <  0.01) and yeasts 
( P <  0.001) were detected in SN bottles. More Bacteroides jagifis group 
bacteremias were detected only in the FN (6) Venus the SN (1) anaerobic 
bottle (P=NS). Overall, the mean rime to detection was shorter with FN 
(16.8 h) versus SN (18.2 h). This difference in time to detection was greatest 
for the B.f.gifis group: FN, 28.1 h versus SN, 60.0 h. Many of the facultative 
microorganisms recovered in either FN or SN were also found in the 
companion FA. When microorganisms found in the companion FA bottle 
were omitted fiom the analysis, significantly more staphylococci (D< 0.001), 
including S. aureus (P< 0.001), and Enterobacteriaceae (P<O.Ol) still were 
detected in FN bottles, whereas there were no sigruficant digerences for 
I? amginma and yeasts, whch were found as expected in FA bottles. 
Conclusions: We conclude that the companion anaerobic FN bottle detects 
more microorganisms than the SN bottle when used in conjunction with 
the nonvented aerobic FA bottle in the BacTIALERT blood culture 
system. 
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IP708; Recovery and time detection of Mywbacterium 
hrbercdosis in the BACTEC MGlT 960 system from clinical 
specimens - comparison with the conventional Lowenstein- 
Jensen medium 
I. Jesus, J. Lopez-Barba, M. -A. Jesus, M. Rodriguez-Iglesias and 
S. Perez-Ramos 
Puerio Real, E 
Objective: To evaluate the automated systems BACTEC MGIT(c) 960 (BM 
system - Becton Dickinson) in comparison to solid media Lowenstein Jensen 
(LJ medium); &om the recovery and time to detection of Mycobacterium used 
routinely in our laboratory during 12 months. 
Methods: Two thousand and fifteen consecutive clinical specimens have been 
processed in the laboratory. The samples were digested and decontaminated 
they were inoculated in flasks ofBM system and in LJ medium and introduced 
in their respective incubation systems. The Statgraphics Plus 4.1 s o f m  has 
been used for the statistical adjustments. 
Results: Ofthe 2015 processed specimens, 136 were positive for some of the 
two methods. The BM system registered 134 positive specimens (98.53% of 
the positive specimens) and LJ medium recovered 106 (77.94%). Thirty 
samples grew alone in the BM system and two (1.47%) alone in LJ medium. 
There is a statistically significant ditlerence between the means of growth of 
the two methods at the 95.0% confidence level. The haIftime ofgrowth is of 
13.47 days in BM system while in the LJ medium was of27.6 days. The time 
ofgrowth was studied for regression analysis; the correlation coefficient equals 
0.66 indicating a moderately strong relationship between the variables. In tbe 
patients with Mycobactmiurn infection and LJ-medium negative has been 
observed that a high percentage of patient were in treatment for the 
tuberculosis. In the patients with LJ medurn positive were not observed 
differences in relation to the treatment. Sensitivity in BM system was 98.53% 
compared to 77.94 in LJ medium, this Merence was statistically sigtllficant 
Conclusion: The BM system showed more sensitivity than LJ medium in the 
Mycobactetium detection, since in view of the results, if we use the analyzing 
BM system we recover 22.05% ofthe positive specimens more than that with 
other methods. LJ medium presents a time of growth higher than automated 
systems. The less time ofdetection and the hgher sensitivity make BM system 
a good method for Mycobacterium isolations. 
( P <  0.005). 
Ip709J Controlled clinical comparison of plastic versus 
glass bottles of BacT/ALERT PF medium for culturing blood 
from pediatric patients 
S. Mirrett, C. Woods, C. Petti and B. Reller 
Durham, USA 
Objectives: The pediatric plastic BacT/ALERT (bioMkrieux, Durham, NC, 
USA) PF (PPF) is a new nonvented aerobic culture medium in a clear 
plastic bottle designed to prevent breakage. To assess the new PPF bottle 
versus the current glass BacT/ALERT PF bottle, we compared the perfor- 
mance of these two bottles for the recovery of microorganisms as well as the 
time to detection of growth in samples of blood obtained for culture &om 
children. 
Methods: All bottles were weighed before inoculation and upon receipt; only 
bottles filled with s i d a r  volumes of blood were compared. 
Results. Of 3445 bottle pairs received, 2010 (58.3%) contained comparable 
volumes of blood. Of 97 clinically sigdicant (based on previously published 
criteria) isolates, 74 were detected in both bottles, 13 only in PPE and 10 only 
in PF (2" ns). No organism group was detected sigmficantly more frequently 
from one medium versus the other. Of 74 sets that were positive in both 
bottles within 3 days, the mean time to detection of pathogens from pediatric 
patients was 18.0 h in PPF and 17.8 h in PF bottles. Fake-positive instrument 
signals were detected in 10 of2010 (0.5%) PPF bottles andfive of2010 (0.2%) 
PE 
Conclusions: We conclude that BacTIALERT PPF and PF bottles are 
comparable for recovery of microorganisms and that the safety advantage 
of plastic bottles can be achieved without compromising performance. 
Evaluation of the performance of the VITEK 2 
automated identification and antimicrobial susceptibility 
testing system on Gram-positive cocci 
€? Clerici, C. Agrappi, A. Paganini, L. Bertinotti, E. Vasconi and 
E. E Vigani, 
Legnano, I 
Objective: An evaluation of the performance of the VITEK 2 (bioMkrieux, 
France) for the idendcation and susceptibility testing of Gram-positive cocci 
compared to the currently used routine method was performed. 
Methods A total of 168 fresh isolates of Gram-positive cocci were tested 
usingVITEK2 including 17 Streptocompneumoniae (S.P.), 51 enterococci and 
Streptococcus spp., 50 (S.a.), and 50 coagulase-negative staphylococci 
(CNS).The results were compared to those obtained with the routine system 
currently used in our laboratory (AutoSceptor, BD, Maryland). Strains 
dzscrepant results were compared with API (bioMerieux, France) system 
for identification, and with E-test (AB BIODISK, Sweden), for susceptibility 
testing, according to the NCCLS. 
Resub The comparison of identification results showed an agreement of 
100% for S.p. and Sa., 96.1% for enterococci and Streptowccus spp., and 72% 
for CNS. The results obtained by API, showed the VITEK 2 to be correct for 
100% of the enterococci and Streptococcus spp., and 90% of the CNS (100% for 
S. epidermidis).For the evaluation of the susceptibility test (1680 antibiotic/ 
organism combinations) category agreement between the two automatic 
systems was 88% for CNS (11 antibiotics tested),6S%for S.p. (nine antibiotics 
tested),70% for S.a. (11 antibiotics tested) and 53% for Enterococci and 
Strrptococcus spp. (nine antibiotics tested). No Very Major Errors were found 
with VITEK 2 for any of the organism/antibiotic combinations tested. In 
comparison with E-test, testing of the discrepancies between the two auto- 
mated systems showed the VITEK 2 to give correct results in 100% ofthe cases 
with CNS, in 95% of the cases with Enterococci and Streptococcus spp. (for 
Enterococci, no discrepancy for vancomycin was seen), 92% correct results for 
S.a.(no discrepancies for oxacillin). The agreement between the two systems 
remained unchanged (76.5%) for S.p. This was due to only one antibiotic, 
enicillin, and four strains. VITEK 2 gave results of resistant for two strains and 
intermediate for two strains. Instead, E-test gave intermediate for two strains 
and sensitive for two strains. Considering the time to complete of suscept- 
ibility results, times varied from 7.5 to 10.5 h, with an average time of 8.5 h. 
Conclusion: The VITEK 2 provides rapid results and above all is reliable for 
both identification and susceptibility testing regarding the major part of the 
analysis of Gram-positive cocci. 
m1 Comparison of the PhoenixTM Automated 
Microbiology System to the Dade-MicroScan WalkAway-96 
for identification of clinical bacterial isolates 
E Marco, A. De Bock, W Brasso and M. T. Jimenez de Anta 
Barcelona, E; Erembodegem, 3, Spark, USA 
Objectives: The PhoemTM System (BD Diagnoshc Systems, Sparks, Mary- 
land, USA), a rapid automated ID/AST system, was compared to the Dade- 
M a s c a n  WalkAway-96 System (Dade-McroScan, W. Sacramento, Cah- 
forma, USA) for accuracy of identlticahon (ID) of fiesh c h c a l  laboratory 
isolates as well as a Challenge Set of selected stock strains. 
Methods: A total of 328 bactenal isolates, compnsed of 192 Gram-negahw 
bacdh (GNB) and 136 Gram-poaave cocci (GPC) (27 Staphylocmm u u ~ u s ,  
53 coagulase-negative staphylococa, 45 enterococci and 11 streptococci), was 
evaluated ~fl both the Phoem (PHX) and Ahcrokan (MS) systems. Inocu- 
lum suspensions were prepared for each s t r v n  on the same day horn the same 
subculture plate for both test systems. Standard commercially avadable PHX 
and MS ID/AST panels were inoculated and lncubated followmg each 
manufacturer's procedure If requwed, supplemental tests were used to 
determme a final ID Results fiom both systems were compared for 
genudspecies agreement, and dlscrepanaes were arbitrated usmg a t h d  
system, API (bioMtneux, France) 
Results: The overall rate of agreement between the PHX and MS systems for 
species level ID was 95.3 and 956% for GN and GPC, respechvely 
Enterococcus and Streptococcus species both achleved a 100% rate of species 
level agreement The genus level agreement was >99?? overall Arbitraaon of 
the rnne GNB &agreements resolved wth seven m agreement wlth the 
Phoenix ID. For the su[ GPC dlsagreements, four resolved m agreement with 
Phoenur Supplemental manual ID tests were reqwed for four GN strains 
(2 1%) with MS, whde PHX requred addlhonal tests for two GN strains 
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(1 0%) In addition, PHX correctly idenhfied 60163 (95.3%) of Staphylococms 
species as beta-lactamase produclng stmns. 
Conclusions: The Phoemx Automated Microbiology System prondes a high 
level of agreement to the Microscan WalkAway System for idenhficanon of 
Gram-negative and Gram-positwe c h c a l  isolates 
v1 Comparison of the Phoenixm Automated 
Microbiology System to the Dade-MicroScan WalkAway-96 
for antimicrobial susceptibility testing with Gram-negative 
and Gram-positive bacterial isolates 
E Marco, A. De Bock, W Brasso and M. T. Jmenez de Anta 
Sarcelona, E; Erembodegem, B; Spark, USA 
Objectives: The PhoemTM System (BD Dlagnoshc Systems, Sparks, Mary- 
land, USA), a rapid automated ID/AST system, was comparahvely evaluated 
with the Dade-MicroScan WalkAway-96 System (Dade-McroScan, W 
Sacramento, Cahforma, USA) for accuracy of anhmcrobial suscepnbdxy 
test (AST) results mth a varied group of Gram-negaave bacfi (GNB) and 
Gram-positive cocci (GPC). 
Methods: A total of 306 chmcal bacterial isolates, comprised of 183 GNB 
( f d y  Enterobacteriaceae), and 123 GPC (79 staphylococci lncludmg 39 
methcdhn-reustant (MR) stralns, and 44 enterococa) isolates were tested UI 
standard commercially avadable Phoemx (PHX) and McroScan (MS) AST 
panels Each inoculum suspension was prepared &om the same subculture 
plate for both test systems. PHX and MS panels were each inoculated, then 
incubated and automaacally read m the system’s instrument followng each 
manufacturer’s recommended procedure Thlrteen anmcrobics were eval- 
uated for GNB, 13 for Staphylococnrs species (ST), and rune for Enteromcm 
species (ENT) The m m a l  dubitory concentrahon (MIC) of each anh- 
mcrobic/orgarusm combmatton was mterpreted based on the 2001 NCCLS 
Standards Dacrepant AST results were repeated ln both systems, and 
arbitrated using the NCCLS-recommended broth mcroddution method 
Essential agreement (EA), MIC results wthm f l  doubhng diluhon, and 
categorical agreement (CA) were determned for the Phoemx System. 
Results: Overall, 3610 AST combinahons were evaluated m both systems. For 
GN isolates, the rate of EA was 99 7%, whule the CA rate was 95 6% Fake- 
susceptible (VM) and false-resistant (M) rates for PHX were 1.0 and 0 6%, 
respecavely Arbitratlon of 25 GNB disagreements resolved w t h  22 I I ~  
agreement with the Phoenut MIC. For ST aolates, the EA and CA rates 
were 97 4 and 95 7%, respecnvely All 39 MR strams were correctly idenhfied 
as such by PHX. With ENT species, the EA was 99 3%, and the CA 95 8%. 
figh-level amnoglycoside detectlon was 100% in agreement for the two 
systems PHX also correctly identified three enterococcal s t r a m s  as vanco- 
mycin-resistant 
Conclusions: The rapid AST performance of the Phoem System is nearly 
equivalent to that ofthe McroScan WalkAway overrught system, and provtdes 
an alternahve in automated AST testmg of GNB and GPC for the c h c a l  
laboratory 
[p7131 Controlled clinical comparison of plastic versus 
glass bottles of BacT/ALERT FA medium for culturing blood 
from adult patients 
L. B. Reller, S. Mwrett, C A Pem and C W Woods 
Durham, USA 
Objectives: A new clear plastic nonvented FA bottle, deslgned to prevent 
breakage, has been developed for the BacT/ALERT (bioM&eux, Durham, 
NC, USA). To assess the new plasac FA (PFA) bottle versus the current glass 
BacT/ALERT FA bottle, we compared the performance of these two bottles 
for the recovery of rmcroorgarnsms as well as the nme to detechon of growth 
~fl samples of blood obtamed for culture &om adult panents wth  suspected 
bloodstream infecnon 
Methods: PFA and FA bottles were each filled mth  8-12mL of blood 
Results: Of3191 blood culture sets c o n w n g  both bottles, 2368 (74.2%) met 
the crtterlil for adequacy of fillyg. A total of 176 chcally important (based 
on premously pubhshed criteria) isolates were recovered from 93 panents; 112 
solates were recovered fiom both bottles, 28 were recovered horn the PFA 
bottle only, and 36 were recovered from the FA bottle only (P=ns) Of 
cultures found to be posihve mtm the first 72 h oficubaaon, the mean tune 
to detection was s d a r  for PFA (20.5 h) and FA (20.1 h) bottles. The number 
of false-positive results was comparable: nine (0.4%) in PFA bottles and 12 
(0.5%) in FA bottles. 
Conclusions: We conclude that BacTIALERT PFA and FA bottles are 
comparable for recovery of microorganisms and that the safety advantage 
of plastic bottles can be achieved without compromising performance. 
vl Comparison of BacT/ALERT 3D and Bactec 460 for 
drug susceptibility testing of Mycobacteriurn tuberculosis 
J. C. Toro, J. Werngren, K. A. K. kgeby  and S. E. Hofher 
Solfla, s 
Objective: The aim of the study was to evaluate the nonradiometric 
BacT/ALERT system (Organon Tekruka) against the radiometric Bactec 
460 method (Becton Dickinson) for susceptibility testing of Mycobacrm’um 
tuberculosis to Rifampicin (RIF), Isoniazid (INH), Streptomycin (SM) and 
Ethambutol (EMB). 
Methods: The drug susceptibilities of the fully susceptible reference strain 
M. tuberculosis H37Rv and an earlier established test-panel of 47 clinical 
isolates of susceptible and resistant M. tuberrlosis strains were assessed by 
the BacT/ALERT method. The panel included 23 strains resistant to RIF 
(2mg/L); 25 to INH (0.2mg/L); 16 to SM (4mg/L); and seven to EMB 
(5mg/L), when determined by our conventional standard method Bactec 
460. In the BacT/ALERT system, the following drug concentrations were 
used RIF 1 mg/L, INH 0.1 and 0.5 mg/L, SM 1 mg/L, and EMB 4mg/L. 
Results: Altogether 240 susceptibility tests were carried out with the 
BacT/ALERT system. Of these 239 tests could be evaluated. Full agreement 
between the two methods was seen in 233/239 tests (97.5%). For each drug, 
the concordance between the two methods was 95.8% for RIF, 97.9% for 
INH (high and low concentration), 93.8% for SM and 97.9% for EMB. The 
mean time to achieve a susceptibihty pattern from a strain grown on Low- 
ensteinjensen media was 11 days using BacT/ALERT compared to approxi- 
mately 7days for the Bactec 460 method. For one (resistant) strain, the 
susceptibility could not be evaluated for INH (low) by the BacT/ALERT 
method due to the rapid growth in the drug containing culture vials. 
Conclusions: A good correlation was seen between the two methods. The 
result suggest that the BacT/ALERT system is a valid alternative to the Bactec 
460 system for drug susceptibility testing of M.  tuberdosir, especially in 
laboratories where disposal of radioactive waste is restricted. 
I P715 1 Rapid identification of clinical bloodstream isolates 
of staphylococci with the WTEK 2 system 
T. Spanu, M. Sanguinetti, D. Ciccaghone, T. D’Inzeo, L. Romano, 
F. Leone and G. Fadda 
Rome, I 
Obiedives: Staphylococci are an increasmgly common cause of bloodstream 
infections. Rapid and reliable species identification of these organisms is 
essential in ensuring accurate diagnosis and prompt effective treatment of 
these severe infections. Our aim was to evaluate the abillty ofVITEK 2 system 
(bioMeri&ux, Inc., Hazelwood, MO) to idenafy these o~ganisms rapidly and 
accurately. 
Methods: A total of 350 staphylococcal isolates (Staphybmccuc aureus, n = 117 
and coagulase-negative staphylococci n = 233). collected from blood cultures 
between 1999 and 2001 at the ‘A. Gemelli‘ teaching hospital in Rome, were 
idenrified with the VITEK 2 system and a reference method consisting in the 
ATB ID 32 Staph system (bioMhrieux, Marcy l’Etoile, France) together with 
the standard identification scheme ofKioos and Bannermann (W.E. moos and 
T.L. Bannermann, in P.R. Murray et al. ed., Manual C h i c  Microbiol, 6th 
ed., 1995, p. 282-98). VITEK 2 results were considered correct when they 
were identical to those of the reference method. When discrepancies 
occurred, isolates were retested with both systems and reference-system 
results were confirmed using a nudeic acid-based procedure that combined 
PCR amplification of the gap gene of S. aureur, which encodes glyceralde- 
hyde-3-phosphate dehydrogenase, and resmction-length polymorphism 
(RFLP), using Alu I restriction endonuclease. Primers designed on the 
gap gene were used to amp@ a 933-bp DNA fragment by PCR. A h  I 
digestion of PCR products gave different RFLP patterns that allowed species 
identification. 
Results. The VITEK 2 system correctly identified 337 of 350 isolates at the 
species level (96.3%) with the VITEK 2 system alone and 12 other strains (one 
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S .  aureus, one S. haernolyticus. s ix  S.  horninis, three S. epidemtidis and one 
S. warnen) were identified using simple, rapid manual tests suggested by 
the manufacturer (clumping factor, hemolysis, anaerobic growth, colony 
pigment and polimixin susceptibility). Only one strain (0.3%), an S. horninis, 
was misidentified (as S. epidermidis). Results obtained with phenotypic 
methods were confirmed by PCR-RFLP of the S. aureus gap gene. Results 
were obtained within 2-4 h. 
Conclusions: The VITEK 2 system can provide rapid, accurate and reliable 
species-level identification of staphylococci responsible for bloodstream 
infections. 
Ip7161 Evaluation of an automated extraction method 
(MagnaPure) for the detection of CMamydia trachomatis 
and Neisseria gonorrhwae by Cobas Amplicor PCR from 
urogenital specimens 
R. Geertsen, P. Giachino, P. Friderich and S. Emler 
Ztiiich, Rotkrerrz, CH 
Introduction: Infections with Chlamydia trachomaris (CT) and Neisreria gonor- 
rhoeae (NG) are fiequendy encountered sexually transmitted diseases. Specific 
diagnosis is important as specific treatment can avoid transmission and 
therefore, reduce the incidence. Conventional techniques such as 
immuno-fluorescence or cell culture in case of CT, or specific bacterial 
culture in case of NG, are cumbersome and lack sensitivity. Newer amplifica- 
tion techniques such as commercially available PCR tests (AmpIicodRoche) 
have proven usefd through better sensitivity and better handling. Better 
performance along with automation have promoted this approach for STD 
screening in ambulatory medicine. However, while amplification and detec- 
tion are today handled by an automated device (Cobas Amplicor/Roche), the 
preparation of the clinical specimens is still done manually and may, therefore, 
limit the throughput. 
Methods: We evaluated a newly available automated robotic platform 
(MagnaPure/Roche) for the extraction of DNA f h m  chical urogenital 
specimens for the detection of CT/NG, using the Cobas Amplicor PCR 
system. The automated extraction on 645 c h c a l  samples was done in parallel 
to the standard manual protocol, as recommended by the manufacturer. 
Successful amplification and absence of inhibitory facton were monitored 
through amplification of an internal control (IC) and OD values were 
recorded for all samples. Positive results for NG were confirmed using the 
Roche 16s rDNA N G  confirmation test. Inhibited samples (OD < 0.2) were 
re-extracted using silica matrices (Qiagen Mini-Amp DNA) cartridges 
and amplification was repeated (Cobas Amplicor). Amplification was per- 
formed using the same Cobas Amplicor PCR system and the same batch 
reagents. 
Samples: We tested 566 vaginal/cervical Amplicor swabs, 46 urethral 
Amplicor swabs and 33 native urine samples for presence of CT/NG; the 
specimens were split and subjected to the automated MagnaPure total DNA 
procedure and to the manual standard protocol, without delay. 
Results: The MagnaPure extraction procedure showed a slightly better 
sensitivity, in comparison to the standard technique. More unspecific Neissen'a 
spp. were detected with the MagnaPure, however, at O D  values lower than 
2.0. Finally, samples primarily inhibited by the manual method yielded 
significantly better results via the MagnaPure. 
Conclusion: MagnaPure extraction of urogenital specimens for subsequent 
amplification using the Cobas Anlplicor system is a valuable alternative to the 
standard manual extraction technique. It shows sigcllficant better performance 
with regard to sensitivity and primary inhibition and could be integrated in an 
overall automated analysis procedure for CT/NG testing. 
Molecular diagnostic methods I 
Clinical impact of identification and detection of 
methicillin resistance of staphylococci in blood cultures by 
multiplex PCR 
M. Hallin, Y. De Gheldre, S .  Rottier, N. Maes, B. Byl, F. Jacobs and 
M. J. Struelens 
Bmssds, B 
Objective: To assess the impact on antibiotic therapy of performing a triplex 
PCR that discriminates Sfaphylococrus aureus from the coagulase-negative 
Sfaphylnrocrus (CNS) and detects their methicillin resistance on positive blood 
cultures in comparison with routine testing methods. 
Patients and methods: Consecutive patients with presumptive staphyloccocal 
bacteremia (blood culture positive for clusters of Gram-positive cocci) were 
included. PCR was performed on DNA extracted &om blood culture broth 
using three sets of primers for genes encoding staphylococcal 16s rRNA, 
thermostable nuclease (ntrc) and PBP2A (me&), respectively. PCR results 
were compared to those of conventional techniques of identification (coa- 
gulase and latex tests) and oxacillin susceptibility (disc-ditfusion or Rapid 
ATB-staph microddution test).Endpoints were defined as: (1) turnaround 
time of the result, and (2) the adaptation of empirical antibiotherapy. 
Re~~lts: Atotal of 21 patients were enrolled in the study. In these patients, 
bacteremia was caused by CNS in 14 (methicillin resistant in 13) and S. aureus 
in seven (methicillin resistant in two). Phenotypic and genotypic methods 
shaved 100% agreement. Mean times to communication was: 6.1 h (range: 
5 1-7.5 h) for PCR vs. 43.3 h (range: 24.58-50.58 h) for conventional 
methods ( P  < 0.01). Only three patients (1 4%) benefited from a modification 
of antibiotic therapy based on the PCR results: two patients with methicillin- 
sensible S. aureus were shified &om vancomycin to oxacillin, and one patient 
with methicillin-resistant CNS bacteremia was started with treatment with 
vancomycin. 
Conclusion: This triplex PCR assay was as accurate for diagnosis of staphy- 
lococcal bacteremia as the conventional methods. It provided results on 
average 37 h earlier. However, the therapeutic benefit of this rapid diagnosis 
was limited given that empirical therapy was appropriate in the majority of 
cases. 
[p718) Less than one-hour detection of vancomycin- 
resistant enterococci directly from fecal samples by real-time 
PCR using the Smart Cycler@ 
A. Huletsky, M. J. Ferraro, B. Leclerc, N. Boucher, A. Bernal, J. Frenette, 
S. Atamian, F. J. Picard and M. G. Bergeron 
Que'bec City, CAN; Boston, USA 
Objectives: Nosocomial infections with vancomycin-resistant enterococci 
(VRE) have become a sigrufcant problem in hospitals and institutions 
worldwide. The emergence and dissemination of VRE has prompted recom- 
mendations for surveillance and rapid detection of these organisms. However, 
the usefulness of surveillance cultures for VRE is limited by delayed definitive 
detection time (2-4 days), thereby, slowing the identification of patients 
requiring isolation to limit nosocomial spread. The objective of this study 
was to develop a real-time P C R  screening test for detection of VRE directly 
h m  fecal samples in less than 1 h. 
Methods: A multiplex PCR assay for real-time detection of VRE using the 
Smart Cyclerm was developed by Infectio Diagnostic. This assay combines 
vanA- and vankpecific P C R  primer pain and two molecular beacon probes 
targeting the respective amplified regions of vanA and vanB. Fecal material 
from rectal or perirectal swabs collected during a VRE surveillance program at 
the Massachusetts General Hospital were analyzed by ( 1 )  selective broth 
culture method and (2) our real-time P C R  assay. The P C R  assay was 
performed directly f b m  the fecal material prepared with a simple 10-min 
specimen preparation protocol. 
Results: A total of 62 rectal specimens were tested by both culture and PCR. 
VRE was detected in 12 specimens by culture. The 12 samples positive for 
VRE based on culture were also all detected by our  PCR assay. As compared 
to culture, the P C R  assay detected one additional VRE positive specimen for 
a sensitivity of 100% and a specificity of 98%. Among the P C R  positive 
specimens, nine were positive for vanA, three were positive for vanB and one 
was positive for both vanA and vanB. 
Conclusions: This real-time PCR assay for rapid VRE detection represents a 
powerful screening test for early identification of the colonized patients that 
should be helpful to control VRE transmission. 
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Differentiation of Leptospira intemgans by 
1S1533-and IS1500-based PCR assay 
E. Romero, J. Amaral, C. Bernard0 and P. Yasuda 
SZo Paulo, BR 
Leptospirosis, caused by pathogenic members ofthe genus Leptospira, is one of 
the most widespread zoonotic diseases in the world. Potential sources of 
dection can be known most easily by determining the serovar associated with 
an outbreak of the disease, because certain serovars are often associated with 
specific mammahan hosts, and with the severity and complication of the 
disease. Traditional serological typing of leptospiral isolates is a difficult and 
labor-intensive process involving the use of cross-absorption agglutination 
reactions. Growth of leptospires, particularly Gom clinical isolates, is a slow 
and labor-intensive process and is ofien unreliable. A rapid and accurate 
method for typing leptospires b m  c h c a l  samples is essential for medical 
procedure and the control of leptospirosis. Recently, PCR methodology has 
been used as an alternative approach to typing leptospiral isolates. 
Objectives: In t h s  study, we evaluated the PCR-based assay that targets 
IS1533 and IS1500 sequences for identification of Leptospim interrogans sensu 
strict0 serogroups. 
Methods: The PCR assay was performed with the following serovars selected 
from the reference culture collection: Icterohaemorrhagiae, Copenhageni, Crip- 
potyphosa, Canicola, Pomona, Bataviae, Australis, Autumnalis, Hebdomadis, Cas- 
tellonis and Cynopten'. These serovars represent the serogroups known to be 
prevalent by serology in S b  Paulo, Brazil, although by isolation from clinical 
material the serovan Copenhageni and Icterohaemorrhagiae are the prevalent 
serovars. In addition, an array of microorganisms that frequently are associate 
with contaminated clinical material were used to contaminate other set of 
leptospiral cultures in order to verify the specificity of the primers. 
Results: The PCR-based assay was unable to differentiate the serovars 
Canicola, Baraviae, Australis, Autumnalis and Hebdomadis. The serovars Grip- 
potyphosa and Castellonis were differentiated by both set of primers. The 
primers that targets IS1 500 sequences differentiated the serovars Copenhageni 
and Icterohaemorrhagiae. 
Conclusions: The ability to discriminate some serovars wiIl provide a useful 
tool in epidemiology. These preliminary results showed that the PCR will 
allow us to focus future pathogenesis studies on  dif€erent strains of serogroup 
Icterohaemorrhagiae. The use ofthis assay eliminates the need for dificult and 
time-consuming conventional techniques. 
w) Rapid and sensitive detection of Toxop/asma 
gondii from clinical samples by a single-step PCR 
S.  Jalal, C. E. Nord, M. Lappalainen and B. Evengird 
Stockholm, S; Helsinki, FIN 
Objectives: Toxoplatma gondii can cause severe complications in immuno- 
compromised hosts. Diagnosis ofpathogen directly Gom the clinical samples is 
desirable. A sensitive two-step nested polymerase chain reaction (PCR) 
followed by post-PCR manipulation of the product, for example, liquid 
hybridization or colorimetric detection using internal probes is being used to 
detect Tgondii. Our aim was to develop a rapid, sensitive and simple PCR 
method to detect Tgondii directly from clinical samples. 
Methods: Twenty clinical samples of amniotic fluid, cerebrospinal fluid 
(CSF), vitreous fluid and tissue were tested. DNA was prepared from the 
samples using Qiagen DNA mini kit with some modification. A pomon of 
DNA sample was amplified by single PCR using specific primers for 35-fold 
repetitive B1 gene of Tgondii. To avoid the false-negative resulting from 
inhibition, a positive internal control PCR w a s  run in parallel to a m p e  
human fi-globin gene, whch is present in all biological samples. To detect the 
sensitivity of the method, we estimated the number of tachyzoid cell by 
microscopy and performed a series of PCRs on dduted materials. To ensure 
reproducibility, PCR was performed in duplicate with two Merent sample 
volumes. PCR products were analyzed on agarose gel electrophoresis. The 
procedure is performed in less than 5 h. 
Results: Results ofblind samples analysis using our method were in agreement 
with the results where samples were analyzed using two-step nested PCR 
followed by either liquid hybridization or colorimetric detection using 
internal probes. The detection limit ofthe method was as low as one parasite. 
Conclusion: Ths  PCR technique is a rapid, sensitive and simple method, 
which can be applied for amnion fluid, vitreous, CSF, &sue or blood samples 
without prior culture. A good primer designing and successful optimization of 
the PCR allowed simplifylng the method to a single step PCR. 
[p7211 PCR-restriction fragment length polymorphism for 
rapid identification of Nocardia spp. isolates 
A. Gaafar, M. J. Unzaga, C. Ezpeleta, G. Martin, F. Calvo, M. V. Leal and 
R. Cisterna 
Biibao, E 
Objectives: Nocardia is a wen-recognized human pathogen. Traditional 
differentiation of Nocardiu species has involved the evaluation of various 
biochemical reaction. These methods have not always been reproducible 
and have been inadequate for the identification of recently characterized 
Nocardia species (N.farcinica and N. nova), for which additional antibiogram 
and specialized biochemical data are required for differentiation. All of these 
methods are time consuming and laborious. The objective of this study is to 
evaluate the PCR-restriction h-agment length polymorphism (PCR-RFLP) 
as a rapid method for rapid identification of Nocardia isolates. 
Methods: DNA was obtained by suspending one loop full of bacteria in 
300 mL of distdled water, subjected to sonication for 15 min, boiled in water 
bath for 15 min Primers Tb l l  and Tb12 were used for the amplification of 
439 bp 6agrnent of the gene hsp 65. For restriction hgment analysis 20 pL of 
PCR products was digested by 5 U of either MjpI or H i d .  The type strains 
Nocardia atreroids CECT 3051 and iV farcinica CECT 3053 were used as 
control strains. 
Results: We identified four Nocardia isolates from clinical samples by this 
method two N. nova isolates (one fiom a respiratory infection and the other 
one from skin infection), one N.3rcinica and one N. asteroids (both were 
isolated Gom respiratory samples fiom the same patient, with 10 years interval 
between the fist and the second isolate. The first isolate was identified 
10 years ago by traditional methods as N. atteroides). The PCR-RFLP analysis 
ofthe isolates: (1) By digestion with H i d ,  all isolates produced only one band 
of 439 bp (2) By digesaon with MspI: N nova produced thee bands of 130, 
110, 75bp; N.atteroides produced three bands of 180, 145, 120bp; and 
N.farcinica produced one band of 439 bp. 
Conclusion: PCR-FWLP represents a rapid, sensitive, reliable and reprodu- 
cible method for the identification of Nocnrdia isolates in clinical practice. By 
this method, Nocardia isolates can be identified within 8 h. 
lp7221 Efficiency of PCR and RT-PCR for detection of 
Treponerna pallidurn DNA in plasma 
A. E. Guschin, E. N. Rodionova, G. A. Shipulin, L. M. Toporovsky and 
Y. A. Nikolenko 
Mosm,  RUS 
Objective: For improvement of detection of Tpaliidum, it is necessary to use 
hghly effective methods of molecular diagnostic. The PCR approach i s  able 
to detect single copy of DNA target. The application of RT-PCR with 16s 
RNA as a target may greatly increase the sensitivity of assay. The aim of our 
study was to evaluate these two approaches for detection of Tpaliidum in 
plasma of infected patients. 
Methods: Blood plasma samples from 157 patient with different stage of 
syphihs (14 cases ofprimary syphilis, 74 cases ofsecondary syphilis, 14 cases of 
secondary syphilis relapse, 51 cases of early latent syphilis and 4 cases of late 
latent syphilis) were tested for the presence of treponemal DNA and RNA. 
Nucleic acids were purified with silica-GuTC method. To increase the 
sensitivity of the assay bacteria from 1 mL of plasma were concentrated by 
centrifugation so that each PCR mixture contained nucleic acids &om 250 pL 
of plasma. Isolation of nucleic acids, reverse transcription and amplification 
were carried out in presence of recombinant internal RNA and DNA 
controls. We designed oligonucleotide primen which amplified 273-bp 
fragment of the gene encoding 47-kDa lipoprotein and 382-bp Gagment 
encoding 16s RNA gene of Tpallidum. The detection limit ofPCR test was 
measured using the PCR-based limiting diiution assay with purified DNA 
Tpanidum Nichols strain. Workjng concentration of internal control was 
twofold higher of detection-limit value. 
Results: Detection limit of the PCR assay with chosen primers was equal to 
four copies of treponemal DNA in PCR reaction mixture. In primary 
syphilis, the treponemal DNA and RNA were detected in 100% of samples. 
In secondary syphilis, DNA was detected in 73% and RNA in 78% ofsamples. 
In secondary syphilis, relapsers DNA and R N A  were detected in 79% of 
samples. In early latent syphks, the DNA and RNA were detected in 17 and 
20% samples, respectively. In all, late latent syphilis samples neither DNA nor 
RNA were detected. 
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Conclusion: The efficiency of RT-PCR assay for detection Tpallidum 16s 
RNA in plasma in comparison with PCR assay is higher in some stages of 
syphilis. The active forms of syphilis (primary and relapse to secondary) are 
accompanied with increasing frequency of positive results in molecular 
biology tests. 
1 P723 I PFGE typing of sa/mone//a strains 
A. Jimenez, Y. Moreno, R. M. Montes, M. A. F e d s  and J. Hernindez 
Wenria, E 
O b w i :  Salmonellosis is the most common food- and water-borne disease 
in Spain. Serotyping is one of the methods frequently used for epidemio- 
logical studies. In our work, we have evaluated the usefulness of PFGE 
method for detecting DNA polymorphism in Salmonella strains. 
Methods: A total of 44 isolates were used in this stuCty. Serotypes were 
analyzed at Instituto de Salud Carlos 111, Madrid, Spain. Thirteen Merent 
serotypes were detected serotype anatum being the most common. The 
macrorestriction DNA of the isolates was performed by XbaI endonuclease 
and the digestion products were analyzed by PFGE using Contour-clamped 
Homogenous Electric Field System (CHEF 111). Images were processed with 
TDI soha re  and clusters analyzes were carried out using WGMA algorithms. 
AU computations were performed using the NTSYS program, version 2.0 
(Exeter Software, NY, USA). 
Results: Four isolates were untypeable by using the XbaI enzyme (one 
S.goldcoast, two S. ohio strains and one S. brandenburg). A total of 20 different 
XbaI pulsed-field profiles were observed for the other 40 typeable strains. 
Conclusion: PFGE patterns allowed the discrimination of serotypes. More- 
over, strains belonging to the same serotype showed different PFGE patterns 
disclosing a close-related homology, as they shared a high number of DNA 
fragments. These results indicate that PFGE technique may be used as a 
epidemiological tool for the subtyping of different Salmonella strains. 
lp7241 Identification of Salmonella enteritidis strains of 
human and food origin by phage-typing and by analysis of 
plasmid profile 
L. Majthovi and V. Majtin 
Bratislava, SK 
Objectives: To identify the epidemiologically unrelated S. enterifidis strains 
isolated from clinical samples (stools, blood) (n=35) and from food (n = 38) 
using the phage-typing and analysis of plasmid profile. 
Methods: All isolates were phage-typed according to the international 
scheme of Ward et al. (1987) using of 10 standard bacteriophages. The 
plasmid DNA was isolated by the method of alkahne lysis (Maniatis et al. 
1982). The samples were analyzed in 0.7% horizontal agarose gels electro- 
phoretically at 60 V for 5 h and visualized by staining with ethidiumbromide. 
The plasmids harboring E. coli strain V517 was used as a control. 
Results The human strains belonged to four phage types - PTI, PT2, PT4, 
PT8 and the food isolates to five phage types - PTl, PT2, PT8, F'T13a, PT26, 
respectively. The highest number of strains from both groups represented the 
strains ofphage-type PT8 (88.6 and 76.3%, respectively). However, the strains 
were epidemiologically unrelated. Thirty-five human and 38 food strains 
could be dwided into six groups by the analysis ofplasmid profile. The 74.3% 
of human and 65.8% of food isolates harbored a 59-kb plasmid. 
Conclusions: Although the S. enteritidis strains were epidemiologically unre- 
lated, they belonged mostly to phage-type PT8, which has been the most 
frequent in the Slovak Republic since 1995. The plasmid analysis revealed six 
different plasmid profiles. The 59-kb plasmid found in the most of isolates 
corresponds, probably, to the serotype-specific virulence plasmid. 
(p725/ Sensitivity and specificity of the polymerase chain 
reaction (PCR) method for the rapid diagnosis of 
rneningococcal disease 
G. Tzanakaki, M. Tsolia, V. Vlachou, A. Pangah, M. Foustoukou, 
T. Karpathios and J. Kremastinou 
Athens, GR 
Objectives: The aim was to evaluate the sensitivity and speclficity of the 
polymerase cham reaction (PCR) as a diagnostic tool for meningococcal 
meningitls compared to conventional methods. 
Methods: A total of 574 cerebrospinal fluid (CSF) or blood samples collected 
between 1998 and 2000 &om patients with symptoms ofbacterial meningitis 
were examined. Each sample was analyzed by PCR and standard culture 
methods. Patients were classified into seven categories on the basis of their 
clinical findings: (1) culture positive (n =45); (2) culture negative but positive 
for duect smear, antigen detection or stain of skin lesion (n = 27); (3) culture 
negative and antigen detection negative or not done (n = 274); (4) culture 
positive for other bacterial species (n = 29); (5) clinically diagnosed viral 
meningitis with (n = 38)and 6: without antibiotic treatment (n = 105); and (7) 
patients with no symptoms of meningitis (controls) (n = 56). Extraction of 
DNA from whole blood was carried out by IsoQuick extraction kit (ORGA, 
USA). CSF samples were boiled and a modification of the procedure of 
Zambardi et al. was used. PCR was carried out with the following primen: 
IS01 16 specific for N. meflingitidis. The gene amplified was r i d 3  for serogroups 
B, C, Y, W-135. For serogroup A the amplified gene o@ was used. The 
amplification products were 650 bp (NM), 450 bp for serogmup B and 250 bp 
for serogroup C, 400 bp for serogroup A, 120 bp for serogroup Y and 120 bp 
for W-135. 
Results: In category 1, 43 out 45 samples were positive by PCR yielding a 
sensitivity of 96%. In category 2, the overall sensitivity was 63% of the samples 
positive by PCR; 6/6 (100%) samples that were positive by direct smear were 
positive by PCR but only 1/3 (34%) positive by antigen detection were PCR- 
positive. Of the 18 samples in which Gram stain from skin lesions were 
positive, 10 (55.5%) were PCR-positive. For possible meningococcal disease, 
category 3, 170 (62%) specimens were confirmed by PCR. Two of the false 
positive results were obtained with blood samples from patients with septi- 
cemia due to Escherichia coli (category 4). For categories 5, 6, and 7 only 2 of 
199 ofsamples were positive by PCR and the calculated speclficity was 96.5%. 
Conclusions: The sensitivity ofthe PCR method was 96% and the speciftcity 
was 96.7%. We conclude that the PCR methodis an efficient approach in the 
surveillance of meningococcal disease when culture fails to isolate N. menin- 
gitidis. 
Lp7261 Prenatal diagnosis of toxoplasmosis: timing 
influences prediction 
M. C. Angelici, S .  Cherchi and A. Possenti 
Rome, I 
Objective: The validity of prenatal diagnosis for congenital toxoplasmosis 
(CT) by PCR is s t i U  a vexed question. We enrolled 10 clinical centers in Italy 
to get established or  supposed seroconversions to assess the validity ofprenatal 
diagnosis on the basis of our standardized protocol for molecular and 
parasitological diagnosis on amniotic fluid. An accompanying card with all 
serological, therapeutic and ecographic data were requested for each diag- 
nosis. Moreover, a serum sample was demanded to test serology at the 
moment of amniocentesis. 
Methods: In t h s  work, data concerning 660 prenatal diagnoses for CT in 
seroconverted pregnant women are analyzed. Diagnostic procedures have 
included PCR and Toxoplatma culture on amniotic fluid and maternal 
peripheral blood to assess both maternal and fetal infection. In a limited 
number of women, one or more amniocenteses were carried out and for a 
large amount of enrolled patients also IgG avidity test values were available. 
Results: Results analysis showed that prenatal diagnosis carried out by 
molecular and parasitological methods can be indicative of vertical transmis- 
sion when the molecular and parasitological results are correlated with 
time interval among maternal infection, avidity test, beginning of treatment 
and amniocentesis. Moreover, few false negatives were founded in our 
PCR analysis. PCR and cultural results were in agreement each other for 
positivity but positive data were obtained much more by molecular (37%) 
then by parasitological (7.5%) methods. If both tests x e  used for parasite 
detection in following amniocentesis a control therapy effectiveness can be 
achieved. 
Conclusion: Our results suggest the following conclusions: (1) the predxtive 
value for prenatal toxoplasmosis is high if both molecular and parasitological 
approaches are used; (2) positive prenatal tests are more associated to previous 
rather than to recent mother infections, serologically established; and (3) 
molecular and parasitological approaches are very good markers of therapy 
efficacy when two amniocenteses are carried out. Most serious danger could 
be caused by false-negative PCR, because the need for CT diagnosis is 
suggested by a serological maternal situation whch could be too premature to 
check parasites in amniotic fluid. A later fetus infection could not be excluded 
in this situation and the need of specific preventive prolongation treatment 
must be emphasized. 
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m1 Identification by 165 rDNA sequence analyzes of 
Ehrlichia sp. and Anaplasma marginale in Boophilus 
micropus ticks in Tibet, China 
B. Wen 
Beijing, CHN 
Objective: To idenhfy ehrlichial pathogens in Boophilus micropus ticks in 
China. 
Methods: The DNA samples (each sample was prepared from three ticks) of 
Boophilus micropus collected from Tibet and Sichuan of China were 
screened by a nested PCR analysis specific for amplification of 16s rRNA 
genes of tick-borne Ehrlichia spp. The 3’(!/-}-end and 5’{!/-}-end frag- 
ments of 16s rDNA were amplified from the positive samples in nested PCR 
by semi-nested PCRs, respectively, and the DNA fragments were cloned and 
sequenced. 
Results: Sixteen of 43 DNA samples (3744) of B. micropus from Tibet were 
positive in nested PCR analysis, but 27 samples from Sichuan were all 
negative. Two kmds of 16s rDNA sequences were found by sequencing 
the 5‘{!/-}-end kagments (--450-bp) of the positive samples, one sequence 
identical to that of Anplasma marginale, an etiological agent of cattle anaplas- 
mosis, and other most s i d a r  to that of E. chuJeensis, an etiological agent of 
human monocytic ehrlichiosis. The almost complete 16s rDNA sequences 
(1501-bp) of the novel ehrlichial agent was obtained by linking its 5’{!/-]- 
end and 3’{!/~}-end sequences (1440-bp) based on their overlapping 
regions. In 16s rDNA sequence (1400-bp) comparisons with other 
members of the tribe Ehrlichieae and related species, the sequence of 
the novel ehrlichial agent was most similar to that of E. chuJecnsis (Arkansas 
strain, G e d a n k  M73222), but they were different in 19 nucleotides 
(-1.4%). 
Conclusion: Based on 16s rDNA analysis, the novel ehrlichial agent in B. 
micropus in Tibet of China is a new species of genus Ehrlichia, Ehrlichia sp. 
Tibet, that is most closely related to E. chag^ensis. Ehrlichia sp. Tibet is firstly 
identified in the Boophilus rnicroprs ticks and whether it infects human or 
animals is well worth studying in future. 
1 P728 1 Molecular diagnosis of Legionella infections using 
NASBA with ‘real-time’ detection 
I? SilIekens, M. Overdijk, 1. Roosmaien, K. Loens, M. Ieven, l? Haima 
and M. Jacobs 
Boxfel, NL; Antwerp, B 
Objective: Pneumonia caused by Legionella species has a poor prognosis unless 
it is diagnosed early. The objective of this study was the construction of a 
molecular assay for fast and reliable detection of Legionella species in clinical 
respiratory-tract specimens. 
Methods: Oligonucleotide primers and a molecular beacon were derived 
from regions of the 16s ribosomal RNA that were conserved among the 
different Legionella species. For nucleic acid extraction and subsequent RNA 
amplification, reagents h m  the NucliSens@ Basic Kit were used. To monitor 
amplicon formation throughout the amplification process, a molecular 
beacon was added to the reactions. 
Results: Sensitivity of the ‘real-time’ NASBA assay was between 1 and 10 
bacterial cells for most Legionelfa species. In simulated respiratory tract 
specimens, between 1 and 10 colony forming units (ch) of Legionella 
pneumophila could be detected. Specificity of the primers and molecular 
beacon probe was demonstrated with 26 Merent microorganisms. Preli- 
minary data on diagnosis of Legionello infections in clinical specimens (n = 17) 
indicated that positive results obtained by culture could be confirmed with 
this assay. 
Conclusion: The NucliSens Basic Kit Legionella application with ‘real-time’ 
detection revealed a sensitive and specific method for the detection of 
Legionella pneumophila and other Legionella species. 
I P729 1 Improved detection of Legionella pneumophila in 
environmental water samples with a real-time PCR 
hybridization assay 
K. Levi, J. Smedley and K. Towner 
Nottingharn, UK 
Objectives: Legionella pneumophila is the causative agent of Legionnaire’s 
disease in more than 90% ofcases. As culture-based identification of L.peu-  
mophila is a lengthy process (>lo days), DNA amplification techniques have 
been suggested as rapid, sensitive and specific alternatives for monitoring 
possible environmental reservoirs during routine surveillance and suspected 
outbreaks. This smdy evaluated an improved real-time Lightcycler assay for 
the rapid detection of L. pneumophila in environmental water samples. 
Methods: An existing real-time Lightcycler assay based on detection of the 
macrophage infectivity potentiator (mip) gene was modified in an attempt to 
improve the sensitivity. The modified assay was used to test 100 environmental 
water samples received &m a variety of sources for routine testing by culture. 
Also tested were 16 environmental water samples previously found to be 
culture positive for L. pnaumophiia. 
Results. The improved assay had a detection limit of 10 pg (i.e. c. 2 cWassay), 
equivalent to 300 ch/L in the original water sample. When compared with 
conventional culture, the assay failed to detect 10 samples containing L. pneu- 
mophila cell counts helow this detection limit, but successfly detected 
samples with higher cell counts. One additional sample was repeatedly 
positive by the Lightcycler assay but negative by culture. Of the 16 known 
culture-positive samples tested retrospectively, 14 were positive by Light- 
Cycler PCR. The two negative samples were estimated to contain 20 and 40 L 
pneumophila cfu/L by culture, i.e. again below the detection limit ofthe assay, 
although other samples also estimated to contain <50 ch/L were detected 
successfully No PCR inhibitors were detected in the two negative samples. A 
major advantage in comparison with culture was that the Lightcycler assay 
generated results on the same day that a sample was received. 
Conclusion: The Lightcycler hybridization assay provides a promising rapid 
alternative to culture-based identification of L. pneumophila in environmental 
water samples. The assay seems to be most suitable for screening large numbers 
ofsamples during outbreak situations when there is an urgent need to identify 
possible heady contaminated environmental sources of infection. 
rP730) Molecular diagnosis of Chlamydia pneumonia? 
infections by using NASBA with ’real-time’ detection 
€? Sillekens, M. Overdijk, I. Roosmalen, K. Loens, M. Ieven, F! Haima 
and M. Jacobs 
Boxtel, NL; Anhqv, B 
Objective: Chlamydia pneumoniae has been established as an important human 
pathogen causing acute respiratory illnesses such as pneumonia and broncht%. 
Conventional diagnosis on the basis ofserology or by isolation of the organism 
in cell culture is time consuming and laborious. An assay was developed for 
the detection of Cpneumonine in respiratory tract specimens based on 
NASBA amplification and ‘real-time’ detection using a molecular beacon. 
Methods: Oligonucleotide primers and a molecular beacon were derived 
h m  16s ribosomal RNA sequences. For nucleic acid extraction and 
subsequent RNA amplification, reagents from the NucliSens Basic Kit were 
used. Amplicon formation was measured over time by a molecular beacon 
labeled with a fluomgenic reporter molecule. 
Resuftr: The sensitivity of the may was determined at 10 molecutes of 
synthetic RNA in the amplification reaction. Using simulated respiratory 
tract specimens, about 1000 molecules of synthetic RNA revealed a con- 
sistently positive test result. Cultured C.pneumoniae could be detected down 
to 0.01 inclusion forming unit (Ifu). Specificity was demonstrated with 26 
Merent microorganisms, including C. trachomatis and C. psittaci. 
Conclusion: NASBA amplification using genus-specific primers could be 
combined with ‘real-time’ detection by a species-specific molecular beacon to 
reveal a sensitive and specific assay for the detection of C.pneumoniae in 
respiratory tract specimens. 
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[ P731 1 NASBA with 'real-time' detection for the molecular 
diagnosis of Mycop/asm pneumoniae infections 
l? Sillekens, M. Overdijk, 1. Roosmalen, K. Loens, M. Ieven, P. Haima 
and M. Jacobs 
Boxtel, NL; Antwerp, B 
Objective: Mycophma pneumoniae is a well-known causative agent of upper 
and lower respiratory tract infections. Culture-confirmed laboratory diagnosis 
is hmdered by the slow growth kinetics of the organism and serology-based 
diagnosis often is retrospective owing to the requirement of both acute and 
convalescent-phase sera. Aim ofthis study was the construction of a molecular 
diagnostic assay for the detection of M. pneumoniae in clinical respiratory tract 
specimens. 
Methods: Oligonucleotide primers and probes were derived &om the 16s 
ribosomal RNA (rRNA). For nucleic acid extraction and subsequent RNA 
amplification, reagents fiom the NucliSens@ Basic Kit were used. For the 
detection of amplicon formation during the NASBA process, a molecular 
beacon was added to the amplification reactions. 
Results: Sensitivity of the assay was about 100 molecules of synthetic RNA in 
the amplification reaction. Simulated respiratory tract specimens spiked with 
cultured M. pneumoniae revealed a sensitivity of 5-50 color changing units 
(ccu). Specificity of the assay was demonstrated with 26 different micro- 
organisms. Analysis of clinical respiratory tract specimens for the presence of 
Mycoplama pneumoniae confirmed results obtained by culture and was com- 
parable to detection by an in-house PCR assay based on the P1 adhesin gene. 
Conclusion: Sensitive and spec&c detection of M.pneumoniae could be 
achieved by NASBA amplhcation of 16s rRNA combined with 'real-time' 
detection using a molecular beacon. 
Table 1 Resistance rates of E.faecnlis and EJheciurn to the antibioncs tested 
Positive sample (?h) 
1-1 Development of real-time PCR assays for detection 
of U. urealyticum, M. hominis, C. trachomatis, T. vaginalis 
and G. vaginalis 
A. N. Ekunov and G. A. Shipulin 
Moscow, RUS 
Objectives: There are many &agnostic methods for detection of L? urealy- 
ticum, ?: vaginalis, G. vagimalis, C. trachomatis and M .  hominis based on 
PCR. However, there is a little real-time PCR methods for detection of 
these bacteria. The aim of this study was to develop technologies for 
detection of these bacteria by means of real-time PCR; to develop software 
for automatic registration ofreceived results. and to compare the results ofthe 
newly developed method with the results of routinely used PCR assay where 
the amplification products are analyzed on gel electrophoresis. 
Methods: PCR, real-time PCR, gel electrophoresis. 
Results: We developed strategies for detection of U. urealyticum, T vaginalis, 
G. vaginalis, M .  hominis and C. trachomatis D N A  based on the real-time PCR 
technique. SYBR Green I was chosen as fluorescent agent. The real-time 
PCR was performed on iQ iCycler (Bio-Rad). Specificity ofPCR-amplified 
products was confirmed by melting curve analysis and comparison of melting 
temperatures of received products with known melting temperatures of 
specific products. These calculations were produced by special software 
developed in this study. This software allows to eluninate subjectivism in 
analysis of real-time PCR results, powerfully relieves and accelerates under- 
taking the analysis. To avoid false-negative results, we constructed specific 
internal controls for each newly developed assay. These internal controls were 
cloned into modified lambda phages. The length and melting temperature of 
internal control's amplification products significantly differed tiom 
analogous specific products. So, this approach allowed us to Werentiate 
these products. The results of the developed assays were compared to the 
results of the routine PCR, which were developed and used in Central 
Research Institute for Epidemiology (see Table 1). The comparison of the 
results of two methods shows perfect agreement, which indicates that the 
developed assay is a reliable one. 
Number of Red-hme Rouhne Agreement 
samples PCR method PCR method (%) 
U. ureulyticum 3245 48 48 100 
C. trachomatis 2970 7 7 100 
M. hominis 1650 15 15 100 
Z vaginalis 548 0.5 0.5 too 
G. vuginab 1247 34 34 100 
Discussion: This study c o n f i i  that the real-time PCR method is powerful 
approach for scientific and diagnostic application. Absence of gel electro- 
phoresis or hybridization steps totally eliminates risk of false-positive resulu 
owing to the contamination by amplification products. The developed soft- 
ware allows to  simp^ and accelerate analyzing the results. The real-time 
PCR can be used instead of routine PCR which is labor consuming and 
contamination dangerous. 
lp7331 Detection of Chlamydiae trachomatis in cervical 
smear samples with determined HW 
E. Beslagic, J. Gutic, J. MagIajlic, S. Zvizdic and J. Dizdarevic 
Sarajevo, BIH 
Objective: Chlamydia trachornatis causes infertility, ectopyc pregnancy, pelvic 
inflammatory disease/PID and conjunctivitis. Humane Papiloma virus/ 
HPV/is a virus with broad spectrum effects. This particularly refers to 
HPV of high oncogenic potential because of its participation in cervical 
oncogenesis. The authors wanted to determine correlation between cervical 
HPV infection and isolation of Chlamydia trachomatis taken from female 
patients' smear of Werent levels of cervical intraepithelial neoplasia/CIN 
I-III/and ASCUS modifications. 
Methods: Cytological analysis was used for 64 cervical samples - Papanicolau 
method. The samples were presented in accordance with vahd Bethesda 
Classification. The samples were treated by HPV DNA/Digene Hybrid 
Capture 111. 
Results: Out of 64 HPV positive samples, isolated C. trachomatis was found in 
24/37 (5%) samples. Out of 50 HPV-positive group samples with high-degree 
risk/HR/, 18/36%/contained C. trachomatis. Frequency of C. trachomatis was 
registered in ASCUS moddications in 25%, CIN I 22%, CIN I1 23.5% and 
CIN I11 20.2% samples. We found 9% of isolated C. trachomafis in HPV- 
negative control group. 
Conclusion: Research results showed correlation between HPV cervical 
infection and C. trachomatis. The higher the level of cell dediEerentiation/ 
ASCUS CIN I-III/is, the higher number of cervical infections with C. fra- 
chomatis/is. 
/p73QI APTIMA CT and APTlMA G C  discrete and 
confirmatory assays for the deteaion of Chlamydia 
trachomatis and Neisseria gonorrhoeae 
M. Mauricio, S. Spencer-Covill, M. Castdo, J. Light, J. Shaw, L. Ivor, 
M. Bott and R. Johnson 
San Diego, USA 
Objectives: Chlamydia trachomatis (CT) and NeiSseria gonorrhoeae (GC) infec- 
tions are among the most common bacterial sexually transmitted diseases in 
the world. The Gen-Probe APTIMA Combo 2 Assay (AC2) is a commer- 
cially available amplified assay for the simultaneous detection and dserentia- 
tion of CT and GC. Amplified assays like AC2 are extremely sensitive 
compared to commonly used methods such as culture and EIA. Because 
of this sensitivity and the large amount of amplicon these tests generate, some 
laboratories choose to confirm positive results by re-running the test. A better 
approach to validating positive results is to use a test that amplifies a different 
target sequence than originally targeted. 
Methods: The APTIMA CTand APTIMA GC assays target different rRNA 
sequences from those of the AC2 assay. Because of the unique rRNA target 
molecules, APTIMA CT and AF'TIMA GC can be used to check positive 
specimens as well as direct, stand-alone tests for CT  and GC. 
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Results: Analytical sensitivity of APTIMA CT for all 15 serovars was 
determined to be 1 ifu/reaction. Analytical sensitivity of APTIMA G C  with 
20 clinical isolates was determined to be 50 celldassay Analpcal specificity 
was determined for both assays by evaluating 109 bacteria, fungi, yeast and 
viruses; no cross-reactions were detected. A performance q u a c a t i o n  of the 
single APTIMA assays was run on endocervical and male urethral swabs and 
male and female urines with concordant positive and negative results (agree- 
ment of both reference methods) in AC2, LCx (CT, GC), PCR (CT), and 
GC culture. APTIMA CT and APTIMA GC detected 578/588 (98.3%) C T  
and 671 /70S (95.2%) G C  concordant specimens, respectively. These data 
demonstrate that the CT and GC individual assays accurately detect target 
rRNA. The assays also were used to check samples positive only in AC2 and 
negative with the reference tests. These could be false positive samples, 
samples with very low target levels subject to sampling errors, or samples 
positive because AC2 performs better than the reference tests. For C T  and 
GC, respectively, 203/269 and 194/212 samples were positive with the 
APTIMA C T  and/or APTIMA GC assays. 
Conclusions: The data in this study show that the APTIh4A CTand APTIMA 
GC Assays yield accurate detection of C T  and GC and, as such, may have 
applications as both confrmatory and stand-alone diagnostic assays. 
Methods in virology 
I P735 I PCR muftiplex in the diagnosis of pulmonary 
opportunistic pathogens 
M. Screm, P. Lanzafame, A. Bertolissi and E. Pitzus 
Udine, I 
Objectives: the aim of this study is to evaluate the reliability of multiplex PCR 
for a rapid diagnosis of opportunistic pathogens in immunocompromised 
patients. 
Methods: A total of 158 bronchoalveolar fluids were assayed. The patients 
were immunocompromised for AIDS, ernathologic disorders, immunosup- 
pressive therapy or intensive care. The samples were analyzed by optimized 
PCP-MPCR !at (Maxim Biotech Inc.) for the simultaneous detection of 
Chlamydiapneumoniae, Legionella pneumophila Mycoplasma pneumoniae and 
Pneumocystir carinii. One tube PCR was performed. The amplified Gagments 
have a different sue: 871 bp (Cpneumoniae), 700bp (Lpneumophila), 375bp 
(Mpwumoniae) and 300bp (Pcarinir). These Gapents  were easily &tin- 
guishable by electrophoresis in 2% agarose gel. All positive results were 
confirmed by a conventional PCR. The whole assay can be performed in 
a one-day routine. 
Results: Sensitivity of PCP-MPCR for P cntinii seem to be greater than that 
of microscopy: 10 (6.3%) samples were positive by both immunofluorescence 
and PCP-MPCR but one patient submitted to liver transplant had a negative 
microscopy and a positive PCP-MPCR test. One positive assay for L. pneu- 
mophila was detected by PCP-MPCR and the same sample had a positive 
culture. C. pnnrmoniae, a common microorganism of the upper respiratory 
tract in absence of disease, is the most frequent pathogen (13.9%) in our study. 
Only six samples (3.8%) were positive for M .  pneumoniae. 
Conclusions: microbiological diagnosis of opportunistic pathogens in immu- 
nocompromised patients is very difficult. Immunofluorescent microscopy, cell 
culture or conventional cultures which take several days are required. PCP- 
MPCR assay is a more satisfactorydiagnostic tool than traditional methods for 
an accurate, sensitive and rapid detection of the overcalled pathogens. 
lp7361 Comparative evaluation of three methods for 
serological diagnosis in EB-infection 
I. Varzakakos, 0. Zarkotou, I? Hatzivasileiou and E. Papavasileiou 
Athens, GR 
Objectives: To evaluate the following methods: indirect immunofluorescence 
assay, ELISA and Western blot for efficient dtagnosis in acute EB-infection 
and to estimate sensitivity using WE%-assay as the gold standard. 
Methods: During 1-year period (12/99-11/00), 378 serum samples were 
obtained f b m  children up to 14 years old-presented with clinical symptoms 
of acute mononucleosis. All samples were examined so as to detect IgM and 
IgG antibodies to VCA antigen by IFA (Stellar Biosystem) and ELISA (Gull 
Laboratories). WB assay (Blot 3.0 Genelabs Diagnostics) was performed on 
samples which were found positive for IgM antibodies by the other two 
methods. Both IgG and IgM antibodies to specific EBVantigens: VCA (p23). 
EA diffuse (p54), EA @138), EBNA-1 (p72) were determined. Each method 
was carried out according to manufacturer’s instructions. 
Results: A total of 153 samples out of 378 were found positive for IgG 
antibodies by IFA and 130 by ELISA. WB detected 152 positive samples. 
ELISA sensitivity for IgG was 86%. IgM antibodies were positive detected by 
IFA in 40 samples, while ELISA detected 27 positive samples. Examining 
these serums by IgM-WB assay 34 out of40 were positive. Sensitivity in IgM 
detection was 85% for IFA and 82% for ELISA. Furthermore, WE% assay 
enables btinction amongprimary, past infection and reactivation of the virus. 
Thus, according to WB results the infection was primary in 76% of the 
patients, past in 1896, while in 6% of the patients the virus had been 
reactivated. 
Conclusions: Both methods correlated well with WB. Indirect immuno- 
fluorescence assay proved to be slightly prevalent. These results indxate that 
IFA remains reference method for the everyday diagnostid practice. WB 
assay will be useful to resolve questionable cases and improve diagnostic 
potential of EB serology. However, its cost and time-consuming procedure 
doesn’t permit yet its use as routine method. 
I P737 I Novel markers facilitate the diagnosis of Borna 
disease virus infections in psychiatric patients and healthy 
carriers 
L. Bode and H. Ludwig 
Berlin, D 
Objectives: Borna disease virus (BDV)specific circulating immune com- 
plexes (CICs), their antigen part consisting of BDV N/P proteins, are 
detectable in blood plasma. They represent novel tools to monitor productive 
infection in psychiatric patients, and to identify healthy carriers. 
Methods: Novel ELISA tests detect BDV-CICs, antigens (NIP) in plasma, or 
antibodies directed against N and P proteins, in the same blood sample. Their 
specificity is based on two monoclonal antibodies recognizing conserved 
conformational epitopes on either proteins (anti-N; anti-P). 
Results: BDV, an  unique enveloped R N A  virus (Bomaviridae) with a broad 
host spectrum (e.g. horses, sheep, cats, cattle, and man), infects neurons ofthe 
limbic system, but also other cells ofbrain and blood. In animals, episodes of 
behavioral changes are a major pattern of overt disease, resembling recurrent 
mood disorders in humans. Infections persist, are dormant and productive in 
turns, and cause n o  structural damage. This matches with the hypothesis of a 
functional disturbance of the neurotransmitter network by viral components. 
Human infections and their possible association with major effective disorders 
raised world-wide interest, but inconstant findings of serum antibodies, and 
antigens and/or R N A  in leukocytes weakened a linkage. Discrepancies can 
now be explained by CICs, the discovery ofwhich was unexpected due to the 
low multiplicity of infection of BDV. In contrast to low amounts of infectious 
particles, N and P proteins, the major components of the viral core, were 
abundantly produced. Longitudlnal studies of some thousand patients 
revealed that these proteins are released into the blood, followed by antibodies, 
and the formation of CICs. In acute major depression, almost 100% of the 
patients were CIC-positive, indicating a productive infection period, whereas 
previous serology missed the majority. Likewise, the CIC assay could detect 
10-fold higher infection rates in healthy subjects (2C-30%) than 
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previous antibody assays did, suggesting that the majority ofinfections may be 
harmless. 
Conclusions: The discovery of novel infection markers (BDV-CICs) further 
supports an association of BDV infection and major mood disorders. These 
easy-to-use CIC tests are superior to antibody-only and RT-PCR approaches, 
and will considerably improve the identification ofinfected patients, as well as 
fachtate a monitoring of subclinical infections in the normal population. 
lp7381 Evaluation of CMV lgG avidity on sera from 
patients with a primary CMV infection 
E. Vanderstraeten, H. Heremans, S .  Lauwers and A. Naessens 
Brwsels, B 
Objectives: Both primary and recurrent CMV infection during pregnancy 
can lead to congenital infection. Since congenital infection acquired after 
primary maternal CMV infection is more often associated with sequelae it is 
important to Merentiate primary kom recurrent CMV infection. The 
presence of CMV IgM antibodes is not always inhcative of a primary 
infection. Additional tests to differentiate between primary and recurrent 
infection are necessary. In this study, we evaluate the evolution of CMV IgG 
avihty after primary infection. 
Methods: Fifiy-one sera fiom 30 patients, with a CMV seroconversion, and 
27 sera from 27 patients, with a stable serology for at least lyear, were 
analyzed. For each patient with a seroconversion, the time of infection was 
estimated. This estimation was based on the dates of the last negative serology, 
the first positive serum sample and the serological profile following sero- 
conversion. All these sera were analyzed retrospectively with two commercial 
enzyme immunoassays, measuring CMV IgG avidity: BioMCrieux: VIDAS 
CMV IgG AVIDITY and Bouty: BELA CMV IgG AVIDITY. The results 
were interpreted according to the manufacturers’ instructions. The cut-off 
values Merentiating between an infection ofless or more than 3 months were 
an index value of 0.8 for BioMCrieux and a value of 25% for Bouty. 
Results: Avidity above the cut-off value was not found during the first 
12weeks after CMV infection. Most samples obtained between 13 and 
30weeks after infection still show avidity values below the cut-off. 
Most samples from patients with a stable serology show avidity values above 
the cut-off. 
Avidity 
Weeks after 
CMV infection N Index <0.8 Index 20.8 
BioMirieux G12 
13-25 
2G30 
>50 
Control group 
24 100% 
16 100% 
5 100% 
6 17% 
27 4% 
0% 
0% 
0% 
83% 
96% 
Bouty 0-12 
13-25 
26-30 
>50 
Control group 
<25% 
24 92% 
16 81% 
5 40% 
6 0% 
27 0% 
2545% >45% 
8% 0% 
13% 6% 
40% 20% 
33% 67% 
4% %% 
Conclusion: This study demonstrates that avidity above the cut-off values 0.8 
and 25% for BioMCrieux and Bouty, respectively, excludes a recent infection, 
however, avidity values beneath these cut-off values do not necessarily 
indicate a recent infection. 
(p739j Evaluation of the ImmunoCardm STAT ! RSV 
(IC-RSV) for the detection of RSV in pediatric 
nasopharyngeal aspirates 
M. Ieven, H.  Goossens, M. Defoor, M. Duys, 0. Vandenberg and 
D. Van Beers 
Edegem, Brussels, B 
Objective: To evaluate the sensitivity and specificity of the IC-RSVusing the 
immunofluorescence (IF) on the specimens and culture by IF on inoculated 
shell vials as reference methods for the detecaon of RSV m nasopharyngeal 
aspirates (NPA) 
Material and methods: During the 2000-2001 wmter, 59 pehatnc NPA 
collected in each of the Brussels and Antwerp Hosp~tals were mvesagated by 
three techniques: (1) the IC-RSV, a fast and simple immunochromatographc 
test, (2) IF m t h  monoclonal antlbohes on the specunen, and (3) culture by IF 
on inoculated, centrhged shell wals wth Hep-2 cells afler 2 days incubahon 
Results: 
Table 1 
IF on specunen CUlNIe 
+ - + - 
IC-Rsv+ 48 
IC-RSV- 12 
2 37 14 
56 8 59 
Total 60 58 45 73 
se = 80.0% se = 82.2% 
sp = 96.5% sp=80.8% 
Conclusions: The sensitivity of IC-RSV compared with IF on the specimens 
and on shell vials is rather low: 80 and 82.2%, respectively. The specificity of 
IC-RSV is high (96.5%) compared with IF on the specimens but low 
compared with the shell vial assay. Ths,  however, results hpm the well- 
known lower sensitivity of the latter. The ImmunoCard STAT ! RSV test 
cannot replace the IF reference for routine use but we could be helpful in 
special situations such as out of working hours to exclude a possible RSV 
infection, pending the results of the reference test. 
I P740 I Comparison of three commercial methods for the 
characterization of the avidity of cytomegalovirus-specific IgG 
E de Ory and M.-E. Guisasola 
Majadahonda, E 
Objectives: Serological diagnosis of cytomegalovirus (CMV) infections is 
usually done by detection of specific IgM. However, this approach does not 
discriminate primary infections kom reinfections or reactivations. Further- 
more, cross-reactions and polyclonal stimulation of B lymphocytes can lead 
to CMV IgM false positive results. The assays for the characterization of the 
avidity of specific IgG allows the difjlerentiation of primary and secondary 
infections. The aim of the present study is to compare the performance 
characteristics of three avidity assays for CMV-specific IgG. 
Methods: Ninety-six samples were used for the comparison. The samples 
were selected on the basis of showing CMV-specific Igh4 (83 samples), or 
were taken hpm pregnant CMV seropositive women (13 samples). Three 
avidity assays were compared: Enzygnost anti-CMV Avidity (Dade Behring, 
Germany), Vidas CMV IgG Avidity (BioMkrieux, France), and CMV IgG 
avidity EIA Well (Radim, Italy). The method from Dade Behring establish as 
cut off a reduction in the titer after treating the samples with the denaturating 
agent of 40%; in the case of BioMCrieux the cut-off is a reduction of 80%. 
CMV IgM was tested by indirect ELISA (Dade Behring) and by a capture 
ELISA (Medac, Germany); CMV-spec& IgG was measured by indirect 
ELISA (Dade Behring). The results obtained in Enzygnost and BioMCrieux 
were compared to those obtained by Radim, since this method is currently 
used in our laboratory. 
Results: In comparison with the method kom Radm, Enzygnost recognize as 
low avidity samples 18 of24 (sensitivity: 75%), and as high avidity 65/67 
(spechcity: 97%). Vidas recognize as low avidity 24/24 samples (sensitivity: 
100%), but only 23/67 as high avidity (specificity: 34.3%). If a reduction of 
50% is considered as cut offin this method, the figures are 23/24 (sensitivity: 
95.8%) and 61/67 (specificity: 91%), respectively. 
Conclusions: The methods studied are comparable tools for the character- 
ization of the avidity of CMV-spedc IgG. However, the cut off the method 
&om BioMCrieux must be redefined. 
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[ P741 1 Development of a CMV lgG avidity assay for the 
diagnosis of primary cytomegalovirus infection in pregnancy 
London, UK 
R. Devi and I? Rice 
Background and objectives: Primary CMV infection during pregnancy is the 
commonest cause of congenital virus infection, resulting in severe fetal 
damage in 10% of cases. It is fiequently asymptomatic. Unless a CMV-specific 
IgG seroconversion can be demonstrated, hagnosis is often difficult using 
CMV IgM alone as a marker of recent infection since it may persist for many 
months after acute infection. The maturation of CMV-specific IgG affinity 
over time, however, predicts that antibodies of hgh avidity will reflect a past 
infection, with acute infection presenting naive antibodies of low avidity. We 
modtfied an existing CMV IgG assay and used serial samples from patients 
with acute CMV infection where the date of symptom onset was known to 
develop an in-house CMV IgG avidity test. We then compared our current 
CMV IgM testing method with this test in pregnant women attending the 
Fetal Medicine Unit for investigation of maternal illness or fetallneonad 
abnormalities. 
Methods: The standard semiquantitative enzyme immunoassay (EIA) for 
CMV IgM (Eurogenetics) was performed and followed by the I g G  avidity 
EL4 (modified Biokit method). T h s  involved an additional wash procedure 
using an 8 M urea solution to dissociate low avidity IgG antibodies. The avidity 
index (AI) was then calculated by comparing the binding of CMV IgG with 
normal and 8~ urea wash buffers. 
Results: A total of 45 immunocompetent patients with symptoms and 
laboratory markers of acute CMV infection (increased liver enzymes/jaun- 
dice, blood lymphocytosis, malaise, lymphadenopathy) each provided a mean 
of two samples. These serial samples enabled us to estimate the rate of avidity 
development to be 4% (range 2-9%) per week during the primary infection. 
Over a period of 2.5 years a total of 16 women with a d illness and/or fetal 
abnormalities had CMV IgM detected. Of the five women with high level 
CMV IgM, all had low avidity IgG antibodies consistent with current 
infection. Of the 11 who had low to moderate levels of CMV IgM, 5 
(45%) had a high avidity index (AI), 6 (55%) having a low AI. Measurement of 
IgG avimty was found to be superior to the IgM result in defining an mfection 
as acute or chronic. Out of the 13 pregnancies where fetal outcome was 
known, 6 were udec ted ,  2 were terminated and 5 had signs of congenital 
infection. 
Conclusion: The CMV I& avidity index can be used to more accurately 
define the timing of CMV ideCh0n in pregnant women. 
wl Reduced need for HBsAg confirmation of Abbott 
h y m  HBsAg (VZ) results 
R.C Hawkins and T.M S. Barkham 
Stngapore, SGP 
Objectives: To assess If the S/N raho &om the Abbott k y x n  HBsAg (V2) 
assay can rehably predlct the results of confirmatory testmg and thus, reduce 
the number of samples requiring confirmatory testmg. 
Methods: The Axsym assay uses a SIN at-off >2.0 to define reactivity and 
the manufacturer suggests Confirmaton of a l l  repeatedly reactive samples. Our 
present practrce IS to confirm samples wth S/N < 10.0. Over a 8-month 
period, all serum samples submtted for HBsAg testmg with in~tial HBsAg S/ 
N from 1.6 to 10.0 underwent duphcate retestmg after recentrifugation and 
then HBsAg confirmatory testmg using the Abbott Auszyme Mono HBsAg 
confirmatory system on the Abbott Commander system. The ltlltial and 
repeat S/N-dues were noted and compared agamst the final confirmation 
result. Senslhmty, speuficity, posiave and negative predichve vahes for each 
S/N cut-off value were calculated and ROC curves constructed. 
Results: Of 7324 HBsAg requests, 40 samples had S/N 1.6-10.0 of whch 
eight were subsequently confirmed as posihve. The areas under the ROC 
curves were: mihal S/N 0.900 and mean ofrepeat duplicate S/N 0.895. At a 
S/N cut-off of 6.0, semhvity was 50%, spenfiaty IWh, poslbve predlcuve 
value 100%, negahve predichve value 89%, test efficiency 90% 
Conclusions: By performmg confirmatory teshng only on samples wth  S/N 
1 6-6.0, the number of samples requmng confumaaon can be safey reduced 
by 10%. Such an approach can reduce cost and -rove result turnuound 
time. 
Quality of blood drawing 
1 P743 1 Study to validate diversion and an improved donor 
arm disinfection procedure in reducing bacterial 
contamination in blood donation 
C.P. McDonald, A. Roy, P. Mahajan, R.M. Smith, M. Cox, 
S.W. Robbins and S. Hartley 
London, UK 
Introduction: Bacterial contamination of blood products is still the major 
cause of morbidity and mortality. The UK Serious Hazards of Transfusion 
(SHOT) surveillance system reported between 1995 and 2000, 15 incidents 
due to bacterial contamination with 5 associated fatalities. A study was 
therefore, undertaken to validate the effectiveness of diversion and an 
improved donor arm hsisinfection procedure in reducing bacterial contam- 
ination in whole blood donation. 
Diversion is based on the concept that most bacterial contamination of 
blood components is skin derived: removal of the initial 20 mL containing 
these skin contaminants wiIl reduce contamination. 
An improved donor arm disinfection procedure consisting of a two-stage 
process of isopropyl alcohol followed by tincture of iodine has been shown to 
be 10 times more effective than the current procedure ofan isopropyl alcohol 
wipe. 
Methods: The study was performed in two stages, consisting of 1409 blood 
donations in each, one consisting of disinfection using the current procedure 
and the other the new improved technique. 
Donations were collected using bags specifically manufactured for the 
validation of diversion. These bags incorporated two satellite pouches (in each 
of which 20mL of blood was collected) welded to the normal collection 
system. Blood initially flowed into sample bag one (Pl) representing the initial 
20 mL of collection then into a second sampler bag (F’2), which held a sample 
ofthe collection bag ifdiversion was in operation. Blood then flowed into the 
standard collection bag and the donation collected. The contents of the 
sample pouches were cultured anaerobically and aerobically. 
Resub. The intervention of diversion only gave a 52% reduction in con- 
tamination and improved donor arm disinfection only gave a 57% reduction. 
Diversion plus improved donor arm disinfection gave a 71% reduction in 
contamination. 
Conclusion: In conclusion, the study validates diversion and an improved 
donor arm disinfection procedure. Combined these two interventions gave a 
substantial reduction in contamination, that should reduce bacterial transmis- 
sion and result in a safer blood supply. 
Whole blood cytokine response as a measure of 
airborne microbial contaminations 
I. Kindmger, S. Fennrich. J. Banr, B. Zucker, G. Linsel and T. Harmng 
Constance, Karlsnrhe, Berlin, D 
The pathogenic effects of inhaled environmental microorganisms as well as 
their pyrogens (especially endotoxins) for humans is increasingly recognized. 
Various syndromes are described after contact with air-borne microbial 
contaminations via the respiratory tract: Sick-building-syndrome, humidifier 
lung (a form of hypersensitive pneumonitis), ‘monday sickness’, among 
others. 
Air-conditioning and ventilating systems intensify th is  problem, but 
storage of organic garbage in households also represents a considerable source 
of air-borne pollutants. In 1995, we k i b e d  a new method for the detection 
of pyrugenic (fever-indncing) substances. This whole blood assay utilizes the 
natural reaction of the immune system in order to detect a broad spectrum of 
pyrogens (including Gram-positives and hngal spores) very sensitively in the 
relevant species. 
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Injectable drugs are the main area of application in which this test has 
already proven effective and is currently vabdated in a collaborative study in 
collaboration with European Pharmacopoeia. We adapted this whole blood 
system for Werent filter materials, which are used in air-control pump 
systems. We show that it is possible to measure the cytokine response after 
incubating the contaminated filters directly with whole blood. The measure- 
ment was performed with samples &om different surroundings, stables ofpigs, 
sheep and cows and in flats. Air-borne pyrogens up to 3 x lo6 international 
units per square meter (300pg) were found a t  such work places. Micro- 
biological burden with fungal and bacterial colony forming uNts were 
roughly correlated with the whole blood response. With this integral attempt, 
it  might be possible to correlate contaminated air and the resulting reaction of 
the inunune system, indicating therefore, a potential risk for the person 
exposed. 
v] National monitoring of the bacterial contamination 
rate of blood products using the BacTIALERT system 
C.P. McDonald, A. Roy, P. Mahajan, J. Vegoda, J. Colvin, S.W Robbins 
and S. Hartley 
London, UK 
Objective: Bacterial transmission is still the major cause of morbidity and 
mortahg associated with transfusion transmitted infection. The UK Serious 
Hazards of Transfusion surveillance system reported 15 incidents due to 
bacterial contamination, 5 of which were f a d .  Internal reorganisation of the 
National Blood Service (NBS) of England resulted in the establishment of a 
National Bacteriology Laboratory with the remit to provide a centralized 
bacteriological service. The laboratory was given the task to determine the 
bacterial contamination rate on a 'truly' national basis. Prior to the establish- 
ment of the National Bacteriology Laboratory, a collection of blood centers 
nionitored the bacterial contamination rate of blood products, but for the 
majority this was unknown. 
Methods: Time expired red cells and platelet concentrates are sent from the 
10 blood processing sites within the NBS. The BacT/ALERT 3D automated 
culture system was utilized in the study. Aerobic and anaerobic culture was 
performed, 5-1OmL of blood product was inoculated into standard BacT/ 
ALERT culture bottles and incubated for 7days at 37°C. Initial reactive 
samples were confirmed by retesting the indicated units. All isolates obtained 
were identified to genus and species level. 
Results: From April 1999 to October 2001, 5679 platelet concentrates have 
been tested with a 0.5% (1 in 210) confirmed positive rate. Pooled platelet 
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(3766 tested) and apheresis platelet concentrates (1913 tested) gave a con- 
firmed positive rate of0.6% (1 in 171) and 0.3% (1 in 383). respectively. The 
redcell confirmed positive was 0.1% (1 in 1394) firom testing4183 units. Skin 
flora were almost exclusively isolated. 
Conclusion: The bacterial contamination rate was found to be extremely 
high particularly in comparison to viral markers screened for by the blood 
service. Interventions such as an improved donor arm disinfection technique 
and diversion of the initial 20mL of donation h m  the collection bag 
are now planned to be implemented by the NBS to reduce bacterial- 
transfusion transmission. Monitoring will indlcate the effectiveness of these 
interventions. 
1 P746 1 Contaminated blood cultures: is it worthwhile to 
use alcoholic chlorhexidine in skin preparation? 
L. Cahral, F. Antunes, 0. Neto, E Serralheiro, A. Valente, J. Narciso, 
M. Ceia, E Ferreira and A. Vaz 
Lisbon, P 
Introduction: Despite all the new blood culture methods, contamination of 
cultures continue to cause problems with the interpretation of test results. A 
proper skin preparation is one of the most important measures to reduce the 
rate of contamination. 
Objective: To evaluate the impact of changing the bactericidal agent (povi- 
done-iodine to alcoholic chlorhexidine) for skin antisepsis in the contamina- 
tion rate of blood cultures. 
Setting: General Intensive Care Unit (ICU) and General Ward of a private 
Community acute-care Hospital in Lisbon (SAMS) .  
Methods: From November 1997 to March 1998, an aqueous solution of 10% 
povidone-iodine was used for skin preparation before blood culture collec- 
tion. After April 1998 antisepsis with an alcoholic solution of 0.5 chlorhex- 
idine, prepared in the hospital pharmacy, was implemented. 
Results: The contamination rate in UCI and General Wards was, respectively, 
7% (3/41) and 13% (22/167) at our Institution between November 1997 and 
March 1998. The rate ofcontamination decrease was 5% (5/104) in ICU and 
6% (15/232) in General Wards by the end of 1998. In 1999, the rate was 3% 
(6/219) in ICU and 7% (22/334) in General Wards. ICU maintained 3% (6/ 
240) in 2000 and General Wards decrease was 3% (101296). 
Conclusions: The use of alcoholic chlorhexidme indeed contribute for our 
objective: decrease blood cultures' contamination rate. Motivation of the staff 
and feedback are other factors that also contribute to t h  purpose, and may be 
an explanation for the delay of General Ward in achieving the recommended 
contamination rate (2-3%). 
/p747/ Oxapenem XOB (AM-114): in vitro activity alone 
and in combination with amoxycillin or cefaclor against 
community-acquired respiratory tract pathogens 
D. F? Nicolau, I. N. Simpson and C. J. Urch 
Connecticut, USA; Cambridge, UK 
Background Resistance to 8-lactams is a rapidly emerging problem among 
common community-acquired respiratory tract (RT) pathogens. XOB is a 
novel, orally absorbed, oxapenem with both antibacterial and broad-spectrum 
8-lactamase inhibitory properties. The present study reports on the in vitro 
activity of XOB alone and in combination with amoxycilh (AMX) or 
cefaclor (CCL) against isolates of S. pneumoniae, H .  injuenrae and M .  catarrhah 
with characterized resistance phenotypes. 
Methods: MICs of each agent alone and combinations of amoxycjllin or 
cefaclor with XOB, either 2:l ratio or using sub-MIC concentrations of 
XOB, were determined (NCCLS guidelines). Arnoxyc&n/clavulanate 
(AMXICLV) was included as a control. 
Results: MICs for XOB alone and in combination with AMX or CCL are 
summarized here: 
MIC (mg/L) 
s. pne!Aumo"l*c H .  inJwmm M. rntanhalir 
pcn-s Pen-I Pen-K P-la- P-k+ BLNAR &la+ Phenotype 
N 5 6 4 5 3 4 6 
A p ~ r  aLnc 
XOB 1-2 1-2 264 8-16 8-16 ~4 0.12-1 
CCL n.zw.5 0 . 2 ~ 1  264 0.5-1 4-16 4 4 4  1-2 
AMX 50.06 50.06 05-2  0.12-0~5 >64 1-16 4-16 
Azcntr in 2 .  1 combinohon 
CCL+XOB 0.124.25 0.25-1 32->64 1-2 1-2 4-Ih 0.12-025 
AMXf XOB 50.06 50.06 0...2 0.12-0.25 2 4  1-8 _<0.060.25 
AMXtCLV 5 0 0 6  50.06 0.252 0.12-0.25 O.%l 1-16 50.06-0.12 
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Conclusion: XOB possesses s d a r  actiwty to cefaclor against RT pathogens. 
combinahons of Ah4X and XOB are as potent as amoxycillin/cladanate 
against RT pathogens. 
Oxapenems: unexpected synergistic activity with 
other p-lactams against €nterococcus spp. 
C. J. Jamieson, €? A. Lamhert, D. F. J. Brown, R. Hakenbeck, C. J. Urch 
and 1. N. Simpson 
Birmingham, Cambridge, UK; Kaiserlautern, D 
Background: Enterococci are responsible for an increasing number of noso- 
comial infections. Isolates are generally 8-lactamase negative hut resistant to 
cephalosporins. Oxapenems are broad-spectrum fi-lactamase inhibitoe, 
which exhibit little antibacterial activity except against S. aureus and common 
respiratory tract pathogens. We report an unexpected synergy between 
oxapenems and other 8-lactams against Enterococcus spp. 
Methods: MICs and bactericidal activity of agents alone and in combination, 
including checkerboard studies, with oxapenems against vancomycin sensitive 
(Van-S) and resistant (Van-R) Enterorocmq spp. were determined to NCCLS 
guidelines. Affinity for penicillin binding proteins (PBPs) of E.faecalis SFZ 
was determined in a competition assay with 3H-propionylampicillin. 
Results: Oxapenems AM-112 and AM-1 13 possessed variable activity against 
Enterococcus spp. (MICs 8 to >64 and 2 to >64mg/L, respectively), but at 1:l 
ratio or tixed 4 rng/L, exhibited synergy (>4-fold reduction in MIC of both 
components) in combination with ceftazidime. Their C1 prime stereo- 
isomers, AM-I 14 and AM-I 15 and clavulanic acid were inactive. AM-1 12 
ehbi ted  synergy or additivity in combination with s i x  other cephalosporins 
tested, includmg a 16-fold reduction in ceftazidime MIC against an E.faecalis 
Van-R (vanB) isolate. Synergy was more pronounced in viable count studies 
against Van-S and Van-R isolates. Little evidence of synergy was noted 
between AM-1 12 and imipenem or ampicillin. AM-I 12 exhibited sigmficant 
binding to all enterococcal PBPs at concentrations of 0.095-2.6mg/L but 
required higher concentrations to totally idubit PBP3. 
Conclusion: Some oxapenems show unexpected synergistic activity with 
cephalosporins against enterococci. The synergistic effect may be attributable 
to complementation at the PBP level. 
)p749] Comparison of in vitro oxidative action of Cu(1l)- 
aminoglycosides complexes with their bactericidal efficacy 
M. Jezowska-Bojczuk, W. Szczepanik, E. Dworniczek and M. Fleischer 
Wrociaw, PL 
Objectives: Aminoglycoside antibiotics are potent copper(I1) ions 
chelators. They form stable complexes in physiological conditions and 
the resulting species are capable of hydrogen peroxide conversion to 
hydroxyl radicals. These complexes were screened for their antibacterial 
activity. 
Methods: Nucleic base oxidation by Cu(1I)-aminoglycosides was studied by 
HPLC assay. RNA and DNA damage was followed by polyacrylamide and 
agarose gel electrophoresis. Bactericidal action of kanamycin A and B, 
amikacin and sisomicin complexed with copper(I1) ions was tested in 
timekill assay, against bacterial strains of Escherichia coli (PCM 2427), 
Staphylococcus aureus (PCM 2054) and Pseudomonac aeruginosa (PCM 2058). 
Results: The process of reactive oxygen species generation is responsible for 
nucleic base oxidation and plasmid DNA nicking, linearization and 
fiuther degradation. Cu(I1) cornpIexes of aminoglycosides are also proved 
to cause highly specific cleavages in the anticodon loop of tRNA Phe. These 
complexes, III our stud~es, &d not mcrease the bacteriadal achon of anh- 
biohcs 
Conclusions: A dscovery of a very high cadyhc achwty of Cu(I1) complexes 
of armkacm, kanamyun A and B, as well as sisomcm in the IeaChOn of 
2'-deoxyguanosme hydroxylahon and nucleic acids cleavage were of pam- 
cdar  Importance. Oxygen achvahon by these complexes opens up new 
perspechves for their apphcahon. It may ConshNPe the intracellular achwty of 
these drugs, a6ecnng therapeuhc and toxtc properties Further stuudtes are 
needed to eshmate mcrobiologd efficacy and cluucal sipficance of the 
complexes tested 
In vitro actlvlty of the oxazolidinone AZD2563 
against vancomycin-resistant enterococci determined by 
t imdi l l  methods 
G. Ehopoulos, C. Wennenten, C Thauwn-Ehopoulos and 
R. Moellering 
Boston, USA 
Objectives: We have prewously shown that the new oxazohdmone, 
AZD2563, dubits growth of a broad range of enrerococcal mlates at 
concentrahons less than or equal to 2mg/L. In general, AZD2563 was 
two-fold more achve than hezohd (L,ZD). In the present study, we exammed 
the potential m ntro bactericidal achwhes of the two oxazohdinones apns t  
vancomyci-resistant enterococci (VRE) usmg nme-lull methods. 
Methods: Bactencidal aChvlheS of AZD2563 and LZD were determmed m 
20mL volumes of Mueller-Hinton I1 broth against 10 strains of VRE: 
five Enferococn*Ffaecuhs (four vanB, one vanA) and five E.faerium (four vanA, 
one vanB). For each isolate, the antnmcrobiak were e m n e d  at 2 and 4~ 
the MIC of each compound. Stamng mocula were appmximately 
5 x lo6 cfu/mL. Flasks were sampled at 4, 24 and 48 h of incubahon at 
35 "C, samples were senally chluted in sahne and spotted m duphcate onto 
blood agar plates for colony counnng. 
Results: At concentrahons represennng 2 and 4 X  the MICs determined 
prmously by standard broth nIICroddUhOn methods, both AZD2563 and 
LZD inhbited the growth of VRE for up to 48 h of incubahon at 35 "C. 
Neither agent demonstrated bactericidal achvlty (i.e. %log 10 reduchon in 
cfu/mL) apns t  any strain The mean changes in log 10 &/mL rehhve to the 
moculum at the gwen mdhpfe of MIC are shown m table. 
Sample at 24 h Sample at 48 h 
Agent Mean Range Mean Range 
AZD2563 2 XMIC -0.05 fo.27 to -0.58 fO.11 f1.22 to -0.73 
AZD2563 4 X MIC -0.25 fO.O1 to -0.84 -0.32 +0.19 to -1.15 
LZD 2 x MIC -0.17 +0.20 to -1 26 -0.28 i-0.31 to -1.80 
LZD 4 X MIC -0.34 +0.05 to -1.21 -0.71 -0.08 CO -1.94 
Condusions: This study contirmed the bacteriostatic effect of AZD2563 
against VRE. Neither AZD2563 nor LZD demonstrated bactericidal activity 
over a 48-h period of incubation. 
I P751 I In vitro activity of AZD2563 in combination with 
various antibacterial agents 
J. M. Greenhalgh, A. Wookey, M. Eastwood and C. Sefton 
Macclesfield, UK 
Objectives: AZD2563 is a new oxazolidinone, with targeted activity against 
Gram-positive bacteria including multiresistant strains. Combinations of 
antibiotics may be used to enhance antibacterial activity. Combinations 
known to act synergistically may also be employed to enhance the anti- 
bacterial potency against known pathogens. It is therefore, important to test 
the synergistic potential of any new agent and idennfy any antagonistic 
interactions, which may jeopardize treatment. 
Methods: The in vitro activity ofAZD2563 alone and in combination with 
up to 19 antibiotics representing all major classes, including /?-lactams 
(including meropenem), glycopeptides, aminoglycosides, macrokdes 
and quinolones, was evaluated against multiple strains of staphylococci, 
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pneumococci and enterococci. The strains included multiresistant Stuphylo- 
c o m s  aureus, vancomycin-resistant enterococci and penicdlin-resistant 
S.pneumoniae. By using the checkerboard broth dilution method, drug 
interactions were determined and expressed as fractional inhibitory concen- 
trations (FIC) indices. 
Results: FIC indices in the range 20.5 to 5 4  denoting indiflerence/additive, 
were recorded for AZD2563 in combination with every antibiotic tested, 
against all 21 strains of S.  pneumoniae, including 9 penicillin-resistant strains. 
Ths result was also obtained against 10 strains of S. epidnmidis. AZD2563 
combmations also demonstrated inditTerence against 23/24 strains of S.  aureus 
and 19/23 strains of enterococci. Synergism (FIC 5 0.5) was seen in five 
instances with AZD2563 in combination with clarithromycin, against 1/24 of 
S.  aureus, 3/13 Enterococouusjaecalis and 1/10 E.faecium strains. One example 
of synergism was recorded against 1/13 strains of E.faecalis when AZD2563 
was combined with meropenem. 
Conclusion: These results demonstrate that AZD2563, combined with 
various antibacterial agents, produces interactions that are primarily indif- 
feredadditive. No antagonistic responses were recorded against any of the 
strains tested. 
(p7521 Activity of AZD2563. a new oxazolidinone, against 
worldwide Gram-positive isolates 
P. Turner 
Macclesfield, UK 
6equency with which mutants resistant to novel oxazolidinone AZD2563 
could be derived in vitro h m  clinical isolates of major nosocomial Gram- 
positive pathogens. 
Methods: Five clinical isolates each of Enterococmfaecalis, E.fuecium, Staphy- 
locoas aureus and coagulase-negative staphylococci (CNS) were studied. For 
each isolate, 10' cfu were plated onto Mueller-Hinton agar plates containing 
two-fold increasing concentrations ofAZD2563. These plates were examined 
for the appearance of colonies daily for 4 days, which were subcultured on 
drug-6ee MH agar. In parallel experiments, log& of each isolate were 
inoculated into MH broth containing 0 . 5 ~  MIC AZD2563. After overnight 
incubation, a sample of each turbid broth was subcultured in fiesh broth 
containing a two-fold increased concentration of antibiotic. This was repeated 
daily, with further two-fold increases in AZD2563 concentration, until the 
broths failed to support visible bacterial growth. Growth &om the highest 
concentration to show turbidity was then subcultured on drug-fiee MH agar. 
The identification of aI1 suspected mutant colonies was checked, pulsed-field 
gel electrophoresis was used to confirm that mutants were derived h m  the 
parent strains, and MICs of AZD2563 and linezolid were determined. 
Results: No mutants resistant to AZD2563 were generated from any species in 
the broth enrichment experiments. The plate selection protocol failed to 
generate mutants &om E.faedurn, S.  aureus, or CNS. However, mutants were 
obtained hPm two E.faecalk strains,  with MICs (AZD2563 MIC, 8 mg/L; 
linezolid MIC 4 mg/L) four-fold higher than those for the parent. 
Conclusion: Mutants with raised MICs of oxazolidinones were selected fiom 
occasional isolates of E.&ecalk, but at fiequencies of <lo-% Resistance was 
not selected in isolates of E.fuecium or staphylococci. 
Objectives: The increasing number of drug-resistant Gram-positive orgar- 
isms worldwide is well known and is severely limiting treatment options. Ths  /p754/ AZD2563, a new oxaolidinone: bactericidal 
poster exammes the achvlty of AZD2563, a new oxazohdmone, awnst 
worldwde Gram-positive isolates 
Methods: Bacterial isolates were obtamed &om worldmde sources. In vltro 
synergy studies wiyl gentamiin and 
vancomycin against and stre~tococci 
susceptibility against AZD2563 and comparators including linezolid, quinu- 
pristin/dalfopristin, erythromycin, vancomycin and levofloxacin was deter- 
mined according to NCCLS criteria. 
R. Jones, T. AndeKgg, L. Deshpande and D, Biedenbach 
North 
Results A total-of 5643 Gram-positive isolates were examined. AU isolates 
were inhibited by AZD2563 at <4mg/L and, all except two penicillin- 
resistant Streptococcus pneumoniae, were idubited by linezolid at the same 
concentration. However, at <I mg/L, AZD2563 ihbi ted  82% of all isolates 
whereas linezolid only idubited 57% of isolates. Against S.pneumoniae 
(n = 1337 isolates) 41% were penicillin-resistant and MIC9* for AZD2563 
and linezolid were 1 and 2 mg/L, respectively. This improved in vitro potency 
of AZD2563 against linezolid was also seen against Enterocoms faecium 
(n = 626 isolates; MICgo 2 versus 4 mg/L, AZD2563 versus linezolid, respec- 
tively), while similar activity was demonstrated against E.faecalis (H = 724 
isolates; MIC9" 2mg/L for both compounds). The isolates tested also 
included methicillin-susceptible (MS) Stupbylococcus aureus, methicillin-resis- 
tant (MR) S. aureus, MS S. epidemidis, and MR S. epidermidis (see table). 
AZD2563 Linezolid 
MS S. aureus (n = 523) 1 2 2 2 
MR S. oureuj (n  = 591) 1 1 2 2 
MS S. qidermidis (n = 115) 0.5 1 1 1 
MR S. epidermidis (n= 174) 0.5 2 1 2 
Conclusion: AZD2563 is a promising new oxazolidinone which in many 
instances shows a 1-2 ddution improvement over linezolid. 
Background: Emerging resistances among Gram-positive organisms has 
limited treatment options and stimulated development of new antimicrobial 
classes such as oxazolidinones. This report summarizes comparative cidal 
activity and synergy studies of AZD2563 and linezolid (LZD) using non- 
pneumococcal streptococci and staphylococci. 
Methods: Kill-curves were determined for AZD2563 at concentrations two-, 
four-, and eight-fold the measured MIC. Drug interactions (synergy) were 
evaluated also by kill-curve techniques using AZD2563 ( 4 ~  MIC) combined 
with subinhibitory concentrations of either gentamicin (MIC/4) or vanco- 
mycin (MIC14). Tested organisms were: S. a u m  (one mehcillin-susceptible 
[MS], two methicilltn-resistant [MR]), CONS (one MS, one MR), viridans 
gr. (three; penicillin-susceptible, -intermediate, -mistant) and &hemolytic 
streptococci (two; gr. A and G; macrolide-susceptible and -resistant). 
Results: Consistent patterns of cidal activity was observed for both organism 
groups and the two oxazolidmones (LZD by earlier experiments): (1) static 
action; and (2) 30% of strains showing a modest concentration-dependent 
inhibition. AZD2563 plus vancomycin combinations were indifferent and 
remained static versus both genus groups. Also static action and indifferent 
interactions were noted for AZD2563 plus gentamicin versus the five 
staphylococci tested. In contrast, all streptococci were rapidly killed 
(>31og10cfu killing; cidal action) by AZD2563 plus gentamicin. No 
antagonism was observed and AZD2563 findings were the same as prior 
experience for LZD. 
Conclusions: AZD2563, a long-acting oxazolidinone with once-daily dosing, 
was observed to be predominantly static in action, and generally was 
inwerent when combined with an aminoglycoside or glycopeptide. Cidal 
effects were only noted for streptococci when AZD2563 was combined with 
gentamicin. AZD2563 appears to possess oxazolidinone class characteristics 
(like LZD) and PK/PD features favorable to continued development. 
/p7531 LOW in vitro selection frequencies of enterococcal 
and staphylococcal mutants resistant to novel oxazolidinone 
AZD2563 
M. Stockdale, L. Tysall, N. Woodford, A. Johnson and D. Livermore 
London, UK Birmingham, UK 
Objectives: Oxazolidinones are a novel class of antibacterial agents active 
against most Gram-positive genera. This study aimed to determine the 
/p755) Concentrations of gemifloxacin in potential sites of 
respiratory Infection in patients following once-daily 320 mg 
dosing for 4days prior to diagnostic bronchoscopy 
J. Andrew, 0. Khair, D. Honeybourne, G. Jevons and R. Wise 
Objech'ves: Gemifloxacin (GEM) is an advanced-generation, enhanced- 
affinity fluoroquinolone with excellent activity against Gram-positive cocci, 
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in particular Streptocowpneumoniae. It has been shown to have higher a f h i t y  
than other quinolones for topoisomerase W, including isolates displaying 
resistant mutations. The aim of this study was to measure concentrations of 
GEM in respiratory samples following multiple once-daily dosing of 320 mg 
in patients undergoing elective fiber-optic bronchoscopy. 
Methods: Twelve patients were enrolled into the study; however, data for two 
patients are not included in the analysis 2s one was shown to have an active 
lung infection and the other became distressed and the bronchoscopy 
procedure had to be halted. Samples were collected by standard lavage and 
biopsy procedures. A validated microbiological assay was used to measure 
concentrations of GEM in plasma, epithelial lining fluid (ELF), alveolar 
macrophages (AMs) and bronchial mucosa (BM). 
Results: Data for the 10 evaluable patients are shown in the tahle below. 
003 2.0 1.72 2.50 1 50 60.4 35.1 1.30 0.8 
007 2 1 1.20 0.62 0.50 NDL - 1.M) 1.3 
012 3.0 0.37 NDL - 34.2 92.4 NS - 
010 3 3  1.40 0.90 0.60 57.5 41.1 1.50 1 . 1  
009 3.9 0.70 0.W 1.30 46.0 65.4 1.30 1.9 
004 4.2 0.80 1.00 1.30 24.0 30.0 1.30 1.6 
002 4 8  0.83 0.71 0.86 10.4 12.5 1.47 1.8 
005 1 1 4  0.50 0.20 0.40 NDL - NDL - 
011 124 0.38 0.20 0.50 77.9 205.0 NDL - 
006 128 0.70 0.50 0.70 29.7 42.4 0.80 1.1 
S:P, s1te:plasma; NDL, no detectable level; NS, no sample. 
Conclusion: Measurable concentrations of GEM in ELF, AMs and 
BM exceeded the GEM M I C L ~ I  for the common respiratory patho- 
gens s. pneumoniae (0.06 mg/L), Haemqhilus intuenzae (0.008 mg/L) and 
MoraxeNa catanhalk (O.O15mg/L) in most samples for a 12-h period after 
dosing. 
Activity of ABT 773 against Staphylococcus 
epidemidis biafilms on plastic bimterials 
S. Ballesta, A. Pascual, L. Martinez-Martinez. I. Garcia and E. J. Perea 
Seville, E 
Objectives: Bacterial b i o f h  are commonly resistant to antirmcrobial agents. 
The III vitm acnvlty of a new ketoltde, A3T 773, against S. epidermidif biofilms 
on dconized latex catheters was evaluated. The effect of this agent on 
S. epidermidk adherence to thxi biomaterial was also assessed. 
Material and methods. Two S. epidemridk strains (one slime producer and one 
non slime producer) were used. Bacterial b i o h  were prepared by incubat- 
ing 1-cm length catheter segments and bacteria (IO5&/ml) in Mueller- 
Hinton broth (MHB) for 24 h at 35 "C. Catheter containing the bacterial 
biofilms were incubated in MHB for 24 h containing different concentrations 
of ABT 773 ( l x  MIC, 4x  MIC and 8x MIC). At this m e ,  catheter 
segments were washed and sonicated to remove adherent bacterm Viable 
bacteria were counted by a colony counting method. In other series of 
experiments, the effect of subMIC of ABT 773 on the adherence of 
S. epidermidis to plastic biomaterials was evaluated. For these assays, either 
catheter segments or bacteria were preincubated in the presence of 1 /4 and 1 / 
8 MIC of AET 773. Afterwards, bactenal adherence was performed as 
described above. 
Results: ABT 773 at 1 x MIC, 4x MIC and 8 x MIC significantly decreased 
the bacterial viability of 24 h-biofilms (2.5 f 0.6 x lo3, 2.5 * 0.3 x lo3 and 
1.5 zk 0.5 x 1 O3 cfU/cm*, respectively, compated to conmk mthout antimi- 
crobial agent: 6.7 +c 1.9 X lo3 cWcm2) for the slime producing strain. Pre- 
incubahon of slime producing S.epiderwridis with subMIC of ABT 773 
significantly decreased bacterial adherence to the catheter (281 f 117 &I/ 
cm2 for 1/4 of MIC, 316 f 141 cfu/cm2 for 1/8 of MIC and 493 f 123 c h /  
cm2 for control). These effects were not observed with the slime non- 
produung strain. 
Conclusions: The new ketolide, ABT 773, showed in vim activity against a 
S. epidermidis stram (slime producer) biofilm. This agent also inhibited the 
adherence of this strain to a sihconized latex catheter. 
I P756 I In vitro activity of gemifloxacin against 
rnultiresistant and invasive clinical isolates of Streptococcus 
pneumoniae from diverse UK hospitals 
A. Johnson, M. Warner and D. Livermore 
London, UK 
Objectives: Gemifloxacin is an advanced-generation, enhanced-afKnity qui- 
nolone with potent in vitro anhpnelunococcd activity. We evaluated its 
comparative in vitro activity against 1082 recent clinical isolates of Streptacoaids 
pneumoniae &om 167 geographically diverse UK hospitals, comprising 201 
isolates referred primarily for confiimation of resistance to first-line ther- 
apeutic agents and 881 isolates obtained during continuous national surveil- 
lance of invasive pneumococcal infections. 
Methods: MICs were determined in air on Diagnostic Sensitivity Test agar 
supplemented with 5% lysed horse blood. 
Results: Among referred isolates, the prevalence of resistance to penicillin, 
erythromycin and tetracycline was 87.1% (42.3% intermediate and 44.8% 
rully resistant), 48.8 and 40.8%. respectively. The corresponding prevalences 
among surveillance isolates were 5.1% (3.4% intermediate and 1.7% fully 
resistant), 14.4 and 5.8%, respectively. Seventy (34.8%) ofthe referred isolates 
and 12 (0.2%) of the surveillance isolates were resistant to penicillin, ery- 
thromycin and tetracycline. Modal MICs of gemifloxacin, moxifloxacin and 
ciprofloxacin were 0.06, 0.25 and 2mg/L, respectively, for the referred 
isolates and 0.06,0.25 and 4 mg/L for the surveillance isolates; corresponding 
MICIm1 were 0.125, 0.5 and 4mg/L for both groups of isolates. Apart h m  
one referred isolate with a gemifloxacin MIC of 1 mg/L, the MICs ofthe drug 
were ~O.OlS-O.Umg/L. 
Conclusions: Gemifloxacin was the most active quinolone tested and gen- 
erally retained full activity against mulhresistant isolates. 
I P758 I In vitro activity of linezolid against MRSA clinical 
isolates using E-test strip method 
M. Cuervo, M. Lecuona, T. Delgado, M.-J. Ramos, M. A. Miguel, 
I. Montesinos and A. Sierra 
La hguna, E 
Obi&=: The aim of t h l s  study was to investigare the in v im activity of 
linezolid against methi&-resistant Sfuphylocprnrs awws (MRSA) &om 
patients sutkring community or nosocomial infections, as an alternative 
therapy in an 660-bed temary hospital where there is a wide spread use of 
vancomycin for treating this kind of infections. 
Methods: Between April 2000 and September 2001, we isolated consecu- 
tively a total of 125 clinical strains of MRSA in our laboratory, from an equal 
number of patients. Idenhfication and susceptibility testing to other anti- 
biotics than linemlid was performed by the VITEK I1 (bioMSrieux) auto- 
matized system. Methicillin resistance was proved by standard oxacilin disk- 
a s i o n  test and gene mer-A detection. Linezolid activity was performed by 
E-test strip method. 
Resulk A total of 38.4% of the strains were isolated from wound infections, 
33.6% fium tracheal aspirates and sputum, 11.2% &om blood, 11.2% &om 
urine and 5.6% h m  other locations. These strains were found most &e- 
quently in ICU (24%) and medical wards (52.8%). 8% of the strains were 
sensible to clindamycin, 10.4% sensible to erythromycin, 4% sensible to 
tobramycin, 84% sensible to tetracyclin and 1OG% were sensible to trimetho- 
prim sulfametoxazole, teicoplanin and vancomycin. Linezolid showed MIC 
ranged between 0.25 and 1.5mg/L (CMISO= 1, CMIw= 1). 
Conclusion: Based on our in vitro data linezolid appears to be very active 
against methicillin-resistant S. auras and can be a viable alternative to 
vancomycin in treatment of th is  kind of patients. 
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vl Superiority of linezolid over ceftriaxone/ 
cefpodoxime for the treatment of hospitalized patients with 
pneumonia: analysis using a severity of illness system 
J. B. BNS, V. H. Lee and S. K. Cammarata 
Porrage, USA 
Objectives: A retrospective analysis was conducted using data from a phase 111, 
double-blind, multinational mal in patients hospitalized with community- 
acquired pneumonia (CAP), comparing IV/oral linezolid (LZD) 
600mgq12 h (N=381), versus a regimen of IV cefbiaxone 1 gq12 h fol- 
lowed by oral ce+odoxime 200mgql2h (N=366). The purpose of this 
analysis was to further explore the prospective observation that linezolid was 
significantly more effective in the intent-to-treat (ITT) population (83% cure 
rate for LZD vs. 77% for the comparator group, P= 0,040, 95% confidence 
interval 0.3, 12.8). The most frequently isolated baseline pathogen was 
Streptococcus pneumoniae. 
Methods: Severity ofillness was determined by the method of Fine et al. [l], 
using age, comorbid illnesses, selected physical and laboratory examination 
results, and the presence of concurrent bacteremia, multilobar pneumonia or 
pleural effusion. Distribution of baseline severity was similar in both groups. 
Step-wise logistic regression analysis confirmed a si&icantly higher cure rate 
in patients treated with linezolid (83.0% vs. 76.4%, P=O.O25, odds ratio 
1.580). 
Results: Failure rates were si&icantly higher regardless of treatment in 
patients who had elevated BUN or glucose levels, decreased hematocrit levels, 
or pleural effusion. LZD had si&icantly higher cure rates in subgroup 
analyzes for diabetes (83% vs. 60%, P= 0.040); cardiac comorbidlties (90% vs. 
62%. P=0.009); elevated W3C (87% vs. 78%, P=0.029), pleural e&sion 
(86% vs. 49%. P =  0.001); and bacteremia (91% vs. 59%. P =  0.004). LZD also 
had a signhcantly higher cure rate (82% vs. 71%, P =  0.016) in patients with a 
Fine score higher than the medlan (280). There were no variables in this 
model that showed a significantly better outcome for cefiriaxone/cefpodox- 
ime compared to LZD. 
Conclusions: These data support the efficacy of LZD for the treatment of 
patients with CAP, and show that LZD has a sigruf!cantly higher cure rate than 
the cephalosporin comparators for the treatment of patients hospitalized with 
pneumonia, including patients with diabetes, cardiac conditions, pleural 
effusions, and bacterenlia. 
Reference 
[l] Fine MJ, Auble TE. Yealy DM, ti a1.A predicaon rule to identify low-risk patients with 
commumry-acquired pneumonia. N Eiigl J Mid 1997: 336(4) 24S50. 
I P760 I Linezolid shows efficacy in eradication of nasal 
MRSA carriage status 
J. de Otero, L. Ferrer, S. Elia, C. Miarons, M. Sandiumenge, M. Puig, 
J. Masip and F. Ferrer-Ruscalleda 
Barcelona, E 
Carriage with methicillin-resistant Staphylococnrs aweurr (MRSA) is a prevalent 
and serious problem that has been shown to precede infection. Eradication of 
MRSA carriage is of interest because it may reduce MRSA infection rate. 
Mupirocin is only moderately effective in the eradication so new strategies are 
needed in this setting. Linezolid is a new oxazolidinone with enhanced 
activity against Gram-positive cocci, including MRSA. 
Objectives: To analyze the effect of linezolid compared to glycopeptides in 
nasal MRSA carriage in term of eradication. 
Methods: We performed a retrospective analysis of MRSA nasal carriers with 
demonstrated infection of any location that were admitted to our hospital 
during a period of 3years (199F2001). All patients received combined 
treatment with intranasal mupirocin at standard doses plus either a course 
of intravenous glycopeptide (vancomicin or teicoplanin, standard doses) or 
linezolid (intravenous or oral) at a dose of 600 mg/12 h, for at least 7 days. 
Nasal swab cultures were performed at 1, 2 and 3weeh after mupirocin 
treatment and lmonth after finishing systemic treatment. Patients with 
positive swab controE were considered persistent carriers. 
Results: Of the 55 patients nasal MRSA carrien admitted for MRSA 
infection 29 were not included 18 died prematurely and 11 were lost during 
the follow-up. Twenty-six patients were studied, median age was 79.5~- 
(57-93years), 10 (38.5%) were female, and 84.5% bad at least two underlymg 
diseases (mainly heart disease, COPD or vasculopathy). Sixty-one percent 
presented soft-tissue infection, 15.4% surgical wound infection, 7.7% sepsis, 
7.7% respiratory tract infection, and 7.7% other sites of infection. Seven 
patients received linezolid that was well tolerated. Adverse events with this 
drug included one case of thrombocytopenia, one constipation and one 
muguet. In no case was discontinuation of linezolid dosing required. All 
patients receiving linezolid responded clinically well to treatment. Linezolid 
treatment showed efficacy in eradication of MRSA nasal carriage (only 117 
were persistent carriers with linezolid vs. 12/19 with glycopeptide treatment; 
P=O.O36, X2-test). 
Conclusion: Linezolid showed excellent activity both in terms ofresolution of 
infections and in eradication of MRSA nasal carriage. Linezolid was well 
tolerated with a scarce number of advene events. 
Ip7611 Effect of linezolid on the bactericidal activity of 
human polymorphonuclear leukocytes (PMNs) 
I. Garcia, A. Pascual, S. Ballesta and E. J. Perea 
Seville, E 
Objectives: To evaluate the effect of a new oxazolidinone, linezolid, on the 
phagocytic and bactericidal functions of human PMN. The intracellular 
activity of linezolid against S t a p l ? y h ~ ~ t ~  QURW was also assessed. 
Materials and methods Superoxide and peroxide hydrogen radicals produc- 
tion by PMA-stimulated PMN was measured using a modifcation of the 
ferrocytochrome c reduction assay and a modification of the phenol red 
method, respectively. The phagocytic activity of human PMN was deter- 
mined by a radiometric assay. Radiolabeled opsonized bacteria and human 
PMN were incubated for 12 min at a ratio bacteria/PMN: 10/1. The effect of 
PMN exposed to Merent concentrations oflinezolid (2,lO and 20mg/L) on 
the phagocytosis of opsonized bacteria (2 S.oureus strains: 1 methicillin- 
susceptible/ 1 methtcillin-resistant; 2 Enterocoawrfaecalis strains: 1 vancomycin- 
susceptible/l vancomycin-resistant) was evaluated. The phagocytosis of 
bacteria preincubated (18h; 37OC) with 1/4 MIC of linezolid was also 
evaluated. The intracellular activity of linezolid (extracellular concentrations: 
2, 10 and 20mg/L) against S. aureus in human PMN was assessed in a 3-h 
assay. 
Results: Linezolid did not atfect either superoxide and hydrogen peroxide 
production by human PI”. This antimicrobial agent did not modify the 
phagocytosis of opsonized bacteria by human PI”. Neither the exposure of 
S. aurew strains, nor the exposure of E.faedis strains to 1/4 h4IC oflinezolid 
sigtllficantly afTected the phagocytosis of these bacteria by human PMN. At 
the extracellular concentrations evaluated, linezolid did not affect the bacter- 
icidal activity of human PMN against intracellular S. aureurr. 
Conclusions: Linezolid (subMIC and therapeutical) did not affect the pha- 
gocytic and bactericidal functions of human PMN. 
lp762/ Treatment of bone and prosthetic joint infections 
with linezolid 
E. Tagliaferri, A. Lucarini, A. Leonildi, E Menichetti and C. Tascini 
RSQ, 
Background Methicilhn-resistant S. aurerrr (MRSA) is fiequently isolated 
f b m  osteomyelitis or prosthetic joint infections. The treatment of this 
infection is problematic. For prosthetic infections complete removal is 
fkquently needed to cure the infection. 
Material and methods: Six patients, four with chronic osteomyelitis and two 
with hip prosthesis infections, were treated with linezolid. All MRSA isolated 
were nosocomial and susceptible to lmezolid (range 0.25-1mg/L). The 
patients received 1200% dady dose of linezolid per oral route, until the 
cure was reached or a severe adverse event was noted. 
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Results: One patient with h p  prosthesis was cured as demonstrated by 
negative leukocyte scan after 3months of therapy. The other patient with 
h p  prosthesis infection stopped the drug after 2 months of therapy because of 
severe anemia that recovered after the suspension of the drug; the infection 
was improved as demonstrated by reduction of ESR, pain and intensity of 
leukocyte scan. Among patients with osteomyelitis, one habetic patient with 
nosocomial sternal infection was completely cured. The second with the same 
type of infection is still on treatment with improvement of the symptoms and 
radiology evaluation. A third patient with nosocomial lumbar dyscitis was 
improved but unfortunately he stopped the drug due to a concomitant 
cerebral stroke not correlated to the drug. The fourth patient with a tibia 
osteomyelitis was lost at follow-up after 2 months of treatment with symptoms 
completely recovered. 
Conclusions: Linezolid might be a safe and easy option in the treatment of 
bone and prosthetic infections due to Micult to treat MEGA. Most of these 
patients were treated for prolonged time without adverse events, except severe 
anemia in one case. 
methich-resistant staphylococci and glycopephde-resistant enterococci 
There are few pubkcahons descnbing the pharmacokmehcs of LZD, espe- 
cially relahng to bone and hSSUe. In ths study, we report the concentrauons 
and penetrahon of LZD for bone, fat and muscle after a single dose of LZD. 
Methods: A total of 12 paaents undergoing h p  arthroplasty received 600 mg 
LZD as a 20mn lnfusion immedlately before surgery and again 12h after 
surgery Samples ofbone, fat, muscle and blood were collected at 10, 20 and 
30 mm after the LZD infusion and samples of dramage from the operanon site 
were collected at 6-8,10-12 and 14-16 h after surgery Samples were assayed 
by a d d a t e d  hgh performance hqlud chromatography method. Tissue 
samples were extracted mto phosphate buffered d n e  and any bone or fat 
samples wth  wsible blood contammation were mscarded 
Results: The mean (S.D.) levels of LZD found m the assues and penetrahon 
rehhve to serum are shown m the table above Mean (S.D.) levels of LZD in 
dramage were 6-8h 8.2 (3.3) mg/L, 10-12h: 5.6 (2.1) mg/L and 1 4 1 6 h  
7.0 (5.4) mg/L 
lp7631 Clinical experience with linezolid in patients with a 
variety of Gram-positive infections 
A. Papadopoulos, G. Poulakou, L. Karnesis, K. Kanellakopoulou and 
H. Giamarellou 
Athens, GR 
Background: Linezolid is the fiat oxazolidinone antibacterial agent with 
inhibitory activity against Gram-positive bacteria including MRSA and VRE. 
Clinical experience with the new antibiotic does not exist in Greece, since it 
has not received license to the market yet. 
Objective: To present clinical data concerning the experience of linezolid in 
the therapy of documented or presumed Gram-positive infections. 
Methods: We evaluated 27 patients with 32 episodes of various 
infections who participated in an expanded access protocol. Linezolid 
was administered i.v. or orally 600 mg hid for 1-4 weeks or longer ifnecessary 
and results concerning efficacy, safety, intolerance and follow-up were 
recorded. 
Results: Fifteen paaents with skin- or soft-tissue infections (SSTIs, mostly 
erysipelas, cellulitis and skin abscess) with mean age 56 years received linezolid 
for a mean of 29.5days (range 18-45). The causative microorganism was 
recognized in seven cases (MRSA four, MRSE two, MSSE one). Twelve 
patients were cured (80%) and the rest showed a marked improvement. After a 
mean follow-up period of 45 days only one patient relapsed. Ten cases with 
chronic osteomyelitis (CO) of the lower limbs (mean age 46 years) due mostly 
to MRSA, received linezolid for a mean of 37 days (range 28-50) s idcan t ly  
longer than the patients with SSTIs (P<0.05). S i x  of them (60%) had a 
successful clinical response and four a partial one. After a follow-up period of 
15-180days (mean hodays), only two cases relapsed. Three cases of non- 
puerpual mastitis due to MSSA (2) and S. hominis received linezolid for 28- 
42 days with cure or marked improvement. Two cases of bacteremia due to 
MRSA and MRSE were cIinicaUy and microbiologically cured with no 
relapse. The most frequent adverse effect was anemia recorded in 10/27 
(37%). The mean drop of the hematocnt was 7.4% (range 3-10%) and 
presented 14-48days (mean 28.4) after starting therapy. None required 
transfusion or discontinued therapy and the condition was completely 
reversed in 15-48days (mean 28) after the cessation of therapy. A 
mild and fuuy reversible thrombocytopenia occurred in three patients 
(11%). 
Conclusions: Linezolid is a highly effective agent in the treatment of 
various Gram-positive infections and especially CO and/or SSTIs. Longer 
duration of treatment (>18days) is associated with a higher incidence of 
reversible anemia and thrombocytopenia. Close monitoring of the patients is 
required. 
1 P764 I The concentrations and penetration of linezolid for 
bone, fat and muscle 
A. Lovering, J. Zhang, G. Bannister and A. MacGowan 
Bristol, UK 
Objectives: Linezolid (LZD), the first clinically useful oxozolidinone anti- 
microbial, is characterized by a spechum of activity which includes both 
Concentration (mg/L) pcnnntion (%) 
Bone Fat Made S e m  Bone Fu Mu~clr 
lO(min) 9.l(2.6) 4.5(2.7) 10.4(4.0) lY.2(6.5) 51.0 26.5 58.3 
20(-) 8.6(5.3) 5.2(2.1) 13.4(5.6) 15.8(5.8) 60.0 M.9 94.3 
30(-) 6.3(4.0) 4.1(1.2) 12.0(4.7) 14.3(5.0) 46.4 31.4 910 
Conclusims: LZD exhibits rapid penetrahon in bone, fat and muscle 
of patients undergoing hip arthroplasty to acheve levels in excess of the 
MIC for sensihve organisms (MIC of <8mg/L); with therapeutic levels 
wntamed m the drainage which surrounds the operation site for more than 
16h. We conclude that LZD exhibits a phannacokinetic profile which 
appean appropriate to investigate the treatment of bone and associated soft 
ussue infections. 
/p7651 Single and multiple dose pharmacokinetics of 
linezolid and amoxicillin/clavulanic acid in healthy human 
volunteers 
0. Burkhardt, K. Borner, N. von der Hoh, E! Koppe, M. W. Pletz, 
C. E. Nord and H. Lode 
Berlin, 0; Stockholm, S 
In an open, randomized, two-period crossover study the ecological effects of 
hezolid versus amoxiciUin/clavu~c acid on the normal intestinal micro- 
flora and the pharmacokinetics oftwo antibiotics were investigated &er single 
and multiple dose in 12 healthy volunteers ( s i x  females and six males). 
Linezolid was given in tablets of 600 mg bid for 7 days and amoxicillin/ 
clavulanic acid in tablets of 1000 mg od for 7 days. The wash-out period w a s  
4 weeks between the administration ofthe two antibacterial agents. Blood and 
urine samples were collected on days 1 and 7 before and at different time 
points up to 48 h after medication. The concentrations of the three antibiotics 
in serum and urine were measured by validated high-performance liquid 
chromatography methods. Linezolid concentrations in serum and urine were 
also determined by a microbiological assay. The agreement between the results 
obtained by bioassay and those of HPLC was good. Linezolid exhibited a 
mean Cmof14.5k4.6pg/mLafter T-of47.5k20.1minonday 1, with 
a sigmficant increase to 24.0k6.9 pg/mL on day 7 ( P <  0.01). The AUDtot 
revealed a highly significant increase from 140.5f28.3pgh/mL on day 
1-220.2&42.6pgh/mL on day 7 (P<0.01). There were no significant 
dif3erences of terminal half-life between days 1 and 7 (9.53f2.87 
vs. 7.97k3.08pgh/mL) and of total clearance (71.6f 17.6 vs. 
81.5 k 14.7 mL/min 1.73 m2). Results are in agreement with the assumption 
of cumulation of linezolid under the given dosage regimen. Serum concen- 
trations of females were always higher than those of males. The volume of 
distribution Vss/f Wered sigmfkantly between females and males (41.6 & 4.2 
vs. 52.2 f 3 . 3  L/70 kg; P <  0.01). No accumulation was observed. No serious 
adverse event was observed in all three drugs during the study. 
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[p7661 The normal human intestinal microflora and BMS- 
284756 
D. A. Gajar, D. M. Grasela, R. L. Russo, E. Sillerstriim, E. Wahlund and 
C.E. Nord 
Primeton, U S A ;  Stockholm, S 
Objective: BMS-284756 is a new des-F(6)-quinolone agent active against 
many aerobic and anaerobic bacteria. The ecological effect of BMS-284756 
on the intestinal microflora was investigated in two trials. 
Methods: Forty healthy subjects participated in the fiat trial. Eight 
subjects were assigned to each of five dose panels (100, 200, 400, 800, and 
1200mg BMS-284756) and received daily oral dosing with either 
BMS-284756 (n=6) or placebo (n=2) for 14days. Fecal samples were 
collected before (days -2 and -l), during (days 7 and 14), and after 
completion of the administration period (days 21,28, and 45). In the second 
trial, 16 healthy subjects were given 600mg BMS-284756 for 7days. 
Fecal samples were collected before (days -2 and -l), during (day 5), 
and after withdrawal of administration (days 8 and 26). The fecal samples 
were diluted in prereduced media and inoculated aerobically and anaerobi- 
cally on nonselective and selective media. The different colony types were 
identified to genus level by morphological, biochemical and molecular 
analyses. 
Results: In subjects receiving 100 or 200 mg BMS-284756, no significant 
changes in the intestinal aerobic and anaerobic microflora occurred. 
The number of enterococci, bacilli, corynebacteria, brtidobacteria, lactoba- 
cilli, clostridia, and bacteroides decreased in subjects receiving 400, 600 or 
800 mg BMS-284756, whereas the number of eubacteria increased. 
Subjects who received 1200mg BMS-284756 had sigmfkant changes in 
the microflora: enterococci, bacilli, corynebacteria, enterobacteria, bifido- 
bacteria, lactobacilli, closmdia, and bacteroides were suppressed, whereas 
eubacteria and yeasts were increased. Regardless of dose, the microflora 
returned to normal levels at days 26-28 (2weeks after the administration 
of BMS-284756 had stopped). Fecal concenttations of BMS-284756 
increased with the higher doses, from 35.7 (lO0mg) to 262.8mg/kg 
(1200mg). 
Conclusion: During the administtation of BMS-284756, enterococci, bacilb, 
corynebacteria, bifidobacteria, lactobacilli, clostridia and bacteroides were 
suppressed in the intestinal microflora, while eubacteria increased. The 
eubacteria may inactivate different drugs in the intestine. 
Ertapenem 
lp767/ Antimicrobial activity of BMS-284756 against 
staphylococci and respiratory pathogens 
S. Esposito, S. Noviello and E Ianniello 
Naples, I 
Objectives: BMS is a novel des-F(6)-quinolone that has shown excellent 
antimicrobial activity against a wide range of clinically important micro- 
organisms, including Gram-positive and Gram-negative aerobes and anae- 
robes. In this study, the activity ofBMS-284756 against Staphylococci (MSSA 
and MRSA) and respiratory pathogens (S. pneumoniae, H. intuenrae, M. cafar- 
rhalis and S.pyogenes) was hrther examined in comparison with other 
antimicrobial agents [ciprofloxacin (cip), levofloxacin (Ivx), moxifloxacin 
(4, penicillin (pen), amoxicillin, coamoxi-chv, cefixoxime, cefotaxime, 
ceftriaxone, imipenem, erythromycin (ery), clarichromycin]. In addition, the 
bactericidal activity ofBMS-284756, d, lvx and cip was evaluated by time- 
kill analysis against four strains of staphylococci (two MSSA and two MRSA) 
four strains of S. pneumoniae (two pen-S and two pen-R) and four strains of 
S.pyogenes (two eryS and two ery-R). 
Methods: Overall, 100 clinical isolates were selected for invitro testing. MICs 
were determined by standard microdilution method (staphylococ- 
ci + streptococci + H. intluenzae) and by agar dilution procedures for M. cafar- 
rhalis, in accordance with the NCCLS guidelines. Timekill studies were 
performed in flasks according to standard procedures. Antibiotics (BMS- 
284756, nud, lvx and cip) were tested at concentrations 1-8 times the MIC. 
Results: The MIC9,, of BMS-284756 for the MSSA and MRSA were 0.03 
and 0.06 pg/mL, respectively. Among all the quinolones tested, BMS-284756 
yielded the lowest MIC values against all the pneumococcal strains 
(ME90 5 0.06 pg/mL) irrespective ofpenicillin and/or macrolide resistance; 
the rank order of activity was BMS-284756 > mxf> lvx > cip. Excellent 
activity was shown also against H. inzuenzae (MICm 5 0.03 pg/mL) and 
M. cafarrhalis (MIC9,, 5 0.03 pg/mL). A total of 90% of S.pyngenes were 
inhibited at BMS-284756 concentration equal to 0.25 pg/mL, its activity 
being not influenced by macrolide susceptibility. BMS-284756 was rapidly 
bactericidal against staphylococci, producing 3 log 10 decrease in viable 
counts (cfu/mL) within 3 h at 4x MIC whereas a moderate, slower killing 
rate was observed versus pneumococci and streptococci. 
Conclusions: The enhanced activity of BMS-284756 against staphylococci, 
pneumococci and other respiratory pathogens would suggest its suitability for 
treatment of community acquired respiratory tract infections. Clinical trials 
are warranted to establish its clinical efficacy and sdety. 
lp7681 Comparative in vitro activities of ertapenem 
against aerobic bacterial pathogens isolated from patients 
with complicated intra-abdominal infections 
B. Pelak, K. Bartizal, G. Woods, I. Friedland and M. Motyl 
West Point, USA 
Objectives: Determine the in vitro activity of ertapenem, a new b-lactam 
with the potential to eliminate the need for combination and multidose 
regimens for ueatment of community-acquired and mixed infections, against 
bacterial pathogens recovered f b m  patients with complicated intra-abdom- 
inal infections (IAI) and compare it with the activities of other agents 
commonly used to treat such infections. 
Methods: In two prospective, double-blind, multicenter studies, adults with 
complicated LA1 were randomized to receive ertapenem or comparator 
therapy. Specimens &om the site of infection were cultured for aerobic 
and anaerobic bacteria. Aerobic bacteria were shipped to Merck Research 
Laboratories, where they were tested for susceptibility to ertapenem, cef- 
triaxone, amoxicillin-clavulanate, ampicillin-sulbactam, and piperacillin- 
tazohactam by microtiter dilution following NCCLS guidelines. 
Results: A total of 1018 aerobic bacteria hpm 531 patients were tested. 
Enterobacteriaceae accounted for 66.3%; Escherichia rali was the most com- 
mon isolate. The ertapenem MIC was 5 4  p g / d  for 78.1% of all aerobic 
isolates and 2 1  6 pg/mL for 14.3% (enterococci, methicillin-resistant 
Staphylocoaus aureus, Pseudornonac aeruginosa, Acinetobacter spp.). Excluding 
enterococci (NCCLS breakpoints for carbapenems, cebiaxone, and piper- 
acillin-tazobactam are not defined), the proportion of all aerobic isolates 
susceptible to the drugs tested were: ertapenem, 91%; ceftriaxone, 86% 
amoxlcilbn-clavulanate, 78% ampicillin-sulbactam, 58% piperacillitl-razo- 
bactam, 92%. Against Enterobacteriaceae, ertapenem was the most active 
(100% susceptible); ampicdh-sulbactam was least active (64% susceptible). 
Piperacillin-tazobactam was the only drug with c h c d y  useful activity 
against I? amginosa. 
Conclusions: Ertapenem was highly active against the aerobic bacterial 
pathogens recovered h m  patients with complicated W. Against Entero- 
bacteriaceae, ertapenem was more active than ceftriaxone, amoxicilh- 
clavulanate, ampicillinsulbactam, and piperacillin-tazobactam. 
/p769/ Use of surrogate antimicrobial agents to predict 
susceptibility to ertapenem 
I. Friedland, R. Isaacs, L. Mixson and G. Woods 
West Point, USA 
Objectives: Ertapenem (ETP) is a once a day b-lactam antimicrobial agent 
that recently was licensed for treatment of various community-acquired and 
mixed infections. It is not yet on panels for automated susceptibihty test 
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systems. The aim of this study was to identify surrogate antimicrobial agents 
for evaluating susceptibility to ETP against the major organism groups for 
which ETP is indicated. 
Methods: Susceptibdity-test results for 10 992 Enterobacteriaceae, 2888 
anaerobes, 2206 staphylococci, 840 Huerrtophifus spp., 709 Streptocoms pneu- 
moniue, and 709 other streptococci were analyzed Organisms includeddinical 
trial isolates, 'challenge' strains with known resistance mechanisms, and 
Enterobacteriaceae from a 1999 ICU Susceptibility Surveillance Study. 
Testing was pedormed by broth or agar dilution, following NCCLS guide- 
lines. Isolates were tested against ETP and imipenem (IPM); staphylococci 
also were tested against oxacillin (OX) and streptococci against peniciIlin 
(PEN). For an agent to be considered a reliable surrogate, the very major error 
(VME, false susceptible) rate should be 1.5% or less and the absolute 
categorical agreement, 90% or more. 
Results Of the Enterobacteriaceae. 10 663 (97%) were susceptible (S) and 17 
(0.2%) were resistant (R) to ETP and IPM. Absolute agreement between the 
two drugs was 97% (10681/10992); there were 94 VME (O.Y?) and 40 
(0.4%) major errors (ME, false resistant). 95/104 (91%) IPM-intermediate (I) 
Enterobacteriaceae were ETP-S. For anaerobes, absolute agreement between 
ETP and IPM was 99% (285812888); VME = 6 (0.2%); ME = 0. All OX-S 
staphylococci, all Haemophilus spp., all PEN-S/I S.pnelrtMniae, all group, A 
and B streptococci, and all other PEN-S streptococci were ETP-S. 
Conclusions: The following agents were excellent in predicting susceptibility 
to ETP: IPM for Enterobacteriaceae and anaerobes, OX for staphylococci, 
and PEN for streptococci. For confirmed IPM-R/I Enterobacteriaceae, 
PEN-R Spnarmoniae, and other streptococci that are PEN-I/R, the ETF' 
MIC should be determined. All OX-R staphylococci should be reported as 
ETP-R. Testing Huemophitus or groups A or B streptococci against ETP is not 
necessary; resistance has not yet been identified. 
p x l  Ertapenem 1 g once a day is highly effective in 
treatment of severe community-acquired and mixed 
infections 
R. Isaacs, 1. Friedland, R. Gesser, H. Teppler and A. Meibohm 
West Point, USA 
Objectives: Assess the efficacy of ertapenem, a new once a day parented p- 
lactam, in the treatment of severe community-acquired and mixed infections 
and compare it with piperacilliwtazobactnm (P/T) and cehiaxone (CRO). 
Methods: The efficacy of ertapenem, 1 g once a day, in treating complicated 
intra-abdominal (IAI), acute pelvic (PI), complicated skin and skin structure 
(SSSI), and complicated urinary tract infections (UTI) and comunity- 
acquired pneumonia (CAP) w a s  evaluated in seven randomized, double- 
blind t r d s  at 425 sites worldwide. Comparator antimicrobials, considered 
standard of care, were P/T, 3.375 per every 6 h, for IAI, PI, and SSSI and 
CRO, 1 g once a day, for CAP and UTI. Each patient's lnfection was rated as 
dd-to-moderate or severe, based on predefined scoring criteria. For IAI 
generalized peritonitis was the marker for severe infection. Clinical and/or 
microbiologic efficacy was assessed in protocol-evaluable patients at pre- 
specified timepoints post-therapy, defined by indication. 
Results: Infection was rated severe in 29% (347/1178), 23% (119/520), and 
36% (189/518) of evaluable patients, who received ertapenem, PIT, and 
CRO, respectively. Cure rates (96) for severe infections in each indication are 
shown in the Table 1 below. 
Table 1 Cure rates (%) 
IAI PI SSSI O v e d  CAP UTI Overall 
Ertapenem 50/60 40/42 32/40 122/142 81/90 112/121 193/211 
P/T 39/53 30/35 (86) 22/31 91/119 
(83) (95) (80) (86) (90) (93) (91) 
(71) (76) 
74/85 97/104 171/189 
(74) 
CRO 
(87) (93) (90) 
"Cbmcal & mcrob~olog~c response for I N ,  chnical for PI and CAP, mcrobiologc for 
UTI 
Cure rates (ertapenem vs. comparator) for all (dd-moderate + severe) 
dechons were: IAI, 176/203 (87%) versus 157/193 (81%); PI, 153/163 
(94%) versus 140/153 (92%); SSSI, 152/185 (82%) versus 147/174 (84%); 
CAP, 335/364 (92%) versus 270/294 (92%); UTI, 229/256 (89%) versus 2041 
224 (91%) Ertapenem and comparator agents were genedy well tolerated. 
Conclusions: Ertapenem, 1 g once a day, was hghly effective for treatment of 
IAI, PI, SSSI, CAP, and UTI ,  including severe infections, and as effective as 
comparator therapy. The safety and tolerabihty profiles of ertapenem and 
comparator agents were similar. 
I P771 1 Efficacy and safety of ertapenem 1 g once a day: 
the European experience 
R. Gesser, K. McCarroll, H. Teppler, I. Friedland and R. Isaacs 
West Point, USA 
Objectives: Large clinical trials have recently been conducted worldwide to 
evaluate the efficacy and safety of ertapenem, a new once a day parenteral 
p-lactam, as monotherapy for treating serious community-acquired and mixed 
infections. We report here on the clinical experience of371 patients from nine 
European countries treated for serious bacterial infections in these studies. 
Methods:Ertapenem, 1 g once a day, was evaluated in six separate randomized 
double-blind trials in h e  treatment of complicated intra-abdominal infections 
(W), acute pelvic infections (PI), community-acquired pneumonia (CAP) 
and complicated urinary tract infections (UTI) versus either piperacillin/ 
tazobactam (P/T) 3.375 g per 6 h (W and PI), or cefkiaxone (CRO) 1 g once 
a day (UTI and CAP). Clinical and/or microbiologic efficacy was assessed in 
eduable patients at pre-specdied post-treatment timepoints as defined for 
each indication. 
Results: Ofthe 371 patients randomized to treatment in Europe, 68% (251/ 
371) were protocol evaluable. Treatment groups for each indication were 
similar with respect to age, gender, and ethnicity. Favorable primary eficacy 
response rates overall and by indication are shown in the table below. 
O v e d  Overall 
Drug W PI vs.P/T CAP UTI vs .CR0 
~ ~ 
Ertapenem 27/34 9/10 36/44 53/58 49/52 102/110 
(79%) (90%) (82%) (91%) (94%) (93%) 
P/T 25/30 4/4 29/34 
(83%) (100%) (85%) 
CRO 27/32 26/31 53/63 
(84%) (84%) (84%) 
'Clinical & microbiolopc response for IAI, clinical for PI & CAP, microbiologic for 
UTI. 
The most commonly treated pathogens in these patients were: Eschenchia coli 
(IAI, PI, and UTI) and Streptocome pMumoniae (CAP). Enhcahon ntes, by 
pathogen, for these and other organism were comparable for ertapenem 
versus comparator agents. The hquency and seventy of drug-related adverse 
events were generally similar in ertapenem and comparator groups. 
Conclusions In thu subgroup analysis ofEuropean patients treated for serious 
commumty-acquired and mixed bacterd mfections, ertapenem, 1 g once a 
day, was hghly effechve in the treatment of LAl, PI, CAP, and UTI. 
Ertapenem was as effechve as either ceftriaxone or piperacillin/tazobactam, 
and had a comparable safety profile. 
lp7721 Superinfections in dinical trials with ertapenem, 
ceftriaxone, and piperacillin-tazobactam therapy 
I. Friedand, R. Isaacs, H. Teppler, R. Gesser and A. Meibohm 
Waf Point, USA 
Objectives: To identify organism that cause superinfections during therapy 
with ertapenem, a new once a day parenteral p-lactam with the potential to 
eliminate the need for combination and multidose regimens for treating 
community-acquired and mixed infections, piperacihn-tazobactam (P/T), 
or ceftriaxone (CRO), and to compare superinfection rates associated with 
these therapies. 
Methods: During seven randomized, double-blind clinical hi& of ertapenem 
therapy, data were collected on emergent pathogens isolated during treatment 
(superinfection) or up to 6weeks after study therapy was completed (new 
infection). In these trials the efficacy of ertapenem, 1 g once a day was 
compared to P/T, 3.375 g/day, for complicated intra-abdominal (rtu), acute 
pelvic (PI), and complicated skin and skin structure (SSSI) infections and with 
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CRO, 1 g/day, for community-acquired pneumonia (CAP) and complicated 
urinary-tract infections (UTI). 
Results: In the trials, 3301 adult patients (on ertapenem or comparator) were 
randomized at 425 sites worldwide. Superinfections occurred in 15/1217 
(1.2%). 30/567 (5.3%). and 7/525 (1.3%) evaluable patients who received 
ertapenem, P/T, and CRO, respectively; 63 (5.2%), 12 (2.1%), and 30 (5.7%) 
developed a new infection. Super and new infections were infrequent, 
regardless of treatment; rates (in percentage) for each indication are shown 
in the Table 1 below. 
Table 1 
IAl PI SSSl CAP UTl 
~~ 
Ertapenem 2.1/3.8 0.6/1.2 3.8/1.6 0.3/2.5 0.4/15.1 
P/T 6.3/2.1 2.0/0.7 6.913.4 
cno 1.0/1 .O 1.7A1.7 
Most new infections represented recurrent UTIs; enterococci and Escherichia 
coli were the most fiequent pathogens. Superinfection was documented most 
often in SSSI and IAI; Staphylococcus aurew (SSSI) and enterococci and Gram- 
negative anaerobes (IAI) were isolated most frequently. Susceptibility profiles 
of the bacteria responsible for these infections were comparable to those of 
baseline pathogens. 
Conclusions: Overall, super and new infections were infrequent and isolation 
of ertapenem-resistant organisms was rare in patients treated with ertapenem. 
Both the rates of occurrence and the pathogens recovered were generally 
similar between ertapenem and the comparator. 
(P773l Ethnicity does not effect the efficacy and safety of 
ertapenem therapy 
G. Woods, L. Jonas, R. Gesser, H. Teppler, I. Friedland, A. Meibohm 
and R. Isaacs 
Wesf Point, USA 
Objectives: To assess the impact of ethnicity on efficacy and safety of 
ertapenem, a new once a day j?-lactam with the potential to eliminate the 
need for combination therapy and multidose regimens when treating com- 
munity-acquired and mixed infections, compared with comparator therapy. 
Methods: Eligible patients with complicated intra-abdominal (IAI), compli- 
cated skin, acute pelvic (PI), or complicated urinary tract (UTI) infections or 
community-acquired pneumonia (CAP) were enrolled in seven separate 
double-blind clinical trials conducted worldwide and randomized to ertape- 
nem, 1 g once a day, or comparator (piperacilliwtazobactam Ip/T], 3.375 g 
per every 6 h, for IAI, PI, skin; ceftriaxone [CRO] 1 g once a day for UTI, 
CAP). Clinical and/or microbiologic efficacy was assessed in evaluable 
patients at pre-specified timepoints post-therapy, defined by inhcation. 
Results: Of the 3301 patients randomized to ertapenem or a comparator 
group, 2209 (67%) comprised the primary efficacy population. Overall 
response rates (oh) are shown in the Table 1 below. 
Table 1 Overall response rates (%) 
Caucasian Black Hispanic Other 
Ertapenem vs. (n = 1180) (n= 266) (n = 549) (n=214) 
cno 91 vs. 92 96 vs. 91 90 vs. 92 90 vs. 87 
P/T 82 vs. 84 88 vs. 82 93 vs. 88 94 vs. 88 
Comparator 87 '15. 89 91 vs. 86 91 vs. 90 92 vs. 87 
'Clinical & microbiologic response for IAl; clinical for skin, PI, and CAP; 
microbiologic for UTl. 
A total of 1747,751, and 775 patients received at least one dose of ertapenem, 
CRO, and P/T, respective+. The most common clinical drug-related advene 
experiences (AEs) were diarrhea, nausea, and headache for all drugs. The 
fiequency of their occurrence was generally similar in all ethnic groups 
(T5%), although the rate of darrhea associated with P/T was highest in 
Caucasians (9%). The most common laboratory drug-related AEs for all drugs 
were elevated liver transaminases, which occurred most fi-equently in His- 
panics: 7-13% versus 2 4 %  in Blacks and Caucasians. Study therapy was 
discontinued owing to a drug-related AE in <2% of patients in all ethnic 
groups. 
Conclusions: Ertapenem 1 g once a day was highly effective in treating IAI, 
skin, PI, CAP, and UTI in all ethnic groups and was as effective as P/T and 
CRO. Ertapenem was generally well tolerated in all ethnic groups and had a 
safety profile comparable to P/T and CRO. 
I P774 1 Efficacy of ertapenem (ETP) in treatment of 
Escherichia coli infections 
R. Gesser, H. Teppler, K. McCamll and G. Woods 
West Point, USA 
Objectives: Esrherichia coli is a common serious pathogen in community- 
acquired and mixed dections. The activity of 1 g ETP. a new parented once 
a day /?-lactam, against E. coli, was compared with piperacillin/tazobactam 
(P/T) 3.375 per every 6 h or ceftriaxone (CRO) 1 g once a day, in clinical 
studies of bacterial infections requiring parented antimicrobial therapy. 
Methods: Appropriate cultures were obtained at baseline in 2435 adult 
patients (pts) enrolled in five multinational, randomized double-blind clinical 
trials evaluating the efficacy of ETP for ueatment of intra-abdominal (IAI), 
skin (SI), pelvic (PI), and urinary tract (UTI) infections. The pts with baseline 
cultures identlfjring E.coZi as a pathogen were inclnded in this subgroup 
analysis. Clinical and/or microbiologic efficacy was assessed in evaluable pts at 
pre-specified t imes post-treatment, as defined by each indication. 
Results: E. coli was a baseline pathogen in 35% (845/2435) ofthe randomized 
pts. Ninety-nine percent of the isolates tested were susceptible to ETP; 97% 
were susceptible to the comparator. Of pts with E. coli, 87% (735/845) were 
protocol evaluable. Evaluable treatment groups were similar with respect to 
age, gender, ethnicity, and dection diagnosis. Of evaluahle pts with IAI, SI, 
or PI, 86% overall had polymicrobial infection; 97% with UTI had mono- 
microbial infection. 33, 6, and 17 pts treated with ETP, P/T, or CRO had 
E. coli bacteremia. Favorable primary efflcacy response rates (RK) are shown 
in the Table 1 below. 
Table 1 Favorable primary escacy response rates (RR) 
ETP P/T CRO 
vs. P/T 
1AI (one study) 86% (127/147) 80% (106/132) 
PI (one study) 88% (36/41) 92% (36/39) 
Skin (one study) 94% (15/16) 80% (12/15) 
Overall 87% (78/204) 83% (154/186) 
UTI (two studies) 92% (1741190) 95% (143/150) 
"Clinical & microbiologic response for IAI, clinical for PI & Sl, microbiologic for UTl. 
vs. CRO 
In pts with bacteremia, the primary RR in UTI was 92% (22/24) for ETP and 
82% (14/17) for CRO; in other indications, it was 100% (9/9) for ETP and 
83% (516) for P/T. Persistent bacteremia was not documented in any patient. 
Overall bacterial eradication rates were 91% (196/216) and 86% (162/189) for 
ETPversusP/Tand92% (176/191) and92% (143/155) forETPvenusCR0. 
Conclusions: In this subgroup analysis, ETP was highly effective for treatment 
of community-acquired and mixed infections caused by E. coli, including 
bacteremia. and was as effective as P/T and CRO. 
1 P775 1 Ertapenem 1 g once a day is highly effective for 
treatment of postpartum endomyometritis 
H. Teppler, K. McCarroll and G. Woods 
West Point, USA 
Objectives: Ertapenem is a new once a day B-lactam with the potential to 
eliminate the need for combination and multidose regimens when treating 
community-acquired polymicrobial infections. The purpose of this subgroup 
analysis was to determine the efficacy of ertapenem in the treatment of 
postpartum endomyometritis and compare it with piperacillin-tazobactam 
( P m  
Methods: In a prospective, multicenter, double-blind study, females at least 
16 years of age with acute pelvic infection requiring parented therapy were 
stratified by obstetric/postpartum infection or gynecologic/postoperative 
infection and randomized to ertapenem 1 g once a day or P/T 3.375 g per 
every 6 h. The underlying specific diagnosis was identified for each patient at 
entry Patients with postpartum endomyometritis were included in this 
subgroup analysis. At enrollment, appropriate aerobic and anaerobic cultures 
were performed. Prior to unblinding, the severity of the infection (moderate 
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or severe) was rated based on predefined criteria. The primary efficacy 
endpoint was the proportion of clinically evaluable patients who were cured 
2 4  weeks post-therapy (test of cure FOCI). 
Results: A total of 73% (299/412) of the randomized patients had postpartum 
endomyometritis, ofwhom 116 in the ertapenem group and 113 in the P/T 
group were climcally evaluable. Treatment groups were similar with respect to 
age (mean, 23-25yean), and duration of therapy (median, 4days for both 
groups). The infection was rated severe in 31 (27%) ofthe clinically evaluable 
patients who received ertapenem and 23 (20%) who received P/T. The most 
common pathogen in both the groups w a q  Escherichia mli. Five patients in the 
ertapenem group and two in the P/T group were bacteremic at baseline. Cure 
rates at TOC were 93% for ertapenem and 90% for PIT; 94 and 87%. 
respectively, for severe infection and 93 and 91% for moderate infection. 
Overall favorable microbiologic response rates by patient were 94% 
(empenem) and 94% (P/T). Both ertapenem and P/T were generally well 
tolerated. 
Conclusions: In thls subgroup analysis, ertapenem, 1 g once a day was h w y  
effective for treatment of postpartum endomyometritis overall, and in severe 
and moderate infections, and was as effective as P/T. The safety and toler- 
ability profiles of ertapenem and P/T were similar. 
I P776 I Analysis of ertapenem (ETP) efficacy and safety by 
gender 
R. Gesser, L. Jonas, A. Meibohm and G. Woods 
Wpst Point, USA 
Objectives: To determine the effect of gender on the efficacy and safety of 
ETP, a new once a day B-lactam, in community-acquired and mixed 
infections as compared with ceftriaxone (CRO) or piperacillin-tazobactam 
(P/T), a multidose ~-lactam/~-lactamase inhibitor combination. 
Methods: Males and females with inm-abdominal (IAI), skin (SI), or urinary 
tract (UTI) infections or community-acquired pneumonia (CAP), and 
females with acute pelvic infection (PI), were randomized in seven dou- 
ble-blind studies at 425 sites worldwide. Therapy was ETP 1 g once a day or 
standard comparator agent: P/T 3.375 gper every 6 h (IAI, SI, PI) or CRO 1 g 
once a day (UTI, CAP). Clinical and/or microbiologic efficacywas assessed in 
evaluable patients at timepoints pre-specified for each indication. Safety was 
evaluated in all treated patients in all studies. 
Results: Of the 3301 patients randomized, 1166 females and 1043 males 
comprised the primary etficacy population. Overall cure rates (%) are shown 
in the Table 1 below. 
Table 1 Overall cure rates (%) 
ETP vs ETP Comparator ETP Comparator 
CRO (UTI, CAP) 92 (299/324) 92 (2511274) 90 (265/296) 91 (223/244) 
P/T (IAI. SI) 82 (108/132) 79 (951120) 86 (220/256) 85 (209/247) 
P/T (PI) 94 (153/163) 92 (140/153) - - 
Comparators combmed 90 (560/619) 89 (486/547) 88 (485/552) 88 (4321491) 
'Chmcal and rmcroblologx response for IAI, climcal for SI, PI, and CAP, 
nucrobiologrc for UTI 
The most common chica l  drug-related adverse experiences (DRAEs) for 
ETP, P/T, and CRO, respechvely, m both genders (1736 females, 1537 males) 
were dlarrhea (4.7, and 3% in females; 5 6 ,  5% in males) and nausea (4,4, and 
3% m females; 1,2,2?40 111 males). The most frequent laboratory DRAEs for 
ETP, P/T, and CRO m both genders were elevated ALT (4, 3, and 5% of 
females, 8,6,7% of males) and elevated AST (3,2, and 5% of females; 7,7,5% 
of males). ETP, P/T, and CRO were dlsconanued owng to a DRAE m 14 
(2%), 6 (l%), and 1 (<1%) females and 11 (l%), 8 (2%), and 3 (1%) males. 
Conclusions: ETP was hghly effechve for treatment of commumty-acquired 
and mured mfecaons and as effectwe as comparator therapy. ETP was 
generally well tolerated w t h  a safety profile comparable to that of P/T 
and CRO. The efficacy and safety of ETP were generally s d r  in males and 
females. 
lp7771 Complicated intra-abdominal infection (IAI): impact 
of microbiology on outcome in patients treated with 
ertapenem versus piperadtin-tazobactam 
A. Yellin, D. Citron, H. Teppler, V. Satishchandran, A. Meibohm and 
G. Woods 
Protocol 01 7 Wriring Group, Las Argeles, West Point, USA 
Objectives: To assess the impact of the microbiology of complicated IAI on 
outcome in patients (pts) treated with 1 g ertapenem (ETP), a new once a day 
parenteral /?-lactam, or piperacillin-tazobactam (P/T) 3.375 g every 6 h. ETP 
has minimal activity against enterococci or Pseudomonas aeruginosa; P/T has 
relatively good activity against both organisms. 
Methods: In a prospective, randomized, double-blind (with sponsor blind- 
ing), multicenter trial, pts were stratifed at enrollment by primary site of 
infection and APACHE I1 score. The primary analysis was clinical and 
microbiological efficacy in the microbiologically evaluable (micro evaluation) 
pts -weeks post-therapy Additional analyzes were performed in 
this population to determine the impact of the following on clinical and 
microbiological efficacy: (1) one or more isolate resistant (R) or intermediate 
(I) to study therapy in addition to at least one susceptible isolate (2) isolation of 
Enterococcus, and (3) isolation of Z? amginosa. 
Results: A total of 203 pts in the ETP group and 193 in the P/T group were 
micro evaluated. Overall success rates were 87% for ETP and 81% for P/T. For 
pts with polymicrobial infections and 0, 1, or 2 or more R/ I  isolates, 
respectively, success rates were 86% (111/129), 85% (34/40), and 82% (9/ 
11) for ETP and 82% (112/137), 87% (13/15), and 100% (3/3) for P/T. 
Success rates in pts with and without Entermaus were 80% (45/56) and 89% 
(131/147) in theETP group (P= 0.101) and 70% (23133) and 84% (134/160) 
in the P/T group (P=O.O60). Irrespective of s tudy  therapy, pts with 
Enterococcur at baseline were less likely to have a favorable outcome than 
those without it (P=O.O13 in overall analysis accounting for treatment 
group). For pa with and without Paenrginosa, success rates were 72% (181 
25) and 89% (158/178) in the ETP group (P=0.021) and 89% (23126) and 
80% (134/167) and in the P/T group. 
Conclusions: The presence of R/1 isolates with at  least one susceptible isolate 
did not adversely effect outcome in either treatment group. Although pts in 
both treatment groups with baseline Enterococm were less likely than pts 
without it, to have a favorable outcome, this did not appear related to specific 
anti-enterococcal activity of the study therapy, which suggests that routine 
enterococcal coverage is not required in the treatment of IAI. 
)p7781 ~ f f i c q  of ertapenem in treatment of 
Bactemides fragilb group infections 
H. Teppler, R. Gesser, K. McCarroll and G. Woods 
West Point, USA 
Objectives: Members of the B.fragi/is group (B.fiagilis, B. distaronis, B. mi- 
fbrmis, B. thetaiotaomanon, B. ovatus, B. v u ~ a m )  are the anaerobes most fte- 
quently isolated &om clinical specimens and are more resistant to 
antimicrobial agents than most other anaerobes. The purpose of this subgroup 
analysis was to determine efficacy of ertapenem, a new parented once a day 
8-lactam, for treatment of complicated intra-abdominal (IAI), complicated 
skin and skin structure, and acute pelvic (PI) infections caused by B.fragiZis 
group pathogens and compare it with piperacillin-tazobactam (P/T) 3.375 g 
per every 6 h. 
Methods: The efficacy of ertapenem, 1 g once a day, in treating MI, skin, and 
PI was evaluated in 1585 adult patients (on ertapenem or P/T) in the United 
States and internationally. In three randomized, double-blind trials, appro- 
priate specimens were cultured for aerobic and anaerobic pathogens. Patients 
whose cultures grew B.fMelis group were included in this subgroup analysis. 
Clinical (skin, PI) or clinical and microbiologic efficacy (IAI) was assessed as 
primary egcacy response in protocol evaluable patients at post-therapy 
timepoints pre-specified for each indication. 
Results: Of the 353 patients with B.3agilis group isolates, the majority (7%) 
ofwhom had IAI, 86% (303/353) were protocol evaluable. Treatment groups 
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were similar with respect to age, gender, and ethnicity. Of all isolates tested, 
98% were susceptible to ertapenem and 9Yh were susceptible to P/T. 
Infection was polymicrobial in 9% of evaluable patients treated with 
ertapenem and 96% treated with P/T. Favorable primary d c a c y  response 
rates for ertapenem versus P/T were: IAI, 86% (107/124) versus 85% 
(94/111); skin, lOO?? (7/7) versus 90% (9/10); PI, 96% (24125) versus 
96% (25/26); overall, 88% (138/156) versus 87% (1281147). Bacterial 
eradication rates, by pathogen, for ertapenem versus P/T were: IAI, 90% 
versus 94%; skin, 1ooO? versus 92%; PI, 100% versus 91%; over&, 91% versus 
94%. Ertapenem and P/T were generally well tolerated. 
Conclusions: In this subgroup analysis, ertapenem was highly effective for 
treatment of complicated intra-abdominal, complicated skin, and acute pelvic 
infections with B.fiagilis group, almost all of which were polymicrobial, and 
was as effective as P/T. The sdety and tolerability profde of ertapenem was 
similar to that of P/T. 
)p779] Comparative in vitro activities of ertapenem 
against aerobic bacterial pathogens isolated from patients 
with complicated skin infections 
B. Pelak, K. Bartizal, G. Woods and M. Motyl 
West Point, USA 
Objectives: Determine the in vim activity of ertapenem, a new B-lactam 
with the potential to elirmnate the need for combination and multidose 
regimens for treatment of community-acquired and mixed infections, against 
bacterial pathogens recovered &om patients with complicated skin infections 
Meropenem 
and compare it with the activities of other agents commonly used to treat such 
infections. 
Methods: In a prospective, double-blind, multicenter study, adults with 
complicated skin infections were randomized to receive ertapenem or 
piperacillin-tazobactam. Specimens from the site of infection were cultured 
for aerobic and anaerobic bacteria. Aerobic bacteria were shipped to Merck 
Research Laboratories, where they were tested for susceptibility to ertape- 
nem, ceftriaxone, amoxiclllin-clavulanate, ciprofloxacin, and piperacillin- 
tazobactam by microtiter dilution following NCCLS guidelines. 
Results: A total of 518 aerobic bacteria &om 340 patients were tested. 
Facultative Gram-positive cocci accounted for 68.1%; S t a p h y l o c a  aureus 
was the most common isolate (45.6%). The ertapenem MIC was 4 pg/mL or 
less for 83.8% of isolates and 16 p g / d  or greater for 8.7% (enterococci, 
methicillin-resistant S. aureus, Pseudomonas aeruginosa, other non-fermentative 
Gram-negative bacilli). Excluding enterococci (NCCLS breakpoints for 
carbapenems, ceftriaxone, and piperacillin-tazobactam are not defined), 
the proportion of all isolates susceptible to the drugs tested were: ertapenem, 
93%; ceftriaxone, 85% amoxicillin-clavulanate, 81%; ciprofloxacin, 92%; 
piperacilliwtazobactam, 92%. Activity against S. aureu~ was s d a r  for all 
agents. Ertapenem was the most active against Enterobacteriaceae (100% 
susceptible); amoxicdlin-cladanate was least active (78% susceptible). 
Against P amginosa, piperacillin-tazobactam was most active (lOO?? suscep- 
tible), followed by ciprofloxacin (87% susceptible); ertapenem and ceftriaxone 
had minimal activity. 
Conclusions: Ertapenem was highly active against aerobic bacterial pathogens 
recovered from patients with complicated skin infections. Against S. aureus, 
ertapenem was as active as cefniaxone, amoxicillin-clavulanate, ciprofloxacin, 
and piperacillin-tazobactam, against Enterobacteriaceae, it was the most 
active of these agents. 
I P780 1 A snapshot from Spain: antimicrobial resistance 
patterns from the MYSTIC Program during 1999 and 2000 
J.-A. Garcia Rodriguez and the Spanish MYSTIC Group 
Salamanca, E 
Objective: To determine antimicrobial resistance patterns of broad-spectrum 
antibiotics in seven Spanish hospital units over 2years (1999 and 2000). The 
participating units are part of the global Meropenem Yearly Susceptibility Test 
Information Collection (MYSTIC) Program, a longitudinal antimicrobial 
resistance surveillance study. MYSTIC monitors susceptibikty patterns in 
hospital units that prescribe the carbapenem meropenem. 
Methods: Three ICUs, two neutropenia units and two general wards 
provided a total of 1637 Cram-negative and Gram-positive isolates over 
the 2 years. National Committee For Clinical Laboratory Standards (NCCLS) 
methodology was used to determine the minimum inhibitory concentration 
(MIC) values (mg/L) and susceptibility breakpoints of MEM, imipenem 
(IPM). ceftandime (CAZ), gentamicin (GM), piperacillin-tazobactam 
(TAZ), and ciprofloxacin (CIP). 
Results: The most common species tested were methicillin-susceptible 
Staphylocoms a u m  ( 1  1.2%), Pseudomom anuginosa (10.8%), Eschmkhiu coli 
(lO.O%)), Enterocoms faecalis (8.8%), Klebsiella pneumoniae (6.5%) and Enter- 
obatter cloacae (5.9??). MEM and IPM showed high activity against the most 
common organisms, and the highest activity against S. aureus, E. coli, K.  pneu- 
moniae and E. cloacae (all >99.5% susceptibility, MICqO = 0.064-0.25 and 
0.13-2 mg/L, respectively) compared with the other antimicrobial agents. 
CAZ and TAZ were the least active antimicrobial agents against E. cloacae 
(77.1 and 72.6% susceptibility. respectively; MICw > 128 for both). MEM 
and TAZ were the most active agents against P m g i n o s a  (89.2 and 90.2% 
susceptibility, MICw = 8 and 64mg/L, respectively), while IPM and TAZ 
demonstrated the hghest activity for E.fderalis (both 98% susceptibility, 
MICgo = 4 and 8 mg/L, respectively). 
Conclusion: Carbapenems remain the most active antimicrobial agents tested 
against a broad range of Gram-positive and Gram-negative organisms from 
hospital centers in Spain. 
vp781 Ciprofloxacin-resistant Cram-negative bacteria 
from European MYSTIC Program centers for 1997-2001: 
trends in co-resistance with other antimicrobial agents 
R. Masterton 
EdinbuJgh, UK 
Objectives: Increased use of fluomquinolones (in particular ciprofloxacin 
[CIP]) has led to a progressive loss of susceptibility to this antibiotic class, 
predominantly among Gram-negative bacteria. The use of longitudinal 
surveillance studies to monitor these trends is essential to guide empirical 
therapy. MYSTIC (Meropenem [MEM] Yearly Susceptibility Test Informa- 
tion Collection) gathers antimicrobial susceptibility data from MEM-pre- 
scribing clinical units worldwide, 1997-present. Analysis of MYSTIC data in 
the UK has revealed a trend towards loss of susceptibility to CIP which is 
associated with a marked level of co-resistance to other commonly used 
antibiotics. The objective of this analysis was to examine the wider European 
MYSTIC data to determine whether similar trends exist outside the UK. 
Methods: Isolates were tested using National Committee for Clinical Labora- 
tory Standards methodology to determine the minimum inhibitory concen- 
tration (MIC) (mg/L) and breakpoint susceptibility (%S) for MEM as well as 
imipenem (IPM), ceftazidime (CAZ), piperacillin-tazobactam (TAZ), gen- 
tamicin (GM), and CIE? 
Results: Over the study period 15 442 Gram-negative isolates from European 
units have been tested. A total of 12195 (79%) were found to be CIP- 
susceptible/intermediate (CIP-S). Of the 3247 (21%) CIP-resistant (CIP-R) 
isolates, the most common were Pseudomow mginosa (39.4%), Acinetobacrer 
baumannii (14.3%), Esrkmdiia coli (13.7%) and Klebsiella pneumoniae (5.7%). 
Overall, the carbapenems showed the greatest activity against the isolated 
CIP-S and CIP-R organisms. MEM was significantly superior to IPM against 
CIP-S and CIP-R Z3.cepa~ia (83%, 50% vs. 56%, 19%, respectively) and 
I? ueruginosa (85%. 58% vs. 73%, 47%, respectively). As in the UK, whilst all 
the antimicrobial agents demonstrated lower susceptibility rates with CIP-R 
organisms, carbapenems appeared least affected. The most marked differences 
in the susceptibility of CIP-S organisms compared with CIP-R were evident 
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in the CAZ, TAZ and GM activity against A. baumannii (71.2% vs. 17.4%, 
63.7% vs. 15.3% and 8 1 . 8 % ~ ~ .  12.9%, respectively). There is a trendshown to 
increasing CIP resistance over time. 
Conclusions: As observed in the UK, loss of CIP-susceptibihty in Europe is 
associated with trends towards co-resistance to other commonly used anti- 
microbials. Led by MEM, carbapenems remain useful first-line agents against 
both CIP-R and CIP-S Gram-negative bacteria. 
ml Susceptibility of bacterial isolates from Turkey - a 
report from the MYSTIC Program 2000 
H. Eraksoy, A. Basustaoglu, V. Korten, H. Kurt, R. Oztiirk, S. Ulusoy, 
A. Yaman, A. Yiice and €? Zarakolu 
Istanbul, Ankara, Irmir, Adana, 7R 
Objective: To determine the invitro activity ofmeropenem (MEM) and seven 
comparator antimicrobial agents against nosocomial isolates obtained in 2000 
h m  units that use MEM in nine Turkish university hospitals. This is part of 
the MYSTIC (Meropenem Yearly Susceptibility Test Information Collec- 
tion) program. 
Methods: Minimum inhibitory concentrations (MICs) for MEM, imipenem 
(IPM), ceftazidime (CAZ), cefotaxime (CTX), cefepime (CPE), piperach- 
tazobactam (TAZ), ciprofloxacin (CIP) and tobramycin (TM) were deter- 
mined for 100 Gram-positive (Gfve) and 100 Gram-negative (Gve) species 
a t  each center using E-test (AB BIODISK, Sweden) and NCCLS suscept- 
ibhty breakpoints. 
Results: A total of 373 Gfve strains and 993 G v e  strains were studied. 
Methicillin-susceptible S. nureus (MSSA; n = 212) and MS coagulase-negative 
staphylococci (CNS; n = 85) were the most often tested. Pseudomonas a m -  
ginosa (n = 21 4), Exherickin coli (n = 203), KZebsiella pwumoniae (n = 156), 
Adnetobacter baumannii (n = 116) and Enferobacter spp. (n = 57) were the most 
common G -ve isolates. Of MSSA isolates, >93% were susceptible to all 
agents tested. MEM and IMP were the most active agents against E. coli (both 
99% susceptibility); the other /&lactams tested inhibited only 78-85% of E. coli 
isolates. The carbapenems were also the most active agents against K .  pneu- 
moniae isolates (295% susceptibhty); the remaining agents tested inhibited 
<71% of isolates. Of K. pnnrmoniae isolates, 41 % had a phenotype consistent 
with ESBL production, and in 15% of E. coli isolates ESBL production was 
suspected. All the Enterobacter spp. strains were susceptible to carhapenems; 
other 8-Iactams tested were less active (88% with CPE, and <70% with 
others). Against P aeruginosa isolates, TAZ (69%) was the most active agent 
followed by MEM (52%), IPM (48%). CAZ (46%), CIP (46%), and CPE 
(44%). MEM and IPM were the most active agents against A .  baumannii (70 
and 67% susceptibility, respectively). 
Conclusion: Carbapenem (MEM > IPM) were the most potent agents 
overall against G+ve and G v e  isolates from Turkish hospitals in 2000. 
MEM and IPM are also highly active against G v e  isolates that include 
ESBL/AmpC producers. MIC90 results against P aetuginosa and A. baumannii 
indicate that the use of carbapenems in combination therapy could be 
clinically beneficial. 
jP7831 No evidence of increasing Gram-negative 
resistance to meropenem in Germany: data from the MYSTIC 
Program 1997-2001 
B Grabein 
Munlch, D 
Objective: To momtor resistance trends to meropenem (MEM) and other 
broad-spectrum anhbiohcs among Grani-negatxve orgamms lsolated over a 
5-year period 111 Gernm hospital units where meropenem IS prescribed 
Methods: Isolates were tested usmg Nahonal Co-ttee for Chmcal Labora- 
tory Standards methodology to determine the m u m  dubitory concen- 
trahon (MIC) values (mg/L) and suscephbhty breakpoints of MEM and 
several other anmcrobial agents mcludmg impenem (IPM), cefrazidme 
(CAZ), piperaah-tazobactam (TAZ), ciprofloxacm (CIP) and gentammn 
(GM) Isolates were collected from seven centers rn Germany; four mtensive- 
care umts, one general ward, one neutropenia center and one cyshc fibrosis 
(CF) umt. 
Results: Dunng the period 1997-2001, a r o d  of 2696 Gram-negative s&s 
were collected and tested at the non-CF hospital units in Germany, ofwhich 
2003 (74.3%) were members of the Enterobacteriaceae. The most common 
species tested were Eschenchia coli (25.6%), Pseudomonas aeruginosa (19.7%) and 
Nebriella pneumoniae (9.5%), followed by Enferobacter cloacae (8.2%), ploteus 
mirabilas (5.8%) and Nebsdla  oxytora (4.3%). The activlty ofMEM was higher 
than or equal to IPM against the most commonly isolated organisms. Against 
E. coli and K pneumoniae, MEM and IPM were the most potent agents (98.5- 
100% susceptibility). Interestingly, the percentage susceptibility of I! aeruginosa 
isolates to MEM and IPM was much greater in 2001 (95.6 and 87.6%. 
respectively) compared with 1997 (78.5 and 69.8%, respectively). Overall, the 
5-year data show no evidence of a trend to increased resistance to the 
carbapenems. Agamst Paenrginosa, a higher proportion of isolates overall 
were susceptible to TAZ (95.1%) than to the carbapenems (81.0-86.5%), 
although MICqO values were four-fold lower for both MEM and IPM than 
TAZ. Generally CIP demonstrated the lowest activity against the most 
commonly lsolated organisms. In the CF center, Raenrginosa was by far 
the most common organism (n = 579 strams; 88.4% of the total). MEM and 
TAZ were the most active antimicrobial agents against these isolates (85.3 and 
89.5% cumulative suscephbdiv, respectively). 
Conclusion: Data from t h i s  5-year study period show no evldence of 
increasing resistance among Gram-negative organisms to meropenem in 
German hospital units where this carbapenem is prescribed. However, 
continued surveillance is needed, in order to monitor any future resistance 
trends. 
m] Analysis of 5-year antimicrobial surveillance data 
from the MYSTIC program in Italy (1997-2081) 
E. Giacobone, E. Romero, P. Cipriani, R. Sessa, R. Fontana, G. Lo 
Cascio, G. Nicoletti, G. Russo and G. Bonfigho 
Pauia, Rome, Vmonu, Catania, I 
Objective: The MYSTIC (Meropenem Yearly Susceptibility Test Informa- 
tion Collection) Program is a global longitudinal antimicrobial surveillance 
study that collects isolates h m  intensive care units (ICU), neutropenia units, 
cystic fibrosis (CF) centers and general wards where meropenem (MEM) is 
prescribed. The four participating Italian centers represent each of these four 
types of hospital unit. Here we present a summary of combined cumulative 
data from 1997 to 2001. 
Methods: Organisms were tested using National Committee for Clinical 
Laboratory Standards (NCCLS) methodology. Minimum inhibitory concen- 
tration (MIC) values and percentage susceptibilities at NCCLS breakpoints 
(%S) were obtained for MEM and a range ofcomparators including imipenem 
(IPM), ceftazidime (CAZ), piperacan + tazobactam (TAZ) ciprofloxacin 
(CIP) and gentamicin (GM). 
Results: The four Italian centefs contributed a total of 2654 Gram-negative 
and Gram-positive isolates between 1997 and 2001, the most common isolate 
of those collected and tested being P am@nosa (n = 841; 31.7%). Just under 
half of the P~enrginos~ isolates (n=411) were obtained &om the CF unit, 
while 235 were &om the ICU. E. coli (14.5% overall) was the most common 
isolate obtained h m  neutropenia units and general wards. Other common 
species were methicillin-susceptible S.  aurm (9.3%), K.pneumoniae (6.9%). 
E. cloacae (5.9%) and P mirabifis (5.1%). In general, the carbapenems (h4F.M 
and IPM) were the most active antimicrobial agents tested against the 
common organisms (range of susceptibility: 1*76.3% and 100-60.2%, 
respectively). The percentages of MEM was the same as or higher than 
IPM against every organism tested. Like MEM, TAZ also showed good in 
vitro activity against P aencginosa (>76% susceptible), however, the activity of 
CIP and GM against P aencginosa was relatively poor (<40% susceptible). AU 
the agents tested demonstrated a high potency against E. coli (84.6-1Wh 
susceptible) with the exception of CIP (67.7%). K.pneumoniae was 1Wh 
susceptible to MEM and IPM throughout the study period while the activity 
of the other agents was considerably lower (CAZ 78.1%, TAZ 75.4%, CIP 
61.8%, GM 78.1%). 
Conclusion: The carbapenems, in particular meropenem, remain the most 
active antimicrobials against the range of Gram-negative and Gram-positive 
bacteria isolated from various hospital units in Italy. There was no apparent 
increase in resistance to meropenem over the 5-year period. 
164 Abstracts 
LP785 I Antimicrobial resistance patterns from organisms 
causing bacteremia in European intensive-care unib. 
cumulative data from the MYSTIC program 
S. Unal 
Ankara, 711 
Objective: To determine the antimicrobial resistance of bacteria causing 
bacteremia in European intensive care units (ICUs). Data were analyzed 
from the Meropenem Yearly Susceptibility Test Information Collection 
(MYSTIC) Program. MYSTIC is a global, longitudinal surveillance study 
in which data are collected on antimicrobial resistance patterns from hospital 
centers where the carbapenem meropenem (MEM) is prescribed. 
Methods: National Committee for Clinical Laboratory Standards methodol- 
ogy were used to determine the minimum inhibitory concentration (MIC) 
values (mg/L) and susceptibility breakpoints of MEM and a range of other 
antimicrobial agents including imipenem (IPM), ceftazdime (CAZ), genta- 
micin (GM) or tobramycin (TM), piperacillin-tazobactam (TAZ), and 
ciprofloxacin (CIP). 
Results: A total of 2228 blood-culture isolates were obtained from ICUs in 
Europe during the period of 1997-2001. A wide range of organisms were 
collected and tested, the most common being methidlin-susceptible S. aureus 
(13.6%). E. coli (10.9%), S. epidermidis (8.8%), E.faecalis (8.3%). and Paerugi- 
nosa (7.6%). MEM, IPM, GM and TAZ demonstrated high potency for 
methich-susceptible S.  aurem (9497% susceptibility, = 0.25-4) and 
CAZ demonstrated the lowest activity (77% susceptibility, MICw= 16). 
MEM and IPM were the most active agents against E.coli (both 100% 
susceptibility, MICyO = 0.064-0.5) compared with the other agents tested 
and CIP was the least active agent (75% susceptibility, MIC90 = 32). MEM, 
IPM, and TAZ were most active against S. epidermidis (9697% susceptibility, 
MICK, = 2-4). CAZ and CIP were the least potent agents against S. epider- 
midis (64 and 66% susceptibility, respectively, MICw = 32 for both). IPM and 
TAZ demonstrated the highest activity against E.faecolis (93 and 91% suscept- 
ibility, MICW = 4 and 16, respectively) and CIP demonstrated the lowest 
(75% susceptibility, MICyo = 32). The antimicrobial agents that demonstrated 
the highest potency against I? aeruginosa were TAZ and MEM (79 and 75% 
susceptibility, MICw 2128 and 64, respectively). 
Conclusion: Carbapenems remain the most active antimicrobial agents against 
a broad spectrum of Gram-positive and Gram-negative blood-culture isolates, 
with meropenem demonstrating the highest activity against the majority of 
organisms isolated. CAZ, GM, and CIP generally demonstrated the lowest 
activities against the commonly isolated organisms. 
F I  Bacteremia in European neutropenic patients: a 
report from the MYSTIC Program 
R .  Masterton 
Edinburgh, UK 
Objective: The Meropenem Yearly Susceptibility Test Information Collec- 
tion (MYSTIC) Program is a global, longitudinal surveillance study initiated 
in 1997 that collects data on antimicrobial resistance patterns from centers 
where meropenem (MEM) is prescribed. The objective of this study was to 
examine the MYSTIC Program data in relation to bacteremia from European 
units with neutropenic patients and to id en ti^ any trends in antimicrobial 
resistance. 
Methods: Blood-culture isolates from neumpenic patients in Europe were 
speciated using standard methods. The minimum inhibitory concentrations 
(MICs) and breakpoint susceptibilities (Y') for MEM, and a range of 
comparator agents including imipenem (IPM), ceftazidune (CAZ), piper- 
acillin-razobactam (TAZ), ciprofloxacin (CIP) and gentamicin (GM) were 
determined using the National Committee for Clinical Laboratory Standards 
methodology. 
Results: To date, a total of 567 bacteremias (Gram-positive and Gram- 
negative) have been identified and tested from European neutropenia units. 
The most commonly isolated and tested organism were EEchm'ckia coli 
(30.3%). Pseudomonas aeruginosa (9.7%). Staphylocom aumus (7.9%), Sraphy- 
locorms epidermidis (7.4%) and Klebsiella pneumoniae (6.0%). 
The carbapenems, MEM and IPM, were the most active antimicrobial 
agents against all the most commonly isolated and tested organisms 
(?/& = 83.6-100%) with the exception of S. epidermidis against which TAZ 
(76.2%) and MEM (71.4%) were more active than IPM (66.7%). Activity 
against S.epidmidis was low for all antimicrobials with CAZ showing 
particularly decreased activity (51.3%). The activity of MEM was 2IPM 
against all the most commonly isolated organisms and notably greater than 
IPM against Paemginosa (94.6% vs. 83.6%. respectively). MEM was parti- 
cularly more potent than IPM against E. coli, I ? q ' n o s a ,  and K.pneumoniae 
(MICy0=0.064 vs. 1, 4 vs. 16 and 1 vs. 2, respectively). CIP generally 
exhibited poor activity against the most commonly isolated and tested 
Conclusions: The carbapenems MEM and IPM remain the most active 
antimicrobials against a range of Gram-negative and Gram-positive bacter- 
emia in neutropenic patients. MEM in particular demonstrated higher 
activity against P ueruginosa isolates compared with IPM (94.6 and 83.6%, 
respectively). Continued surveillance by the MYSTIC program appears 
prudent. 
organism (42.1-86.7%). 
I P787 I Comparison of antimicrobial susceptibility of 
organisms isolated from blood cultures and other sources: 
data from the MYSTIC Program in Europe 
H. Goossens and €? Turner 
T h e  MYSTIC Advisory Board, Europe 
Objective: To evaluate the antimicrobial susceptibility of organisms isolated 
from blood cultures (BC) and other sources, using data from the Meropenem 
Yearly Susceptibility Test Information Collection (MYSTIC) Program. 
MYSTIC is a global surveillance study, in which data are collected on 
antimicrobial resistance patterns from intensive care units (ICUs), hematol- 
ogy/oncology units, cystic fibrosis (CF) units and general wards, where the 
carbapenem meropenem (MEM) i s  prescribed. Evaluating the susceptibility 
patterns of invasive pathogens versus noninvasive pathogens is particularly 
important, due to the potentially greater threat of invasive pathogens to the 
patient. 
Methods: National Committee for Clinical Laboratory Standards methodol- 
ogy were used to determine the minimum inhibitory concentration (MIC) 
values (mg/L) and susceptibility breakpoints of MEM and a range of other 
broad-spectrum antimicrobial agents including imipenem (IPM), ceftazidime 
(CAZ), gentamicin (GM), piperacillin-tazobactam (TAZ) and ciprofloxacin 
Resultr: A total of 3136 BC isolates and 17261 non-BC isolates were 
collected and tested from 1997 to 2000. The same three organisms were 
isolated and tested most frequently fromBC and other sources: E. coli (16%), 
methicillin-susceptible S. aureus (12%), Paemginosa (8%) were the most 
common BC isolates and I? aenrginosa (21%). methicillin-susceptible S. aureus 
(14%), E. coli (11%) were the most common isolates from other sources. The 
higher proportion of Pawginma in non-BC isolates was derived &om 
respiratory samples fiom the CF units, which only provided non-BC data. 
MEM and IPM demonstrated the highest activity (greater percentage sus- 
ceptibility) against the Gram-negative organism E. coli and against the Gram- 
positive organism methicillin-susceptible s. aureus in both BC and non-BC 
isolates (97-100% for both). MEM and TAZ demonstrated the hghest 
activity against the Gram-negative organism I? aeruginosa from BC (81 and 
82% susceptibility, respectively) and non-BC isolates (79 and 84% suscept- 
ibility, respectively). 
Conclusion: We found no substantial Werence in the antibiotic susceptibility 
between BC and non-BC isolates. Carbapenems remain the most widely 
active antimicrobial agents against a broad spectrum ofisolates obtained &om 
bacteremic and non-bacteremic patients. 
(CIP). 
Antimicrobial resistance trends from intensive care 
units in Ostrava, Czech Republic: 5-year data from the 
MYSTIC program 
E. Chmelarova, V Tonova and A. Andelova 
Ostraoa, CZ 
Objective: To evaluate antimicrobial susceptibility patterns in organisms 
isolated over a 5-year period (1997-2001) h m  the four intensive care units 
(ICUs) of Ostrava Teaching Hospital, Czech Republic, participating the 
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 
program, a global longitudinal surveillance study evaluating resistance trends 
m units where meropenem (MEM) is prescribed. 
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Methods: Using National Committee for Clinical Laboratory Standards 
(NCCLS) methodology, minimum inhibitory concentration (MIC) values 
and susceptibility breakpoints were determined for 1025 Gram-negative and 
Gram-positive isolates obtained from patients in the ICUs. Organisms were 
tested against MEM and other antimicrobial agents including imipenem 
(IPM), ceftazidime (CAZ), gentamicin (GM), ciprofloxacin (CIP) and piper- 
acillin/tazobactam (TAZ). 
Results: The most common Gram-negative organisms tested were Pseudo- 
monus aetuginosa (9.3%), Escherichia coli (8.8%) and Klebsiella pneumoniae 
(8.2%) while the most commonly isolated Gram-positives were Enterococcus 
faeculis (17.9%) and methicillii-susceptible Staphylococcus aureus (16.8%). 
Susceptibdity rates to the carbapenems were greater or similar overall than 
those to the other antimicrobials for the most commonly isolated organisms. 
E.  coli and K. pneumoniae were 100% susceptible to MEM and IPM. K.pneu- 
moniae demonstrated relatively lower susceptibility to CIP (86.9%), CAZ 
(73.8%), GM (67.9%) and TAZ (67.7%). The susceptibility of I! amginma to 
all agents was lower (52.6-71.6%). but particularly for CIP and GM (both 
52.6%). The susceptibility of S. aureus to carbapenems was 100% during the 
surveillance period except in 2000 (both 93.3%). E.faecalis was more sus- 
ceptible to the carbapenems (71.6-94.5%) and TAZ (100%) than to the other 
antimicrobials (CIP 58%, CAZ 15.3%, GM 16.9%). Resistance rates to CIP 
for K. pneumoniae, E.&eculis, and I? aemginosa appeared to increase between 
1997 and 2001. No trend towards resistance to the other antimicrobials was 
observed. 
Conclusion: Carbapenems like MEM were consistently the most active of the 
antimicrobials tested overall against the commonly isolated ICU organism 
with no obvious trend to increased resistance over the 5 years. In contrast, 
steadily decreased susceptibility of several organisms to the fluoroquinolone 
was demonstrated over the surveillance period. 
wl Antibiotic susceptibility of Gram-negative bacteria 
isolated in the intensive care unit: 5years of the Meropenem 
Yearly Susceptibility Test Information Collection (MYSTIC) 
study 
J. Patzer and D. Dzierzanowska 
Warsaw, PL 
Objectives: To compare the in vitro activity of meropenem (MEM) and eight 
other antibiotics against Gram-negative bacteria isolated in the intensive care 
Methods: Gram-negative aerobes (n= 500) were isolated &om specimens 
obtained &om children hospitalized in an ICU during 1997-2001. The 
isolates were identified using conventional methods. Minimum inhibitory 
concentrations (MICs) of MEM, imipenem (IPM), piperacillin/tazobactam 
(TAZ), cefotaxime, cefcazidime, cefepime, ciprofloxacin (CIP), gentamicin 
(GM) and tobramycin (TM) were determined using the NCCLS agar dilution 
method. 
Results: MEM and IPM were active against >90% of Gram-negative isolates 
(Escherichia coli, Enterobacter cloacae, Klebsiella oxyfoca, K. pneumoniae, Serrafia 
marcescens and Acinetobucter baumannii], except Pseudomonas aemginosa. The 
carbapenems were highly active against the Enterobacteriaceae (MICgo 0.03- 
0.25mg/L MEM; 0.25-0.50mg/L IPM) even though there was a high 
prevalence of j-lactamase or AmpC-producing strains (>40%). The 
MICg0 for both MEM and IPM was l.Omg/L for A .  baumannii. For CIP, 
the majority of tested organisms had very low MICw values (0.015-0.5 mg/ 
L), except K. pneumoniae (2 mg/L in 1998), S. marcescens (16 mg/L in 2000 and 
2mg/L in 2001) and A.baumannii (4mg/L in 1997, 16mg/L in 1998, 
128mg/L in 2000 and 1 mg/L in 2001). MICw values for TAZ ranged 
between 32 and >128mg/L (44.0-77.3% susceptibility). GM and TM were 
active against 58.8 and 52.3% of isolates, respectively. The MICW (mg/L) for 
I? aetuginosa o f W  was 8 in 1997 and 2001, and for IPM the MIC90 was 16 
in 1997 and 2001. 
Conclusion: MEM and IPM demonstrated low MICw for tested strains in the 
children's ICU with no observed reduction in activity over 5 years. Carba- 
penem MICs for I! aeruginosa also appeared to remain stable during the review 
period. 
unit (ICU). 
F I  In vitro activity of meropenem, imipenem, 
piperacillinltazobactam, dprofloxacin, amikacin, and 
cefepime against P. ZWNQhWSa and A. baumannii isolated 
from Brazilian intensive care units - MYSTIC Study Group 
(Brazil 2001) 
C. Mendes, C. H e r ,  C. Oplusfil, S. Sinto, I! Turner, 
R. Jones and A. Hsiung 
On behagof the MYSTIC Study Group 
The selection of mdhresistant bactena has increased subsequent to the 
introduchon of a large number of anhbiohcs with various mechanism of 
achon. The scale of thu problem IS best exemphtied by the fact that most 
nosocornid mfechon, n d y  in ICUs, involve mdtiresistant bacteria produ- 
cing several types of enzymes such as extended spectrum 8-lactamases, 
depression of chromosomal ampC j-lactamases, plasmid-coded ampC 
j-lactamases in members of Enterobactenaceae, and rndhresktant Pseudo- 
monas amginosa and Acinetobacter baumannii. In this study, the invitm activities 
of rneropenern (MEM), impenem (IMP), piperacillin/tazobactam (PIP/ 
TAZ), ciprofloxacm (CIP), a d a m  (AMI), and cefepune (CPM) were 
momtored and compared against 135 ICU isolates of Pseudomom anuginosa 
(n = YO) and Acinetobar baumanraii (n = 45). Mmimal Inhtbitory Concenaa- 
tions (MICs) were determined by E-test methodology, using standardized and 
controlled procedures. Overall suscephbllity results, MICw and MICw values 
are shown m the table below. A high rate of resistance was noticed among the 
tested strains. Mempenem was the most acme agent against both species 
evaluated. Addihonally, the MICs for I? amginma were steadily lower when 
compared to mipenem. Towards Acinefobacter kurnannii, performances of 
meropenem and lrmpenem were sirmlar, showing much superior 
efficacy comparmg to other class of agents. Currently, as we can see, there 
are few altername therapies for lnfecnons c a d  by these two species. 
Infechon control measures, rational antibiohc policies and rapid laboratory 
detection of resistance are the key measures m preventing the spread of these 
Saains. 
MEM 72.2 7.8 20 0.38 >32.0 93.3 6.7 1.0 2.0 
IMP 66.7 3.3 30 1.0 >32.0 93.3 6.7 0.5 2.0 
Pmnm 76.7 23.3 4.0 >256.0 24.4 8.9 66.7 >256.0 >256.0 
CIP 53.3 2.2 44.5 0.38 >32.0 22.2 2.2 75.6 >32.0 >320 
AM1 60 4.4 35.6 8.0 >256.0 22.2 11.1 66.7 >256.0 >256.0 
CPM 71.1 11.1 17.8 4.0 32.0 26.7 2.2 71.1 %.O >256.0 
I P791 I Emerging resistance among Proteus mirabilis 
isolates in Europe: report from the MYSTIC program 
(1 997-2001) 
R. Jones, F! Turner and A. Mumck 
On behalf offhe MYSnC Study Group, Europe, North Liberty, USA; 
Mmlesjeld, UK 
Objective: Resistance (R) patterns that are currently problemahc m Europe 
(EU) can vary greatly m b  the same species over m e ,  among various 
pahent pOp&hOnS and among geographc rwons on the same conanent 
The results fiom the MYSTIC Program wbch momtors meropenern (MEM; 
a carbapenem)-R m mshtuhons using MEM, were used to dete-e R 
Merences among Pmrrabdis for EU from 1997 to 2001. 
Methods: MYSTIC collected MIC results from 688 I! mirubtlis stmns that 
were classfied mto pahent care groups ICU (n=426), neutroperua (m 
n = 145), general wards (n = 97) and cyshc fibrosis pahents (pts) (CF n = 20). 
A total of 31 centers from 10 countries pmcipated, dmded mto three regons 
(East, North, South). All testing was by reference methods and mterpreted by 
NCCLS criteria, lncludmg screerung of ESBL phenotypes (clavulanate 
inhblhon) SIX p-lactams, ciprofloxacin (CIP), gentarmun (GM) and tobra- 
mycin (TM) were tested 
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Results: Over the monitored 5 years, the R rates varied for each agent without 
a clear trend toward greater R. Rank order ofsusceptibility was: MEM (99%) 
>piperacillin-tazobaaam (TAZ; 96%) > cefepime (95%) > ceftazidime 
(CAZ; 94%) > imipenem (IPM 92%); CIP was least active (MICm, 4 mg/ 
k 86% susceptible). Unexpectedly, 3.6% of Pmirabilis were PM-R 
(MIC, 216mgL). Greater was found for strains &om NP and CF, for 
example 40-77% susceptibility to CIP Pmirabilis in East-EU sites were 
significantly more R to cephalosporins (ESBL rate, 24%). but CIP- and 
GM-R was greatest in South-EU centers. ESBL rates were 8% in North-EU, 
lmmunomodulation by antibiotics 
but >ZO% for the other geographic regions. Carbapenems (MEM > IPM) 
and the B-lacmase inhibitor combmahon (TAZ) remained most active 
overall. 
Conclusions: Normally susceptible species such as i? mirubilk have emerged as 
therapeutic problems in EU, following R mutations compromimg CP, CAZ 
and ammoglycoside use. IPM also showed decreased susceptibility of nearly 
7% compared to only 4% wlth MEM. Continued surveillance by the 
MYSTIC Program appears to be a prudent practice to guide effective empiric 
treatment regmens. 
Jp792) lmmunomodulating effects of antibiotics 
H. Ziglam, I. Daniels and R. Finch 
Nottingham, UK 
In addition to their well-known antimicrobial properties, antibiotics have also 
been shown to have a wide range of immunomodulatory effects. Isoniazid 
(INH) is an essential agent in the management of tuberculosis, while cipro- 
floxacin (CPF) is extensively used in treating many infective states. There i s  no 
published data with regards to INH, and only limited information on CPF 
regardmg their possible effects on the idammatory response. We have 
evaluated the effect of INH and CPF on reactive oxygen species (ROS) 
generation by human neutrophils with lucigenix-dependent chemilumines- 
cence assay using N-formyl-L-leucyl-phenylalanine (FMLP), phorbol-12- 
myristate-l j-acetate (PMA) stimulation or spontaneous lucigenin-enhanced 
chemiluminescence. INH at concentrations of 1.25 mg/L sigtllftcantly inhib- 
ited cheduminescence, while CPF had no inhibitory effects at concentra- 
tions achievable in man. We have also examined the effect ofINH and CPF on 
cytokine expression by monocytes obtained &om healthy human volunteers 
and stimulated with either lipopolysaccharide on heat-killed S ~ A ~ ~ ~ ~ O C O C C U S  
aureus [Pansorbin]. INH at level achievable in man suppressed the in vitro 
synthesis of interleukin-la (IL-la), and IL-10. However, there was no 
significant in vitro effect on the synthesis of IL-6 and tumor necrosis factor 
alpha. In contrast, CPF exhibited signifcant inhibitory effect on all tested 
cytokines in a concentration-dependent manner at lewls ranging fiom 1.25 to 
lOmg/L. These effects were not due to any direct effect of the drugs on 
cellular viability as determined by ATP assay. These results reveal that INH 
and CPF possess si&icant immunomodulatory activity in vitro and suggest 
that suppression of acute-phase in8ammatory responses may occur in vivo by 
modiijmg human monocyte's cytokine synthesis. 
Moxifloxacin inhibits staphylococcal superantigen- 
induced apoptosis in T lymphocytes 
B. Konig and W. Konig 
Magdeburg, D 
Objectives: Staphylococcus auras represents a potent threat to both healthy and 
immunocompromised indwiduals. In this regard, S. nureus is a major cause of 
respiratory infection, including patients with cystic fibrosis (CF). The clinical 
isolates release a wide array of toxins including superantigem, which cause 
extensive T-cell proliferation, induce the release of excessive quantities of 
cytokines and promote programmed cell death. Programmed cell death or 
apoptosis is shown to be of central importance in immune functions. As the 
number of immunosuppressed patients requiring antibiotic treatment is 
increasing, the impact of antibacterials on immune responses has become 
of increasing interest. Therefore, we attempted to determine the modulatory 
role of the new antistaphylococci fluoroquinolone modoxacin on super- 
antigen-induced apoptosis. 
Methods: Moxifloxacin was used at physiological concentrations, which can 
be found in the serum of moxifloxacin-treated patients. For this purpose, the 
effects of staphylococcal enterotoxin B (SEB) on regutatory molecules in 
apoptosis (TNF-RI, Fas, Fas-L) on human peripheral blood mononuclear 
cells and Jurkat cells were analyzed in the absence and presence of moxi- 
Boxacin. 
Results: Modoxacin inhibits apoptosis as well using annexin V binding to 
Jurkat cells by FACS analysis. Furthermore, modoxacin suppressed the 
expression of Fas, FasL, TNF-RI mRNA in the absence and presence of SEB. 
The two death receptors, TNF-RI and Fas, promote apoptosis when activated 
by their ligands, e.g. TNF-a and FasL, respectively. Therefore, we further 
analyzed whether modoxacin modulates the apoptotic pathway induced via 
the TNF-RI and Fas molecule. For this purpose Jurkat cells, sensitive to 
TNF-a and anti-Fas mediated apoptosis were left untreated or were treated 
with TNF-a, with anti-Fas or with TNF-a plus anti-Fas in the presence and 
absence of moxifloxacin. 
Conclusion: The results clearly show that moxifloxacin influences apoptosis as 
could be demonstrated using amexin V binding to Jurkat cells by FACS 
analysis. The inhibitory effects of moxifloxacin on apoptosis were at least due 
to the inhibition of caspase-3 activity shown by enzymatic "say. The findings 
support the theory that modoxacin might diminish cell injury by inter- 
ference with apoptotic effector molecules. 
vl Moxifloxacin modulates effector functions of 
human neutrophils 
W. Konig, R. h o l d ,  B. Konig and C. Freytag 
Magdeburg, D 
Objectives: Evidence has been obtained that m d o x a c i n  exerts immuno- 
modulatory effects in human effector cells, which then improves host defense 
mechanisms. In the present studies, modoxacin, clindamycin, rifampicin 
and ampicillin were interacted with human neutrophds which were subse- 
quently stimulated with the bacterial peptide fMLP or the phorbolmyristate 
acetate (PMA), a protein kinase C activator. 
Methods: The following parameters were investigated (1) the expression of 
CD62L, CDl lb, chemotaxin receptor CXCR2, fTklLP-receptor by FACS 
analysis, (2) by ELISA the release of cytokines IL8, TNF-a, of the prostanoids 
leukotriene-B4, prostaglandin-E, the release of elastase, bacterial killmg for 
MSSA and E. coli, (3) by RT-PCR the expression of chemotaxin receptors 
CXCR1, CXCR2, Toll receptors 2 and 4, cyclooxygenase 2 and S-lipox- 
ygenase. 
Results: Each compound exerts individual and different characteristics as to 
the above parameters. Modoxacin induces: (1) enhanced bacterial killing in 
neutrophils, (2) suppresses PMA and MP-induced leukotriene-B4 forma- 
tion with regulatory activity on prostaglandin-E2, (3) increased IL8 induction, 
(4) enhanced CXCR2 and fMLP receptor expression on the surface, and also 
(5) modulates the mRNA expression for chemotaxin receptors and Toll 
receptors. 
Conclusions: The data clearly indicate that various compounds behave 
Merently and also that moxifloxacin most likely via defined cell biological 
propeaies of the signal d u c t i o n  cascade exerts potent immunomodula- 
tory activities which are supportive in host defense and bacterial clearance 
beyond its effects on individual microorganisms alone. 
/p7951 Ciprofloxacin versus ceftazidime in cytokine 
generation in severe sepsis 
A. Lekkou, E. Drosou, H. P Bassaris and C. A. Gogos 
Pahas, GR 
Objectives: To determine the effect of ciprofloxacin and ceftazidime on 
cytokine production in patiena with severe sepsis, 
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Patients and methods: Forty-two patients with severe sepsis (septic SIRS plus 
at least one organ dysfunction) were randomized to receive either cipro- 
floxacin 400 mg x 3/day i.v. (n= 22) or ceftazidime 2 g x 3/day (n = 20). 
Both groups were matched for age, sex and simplified acute physiology I1 
score. Serum cytokine levels were determined by using Elisa (Quantikine, R 
& D Systems, Minneapolis) on admission and 48 h during treatment. 
Results. No diflerences in tumor necrosis factor-a (TNF-a), interleukin-1 
(IL-l), IL-6, IL-1 receptor antagonists (ILlra), soluble TNF receptors 
(sTNFR-I and 11) were found between the two treatment groups on 
admission and 48h during treatment. Although, baseline IL-10 levels in 
ciprofloxacin-treated group were not sigmficantly Merent from the ceh-  
zidime group (147.23 =k 70.06 vs. 139.81 + 51.3 pg/mL.), we detected a 
sigdcant increase in serum IL-10 levels 48 h post-treatment in patients 
receivingciprofloxacin compared to those under cefiazidime (154.00 f 64.01 
vs. 117.58*44.04, P=O.O42). In order to investigate the effect of both 
antimicrobials on anti- versus pro-infiammatory response, we compared the 
ratio of I L l O  : TNF-a in both the groups. No sigmficant differences were 
noted between the two groups on adrmsion, while 48 h during treatment a 
significant decline of IL-10 : TNF-a ratio was observed in the ceftazidime 
compared to ciprofloxacin group (1.96f 1.26 vs. 3.1411.57, P=O.Ol). 
Conclusion: It seems that ciprofloxacin but not cefiazidime induces a sig- 
&cant anti-inflammatory response through an increase of IL-10 : TNF-a 
ratio in patients with severe sepsis. This immunornodulatory effect might be 
important for the outcome of such patients as the excess proidammatory 
response could be deleterious. 
[p796 Quinolone antibiotics have selective effects on 
polymorphonuclear leukocyte functions 
A. Williams, H. Galley and N. Webster 
Aberdem, UK 
Objectives: Polymorphonuclear leukocytes (PMN) have an important role in 
innate immune responses and damnat ion ,  through phagocytosis and 
intracellular killing, and cytokine release. We have shown previously that 
moxifloxacin (Bay 12-8039, Bayer PIC) has profound inhibitory dects on 
interleukin-8 (IL-8) release from human PMN at therapeutic concentrations 
[l]. Ciprofloxacin has also been shown to modulate IL-8 and IL-6 release h m  
PMN and endothelial cells via effects on transcription (2, 31. The effect of 
moxifloxacin and ciprofloxacin on other aspects of PMN function are not 
known. We therefore investigated the effect of these antibiotics on PMN 
release of the enzyme myeloperoxidase from activated human PMN in vitro. 
Methods: PMN were isolated f?om 15 healthy volunteers aged 20-47 years, 
following Ethical Committee approval and informed consent, using single 
density gradient centrifugation. Cells were incubated with 2 pg/mL lipopo- 
lysaccharide (LPS) plus 0-50 pg/mL moxifloxacin or C-100 pg/mL cipro- 
floxacin at 37 "C in 95% air/5% COz for 24 h. Myeloperoxidase was measured 
in cell culture supernatants using enzyme immunoassay. Data are expressed as 
median (range) and were analyzed using Friedman analysis of variance. 
Results: Despite the marked effects ofboth ciprofloxacin and moxifloxacin on 
IL-8 release, there was no effect on the release of myeloperoxidase from LPS- 
stimulated PMN. Concentrations remained constant at all concentrations of 
both antibiotics (Fig. 1). 
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Figure 1 
Condusions: The immunomodulatory effects of moxifloxacin and c~pro- 
floxacin in terms of PMN function are specific and do not represent general- 
ized effects on cellular activity. 
Acknowledgment: We are grateful to Bayer AG for financial support. 
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m1 Impact of carbapenem administration on 
endotoxin and interleukin-6 blood levels of septic patients 
I. Pavleas, N. Archontoulis, E. J. Giamarellos-BourboU, A. Mega, 
K. Rigas, N. Scarpa, F. Giardina, N. Kaantzis, H. Giamarellou and 
G. Thomopoulos 
Athem, GR 
Objective: It has been proposed that a-lactams may elicit the in vim release of 
endotoxins (LPS) by Gram-negative bacteria so as to perpetuate the inflam- 
matory response. In the present study, endotoxemia was monitored following 
administration of imipenem and meropenem in critically ill patients. 
Methods: Eleven septic patients aged 75.5 f 8.7 years with 6.5 f 4.3 SOFA 
score were enrolled in the study score. All had Gram-nepative bacteremia 
(Pseudvmonac aerugiinos: five; Mebsiellapneumoniae: three; others: three); seven 
were administered i.v. imipenem 1 g tid and four meropenem 2 g tid. Blood 
was collected by venipuncture at regular time intervals before and after the 
initiation oftherapy. LPS was assayed by LAL. QCL-lO00, interleukin-6 (IL-6) 
by EL4 and C-reactive protein (CRP) by nephelometry. 
Results: Mean levels of LPS before administration of imipenem and 1,2,4,6, 
12,24,48 and 72 h after administration of imipenem were 5.22,2.90,4.97, 
2.67, 3.10, 2.67, 18.82, 3.93 and 2.02IU/mL, respectively. At the respective 
time intervals for meropenem, mean LPS were 3.37, 1.86, 3.00, 3.47, 3.23, 
2.67,3.42,4.87 and2.63 IU/mL. Mean levels of U-6 before administration of 
imipenem and 1,2,4,6,12,24,48 and 72 h after administration of imipenem 
were 161.9, 140.9, 158.4, 149.3, 148.3, 148.5, 50.1, 76.2 and72.1pg/mL, 
respectively. At the respective time intervals for meropenem, mean IL-6 were 
1029,214.3,170.9, 188.2,160.6,89.7,1S7.1,241.2andl99.1~//mI,Mean 
levels of CRP before administration of imipenem and 24,48 and 72 h h e r  
administration of imipenem were 135.9, 147.7, 133.6 and 120.6mg/L, 
respectively. At the respective time intervals for meropenem, mean CRP 
were 133.1, 160.3, 148.9 and 78.7mg/L. 
Conclusions: Systemic endotoxemia does not dig,, considerably following 
intravenous administration of imipenem or meropenem so as to change the 
concentrations of IL-6 and CRP which are markers ofsystemic inflammation. 
Both carbapenems may be administered in critically ill patients without fear of 
antibiotic-induced endotoxemia. 
(p7981 Effects of doxycycline on human 
polymorphonuclear leukocyte (PMN) function 
A. Naess 
Bewen, N 
Objectives: Some in vitro studies have suggested that tetracyclines have 
depressive effects on polymorphonuclear leukocyte bct ion.  We 
have previously found doxycycline in vivo and in vim to be associated with a 
decrease in human PMN Fc-gamma-receptor expression. In the present 
study, we examined the effects of pure and commercial preparations of 
doxycycline on PMN chemiluminescence and random migration. 
Methods: PMNs were incubated in dilutions of pure and commercial 
(Vibramycin (R), Pfizer, NY) doxycydine. Chemiluminescence following 
zymosan phagocytosis was recoded in an automatic photoluminometer. 
Random migration was measured in cap- tubes. 
Resutts: Incubation in increasing (25-200 pg/mL) concentrations of doxy- 
cycline resulted in decreased chduminescence and tube migration (less 
than 50% of conerols at 200 p g / d ) .  In contrast, incubation in %bramy&@ 
was associated with mean values of chemiluminescence and tube migration of 
between 80 and 95% of controls for all concentrations. 
Conclusion: These results show that incubation in increasing concentrations 
of doxycyche is associated with decreasing Ph4N chemiluminescence and 
tube migration. However, this finding was absent with a commercd dox- 
ycycline preparation containing ascorbic acid as a preservative. This suggests 
caution in interpreting the results of in vim studies of the effects of 
doxycycline on PMN function. Such studes with pure doxycycline may 
not be relevant in vivo when commercial solutions are used. 
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Variation in the propensity to release endotoxin 
after cefuroxime exposure in different Gram-negative 
bacteria: uniform and dosedependent reduction by the 
addition of tobrarnycin 
G. Goscinski, M. Lundhoh, I. Odenholt and J. Sjolin 
Uppsala, S 
Gram-negative (G) bacterial infections associated with shock still have a 
high mortality rate despite optimal treatment. Endotoxin (E), a major 
constituent of the outer cell membrane of the G bacteria, is a potent 
stimulator of the systemic inflammatory response and has been considered 
to play an important role in the pathophysiology ofseptic shock. In a previous 
study, we have shown that the cefuroxime (CEF)-induced E fiom an 
E .  colr strain could be considerably reduced by the addtion of tohramycin 
(TM). 
Objectives: The aim ofthis study was to investigate whether this response was 
generally applicable to other G bacteria. 
Methods: The release of E from Werent strains of Eschm'chiacoli, Mebsiel- 
lapneumoniae, Salmonella entm'tidis and Neisseria meningitidis was studied in 
vitro. The strains in logarithmic phase were exposed to 2, 10, and 50 x MIC 
of CEF, TM and a combination of CEF and TM, respectively. Samples for 
In vitro evaluation of antimicrobials in enterococci 
viable counts and E were drawn at 0, 2, and 4 h. All the experiments were 
made in triplicate. For the analysis of E, a chrornogenic LAL assay was used. In 
an additional experiment with the K,pneumoniae strain exposed to 2 x MIC 
of CEF, TM, and the combination, the starting inoculum was varied fiom 103 
to 107 bacteria/mL. 
Results: The MICs of the strains varied h m  0.05 to S.Omg/L for CEF and 
&om 0.75 to 2.0 mg/L for TM. The experiment with varying inoculum sizes 
demonstrated that there was a propomonal and sigdcant linear relationshp 
between the E release and the number of killed bacteria for each antibiotic 
(P< 0.001). Therefore, the propensity to liberate E was expressed as the E 
release per killed bacterium. After 4 h, the CEF-induced E release per killed 
bacterium (CEF 2XMIC) was 3.7+0.9 (+SE), 2.5+0.7, 5.7+1.0, 
2.3 + 1.7, 7.7 + 1.8, and 0.4+ 1.43 X iO-3EU per killed bacterium for 
the three E .  coli strains, K.pneumoniae, S.  entwitidis and N. meningitidis, respec- 
tively. This E liberation was sigrufcantly and considerably lower for al l  strains 
when exposed to TM or the combination than to CEF alone (P<O.OOl), 
except for N. meningitidis for which only a nonsigdcant trend was seen. With 
increasing doses of TM or the combination, the E release was significantly 
reduced (P< 0.05). 
Conclusion: There was a large variation between the tested strains in the 
propensity to release endotmin. However, regardless of the strain, TM 
sigdcantly reduced the CEF-induced endotoxin release despite a htgher 
k&ng rate. 
vl Evaluation of antimicrobial resistance in 
Enterococcus spp. isolated in Romania from January 1999 to 
December 2000 
M. Ghita, M. Pana, R. Papagheorghe, N. Popescu, L. Vasile, 
M. Andrei, V. Ungureanu, S. Iacob and D. Andnes 
Bucharest, RO 
Objectives: To study the antibiotic resistance in enterococci. 
Methods: A total of 288 Enterococnrs strains isolated between January 1999 and 
December 2000 were collected from: urine (N=144), surgical wounds 
(N= 76). others (N= 68): drain, bile, blood, prosthesis, catheter, CSE 
peritoneal fluid, sinus. The strains were characterized by using standard 
protocols and tested for B-lactamase. The enterococci were studied for 
susceptibility to nine antibiotics: penicillin (Pc),  ciprofloxacin (Cip), ery- 
thromycin (Em), chloramphenicol (Cm), tetracycline (Te), gentamicin (Gn), 
streptomycin (Str), vancomycin (Va), teicoplanin (Tei) by two methods: 
screening agar plates and agar dilution according to NCCLS recommenda- 
tions. 
Results: The data were analyzed according to NCCLS 1999 and showed the 
following aspects: 78.1% strains were identified as E.faecalis, 15.9% as 
E. faecium, 2.08% as E .  durans, 1.4% as €. auium, 1% as E. cassel@vus, 0.7% 
as E. hirae, 0.3% as E .  rafinosus, and 0.3% as E.gallinumm. Penicillin resistance 
was seen in E.faecium only: 80% (MICsO: 32 mg/L, MCW: 128 mg/L). No B- 
lactamase producers were detected. Ciprofloxacin resistance for E.faeCum was 
80% (MIC5[,: 32mg/L, MIC90: 128mg/L) and for E.fecalis was 12.5% 
(MICso: 1 mg/L, MICgo: 4 mg/L). Em resistance for E.faecium revealed 
67.5% (MICso: 128 mg/L, MICw: 256mg/L)and for €.faecalis 40.6% 
(MIC5o: 1 mg/L, MICw: 256mg/L). Cm resistance for E.faecium was 
12.5% (MI&,: 8mg/L, MICgo: 32mg/L) and for E.faecalis 30.5% 
(MICso: 8mg/L, MI&: 64mg/L). Resistance to TC was observed for 
E .  faecium 92.5% (MIC5o: 64mg/L, MICw: 128mg/L) and for E. faecalis 
91.5% (MICso: 128mg/L, MICgo: 256mgIL). Concerning E.faedum high 
level resistance (HLR) to Gn was 69.5% and to Str  43.4%. For E.fecalis HLR 
resistance to Gn was 14% and to Str 39%. No resistant strain to Va, Tei was 
found (vancomycin 8mg/L was detected in three motile enterococci, 
Conclusions: Enterococci phenotypes to Pc, Cip, Em, Crn, Gn and Str 
Mered among species. HLR was increased in E.fadum, versus E.faecalis. In 
the future, more prudent policy for antibiotics, but preserving for seriously ill 
and immunosuppresed patienu is needed. 
only). 
JP8011 A rnulticentre European study on the prevalence 
of glycopeptide resistance among clinical isolates of 
enterococci 
G. Privitera, I? Courvalin, A. Porretta, D. Jabes, R. Rossi 
and G. Mosconi 
On behalf of the European Ramoplanin Study Group 
Objectives: To assess the prevalence of glycopeptide-resistance in cltnical 
isolates of enterococci (GRE) &om hospitahzed patients in Europe and to 
determine their susceptibility to ramoplanin. 
Methods: Between March and June 2001, 13 clinical microbiology labora- 
tories in eight European countries prospectively collected all isolates of 
enterococci. A total of 1317 nonduplicate strains, identified as enterococci 
according to standard laboratory methods, were tested for glycopeptide 
resistance by plating on vancomycin screen agar (VSA) supplemented with 
vancomycin, 6 mg/L. For all strains that grew on VSA, the minimal inhibitory 
concentrations (MICs) of vancomycin and te icophn were determined by 
E-test. Species confirmation and susceptibility testing by microdilution 
(NCCLS) were performed in a single laboratory. 
Results: A total of 50 (3.8%) strains were confirnied to be GRE, with a 
prevalence varying widely between laboratories, and ranging fiom 0 to 50.0%. 
The mean country rates (%) were Austria (1 lab) 0, France (two labs) 1.1, 
Germany (one lab) 2.5, Italy (three labs) 20.6, Spain (two labs) 3.1, the 
Netherlands (one lab), UK (one lab) 10.4. The strains were identified as 
E.faerium 28 (56%), E.faecalis 12 (24%), E.gallinamrn 6 (12%), E. cosselijlavus3 
(6%) and E.species 1 (2%). A total of 36 out of 40 (90%) E.faecalis and 
E.faen'um isolates were ofVanA type ofresistance. The sites ofisolation were: 
blood or i.v. catheter 17 (34%), wound infection 11 (22%). urine 8 (16%), 
respiratory tract 4 (8%) and other 10 (20%). The wards involved were intensive 
care 19 (38%), hematology-oncology4one marrow transplant unit 5 (10%). 
surgery 6 (12%). medicine 5 (lo%), transplant units 3 (6%) and other 12 (24%). 
Ramoplanin was uniformly active against GRE regardless of species and 
phenotype, with a MICw of 0.5 mg/L. 
Conclusions: Although a great variability was observed between participating 
centers and countries, GRE were isolated at sigmflcant rates in intensive care 
units (7.7% of all enterococci) and fkom clinically relevant sites, representing 
10.2% of bloodstream and 6.4% of wound infection isolates. GRE epide- 
miology deserves careful survedlance at least in hlgh-risk wards. b o p l a n i n ,  
which is effective in suppressing gastrointestinal carriage, may be useful in 
preventing GRE infection. 
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vl Characterization of enterococci isolated from 
nosocomial infections in a university hospital in Greece 
E Kolonitsiou, D. Klefiogiannis, G. Dimitracopoulos 
and I. Spihopoulou 
Pafras, GR 
Objective: Enterococcal infections are becoming an increasing concern, 
particularly due to the emergence and spread of resistance to antimicrobial 
agents. A total of 121 enterococci recovered &om inpatients during the period 
of April 2OOO-October 2001 have been studied for their phenotypes. 
Materials and methods: All isolates were characterized at species level by 
Gram stain, catalase production and by the Crystal ID Gram-Positive System 
(BBL). B-Lactamase production was tested by nitrocefin disks (Difco). 
Minimal inhibitory concentrations (MIC) to the antimicrobials: ampicillin 
(Amp), erythromycin (Em), chloramphenicol (Cl), gentamicin (Gm), cipro- 
floxacin (Cip), vancomycin pa), teicoplanin (Tp), quinupristin/dalfopristin 
(Rp) and linezolid (Ln), were performed by the E-test (AB Biodisk) according 
to NCCLS recommendations. 
Results: Fifty E.fecalis, 62 E.faecium and 9 other species (4 E. hirae, 2 
E. duranr, 2 E.gallinarum and 1 E. auium isolates) have been identitied No 
isolate was found to be B-lactamase producer. The clinical sources included 
blood: 17 isolates (7 E.faecaIis, 9 E.ferium, 1 other spp.); urine: 29 isolates (17 
E.faecalis, 11 E.faecium, 1 other spp.); catheter tips13 isolates (7 E.fuemlir, 6 
E.faecium); wounds and iutra-abdominal: 62 isolates (19 E.faecalir, 36 E.fe- 
cium, 7 other spp.). Fifty-eight (93.5%) E.jzeci'urn and 2 E.faecaliswere resistant 
to ampicfin, while 55 (88.7%) and 29 (58%) to erythromycin, respectively. 
Forty-two (67.7%) E.faen'um isolates were of the VanA phenotype. Thirty 
E.faecium (48.3%) and 16 E.faecds (32%) showed a high-level resistance to 
gentamicin. Sixteen E.faecium (25.8%) and all the other enterococcal species 
(100%) were resistant to quinupristddalfopristin, while the MIC to linezolid 
ranged from 0.5 to 6 mg/L among all species. 
Conclusions: Glycopeptide-resistant enterococcal infection is emerging as an 
important problem in our hospital. The idendftcation of quinupristin/ 
dalfopristin-resistant isolates is a threatening problem for hospitalized patients 
as well. Since these observations suggested a sigmficant nosocomial problem, 
hrther infection control measures should be applied. 
Antimicrobial resistance of Enterococcus spp. from 
systemic and urinary tract infections (UTI) (1991-2000) 
T. Turcu, V Luca, R. Scum, C. Petrovici, R. Fantanaru 
and C. Dorobat 
Zasi, RO 
Objective: To evaluate Enterococnrs species distribution and antimicrobial 
resistance in different clinical forms of infection, in order to monitories 
etiological therapy. 
Methods: A total of 454 strains of Enterococcur spp. from hemocultures (46) 
cerebrospinal fluid (19), different collections (loo), i.v. catheters (18) and 
urine (217) were isolated and identified by conventional methods. Anti- 
microbial resistance and sensitivity were determined by disk diasion test 
(NCCLS guidelines). 
Results: Enterococcal infections (sepsis, meningitis, localized infections, UTI) 
were caused in 88% by Enrerocouus faecalis. Resistance to penicillin and 
ampicillin was 55.5%, respectively, 44.3%. In contrast, only 1.5% strains 
were resistant to ampicilln/sulbactam and 14% to amoxicillin/clavulanic 
acid. 44.5, 31.6 and 64.8% enterococci were resistant to erythromycin, 
chloramphenicol and tetracycline. High-level resistance to gentamicin was 
of 26.2%. Sensitivity to imipenem was 100% and two strains (out 57 tested) 
were resistant to vancomycin. There were dif€erences between systemic 
mfections and UTI isolated enterococci, the last being more resistant to 
antimicrobds. 
Conciusions: Enterococci resistance to common antimicrobials was relatively 
high (31-44%), the strains being pluriresistant. Resistance to B-lactamd 
inhibitor of B-lactams was 8% on average, depending on specie and infection 
localization. vancomycin resistance was uncommon (<1%) and all strains 
were susceptible to imipenem. 
wl Prosthetic valve endocarditis due to 
vancomycin-resistant Enterncoccus faecium (VREFI treated 
successfully in the setting of quinupristin/dalfopristin (QP/ 
DP) failure 
A. Safdar, S ShnSOn, D E. Saunden, Jr and C S Bryan 
Columbia, USA 
Introduaion: Early prosthehc valve lnfechons are serious and associated wth  
hgher mor&ty, especially m the sethng Of rndhdrug resistant mcroorgan- 
isms Optimat antlimcrobiat therapy for endovascular idectlons due to VREF 
remam uncertam 
Resub A 68-year-old Caucasian woman presented with low-grade fever, 
dyspnea, and fahgue 4weeks followmg e k h v e  aorac valve replacement and 
coronary artery bypass surgev Her past mehcal h to ry  was remarkable only 
for adult-onset dabetes mehtus, whch was well controlled. PhyslcaI exam- 
mahon revealed her to be m mld resplratory distress, and a md-systohc 
murmur mth mechmcal heart sounds. All surgcal wounds were well healed 
and there were no cutaneous or mucosal shgmata of endocardltls. Laboratory 
stu&esshowedthefollowmg:WBC9.8 K/pL,platelet210K/pL,AST29U/L, 
ALT 15U/L, and ESR 97mm/h. Transesophageal echocadogram showed 
an dl-dehned, moblle mass rneasurmg 0.5 cm at the p r o d  aomc root. All 
peripheral blood cultures (SIX sets) grew VREF wth  hgh-level resstance 
to pemcfin G (>16pg/mL), a m p i c h  (>256pg/d),  genrarmcin 
(>1024pg/mL), and vancomyun (>256pg/mL). Imhd therapy wth van- 
comycm was changed to QP/DP (7.5 mg/kg every 8 h). Blood cultures on 
day 5, day 8, and day 12 followng QP/DP therapy remned posihve. On day 
12, treatment mth chloramphemcol (2g dady), and doxycychne (200mg 
M y )  was started and QP/DP was msconanued. Blood cultures on days 4 
and 6 ofnew antlrmcrobial regunen were sterde. She was comdered too hgh- 
risk for repeat aorhc-valve replacement surgery Medcal treatment 
was contmued for 8weeks. On 18-month follow-up, no recurrence was 
observed. 
Conclusions: In our pahent, coadmuustrahon of chloramphemcol and 
doxycyche for persistent refkctory bacterema and probable prosthehc 
aorac-valve endocardm had favorable outcome and therapy for 2months 
was tolerated mch no adverse events 
(p8051 Vancomycin-resistant enterococci are prevalent in 
urban sewage and in sewage from a hospital in the 
Stockholm area of Sweden 
A. Iversen, I. Kiihn, A. Franklin and R. Mollby 
Stockholm, Uppsala, S 
Objectives: Enterococci are members of the normal gut flora of animals and 
humans, and are &us, released into the environment directly or via sewage 
outlets, where they can survive for long time periods. Their role in noso- 
comial infections has increased due to their ability to acquire high-level 
resistance to antimicrobial agents that make them difficult to treat. In Europe, 
the use of the growth promoter avoparcin is considered to have selected for 
vancomycin-resistant enterococci (VRE). Sweden ceased using avoparcin 
1986 and only occasional cases of clinical VRE have been reported since 1995. 
Within the h e w o r k  of a European study, samples &om urban raw sewage, 
treated sewage, surface water and hospital sewage in Sweden were screened for 
m. 
Methods: VRE were isolated both through enrichment in broth supple- 
mented with vancomycin and through membrane filtration followed by 
growth on agar lates with vancomycin. The isolates were phenotyped with 
the PhenePlateTM rapid screening system and genotyped with PFGE. All 
isolates were subject to antimicrobial susceptibility testing. Detection of the 
resistance genotypes uanA and uonB and idendfication to the species level of 
E.faecalir and E.faecium were done by PCR. 
Results: VRE were isolated from 21 of 35 (60%) untreated sewage samples, 
h m  5 of 14 (36%) hospital sewage samples, from 6 of32 (19%) treated sewage 
samples and &om 1 of 37 surface water samples. Thirty-five isolates from 33 
samples were characterized with the specified methods. Most isolates (30 of 
35) carried the uanA gene and the majority (24 of 35) of the isolates were 
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Enterococcus faenurn. Most of the VRE were multiresistant. The typing revealed 
a high diversity for the isolates. However, one major cluster with seven 
identical or similar isolates w a s  found. These isolates came from three different 
sewage treatment plants and were collected at Werent occasions during 
1 year. All VRE h m  hospital sewage originated from one ofthe two hospitals 
studied. That hospital also had a consumption of vancomycin 10-fold that of 
the other. 
Conclusions: We conclude that VRE were commonly found in sewage 
samples in Sweden. The origin might be healthy individuals or individuals 
in hospitals. Alternatively, antimicrobial drugs or chemicals released into the 
sewage system may sustain VRE in the system. 
I P806 1 External quality control of a multicentre European 
study on the prevalence of glycopeptide resistance among 
clinical isolates of enterococci 
M. Chauvel, P. Courvah, A. Porretta and G. Privitera 
On behalf .f the European Ramoplanin Study Group 
Objectives: Estimation of the variability of the results of in vitm susceptibility 
tests among 13 clinical microbiology laboratories in eight European countries 
participating in a multicenter study on the prevalence of glycopeptide- 
resistance enterococci (GRE). 
Methods: The minimal inhibitory concentrations (MICs) ofvancomycin and 
teicoplanin were determined by E-test against E .  fiecium UA210 ( VanA-type 
of resistance), E.faecalir UA605 (Van€?), E.gallinorum UA604 (Vanc), and 
E.faerium UA392 (susceptible). Each laboratory proceeded from 4 to 10 
independent determinations of MICs, with a total number of 904 measure- 
ments. One center was not included on the basis of a too low number (<5 per 
strain) of determinations. Variance analysis with two criteria (strain-center), 
by the method of the complete blocks with repetitions and the protected least 
significant different test (PLSD) of Fisher, were carried out with StatViewTM 
sofhnare. MIC values were converted into clinical categories and analyzed by 
the X2-test. 
Results: There was full concordance in terms of clinical categorization among 
all centers for vancomycin and teicoplanin resistance ofE.fecium UA210 and 
for vancomycin resistance of E.fuecalis UA605; however, three laboratories 
found the latter strain teicoplanin-resistant, which represents a discrepancy. 
E.gallinarurn UA604 was correctly categorized as vancomycin intermediate 
and teicoplanin susceptible except by one center which displayed great 
variability (from 12 to 256 mg/L) among the different, MIC determinations 
for vancomycin. E.faecium UA392 was categorized as glycopeptide suscep- 
tible by all centers but two, which reported it as intermediate in two and four 
instances, respectively. 
Conclusions: The overall concordance of data for c h c a l  categorization of 
glycopeptide susceptibility of enterococci was high. Three out of 12 labora- 
tories, however, failed in identifying correctly the VanB phenotype of 
resistance. There were more minor discrepancies for vancomycin than for 
teicoplanin. 
Prevalence and resistance phenotypes of 
glycopeptide-resistant enterococci from hospitalized 
patients during a 2-year period 
D. Mylona-Petropoulou. H. Vagiakou-Voudris, A. Vkhaki, A. Sideri, 
S. Politaki and H. Malamou-Lada 
Athens, GR 
Objectives: To study the prevalence and resistance phenotypes of glycopep- 
tide resistant enterococci (GRE) isolated f b m  chical specimens, obtained 
from hospitalized patients, during 2-year period (November 1999-Novem- 
ber 2001). 
Methods: Enterococcal strains were identified and tested for antimicrobial 
susceptibility with the automated Vitek-I1 system (bioMhrieux, France). The 
susceptibility was also tested by d i s k - W o n  procedure according to 
NCCLS standards. 
Results: During 2-year study period, 60 GRE strains were isolated from 51 
patients. Most of them were hospitalized in the ICU (36/51) and the 
Hematology Unit (5/5 I). The isolated strains included 28 (46.7%) Enterncoccus 
&ecalis, 31 (51.7%) E.&ecium and 1 (1.6%) E. carselfitnu. Thuty-one strains 
were recovered h r n  blood cultures, 4 from peritoneal fluids, 10 from pus and 
15 from venous catheters. Fifty-four (90%) GRE strains were resistant to 
vancomycin and to teicoplanin (MIC > 32 mg/L), which characterizes VanA 
glycopeptide resistance. Five (8.3%) GRE strains were resistant to vancomycin 
(MIC > 32 mg/L) and susceptible M teicoplanin (MIC < 0.5-1 mg/L), EnB. 
One strain w a s  idenhfied as E. casselzjbvus with MIC = 8 mg/L to Mncomycin 
and <0.5mg/L to teicoplanin, VmC. All E.faernlis/faecium strains were 
resistant to quinolones (MIC > 8 mg/L), lincosamines (MIC > 8 mg/L) 
and streptomycin (hgh level), while they were sensitive to tetracycline 
and chloramphenicol. E.faecalis strains (n = 28) were sensitive to ampicillin 
(MIC < 2 mg/L) and 67.8% (19/28) of them were resistant to gentamicin 
(high level). E.faecium strains (n=31) were resistant to ampicillin 
(MIC > 32mg/L) and 32.3% (10/31) of them were resistant to gentamicin 
@gh level). E. casselifivus was resistant to clindamycin (MIC > 8 mg/L) and 
tetracycline (MIC > 16 mg/L). 
Conclusion: Glycopeptide-resistant enterococci have become an increasing 
problem in our patients, especially in ICU and Haematology Unit. Most of 
them belong to VanA phenotype with high level aminoglycoside resistance. It 
is worthwhile to emphasize the isolation of VanB and VanC resistance 
phenotypes from our patients. 
vl First cases of vancomycin-resistant enterococci 
infection in a university hospital, Greece 
A. Christidou, E. Stathatou, M. Roumpelaki, V. Sagia, A. Gikas and 
E. Scoulica 
Heraklion, GR 
Objective: To study the first vancomycin-resistant enterococci (VRE) infec- 
tions in our hospital. 
Material and methods: On December 18, 2000, the fust case of VRE 
infection was detectedin our hospital. From December 18, ZOWJanuary 19, 
2001, four other VRE infections appeared. The clinical and epidemiological 
features of these cases were studied and the isolates were investigated by 
conventional and molecular methods. 
Results: Case no. 1 was a 78-year-old woman in renal dialysis. She had 
developed respiratory infection and pleuritic fluid. VRE was isolated f b m  
pleuritic fluid on the 43rd day of hospitalization. She had received cefaos- 
porins, aminoglycosides, imipenem, vancomycin and fluconazole. Case no. 2 
was a 36-year-old man treated in the orthopedic ward and VRE was isolated 
Gom decubitus ulcer on the 1 lth day. He had received norfloxacin, ceftriax- 
one, and doxycycline. Case no. 3 was a 70-year-old woman who had 
undergone a surgical operation because of bowel rupture and was admitted 
in intensive care unit (ICU). VRE was isolated from peritoneal fluid on 10th 
day. She had received ciprofloxacin, vancomycin, and piperacillin/tazobac- 
tam. Case no. 4 was a 52-year-old man suffering Gom quadriplegia. He had 
been treated in ICU for 15 days, in neurological ward for 60 days, and in 
pathological ward for 3 days. VRE was isolated fium decubitus ulcer on 78th 
day. He had received vancomycin, piperaciUin/tazobactam, and imipenem. 
Case no. 5 was a 70-year-old man who was admitted in ICU because of crush 
syndrome. He had undergone a surgical treatment. VRE was isolated Gom 
peritoneal fluid on 23rd day. He had received vancomycin, ciprofloxacin, 
ticarcillin/clavulanic acid, and imipenem. One VanB Efaecium strain was 
isolated from each of the patients no. 1, 2, and 5. Each of these strains 
presented a different antibiotic susceptibility profile. Four VnA E.faecium 
strains with Uerent  antibiotic susceptibility profiles and 1 VanCE.gallinamm 
were isolated from patient no. 3. One VanA E.faen'um and 1 VanA E.faeculis 
were isolated &om the patient no. 4. The patients no. 1,4, and 5 died, while 
the patients no. 2 and 3 were discharged fium the hospital. During the next 
6 months, no other case of VRE infection was determined in our hospital. 
Conclusion: The first five cases of VRE infection occurred in our hospital 
during a short period (lmonth), but a spread of a unique clone did not 
proved. VRE epidemiology needs more investigation. 
Ip809 General characteristics and antimicrobial 
susceptibility of vancomycin-resistant enterococci isolated 
from clinical specimens 
A. Xanthaki, V. Skandami, V. Karabassi, M. Toutouza, K. Zambitha 
and C. Kontou-Castellanou 
Athens, GR 
Objectives: The aim of this study was to examine the characteristics and 
resistance profde of VRE isolated from clinical specimens in our hospital. 
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Methods: The study was performed on 18 strains of enterococci all vanco- 
mycin-resistant as determined by the disk-diffusion method. They were 
isolated h m  clinical specimens between January and October 2001 in OUT 
hospital. Sources of these specimens included blood (7), urine (4). central 
catheter tips (3), wound (2), sputum (l), drainage (1). Species identification 
was pelformed using the VITEK 2 system. Enterococcal strains were tested for 
the production of&lactamase. Disk-diffusion test results were compared with 
those of VITEK 2 and E-test methods. Antimicrobial agents tested included 
ampicdlin, penicillin, ciprofioxacin, vancomycin, teicoplanin, quinopristin/ 
dalfopristin (VITEK 2, E-test) and linezolid (E-test). The strains were also 
tested for the presence of hgh level gentamycin (HLGR) and streptomycin 
(HLSR) resistance. 
Results: E. fmciurn was the most fkequently isolated species (13/18 strains) 
followed by E.faecalis (5/18 strains). No organism was found to produce fi- 
lactamase. Two E.  faecalis isolates reported as vancomycin resistant by disk- 
diffusion method were susceptible to the antibiotic by VITEK 2 and E-rest 
methods. AU other isolates were tested highly resistant to vancomycin 
(2256 pg/mL) and teicophin (216 pg/mL) suggesting for the presence 
of a vanA phenotype. All E.faen'm isolates were uniformly resistant to 
ampicdlm and penicillin and all E.faerdis isolates sensitive to those two 
antibiotics. All enterococcal isolates were resistant to cipmfloxacin. All 
E.fiecalis and all but one Efaeciurn isolates were tested positive for the 
presence of HLGR and HLSR. AU E.faecalk isolates were uniformly resistant 
to quinopristiddalfopristin but the antibiotic showed relatively high activity 
against E.fecium isolates with only 2/13 strains tested resistant. All VRE were 
tested sensitive to hezolid. There were no dxrepancies between results 
obtained by the VITEK 2 system and E-test method. 
Conclusions: E.jaecium was the most fkequently isolated VRE with high 
level of resistance to many antibiotics (multiple drug resistant). Newer 
antibiotics such as quinopristin/dalfopristin andlinezolid show good promise. 
Identification of VRE to the species level and knowledge of the type of 
resistance is critical for infection control purposes in the hospital environ- 
ment. 
ml Vancomycin-resistant enterococci: a prospective 
microbiological and clinical study 
E. Cercenado, S. Cercenado and E. Bouza 
Madrid, E 
Objectivsr: To evaluate the incidence and clinical s e c a n c e  of vancomy- 
&-resistant enterococci (VRE) in a teaching g e n d  hospital over a 13-year 
period. 
Methods: From July 1988 (when the first VRE was isolated in our hospital) to 
December 2000, all VRE recovered in our microbiology laboratory were 
studied. The isolates were identified by standard methods and susceptibility 
testing was performed by the broth microdilution method following the 
NCCLS guidelines. All patients from whom VRE was isolated were pro- 
spectively followed up. 
Results: Over the study period a total of 18 277 enterococci were isolated. 
Among those, 130 isolates (0.7%) were VRE. The isolates were 71 E.fmciium, 
49 E.faecalis, 8 E. casselfivus and 2 E.gaZlinamm. From now on we will refer 
only to E.faecaZis and E.faeciurn (0.65%). Among those, 65 presented the VanA 
phenotype and 55 the VanB; 15% were ampich-resistant (all E.fapcium), 
20% presented high-level gentamicin resistance and 35% presented high-level 
streptomycin resistance. VRE were isolated from wounds (32), urine (30), 
blood (15). abscesses (12), peritoneal fluid (l l) ,  other sterile fluids (8) and 
miscellaneous (12), and corresponded to 108 patients hospitalized in 15 
diaerent wards. Seventy-two patients (66.6%) were infected and 36 were 
colonized. Among the infected patients (53% males, median age 65 years, 89% 
adults), 68 (95%) presented underlying diseases (45 organic, 21 tumoral and 2 
HlV positive) and 20 (28%) received prior glycopeptide therapy. In all cases, 
VRE was nosocomially acquired. Infections were: surgical wound (20), UTI 
(19), bacteremia (12), abdominal (12), abscesses (6), other (3). The infection 
was polymicrobial in 41 cases (57%). Eighty percent of the patients recovered 
despite inadequate treatment or no treatment, and 15% &ed, with a 5.5% 
mortality directly attributable to ERV int'ection. 
Conclusions: In our hospital, the rate ofVRE is low, representing 0.65% ofall 
enterococcal isolates. Only 66% of VRE have clinical significance and in 
general, infections due to ERV present good evolution despite inadequate 
antimicrobial treatment. 
Vancomycin-resistant enterococci OIRE): a point 
prevalence study of colonization in hospitalized patients 
and healthy hospital workers 
S. Gergm, A. W&, A. Karadenmh and B. Ates 
Kocaeli, TR 
Objectives: Following the frrst VRE infechon in our hospital, we inveshgate 
the prevalence of fecal carriage of VRE among patients and healthy hospital 
workers m a umversity hospital, m Turkey 
Methods: We carried out a pomt prevalence culture survey in a single day by 
culmrmg fecal samples of all hospitahzed pahents m intensive care umt and 
surgcal wards Rectal swabs were taken from 49 panents, 32 volunteer nurse/ 
doctors and cultured on blle escdn agar supplemented wth  10 pg/mL of 
vancomycin and 60 Irg/mL axreom. Escdm-poslt~ve colomes were ver- 
died wth  Gram stairung, p h d o n y l  peptihe (PYR) tests and the Vitec 
system. Vancomycm reslstance was detected by E-test. 
Results: Enterococci were rsolated from 5 of49 patients h m  all mtensive care 
unit and surgcal wards, 2 of 32 healthy hospital workers. All of the lsolates 
were Enfeerococcurfaenurn. None of the strams exhibited reslstance to vanco- 
mycin. 
Conclusion: After the first VRE infection observed in our hospital, OUT study 
on determination the rate of fecal colonmahon showed no carriage of= in 
our hospital 
wl In vitro activity of daptomycin against a 
prospective collection of European enterococci 
M. E. Jones, I. A. Critchley, D. C. Dragh~, J. A. Karlowsky, 
C. Thornsberry and D.E Sahm 
Hilversum, NL; Hemdon, Franklin, USA 
Objectives: Treatment of patients with vancomycin-resistant (VAN-R) and 
multidrug-resistant (MDR resistant to 2 3  antimicrobial classes) entemcocci 
infections, especially E.faecium (EM), is a common challenge faced by 
physicians worldwide. Daptornycin (DAP), a novel cyclic lipopeptide cur- 
rently in Phase I11 clinical trials, has shown in vim activity against both VAN- 
R and h4DR enterococci. This study examined the activity ofDAP against a 
current European collection ofenterococci to serve as a benchmark for future 
S t u d i e s .  
Methods: During 200C-2001,1840 E.faemlis (EF), 454 EM, and 160 other 
Entwococcus spp. (ESP; non-EE non-EM) were collected from 40 European 
laboratories in 15 countries. Isolates were centrally tested by NCCLS broth 
microdilution against ampi& (AMP), VAN, teicoplanin mI), cipmflox- 
acin (CIP), quinupristin/daEopristin (QD), linezolid (LZD), and DAP 
Results: The VAN-R rate among EE EM, and Esp was 2.2,25.1, and 10.6%, 
respectively. Nationally, EM VAN-R rates ranged h m  0% in Switzerland and 
Scandinavia to 60.6% in Italy. The percent resistance to other agents for EF, 
EM, and Esp, respectively, was AMP (0,69.8,37.5), TEI (1.9, 19.6,8.8), CIP 
(30.0.67.8, 31.3). and QD (82.1,3.5, 11.9). DAP showed equivalent activity 
against both VAN-susceptible (S) and VAN-R EF (MEw, 2mg/L), EM 
(MICw, 4mg/L), and Esp (MK&, 4mg/L). LZD aIso showed consistent 
activity against VAN-S and VAN-R isolates with MICw of 2 mg/L for all 
species. As expected, QD was not active against EF (MIC,. 8 mg/L; 82.1% 
R) but was consistently active against VAN-S and VAN-R EM (MICw, 
2 mg/L) and Esp (MICw, 4mg/L). Among the EM tested, 89 (19.6%) were 
MDR with resistance to AMP, CIP, and VAN being the most common 
phenotype (95.5% of MDR isolates). 
Conclusions: Overall, DAP demonstrated consistent MIC90 against all enter- 
ococci tested, regardless of VAN-R or MDR phenotypes. Based on these 
data, DAP may represent a potential therapy for the treatment of enterococcal 
infections. 
I PSI3 I in vitro activity of quinupristin/dalfopristin 
against vancomycin-resistant fntemoccus faeciun isolated 
from blood 
M. Bronk, A Samet, M Kochowska-Bmnk and L. Naummk 
Cdansle, PL 
Objectives: To determne the m vlw actlvlhes of qumuprlstm/daEopristm 
(Q/D) for c h c a l  isolates of vancomycm-resstant LhnA Enteromcus 
faeciurn (VREM) Qnmupnstln/dalfopristm is a new parenteral annbtonc 
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combination belonging to the streptogramin group, leadmg to an irreversible 
mlubition of bacterial protein synthesis. 
Methods: The activity of Q/D was assessed against 12 clinical isolates of WnA 
VREM isolated hom blood. The minimal inhibitory concentrations (MIC) 
Q/D was determined by the E-test method. 
Results All isolates of VREM were found susceptible to Q/D. These isolates 
were characterized by MIC values of 4-8 pL/mL. 
Conclusion: The study revealed a very good activity of Q/D against VREM. 
The antibiotic may be useful in treatment of serious infections caused by 
multiresistant E.faetium. 
1 P814 1 Linezolid-iittle biological variation in wild type 
populations of Gram-positive bacteria 
Klxjo, Stockholm, s 
G. Kahlmeter and M. Rylander 
introduction: Already, linezolid resistance has been described in vancomycin- 
resistant Enterococcus spp. and in tnethicillin-resistant S t a p h y l m m s  aureus 
Representing the first drug of its class to come on the market and exhibiting 
no mechanistic cross resistance with other classes of drugs, linezolid offers the 
first real chance ofsuccessfully counteracting resistance development through 
strategic measures such as limiting the use of the drug and combating the 
spread of resistant bacteria through infection control. The present study was 
performed to elucidate the biological variation within wild type strains of 
target microorganisms. 
Material and methods: A representative prospective selection of micro- 
organisms (see below) fioni 25 Merent geographical areas of Sweden was 
investigated with E-test (AB Biodisk, Sweden) and disc-diffusion (linezolid 
10pg disc from Oxoid, UK) by 25 laboratories. All laboratories simulta- 
neously analyzed three type strains for comparison. 
Results: The inhibitory concentrations (nig/L) obtained for 125 isolates of 
each of S. aureus, coagulase-negative staphylococci, Enterococnrs Jaecalis and 
E.faecium and Streptococrus pneumonioe were between 0.125 and 2 mg/L. The 
degree of biological variation among the wild-type strains was exactly of the 
same magnitude as the variation obtained when three representative type 
strains were analyzed under the exact same conhtions. 
Discussion: The national breakpoint committees in Europe have decided on 
the following brekpoints: BSAC and SRGA S 5 4, R 2 8, CRG S 5 2, 
R > 8, SFM S _< 2, R > 4 mg/L and the ESCMID breakpoint committee 
EUCAST S 5 4, R > 4mg/L. All the breakpoints seem appropriate; neither 
of them will split homogenous biological wild-type populations and all of 
them will allow the early detection of resistance development. The linezolid 
resistance that has so far been described in VRE and MRSA have generated 
MICs of >32mg/L and should be easy to detect with a reasonably standard- 
ized MIC- and/or agar disc-dffusion methods. The fact that the ranges of 
MICs and zone diameters were identical for the clinical isolates and the type 
strains shows a lack ofbiological variation withm the wild-type population of 
a species and emphasizes the importance ofnot splitting wild-type populations 
with breakpoints. 
Fecal carriage of vancomycin-resistant enterococci 
in patients of the university hospital, Crete, Greece 
A. Cbnstidou, E. Scoulica, M. Roumpelaki, V. Sagia, S. Maraki and 
A. Gikas 
Heraklion, CR 
Objective: To investigate fecal colonization of vancomycin-resistant enter- 
ococci (VRE) among the patients of the hospital, 1 month after the appear- 
ance of first cases of VRE infection. 
Material and methods: The study was performed on 1 February 2001. All 
patients (98) cared in high-risk departments were tested, from which four in 
intensive care unit (ICU), 7 in cardiological intensive care unit (CICU), 72 in 
renal unit, and 15 in neonatal unit. In parallel, a representative number of 120 
(25.8%) out of the 465 patients treated in all other wards of the hospital were 
also tested. Fecal samples or rectal swabs were inoculated into enterococci 
broth with vancomycin (6mg/L) and subcultured onto bile-eseuhn agar 
plates with vancomycin (6 mg/L). Enterococci were identified in genus and 
species level by conventional methods and specific PCR. Glycopeptides 
susceptibility testing was performed by disk-difbion method, E-test, and 
MIC (by agar dilution method). Glycopeptides resistance types were con- 
firmed by multiplex PCR. Sex, age, days of hospitalization, surgical and 
antibiotic treatment, hospitalization in ICU, and renal dialysis were studied as 
risk factors. 
Results: A total of 218 samples were tested and 42 VRE strains were isolated 
&om 41 patients. Glycopeptides resistance types were as follow: VanA 
E. faetium, 4; VanB E.faecalis, 1; VanB E,faecium, 7; VanC1 E.gallinarum, 
24; VattCZ/C3 E. casselt@zpavus/j7aoescens, 6. VRE were detected in 25.5% of all 
patients treated in high-risk departments: 50% in ICU, 14.3%in CICU, 6.7% 
in neonatal unit, and 29.2% in renal unit. VRE were also detected in 16 
(13.3%) of 120 patients tested. Vm4 strains were detected only in high-risk 
departments. No sigdcant Merence was found regarding sex, age, duration 
of hospitalization, surgical and antibiotic treatment, except glycopeptides 
(14.6% in VRE colonized patients vs. 5% in no VRE). Hospitalization in ICU 
wasin 17%ofVREcarriersversus9.6%ofnoVREandrenaldialy~isin 51.2% 
Venus 28.8%, respectively. 
Conclusions: Ditferent VRE strains were isolated from patients in the hospital. 
Higher prevalence of VRE! colonization was found in ICU and renal unit. 
Treatment with glycopeptides, admission in ICU and renal dialysis were 
detected as risk factors. 
Fl prevalence of gastrointestinal carriage of 
glycopeptide-resistant enterococci in Europe 
G. Privitera, F? Courvalin, A. Porretta, D. Jabes, R .  Rossi and 
G. Mosconi 
O n  behalf of the European Ramoplanin Study Group 
Objectives: To assess the prevalence of gastrointestinal carriage of glycopep- 
tide-resistant enterococci (GRE) among hospitalized patients in Europe and 
to determine the ramoplanin susceptibility of the isolates. 
Methods: During the second quarter of 2001, 3499 stool samples were 
processed for GRE by 13 laboratories in eight countries. Samples were plated 
on vancomycin-cohtir-naliin-nalidixic acid Agar (VCNA) containing vancomycin 
6mg/L and for all strains identifted as enterococci the minimal inhibitory 
concentrations (MICs) of vancomycin and teicoplanin were determined by 
E-test. Species confirmation and susceptibility testing by microdilution 
(NCCLS) were performed in a single laboratory. 
Results: A total of 388 (11.1%) samples were confrmed to yield GRE, 
prevalence, however, varied widely among laboratories, ranging from 1.7 to 
39.1%. The mean country rates ("h) were Austria (one lab) 5.9, Belgium (two 
labs) 4.4, France (two labs) 7.0, Germany (one lab) 4.6, Italy (three labs) 20.0, 
Spain (two labs) 8.5, UK (one lab) 39.0. The strains were identified as 
E.gallinamm 178 (46%), E.faecium 117 (30%), E. casselijlavus 75 (19%), 
E.faecalis 14 (4%) and E. species 4 (1%). One hundred and fourteen out of 
131 (87%) Efaecalir and E.Jm'um isolates were ofthe VanA type ofresistance. 
The wards that contributed the majority of st ra ins  were intensive care 127 
(32%), hematology-oncology-bone marrow transplant unit 91 (23%) and 
medicine 74 (19%). Ramoplanin was active against all GRE regardless of the 
resistance phenotype, with a 
Conclusions: Despite the fact that ward or patient selection and local 
epidemiology may have duenced  the results, intestinal GRE carriage 
appears to be increasing in Europe, involving mainly high risk patients 
admitted in intensive care or oncohematology wards. Ramoplanin, that 
has been shown to be effectiiw in suppressing gastrointestinal GRE carriage 
in the USA, is also highly rffective in vim on European isolates. 
of 0.5 mg/L. 
vl The comparison of high-level aminoglycosides 
resistance in vancomycin-sensitive and vancomycin-resistant 
enterococci strains 
H. Yazgi, M. Ertek, S. Erol and A. Ayyddiz 
Erzumm, TR 
Objectives: Today, enterococci are among common causes of nosoconual 
morbidity and mortahty. Recent attention has been focused on enterococci 
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because of their importance not only in nosocomial infections but also their 
increasing resistance to antibiotics. One of the most important antibiotic 
resistance is high level aminoglycoside resistance (HLAR). The aim of this 
study was to investigate whether there was a significant distinction in high 
level anlinoglycoside resistance between vancomycin-sensitive enterococci 
(VSE) and vancomycin-resistant enterococci (VRE). 
Methods: In the study, 116 enterococci strains &om rectal swabs of 163 
hospitalized patients were investigated. Vancomycin resistance was deter- 
mined by screening test using brain-heart infusion agar (BHI) containing 
6 pg/mL vancomycin. The HLAR was determined by two different methods, 
the standard agar screening and the disk-difhsion screening method. Standard 
agar screening method was applied in  two BHI agar, one of which contained 
500pg/mL gentamicin and the other 2000pg/mL. The disk-diffusion 
method was performed on Mueller Hinton Agar by using two Merent 
antibiotic disks, one ofwhich contained 120 pg/mL gentamicin and the other 
300 pg/mL streptomycin. E.faecalis ATCC 51299 and E.faecalis ATCC 
29212 were included in the test as reference strains. 
Results: Vancomycin resistance was determined in 17 of 116 Enterococnrs 
strains tested. HLAR in VRE was found significantly higher than that ofVSE 
( P < O . O O l ) .  There was no significant Merence between the two methods 
with respect to HLAR determining rates of Enteromccus strains. Among the 
Enferococcus strains, 1 was found to be resistant only to gentamicin, the 11 were 
to only streptomycin and the 29 were to both. In the study, HLAR was 
determined in 41 of 116 strains (35.3%). 
Conclusion: HLAR rate in VRE was found two-fold higher than in VSE. 
But, clinical importance of HLAR in VSE strains is much more than the 
others. Because, the synergism among j-lactam antibiotics and aminoglyco- 
sides will not be seen in the treatment of infections due to VSE strains with 
HLAR. The causative agent should be examined for HLAR before admin- 
istering of p-lactam antibiotic plus aminoglycoside combination. 
I P818 I Antibiotic resistance and molecular identification 
of vancomycin-resistant enterococci isolated from patients 
and fecal carriers in a Greek hospital 
A. Christidou, A. Georghdakis, S. Mar&, S. Dimit~iou, A. Gikasand 
E. Scoulica 
Heraklion, GR 
Objective: To determine the susceptibilities of vancomycin-resistant entero- 
cocci (VRE) to 1 1  antibiotics in correlation with vancomycin resistance type 
detected by molecular methods. 
Material and methods: The first VRE strain was isolated in the laboratory in 
December 2000. From December 2000 to August 2001, a total of 60 strains 
were isolated from 6 patients and 45 fecal carriers. Enterococci identification 
was performed by conventional methods and confirmed by molecular assays. 
Susceptibilities to vancomycin (VA), teicoplanin (TEC), penicillin (PEN), 
streptomycin (STR), gentamicin (GM), tetracycline (TE), rifampicin (RA), 
chloramphenicol (CHL) erythromycin (ER), nor5oxacin (NOR), and imi- 
penem (IP) were detected by rksk-diffusion method, E-test and MICs by agar 
dilution method according to NCCLS guidelines. Glycopeptide resistance 
genotypes (VanA, k n B ,  knC1, VanCZ/C3) and species level identification 
of Efaecalis, E.fmcium, E. gallinarum, and E. rassef$avus/~escens were 
detected by multiplex PCR. 
Results: Vancomycin resistance genotypes and species distribution were as 
follow: VanA E.faecium, 8; VanB E.faecium, 16; VanA E.faecalis, 1; VanB 
E.faecalis, 1; VanCl E.gallinatvm, 27; VanC2/C3 E. casseliJavus/'vescens, 7. 
RangesofMICs toVAwere: VanAstrains256-1024mg/L, VanB 16-512mg/ 
L, and VanC 8-16mg/L; to TEC: 64256mg/L, 0.125-1 mg/L, and 1.5- 
1 mg/L, respectively. High-level resistance (HLR) to STR was detected in 
67% of VanA strains, 70% of k n 3 ,  and 3% of WnC. HLR to GM was detected 
in 44% of knA, and 47% of VanB. Resistance rates of VanA were as follow: 
PEN, 78%; TE, 67% RA, 55%; CHL, 44% ER, 100%; NOR, 55%; and IP, 
89%. VanB presented the following resistance rates: PEN, 94%; TE, 59%; RA, 
94%; CHL, 35%; ER, 100%; NOR, 94%; and IP, 100%. All VanCstrains were 
sensitive to PEN, CHL, and IP. Among L'nnC 20% were resistant to TE, 35% 
resistant and 6% intermediate resistant (IR) to RA, 23% resistant and 9% IR to 
ER, and 50% IR to NOR. 
Conclusion: VRE presented h h  resistance rates to the antibiotics 
tested. Multi-resistant strains were detected among VanA and VanB 
types. VanC strains presented lower resistance rates compared to VanA and 
VanB. 
Genetic relationship between wanA-containing 
Enterococcus spp. isolated from human and poultry in Korea 
Y. H. Choi, Y S Lee, J. K Lee, J. I. Yo0 C. K IClm, and B. S Kun 
Seoul, KOR 
Background: The number of vancomycin-resstant enterococci (VRE) iso- 
lated m terhary hospitals have been rapidly increasing mce  firstly reported m 
1992 m Korea. But the epidermobgy on mdespread rkssermnahon ONRE in 
Korea was not fully elucidated To iIWeshgate the posslbhty of horuontal 
transfer from poultry to human, we compared the phenotypic and genotypic 
characteristlcs of human isolates wth  poultry ones 
Methods: Total 148 Isolates, mcludmg 58 E.faen'um, 12 E.feaculu, 3 E. casseb- 
Javus, and 4 E.gallinatum from humans and 71 E.$enum from poultry, were 
studied A n m c r o b d  suscepubhty tests were done by cksk-ffision or agar 
dIhhOn methods. Pulsed-field gel electrophoresis (PFGE) was performed. 
The internal and structural regons of vanA gene cluster were analyzed by 
PCR fragment length polymorphm and EWLP 
Results: The antibiohc resstance patterns of human lsolates were different 
&om those ofpoultry ones. PFGE patterns revealed hgh heterogeneity. Three 
types of PCR fragment length patterns were found, as follows; (Yo) PCR 
amphcom of the same slze as prototype (E.faenum BM4147) for all genes m 
the v a d  cluster (13% of human Isolates, 100% of ooltry ones) (Yk)  
vanY lntergemc and Or$' repons (84, 0%). IS1216V and IS1542 were 
located wthm vanX-vanY mtergemc and orfz reg~ons, respechvely. 
The base pax variahon u1 vanX gene of human and podtry Isolates was 
not found. 
Condudon: Despite of the &verse PFGE patterm, 84% of human lsolates and 
all ofpoultry onesbelonged to vanA gene cluster type Yz and Yo,  respecnvely. 
These data suggest that vancomycm rsstance IS spread through horEontd 
transfer of the wnA genes within each groups, and there was low genetic 
rekhonshp between the vanA cluster of human and poulhy Isolates. Most of 
human isolates belonged to vanA gene cluster type 1s Merent from poultry 
ones. These data supported the low possibkty that VRE nolam h m  poulay 
contribute to wdespread hemna t ion  ln terhary hospitals in Korea, 
although vancomycm resistance would be horlzontally transferred wthin 
each group 
mserhon in vanx-vanY mtergemc regon (3%,0%) ( 2 ) m m n  m vanX- 
I P820 I ~~pressim of proteins in enterocorcal strains 
regulated by iron deficiency 
P K. Lisieclu, P Wysoclu and J M h c h  
Lodz, PL 
Objectives: Entemcocci as faCdtahVe anaerobes have an obhgate m n  
requrrement. The most produrnve m n  assdabon system c o m t  of a 
siderophore and the protem transport apparatus We have shown that enter- 
ococa pmduce hydroxamate type of siderophore. The a m  oftius study was to 
eshmate the expression of Iron-regulated protems 
Methods: Four stram of the genus Enferococnrs, isolated from the c h c a l  
material, were used m the study. Two of them belonged to the species 
E faecah-BL? 123 and BD 181, and the r e m m g  two to E famum-EN 5 
and EF 5 The str;uns were cultured in the iron-deficient me&um (0 35 m) 
and m mehum contammg excess m n  ( loom)  for 24 h. Total sderophore 
amount m the culture supernatants was determmed wth  the muvenal 
Chrome Azurol S method The whole cell fysates obtamed mth  lysozyme 
and by e e r e n h d  centrifugaaon were subjected to electrophoresis UI 12% 
polyacrylarmde gel (SDS-PAGE) under reducave condmons. 
Results: The inveshgated stram dlffered m the quanhty of the produced iron 
cbelatoa. The most achve producer was the E faecalis BD 123 stram, whch 
produced them in 8 45mg/mL quannty The smallest quanhty of sidero- 
phores -2 6mg/mL,wasproduced byE.faenumEN5. The E fueculuBD 181 
and E.faenum EN 6 strams produced 6.76 and 5 85mg/mL, respecnvely. 
None of the s m s  produced siderophores in the excess of Iron medmm. The 
compatlson of electmphorograms of the whole cell lysates harvested from 
deficient and excess iron mecha showed that under m n  deficlency addhonal 
protems appear m all the inveshgated strams. The Efaeaum EN 5 s t r a m  
synthesized only one addthod protern of 31 kDa molecular weight, s&ly 
as Efoenum EN 6, synthesumg one more protem of 24kDa molecular 
weight. A protem of 38 kDa molecular weight occurred m both E fmmhs 
strams-BD 123 and BD 181. The Efuecub BD 181 shwn synchestzed one 
more protein-of 35 kDa molecular weight, and E faecalu BD 123-f 
17kDa 
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Conclusions: Under conditions of iron deprivation all tested enterococci 
produce additional proteins. Their significance as the potential iron transport 
or iron receptor proteins has not be elucidated yet. 
1 P821 I Genetically related isolates among high-level 
gentamidn-resistant Enterococcus faecalis in Swedish 
intensive care units 
A. Hagren, B. Saeedi, B. Isaksson, H. Hanberger and L. E. Nilsson 
Lingkiiping, S 
Objectives: To investigate genetic relatedness among Enrerocom faecah 
isolated &om patients in Swedish intensive care units (ICUs) with specific 
focus on high-level gentamicin and ciprofloxacin-resistant isolates. 
Methods: Three hundred twenty-two (322) clinical enterococcal isolates 
were collected during 1996-1998 from ICUs at eight Swedish hospitals. 
MICs for 14 antibiotics were determined with E-test (AB Biodisk, Solna, 
Sweden). Isolates with high-level gentamicin-resistance (HLGR) and/or 
resistance to ciprofloxacin were selected for detection of genetic relatedness. 
Detection of related clones using pulsed-field gel electrophoresis of SmaI 
DNA macrorestriction fragments. 
Results No HLGR was found among the E.faecium isolates. Among the 244 
E.faecalis isolates, 48 showed HLGR, and all but one isolate were at the same 
time resistant to ciprofloxacin. Another 25 E.faecalis isolates showed cipro- 
floxacin resistance, but no HLGR. These 73 isolates were tested for genetic 
relatedness. Three clusters of PFGE patterns (I, I1 and 111) were found and 
several unique patterns. The isolates belonging to a cluster showed similarities 
in their antibiograms. Among isolates with HLGR almost 90% of the isolates 
belonged to cluster I or cluster 11, and only a few had unique PFGE patterns. 
Among the isolates with ciprofloxacin resistance but no HLGR most isolates 
had unique PFGE patterns, and 20% belonged to cluster 111. Cluster I was 
found in five hospitals, located in three geographically separated cities in the 
south-east of Sweden. Cluster I1 was predominantly found in one city in the 
south-west of Sweden. 
Conclusion: The results show genetic relatedness among E.faeca2is with 
HLGR in Swedish ICUs and suggest a spread of resistant clones within 
and between Swedish hospitals. 
w] Molecular epidemiology of vanA-containing 
Enterococcus faecium in a Korean hospital 
J.-Y. Huh, W.-G. Lee and S.-W. Kim 
Seoul, KOR 
Objectives: Vancomycin-resistant enterococci(VRE) has been isolated fiom 
hospitalized patienu worldwide. According to recent reports, molecular 
epidemiological studies of nosocomial spread of VRE indicate that the 
horizontal gene transfer plays an important role in the dissemination of 
vancomycin resistance. To better understand the spread of vad-containing 
enterococci in Korea, a series of v a d V R E  collected over a 15-month period 
fium Ajou University Hospital in Korea were analyzed. 
Methods: Seventeen isolates of vanA-containing enterococci were obtained 
from the patients of the Ajou University Hospital from January 1998 to 
April 1999. PFGE was pedormed with Smal for bacterial genomic 
heterogeneity. Restriction analysis of the long distance PCR amplicon by 
EaeI was performed for structural analysis of Tn1546. All isolates were 
typed by ORF-, vans-vanH-, Vanx-, vanY-Mnz, vanZ-, IS1216-, and 
IS1251-specific PCRs. Filter mating was performed to investigate transfer 
fiequency. 
Results: PFGE revealed coexistence of sporadic unrelated sadins and a 
predominant clone suspected of intrainstitutional spread. Restriction fiag- 
nient length polymorphism (RFLP) and PCR mapping ofTn1546 revealed 
two different patterns. The difference between the two of PCR mapping is 
whether the isolates contain larger vans-vanH amplicons and IS1251 or not. 
IS1251 represents 24% (4/17) ofthe isolates. Transfer efficiency ofAJ22 and 
AJ43 were 8.7 x 10' and 9.0 x 
Conclusions: Molecular typing of the uad-containing VRE in Ajou Uni- 
versity Hospital reveals a mixed pattern with clonal dissemination of strains 
and horizontal transfer of Tn1546. However, the horizontal hansfer of 
Tn1546 dominates the dissemination of vancomycin resistance. Therefore, 
epidemiologic investigation to target infection control of VRE should indude 
structural analysis of resistance gene and typing of bacterial genomic hetero- 
geneity, 
respectively. 
-1 Fingerprinthg of enterococa colonizing the 
respiratory tract of mechanically ventilated patients at a 
Swedish intensive care unit 
B. Lund, C. Agvald-Ohman, A. Hultberg and C. Edlund 
Huddinge, S 
Objectives: To investigate colonization of enterococci in the respiratory tract 
within and bemeen patients treated with mechanical ventilation at an 
intensive care unit (ICU) and to determine the antibiotic susceptibility 
pattern for the isolated enterococci. 
Methods: Twenty consecutive patients undergoing incubation at an ICU in a 
Swedish hospital were included. Samples were collectedhm the oropharynx, 
the subglottic space, the stomach and the trachea within 24 h of incubation 
and then every third day until day 18, thereafter every fifth day u n d  day 33. 
Enterococcal isolates were genotyped with pulsed-field gel electrophoresis. 
Minimal inhibitory concentration was determined against ampicillin, im- 
penem, vancomycin, gentamicin and moxifloxacin with agar dilution 
method. 
Results: Enterococci were isolated &om the respiratory tract in 17 patients, in 
12 of these 6om the lower respiratory tract. In 16 of the subjects were 
enterococci recovered from the respiratory tract already at the onset of 
incubation. Ten patients harbored only one enterococcal genotype. In three 
of five patients incubated 12 days or more the number of genotypes increased 
with time. Genotyping analyses suggested that seven Werent strains were 
shared by two or more patients. Thereby seemed 13 of the 20 patients to be 
involved in an enterococcal transmission event. Enterocornrs faecium was more 
resistant than Efaecnlis most commonly against ampiclllin (67%) and imipe- 
nem (58%). No vancomycin-resistant enterococci were isolated and high- 
level gentamicin resistance was rare. Moxifloxacin resistance occurred &e- 
quently. 
Conclusions: Occurrence of enterococci in the respiratory tract of this patient 
group was common. Transmission of enterococci between incubated patients 
appears to be a frequent event since 13 of the 20 patients shared one 
genotypically related s t r a i n  with at least one other patient. 
wl Comparison of random-amplified polymorphic 
DNA analysis, pulsed-field gel electrophoresis analysis, and 
amplified fragment length polymorphism for typing of 
vancomycin-resistant enterococci 
J. Lu, Y. Wang and S. Li 
Taipei, TW 
Fifty-seven vancomycin-resistant enterncocci (VRE), including 28 vanA 
Enterococcus faecalis and 29 vanB E.faecium, were isolated h m  nine hospitals 
in Taiwan during a period of 29 months. These isolates were genotyped using 
random-amplified polymorphic DNA (RAPD) analysis and amplified frag- 
ment length polymorphism (AFLP). Results obtained h m  these tests were 
compared with those derived h m  pulsed-field gel electrophoresis (PFGE), 
which is currently considered as the gold standard for VRE typing. The 28 
E.faecalis isolates were classified into 15 types by RAPD, 23 types by PFGE, 
and 24 types by AFLF! The 29 E. faecium were classified into three types by 
RAPD, eight types by PFGE, and nine types by AFLP. In general, data 
generated by PFGE and AFLP were consistent, whereas RAPD showed a 
lower discriminatory power than PFGE and AFLP for Werentiating VRE 
isolates. We conclude that AFLP is a useful alternative to PFGE for VRE 
typing. 
188251 Iron supply of enterococci by carboxylate 
compounds 
P. K. Lisiecki, P. Wysocki and J. Mikucki 
Lodz, PL 
Objectives: Enterococci have an obligate iron requirement but little is known 
about its assimilation. The aim of h s  study was the investigation of the 
utilization iron by enterococci with a-hydroxy or a-ketocarboxylate as 
siderop hores. 
Methods: The 79 strains of the genus E n t e r o m  belonged to 16 species 
of diverse origin were used. Twelve a-keto and a-hydroxy acids iron 
complexes serve as iron carriers. The solid medium containing ferric ions 
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chelator-o-phenanthrohe to ihlbit  bacterial growth was used The test of 
iron uthation was performed wth dlsc-d&mon techque  In the presence 
of iron complexes, growth ihb ihon  was reversed to provlde a zone of 
growth shrnulahon Uptake of 55Fe by cells medmted by a-hydroq and 
a-ketoacids was also esnmated. a-Keto acids released from cells to medlum 
were determned as of 2-qumohol denvahves by means of HPLC 
Results: All tested strams udzed  lron complex of citnc acid The m n  
complexes of a-keto and a-hydmxy acids have shmdated growth of 9 fiom 79 
enterococcal s t r a m  only All t b ~ ~  strms uhhzed m n  complexes of p y ~ v l c  
aad, a-ketobutyric acid, DL-a-8-methylvaleric and, a-ketoadrpic aad and 
a-ketoisocaproic aad provldmg the best growth response. Eight of those m e  
stmns uthzed addlhonally y-amnolevulernc acid and dOaCehc acid, 
COtlseCuhVe SIX strains a-ketomalomc and and a-ketoglutaric acid, four 
s t r m  p-phenylpyruvic acid, three stmns a-ketoisovdenc acid and two 
strains a-hydroksyphenylpyruwc acid a-Keto acids 111 bacterial culture 
supernatant of these m e  st rams were detected Increasing iron stress resulted 
m the extrachon of greater amounts of a-ketoacids. 
Conclusion: Enterococci commonly infect the urinary h'act Ths  infechon 
are often associated w t h  underlymg metabolic msorders whch can lead to 
increased COnCentrahOn of hydroxy and keto acids in urine. Enterococci are 
able to u&ze uon fiom complexes mth  those acids. T l s  abllity may be of 
great lmportance for s m v a l  m unne and enterococcal pathogemcity 
wl Gastrointestinal and skin colonization of 
enterococci in hospitalized patients in an university hospital 
in Turkey 
M. Erdenizrnenli, N. Yapar, N. Sezak, B. Karaca, H. Tarakci, S. Alp 
Cavus, Z. Gulay and A. Yuce 
Izmir, TR 
Objective: To evaluate colonization of Enterococrus spp. in antibiotic admini- 
strated hospitalized patients. 
Methods: We collected rectal and d a r  swab specimens from 133 patients 
who were hospitalized and given an antibiotic during at least past 2 days in 
Dokuz Eylul University Hospital, on September 26,2001. Bacteria grown on 
culture media were identified with Vitek system (bioMkrieux), and disk- 
difision method was used for determining antibiotic susceptibility. 
Results: Of 133 patients investigated, 62 (46.6%) were colonized with 
Enterococrus species. Of 68 isolates from 62 patients, 58 (85.2%) were isolated 
from rectal swab specimens and 10 (14.8%) were isolated 6om axillar samples. 
Point prevalence was calculated as 42.1% for gastrointestinal tract and 7.5% for 
a d a r  region skin colonization of enterococci. AU isolates obtained hum 
axillar swab samples were E. faecalis, but isolates from rectal swab specimens 
were E. faecalis, E.faecium, E.flavescens and E.gallinatum (67.3,27.6,2.4,1.7%, 
respectively). Three E.faeciurn strains were found to be resistant to vanco- 
mycin with MICs >32 mg/L. E.Jauescem and E.galZinatum strains were found 
to be susceptible to all antibiotics tested (Table 1). 
Fluoroquinolone resistance 
Table 1 Resistance rates of E foemlu and E faeciurn to the anhbloacs tested (96) 
Vancomyan Teicoplmn Ampmllm HLGR' HLSR' 
E. fmcalis 0 0 2.0 24.5 14.3 
E.foecium 18.8 18.8 0 62.5 50.0 
'HLGR: High level gentamicin resstance, 'HLSR: High level streptomycin resistance 
(%) . 
Condusion: No stahshcally sigruficant werence was found between pahent 
groups whch enterococn were lsolated or not isolated, in terms of age, 
gender, duranon of hospitahahon and anhbiohc adnurustranon But in the 
pahents m mtensive care units and department of oncology, d a r  coloma- 
non was found to be signlficantly hgher than the pahents m other wards of 
hospital 
Human Fe-transferrin and Fe-lactoferrin as iron 
sources in enterococci 
P. Lisiecki, I? Wysocki and J. Mikucki 
b d z ,  PL 
Objectives: lron is not largely available in human tissues. It is complexed with 
high-affinity iron-binding proteins transferring (TR) and lactoferrin (LF). In 
this study, we have tried to estimate the ability of enterococci to growth in 
serum and iron acquisition fiom human TR and LE 
Methods: The study was carried out on 20 strains of the genus Enterococcus 
belonging to the species E.  fumlis,  E.  faecium, E .  suljimus, E. mundtii and 
E. duram isolated from clinical material, animals and environment. The 
preliminary experiments involved checking the ability to grow in native 
human serum (containing Fe-TR and Fe-LF) and in serum where these Fe(1I) 
carriers had been maximally saturated with iron. The proper investigations 
involved utilization of 59Fe-labeled T R  and LE 
Results: Eleven of the 20 investigated strains grew in the native serum, 
whereas the iron-saturated serum stimulated the growth of only two strains. 
Seventeen of the investigated strains assimilated iron hum 59Fe-TR, whereas 
none of them utilized the iron knn 59Fe-LE It is in accordance to the 
physiology of iron assimilation by bacteria from systemic sources. All the 
strains growing in the serum assindated iron from 59Fe-TR. 
Conclusions: Over the half of the investigation strains have grown in serum 
with physiological 30% iron saturation of TR. Maximal saturation of TR did 
not stimulate either the growth of strains failing to grow in the native serum of 
those which grew in it. To lack ofLF utilization has corresponded with better 
iron availability in normal habitats ofenterncocci found-gztrointestinal tract 
and oral cavity. The ability to utilize iron bounding to TF may be of 
importance for promoting host colonization. 
I P828 I Genetic background of resistance to 
fluoroquinolones in epidemiologically defined clinical 
isolates of Acinetobacter baumannii 
H. WisphnghofF, M Decker, C Haeti, 0 Kmt, G Plum and H. Seifert 
Cologne, D 
To mvestigate the correlahon between mutahons in the gyrA and pad2 
genes and decreased suscephbhty to fluoroquinolones, 147 c h c a l  
lsolates of Annetobacter baumanm (outbreak related as well as sporadlc 
Isolates) hum Europe (n = 79) and the Umted States (n = 68) were examned. 
Orgamms were selected on the basis of ehb ihng  a unlque fin- 
gerprmt pattern as d e t e m e d  by randomly amphfied polymorphc 
DNA (RAPD) analysis and pulsed-field gel electrophoresls (PFGE) The 
in wtro actlvlties of ciproflaxacm, clmaflaxacin, gatifloxacin, gem- 
Ifloxacm, levofloxacm, mox&xacm, and mdoxam were dete-ed 
usmg agar dduhon. Q u o l o n e  resistance-deterrg repons (QRDR) 
of both gyrA and parC genes in all isolates were sequenced Mutanons in 
the gyrA gene were found in isolates w t h  a ciprofloxacin MIC from 2 4  to 
>lZSmg/L, addrhonal mutahons in the parC gene in isolates wth  a cipro- 
floxacin MIC of 264mg/L. Elevanon in MICs of novel qlunolones was 
sidarly correlated. In outbreak-related strams, mutabom were sigmficantly 
more fkquent than m sporad~ shams. Ammo aad exchanges in GyrA were 
Ser83 -+ Leu and Glu87 --t Gly conferred by a novel mufaaon. Other pre- 
vlously descnbed mUtahOnS in the gyrA gene could not be detected. In ParC, 
Ser80--tLeu and Glu84-+Lys were seen as well as Ser80-+Phe 
Ammo acid exchanges at Ser83 of GyrA were detected in 42 strams 
followed by subsntutions at  Ser80 of ParC in 20 strams Novel qmnolone 
compounds, especially clinafloxacin, were up to five nmes less affected by 
these mutahons Due to MIC-variahons in strains mth  idenhcal mUtahOIIS, 
other mechamsms are hkely to contribute to resistance to fluoroquinolones m 
A. baumannrr 
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In vitro selection of quinoloncresistant mutants of 
Escherichia coli ATCC 25922 by nalidixic acid, ciprofloxacin, 
clinafloxadn, levofloxacin, ofloxacin, sparfloxacin and 
trovafloxacin at different growth conditions 
H. J. Linde, B. Denkow and N. Lehn 
Repsburg, D 
Due to spontaneous mutations, quinolone-susceptible bacterial populations 
contain mutants resistant to quinolones. The mutant prevention concentra- 
tion (MPC) is the concentration of an antimicrobial agent necessary to 
prevent the growth of resistant mutants among lOElOcfu, and can be 
employed to compare different antimicrobial agents. We investigated in vitro, 
how different temperatures (37 and 20 "C) in aerobic and anaerobic atmo- 
sphere affected the number of mutants of Escherichiacoli ATCC 25922. 
Nalidixic acid (NA), nodoxacin (NOR), ciprofloxacin (CIP), ofloxacin 
(OFX), levofloxacin (LVX), trovafloxacin (TVA), and clinafloxacin (CLX) 
were compared for the selection rate of resistant mutants and MPC of 
-1OElOcfu of E .  coli ATCC 25922. The 2 x MIC (TVA), 4 x MIC (CIP, 
NOR, OFX), 8 x MIC (CLX, LVX), 16 x MIC (SPX), or 32 x MIC (NAL) 
were required to suppress the growth of resistant mutants among -1OElO du 
of E. coli ATCC 25922 at aerobic conditions. The MPC of CIP at anaerobic 
conditions was 16xMIC. The MIC of mutants was one out of the 
256 X wdd-type MIC, and thus higher than the respective MPC, irrespective 
of the quinolone or growth conditions. Calculated &om the serum half-life 
and the MPC, respectively, the selection period of each quinolone, in which 
resistant mutants might be selected, was calculated to be 14 h for NAL., 16 h 
for NOR and CIP, 28 h for OFX, 30 h for TVA, 40 h for CLX, and 120 h for 
SPX. These in vim data indicate that compounds with long serum half-lives 
and high MPC might favor the development of quinolone resistance. 
I P830 I The role of gyrB and dnaA proteins in bacterial 
conjugation 
S .  Roveta, M. Bozzolasco, E. A. Debbia and A. Marchese 
Genoa, I 
Objectives: Quinolones have been demonstrated to eliminate plasmid and to 
inhibit conjugal transfer. To assess whether the inhibition of plasmid Flac 
transfer by quinolone requires a functional DNA gyrase, merent mating 
experiments were performed. 
Methods: Echerichiacoli K 12 N4177 (Flac) and El77 (Flac) which encode for 
a termolable gyrB and dnaA protein, respectively, were used as donor strains. 
5-53 rifampicin resistant was employed as recipient organism. Conjugation 
was carried out by standard methods employing 2 x lO*cells/mL in rich 
broth. 
Result: Mating experiments were performed at the permissive and nonper- 
missive temperatures at the presence of 100 mg/mL of nalidixic acid for 1 h. 
Under permissive conditions (32 "C), Flac was transferred h m  the donor to 
the recipient with about the same frequency irrespective of the bacterial host 
considered. As expected, nalidixic acid reduced the number of recombinants 
ofabout 99% in comparison to the control. When the same experiments were 
performed at the nonpermissive temperature (43 "C), nalidixic acid inhibited 
the transfer of Flac of about 99% &om dnaA (Ts) mutant but not &om gyrB 
(Ts) host. 
Conclusions: The present finding supports the hypothesis that Flac transfers 
does not require a functional DNA gyrase activity in F-conjugation and 
suggests the presence of an unknown target of the quinolone in the bacterial 
cell. The role of gyrB and the dnaA proteins in bacterial conjugation are under 
investigation. 
Bayer) shows enhanced antipneumococcal activity, and is recommended for 
the treatment of community respiratory tract infections. 
Objectives: We have used MXF to examine the development of quinolone 
resistance in penicillin-resistant (F'ENR) and -sensitive (PENS) S. peumoniue. 
Material and methods: The MXF susceptibilities of 10 c h c a l  S. peumoniue 
isolates (five PENR and five PENS) were assessed by agar dilution, and 
mutation fiequencies determined using -10" cfu. Quinolone-resistant 
mutants were subjected to PCR and sequencing of the quinolone-resistance 
determining regions (QRDR) of gyrA, gyrB, parC and parE by previously 
described methods. Relative fitness was evaluated by growing mutants in 
direct competition with their susceptible, otherwise isogenic counterparts in 
mixed batch culture. 
Results: MICs for MXF were in the range 0.06-0.12mg/L. Mutation 
frequencies to resistance to MXF ranged f b m  <lo-' to lo-''. No differ- 
ences were observed between PENR and PENS strains, either in terms of 
MIC distribution, or in the fkequency with which resistance to MXF 
emerged. Sequencing of the QRDR regions of the four target genes revealed 
no differences between PENR and PENS strains, and confirmed gyrA as the 
primary target of MXF in ths organism. Fitness costs of -20% were apparent 
in all drug-resistant strains, relative to wild-type. 
Conclusions: PENR S. pneumoniue strains do not appear to exhibit an elevated 
MIC, or propensity to develop resistance to MXE compared to PENS 
S. pneumoniae. Quinolones are a valuable class of antimicrobial for treatment 
of S.yneumonine that do not appear to be compromised by PEN resistance. 
lp8321 Nalidixic acid does not inhibit DNA transfer in a 
quinolone-suscepti ble derivative 
S. Roveta, M. Bovolasco and E. A. Debbia 
C e n O A ,  I 
Objective: Quinolones exhibit a rapid bactericidal activity interfering with 
DNA gyrase activity. In addition, these compounds promote loss ofplasmids 
from their hosts and block bacterial conjugation. The mode ofkilling of these 
drugs is not fully elucidated. To acquire more information about this matter, a 
mutant strain able to transfer its entire genome at the presence ofnalidixic acid 
was selected. 
Methods: A H&H (Eshcm'chiacoli 3300) with TnlO inserted near the gene serB 
on the E. coli chromosome was used on a donor, while a J-53 rifampicin- 
resistant derivative and AB1157 were employed as recipients. Conjugation 
was carried out by standard methods employing 2 x 108ceUs/mL in rich 
broth. In this HfrH strain, TnlO (which confers tetracycline resistance) is 
transferred as last marker, so the recipient, virtually, may acquire the entire 
chromosome of the donor includmg the F episome. Thus the recombinants 
obtained at the presence ofnalidixic acid might become Hfi and, acquire the 
genetic dormation for the property to donate genetic material even if 
nalidixlc acid is present at a level known to inhibit the growth of the strain. 
Results: When H&H was mated for 2 hat 37 "C with J-53 rifin the presence 
of 25 mg/mL of nalidixic acid, the number of recombinants was reduced by 
about 99% in comparison to the control. Twelve colonies obtained in the 
conjugation in the presence of the drug were used as donor in further crosses, 
carried out as above, and employingABll57 as recipient. One strain was able 
to transfer genetic material in the presence of nalidix acid at the same 
fkequency noted with the control. This last experiment was again repeated 
and results were confirmed. Susceptibility test carried out with all strains 
obtained in the mating experiments showed that they maintained the 
susceptibility to nahdixic acid as the original strain. 
Conclusions: The results obtained in this study suggest that quinolones have a 
target in the cell that sect DNA transfer without interfering with DNA 
gyrase activity. Experiments are underway in order to detect this unknown 
function. 
Ip8311 U s e  of moxifloxacin to examine development of 
quinolone resistance in clinical Streptococcus pneumoniae 
strains showing resistance or susceptibility to penicillin 
E H. M'Zali, P. Hawkey, A. O'Neill and V Heaton 
Leeds, Birmingham, Newbury, UK 
Introduction: Streptocomspneumoniae is the major causative pathogen in 
community-acquired pneumonia. In recent years, pneumococci resistant 
to penicillins (PEN) and other 8-lactam antibiotics have emerged, posing 
a serious medical challenge. The novel fluoroquinolone moxifloxacin (MXE 
I P833 1 Isolation and characterization of a quinolone- 
tolerant Escherichia coli strain 
M. Dolcino, A. Zoratti and E. A. Debbia 
O n O A ,  I 
Objectives: Quinolone andmicrobial agents exhibit a rapid bactericidal action 
against most pathogenic bacteria and their use has increased markedly world- 
wide in recent years. DNA gyrase, required for bacterial DNA replication is 
the primary target of quinolones. However, the mechanism of quinolone 
killing, apart h m  the involvement of DNA gyrase remains largely unknown. 
To gain more knowledge about quinolone killing, we have devised a 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 177 
technique that makes possible the isolation of strain of Escherichia coli tolerant 
to quinolones. 
Methods: A strain defective in the lor gene and carrying the Flac plasmid 
(lo9 cfU/mL in 20 mL of Muller-Hinton broth) was allowed to grow in the 
presence of graded concentrations of nalidixic acid at 37 "C overnight. The 
culture tubes with no detectable bacterial growth were harvested and the cells 
were collected and transferred in 6esh broth at 37 "C for 3 h in order to stop all 
antibiotic effects. The cultures were concentrated to 1 mL and, afrer dilution, 
plated on of Mac Conkey agar containing nalidixic acid (2mg/L). Since a 
tolerant mutant is as susceptible to the antibiotic as the wild-type parent strain, 
but undergoes only a slow loss ofviability even in the presence ofhigh doses of 
antibiotic, such strain may be able to survive drug concentrations that exceed 
the MIC but may be affected by sub-MICs. To test thts hypothesis, colomes 
wlth lac-negative papdlae were studied to evaluate their susceptibkty to 
n & h c  acid. 
Results: Slxsuch colornes were isolated showmg MIC values mgmg between 
16 and 64mg/L and m d  bactericidal concentration (MBC) up to 
2048mg/L. Time-kill curves showed only a 1-log redUchOn for the mutant 
stram despite a S log  reduchon observed wth the parent s t r a m  after 24 h. 
Conclusion: Tolerance showed by these strains is not related to a decrease m 
permeabkty for nabdmc acid, because the MIC values are no affected d 
EDTA (0.25 x M) is added to the annbiotic. Ongoing expenments are 
currently carried out m order to charactenze the mutation responsible €or 
tolerance. 
Resistance in 5. pyogenes 
lp8341 Streptococcus pyogenes susceptibility to 
macrolides from inpatients at a clinical hospital Mostar 
M. Ostojic, I. Kuzman, I. Curic and B. Vidovic 
!VfOStUr, BM 
Since February 2000 till September 2001, a survey of antimicrobial resistance 
of Streptococcuspyogenes was performed. Six hundred and thirteen (613) strains 
of S. pyogenes were tested against penicillin and macrolides-erythromycin, 
clarithromycin and azithromycin. The strains were isolated 6om throat swabs 
(552), nose swabs (50), ear swabs (4). vagina swabs (2). wound swabs (4) and 
broncho aspirat (1). Disk-dXusion tests were used for susceptibility testing. In 
C h c a l  Hospital Mostar, the resistance of S.pyogenes to erythromycin, 
azithromycin and clarithromycin was 7.99, 8.48, 8.68%, respectively. AU 
strains were susceptible to penicillin. We bad also intermediate strains to 
erythromycin (5.22%), azithromycin (5.34%) and clarithromycin (11.39%). 
The average resistance rates of S. pyogena to erythromycin, azithromycin and 
clarithromycin in strains isolated in clinical hospital mostar were not higher 
than 9%. This percentage ofmacrolide resistance is similar to other neighbor 
countries. We did not detect any significant di€ference of resistance to tested 
macrolides. We detected only dXerence at intermediate strains; to clarithro- 
mycin is significantly higher than to erythromycin and azithromycin. Our 
results contirm the importance of global resistance data, but also regional 
resistance data in order to create an antibiotic policy. 
Antibiotic susceptibility of Streptococcus pyogenes 
and other fi-hemolytic streptococci isolated from respiratory 
tract infections in Istanbul 
R. Berkiten and S.-D. Giirol 
Istanbul, TR 
Objectives: The present study was performed to investigate the susceptibility 
to penicilhn (PEN), erythromycin (ER), az ihmycin  (AZ), chlarithromycin 
(CL), ciprofloxacin (CIP) and levoflomcin (LEV) in @-hemolytic streptococci 
isolated fiom upper and lower respiratory tract infections between 1997 and 
2000. 
Methods: In total 103 (34 children, 69 adults) @-hemolytic streptococci 
strains were isolated fiom throat swabs (n = 81) and sputum (n = 22). Among 
these isolates classified by latex agglutination test (Dry Spot Streptococcal 
Grouping Kit-Oxoid) 62, 5, 6, 4, 14 and 12 were detected to be strains of 
groups A, B, C, D, F and G, respectively. Antibiotic smceptibility were 
determined by standard E-test methodology accordmg to the recommenda- 
tions of the manufacturer. 
Resulh: All strains were found to be susceptible (MIC LO.l2rng/L) to PEN 
(one moderately susceptible in group D), but three (2.91%) to ER (one 
moderately susceptible), 2 (1.94%) to CL, 11 (10.67%) to AZ (eight mod- 
erately susceptible), five (4.85%) to CIP (one moderately susceptible) were 
detected to be resistant and two(1.94%) moderately susceptible to LEV. 
Conclusions:Our results suggest that there is no change in the susceptibility to 
penicillin in S . p y u p ~ ,  and resistance to ER remains at a low level (2.92%). 
Sixteen of 103 /l-hemolytic streptococci (15.53%) and 13 of 62 S.pyogenes 
(20.96%) strains were detected to be resistant or moderately susceptible to one 
or more than one antibiotic, whereas only 2 of the 62 S. pyogenes strains were 
found resistant or moderately susceptible to two or three antibiotics. 
[ P836 I Macrotide resistance in Streptorwcuspyqsenes: 
genes, frequencies and types in Denmark 
H.U Nielsen, K. Ekelund and N. Fnmodt-M0ller 
Copenhagen, DK 
Objective: To set up a mulhplex PCR, which detects macrohde resistance 
genes m group A streptococci (GAS). To collect macrohde-resistant GAS, 
analyze and report the fiequencles of the Merent macmhde resistance genes 
and T-types 111 macrohde-resistant GAS 
Methods: We developed a multip1ex PCR for detection of e d ,  emB and 
m$A macrohde reststance genes in GAS All chrncal mcrobiological depart- 
ments in Denmark were asked to send in all isolates of macrohde-resistant 
GAS, and from selected departments we received resistance data The 
collecuon started m November 2000 and IS shll gomg on. The s t r a m  were 
phenotyped and reststance were determmed by tablet &&ion (Rosco, 
Denmark) on Danish blood agar (Statens Serum Inshtut, Denmark), T-typing 
was done at the N a h o d  Reference Laboratory at Statens Serum Inshtut 
Results: Among the first 53 strams send to us, we found that 44 were 
macrohde-reistmt in our laboratory. All resistant strains harbored a resistance 
gene, none harbored more than one gene. A total of 32% were mlfA positive, 
20% were emA positive and 48% had the ennB gene. In the 0rnB group 38% 
were inducible and 62% were constitutive. Phenotypes and genotypes 
matched 100%. Eleven Merent T-types were present, the two most frequent 
types were T-28 (27%. includes e m A  and e r m q  and T-1 (18%; all m&) 
(Table 1). In the greater Copenhagen area, the fiequency of macrohde 
resistance among GAS was 3.8% (99 of 2598). 
Table 1 Gene frequency, inducibility and T-types among Danish macrolide-resistant 
group A streptococci 
Gene Frequency (%) Inducible T-type (no.) 
No m$A 32 
ermA 20 Yes 
38% Yes ermB 48 
62% No 48 
T1 (8); T4 (1); T3. 13, B3264 (2); NT (3) 
T28 (6); T8 (1); T13, 28 (1); NT (1) 
Yes: T14, 49 (5); T3 (1); T4 (1); T9 (1) 
No: T28 (6); T12 (3). T3, 13, B32.64 (2); T8 (2) 
Conclusion: The three macmlide resistance genes are all &equenely occurring 
in Denmark. Of al l  macrolide-resistant GAS 68% are resistant to clindarnycin 
eigher inducible or constitutive. Eleven different T-types were present, and 
macrolide-resistant GAS, therefore, is not exclusively a clonal problem. 
Macmhde resistance in Denmark is still low in Denmark (<4%) but should 
be monitored. 
w] Phenotypic characterization of macrolide resistance 
in 362 Streptococcus pyogenes isolates coming from acute 
pharyngotonsillitis 
L. Ricci, A. Fabio, P. Ragni and L. Vecchia 
Reg+ Emilia, I 
Objectives: We estimated the phenotypes of macrulide-resistant of S. pyogenes 
isolates among patients with upper respiratory tract infections in Reggio 
Emilia (Italy). 
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Methods: The study was conducted over a 9-month period and included 
patients with symptoms of acute pharyngotonsillitis. The 362 S.pyoppnes 
isolates were identified according to standard laboratory techniques. Catalasi 
negative and 8-emolitic colonies isolated b m  5% sheep blood agar were 
idenhfied with using latex agglutination test and api 20 S system. The 
phenotypes of the erythromycin resistance strains were determined by 
double-discs test with erythromycin and clindamycin. Antimicrobial sensi- 
tivity to penicillin, erythromycin, clindamicyn, rokitamycin, cefaclor and 
amoxic&n/clavulanate was determined by the disk-diGsion Kirby-Bauer 
method according to NCCLS recommendations. 
Result% All the 362 isolates were uniformly susceptible to p e n i c h .  Overall, 
45 isolates (12.43%) showed resistance to erythromycin and 6 (1.68%) were 
also resistant to clindamycin (constitutive resistance) erythromycin-resistant 
but clindamycin-susceptible with no blunting of the erythromycin zone was 
found amongst 39 S.pyogenes isolates. These s t r a i n s  had the M phenotype of 
resistance. Only two isolates (0.56%) showed resistance to rokitamycin, these 
were resistant also erythromycin (cMLSb phenotype). 
Conclusion: Tonsillitis is a complex infection that can involve streptococci 
as well as other bacteria and viruses. Although streptococci may be the most 
d e n t  organism, causing septic and nonseptic complications. Fatlure to 
eradicate streptococci from patients can occasionally lead to rheumatic 
fever rarely to glomerulonephritis. With the emergence of increased treat- 
ment failures, it has been necessary to consider alternative therapies for 
patients who cannot tolerate or who do not respond to penicillin. Erythro- 
mycin resistance in our area is 12.43% and among these strains was 
found to be lower than in previous studies (30% in 1999 and 24.63 in 
2000). The prevalence ofrokitamycin-resistant isolates in acute pharyngitis is 
0.56% so rokitamycin can be an alternative for the treatment of particular 
patients. 
)p838) Resistance trends in Streptococcus pyogenes to 
erythromycin in Slovakia: is there a correlation with 
consumption? 
R. Babela, V. Krcmery, V. Foltan, A. Liskova and L. Langsadl 
Bratislava, Nitra, S K  
Objectives: There is an increasing trend ofmacrolide resistance in St~eptococcus 
ppfenes and S. pneumoniae worldwide. Probably one of the risk factors for 
development of macrolide resistance (MR) is increasing consumption of 
macrolides. 
Methods: We investigated consumption of ‘older’ macrolides erythromycin 
(ERY), spiramycin (SPI) and roxitromycin @OX) and ‘newer’ macrolides 
azithromycin (AZI), clarithromycin (CLA) from the state institute of Drug 
Control Consumption Database and compared it with the level of resistance 
of S. pyogenes and S. pneumoniae to ERY from a yearly report of Antibiotic 
Resistance Surveillance in 1995-1998 and 1998-2000. 
Results: Significant increase of consumption of macrolides has been observed 
in 1995-2000, h m  835DDD/1000 in 1995-1382DDD/1000 in 1999 and 
1265 DDD/ 1000 in 2000. The proportion ofmacrolides among all antibiotics 
increased from 12.7 to 17.2% (1995-1999) to 16.4% (2000) because of 
increasing consumption of ‘newer’ macrolides-MI f?om 15 DDD/1000 
in 1995 to290DDD/1000in 2000andCLAf?omO to 14DDD/1000withm 
last 5years. Concerning the level ofERY resistance in S.pyogenes (14.9%) and 
in S. pneumoniae (12.1%) in 2000, we found that resistance in both pathogens 
in Austria (1 1.3 and 10.5%) and in Czech Republic (6.5%) is lower than in 
Slovakia, however, in Poland and in Italy-about 40% in S. pyogenes is much 
higher than in Slovakia. However, the data h m  ESAR Project testing 3249 
strains h m  five countries in UK and Germany found only 1.5% ERY 
resistance in S. pyogener. 
Conclusions: Increasing consumption of ‘newer’ macrolides including ERY, 
SPI and ROX, may led to increasing ERY resistance in S.pyogenes (5.5-14.9% 
during 6 years). However, if consumption only is responsible for an increase of 
ERY resistance, is not clear and would be too simple explanation for this 
complicated issue. Since 2000, consumption of macrolides starts to decrease 
(in fint quarter of 2001 - 20% decrease has been noted in addition to 2000) 
and ifresistance is consumption related, reversibility ofERY resistance should 
be noticed in 2001-2003. 
1-1 Erythromycin-resistance phenotypclgenetype and 
number of RD2 repeats of the internalization-associated 
gene prtFl in Italian group A streptococci (GAS) 
C. Spinaci, G. Magi, E. Giovanetti, P. Varaldo and B. Facinelli 
Ancona, I 
Objectives: Following the recent demonstration by our group of a close and 
unsuspected association between erythromycin resistance and cell invasiveness 
in GAS isolated in Italy, suggesting that strains combining the two features 
may be able to escape /?-lactams by virtue of intracellular location and 
macrolides by virtue of resistance, the present study was undertaken to 
characterize the Itahan erythromycin-resistant cell-invasive isolates with a 
view to understandmg the biological basis of this association. 
Methods: A total of 77 (66 erythromycin-resistant and 11 erythromycin- 
susceptible) independent clinical strains of GAS recently isolated in Italy (all 
carrying the internalization-associated prtFf gene) were studied. The macro- 
lide-susceptibility/resistance phenotype was determined by conventional 
methods. Erythromycin-resistance determinants were detected by PCR 
using specific primer pain. The prtFl gene was detected by PCR using 
primers complementary to the flanking region of RD2; the expected 
PCR product depended on the number of KD2 repeats, one repeat being 
l l l bp .  
Results: Amplicon size ranged from ca. 110 to ca. 550 bp, suggesting that the 
number of KD2 repeats ranged from 1 to 5. Most fkequently, ampiicons 
consisted of 4 or 3 repeats (32 and 27 strains, respectively) or of a single repeat 
(16 strains); 2 and 5 repeats were found in one strain, respectively. Among 
inducibly erythromycin-resistant isolates (n = 34). all those carrying the ermB 
methylase (n = 13) had four RD2 repeats, whereas all those carrying the 
erm7’R methylase (n = 21) had three repeats. The picture was more varied 
among constitutively resistant strains (n = lo), the majority ofwhich had four 
(n=5) or three ( n = 3 )  repeats; among the strains of the M phenotype 
(n=22), all carrying the efflux m.fA gene), most of whch had one 
(n= 13) or four (n=7) repeats; and among the erythromycin-susceptible 
strains (n = 1 l), most of which (n = 7) had four repeats. 
Conclusions: A further issue in the context of the association between 
erythromycin resistance and cell invasiveness in GAS is the association 
between the resistance-phenotype/genotype and the number of RD2 repeats 
of prtF2. 
rp84oj Nationwide surveillance of antimicrobial resistance 
in Streptococcus pyogenes in Slovenia 
I. Strumbelj, H. Ribic, T. Franko-Kancler, V. Bozanic, I. Grmek Kosnik, 
L. Merljak, M. Kavcic and T. Harlander 
Murska Sobota, LjubQam, Maribor, Celje, Kranj, Nova Gorica, Koper, N o w  
Mesfo, SLO 
Objectives: To determine rates of resistance to selected antimicrobial agents 
and phenotypes of resistance to macrolides and lincosamides. 
Methods: A total of 1032 nonrepiicated strains of Streptococcus pyogmes 
were isolated by eight microbiology laboratories fiorn all regions of 
Slovenia between January and September 2001. Laboratories are part of 
public health institutes. Saains were isolated h m  outpatients and patients 
from general, but not from tertiary care hospitals. Most strains were isolated 
from throat swabs. P-Hemolytic colonies were identified as S.pyogenes by 
positive PYR test and group A latex agglutination or bacitracin test. Suscept- 
ibility to five antibiotics (penicillin, vancomycin, tetracycline, erythromycin 
and clindamycin) was determined by standard disk-ditfusion procedure 
according to NCCLS. Intermediate and resistant categories were interpreted 
as resistant. Phenotype of resistance to rnacrolides and lincosamides was 
determined by double-disk induction method with disks of erythromycin 
and clindamycin. 
Results: All strains were susceptible to penic ih  and vancomycin. Resistance 
rate to tetracycline was 12%, to erythromycin 6% and to clindamycin 2%. 
There were wide differences among regions: the lowest rate of erythromycin 
resistance was in the eastern part of Slovenia, around Maribor (2%) and the 
highest rate in the western part of Slovenia, around Koper (24%). Three 
phenotypes were found in 64 erythromycin-resistant isolates: 22% M phe- 
notype, 47% inducible MLSB phenotype and 31% constitutive MLSB 
phenotype. 
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Conclusions: Current rate of resistance to erythromycin in S.pyogenes in 
Slovenia is not high, except in one region. Resistance monitoring will be 
continued. Erythromycin-reshnt strains were fmzen and should be 
studied further. Detailed epidemiological analysis of collected data is also 
necessary. 
Antimicrobial resistance in Streptococcus pyogenes 
isolates in a town in northern Italy from 1998 to 2000 
R. Bandettini and R. Monacelli 
Genoa, I 
Objectives: The aim of this study was to know the evolution of Streptococrus 
pyogenes susceptibility to erythromycin, rokitamycin, chdamycin and tetra- 
cycline in a period between 1998 and 2000. 
Methods: One hundred and ninety-three isolates of S. pyogenes were collected 
in the Laboratory ofMicrobiology of A. Gallino Hospital, in Genoa, in 3 years 
(67 in 1998, 58 in 1999 and 68 in 2000). The strains were recovered h m  
throat swabs ofoutpatients affected by phnryngitis and/or tonsilkis. In 1998, 
we started this study using only three antibiotics (erythromycin, clindamycin 
and tetracycline). In the following year, we added another macrolide (rob- 
tamycin). The susceptibilities tests were determined by the disk-difksion 
method on Mueller-Hinton agar supplemented with 5% sheep blood (Becton 
Diclunson). Besides, in 1999 and 2000, we evaluated the macrolide-resistance 
phenotypes using a double-disk test with erythromycin and clindamycin. 
Results: The observed resistance data are reported as follows: 
In 1998: 26.8% to erythromycin, 20.9% to clindamycin and 35.8% to 
tetracycline. 
In 1999: 51.7% to erythromycin, 3.4% to rolutamycin, 27.6% to clinda- 
mycin and 17.2% to tetracycline. 
In 2000: 23.5% to erythromycin, 4.4% to rokitamycin, 14.7% to clinda- 
mycin and 4.4% to tetracycline. 
In the last 2 years, we observed a larger prevalence of constituhve resistance 
(42.1% in 1999 and 60% in 2000) compared to the other phenotypes. 
Conclusions: While the resistance to tetracycline decreased during 3 years 
(from 35.8 to 4.4%), the resistance to erythromycin increased significantly 
during 1999 (from 26.8 to 51.7%) and it decreased in the following year 
(23.5%). This trend indicates that erythromycin resistance is still a problem 
and it emphasizes the need to screen for resistance to macrolides in S. pyogenes. 
Besides, the evaluation of these data indicates that rokitamycin is a good 
alternative to the other antibiotics under study. 
1 P842 1 Colonization by Streptococcus pyogenes and 
susceptibility patterns against clinical relevant 
antimicrobials 
I. Santos-Sanches, G kbeuo,  I. Bonfmi, A Moms, I. Valadares, 
T Ramos, E Ferrem, C. Gamelro, F Andrade, L Rorneiro, E Vaz, 
P Broeiro, P Correia, C Pereua, L. Lito, M Salgado and J Marques 
Oeirus, Lisbon, P 
Objectives: To evaluate trends Of CO~OnIzahO~ by S&eptoco~%us pyogemf (GAS) 
and compare anmcrobial rewtance profiles of coloIllung and dsease 
causing isolates 
Methods: Bactenal idenhficahon was carried out by standard methods. 
Anmcrobial suscephbhty testmg was performed by dlsk-&ion 
(NCCLS) agamt pemcillm (P), erythromycin (E), chdamycm (Da), clar- 
ithroman (Cl), avthromycin (Az), J O S . Y " Y C ~  u), tetracyclme (Te), chlor- 
amphemcol (C), clprofloxacm (Cip) Macrolides resistance phenotype was 
based on a triple-dlsc test w th  E, Da and J 
Results: During four periods in 2000-2001 oropharyngeal samples were 
taken &om different populaaons: 1351 Liom chddren (Myears) in day-care 
centers (DCC), 442 from schoolaged chddren (7-15 years) and 273 from 
adults (226 school staffand 47 famdy members). Carrlage myounger chddren 
was hgher (13%) than among older than 7years (6 7%), however, carnage 
rates varied mth DCC and dunng the year. Co~on3zahotI was hgher among 
f d y  members (15%) than among school s&(4%). A total of295 GAS were 
isolated. 218 &om carriers, 42 h m  pahents mth  tonsdhbs attendmg p"mary 
care settlngs and 35 &om hospital origm (19 mvasrve; 26 abscess), collected 
during March 1999-January 2001. Resistance to one or more antimicrob~als 
was hgher in s t r a m s  coloming older chldren (41% vs. 10%). Resstance to 
macrohdes was 10% for carriage, 17% for tOnS&hS and 6% for hospital 
isolates. The M phenotype was prevalent in carriers (20/23 s h a m )  whereas 
the MLSB phenotype was dormnant among mfecaon isolates (519 smns). 
Resistance to Te was 6% for colonrang s m s  (2% among the youngest and 
17% among oldest chddren), lo?? for t o n s d h  and 47?? for hospitd strams, 
being most of the isolates suscephhle to E (29138). Resutance to C and Cip 
was found m two &ease stra~ns. 
Conclusions: Resatance to E was hlgher for tonsfits isolates than for carriage 
or other msease sham In admhon, dlfferences ~fl the anhmcrobd resistance 
profiles of colomzing and dsease-causing Bolates were observed, namely for 
macrohdes resistance phenotypes, suggeshng that dderent stram may be 
involved in colomzahon and disease. Of mterest was J o  the fmdmg of 
resistance to tetracyche among carrier chddren since tetracyche m contrast 
to macrolides it is rarely used m pedlamcs. 
[pg43/ Prevalence of erythromycin A resistance and 
activity of telithromycin against isolates of 5. pyogenes from 
pediatric patients collected during 1999-2000 from the 
PROTEKT surveillance study 
D Felmingham 
London, UK 
Background Streptomaus ppgenes IS responsible for various acute suppomve 
CondIhons, mduding the mjonty of cases of t o d h t d p h a r y ~ t i s  m chtl- 
&en. Whereas macrohde antibacterials have proved a valuable alternative to 
pem&n G m treating S.pyogener respuatory tract infections (RTIs) m 
pemcdhn-allergic pahents, increasing resistance to these agents has been 
observed recently. 
Objective: A subanalysis of the PROTEKT antibacterial resistance surved- 
lance study was performed to assess the prevalence of erythromycin A 
resistance (EryR) among S pyogenes isolated from pedlatric patients wsth 
commmty-acquired RTIs (CARTIs), and to measure the activity of the new 
ketohde, tehthromycm, apns t  these isolates 
Methods: During the wmter of 1999/2000, S. pyogenes lsolates were collected 
&om chddren (aged <12years) mth commumty-acqwred RTIs attending 
centers (n = 69) across Europe, Asia, Australia, North and South America (25 
countries). MCs were determined centrally for a panel ofantibaaerias wing 
an NCCIS broth mcmdhtion method. Susceptibility data were analyzed by 
culture source. 
Results: In total, 676 isolates of Spyogenes were tested, comprising 14 
sputum, 30 nasopharyngeal, 50 ear and 563 throat cultures, plus a small 
number of 'other' sources. The prevalence of EryR among these isolates IS 
shown by source 111 Table 1. 
Table 1 Prevalence of EtyR among isolates of S. pyogener from pdaaicn 
Culture source N % EryR 
spunun 14 
Nasopharyngeal 30 
Ear/middle eat fluid 50 
Throat 563 
AU sources combined 676 
21.4 
20.0 
12.0 
9.6 
10.2 
Analysls by culture source showed sputum and nasopharyngeal sources to 
have the hghest prevalence ofEryR. Isolates reslstant to erythromycin A were 
also resistant to clarithromycm and azithromycin. Tehthromycm showed 
potent m mtro activity agamst S pyogenes (MICSO, O.O15mg/L, MlCw, 
0 03 mg/L). 
Conclusions: The prevalence of EryR among S. pyogenes IS hgh in chddren, 
averagmg 21% 111 sputum, 20% m nasopharyngeal, 12% in ear and lo?? m 
throat lsolates collected in ths 1999-2000 survedlance study. The ketolide 
tehthromycm showed excellent achmty agamst isolates of S.pyogmes 
fmm pebtric pahents, mcludmg EryR s t r a m ,  and appears a p m e g  
dternahve for management of CARTIs caused by Gmup A sheptococci in 
chddren 
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/p8441 Macrolide and ketolide susceptibility of 
5. pyogenes isolates collected in Austria during 200&2001 
C. Jebelean, C. Luger, L. Binder, R. Watschinger, M. Haditsch and 
H. Mittermayer 
Linr, A 
Background: An increase in macrolide resistance of S.pyogenes strains was 
recently reported &om many European countries. Telithromycin is the first 
member of the ketolide family of antimicrobials with activity against Gram- 
positive bacteria including those with acquired resistance to erythromycin. 
Objective: To investigate the activity of telithromycin and various macrolides 
on S.pyogenes strains collected in Austria. 
Methods: A total of 296 strains of S. pyogmes isolated during the last year &om 
children (222 strains) and adults (72 strains) from Merent regions of Austria 
were tested for susceptibility to telithromycin, erythromycin (E), roxithro- 
mycin (R), clarithromycin (C), azithromycin (A), clindamycin (Cl) and 
tetracycline (T) using an agar dilution method. E-resistant strains were further 
investigated for the presence of macrolide resistance genes (m$ erm, and 
emtTR) using a PCR-based method. 
Results: Overall, the E, C1, T resistance was 11, 1, 16%, respectively, with 
lower prevalence in children (1 1, 0.4, 11%) and higher prevalence in adults 
(13.3, 33%). (In a similar investigation on strains collected during 1999 and 
2000, the overall E and T resistance was 11 and 24%.) 
The respective MIC50 and MIC9o of the antibiotics tested were: telithro- 
mycin 50.015 and 50.015 mg/L; E 0.03 and 1 mg/L; A 0.12 and 4mg/L; C 
50.03 and O.Smg/L; A 0.12 and 4mg/L; C1 50.06 and <O.O6mg/L. 
Resistance to E was exhibited by 33 strains, 25 of them harboring m.f, 3 
erm, 4 ermTR and 1 mtf+ e m  genes. Telithromycin showed the lowest MICs 
and retained a good activity also on strains containing E resistance genes; the 
range of MICs for those strains was <0.0154S mg/L. 
Conclusions: The macrolide resistance prevalence of S. pyogenes strains col- 
lected in 2000-2001 was similar to that found in strains collected in 1999- 
2000. Telithrornycin was highly active against isolates of S. pyogenes collected 
during the last 2 years in Austria. 
Staphylococci 
1 P8451 A 7-year study of prevalence of resistance to 
erythromycin and penicillin among group A streptococci in 
Brazil 
L. Mimica, H. Caiaffa Filbo, A. Navarini, M. Martino, S. Ueda and 
I. Mimica 
SCo Paulo, BR 
Since the late of 1980s, a resurgence of severe Group A streptococci 
(GAS) infections has been noted through out the world, including the 
streptococcal toxic shock syndrome, necrotiziig fasciitis, sepsis and rheumatic 
fever. As the most common bacterial cause of pharyngitdtomillitis in 
children, prevention of acute rheumatic fever is the principal goal of treatment 
with antibiotic therapy. Although penicillin is the drug of choice, several drug 
failure episodes have been reported during the past 20 years. Erythromycin has 
remained as the recommended alternative to penicillin clinical resistance since 
then. The aim of this study was to determine MICs of penicillin and 
erythromycin among St~teptococcus pyogenes strains isolated fium acute infec- 
tions in children over a period of 7 years at Santa Casa Hospital in S3o Paulo, 
Brazil. The MICs of the1047 strains studied were determined by the E-test 
(AB Biodisk, Sweden). All strains were susceptible to penicillin G: MICs 
ranged from 0.002 to O.O94pg/mL. and MICw varied &om 0.032 to 
0.047 pg/mL over the period. For erythromycin MICs varied &om 0.016 
to 32 pg/mL and M I C ,  changed from 0.5 to 1 .O WmL. over the 7-year 
period study. The results showed a not statistically sigdcant erythromycin 
resistance that varied Erom 6.25 to 10.95% during the study period, indicating 
that the prevalence of resistant strains were almost the same at the fint an the 
last year of study. The intermediate susceptibility to erythromycin w a s  
observed varying between 14.29 and 21.74% during study period. Our 
conclusion was that no progressive increase of resistance to p e n i c k  
and erythromycin was observed among our GAS strains over a period of 
7 years. 
lp846( Staphylococcus warneri, 5. hominis and 
5. haemolyticus are emerging nosocomial bloodstream 
pathogens in neonatal and pediatric intensive care units 
G. Manno, E. Ugolotti, M. L. Belli, M. L. Fenu, G. Pittaluga, 
S. Ferrando, G. Serra, I? Tuo and E. Mantero 
Gmoa, I 
Background: Lacks data on epidemiology of coagulase-negative Staphylo- 
cocci (CoNS) other than Staphylococcus epidermidis (SE) involved in nosoco- 
mid bloodstream mfections. 
Objective: To assess the isolation rate, species distribution and antibiotic 
susceptibility pattern of CoNS recovered &om blood cultures (BCs) in 
neonatal intensive care unit (NICU) and pediatric PICU. 
Methods: We reviewed for the period 1 January to 31 December 2000 
microbiological data referred to 1428 BCs of 493 patients @ts) hospitalized in 
a 30-bed-NICU and a 25-bed-PICU. BCs were performed in BactAlert 
Pediatric bottles (Organon Teknika), species idendfication was obtained by 
coagualse test and API Staph System (BioMerieux), antibiotics susceptibility 
by WIDER MIC Gram-positive panels (Soria Melguizo - DADE manu- 
factured). 
Results: A total of 144 pts had pos BCs, 86 pts (59.7%) with CoNS: 46 Se, 
16 S. warneri (SW), 13 S. hominis (SHO) and 11 S. haeaolytieus (SHAE). 14/86 
(16%) pts had 2 2  consecutive posBCs for SW, 12/86 (14%) for SHO and 11/ 
86 (13%) for SHAE. In pts with microbiological documented bloodstream 
mfection risks factors present were: CVC and/or total parental nutrition and/ 
or arterial catheter. On a total of 177 isolated, 106 s t r a i n s  were CNS (60%): SE 
was the prevalent species (36%). followed by SW (14%), SHO (9.4%) and 
SHAE (9.4%). The rate (%) of R strains was: for SW oxacillin (OX) 71, 
vancomycin (VA) 0, teicolanin (TE) 0, ciprofloxacin (CIP) 0, levofloxacin 
(LE) 25, trimethoprim/sulfmetoxazole (T/S) 0, cloramphenicol (C) 9, 
rifampin @I) 27, quinupristin/daKopristin (Q/D) 12, linezolid &I) 6; for 
SHO OX 57, VA 0, TE 0, CIP 0, LE 25, S/T 0, C 75, RI 0, Q/D 14, LI 12; 
for SHAE OX 100, VA 0, TE 9, CIP 0, LE 25, S/T 14, C 43, RI 57, Q/D 12, 
LI 0. 
Conclusions: Our data shows the emergence of SW, SHO and SHAE as 
antibiotic resistant pathogens of BSIs in NICU and PICU and stress the 
importance in the species identification ofCoNS recovered &om BCs in these 
units to better understand their epidemiology. 
I P847 1 Interpreting PFGE patterns and antibiotypes 
for strain typing of methiallin-resistant Staphy/omcus 
aureus, S. haemolyticus and S. hominis 
C .  Bartzavali, G. Dimitracopoulos and I. SpiLiopoulou 
Purras, GR 
Objectives: The purpose of this study was to correlate antibiotypes to PFGE 
patterns of 69 methcillin-resistant S. aureus (MRSA), 21 metkcillin-resistant 
S. h w t d y t i n r s  and 11 S. hominis isolates recovered &om inpatients with 
S e r e n t  pathologies and interned in Merent departments at the University 
Hospital of Patras, in Greece during a two year period (1999L2000). 
Materials and methods: Biotypes of coagulase-negative staphylococci (CNS) 
were performed by the API Staph system Minimal Inhibitory Concentration 
(MIC) to oxacillin was determined by the agar dilution method according to 
NCCLS guidelines. The antibiotic susceptibility testing was performed by the 
disk diifusion method against the antimicrobials: ampicillin, amoxicillin/ 
clavulanic acid, cefaclor, ceftriaxone, ceftazidime, imipenem, amikacin, 
netilmicin, erythromycin, ciprofloxacin, hsidic acid, SXT and vancomycin. 
All isolates were analyzed by pulsed-field gel electrophoresis (PFGE) of small 
macro-hgments, transferred onto nylon membranes and hybridized with the 
mecA specific DNA probe. 
Results: Five biotypes were revealed among the S. haemolytuus and three 
among the S. horninis climcal isolates. All MRSA showed high MIC to 
oxacain (>lo24 mg/L), while 24 out of 32 S. haemolyticus, S. hominic isolates 
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expressed lower MIC levels, ranging between 32 and 512 mg/L. All oxacillin- 
resistant isolates were mectl-positive and expressed resistance to all 8-lactams, 
while no isolate was found to be resistant to amikacin, netilmicin and 
vancomycin. Four PFGE types were characterized among the M R S A  
(A14, B:29, C:10 and E:16 strains), where S. haemofyticus and S. hominis 
were classified into two distinct PFGE types each (t‘:14, u‘xeven strains, p’:10 
and q’:one strain, respectively). Strains oftypes A and C were resistant only to 
/I-bactams while strains of types B and E were multiresistant, expressing 
resistance to more than three antibiotics including quinolones and hsidic acid. 
All S. haemolyticus of PFGE type 6 ,  expressed the same MIC (>128mg/L). 
There was not found any correlation between the antibiotype and PFGE type 
of CNS isolates. 
Conclusions: The MRSA clinical isolates with certain antibiotypes were 
correlated to common PFGE patterns, whde this was not observedamong the 
CNS strains. Four distinct PFGE patterns of methicillin-resistant S. haemo- 
lyticus and S. hominis clinical isolates are associated with nosocomial infections 
in our hospital during a 2-year period. 
jp8481 Sternal wound infections due to persistence of a 
single clone of coagulase-negative staphylococci 
C. Balmelli, C. Vanoli and C. Ruef 
Zurich, C H  
Objectives: to describe three cases of coagulase-negative staphylococci 
(CoNS) sternal wound infections after open heart surgery caused by the 
same multiresistant pathogen over a period of 10 weeks. To evaluate possible 
ways of persistence and spread of this CoNS clone. 
Methods: Three cases of sternal wound iilfection after cardiac surgery caused 
by a multiresistant CoNS (sensitive only to vancomycin and teicoplanin) were 
identifted by antibiogram over a period of 10 weekc. DNA-fingerprinting of 
the three isolates (pulsed field gel electrophoresis) showed the isolates of the 
patients to belong to a single clone. Chart review of the cases was performed in 
order to identify the pathway of persistence and spread ofthis CoNS clone. It 
included the identification of the members of the scrubbed and non-scrubbed 
surgical team and other hospital workers with contact with those patients 
during the postoperative period (such as the ECG team), identification of 
theatre rooms and hospital rooms. Nose and hand cultures were obtained from 
all identified hospital workers. The antibiotic resistance pattern of the isolates 
h m  these cultures were then matched with the previously obtained clone 
h m  the three patients. 
Results: No theater room and no hospital room were common to all three 
patients. No surgeon, anesthesiologist or theatre nurse was involved in more 
than one operation in the three patients, which virtually excludes a direct 
contamination of the three patients during surgery from the same medical 
workers. A total of 34 swabs were obtained from the nose and hands of the 
idenrifed medical workers. None of the isolates from those cultures showed 
the same multiresistant pattern of the clone. It  was not possible to idenhfy the 
ward nurses who took care of the patients during the postoperative hospital 
stay. 
Conclusions: The finding of the same clone of CONS causing sternal wound 
infection in three different patients over a period of 10 weeks shows that a 
single clone can persist over a long time period. Such persistence could be a 
major source of infection. Our results argue against a direct contamination 
during surgery &om a single medical worker. We hypothesize that infection of 
the three patients may have occurred during the postoperative period from 
an unidentified colonized healthcare worker. Our study demonstrates that 
CoNS may also be involved in outbreaks of postoperative surgical site 
infections. 
Altered phase variation (switching) of 
polysaccharide adhesion production in a biofilm-forming 
cerebrospinal fluid isolate of Staphy/ococcus epidemtidis 
K. Cordon, H Humphrey and J. OGara 
Dublin, I R L  
Objacths: The ica operon of Skzpkylocoaus eprdermidis encodes the enzymes 
required for polysaccharide adhesion (PIA) biosynthesis and ES required for 
b i o f h  formation Expression of these genes is subject to phase-vanable 
regdahon (on-off switching), partIcdarly in the on-to-off dlrechon, 
although the molecular basu and c h c a l  sigdcance of this phenotype are 
poorly understood. We have charactenzed a biofilm-formg S. eprdmrdis 
strain, CSF41498, isolated from cerebrospmal fluid m which the on-to-off 
swtchmg kequency is up to 18-fold slower than the reference %tram ATCC 
35984 (RP62A). 
Methods: Reverse transcripaon PCR (RT-PCR) was used to examme the 
transcnphond reguladon of the ica locus. Sem-quanhtahve assays of stamed, 
adhered bactenal cells were conducted in 96-well hsue culture plates to assess 
b io fh - fo rmg  capacity. Subinbibltory tetracychne (0.06 pg/mL) or 4% 
NaC1/0.5% glucose were added to growth medla to enhance b i o f h  for- 
mahoon On-to-off mtchmg rates of PIA produchon were measured by 
phtmg serial dduhons of phase-on (black) colorues onto Congo red agar and 
determmq the proport~on of phase-off (red) colomes. 
Results: DNA sequence analysu dld not idenhfy any genenc Merences 
between the ica loci fiom CSF41498 and RP62A. Using RT-PCR sirmlar 
J C ~ A  transcripphon levels were detected In phase-on varlants of CSF41498 and 
RP62A. Expression of the ica operon m phase-on variants of both s t r a m  was 
also found to be temporal, characterrzed by esenhally Consahlhve transcrip- 
hOn during expomnhd growth followed by a sharp declme m late stahosary 
phase Phase-on variants of CSF41498 and RP62A &played a sirmlar capacity 
for biofilm formanon Growth of both s t rams under biofilm/ica-mnducmg 
enwonmental condmons dld not d u e n c e  PIA switchmg rates. Expression 
ofthe id gene was dramahcdy reduced m biofilm-negahve phase variants of 
both strams, parhcularly W62A variants. 
Conclusions: These data suggest that on-to-off PIA switchmg is conhngent 
upon the achvlty of a tram-actmg factor(s) and funchons lndependently of ica 
operon regdahon to control biofilm formahon. 
I P850 1 Coagulase-negative staphylococci with reduced 
susceptibility to glycopeptides in a Greek cancer hospital 
N. Panayotou, E. Katsa-Tsiopoulou, E’. Kada and 0. Manou 
7hessafonrki, GR 
Objectives: Staphylococci w t h  reduced suscephbity to glycopeptides, 
although of uncertain c h i d  relevance, challenge the abiity of 
routme microbiology laboratones to recogmze them. In our mdy, we tried 
to detect subpopuktions with mcreased resistance III clinical isolates of 
coagdase-negahve staphylococci (CNS) with borderhne suscephbity to 
glycopepades 
Methods: Twenty methich-resistant CNS, 12 S. haemofyfinrs (shl) and eight 
S epidermidu (sep) with vancomycm (V) MIC = 4 mg/L and/or teicoplanin 
(T) MIC 2 8 mg/L (broth microdilution: WIDER) have been isolated ln the 
current year, manly from blood cultures of patients with hematologd 
mahgmncies. In order to detect mutant subpopulations of these strains, we 
used an agar screen method (Mueller-Hinton Agar [MHA] with 5mg/L 
vancomycin) and the E-test ‘macro’ method (a heavy inoculum of 
two MacFarland on Braln Heart Infusion Agar [BHIA] and 48 h incubation). 
Accordmg to the manu6acturer, strains wth V 2 8 mg/L and T 2 8 mg/L 
or T 2 12 mg/L alone are considered glycopeptide-resstant and glycopep- 
tide-heteroresistant, respechvely. Fifteen glycopephde-susceptible CNS 
isolates and S.aurew UA 166 (EARSS) were used as negahve controls 
while vancomycin-resistant E. faecalis UA 605 (EARSS) was used as pOsihve 
control. 
Results: Ofthe 20 ~~olates, when re-tested by mcrodilution, five sep and one 
shl had lower MICs (V < 4mg/L and T < 8 mg/L) and appeared suscephble. 
By the E-test 13/20 isolates (seven sep and SIX shl) had V <6mg/L and 
T 2 12mg/L (‘heteroresistant’). 4/20 isolates (three shl and one sep) had 
V 5 4 mg/L and T 5 4 mg/L (‘suscepttble’). three shl had V = 8 mg/L and 
T = 32 mg/L (‘resistant’). These were consecutive isolates b m  one patient 
wth V = 4mg/L and T = 16 mg/L when m h d y  tested by microddution and 
V = 8 mg/L and T = 16 mg/L when re-tested. Only the above menaoned 
three shl s m n s  grew on agar screen plates. 
Conclusion: Reduced suscephbdity to glycopeptides among staphylococn IS 
usually heterogeneous, often unreproducible and difficult to confium. In this 
study, we have been able to tsolate subpopulations wth increased MICs for 
both glycopeptides &om h e  smns. Other strains could also contain 
subpopulahons at frequencies so low that were a c d t  to detect without 
more specihed methods like population analysu. Laboratories should be on 
alert for strains inlcahve of decreased susceptibdity to glycopephdes. 
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jp851/ Why Staphylococcus cohnii prevail in the intensive 
care unit environment 
E. Waldon, M. Rbzalska, T. Nowak and E. M. Szewczyk 
L d z ,  PL 
Objectives: Staphylococcus cohnii ssp. cohnii strains are the main Gram-positive 
flora in a environment of the pediatric hospital ICU. The species is seldom 
isolated from patients so that it seems strange that all stclins are methicillin- 
resistant and resistant to many other antibiotics. Which features promote the 
numerous attendance of S.  cohnii in hospital environment and their ability to 
gain resistance genes? 
Methods: The survival period of strains in dry conditions on metal surface in 
albumin presence as well as the resistance to osmotic stress caused by NaCl and 
sucrose high concentrations were estimated. Using the plate di&sion method 
we assayed their ability to excrete bacteriocins active on 10 different species of 
Gram-positive and Gram-negative bacteria. Adherence of native (directly 
fiom culture) and sonificated cells (devoid of extracellular film) to plastic, g l a s s  
and metal surfaces were controlled. We estimated hydrophobicity (SAT test) 
and extracellular slime as well as the relation with the ability of clusters 
forming and rough type of growth. 
Results: Staphylococcus cohnii survived in dry conditions on metal surface for 
many months. More than a halfof the investigated strains were able to grow in 
the presence of 2 M of sucrose and 60% of strains in the medium with 2.8 M 
NaCI. All the 50 investigated strains expressed bacteriolytic activity to 
Minocows lysodeicticus and 23 strains produced bacteriocins active to other 
bacteria: Enterocorcus faecalis, Enterococnrs faecium and BacilZus subtilis. As many as 
66% of investigated strains produced slime, 80% were hydrophobic and 67% 
spontaneously formed clusters in liquid media. More than a half of the strains 
strongly adhered to surfaces - especially to PCV floor finish. The feature was 
shared by the cells covered with slime, those formed clusten and naked cells 
(sonificated). During the growth clusten of S. cohnii ssp. cohnii captured in 
themselves cells of other bacteria. 
Conclusions: Unusually active adhesion to surfaces of plastic, metal and glass 
and high endurance are the reasons for the long-life survival of S. mhnii ssp. 
cohnii in the hospital environment. Activity of their bacteriocins may support 
their prevalence in the environment. The ability ofthe cells clusters to capture 
other bacteria and their co-growth may be the reason for genetic exchange 
and lead to phenotypic diversity and resistance to antibiotics. 
Biological properties of Staphylococcus cohnii 
strains found persisting in an intensive care unit 
T. Nowak, M. Rbzalska, E. Waldon and E. M. Szewczyk 
Lodz, PL 
Objectives: To study biological features of Staphylocms cohnii ssp. cohnii and 
S. cohnii ssp. urealytinrs whose numerous strains were isolated fiom hospital 
environment, fiom medical s t aand  patients of ICU in the pediatric hospital. 
Methods: We performed biotyping studies of 238 S. cohnii ssp. cohnii and 
15 S. rohnii ssp. urealytirus strains based on sugan decomposition on Purple 
Agar. We also studied the abiJity of these stains to express enzymes and toxins 
recognized as important agents of staphylococcal pathogenicity: lipase and 
phospholipase, thermostable DNAase, proteases (gelatinase and caseinase), 
elastase, hyaluronidase, fibrinolysin, enterotoxins A, B, C and D and hemo- 
lysins as well as lactate dehydrogenase and esterases. The number and size of 
plasmids were established by gel agarose analysis of extrachromosomal DNA 
of 60 strains. 
Results: Most of S. cohnii ssp. cdn i i  strains belonged to three out of the six 
recognized biotypes. Almost all S. cohnii ssp. urealytincc strains were restricted 
to one of them. Lipases and phospholipases were produced in 40% of the 238 
investigated S. cohnii ssp. cohnii but only in 15% of S. cohnii ssp. urealyticus. 
Almost all the investigated strains excreted thermostabile DNAase and 
gelatinase. All S.cohnii ssp. UWQ~Y~'CUS produced caseinase but this was the 
feature of only 4% of S.cohnii ssp. cohnii. Differences between the two 
subspecies on intracellular level of expression of lactate dehydrogenase and 
esterases were also detected. None of the 116 investigated strains produced 
elastase, hyaluronidase or fibrinolysin. We did not find strains able to 
excrete enterotoxins. However, all the strains hemolyzed rabbit, sheep and 
human erythrocytes and caused synergistic hemolysis. Our preliminary study 
showed that S. cohnii produces highly thermostabile, low-weight deh-hke 
hemolysin. All the investigated strains contained plasrmds. Most ofthem were 
small with a size ofabout 1-10 kbp. The biggest ones were of25 kbp but these 
were only about 7% of all plasmids. Eighty-four per cent S. cohnii ssp. cohnii but 
only 69% S. cohnii ssp. urealyticus strains contained 4-10 plasmids in their 
cells. 
Conclusions: The investigated S. cohnii strains were phenotypically diverse. 
Both subspecies differ significantly, There is a series of biological traits 
conditioning good metabolic prospects and providing the staphylococcal 
species with important position in the hospital environment. 
Ip853J The predominance of multiple resistant 
Staphylococcus epiaermidis in bloodstream infections of 
neonates in neonatal intensive care units 
K. Kamotsay, A, Ghidin and E Rozgonyi 
Budapest, HUN 
Objectives: Strains of Staphylococcus ep idmid i s  have increasingly been impor- 
tant nosocomial pathogens, particularly in critically ill neonates. The aims of 
ths study have been to quanttfy the impact of S. ep idmid i s  in NICU-aquired 
infections occurred since January 2000. 
Methods: S. epidermidis isolates were taxonomically identified with tramtional 
methods. Confirmations were made in the API or ATB system. Antihiotic 
sensitivities were determined with the disc difision test, 6 pg oxacillin agar 
plates, and automated system of VITEK GPS 101. Oxacillin resistance was 
confirmed by PCR techniques. A stra in  was judged to be a probable cause of 
the infection if it was a single microorganism in the blood culture(s) of a 
neonate with clinical signs or symptom of infection. 
Results: Of2909 blood cultures fiom neonates cared at the three NICUs of 
the university hospitals 474 (16.29%) gave positive results and 199 isolates 
(42% of the total positive hemocultures) proved to be S. e p i d m i d b  strains. 
Most of the strains were resistant to B-lactamase-susceptible penicillins (99%), 
oxacdlin (88%). macrolides (75%). fluoroquinolones (39%), gentamicin (80%) 
and netilmicin (6Ph) but sensitive to vancomycin. The strains fell into 18 
distinct resistance phenotypes based on antibiotic resistance patterns, however, 
strains (28%) with simultaneously resistant to all /l-Iactams, aminoglycosides, 
macrolides and fluoroquinolons and those (33%) resistant to all /?-lact.ms, 
aminoglycosides and macrolides were predominant. A limited number of 
strain showed an intermediate resistance to teicoplanin with the disc method, 
however, using MIC determination a reduced glycopeptide susceptibhty 
seems to be more frequent than is currently estimated. Such a comparisons 
and the clonal relationshp of resistant strains are in progress. 
Conclusions: S. epidermidis strains are the most frequent Gram-positive 
causative agents of NICU-acquired infections because of their known high 
affiity to plastic devices and extraordinary ability to adapt and tolerate the 
environmental antibiotic pressures. We hypothesize that multiple resistant 
strains of S. epidermidis may be the reservoir of resistance genes for transfer into 
clones of Staphylococcus aureus and other Stapaphyfocorcus species. 
v] High prevalence of nasal carriage of methicillin- 
resistant coagulase-negative staphylococci in the community 
and in hospitalized patients 
1. Santos-Sanches, M. Miragaia, N. Augusto, R. Mato, I. Bonfun, 
R. Pimentel, G. O h  and H. de Lencastre 
Oeiras, Lisbon, 0; New York, USA 
Objectives: To evaluate the frequency of methicillin-resistant Staphylococlus 
aurew (MRSA) and methicillin-mistant coagulase-negative (MRCNS) car- 
riage among ambulatory patients and patients interned in the hospital. 
Methods: 
1 Sampling. Nasal swabs were taken &om (i) ambulatory patients attending 
general and ENT services; (ii) patients at four main internment services; 
(i) hospital staffi. 
2 Screening of methidfin-resistant st~phyl0~00Cn'. Staphylococci were selected in 
mannitol-salt media with oxacillin disks (1 pg). Individual colonies were 
further tested for coagulase production or clumping factor. Staphylococcal 
identification was performed by ITS-PCR, m e d  detection by PCR and 
oxacillin resistance was confirmed by disk diffusion. 
Results: A total of 3890 staphylococcal isolates were recovered from 2806 
individuals attending the two ambulatory services. Carriage rates (%) were 81 
for MSCNS, 49 for MRCNS, 17 for MSSA and 0.05 for MRSA. From 353 
patients of the four internment services, 555 samples were obtained 89 
patients were screened at adrmssion only (<48 h) and 264 were also followed 
during internment. Carriage among patients at admission and during intern- 
ment was, respectively, 85 and 60% for MSCNS, 72 and 85% for MRCNS. 
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MSSA carriage was identical in both groups (9%) and MRSAwas detected in 
2% of the inpatients. MRCNS carriage among the 99 healthcare workers 
sampled was also high (80%) but only two MRSA carriers were isolated. 
Contact with hospital and age were identified as risk factors for colonization 
by MRCNS. A representative sample of 39 strains from 34 patients fiom 
orthopedics was analyzed for the presence of m e 4  and species identification. 
Out of 39 m e d +  MRCNS isolates, 22 were S .  haemolyfinrs and 16 S. 
epidermidis; we found that carriage of S. hatwoiyficur increased with the length 
of the internment period whereas the opposite was observed for S. epidermidis. 
Conclusions: Infection by MRSA or MRCNS was very low (0.9%) in 
contrast with the high frequencies reported for Portuguese hospitals. This 
difference is probably due to the characteristics ofthis health institution. A low 
fiequency of MRSA carriage was also found among both the community and 
inpatients whereas a high rate of MRCNS carriage was detected amongst all 
study populations. This evidence together with the capacity of prolonged 
carrier status may be challenging since it constitutes a reservoir of drug- 
resistant bacteria inside and outside the hospital. 
Methods: We tested 142 consecutive clinical isolates from primary sterile sites 
and urine using a custom-made microbroth-dilution assay (Merlin Micro- 
naut) and Vitek 2 AST-P515 cards @ioMkieux) to determine minimum 
inhibitory concentrations (MIC). me&-PCR served as gold standard. 
Results The prevalence of oxacillin-resistance was 53.5% as determined 
by meul-PCR. Merlin Micronaut detected 98.6% (91.9-99.9; confidence 
interval 95%), Vitek 2 97.4% (90.0-99.5) of mec.4-positive isolates. 
At MICsL4mg/L 100% of isolates were me&-positive and at 
MICs 5 0.25 mg/L 98.3% of isolates were med-negative. The rate of 
false-resistance was 10.6% (4.7-21.2) for Merlin h4icronaut and 12.1% 
(5.7-23.0) for Vitek 2. S. sapmphyticus and S. lugdunensis were wer-repre- 
sented in the false-resistant group. 
Conclusions: The new breakpoint for oxacillin of OSmg/L yields high 
sensitivity. Vitek 2 and Merlin Micronaut are equivalent. The relatively high 
rate offalse-resistance may be addressed by testing all isolates with MICE from 
0.5 to 4mg/L with specific secondary assays. 
[ P855 I Molecular characterization of methicillin-resistant 
Staphylococcus epidermidis (MRSE) clones: evidence of 
geographic dissemination 
M. Miragaia, I. Couto, S. Pereira, K. Kristinsson, H. Westh, J. Jarlov, 
J. Carrigo, J. Almeida, I. Santos-Sanches and H. de Lencastre 
Oeiras, P; Reykjavik, IS; Hvidovre, Herlev, DK; New York, USA 
Objectives: The aim of this study was to: (i) identifi the MRSE clones 
circulating in one central hospital in Iceland and five hospitals in Greater 
Copenhagen, Denmark and (ii) compare the MRSE clones from Iceland and 
Denmark with representative MRSE strains isolated in hospitals h m  other 
countries in Europe, South America and Afiica, in order to track the 
geographic spread of MRSE clones. 
Methods: The MRSE isolates were tested for mannitol fermentation and 
coagulase production and identified by Internal Transcribed Spacer PCR 
(ITS-PCR). Antimicrobial susceptibility was determined by disk difliusion 
method (NCCLS). The med gene was detected by hybridizing the SmaI 
digests with a DNA probe internal to the meul. The molecular typing of 
isolates h r n  Denmark (n = I36) and Iceland (n = 94) collected in 1997 and 
1998 was performed by pulsed-field gel electrophoresis (PFGE) and visually 
compared with the patterns obtained &om a sample of MRSE h m  Greece 
(n=34), Uruguay ( n = l O ) ,  Mexico (n=74) and Cape Verde (n=48). 
Cluster analysis was performed using Dice similarity metric and single linkage 
amalgamation scheme. The representativity of the dendogram was verified by 
determining the cophenetic coefficient. A test of differences between pro- 
portions ( P <  0.5) was performed to analyze possible relations between the 
different clones and the clinical data. 
Results: The 230 MRSE strains b m  Denmark and Iceland were classified in 
40 merent PFGE patterns. Tmlve PFGE types were common to both 
countries and five (A, B, C, G and K) accounted for the majority of strains. 
Three PFGE types were also shared by isolates recovered in Denmark (type A 
and C), Iceland (A, GG and C), Mexico (GG), Uruguay (GG), Greece (A, 
GG and C) and Cape Verde (GG). The cluster analysis reflected the 
correctness of our visual PFGE pattern analysis considering a similarity 
distance of 78% and the cophenetic value of 0.84 validated the dendogram 
representation. The PFGE type K was found to be associated with an infection 
origin ( P <  0.05). 
Conclusions: PFGE met our aims for molecular characterization of the 
MRSE strains, identifying the major clones as well as the diversity among 
them. Notably, some multiresistant MRSE clones appear to be highly 
geographically disseminated. Ths  suggests that in the future it may be 
necessary to establish infection control procedures directed at MRSE in 
order to prevent infection with multiresktant endemic/epidemic hospital 
flora. 
mq Detection of oxacillin-resistance in coagulase- 
negative staphylococci 
D Burh, J Zoknger-Iten and R Frei 
Basel, Geneva, CH 
Objectives: To study the effect of lowering the breakpomt for oxacdh for 
resstance from 4 to 0.5mg/L to improve sensiavlty for the detecnon of 
oxaclllln-resistant coagulase-neganve staphylococci (NCCLS, 1999). 
1 P857J Rapid entrapment of vancwycin in dense cultures 
of slime-produang Staphflocotzus epkiknnfdis 
A Hallgren. C Ekdahl, H. Hanberger, M. Nhson, E. Svensson and 
L E. Ndsson 
Lnkoptng, S 
Methods: She-prudunng S t a p h y l o c m  eptdermidts ATCC 35984 at differ- 
ent mocula (lo5, lo6, lo', 1O'and lo9 cWrnL.) were exposed to vancomycin 
(0 5-16 mg/L). The bacterial numbers durmg the 24 h drug exposure were 
determmed unth blolummescence assay of bacterial ATF! Control expert- 
ments included heat-treated bactena. An agar well bioassay was used for the 
determnaaon of vancomycm m the broth during drug exposure. Samples 
were centrifuged and filtered before assay. 
Resulti: At low inocula (lo5 cfu/mL) the bacteria were ihb i t ed  at 2 mg/L. 
At a dense inoculum (10' &/I&) a fourfold hgher concentrahon (8 mg/L) 
were needed for growth mhbihon. A dense moculum (108du/mL) reduced 
the vancomycm concentrahons after 30-rmn incubahon appmmtely  5G% 
m cultures exposed to 1-8 mg/L. After 3 h mcubahon the COnCentrahons m 
cultures contamng an imtial concentrahon of 1-4mgIL were below the 
derecaon h t  of the bioassay (0.5mg/L). Control experments wth non- 
p u n n g  (lo9 c f d m l )  and dead bacteria (heat-treated) showed slrmlar results. 
Conclusion: The decrease of vancomycm COnCentrahotB in cultures contam- 
mg large numbers of dead, nongrowng and g r o w  cells IS probably due to 
bmdmg of vancomycm to cells and cell debris. Th~s  entrapment may be 
an explanahon for treatment fahre of staphylococcal infechons wlth 
hgh denshes of bacteria (e.g. abscesses, foreign body mfechons and endo- 
cardrtls). 
(ps58/ Effects of antibiotics on slime-producing 
Staphyibcoccus epidemidis adhered to pacemakers 
C. Persson, J. Eckerdahl, E. Micski, P-E. Lindgren, M. Nilsson 
and L. E. Nilsson 
Linkoping, Ja$dIla, S 
Objectives: Bacteria adhered to foreign bodies are often more resistant to 
antibiotics than bacteria of the same strain growing planktonically. Some 
strains also encapsulate themselves in slime consisting of extracellular biopo- 
lymers. The aim of this study was to investigate the biofilm formation on 
pacemakers and the antibacterial effect by rifampicin alone and combined 
with ofloxacin on a slime-producing s& of s taphy~ucom epidermidis. 
Methods: S. epidermidis ATCC 35984 w a s  adhered to Microny@ pacemakers 
(St Jude Medlcal) in supplemented Mueller Hinton Broth (MHB) for 24,48, 
72,96 and 120 h, respectively. Adherence and slime production were studied 
in an environmental scanning electron microscope (ESEM). The adhered 
bacteria were washed and exposed to rifampicin (8mg/L) alone or in 
combination with ofloxacin (16mg/L) for 20h at 37°C. The bacterial 
numbers on the pacemakers were determined by bioluminescence assay of 
inhacellular bacterial ATP afkr eXtraCEion of ATP in boiling TrisIEDTA- 
buffer. 
Resulk After 24-h incubation of the pacemakers in broth containing a start 
inoculum of 1 x lo4 c fu /mL ESEM showed adhered bacteria. The incracel- 
lular ATP level on these pacemakers was 2.0 X I 0-9 M ATP corresponding to 
2.0 x lo9 bacteria. After further 24 h incubatian of the pacemakers in fresh 
broth ESEM showed adhered slime-producing bacteria. The intracellular 
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ATP level on these pacemakers was 2.6 x 1 0 - ' ~  ATP corresponding to 
2.6 X 10" bacteria. The minimal inhbitory concentrations (MICs) of oflox- 
acin and rifampicin were 0.125 and 0.008mg/L, respectively. During treat- 
ment of the pacemakers with rifampicin alone development of rifampicin 
resistance occurred with a MIC increase to >256mg/L. Development of 
rifampicin resistance was prevented when rifampicin was combined with 
ofloxacin. The reduction of intracellular ATP on pacemakers with bacteria 
adhered for 24 h was 1 .41ogI0 (meaning 101 -4) after exposure to rifampicin in 
combination with ofloxacin. After the same treatment of the 48h slime- 
producing bacteria corresponding figure was 0.87 log,,. 
Conclusions: This study shows that ofloxacin can prevent development of 
rifampicin resistance. Furthermore the bactericidal effect was more pro- 
nounced on adhered bacteria prior slime production. This indicates the 
importance to assess the age of the biofilm and whether slime production 
occurs or not in models studying antibacterial effects on bacteria adhered to 
foreign bodies. 
Ip8591 Synergy of glycopeptides and p-lactams against 
teicoplanin-resistant Staphylococcus haernolyticus 
C. Vignaroli, M. Catena, P. E. Varaldo and E Biavasco 
Ancona, I 
Objectives: Synergy between glycopeptides (GPs) and fi-lactams has been 
reported in staphylococci. The purpose of this study was to compare the 
effectiveness of the association of GPs and j3-lactam against S. h a e m o l y t h  
strains susceptible or resistant to teicoplanin (TE) and methicillin. 
Methods: Four isogenic pairs of TE-susceptible/resistant strains of  S. haemo- 
lytkus, two (lS/lR and 2S/2R) med-negative and two (3S/3R and 4S/4R) 
meul-positive, were used. Resistant derivatives were obtained &om 
susceptible clinical parents by exposure to GPs. MlCs were determined by 
broth microdilution. Drug combinations were tested by disk diffusion and 
checkerboard assays. Autolync activity was determined by a turbidimetric 
assay. 
Results: Compared with the TE-susceptible parents, all resistant derivatives 
exhibited an 8-16-fold increase in TE MICs and no variation in vancomycin 
(VA) and oxacan (OX) MICs; penicillin (PE) MICs dropped hy >64 and 8- 
fold in the two med-negative derivatives (1R and 2R, respectively), but 
remained unchanged in the two med-positive derivatives. Ampicillin (AM) 
MlCs remained unchanged in all derivatives with the exception of 1R (32- 
fold decrease). Combinations of TE or VA with OX, PE, or AM were 
synergistic against all parents and derivatives; however, a paradoxical effect, 
associated with reduced autolysis, was observed with some fl-lactam con- 
centrations. Synergy was most evident against the md-positive TE-resistant 
derivatives. The latter strains, in agar plates containing TE, showed a double 
zone around PE and AM disks, and an incomplete zone around OX disk. By 
population analysis, heterogeneous or homogeneous resistance to TE asso- 
ciated with homogeneous susceptibility or heterogeneous resistance to VA was 
observed. 
Conclusion: Synergy between GPs and 8-lactams was particularly evident 
against med-positive TE-resistant derivatives of S. haemolytinrs. The 
double zone shown by these strains around PE and AM disks and the 
incomplete zone around OX disk appeared to correlate with OX resistance 
rather than with a heterogeneous phenotype of GP susceptibility. A reduced 
autolytic activity in the presence of particular concentrations of B-lactams 
could be responsible for the paradoxical effect and the double zone around PE 
and AM disks. 
)ps6oj The relationship between antibiotic susceptibility 
and pathogenicity of staphylococci isolated from clinical 
samples 
U. Altoparlak, E Aktas, H. Uslu, E. Kirecci and S. Erol 
Errurum, TR 
Introduction: In this study, we aimed to investigate the relationship between 
antibiotic susceptibility and pathogenicity of staphylococci isolated &om 
clinical samples. Pathogenicity criteria including slime production, crystal 
violet reaction were investigated. 
Methods: In t h ~ ~  study, total 200 staphylococci strains were isolated 
from various clinical samples for control groups 64 staphylococci strains 
and 56 staphylococci strains were obtained h m  nasal culture of hospital 
personals and nasal swabs &om persons who had no relation with the hospital. 
Congo-Red Agar method was used to investigate slime production. Bacterial 
strains were studied for crystal violet reaction on a nutrient agar medium 
containing one part in 100000 crystal violet. Antibiotic susceptibility testing 
was performed using agar dilution method as described by the National 
Comittee for Chical Laboratory standards. 
R ~ s u ~ .  Out of 200 staphylococci strains isolated 117 (58.5%) were identified 
as coagulase-negative Staphylococnsz (CNS) and 83 (41.5%) Staphyolococcus 
aurew (68 MRCNS, 49 MSCNS, 48 MRSA, 35 MSSA). Slime production 
was detected in 14.3% ofMRCNS and 29% ofMSCNS. 76 ofS. aureus strains 
gave positive crystal violet reaction whch is composed of 93.8?? MRSA, 
88.6% MSSA were determinated. No statistically sigmfuzant difZerence 
between crystal violet reaction (CVR), slime production and/or methicillin 
resistance (Pa 0.05). All ofthe strains were susceptible tovancomycin whereas 
0.5% of pathogenic strains were resistance to teicoplanin. The antibiotic 
resistance ratio of slime-producing CNS was summarized like t h :  isepanlicin 
0.9%. cefepim 0.9%, arnpicillin-sulbactam 0%, tetracydin 5.1%. erythromy- 
cin 7.7%, rifunpicin 6.8%. S. aureus strains with positive crystal violet reaction 
have shown antibiotic resistance hke this: isepamicin 2.6%, cefepim 9.2%, 
ampicillinjulbactam 10.5%, tetracyclin 13.2??, erythromycin 13.2%, rifam- 
picin 13.2%. 
Conclusions: Our results showed that positive crystal violet reaction was 
reliable marker for pathogenecity of S. aureus and slime production was an 
important marker for pathogenecity of CNS strains However, there has been 
no relationship observed between antibiotic resistance and/or crystal violet 
positive S. aureus, slime-producing CNS strains. 
jp8611 Identification of Sraphy/ococcus spp. in blood 
cultures by a rapid DNA probe test 
C. Farina, M.-A. Facheris, D. Masnada, A. Callegaro and A. Gogho 
Bergamo, I 
Objectives: To evaluate sensitivity and specificity of 'Accuprobe Staphylocom 
aurew probe' (Gene Probe Incorporated, USA) for duect, rapid identdication 
of staphylococci (S. aureus vs. coagulase-negative strains) from blood cultures 
bottles Staphylococcus positive at the microscopic smear. 
Methods: A total of 70 blood cultures broths were tested by traditional 
techniques (direct coagulase test, culture onto Blood Agar plates, followed by 
identification with API Staph, bioMtriew and Crystal GP, BD) and by 
'Accuprobe Staphylococcus aureus probe'. Accuprobe uses a chemiluminescent 
DNA probe that detects specific rRNA sequences of the target microrganism. 
Two centrifugation steps were done before the Gene Probe procedures. The 
results of the test are based on the following cut-off values: S. aureus > 1500 
AccuLDR, coagulase-negative staphylococci < 1200 AccuLDR. Samples 
included in the 'repeat range' (1200-1499 AccuLDR) were re-tested, u t i i -  
ing a preliminary additional wash with saline and ultrapure water. 
Results: Ted70 samples were positive for S. aureus (range: 3911-11012 
AccuLDR) and 60 for coagulase-negative staphylococci (range: 87-1 166 
AccuLDR) using Accuprobe Staphylococcus aureus probe. Cultures confirm- 
ed the Accuprobe identification. Three samples were in the 'repeat 
range' (AccuLDR: 1201, 1210 and 1362, respectively), but afcer the addi- 
tional wash test results confirmed the coagulase-negative staphylococci 
growth. 
Conclusions: Staphylococcus sp. is the most frequent microrganism from blood 
Staphylococcw aurew is 7.8% and coagulase-negative staphylococci are the 
43.4% of our blood cultures isolates. It is important the rapid identification of 
the species level of Staphylococcus, considering the clinical role of S. auieus and 
the doubtful significance of coagulase-negative strains. Our data confirm that 
Accuprobe Staphylocow a u r a  probe is characterized by sensitivity and 
specificity values of 100.0%. This test is time-saving (1 h in a routine activity) 
versus traditional techmques (coagnlase test: several hours to overnight), if 
done dlrectly from broth. This method is an excellent method for preliminary 
testings permitting a more rapid clinical management. 
I P862 I A comparison of phenotype and genotype 
methods for the identification of coagulase-negative 
staphylococci 
E. K. Girvan, K. G. Liddell, D. Morrison and C. G. Gemmell 
Wishaw, Glasgow, UK 
Objectives: As coa&e-negahve staphylococci (CNS) have become increas- 
ingly recogmzed as chnically significant pathogens, the need for them to be 
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identified to species level occurs with greater frequency than before. Phe- 
notypic methods have largely been used in the past, but problems such as 
variable accuracy with test substrates and subjectivity exist. Genotypic 
methods have now been developed to speciate CNS. It is the aim of this 
study to compare and evaluate three phenotypic methods, with two genotypic 
methods, for their abdity to idenafy CNS. 
Methods: A collection of 99 isolates comprising 48 clinical isolates and 51 
reference isolates, were identified using three phenotypic methods (API 
Staph, ID 32 Staph and an in-house method) and two genotypic methods: 
the 16s-23s Spacer Length PCR (SL-PCR) of de Baere et al. (Abstract 1573, 
ICAAC 1999) and the eight CNS species-specific primers of Gribaldo et al. 
(1997, J. Med. Micro. 4 5  45-53). The species-specrfic primer PCR method 
(SS-PCR) was regarded as the 'gold standard' and all other methods were 
evaluated against it. 
Results: The SL-PCR idenhfications corresponded to those obtained with 
the SS-PCR method. One isolate could not be identifled by SS-PCR but 
produced a unique pattern by SL-PCR. Intra-species pattern variations were 
observed with SL-PCR, however, these were easily distinguishable from 
interspecies patterns. The phenotypic methods identified the CNS with 
varying degrees of accuracy: API Staph (84%); ID 32 Staph (81%); In-House 
Method (58%). 
Conclusions: Genotypic methods were shown to be superior to the pheno- 
typic methods employed in this study for the identification of CNS to species 
level. Problems remain with the ability of. each of the phenotypic methods to 
idenhfy CNS. The SL-PCR was demonstrated as an excellent alternative to 
SS-PCR. It is more cost effective than SS-PCR requiring only a single PCR 
amplification, compared to the seven required for SS-PCR. In addition, SL- 
PCR can idenhfy species for whch there are no species-spec& primers 
avadable. 
Resistance in Gram-positive bacteria 
/p863/ Teicoplanin in autpatient/home parenteral 
antibiotic therapy (OHPAT): the Dundee experience 
G. D. Barlow, J. Morrison, K. Gray and D. Nathwani 
Dundee, UK 
Objectives: To describe the experience of usmg teicoplamn by a well- 
developed Umted Kmgdorn OHPAT semce 
Methods: Bauc demograpbc and chmcal data about all pahents who 
had received teicoplanin as part of OHPAT were acquired &om the 
Dundee OWAT database (1998-2031). Mmobio1ogm.l results and teico- 
planin levels were ascertamed fhm the computerized laboratory results 
semce. 
Results: One-hundred and five (105) patlent-epnodes were idendied m 98 
pahents (63% male). The most common infechons were bone or jomt 
(including prosthehc) (53%), skm or soft hssue (34%) and endocardhs 
(10%). Fifty-three paaents (50%) had poslhve mcrobiologcal specunens, 
of whch 41 (39%) were &om bone or joint hSSUe/pUS or blood culture The 
most commonly cultured organums were methcdhn-resistant Staphylococcus 
eprdmrdis (32?h), MRSA (24%) and MSSA (16%). At predmharge out- 
pahent revlew, 58% of pments we= deemed to have been cured and 41% to 
have improved. One patient died, but this was unrelated to the underlymg 
infectlon or therapy. Five (5%) pahents are known to have subsequently 
relapsed requltmg further inteIWnh0n. Adverse events reqwrmg cessation of 
therapy occurred m only two (2%) paaents Five (5%) patients, however, 
requlred a PICC kne change due to catheter blockage. 
Conclusions: Teicophm appears to be a safe and efficacious anmcrobial 
when used as OHPAT 
I P864 I High-level glycopeptide-resistant Enterococcus 
faecalis: a second isolate from Turkey 
A. Karadenizli, A. Willke, B. Mutlu and E Kolayli 
Kocaeli, TR 
Objective: We aimed to present a high-level glycopeptide-resistant Enfero- 
coccus faecalis strain which is the second isolate h m  Turkey. 
Methods: Patient from whom the bacteria was isolated, was transferred to our 
hospital with the diagnosis of acute abdomen + pelvic peritonitis and sepsis. 
After the pelvic abscess operation, patient was given many antibiotics 
includmg teicoplanin for 2 months. Strain isolated from two blood cultures 
of this patient was identified as Enterococcus by classical methods. API 20 
STREP and VITEK (BioMerieux, France) were used for the analysis of 
species. By these systems, strain was ident&ed as E.faecafis. Susceptibility of 
antibiotics were evaluated by disk-diffusion, agar dilution and E-test (AB 
Biodisk, S o h ,  Sweden) methods. Strain was tested for all antibiotics used for 
enterococci suggested by NCCLS. 
Results: Isolated strain was found sensitive to ampicdlin and nitrohrantoin. 
Minimal inhibitory concentration (MIC) level was 256mg/mL both for 
vancomycin and teicoplanin. VanA gene responsible for high-level glycopep- 
tide resistance was shown by PCR. High level resistance to aminoghcoside 
was also detected. B-Lactamase activity was shown negative with nitrocefin. 
Conclusion: High-level resistant E.faecalis to glycopeptide was firstly isolated 
in our hospital. It should be noticed that E.fmulk can cause a problem both in 
therapy and in prevention of its spreading. Therefore, investigation of 
glycopeptide resistance of isolated enterococci is especially suggested in 
routine bacteriologic tests. 
jp865\ Characterization of a novel gene aac(6') from 
En terococcus hirae 
R. Del Campo, C. Tenorio, J. C. Galan, M. Zarazaga, R. Gomez-Lus 
and C. Torres 
Madrid, LogroCo, Zaragoza, E 
The objective was to characterize a new aaC(6') activity in Enterococcllr hirae 
strains. In this study, 10 E. hirae strains were included. They were identified by 
biochemical and molecular methods and were probed to be unrelated 
by PFGE-SmaI analysis. All strains were susceptible to penicillin (MIC: 
0.5-4 pg/mL) and none of them showed high-level mnoglycoside resis- 
tance. SyrIergShc studes were performed by tune-lull curves using Merent 
ammoglycosides and pemcdhn combinanons. All s t r a m  showed synergy 
when streptomycm or gentarmcin were combmed with penicdlin, but not 
when pemcilhn was combined urlth tobramycin or kanamycin. A typical 
aac(6') achvlty. that moddied tobramycin, kanamycin and netllmym but not 
6'-netllmycm, was demonstrated by the radoenzymaac assay method. Nega- 
uve results were obtamed when presence of aac(6'f-Ii gene was tested by PCR 
or by dot blot hybriduaaon mth an aac(6')-li rnternal probe. Degenerated 
pruners were designed based in the companson of four dfferent auc(6 ') genes, 
that yielded a 240-bp PCR product w t h  all these strams. Udorm DNA 
sequences were obmned from amphcons of three of the E. hrrae strains that 
were analyzed The deduced ammo aad sequence from PCR products 
showed an idenaty of 61% mth  au(6')-6 &om E.faectum 
Conclusion: An aac{6')-11 acavlty was detected in E. hrrae strains. Ths enzyme 
does not confer bgh-level tobramycin or kanamycin resistance, but idubit 
the synergshc effect between these ammoglycosides and peninhn A novel 
aar(8') gene, that showed an tdenhty of 61% wth  aacf6')-h &om E.faecium, 
has been characterized 
lp8661 Molecular characterization of van genes related to 
vancomycin-resistant enterococci isolated from hospital 
infections in Brazil 
H. Caiaffa Fdho, G. Oliveira, G. Almeida, E. Mamizuka, L. Mimica and 
M. Burattini 
Sio Patslo, 3R 
Enferococcus spp. is part of the intestinal normal flora, together with close to 
100 other species of aerobic and anaerobic bacteria. Initially, the enterococci 
were considered as being l o w - d e n t  microorganisms, but the rapid emer- 
gence and hemination of vancomyck-misw enterocecci strain9 (IRE) 
has completely changed the clinical relevance of such pathogens. At present, 
VRE is an important pathogen related to hospital infections in many 
countries, presenting limited or no therapeutic options for treating serious 
infections. The present study was initiated to investigate the prevalence of van 
genes among clinical VKE strains related with a possible outbreak (under 
investigation) that occurred at the Hospital das Clinicas da Faculdade de 
Medicina da Universidade de Sio Paulo (HCFMUSP). The samples were 
isolated &om 48 different patients. Five strains were identified as Enterocow 
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faecium and 43 as E. faecalis. The oligonucleotide primers directed to v a d ,  
vanB and vanC genes in enterococci and the polymerase chain reaction (PCR) 
technique applied were the same as previously described by CDCs Anti- 
microbial Resistance Working Team (Clark et al., 1998; Tenover et al., 1998). 
The results showed that all strains tested presented the vanA gene and 
produced the expected 1030bp amplicon with v a d  primers. No strains 
with vanA gene showed positive PCR results when tested with vanB or vanC 
primen. As all strains in our study presented the vanA gene, there is a potential 
high risk for spreading into Merent hospitals. Consequently, restricted 
infection control measures to prevent spread of VRE have been implanted 
since then. The HCFMUSP is a large complex temary hospital with 1500 
beds that attends seriously ill patients with high risk for acquiring hospital 
infections. This fact increases the risk of the dissemination of VRE. Besides 
that, as enterococci are enteric bacteria and the intestinal lumen offers an 
environment for bacterial conjugation, the dissemination of vanA gene could 
occur among other enterococci species and also to other bacteria genus 
bringing an important issue to be monitored and solved by the hospital 
infection control team and the microbiology laboratory. 
lp8671 Characterization of teicoplanin-susceptible and 
teicoplanin-resistant Staphylococcus aureus by matrix- 
assisted laser desorption ionization timeof-flight mass 
spectrometry (MALDI-TOF MS) and peptidoglycan 
muropeptide analysis 
P. Majcherczyk, T. McKenna, P. Vaudaux and P. Moredlon 
Lausanne, CH; Manchester, UK; Geneva, CH 
Background and purpose: Teicoplanin (Tec) is a glycopeptide antibiotic that 
inhibits the polymerization of peptidoglycan (PG) glycan chains, and hence 
the crosslinking of its muropeptides. Glycopeptide-resistant (r) Staphylucoms 
aureus isolates emerge under therapy with Tec. Unexpectedly, Tec-r sub- 
populations also emerged in the tissue-cage fluid of rats infected with s. 
aureus, never exposed to this drug (J. Antimicrob. Chemotherapy 2001; 
47 : 163-70). The present study used two different techniques to analyze 
perturbations of the cell wall present in such Tec-r subpopulations. One 
examined the ionizable components on the surface of intact bacterial cells by 
MALDI-TOF MS. This provides information on global modifications of cell 
surface components. The other analyzed the PG muropeptide pattern after 
digestion of their glycan chains, a method generating structural information 
on the PG scaffold skeleton. 
Methods: The Tec-sensitive parent (isolate MRGR3) and its stable Tec-r 
variant recovered fium tissue-cage fluids (isolate 14-4) were studied. MALDI- 
TOF MS was performed directly on colonies picked off agar plates, embedded 
in matrix and the ionisable cell surface components directly analyzed. For 
muropeptide analysis walls were purified, stripped off their teichoic acids, 
their glycan chains digested with mutanolysin and separated by HPLC. Eluted 
muropeptides were detected by W absorbance. 
Results and conclusions: MALDI-TOF MS revealed fingerprints compatible 
with reference S. aureus. However, each isolate contained unique and very 
reproducible peaks that enabled them to be differentiated. For example, an 
intense 825Da peak was present in the Tec-r variant, but was practically 
absent from the Tec-sensitive parent. These results indicate that Tec-sensitive 
and Tec-r variants difCered in some surface components that affected their 
ionization. On the other hand, both strains revealed indistinguishable mur- 
opeptide patterns that were compatible with published S. aureus PG. Thus, 
although surface alterations were present in the Tec-r variant, they were not 
related to an abnormal PG skeleton. The combination ofthese two techniques 
is an elegant new strategy to help determine the localization of wall alterations 
in different bacterial variants. The ionizable nature of the altered molecules 
and the fact that they are not associated with an altered PG scaffold should help 
target further investigations on other surface components such as teichoic 
acids or proteins. 
(p868] Emergence of a teicoplanin-resistant small colony 
variant of Staphylococcus epidemidis during vancomycin 
therapy 
H. Adler, A. F. Widmer and R.  Frei 
Basel, CH 
Small colony variants (SCVs) of Staphylococcus aureus have been reported 
to cause persistent and relapsing infections. Little is known about 
SCVs of coagulase-negative staphylococci. 
Objective: To characterize a teicopknin-resistant SCV of S. epidermidis that 
developed in an immunocompromised patient during vancomycin therapy 
for blood stream infection PSI). 
Methods: Bacterial isolates were identified based on their biochemical protile 
with the API Staph @ioMerieux). Susceptibility testing was pe&ormed 
according to NCCLS guidelines by broth microdilution. Resistance to 
m e t h i c h  was confirmed by detection of penicillin binding protein 2' 
(MRSA-Screen, Denka Seiken Co.). MICs of teicoplanin and vancomycin 
were determined by E-test methodology (AB Biodisk). Molecular typing was 
performed by pulsed-field gel electrophoresis (PFGE). 
Results: On day 1 and day 2, S. epidnmidis was isolated from blood cultures of 
a patient with acute myeloic leukemia undergoing chemotherapy. The isolates 
were resistant to m e t h i c h  and susceptible to both vancomycin and teico- 
planin. On day 3, the patient was treated for catheter-related BSI with 
vancomycin including a vancomycin-lock. Blood cultures taken 1 h before 
vancomycin-lock grew again teicoplanin-susceptible S. epidermidis. From 
blood cultures taken 1 1 h after vancomycin-lock, S. &midis  with the same 
susceptibility profile was isolated. In addition, a methicillin-resistant SCV of 
S. epidermidis was detected which was susceptible to vancomycin (MIC, 3 mg/ 
L) but resistant to teicoplanin (MIC, 24mg/L). The intravenous catheter was 
replaced on day 5. Despite therapy with vancomycin plus other antibiotics, 
teicoplanin-resistant SCVs were repeatedly isolated until day 15 and teico- 
planin-susceptible large colony forms were isolated until day 21. The patient 
died on day 23. Typing with PFGE showed that all isolates belonged to the 
same clone. 
Conclusions: A teicoplanin-resistant SCV of S. epidemidis developed rapidly 
during vancomycin therapy and persistent S. epidermidis BSI. Small colony 
variants of coagulase-negative staphylococci can cause serious and persistent 
infection. Due to their slow growth and their tendency to revert to the large 
colony form they can easily be missed in culture. 
(p8691 Competition between antibiotic sensitive and 
resistant coagulase-negative staphylococci (CoNS) on skin 
I. Gustafsson and D. I. Andersson 
Uppsala, Sulna, S 
Objectives: To study how CoNS, with resistance to fusidic acid, ciprofloxacin 
and streptomycin compete with its isogenic sensitive strain on human skin. 
Methods: A CoNS was isolated from a healthy person, and a rifampicin- 
resistant ( r i a )  clone was selected. The rifk marker was used to distinguish 
between the inoculated strains and the resident CoNS strains. The r i m  strain 
was used to select for mutants resistant to hsidic acid, ciprofloxacin and 
streptomycin. The rifR strain w a s  mixed 1:l with each double-mutant strain 
(fusR, cipR and s m R ) .  The mixture was applied on the forearms of 18 
volunteers. Samples were taken on day 1.3 and 10, and cultured on blood agar 
plates containing 50 mg/L rifampicin. Colonies were counted and replicated 
to selective plates containing hsidic acid, ciprofloxacin or streptomycin. 
Results: The ciprofloxacin- and streptomycin-resistant strains had a similar 
biological fitness as its isogenic sensitive strain. During 10 days the ratio varied 
for cipR/cipS between 1 and 0.65 and smR/smS 1.3-0.76. The fusidic acid 
resistance caused a clear fitness loss. The ratio fusR/fusS day 1, 3 and 10 was 
0.60, 0.13 and 0.23, respectively. The fusR-strain had the same generation 
time as fuss in broth, but in the natural environment the fusR mutation 
became detrimental. 
Conclusions: Resistance to ciprofloxacin and streptomycin in CoNS did not 
confer a biological cost, and the bacteria had the same ability to survive on the 
skin as the sensitive isogenic strains. Resistance to fusidic acid was a dis- 
advantage for the bacteria and the resistant bacteria could not compete with 
the sensitive strain in the natural environment. 
PFGEdetermined clonal linkages of fusidic acid 
resistant (FusR) versus sensitive (FUSS) Slaphy/ococcus 
aureus (SA) 
J.A. Maeland, J. E. Afset and L. Marstein 
Trondheim, N 
Objectives: To test skin and soft tissue isolates of SA for sensitivity to fusidic 
acid. 
Methods: SAs (n=255) which caused skin and soft tissue infections in 
outpatients were tested. E-test was used fbr MIC determination, 
nitrocefin test for j?-lactamase expression, and PFGE (SmaI) for testing of 
genotypes. 
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Results: FusR (MIC 1 mg/mL) was shown by 83/255 (32-5%) of the SAs. Of 
the FusR SAs, 80/83 (93%) produced 8-lactamase versus 1141172 (66%) of 
the FUSS SAs. Among 24 FUSS strains tested by PFGE, 16 different patterns 
were recorded without domtnance of anyb+m pattern. Among 48 FusR SAs 
tested, 11 different patterns were recorded and 36/48 (75%) of these strains 
produced identxal or nearly identical patterns. 
Conclusion: FusR was more common among the SAs than we had expected. 
This was largely due to spread in the population of SAs which exhibited 
similar PFGE patterns, probably a particular clonal lineage of the FusR 
SAS. 
In vitro activity of daptomycin against 
staphylococci isolated in Europe during 200&2001 
M. E. Jones, D. C. Draghi, I .  A. Critchley, J. A. Karlowsky, 
C. Thornsberry and D. F. Sahm 
Hilversum, NL; Herndon, Franklin, USA 
Objectives: Staphylococnrs aureus (SA) and coagulase-negative staphylococci 
(CNS) resistant to oxacillin (OX) are prevalent in many countries. Dapto- 
mycin (DAP), a novel cyclic lipopeptide currently in Phase 111 clinical 
development, has been reported previously to possess in vitro bactericidal 
activity against OX-resistant SA (ORSA), multidrug-resistant (MDR; resis- 
tant to 2 3  antimicrobial classes) SA and CNS. The current study surveyed 
DAP activity in Europe and provided a baseline to monitor the activity ofDAP 
against both susceptible and resistant (R) organisms. 
Methods: During 2000-2001, 1222 SA and 1040 CNS were collected from 
40 laboratories in 15 European countries. All isolates were centrally tested by 
NCCLS broth microdilution against OX. vancomycin, teicophnin, erythro- 
mycin (ERY), clindamycin (CLI), gentamicin (GEN), ciprofloxacin (CIP), 
quinupristin-dalfopristin (Q-D), lmezolid (LZD), cotrimoxaeole (COT), 
and DAP. 
Results: Overall percent resistant (R) rates for SA and CNS were ERY (34.1, 
49.9), OX (27.3, 53.3), CIP (30.6, 31.6), CLI (19.0, 22.0), and GEN (14.6, 
31.4). At the national level, OX resistance ranged horn 4.0% in the Nether- 
lands to 36.9% in Portugal. MICw (mg/L) for the new directed-spectrum 
agents against all SA and CNS were DAP (0.5, 0.5), Q-D (0.5, 0.25), and 
LZD (2.2). Against ORSA, DAP and Q-D were the most active agents, based 
on MICgo (0.5 mg/L) compared with LZD (2 mg/L). Among the SA tested, 
301 (24.6%) were MDR with resistance to OX, CIF', and ERY being the most 
common phenotype (44.2% of MDR isolates). DAP MICm (mg/L) against 
SA were 0.25 for non-MDR isolates and 0.5 for MDR isolates. Against OX- 
R CNS, Q-D and DAP were the most active agents, based on MICgo (0.25 
and 0.5 mg/L, respectively) compared uith LZD (2 mg/L). 
Conclusion: ORSA and OX-R CNS are prevalent in many countries in 
Europe. DAP is a novel antimicrobial that is active against both susceptible and 
resistant isolates and shows promise for the therapy of infections caused by 
these organisms. 
[ P872 I In vitro activity of daptomycin against streptococci 
isolated in 15 countries in Europe during 2000-2001 
M. E. Jones, D. C. Draglu, I .  A. Critchley, J. A. Karlowsky, 
C. Thornsberry and D. F. Sahm 
Hilversum, NL; Hmdon,  Franklin, USA 
Objective: The emergence of Streptococcus pneumoniae (SP) multidrug resis- 
tance (MDR, resistance to 2 3  antimicrobial classes) and S. agalactiae (GBS) 
resistance to erythromycin (ERY) and clindamycin (CLI) is a concern in many 
countries. Daptomycin PAP) is a new cyclic lipopeptide agent reported to be 
active against clinically important Gram-positive pathogens, including SP and 
GBS, resistant to currently available agents. This study was designed to assess 
the current activity of DAP against streptococci in Europe and provide a 
baseline by which to monitor future studies. 
Methods: During 200@2001,865 SP and 367 GBS were collected from 40 
hospitals in 15 European countries. Isolates were tested by NCCLS broth 
microdilution against DAP, PEN, cefuroxime (CEF), other /Llactames, 
vancomycin, EKY, CLI, levofloxacin (LEV), linezolid (LZD), quinupris- 
tindalfopristin (Q-D) and cotrimoxazole (COT). 
Resuk Overall resistance rates (%) among SP were ERY (24.4), COT (18.9). 
CLI (18.0), CEF (18.2), PEN (9.4) andLEV (0.6). At the nationallevel, PEN 
resistance in SP ranged from 0% in the Netherlands to 20.7% in Portugal. 
Based on MICw, DAP w a s  the most active agent tested against SP (0.25 mg/ 
L) The prevalence ofMDR m SP was 3.6% (31 isolates) wth resistance to 
ERY, PEN and COT bemg the most frequently encountered MDR phe- 
notype (29 isolates; 93.5% of h4JlR Isolates) PEN-reastant SP were cross- 
resistant to many other agents mdudmg other 8-lactames, ERY, CLI and 
COT The achvltles of DAP, QD and LZD were not affected by PEN 
resistance mth  MICm (mg/L) of 0.25, 0.5 and 1, respechvely, a g w t  both 
PEN-suscephble and -resistant isolates. DAP was also equally acnve agamt 
both MDR and non-MDR SP Among GBS, resistance rates (%) were ERY 
(10.4), CLI (6.5) and LEV (0.3) The MICm (mg/L) for DAR Q-D and LZD 
a m s t  GBS were 0 25, 0 25 and 1, respechvely 
Conclusions: Antlbiohc-resistant streptococn conhnue to occur m many 
European countries, and it prudent to develop new therapeuhc agents to 
combat these organisms Dhp, one such novel agent, demonstrated potent in 
vltm acunty agamst both SP and GBS includmg Isolates that were resfstant to 
currently avadable agents. DAP shows promse for the therapy of urfectlons 
caused by orgamsms resistant to other agents. 
/m Antimicrobial susceptibility of 60 Stmptoccocus 
oralis isolates 
G. Bancesu, D. Ionescu, A. Bancescu, C. Defta, S. Alecu and S. Dumitriu 
Bucharest, RO 
Objectives: To investigate the antimicrobial susceptibility of 60 Srreprococ-rus 
oralis isolates to seven antimicrobial agents as several studies reported an 
increased resistance of these bacteria to some commonly used antibiotics. The 
strains were isolated in pus sample collected from Romanian patients with 
different oral and maxiUoficial (OMF) infections. Correlating the microscopy 
with the culture results, Streptoccocus oralis was the only microorganism 
found to be involved in infection in four cases. 
Methods: The E-test (AB Bio-Disk, Sweden) was used accordmg to the 
manufacturer recommendations to test susceptibility of the isolates to the 
following antibiotics: benzylpenicilin (PG), ampicih (AM), cefotaxime 
(CT), erythromycin (EM), clindamycin (CM), chloramphenicol (CL) and 
tetracycline(TC) . 
Results: The MICs (pg/mL) ranges were as foHows: PG 0.016-0.75 (83.3% 
susceptible, 16.7 intermediate susceptible), Ah4 0.016-0.5 (95% susceptible, 
5% intermediate susceptible), CT 0.016-0.38 (100% susceptible), EM 0.016 
3 (91.7% susceptible, 5 intermediate susceptible, 3.3% resistant), CM 0.016- 
0.047 (100% susceptible), CL 0.5-4 (100% susceptible) and TC 0.047-64 
(48.3% susceptible, 11.7% intermediate susceptible, 40% resistant). 
Condusions: (1) The resistance bund to some antimicrobial agents recom- 
mends periodical susceptibility testing of S. oralis and other oral streptococci 
isolates of clinical sigmficance; (2) CM or CL might be alternatives to the 
treatment of OMF infections involving oral streptococci with reduced 
sensitivity to 8-lactam antibiotics. 
lp8741 Effects of Helichrysum italicurn extracts on growth 
and in vitro adherence of cariogenic streptococci 
A. Nostro, M. A. Cannatelli, A. D. Musolino, E Pmcopio, G. Crisafi and 
v Alonzo 
Sicily, I 
Objective: Phytochemid have recently been shown to be a good alternative 
to synthetic chemical substances for caries prevention, one of the most 
ubiquitous disease in the modern society. The purpose of the present study 
was to examine the susceptibility of cariogenic streptococci to Helichryrum 
itolicum, a plant rich in flavonoids and terpenes with antidammatory, 
antiallergic and antierythematosus activity, for hture usage as antimicrobial 
agent in oral hygiene formulations. 
Methods: We tested the activity of various extracts of H. italicurn (ifusion, 
aqueous macerate, diethyl ether and ethanolic extract) against Srreptococcus 
mutam ATCC 35668, S. sulivurius ATCC 13419, S. sanguis ATCC 10556 and 
the effect on adherence to smooth glass suIface of S. mutam. Antimicrobial 
activity was determined by the disc diffusion test, MIC and MBC. To study 
the influence on adherence, the organisms were grown for 18 h a t  37 "C in 
BHI broth containing 2% sucrose and various concentrations ofthe extract, in 
test tubes inclined at 30" angle. The bacteria adhering to the glass surface were 
removed by sodium hydroxide 0.5 M, centrifuged and suspended in saline. 
The adherent and nonadherent bacteria were quantified spectrophotome- 
trically at 540 nm. 
Results: The diethyl ether and etbanolic extract inhibited aU streptococci 
tested, showing the largest inhibitory zone (2530mm in diameters) 
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and the best MIC (31.25-62.5 pg/mL) and MBC values (25Cr500 pg/ 
mL). The infusion and aqueous macerate demonstrated a lower activity. 
Cell adherence was almost completely inhibited by both the diethyl 
ether and ethanolic extract at concentration equal to 0.5 and 0.25 
MIC. 
Conclusion: In conclusion, being the adherence of S.  mufaans to teeth the 
essential step for caries formation, the data presented in this study suggest that 
H. italicurn could be proposed for preventive treatment of dental caries. 
Research is in progress to evaluate the biological effects of this plant under 
conditions similar to those existing ‘in vivo’. 
Community-acquired RTI 
/p8751 Community-acquired pneumonia: analysis of 977 
cases in a clinical setting 
L. Ortega, J. Martinez Montauti, M. Sierra, R. Cid, M. Paricio, 
J. Fornaguera and C. Gomez Vaquero 
Barcelona, E 
Objective: Analyze the clinical characteristics of all the patients with com- 
munity-acquired pneumonia (CAP) attended in a tertiary hospital during a 3- 
year period (1998-2000). 
Methods: All the patients hagnosed of CAP in the Emergency Department 
were included. The diagnosis was made on basis to clinical and radiological 
criteria. The data recorded were: (a) sex, @) age, (c) seasonal distribution, (d) 
Fine defined risk-class, (e) time until arrival to the hospital, (t) presence of 
underlying diseases, (9) admissions, (h) hospital stay, and (i) outcome. 
Results Nine hundred and seventyseven consecutive patients (525 male, 472 
female) with a mean age of 64 f 19 years were included. Mean age of male 
with CAP was higher than mean age offemale (66 f 18 vs. 62 f 20). Seasonal 
distribution was not homogeneous: the incidence of CAP in summer was 
lower than in winter. Fine defined risk-class was as follows: I, 254; 11, 198; 111, 
204; N, 251; V, 60. Mean time until arrival to the hospital was 3.8 f 3 days. 
Three hundred and forty-seven patients (35%) had one or more underlying 
diseases. Five hundred and fifcy-seven patients (57%) were admitted; 18 in a 
ICU. Mean hospital stay was 7.8 f 4.9 days; it became progressively longer as 
Fine risk-class increased. Thirty-seven patients (4%) died; 18 in Fine risk-class 
IV and 19 in Fine risk-class V. 
Conclusions: Fine defined risk-class is useful to idenbfy patients with a hgh 
risk of death. Mean hospital stay is related with Fine risk-class. 
[ P876 I Validation of the pneumonia port prediction rule in 
HIV-infected patients with community-acquired pneumonia 
(CAP) 
E. Cordero, J. Pachon, A. Rivero, R. Palacios, L. Aliaga, J. Gbmez- 
Mateos, M. Torres-Tortosa, A. Dominguez, A. Collado, J. A. Gir6n, 
R. Valiente, S .  AIcaraz and E. Nuiio 
Seville, Cdrdoba, Mdlugu, Granada, Aken’rus, Almenh, Cridiz, h e r t o  Real, 
Jerez de la Fronferu, L@ez-Mdlaga, E 
Objectives: The use of the pneumonia PORT prediction rule has been 
recommended to evaluate the risk and to determine the site of care in non- 
HIV-infected patients. The objective of this study has been to validate the use 
of ths rule in patients with HIV infection and CAP. 
Methods: A prospective, observational, hospital-based study of 
consecutive cases of CAP was carried out in 12 hospitals in Andalucia 
(southern Spain), between July 2000 and September 2001. Patients were 
stranfed in risk classes according to the PORT score, P < 0.05 was considered 
sigdicant. 
Results A total of 408 CAP were included, 394 ofwhich could be stratified in 
risk groups. In 248, the etiology was bacterial and in 139 nonbacterial. The 
overd mortality rate was 9.5% (9.5% for bacterial CAP and 9.1% for 
nonbacterial CAP). Following the PORT prediction rule, the mortality 
for each risk class for the total of CAP was: group I 4/227 (1.7%), 
group I1 8/79 (10.1%), group 111 3/38 (7.8%), group IV 15/42 (35.7%) 
and group V 5/8 (62.5%), P <  0.0001. In the group of bacterial CAP, the 
mortality of the ditrerent groups was: group I 31147 (2%), group I1 3/42 
(7.1%), group I11 2/24 (8.3%), group IV 7/27 (25.9??6) and group V 5/8 
(62.5%), P <  0.0001. 
Conclusion: The pneumonia PORT prediction rule is useful to idennfl a 
high-risk population in patients with CAP and HIV infection. However, 
this prognostic system, if not modified, might not be used to determine 
the site of care the patients, given the high mortality of the ‘low risk’ 
groups. 
Etiology of respiratory tract infection in a 
primary care setting 
A.M. Rubio, M.L. Rodriguez, G. Azcarate, M. Imaz, MJ. Pkrez, 
A. Butr6n and R. Cisterna 
Vitoria, Bilbao, E 
Objective: The aim of this study is to evaluate the rate of specific pathogens 
and clinical syndromes associated with upper respiratory tract infection in 
adults attending Primary Care. 
Methods: Design: prospective descriptive study, without intervention. 
Setting: Primary Care Setting in the south of Vitoria (Basque Country). 
Participants: Subjects aged 25 years and older of a consult of Primary Care 
with clinical of upper respiratory tract infection (cough, coryza, sore throat or 
hoarseness with or without fever) in the later 6days and gave informed 
consent to participate in the study. The following patients were excluded 
(women who were pregnant, HIV-positive, patients with coagulopaties and 
therapy with Sintrorn, mental disease, sinusitis, otitis and tonsillitis). 
Measurements: Demographic, interval between onset of illness and medical 
consultation, chronic medical conditions and symptoms were collected when 
111. A throat and nasal swabs were collected for viral culture (cell culture and 
shell vial). Cell lines were observed for cytopathic effect for 10 days. Acute and 
convalescent sera (15days after onset of Illness) were also collected and 
examined for viral and Coxiplla burnetii by complement futation test, Chla- 
mydia spp. and Mycoplusma by EIA, and Legionella by IFI. 
Results: From October 18, 1999 through May 31, 2001, 290 patients 
participated in the study, with 330 episodes. A total of 146 (44.2%) males 
and 184 (55.8%) females. The mean age was 49.08yean (range 25-88years). 
The interval between onset ofillness and medical consultation was 3.16days. 
The 26.4% of individuals had chronic medical conditions (cardiac 2.12%. 
pulmonary 12.72%, diabetes 5.15%. liver disease 3.33% renal disease 1.21%, 
anemia 0.9%, immunodeficient 1.81%). The 0.9% of subjects received 
pneumococcal vaccine and 23% received influenza vaccine. Of these, active 
smokers 24.5%, had young children 26.1%. The symptom more frequent was 
cough (77.27%). An etiological diagnosis was established in 118 (35.75%) 
episodes with 126 isolations (38.18%). Si - seven  i&uenza A, 6 influenza B, 
15 paraiduenza 1 , 4  parainfluenza 2,5 paraiduenza 3,9  respiratory syncytid 
virus, 2 adenovirus, 5 enterovirus, 1 Chlamydia spp., 4 Mycoplusmapneumoniae, 
7 Q fever, 1 Legionella. The parainfluenza was more of fall and influenza and 
RSV more of winter. 
Conclusions: Infections were most common in fall and winter months. The 
pathogen most common was influenza A. The RSV was associated to chronic 
pathalogy. 
ml Pneumonia in nursing home residents 
R. Erzen, V. Tomic and E. Music 
Golnik, SLO 
Objectives: RTI are major cause ofmorbidity and mortality in the elderly. In 
analysis, we wanted to establish clinical, rentgenologic and microbiological 
characteristics of pneumonia in nursing home residents. 
Methods: Nursing home residents hospitalized in our hospital in year 2000 
due to CAP were included into analysis. 
Results: Among 367 patients hospitalized in our hospital in year 2000 there 
were 30 nursing home residents (17 women). Their average age was 
82.5 years. A total of 60% of patients had at least two accompanying chronic 
diseases, most frequently cardiovascular and neurologic diseases. A total of 
83% of patients presented with severe clinical picture. In all, 93% of patients 
had dispnea, 67% cough, 67% elevated body temperature, 47% were confused. 
The 93% were xypoxemic, had electrolyte disturbances, 67% had elevated 
urea. Isolation of etiologic agent were rarely successfd. We isolated S. pneu- 
moniae, H. influenzae, anaerobes, Gram-negatives. 63% ofpatients were treated 
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with parented hydration, 90% with oxygen inhalation, all of them received 
antibiotic, in 70% amoxycillin with clavulanic acid (AMC) was used. Nine 
patients died (30%). 
Conclusions: Patients were characterized with advanced age, numerous 
comorbidities, unspecific and severe clinical picture. Mortality is high. 
Treatment includes effective support measures (hydration, oxygenation) 
and choice of proper empirical antibiotic-AMC, high generation cephalos- 
porines or new fluoroquinolones. 
)p879] Community-acquired pneumonia in a medical 
department: characteristics and clinical management 
E. Karabatsaki, I. Katsika, P. Tsiodra, S. Hini and A. Efstratopoulos 
Athens, GR 
Objective: To study the demographic, clinical and laboratory characteristics, 
as well as the management of patients admitted for a community-acquired 
pneumonia (CAP) in the medical department of a tertiary hospital. 
Methods: A retrospective study of the data of all patients consecutively 
admitted for a CAP in the period from January 1998 to June 2001. 
Results: Admissions for CAP accounted for 6.8% of all adrmssions during this 
period. The mean age of the patients was 64.7 & 17years. Ffty-two percent 
were males. Eight percent were residents of a nursing home. Comorbid 
conditions were present in 71%, the most prevalent of them being chronic 
pulmonary disease (18%), immunosuppression (17%), cerebrovascular &ease 
(16.5%), diabetes mellitus (8%) and alcohol abuse (6%). The most frequent 
clinical findings on presentation were: cough 70%, fever 82%, dyspnea 40%, 
tachypnea 38%, chest pain 24%. positive findings on auscultation 84%. 
Leucocytosis was present in 62% and hypoxia in 59%. Criteria of sepsis were 
present in 17% of the patients on admission. Blood cultures were taken from 
68%, sputum examination from 29% and rerologic studies in 1 1%. A pathogen 
was identified in 26%. The most frequent were: Streptococcus pneumoniae, 
Haemophilus infuenrae, Klebsiela pneumoniae, Mycoplasma pneumoniae and 
S. aureus. Combination therapy was used as treatment in 51% of the patients. 
The mean length of hospitahzation was 10.2 f 5 days. Mortality was 7%. 
Admission to ICU was necessary for 3.6%. 
Condusions: In the majority of the patients with CAP, the laboratory Studies 
did not reveal the pathogen, so as to determine the antimicrobial prescription. 
Nevertheless, the success rate of the fmt empirical antibiotic regimen was 
satisfactory (86%). Halfofthe patients were treated initially with combination 
therapy. 
w] Epidemiology of recurrent bacterial pneumonia in 
AIDS patients in Europe, 1993-1999 
D. Serraino, E. Boumis, N. Petrosillo, S. Cicaltni and G. Ippolito 
Rome, I 
Objectives: To assess the association between recurrent bacterial pneumonia 
(RBP) as an AIDS-defining illness in the European population and the 
following data: age, sex, country of residence, risk factors for HIV infection 
and year of AIDS diagnosis, in order to better characterize the epidemio- 
logical characteristics of this clinical condition. 
Methods: Data on all adolescent and adult cases ofAIDS diagnosed in Europe 
between 1993 and 1999 were analyzed using the June 2000 update of the 
European Non Aggregate AIDS Dataset (ENAADS) prepared by the Eur- 
opean Centre for the Epidemiologcal Monitoring of AIDS, Paris, France. 
ENAADS  contain^ standardized information for each individual AIDS case 
recorded in the 36 European countries which have a national surveillance 
system. Odds ratios (OR) and 95% confidence intervals (CI) were computed 
to assess the association between Rl3P and age, sex, country of residence, risk 
factors for HIV infection and year of AIDS diagnosis, using a multiple logistic 
regression analysis. 
Results: A total of 130 208 AIDS cases were diagnosed in Europe between 
1993 and 1999. PBR was the AIDS-defining condition in 4765 cases (3.7%). 
A sharp variation in the eequency of FU3P was noted among different 
geographical areas. RBP was more frequent in eastern (11.8%) than in 
northern Europe (2.4%). In comparison with heterosexuals, the highest risk 
for of RBP was seen among intravenous drug users (IVDU) (OR = 2.9) and 
female sex (OR = 1.4); men who have sex with men (MSM) who were not 
I W U  had a 40% reductlon 1x1 the RBP nsk. Fmally, an upward persistmg 
trend was regntered UI the frequency of RBP over m e ,  whch was apparently 
not modJfied by the mtroducaon of W T .  
Conclusions: The frequency of RBP as an AIDS-defiwng condmon IS 
strongly assonated with geographic factors and mchwdd risk factors. The 
persstmg upward trend smce 1993 deserves a better monitorlng of thls 
condmon 
Incidence of community-acquired pneumonia in a 
10-month period serological tests 
S .  Jimenez, L. Perez, M. Modes, M. Lopez-Brea, T. Alarc6n and 
E. Casal 
Madrid, E 
The aim of this study was to determinate the incidence of pathogens involved 
in community-acquired pneumonia in a 10-month period in a 500-bed 
teachmg hospital and to know the severity of the illness caused by them. 
Material and methodr: During a 10-month period ~anuary-October 2001) 
a total of 960 serum samples from 730 adult patients were analyzed. A 2-mL 
aliquots were frozen until the test was performed. The diagnosis of Mycoplasma 
pneurnoniae (Mp), Influenzae A and B virus (IV), p d u e n z a e  virus (PV), 
adenovirus (AV), syncitial respiratory virus (SRY), CmieNa burnetti (Cb), 
Chtamydiu pneummiae (Cp) were carried out by complement fixation in 
microtiter panels (dilutions ranging h m  118 to 112048). The diagnosis of 
Legionella pneurnophila (Lp) was performed by indirect immunofluorescence 
with a initial screening of 1/64 and further dilutions when positive. A 
sigdicant result was considered when titers were 21/16 for Cb, 11/32 
for Cp, 21/64 for Mp and AV, and 211128 for IV, PV, SRVand Lp or when a 
four-fold rise in titer was observed. 
Results A total of 442 (46%) samples from 308 patients (42%) were positive 
for one or more pathogens. From the patients with positive samples, 188 
(62%) showed a severe disease and they required admission in the hospital. A 
total of 246 patient (80%) showed a positive result for a unique pathogen and 
62 (20%) for more than one, The distribution of patients with slpprfcanr 
results for a unique pathogen was as follow: 
0 One hundred and twenty-nine were positive for Lp (52.4%), 90 of them 
0 Thirty-six were positive for IV (14.6%), 21 of them required admission 
Twenty-one were positive for Mp (1 1.7%), eight of them required admis- 
0 Twenty-eight were positive for PV (1 1.3??), 21 ofthem required admission 
Eight were positive for Cb (3.2%), seven of them required admission (87%). 
Seven were positive for SRV (2.8%). four of them required admission 
0 Six were positive for AV (2.4%). three of them required admission 
Three were positive for Cp (1.2%), 1 of them required admission 
From the 62 patients with a sigdicant result for more than one pathogen, 14 
presented a four-fold rise in the titer of at least one of them (thee patients had 
a four-fold rise in the titer of two pathogen). Eleven out of the 14 required 
admission. 
Conclusion: Lp was the pathogen most frequently detected in our hospital 
followed by IV. Eighty-seven percent of patients with Cb required admission 
in the hospital. The second more severe disease was produced by Lp. The third 
pathogen detected was Mp, despite of being an adult population, and 27% of 
patients infected with Mp required admission. 
required admission (69.7%). 
(58.3%). 
sion (27.5%). 
(75%). 
(57%). 
(50%). 
(33%). 
lp882j Role of respiratory syncytial virus in the upper 
respiratory tract infections in adults 
A.M. Rubio, M.L. Rodriguez, G. Azcarate, M. Imaz, M.J. Pkrez, 
A. Butr6n and R. Cisterna 
Viforia, Bilbao, E 
Objective: The aim of this study was to evaluate the rate of specific pathogens 
and c l i~ca l  syndromes associated with upper respiratory tract infection in 
adults attending Primary Care. 
190 Abstracts 
Methods: Design: Prospective descriptive study, without intervention. 
Setting: Primary Care Setting in the south of Vitoria (Basque country). 
Participantr: Subjects aged 25 years and older of a consult of Primary Care 
with clinical of upper respiratory tract infection (cough, coryza, sore throat or 
hoarseness with or without fever) in the later 6days and gave informed 
consent to participate in the study. The following patients were excluded 
(women who were pregnant, HIV-positive, patients with coagulopaties and 
therapy with Sintrom, mental disease, sinusitis, otitis and tonsillitis). 
Measurements: Demographic, interval between onset of illness and medical 
consultation. chronic medical conditions and symptoms were collected when 
ill. A throat and nasal swabs were collected for viral culture (cell culture and 
shell vial). Celllines were observed for cytopathic effect for 10 days. Acute and 
convalescent sera (15days after onset of illness) were also collected and 
examined for viral and Coxiefla burnetii by complement fixation test, Chla- 
mydia spp.. and Mycoplasma by EIA, and Legionella by IFI. 
Results: From October 18, 1999 through May 31, 2001, 290 patients 
participated in the study, with 330 episodes. An etiological diagnosis was 
established in 118 (35.75%) episodes with 126 isolations (38.18%), 9 were 
respiratory syncytial virus (TGV). RSV were more fiequent of winter. Two 
(22.22%) males and seven (77.77%) females. The mean age was 59.2years 
(range 44-74years). The interval between onset of illness and medical 
consultation was 3.22days. The 44.4% of individuals had chronic medical 
conditions as systemic sclerosis, CREST and pernicious anemia. 66.6% 
received influenza vaccine. Of these, active smokers 22.2%, had young 
children 22.2%. Symptom more frequent were cough and sore throat 
(100%)). Nobody had fever >37.8"C. Nobody was admitted to hospital 
and nobody died. RSV was yielded in four patients by culture, in other four 
patients by serological methods and in one patient by both methods. 
Conclusions: RSV, in adult living in the community is an important 
etiological agent of the upper respiratory tract mfections and infects 
mainly to patients with chronic medical conditions or in contact with 
children. 
I P883 1 Does addition of a macrolide to p-ladam empirical 
treatment improve mortality rates in patients with 
community-acquired pneumonia? 
E. Garcia Vizquez, J. Mensa, M. Marco, A. de Roux, J. Gbmez, 
J. Puig, J. A. Martinez and A. Torres 
Barcelona, E 
Objectives: To analyze whether treatment of patients with community- 
acquired pneumonia (CAP) with a macrolide in addition to a 8-lactam 
improves mortality rates compared to those of patients treated only with a 
B-lactam antibiotic. 
Methods: A cohort of 1518 patients with CAP was studied according to a 
standard protocol. CAP definition was established according to ATS criteria. 
Severity was assessed within the f i t  day of admission using PORT score. At 
least one sputum sample, two blood cultures and two serum samples for 
serology (4-8 weeks apart) were obtained. Pleural puncture, transthoracic 
needle puncture, tracheobrochial aspiration and protected specimen brush or 
BAL sampling were performed according to clinical indication. Urine was 
collected for detection of soluble pneumococcal antigen by antibody assay as 
well as L. pneumophila antigen by EIA. 1391 patients with CAP of unknown 
etiology, atypical, L. pneumophila, viral or pneumococcal pneumonia were 
included in the analysis. Patients treated with only /Hactams (BL) or 8- 
lactams together with a macrolide (BL-MC) were assessed to analyze a 
possible relation with mortality rates. 
Results: An etiologic diagnosis was achieved in 498 patients out of 1391 (257 
infections due to Spneumoniae). Treatment consisted of BL in 270 patients 
and in BLMC in 918. Mortality rates were 13.3 and 6.9%, respectively 
(P=O.OOl). Distribution of patients in PORT groups was not significantly 
different (P= 0.17) among EL and BL-MC treatments (BL treatment: 19.4% 
in group 141.15% in group I11 and 65.6% in group IV-V; BL-MC treatment: 
15.6% in group 1-11, 19.5% in group 111 and 64.8% in group IV-V). After 
controlling for PORT score, the odds of fatal outcome was two times hgher 
in patients treated with only BL than in those treated with BL-MC 
(P=O.O008). Same analyses in patients without etiologic diagnosis and in 
patients with CAP due to S.pneumoniae showed higher mortality rates in 
patients with 8-lactam monotherapy. 
Conclusion: Patients with CAP treated with fi-lactam have a higher mortality 
rate than patients treated with p-lactam together with macrolide, indepen- 
dently of severity of infection. 
I P884 I Patients with community-acquired pneumonia: the 
frequency of atypical agents 
M. Sayan, 0. Kiling, A. Yuce, E. Usan and S. Geng 
kmir,  TR 
Objective: Some series of reports of patients with community-acquired 
pneumonia demonstrate atypical pneumonia agents. A single IgG elevation 
is commonly used as a mean of diagnosis. In this study, we aimed to evaluate a 
rapid and simultaneous method in diagnosis of the main etiological agents of 
atypical pneumonia in adult patients with community-acquired pneumonia. 
Methods: This study was conducted in Chest Diseases, Infectious Diseases, 
and Clinical Microbiology Department of Dokuz Eylul University Hospital 
in Irmir. Our study included 53 adult patients with acute one or more 
symptoms or signs suggestive of pneumonia. Twenty blood donors were used 
as a control group. The atypical pneumonia agents were determined by 
indirect immunofluorescent assay (Pneumo-slide:Vircell SL, Spain) in a single 
serum sample for each patient. Antibodies detected in samples were against 
Legionella pneumophila serogroup 1 ,  Mycophma pneumoniae, Coxiellu burnetii, 
Chlamydiapneumoniae, Adenovirus, Respiratory Syncytial Virus, Influenza A, 
Influenza B, Parainfluenza serotypes 1, 2 and 3. 
Results: In the study population total IgG and IgM antibodies for several 
etiological agents were detected in 48 (9Wo) and 40 (75%) patients, respec- 
tively. Etiological agents included Lpneumophila 23,28% M. pneumoniae 7.5, 
6%; C. burnetii 26,7.5%, C .  pneumoniae 34,4%; Adenovirus 28%; Respiratory 
Syncytial Virus 68, 2% Influenza A 28, 25%; Iduenza B 34, 7.5% Para- 
influenza 70,2%, respectively. However, in control group total IgG antibodies 
were determined in 17 (85%) donors while IgM antibodies were positive for 8 
(40%) of them. 
Conclusions: A single IgG elevation may not be as specific as a fourfold rise in 
antibody levels, thereby falsely increasing the incidence of infections. What 
causes also an increase in the incidence of infections is the ages of our patients. 
However, indirect immunofluorescent assay is found to be a rapid micro- 
biological method for simultaneous diagnosis of the atypical pneumonia 
agents, 
I P885 I Contribution of an antigen urinary assay (Binax) to 
the early diagnosis of pneumococcal pneumonia 
N. Fernandez-Sabk, B. Roson, J. CarrataL, R. Verdaguer, J. Dorca, 
E Manresa and E Gudiol 
Barcelona, E 
Objebive: To evaluate the yield of a rapid immunochromatographic assay 
(NowTM, Binax, USA) to detect Sfreptococim pneumoniae antigen in urine 
samples and its conmbution to the early diagnosis of pneumococcal pneu- 
monia. 
Methods: Urine samples from 116 nonimmunosuppressed adult patients with 
CAP were tested once for Spneumoniue urinary antigen (unconcentrated 
urine). Sensibility and specificity were calculated for all cases with etiological 
diagnosis obtained by standard microbiological methods (definitive 
diagnosis: positive sterile samples and serology; and presumptive diagnosis: 
positive sputum culture with a compatible Gram stain). To evaluate the assay 
value as a rapid diagnostic tool, it was compared with sputum Gram stain 
results. 
Results: When using only standard microbiological methods, 23 @PA) out of 
116 patients were diagnosed of pneumococcal pneumonia (8 definitive 
diagnosis and 15 presumptive diagnosis). Other pathogens were identified 
in 14 patients: Legionella pmmophila (7), Mycoplamra pneumoniae (4), Escher- 
ichia coli (1). Codla bwrnetii (l), Haemophilus inJuenzae(1). No causative agent 
was identifed in 79 patients. Overall, urinary anagen assay was positive in 32 
(28%) of 116 cases (16/23 patients with pneumococcal pneumonia, 0/14 
patients with pneumonia caused by other agents, and 16/79 without an 
etiological diagnosis by standard methods). Sensibility and specificity of the 
assay were 69.6 and loo%, respectively. Assuming a 10% specificity of the 
assay, there was an increase in the number of pneumococcal pneumonia 
diagnoses h m  23 to 39 cases. Sputum Gram stain results in these 39 cases 
were as follows: no sample collected (9 patients), bad quality specimen (lo), 
Gram-negative coccobacilli (1) and Gram-positive diplococci (1 9). Com- 
pared to sputum Gram stain, the antigen urinary assay increased the rapid 
diagnosis of pneumococcal pneumonia from 19 to 32 cases [48.7% when 
considering only the Gram stain vs. 82.1% when using also the urinary test; 
95% C1 ofthe difference 13.646%; P<O.O16]. 
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Conclusions: Binax is a sensitive and highly specific assay for the diagnosis of 
pneumococcal pneumonia. This test permitted an early recognition of 33% 
more cases of pneumococcal pneumonia than sputum Gram stain did. It can 
be useful in the initial approach to patients with CAP in whom a demon- 
strative Gram stain is not available. 
jp886/ Detection of atypical pathogens among patients 
hospitalized with a community-acquired respiratory 
infection 
P.M. Schneeberger, J.W Dorigo-Zetsma, A. Van der Zee and 
J. Van Opstal 
Den Bosch, Bilthoven, Tilbutg, NL 
Objective: To determine the proportion of atypical respiratory pathogens 
using PCR and serology among patients hospitalized with a community- 
acquired respiratory infection. 
Methods: From September 1997 to May 1999, 159 patients (57% male, 
median age 55, range 1-88yean with 12% <13years) admitted to three 
regional hospitals for a community acquired respiratory infection, were 
enrolled in the study. A throat swab, sputum and/or broncho alveolar lavage 
PAL) was collected and processed for PCR for Mycopfasma pneumoniae, 
Chlamydia pneumoniae, and Legionelfa pneumophila and L. non-pneumophila 
species. Two serum samples were collected and processed for M. pneumoniae 
(Mp ELISA, Serion/Virion(R) and Mp microparticle agglutination test, 
Fujirebio(R)) and C.pneumoniae (in-house ELISA). On request of the 
physician standard microbiological procedures were performed on sera and 
sputum or BAL. 
Results: Infection with M.pneumoniae was detected in 18 patients (11%) 
(PCR positive n = 7). with C. pneumoniae in six patients (4%) (PCR positive 
n = 3) and with L. pneumophila in four patients (2.5%) (PCR positive n = 4). 
In two patients, C. pneumoniae was detected in combination with M .  pneu- 
moniae and L.pneumophila, respectively. In total 28 patients (18%) were 
diagnosed with an atypical pathogen. Among them were 11 children 
<13 years (39%), all diagnosed with M.pneumoniae mfection. Furthermore, 
L. non-pneumophila species by PCR was found in 13 patients (8%). Routine 
microbiological investigations revealed etiologic agents other than the three 
atypical pathogens in 59 patients (37%). the most frequently dqnosed 
pathogens being Streptococas pneumoniae (n = 15), Haemophilus injuenzae 
(n = 9), Branhamelfa catharralis (n = 5) and Staphylococcus aureus (n = 5). 
Conclusion: Among patients hospitalized with a community acquired respira- 
tory mfection 18% were diagnosed with M.pneumoniae, C.pneumoniae or 
L. pneumophila, using PCR and serology. M .  pneumoniae was dngnosed most 
frequently, 61% of the patients being children aged 1-13years. The role of 
L. non-pneumophila species in community respiratory infection needs to be 
determined. 
(p8871 Chlamydophilla (Chlamydia) pneumoniae as a 
causative agent of respiratory tract infections in children 
and adolescents 
R .  Botek, V. Melichacova, V. Krcmery and F. Mateicka 
Piestany, Trnava, S K  
Chlamydophilla (Chlamydia) pneumoniae is an important human pathogen 
having a sigdcant tendency to chronic course and acute exacerbations 
causing far-reaching late consequences with a high worldwide population 
exposure. It causes fiat of all inflammatory diseases of respiratory tract. Its 
attendance in cardiovascular diseases, degenerative diseases of central nervous 
system, systemic immunopathologic manifestations and others have been 
proven. Examination of C. pneumoniae infection is not a routine procedure in 
microbiology and its importance in &cal practice has been underestimated. 
In the Slovak Republic no study on the prevalence of C.pneumoniae has been 
published yet. The authors have concentrated on the survey of the participa- 
tion of C.pneumoniae in infections of respiratory tract in children and 
adolescents in Piestany region. In the period from January 2000 till May 
2001, the authors have examined 293 patients ranging from 0 to l8yean of 
age sdering fiom respiratory system infection, where a dry, irritative cough 
lasting 5 or more days was dominating and/or the clinical picture has not 
improved after application of j-lactam antibiotics. IgM and IgG antibodies 
apns t  C pneumonia have been exammed wa MIF method (Euroimmun, 
Laboratorium fur experimentelle m u n o l o g e ,  GmbH) Slmultaneously a 
rouhne bacteriologd examination has been executed, detenrunahon of 
anhbomes agamst Myroplamd peumoniae vla ELSA method (Genenzyme 
Vmtech GmbH) and 111 a part of the group also a CdhvahOn of M pneu- 
moniae In 38.8% of exammed pahents p r m r y  aChVe mfechon of C.pneu- 
moniae has been proven (0-5 years 24%, 6-10 years 33 4%, 11-15years 32.3, 
16-18years 39.2%), but in 13.6% of pahents, the rest of mcrobiologcal 
exammahons have been negahve 
lpsssl The role of c/t/amydia pneumoniae infection in 
asthma exacerbations 
E. Ayasliogh, D. Tosun, S. Ornek, I. Kihc and A. Erturk 
Kirikkale, Ankara, TR 
Objectives: C. pneumoniae is a recently described human pathogen implicated 
~n upper and lower respiratory tract infections. C. pneumoniae has also been 
reported as a possible cause of asthma. It is suggested that acute infection mth 
this organism can initiate and exacerbate asthma in some pahents. In this study, 
we aimed to evaluate the role of C. pneumoniae infection in exacerbations of 
asthma in adults. 
Methods: F6ty-three adult patients with acute exacerbations of asthma (37 
female, 16 male and mean age of 41.6yem) and 25 control subjects matched 
for age, sex, and smoking status were studied. Serum samples were tested for 
C.pneumoniae Igh4 and IgG anhbodies by using enzyme immunoassay (EIA) 
methods. 
Results: C.pnnunoniae IgM anhbodies were found positive in three patients 
who had severe asthma symptoms while the others were negative. The 
prevalence of C.pneumoniae IgG was sipficantly higher in asthma cases 
than in controh (73.6% vs. 48%, P <  0.05). Mean titer of IgG was greater in 
asthma cases than m controls (11.3 vs. 9.3). 
Conclusions: It is becoming clear that acute C .  pneumoniae respiratory tmct 
infection may trigger wheezing and asthma exacerbations and our study also 
shows h s  role of Chlamydia pneumoniae infection m asthma exacerbations. 
1 P889 I Evaluation of sELlSA medac for the detection of 
Chlamydia pneumoniaespecific IgG. IgA and IgM in 
comparison to microimmunofluorescence (MIF) 
S. Rund, M Maass, S. Blrkelund, E. Straube, R. Blatz, M Drasbek, 
K. Persson, M. Bottcher and D. Franke 
Hamburg, Lubeck, D; Aarhur, O K ;  Jena, Lkpzg, 0, Malmoe, S 
Objective: The evaluation of three new Chlamydia pneumoniae (C.pn.) 
EIAs, Chlamydia pneumontae-IgG/A/M-sELISA medac (medac, Hamburg, 
Germany), regardmg precision, sensitlvlty, specificity, and smtabhry for 
automahon. 
Methods: The assays are mdirect ELISAs m n g  highly specific LPS-reduced 
nahve C.pn. antigen for the detection of speafic immunoglobh We 
mveshgated intra- and mter-assay variahon in manual and automated 
procedures. Speclfcity and sensiumty were determmed usmg 376 MIF 
( M I U  Dugnoshcs, Cypress, CA, and m-house MIF) defined sera 
Regardmg speclficlty 44 (IgG), 87 (IgA), and 121 (IgM) MF-negahve sera 
were mvesagated. In addihon, 11 (IgG), 14 (IgA), and 12 (IgM) MIF 
Chlamydia trachomatrc (C.tr.) as well as 2 MIF C pstffao (C ps ) posiuve 
sera (IgM) were tested to inveshgate cross-reachvlty. For sensihwty determ- 
nahon 119 (IgG), 77 (IgA), and 38 (IgM) MIF-posihve sera were used. 
Automahon stntabhty was inveshgated by using two different aUtOmahC 
ELISA systems 
Results: Coefficients of variahon fiom sera mthm the relevant OD range 
(positive or borderlme) were low (<11%). The specificihes determmed were 
95% (IgG), 93% (IgA), and 97% (IgM). Cross-reachwty mth  C.tr. was 9% 
(IgG) and 7% (IgA). Regardmg IgM cross-reachwty mth C.ps but not w th  
C tr. was found Sensihvlhes were 99% (IgG), 95% (Id) and 97% (I@). 
Borderhne results were excluded from the calculations. Good agreement was 
found between manually and aUtOmahdy performed test runs. 
Conclusion: C. pneumoniae-IgC/A/M-sELISAs medac are easy to perform, 
p m d e  rehable results mthm less than 3 h, and are mtable for automahon. 
Cross-reachnty mthm the genus Chlamydia s t d  occurs but the assays provide 
good precision and excellent concordance mth  the MIF. Further studm are 
needed to estabhsh fmm chnical Interpretahon guidelmes for the test results. 
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global assessments of efficacy and tolerability of h4XF by physicians is shown 
m the followmg table. Comparative study of bacterial community- 
acquired pneumonia (CAP) caused by S. pneumonia (CAP-SP), 
L pneumophila (CAP-LP) and C. pmu~uniae (CAP-CP) 
N. Sopena, D. Garcia-Pares, M. L. Pedro-Botet, E. Reynaga, 
M. A. Garcia-Nuiiez, C. Rey-Joly and M. Sabria 
Badalona, E 
Objectives: From May 1994 to February 1996, 392 episodes of hospital 
assisted CAP in 389 patients were stuhed prospectively. A definitive etiolo- 
gical diagnosis was made in 173 cases (44.1%). with S.pneumoniae (group l), 
L. pneurnophila (group 2) and C. pneurnoniae (group 3) being the most prevalent 
microorganisms. Epidemiological data, clinical manifestations and evolution 
were compared among the three groups. 
Methods: Risk factors, clinical manifestations, laboratory and microbiological 
data and complications were prospectively collected. Only microorganisms 
with a defirutive etiological diagnosis were included S. pneumoniae (n = 68), 
L.pwurnophi[a (n = 48) and C. pneurnoniae (n = 41). 
Results: Enohm and tabaquism were sigmfkantly more frequent in group 2 
(P=  0.016 and P= 0.07, respectively), chronic obstructive pulmonary disease 
(COPD) in group 3 (P= 0.03) and HIV infection and neoplasm in group 1 
( P =  0.001 and P =  0.017, respectively). Non underlying disease was of note 
in group 2 (P=O.O01). Most patients in the three groups were males with a 
mean age of 59.5 (group l), 55 (group 2) and 65 (group 3). Cough, 
expectoration and thoracic pain were more frequent in groups 1 and 3 
(P=0.003, P=0.003 and P =  0.07, respectively). Headache, diarrhea and 
confusion were more frequent in group 2 (P=  0.01, P =  0.003 and P =  0.08, 
respectively). Delay in the initiation of an efficacious treatment was longer in 
groups 2 and 3 ( P =  0.004). Previous antibiotic treatment ( P =  0.004)/ipe- 
cially with /?-lactams ( P =  0.004) was more frequent in groups 2 and 3. ‘Shift 
to the left’ was more frequent in group 1 (P=O.O5), hyponatremia and 
increase in CK were sigtllficantly more frequent in group 2 (P=O.OOl  and 
P =  0.03, respectively) and increase in AST was of note in groups 2 and 3 
(P=  0.003). Complications ( P =  0.01) and specially septic shock (P=0.003) 
were more kequent in groups 1 and 2. Lastly mortality was 14.7% in group 1, 
8.3% in group 2 and 4.9% in group 3 (P=ns) 
Conclusions: CAP-SP mainly atfects patients with underlying diseases and 
have a high morbidity and mortality. Efficacious antibiotic treatment is started 
sooner in CAP-SP than in CAP-LP and CAP-CP CAP-LP mainly affects 
smokers and patients without underliying diseases. Exaarespiratory manifes- 
tations and laboratory abnormalities are specially frequent in CAP-LP. 
CAP-CP mainly aflects COPD patients and its morbidity and mortality 
are low. 
I P892 1 Therapy of acute exacerbation of chronic 
bronchitis with rnoxifloxacin in pneurnological practice 
H. Landen, T. Bauer and K. Stauch 
Lwerkuren, Bochum, D 
Objective: The aim of this post marketing surveillance (PMS) Study was to 
evaluate the eficacy and safety of moxifloxacin (MXF) in acute exacerbation 
of chronic bronchitis (AECB) therapy, the time until improvement and 
recovery and patient acceptance of MXE 
Methods: PMS-study conducted in Germany with pulmonologists. Physi- 
cians documented their “real world” experience in =eating AECB patients 
with MXF (400 mg qd) by use of structured case report forms. Demographic 
characteristics of the patients and the course of the symptoms, fever, cough- 
ing, expectoration, dyspnoea, chest pain and auscultation were assessed. At the 
end ofthe treatment period, global assessments ofMXF therapy with regard to 
efficacy, tolerability and patient acceptance were made by physicians. Due to 
the intensive efforts to monitor the documentation and to validate the patient 
data a high quality and consistency could be achieved in the evaluation. 
Results: The data from 2338 AECB patients documented by 399 investigators 
could be included in the statistical analysis. For most of the patients, a 5-day 
(62.3%) or 6-7-day (24%) course of MXF therapy was chosen. Temporary 
comedications for AECB in addition to basic therapy of COPD were 
antitussives/expectorants in 176 cases, corticosteroids in 103 cases and other 
antibiotics in 25 cases. Bronchodilators/antiastbtics were by far the most 
documented continuous concomitant medications (1228 cases, 52.5%). 
9 1.6% of the patients experienced an improvement of their AFCB in a range 
of 1-5 days after start of=. Cure f b m  the acute exacerbation was seen in a 
mean of 6.5 2~ 2.7 days afier start of MXF therapy. Especially high cure rates 
were observed for the symptoms, fever (96.2%) and chest pain (86.0%). The 
Physician’s global assessments (percent of patients; N= 2338) 
Efficacy Cure Improvement Fatlure Not assessable Missing 
59.2 36.9 1.9 1.4 0.5 
Tolerability Very good Good Sufficient Insufficient Missing/Not ass. 
63.9 31.5 2.7 0.9 1 .o 
A total of 2178 patients (93.1%) rated their MXF therapy as very satistjmg or 
satisfying. The overall incidence rate for adverse events was 1.5%. Two 
patients (0.1%) experienced serious adverse events (psychosis and anaphy- 
laxis). The psychosis was assessed by the investigator as “not related to MXF” 
and anaphylaxis as “probably related” but with full recovery. 
Conclusions: MXF 4OOmg qd is a safe and effective therapy for AECB 
patients treated by pulmonologists and provides rapid improvement of 
symptoms in a population where the majority of patients was without 
concomitant corticosteroids. 
lp8931 Monotherapy versus combination of antibiotics 
and the prognosis of community-acquired pneumonia 
A. Ochoa de Echagiien, E. Calbo, C. Ferrer, M. Rodriguez-Carballeira 
and J. Garau 
Ewassa, E 
Introduction: Recent publications suggest that patients treated with a com- 
bination of antibiotics in the initial treatment of CAP is associated with a 
laver mortality rate than those treated with monotherapy 
Objectives: To determine the impact of monotherapy versus combination of 
antibiotics in the prognosis of CA€? 
Methods: All patients 18 y diagnosed as having CAP seen in the 
Emergency Department (ED) during the calendar year 1999 were included. 
A predesigned protocol was applied to all patients admitted to hospital 
including demographic data, comorbilities, PSI according to Fine et al. 
antibiotics and outcome. Antibiotic treatment was instituted following the 
recommendations of the Infections Disease group. Mortality was defined as 
global (30 days or hospital discharge), during the first 72 h or related to the 
infection. 
Results Four hundred and forty-five (out of a 447) patients seen at ED with 
CAP were evaluable. Three hundred and sixty-seven (82.5%) received 
monotherapy (aminopenicillins, 185; third gen ceph, 110; macrolides, 39; 
fluoroquinolones, 9) and 78 (1 7.5%) were treated with dual therapy @-lactarn 
plus macmlide, 74; other, 4). Twenty-six patients died, 13 within the first 
72 h. One was in category 111,9 in category lVand 17 in category V. Ofthose 
on monotherapy, 14/367 (3.8%) died, and hadamean PSI of96 (range &218) 
versus 12/78 (1 5.4%) in those treated with a combination of agents, and with a 
mean PSI of 107 (range 17-205). 
Considered separately, 163 patients belonged to category 1 V 137 were 
treated with monotherapy and 130 (94.9%) survived, whereas 26 patients 
were treated with the combination and 24 (92.3%) survived (P=0.6). 
Ninety-one patients belonged to Category V: 67 were treated with mono- 
therapy and 60 (89.6%) survived whereas 24 were treated with the combina- 
tion and 15 (62.5%) survived (P=  0.005). 
Conclusions: Mortality in CAP is primary determined by severity of disease 
and the presence of comorbidity. Monotherapy does not appear to be 
associated with higher mortality rates. 
rp8941 The efficacy and safety of telithromycin (TEL) 
administrated once daily for 5days at a dose of 600mg in 
patients with respiratory tract infection (RTI) 
N. Aoki, Y. Niki, A. Watanabe and S. Kohno 
Niigata, Kurashiki, Sendai, Nagasaki, JP 
Objective: The clinical and bacteriological efficacy and safety oftelithromycin 
(TEL), a novel oral ketolide antibiotic, administered once daily for 5 days at a 
dose of 600% to the patients with respiratory tract infecaon @TI) was 
evaluated. 
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lp8961 The efficacy and safety of telithromycin (TEL) Methods: Adult pauents (n=  120), aged 26 to <80years, wth  RTI (acute 
upper respiratory mnficaon, commumty-acquired pneumonia and acute 
bacterial exacerbatlon of chronic Duhon.lrv dlsease) presumably caused by administered Once at 6oo Or 8oo mg in patients with 
. I  
typical or atypical/intracellular (Mycoplusma pneumoniae, Chlamydia pneumoniae 
or Legionellapneumophila) bacteria, received TEL 600 mg once daily for 5 days. 
Clinical and bacteriological efficacy were assessed a t  the end of treatment 
(4-7 days after the initiation oftreatment or at the discontinuation) and at test 
pneumonia 
Y. Niki, N. Aoki, A. Watanabe and s. KohnO 
Kurahiki, Nikata, Sendair Nagasaki, J p  
of cure.(14-28days after the initiation of treatment). 
Results: The clinical efficacy rate at  the end of treatment and at test of cure 
was 92.7% (89/96) [merence: 95% CI (87.0, 98.4)] and 85.6% (83/97) 
[difference: 95% CI (78.1,93.1)], respectively. The bacteriological efficacy by 
subject, including microbial substitution, was 86.0% (37/43) [difference: 95% 
CI (74.5, 97.6)]. The eradication rate of S.pneumoniae, the most fkequently 
identified pathogen in this study, was 92.3% [difference: 95% CI (74.0, 
100.0)l. The MIC& of TEL to S. pneumoniae was 0.12 pg/mL that was eight 
doubling dilutions lower than that of macrolide antibiotics (erythromycin 
(EM) and clarithromycin (CAM)). The MIC9" of TEL to H.  influenzae 
was 2pg/mL that was four doubling dilutions lower than that of 
macrolide antibiotics (EM and CAM). TEL was generally well tolerated. 
The incidence rate of adverse events, for which the causality ofdrug could not 
be ruled out, was 34.5% (411119) and were considered either mild or 
moderate.The clinical eficacy of this shidy was similar to that of another 
study in which the clinical efficacy of TEL 600 mg once dady for 7 days 
was compared to levofloxacin 100mg three times daily in patients with 
RTI. 
Conclusion: TEL 600 mg once dady for 5 days is an effective, well-tolerated 
empiric treatment for RTIs in adults. 
lp8951 Comparative study of the efficacy and safety of 
oral telithrornycin (TEL) 600 mg once daily versus oral 
levofloxacin (LVFX) 100 mg three times daily in adult 
subjects with community-acquired pneumonia (CAP) 
A. Watanabe, Y. Niki, N. Aoki and S. Kobno 
Sendai, Kurashiki, Nikata, Nagasaki, JP 
Objective: Ths double-blind, randomized, two-arm parallel-group compar- 
ison study evaluated the clinical eficacy and safety of telithromycin (TEL), a 
novel oral ketolide antibiotic, versus levofloxacin (LVFX) in patients with 
community-acquired pneumonia (CAP). 
Methods and results: Adults and adolescents (n = 250), aged 16 to <80 years, 
with CAP presumably caused by typical or atypical/intracellular (Mycopfasma 
pneumoniae, Chlamydia pneumoniae or Legionelh pneurnophila) bacteria, were 
randomized and treated with TEL 600 mg once daily or LVFX 100 mg three 
times per for 7 days. Clinical outcome was assessed 14-28 days &er initiation 
of treatment. There were no significant eerences in the baseline demo- 
graphics between the TEL and LVFX groups. Chical efficacy rates at the end 
of treatment were equivalent between the two groups (per protocol popula- 
tion): TEL 93.6% (102/109) and LVFX 87.8% (86198) and 87.8% (86/9). 
Difference (95% CI): 5.8 [-3.1, 14.71, The point estimation of successful 
clinical cure rate of TEL group at clinical outcome assessment was 10.1% 
higher than that ofLVFX group, which were 91.5% (97/106) and 81.4% (79/ 
97), respectively. The most common bacterial strains were S.pneumoniae 
including penicillin or erythromycin-resistant mains and H. influenzae. The 
clinicalcureratesofin theTELandtheLVFXgroupswere93.3% (14115) and 
89.5% (17119)' respectively, for S.pneumoniae. For p e n i c h  and erythro- 
mycin-resistant S. pneumonia, the clinical cure rates in the TEL group were 
100% (5/5) and 91.7% (11/12), respectively Five penicdlin-resistant S.pneu- 
moniae isolates were also resistant to erythromycin. For H. influnezae, the 
clinical cure rates ofin the TEL and the LVFX groups were 93.3% (28/30) and 
86.7% (13/15), respectively. There were no significant Werences in the 
incidence rates of adverse events, for which drug causahty could not be ruled 
out [(TEL 33.6% (42/125) and LVFX: 33.9% (39/115)]. No possibly 
treatment-related serious event was reported. 
Conclusions: TEL 600mg admmktered once daily for 7days is 
equivalent in efficacy to LVFX in CAP in adults. TEL is as well tolerated 
as LVFX. 
Objective: Ths  double-blind, randomized, parallel-group comparison study 
evaluated the chnical and bacteriological effectiveness and safety of teltthro- 
mycin (TEL), a novel oral ketohde anabiotic, 111 paaents wth  community- 
acquued pneumom (CAP). 
Methods and results: Patlents (n = 104) with CAP presumably caused by 
typical or atypicallmtracellular (Mycopfasma pneumoniae, Chlamydia pneumonia 
or kgiordupmmophi la)  bacteria were treated with TEL 600 or 800 mg once 
daily for 7 days. Clinical and bacteriologxal efficacy was assessed at 6-9 days 
after the inihation of treatment, and reIapse/reinfection was assessed at 14- 
28 days after the haahon  of treatment. There was no significant difference in 
the basehe demographcs between the TEL 600- and 800-mggroups except 
body weight. Clinical efficacy at the end of t r ea tmdwa  92.9% (39/42) m 
the 600-mg group versus 95.8% (46148) in the 800-mg p u p .  There was no 
stahsucd sigtllficance between the two groups [ W o  Ck (-7.3, 13.3)]. Non- 
relapse/nonremfecaon rates (percentage of patients wthout r&pse/reinfkc- 
tion) were 85.0 and 85.1% ~fl rhe 600- and the 8OO-mggroup, respectively, at 
14-28 days after treatment [90% CI (-17.5,0.5)]. Bacteriologcal efficacy by 
subject was 92.9 and 95.7% m the 600- and the 800-mg p u p ,  respectively 
[90% CI: (- 16.2, 21.8)]. The MIC, of S.pneumoniae, including penicillin- 
resistant S. pneumoniae (PRSP) or erythromycin-resistant S. pneummiue 
(ERSP), to TEL was 0.12pg/mL that was eight times or more doubling 
dilutions lower than to other antihiotics (erythromycin (EM), clarithromycin 
(CAM), cefdinir (CFDN) and penicillin G (PCG)). The MIC, of H. infu- 
mzae to TEL was 4pg/mL that was four hmes higher than to mamlide 
antlbioucs (EM and CAM). Chnical efficacy rate, bacteriological efficacy rate 
in 10 subjects with S. pneumonia resistant to penicdlin G and/or erythromycin 
were excellent (loo??). TEL was well tolerated and all adverse events for 
whch drug c a d t y  could not be ruled out were mild or moderate intensity 
(34.8% inthe600-mggroupand50.0%ofthe800-mggroup). Therewereno 
slgmficant Merences between two treatment groups. 
Conclusions: TEL 600mg once daily is as e&ctive as TEL 8OOmg once 
daily for 7 days in the treatment of CAP, including CAP caused by PRSP and 
ERSP. 
Quantitative determination of respiratory 
pathogens from throat cultures: does it indicate sinusitis? 
A. Iki, G. SoyIetir, N. W r ,  S. Inanli and M. Bakir 
Irfanbul, .la 
Objectives: Sinusitis is one of the most common disorders of chddhood. Due 
to the h i r e d  knowledge about the causative agents ofsinusitis and difficulties 
in diagnosis of microbial etiology, treatment is almost always empirical. In this 
study, we tried to determine the bacterial pathogens present in ciuldren with 
sinusitis and correlation of the cultures obtained from throat and maxillary 
sinuses. 
Methods: This prospective study was performed between November 1999 
and August 2001 on 90 children having adenoidectomy for their chronic 
adenoiditis. On the day of operation, throat cultures were obtained pre- 
operatively and sinus aspirates at operation. Throat swab suspensions were 
serially diluted and were inoculated onto Columbia agar @ioMPrieux) and 
Polyvitex Chocolate agar (bioMPrieux) using quantitative method. Maxillary 
sinus aspirates were also inoculated onto Columbia agar, Polyvitex Chocolate 
agar, Schaedler agar and incubated in 5% COz at 35 "C in an anaerobic jar. 
The organisms were isolated and identified by the standard methods. 
Resulk A total of 72 isolates from 47 (52%) of the patients were obtained. 
Multiple growth was detected in 20 (42.5%) patients, consisting of 19 patients 
with chronic and subacute sinusitis and one acute sinusitis. Ofthese patients, 
three had anaerobes (pratofella spp.. Potphyromonas spp., Pepto~trcptococc~s spp.) 
accompanying respiratory pathogens. H. injuenzae, M .  catanhalif, S.  pneumo- 
niae, S. aureus, S. pyogenes were the most common isolates of sinusitis, respec- 
tively. Relationship between pathogens from maxiIlary sinus aspirates and 
quantity of throat isolates are shown in table. 
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Table: Relationship of quantity of throat isolates and maxillary sinus aspirates 
T h a t  colonization 
>lo2  Sind th roa t  (%) 
Pathogen 
>lo5 Sindthroa t  (%) 
H .  influenme 18/14 (41) 
M. rntndt~ l is  11/15 (66) 
S. pneumoniae 8/ 17 (47) 
S. sums 519 (55) 
S. pyogenes 3/11 (27) 
13/30 (43) 
6/9 (66) 
5/13 (38) 
1/3 (33) 
1/5 (20) 
Conclusion: There are s t i l l  controversies regarding relationship between 
throat colonization and etiology of sinusitis. Data of this study clarifies that 
there is not a cut off value of pathogens found in throat cultures predicting 
etiology of sinusitis. 
I P898 ] Therapy of acute exacerbation of chronic 
bronchitis with moxifloxacin in patients with prior 
rnacrolide therapy 
H. Landen, T. Bauer and K. Stauch 
Leverkusen, Bochum, D 
Objective: The aim of &IS post marketing surveillance (PMS) Study was to 
evaluate the efficacy and tolerability of modoxacin (MXF) therapy in acute 
exacerbations of chronic bronchitis (AECB), time until improvement and 
recovery, and patient satisfaction in comparison to previous macrolide 
therapies. 
Methods: PMS study conducted in Germany with physicians in general 
practice. Investigators documented their experience with MXF therapy for 
AECB patients with a prior macrolide treatment by use of structured case 
report forms. Course of the AECB symptoms was assessed. At the end of the 
treatment period, global assessments ofMXF therapy were made by physicians 
concerning efficacy, tolerability and patient acceptance. In addition, they 
judged efficacy and time until onset of action in comparison to prior 
macrolide therapies. Patients rated their MXF therapy in comparison to their 
prior AECB therapy with macrolides. 
Results: Data &om 7223 patients could be included in the statistical analysis. 
Thirtynine percent of patients received prior treatment with roxithromycin, 
21% with clarithromycin, 17% with acithromycin and 13% with erythro- 
mycin. For 10% of the patients other macrolides, combination therapies or no 
specification was documented. For most of the patients MXF therapy was 
adnunistered 5 5  days (67.2%) or 6-7 days (20.7%) with nearly all patients 
receiving 400mg qd (only five patients received a different, hgher dose). 
75.5% of patients had an improvement of the acute infection at day 3, and 
95.9% by day 5. Cure from the acute AECB was seen on the average after 
6.242.4days of MXF therapy. The global assessment of physicians with 
regard to the efficacy of MXF therapy w a s  “cure” or “improvement” for 
98.2% of the patients. The tolerability of MXF therapy was rated as “very 
Legionella 
good” or “good” for 97.8% patients. 96.3% ofthe patients were very satisfied 
or satisfied with their MXF therapy. The assessments in comparison to the 
prior macrolide therapy are shown in the following table. 
PhysicianS assessments (% of panents; N=7223) comparing MXF to prior macrolide 
Efficacy Better Same worn Missing 
Start of action Earlier Same Later Missing 
77.5 17.5 1.5 3.6 
75.8 18.3 2.3 3.6 
Patient’s assessments (% of patients; N= 7223) comparing MXF to prior macrolide 
Genecll assessment Better Same Worse MiSSlr lg  
76.1 19.1 1.3 3.6 
The overall mcidence rate for adverse events was 0.7%. There were 5 (0 07%) 
serious adverse drug reactions documented (anaphylactlc reachon, ch& and 
fever, hypotension, nervousness and tremor) All events were resolved. 
Conclusions: Therapy mtb MXF leads to rapid improvements m AECB and 
is well tolerated. More than 75% of physicians and pahents rated MXF better 
than their prior macrohde therapy 
1 P899 1 Otitis media due to Vibrio a/gino&ficus after 
Tympanoplasty 
M. Cuervo, B. Perez-Piiiero, M. Lecuona, I. Montesinos, T. Delgado and 
A. Sierra 
Enen3, E 
Objective: Vibrio alginolyticus have been recognized in a few cases as a 
potentially pathogenic bacteria in otitis externa, usually after prolonged 
contact with sea water. We report an isolate of this microorganism in an 
22-year-old man, 6 months h e r  a tympanoplasty and colesteatoma in his right 
ear. The patient didn’t refer a prolonged contact with sea water and presented 
a suppurative chronic otitis media in the same ear than surgery. 
Methods: Ear drainage was processed in the Microbiology Service, getting the 
following results. 
Results: In Gram stain we observed polymorfonuclear leukocyte and mixed 
flora mainly with Gram-negative rods. Ka[ginolyticus was isolated in pure 
culture in all media plated (Columbia, McConkey, Chocolate and TCBS 
agar). Identification was performed by Vitek I1 automated system (bioMtr- 
ieux) with an tipicity index 1 and by AF’I 20NE system (bioM6rieu) with 
none error test. By NCCLS disk-&ion test the organism was susceptible to 
all 8-lactam antibiotics as well as to macrolides, aminoglycosides and qui- 
nolones. Patient was treated with tobramicyn during 10 days, with succeeded 
in the remission of the symptoms. 
Conclusion: Kalgynoliticus idkction, besides to be related to prolonged 
contact with sea water, can also be favored by traumatic processes. 
1 P900 1 Epidemiological evaluation about Legionella 
incidence in Liguria in a &month period 
E Minetti, M. Scogna. M. Ansehno, G. Menardo, A. Ghighotti, 
E. Magnano and M. Murialdo 
Savona, I 
Legionellosis is an infectious disease of severe gravity and height mortality. 
The predisposition factors are, besides old age, alcohol addiction and smoking, 
air inhalation, especially that from air conditioning systems, and ingestion of 
contaminated water. There is also a comorbi&ty with a great number of 
immunodepressing illnesses like BPCO, neoplastic diseases, renal insuffi- 
ciency, diabetes, heart diseases, organ transplants and corticosteroid treat- 
ments. The incidence of Legionellosis in Community Acquired Pneumoniae 
(CAP) depends on the age; the diagnosed cases in patients under 65 years of 
age are about 2%, but they can even reach 6% in aver 65 ones. This percentage 
varies &om 4 to 10% in patients with Hospital Acquired Pneumoniae (HAP). 
In our research, we have tested 426 urine samples of patients with pneumonia 
diagnosis in 25 Ligurian hospitals and in the University of Genoa (Department 
of General Medicine, Infectious or Pneumological Diseases). The samples’ 
collection has been made between December 1, 1999 and March 31, 2000. 
The samples have been frozen at -20 “C in special containers and tested in our 
laboratory every 2 weeks. The kit used is ‘Binax Legionella Urinary Antigen 
EIA,’ an immunoenzymatic kit, able to reveal the serum group 1 Legionella 
gneumophila antigen in human urine. 
Results: 
0 Total samples tested 426 
0 Positive samples: 5 
0 Positive samples: 421 
Percentage and positive samples: 1.07 
Conclusions: The Legionella pneumonia incidence in our province is about 
I%, less than the data found in literature. 
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I P901 1 Distribution of ba&ria causing Legionnaires' 
disease at potable water sites in Istanbul, Turkey 
Z. Zeybek, A. Kimiran and A. Cotuk 
Istanbul, TR 
Objectives: Legionella pneumophila (especially L. pneumophila Serogroup 1 )  
known as causing Legionnaires disease lives in surface waters such as river, 
lake, stream in nature. These bacteria pass man-made water systems via these 
natural waters. It is known that these bacteria cause merent infections and 
even death in man. For this reason, in this article, it was aimed to study, in 
respect of Legionelh, potable water systems in buildings (especially hotels) in 
the vicinity of Istanbul. 
Methods: Seven hundred and one potable water samples taken from 162 
buildings between 1996 and 2001 were concentrated by filtration, and 
inoculated onto buffered charcoal-yeast extract agar (BCYE) added glycine, 
vancomycin, polymyxin, cycloheximide and incubated at 37 "C for 14 days. 
Colonies consistent with Legionella morphology were subcultured to tryptone 
soy agar (TSA). Definitive identification was performed by latex agglutination 
(OXOID). 
Results: The water systems of 63 (38.8%) of the buildings surveyed were 
found to be positive for Legionella. It was found that 31 (23.7%) of the 131 
strains determined as Legionella pneumophila were L. pneumophila Serogroup 1, 
101 strain (%76.4) were L.pneumophila Serogroup 2-14. The lowest and 
highest viable counts of L.pneumop,phila Serogroup 1 were determined as 
72 cfu/L and 20 000 cfu/L, respectively. 
Conclusions: According to the results, it is suggested that the large number of 
buildings (hotels) in the vicinity of Istanbul have low risk category as to 
Legionnaires disease. 
jP902/ Sampling and evaluation of Legionella 
pneumophila in cooling tower water systems 
I. Turetgen, E. Ilhan Sungur and A. Cotuk 
Istanbul, 7R 
Objectives: Legionella pneumophila, the causative agent of Legionnaires' &- 
ease, is known to be colonized and grown frequently in cooling tower water. 
Disease is acquired by inhaling aerosol contaminated by Legionella. Determi- 
nation ofthe count of L. pneumophila in cooling tower water may be useful for 
risk assessment. In our survey, 103 water samples fiom 50 cooling towers were 
examined over a 5-year period to indicate the seasonal distribution and the 
ecology of L. pneumophila regarding temperature and pH values. 
Methods: Water samples were collected in sterile plastic bottles; temperature 
and pH were measured at the time of sampling. Water samples were 
concentrated by filtration and membrane filters were resuspended in sterile 
distilled water. Acid and heat treatment were used as a decontamination 
method. Treated samples were inoculated onto cc-ketoglutarate-suplemen- 
ted buffered charcoal-yeast extract (BCYE) agar (containing glycine, vanco- 
mycin, polymyxin, cycloheximide) and incubated at 37'C for lodays. 
Colonies consistent with Legionella morphology were subcultured to blood 
Surveillance of antibiotic resistance 
agar and BCYE agar plates Defimtrve idenhficahon was performed by latex 
agglutlnahon and B-lactamase activlty. 
Result% L pneumophila was detected in 26% of the water samples and the 
highest viable count was determned as > 100 000 cfu/lOO mL L. pneumophila 
Serogmup 1 was found m 44% of the lsolated strams, whch IS pnmady 
responslble for the majorlty of Legonnares' &ease. The temperature range 
for mulnplicasion OfLegionelta shim Isolated h m  the cooling towers varied 
from 4 to 30 "C and the pH rvlge h m  6.56 to 9.40. 
Conclusions: C o o h g  towers have been W e d  to many outbreaks of 
Legonnaires' disease The large majorlty of exarmned towers had levels of 
Legonellae m the low-mk category. However, the detectLon of low numbers 
of L. pneumophila after a smgle sample cannot be used rehably to predct a low 
risk Appropriate mamtenance and momtorlng by MUMe samphg are the 
effechve control measures 
v( In vitro activities of various antibiotics against 
Legionella pneumophila 
A. S. BirteksSz, 2. Zeybek and A. Cotuk 
Istanbul, TR 
Objectives: When Legonellapneumophila known as the fktor OfLegionnaires 
disease is located in Merent setting such rivers, lakes and stream, it does not 
cause a healthy risk, but it colonizes in man-made water system found suitable 
conditions and causes infections contaminating human beings this way. 
L.pn@umophilu infections which cannot be defined because of inefficiency 
of diagnosis very often can only be therapiedby early diagnose and an effective 
antibiotic practice. In this study, in vitro activities of erythromycin, azithro- 
mycin, ciprofloxacjn, ofloxacin, levofloxacin, doxycyclin and Sampisin 
against environmental L. pneumophila were compared. 
Methods: In this study, 8 (10%) of 80 water samples which belong to 20 
buildings were determined as L.pneuPnophila. The determinations of sero- 
group strains were done by Oxoid dqnostic test kit. The minimum 
inhibitory and bactericidal concenmtions (MIC and MBC) of these anti- 
biotics were determined by microbroth dilution technique against eght 
L. pneumophila. 
Resub.  MICs determined by microbroth dilution methods were in the range 
0.25-0.0078 pg/mL of erythromycin, 0.125-0.0078 p&mL of azithromycin, 
0.031-0.0078 pg/mL of cipmfloxacin, 0.031-0.015 pg/mL of oflaxacin, 
0.0156-0.0078 pg/mL ofkvofloxacin, 0.5-2 p g / d  of doxycyclin, less than 
or equal to 0.001 &mL of rifampicin. MBCs were in the range 1-32 pg/mL 
of erythromycin, 0.25-8 pg/mL of azithromycin, 0.0625-2 pg/mL of cipro- 
floxacin, levofloxacin, 0.0625-1 pg/mL of ofloxacin, 4-32 pg/mL of dox- 
ycyclin, more than or equal to 0.015 pg/mL of rifampicin. 
Conclusions: In chis study, none of the st ra ins  examined showed resistance to 
antibiotics. Rifaampicin had significantly the highest activity against Lpneu-  
mophila. MICs and MBCs of cipmfloxacin, ofloxacin and levofloxacin found 
against the strains of Lpneumophila showed s& concentrations. This 
situation shows that these antibiotics can be selected in the therapy of 
L .  pneumophila infections required bactericidal activity. 
1 P904 I European Surveillance of Antibiotic Resistance 
(ESAR) in Gram-positive alert organisms 
I. M. Gould, H. Haverkamp, V. Krcemry, J. Trupl, W. Hryniewicz, 
A. Rodloff, M. Helmerking and F. M. MacKenzie 
Abevdeen, UK; Munich, 0; Bratisha, SK; Wanau( PL; Lzipzk, D 
Background: Smce 1998, European Surveillance of Antibiohc Reststance has 
been funded by the European Cornss ton  to p m d e  data through alert 
o r p s m .  
Methods: European t e r w  referral centers are in Slovka, Poland, 
Germany wth a comparator in Scotland. Rouane laboratory data are sent 
to the European Society for Biomoddahon and Chemotherapy (ESBIC) data 
center and analyzed. Comparahve data for 1999 and 2000, on more than 
100 000 Gram-posihve denommator isolates are presented 
Results: Macrolide resistance is stable in B-hemolytic streptococci (BHS) 
(1.3-1.5%), but rose in pneumococci (1.5-6.2). Low-level penicillin resis- 
tance in pneumococci increased (3.1-10.8%). A total of 33% BHS and 50% 
pneumococcal alert organisms were hospitalized (12 and 22%, respectively, in 
ICU). Mast @3S were h m  URTI or SSTI with one disseminated infection. 
Over 50% of pneumococci were h m  URTI, 15% h m  LRTI and 3% h m  
blood cultures. Glycopeptide resistance in enterococci was low but B- 
lactamase production and high-level gentamicin resistance doubIed (1.4 
and 6.1%, respectively). Greater than 90% of alert enterococci were hospi- 
talized (50% in ICU). Greater than 15% were fiom UTI, 10% from LRTI and 
3% from blood cultures. Methicillin resistance remains <5% with one 
glycopeptide intermediate strain.  Over 80% of MRSA were hospitalized 
(30% in ICY.  LRTI and SSTI were the most common sites ofisolates; 3% 
were &om blood cultures. 
Conclusions: Although alert organism resistance is increasing, rates remain 
much lower than published resistance studies. Selection of organisms for 
resistance studies may be the explanation for this. Use of routine susceptibility 
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data from diagnostic laboratories may give a lower estimate of resistant 
problems. There were marked ditferences in the number of alert organisms 
between the different centers. 
Quality assessment of antibiotic susceptibility 
testing by 608 laboratories of the European Antimicrobial 
Resistance Surveillance System (EARSS) 
N. Bruinsma, A. de Neeling, S. Bronnvaer, J. Snell, G. Cornaglia, 
J. Degener and P. Courvalin 
On behalf ofthe EARSS participants 
Objectives: EARSS organized in collaboration with UK-NEQAS (National 
External Quality Assurance Scheme), an external quality assessment (QA) of 
antibiotics-susceptibility testing to test the comparability of data across 
European countries and guidelines. 
Methods: E.faecalis UA605 (vanB, aac6‘-aph2’, erm) and UA1529 (suscep- 
tible), E.faecium UA1527 (Ap@, em) ,  S. aureu UA166 (susceptible), E. coli 
UA1530 (susceptible), E. coli UA1526 (CTXM j-lactamase, aminoglyco- 
side@) and E. coli UA1528 (TEM8 B-lactamase, aac(6’)-Ib) were distributed. 
The laboratories had to report the guidelines followed and the clinical 
categorization of the strains. The classification was considered as ‘concordant’ 
if similar to that of three reference laboratories based on ‘interpretative 
reading’ of the data. 
Results: Of the 608 laboratories &om 24 countries, 552 (91%) replied 73% 
used the NCCLS guideline, alone (60%) or in combination (13%). The 
overall concordance for the three enterococci and amo&n/ampicillin, 
gentamicin and glycopeptides was high (291%). except for vancomycin 
(85%) and amoxicdlin (77%) for strains UA605 and UA1527, respectively. 
Concordance for vancomycin was higher with MIC-yielding (90??) than with 
non-MIC-yieldmg methods (75%). The overall concordance for the three 
E. coli strains for amoxicillidampicillin, gentamicin, tobramycin, ciproflox- 
acin and ofloxacin was also high (292%). Detection of ESBL production by 
E. coli UA1526 and UA1528 was achieved by 85 and 90% of the laboratories, 
respectively. For these strains, the overall concordance for cefotaxime, 
ceftriaxone and ceftazidime varied from 71 to 100%. 
Conclusions: The QA data indicated that the resistance rates monitored by 
EARSS allowed comparison between the countries. The low concordance for 
amoxicillin could be accounted for by ditferences in breakpoints among 
guidelines stressing the need for European breakpoints. Not all laboratories 
that detected ESBL production altered their data to resistance to cephalo- 
sporins. 
(P906j Frequency and resistance rates of Pseudomonas 
aeruginosa in Europe: update from SENTRY surveillance 
program 2000 
H. Rodriguez-ViUalobos, M. J. Struelens and R. Jones 
On  behalf of the Euro SENTRY program 
Objectives: The aim of this study w a s  to describe antibiotic resistance rates of 
Pseudomonas aenrginosa from hospitalized patients monitored in SENTRY 
Europe surveillance program during 2000. 
Methods: During the year 2000, a total of 766 I? aeruginosa strains from 18 
hospitals were analyzed. These centers were distributed among 12 European 
countries: six Mediterranean countries (Spain, France, Italy, Greece, Turkey, 
Israel) and six other countries (UK, Belgium, Germany, Switzerland, Poland, 
Sweden). Antimicrobial susceptibility for 28 antimicrobial agents was tested 
by broth microddution method as described by NCCLS. 
Results: Of these isolates, 48% were obtained from hospitahed patients with 
pneumonia, 30% were hom bloodstream infections (BSI), 13% from skin and 
soft tissue infections and 9% from urinary tract infections. More than 60% 
isolates were &om nosocomial infections, 16% were of undefined place of 
acquisition and 36% were from patients admitted to intensive care units 
( 1 0 .  I! aeruginosa was among the five most fkquently reported pathogens 
causing BSI. A large variation in resistance rates was seen between the centers. 
The mean proportion of isolates nonsusceptible to piperacillin and ticarcillin 
was 23 and 36%. respectively; piperacdin-tazobactam 18% ticarcillin-clav 
35% ceftazidime 28% (31% in ICU patients vs. 25% in non-ICU patients; 
P<O.OOl); cefepime 29% (35% in ICU vs. 23% in non-ICU patients; 
P=O.O7); imipenem 25% (32% in ICU vs. 20% in non-ICU patients; 
P<O.Ol); meropenem 23% (31% in ICU vs. 17% in non-ICU patients; 
P <  0.01). Rates ofnonsusceptibhty to aminoglycosides was 27% for tobra- 
mycin, 16% for amikacin and 31% for gentamicin. The and MI% 
results for isepamidn were 4 and >32 p g / d ,  respectively. The proportion of 
ciprofloxacin-nonsusceptible isolates was 32%. 
Conclusions: I? aeruginosa was a fkequent pathogen causing respiratory, skin 
and bloodstreani infection among the hospitalized patients in this European 
survey Rates of resistance of Puoeruginosa in 2000 were >15% for all 
antipseudomonal agents and were higher than in the previous surveys in 
1997-1 998. 
IP907/ Antimicrobial susceptibility patterns of /?-hemolytic 
and viridans group Streptococck report from the SENTRY 
antimicrobial surveillance program (1997-2000) 
K. Gordon, M. Beach, R. Jones and A. Mutnick 
North Liberty, USA 
Objective: To determine susceptibdity patterns of 15 antimicrobial agents 
tested against /I-hemolpc (BetahS) and viridans group (VgS) streptococci in 
four regions ofthe SENTRY program: Asia-Pacific (AP), Europe (EU), Latin 
America (LA) and North America (NA). 
Methods: Between January 1997 and December 2000, SENTRY program 
monitors received 3400 BetahS (n = 2248) and VgS (n = 1152) isolates from 
four geographc regions: AP (408), EU (777). LA (332) and NA (1883). All 
isolates were tested by reference broth microdilution methods and interpreted 
using NCCLS criteria. Among the BetahS tested, 81.9% were either sero- 
group A (650) or B (1190). The VgS were classified as unspeciated a-strept 
(512; 44%), Streptococcus mitis (254; 22%) and other speciated Streptococm spp. 
(386; 34%). Seven quinolones, two B-lactams, erythromycin (ER), clinda- 
mycin (CM), quinupristin/dafopristin (Q/D), vancomycin FA), teicophin 
(TP) and linezolid (LZ) were routinely tested. 
Results: Rank order of susceptibihty for BetahS was: ceftriaxone 
(CTX) = Q/D =VA =TP = LZ (lOO.W?) > gatifloxacin (GATI; 99.8%) = 
trovafloxacin (TROV; 99.8%) > levofloxacin (LEVO; 99.7%) > penicillin 
(PEN, 99.3%) > grepafloxacin (GREP; 97.4%) > CM (94.4%) > ER (85.5%). 
GATI, GFLEP and TROV a l l  had the same MICSO (0.25 mg/L) and MICm 
(0.5 mg/L) result against BetahS, while LEVO had MICso and MICw results 
that were two-fold higher. ER versus BetahS had the highest MI% value 
(2 mg/L) and the lowest susceptibility across all regions (range: 81.4% in NA to 
97.3% in LA). Among the VgS, susceptibility rank order was: VA = TP = LZ 
(100.0%) > Q/D (99.1%) > GATI=LEVO =TROVA (98.0%) > GREP 
VgS was 62.7, 68.1 and 57.8% susceptible to ER in M, LA and NA, 
respectively. 
Conclusions: Among BetahS, macrolide resistances increased to 13.8% and 
CM resistance w a s  at 5.3%. These rates were two-fold greater in VgS and 
quinolone-resistant strains were observed at 0.6-1.3%, a disturbing level as 
was the low 68.6% susceptibility to PEN. Like pneumococci, other strepto- 
cocci have acquired resistances and require continued surveillance. 
(96.5%) > CTX (92.8%) > CM (90.3%) > PEN (68.6%) > ER (64.5%). 
IP908( Epidemiology of antibiotic resistance of bacterial 
pathogens from intensive care units: the SENTRY 
surveillance program in Europe 2000 
H. Rodriguez-Villalobos, R. Jones and M. J. Struelens 
On behalf of the Euro SENTRY Program 
Objectives: To describe the eequency and resistance rates of bacterial 
pathogens fkom patients admitted to intensive care units (ICU) from a 
network of European hospitals. 
Methods: During the year 2000, 18 hospitals &om 12 European countries 
referred a total of 8062 bacterial pathogens. In v i m  susceptibility of 32 
antimicrobial agents isolated from hospitalized patients @a), was tested by 
broth microdilution method as described by the NCCLS. 
Results: Among all pathogens, 30% were fkom pts admitted to ICU. In these 
patients, the most Gequent pathogens were S. w e u s  (20%), P aeruginosa (15%), 
E. coli (1 l%), Kpnerrmoniae (8%), coagulase-negative staphylococci p?), 
A. baumannii (7%). E. cloacae (5%) and E. f u m b  (4%). Isolates from ICU 
pts were recovered h m  bloodstream (49”/.), lower respiratory tract (39%), 
skin (7%) and urinary tract infection (6%). The mean (intercenter range) 
proportion of I? aeruginosa isolates nonsusceptible to ceftazidime and cefepime 
was 31% (G82) and 35% (0-82). respectively, in ICU pts, versus 25 and 23% 
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in non-ICU pts (P=0.07 and P <  0.01, respectively). Ciprofloxacin resis- 
tance rates in ICU was 33% (M8) .  Rates ofnonsusceptibility to imipenem 
and meropenem were 32 and 31%, respectively, versus 20 and 17% in non- 
ICU pts (P< 0.001). In Kpneumoniae, the proportion of decreased suscept- 
ibility to ceftazidime (MIC 32pg/mL) was 43% versus 29 in non-ICU 
(P<O.01); cefepime 15% versus 7% in non-ICU pts (P<O.Ol). Resistance 
of A. baumannii to meropenem was seen in 43% isolates h m  ICU pts versus 
16 in non-ICU pts (P < 0.01). The proportion of oxacillin resistance in 
S.aurerrs from ICU pts was 47% (&loo) versus 25% in non-ICU pts 
(P< 0.0001). Resistance to vancomycin was similarly low in ICU versus 
non-ICU pts in E.faecafir (1% vs. 3%). High level ofgentamicin resistance was 
expressed by 36% of E.fuecalis isolates from ICU pts versus 32% in non-ICU 
Pts- 
Conclusions: These data confirm that the prevalence of antimicrobial resis- 
tance in several Gram-negative pathogens and S. aureus isolates is higher &om 
patients admitted to ICU than to other wards in these hospitals. Large 
intercenter variation underline the need to adapt the therapeutic approach 
to local resistance data. 
IP909) Antimicrobial Susceptibilities of hospital pathogens 
to ceftriaxone and other antimicrobials: outpatienu 
inpatient and ICU data submitted to TSN@ databases 
(Europe and USA, 1999-2001) 
M. E. Jones, J. A. Karlowsky, L. J. Kelly, C. Thornsberry and D. E Sahm 
Hiluersum, NL.; Herndon, Franklin, USA 
Objectives: In th is  study, we report current susceptibility rates of antimicro- 
bials for key hospital pathogens as reported to physicians by clinical micro- 
biology laboratories in Europe and the USA. 
Methods: We analyzed data (January 1999-September 2001) &om The 
Surveillance Network@ (TSN) Databases in France (Fr), Italy (It), Germany 
(Gy) and the USA to determine susceptibilities &om routine test results. Data 
was divided into intensive care unit (ICU), inpatient (IP) or outpatient (OP) 
origin, and comprised a l l  specimen types. 2001 NCCLS breakpoints were 
used, except for Fr (CA-SFM) and Gy (DIN) data. 
Results: More than 50% of all isolates routinely tested were S. uurm and 
E. coli. For ICU patients, IPS, and OPs, rates of oxacillin-resistant S. aureus 
(ORSA) were 39.4,43.3 and 29.90h (Fr), 40.8,62.5 and23.4% (It), 9.2, 17.4, 
and 2.9% (Gy), and 45.1, 52.2 and 28.3% (USA), respectively Oxadin- 
susceptible SA (OSSA) were susceptible to ceftriaxone (CRO) (>96%) 
irrespective of patient location. Erythromycin and cipmflmacin (CIP) resis- 
tance was common among OSSA irrespective of patient location. Among 
E. coli (EC), >9Y? ofisolates in Fr, >96% in Gy, >95% in It, and >970/0 in the 
USA from ICU patients, IPS and OPs were susceptible to CRO, similar to the 
activity of other third-generation cephalosporins (3GCs), amikacin (AMK) 
and CP.  CRO susceptibility in Kpneutnoniae (KP) in ICU, P and OPs, 
respectively, was 85.2, 91.0, 91.7% (Fr), 100, 93.5, 94.4% (Gy), 77.8, 88.3, 
95.2% (It), 91.7, 95.3, 97.7% (USA), similar to rates for AMK, other 3GCs, 
and CIP, but higher than amoxycillin/clavulanate. For I! mirabiiis from It, 
lower susceptibilities were observed than in isolates from Gy, USA or Fr for 
CRO and other agents. Against C.fieundii imipenem, AMK and CIP were the 
most active agents. Using ceftazidime nonsusceptibility as a surrogate marker, 
ESBL production in EC was <4% in each country, with the highest levels 
observed in ICUs. For U, <10% of isolates in Fr and Gy produced ESBLs in 
contrast to 12.8/31.2% (It) and 7.0/11.4% (USA) of isolates &om ICU 
patiena/IPs, respectively. 
Conclusions: ORSA varied by patient location, but this was not always true 
for Gram-negative species. Isolates h m  outpatients tended to be more 
susceptible than hospital isolates. ESBL production in EC remains low, but 
in KP appear to be a sigdicant problem, particularly in ICUs in Europe and 
the USA. 
I P910 1 Monitoring of drug-resistant strains in intensive 
care units in 1998-2000 
A. Zoratti, M. Bozzolasco, E. Tonoli and A. Marchese 
Genoa, I 
Objecthres: The increase of drug resistance 111 nosocomial pathogens is 
a worldwide problem. In this study, climcal specimens f h m  intensive care 
units have been considered and resistance to specific drugs m S.aureus, 
coagulase-negative staphylococci (CNS), E. roti and I! amrginosa, the major 
opportunistic pathogens in these clinical settings has been analyzed. 
Methods: A total of 666 pathogens processed in the Clinical Microbiology 
Laboratory have been considered; specimens were collected during a 4- 
month period in 1998,1999 and 2000 b m  the intensive care units (ICU) of 
the regional hospital. The collection included S. aureus (21 1 samples), CNS 
(164), E.coli (171) and I?umgitwsa (117). 
Results: Gram-positive bacteria were tested against nine different antibiotics. 
The results obtained shows that teicoplanin was the more etrective compound 
with 100% of susceptible strains, together with doxicycline (from 93.5% in 
1998 to 100% in 2000) and cotrimoxazole (about 95% during the 3years 
considered). The incidence of oxacillin-resistant S. aurru~ did not vary sig- 
nificantly in the strains analyzed (from 42.3 to 39.2%), similarly in CNS this 
character varied from 57.7 to 54.5%. With Pamginosa, hgh levels of 
resistance was noted, in particular for ciprofloxacin (from 26.1 to 35.1% of 
resistant) and piperacillin/tazobactam (21.7 to 29.8%). With E. coli imipenem 
inhibited all strains tested, while piperaciLlin/tazobactam (from 84 to 85.8%), 
ceftazidime ( b m  89.2 to 97.6%) and amikacin (from 98.6 to 100%) showed 
high rate of activity. 
Conclusion: The preseatiindins showed that antibiotic resistance in ICU was 
essentially stable during the period of time considered. The importance of a 
strategic approach in monitoring drug resistance in nosocomial infections is 
confirmed. 
The impact of hospitalization on the epidemiology 
of antibiotic resistance in the ompharyngeal and fecal flora 
of intensive care patients 
P M, G. Fhw, I. C Gyssens. A G. Vulto, €? J. E. Rooven, 
H. A. Verbrugh and H. €? Endtz 
Rotterdam, NL 
Objectives: To assess whether hospitahzaaon leads to (1) a change m anabioac 
suscephbhty patterns over m e ,  or (2) the acqwsinon of new and resstant 
strains in the fecal and oropharyngeal flora 
Methods: Oropharyngeal and rectal swabs were collected on admxssion 111 the 
intensive care unit (ICU), once weekly and on dscharge. The swabs were 
moculated on a chromogemc agar and five colorues per sample were randomly 
selected. MICs for 20 anhbiohcs were deterrmned by Vitek 2. NCCLS 
breakpoints were used A sigrufcant change m suscepabhty pattern was 
defined as a change in category from suscephble to resistant or as a four-fold 
increase in MIC 
Results: A total of 75 pahents were mcluded m the analysis. The m d a n  
length of stay was lodays (range: 5-116days) and the median number of 
samples collected was 2 (2-15). In 43 panents (57%), s w c a n t  changes in 
suscepab&y patterns or acqrusihon of new reststant strams were observed. 
Changes m susceptibhty patterns were found in 19 out of 75 paaents (25%). 
These changes occurred both in the fecal and ompharyngeal flora, 17/19 and 
8/19, respecavely Thnty-three out of 75 paaents (44%) a c q m d  new 
reslstant bacteria dunng the= stay m the ICU, 18/33 of whom III them fecal 
flora and 17/33 m the ompharyngeal flora. 
feces mady  concerned E coli, whereas 111 
ugrnora were d y  mvolved Thnty percent ofthe overall number of changes 
in suscephbhty or acqmsihon of resistance was to amInopeNcih5,23% to 
first- and second-generatmn cephalospom. 20% to tturd- and fourth- 
generahon cephalosporms, 12% to qumolones, 6% to trmethopnm/sulfa- 
methoxazole, 6% to ammoglycosides, and 
Conclusions: Changes in suscephbhty pat 
stralns occurred fiequently dunng adrmsnon on an mtensive care umt and 
points to a hghly dynarmc bactenal popdahon m these pahents. 
v] Antimicrobial resistance in Italy: preliminary results 
from the AR-ISS Project 
D. Boccia, A. Pantosti, F. D’Ancona, S. Giannitelli, M. Monaco and 
s. S h o  
AR-ISS Workgroup, Rome, I 
Objectives: The AR-ISS Project is a laboratory-based sentinel surveillance 
system on antimicrobial resistance established in 2001 by the Istituto 
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Superiore di Sanid (ISS), the Italian Public Health Institute. The main 
objective of the project is to collect and analyze antimicrobial resistance data 
on pathogens of particular epidemiological and clinical interest in order to 
describe the pattern of susceptibility and monitor changes providing the 
scientific evidence on which strategies for control and prevention have to be 
based. Preliminary results on the first 4 months of activity are presented. 
Methods: Since June 2001, 69 Itahan laboratories, serving a total of 77 
hospitals, collect and send to ISS data on invasive isolates of S.pneumoniae 
(blood and cerebrospinal fluid), S. aureus, E.faecalis/faecium, K.  pneumoniae/ 
q r ~ a ,  E . coli (blood only). Repeated isolates h m  the same infection are 
excluded. Data on clinical characteristics ofthe patients are also collected and 
transmitted using standard paper forms, while 10 labs transmit data electro- 
nically Strains with a defined pattern of antibiotic resistance are collected and 
shipped to I S  for hrther characterization. 
Results: From June to September 2001, 1017 isolates were reported (average 
of 13 isohtesAaboratory, range 1-76). 
1 S. u u m  (540 isolates): all isolates were susceptible to vancomycin; 42.8% 
were metkcillin-resistant S. aureus (MRSA); average age of patients was 
62 years (SD = 20.6); 61% were males. 
2 S.pneurnoniae (69 isolates): 14.3% were nonsusceptible to penicillin 
(PRSP); 31% were resistant to erythromycin; average age of patients 
was 55years (SD = 26.9); 61% were males. 
3 E.faecalis/’aecium (173 isolates): 1% of E.faecalis and 11.8% of E.facium 
were resistant to vancomycin; average age of patients was 66 (SD = 19.3); 
64% were males. 
4 K .  pneurnoniae/oxytoca (137 isolates): 13% were ESBL-positive; average age 
of patients was 56 (SD = 25.5); 60% were males. 
Conclusions: The proportion of MRSA higher than 40% is in line with 
previous observations in Italy On  the contrary, the recorded PRSP level 
(14.3%) is higher than that previously reported (11.4% in 1999), but the result 
needs confirmation. As expected, erythromycin resistance in S. pneumoniae is 
very high. The proportion of vancomycin resistance is quite Herent in the 
two species of Enteroclocus, being higher in E.faecium as expected. ESBL 
production by Klebsiella spp. isolates needs to be confirmed by further 
tests. 
I P913 I Analysis of alert organism and risk factor data 
from a European Surveillance Program 
I. M. Gould, H. Haverkamp, V. Krcmery, J. Trupl, W. Hryniewicz, 
A. Rodloff, M. Heherking and E M. MacKenzie 
Aberdeen, UK; Munich, D; Bratislava, SK; Warsuw, PL; kipzig, D 
Background: European Surveillance of Antibiotic Resistance (ESAR) is 
funded by the European Commission to provide alert organism data. 
Methods: Slovakian, Polish and German tertiary referral centers were com- 
pared with a large Scottish center. Routine alert organism and risk factor data 
fiom 1999 and 2000 were analyzed by the ESBIC data center. 
Results: Annual alert organisms increased fiom 4565 to 5777. Seventy-five 
percent were inpatients (20% internal medicine, 20% surgery) and 
40% had an ICU stay. Eighteen percent of the specimens were surveillance. 
Forty-nine percent were definitely/probably causing infection and 33% 
were possibly causative. Common organisms were Pseudomow (20%), Sta- 
phylococci (17%), E.  coli (16%) and enterococci (10%). Isolates were from urine 
(34%), respiratory tract (32%). wounds (14%) and blood cultures (5%). 
Seventy-five percent of the cases documented an infection; UTI (29%), 
LRTI (13%), wounds (lo%), SSTI (8%), URTI (8%) and bacteremia (3%). 
Prior antibiotic treatment was known in 60% of the patients; 16% received no 
antibiotics, 26% received one antibiotic, 12% two and 7% more than three. 
The commonly used antibiotics were coamoxiclav, ceftazidime, cefotaxime, 
ciprofloxacin, pip-tazo, metronidazole, cotrimoxazole and vancomycin. 
Antibiotic use varied considerably between centen. A total of 69% of the 
patients were known to suffer h m  at least one underlying disease, commonly 
neoplasm (14%). circulatory disease (1 l%), respiratory tract disease (lo??), and 
genitourinary disease (12%). 
Conclusions: Alert organisms were predominantly fiom inpatients 
(often 6om surgical ICUs) with underlying disease. The majority caused 
urinary or respiratory infection. Most patients received prior broad-spectrum 
antibiotics. There were marked dzerences in antibiotic use between 
countries. 
w/ Analyzing the antibiotic resistance of community- 
acquired bacteremia in Southern Taiwan 
M. Yen, Y. Liu and Y. Yang 
Kaohsiung, TW 
A total of 313 episodes of community-acquired bacteremia were collected 
from the emergency department of Veterans General Hospital, Kaohsiung 
prospectively and analyzed fiom July 1998 to June 1999. Microbiologically, 
there were 140 strains of Escherichiacoli, 66 strains of iaebsiella pneumoniue, 25 
strains of Staphylococcusaureuz, which account for over 70% of the whole 
isolates. Most of the community-acquired bacteremia were secondary bac- 
teremia h m  primary infectious foci such as urinary tract infection, biliary 
stone, with underlying &eases ofliver cirrhosis or diabetes mellitus. The most 
frequently prescribed antibiotics in the emergency department, include 
cefazolin which is the first-generation cephalosporin, is still sensitive to E. coli 
in 84%, K .  pneumoniae in 89%, S. auras in 76%. Gentamicin also remains 72, 
92,68% sensitive to the three major pathogens, respectively. In contrast, when 
analyzing the trend of nosocomial bactezemia in the same period, primary 
bacteremia accounts for over 70% of the total isolates. The antibiotic resistance 
of those nosocomial pathogens against the first-line antibiotics such as 
cefazolin, gentamicin, oxacillin mostly exceed 70-900?. In comparison, 
the drug susceptibihty of community pathogen is relatively constant and 
stable. Indicating that the community outside the hospital possesses a much 
huge microecological buffer system, so as to retain a greater capability to 
stabilize the antibiotic susceptibdities for longer years than we had expected. 
Cefizolin and gentamicin can be used as the tint line antibiotics to treat vast 
majority of community-acquired infections in Southern Taiwan. Further 
constant monitoring on bacteremia in a nation-wide scale is needed. 
v1 Are community-acquired organisms less resistant 
to antibiotics? 
J. M. Ling, E. W. Chan and A. F. Cheng 
Hong Kong, CHN 
Objectives: (1) To study the distribution of general practice organisms and (2) 
to determine the antimicrobial susceptibhties of these organisms. 
Methods: Private doctors practicing throughout Hong Kong collected speci- 
mens such as sputum, urine, stool, etc. h m  patients with suspected infec- 
tions. These specimens were cultured and identified in the laboratory 
according to standard procedures. Susceptibility to diflerent antimicrobial 
agents was determined by the disk &ion test as set out by the National 
Committee for Clinical Laboratory Standards. 
Results: A total of 4741 specimens h m  3977 patients were submitted for 
culture by 89 private practitioners h m  July 2000 to October 2001. Of these, 
28% were culture-positive. Throat swabs made up the largest proportion of 
specimens (26%), followed by urine (23%) and sputa (15%). More than 1300 
organisms were isolated, with 50% Gram-negatives and 42% Gram-positives. 
Escherichiacoli was the most common organism isolated (18%), followed by 
Staphylococcus aurcus (12%). B-hemolytic Streptococcus (BHS) group G (8%), 
Cundida albiurns (8%) and Haemophilus influenrue (6%). There were 50 isolates 
(4%) of Srrepfococnrrpneumoniue and 47 isolates (3%) of Neissm’agonorrhea. Of 
the 245 isolates ofE. coli, 61% were resistant to ampicillin, 20% to amoxicillin/ 
clavulanic acid, 30% to c e h x i m e  and 14% to ciprofloxacin. There were only 
three methicillin-resistant S.aureus (2%). however, more than 30?? were 
resistant to erythromycin or clarithromycin. All the 60 isolates ofBHS group 
A were susceptible to penicillin, but 5% of 103 BHS group G isolates were 
resistant. Up to 30% of all BHS were resistant to erythromycin or clarithro- 
mycin. Nineteen percent of the 79 H. intuenzae isolates were resistant to 
ampicillin, 9% to cefador, 26%€0 clarithromycin, but only 1% to amoxicillin/ 
clavulanic acid. All the 47 isolates of N.gonotrhoeue were resistant to penicillin, 
but none to ceftriaxone, 89% were resistant to ciprofloxacin and 13% to 
spectinomycin. A large proportion of the 50 S. pneumoniue isolates (>70%) 
were resistant to penicilhn or clarithromycin. 
Conclusions: (1) E. coli was the most common organism isolated; (2) the level 
of ciprofloxacin and macrolide resistance was high; (3) the large proportion of 
S. pneumoniue resistant to penicilIin was alarming; (4) community-acquired 
organisms were definitely not less resistant to antibiotics. 
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Nosocomial bloodstream infections 
Ip9161 Bloodstream infections in ICU patientr: analysis of 
risk factors influencing outcome 
A. Tamborini, A. Endimiani, G. Lombardi, V Elia, E Luzzm and 
A. Toni010 
Varese, I 
Objectives: Bloodstream infections (BSI) represent a serious health problem 
in ICU. A 2-year analysis was performed at our hospital to evaluate risk factors 
influencing the outcome among ICU patients that either survived or died 
from BSI. 
Methods: During the years 1999-2000, clinical records of ICU patients with 
BSI were evaluated with regard to severity of underlying disease (McCabe and 
Jackson groups), comorbidq scores (Charkon welghred index), severity of 
septicemia, predisposing factors, sources of secondary BSI, and empirical 
treatment. Statistical analysis of patients was performed using an appropriate 
software (Statistica; StatSoft, Tulsa, OK). 
Results: Ninety-two BSI occurred over the study period, with an incidence of 
86/1000 admissions. Seventy-five patients survived (81 .5%), whereas 14 died 
from BSI (15.2%). With respect to survived and dead patients, the following 
risk factors were considered: age (49.7 vs. 68.6), nonfatal (89.3% vs. 71.4%) 
and ultimately fatal underlying diseases (15.2% vs. 10.7%), comorbidity scores 
(0.9 vs. 2.7), sepsis (88% vs. 28.6%), severe sepsis (9.3% vs. 0%). septic shock 
(2.7% vs. 57.1%). The most frequent predisposing factors for BSI were: 
intravascular (93.3% vs. 100%) and bladder catheter (92.0% vs. loo%), 
intubation (74.7% vs. 92.9%), and previous use of antibiotics (78.7% vs. 
71.4%). Overall, 54.7% of the survived and 57.1% of the dead patients had 
four or five predisposing conditions, whereas 29.3 and 42.90/0, respectively, 
had s i x  or more. Secondary BSI dected 53.3% of the survived and 78.6% of 
the dead patients; lower respiratory tract (67.5% vs. 42.9%), intravascular 
catheter (27.5% vs. 28.6%) and urinary tract (27.5% vs. 0%) were the most 
fiequent sources of secondary BSI. Patients who either survived or died 
received adequate empirical treatment in 45.8 and 35.7% of the cases, 
respectively. Statistical analysis of independent risk factors showed that 
mortality was sigmficantly related to age (P< 0.002), comorbidity scores 
(P<0.026), and septic shock (P<O.OOl) .  
Conclusions: Our study demonstrates that outcome is not sigrtlficantly related 
to the number and type of predisposing factors; on the contrary, it is 
influenced by age, underlying dlseases, and severity of septicemia. On the 
basis of our findings, we suggest that the treatment of BSI should be based 
more on the data of the epidemiological survey provided by the local 
microbiology laboratory than on empirical therapeutic protocols derived 
&om the literature. 
Ip917) Bacteria isolated from blood in intensive care unit 
A. Samet, J. Nalewajska, M. Bronk and J. Lammek 
Gdansk, PL 
Objectives: The aim of t h s  study was to analyze the incidence of bacteria 
recovered from blood cultures patients from 12-bed intensive care unit in OUT 
hospital. 
Methods: The study involved patients hospitalized at the ICU hmJanuary 
1999 to September2001. The samples were incubated in BacT/Alert System 
(Organon Teknika) and VITAL (bioMerieux). The identification was done in 
the VITEK system (bioMerieux). 
Results: A total number of 3736 blood cultures were examined; 669 bacteria 
were isolated out of 605 positive blood cultures. A total of 54.3% of all were 
Gram-positive, 44.2% Gram-negative, and 1.8% fungi. The most frequently 
isolated microogcanisms were: coagulase-negative staphylococci (CNS, 
36.9%), Pseudomom spp. (19.5%), Staphylocoms aureus (7.2%). Enterococcus 
spp. (7.2%). Serratia spp. (4.9%), Hehiella spp. (3.9%), Streptococw spp. (2.3%), 
Entembacterspp. (2.1%), Escherichia cofi (1.8%), Proteus spp. (1.8%), Acimtobacter 
spp. (1.5%)- StettolmphorcMnacmaltophifia (1.2%), and Candida spp. (1.8%). 
Conclusion: The frequency of positive blood culture was 16% 51 were a 
polymicrobial cultures. The most conmon microorganisms were Gram- 
positive bacteria, especially CNS, which are the main etiologic agents of 
nosocomial bacteremia. We noted increased fkequency Pseudomonas aemgitaosa 
isolation from 11.1% (1999) to 18.1% (2000) and to 27.5% (I-& 2001) and 
Enfemcoccus spp. &om 4.8% (1999) to 8.8% (2000) and to 7.4% (I-X, 2001). 
Ip918j Eacteremia in a general hospital, Spain, 1994-2000 
C. Ezpeleta, I. Atutxa, C. Busto, J. Martinez, E. GBmez, V. Cabezas, 
J. Unzaga and R. Cisterna 
Bilbao, E 
Objective: The aim of this study is to assess the features of bacteremia in the 
Hospital of Basurto m the last 7 years. 
Methods: The Hospital of Basurto where the study was carried out is a 800- 
bed primary and tertiary care teaching hospital that provides care in the urban 
area of Bilbao. Blood cultures are performed by means of BACTEC 9240. 
The Infection Control Team studies every patient with positive blood 
cultures. Variables under surveillance are patient's age and sex, underlying 
illness, pre-ng conditions, source of bactema,  ncxocomiaycomma- 
nity acquired, rmcroorganism and antibiotic susceptibility, antimicrobial 
treatment, comphcatiom and outcome. A computer-based surveillance sys- 
tem (SEPSIS-DATA) was used. 
Results: A total of 3874 episodes of bacteremia were studied during ths 
period. The mcidence remained stable from 1994 to 2000 at about 19cases/ 
1000 dlscharges. The higher incidence rate was rwtered in the nonsurgical 
ward. A trend towards increasing rate was observed in pediatric ward. Men 
(57.38%) aged over 60years (56.91%) accounted the majority of the cases. 
The most frequent underlymg illness was neoplasia present in 870 patients 
(22.45%). The urinary (28.76%). gastrointestinal (17.65%) and respiratory 
tract (15.69%) were the most common sources of bacteremia. N o s o c o d  
bacteremia accounted 38.7% o f  the cases in 1994 and 30.39% in 2OOO. 
Etiology: in 1994 Gram-negatives 49.7%, Gram-positives 46.6%, and yeast 
2.66%. in 2000. Gram-negatives 56.16%, Gram-positives 41.25%. and yeast 
2.59%. E. coli (32.57%), S.pneumoniae (10.35%), S. a u w  (8.37%), S. egrder- 
mrdu (5.02%), Paenrginosa (3.2%) and Sdmonelfa spp. (2.44%) are now the 
most hquent agents of bacteremia. Nosocod-acquired bacteremia: in 
1994 Gram-positives 58%, Gram-negatives 36%, yeast 4.7%; In 2000: Gram- 
posihves 42.79%. Gram-negatives 49.25%. and yeast 7.96%. Ceficiaxone and 
vancomycin are the most fkequently prescribed antibiohcs. Eighty-four 
percent of the correct antibiotic treatments were started the same day when 
the blood cultures were obtained. Crude morality until the end of the episode 
was 15% in 1994 and 17.9% in 2000. 
Conclusions: Inadence ofbacteremia has remained stable in last 7 yeam The 
number of cases in pediatrics is increasing. Gram-negatives are increasing in 
nosocomial-acquired bacteremia, E. coli and I! aenrgin~sa are the most fie- 
quently recovered microorganism in nosocornial cases. 
Microbiological surveillance of bloodstream 
infections in a pediaric hospital, k l y  
G. Manno, E. Ugolotti, M. L. Belli, M. L. Fenu, S. Piana and G. Pittaluga 
Genoa, I 
Objective: We conducted a study to asses the prevalence and the antibiotic- 
susceptibility pattern of nosocomial bloodstream isolates in an 18-month 
period in a large pediatric hospital. 
Methods: With the he4 of xnicrobiological and epidemiological management 
software (0/3 - Soluzioni Infonnatiche, Vicenza, IT) connected to laboratory 
instruments, we analyzed the microbiological data ofblood cultures (BCs) for 
the period from 1 January 2000 to 30 June 2001. BCs were performed in 
Bact/Alert pediatric bottles (Organon Teknka); microorganisms were iso- 
lated by conventional methods, identification obtained by API system 
(BioMerieux); MICs of antibiotics were determined with broth microdilu- 
tions, with wider MIC panels (DADE-Soria-Melguizo) for Gram-positive 
organisms and Enterobacteriaceae, with semititer MIC panels (accumed for 
nonfermenters, with E-test for Candida spp.; NCCLS-proposed breakpoints 
were applied. Internal (ATCC strains) and external (NEQAS) QC were 
carried out regularly. 
Results: A total of 815 patients were monitored and total of 2949 blood 
cultures were performed (6% in PICU, 32.5% NICU, 16% surgeryand CCY 
8% infectious diseases, 7% neurosurgery, 5.5% pediatrics. Total 169/815pa 
(21%) had 388/2949 (13%) pos BCs and 444 strains were recovered 208 
(46.8%) coagulase-negative staphylococci (139 S. epidmnidis, 32 S. wameri, 28 
S. hominis, 21 S.  huemolyticus), 59 Candida (10 albicans, 49 nonalbicans) (13%), 
16 r? amginosa (3.6%), 16 Enterobacter/Kebsiella (3.6%). 15 Entemcoaus spp. 
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(3.4%). 14 S. nureus (3.1%), 12 Streptococnrsspp. (2.7), 10 S. mulfhophiliu (2.2%). 
All S .  a u m s  isolates were susceptible to oxacilline (OX); 82% of CONS were 
OX-resistant and 4.8% resistant to teicoplanin, only one Shaemolytiw was 
resistant to vancomycin: 35% of Cundida nonalbicans were resistant to 
amphotericine B and fluconazole; among Enterobacter and Kebsiella, we found 
25% resistant to cefotaxime/ceftazide and 75% resistant to cefuroxime; 20% 
of P aenrginosu were resistant to meropenem and/or ceftaadime, no strain was 
resistant to piperacillin; among enterococci 38% were highly resistant to 
gentamicin, and no strain was resistant to vancomycin and teicoplanin. 
Conclusions: Our results on bloodstream infections laboratory surveillance 
show a high prevalence in our institution of resistant S. epidermidis and the 
emergence of other CONS and Candidu nonalbicam with high resistance. This 
trend suggests the need to improve local infection control measures and 
antimicrobial therapy policies. 
Nosocomial bacteremia in a university hospital 
T. Delgado Meliin, A. Torres, I. Montesinos, M. Cuervo, M. Lecuona, 
Z. Cubas and A. Sierra 
LA Laguna, E 
Objective: The purpose of this study was to describe the epidemiological 
characteristics of nosocomial bacteremia. 
Methods: Prospectively, we reviewed the medical records of all patients with 
positive blood culture between April and September 2001 in our hospital 
(650-bed university hospital). 
Results: There were 185 episodes ofnosocomial bacteremia, which represents 
an incidence rate of 1.9 per 100 patients and 1.8 per 1000 patient-days. The 
patients most commonly affected were in Neonatal Intensive Care Unit 
(15.68%) and Medical-Surgical Intensive Care Unit (11.35%). Identifiable 
portals of entry included intravenous catheters (34), surgical site (6), geni- 
tourinary tract (4). respiratory tract (3) and intra-abdominal foci (3). but 
72.97% had no recognizable source. Aerobic Gram-positive were isolated in 
109 cases, aerobic Gram-negative in 73 cases, anaerobic bacteria in two cases 
and Cundida in 17 cases. There were polymicrohial bacteremia in 15 cases. 
The five most common microorganisms were S. epidennidis (18.41%). E.fue- 
calk (1 1.44%), E.  cloacae (10.95%), S. auras (8.96%; 27.78% were MRSA) and 
E.coli (7.96%). There was an outbreak of nosocomial septicemia due to 
E. cloacae in the Neonatal Intensive Care Unit in May. 
Conclusions: Coagulase-negative staphylococci were the prime etiologic 
agents, and catheter-related bacteremia was the prime source. The patients 
most commonly affected were those in critical areas. So, implementation of 
diaerent strategies will be necessary to reduce these infections, promoting 
more strict compliance with aseptic practices and a more controlled use of 
invasive procedures. 
[ P921 I Nosocomial bloodstream infections in an Iranian 
hospital, 1999-2000 
M. Rahbar, R. Grah-Agaji and S. Hashemi 
Urmia, IR 
Background and objectives: Nosocomial infections, especially bloodstream 
infections, are serious causes of morbidity and mortality. The aim of this study 
was to determine agents of nosocomial bacteremia in Imam Khomeini 
Hospital, a 300-bed University-ddiated teachug hospital in Urmia, West 
Azarbayjan, Iran. 
Methods: In this 2-year retrospective study, database of Microbiology 
Laboratory in Imam Khomeini Hospital was reviewed to idennfy patients 
who had bacteremia between 1 May 1999 and 31 March 2000. A nosocomial 
bloodstream infection was defined occurring in a clinically ill patient when 
one or more cultures of blood drawn at least 48 h after admission yielded a 
pathogenic organism. Isolation of potential slun contaminant (e.g. coagulase- 
negative staphylococci, Propinobacfm'um spp., diphtheroids and micrococci 
spp.) only from one specimen in asymptotic patient considered as contam- 
ination. 
Results: Our analysis revealed that 587 (9%) of 6492 admitted patients in 
various wards of Imam Khomeini Hospital had positive blood cultures. The 
kequency of isolated bacteria were as follows: coagulase-negative staphylo- 
cocci I l l  (18.9%) strain, Sfaphylococwuureus 104 (18.3%) strain, Pseudomo- 
nasaemginosa 104 (17.7%) strain, Enterobacter spp. 48 (8.2%) strain, 
Eschm'cbia coli 41 PA),  Streptocoauspneumonia 24 (4%) strain, Klebsielfapneu- 
mmia 19 (3.2%), Citerobartn spp. 19 (3.2%), other Gram-positive cocci 9 
(1.6%) strain, and other Gram-negative rods 20 (3.4%). The highest frequency 
of positive cultures was found in neonatal ward (aged <45 days). At th is  ward, 
there were 323 (55.1%) patients with positive blood cultures. The mean age in 
this group was 8.9days (SDiz5.9). Levels of antimicrobial resistance in 
S. aureus were: penicillin 82.6%, oxaciUin 40.7%. vancomycin 090, gentamycin 
36.5%, ciprofloxacin 0%. clindamycin 1.9%, cotrimoxale 7.6%, while resis- 
tance of coagulase-negative staphylococci against above-mentioned antihio- 
tics were 76.8, 61.5, 0, 25, 0, 3.7 and 6.4%, respectively. Resistance of 
l? aeuroginosa to aminoglycosides included gentamycin 32%, tobramycin 21%, 
and amikacin 21%. There was no resistance ofthis organism to ciprofloxacin. 
Resistance of Enterobacter spp. to commonly used antibiotics was as following: 
gentamycin 71.1%, tobramycin 56.5%, ciprofloxacin O??, cotrimoxazol8.6%, 
cefazobn 30.4%, cephalothin 65.2%, while resistance of E. coli to the pre- 
viously mentioned antibiotics were 22.5, 22.5, 0, 22.5, 12.5 and 42.5%, 
respectively. Finally, resistance of S. pneumonia to penicillin and erythromycin 
was 3 1.8 and 4%, respectively. 
Conclusion: Our study reveals that S. aureus, coagulase-negative staphylococci 
and l? aemginosa are most commonly isolated bacteria in nosocomial blood- 
stream infections in Imam Khomeini Hospital of Urmia. We have found 
increased rate ofGram-positive cocci in nosocomial bateremia. The reason for 
the high frequency of l? aeruginosa was due to patients in burning ward. 
1 P922 1 Haemophilus parainfluenzae: an uncommon case of 
primary septicemia in adult 
E. Trikka-Graphakos, N. Charalampaks and 2. Salem 
Athens, GR 
HuemopbiIusparuinzuenrar is a normal inhabitant of the upper respixatory tract 
that rarely causes serious infections in human beings. The most common 
infections described are epiglottitis, pneumonia, subacute endocarditis, 
meningitis, abscesses and urinary tract infections. W e  describe a case of 
primary septicemia caused by H.parainfueznae. A 49-year-old male was 
admitted to the internal medicine department with symptoms of fever, c M ,  
malease and melena. The physical examination of the respiratory, circulatory 
and urogenital uact did not reveal any pathological findings. Colonoscopy was 
negative, while gastroscopy showed pyloric ulcer without recent hemorrhage. 
Moderate leukocytosis, mild anemia and elevated ESR and CRP were 
present. Serologic tests for various bacteria and viruses were negative. Two 
sets of blood culture were positive for H. parainzuenzae biotype I, p-lactamase 
negative. A second effort to find the source of infection from the upper 
respiratory tract was negative. Trancesophagal echocardiogram for the 
diagnosis of possible endocarditis was also negative. Gradual decline of 
fever and improvement of the clinical picture was observed after treatment 
with a combination of ampicillin and gentamycin i.v. In conclusion, during 
last decade a few cases of H. paruinjluenaae endocarditis have been described 
but primary septicemia, without known infectious focus, is extremely 
rare. 
I P923 1 Clinical and laboratory predictive markers in septic 
patients 
A. Lekkou, D. Siagris, 0. Papageorgiou, H. €! Bassaris and C. A. Gogos 
Patras, GR 
Objectives: The aim ofthe present study was to estimate the prognostic value 
of certain early clinical and laboratory markers of outcome in severe sepsis. 
Patients and methods: A total of 139 patients (68 males, 71 females, mean age 
67.5 f 13.7years) with severe sepsis were studied. The etiology ofsepsis was: 
pneumonia (n= 50), pyelonephritis (n = 51), inua-abdominal infection 
(n=24), skin or joint infection ( n = l l )  and intrapelvic infection (n= 3). 
Twenty-nine patients were in septic shock. O n  admission, Simplified Acute 
Physiology I1 score (SAPS 11) and Glasgow Coma Scale (GCS) were used to 
access the severity of sepsis. Blood gases, white blood cells (WBC), liver and 
renal function tests, serum lactate levels and the presence of disseminated 
intravascud coagulation (DIC) on admission were determined as well. 
Logistic regression analysis was used for statistical evaluation. 
Results: Thirty-seven out of 139 patients (26.6%) died. Old age was a 
significant predictor of poor outcome (P< 0.05). The presence of septic 
shock (P< 0.0001) and renal dysfunction (P< 0.05) bad a negative influence 
on outcome in septic patients, while no sigtllficant Merences in liver 
chemistry, GCS and SAPS I1 were detected between survivors and non- 
suMvors. Metabolic acidosis (P< 0.005) and DIC (P< 0.05) were also found 
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to correlate w t h  poor outcome. On  the contrary baselme lactate levels, p 0 2  
and WBC &d not seem to predm the outcome 
Conclusion: As severe sepsis is respomlble for sigmticant mortahty, deterrm- 
nation of early prognoshc markers of outcome IS helpful to identify patlents at 
high risk Among the various basehe chmcal and laboratory parameters, age, 
sephc shock, renal fadure, DIC and metabohc acidosis seem to have a 
sipficant impact on  SUM^ 
/p9241 Severe sepsis and septic shock in critically ill 
patients 
J. J. Camarena, A. h e r o ,  R. Zaragoza, R. Gonzalez, A. Lopez 
and J. M. Nogueira 
Vblencia, E 
Objectives: To know the prevalence of severe sepsis and septic shock among 
patients with bacteremia in an intensive care unit. To know their climcal and 
microbiology characteristics and prognosis, and to idenhfy the risk factors for 
developing these forms of sepsis. 
Methods: During a 43-month study period (June 1995-January 1999), we 
have evaluated all clinical significant ICU-bacteremias of a teaching hospital 
and specially those associated with severe sepsis and septic shock. These terms 
were defined following consensus conference of the American College of 
Chest Physicians, 1992. Clinical and microbiological variables were recorded. 
A multivariate analysis was performed to assess the risk factors for developing 
severe sepsis and septic shock using SPSS package (9.0). 
Results: Among 166 intensive care bacteremias, 93 (56%) of them developed 
severe sepsis (n = 66) and septic shock (n = 27). The proportion ofnosocomial 
acquired bacteremia was 79.4%. The mean age of the patients, 57 years for 
men and 36years for women, was 63.4115.6years. An ultimately fatal 
underlying disease was present in 33.4% of the patients. The most fiequent 
focus of infection causing bacteremia were: respiratory tract (22.6%), intra- 
vascular catheter (17.2%). urinary tract (10.8%), and gastrointestinal tract 
(7.5%). In 28% of the cases, a source of bacteremia was not identified. One 
hundred and thirteen organisms were isolated, and four ofthem accounted for 
almost two-thirds of all isolates: Acynetobcicter baumanii 19.3%, CNS 18.5%, 
Escherichiuroli (14%), and Enterococmx spp. (12%). Global and related mortality 
in patients with septic shock were 74.1 and 25.9%, and in the group ofsevere 
sepsis were 54.5 and 24%. respectively. Multivariate analysis demonstrated that 
the communitarian origin of the bacteremia was the only risk factor for 
developing severe sepsis and septic shock. 
Conclusions: Severe sepsis and septic shock were the forms ofpresentation of 
more than a half of ICU-bacteremias. A s m a l l  number of organisms produced 
the majority of these cases. The communitarian origin of the bacteremia w a s  
the only predictive factor for developing these severe forms of sepsis. 
Eubacteriutn lentum and Staphylococcus 
epidermidis fatal septicemia in an adult 
C Papaefstathiou, M Zoumben, C Chnstopoulos, P Economopoulos 
and G. Kouppari 
Athens, GR 
Objectives: A case of Eubartenum Zentum and Staphylococnrs eprdermidis fatal 
sephcerma in an adult is presented 
Methods: Blood cultures were carried out by BACTEC system (Becton 
Dickmson) The idennficabon of E lentum was performed by Gram-stam, 
catalase test and API ID 32 A system (bioMerieux) The idenhficaaon of 
S epidermrdrs was carried ont by standard methods and API ID 32 Staph system 
(bioMerieux). Suscepnbhty tesfmg for S. epsdemidis was performed by duk 
Musion method. An 83-year-old woman with history of anola who was 
hvmg at nutsing home was adrmtted to the hospital because of feedmg 
mabhty. The c h c a l  exarmnahon revealed cachema, tachyarrythrma, swel- 
hngs of the lower h b s  and extensive decubitus ulcers ~fl sacral region 
and h~ps, and less extenswe m the back and lower h b s .  The blood pressure 
was 100/60 mmHg and the temperature 37 "C. The laboratory exammanon 
revealed WBCs 9800 /a  (90?? neutrophls), Ht 37.2%. glucose 187mg/dL 
and dehydration mth urea 98 mg/dL, creahnlne 1.1 mg/dL, Na 152 meq/l, 
K 3 7 meq/L. The ESR was 51 mm/l h Ampi&/sulbactam (1.5 g X 3, 
1 v.) was admstered to the pahent. On day 3, two sets of blood cultures 
because of fever at 38OC were &en The therapy was replaced mth 
tazobactadpiperacdhn (4.5 g x 3, 1.v) S epiderrnrdrr was lsolated h m  four 
blood cultures, whle E lenturn &om two anaerobic cultures. S eptdermrdrs 
isolate was resistant to oxaullin, clindamycin, erythromycin, tetracycline, 
chloramphenicol and susceptible to ciprofloxacin, gentamicin, trimetho- 
prime/sulfamethoxazole and rifampicin. Ciprofloxacin (400mg x 2, i.v.) 
after the results of cultures was added. The patient on day 10 died because 
of septic shock. 
Conclusion: The decubitus ulcers considered as a probable source of bacter- 
emia, which is usually polymirrobial with participation of anaerobic micro- 
organism. E.  lentum is an unusual cause of infections. 
lp926/ Polymicrobial bacteremia in patients in a tertiary 
care hospital 
A. Samet, J. Komamicka, M. Bronk and L. Naumiuk 
Gdansk, PL 
Objectives: To establish the prevalence of polymicrobial bacteremia (pb) in 
patients of Public Hospital No. 1 in Gdansk. 
Methods: We analyzed 7100 blood cultures, h m  January to November 2001 
in two automated systems: BacT/Alert (Organon Tecknika) and Vital (bio- 
MCrieux). Blood cultures with more than one isolate, and with different 
isolates in blood samples drawn within 48 h, were recognized as polymicrobial 
bacteremia. We omitted coagulase-negative staphylococci with no obvious 
clinical importance. 
Results: A total of 976 (14%) blood cultures were positive and in 83 we 
yielded more than one isolate. After analysis, we found 53 episodes of pb. 
There were 47 bacteremia with two different isolates, three with three isolates 
and three with four. Most ofthe pb were noted in hematology (32%) and ICU 
(22.6%). In surgery, eight were found (15%) and in the internal medicine nine 
(17%) - five of them from kidney transplant patients. Predominant pathogens 
were as follows: S. epidermidis: 29 isolates (25%); enterococci: 18 (15.6%); 
Pamginosa: 13 (11.3%); and E. coli: 10 (8.7%). 
Conclusion: We observed polym~robial bacreremia in most serious patients 
with many risk factors (immunosuppression, mechanical venalation, vesical 
and central vascular catheters). They were hospitalized for a long time and 
often experienced multiple bacteremia, both poly- and monomicrobid. We 
consider that frequent blood cultures enable accurate diagnosis and optimal 
treatment in these patients. 
wl Outcome in critically ill patients with bacteremia 
involving Klebsiella species: results of a matched cohort 
study 
S. I. Blot, K. H. Vandewoude and E A. Colardyn 
Ghent, B 
Objectives: To evaluate the clinical impact of N e b s i e h  bacteremia in critically 
ill patients admitted during a 9-year period. 
Methods: A matched cohort study was performed. All ICU patients with 
K. barkremia were defined as cases. Matching of the control patients (1 : 2 
ratio) was done on the basis ofthe APACHE I1 system: an equal APACHE I1 
score (fl point) and admission diagnosis. As expected mortality can be 
derived from the severity of the disease scoring system, t h i s  matching 
procedure results in an equal expected mortality for cases (n = 50) and controls 
(n = 100). 
Results Following the matching procedure, cases and controls had nearly 
equal APACHE I1 scores (respectively, 21 f 8.1 vs. 21 f7 .9 ;  P =  0.903) and 
related expected mortality (respectively, 36 f 26.4% vs. 36 f 26.5%; 
P=O.979). Patients with K. bacteremia had more acute renal failure (30% 
vs. 14%; P =  0.019) and hemodynamic instability (8P? vs. 49%; P <  0.001). 
They had a longer ICU stay (38 131.6 vs. 11 f 16.7days; P <  0.001) and a 
longer ventilator dependence (28 i 25.6 vs. 8 5 13.0 days; P < 0.001). There 
was no si&icant dxerence between cases and controls in age (respectively, 
52 f 15.9 vs. 56 & 18.6; P =  0.225) and prevalence of acute respiratory failure 
(88% vs. 79%; P =  0.176). In-hospital mortality rates for cases and controls 
were nearly equal (respectively, 36% vs. 37%; P =  0.905). Logistic regression 
analysis demonstrated acute rend failure (OR: 3.7, 95% CI: 1.5-9.0; 
P=0.004) and increasing age (OR 1.02, 95% CI: 1.00-1.05; P=0.048) 
to be independent predictors of mortaliq. 
Conclusions: Afeer accurate adjustment for severity of underlying disease and 
acute illness, no difference in mortality was found between ICU patients with 
K. bacferemia (36%) and their matched control subjects (37%). Bacteremia 
involving KIebsiella species does not adversely affect the outcome in critically 
ill patients. 
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(p92s1 The frequency of isolation and resistance patterns 
of microorganisms from 5637 blood cultures 
v. Mirovic 
&&pde, W 
Objectives: To analyze the frequency of isolation and resistance patterns of 
microorganisms isolated fkom 5637 blood cultures. 
Methods: A total of 5637 blood cultures were processed by BacTIAlert 
system (Organon Teknika) during 199S1999. The isolates were idenhtied by 
conventional methods. Susceptibdity testing was pedormed by Kirby-Bauer 
disk-di&sion method following NCCLS guidelines. For the isolates of 
enterococci that were resistant or intermediate to vancomycin by disk- 
diffusion and/or agar-screen test were determined - idubitory con- 
centration for vancomycin and teicoplanin by broth-dilution method. For the 
detection of extended-spectrum fi-lactamase (ESBLs), we used the double- 
disk synergy test, based on synergy between 8-lactamase inhibitor clavulanate 
and cefotaxime, ceftriaksone, and ceftazidime. 
Results: The most kequently isolated microorganisms among a total of 1743 
isolates &om 1278 patientdepisodes were: coagulase-negative staphylococci 
Miscellaneous nosocomial infections 
(CNS), 536 isolates f?om 405 patients (31.7%); Sfuphylocuccusaureus (Sa), 
289/187 (14.6%); Enferocoaus spp., 171/128 (10.0%); AcinetobartPt spp., 
115/78 (6.1%); Corynebacm'um spp.. 69/63 (4.9%); Mebsiella spp., 85/59 
(4.6%); Cundida spp., 86/57 (4.5%); Escherichiacoli, 62/48 (3.7%); Pseudorno- 
nusaetuginosa, 49/32 (2.5%); and Stqtocoumviriduns group 42/29 (2.3%). 
Gram-positive bacteria were isolated more kequently (66.4%) than 
Gram-negative bacteria (24.8%). Among CNS (416) and Sa (199), there 
were no strains resistant to vancomycin, but 76.2% of CNS and 80.5% 
of Sa were resistant to oxacillin. High level of aminoglycoside resistance 
among enterococci (69) was: 65.2% to gentamicin, 50.7% to 
streptomycin, and 36.2% to both of the drugs. Only one strain among 
enterococci was resistant to vancomycin (Enferococcus&.zium, VanA pheno- 
type). Among Enferobucteriaceae (128) and Acinetobucfer spp. (85). no strains 
were found resistant to imipenem, but the rate of resistance among Pseudo- 
rnonm spp. (48) was 39.6%. The rate of ESBLs producers among 46 Mebsiella 
spp. strains was 84.8%. All Gram-negative aerobic bacilli, except E.coZi, 
expressed high frequency of resistance to ceftriaxone, aminoglycosides, 
and ciprofloxacin. 
Conclusions: The multiresistaut 'problem' bacteria dominated as the agent of 
bacteremia in our hospital that reflected ecosystem of the hospital. 
vl Infections after open-heart surgery 
C. Ezpeleta, E. GAmez, C. Busto, I. Atutxa, J. Zuazo, J. Unzaga and 
R. Cisterna 
Bilbuo. E 
Objective: The aim of this study is to know the rates of nosocomial infection 
(NI) in patients operated on open-heart surgery and to compare with those of 
National Nosocomial Infection Surveillance (NNIS) 
Patients and methods: The 222 patients operated on open-heart surgery in 
the hospital of Basurto between January & December 2000 were included. 
Preoperative protocol regarding infection control includes: shower with 4% 
chlrohexidine soap the night before surgery and repeated the day of surgery; 
and shave just before surgery. Antibiotic prophylaxis: cefuroxjme 1.5 g. i.v. 8 h 
beginning 30 min before surgery until vascular catheters are withdrawal. The 
infection-control team makes infection s u r v h c e .  All the patients under- 
going Open-heart surgery are prospectively studied since the day they are 
operated untd the end of the episode. A computer-based surveillance system, 
INOZ, designed for the incidence studies of NI is used during admission and 
continued 1 year after discharge. CDC definitions ofnosocomial infection are 
used. AU the nosocomial infections not only surgical-site infections (SSI) are 
recorded. NNIS SSI-risk score is used and results are compared with those 
h m  "IS reports. 
Results: Age and sex: 147 (66.2%) men, mean age 6 6 . 6 ~ ~ .  Mean pre- 
operative stay in the hospital 6.8days (SD 9.5). NNIS score 0, 7 
patients; score 1, 156 patients; score 2, 59 patients; and score 3, 0 patients. 
Infection and admission: nine patients (three urinary tract, three 
respiratory, one skin and two endocarditis). Nosoeonlid infections: 55 
patients acquired 68 NI, 13 of them were SSI. Surgical site infection: three 
incisional superficial, 5 deep incisional and 5 organ space. NNISS score 0, 0% 
score 1, 5.8%, score 2, 6.8%. Microorganisms: S. aureus three, CNS three, 
polimicrobial two, S. marcescens one, Propionibuctm'urn one. Urinary tract 
infections (UTI): 13 patients, nine cases in patients undergoing valvular 
replacement. E. cofi (4) and E.fnecafis (4) were the most fkequent etiological 
agents. Respiratory infections: 22 patients. Pneumonia: five cases. Bacter- 
emia: seven cases 1 catheter related, 3 secondary to surgical site infection, one 
secondary to pneumonia and two primary bacteremias. Microorganism: 
S. rnanescem, Z? anuginosa, S. epidemtidis, S.  aureuz, Cundida spp., E.  cloacae and 
E .  coli. 
Conclusions: Incidence of surgical infection is lower in patients with valvular 
replacement than in CABG. Comparing our data of SS1 with those of NNIS 
report the results are below the rates of percentile 90. 
IP930/ Risk factors for wound infection in oral-cavity 
cancer surgery with neck dissection 
J. Palomino, M. Moha,  A. Garcia-Perla, M. Jimenez, P. Infante and 
J. Pachon 
Swille, E 
Objective: Information about the wound infection (WI) in oral-cavity cancer 
surgery is limited. The goal of t b  prospective study was to determine risk 
factors predisposing to WI among patients with oral-cavity cancer who 
underwent surgical procedure with neck dissection. 
Methods: Eighty-one consecutive patients (77.8% male, 22.2% female, mean 
age 60.43 f 12.37yean) with oral-cavity cancer who underwent surgery with 
neck dissection were prospectively evaluated in the 1999-2000 period. In all 
cases, surgery was pedormed with curative purpose. Antimicrobial prophy- 
laxis was carried out with amoxicillin-clavulanate. WI was defined as the 
presence ofpudent  drainage &om the wound. For each patient, we look after 
the link between WI and several variables. Statistical analysis was made using 
x"- and Mann-Whitney tests. 
Resulb: Thirty-five WI were recorded during the study period, resulting in 
an overall rate of 43.2%. Univariate analysis investigating the link between WI 
and possible risk factors revealed the following results: age (P=O.75), sex 
(P=  0.13), chronic underlying disease (P= 0.36), current smoker (P= 0.02). 
chronic p u k n o ~ r y  disease (P=  0.60). chronic alcoholism (P= 0.33), chronic 
hepatic disease ( P =  0.41), diabetes mellitus ( P =  0.39), intraoperative 
corticotherapy (P=O.14), ASA score (P=O.23), T stage (P=O.O02), N 
stage (P=  0.60), postoperative corticotherapy (P=  0.61). NNIS index 
(P< O.OOOl), lymphocyte count (0.33), duration of total preoperative stay 
(P=O.11), and duration of surgical procedure (P< O.ooOl).%. Patients with 
WI had a median postoperative hospital stay of 28.48 f 13.12 days compared 
with 10.63 f 5.08days for whose without WI (P<O.OOOl) .  
Conclusion: The incidence of WI in oral cavity cancer surgery with neck 
dissection is very high. The most closely related factors to Wi are advanced 
T stage, NNIS index and duration of surgical procedure. WI signhcantly 
increases the length of hospital stay. 
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1 P931 I Surgical site infections in a carciiothoracic surgery 
ward: incidence and risk factors 
R. Cocconi, R. Lumini, R. Fabro, M. Prezza and 0. Dal Bo 
Udine, I 
Objectives: To determine median stemotomy-site infection rate and safe- 
nectomy site infection rate in a Cardiothoracic Surgery Ward, we observed 
patients submitted to coronary artery bypass graft surgery (CABG) and 
patients submitted to cardiac valves interventions during a five month 
surveillance. 
Methods: Patients admitted to Cardiothoracic Surgery Ward of Azienda 
Ospedaliera S. Maria della Misericordia in Udine, Italy - from 15th August 
1999-15th January 2000 and submitted to surgical treatment, were observed 
accordlng to these criteria: procedures were codified with specific codes 
(between 35.20 and 35.2 8 -for CABG- or between 36.10 and 36.19 -for 
cardiac valves - ofICD-9-cm classification); procedures were executed during 
a single access to the operating room; procedures involved at least one skin 
incision; wounds were closed by primam intentionem (at the end of the 
intervention, before leaving the operating room). Patients undergoing more 
than one procedure in different operating rooms were excluded. Patients 
under surveillance were followed during their length of stay in hospital and 
evaluated about surgical site infection. Surveillance continued after discharge 
during programmed outpatient controls were used CDC definidons of 
surgical site infections. 
Results: Were collected 177 observation forms, whose 98 were patients 
undergoing CABG, 60 were patients undergoing cardiac valves interventions 
and 19 were patients undergoing both types of intervention in the same 
session. The incidence of surgical site mfertion w a s  5.6% as a whole; 8.2% for 
CABG (4.1% in sternotomy site and 4.1% in safenectomy site), 3.3% for 
cardiac valves interventions, none for both interventions associated. No 
deaths after wound infections were observed. Variables associated with 
infection by univariate analysis (P<O.Ol) were: diabetes (OR 4.05; 95% 
CI between 1.2 and 16.5); obesity (OR 9.3; 95% CI between 1.6 and 25.03). 
Conclusions: Rates observed are higher then NNIS System and represent a 
significant complication in our hospital. This fact induces us implementing a 
continuos surveillance system in Cardiothoracic Surgical Ward. 
] P933 1 Ceftazidime in patients with nosocomial 
pneumonia and septicemia: results of a German surveillance 
study 
F Vogel and K. F Bodmann 
Hofieim, Hildeshnm, D 
Objectives: LLe-threateruog dechons ltke nosocomd pneumotlla and 
sepncemia r e q m  -&te anhbiohc treatment. I n t e m h o d  gUldeh3 
recommend miad therapy mth an anu-pseudornonal broad-spectrum beta- 
lactam alone or in combmanon with an am*noglycoside or a fluoroqumdone. 
Cefcaakme IS one of the drug of choice. It has been successfully meshgated 
UI numerous c h c a l  &. Besides the favorable tn vltro data against the most 
kequent pathogens includmg Pseudomonas aeruginosu, it is important to survey 
and document the c h d  efficacy in pahents under day to day fauMe 
condmons 111 hospltal. 
Methods: The present reaospecnve mulacenter survehnce study compmed 
581 pahents mth nosocomd pneumoma and 168 septicemia pahents, 
recruited b m  February 2000 hll February 2001 in German hospitals. 
S q - f o u r  percent (pneumoma) and 76% (sepacem) under mtemve care 
were m e c h c d y  ventdated (31, 43%, respecavely). 
Resuk Meman duraaon of ceftau&me therapy was 9days. mtdian 
dosage 6g. Thuty-three percent of pneumoma paaents and 1% of 
sephcerma pahents recewed ceftavdune ahne, combmaaon therapy was 
used, rmunly mth ammoglycosides The most fkquently lsolated pathogens 
were Pseudomonas mginom (45%) followed by other G-negative 
pathogens (17%), E .  colr (10%). S. a w s  (14%). other Gram-pmuve patho- 
gens (11%) and S. maltophilia (3%). The overall clmlcal-success rate at the end 
of therapy was 85% (47% cure, 38% Improvement) ~ IL  pneumoma and 76% 
(44% cure and 32% Improvement) III sephcema. O v e d  tolerabdity was very 
good. 
Conclusion: The study confirms the l g h  &caq and good tolerablkty of 
cehuhme  UI hospitabed paaents mth n o s o c o d  pneumoma and sepe- 
cema under day to day clmlcal routine condmons. 
] P932 I Microbiology of nosocomial and community- 
acquired spontaneous bacterial peritonitis 
E Bert, M. Andreu, F. Durand, E Degos, J. Galdbart, R. Moreau, 
C. Branger, N. Lambert and D. Valla 
Clichy, F 
Objectives: Ascitic fluid infection is a fiequent complication in cirrhotic 
patients with ascites. The aim ofthe study was to compare the microbiological 
characteristics of nosocomial and community-acquired episodes of sponta- 
neous bacterial peritonitis. 
Methods: We retrospectively reviewed 95 consecutive episodes of ascitic 
fluid infection that occurred in 75 patients. Seventy episodes were bacter- 
iologically documented (45 spontaneous bacterial peritonitis and 25 bacter- 
ascites). F&y-three (55.8%) were nosocomial and 42 (44.2%) were 
community-acquired. 
Results: The 78 isolated pathogens included 40 Gram-positive cocci (34 
streptococci/enterococci, 6 Staphylomms aurew), 35 Gram-negative bacilli 
(including 23 Escherichiu colr), 2 Gram-positive cocci (one Lisfetia monocyto- 
genes, one Rofhiu denfocariosa) and one yeast. There was no difference between 
spontaneous bacterial peritonitis and bacterascites regarding flora. Strepto- 
cocci were more fkequent in community-acquired episodes (53.8%) than in 
nosocomial episodes (33.3%). Gram-negative bacilli were sigdicantly more 
frequent in nosocomial episodes than in community-acquired episodes 
(56.4% vs. 33.3%, P < 0.05). The patients receiving norfloxacin prophylaxis 
had more fiequendy Gram-positive organism (68.7% vs. 51%) than did the 
patients without prophylaxis, but this difference did not reach statistical 
significance. Nosocomial isolates were sigmficantly more resistant to amox- 
icillin-chvulanate (48.7% vs. 18.4%. P<O.OI)  and cefotaxime (33.3% vs. 
13.2”/., P<0.05) than community isolates, but there was no difference 
regarding resistance to ciprofloxacin. 
Condusions: There are sigmticant differences in microbial epidemiology 
between nosocomial and community-acquired episodes of spontaneous 
bacterial peritonitis. The empirical treatment strategy should differ 
according to whether the infection is acquired in the hospital or in the 
community. 
Fl Escherichia fergusonii strains isolated from clinical 
specimens 
E Durakoglu, A Basustaoglu and H Aydogan 
Tirana, AL., Ankara, TR 
Objective: The a m  of thrs study is to descnbe two strams of Ederichia 
fergusonii lsolated fiom the pus of an mfected surgcal wound of a 31-year-old 
woman operated at the Trauma Department of Central M h ~ u y  Hospltd- 
Tirana, Albania. for ‘Pseudoarthrosis mns’. The presented data lndtcates the 
pathogemc pOtenhd of Eschmchia fergusonii, whch 1s a very rarely isolated 
agent. 
Materials and methods SIX days aher surg~cal treatment, slgns of an evldent 
wound lnfechon were present and h m  two pus specimens, taken mth  a 4- 
day m t e d  E fiusonii was isolated Convenaod biochemcal tests were 
performed These strams were transported to Department of Mcrobiology, 
Gulhane Mhmy MecLcal Academy for confirmahon. By usmg convenhonal 
methods and API ID 32GN strips confrmed as E.ferguusonu. All the MIC 
determmahons of these strams were performed at the same department by 
us% E-test strips. 
Results: Both strams demonsmted the morphologxal, cultural and biochem- 
ical charactenshcs of the famdy Enterobacteriaceae: also mamfested blo- 
chemcal features of the genus Eschenchia. They are rllsunguished fiom E coli 
by theu abhty to ferment adomtol and cellobiose and fdure to ferment 
sorbitol The three above-menhoned characterlshcs, combmed mth posiave 
test for orxuthme decarboxylase and negahve tests for lactose, sucrose, d inose  
and mehbiose fermentahon are the most mportant features for theidenclfica- 
aon of isolated s m s  as Erchenchia fergucanzi. It nught be stressed that both 
strams showed the same b i o c h c a l  prohle and also the same anttbionc 
suscephbhy pattern bemg suscephble to aqxcilkn, cefzoh ,  a m o x l c b  
clavula~~c a id, nprofloxaan, lwofloxacm, armkaan, cefotanme, nehhcin,  
impenem, meropenem, ceftnaxone, mtrofurantoin, mezlodh,  gentammn, 
and ceftannude. 
Conclusion: Little is known about c h c a l  ngntficance of some very rare 
isolahon in pahents mth  sepsls, urinary tract infechons or k h e a  suggest its 
pathogemc potenhal. The data gwen in thts study clearly mdtcate the role 
played by E fergusonii as ehologc agent in a surgcal wound lnfechon 
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F] Monotherapy vs. combination therapy in 
Pseudomonas aeruginosa bacteremias: influence on the 
outcome 
M. Aldntara, J. Gomez, B. Mamnez, J. Ruiz, E. Simarm, J. A. Herrem, 
M. Canteras and M. ValdPs 
Murcia, E 
Background: Infections caused by P aemginosa are very aggressive and the 
development of resistance to antimicrobials during the treatment is common. 
To overcome these problems many authors recommend the combined use of 
several active antibiotics. 
Objective: To compare the eficacy of monotherapy (M) and combination (C) 
therapy in the treatment of PAB. 
Methods: During a 7-year period, 211 consecutive cases of PAB were 
included. Microbiologic studies were performed with standard methods. 
Epidemiological factors, baseline disease and clinical parameters were 
recorded. The decision of treating and the choice of antibiotic was not 
randomized and taken depending on the epidemiological and clinical data. 
We excluded 21 patients who did not receive any active antimicrobial against 
Paeruginosa. Minimum follow-up was 1 month after the end of antimicrobial 
treatment. Cure was considered when there were no relapses in the month 
after completing treatment or related death is (defined as occurring while the 
infection was active). Comparison between groups was done with de Chi- 
square test. 
Reruk: Patients who received M were 132 (69%), and 58 (31%) different 
combinations of antibiotics. Antibiotics used as M were ceftazidime (52, 
3 9 4 ,  cipmfloxacin (31, 23%), imipenem (24, 18%), piperacillin/tazobactam 
(21, 16%) aminoghcosides (4, 3%). No differences in mortality or relapse rate 
were found depending on the choice of antibiotics. In group C, ceftacidime 
plus amikacine were mainly used (32.58%). No sigdcant Werences for sex, 
age, nosocomial acquisition, length of stay, origin, previous procedures, or 
presence of complications were found between patients receiving unique or 
Fungi and fungal infections 
several antimicrobials. No statistically sigdcant ditterences in the cure rate 
(M 80, 60%; C 33,57%), relapses (M 19, 14%; C 5,Yh) and related deaths 
(M 34.26%; C 20, 34%). 
Conclusions: In our study, M and C therapy have a sirmlar effectiveness in the 
treatment of PAB. 
(p9361 serratia marcescens nososcomiat infections: 
epidemic investigation using pulsed field gel electrophoresis 
A. Dubouix, C. Roques, S. Malavaud, S. Daude, C. Segonds and 
N. Marty 
T O U ~ O U S ~ ,  F 
Between February and December 1999.30 st ra ios  of Senatia marcscens where 
isolated from 30 patients throughout Rangueil hospital in Toulouse, France 
which is a large 1000-bed teaching hospital. Bacterial isolates where identified 
within current phenotypic methods and antimicrobial susceptibility was 
tested. Because stra in  typing was necessary, a specific genotyping tool based 
on pulsed field gel electrophoresis (PFGE) was carried out. Only two isolates 
out of 30 had the same clonal origin. This result indicated no cross- 
transmission between infected patients. This typing method was used once 
again during another outbreak of S. mamscens infections occurring in the 
neurosurgery department during 2001 (April-December). Among 46 clinical 
strains isolated from 7 patients, a genetic link was demonstrated for 6 patients. 
The outbreak investigation identified the patient responsible for introducing 
the outbreak strain: he was hospitalized at first from November 2000 to 
February 2001, and then h m  April to September 2001. The antibiomicrobial 
susceptibility revealed a resistance evolution of his isolates which was also 
found for all clinical isolates through the episode (i.e. gentamicin resistance). 
The implementation ofcontrol measures jugulated the outbreak on December 
2001. This recent episode allowed us to validate the PFGE method as a useful 
epidemiological tool. 
Encapsulation of Cryptococcus neoformans inhibits 
maturation and activation of human dendritic cells 
D. Pietrella, P. Lupo, R. Mazzolla and A. Vecchiarelli 
Pemgia, I 
Objective: The capacity of dendritic cells (DC) to function as antigen 
presenting cells is unrivalled. They play a pivotal role in initiating T-cell 
response to microbial antigens. In this study we evaluated the ability of 
encapsulated and acapsular strains of Cryptocouus neofomans to activate DC 
derived from monocytes stimulated with GM-CSF and IL4. We observed 
profound differences in the response of DC to encapsulated and acapsular 
C. neoformans strains. 
Methods: Human DC were obtained from monocytes cultured in the 
presence of GM-CSF plus IL-4. Two strains of C. neoformans (C. neofmans 
var. neoformans serotype D ATCC B3501 and its parental acapsular strain, 
CAP67) were used to samulate DC. 
Results: The acapsular strain was easily phagocytosed by immature DC and 
the process induced several molecular markers characteristic of mature DC 
such as MHC Class I, Class 11, CD40. In contrast, there was no up-regulation 
ofMHC Class I and Class I1 molecules by exposing DC to encapsulated cells. 
However, the addition of monoclonal antibody to capsular material (glucur- 
onoxylomannan) to encapsulated strain promoted ingestion of C. neofomans 
by DC and facilitated APC maturation by enhancing MHC Class 11, CD40 
and CD86 expression through a process mediated by engagement of Fc-y RII 
(CD32) and Fc-y R 111 (CD16). This event led to optimal autologous T-cell 
activation and Werentiation as documented by enhancement of lympho- 
proliferation and IFN-y production. 
Conclusions: Encapsulation of C. neoformans has an inhibitory effect on DC 
activation and maturation. This event could have profound implications given 
the preeminent role of DC in initiating the immune response against 
pathogens. 
lp938 A Cryptococcus luteolus strain isolated from 
endoscopic sinus surgery specimens of an apparently 
normal host 
A. S. Kantarcioglu, M. Yener, A. Yucel and T. Altug 
Istanbul, TR 
Almost all pathogenic fungi produce air-borne conidia and via inhalation, 
they can enter and adhere to the mucosal surfaces of the nose and sinuses. The 
host immune status and the virulence of fungus are the major factors in 
determining the pathogenic entity. In recent years, fungal infections of the 
sinuses in both their invasive and non invasive forms appear to be increasingly 
common and normally saprophytic fungi may invade patients with underlying 
disease. We report a Cryptoroccus lureofus strain isolated &om endoscopic sinus 
surgery specimen of a patient without any underlying disease. A 45-year-old 
male patient, being neither diabetic nor human immunodeficiency virus 
positive, without underlying disease, presented with a chronic sinusitis hstory. 
There was no history of previous surgery, facial trauma, distant navel, or drug 
abuse. The tissue biopsy specimen obtained at functional endoscopic sinus 
surgery (FESS) was examined. In direct examination of microscopic slides of 
the specimen stained with Gram, Ehrlich-Ziehl-Neelsen, methylene blue, 
Giemsa techniques revealed many thinly encapsulated globose to elliptic yeast 
cells. Aseptically cut pieces of specimen were inoculated onto Sabouraud 
glucose agar, brain heart infusion agar, cooked sheep's blood agar, corn meal 
agar and Guizotia ubyssinica extract agar media. The plates were incubated at 
35, 30, and 25 "C. After 4 days cultures showed pink-colored yeast-like 
colonies grown just around the embedded pieces of tissue on all plates. 
The fungus was isolated as a single microorganism from all pieces and was 
identified as C. lure& using classical mycological and biochemical methods. 
Owing to the patient's immunosuppressed state, inhaled fungus elements even 
apathogenic ones, can easily spread beyond the sinus region and may 
eventually lead to fulminate disease. However, in the present case, a normally 
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apathogenic fungi, Cryptorom luteolus was isolated &om FESS specimen of 
immunocompetent patient who has radiologically confirmed sinusitis with 
intractable recurrent symptoms despite the adequate treatment for bacte- 
riological sinusitis. The fungi spectrum which have caused fungal sinusitis is 
broad. To our knowledge, C. luteolus have not previously been reported in 
human infection in the world. 
rp939) Serial isolates from a clinical Case of recurrent 
Cyprococcosis exhibit differential virulence in mice 
E. Blasi, R. Barluzzi, R .  Negha, G. Cardinali, D. Francisci, E Bistoni, 
A. Mucci and E Baldelli 
Modena, Pmgia, I 
Aim: The present work was aimed at comparing serial isolates of Cryptococcus 
neojortnans (Cn) obtained fkom a clinical case of recurrent meningoencepha- 
litis for virulence in mice. 
Background Recently, we provided evidence of ‘microevolution’ in a clinical 
case of recurrent Cn meningoencephalitis (EurJ Clin Microbiol Infect Dis, 
20: 535-43, 2001). When comparing for genotypic and phenotypic char- 
acteristics, three serial isolates, obtained fi-om an AIDS patient during a 3-year 
period, it was shown that the same microorganism persisted throughout this 
period, yet over time, it acquired resistance to phagocytic cells and capacity to 
interfere with cytokine response (impairnlent of IL-12 and enhancement of 
IL-10 production). Antifungal drug resistance remained unchanged in the 
three isolates, whereas extracellular eruynie production was enhanced in the 
relapse isolate with respect to the others. 
Methods: The clinical isolates, 1525 and 1526 (blood and cerebrospinal fluid 
isolates fiom the first episode) and 1782 (cerebrospinal fluid isolate &om the 
relapse), were inoculated intranasally (in.) or intracerebrally (i.c.) in adult 
naive mice and in iron overloaded mice (FeDextran 50mg/kg, lox).  The 
outcome of the infections was evaluated as organ fungal load (cfu assay), 
cytokme content (ELISA) in tissues, mean survival time (MST) and percent 
survivors. 
Results: The results 0fi.n. dection showed that the 1525 was the most lethal 
isolate, being the phenomenon associated with a rapid and irreversible 
colonization of the lung. Differently, both 1526 and 1782 colonized the 
lung transiently and to a similar extent; yet, 1782 exhibited the most marked 
neurotropism. This was confirmed by the i.c. infection model, where 1782 
caused the most rapid brain colonization and the lowest MSTwith respect to 
the other isolates. Immune system disturbance by iron over-load exacerbated 
the outcome of all the infections to a similar extent. Cytokine content assays in 
tissues revealed that IFNg was produced in a fungal load-dependent manner, 
IL-12 was down-regulatedby the infection especially in iron overloaded mice. 
Conclusion: The ‘microevolution’ phenomenon, recently documented in 
serial isolates of Cn &om an AIDS patient, allows fulfillment of phenotypes 
with enhanced virulence in mice, thus emphasizing the role of Cn bio- 
molecular plasticity in pathogen persistence/reactivation and clinical relapse. 
Acknowledgments: Work supported by the IX Progetto AIDS-ISS, 1998 
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1 P940 1 Adhesion of AspeqNus spp. to biomaterials 
A Gonplves Rodngues, S Sdva, M. Vale, R Araqo and C. Pma-Vaz 
Porto, P 
Introduction: The incidence of deep seated aspergdlosis IS mcreasmgly 
growng in crincal care pahents, w t h  most of the pathogemc mechamsms 
remanmg yet unknown Adherence to hquid hydrocarbons is considered an 
mdxect method to assess mcrob?al cell surfice hydrophobinty (CSH), whzch 
is beheved to have an important role m the adherence of pathogemc 
mcroorgamsms to host cell or forelgn surfaces, namely plasac 
Objective: To determme the potenaal abhty ofchrucal d a t e s  ofhpergdus 
to adhere and colonwe the surface of m e d d  m d w e h g  devlces, namely 
plasac and shcon rubber. 
Materials and methods: Both resang and germmated spores (5 and 11 days 
old) of c h c a l  lsolates ofA firmigatus (three strms), A niger (two stram) and 
A JEavur (two s m s )  were assayed (in an assay for hydrocarbon adheslon 1) for 
the capacity to adhere to n-hexadecane and xylene The adheslon to shcon 
(shcon od) w a s  assayed accordmg to a prevlously developed assay 2. All tests 
were run m triphcate. 
Rerub: Non-germmated spores showed a slgmficant adheslon to n-hex- 
adecane and xylene and s&ly to shcon, wluch d d  not change slgtllftcandy 
with age. However, following germination and initial hphal growth, both 
CSH and silicon adhesion increased significantly, in all tested strains. 
Conclusions: Aspergillus shows a promoted adhesion to biomaterials of plastic 
nature as well as silicon materials, bke vascular catheters or peritoneal shunts, 
particularly following hyphae formation. Such a fact may be evoked to help to 
explain colonization and infection of medical indwelling devices like those 
seen in critical care patients. 
References 
1 .  Van derMei e ta .  Cum M i d i 0 1  23:337-341, 1991 
’2. Rodrigues et d. Mycws 44(S1):24, 2001 
w) lnvasiw aspergillosis (IA) in the critically ill: is there 
a relationship between predisposing risk factors (RF) and 
outcome? 
K. H. Vandewoude, S. I. Blot, W. Temmerman and E A. Colardyn 
Ghent, B 
Objectives: To investigate outcome in ICU patients with IA. A cornpariron 
was performed between patients with specific (n = 17) versus nonspecific RF 
Methods: Retrospective cohort study (711997-12/2OOO). IA was diagnosed 
when proven on histology or in case of an abnormal chest radiography or 
CT thorax with predisposing specific RF or positive findings (microscopy 
or culture) on a bronchoalveolar lavage. Haematological mahgnancy, 
neutropenia and immunosuppressive thetapy were considered as specific 
RF for the acquisition of IA. Previous lung damage (COPD, viral pneumonia, 
ARDS), liver failure, bums, severe bacterial infection and malnutrition were 
categorized as nonspecific RF in previously immunocompetent patients. 
Results: All patients with IA were mechanically ventilated. Patients with 
specific RF had higher APACHE I1 scores (31 f 7.6 vs. 22 f 8.4; P= 0.003) 
and related expected mortality (69 f 21.3% vs. 44 f 26.8%; P =  0.009). No 
Uerence between patients with specific versus nonspecific RF were found in 
age (53 f 15.3 vs. 56 f 13.4 years; P= 0.780), acute renal failure (respectively, 
53% vs. 42%; P =  0.360), hemodynamic instability (respectively, 8Wo vs. 86% 
P= 0.778), length of ICU stay prior to the first positive culture (respectively, 
7 f 7.6 vs. 6 f 6.2 days; P =  0.506). total length of ICU stay (respectively, 
23 f 22.4 vs. 26 & 24.0 days; P= 0.638), length of vendlator dependence 
prior to the first positive culture (respectively, 6 f 7.3 vs. 6 f 6.4days; 
P= 0.975) and total length of ventilator dependence (respectively, 19 f 17.4 
vs. 24zt22.6days; P=O.360). Ninety-four percent of the patients with 
specific RF received appropriate antifbngal therapy versus 86% of patients 
with nonspecific RF ( P =  0.401). For the outcome comparison, no difference 
was found between patients with specific and nonspecific RF in t4-days 
mortality (respectively, 71% vs. 57%; P= 0.393), 28-days mortality (respec- 
tively, 8 2 % ~ ~ .  67% P =  0.275) and in-hospital mortality (respectively, 82% vs. 
71% P= 0.431). In alogistic regression analysis novariables were found to be 
independently associated with mortality This is probably owing to the smal l  
sample size. 
Conclusion: No Werence in mortality was found between patients with 
specific and nonspecific RF for the acquisition of IA. The absence of an 
association between RF for IA and death could be owing to insufficient study 
power. Furthermore, data are difficult to interpret because of the hetero- 
geneous nature of nonspecific RF for LA. 
(p942] Albumin promotes germination and mycelium 
formation by Aspetyillus fumigatus 
Pwto, P 
Introduction: Aspgillus spp. are increasingly common agents of fungal 
infections in immunocompromised patients, with A.fitmigutus being the most 
flequently isolated species, particularly in case of inwive disease. 
Objective: To evaluate the effect of albdtnin on germinadon of spores of 
A.fitmgatus and A.jfavus. 
Material and methods: Spores (5 and 11 days old) of clinical isolates of 
A.fumigatus (4 strains) and ofA.flavur (2 strains)  were assayed for germination 
and hypha formation in presence of 2 and 4% albumin (human and bovine), in 
RPMI 1640 medium, at 37°C. 
Results: A si@icant, dose-related, promotion of germination rate and of 
hypha formation was observed, shortly &er 6-h of incubation, p d c d a d y  
with 5 days old spores of A.fumigatus. A.$avw demonstrated a considerably 
slower rate of germination in comparison to A.furnigatus, which was further 
A. Gongalves Rodrigues, R. Araujo and C. Pina-Vaz 
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decreased in presence of albumin. Similar results were found both in human 
and bovine albumin. 
Condusions: Our results may help to jus@ the mechanisms of infection and 
the inteapecies variabil~ty commonly found among A r p q l l u s  regardmg its 
pathogenic potential. Albumin, hy promoting mycelium formation, enhances 
Conclusions: S. w&iae shows an overall CSH that predicts its promoted 
adhesion to biomaterials of plastic naNIe as well as sdicon materds, like 
vascular cathetea or peritoneal shunts. Such a fact may be evoked to help to 
explain its increasing isolation from critical care patients, frequently carriers of 
plastic or similar foreign bodies. 
the pathogenic potential by A.fumigatus, a fact that may be evoked to explain 
its common involvement in invasive infection. References 
1 Van der Me1 et al Cwr Mtcrobrol 23337.341, 1991 
2. Rodr~gues et al. Mycosls 44(S1):24, 2001 
Identification and antifungal susceptibility testing 
of fungal strains isolated from chronic rhinosinusitis 
E. Dosa, E. Molnk, L. Mojzes, J. Varga, 1. D6czi and E. Nagy 
Szeged, HUN 
The fungal revolution taking place in otorhinology, inspired a study of chronic 
rhinosinusitis (CRS) patients (with or without polyposis), and the frequency 
of occurrence of fungi in their nasal mucus. This prospective study assessed, 
the incidence of eosinophilic fungal sinusitis (EFS) in CRS patients. A total of 
96 samples were examined h m  patients &om EFS and CRS. In 74 cases 
mucus was collected noninvasively, and in 22 cases during operation. The 
Gram-stained direct smem of a l l  samples were also evaluated. Bacteria and 
fungi colonizing in the mucus were detected by culturing method. The 
special mould plates were incubated at 30 "C and allowed to grow for 30 days. 
Finally, were the total IgE levels determined. The control group consisted of 
the nasal secretion horn 50 healthy volunteers. Typical aerobic pathogenic 
bacteria could be isolated &om 34 patients. F&y-seven aerobic bacteria were 
isolated, i.e. 1.6 bacteria/positive patient with a maximum of three Merent 
bacteria/sample. The isolated bacteria were S. auras, S .  pyogem, S. pneumo- 
n i a ,  S. agalartiae and E.faecalis strains. Yeasts and moulds could be detected 
tiom 79 patients (83%): C. albirans, C. krusei, C.glabrata, C.parapsilosis, Arper- 
gillus spp.. Cladosporium spp., Georrichum candidurn, Penicillium spp., Scopular- 
iopsis spp. and Zygomycetes. 237 yeasts and moulds were isolated, i.e. 3.0 
different fungi/positive patient, with a maximum of five merent iungi/ 
sample. In the control group no were aerobic pathogens isolated, but only 
apathogens. Fungi were isolated &om 22 patients (44%). Antifungal suscept- 
ibility testing of the yeasts and moulds is complicated by drug, organism and 
medium-specific factors. The E-test (AB Biodisk) is a new agar-based MIC 
method that makes use of a plastic strip with a preformed exponential 
concentration graQent of an antifungal agent. E-test strips for fluconazol, 
iaaconazol, ketaconazol and amphotericin B were placed on separate 
plates. 
vl Adhesion of Saccharomyces cerevisiae to 
biomaterials 
A. GonpIves Rodrigues, M. Vale, S .  Silva, S. Costa-de-Oliveira, 
C. Tavares and C. Pina-Vaz 
Porto, P 
Introduction: An increase in fungal infections bas been registered in late years, 
particularly in intensive care patients, in whom is common the widespread use 
of medical indwelling devices. Among etiological agents, the yeast Smhar- 
omyces cmisiae is being registered with increasing kequency. Adherence to 
liquid hydrocarbons is considered an indirect method to assess microbial cell 
surface hydrophobicity (CSH), which is believed to have an important role in 
the adherence of pathogenic microorganisms to host cell or foreign surfaces, 
namely plastic. 
Objective: To determine the po tend  ability of clinical isolates of S.  cerevisiae 
to adhere to components of medical indwelling devices, namely plastic and 
silicon rubber. 
Materials and methods: BlastoconiQa of eight clinical isolates of S. rerwisiae 
were assayed (in an assay for hydrocarbon adhesion 1) for the capacity to 
adhere to n-hexadecane and xylene. The adhesion to &con (silicon oil) was 
assayed according to a previously developed assay 2. AH tests were run in 
triplicate. 
Results: Seven strains showed a sigruficant adhesion to n-hexadecane and 
xylene and similarly to silicon. The single strain with reduced CSH, thus 
revealing a hydrophilic behavior, corresponded to a v a g d  isolate (recurrent 
vaginosis), which however, showed a comparable greater adherence to silicon 
Oil. 
v/ Species distribution and antifungal susceptibility 
pattern of yeasts and moulds isolated at Cerrahpasa Medical 
Faculty Department of Microbiology and Clinical 
Microbiology Deep Mycoses Laboratory between 01 April 
1999-27 March 2001 
A. S. Kantarcioglu and A. Yucel 
Irtanbul, 7R 
The purpose of this study was to characterize the species dismhution and 
antifungal susceptibility patterns ofyeast and mold strains isolated at a Turkish 
University Hospital deep mycoses laboratory. The species distribution and 
antifungal susceptibility patterns of the clinically sigmficant yeast and mold 
isolates recovered from deep mycoses suspected patients' specimens over a 2- 
year period determined against amphotericin B (AMB), fluconazole (FLC), 
itraconazole (ITZ), ketoconazole (KTZ), miconazole (MCZ), flucytosine 
(5FC) and terbinafine (TRB) using the National Committee for Clinical 
Laboratory Standards M27-A and M38-P reference methods. A total of 146 
yeast and 12 mold strains were isolated. C. albicans strains were 66% (97/146), 
and nonalbicans Candida species were 33.6% (49/146). The kequency of 
various yeast species identified was Candida catenrtlata 1 (0.7%), C.glabruta 6 
(4.1%). C. k e f r  4 (2.7%), C. k w e i 6  (4.1), C. lipolytica 3 (2.0%), C. lusitaniae 1 
(0.7%), C.parapsilosis 8 (5.5%). C. mgosa 2 (1.4%), C. tropicalis 12 (8.2%). 
Mnlasseziafic@r 1 (0.7%), Trichosporon beigelii 3 (2.0%), Cwrocoms neofmans 
2 (1.4). The frequency ofmold species identified AspergillusSpavus 4 (33.3%), 
A.fumigafus 2 (16.6%), A. niger 3 (25%), A. venicolor 1 (8.3%), Cladosporium 
cladosporioides 1 (8.3%), Scopulariopsis candida 1 (8.3%) and Chdosporium sp. 
(8.3%). Resistance to FLC (MIC higher than or equal to 64 pg/mL) as per 
NCCLS criteria was observed in 21 Calbicans (21.6%), 19 nonalbicans 
Candida strains (38.8%); resistance to ITZ (MIC higher than or equal to 
1 pg/mL) in 31 C. albicans (32.2%), 15 nonalbicans Candida (30.6%) and 
resistance to 5FC (MIC b h e r  than or equal to 32pg/mL) in 5 C. albicans 
(5.1%), 7 nonalbicans Candida strains (14.3%). Multiresistant strains evaluated 
as resistant to one or more azole antifungal agent along with AMl3 were 37 
Candida isolates. Of those, 29 was found in vitro resistant to FLC and AMB 
and 14 of them was C.albhns .  Other multipresistant strains and their 
frequencywas C. cnntenulatu (ill), Cglabrata (1/6), C .  kmsei (516). C. lrrsitaniae 
(ill), C. tropicalis (6/12). The present study indicates that Candida spp. are 
emerging as important pathogens in immuuocompromised patients and the 
tendency of yeasts to develop resistance to antifungal agents and the appear- 
ance of species specific susceptibility of molds, in vitro tests seem to be useful 
for patient management. 
jp9461 Comparison of microdilution and E-test with 
reference broth macrodilution method for antifungal 
susceptibility determination of bndida, Cryptococcus, 
Trichosporon and Malassezia spp. strains 
Istanbul, TR 
In the present study, a comparison of microdilution and E-test with reference 
macrodilution method was performed to determine antifungal susceptibility 
of clinical Candida, Cryptocornsc, Trichsporon and Malassezia strains against 
amphotericin B (AMB), fluconazole (FLC), itraconazole (ITZ), ketoconazole 
(KTZ) and flucytosine (5FC). A total of 102 clinical yeast strains and 14 
ATCC reference strains were used for quality control. Macro- and micro- 
dilution methods was performed according to the recommendations of the 
National Committee for Clinical Laboratory Standards (Document M27-A). 
A. S.  Kantarcioglu and A. Yucel 
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The Iipophhc species Malarseztafwrdur wa.. tested accordmg to the Nenoffs 
modification and E-test was performedas recommended by the manufacturer. 
MIC paus were considered m agreement when the Merence between the 
pain w a s  wthin 2 two-fold dilutions. General agreement was 95% for AMB, 
FLC, ITZ and 5FC, and was 96% for KTZ between the mcro and macro- 
dlluhon tests The agreement between E-test and macrodilution methods was 
95% for Ah4B and 5FC, 96% for FLC and ITZ and 56% for KTZ and high 
agreement was demonstrated between the methods except KTZ for the tested 
strams. In conclusion, microddution and E-test methods are rehable 
dternahves to the reference macrodilution method for the m vltro suscept- 
ibility determinaaon of Cundida and non-Crtndida yeasts with convenhonal anti- 
fun&, however, azole resstance should better confirm by the reference 
tests 
w] Resorting to the microbiology laboratory for 
evaluating dinical specimens submitted for fungal culture 
and eventual identification: the experience of a large Italian 
university hospital 
A. Nanetti, R. Manfredi, R. Valentini, L. Calza and E Chiodo 
Bologna, I 
Objective: To carry out a 12-month prospective survey ofclinical samples sent 
to the Microbiology laboratory of a tertiary care Hospital, for fungal culture 
and identification. 
Methods: During the last year, 27959 specimens were processed from either 
inpatients (inp) or outpatients (outp). Multiple daily samples sent f h m  one p 
were considered as a single submission. 
Results: Most of clinical specimens regarded blood culture/intravascular 
catheters (9977 cases: 35.7%). but the frequency of positive assays proved 
very low in this field (103 cases: 1.03%), with only nine strains from i.v. lines. 
The genitourinary tract accounted for 7644 samples (positive in 13.2% of 
cases), with a sigdcant p r d e n c e  of positive assays &om the female genital 
tract (761) versus other samples (247 cases: P <  0.001). Both upper and lower 
airways were the origin of 5334 specimens, characterized by an overall 
elevated fiequency of isolation (29.8%), although 36.3% of positive samples 
were from sputum and 12.4%fiom nasal/oral swabs. The gastrointestinal tract 
accounted for 2222 specimens, but the apparently hlgh positivity rate (28.9%) 
was influenced by frequent stool colonization (1911 cases: 86%). Other 
samples came fiom skin/soft tissue (878 cases, with a 7.7% positivity rate), 
eye (129 samples, with a limited 1.5% fungal recovery), ear (78 cases, with a 
6.4% culture rate), central nervous system (145 samples, positive in 2.8% of 
cases), and miscellaneous sites (1552 specimens, with a 10.3% positive culture 
rate). When considering some representative inp units, a greater fungal 
recovery was recognized in pneumology (47%), followed by infectious 
diseases (28.7%), internal medicine (25.5%), and overall surgical and transplant 
units (23.7%), while cardiology, hematology, general and speclalized ICU, 
obstetrics/gynecology, nephrology/dialysis, and day-hospital services had a 
positive culture rate of 10.3-21%. 
Conclusion: Tertiary care-based mycology laboratories are borne by a high 
request of fungal culture and identification, fiom a broad spectrum of inp/ 
outp units. Whereas search fiom sterile sites (blood and CSF) account for the 
minority of positive assays (1.03-2.8% of cases), either respiratory, genitour- 
inary, gastrointestinal tract, or skin and soft tissues, eye and ear, are interested 
by an elevated colonization, often caused by the concurrent use of antibiotics 
or underlying immunodeficiencies. Surveillance cultures should be correctly 
interpreted, especially when p at risk for local or systemic fungal disease are of 
concern. 
mens comng to our laboratory and to evaluate the accuracy of duect 
mcroscopic exammaaon m detecang the presence of b g ~  companng it 
to culture results. 
Material and methods: A total number of 130 chnicd specmew collected 
between October 1st 2000 to October 1st 2001 at the Mycology semon of the 
Saint George Hospital laboratory, Beirut, were included in thn pmspechve 
study The informaon concermng epidenuologml and climcal character- 
ishcs, as well as laboratory tests and results, was stansacdy analyzed. Idena- 
ficahon characters of the isolates included colomal morphology and 
biochemcal tests. Culture results were correlated to Duect Wcroscopic 
Exarmnation (DME). 
Results and dfscurslom: Results are shown in Tables 1-3. 
Table 1 Staastical characterifdcs of the stu&ed populaaon 
Pvlmetrr De+aip%nx 
PJlm/ Typ L e h  Omco 
Numben @) 109 (83 8) 7 (5 4) 
Nombrr @) 24 (18 5) 48 (569) 58 (446) 
Numbm (%) 60 (45 2) 31 (23 8) 32 (246) 7 (5 4) 
Numbm (w) 5 (38) 15 (11 5) 3 (3 1) 6 (46) 82 (83 I)  
0-18 1%39 >40 & 
Spenmn T p  NulWC)  N d O  Skm H a d  
Anmulr xlod Cat Dog hbbt Bud NO 
Cvio~cruolt N G  Trwlemm Tnr6Nm T d - p p h W  E J k s m  CddEsp 
Number (96) 100 (769) 4 (3 1) 12 (92) 8 (6 2) 1 (0 8) 5 (3.8) 
The total number of rsoktes between 3 October 2000 and 31 October 2001 was 130. 
Table2 Correlation between direct microscopic examination (KOH) and type of 
specimeu, previous treatment and culture’s result 
No spores no hyphae Spores and hyphae present 
# of specmens 
Trpe ofspecimen 
N d  (foot) 
Nad (hand) 
S h  
Deufmenf 
No 
Coracostemids 
Chemotherapy 
Others 
Result of culture 
No. growth/3 weeks 
r rubnrm 
T.vblaa?rm 
1: mentqrophyies 
E froccosum 
nm 
A n o w  
84 
46 (55.4) 
19 (22.9) 
14 (16.9) 
4 (4.8) 
64 (77.1) 
10 (12.0) 
0 (0.0) 
2 (2.4) 
2 (2.4) 
82 (97.6) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
13 
4 (30.8) 
2 (15.4) 
7 (53.8) 
0 (0.0) 
6 (69.2) 
2 (15.4) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
1 (7.7) 
4 (30.8) 
2 (15.4) 
6 (46.2) 
0 (0.0) 
Table 3 Repvtltlon of the positive cultures of filvnentous fmg~ by clinical specimens 
Posiave Nd Nd 
cultures (foot) (hand) Skm H u r  
1: nrbrum 12 3 (25.0) 3 (25.0) 6 (50.0) 0 (0.0) 
?: mentagrophytes 8 4 (50.0) 0 (0.0) 4 (50.0) 0 (0.0) 
T. viilaceum 4 0 (0 0) 1 (25.0) 3 p5.0) 0 (0.0) 
E.Jouosum 1 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 
jp948j Epidemiology of dermatophytes and accuracy of 
direct microscopic examination: correlation with positive 
cultures 
Z. Daoud, M. Bejjam, M. Hajar, 2. Ghantous, K. Taouk and N. Haknne 
Beinrf, LBN 
Objective: Epidemiology is important in infection control and pubhc health 
issues related to the M m n t  types ofdermatophytoses. To our knowledge, no 
laboratory data concerning dermatophytosesin Lebanon were published yet. 
In thts study ,  our objecave was to collect epidemiological data of the speci- 
The majority of the specmens were foot (45.2%) and hand (23.8%) n d s  
commg from people above 40yean of age (44.6%). Most of the pauents had 
no 4 s  at home and were not occupahon& exposed. Our resulu show 
that 97.6% of the cultures were negative when the DME revealed absence of 
spores and hyphae On the other hand, 52% of the cases with positive DME 
revealed posinve cultures. Among all cases, T?ychophyton nrbnrm followed by 
Tqdzophyfon mentagrophytes were the most lsolated fungi. The use of 
anafungal agents si&icantly a6ected the percenmges of positwe cultures. 
These data demonstrate the accuracy and reliabdity of Brect Microscopic 
Exanunahon in detectmg dermatophytosis 
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I P949 1 Comparison between prevalence of occult 
fined pedis (Athlete's foot) in professional and students 
soccer players 
M. Mahzounieh, A. Azamian and E Nikokhah 
Shahrekord, IR 
Our purpose of this study was determination of any probably effects of 
duration oftraining and exercises and prevalence of athlete's foot. The current 
research has been carried out for the first time in Iran. Tineapedis, a fingal 
infection ofthe interdigital toe web spaces as well as solely dermatophyte fungi 
cause the skm of the feet, includes Trichophyton spp. and Epidmophyton 
j7ouosum. The symptoms and signs of athlete's foot are scales, cracks, peels, 
redness, blisters and itching. However, it has occasionally had no any 
symptoms. Athlete's foot is fkequently found in adult men between 20 and 
40 years old. In this research, two groups include 180 elite soccer players fkom 
eight sports clubs and 272 student &om 11 university teams were selected as 
professional and nonprofessional soccer players, respectively. Their skin 
samples were collected from two-forth inredigital toe web spaces and 
cultured on SCC agar medium and incubated for 3 weeks. The results showed 
that about 3.35% (n = 6) of professional players were positive in three out of 
eight teams. Zirhophyton mbmm had a most f+equency (four cases). Zirho- 
phyron mmtagrophytes and Epidemrophytonjlorcosum isolated &om two cases. In 
contrast, we find only two positive cultures at student players. Besides, some 
factors includes duration of training, taking a shower after exercise, foots 
moisture, hstory and symptom with positive cases detected by questionnaire. 
there were not any sigdcant difference between these factors and frequency 
of infection (P> 0.05). However, significant relation observed between 
different clubs and the frequency of infections in professional players 
(P=0.035). We could not find any correlation in factors and infection at 
student's teams because of low cases. This study revealed that Tinea pedis is 
endemic a t  some clubs which prevention and treatment operation must be 
done. 
1 P950 I Necrotizing fasciitis caused by Absidia corymbifera 
in a patient without local-risk factors 
C. Serrano, J. Corzo, B. Fernandez, V. Castellano, A. Valverde, R. Claro, 
M. Ramirez, S. Bernal and E. Martin-Mazuelos 
Sevifle, Reus, E 
Objective: We report here, the case of a patient with hyperglycemia and 
immunosupression secondary to steroid therapy who had no local risk factors 
but developed invasive necrotizing cutaneous rnucormycosis caused by 
Absidia rorymbijira. 
Material and methods: A 78-year-old man was admitted to the emergency 
ward with breathing Wiculties and serosanguenous nasal dscharge. Six days 
after hospitalization a very painful, red, hot swollen area in the external side of 
his right thigh appeared. Several days later the nasal lesion disappeared 
spontaneously but the skin lesion progrwed with large necrotic areas. 
Bacterial and fungi cultures were obtained fiom the black sinus discharge 
and b m  necrotic skin area. For bacterial culture we used blood, MacConkey, 
chocolate and Sheadler agar plates and thioghcolate medium incubated at 
35 "C. For fungal cultures, we used tubes containing Sabouraud dextrose agar 
with and without clorammphenicol and cicloheximide that were incubated at 
25 "C and 35 "C. 
Results: The bacterial and fungi cultures of the black sinus discharge were 
negative. Histopathologic examination of the specimens of the necrotic skin 
area revealed fungal invasion by a nonseptate fungus. Forty-eight hours later 
cultures of this specimens showed a white, flq profusely growing fungus. 
No sporulation was seen in cultures even after 7days of incubation on 
Sabouraud or  Potato dextrose agar. Stimulation ofsporulation was attempted 
with culture in malt extract agar and we identified the fungus as Absidia 
mrymbijma. Owing to the continued progression of the necrosis successive 
debridement were performed and lipososmal amphotericin B was given (total 
dose 5100mg). Amputation of the limb was necessary at last. 
Conclusion: The significance of this case is that the origin of the Absidia 
infection in this patient is unknown as we failed to observe any recognizable 
entry p o d  for the fungi and no apparent local trauma was identified. 
lwl Fungemia in patients at a university hospital: 
impact of concurrent infections, cancer, coronary artery 
disease, diabetes, and renal failure on short-term mortality 
A. Safdar and T. Bannister 
Columbia, U S A  
Objective: The current study was performed to determine the association of 
host flctors, and nosocomial interventions on the outcome of fungemia. 
Methods: During 01 January 1998-31 December 1999, all consecutive 
episodes of fungemia were evaluated retrospectively. Mortality was death 
during the course ofantifungal therapy, and/or <30 days oflast positive blood 
culture during the same hospitalization. Mortality is abbreviated (M%). 
Results: Seventy-five patients (37 male) developed 81 episodes of fungemia. 
Median age was 48 & 29yem and WBC 10 % 9.3 k/pL. Overall mortality was 
44.3%. Five among eight neutmpenic patients expired (M 62.5). Forty-five 
had fever (>100.5 F) (M 44.2) and mortality in 25 patients without fever 
was (M 48). In 47 individuals fungemia developed while on hypenlimenta- 
tion (M 49). S i  (80%) received antibiotics within 30 days of bloodstream 
invasion (BSI) (M 43.3). Similarly, 22 were exposure to antifungals (M 55); 15 
tirazole-based agent (M 57.1), 5 amphotericin B (M 75), and in 5 two 
antifungals (M 75). Forty-two developed fungemia during postsurgical period 
(M 40), including 22 abdominqelvic (M a), 6 vascular (M 33.3), and 7 
following severe trauma (M 42.9). Among 81 episodes, 37% were owing to 
C. albiram (M 42.3), 30.9% Cglabrata (M 58.3), 17.3% C. parapsilosis (M 21.4). 
7.4% C. fropiadis (M 50), 6.2% C. knrsei (M 20) and 1.2?? C. lucitaniae (M 100). 
Sixty-nine had single species fungemia (M 45.3), and six patients with dual 
spp. BSI (M 33.3). Forty-three had a concurrent infection (M 51.2); 21 with a 
single microorganism (M SO) and 22 patients with polymicrobial BSI (M 52.4). 
An underlying d g n a n c y  was present in 34 (M 59.4); 18 solid-organ 
(M 56.3), 16 hematological (M 62.5), and 9 allogeneic marrow grafi recipients 
(M 44.4). Sixteen had coronary artery disease (M 80), 14 r e d  Mure 
(M 61.5). including 6 on hemodialysis (M 40), 1 peritoneal dialysis 
(M 100). and 7 patients with acute azotemia (M 71.4). Thirteen had diabetes 
(M 58.3), 2 pancreatitis (M 50), and four patients had cirrhosis ofliver (M 25). 
No deaths were observed in patients with AIDS, short bowel syndrome, and 
11 premature infants including three being treated in the neonatal ICU. 
Conclusions: Hemorogenous cadidiasis is a serious complication even in the 
immunocompetent inctviduals, especially those with coronary artery disease 
or acute azotemia. Universal response to treatment in premature infants in th is  
setting was encouraging. 
rP95z-j Consequences of nephrotoxicity in hospitalized 
hematology patients receiving amphotericinB 
A. Thiebaut and A. Lafuma 
Lyon, h u g  la Reine, F 
Objectives: Amphotericin B desoxycholate (d) has been the standard 
treatment for most systemic mycoses although it carries sigtllficant risk of 
nephrotoxicity (NT). A study was conducted in a hematology ward of a 
district hospital located in Lyon, France to estimate the incidence and 
consequences of NT among hospitalized patients receiving amB. 
Methods: Data were collected through a retrospective review of medical 
records. Consecutive patients receiving amB therapy were identified. The first 
day of and3 constituted the beginning of the evaluation period. NT was 
defined a priori to data collection as: none; slight: increase in serum creatinine 
(SCr) 2 0.5 mg/dL above basehe; moderate: 50% increase in baseline SCr 
with a maximum of 22.0 mg/dL, or severe: baseline SCr tripled or reached a 
peak 23.0mg/dL (each category mutually exclusive). Hospital costs were 
estimated by multiplying length ofstay (LOS) by the average hospital pet diem 
cost (ex.iressed as 2001 Euros). 
Results: From February 1997 to March 2001, 129 eligible patients were 
identified. Mean age at admission w a s  51 years; 61% were male. Reason for 
initiating a&, using EORTC criteria, was proven lo%, probable 36%, and 
possible 54% fungal infection. All patients received pre-medications and had 
conconlitant use of other nephrotoxic medications. 56% ofpatients developed 
some degree of NTafker starting amB [44% none (SCr change = +32%); 44% 
slight (SCR change=+@%); 7% moderate (SCr change= +134%); 5% 
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severe (SCr change = +235%)]. 46% ofpatients presented with NT that led to 
the &continuation of amB. AmB treatment duration and cumulative dose did 
not differ among patients who did and did not develop NT (15days, 
P=O.968; 820mg, P=O.651). In hospital mortality was sigdcantly higher 
for patients developing NT (none: 4%, slight 17%, moderate: 2904 and 
severe: 50%). LOS after starting amB and adjusting for mortahty was also 
significantly longer for patients experiencing NT (P= 0.02). Lastly, hospital 
costs after starting aml3 and adjusting for m o d t y  were also significantly 
higher for patients experiencing NT (0.04). 
Conclusion: NT occurred 6equently in this cohort of patients receiving 
amB and may contribute to increased it-hospital m o d t y ,  LOS and hospital 
costs. 
wl Alveolar macrophages are destroyed by their 
interaction with Aspergi//us fumigatus conidia and lung 
surfactant 
C. Jarstrand, N. Gross, l? Camner and B. Zhivotovsky 
Stockholm, S 
Introduction: Aspergillus fumigatus conidia are ubiquitous, airborne, might 
colonize the lungs and cause chronic inflammation. We have found that when 
alveolar macrophages (AM) are challenged with A.fumigatus conidia, they 
increase their production and extracellular release of reactive axygen species 
(ROS). Ths  increases lipid peroxidation (LPO) of lung surfactant by AM. 
Objective: To determine whether products from the increase in oxidative 
metabolism or those of LPO kill AM. 
Methods: We cultured AM with A.fumigufus conidia for 48 h with or without 
a surfactant preparation (CurosurfJ and then measured the malonaldehyde 
levels, which reflect the degree ofLPO activity. At the same time, we counted 
the numbers of AM that had become detached &om the surface of the culture 
dishes during the culture. Finally, we studied DNA fiagmentation of the AM 
with agarose gel electrophoresis. 
Results: After the 48-h incubation period, about 15% of the AM population 
had separated &om the culture dish into the medium. In the presence of 
surfactant, the amount of detached AM increased in a dose-dependent way 
and was about 50% with 1.6mgmI-' Curosurf. In parallel experiments the 
MDA level increased with the concentrations of surfactant. The correlation 
between the MDA level and cell detachment was highly sigmfkant. In similar 
experiments we found DNA ftagmentation of the AM already after 24 h, with 
Curosurf against 48 h without this agent. 
Conclusions: On the basis of this and our previous studies (Nessa K 1997, 
Gross NT 2000), we suggest that (1) A.fumigatus conidia nuy in the lung 
activate AM to increase their oxidative metabolism. (2) In the AM the conidia 
are ofien located in open phagolysosomes from which ROS are released 
extracellularly. (3) Lung surfactant is peroxidzed by ROS. (4) Products of 
surfactant LPO together with ROS cause death ofAM and presumably also of 
other cells in the lungs. LPO products, rather than ROS, are primarily 
responsible for the cell destruction. Thus Ah4 stimulated by hngi tend to he 
destroyed early because of their exposure to surfactant lipids. Cystic fibrosis is a 
genetic disorder with pathological secretions in the airways. Sputum samples 
f b m  such patients contain A.fumigufus in about 30% of the cases. We believe 
that the LPO oflung surfactant and subsequent cell death, found in t h i s  study, 
contribute to the lung destruction seen in these patients. 
F l  Epidemiology of Pneumocystis carinii 
dihydropteroate synthase mutations associated with drug 
resistance 
A Nahmana, M Rabodomrina, P Francioli, D S Blanc, S Picot, 
J. Bde  and P. M. Hauser 
Lausanne, CH; Lyon, F 
Pneumocystu curmi is a fungus whch causes severe pneumoma (PCP) 111 
immunocompromed pahents, mady those infected mth HN. To prevent 
and treat d n s  disease, sulfa drugs are wdely used. Fadure of s u b  prophylaxis 
and treatment has been shown to be associated wth  two mutanons altenng 
the achve site of the dhydroptemate qynthase (DHPS), the target of sulfa 
drugs. Theses mutations result 111 an ammo acid change at poslhon 55 or 57 of 
DHF'S, and were observed elther as a smgle or double mutahon m the same 
isolate We developed a rapld and simple method whch discrunmates 
between the dh-erent DHPS genotypes It consists of the amplhcation by 
PCR of the DHPS gene, followedby the detechon of its polymorphsm usmg 
the smgle strand conformanon polymorptusm tecbque. The method was 
apphed to 397 speclmens collected from Swss and French hospitals. The 
frequency ofDHPS mutant genotypes was lower in Swss hospitals (10%) thvl 
in the French one5 (33%) (P-value < 0.0001). The use of the s&a drug 
sulfadome (as pan of Fmdar)  for prophylaxis in some French hospltals was 
assoclated wth  the DHPS mutant genotype carrying a single ammo 
acid change at position 57 (P-value = 0.001). whereas the use ofsulfamethox- 
azole (as part of cotrmoxazole) was associated wth the double mutaaon at 
poslhons 55 and 57. Analysls of cases who had two eplsodes of pneumonia 
suggested that selechon of the mutant genotype occurred between the two 
episodes. 
lp955/ Surveiliance for antifwgal resistance of clinical 
yeasts isolated in a general hosphl during a honth 
period 
J. Gumea, 0. Cuevas, L. AIcali, J. Gmez-Rodriguez, T. Pe16ez 
and E. Bouza 
Madnd, E 
Introduction: Surveillance for anfingal resistance of clinical yeasts is neces- 
sary for help gude emptric therapy of yeast infections. 
Objectives: To determme the anciiungal susceptibility patterns of all adab le  
clinical yeasts isolated in a General Hospital during a 3-month period 
(September-November 2001). 
Materiel and methods: Susceptibility testing was performed using a com- 
mercd microdilution method (Sensititre Yeast-ONE). Antifhgal drugs 
tested were amphotericin B (AB), flucytosine (FC), ketoconazole (KZ), 
fluconazole (FZ) and itraconazole (12). 
Results: A total of162 yeasts from 157 specimens were tested. Specimen types 
were as follows: profound (71). mucocutaneous (63). and superficial (23). The 
MICw (pg/mL) for anphotericin, fluocitosine, ketoconazole, fluconazole and 
itraconazole in the species tested were as shown: 0.5, 0.5,0.008, 1 and 0.125 
for C. albicans; 1,0.25,0.25,4 and0.5 for C.parapsilosis; 0.5.0.06, 1,32and 2 
for C.glabrofa; 1,0.125,0.03,1 and 0.25 for C. tropic~lLand4.32,2,128 and 1 
for C. kmsei. In overall, the MICw (pg/mL.) were 1, 0.5, 0.5, 16, 1. There 
were no Berences in MICw values for C. afbicans when the specimen types 
were compared. Four C. albicuns strains (3.6%) (each one from wound, urine, 
pharingeal, and esophagus specimens) had high azole MICs (KZ: 0.25,0.25,4 
and >16lrg/mL; FZ: 32, 64, 128 and >256pg/mL; I 2  0.5, 1, 16 and 
>16 pg/mL. 
Conclusions: AB showed the best activity with an overall MICw of 1 pg//mL. 
Globally, the azoles were active against most isolates except for C.glubmta and 
C. krusei. FC showed good activlty against most isolates tested with the 
exception of C . h e i .  In spite of antSungal therapy over last years, the 
clinical yeasts isolated in our hospital showed an expected pattern of suscept- 
ibiliv. 
Assessment of the identification of 271 fungal 
strains by the VrrEK 2 (R) system 
E Moahc, M Viraux, P Lecordler, C Carrou and A M Le Flohc 
Brest, F 
Objectives: The boMGneux VITEK 2 system enables the identlfcaaon of 
chmcal yeasts uung the VITEK 2 ID-YST card T b  system was evaluated 111 
our lab a t  the Brest University Hospital (France), in comparison wth  the 
ID32C method (bioM6rieux) using 271 chmcal yeast strams 
Methods: A total of271 strains representlng 30 dlfferent species were studed 
The strams were lsolated from pahents and/or hospital enwnment  Tests 
were performed &om subcultures grown for 24-55 h on Sabouraukhlor- 
amphemcol-gentanucm agar plates Inocula were adjusted to a two McFar- 
land standard in 0.45% aqueous NaCl Fdhng, seahng and readmg of cards 
were automatlcally processed by the VITEK 2 system Fluorescence measure- 
ments every 15 mm for 15 h were computerued to gwe the final idenhfica- 
non The data base allows the idenhficahon of 5 1 species of c h c a l  yeast. Each 
stram was tested in parallel uang the ID32C strip, accodng to the manu- 
facturer's recommendahons. The results obtamed wth  the VITFX 2 system 
and the ID32C strips were classified mto four categories: Concordant 
(idenncal identlfcanon mth both methods, i n c l u b  low dmrmunahon 
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solved with supplemental test), Low Discrimination not solved with 
supplemental test, Mis Identification (VITEK 2 system leads to an error of 
idendfication), and No Identification (VITEK 2 gives no identification 
answer). 
Result% Of the 271 strains tested, 247 (91.1%) were correctly identified, 
including low discrimination solved with supplemental test. For 12 (4%) 
strains, no additional test w a s  available to finalize identification. Nine (3.3%) 
strains were Mis identified, and 3 (1.1%) were not identified with the 
system. 
Abdominal infections - empiric treatment 
Conclusions: The VITEK 2 system represents a sigtllficant advance for 
idenaficahon of chnical fungal s m s .  The most common sttams m our 
laboratory were all correctly idenhfied wthout addmonal tests Its major 
advantages are. 
Slmpliaty of the procedure, mcludmg fully automated card fillmg and 
Idenhficaaon results obmned mthin only 15 h; 
The presentation of reagents m the form of sealed cards, whch is hygeruc 
readmg; 
and ensures user safety. 
Risk factors for in-hospital mortality in patients 
undergoing surgery for intra-abdominal infections 
R. Lyu, S. Crowley and D. Yin 
Piscatamy, USA; Sydney, AUS; Whitehouse Station, USA 
Objectives: Intra-abdominal infections (IAI) requiring surgery can result in 
substantial morbidity and mortality. This study examined the risk factors for 
in-hospital mortality (IHM) in patients undergoing surgery for IAI in 
Australia. 
Methods: Data were extracted &om the National Hospital Morbidity Data- 
base (Austrahan Institute of Health and Welfare) for all states/territories 
except Australian Capital Territory and Victoria. Patients hospitalized 
between 1995 and 1999 who had a primary discharge diagnosis suggesting 
IAI and at least one surgical procedure were included. The following 
covariates were evaluated in multivariate logistic regressions to identify risk 
factors for IHM: infection type, age category, gender, existence of comorbid 
conditions, public versus private hospital and whether patient had private 
insurance. 
Results: A total of 15876 admissions for IAIs requiring surgery were 
identified. Mean age was 38; 43% were female. Seventy-eight percent 
occurred in public hospitals. Twenty-six percent had private insurance. 
Fifty-five percent had acute appendicitis with generalized peritonitis (ICD 
540.0). 21% had acute appendicitis with peritoneal abscess (540.1), 5% had 
perforation ofintestine (569.5), 3% had abscess ofintestine (569.83). and 16% 
had other secondary peritonitis (567.0, 567.1, 567.2, 567.0). Almost two- 
third had at least one comorbid condition. Average IHM rate was 2.6% (95% 
CI: 2.42.9%) compared to 1.2% (1.2-1.3%) for al l  conditions. The following 
risk factors were independently associated with a greater IHM rate: pe*ora- 
tion ofintestine (odds ratio: 17; 95% CI: 12-25; relative to acute appendicitis 
with peritonitis or abscess), other secondary peritonitis (7.9; 5 .61  I), abscess 
ofintestine (2.2; 1.1-4.3),ageL 65 (3.9; 3.1-5),publichospital(1.5; 1.1-2.2), 
neoplasm (21; 8.9-50), mental msorders (6.9; 1.9-25), diseases of blood/ 
blood-forming organs (21; 7-66), nemus system (9.2; 1.7-49), skin and 
subcutaneous tissue (8.2; 1.5-44), musculoskeletal (9.8; 1.8-52), circulatory 
(12; 5.5-29). respiratory (13; 5.7-32). digestive (1 1; 5AV24) and genitour- 
inary systems (10; 4.>24). Patients with private insurance had a lower IHM 
risk (0.7; 0 .549) .  
Conclusion: Among patients undergoing surgery for IAI, the risk of IHM was 
independently associated with infection type, older patient age, existence of 
certain comorbid conditions, public hospital admission, and lack of private 
insurance. 
lp958/ Determinants of hospital length-of-stay in patients 
undergoing surgery for intra-abdominal infections in 
Australia 
R. Lyu, S. Crowley and D. Yin 
Pimafaway, USA; Sydney, AUS; Whitehouse Station, USA 
Objective: Intra-abdominal infections requiring surgery can result in sub- 
stantial healthcare resource use. Ths  study examined the determinants of 
hospital length-of-stay (LOS) in patients undergoing surgery for IAI. 
Methods: Data were emacted from the National Hospital Morbidity Dam- 
base (Australian Institute of Health and Welfare) for all smtes/territories 
except Australian Capital Territory and Victoria. Patients hospitalized 
between 1995 and 1999 who had a primary discharge diagnosis suggesting 
IAI and at least one surgical procedure were included. The following 
covariates were evaluated in multivariate linear regressions to estimate the 
determinants of LOS (log transformed): type of infection, age category, 
gender, comorbid conditions, hospital type (public vs. private) and whether 
patient had private insurance. P-value 5 0.05 was considered significant. 
Results: A total of 15 876 admissions for IAI requiring surgery were identified 
from 1995 to 1999. Mean age was 38; 43% were female. Seventy-eight 
percent of admissions occurred in public hospitals. Twenty-six percent were 
covered by private health insurance. Fifty-five percent had acute appendicitis 
with generalized peritonitis (ICD 540.0), 21% had acute appendicitis with 
peritoneal abscess (540.1), 5% had perforation of intestine (569.5). 3% had 
abscess ofintestine (569.83), and 16% had other secondary peritonitis (567.0, 
567.1, 567.2, 567.0). Majority of patients (60%) had at least one comorbid 
conddon. Average LOS was 6.7 days (SD = 7.8). The following MIS were 
sigrufcantly associated with longer LOS: perforation of intestine, abscess 
of intestine, other secondary peritonitis, and acute appendicitis with perito- 
neal abscess (aU P=0.0001, relative to acute appendicitis with peritonitis). 
Other determinants of longer LOS were age 2 65, neoplasm, endocrine/ 
nutritional/metabolic diseases, mental disorders, diseases of the blood and 
blood-forming organs, skin and subcutaneous tissue, musculoskeletal system, 
circulatory system, respiratory system, hestive system, genitourinary system 
(all P <  0.01). Patients with private insurance were associated with shorter 
LOS (P=O.O001). 
Conclusion: Patients undergoing surgery for IAI in Australia stayed an average 
of 6.7 days per hospitalization. The LOS was independently associated with 
the type of infection, age 2 65 and certain comorbid conditions. Patients with 
private insurance were also associated with shorter LOS. 
1 P959 1 Empirical treatment of patients with bloodstream 
infection: evaluation of efficacy and possible strategies to 
achieve better results 
A. Enduniani, A. Tamborini, M. Bonsignori, G. Lombardi, E Luzzaro 
and A. Toni010 
Varese, I 
Objectives: The study analyzed the aicacy of empirical treatment (ET) in 
patients with bloodstream infection (BSI). Based on bacterial identification 
and drug susceptibility results, we wanted to suggest possible local guidelines 
in order to improve ET strategies. 
Methods: Clinical records of patients with BSI were studied to evaluate the 
effectiveness of ET. Administered drugs were grouped on the basis of the 
antimicrobial class. Based on patient admission, results were grouped in ICU, 
medical or surgical. 
Results: During 1999, we found 251 BSI (125 medical, 81 surgical, and 45 
ICU patients). In medical wards, the most frequent agents were Sfaphyto- 
coccus aurm (27.2%) and EKherichiaculi (22.4%). Patients receiving ET were 
85.6%; in 60.7% of the cases, it was adequate. Third-generation cephalos- 
porins (C3G) were the most iiequently used drugs (63.6%) either as mono- 
therapy (48.6%) or associations (15%). In surgery, Candida spp. (23.5%) 
overcame S. aureus (1 9.8%). Patients receiving ETwere 75.3%, being adequate 
in 60.7%. C3G accounted for 36.1% of the therapeutic regimens (mono- 
therapy 26.2%, associations 9.8%). In ICU, 33.3% of BSI were caused by 
Enterobacteriaceae and 28.9% by coagulase-negative staphylococci. All 
patients were empirically treated (53.3% with associations), but only 
37.8% adequately. Aminoglycosides plus C3G was the most commonly used 
association (15.6%). Monotherapy was mainly administered using B-lactams 
plus inhibitor (15.6%) or glycopeptides (11.1%). In medical BSIs, the best in 
vitro association was QG plus aminoglycosides (84.1%), in surgical ones 
C3G plus cotrimoxazole (88.5%), and in ICU C3G plus fluoroquinolones 
(57.8%). 
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Conclusions: Based on these results, monotherapy with C3G remains an 
acceptable option for noncomplicated septic patients in medical and surgical 
wards. However, C3G plus aminoglycosides may be needed in medical 
patients with severe sepsis and septic shock, whereas association with cotri- 
moxazole may be the best choice in surgical wards. Therapeutic failures are 
frequent in ICU, even if C3G are used in association. Wide diffusion of 
resistance makes effectiveness of ET barely predictable. In fact, we did not 
detect any C3G association that could guarantee acceptable success. Thus, 
with special regard to severe septic patients, monotherapy with glycopeptides 
or carbapenems remains the only choice in life-threatening situations. 
Ip9601 Simple categorization of patients w[th positive 
blood bacterial and yeast cultures guides empirical 
antimicrobial therapy 
T. Hautala, €? Hautala, H. Kauma, F! Kujala, I. Pietarinen, H. SyrjSEa and 
M. Koskela 
Oulu, FIN 
Objectives and methods: Gram-stain of blood cultures offers the first 
microbiologic data to guide therapy usually within 24 h after blood samples 
are drawn. We categorized 989 consecutive positive culture fin- from 1 
January 2000 to 30 September 2001 into four groups: patients with com- 
munity-acquired infection (CAI, 437 cases), hospital-acquired lnfection 
(HAI, 328 cases), infections in hematological units (HEAI, 116 cases), or 
contamination (108 cases). Categorization is done routinely at OUT hospital 
immediately after Gram-stain findings; the clinician responsible for treatment 
of each patient is consulted by phone. Aim of the study is to create empirical 
treatment guidelines for septic infections based on patient category and stain 
result. 
Results: Gram-negative rods were found in 215 (49.2%) cultures of CAI, 110 
(33,5%) HAI, and 23 (19,8%) Hw patients. E. coli was the most common 
Gram-negative rod with 133 (61.9%), 18 (43.6%), and 7 (30.4%) findings. 
Klebsiella strains were found in 21 (9.8%) CAI, 19 (17.3%) HAI, and 11 
(47.8%) HEAI patients. Enterobacter strains were concentrated in HAI class 
(16 cases, 14.6%). Gram-positive cocci in clusters (staphylococci) was in 79 
(18.1%) CAI, 127 (38,7%) HAI, and 51 (44.0%) HEAI cases. Proportion of 
S. aureus among the staphylococci was 77.2% in CAI, 31.5% in -1, and 
21.5% in HEAI patients. Percentages of coagulase-negative staphylococci 
(CNS) were 22.8,68.5, and 78.5%, respectively. Gram-positive cocci in chain 
were found in 51 (11.2%), 62 (18.9%), and 26 (22.4%) in CAI, HAI, and 
HEAI categories, respectively. Within these cases, proportion of enterococci 
was 25.5% in CAI, 33.8% in HAI, and 38.5% in HEAI findings. Gram- 
positive diplococcus (S.pneumoniae) was in 74 (16.9%), 9 (2.7%), and 5 (4.3%) 
cases in these categories. Candida strains (18 cases) were seen in HA1 and 
HEAI categories only. Contamination was caused by Gram-positive bacteria: 
CNS were in 74 cases (68.5%). Propionbacterium sp. in 15 cases (13.9%), Bacillus 
sp. in 7 cases (6.5%), and other Gram-positive cocci in 10 cases (9.3%). 
Anaerobes 
Conclusions: We conclude that classification of positive blood cultures 
according to Gram-stain and simple clinical data generates practical informa- 
tion for empirical antimicrobial treatment. Combining these statistics to 
locally collected antibiotic resistance data and good clinical judgment should 
offer meam for creating more accurate treatment guidelines for septic 
infections. 
The use of Pime-trend analysis in the design of 
empirical antimicrobial treatment of urinary tract infection (Un) 
D. Raveh, B. Rudensky, M. Huerta, Y. Anv and A. Ymnon 
jerusalem, IL 
Background Selechon ofemplncal treatment ofUTI is traditionally based on 
unne culture results from the local mrcrobiology laboratory. These results may 
be too general to be applicabie to treatment of the individual paaent. 
Methods: We analyzed a large database of urme cultures from the first 
3months of each year over a 10-year period (1991-2000). Included were 
only samples, from whch one organum was grown at >lo5 colony forming 
un~ts  (A) per mllhter. Trend statistical tools were applied to assess the decay 
in actlvity of indindual antibioac agents over time and to calculate suscept- 
ibdity rates of subsets of urine samples. 
Results Durmg the study period, 5272 (14%) of all sent samples grew a smgle 
orgasm at >105cfu/mL.: 36% ofpositwe cultures were catheter associated. 
The most flequently isolated orgarurns were E. coli (48%), K.pneumoniae 
(ll%), Paenrginosa (9%), Enterococcus spp. (8%), and Pmirabilis (6%). In the 
presence of a urmary catheter, compared to a clean-catch specimen, the 
relahve risk of lsolatmg E. Colr was 0.7 (95% CI: 0.7-0.8). K. pneumoniae 1.3 
(1 I-1.5), Pamgmosa 1.5 (1.3-1.8) and E.faecatrs2.1 (1.7-2.5) (P<O.W1 for 
all). Of 1923 positive cultures obtained in the emergency department (ED), 
1586 (82%) were Enterobactenaceae, compared to 221613349 poat~ve cultures 
(66%) from inpatient departments (P< 0.001). E. coli, Pseudomonnr and 
Enterococcus were isolated IJI 63, 6 and 3% of ED samples, respectively, 
compared to 38, 11 and 11% of hospital-acquired specimem (P<O.OOl). 
SuscephbhtyntesofE. cDli(n-2508) of10/14 (71%) testeddrugsdecreased 
annually by 1.7&0.6% from 1991 to 2000; that of I! mirabilis (n=333) 
decreased to only four drugs. Susceptibhty of E. cloarae (n = 129), P amginosa 
(n = 461) and Enterococcus (n = 414) r e m e d  unchanged; that of K.pnatmo- 
nrae &d not change sigdicantly over the decade for various subsets ofisolates, 
except for d a c i n  and ciprofloxacm. 
Conclusions: Trend analysis helps identify and quanafy the presence of decay 
in antirmcrobial suscephbdihes. Stratified trend analysis is a readily available 
tool which is useful IJI designing and adapting guidelines for the selection of 
empirical antibioclc treatment for the indmdual pahent mth UTI. 
vl Bacterial Endotoxins Test (BET) application to 
determine the biological activity of Bacteroides 
lipopolysaccharides and capsular polysaccharides 
A. Rokosz, J. Aleksandrowlcz, M. Fiejlia, F! Gorska, E Meisel- 
Mkolajczyk and M. Luczak 
Warsaw PL 
Objectives: To deterrmne the biological acnwtxes of LPS and CPS prepara- 
tfom lsolated from BacteroiderfraSrb and B. thetaiotaominon stnctly anaeroblc 
rods using quantitative BET (formerly LAL) method. 
RMhods: Lipopolysaccharides were extracted wtth the method of Westphal 
and Jann (1965) from three B.fmgi[is strains - two nonenterotomgemc 
(NTBF) NCTC 9343 and IPL E 323 and one enterotoxigemc (ETBF) 
ATCC 43858, as well as tiom three B. thetaiotaomicron stram of Herent 
ortgm - reference NCTC 30582, clinical 312185 and fecal 9/18. LPS 
preparanoxm were purdied accordmg to the procedure described by Gmemer 
(1975). Capsular polysaccharides were prepared from two s m n s  B jagdis 
ATCC 43858 and B hefaiotaomicron 312/85 by the method of Poxton and Ip 
(1981). Bio logd  achvity of bacterial compounds was determed wth  the 
use of quanhtahve BET method wlth chromogemc substrate S-2423 
(ENDOCHROME kt )  The test was performed accordmg to the recom- 
mendahons of producer (Charles fiver Endosafe Ltd, USA). E mli 055:BS 
LPS (Sigma Chermcal Co., USA) was apphed for comparison of LAL 
actInheS 
Results: Lipopolysacchandes showed considerably greater acavity wth  LAL 
(Lmulus Amoebocyte Lysate) reagent than capsular polysacchandes. The 
results obtamed for all Bactemrdes hpopolysacchandes (except of LPS h m  
ETBF stram) were comparable. The most acme among determmed prepara- 
hons was E colr 0 5 5  B5 LPS E colr LPS was generally several hmes more 
actwe than hpopolysacchartdes isolated h m  strictly anaerobic rods ofgenus 
Bactemides 
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Conclusions: It  can be stated that the quanticative, chromogenic BET test 
with application of LAL reagent is an useful method for determination of the 
biological activity of cell-surface antigens (LPS and CPS) isolated from the 
Bacteroidafiagilis group (BFG) rods. 
Bfg to AA and the need for continued monitoring of AR among the Bfg 
pathogens to encourage appropriate selection of AA for effective patient 
care. 
pw Enterotoxin-producing Bacteroides fragi/is (ETBF) 
strains-susceptibility to antimicrobial agents 
€? Obuch-Woszczatynski, A. Rokosz, A. Sawicka-Grzelak, H. Pituch, 
F. Meisel-Mikolajczyk and M. Luczak 
Warsaw, PL 
Twenty-two Bucteroidesfragilis strains isolated from clinical samples in Merent 
countries (England, France, the Netherlands, Poland and USA) were used in 
the experiments. In all strains the presence of enterotoxin (fkglysin) gene was 
found by PCR with primers 404/407. Drug susceptibility of B.fragilis strains 
was determined with Etest (MICs for penicillin G, ceftriaxone, amoxicihn/ 
clavulanic acid, imipenem, clmdamycin and metronidazole). MICs were 
estimated in accordance to the NCCLS recommendations (1999). All tested 
strains were susceptible to imipenem and metronidazole. Twenty-one strains 
were susceptible and one was intermediate susceptible to amoxicillin/clavu- 
lanic acid. Fourteen strains were resistant to ceftriaxone and five were found 
highly resistant to clindamycin. Au examined strains were resistant to peni- 
cillin G. Four tested strains were simultaneously resistant to penicillin G, 
ceftriaxone and clindamycin (three French human strains isolated from 
postoperative wound, peritoneal fluid and bone inflammation, and one strain 
isolated h m  pig). 
m] The increasing and decreasing antimicrobial 
resistance (AR) of the Bacteroides frag8is group (Bfg): 
comparison of 1989-1990 and 1998-1999 susceptibility 
results 
K. Aldridge 
New Orleans, USA 
Objectives: Because of numerous reports worldwide of increasing antimi- 
crobial resistance (IAR) among the Bfg we compared the MIC results of two 
studies loyears apart (1989-1990 vs. 1998-1999) to establish any IAR or 
conversely decreasing antimicrobial resistance (DAR) among selected anti- 
microbial agents (AA). 
Methods: A total of 1240 isolates were tested during 1989-1990 and 401 
during 1998-1 999. All test isolates of the Bfg were from clinical specimens 
and idendfied using selective media, biochemical proftles and GLC methods. 
Susceptibility testing was performed using a broth microdilution method as 
recommended by the NCCLS with a standard inoculum size and MIC 
determination h e r  48 h of anaerobic incubation at 35 “C. 
Results: Comparison ofthe results showed both IAR and DAR to various AA 
by the Bfg. Methronidazole was active against all test isolates. Inlipenem and 
piperacillin/tazobactam (P/T) showed equal activity at both time periods 
(>99%). Ertapenem (ETP), a new j-lactam agent, had DAR by 6% (92 and 
98%) while AR to meropenem remained virtually unchanged. The MIC90 
values for ETP and P/Twere four- and eight-fold lower, respectively, for the 
1998-1999 study. Cefoxitin resistance decreased by approximately 10% 
from 1989-1990 to 1998-1999. Clindamycin resistance remained stable 
but high (76 and 77%) at the two time periods. Conversely, ampicillin/ 
sulbactam was less active against Bfg with IAR from 3 to 8% predominantly 
among non-B.fiugi& species. Trovafloxacin activity remained comparable 
for the two time periods (AR-<lo%). All isolates h m  both time periods 
were resistant to penicillin G based o n  MIC values and/or B-lactamase 
production. 
Conclusion: Unlike IAR among aerobes which can be linked to 
antimicrobial selective pressure, the changes in AR among the Bfg lack such 
an established link. The present data emphasize changing susceptibility of the 
I P965 I Increased cross-resistance to antimicrobials among 
the Bacteroides fragiiis group (Bfg) from blood using 
clindarnycin (CL) and cefoxitin (FOX) as phenotypic markers 
K. Aldridge and M. Gelfand 
New Orleans, Louisiana, Memphis, Tmnessee, USA 
Objectives: Bfg bacteremia has been shown to be a risk factor for increased 
morbidity and mortality in patients receiving inappropriate antimicrobials 
based on in vitro susceptibility. This study compares cross-resistance para- 
meters of blood isolates showing reduced susceptibility (n) to CL and FOX. 
Methods: Cumulative MIC data was collected over a 10-year period for Bfg 
blood isolates (maximum of 542 isolates). MIC values were determined using 
a broth microdilution method as recommended by the NCCLS. Rs was 
defined as an MIC value interpreted as intermediate or resistant by NCCLS 
guidelines. 
Results: The overall incidence of rs to CL was 22% and n to FOX was 16%. 
Isolates with nCL showed decreased antimicrobial susceptibility (DAS) of 34- 
54% to ceftriaxone (CTR), cefotaxime (TAX), and cefotetan (TAN) while 
rsFOX showed DAS of 3r%6%. For ertapenem (ETP), meropenem (ME), 
and imipenem (IM) DAS of 2 . 5 4 %  for rsCL isolates and DAS of 444% for 
rsFOX isolates was noted. For ticarcillin-clavulanate VC), ampicillin-sul- 
bactam (AS), and amoxicjllin-clavulanate (AC) DAS of 13-23% for aCL 
isolates and DAS of 1519% for rsFOX was found. No resistance to 
piperacillin-tazobactam (PT) was found among any isolates. Isolates with 
double phenotypes of nCLFOX showed DAS of >25% for CTR, TAX, 
TAN, ETP, ME, TC, AS, and AC. 
Conclusion: Continued increases in antimicrobial resistance among Bfg to 
individual agents has been repeatly documented. This study has documented 
that IS to CL and FOX compromises the activity of other agents in the same 
and other classes of antimcrobial agents against Bfg isolates. 
/p9661 Fatal gas gangrene and septicemia caused by 
Clostridium septicurn. a case report 
C. Pappa, Z .  Salem, N. Chardampalus and E. Trikka-Graphakos 
Athens, GR 
Septicemia caused by Clostridium septirum is an uncommon but almost 
invariably fatal idection. Most of the cases have been described in patients 
with colonic carcinoma, hematologic maltgnancies and cyclic neutropenia. 
We describe a case of gas gangrene and septicemia in a patient without any 
underlying disease. A 64-year-old male was admitted to the emergency 
department with clinical signs of acute abdomen, in severe septic shock. 
Skin lesions characteristic of gas gangrene (tense, white, cyanotic skin) were 
observed during inspection of the perineum and scrotum. Treatment with 
penicillin and clindamycin initiated immediately. The laboratory tests at the 
time of admission showed coagulation disorders while the abdominal CT-scan 
revealed gas in the peritoneal cavity and retroperitoneal space. During 
sigmoidoscopy a penetrating injury, 4-5cm from the anal sphincter was 
found. During exploratory laparoscopy signs of myonecrosis (gas gangrene) 
and focal necrotic lesions ofthe intestine were observed. After that Hartman’s 
operation was performed. The patient died 6 h after the operation. Gram’s 
stain smear showed the presence of large Gram-positive rods and absence of 
neumphils. C. repticum was isolated &om blood, peritoneal and perianal tissue 
culture. Gas gangrene and septicemia, caused by C. septicurn is not common 
and has been described mainly in patients suffering fiom mahgnant diseases, 
cyclic neutropenia, diabetes mellitus and severe cardiovascular disorders, but 
our case shows that it occasionally may occur in patients without any 
underlying disease. 
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1 P967J Rate of anaerobic and nonanaerobic bacteria in 
human mixed infections 
M. H. Salari, G. Hassanpour and M. Najafi-Mosleh 
Ehran, IR 
Objectives: It is now generally recognized that anaerobic bacteria may be 
involved in most human bacterial infections that follow any form of surgery or 
are related to those body sites that have a large anaerobic population. The aim 
of this study was the detection of anaerobic and nonanaerobic bacteria in 
human mixed infections. 
Methods: In this study, samples of 498 patients with periodontitis, abscess and 
sinusitis were collected. Then the samples were cultured under anaerobic, 
capnophilic, microaerophilic and aerobic conditions using selective and 
nonselective media. Isolates were characterized to species level by conven- 
tional biochemical tests and by a commercial rapid test system. 
Results: In the patients with periodontitis, detected bacteria were Pophyr- 
omonas gingivalis (45%), Adinobm'llus actinomyretemcomitans (36.8%), EikneUa 
corrodens (34.4%), Prevotellu intermedia (33.1%), Capnocytophaga spp. (31.9%), 
Ftrsobacterium nucleatum (22.5%) and Prevotella melanogenica (17.5%). In the 
head and neck abscesses, isolated bacteria were Staphylococcus aureus (15.8%), 
Prevotella me2utiinogeniur (15.8%), Esherirltia coli (14.9%). Mebsiella pneumonia 
(14.9%) and Pseudomonas aeruginosa (13.2%). The predominant bacteria 
species of intra-abdominal abscesses were identified as Staphylomms aureus 
(77.6%), Streptocorns group A (46.3%) and Bacteroidesjagilis (37.3%). Brain 
abscesses had Streptococcus nongroup A (36.4%) and Peptostreptocouuc spp. 
(10%). Also, Streptococnrs nongroup A (36.4%) and Staphylococcrrs epidermidis 
(15.2%) were isolated from sinusitis. 
Conclusion: The studies and our findings have shown that many of the 
infectious processes involving anaerobes are polymicrobial, consisting of 
mixtures of obligate anaerobes or mixtures of obligate or microaerotolerant 
anaerobes and facultative organisms. Symbiotic relationships frequently exist 
between some ofthe bacteria involved in polymicrobial infections, which can 
act synergistically in the production of diseases. Anaerobes must therefore be 
sought in a wide variety of clinical specimens. 
microorganisms in all diagnostic groups. The other bacterial species, including 
Prevotella spp., Fusobacterium spp., Peptostreptococcus spp. and Wolinella recta were 
detected in the samples of patients. The data show prevalence rate of 
monobacterial and polybacterial infections in the patients with adults period- 
ontitis were 47 (19.4%) and 70 (28.9%), respectively. 
Conclusion: The data of the present investigation suggest that there is great 
heterogeneity in the subgmgival bacteria among subjects. Cultural methods 
for recovery of bacteria are stiil scaodard in microbiology. However, as many 
bacteria in the oral cavity cannot be cultured, it is likely that these still 
uncharacterized bacteria mtght play a role in the initiation and progression of 
periodontal diseases. 
IP969jl In vitro activity of moxifloxacin in patients with 
severe odontogenic infdons 
B. Al-Nawas, S. Buff and M. Maeurer 
Mainz, D 
Introduction: Penicillin resistance is reported in more than 50% of patients 
with severe odontogemc infecaons (Lews 1995). 
Objectives: Prospective longitudmal study on paaent related in vim activity 
of moxifloxacin in eplsodes with severe odontogenic mfections. 
Methods: In 19 patients with severe, life-threatening odontogenic abscesses 
microbiologic samples were drawn by extraoral incision or intraoral needle 
aspwanon. Clinical data on prior therapy and d d o n  of post operative 
treatment was collected. After cultivation and identification of aerobic and 
anaerobic pathogens MIC were determined using E-test stripes for pemcillin, 
amoxicillin + clavulvlic acid (amoxiclav), levoflowcin (levo), moxifloxacin 
(moxi), c h i a m y c i ~ ~  (clinda), metmnidazole (mem). 
Results: From 19 episodes, ofwhch 1 was culture negative, 28 aerobes and 14 
anaerobes were isolated. The rate of resistance using DIN breakpirits is given 
in the table. 
1 P968 1 Prevalence rate of monobacterial and polybacterial 
infections in patients with adult periodontitis 
M. H. Salari 
Tehran, IR 
Objectives: There is no doubt that anaerobic and capnophihc bacteria play a 
major role in the pathogenesis of human periodontal disease. Microbiological 
studies have identified more than 242 bacterial species in periodontal pockets 
which less than 20 species are periodontopathogen. The purpose of this study 
was the detection ofmonobacterial and polybacterial infections in the patients 
with adults periodontitis. 
Methods: In this study, samples of 242 patients with adult periodontitis were 
collected with sterile paper points from the deepest periodontal pockets. The 
samples were cultured under anaerobic and capnophilic conditions 
using selective and nonselective media. Isolates were characterized to 
species level by conventional biochemical tests and by a commerical 
rapid test system. 
Results: Ach'nobm'llus acfinomyretemcomitans (25.2%), Porphymmonas gingivalis 
(20.7%) and Eikenella corrodens (16.5%) were the most frequently detected 
Community-acquired UTI 
Penlcilltn Amonclav Chda Lev0 Maxi Meem 
(96) ("/.I W) W) W) W) 
Aerobes (n=28) 11 0 7 0 0 100 
Anaerobes (n = 14) 0 0 8 8 0  15 
Paaents (ti = 18) 13 0 20 6 0 100 
Prior treatment Four patients developed the severe infection m spite of 
adequate antiblotic theraps one panent, who received memnidazole had 
resistant bacteria, 14 patients had no prior therapy Patients were hospitalized 
for a mean of 8.25 days. The mean total treatment time was 16.7 days. Most 
patients received arnomclav postoperatively. 
Conclusion: Although metromdazole is found in many guidehes for treat- 
ment of odontogemc UIfeChOnS its routine use should be &cussed crihcally. 
The role of penicdhn and clindamycm in Me-threatening SituahOns is 
questionable. In none of the patients reslstance against ammclav or mon- 
floxacln was found. A possible mle of ~~~xiiloxacin as an alternative for 
patlents with hypersensitivity to fl-lactam antibiohcs is to be tested in future 
prospective clinical trials. 
Fl Acute pyelonephritis: 5-year experience in a 
general hospital 
J. De La Torre, J. L. Prada, A. Del Arco, M. Perez, M. P. Molina 
and N. Montiel 
Marbella, E 
Introduction: Pyelonephritis is one of the most prevalent cause of morbidity 
and mortality. Our goal is to analyze the clinic and epidemiologic character- 
istics of all the inpatient pyelonephritis treated in our hospital. 
Methods: This is a retrospective study which analyzes all the pyelonephritis 
attended in our center fiom 1 January 1996 to 31 December 2000. Data were 
obtained fkm administrative and microbiology records. 
Results From a total of 59329 admissions, 353 were diagnosed of acute 
pyelonephritis (0.59%). This was the main diagnosis in 85% of the patients. 
The mean age was 47 years (ranged from I to 92 years). The rate of female/ 
male was 1.7. The mean length of stay was 5.97days. 
Concurrent problems: Diabeteswas foundin 61 patien& (17.28%). pregnancy 
in 19 patients (5.38%), chronic renal failure in 19 patients (5.38%), and 
congenital anomahes in five patients (1.41%). Urine culture were carried out 
in 284 (83%) cases with the next results: 149 positives (52.46%), 110 negatives 
(38%), and 25 contaminated (8%). Causal microorganisms were identified in 
160 cases (45%): Esclterichiacoli 107 (66.85%), Proteus 10 (6.32%). E n t m m s 9  
(5.69%), Mehiella 8 (5.06%). Staphylococcus 7 (4.43%) and Citrobacter 5 
(3.16%). The E. coli antibiotic-susceptibility study demonstrated resistance 
to: quinolones in 30 cases (28.04%), amoxicilin-cladanate in five cases 
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(4.67%), cefotaxime/ceftciaxone in two cases (1.87%). E. coli quinolone 
resistances increased from 27% in 1996 to 38.5% in 2000. Abdominal 
ultrasound scans were done in 230 patients (82.43%) and intravenous uro- 
graphy in 21 patients (6%). Obstructive uropathy was detected in 98 patients 
(27.76%), the main came was kidney and ureteral lithiasis (71 patients). 
Therapeutic procedure was required in 42 cases (12??), mainly nephostomy 
(36 patients), and in six partial nephrectomy or ureter-nephrectomy. Acute 
renal fdure was detected as complication in 28 cases (7.93%). Mortality was 
1.7% (seven patients). 
Conclusionc In our hospital, the inpatient pyelonephritis is an infection 
affecting predominantly women, in the middle of their He, with obstructive 
uropathy in one-third ofthe cases. Causal agent is detected in about halfofthe 
cases. E. coli causes more than 65% of these cases with a si&icant increment 
of quinolone resistance. So in OUT area, severe pyelonephritis must be treated 
with other antibiotic than quinolone, as amoxicihn-cladanate or cephalos- 
porins. 
1 P971 I Acute focal bacterial nephritis in children 
J. Bernatoniene and A. Jankauskiene 
Vilnius, LIT 
Objective: Acute focal bacterial nephritis (AFBN) is a focal bacterial infection 
localued within the parenchyma of the kidney which may develop with 
abscess formation. Clinical features of such evolution include fever, chills, 
flank pain and the hematological findings of infective disease. The aim was to 
review the presentation, methods of diagnosis, incidence of concomitant 
urological abnormalities and treatment effectiveness in children with AFBN, 
also known as lobar nephronia, a severe nonliquefactive infection involving 
one or more renal lobules. 
Patients and methods: Twenty-eight children (age range of 6 days to 15 years 
with an average of 8years) diagnosed with AFBN over a 5-year period in 
Vilnius University Children Hospital were retrospectively reviewed. Their 
age, gender, presenting symptoms, presence of urinary tract abnormalities, 
methods of diagnosis and treatment were assessed. 
Results: All the patients presented a fever and persistent flank and abdominal 
pain on affected kidney. Ultrasound showed local enlarged renal volume and 
space-occupying masses with low-level echoes. CT scans demonstrated focal 
enlargement of affected kidneys and low-density solid space-occupying 
lesions. Predisposing conditions were found in 10 patients: vesico-ureteric 
reflux (three), urethra diverticulum (one), hydronephrosis (one), nephro- 
sclerosis (two), and urethra stenosis (three). Evolution to renal abscess 
occurred in 10 patients. All 28 children received intensive intravenous and 
oral antibiotics. 
Conclusions: Acute focal bacterial nephritis should be strongly suspected 
when a patient presents fever, chills and pain on the aected side and has 
a history of urinary tract infection. In addition, ultrasound and CT examina- 
tions suggest evidence of parenchymal space-occupying lesion, and the 
renal mass and its clinical symptoms disappear following anti-infection 
treatment. 
nondabetic females were: E.coli (64.2% vs. 66.8%). Prateus sp. (8.1% vs. 
7.6%), Pseudomona sp. (7.6% vs. 8%). Enterocow sp. (7.6% vs. 8.8%). 
Conclusions: The prevalence of ASM is increased in women with diabetes 
melhtus. The commonest mcroorgamm isolated IS E. coli. The good gly- 
cemic control does not decrease the kequency of ASM. 
I ~ 9 7 3  1 Antimicrobial therapy for lower urinary tract 
infections (LUTI) 
G.-A. Popescu, A. Hristea, A. Dobrita, G. Sterioiu, L. Gavriliu, 
S. Gavriliu, R. Hristea and C. Popescu 
Bucharest, RO 
Background: Ethiological therapy of LUTI changes because of antimicrobial 
resistance of germs and of improved eEciency-zost relation need. 
Objectives: To evaluate some LUTI therapy regimens in accordance to: 
known or unknown ethiology uncomplicated or complicated/iterative 
LUTI, respectively. 
Methods: There was a 192 LUTI patients retrospective study. The suggestive 
symptoms for LUTI associated with positive uroculture or leukocyturia 
represented inclusion criteria. High fever suggested upper UTI, represented 
exclusion criteria. Ethiology has been identified for 96 patients. Therapy 
results were defined on the basis of clinical (symptoms remission in less than 
72 h) and bacteriological results. 
Results: 
1 Clinical success rate (CSR) has been 91.6% and bacteriological eradication 
(ER) 86.45%. Aminopenicillins and fist-generation cepbalosporins have 
been less effective (76.19 and 66.67% with P=0.008 and P=O.OOl). 
2 Uncomplicated LUTI (114 patients) CSR has been 93% and ER 87.3%, 
respectively. Among the used regimens, more effective than the average 
proved to be fosfomycin (CSR = 100%. ER 8/8 cases) and F-quinolones 
(CSR= 98.5% and ER= 97.5%, respectively). We noticed a quite high 
frequent 5 3  days therapy rate: 50.7%; the efficiency being approximately 
the same for short or standard (7days) therapy; CSR having P=O.47, 
ER= 0.72. 
3 The CSR regarding the complicated LUTI has been 97.3% and 
ER = 84.6%. According to this, <3 days therapy proved to be a clinical 
failure (14.2% vs. 4.65% for uncomplicated LUTI, P=0.025) and a 
bacteriological failure (8/21 cases vs. 20/21 cases) more fkequently. The 
most useful antimicrobds proved to be the F-quinolones (CSR =94.1% 
and ER=97.7%). 
4 The CSR for unidentified ethiology (96 cases) has been 90.6% and the 
most usell antimicrobials proved to be the F-quinolones (96.2%), fosfb- 
mycin (100%) and cotrimoxazole (9/11 cases). 
Conclusions: The most-effective first-line therapy for uncomplicated LUTI 
proved to be fosfomycin in monodose and F-quinolones for 3days (F- 
quinolones monodose not evaluated). A 7-day course of F-quinolones proved 
to be effective for the complicated or recidimt LUTI. If we cannot idennfy 
LUTIS causative agent, we may use F-quinolones or cotrimoxazole. Using 
aminopenicillins or first-generation cephalosporins meant an unacceptable 
failure rate. 
I P972 I Asymptomatic microbiuria in diabetic females 
E. Kalcgeropoulou, E. Karabatsaki, P. Tsiodra and A. Ehtratopoulos 
Athens, CR 
Objective: To study the prevalence of asymptomatic microbiuria (ASM) in 
diabetic females. 
Methods: The s t u d y  included 408 females with diabetes mellitus type I and I1 
and n o  abnormalities of the urinary tract (mean age: 62 z t  9 years; range: 
19-88years) and 410 nondiabetic females (controls) of a mean age of 
6 1 f 8.6 years, all admitted in our department in a 4-year period. We defined 
ASM as the presence of at least 10 (five) colony-forming units per milliliter of 
one or two bacterial species in a culture ofclean-voided midstream urine from 
a female with no symptoms of a urinary tract infection. The patients were 
distinguished in two groups according to their glycemic control indicated by 
their HbAalc: in group A, HbAlc was<8,0, and in group B, HbAlc 
was >8.0. 
Results: Group A included 150 patients (36.7%). The prevalence ofasympto- 
matic microburia was 22% in diabetic females and 6% in nondiabetic ones 
( P <  0.01). The prevalence ofasymptomatic microbiuria was 23.6% in group 
A and 21% in group B. No association was evident between current HbAlc 
levels and the presence of ASB. The pathogens isolated in diabetic and 
189741 Urinary tract infections in adults with diabetes 
mellitus 
D. Kofteridis, E. Papadimitraki, S. Lazaridou, Z.  Saridaki, I. Mixaki, 
I. Kazakou and E. Ganotakis 
Herakliun, GR 
Objectives: Urinary tract infections (UTIs) are common and sometimes life- 
threatening infections in diabetic patients. The aim of ths study was to 
investigate the epidemiologic, microbiologic and clinical features of UTI in 
adults with mabetes mellitus @M). 
Methods: Patients were identifiedkm a retrospective study of diabetic adults 
hospitalized with UTI. The medical records of 101 patients with type 2 DM 
and UTI,  65 (64.4%) female and 36 (35.6%) male, were reviewed on the basis 
of a specific questionnaire. 
Resuk The mean age was 70.7 + 12.8 (range 18-95) years with mean 
diabetes duration of 14+8yem. Ninety-six out of 101 (95.1%) were 
community-acquired UTIs. Pyelonephritis had 97 (96.1%) patients. Thirty 
diabetics (29.7%) were classified as complicated U T I  and the majority of 
underlying conditions found, were indwelling urinary devices in 16 (15.8%), 
calculi in 14 (13.9%), andresidualurine in 8 (7.9%) patients. Common clinical 
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features included fever, dysuria, flank pain and vomiting noted in 100, 51, 
46.9 and 35.7%. respectively. Urine analysis showed pyuria in 89%. and 
bactemria in 84% of the patients. Bacteremia in 17% and increased levels 
of urea and creatinine in 23% were common complications. From 102 
avadable urine cultures, 81 microorganisms were isolated. Esdterichia coli 
was the most-common bacteria isolated in 49 (60.5%) cases followed by 
Enterococnccfaecnlis and Proteus in six (6.2?6) and Mebsiellapnarmoniae in three 
(3.7%) cases. AU patients received antibiotics. Apyrexia was obtained in a 
mean time of 5.2+3.7 (1-20) days. Four patients (3.96%) died fium the 
underlying infection. 
Conclusion: Our data suggests that E. coli was the most common bacteria 
isolated in elderly diabetic patients with pyelonephritis. Complicated UTIs 
and bacteremia was another quite common finding among these patients. 
Apyrexia occurred in a mean time of 5 days, which probably means a more 
dificult eradication of infection. 
j ~ 9 7 5  1 E I T ~  of pivmecillinam in acute uncomplicated 
urinary tract infections due to ampicillin-sensitive and 
ampicillin-resistant Escherichiacoli 
€? Menday and S. Nielsen 
South Molton, UK; Ballemp, DK 
Objective: Current level of resistance to ampicillin in Escherichiacoli is such 
that alternative first-line empiric treatments for acute uncomplicated urinary 
tract infection are required. The efficacy of pivmecillinam in urinary tract 
infections due to E.coli in relation to ampicillin susceptibhty has been 
determined. 
Methods: Data were taken &om a large prospective double study. The analysis 
involved women with community-acquired infection who were given a 7&y 
course of pivmeclllinam of 200 mg two or three times daily. Bacteriological 
efficacy (E.  coli eradication) and clinical response (cure or significant improve- 
ment) were determined at day 8-10 (short term) and day 3 5 4 9  (long term). 
Short-term outcome was used when no long-term data was available. 
Ampicillin and mecillinam susceptibility was determined by agar disk &- 
sion using the SRGA methodology. Isolates reported as sensitive or inter- 
mediate were considered susceptible for the analysis. 
Results No significant differences were seen between the two dosages, so the 
data were pooled. 
Ampicillin- and mecillinam-susceptible E. coli (n = 288 bacteriological; 
n =  299 clinical): bacteriological success was achieved for short-term in 
273 (94.8%) and for long term in 240 (83.3%). Clinical response was 
achieved for short term in 272 (94.1%) and for long term in 253 (87.5%). 
Ampicillin-resistant and mecillinam-susceptible E.  coli (n = 54 bacteriolo- 
gical and clioical): bacteriological success was achieved for short-term in 54 
(100%) and for long term in 44 (81.5%). Clinical response was acheved for 
short term in 54 (100%) and for long term in 51 (94.4%). 
There were no statistically sigNfcant differences in outcomes for ampic&- 
susceptible/resistant E. coli [l]. 
Conclusions: Pivmecillinam is bacteriologically and clinically effective in 
patients with acute uncomplicated urinary tract infection due to E.coli, 
regardless of ampicillin susceptibility. Pivmecillinam is therefore a suitable 
empiric first-line treatment, particularly in areas where resistance h t s  the 
value of ampicillin. 
Reference 
1. IOhlmctcr G. Journal of Antiminobid Ckemithmpy. ZMX), S1 (46 Suppl.): 15-22. 
/p976j Once-daily versus thrice-daily gentamicin in the 
treatment of acute pyelonephritis in children 
C. Y. Chong, A. S. L. Tan, W. Y. M. Ng and S. M. Chao 
Singapore, S C P  
Objectives: Urinary tract infections (UTI) are a common cause of hospital 
admissions in children. The aim of this study was to examine the safety and 
efficacy of once-daily (OD) gentamicin compared to conventional eight 
hourly dosing (TDS) in chddren with acute pyelonephritis. 
Methods: This is a prospective, randomized-controlled trial of children 
between lrnonth and 13years of age with presumed UTI. They were 
randomized, with parental consent, to OD gentamicin 5mg/kg/day or 
TDS gentamicin 6 mg/kg/day divided eight hourly. Oto-acoustic emission 
hearing tests, serum creatinine were done at baseline and at the end of 
gentamicin treatment. When the patient was afebrile, the gentamicin was 
converted to a suitable oral antibiotic to complete the course of treatment. A 
renal ultrasound and dxmercaptosuccmic acld (DMSA) scan were done w h n  
5 days of admission A follow-up micturahng cystourethrogram was done at 
6 weeks and repeat DMSA at 3 months to look for renal scarring. 
Results: A total of 220 patwnts wth  presumed UTI were recruited out of 
which 134 hadpyelonephritls and 117 were analyzable (57 OD, 60 TDS). The 
median age was 7 months, males constituted 50%. The majority were due to 
E.  coli (8Wo) ofwhich 93% were sensihve to gentamicin and e@t (6.8%) had 
positwe blood cultures. Comparing the two groups, there was no n&cant 
Merence in age, sex, duraaon of fwer before admission, pyuna, mtrite 
positiwcy, Uihd total whte blood count. All had negahve urine cultures after 
2-3days of treatment, demonstmhng mcrobiolgic efficacy. There was no 
M i n c e  between the two groups in terms of ototoxmty, nephrotoxinty, 
duration of gentamicin treatment, time to fever defervescence and r e d  
scarrmg. 
Conclusion: OD gentaminn IS as efficacious as TDS gentarmCin in the 
treatment of pyelonephritis ID children mth  no M m n c e  111 ototoncity 
and nephrotoxmty. More impoaantly, there was no Merence III the inci- 
dence of renal scarrmg in the long term. 
[ P977 I Readmission factors in infectious pyelonephritis 
J. De La Torre, J. L. Prada. A. Del Arco, M. Perez, M. P. M o h  
and N. Monhel 
Marbella, E 
Objective: To analyze factors prowdmg to hospital readmission in 6months 
after discharge by infecnous pyelonephrins (IP). 
Methods: Ths  1s a retrospechve and descriphve study of IP cases treated as 
inpahent in our center h m  January 2000 to December 2000. We have 
considered the new a b i o n s  6 months later. Readmitted IP (IUP) patient 
characterishcs were analyzed and compared w t h  the no-readmitted IP 
(NRIP) group. Student’s t test was used to compare and Chi-square to rate 
the comparison. 
Results: From 73 IP patients, 13 (17.8%) were RIP patients. The mean age 111 
RIP group was 66.38 * 21 versus 47 i 24 in NRIP patients (P= 0.046). We 
found no Merewes when compared gender, prewous urine tract mfection, 
previous uro logd  procedure, urine tract abnordhes ,  pregnancy, diabetes, 
neurogemc bladder, permanent urinary catheter or clinical data (dysuna, 
fever, shahng chills, flank pain, nausea, vomting and painful kidney percus- 
sion) or general laboratory data (leukocytes, platelets or creatinine) We found 
Merences m the presence of obstructlon in the urme tract (by ultrasounds or 
lntravenous urography): there was obstruchon m 26% in RIP group versus 9% 
m NRIP group (P=  0.018). Rate ofposihve blood cultures andurine cultures 
were s d a r  in both groups and we found no Merences in the isolated 
rmcroorgamms. The mvasive procedures (nephmstomy or surgery) were 
more frequent in RIF’ patients compared wth  NRIP (53% vs. 9%. P =  0.W). 
The length of stay m RIP group was 6.85 versus 6.01 ID NRIP pahents 
Conclusion: In IP, the urine tract obstrucnon and the need of mvasive 
procedures (nephrostomy or surgery) are associated mth a higher rate of 
readrmssion 
lp9781 Acute obstructive pyelonephritis: epidemiologic 
and clinical characteristics 
J. De La Torre, J. L. Prada, A. Del Arco, M. Perez, M. P. Molina 
and N. Montiel 
Marbella, E 
Introduction: Obstruction of the genitourinary tract can facilitate pyelone- 
phritis (obstructive pyelonephritis, OP). Our goal is to analyze the clinical and 
epidemiologic characteristics of all the inpatients suffering &om pyelone- 
phritis treated in our hospital compared with OP cases. 
Methods: Retrospective and descriptive study of OP cases treated as inpatient 
in our center from January 2000 to December 2000. We have considered OP, 
all cases with kidney litiasis and/or pyelocalicial enlargement, both detected 
by ultrasound scan and/or intravenous urography. Student’s t test was used to 
compare and Chi-square to rate the comparison. 
Results: A total of 73 inpatients were treated of infectious pyelonephritis, 39 
of them (53.4%) were OP. Mean age was 51 f 2 2 .  Compared with non- 
obstructive pyelonephritis (NOP), there were no differences in age, gender, 
previous urine tract infection or previous urological procedures. In OP group, 
the abnormalities of urine tract were sigtllfcantly higher (882% vs. 47%, 
P= 0.003). There were no diflerences in incidence of diabetes, pregnancy, 
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HIV infection or existence of permanent urinary catheter. There were no 
signrfcant differences in the c h c a l  data (dysuria, fever, flank pain, nausea, 
vomiting and painful kidney percussion) or general laboratory data (leuko- 
cytes, platelets or creatinine). Rate ofpositive blood cultures and urine culture 
were similar in both groups (blood 24.75% vs. 26.11% urine: 48.7% vs. 
50.0%). In OP group, the microorganisms isolated by incidence were E. coli 
(52??) and Klebsielh (13%), without differences in comparison with NOP 
group. Invasive procedure were used more frequently in OP patients (38% vs. 
15%. P =  0.041), mainly nephrostomy (13 patients, 33%) and kidney surgery 
(two patients, 5%). We found no differences in time of antibiotics course or 
length of stay. In OP group, two patients died, and in NOP one person. The 
readmission rate in 6 months was higher in OP group, but without statistical 
sidicance (26% vs. 9%. P =  0.061). 
Conclusion: The only difference found between OP and NOP patients is that 
OP is more frequent in patients suffering fiom urine-tract anomalies. In our 
study, there were no clinical differences defining OP  and OP need of 
aggressive therapeutical procedure in more than 3P? of the cases. So t h i s  
suggests that an ultrasound scan, to rule out OP, is always necessary in patients 
with pyelonephritis requiring hospital admission. 
/p97911 Rate of Chlamydia trachomatis and genital 
Mycoplasma in men with nongonococcal urethritis and its 
comparison with control group 
M. H. Salari and N. Badanli 
Tehran, 1R 
Objectives: Urethritis in men has been categorized historically as gonococcal 
or nongonococcal (NGU). The major pathogens causing NGU are Chla- 
mydia trarhomatis and Ureaplasma urealyticum. Trichomonas vaginalis may be 
involved occasionally. In up to one-half of the cases, an etiologic organism 
may not be identified. The aim ofthis study was the detection of C. trachomatis 
and genital Mycoplasma in men with nongonococcal urethritis and its com- 
parison with control group. 
Methods: In this study, urine urethral swab specimens and blood samples 
collected from 125 men with nongonococcal urethritis and 125 men without 
NGU as control group were examined by culture, microimmunofluorescence 
and cell culture methods. 
Results: C. trachomatis seropositive NGU was detectedin 20% ofthe cases and 
0.8% of control group. U. urealyticum, Mycoplama hominis and M.genitalium 
were isolated from 22.4,7.2 and 0.8% of the patients, and 7.2, 6.4 and 0% of 
the control group, respectively. 
Conclusion: Zstatistical analysis test with 95% confidence interval showed 
that the difference rate of isolated C. trarhomatis (P< 0.00003) and U. urea- 
lyticum (P< 0.0004) in case and control groups were s imcant .  
I P981 I The role of 0-antigen of proteus bacilli in infection- 
induced urinary stones' formation 
A. Torzewska, P. W Staczek and A. Rozalski 
Lodz, PL 
Proteus bacilli causes urinary tract infection (UTI)  primarily in the complicated 
urinary tract, most frequently in patients with indwelling catheters or 
structural abnormalities of the urinary tract. Urinary stones are a common 
complication of these infections. Urease is the essential virulence factor in 
stones' formation. Ammonia, produced hy the enzymatic hydrolysis of urea, 
elevates urine pH causing a supersaturation and crystalltzation of magnesium 
and calcium ions as struvite (ammonium magnesium phosphate) and apatite 
(calcium phosphate), respectively. Additionally, extracellular polysaccharides 
HIV I1 
of Proteus sp., which have negative charged residues may accelerate crystals' 
growth and calculi formation by concentrating magnesium and calcium ions 
during crystals formation. The goal ofthis study was the analysis of the in vim 
crystal growth in the presence of urease-negative mutants of various hoteus 
strains or their 0-antigen of known chemical structures. Polyvalent cations 
(magnesium and calcium) binding by 0-antigen and whole cells of urease- 
negative mutants in artificial urine was measured by atomic absorption 
spectroscopy. In crystallization experiment, polysaccharide or urease-negative 
mutant was added to artiftcial urine, pH was elevated to 8.0 (to mimic  urease 
activity) by addition of 1 M ammonium hydroxide to induce crystallization. 
Crystal formation was examined by phase-contrast microscopy and by particle 
analysis with Coulter Counter. It was found that al l  of the examined strains 
bound cations through the electrostatic interactions from artificial urine but 
enhancement of stmvite formation was inversely proportional to their 
binding ability. Of all tested strains and their 0-antigens, only I? vulgaris 
012, which bound cations very weakly, enhanced the formation of crystals in 
vitro. Most probably, in this case 0-antigen binds cations, which then are 
easily released to the surrounding urine. Subsequent supersaturation of the 
magnesium and calcium leads to the precipitation of struvite and apatite 
crystals. We hope that our results will be confirmed in the future using an in 
vivo experimental model. The knowledge concerning molecular basis of 
urinary calculi formation will be useful in the diagnostics and treament of 
Proteus infections which lead to this complication. 
lp982) Uropathogens: a laboratory view 
A. M. Khalil, E. A. El-Sawy, H. Abol-Enein and M. A. Ghoneim 
Mansoura, E G Y  
Objective: To find out the frequency and antimicrobial susceptibility of 
urinary pathogens in hospitalized patients. 
Methods: All urine isolates Gom urine cultures were collected Gom inpatients 
in Urology and Nephrology Center in Mansoura University. The analysis was 
based on the microbiology laboratory data. Urine cultures were done in 
laboratory according to the standard techniques. The identification of isolates 
and antimicrobial Susceptibility tests were performed using the Microscan 
Walk Away 40 dried MIC/ID panels. 
Results A total of 235 isolates &om urine cultures were analyzed. There were 
89.4% Gram-negative pathogens among them and 9.4% were Gram-positive 
pathogens. The predominant species was Eschichiucoli which represented 
29.4% of the isolates. The isolates that followed were mebsielh spp. (19.6%), 
Pseudomonac aeruginosa (11.9%), Enterobucter spp. (8.9%). Serrafia spp. (8.5%), 
Citrobacter spp. (5.5%) and coagulase-negative staphylococci (4.7%). These 
seven pathogens accounted 98.8% of the isolates. The highest rate of 
susceptibility among all Gram-negative pathogens was that of 
imipenem (93%) and amikacin (83.3%), the susceptibility rate of amoxicil- 
lin-clavulanate was (59%) and trimethoprime/sulphamethoxale was (36.9%). 
E. coli alone was susceptible to imipenem (92.8%), amikacin (76.8%), nitro- 
furantoin (58%), aztreonam (55%), cefotaxime (53.6%), amoxicillin/clavu- 
h a t e  (52.2%), and gentamicin (42%). Mebsiellu spp. was susceptible to 
amikacin (92.5%), ceftazidime (60%), cefotaxime (52.5%), gentamicin 
(50?h), and amoxicillin/clavulanate (50%). The susceptibility of I? aeruginosa 
to imipenem was 85.7% and to ceftazidime 60.7%. The susceptibility of 
Enterobacter spp. to imipenem and amikacin was 85.7 and 71.4%. respectively. 
The susceptibility of coagulase-negative staphylococci to penicillin was 
81.4%, cefotaxime 54.5% and was lower (50%) to the rest of the tested 
antimicrobials. AU the tested Gram-positive pathogens were susceptible to 
vancomycin. 
Conclusion: The most common pathogen among isolates from urine cultures 
was E. coli. There was no slngle antimicrobial agent with acceptable rates of 
activity against all the isolates. 
lp9841 In vitro action u
human mammary cells 
the basis of the vertlcal transmsslon of HIV dunng breast feedmg We also 
evaluate the pattern ofbasal expression of the chemokme receptors and some 
mterleukmes m t h s  system for analyzma possible level mokficauon due to the 
Of the "IV TAT in 
specific treatment with the protek T E .  
Methods: We used cellular culture of different gland epithelial cell lines: 
mec-1 and mec-2 (SV40 immortalized primary mammary epithelial cells), 
MCF-IOA (spontaneously immortalized mammary epithelial cells), and 
MCF-7 lines. The evaluation of the cellular proliferation was made with 
V. Orlandi, A. Bettaccini and A. Toni010 
Varese, I 
Objective: We aimed to assess the possible iduence ofpleiotropic factor TAT 
on mammary epithelial cells for a better understanding of the mechanism on 
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an image acquisition computer system linked to a camera microscope u b e d  
at Merent time after stimulation with exogenous TAT (100ng/mL with 
DTT). For neutralizing the action of TAT, we used an antibody anti-TAT. 
The expression of the chemokine receptors and interleukine was seen at 
cellular mRNA level with an extraction of the nucleic acid, the spectro- 
photometric quahty control, the retrotranscription and the final amplification 
of the selected regions through the specific primers. 
Results: After 24 h, TAT starts stimulating the proliferation of the MCF7 line 
cells in the order of the 25% with respect to not stimdated cells, this effect is 
neutralized specifically by the co-stimulation with TAT and antibody anti- 
TAT (1 mg/mL). In MCF 10A the proliferating effect achieve the level of the 
50% after 24 h ofstimulation respect to untreated cells; at the same manner the 
proliferating effect is neutralized by the anti-TAT. In mec-2, there is a 
proliferating effect in the order of the 25% after 24h but not in mec-1 line. 
The mec-1, mec-2, MCF7 and MCFlOA express CD4 and CXCR4, but not 
CCR5, CCR1, CCR2, CCR3. Mec-1 and mec-2 express IL-6 and IL-6 
receptor, MCF-7 only IL-6 receptor and MCF-1OAno one. No lines express 
IL 8, wMe the three isoform of vascular endothehal growth factor (vea  are 
expressed from mec-l and mec-2. 
Conclusion: The human mammary epithelial cells lines respond to the 
stimulation with TAT proliferating 24 h after, this action is specifically blocked 
with anti-TAT demonstrating that the proliferating effect is mediated by TAT. 
The line express CD4 and CXCR4 that sinergically can mediate the, already 
demonstrated in those lines, virus entry. 
lp9851 Role of cytokines and C-reactive protein (CRP) in 
the diagnosis and outcome of HIV-1-infected patients with 
pulmonary infections 
N. Benito, A. Moreno, X. Filella, J. M. Mi&, J. Gonzilez, T. Pumarola, 
M. E. Valls, M. Luna, A. Rafi6, A. TorresandJ. M. Gatell 
Barcelona, E 
Objective: To evaluate the role of several cytokines and CRP in the diagnosis 
and outcome of HIV-1-infected patients with PI. 
Methods: Prospective study of all consecutive HIV patients diagnosed of PI in 
our institution between April 1998 and May 2001. Plasma CRP and IL-lb, 
IL-6, IL-8, IL-10 and TNFa were performed at admission and 5 days later. 
Patients were included in a protocol addressed to study the etiology and 
outcome. 
Results: A total of 249 PI were diagnosed in 220 patients (160 males). Mean 
(SD) age was 39 (11) years. The main etiological groups were: bacterial 
pneumonia (BP) in 114 episodes (59 caused by Spneumoniae), Pcarinii 
pneumonia (PCP) in 37 episodes and tuberculosis (TB) in 36 cases. A total 
of24 patients &ed (10%) -PCP, 6 cases; BP, 4 and TB, 1 case. Medianlevels at 
admission of CRP and cytokines for BP, PCP and TB were: CRP (normal 
values <0.8 mg/dL) 10.2, 3.75 and 5 mg/dL, respectively (P= 0.0001); IL-8 
( N V <  10pg/mL): 19, 3 and 2.9, respectively (P=0.045); TNFa 
(NV < 20pg/mL): 46.5, 44 and 75 pg/mL, respectively (P= 0.029). Con- 
cerning the levels of IL-lp, IL-6 and IL-10, there were no statistically 
sigrdcant differences among the three etiological groups. Neither there 
were correlation between the etiologies and the values of cytokines and CRP 
performed on the 5th day. There was also no correlation between the CD4+ 
cell count and the levels of CRP and cytokines. Patiena with undetectable 
plasma RNA HIV-1 viral load (VL) had higher levels of IL-lB than patients 
with a positive VL (13pg/mL vs. .Ipg/mL, P=O.Ol). Patients with 
VL>200.000 copies/mL had higher levels of TNFa (75pg/mL vs. 
46pg/mL, P=0.006). Compared with survivors, patients who died had at 
admission higher levels of IL-6 (NV < 5 pg/mL) 95 pg/mL vs. 36pg/mL 
(P=0.014), IL-10 ( N V <  lOpg/mL) 22pg/mL vs. 6pg/mL (P=O.Ol) and 
TNFa 70pg/mL vs. 46pg/mL (P= 0.041). At day 5 post-admission, the IL-6 
remained statistically higher in those patients who &ed (126.5mg/dL vs. 
24mg/dL; P=O.O43). 
Conclusion: At admission, plasma CRP and IL-8 levels were hgher in HIV-1 
patients with BP and TNFa was higher in those with TB. There was no 
correlation between the CD4+ cell count and levels of CRP or cytobes. 
Patients with high plasma VL had h_lgh plasma levels of TNFa and patients 
with undetectable VL had high levels of IL-1fi. Patients with PI and a worse 
outcome had higher plasma levels of IL-6, IL-10 or TNFa at admission and 
maintained high plasma CRP levels on the 5th day 
I P986 1 Longitudinal study of density of expression of 
CD38 antigen on CD8+ cells in HlVlAlDS patients treated 
with HAART 
0. Beran, M. Holub, Z Kluckova and J. Spala 
Prague, CZ; Albany, USA 
Objective: HIV lnfeChOn is associated wth chroruc immune achvahon 
includmg mcreased propomon of CD8+ cells expressing CD38 anhgen 
Furthermore, a hgh  percentage of CD8+/CD3Xf cells m HIV pauents may 
correlate mth the dlsease progression. However, less is known about the 
density of expression of tlm achvahon molecule The aim of our study was to 
analyze the density of CD38 expression on CD8+ cells ~fl HIV-1 associated 
dsease treated by HAART and assess whether the degree of CD38 expression 
on CD8+ cells correlates w th  the CD4' T cell count, plasma HIV-1 R N A  
level or stage of the Illness. 
Methods: In a longtudmal prOSpeChVe study of cohort HIV-posihve pauents, 
the patients were followed for a period of 12 months. Seronegahve controls 
were chosen at random to obtam comparison values. T-cell subsets were 
examned by two-color flow cytometry (FACScahbur, Becton-Dickinson, 
San Jose, USA). CD38 expression on CD8+ cells was measured as rehhve 
fluorescence intensity using monodonal anhbody (mAb) anh-CD38PE in 
combmahon mth gahng on ceIls stamed by mAb anh-CD8PerCP to select 
CD8 bnght cells - CD8hgh; fluorescence hneanty was assessed usmg 
QuanaBnte tubes (all BD, Heidelberg, Germany). Clinical evaluaaon was 
performed at 6 months intervals. 
Results: Although the percentage of CD8hgh/CD38+ cells correlated 
(P= 0.05; r =  0.40; Spearman's test) wrh the msease progression, the density 
of expression of CD38 anhgen &d not show any correlahon 
Conclusion: Our results mdicate that an mcrease of the percentage of 
CDShgh/CD38+ cells m HIV-mfected pahents reflechng the progression 
of HIV infection is significantly influenced by subset w th  low density of 
expression of CD38 anhgen (CD8hgh/CD38low cells). However, whether 
CD8h ceh mth Werent density of expression of CD38 anhgen might play a 
role in the disease munopathophysiology needs to be further clarfied, and 
CD38 munofluorescence quanhficahon may serve as an useful tool in such 
a study. 
Acknowledgement: The study 1s supported by the Grant IGA MZ CR NI 
6303-Mar~h 200 .  
Results I Healthy controls (n = 18) HIV/AIDS patients (n = 24) 
Year2ooO Year2001 
CD4+ T cells (cells/mm? 1007 f 95 565 f 80' 579 f 54' 
CD8hl/CD38+ cells (?A) 55.1 f 2 . 8  73.2 f 3.9' 71.2 f 2.8' 
CD8hdCD38- cells (%) 44.4 f 2.6 26.4 f 3 9' 28 3 f 3.5. 
CD8hl/CD3810 cells (Y?) 46.6 f 2 3 55.5 f2.7' 56.8 rt 2.3' 
CD8WCD38med cells (%) 8.1 2 0.7 1 5 0 f 2 . 4  16.2f3.6 
CD8hUCD38h cells ('3'3) 0.4zk0.1 0.420.1 0 6 f 0 . 4  
*P< 0.05 (paaents vs. controls). Staasacal analysis employed one-way ANOVA test Data 
are presented as mean f SE. 
lp9871 Sequential computerized tomography (Cr) 
assessment of thymic size modification in HIV-infected adult 
patients starting their first antiretroviral therapy (ART): 
relationship with virologk and immunological response 
R. Ma&e&, G. Battuta, C. Sassi, L Calza, E Chodo and R C a m  
Bologna, I 
Objective: To assess the relanonshp among first-lie ART, thynuc residual 
hssue, and thym~c size evoluhon in a 12-month follow-up 
Methods: Ten consecunve HIV-mfected pahents @) aged 23-58years. 
underwent contrast-enhanced CT scan of thymus media te ly  before starhng 
the= first ART, mcludlng two nucleoside analogues (AZT-3TC o r  ddI-MT), 
associated mth either a protease dubitor (nelfinaw or mdmaw), or a non- 
nucleoside reverse trascriptase inhbitor (efawenz or newrapine). AIl p had an 
adherence >90% to the prescribed ART, and received a quarterly vlrologtc 
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and immunological evaluation; in six cases a thymus CT scan was 
repeated 1 year after ART initiation. Thymic size was assessed by a G 4  
score proposed by McCune JM (j Clin Invest 1998; 101 : 2301),with 0 
representing no appreciable thymic residuals, and grades 1-4 a progressively 
increased thymic size (minimal tissue a t  stages 1-2, and abundant tissue at 
score 3-4). 
Results: While baseline thymic size did not correlate with p’s age, gender, 
duration of HIV infection, diagnosis of AIDS, concurrent CD4+/CD8+ 
count, and HIV-RNA levels (a score 3 was recognized in two p. a score 2 in 
five p, a score 1 in two p, and a score 0 in one p). ART-related immune 
recovery and drop of viremia were associated with an increase or at  least a 
maintenance of pre-treatment thymic score (three cases each), regardless of 
baseline laboratory assays, and composition of ART. In detail, when compar- 
ing the three p who did not show changes of thymic size after a 12-month 
ART (maintaining a score of 2 in two p, and a score of 1 in one p), the three p 
who experienced an increase of thymic volume (as expressed by a shift tiom 
score 2 to score 3 in two p, and &om score 3 to score 4 in the third p), had a 
greater 1-year mean CD4’ rise versus baseline levels (51 1 f 61 vs. 296 f 116, 
opposed to 441 f 176 vs. 205 f 167 cells/& P =  0.04), whereas virologic 
and immunological workout pelformed at the 3rd month of ART, and all 
temporal evolution ofboth CD8+ count and viremia did not show sigmftcant 
differences between these two p groups. 
Conclusion: Our preliminary experience confirms that thymopoiesis has a key 
role in the immune recovery following effective ARTalso in adults, &om both 
a functional and a morphological point ofview. Prospective studies involving 
large p samples and detailed immunological analysis are needed to investigate 
the sipficance of thymus in HW-infected adults undergoing ART, and the 
complex relationshp among virologic outcome, immune reconstitution, and 
cytokine network. 
[ P988 1 Rhino-orbital mucorrnycosis secondary to diabetic 
ketoacidosis in a HIV-positive patient treated with protease 
inhibitors 
E. Bournis, N. Petrosillo, A. Conte, P. Noto, A. M. Peace&, 
G. Demartino, S. Cicalini and G. Ippolito 
Rome, I 
Objective: To describe a clinical case of rhinoorbital mucormycosis secondary 
to diabetic ketoacidosis in an HIV-positive patient treated with protease 
inhibitors. 
Clinical case: A 42-year-old HIV-positive white heterosexual male was 
admitted to our hospital because of progressive asthenia, visual disturbances 
and polydipsia. He denied intravenous drug use. He was in treatment with 
indinavir, ritonavir, abacavir and lamivudine. On admission, he presented 
with clinical and laboratory signs of diabetic ketoacidosis. He was treated with 
intravenous insulin until normalization ofplasma glucose and acidosis. On the 
3rd day of hospital-stay, he developed fever and left-palpebral ptosis, and a 
standard radlograph evidenced maxillary sinusitis. Meticih-sensitive Staphy- 
locoas aureus grew from two blood cultures and kom a nasal swab, and the 
patient was started i.v. amoxycillin plus clavulanate. On the 3rd day oftherapy, 
the patient showed no ameIioration of his clinical condition. A magnetic 
nuclear resonance of the brain showed a fluid collection in the left maxillary 
and ethrnoida sinuses and signs of orbital cellulitis. In the suspicion of 
mucormicosis, i.v. amphotericin-B was administered, and the patient 
was referred to an ENT specialist for sinus biopsy that confirmed the 
presence of necrotic tissue with hyphae characteristic of mucormycosis. 
Ten days later, an orbital exenteration plus maxillary ostheotomy was per- 
formed. After a prolonged course of amphotericin-B the patient was dis- 
charged, and a 3-month follow-up did not show progression of the fbgal 
infection. 
Discussion: Mucormycosis is rare in AIDS patients without specific risk 
factors such as diabetes or intravenous drug use. Treatment with 
protease inhibitors can induce ketoacidosis in diabetic patients, predisposing 
these patients to this severe and often fatal complication. Clinicians 
should be aware of this nlanifestation when managing diabetic HIV-infected 
patients. 
I P989 I Lipid abnormalities and Ch/amydia pneumoniae 
infection in HIV-positive patients: is there a relationship? 
G. Tositti, M. Rassu, E? Fabris, M. Scagnelli, S. Cazzavillan, M. Giordani, 
M. Zoppelletto, E. Bonoldi and E de Lalla 
Vicenza, I 
Introduction: Lipid abnormalities are relatively common in HIV-positive 
patients, particularly after the introduction of HAART. Chiatnydiapneumoniae 
(CP) is considered an important co-factor in the pathogenesis of athero- 
sclerosis and seems ‘per se’ responsible of lipid abnormalities [I]. To note, the 
prevalence of CP infection and its role in inducing lipid alterations in HIV- 
positive patients have not been investigated yet. 
Aim: To evaluate the prevalence of CP infection among HIV-infected patients 
and to assess the relationship with lipid abnormalities. 
Materials and methods: Blood samples collected f b m  66 (M/F 49/17, mean 
age 41.2 f 7.7) HIV-positive patients were tested for CP by nested-PCR. Out 
of the 66 patients tested 55 were on antiretroviral therapy (44/55 with 
protease inhibitors drugs). From each patients clinical, biochemical, immu- 
nological and virologic data were recorded a t  the time of sampling for CP 
testing. 
Results: CP was detected in 18 (27.2%) of the 66 cases studied. Patients with 
and without CP were comparable in term ofsex, mean age, and risk factors for 
HIV infection. Mean CD4 count was sigdicantly lower in CP+ patients 
compared to CP- (348.8 f 205 vs. 516 f 278; P =  0.02), whereas viral load 
did not M e r  significantly (10341 k24961 vs. 6910f 16650, respectively). 
Patients on antiretroviral treatment had significant higher mean level of both 
cholesterol and triglycerides than untreated patients (192 f 64.3 vs. 132 f 49 
e 212 f 168.2 vs. 91 k64; P< 0.05). The relationship between lipid profile 
and CP is shown in the Table 1. 
Table 1 The relationship between lipid proiile and CP 
P Cfaqd iu  P- 
Cholesterol 193.6 * 28.1 
H D L  59.46 f 20 
LDL 96.3 f 54 
Triglycerides 196.2f 161 
184 f 68.9 NS 
61.4f28 NS 
108f61 NS 
191.2f 162 NS 
Conclusion: In HIV-posihve pahents, the prevalence of CP mfechon seems to 
be mversely related to the CD4’ cell count. Furthermore, our data doesn’t 
support a stsllficant role of CP as cofactor of hyperhpidenua, whch seems 
strictly related to a u h r e t r o d  therapy The relahvely hgh prevalence of CP 
lnfeCh0n together mth  the hlgh prevalence ofhpids a b n o r d h e s  suggest that 
HIV-posihve pahents should be carefully evaluated and momtored as at risk 
for cardovascular dlseases 
IP990/ Efficacy and tolerability of pravastatin in the 
treatment of hyperlipidemia in HIV-tnfected patients 
receiving HAART 
L. Calza, R. Manfredi and E Chiodo 
Bologna, I 
Introduction: Laboratory and clinical abnormalities of lipid metabolism have 
been increasingly recognized after the advent of highly active antiretroviral 
therapy (HAART). Signifkant increases in plasma triglyceride and cholesterol 
levels have been reported especially in protease inhibitor @“)-treated patients, 
and pmlonged metabolic imbalances could significantly act on the long-term 
prognosis and outcome of HIV-infected persons. 
Patients and methods: Sixteen HIV-infected patients on PI-based HAART 
since at least 12 months and presenting hypercholesterolemia (>280mg/dL), 
with or without hypertriglyceridemia (>300mg/dL) and lipodystrophy 
syndrome, of at least 6-month duration and unresponsive to a hypolipidemic 
diet and physical exercise, have been treated with a single daily dose of 
pravastatin (20 mg) for 12 months. 
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Results: Two patients were excluded froin evaluation due to early drop-out. 
Ongoing antiretroviral treatment included ritonavir in five cases, indinavir in 
four, nelfinavir in two, and sequential PI administmtion in three; concomitant 
hypertriglyceridemia and lipodystrophy were observed in eight and five cases, 
respectively. Mean plasma triglyceride values tested signrficantly higher in all 
patients treated with ritonavir compared with other PI, while plasma cho- 
lesterol levels and lipodystrophy prevalence did not show any signhcant 
difference according to the admmstered PI-based regimen. At the close of 
1-year follow-up of pravastatin therapy, a decrease of total cholesterol and 
triglyceride levels of 23.6 and 31.2% versus respective baseline values was 
observed; 6 out of 14 patients reached nomial values for cholesterol and three 
out of eight for triglycerides. Mild gastroenteric symptoms were found in only 
one of the 14 treated patients, while no skeletal muscle and liver toxicity has 
been observed; adherence to pravastatin therapy proved always over 90% of 
daily doses for the overall follow-up. 
Discussion: The statins showed beneficial effects in both reducing cholesterol 
and triglyceride levels in HIV-negative population; in HIV-positive persons, 
simvastatin, lovastatin and atomtatin should be avoided because they are 
extensively metabolized by cytochrome P450 3A4, while pravastatin presents 
a lack of significant interaction with PI. In our study, pharmacological 
treatment with pravastatin proved certainly effective in the management of 
diet-resistant dyslipidemia, and was associated with a favorable tolerabllity and 
adherence profile. 
1 P992 1 Caspofungin in cryptococcal meningitis in an 
HIV(+) patient 
A. Arsenoglou, E. Douka, 1. Boutsikakis, E. Kawada, E. Arvanitaki, 
E. Patelaros, A. Kanstantinidou, A. Vezalis and E. Sioula 
Athens, CR 
Introduction: We report a 32-year-old woman who was first diagnosed with 
HIV infection owing to meningitis with CD4 count 4 cells/pL and 
VL > 50 000 copies/mL. The CSF examination demonstrated increased 
number of cells (75-434, 95% lymphocytes) and a mild raise of protein, 
while the India ink stain proved the existence of Cryptoococcw. Cryptococcus was 
also found on lymph-node biopsy. The cryptococcal antigen titer in CSF and 
serum was 1 : 8192 and 1 : 4096, respectively. The combination of liposomal 
amhotericin B (5-2Omg/kg/Qy) and 5-flucytosine (150 mg/kg/day) were 
used for 4 weeks to treat this generalized cryptococcal infection but unsuc- 
cessfully. Fluconazole 800mg/day and itraconazole 4OOmg/day were used 
instead, for 2 weeks, successively, without any therapeutic response, too. On 
the con-, the patient's condition deteriorated. The cryptococcal antigen 
titer in CSF and serum remained stable, and the f i n k  of the CSF 
examination did not really vary. There was an improvement only when 
caspofungin was given for 12 days (70 mg the 1st day and then 50mg/day) 
although afterwards stopped because of thrombocytopenia. The clinical signs 
of meningitis declined within 5days and the cryptococcal antigen titer 
decreased in serum and CSF to 1 : 1024 and 1 : 512, respectively, 3 weeks 
after caspohngin was administered. The Cryprococrus no longer was found in 
the serum or CSE 
tondusion: Caspofungin is the &t of a new class of fungicidal agents that has 
synergy in Combination with liposomal amphotericin B and gives really safe 
results in specific cases ofcryptococcal meningitis that are resistant to the usual 
therapy. 
w1 Meningeal co-infection with Mycobactdurn 
tuberculosis and Listeria monocytogenes in a HN-infected 
patient 
E. Do&, I. Boutsikakis, 0. Georgiou, A. Arsenoglou, 
E. Papadomichelakis, E. Kawada, E. Mageira and E. Sioula 
Athens, GR 
Objective: We report the case of an HIV-infected man with meningeal co- 
lnfection with Mycobacterium tuberculosis and Listen'a monocytogenes. 
Case-report: A 38-year-old Brazilian man presented to our hospital with a 
36 h history of fever, headache, vomitingand diarrhea. He was a HW-infected 
patient, diagnosed 3 months ago, because of generalized necrotic granulo- 
matous lymphadenopathy, which after adequate work-up was attributed to 
the HIV infection. Of note, the Mantouv testing, lymph node acid-fast stain 
examination and blood cultures were negative for rnycobacteria. H i s  CD4 
count was 166 cells/pL and viral load >50 000 copiedtd and was started on 
HAART with stavudine, lamivudine and indinavir with ritonavir as 
booster. He also received t r i m o t h o p r i m / s u l l e  prophylaxis once 
daily On examination the patient was severely ill with upper and lawer 
meningeal signs. The lymphadenopathy persisted although much improved 
since 3 months ago. Chest X-ray was negative. M R I  scan showed meningeal 
enhancement with no focal lesions. The lumbar puncture performed revealed 
135 ceUs/mL, 60% of whom where lymphocytes, glucose <lOmg/dL and 
protein <1 mg/dL. The Gram stain showed rare Gram-positive bacilli and 
one acid-fast stainingmicroorganism and the cultures were negative. The CSF 
PCR was positive for Mycobactm'wm fuberculosis. The 4a antibody titer against 
Lisreria mnorytogenes was 1 : 8 which was considered positive. The patient was 
started on quadruple antimycobacterial treatment with isoniazid, rifabutin, 
pyrazinamide and ethambut~h e also received prednisone for the first 3 days. 
He was started also on ampicillin and garamycin for l i s t ed  meningitis, as well 
as ceftriaxone and the patient responded by improving clinically and defer- 
vescing completely on the 10th day of treatment. 
Conclusion: We describe t h i s  case as an example of rare meningeal co- 
infection with Mycobaaerium tubernrlosis and Listeria monocytogenes in an HN- 
positive patient, who was treated effectively. As far as we know, there are no 
such previous repoa in the literature up to date. 
I P993 I Human T-cell lymphotropic virus (WnV) antibody 
prevalence in HIV-1-infected individuals attending a sexual 
health clinic in Sauth-east London 
E Cook, A. Geretti and M. Zuckerman 
London, UK 
Objectives: HIV and HTLV are retronruses with similar biological features, 
e.g. route of trawnussion and targeting T lymphocytes. HTLV type 1 is 
associated with adult T-cell leukemia/lymphoma and tropical SpashC para- 
paresis and HTLV-2, found mainly in drug users, IS associated with neuro- 
log~cal conchtions. The epidermology of HIV infection in the UK is changing. 
At our hospital, an increasing proportion of HIV patients are female and from 
diverse ethxnc groups (38% born in sub-Saharan Africa and 4% in the 
Caribbean). This unhked anonyrmsed retrospective study aimed to deter- 
nune the prevalence of HTLV m the local HIV-infected sexual-health c h c  
attendees. 
Methods: Sera were collected b m  777 HIV-1 posltive adult (504 males, 273 
females) attendees (January 200C-March 2001). Patients were anonymised for 
clinic number whilst data on ethniaty, country of birth, gender and age was 
retained. Duplicate samples were excluded. Pools contaimng five sera were 
tested usmg an enzyme luked mununoassay. Indwidual samples firom reactive 
pools were re-tested using the same assay Reactive samples were confinned 
using a passive particle ~ U d n a h O n  test and an immunoblot to discriminate 
between HTLV types. 
R e s u k  In total, 42% ofthe cohort were Black Afkican (EA), 45% White (W), 
8% Black Caribbean (BC), 1% Black other (BO) and 4% other ethnic groups. 
HTLVanubody was detected in 6 of 777 sera (0 77%) Two further sera were 
indetermnate by immunoblot. 
Conclusion: To our knowledge, this is the first study to invesugate the 
prevalence of HTLV-HIV co-infechon m attendees of a UK sexual health 
c h c .  HTLV annbody prevalence was double our antenatal popdahon 
(0.39%). Four of SIX HTLV-1 co-infected panents were f e d e  reflecting 
greater efficiency of transmission b m  males to f e d e s .  Recommendahons 
on reduction of HIV transnussion also apply to HTLV, but those co-infected 
should avoid breast feeding. Patient 5 demonstrates that maminision may 
occur outside recognized areas of high endemcity Potential m&ortf 
between HIVand HTLV include the fmdmg that CD4 counts may be higher 
m those co-infected but do not necessanly prowde immunolagical benefit. 
T h  may affect c h c a l  management as antiretroviral therapy or pmphyks  
against opportumstic infecuons may be delayed. Moreover, the d e c t  of 
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ant i re t rod  therapy on HTLV infection is being elucidated. Thus, con- 
sideration should be given to screening our local HIV population for HTLV 
co-infection. 
Patient Age Gender Ethnicity Origin HTLV type 
46 F 
40 F 
4 0 F  
30 F 
24 M 
40 M 
28 F 
36 F 
BC 
BA 
BA 
BA 
BO 
W 
BC 
W 
Grenada 1 
Ivory Coast 1 
Zaire 1 
UK I 
Jamaca Intermediate 
UK Intermediate 
Ivory coast 
rtdy 2 
I ~ 9 9 4  I Screening of HTLV-IIII in patients related to an 
organ transplantation program 
R. Benito, J. Gil, J, J. Araiz, J. Lirraga and M. C. Rubio 
Zaragoza, E 
Objective: Analysis of the prevalence of HTLV-1/11 infection in patients 
related to the organ transplantation program in the University Clinic Hospital 
of Zaragoza, Spain. 
Methods: Presence of HTLV-1/11 specific antibodies was analyzed in 250 
patients related to the organ transplantation program from December 1998 to 
November 2001: 79 consecutive organ donors, 84 consecutive liver recipi- 
ents, 34 discarded donors (for medical contrainmcation or f d y  lack of 
consent) and 53 possible liver recipients in evaluation. Out of 250 patients, 
179 were male and 71 female, aged between 14 and 78 (mean 50.8; SD 14.8). 
AU patients were Spanish, except four male ones: a Rumanians liver recipient, 
a Moroccan possible donor (whose family denied consent), a Senegalese 
possible liver recipient (he was presenting HBV fulminant hepatitis, but 
grafhng was contraindicated because of HIV infection) and a Senegalese in 
evaluation previous to kidney transplantation. HTLV specific antibodies were 
studied by using two Merent ELA: an indirect viral lysate-based HTLV 1/11 
EIA (Abbott) until August 2000 and a recombinant and synthetic antigen 
sandwich EIA Murex HTLV I + I1 (Abbott Murex) later on. 
Results Two (0.8%) out of 250 patients were EIA-positive. Case 1 was a 
Spanish male liver recipients aged 61 years with an EIA index of 1.1. Case 2 
was a Spanish male liver recipient aged 49 with an EIA index 1.2. Case 1 could 
not be reanalyzed by Western blot or PCR. Case 2 was tested with Western 
blot and PCR by the HTLV Spanish Study Group (Hospital Carlos 111, 
Madrid). Western blot result was indeterminate, showing a weak antibody 
response to rgp21 and PCR was negative. Both cases were EIA-negative 
during the follow-up, 12 and 15months after liver transplantation, respec- 
tively. Both cases were considered as HTLV-false positive. 
Conclusions: HTLV-1/11 infections do not seem a major problem in the 
transplantation prograni in Spain. Nevertheless, as 49 HTLV-I and 377 
HTLV-11-infected patients have been registered by the HTLV Spanish Study 
Group unnl 2000 and as three cases of symptomatic HTLV-I infection in 
Spanish organ recipients, related with the same donor, have been also 
described, screening of organ donors and recipients must be considered. 
Acknowledgement To HTLV Spanish Study Group for their help with 
Western blot and PCR analysis. 
v] Epidemiological characteristics of AIDS in Kosovo 
I. Humolli, I. Dedushaj, N. Ramadani, A. Kalaveshi and L. Gashi 
Pristina, W 
In order to show epidemiological characteristics of AIDS in Kosova we have 
analyzed cases from 1986 until November 2001 using retrospective method. 
During this period of time, 42 persons have been affected while 13 of them 
died. The highest number of disease were register in the year 2001 (till 
November) 12 cases or 5.12 cases in 1000000 inhabitants. The highest 
number of deaths were register in the year 1999 two or 0.8 cases in 1 000 000 
inhabitants Whde the lowest number ofcases were regnter 111 1991,1993 and 
1998 mth  only one case During the year 1988, 1989 and 1990 was not 
regzster any case of dsease Durlng the penod that we analyzed the hghest 
number of cases were regzster in Prlshtma mumcipahty 7, Pep mwcipahty 6 
and Ferizaj 4. Overall, 65% were males and 35% females. The most affected 
age groupswere 30-39 (37.5%), 4C-49 (29.1%) and 20-29 (20.8%). Accord- 
mg to the present data we could say that epidemologcd SitUatIOn in Kosova IS 
not so alarmng compared to other countries. Problem IS not knavlng the 
number of HIV carriers. However, smce there are many foreign clhzens 
coming to Kosova as well as many Kosovar's r e t u m g  from foreign countries, 
the situahon IS expected to be worsen 
Lp9961 Tuberculosis in H N  patients in a Spanish hospital 
A. Del Arco, J. L. Prada and J. De La Torre 
Marbella, E 
Objectives: To know the epidemiology and evolutionary characteristic in 
patients with HIV infection that developed tuberculosis in the area of our 
hospital. 
Materials and methods: We studied the retrospectives cases of tuberculosis in 
HIV patients from 1994 untill2001 in Costa del Sol Hospital. 
Results: Fifty-five patients with HIV mfection were diagnosed of tubercu- 
losis. Forty-seven patients (85.5%) were males and eight (14.8%) females. The 
risk was drug-abusers in 45 cases (81.8%), heterosexuals in six and two 
homosexuals. In two patients, the risk were unknown. In general, all were 
very inmunocompromised patients. Thirty-five patients (63.6%) had less of 
200 CD4/mm3 and were diagnosed ofAIDS. In 20 patients (36.6%), the HIV 
infection were unknown and they were diagnosed of the two infections 
simultaneous. Twenty-five patients (45.4%) were diagnosed of pulmonary 
tuberculosis by bacteriologic examination of sputum. In three patients with 
pleural effusion by biopsy. Twenty-seven (49.6%) patients were diagnosed of 
disseminated tuberculosis (two patients had cultivators of cerebroespinal fiuid 
positives). Eighteen patients (32.7%) the diagnosis was by lymph node 
examination. The evolution was: 38 patients (69%) recovered with treatment, 
10 patients (18.1%) died and eight of this abandoned the treatment. 
Seven patients (12.7%) were lost. The patients that died were not taking 
antiretroviral treatment. 
Conclusion: 
1. Sixtythree percent the patients were very inmunocompmmised 
2. Fifty percent were extrapulmonary tuberculosis or disseminated tubercu- 
3. Twenty patients (36.3%) with HIV infection and tuberculosis were 
4. Eighty percent of the patients that died, previous abandoned tuberculosis 
(CD4 < 200/mm3). 
losis cases. 
simultaneous diagnosed. 
treatment. 
v] Pharmacokinetic evaluation of indinavir and 
indinavirlritonavir containing antiretroviral regimens in a 
clinical setting 
M. Bofito, R. Raiteri, S. Bonora, H. Reynolds, P. Hoggard, A. Sinicco, 
D. Back and G. Di Perri 
Turin, I; Livergoof, UK 
Objective: To describe the pharrnacokinetics of different regimens of indi- 
navir (IDV) in HIV-1-infected subjects and to investigate the relationship 
between plasma concentrations and clinical outcome. 
Methods: Twenty HIV-1-infected subjects receiving IDV (8OOmgtid) as the 
only protease inhibitor (n = 10) or IDV (800 mgbid) in combination with 
RTV (100 mgbid) (n = 10) were recruited. Five blood samples (7 mL) from 
each patient were taken over the dosing interval (before drug intake in both 
groups and after 1 ,2 ,4 ,8  h for IDV alone and after 2 ,4 ,8  and 12 h for IDV/ 
RTV). Plasma drug concentrations were measured using liquid chromato- 
graphy with tandem mass spectrometry detection. 
Results: See Table 1. 
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Table 1 None of the subjects treated with IDVIRTV had Ctrough below IDV MEC 
of 120ng/mL No sigmficant correlation was shown between plasma IDV 
concentrations and CD4+ cell count for both groups (P=  0.534, IDValone 
and P=0.916, IDVIRTV; Pearson’s correlation). IDV Ctrough showed a 
sigmficant relationship with HIV-RNA values in patients on IDV alone 
(P=  0.042; Pearson’s correlation). 
Conclusions Plasma IDV Ctrough showed wide inter-patient variability. Our 
results agree with previously published data where plasma IDV levels correlate 
with HIV-RNA and enhancement of IDV by RTV is often needed to 
maintain concentrations above IDV MEC. 
IDV alone 
423 (313-635) 
IDV/RTV 
399 (13M10) 
28.8 (18.+11,6) 
423 (2234103) 
Median CD4+ (ceWmm3 (range) 
Undetectable VL 6/10 1/10 
AUC (@gh/mL) (range) 30.2 (15.7-57.8) 
Ctrough (ng/mL) (range)’ 177 (81-496) 
*P=O.O14 (Mm-Whitney U-test). 
Pediatric viruses 
1 P999 I Genotype of the wild measles viruses isolated in 
Iran 
S. Rahimi Khameneh and T. Mokhtari-azad 
Zanjan, Tehran, IR 
Measles virus (MV) is an important human pathogen. Despite the encoura- 
ging progress towards control of measles in several areas of the world, it is st i l l  
the cause of up to 1 million deaths each year. MV has one stereotype but wild- 
type isolates are known to be genetically heterogeneous and at least 15 distinct 
genetic clusters have been identified for MV by sequence comparisons of the 
nucleocapsid protein (N) gene. According to implemented measles control 
programs in Iran, mass vaccination will be initiated in 2002, so it is important 
to identlfy the genetic patterns of indigenous measles virus in Iran before mass 
vaccination campaigns are initiated. The comparisons of these data with the 
genetic data obtained &om the wild viruses, which cause outbreaks after mass 
vaccination, would interpret the success of measles control programs in Iran. 
For achteving these purposes and isolating wild-MV, 220 throat-washing 
samples were selected and inoculated into the specific cell lines, such as B95 
and Vero. Total seven wild-type of MV were isolated, which had significant 
CPE and positive IIF tests. The total RNA was extracted from positive cell 
culture and tested by RT-PCR. S p d c  primers amplified about 600 nucleo- 
tides of C-terminal of N gene. Sequencing of this variable region was 
pedormed for five measles viruses. Analyzing these data by the clustal routine 
of MegAhgn program in DNA STAR package indicated that these strains are 
sirmlar to each other and the most diversity was found in 1.3%. Comparison of 
these sequences with the sequence of Edmonston-wild-type (Ed-wt) sug- 
gested that these wild-type viruses are Edmonston-like and belong to Clade 
A. According to phylogenic tree, they form a separated group behind the Ed- 
wt. These molecular epidemiologic studies are an important marker for 
interpretation of the control programs. It d provide a means to describe 
the source of Measles viruses, assess the extent of virus circulation and 
outbreaks. Also they will become a powerful tool for evaluating strategies 
to control, eliminate and eventually eradicate measles. 
Complications of variceila requiring 
hospitalization in previously healthy children 
N. Hernindez, M. J. Garcia-Miguel, E Baquero-Arhgao, 
E Martinez-Cortk and E Del Castillo 
Madnd, E 
Objactive: To describe hospital admissions for comphcated varicella in 
previody healthy children. 
Methods: A retrospective record renew of patients between 1 month and 
14- hospitaiized for comphcatedvaricella between 1 January 1987 and 31 
November 2001 was conducted in La Paz Children’s Hospital, Madr~d, Span 
Children wth  immunosuppressive/imniunodeficient condlhons or treated 
with immunosuppressants and newborn infants were not included in the 
Study. 
Results: During the s t u d y  penod, a total of 246 (134 males and 112 females) 
munocompetent children were hospidzed for comphcated varicella. Of 
these, 79 children presented two or more comphcations. Mean age was 
3.6years (0.2-14) and mean hospital stay was 7days (1-50). Most fiequent 
complications associated with varicella are presented in the Table. 
Mean age f SD Mean hospital stay, Complication N (%) 
patienb (years) days (.mge) 
Skdsofc assue infernon 
Central nervons system 
Bactenal pneumoma 
Thrombocytopenia 
Ear-nosethroat 
Bmchihs 
Gastrointeshd 
Sepsis 
osteoarricular 
127 (51.6) 
54 (21.9) 
34 (13.8) 
18 (7.3) 
17 (6.9) 
17 (6.9) 
16 (6.5) 
14 (5.7) 
6 (2.4) 
3.5 4z 2.8 
3 . 8 f 3 . 1  
3.2 & 3.0 
5.6 & 3.9 
3.6 f 2.9 
2 . 2 3 ~  1.8 
2.5 =t 3.7 
2 . 5 f 1 . 2  
5.7 f 2.5 
7.4 (1-50) 
7.0 (1-50) 
9.2 (2-50) 
11.2 (1-38) 
5.5 (1-14) 
5.9 (1-12) 
5.0 (2-13) 
14 (&SO) 
18 (7-38) 
Conclusions: VariceUa may result in serious disease requiring hospitalization 
in otherwise healthy children. In this study, varicella complications that most 
Erequently prompted hospitalization were secondary skin/sofi tissue infections 
(51.6%) and neurologic complications (21.9%). These data provide further 
evidence that varicella may result in hospitalization in otherwise healthy 
children and may be used for cost-benefit analyses when universal varicella 
vaccination is considered 
ml Picomaviridae and central nervous system 
damages: a role for human Parechovirus type 11 
V. Legay, J. J. Chomel, S. Khalfan, B. Lma and M Aymard 
Lyon, F, State of Bahrain, BH 
Objectives: The study was engaged after the descriphon of a case of 
encephalomyehhs observed m a male chdd aged llmonths dmgnosed in 
Bahrain in 2001 Chmcal specmens were sent to the laboratory and tested for 
vlrologx dlagnosis Classical nd ehologes (CMV, HSV, VZVand EV) were 
inveshgated m accordance w t h  the described symptoms. After being nega- 
hve, partleulatfy when enterovuus RT-PCR was performed, the Human 
Parechovuus type 1 (HPEVl, formerly ECHOwus 22) dtagnos~ was 
engaged. 
Materials and methods: CSF samples, throat and rectal swabs, acute and 
convalescent sera were collected &om the pahent and sent to the laboratory 
CSF and m d  swabs were tested for n r u s  isolahon. Conconutantly, serolopc 
analysis was acheved, and RT-PCR detechon was performed on imaal swabs 
and sera. HPEV1 isolation was carried out by m0CdaMg five cell knes, 
mdudmg HRT. HPEVl was idenhfied wth the conventional neutdmtion 
assv. Neutdmng anabody was htrated by neuh‘ahzahon m acute and 
convalescent sera A sensihve and spec& RT-PCR was developed to detect 
HPEVl RNA m samples and HPEV1-mfected cells. The RNA ~xtraChOn 
w;?s acheved mth an sothyocianate-adapted method. The RT-PCRs usmg 
HPEV1-spenfic primers targeang the 5’NTR and VP1 repons were carned 
out with a one-step procedure Each PCR product was dweedy sequenced 
and ahgned m the EMBL data bank. 
Results: Stool samples and CSF remamed negahve m wus isohhon, whereas 
CPE was observed on HRT cells from mtial throat swab. Neutrahhon test 
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allowed the HPEVl semtyping. Serodiagnosis was negative (<4) with acute 
sera, while convalescent sera timated 128. HPEVl RNAwas detected by RT- 
PCR f b m  initial duoat swab and acute serum as well as f b m  HPEV1- 
infected cells. The sequence *ent of the PCR products confirmed the 
HPEVI specificity. 
Conclusion: Among the clinical symptom, most classically associated with 
HPEVl infections (respiratory infections, diarrhea or gastroenteritis), CNS 
damages have already been described in acute flaccid paralysis or aseptic 
meningitis. The first case of encephalomyelitis due to a recent acute HPEVl 
infection in a child is reported here. In addition, the negative enterovirus 
detection by PCR confirmed the recent classification of HPEVl as a member 
of a new Picornaviridae genus. This study emphasizes the importance of the 
HPEVl diagnosis in cases of severe CNS infections. 
(p10021 The seroprevalence of IgG and IgM Parvo-B19 
antibodies in Greece 
M. E. Alexandrou, A. Voyatzi, E. Zagotzidou, G. Massaant, H. Boussiou, 
A. Evangelopoulou and V. Petrocheilou 
Athens, GR 
Objectives: Serologic survey was carried out to estimate the incidence of 
human Panrovirus-B19 infection among two groups: group A: healthy 
pregnant women during antenatal examination; group B: women who 
underwent laboratory tests to idenhfy the cause of previous spontaneous 
abortions (more than two). 
Nlater‘als and methods: Sera were collected from 259 pregnant women 
(group A) and 76 women (group B). Antibody levels for IgG and IgM 
antibodies agunst B19 were measured. Values of 33.5 IU/mL for IgG and 
’23 U/mL for lgM were considered positive. 
Results: The seropredence of Parvovirus-B19 IgG and IgM antibodies was 
41.7 and 1.9% for group A and 38.15 and 10.5% for group B, respectively. 
Negative or low positive IgG concentrations with negative IgM were found in 
57.5 and 53.9% in groups A and B, respectively. Positive or low positive IgG 
values with negative or low positive IgM were detected in 42.1 and 35.5% in 
groups A and B, respectively. Acute infection with ParvaVirus-Bl9 was 
confirmed in 1.9 and 10.5% in groups A and B, respectively. 
Conclusions: Our results showed: (1) approximately 39.4% of all samples 
tested were h m  women associated with patterns of past B19 mfection, while 
56.7% were found susceptible; (2) specific IgM antibodies were detected in 
1.9% ofwomen ofgroup A, but were significantly higher (10.5%) in women 
with more than two spontaneous abortions and was considered as recent B19 
infection; (3) the markers of IgG and IgM antibodies should help the 
evaluation of the immune status and the discrimination of past or recent 
infection. In cases with borderline values of IgG or IgM antibodies, a second 
blood sample after 15days and an ultrasonographic examination could be 
helpful. 
m] Incidence of infections due to human PARVO 
619-virus in adults 
€? Karaboyia-Karafillid, A. Zoulamaki, M. Ergazalu, A. Vlachaki, 
A. Sided, E. Michaelidou and H. Malamou-Lada 
Holapos, Athens, GR 
Background: PARVO B19-virus, the causative agent of the ‘fifth disease’ or 
‘erythema infectiosum’ in children, can also affect adults. Clinical manifesta- 
tions of primary PARVO B19-virus infection vary greatly (‘chameleon 
infection’). 
ObjbZives: To determine the possible role of PARVO B19-virus as an 
etiologic agent of infections in adults during 18-month period @muary 
20WJune 2001). 
Materials and methods: Serum samples of 160 hospitalized patients and 35 
outpatients (total number: 195), aged from 25 to 55 years. were tested for anti- 
PARVO Bl9-virus IgG- and/or IgM-antibodies (Abs). All serum samples 
were evaluated by an indrect immunofluorescence assay (IFA-BIOTRIN, 
Ireland) and an indirect immunoenzymatic assay (ELISA-SERION, Ger- 
many). Sera with IgG-Abs titers 31/64 (IFA) and >45 U/mL (ELISA) were 
considered as positive. Positive for IgM-Abs were sera with titers %/16 (IFA) 
and >17 U/mL (ELISA). The criteria for the presence of recent infection 
were as follows: 
a. high titer of IgG-Abs; 
b. the presence of 10-Abs; 
c. seroconvenion of IgG-Abs titer between two paired serum samples. 
Results: A total of 106 of the 195 patients (54.35%) were positive for IgG-Abs, 
while 25 of them (12.82%) were found to have high titen of I$-Abs. IgM- 
Abs were detected in seven of them (3.59%). Recent infection was confirmed 
in those seven patients (four outpatients, two patients from the Rheumatology 
Ch ic ,  one &om the Pathology Clinic). Symptoms included fever, insisting 
arthritis and long-lasting exanthema, although clinical manifestations varied 
fiom patient to patient. 
Conclusion: The possibility of PARVO B19-virus infection must be con- 
sidered in the Merential diagnosis of febrile and exanthematous diseases in 
adults. 
Viral infections in childhood bronchial asthma 
V. A. Bulgakova, I. I. Balabohn and T. B. Sentsova 
Moscow, RUS 
The study, carried out by us, of influence of a virus infection contamination 
on gravity of a bronchial asthma in 153 patients (children) in the age group 
from 1.5 to 15 years has revealed that the apposition of an acute respiratory 
infection contamination in 132 (90%) out of the 142 patiens, t a k q  place 
under observation, was accompanied by an exacerbation of a bronchial 
asthma. Higher frequency of exacerbations of a bronchial asthma was marked 
at stratification of an Rs-virus infection contamination (50%), influenza 
(44%), parduenza  (33%), blended virus infection contamination (46.7%). 
The gravity of a bronchial asthma at 600/0 of children was accompanied by 
stratification of often acute respiratory diseases. Eleven patients (children) had 
hepatitis B virus infection, and nine chldren had herpes viral infection. The 
immunologic researches have shown that in all the surveyed children, the 
origin of a virus infection descended at deficiency of an INF-y of blood. 
Changes in the contents of cytokine was expressed in increase of the contents 
of IL-4, L 5  and IL-8, and decrease in the level of IL-6 and L 2 ,  thus it was 
marked hyperproduction common IgE. We conclude that viral  infection 
promotes allergic sensitization and influences gravity of a bronchd astbma in 
children. 
I P1005 I G and P genotyping of human rotavirus strains 
isolated in Korea 
J. 0. Kang, Y. C. Li and T. Y. Choi 
Kuri, KOR 
Objectives: The most prevalent rotavirus genotypes worldwide are reported 
to be P[8]G1, P[4]G2, P[8]G3, P[8]G4. But unusual genotypes have been 
recognized from several countries. To design a vaccine strategy and to evaluate 
success of candidate vaccines, it is essential to know the serotypes or genotypes 
of prevailing rotavirus strains in each country. 
Methods: The diarrheal stool specimens 6om hospitalized pediatric patients 
were tested for rotavirus by enzyme immunoassay (Vidas Rotavirus, bioMer- 
ieux sa, France). EIA-positive stool specimens were analyzed by RT-PCR for 
group A rotavirus, and the group A-positive PCR products were genotyped 
by PCR for P and G types. 
Results: Among the 65 EIA-positive fecal specimens, collected from 2000 to 
2001,33 were both G and P type. G2 genotype, constituting 62.9%, was the 
most prevalent type during the study period, and followed by G4 (1 1.4%), G3 
and G1 (5.5% each). P typing revealed P4 as the most predominant type 
(62.9%). and followed by P6 (22.9%), P8 (11.4%), and P9 (2.9%). The most 
common combined P and G type was P[4]G2 constituting 62.9%. followed by 
22.9% of P[6]G4, two cases of P[8]G1, and one case of P[S]G3, P[8]G4, 
P[9]G3 each. 
Conclusion: The most common rotavirus strain in Korea during 2000-2001 
period was P[4]G2, d c h  shows changing pattern of strain prevalence 
compared to the G1 predominance (SF?) in 1990 report fbm Korea. 
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I P1006 1 Viral gastrointestinal infections among 
inpatients of an infectious diseases dink in Pilsen, Czech 
Republic: first experiences with serotyping of rotaviruses 
€? Pazdiora, M. Svecovi, J. Zborski 
Plze6, CZ 
Objectives: Rotaviruses are the most frequent etiologic agents among patients 
with diarrheal diseases. Epidemiologic data could be the basis for the start of 
vaccination. The role of other viral pathogens must be analyzed, too. 
Methods: The importance of rotaviruses, adenwiruses, and astrovkses was 
analyzed among children inpatients during January 200@-0crober 2001. 
Detected rotaviruses were serotyped with monoclonal antibodies. 
Results: During 2000-2001, 799 younger children were examined with 
gastrointestinal diseases. Viral etiology was obsenred among 33.5% patients. 
The most frequent agents were rotaviruses; a rotavirus etiology was proved 
among children 2 5 6 ~  (32.0%), adenoviruses were detected 9x (1.1%). 
astroviruses 3 x  (0.4%)). The incidence ofrotavirus acute gastroenteritis among 
different age p u p s  was as follows: children under 6months: 17.2%; 
7-12months: 30.8% 13-24months: 46.1% 25-36months: 34.1% older: 
24.5%. The incidence rate during March and April was higher compared to 
the other months. Nosocomial infection was laboratory detected in 30 ofthe 
454 infants repeatedly examined during the hospitalization (i.e. 6.6%). The 
most fkquent agent was rotavirus, too. G-semtypization was investigated in 
164 stool samples. The type was detected 1 3 1 ~  (i.e. 79.9%). The most 
frequent serotypes were types G1 and G3 (40.2 and 20.8%, respectiveb). 
Conclusion: The results indicate the need of vaccination against rotaviral 
infections in the Czech Republic, too. Distribution of serotypes is similar to 
other countries. 
Grant support: IGA MZ Czech Republic No. 6036-3. 
I P1007 1 Outbreak of Notwalk virus gastroenteritis in a 
childcare center 
M. R. Sala, C. Arias, T. Llovet, G. Prats and E. Donate 
Errassa, Barcelona, E 
Objective: To describe an outbreak ofNorwalk virus (NV) gastroenteritis in a 
childcare center. 
Methods: A cohort study was conducted to describe the epidemiology of the 
outbreak and to determinate its cause. A case was defined by the presence of 
vomiting or diarrhea. Environmental health specialists inspected childcare 
center and the local restaurant, which supplied food items served at the lunch. 
Stool samples &om cases and &om the childcare and the restaurant staffwere 
collected for bacterial and d investigations. 
Bone and soft tissue infections 
Results: The gastroenterias outbreak began in the childcare center on 15 June 
2001, with new cases occurring afier 3 days over the ensrung week. The first 
case ate lunch on the childcare center. The pattern of cases was consistent wlth 
person-to-person spread. In the center, 21 cases occurred (attack rate was 
61%). C h c a l  infection was also reported in one employee of the restaurant 
who was not a food handler but shared the food served at the cMdcare center, 
and on 1 1 household contacts of children cases. Predomnant symptoms were 
vomiting (89%) and diarrhea (54%). Taking lunch at the childcare center was 
nof associated with illness. Fecal samples f k m  14 cases were pOSlhVe for NV 
genogroup I1 using RT-PCR. lko food handlers of the restaurant that also 
shared food served at the center were positive for NV but had not reported 
illness, and three members of chddcare center stat€that did not take lunch at 
the center. Inspecaon of the restaurant revealed problems with food handling 
and preparation. In addition, the c h i l k  center had inappropriate hygienic 
practices in hand washing, diapering and food handling. 
Conclusion: Food-borne t r a n s d o n  probably occurred on the first cases but 
the person-to-person transmission spread NVamong childcare assstants, staff 
and them families. Our report appears to be the first description outbreak of 
N V  gastroenterihs in a Spanish childcare center. 
Immunization against poliomyelitis in Kosova 
N. h d a n i ,  I. Dedushaj, L. Gashi, A. Kalaveshi and I. H~moUi 
PfiStina, W 
Introduction: Routine vaccination against poliomyelitis in Kosova is tzrgeted 
to chiIdren 2-4 months administered simultaneously with DTP (three doses). 
First booster dose should be given to children 12-18months together with 
DTP, second booster dose to children 67yean and third dose to children 
12-13years. 
Objective: The aim of this study is to present routine vaccine coverage data 
against poliomyelitis with live polio vaccine during the last loyears with 
approach to strengthening EPI program in Kosova. 
Methods: Surveillance data and descriptive analysis of EPI. 
Results. During the routine OPV3 coverage between 1991 and 2000,0PV3 
was administered to 455 086 children in Kosova with average of 85%. During 
the year 2000,92.5% of the children in average were completely covered with 
immunization. During 2001 (fust 6months), the average was 96%. Supple- 
mentary immunization activities SNIDs (mooping-up) in 2001 in the target 
groups was 69%. 
Conclusions: Due to high immunization coverage against poliomyelitis, no 
cases have been registered in the last 4 years. It is foreseen that the transmission 
of wild polio virus is interrupted and the ground set of eradication of the 
disease by the year 2003, the goal set up by health authorities in Kosova. It is 
expected that the coverage of the population to be vaccinated will be 95%. A 
new immunization reporting form will be introduced to provide more 
realistic, timely and reliable data by age p u p s .  
I Plolo  I Interpretation of microbiological cultures from 
noninfected removed orthopedic devices: preliminary results 
E. Cuclu, J Asuncion, S. Quintana, L. Gomez, A. Matamala, 
J. M. Lacasa, D. Dalmau and A. Bartra 
Tmassa, E 
Objective: To detemne the fkquency and significance of bacterial d a t e s  
cultured fbm removed orthopedtc devices in patients wthout a suspected 
d e m o n .  
Methods: F~ve samples were obtained from each pahent (two from osteo- 
synthws mated ,  two h m  bone, and one from the mterface). Samples were 
processed a c c o h g  to the= characteristm (swab, homogenelzable sample, 
and solid sample). All pahents had a peroperatory biopsy to exclude acute 
dammation. None of the paaents had a past or present lustory of osteo- 
armular lnfechon and they were followed-up for 1 year postsurgery. 
Resub To date, 48 patients have been included. In 25 cases (552%)). one or 
more cultures have been posiave. Smeen pahents had only one posihve 
sample, four pahents two posltive samples, four pahents three poslhve samples 
and in one patlent all the five samples were positive. In three cases, the cultures 
were polymicrobial. The mterface samples were more frequently positive 
(25% of cases) compared to bone and osteosynthesis m a t e d  (16 and 14%). 
The most frequent b a c t d  lsolates were coagulase-negative staphylococci 
(76%) and Propionebacferiumumes. Peroperaave biopsies were negative for 
inlhunahou in a I l  the cases except one. Currendy, we have found no 
correktlon between posltive cultures and the site of or type of sample, the 
type of osteosynthesls matenal or the duration of surgery. 
Conclusion: In our experience, more than half of the removed osteosynthesls 
mated  and the adJacent assue are colonized by comensal cutaneous bacteria 
even m the absence of mfection. 
I PI01 1 1 Soft tissue infections in injecting drug users in 
Scotland, 1996-2000 
E. K. Girvan and C. McGulgan 
Wishaq Glasgoiv, UK 
Objectives: During the year 2000, Glasgow expenenced an outbreak of 
infection among injecting drug users (IDUs) in which 23 died. It was the 
recommendation of the Outbreak Management Team that a study should be 
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undertaken to ascertain the underlying incidence and nature of soft tissue 
infections (STIs) among IDUs. The aim of this study was to estimate the 
incidence, trends in, and name of STIs among IDUs over a 5-year period 
(1996-2000). These trends were compared with the general population 
admitted to hospital in Scotland with STI. 
Methods: Data were collected using hospital discharge records returned to 
ISD Scotland. AU the patients with a diagnosis of abscess and/or cellulitis 
(identitied by ICD 10 codes) were selected. A hrther subsearch was carried 
out for patients with a history of opioid use (also identified by ICD 10 codes). 
The data were analyzed using SPSS 10.0 for Windows. 
Resub. STIs appear to be increasing, both in the general population and 
among IDUS. Among the general population with STI, there was a 60 : 40 
male : female ratio, and a 66 : 34 male : female ratio in IDUs. The incidence of 
general patients presenting with STI increased with age. In 1996, the majority 
of IDUs presenting with STIs were between 21 and 35 years old. Today the 
age range is much wider; with the majority falling between 15 and Myears 
old. Between 1996 and 2000, IDUs generally had a shorter hospital stay than 
the general patient. However, in 1999, IDUs still accounted for 981 hospital 
bed days. The main organisms causing STIs were S. UURUS, group A strepto- 
cocci and S.  millen’. However, the data are incomplete, and it is therefore 
hypothesized that the incidence of STI was underestimated. 
Conclusions: The incidence of STIs, in both the general population and in 
LDUs, is increasing year by year. The age range of IDUs developing STls 
appears to be getting wider. This results in more patients being hospitalized, 
and thus utilizing more resources. This study further supports the recom- 
mendation of the Outbreak Team for better data accumulation and analysis. 
To investigate the true incidence of STI in IDUs, a comprehensive prospective 
study is essential. This would increase our understanding ofthe epidemiology 
and microbiology of such infections, thus providing a better basis for pre- 
vention and treatment. 
(P101z1 Biofilm production in staphylococcal isolates from 
blood cultures and from the skin 
M. Votava, M. Dendis, M. Heroldova, €2. Horvath, E Ruzicka and 
V. Woznicova 
Brnfl, cz 
Objectives: To ascertain if the laboratory detection of the biofilm production 
is of clinical importance, i.e. if it correlates with the supposed etiological 
significance of the isolated strain in question. 
Methods: The identical strains isolated at least twice from blood culture of 
patients with the clinical signs of sepsis were compared with the strains isolated 
&om the skin and respiratory tract of relatively healthy persons. The b i o f h  
production was demonstrated by means of two phenotypic methods (Chris- 
tensen’s method of staining the s h e  on the glass and the appearance of 
colonies on Congo red agar) and one genotypic method (the detection of ica- 
operon, which controls the production of slime). 
Results: In a pilot experiment, 62 S f ~ p h y ~ ~ o c r u s  epidmidis strains isolated 
h m  blood and its 61 strains isolated from the skin and the respiratory tract 
mucosa were compared. Of the 62 blood isolates, 30 (48%) were positive for 
biofilm production by the Christensen’s method and 27 (44%) by the type of 
growth on Congo red agar. Results of 61 skin and respiratory strains were 9 
(15%) and 12 (20%), respectively. Phenotypic and genotypic methods for the 
detection of biofilm production were preliminarily compared in 38 coagu- 
lase-negative staphylococcal strains isolated h m  blood culture. Ica-operon 
was detected in eight (21%) st ra ins  (in S. epidennidis only): in five out of nine 
slime-positive strains (the rest were two strains of S. hwmolytiw and S. homi- 
nis) and in three out of 29 slime-negative ones. 
Conclusions: S. epidemidis strains isolated from blood cultures produce 
biofilm more often than the isolates from skin and respiratory tract. Ica- 
operon can be detected in S. epidennidis only. It is present also in strains in 
which the production of the slime is phenotypically undetectable. 
Acknowledgments: The study was supported by grant IGA 6818-3 h m  
Ministry of Health of Czech Republic. 
Adhesion of coagulase-negative staphylacocc3 to 
biomaterials and biofilm formation 
M. Bartoszewicz-Potyrala, J. Chiciak and A. Przondo-Mordarska 
Wroclow, PL 
Objectives: For many yean, coagulas-negative staphylococci (CNS) was 
considered to be a nonpathogenic microorganism. The results of investiga- 
tions carried out during the recent years have indicated contribution of CNS 
as etiologic factors of infection in particular clinical situations. Amox the 
reasons for the increase in infections caused by CNS are both widespread 
diagnostic and therapeutic techniques of invasion. These bacteria can be 
introduced into a body together with the biomaterial being inoculated, 
ureteral catheter, vascular catheter and the equipment aiding breath. One 
of the most important mechanisms of virulence of these bacteria is their 
adhesion ability and biofilm formation. Biofilm protects bacteria against host’s 
immunological mechanisms, decreases antibiotics and antibodies penetration, 
creates better nutritional conditions for coagulase-negative staphylococci. 
The aim of the study was to determine adhesion ability to biomaterial and 
biofilm formation for coagulase-negative staphylococci. 
Methods: Researches have been performed on CNS strains isolated from 
various clinical materials derived from the patients hospitalized in the 
Intensive Care Unit. Adhesion of coagulase-negative staphylococci was 
analyzed according to Richards and cooperatives method assessing the value 
of subsaate TTC (2,3,5-triphenyltetrmlium chloride) reduced to insoluble 
red formazan. In the studies, biomaterials made of various polymers, Foleys 
ureteral catheter (SL), Nelatos ureteral catheter (PCW) and vascular catheter 
(PTFE) were used 
Results: A total of 11% of the assessed strains showed reduction value of TTC 
at +4, 42% at f3, 20% at +2, and 15% at +1. Among dme, 12% of the 
assessed strains did not reduce TTC. 
Conclusion: 
1 Staphylococnrs epidennidis strains isolated from blood showed the best adhe- 
2 The worst abilities were shown with S. wamnii and S. dzromogenes. 
sive abilities (all the strains showed TTC reduction at +3 and +4). 
1 P1014 I Surgical site infections after hip prosthesis 
C. Ezpeleta, C. Busto, I. Atutxa, J. Martinez, E. Gbmez, J. Unzaga and 
R. Cistern 
Bilbao, E 
Objective: Based on CDC’s National Nosocomial Infections Surveillance 
(NNIS) system reports, surgical site infections (SSIs) were the third most 
common frequently reported nosocomial infection accounting for 1416% of 
all nosocomial infections (NI). The aim of this study is to know the rate ofSSI 
after hip prosthesis in our hospital and to compare our results with the NNIS 
reports. 
Methods: The hospital of Basurto where the study was carried out is a 800- 
bed primary and tertiary care teachq hospital that provides care in the urban 
area ofBilbao (Spain). Infixtion control team from January 1998 to December 
2000 prospectively studied all patients operated on hip prosthesis (CIE-9 
procedures 8151 or 8152). They were followed for a year after the end ofthe 
episode. 
Results: A total of 620 patients were studied, 36 (45%) of them were 
male, and mean age was 73.4yean (SD=12.8). Sixty-four patients 
(10.32%) had 72 NI: 28 UTI, 20 respiratory, 11 surgical site, 4 bacteremia, 
2 phlebitis and 7 other locations. Cumulated incidence of infected 
patients was 10.32/100. Antibiotic prophylaxis was administered in 99.5% 
of the cases. The dosage, time, drug and duration of the prophylaxis 
were appropriated (100, 99.3, 99.2 and 96.1%, respectively). SSIs were 
present in 11 cases: superficial incisional SSIs (6), deep incisional SSIs (2) 
and orgadspace SSIs (3). Cumulated incidence SSIs w a s  1.77/100. ASA 
index 1: 151 patients, 0.7% SSIs; ASA 2: 307 patients, 2.3% SSIs; ASA 3: 152 
patients, 2.0% SSIs; ASA 4 10 patients, O?? SSIs. NNIS score 0: 433 patients, 
1.8% SSIs; score 1: 185 patients, 1.6% SSIs; score 2 2 patients, 0% SSIs. Two 
patients with organ space infection had hip replacement. Mean hospital stay 
was 21.3days (SD=14) in patients with NI and 15.3days (SD=11.3) in 
patients without NI. Crude mortality was 1.9%: 9.4% with NI and 1.1% 
without NI. 
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Conclusions: Comparing our data with the NNIS report from December 
1999, our hospital's rate is between 75 and 900% Nosocomial infection is 
sigtllficantly higher in CIE-9 procedure 8152 than in procedure 8151. 
1 PI01 5 I Medical-conservative therapy of infected 
osteosynthesis 
G. L. Pavoni, P. Baiocchi, P. Carfagna, C. Anzivino, €? Serra and 
M. Venditti 
Rome, I 
Objectives: The conventional therapeutic approach of bone infection asso- 
ciated with osteosynthesis proposes that microbial eradication is most readdy 
achieved by removal of the foreign material together with adequate anti- 
microbial therapy. This strategy usually requires implantation of external 
fixation device with additional discomfort to the patients (pts). Herewith, we 
report our experience with medical-conservative antimicrobial therapy with- 
out removal of the osteosynthesis until adequate bone callus deposition is 
documented by bone radiography scan. 
Methods: Eighteen patients with infections associated with intramedullary 
naihng (8 pa), screw-plates (7 pts) or screws (3 pts) have been treated fkom 
1997 to 2001. Osteosynthesis implantation sites were tibia (6pts), femur 
(4 pa), humerus (2 pts), and others (6 pts). Diagnosis of infection was based on 
clinical-microbiological evidence and confirmed by 99m-TC HMPAO- 
labeled leukocytes scan studies. 
Results Wending pathogens were MRSA (9), MSSA (6). MSSA + P aer- 
uginosa (2). unknown (1). Most cases were initially treated with intravenous or 
intramuscular teicoplanin k ciprofloxacin or rifampin, followed by oral anti- 
microbial therapy usually with ciprofloxacin or mynocicline plus rifampin. 
Mean duration of antimicrobial therapy was 27.6 weeks (range 1&84 weeks). 
Cure (improvement with no relapse after 6 months follow up) was established 
in 15 patients (83%); fdure was observed in one patient who relapsed; two 
patients improved but had positive post-therapy 99m-TC HMPAO-labeled 
leukocyte scintigraphy examination, so they are sdl performing additional 
antimicrobial therapy (one out of these could not remove osteosynthetic 
material). No patient complained side-effects requiring antibiotic therapy 
discontinuation. 
Conclusions: We concluded that medical-conservative therapy is feasible for 
osteosynthesis-associated bone mfection. 
Ip10161 Staphylococci in infections of hip prostheses and 
bacteremia 
D. Kotulova, A Longauerova, L Sloboddova, J Horvath and 
L Klokocmkova 
Brahslava, SK 
Objectives: To follow in pahents, the parhmpapadon of Sfqdzylomm aureus and 
coagdase-negahve staphylococa (CoNS) m bacterermas and catheter sepses, 
and postsurgery mfechons of h ~ p  rostheses To compare the phenotype of 
reslstance to anh-mfeChVe drugs and occuirence of selected mrulence factors 
of staphylococci isolated h m  both groups of pahents 
Methods: Over the penod of January 1999-June 2001, blood, vascular 
catheters and pus taken h m  wounds connected wth hlp prostheses were 
inwhgated Isolated strams were idenhfied biochermcally suscephbibllity 
agamt selected drugs was tested by the d~sk &aon test accordmg to 
NCCLS, MIC was establ~shed by colorunetric method, and SUSCephbhty 
to vancomycin was confirmed by the E-test. Beta-lactamase, coagulase, 
fibrmolysin, alpha-, beta-, delta-hemolysm, and DNase were tested by 
standard rmcrobiologcal methods S h e  layer produchon was detected by 
use of Congo red agar plates 
R-ults: Three methlch-resistant s t m  of S auras (MRSA) and 13 
susceptible smam (MSSA) were isolated from blood and vascular catheters 
of the patlens. All the MSSA were DNase-psihve, MIC of vancomycm 
ranged &om 1.5 to 2.0mgIL. Out of 88 coagdase-negahve s t r a m ,  65 (74%) 
were rnethldm resstant (MRCoNS) Total 61 (94%) of MRCoNS pro- 
duced delta-like t o m  and 16 (25%) of them DNase. MIC to vancomycin 
ranged f k m  1 5 to 4.0 mg/L. Twelve MSSA and one MRSA ( m d  gene not 
proved) were lsolated fkom hip prostheses infeChOns. Out of 25 CoNS strams, 
16 (64%) were MFL DNase-negahve, 12 (75%) of them produced delta-hke 
toxxns. MIC to vancomynn of MRCoNS ranged f k m  2.0 to 4.0 mg/L, and 
of MSCoNS from 0 75 to 2 0 mg/L. Ninety m e  of 113 invesagated CoNS 
were s h e  producers. 
Conclusions: CoNS prevaded (85%) in the group of 104 staphylococcal strams 
lsolated from bacterermas and vascular catheter sepses Characterlshc feature 
of these bacterla was the hgh percentage of methican reslstance and delta- 
hke t o m  produchon. CoNS participated in 66% of staphylococcal h ~ p  
prostheses infechons; they &d not produce DNase, and produced delta-like 
t o m  In a lower percentage m comparison wtth the stratns found in 
bacterermas Total 88% of all mveshgated CoNS produced s h e  layer. From 
therapeuhcal pomt of mew, the fact that MRCoNS showed hgher MICs to 
vancomycin as MS st rams IS important. However, they shU represent smns  
where therapy w t h  vancomycm can be effechve 
/P1017j Osteoarticular infections complicating 
enterococcal endocarditis: report of a case and review 
of the literature 
N. E. Vlahalus, Z. Temesgen, E. E Berbari and J. M. Steckelberg 
Rochestn, USA 
We report a case of &sk space infechon complicatmg enterococcal endo- 
CardIhs, and review eight addihod cases reported in the literature from 1966 
through 1998 for which c h c a l  and treatment data were available. Seven of 
the mne pahents were men. Pd except two were 60yem of age or older. 
Seven pahents had disk space infections; one pahent had SephC arthritis of the 
knee, another had infection of the sacrolliac joint. The median interval 
between the onset of symptoms and the magnosis of deChOn w a s  60days 
(7 days-9months). Fever was present in seven patients. Elevated erythrocyte 
sedimentation rate or C-reactive protern values were noted in all. Blood 
cultures grew Enteroc~~ncc in all nine cases; Enterom&alis in five cases, 
speciation was not performed in four cases. Culture h m  the intervertebral 
space was obtavled in only one case. In the rest, chagnosis of disk space 
infechon was based on a b n o d t i e s  on maging studies. The lumbar spine 
was affected in all cases. With the exception of one patient, the heart valves 
involved were all native valves: two cases of rmtral valve alone, four cases of 
aortic valve alone, and two cases of dual mvolvement of the m i d  and aortic 
valves. Parented pemcillin in combmahon wth  an aminoglycoside was used 
for treatment. Durauon of treatment ranged between 28 and 45 days. Infected 
valves requlred replacement in at least three cases. Osteoarticular infechon was 
considered cured m all cases. One patient died &om dehtscence of a prosthetic 
valve. 
Non-molecular diagnostic methods II 
Ip10181 
containing chromogenic agar 
of two bedside urine culture devices Israel) and Dipstreak (Novmed Ltd, Jerusalem, Israel). Both devices allow the quantitative sampling of urine which is being automatically streaked on 
conventional media, MacConkey on one side and different formulas of 
chromogenic agar in the other, thus enabling the presumptive identification 
of most uropathogens. 
Methods: Elght hundred and fifty urine samples &om patients with leuco- 
cyturia were included in this study. Samples were inoculated in both devices 
and 1 pL ahquotes were plated on sheep blood agar, MacConkey agar, and 
Columbia CNA agar as golden standard. Following 24-h incubation, colonies 
R. Colodner, B. Reznik, V. Aulov, V. Gal, R. Yediliz, P. Levy and 
Y. Keness 
Aflla, IL 
Ob-: To compare the performances of two recently developed bedside 
urine culture devices: Colorex Diastide (Hy Laboratories Ltd, Park Tamar, 
226 Abstracts 
were counted and presumptive identification by both chromogenic agars was 
compared to that obtained using Microscan panels (Dade-Behring, Sacra- 
mento, USA) and a Microscan WalkAway 96 system. 
Results: The sensitivity of the devices in the detection of >1OOOOOdu/mL 
and in the correct presumptive identification was 98.7 and 97.9% for Colorex 
Diaslide and 96.2 and 87.7% for Dipstreak, respectively. When the threshold 
was lowered to include >1OOOOcfu/mL, sensitivity values were 97.5 and 
98.2% for Colorex Diaslide and 81.4 and 87.1% for Dipstreak. Negative 
predictive value was calculated to be 99.0% for Colorex Diaslide and 92.8% 
for Dipstreak. The sensitivity in detecting mixed cultures (three or more 
organisms present) was 96.7% for Colorex Diaslide and 75.0% for Dipstreak. 
The overall full-agreement rates of quantitatlve results (categorized in 
four levels: negative, up to 1OOOOcfu/mL, up to 1OOOOOcfu/mL and 
>lOOOOOcfu/mL) compared to the gold standard were 98.0 and 84.5% 
for Colorex Diaslide and Dipstreak, respectively. Colorex Diaslide succeed in 
presumptively identifying 98.7% of all microorganiuns wbde Dipstreak 
identified 89.4%. 
Conclusions: Both devices demonstrated excellent performance in quantify- 
ing and identifymg uropathogens €-om urine specimens containing 
>lo0 000 cfu/mL compared to conventional methods. However, Colorex 
Diaslide proved to be superior in terms of sensitivity and accuracy with lower 
bacterial counts and mixed cultures. 
Ip1019 
of group 
Evaluation of Granada HT medium for detection 
Streptococci (GBS) in pregnant women 
A. Andreu, M. M. Femenias, J. M. Manresa and R. M. Bartolome 
Bardona, E 
Objective: To evaluate a new commercial Granada agar (Medio Granada HT, 
Biomedics. Spain) for the detection of GBS in vaginal and rectal specimens 
fiom pregnant women. 
Methods: A total of 600 samples including: 221 vagmal, 221 rectal and 11 
vagino-rectal h m  women at 35-37 weeks' gestation, 55 endocervical and 55 
vaginal €-om women with onset oflabor or membrane rupture at <37 weeks 
and 37 vaginal at  any time of pregnancy, were studied. All samples were placed 
in aanspot medium (Modified Anlies) and inoculated in selective Columbia 
agar (with 5% human blood, 15 pg/mL nalidvdc acid and 15 pg/mL colistin), 
Granada agar plate prepared in our loboratory (proteose peptone 25 g, starch 
20 g, MOPS 11 g, Na2HP04 8.5 g, glucose 2.5 g, pyruvate 1 g, MgS04 0.2 g, 
methotrexate 6 mg, crystal violet 0.2 mg, colistine 5 mg, metronidazole 
10 mg, horse serum 50 mL, agar 10 g and water 1 L), Granada HT plate 
and Todd-Hewitt broth (with 5% home serum and 15 pg/mL amikacin). Afier 
18-24h, Todd-Hewitt was subcultured in Columbia, Granada and Granada 
HT. Columbia plates were incubated in 5% CO2 and Granada in anaerobiosis 
and examined at 24 and 48 b. 
Results: Among the 324 pregnant women studied, 60 were colonized by 
GBS. Of the 600 samples processed, 93 were GBS-positive: 42 vaginal, 41 
rectal, seven endocervical and three vagino-rectal. GBS were isolated in the 
following media: 64 in Columbia, 80 in Granada, 79 in Granada HT directly 
inoculated and 83 in Columbia, 89 in Granada and 89 in Granada HT after 
Todd-Hewitt enrichment, with sensitivities of 69, 86, 85, 89, 96 and 96%, 
respectively. For GBS detection in rectal samples, there were no significant 
ditrerences between the two Granada media and before and after enrichment 
(P=O.13, P=0.48, P=0.32, P=0.32). In contrast, sigmfkant differences 
were found for vaginal samples (P= 0.01, P= 0.01, P= 1, P= 1). When 
vaginal and rectal samples were studied separately, 65% of women horbored 
GBS in both vagina and rectum, 2% only in vagina and 33% only in rectum. 
Conclusions: The 18.5% of pregnant women were colonized by GBS. 
Granada agar is more sensitive than Columbia for GBS detection and has 
the advantage of providing results in 18-24 h because its characteristic red- 
orange pigment makes futher identification unnecessary. New commercial 
Granada HTwas as sensitive as our Granada memum and has the advantage of 
easier prepatation. 
[m) Evaluation of the new 'Chrombgenic Salmonella 
Agar' for the selective isolation of Salmonella spp. from 
stools 
A. Babic-Erceg, S. Pavic, M. Erceg, Z. Barisic, E. BoZic, 
M. Smoljanovic, V. Zoranic, V Kaliterna and M. Carev 
Split, HR 
Objectives: The purpose of this research was to evaluate suitability of the new 
'Chromogenic SalmoneZla Agar', CSA (Biolife, Italy) in comparison with 
'SalmonelleShigefla Agar' SSA (Biolife, Italy) for the selective isolation of 
~ d m o n e l l a  spp. from stools. 
Methods: One Gram of stool was put in 9mL of Selenite-F enrichment 
medium (Biolife-Italy) at 37 "C for 24 h followed by streaking onto SSA as a 
referent medmm and CSA as a test medium. Afier incubation at 37 "C/24 h, 
suspect colonies Cmm both media were transfered onto Kligler Iron Agar, KIA 
(Biolife-Italy) for preliminary testing. Strains showing typical reactions on 
KIA were confirmed by biochemical tests using API 10s gallery (bioMeriew, 
France) followed by final identification with sera manifactured by Immunol- 
ogy Institut, Zagreb. Specificity and sensitivity was calculated and compared 
by McNamara test. 
Results: During September to November 2000, total of 300 stools were 
examined. 45 out of 76 suspected colonies were confirmed to be Salmonella 
spp. on SSA (sensitivity loo%, specificity 88%). From the same number of 
stool samples, 45 out of 46 suspected colonies showing magenta colour on 
CSA, were confumed to belong to genus Salmonella with one false positive 
reaction due to Pseudomonas spp. (sensitivity 100%, specificity 99%). In 
comparison these two media CSA showed better results in preliminary test 
(x2 = 28, d.f. = 1, P <  0.01). Confirmation test gave the same results on both 
media. Serotyping confirmed all isolates as: somatic antigen 0 1, 9, 12; 
flagellar antigen H 1 fase: g m  - Salmonella entm'ca serotype Enteritidis. 
Conclusion: Due to its good sensitivity and specificity, CSA can be recom- 
mended for the use for screening of human stools when Salmonella spp. are 
concerned and may help to reduce the work load when this medium is used 
for plating after enrichment. 
[=I Are out-of-houn positive blood cultures 
clinically relevant? 
L. Rajan, H. Humphreys, F. Fitzpatrick, M. Turley, S. Corcoran 
and E. Smyth 
Dublin, IRL. 
Objective: Prompt and appropriate treatment of bacteraemia reduces mor- 
tality significantly. Recent automated continuous blood culture monitoring 
systems facilitate early intervention and the institution of appropriate therapy 
more quickly. We have evaluated the effect of out-of-hours blood culture 
monitoring on reporting and the start of more appropriate antibiotic treat- 
ment. 
Methods: The laboratory rang the medical microbiologist at a specified time 
each night with the microscopy result of new blood cultures. The micro- 
biologist then liased with medical and other s& regarding the relevance of 
these and recommended changes in antibiotics as appropriate. The following 
day each positive blood culture was followed up and an assessment was made as 
to their sigruficance or otherwise. A significant positive blood culture was 
defined as the same organism grown &om two or more blood cultures with 
appropriate clinical signs and symptoms or the isolation of a known pathogen 
from one positive blood culture with appropriate signs and symptom where 
there was no other obvious cause of infection. 
Results: A total of 150 positive blood cultures were phoned during the study 
period. 61 patients were already on appropriate therapy, the positive blood 
culture was considered a contaminant in 47 cases and treatment was reviewed 
in a further 42 cases. In 13 of these 42 cases, the patient was already on 
appropriate therapy but in 29 cases, inappropriate antibiotics were either 
stopped, rationalised and/or appropriate therapy started. In 8 of 18 MRSA 
patients, this was the first isolate of MRSA for that patient facilitating earlier 
treatment and patient isolation. One patient with vancomycin resistant 
enterococci was identified for the fmt time out of hours. Clinical liaison 
by the medical microbiologist took approximately 25 h over the study period. 
Conclusion: The main benefits from out-of-hours blood cultures is that the 
laboratory results are available a day earlier and appropriate therapy can be 
started sooner in approximately 20% of cases. 
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(p10221 Utility of the Gram stain for the diagnosis of 
organic fluid infections 
F. Salceda, E. Morante, M. Barroso, D. Fontanals, I. Sanfeliu and 
J. Hernindez 
Sabadell, Barcelona, E 
Objectives: To evaluate the performance of the Gram stain in the diagnosis of 
the organic fluid infections: Cerebrospinal fluid (CSF), Ascitic fluid (ASCF), 
Pleural fluid (PLEF) and Synovial fluid (SYNF). 
Methods: During 6 months we analyzed 608 organic fluids. We processed the 
Gram stain following an established protocol: (1) leukocytes count of at least 
1 0 / m 3  in CSF, 250/mm3 in ASCF, 1 5 0 / m 3  in PLEF and 2000/mm3 in 
SYNF with predominant polymorphonuclear; (2) when the physician asked 
for it. In case of CSF, we also processed when: (3) predominant lymphocytes 
with glucose below 40 mg/dL and proteiii above 50 mg/dL; (4) suspicion of 
sepsis or meningitis; and (5) immunodeficiency. The culture was carried out 
following standard techniques and was considered as the gold standard. We 
compared the Gram stain result to the culture result. The data were analyzed 
with the statistical program SPSS 10.0. We calculated the sensitivity (S), the 
specificity (SP), the positive predictive value (PPV) and the negative predictive 
value (NPV). 
Results: We analyzed 608 organic fluids: 218 (35%) CSF, 198 (33%) ASCF, 
140 (23%) PLEF and 52 (9%) SYNF. Only 230 (38%) reached the established 
protocol for realizing the Gram stain. All in all the results were: S = 75%, 
SP = 98.9%, PPV = 94.3%, and NpV= 94.3%. According to the fluid studied 
the results were: CSF (84,100, 100,97), ASCF (53, 100, 100, 85), PLEF (78, 
97, 91, 93), and SYNF (100, 97, 83, IOO), respectively. 
Cconclusions: The Gram stain is a simple, rapid, accurate and inexpensive 
method to find out the etiological agent of organic fluid infections in 
approximately 75% of the cases. We have found good S, SP, P W  and 
NPV and we would point out the good sensitivity in the CSF and the poor 
sensitivity in the ASCF. 
] P1023 ] Elastase and alkaline protease activity of 
Pseudomonas aemginosa strains: comparison of two 
methods 
A. Yagci, Y. Tuc and G. Soyletir 
Istanbul, TR 
Objective: Pseudomonas aeruginosa is an opportunistic pathogen that can cause 
fatal infections in immunocompromised hosts. The virulence of E! aenrginosa is 
associated with the presence of various extracellular factors, like elastase and 
alkaline protease. These enzymes are suggested to contribute tissue destruc- 
tion and assist bacterial invasion during infection. Therefore it seems likely 
that, determination ofthese virulence factors wiU be an important prognostic 
marker in the near future especially for follow up of cystic fibrosis patients, in 
order to start antimicrobial agents that are directly or indmctly idubits 
microbial growth or virulence factor production. Herein, we suggested a 
simple test procedure to be used in routine laboratories for estiination of 
elastase and alkaline protease levels and compared them with quantitative 
methods in the literature. 
Methods: Elastolytic activity of the strains was determined by (i). measure- 
ment: of zone diameter in elastin nutrient agar plates containing a nutrient 
agar base with 1% elastin (Sigma)-coiitaining agar overlay. Supernatants 
(20 pL) were added to the wells punched in plates, after overnight incubation 
at 37°C diameter in mm of the zone of clearing were measured; (ii). 
measurement: of the supernatant absorbance at 495nm after mixing with 
elastin-congo red substrate. Alkaline protease activity of the strains were 
determined by (i).measurement: ofzone diameter in skim milk agar plates as 
described above; (i). measurement: of the supernatant absorbance at 595 nm 
after mixing with hide azure blue substrate. After each assay the experimental 
data which were the mean of two or three independent assays compared 
with corresponding standard curves established with standard elastase 
and protease (Sigma). Results were extrapolated according to the standart 
values. 
Results and conclusion: The resulting values were in the range reported in the 
literature and U m e d  fbm one snain to another (elastase: 0-1390 mg/mL, 
alkaline protease: 0-770mg/mL). Linear relationships were found 
when assays compared in pain and sigruficant correlation coefficients were 
obtained (r> 0.788 for alkaline protease, P<O.OOOl, r> 0.926 for elastase, 
P <  0.0001). The plate assay method can be applied to roughly quantify the 
level of these enzymes zegardless the availabhty of techcal equipment. 
I P1024 1 Prodigiosin producing serretia mamscens in a 
tertiary care hospital 
Gdffnrk, Pt 
Objective: The urn of this study was to analyze sensiamty, mcidence and 
biologcal propemes of prodq$osm producing S marcesm ~olated m our 
hospital over 5years. 
Materialsand methock . The collection 527 S. marcescetu lsolates tiom 1996 to 
2000 was analyzed. Produchon of pigment was exarmned on - P e p m e  
Glycerol Agar (PGA) contaming 1% glycerol. Semmty to selected 11 agents 
was determined by the agar dduhon method accodng to NCCLS guidehes: 
piperacilln, prpera&/tazobactam, cehnaxone, cefhdime, cefepime, uni- 
penem, meropenem, amhcin, gentarmcm, nelllrmcm and nproftoxacin. 
Hemohc achvlty was d e t e m e d  on Columbm Sheep Blood Agar and 
protease productlon on Skim Milk Agar. ESBL produchon was examined in 
routine double-dsk synergy ttst (J3DS). 
Retultr: Prodjg~& producing S. mamscem was detected in 20 (4%) of 
Isolates. They were recovered h m  respiratory tract (10). skm and soft tissues 
(4), d r a i ~ g e ~  (2), blood (2), urine (l), and btle (1). Pmdig~osm positwe 
S. marcams were most fkequently isolated m surgical wads (7) m e d a l  (4) and 
neurologd wards (4). The majority of ma~ns were isolated m 1998 (9). 
Pigmented s t r a m  showed wide range of MIG to tested agents. All strams 
were sensitive to c e b d u n e ,  cefepme, carbapenems, 85% to ciprofloxacm, 
and 80% to ammoglycosides. Only 13 (65%) d a t e s  were sewtwe to 
piperach. Among prodqyosln positive isolates 14 produced hemolysln 
and 18 proteases. 
Conclusions: Pigmented S rnarcercenr are thought to be mostly lsolated b m  
enwonmental sourees and only transiently presented m hospital setting. 
However such stram are rare, and probably not epideunologzcaily M e d ,  
they are no longer d o d y  susceptible LO anabloacs. Our s t u d y  pnxres that 
they can penist m hospital envlnmment gaumng some remtant deternunants 
and express wulence factors. 
B. Rybak, L. Naurmuk and A. Samet 
1 PI025 1 Performance of the Sensititre Gram-negative 
Identification panel (GNID) compared to API ZOEIZONE, IDS 
RaplD ONE/NF and the Vitek AMS GNIs 
A J Sornervilk, M. J. Brimecombe and D. A. Butler 
East Gnmtead, UK 
Objectives: A chmcal trial was conducted at h e r i c k  Regonal Hospital, 
Lnenck, Em, to predxt the performance of the new senslhce GNlD 
(Gram-negaave identlfcahon panel, Trek Diagnosnc Systems Ltd, UK) m 
correctly idenhfylng Enterobacferraceae and non-Enterobactenaceae. The GNID 
d replace the cwrent AP80 AutoIdenaficahon plate, wth  the release of the 
new Sensihtre software 
Methods: Performance of GNID was compared to three commonly used 
bactenal idenaficahon systems API 20E and 20NE (bioMerieux, France), 
IDS RapID ONE and RapID NF (Remel Inc USA) and the Vitek 
AutoMcrobic System GNI+ (bioMeneux Vitek Systems Inc. Hazelwood, 
Mo.), all of whch are used to idenhfy common Gram-negaave bacteria. 
Almost 100 c h c a l  isolates were tested. 
Results: GNID correctly identified 95% of Enterobacfemmae isolates (n = 56) 
and 95% of non-EntembacteMceae lsolaces (n=37) to species API systems 
correctly idenhlied 77% of Entdmtenaceae d a t e s  (n = 52) and 6Y? of non- 
Enferobactmacpae isolates (nz26) IDS RapID panels correctly idenhfied 
94% of Enterobaaenaceae lsolates (n= 16) and 81% of non-Entmobacrenaeae 
isolates (n=16) The Vitek GNI+ card correctly idennfied lW? of 
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Enterobactm'aceae isolates (n = 7) to species and 91% of non-Entmbacteriaceae 
isolates ( n = l t ) .  
Conclusions: The performance of GNID compared favourably and in 
most cases exceeded the performance of the other three systems tested in 
correctly identlfjlng common, clinically sigmficant gram-negative bacteria. 
The GNID pedormed equally well in identifying members of the 
Enterobacterraceae and non-Enterobacteriace. 
Lp10261 Identification and biotyping of stains of 
Acinetobacter calcoaceticus-A. baumannii complex 
A. Dueiias, M. A. Bratos, J. M. Eiros, A. Ordufia, P. Gutierrez, 
M. A. Miguel and A. Rodriguez-Torres 
Valkadolid, E 
Objectives: The aim of this work was to biotype the strains of A. cakcoaceticu~- 
A. baumanii complex that were identified at the HCU of Valladolid during the 
period October 1998-january 2000 and to study the biotype distribution. 
Methods: The strains were presuntively identified as Acinetobacter 5pp by 
means of comercial systems and its belonging to A .  calcoa&icutc-A. baumanii 
complex was studied by additional tests: growth at 41'C and 44°C and 
hemolysis. The strains that did not grow at 44 "C were identified to species 
level by means of the simplified scheme by Bouvet and Grimont. All the 
strains that were identified as A. cakoacericuts-A. baumanii complex were 
biotyped according to the procedure by Bouvet and Grimont. 
Results: Of all 504 isolated strains of Acinetobacter, 493 corresponding to 302 
patients were identified as belonging to A. calcoaceticus-A. baumanii complex. 
Nine biotypes were identified 1,2 ,3 ,5 ,6 ,8 ,9 ,  14 and 18. The most kequent 
was biotype 1 (84.4%). followed by 2 (7.9%). 18 (4.1%), and 9 (3.7%). In all 
types of samples biotype 1 predominated, with percentages ranging &om 
73.8% in urine samples to 100% in CSF samples. 48.3% of strains ofbiotype 1 
were isolated h m  the exudates and 27.8% from respiratory samples. Biotype 
2 was observed in all types of samples except in CSF and 59.0% of strains of 
such biotype were isolated h m  the exudates. Biotype 9 was only encountered 
in exudates (88.9%) and respiratory samples (1 l.l%), whereas biotype 18 was 
predominantly isolated h m  exudates (50%) and urine samples (40%). Of all 
459 strains of nosocomial origin, the predominant was biotype 1 in all 
months. Biotypes 2 and 18 were isolated almost every month, whereas 
biotype 9 was predominantly isolated during the 1st month of the studied 
period. Biotype 1 predominated in all areas of the hospital, with percentages 
between 44.4% and 84.3%. Biotypes 1 and 2 were mainly isolated at the 
surgery area and h m  intensive care patients, whereas biotype 18 was 
generally encountered in samples fiom surgery patients and medical patients. 
Finally, 46.7% of patients yielding isolation of biotype 9 came from the 
ambulatory area. 
Conclusions: Nine biotypes of A. cakcoaceticuts-A. baumanii complex have 
been identified. Biotype 1 predominated. Biotypes 1,2  and 18 were mostlyof 
hospital origin, whereas almost halfof the isolation cases ofbiotype 9 came 
6om ambulatory areas. During the studied period biotypes 1, 2 and 18 
coexisted. 
[p10271 Biotyping of Arcanobacrerium haemolyticum 
strains by matrix-assisted laser desorption ionization time of 
flight mass spectrometry (MALDI-TOF-MS) 
P. Carlson and T. McKenna 
Helsinki, FIN; Manchester, UK 
Objectives: Ananobacrm'um haemofyticum is an aerobic Gram-positive rod that 
causes tonsillitis and wound infections. Rough and a smooth A. haemolyticum 
biotypes exist. The rough type predominates in the respiratory tract and the 
smooth type in wound infections. The chemical Merences in the cell wall 
structure of the two types are not known. MALDI-TOF-MS was used to 
distinguish between the biotypes. 
Methods: Five smooth and five rough type A. haemolyticum strains were 
analyzed in a blind fashon. The strains were cultured on Columbia blood agar 
plates for 48 h in 5% COz at 35 "C and colonies were transferred to a MALDI 
target plate with a loop. Twelve replicates were sampled for each of the 10 
strains in order to construct a database h m  the fingerprints obtained. Samples 
were then overlaid with alpha-cyano-4-hydroxycinnamic acid and the dried 
plates were analyzed. Mass spectral data was acquired Over the m / z  range 
50&1000Da. The results were processed using the MicrobeLynx sohare.  
Results: Mass spectral fingerprints were obtained for all 10 strains. In order to 
determine the grouping of strains a database was made. Individual cultures 
were then compared against each entry in the database to obtain a root mean 
square value to measure the relationship of each strain to the other nine. A 
second comparison was made using a database search to determine the five 
closest matches for each strain. The strains could be correctly divided into the 
two biotypes using MALDI-TOF-MS only (P<  0.001). 
Conclusion: The two A. haemolyticum biotypes have differencia in cell wall 
structure that can be demonstrated using MALDI-TOF-MS. The precise 
chemical differences of the the cell wall composition of the two biotypes 
remain to be elucidated. 
[ P1028 1 Point of care inoculating: preliminary 
evalutation of Granada Medium Instant for early detection 
group B streptococci 
L. Ricci, A. Fabio, D. Marchetti and L. Vecchia 
R e g i o  Emilia, Bologna, I 
Objectives: Group B Streptocms (GBS) is etiological agent of serious 
infections that affect newborn babies, children, adults. Recent data show 
the possibility to reduce the incidence of infections, expecially neonatal, 
through a carefdl conmlo of the woman during the pregnancy. We evaluated 
the Granada Medium Instant for early detection group B Streptococcus by rectal 
swabs of women 34th-38th week pregnant. Our laboratory makes also 
diagnostic test coming h m  peripherical hospitals and ambulatories; so that 
we have the necessity to collect specimens directly at the patient's bed, assuring 
the quality of the transport of the specimen and offering to the peripherical 
districts the opportunity to prepare the culture also during the closing hours of 
the laboratory. The GMI is contained in tubes ofglass and the colonies ofGBS 
grow with a red-orange colour characteristic of human isolates. In the 
Granada there are folates that increase the colonies colour intensity. 
Methods: We examinated 200 subjects collecting the material with two rectal 
swabs. One swab was dipped direcdy in the tube containig GMI, while the 
other was used to next preparation in laboratory of the culture standard in 
Blood agar after enrichment and Selecttive Strepto agar. The Granada and 
Blood Agar were icubated under aerobic conditions at 35°C. The direct 
reading of Granada, based on the red-orange colouration of the medium, was 
made after 18 h and in case of negativity extended till 48 h. For verifying the 
specificity of the colouration, the identification of GBS colonies was made 
with biochemical and serological tests. 
Results: The preliminary results obtained in our study are showed in the 
Table. 
Blood agar 
Granada medium Positive Negative 
Positive 
Negative 
40 1 
159 
Conclusion: On the ground of our experience the Granada Medium Instant 
answer to three actual important requisites: 
1 It makes possible the execution at the patient's bed of inoculation on the 
2 It is a means able to screening during the pregnancy both the subjects 
3 It  allows an economical saving because it does not require more biochem- 
culture medium (point of care inoculating). 
carriers of GBS and the newborn babies (specificity 100%). 
ical or serologic tests for the GBS identification. 
I P1029 1 Procalcitonin as a diagnostic marker in septic 
patients 
K. Hryckiewicz, A. Samet and J. Juszczyk 
Poznan, PL 
Objectives: To compare procalcitonin (PCT) plasma levels of septic patients 
with positive and negative blood culture. 
Methods: A total of 49 patients were included 25 patients with positive 
blood culture, 18 patients with negative blood culture and six patients without 
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sepsis. PCTwere evaluated on the 1st day after onset of sepsis symptoms. If the 
result was positive, the next PCTwas done after 24 h. Ifit was sti l l  positive, the 
next one was done also 24 h until gave negative outcome. If first PCT was 
negative, the control was done after 72 h. Procalcitonin level was measured by 
two methods (PCT-Q and LUMItest, BRAHMS Diagnostica, Berlin). 
Results: Observed mortality was 10/49 (20.4%), PCT values were higher in 
patients with positive blood culture (11.244~ SD 16.56ng/mL) vs. 
Patients: with negative blood culture (6.76 f SD 10.75 ng/mL). Patients 
withoutsepsis hadverylowPCTlevels (1.86&SD 10.25ng/mL.). Thehigher 
PCT concentration was found in patients with sepsis caused by Gram-positive 
comparing with Gram-negative. 
Conclusions: PCT presents itself as a diagnostic parameter of sepsis. Patients 
with positive blood culture had signhcantly hlgher PCT level in comparison 
to patients with negative blood culture. Elevated PCT level revealed a 
complicated course and indicated worse prognosis. PCT correlated with 
the clinical outcome in sepsis. 
(p10301 Procalcitonin in patients with Legioneh 
pneumonia 
L. Franzin and D. Cabodl 
Turin, I 
Objective: Procalcitonin (PCT) is a specific marker of severe bacterial and 
fungal infections. The aim of the study was to determine PCT in patients with 
Legionella pneumonia. 
Methods: First serum sample of 140 patients (121 male, 19 females; 51.73 
mean years old and a 7-day-old-neonate) with laboratory confirmed Legionella 
infection (defined by seroconversion with indirect immunofluorescence assay 
and microagglutination test and/or by culture positivity) were examined. 
PCT was measured by immunoluminonietric assay (Lumitest PCT Brahms 
Diagnostica) . 
Results PCT values were positive (>0.5ng/mL) in 57.1% of the sera, 
collected &om 2 to 45 days after symptoms onset. Positive sample rate was 
higher in early samples and decreased progressively in late sera. 69.8% of the 
samples collected in the first two weeks were positive against 29.5% in the 
following period (P<O.OOl).  Mean PCT values (11.76zk27.36ng/mL: 
range 0.51-150.7) of patients sera in the first two weeks of disease were 
higher than those (3.47 f3 .78  ng/mL, range 0.89-14.32) of samples col- 
lected in the following period. PCT was positive in 86.7% of culture 
positive Legionellosis cases; in these patients, mean positive PCT values 
(39.4 i 54.67ngImL; range 1.56-150.7) ofthe sera, collected in the f i s t  two 
weeks, were sigdicantly higher (P< 0.001) than those (5.68 * 9.95 ng/mL; 
range 0.5-63.11) of culture negative subjects. 
Conclusions: Procalcitonin can be a useful marker ofbacterial infection, when 
serum samples are collected at the onset of symptoms. However, LegioneZfa 
pmmonia  is sometimes unrecognized and diagnosis may be delayed. In this 
case, PCT can represent a useful prognostic marker in patients with severe 
bacterial infection only in the first two weeks of disease. 
m] Rapid presumptive diagnosis of bacterial 
meningitis with a new Procalcitonin method 
M. A. Sempere Alcocer, N. Pedrero and J. Fernbdez-Crehuet 
Marbella, E 
We assess a new rapid test for Procalcitonin determination (PCT-Q, 
BRAHMS) in order to differentiate between bacterial (BM) and aseptic 
meningitis (AM). The PCT-Q is a new method that determines procalci- 
tonin, in 0.2mL of serum or plasma samples, in a disposable device without 
need of other instrument. The results are read after 30min and positive 
samples show colour intensity directly proportional to the PCT concentra- 
tion. Using a reference card with a colour scale, it is possible to Merentiate 
three PCT concentrations: mildly elevated PCT (0.5-2 ng/mL), elevated 
PCT (2-10 ng/mL) and highly elevated PCT (more than 10 ng/mL). In order 
to see the correlation of this semiquantitative test (PCT-Q) with the quanti- 
tative method (LUMItest PCT, BHRAMS), 75 serum samples with a range of 
PCT concentration of 0-100 ng/mL were measured by both methods. There 
was a close concordance rate (89.3%). with only two being positive with the 
quantitative method samples (with a low level PCT, 0.5-2ng/mL) and 
negative with the semiquantitative test PCT-Q (two false negative). To 
Werentiate BM from AM with PCT-Q, 26 sera of consecutive pdents 
with acute meningitis (nine bacterial meningitis and 17 aseptic meningitis) 
were studled. All BM cases were codirmed by CSF or/and blood culture 
(seven N. mmingitidis, one S. pneumoniae and one H. influenzap); All AM cases 
were culture negative. The mean of test routinely used to differentiate BM 
6om AM as CSF glucose, CSF protein, CSF leukocytes count were diEerent 
(P<O.Ol) although there was overlapping in some samples between the 
two groups. With the PCT-Q all BM serum sample were positive 
(PCT > 0.5 ng/mL) and only one AM sample was positive in the 'mildly 
level'. Using as cut off the three concentrations obtainable by PCT-Q-test 
(0.5,2 and 10 ng/mL) we achieved a diagnostic sensitivity of 100,78 and 67% 
and a &agnostic specificity of 94,100 and 100%. respectively. If these results 
are confirmed with more samples, a negative result with PCT-Q in meningitis 
patients would indicate a high probability of aseptic meningitis; however, if 
PCT-Q is more than 2 ng/mL there would be a high probability of bacterial 
meningitis. These results shown that PCT-Q-test may be usell in an 
emergency lab to differentiate aseptic &om bacterial meningitis, especially 
when other test routinely used are inconclusive. 
-1 Procalcitonin as a marker of bacterial infection 
after cardiac surgery 
C. Prat, F! Ricart, J. Dominguez, J. Morillas, S. Blanco, T. Torres, 
A. Pallares and V: Ausma 
Badalona, E 
Objective: Cardiac surgery with cardiopulmonary bypass (CPB) generally 
leads to a systemic inaamaatory response syndrome (SIRS) because of 
exposure of blood to nonphysiological surfaces and endotoxines release 
secondary to aomc clamping. Dlfferential diagnosis between hernodynamic, 
respiratory or infectious complications IS then d&cult by usual markem. The 
objechve of the study was to evaluate the reliabdity of p d c i t o n i n  (PCT) 
serum measurement as a marker of bacterial infection after c d a c  surgery, 
disdnguishmg &om unspecific SIRS. 
Methods Serum samples h m  150 patients undergoing cardiac surgery were 
collected at the time of a h i o n  to Intensive Care Unit and 24 and 48 h later. 
Sixty-e&t patients underwent valvular surgery, 69 coronary artery bypas 
with CPB and, 13, coronary artery bypass without CPB. A total of five 
pahents suffered cardiogenic shock (and three of them died). and su( patients 
showed microbiologically documented bactend infechon. PCT levels were 
also measured to a group of 10 patients undergoing surgery of the intestine 
with bacteremic peritonitls. 
Re~ultr:  PCT levels kept below 1 ng/mL on first determination in all patients 
without any complication, even those who needed inotmpic support within 
the first hours. TW-two ofthe uncomplicated patients showed an mcreased 
PCT levelat second postoperative day: mean 1.58 ng/mL (SD 0.6), decraaslng 
below 1 ng/mL at t b d .  No signhcant differences were found between the 
different kinds of stqery.  No mcreased PCT levels were found related to 
duration of CPB, nor to time of aortic clampmg nor to time of mechanical 
ventilation. Those patients who presented cdogen ic  shock, showed slightly 
increased PCT levels (always below 5 ng/mL) mean 1.76 n g / d  (SD 1.95). 
Those patients who presented bacterial infection showed highly increased 
PCT levels: mean 16.02 ng/mL (SD 8.71). Pahents undergoing surgery ofthe 
intestine showed a mean PCT value of 53.26ng/mL (SD 124.1). 
Conclusions: Unspecific SIRS afkz cardiac surgery does not mcrease sig- 
nifxantly PCT levels. Increased PCT concentrations of more than 5 n g / d  
after cardiac surgery highly suggest postoperatwe complication. PCT serum 
measurement can be useful as a predictive marker of bacterial infechon after 
cardiac surgery. 
-1 Rapid identification of Streptococcus pyogenes 
by the use of a new commercial immunocard assay 
A. Pram, C. Skoulakis, E. Petinaki, E Kontos, A. Koulr~ubellt and 
A. Maniatis 
Larissa, GR 
Purpose: To evaluate the performance of a new ht ,  the ImmunoCard Stat 
Strep A test (Meridian Diagnostics, inc). for the rapid and qualitative 
detection of St~eptococnw pyogenes directly from clLniCa1 specimens. 
Methods and materials: A total of one hundred-20 throat swabs obtained 
during 3 months period from individual outpatients at the Depsmnent of 
ENT, have been included. All the specimens have been examined by the 
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ImmunoCard Strep A test in parallel by the conventional methods (culture, 
isolation and identification of B-haemolytic colonies). 
Results Forty-two of 44 specimens positive by culture for Streptocmus 
pyogenec were positive by the ImmunoCard Strep A test (sensitivity 95%). 
Only two specimens positive by the cultures were negatiw by the Immu- 
nocard. These specimens yielded few colonies after an exhausting search. No 
false-positive results were obtained h m  specimens negative by culture 
(specificity lW?). 
Conclusions: The Immunocard Stat Strep A test is simple to pedorm, gives 
results within lo&, and is characterized by In& sensitivity and specificity. 
This test can detect Streptocorcuspycgenes directly fbm throat swabs and allow 
physicians to diagnose and administer therapy immediately. 
Antibiotic testing 
v) Evaluation of phenotypic antimicrobial 
susceptibility testing of VanA and VanB type vancomycin 
resistance in enterococci 
A. R. Larsen, R. Skov, B. Olson Liljequist, A. Friis Moller, R. Smyth, 
E. Kristensen, N. Frimodt Moller and G. Kahheter 
Copenhagen, OK; Stockholm, V&j4 S 
Objectives: Many laboratories find it difficult to detect glycopeptide resis- 
lance in enterococci. The accuracy of disc susceptibility testing (DST) is 
highly dependent on the method used and improvement is warranted. We 
evaluated the disk a s i o n  method recommended by the Swedish Reference 
Group for Antibiotics (SRGA), a method using blood supplementation as well 
as 14 other disdagar variants of the SRGA method. 
Methods: A total of 72 epidemiologically and genetically dif€erent E.faecafis 
and E.faecium with known vancomycin resistance genotype (susceptible, vanA 
and vanB positive) established using the EVIGENE (TM) VRE Detection Kit, 
was subjected to DST for vancomycin and teicoplanin by three laboratories. 
16 variants of the SRGA disk diffusion method were tested with and without 
5% horseblood supplementation, high (10' du/mL) and standard inocula 
(106cfu/mL), incubation with air and 5% COz, respectively, and readings 
after 20 and 44 h, respectively. Furthermore, the methods were evaluated with 
respect to results obtained for: gentamicin, netilmicin, linezolid, ampicillin, 
trimethoprirn and nitrofurantoin. 
Results: All laboratories detected u a d  positive strains and strains susceptible 
to vancomycin with high accuracy (9%100%). However, the number of 
misin-terpretations of uanB positive strains varied for each laboratory h m  2.7 
to 15.2%, with variations for each method used (0-36%). High inoculum and 
44 h of incubation performed best, with a sensitivity of 98% and a specificity of 
99%. The best method using 20 h of incubation and standard in-oculum was 
the variant using 5% horseblood supplementation and incubation with 5% 
COz. This method had a sensitivity of 91% and a specificity of 100%. 
Conflicting results between the SRGA and the alternative method was 
not observed when making DST for gentamicin, linezolid, ampicillin, 
trimethoprim and nitrofurantoin, whereas slight problems where registered 
for netilmicin. 
Discussion: In the Scandinavian countries, the prevalence of VRE is well 
below 1%. In low prevalence areas, a gain obtained with an increase in 
sensitivity, such as seen here with a high inoculum and incubation for 44 h is 
lost with even a slight decrease in specificity. The loss of specificity results in a 
large propomon of false positives and thus a frequent need for confirmatory 
testing (genotyping). 
IP1035) Evaluation of different methods to detect 
extended spectrum p-lactamases (ESBL) producing Serratia 
marcescens 
L. Naumiuk and A. Samet 
Cdansk, PL 
Objectives: To compare Merent methods detecting ESBL production in 
S. marcesens. Production of AmpC /l-lacmnase can mask the concurrent 
production ofESBL makmg such strains diflicult to detect and may leading to 
inappropriate patients' therapy. 
Methods: Over 5 yem we isolated 68 nonreplicate ESBL positive S. marescens 
using double-disc synergy (DDS) test with cetazidime (CAZ), amoxicillin- 
clavulanate (AMC), cefotaxime (CTX) and cefepime (FEP). ESBL E-tests 
with CAZ alone and with clavulanic acid (TZ/TZL), CTX alone and with 
cladanic acid (CTICTL) were used and the results compared to the DDS 
method. MlCs to piperacillin (PIP), piperacillidtazobactam (TZP), cef- 
triaxon (CRO), CAZ and FEP were determined by agar dilution method 
according to NCCLS guidehes. 
Results ESBL E-tests were able to detect only 27 isolates using the man- 
ufacturer suggested MIC ratio TZ/TZL = 8. If the boundary ESBL X pro- 
duction MIC ratio was lowered to 5, 17 other isolates would be regarded 
ESBL positive. The median inhibition zone diameten for CAZ, CTX 
and FEP were 19, 10 and 16mm, respectively. The M I C U , ~  for PIP were 
128/>256mg/L. TZP 1/32mg/L, CRO 128/>128mg/L, CAZ 4/32, FEP 
16/128 mg/L. 
Conclusion: DDS proved to be the most convenient method to detect ESBL- 
producing S. rnarmcens. Poor performance of the ESBL E-tests could be 
related to the presence of AmpC enzyme and therefore the E-tests MICs 
values above the test ranges. Our isolates demonstrated substrate preference 
for CTX/CRO. Increased FEP and CAZ MICs with concurrent lower MIC 
values for TZP could also suggest ESBL production in S. marescm. 
Ip10361 Flow qtometry assay is useful to identify 
heterogeneous and homogeneous vancomycin intermediate 
Staphy/ococcus aureus strains 
A. Alvarez-Barrientos, A. Vazquez, P. Torralbo, M. C. Varela, E Baquero 
and R. Canton 
Madrid, E 
Objective: To explore the possibility of glycopeptide intermediate S. aureus 
isolates (GISA) detection by flow cytomeay assay 
Methods: Five chical heterogeneous GISA strains, includmg the Mu3, and 
two clinical homogenous GISA strains, including the Mu50, were study by 
Flow Cytometry with the EPICS XL (Coulter) and LSR (Becton-Dickinson) 
systems. Membrane potential was analyzed with rhodamine 123, DIOC5(3), 
and Bisoxonol fluorochmmes in the absence or presence (1 h exposition, LB 
broth) ofvancomycin (1 pg/mL). Results were compared with those obtained 
with two vancomycin susceptible strains (ATCC 43 300 and 49 476). GISA 
status was confirmed by the h4H-vancomycin (6 pg/mL) supplemented agar 
screening test and population analysis. 
Results: Relevant results (mean values of 10 assays) of membrane potential 
modification expressed as reduction (*) or increased r) number of times of 
fluorescence mean intensity compared with the corresponding controls were 
as follows: 
Vancomycin status DIOCS (3)' Bisoxonol" Rhodamine-123** 
Susceptible 4.60f1.55 1.60f0.12 1.47f1.17 
Heterogeneous GISA 1.72 f 0.67 1.07 f 0.1 5 0.66 f 0.20 
Homogeneous GISA 1.10f0.60 1.06f0.26 0.77f0.60 
Differences among hetero- and homo-geneous GISA and vancomycin 
susceptible strams were better detected with DIOC5(3) and to a lesser extend 
wth Bisoxonol and Rhodamine 123. 
Conclusion: Flow Cytometry assay was useful to rapidly iden@ hetero- and 
homo-geneous GISA populations. 
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[=I Phoenix ESBL test as a reliable method for direct 
detection of extended-spectrum p-lactamase (ESBL)- 
producing members of the family Enterobacteriaceae 
T. Spanu, D. Ciccaglione, M. Sanguinetti, B. Posteraro, L. Romano and 
G. Fadda 
Rome, 1 
Objectives: Production of plasmid-mediated extended-spectrum B-lacta- 
rnases (ESBLs) has emerged as an important mechanism contributing to 
/?-lactam resistance in members of the family Enterobacteriaceae. Micro- 
biology laboratory plays a crucial role in reveaiing these ESBLpositive 
bacteria, thus rapid and direct methoQ for their detection are desirable 
now. In this study, we evaluated the reliability of a commercial method, 
the Phoenix ESBL test (Becton Dickinson, Sparks, MD, USA), for determin- 
ing ESBL resistance in a wide number of clinical isolates of Enterobacter- 
iaceae. Results were compared with those of the double-disk @D) and E-test 
confirmatory assays. 
Methods: A total of 510 clinical isolates ofEnterobacteriaceae were included 
in the study. Isolates consisting of 88 E. coli, 158 K.pneumoniae, 18 K. oxyfoca, 
106 E! mirabilis, 26 Psfuarfii, 12 M. morganii, 44 E. aerogenec, 23 E. cloarae, six 
S. marcescens, 21 Cjeundii, eight C. kosm’ were recovered h m  patients 
hospitalized at the Catholic University Medical Center. Of these isolates, 
319 were characterized as ESBL producers and the remaining 191 as other 
B-lactamases producers by means of double duk synergy test and determining 
MICs to cefpodoxime, ceftazidime, ceftriaxone, aztreonam, ce&dime/ 
clavulanic acid and cefotaxime/clavulanic acid using E-test. All of the 510 
isolates were analyzed by Phoenix ESBL test that uses five cephalosporins 
alone or in combination with clavuiamc acid, and a continuous monitoring of 
the growth. The results of Phoenix ESBL test were integrated into the 
antimicrobial susceptibility report through the BDXpert system. In addition, 
the 319 ESBL-producing s t r a i n s  were characterized by colony blot hybridi- 
zation method using TEM and SHV genes as probes. 
Results: Phoenix ESBL test was able to detect all of the 319 strains identified as 
ESBL producers by DD and E-test, whereas of the 191 ESBL-not producing 
strains, 189 strains were confirmed as negative, and two strains gave a positive 
result by Phoenix ESBL. The s t r a i n s  with false-positive results were two 
isolates of K. o q t m  overproducing K1-/?-lactamase. Excellent agreement 
between the methods was thus observed, with an accuracy of 99.6%. The 
sensitivity and specificity of Phoenix ESBL test were of 100 and 98.9%, 
respectively. 
Conclusions: Our data demonstrate that Phoenix ESBL can be considered 
a rapid and reliable method for routine laboratory testing of ESBL 
resistance. 
1 P1038 I Evaluation of the E-test for susceptibility 
testing of h4ycobaYerium tubemu/& to first-line 
antituberculous drugs 
L. Alcali, M. J. Ruiz-Serrano, M. Sbchez-Conde, D. Garcia de Viedma, 
M. Marin-Arriaza, M. S Diaz-Mantes and E. B o w  
Madrid, E 
Introduction: The E-test is a dtttision method consisting of a smp with a 
gradient of drug concentrations that permits easy and rapid reading of MICs. 
Although this method has shown excellent results for other bacteria, its yield 
for M. tuberarlosis is shll being studied. 
Objectives: To evaluate E-test for susceptibility testing of M. tubernrlosis to 
streptomycin, isoniazid, rifampicin and ethambutol. 
Methods We evaluated the E-test for susceptibility testing ofM. tuberculosis to 
streptomycin (S), isonlazid (I), dimpicin (R) and ethambutol (E) against 102 
clilucal isolates of M.fubemrlosis and the reference stra in  H37Rv. The 
proportions method (PM) was used as the reference method (NCCLS, 
M24-72) and the following drug concentmtions (pg/mL) were used, S (2 
and lo), I (0.2 and l), R (1) andE (5 and 10). E-test was performed according 
to the manuficturer’s recommendahons. For analysis purpose in PM, 
strains were considered as intermediate to one drug when resistant to the 
low concentration and susceptible to the high concentration, and 
suscephble or resistant when suscephble or resistant to both ConcentraUons, 
respechvely. 
Results: Forty-three stcilllls were mtermednte or rmstant to at least one drug 
using PM According to the E-test results, optunal breakpomts (pg/mL) for 
t h  methodwere: S flow 0.75; hgh: 8), I (low. 0.016; high: 0.06). R (1) and 
E (low: 0.19; w. 10). Agreements between both methods using these 
proposed breakpoints were: 96.1% (S), 99.0% (I), 100% (R) and 99.0% (E). 
Discordant s t r a m s  for S were one PM-susceptible and E-test-intermedate, 
two PM-intermehate and E-test-suscephble and one PM-intermedate and 
E-test-reslstant, for I one PM-intermedate and E-test-suscephble, and for E 
one PM-suscephble and E-test-intermedate. 
Conclusions: E-test represents a rapid and valid alternatlve for the suscept- 
ibihty teshng ofM htbemrlosis to first-lme anhtuberdous drugs in the chmcal 
laboratory roume. 
1 P1039 I Evaluation of methods for detection of extended 
spectrum plactamases (ESBL) in E. coli and K. pneumoniae. 
How reliable are the confirmatory methods? 
A. Hsiung, C. Oplushl, S. Sinto and C. Mendes 
Sao Paulo, BR 
Some of the emerging mechanisms of resistance are of &cult laboratory 
detection. The emergence of these newer /?-lactamam m Gram negative 
pathogens is consequence of abusive, and sometimes inappropriate use of 
extended-spectrum antibiotics. The detection of these new mechamsms of 
resistance requires special procedures and has been challenging for nucro- 
biologists. The extended-spectrum B-lactamases (ESBL) are very potent 
plasmid-mediated enzymes that are able to hydrohe all penicillins, cepha- 
losporins, and monobactarns. The ESBLs are spreading among members of 
Enterobacteriaceae, however, these enzymes are mostly encountered in E. coli 
and K. pneumoniae. There are several methods of ESBL detection, automated 
or not, all ofthem are based on the synergistic effect ofB-lactamases inhibitors 
with cephalosporins (ceftazidtme, cdotaxime, ceftriaxone), or monobactam 
(-onam). In dus study, we evaluated four confirmatory methods: double- 
disk (tested simultaneously at 20 and 30mm). E-test ESBL ‘screen’, Vitek 
GNS-650 card, and ATE3 BLSE panel for the ESBL detection in E.coZi 
(n = 269) and K pneumoniae (n = 204) isolated h m  several Brazilian hospitals. 
Among the conficmaLoFlr methods, the double-disk method presented the best 
resulrs showing a sensit ivi ty of 96% followed by E-test (%.1%), Vitek (90.2%). 
and ATB (57.8%). The red6 of this study show that the double-dxsk method, 
when performed correctly and read by experienced personnel, can be a very 
sensihve and inexpensive method, bemg easily implemented in the laboratory. 
I PIOU 1 mwt ion  of extend~d spectrum mctamares 
(ES6l.s) in Enmobackriaceee with the V i k  ESBL and E-test 
ESBL 
K. Betlejewska-Kielak and T. Kamriska 
Wanatu, PL 
Objectives To compare the Vitek ESBL test and E-test ESBL in detection of 
ESBLs m clmtcal Enterobactenaceae isolates. 
Methods: Nmety-nme isolates of the seven a r e n t  speaes of the family 
Enterobacteriaceae were used in the study. They were collected in 1998 h o r n  
suc hospitals in Poland. ESBL production was imhdy detected by the double- 
disc synergy (DDS) test and later confirmed by a combmation of biochemcal 
and molecular methods, mcludmg m, bioasq PCR and sequencing of 
ESBGencodmg genes. Suc of the isolates, all belongmg to AmpC producer 
species, apart fiom ESBLs produced also Ampc B-ktarnases in the depressed 
manner. The isolates were analyzed with the V*k GNS-650 card containing 
the ESBL detecaon t a t  and the E-test. 
Results: Of the 99 strams exarmned (45 K. pneumoniae, 18 E. coli, 10 S. mar- 
cesce~(, 10 E. cfouae, nine K. duytoca, six C.fresndii and one M. msgcmit), 80 
(80.8%) s m  were found to produce ESBLs by Vitek, and 83 (83.8%) by the 
E-test ESBL. All strains mth ESBLs and depressed AmpC cephalosprinases 
were defined as ESBL negative by the two approaches. 
Conclusions: The Vitek ESBL test and the E-test ESBL are comparable and 
the results obtained are s i d a r  to those obtained by the double disk-test and 
they are useful in microbiologxal routme &agnostic. 
232 Abstracts 
Use of E-test for detection of phenotypical 
expression of hetero-glycopeptide-intermediate resistance 
in nosotomial coagulase negative Staphylococci (CONS) 
E. Ugolotti, M. L. Fenu, M. L. Belli, S. Piana, G. Pittaluga and G. Manno 
Cenoa, I 
Background Recently E-test with High bacterial Inoculum (Et-HI) was 
found to be a reliable and sensitive method for the detection ofphenotipical 
Hetero-Glycopeptide-Intermediate resistance (hGIS) in Staphylococci 
(WaIsh T.R., JCM, July 2001). 
Objective: To screen, with the E-test conventional inoculum (Et-CQ and 
proposed Et-HI, nosocomial bloodstream isolates of CONS for the emergence 
of reduced susceptibility to glycopeptides. 
Methods: The MICs to vancomycin (VA) and teicoplanin (TEI) was assessed 
by (i) Et-CI and Microdilutions Panels (MPs) (Microscan, Dade) (NCCLS 
proposedprotocols and breakpoints applied) and (ii) Et-HI: after induction by 
an E-test strip placed in a Brain-Heart Infusion agar plate streaked out 
with two McFarland bacterial inoculum, the results were read after 24 and 
48h  at 35°C. Strains studied were 105 nonrepetitive oxacillin resistant 
CONS recovered fiom blood cultures of different patients hospitalized in 
PICU (62%) and NICU (37%): 64 S. epidemidis (SE), 17 S. haemoIytinrs 
(SHAE), 12 S .  warneri (SW), and 11 S. hominis (SHO). Species identification 
was carried out with coagukse test and API Staph System (BioMerieux). 
R e s u k  Et-CI and MPs agreed to categorize 100% of SE, SWand SHO as VA 
susceptible (VA-S), but one SHAE strain with Et-CI gave results VA-S and 
MPs VA-intermediate(1); for TEI the agreement was 100% on SHO to 
categorize TEI-Susceptible (S) and one strain of SE, SW and SHAE, 
respectively, resulted Et-CI TEI-I but MPs TEI-S. Afrer 48 h Et-HI, strains 
resulted (1) SE 23% VA-I (MICs 6-8 pg/mL) and 37% TEI-I (MICs 12-24) 
and 8% TEI-R (MICs 2 32); (2) SHAE 65% VA-I (MICs 6-8) and 41% TEI-I 
and 50% TEl-I (MICs 12-24) and 33% TEI-R (MICs > 64); (4) SHO 27% 
VA-I (MICs 6-8) and TEI-I (MICs 12-16). Colonies grown into the 
intermediate and/or resistance zone of the VA or TEI strips in Et-HI 
were re-tested with Et-CI after repeated subcultures in blood agar. Only 
SHAE and SW strains confirmed the results of reduced susceptibility found 
Conclusions: Our results confirm that conventional E-test is more accurate to 
MPs to asses the glycopeptides susceptibility of staphylococci. The E-test 
under induction appears to be a simple way for the detection and monitoring 
of subtle variations (heteroresistance) in VA and TEI susceptibility of CONS 
recovered from blood stream infections in NICU and PICU. 
(MICS 12-16) and 35% TEI-R ( M I 0  2 128); (3) SW 33% VA-I (MICS 6) 
with Et-HI. 
w1 Screening for extended spectrum &lactamases by 
double disk synergy test with different cephalosporins 
I. Strumbelj, Z. Horvat Sardi, T. Zohar Cretnik and A. Andlovic 
Murska Sobota, Celje, Ljubljana, SLO 
Objectives: Jarlier et al. described double-disk synergy test (DDST) with 
cephalosporins and amoxicdin-cladanic acid (AMC) disks for detection of 
ESBL. The aim of our study was to evaluate sensitivity ofDDSTwith Nerent 
cephalosporins to find suitable cephalosporins for DDST to be included in 
routine disk-diffusion antimicrobial sensitivity testing (AST). 
Methods: (1) Thirty ESBL strains of Kfebsiella pneumoniae (determined as 
ESBL strains by NCCLS phenotypic confirmatory tests with disks) were 
isolated in three Slovenian hospitals. Strains were tested by DDSTwith four 
cephalosporins: cephalotin (CF), ceftriaxone (CRO), ceftazidune (CAZ) and 
cefuroxime (CXM). Standard NCCLS disk-dihion procedure was used for 
DDST. Distance between disks was 23 mm (center to center). Three results of 
DDST were possible: positive (enhancement of zones without any doubt), 
questionable (small enhancements), negative (no enhancement of zones 
between AMC and cephalosporin disk). (2) DDSTwith two cephalosporins, 
CRO and C c  was used in 200 consecutive clinical isolates of Escherichia coli 
and K .  pneumoniae. 
Results: 
1 ESBL strains. Percentage of positive, questionable and false negative 
DDST results were: CF 100%, 0 and 0%; CRO 73, 20 and 7; CAZ 30, 
50 and 20%; CXM 47, 37 and 16%, respectively. One ESBL strain was 
falsely negative by DDSTwith both, CRO and CAZ, but DDSTdth CF 
was positive. 
2 Consecutive clinical sttains. DDSTs were negadve with both cephalospor- 
ins in 194 strains. DDST with CF only was positive m four strains ( fhe  
positivity: NCCLS confirmatory ESBL tests with disks were negative). 
Fake positivity rate was 2% (four out of 200). Two strains were positive in 
DDSTwith both CF and CRO (ESBL strains, confirmed by NCCLS 
method). 
Conclusions: DDSTwith CF and CRO can be part of routine AST for every 
strain. Only positioning of CF and CRO disks on each side of AMC disk and 
observation of synergy is necessary. DDST with CF has excellent sensitivity, 
but most of positive results will be falsely positive. When DDSTwith CRO is 
positive, ESBL are probably present. Clinicians can be informed immediately. 
Evaluation of the method in merent epidemiological situations is needed. 
I P1043 I An efficient method for the detection and 
differentiation of plactamases in Enterobacteriaceae 
K. Westphal, I. Wiegand, K. Sherwood, J. Wagner and B. Wiedemann 
Bonn, Berlin, D 
Background: In recent years, an effort has been made to develop methods for 
klactarnase detection with emphasis on extended-spectrum 8-lactamases. 
But other j3-lactamases also present a threat to therapy, especially plasmid and 
chromosomally encoded AmpC 8-lactarnases. Since different 8-lactamases 
leave dif5erent options for therapy we developed a reliable phenotypic test that 
covers the important B-lactamases. 
Methods: Susceptibility testing was performed by a microdilution procedure. 
To establish the differentiation method 87 strains with well characterized 
fY-lactamases were tested against 22 j3-lactams. The strains included 45 E. coli, 
10 K. pneumoniae, eight K .  oxytoca, 11 E. cloacae, six C.jeundii  and seven 
S.  malcescem. For validation of the method the j-lactamases of 41 clinical 
isolates with a minimal inhibitory concentration (MIC) of cefotaxime 21 
were then identified. PCR and sequencing methods used to confirm the 
identification results were standard. 
Results: We succeeded in differentiating the following types of 8-lactamases: 
original spectrum, inhibitor resistandOXA, extended spectrum, inducible 
K1, hyperproduced KI, basal produced AmpC, inducible AmpC, hyperpro- 
duced/plasmid coded AnipC. The merehation was made on the basis of 
MIC ranges towards a minimum ofseven j-lactams (amoxicillin, amoxicillin/ 
clavulanate, cefoxitin, ce@odoxime, aztreonam, cefotaxime, ceftazidime). 
Validation with 41 clinical isolates confirmed our results. 
Conclusions: We developed a simple and eficient method for the detection 
and digerentiation ofj-lactamases in Enterobacteriaceae based on their MICs 
of 7 j-lactams. The identification results were confirmed by PCR and/or 
DNA sequencing. The required substances easily fit on a microdilution panel 
which allows automation in the clinical laboratory. 
jP1044] Intermethod agreement and preliminary quality 
control (QQ guidelines for susceptibility testing A202563 by 
disk diffusion and MIC methods 
T Anderegg and R Jones 
202563 QC Study Group, USA, North bberty, USA 
Objectives: AZD2563 is a new oxazohdmone wth  favorable PWPD featura 
enabhng o n c e d y  dosmg m projected c h c a l  t r a ~ I ~ .  To support the c h c a l  
susceptibhty teshng, method results were compared for the reference agar and 
broth tests, and the QC pdehnes were determmed for the NCCLS broth 
MIC and &sk dihsion methods. 
Methods: AU tests or methods (M2-A7 and M7-A5, 2000) and QC study 
designs (Jvl23-A2,2001) were those pubhhed by the NCCLS Agar cklunon 
results for AZD2563 were compared to those of broth rmcrodduhon usmg 
120 stratns includmg 30 strauls each of S peumomue, other streptococci, 
staphylococa and enterococci QC mals u h e d  eight partupant labora- 
tories and hezohd (LZD) as the drug class control. QC strams S aurew (SA) 
ATCC 25923 and 29213, E.fuecuhs (EF) ATCC 29212 and S pneumonirre (SP) 
ATCC 49619 were tested. Recent reports [ICAAC Abstr. D-167, 20011 of 
LZD disk Q C  range (SA) problems were also addressed. 
Results: AZD2563 broth method MICs were identical to agar dhhOn results 
for 89.2% ofcomparisons (LZD control = 84.2%), the r e m m g  broth results 
were generally lower by one two-fold dduhon step. In the mulhcenter QC 
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trial 240 and 480 results were generated for MIC and &sk tests, respectively. 
AZD2563 MIC modes were. SA at 2 mg/L, EF at 2 mg/L and SP at 1 mg/L 
(LZD at 4,2, and 1 mg/L) Three or four dduhon ranges (>95% of results in 
range) were proposed AZD 30-pg d s k  zone kameters were generally 
2 4  mm smaller than LZD zones, proposed ranges were 6-7 mm mde for 
each Q C  s t r m  SA zones for LZD requlled a 2-4 mm reduchon m the lower 
range l m t ,  pendmg achon by NCCLS (vancomycm used as control). 
Conclusions: AZD2563 suscephbdrty test results for NCCLS reference 
methods were demonstrated to be comparable. QC ranges for AZD2563 
MIC and dlsk &&sron methods were estabhhed m preparataon for chmcal 
laboratory use of t h s  promsmg, new oxuohdmone 
1 PI045 1 Validation of commercial dry-form panels 
(sensititre) for the susceptibility testing of AZD2563, a new 
long-acting oxazolidinone 
R. Jones, T. Anderegg, D. Biedenbach and P. Rhomberg 
North Liberty, USA 
Objectives: The escalating problems of resistant Gram-positive cocci has 
necessitated the rapid development of new molecular classes of antimicrobials. 
AZD2563 is a novel, long-acting oxazolidinone being prepared for clinical 
trials at once-dady dosing. This report suinmarizes susceptibility testing, dry- 
form (DF) panel validations compared to reference NCCLS methods. 
Methods: The susceptibility testing methods compared were Sensititre DF 
panels containing AZD2563 and linezolid (LZD; class control) vs. broth 
microdution panels in reference frozen-form format (NCCLS, M7-A5) 
prepared by TREK Diagnostics (Westlake, OH). 462 strains were tested by 
M23-A2 guidelines using 11 1 S.pneumoniae, 105 staphylococci, 100 enter- 
ococci, 106 other streptococci and 40 selected Gram-negative organisms 
as oxazolidinone-resistant controls. Reproducibhty was also determined 
(10 strains, 90 replicates). 
Results: The validation trial used &I00 strains of four Gram-positive organ- 
ism groups specified by NCCLS M23-A2. For AZD2563 and LZD tests, 462 
determinations showed 382 (82.7%) and 399 (86.4%) with identical MICs for 
DF and reference methods. respectively. All DF MICs were f l  log2 dilution 
of reference results for AZD2563 and LZD. Reproducibility tests used 10 
strains tested 3x daily X 3days (90 determinations). AZD2563 DF MIC 
reproducibility was 100% 3~ 1 log dilution analyzed within same day and 
between day results (87/90 and 76/90 results were identical, respectively). 
The same acceptable DF validation results were produced by a second 
laboratory, TREK Diagnostics. 
Conclusions: The commercial DF panels for AZD2563 produced by Sensi- 
titre were validated as producing reproducible results comparable to the 
NCCLS reference method. These panels appear acceptable for use by 
AZD2563 clinical investigators worldwide and to generate values identical 
to those of NCCLS M7-A5 procedures. 
(p10471 Antimicrobial susceptibility testing for 
10 5-Fluoroquinolones using the PhoenixTM system 
A. -M. Fahr, U. Eigner, G. Dettori and M. G.  Menozzi 
Heidelber~ D; Parma, I 
Objectives: In a performance evaluation of the Phoenix Automated System 
(BD Biosciences, Sparks, USA) for identification (ID) and antimicrobial 
susceptibility testing (AST), 10,5-fluoroquinolones were under investigation. 
Individual drug results were compared to the NCCLS reference broth 
microdilution method, and are presented for both Gram-positive and 
Gram-negative bacteria, derived fiom &esh clinical single patient isolates. 
Methods: A total of 365 Gram-positive s t r a h  (235 staphylococci, 130 
enterococci) and 384 Gram-negative strains (295 Enterobacteriweae, 89 Non- 
fermenters) were tested. For AST the following 5-fluoroquinolones were 
evaluated in parallel with the NCCLS reference broth microdilution method 
ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, lomefloxacin, moxi- 
floxacin, nodoxacin, ofloxacin, trovafloxacin, pefloxacin. Discrepant results 
were repeated in duplicate, all data were evaluated as defined by the ASM 
guidelines, additionally the distribution of the minimal inhibitory concen- 
tration (MIC) values were documented for each individual drug. 
Results The essential agreement (EA), category agreement (CA), very major 
error rate (VME) and major error rate (ME) for all 5-fiuoroquinolones 
combined was 96.7, 98.0, 1.3 and 0.1% for Gram-positive isolates, and 
97 9, 99.2, 0 0 and 0 04% for Gram-negahve isolates, respecuvely The 
observed resistance rates for Gram-posinve coca and Gram-negahve rods 
were: c i p r o f l m  38.6, 18.1%, gatlfloxaan 3 9, 12.2%. grepdoxacm 37.7, 
16.(Wo, levoflcncann 29.1,15.6%, lomefloxacm 38.6,20.2%, m o d o x a m  2.2, 
14.4%. norftaxaun 36.8, 16.5%. ofloxacm 38 2, 18.2%, trovafloxacm 12.2, 
17.8%, respectively, and pefloxacm 41.5% for Gram-posrnve cocci. 
Conclusions: The PhoenurTM System promdes hghly rehable ASTresults for 
5-fluoroqu1nolones m both Gram-posihve and Gram-negahve nolates. The 
MIC &stnbution Wered substanhally between old and new Qumolones for 
Gram-positive strams, whereas for Gram-negahve strams only shght Mer- 
ences were seen. 
Ip10481 Reliability of E-test in the determination of 
in vitro susceptibility to A. otitidis 
N. Cammo, C. Toro, V. M. Martinez, C. G6mez-Hemando, S. De 
Miguel, A. Enriquez and M. Baquero 
Madrid, Toledo, E 
Objectives: To determinate the reliabdity of E-test to study the in vim 
susceptibility to Alloioroccus otitidis. 
Methods ~so~ahons of A. otitidis were identified with standard methods and 
confirmed by PCR. SIX antibiohcs were tested amoxidin, cefotaxbe, 
cefuroxime, azithromycin, tetracycline and cotrimo-le. Agar dilution 
method was performed using MueUer-Hinton agar (OXOD) supplemented 
with 5% defibrinated horse blood. Concentrations were tested (prepared kom 
twofold dilutions) ranging h m  0.06 to 16 w/mL and plates were incubated 
for 72 h at 37 "C in 10% COz atmosphere. E-test was developed with the same 
medium and incubated under the same concttions. 
Results: The results are showed in the following table 
Resistance (%) Agardilution E-test 
b 
CMIso CMI9, CMIso CMIw dilution E-test 
Amoxicillin 0.06 0.5 0.03 0.23 0 0 
Cefotaxime 0.5 1 0.25 0.5 4.8 5 
Cefurmcime 0.12 0.5 0.12 1.5 9.5 10 
Azithromycin 0.5 4 2 256 19 60 
Tetracycline 0.12 0.25 0.5 0.75 0 0 
Cotrimoxazole 4/76 4/76 0.006/0.0024 0.3W7.22 80.9 0 
Conclusions: A l b i o c o m  otitidis shows an excellent susceptibility to p-kctams 
and tetracychne. However, very major kscrepances were found when 
azithromycin and coerimoxazole were tested. Therefore, E-test is not a 
reliable method for testing A.  otitidis to az ihmycin  and cotrimoxazole. 
v) Evaluation of the VlGl@ct software for detection 
of nosocomial infections and multidrug resistant bacteria 
El NicoIetti and P. PeciIe 
Florence, I 
An evaluation of the VIGI@ct software, a new program being developed by 
Bio-Mrieux (Marcy-1'Etoile France), was performed. This software is 
designed to detect nosocomial infections (NI), to analyze data on the 
sisceptibility patterns of bacteria including multidrug resistant bacteria 
(MBR), and to generate epidemiology statistics. The study was performed 
for a period of 2months. The VIGI@ct software was connected to the 
Laboratory Information System (LIS) and to a VITEK and a VITEK2 
instrument. All identification and susceptibility information was received 
automatically &om the two instruments and was analyzed by the VIGI@ct 
software. During the 2-month study, we analyzed cultures from urine, central 
venous catheter, blood, sputum and bronchd aspirates &om the intensive care 
and hematology wards to detect nosocomial infections. The software was set 
to detect suspected nosocomial infections using specific criteria. MBR were 
detected using predetermined resistance profiles. Results were analyzed for 
multiresistant bacteria &om all wards in the hospital. Epidemiology statistics 
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were also determined for all data. The VIGI@ct allows fast detection of 
suspected NI and MRB and for informtion to be rapidly transmitted to the 
ward. When a NI or MRB was suspected, alarms were generated and sent to 
the wards in real time to allow physicians for rapid confirmation, determina- 
tion of appropriate therapy and infection contml measures. Epidemiology 
statistics were also generated to study trends in resistance patterns and verify 
changes in susceptibility patterns. In conclusion, VIGI@act software is easy to 
use, provides alarms on dangerous situations in real-time, provides a means to 
communicate quickly and efficiently with the ward and the physician, and 
provides an additional security measure for microbiology results. 
/p10501 Comparison of three methods for 
determination of antibiotic resistance among clinical 
isolates of Pseudomonas aeruginosa in Ankara, Turkey 
E Aydin, B. Erdem, D. Giir and D. Aysev 
Ankara, TR 
Objectives: To determine the antibiotic resistance among clinical isolates of 
Pseudomonas aeruginosa &om pediatrics departments of two university hospitals 
by disc diffision, microdilution, and BIOMIC, and to compare the three 
methods. 
Methods: In vitro resistance against various antimicrohials of 150 Pseudomnas 
aenrgiwsa strains (57 strains &om Ankara University Hospital and 93 strains 
h m  Hacettepe Univenity Hospital) were investigated by disc diffusion, 
microdilution, and BIOMIC methods, and the results were evaluated accord- 
ing to the NCCLS criteria, between May 1999 and May 2000. 
Results: Antibiotic resistance of 150 Pseudomonas m g i n o s a  strains by BIO- 
MIC is summarized in the Table. The chi-square test did not show a 
significant difference in resistance between Ankara University strains and 
Hacettepe University strains. There was no sigmficant dserence regarding 
antibiotic resistance among disc diihsion, microdilution and BIOMIC. AU 
three methods had almost the same sensitivity to detect resistance of strains to 
antimicrobials. 
Conclusion: It is concluded that although disc diffision test is the easiest 
method to perform, BIOMIC is also an easy technique, and is useful since it 
provides MIC values as well (Table 1). 
Table 1 Antibiotic resistance of 150 Pseudomonas aeruginora strains by BIOMIC 
Resistance MICSO MIC9,J Range 
Antibiotic TW ( P d W  ( P d d )  (P!3/mL) 
Gentamicin 60.0 42 42 <0.22->41 
AmikaCin 42.0 33 156 <0.79->I55 
Cefrazidime 39.3 6.7 127 <0.56->126 
Cefepim 18.0 6.5 42 <0.54->79 
Cefoperazon 46.7 43 405 <0.47->404 
Ciprofloxacin 34.7 0.45 20 <0.11->19 
Imipenem 12.7 1 9.9 <0.56-121 
Piperacillin 44.0 39 609 <0.72->828 
Piperacillin/tazobactani 32.0 4.5 256 <0.17->770 
ml New method for normalized interpretation of 
antimicrobial resistance from disk test results for 
surveillance purposes 
G. Kronvall, G. Kahlmeter, E. Myhre and M. Galas 
Stockholm, Ihxjo, h n d ,  S; Buenos Aires, AR 
Objectives: To evaluate a new calibration method for disc ditfusion antibiotic 
susceptibility tests which relies solelyon zone diameter values generated in the 
individual laboratory for each antibiotic-bacterial species combination as the 
internal calibrator. 
Methods: The high-zone side of histogram distributions was analyzed by 
moving averages to determine the peak position, then the accumulated 
percentages of isolates for the high-zone diameter values were calculated 
and converted into probit values. The normal distribution of the ideal 
population of susceptible strains was determined using the least squares 
method for probit values against zone diameters. Zone diameter values were 
obtained &om Karolinska hospital (KS), &om the VZxjo hospital (VX), and 
&om Buenos Aim hospitals. The method requires a well standardized method 
but is independent of Merences in MIC-limits and zone breakpoints and 
does not require the use of reference strains. 
Results: Normalized interpretation of antimicrobial resistance was first tested 
on3582 test results for control strains S. aureus ATCC 29213 and E. coliATCC 
25922 at KS and VX using SRGA standardization. When the true means were 
compared with the calculated means a very high degree of correlation was 
seen (correlation coefficient r=0.998), confirming the vaiidity of the new 
method. Histograms of inhibition zone diameter values for antibiotics and 
clinical isolates of the two bacterial species, S. a u m  and E. Cali (114217 test 
results) at the two laboratories were then analyzed. The ideal distribution of 
susceptible suains was calculated and isolates showing inhibition zones below 
the 3 SD limit were then taken as resistant. The results showed an almost 
complete agreement with the interpretations in the laboratories. Difficulties 
were seen for E .  coli and mecillinam. The method was then tested on results 
from other laboratories which were using the NCCLS standard for disc 
d&sion tests and the results proved the promising potential for surveillance. 
Conclusions: The normalized resistance interpretation offers a new approach 
to surveillance where existing inhibition zone diameter results fkom disc tests 
in clinical laboratories can be used for calibration of the test and calculation of 
resistance levels. 
Ability of automated IDlMlC systems to detect 
ESBL-producing Enterobacteriaceae: comparison with DDST 
and E-test 
E. Kaitsa-Tsiopoulou, N. Panayotou, I? Tsiatsou and 0. Manou 
ntessaloniki, GR 
Objectives: Extended-spectrum B-lactamase (ESBL) - producing strains of 
Enterobacteriaceae are being isolated with increasihg frequency worldwide and 
compromise antimicrobial therapy of infections caused by them. The objec- 
tive of our study was to evaluate the ability of automated systems we use for 
routine testing to detect ESBLs, comparing their performance with DDST 
and E-test. 
Methods: We tested 61 lsolates (50 E. cofiand 11 Mebsiella sp.) characterized as 
ESBL positive (+) by at least one of the automated ID/MIC systems used in 
our laboratory during the period 1 June 1999 to 31 October 2001, according 
to each system’s expert rules. PASCO ce@odoxime (CPD) > 1 mg/L odand 
ceftazidime (CAZ) > 1 mg/L, MICROSCAN: ceftriaxone (CRO) 2 4 mg/L 
or/and CAZ 2 2 mg/L and WLDER cefo&e (CTX) > 1 mg/L or/and 
CAZ > 1 mg/L or CAZ 2 16 mgh and ceftazidime + clavulanic acid 
(CAZICL) 5 1/4mg/L. These isolates were further tested by: (1) Double 
Disk Synergy Test with CTX, CAZ and aztreonam (ATM) placed on 25 mm 
&om an amoxiciUin/clavulanic acid (AMC) disk and (2) E-test ESBL strips 
with CTX (CTICTL) and CAZ (TZ/TZL). Four QC strains were used as 
positive and negative controls. 
Results: The sensitivity of the antimicrobials used by each system for ESBL 
screeningwas: (1) PASCO: CPD 3/17 (17.6%). CAZ 012 (0%). CPD + CAZ 
7/23 (30.4%) (2) MICROSCAN: CAZ 0/1 (O%), CRO 2/2 (loo%), 
CAZ + CRO 3/6 (50%) (3) WIDER CTX 2/4 (50%), CAZ 0/6 (0%). 
CTX + CAZ 4/16 (25%), CAZ + CAZ/CL 17/18 (94.4%). Therewas lOCP?? 
agreement between DDST and E-test. 
Conclusions: The ability of automated system to detect ESBLs depends on 
the antimicrobials used by their expert rules; one or two 3rd generation 
cephalosporins are insufficient. Newer systems using rules that include a 
cephalosporin alone and in combination with clavulanic acid (e.g. 
CAZ + CAZ/CL) seem to have high sensitivity (94.4% in our study). These 
systems could eliminate the need for time-consuming manual tests like DDST 
and E-test. 
/p10531 Bactometer: alternative method for testing 
antimicrobial preservation efficacy 
T. Zarcba, E. Bocian and S. Tysh 
Warsaw, PL 
Objectives: Antimicrobd preservatives have been added to pharmaceutical 
preparations to prevent proliferahon or to limit microbial contaminamon. It  
should be demonstrate that preservatives provide adequate protection. The 
standard procedure- challenge test - recommended by pharmacopeia is time- 
consuming and require usually a few days of incubatlon. New alternative 
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technique based on impedimetric procedure makes possible to reduce this 
time to several hours. The growing of bacteria in Bactometer (bioMerieux, 
Vitek System, USA) cause a change ofmedia conductivity. The time required 
by bacterial population to create a detectable changes in electrical conduc- 
tivity is proportional to the initial number of cells. 
Methods: The test is based on challenge the preparation with prescribed 
inoculum of microorganisms e.g. Pseudonionus aenginosa ATCC 9027, Sta- 
phylococcus aureus ATCC 6538, Escherichia coli ATCC 8739, Candida albicans 
ATCC 10231 and Aspergillus niger ATCC 16404. Inoculated preparation was 
incubated at a prescribed temperature, followed by collection of samples at 
specified intervals and counting the viable microorganism in the sample by 
plate count in standard procedure or inoculation Bactometer module in 
alternative method. The samples for classical and alternative method were 
prepared in the same way and for Bactometer reading were serially diluted and 
inoculated in duplicate to several cells of module. Logaritmical reduction was 
calculated in comparison to initial microorganisms count estimated by plate 
method. In impednnetric method, the growth or lack of growth in cells witb 
diluted sample was the base to calculation. The study was conducted with 
some pharmaceutical products e.g. ophthalmic preparation and nasal spray. 
Results: AU pharmaceutical preparations were tested in duplicate. As 
expected, in the most cases of ophthalmic drug testing, the reduction 99 
and 99.9% of bacterial population was observed during 6 and 24 h, respec- 
tively, and 90% reduction of fungi in 7 days. For nasal spray the same reduction 
of bacteria was seen in the 2nd and 7th days, respectively, and fungi 14 days 
fiom the beginning oftest. Logarirmical reduction calculated for plate method 
was similar to that obtained in alternative method. The results meet the 
requirements of pharmacopeia. The studies of efficacy of antimicrobd 
preservation indicated a positive correlation between standard plate count 
results and impedance reading. 
LP1054 I Reassessment of cafaclor breakpoints to 
Haemophilus influenzae 
F. M. MacKenzie, K. E. M n e  and I. M. Gould 
Aberdeen, UK 
Background Previously we reported on cefaclor instability in vim, suggat- 
ing that S.pnarmoniae MICs determined by NCCLS methodology are 
consequently falsely high. The objectme of this study was to ascertain if 
standard methods accurately measure cefaclor MICs to H. influenzae. 
Methods: The stahihties of cefaclor and cefuroxnne were established over 
24 h Eight lsolates of H .  rnauenzae were tested, includmg one ATCC and one 
NCTC strain. Standard MICs were carried out by NCCLS broth micro- 
dilution. W curves were carried out by determining &/mL over 6 h. 
Antibiotic concentLatioflS were expressed as multiples ofthe MIC (range 0.1- 
0.9 x MIC), as determined by NCCLS methodology. Cefuroxixnewas usedas 
a comparator 
Results: After 24 h cefaclor had lost 88% activity and cefuroxime 34%. 
Cefaclor MICs by NCCLS methodology were 2 x 1, 3 x 2, 4 and 8mg/L. 
Cefbroxnne MICs were 5 x 0.5, 2 X 1 and 1 X 2mg/L. By kill curve, the 
‘bacteriostahc’ MIC was defined as the concentrahon which showed no 
sigmficant growth and no sigruficant kdl over the test period, taking into 
account cefaclor instability. On average, the cefador bacteriostatic MIC was 
0 . 2 x M C  determined by NCCLS methodology The mean cefador 
NCCLS MIC was thus 2.875mgr‘L and the mean bacteriostatic MC was 
1.725 mg/L. The cefuroxme bacteriostatic MIC was an average of 0 . 6 ~  the 
MIC by NCCLS methodology. Thus, the mean MIC by NCCLS methc- 
dology was 0.812mg/L and the mean bacteriostatic MIC was 0.488mg/L. 
Condudons: Cefaclor MICs by NCCLS methodology were overestimated 
due to chemical instability over 18-24 h. The bacteriostatic MICs by kill 
curve were found to be an average of 0.2 x MIC by NCCLS mexhodolo~. 
Allowing for this overestimate of NCCLS MICs, the cefaclor phannacody- 
namic breakpoint could appropriately be redefined as 2 or 4mg/L. 
Enterobacferiaceae in vitro studies 
1 P1055 1 In vitm susceptibility trends of piperacillinl 
tazobactam in a tertiary care hospital in Athens, Greece 
E. Platsouka, 0. Zarkotou, J. Portolos, N. Zissis and 0. Paniara 
Athenz, GR 
Objectives: Prospective study was conducted in order to evaluate the anti- 
bacterial performance of piperacillin/tazobactam @ip/tazo) compared to 
other antibiotics, aker 5years of use. The trends of bacterial resistance and 
the impact of antibiotic consumption on it were also investigated. 
Methods: During a 6-month period (November 200CbApril 2001), 314 
consecutive samples from hospitalized patients were collected. The cultures 
were performed by conventional methods. The bacteria studied were Enter- 
obacteriaceae, Haemophilus spp.. Enterocom spp., Pseudomonas spp., Acinetobacter 
spp., methicillin-sensitive Staphylococci and Streptococms spp. Antimicrobial 
susceptibility was evaluated by MIC values determination, using microdilu- 
tion method (PASCO MIC/ID Gram (-) and Gram (+) panels, Difco 
Laboratories) for: pip/tazo, ceftriaxone, ceftazidime, cefepime, cefotaxizne, 
imipenem, ciprofloxacin, amodclav, gentamycin, oxacillin and ampicillin. 
Susceptibility interpretation was based on current NCCLS guidelines. Com- 
parative study of susceptibility patterns was carried our, and the results were 
also compared to those published in 1996. Furthermore, the resistance 
incidence versus hospital antibiotic consumption was evaluated. 
Results: A total of 339 bacterial strains were isolated. Fifteen percent of the 
specimens were obtained from ICU patients. Urine and blood were the most 
fiequent type of samples. The predominant pathogen was E.coli (23%) 
followed by Pamrginosa (17%), K.pneumoniae (12%) and S.  aureus (8%). 
Acinetobacter spp. (27%) and Paeruginosa (25%) were the main pathogens 
isolated h m  ICU patients. The susceptibility of all Enterobacteriaceae strains to 
pip/tazo and imipenem remained high (82-97 and 100%, respectively). 
Susceptibllity to other B-lactams was also high except Amox/Clav, whereas 
En&ter spp.’s susceptibility proved to be lower. Susceptibility to cipro- 
floxacin ranged from 64 to 96%. All staphylococci tested were susceptible to 
pip/tazo and Imipenan. Enterococcus susceptibility to pip/tazo was 95%. 
The susceptibility of i? m g i u o s a  to pip/taza. cefiazidime and imipenem was 
extremely high (9698%). According to hospital pharmacy data, pip/tazo 
remains a B-lactam with high consumption. Any significant ditference in 
susceptibility to pip/tazo between 1996 and 2001, despite irs high consump- 
tion, was not observed. 
Conclusions: Pip/tazo r e a m  its initlal high effectiveness to sigtllfcant 
pathogens after 5 years of hospital use as ht-choice antibiotic. 
Lp10561 Antibiotic susceptibility study of 409 clinical 
strains of E. coli isolated during 2000 at an institute of 
infectious diseases, Bucharest Romania 
M Podani, V. Arama, M Chotan, A. A Iancu, S Iancu, C. Sanda, 
V Molag~c and A. Streinu-Cenel 
Bucharest, RO 
Objective: To charactenze the anhbiohc (As) suscephbhty of all E. cob strams 
isolated from d;l.cally sgruficant speclmens o b w e d  from pahents 
hospitahzed at our mshtute, h m  1st of January to 31st of December 
2000. 
Methods: Remspechve analysis of the 409 results of E. cofi dxsk-ddhsion 
anabiograms petformed at our rmcrobiology laboratory. The AB taken mto 
study were: ampicdhn (A), gentamun (G), amkacm (AK), amomcdm/ 
clavulanate (NC), nahdmc acid (NA), norRoxacm (NF), ciprofloxacm (CF), 
ofloxacin (OF), rutrofurantom (NT), co-trunoxazole (CTX), cohsm (CO), 
fosfomycin (FM), second-generahon cephalosporins (2GC). hrd-generanon 
cephalosporins (3GC) and mupenem (IM). The results were expressed usmg 
the 1999 NCCLS standards, as sensitwe (S), intermediate (I) and resistant (R) 
S t r a u U .  
Results: The 409 E coli strams taken Lnto study were isolated m d y  fiom 
urine cultures (83%) and from sputum (6%). naso-pharynx swabs (6%), pus 
[2%), CSF (0.5%). blood (0.5%) and other pathologml products (2%). The 
AB suxephbky to E. colr in our study, III decreasing order, was as follows: IM 
(lOO%), FM (99%), G (84%), CO (82%),3GC (79.7%). OF and CF (77.5%), 
NA (73.9%), AK (72.7%), 2GC (44.3%), A/C (32.8%); the lowest sensinwty 
rates observed, mvolved A (21.4%), NF (13.5%). CTX (6.2%). 
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Conclusions: The E. coli strains isolated at our hospital during year 2000 
showed practically the loss of sensitivity to co-a immole  and nitrofurantoin 
and a very low sensitivity to ampicillin. The strain I and R to amoxicillin/ 
clavulanate have reached a worrisome level of 67.2% but A/C was still 
effective in certain clinical situations owing to the high percentage of I strains 
(48.5%) that responded to an increase of the daily dosage of the drug. Globall3 
the E. coli strains preserved a good enough sensitivity to ~ l id ix i c  acid, and a 
very good sensitivity to fluorquinolones, aminoglycosides and third-genera- 
tion cephalosporins. Our study &d not detect any resistant strain of E. coli to 
imipenem, colistin and fosfomycin. 
[m Antimicrobial activity of $lactam antibiotics 
against Proteus mirabilis strains isolated in Poland between 
1997 and 2000 
E. Literacka, S. Szafraniec, A. Baraniak, A. Mrbwka, W. Kaca and 
W. Hryniewicz 
Warsaw, h d z ,  PL 
Objective: To study the resistance to &lactams in I? mirabilis in Poland over the 
last 4years. 
Methods: A total of350 I? mirabilir strains collected by the National Reference 
Center for Antibiotics in the Sera and Vaccines Central Research Laboratory 
during 1997-2000 were examined. The strains were isolated by more than 20 
microbiology laboratories in Poland from a variety of clinical specimens, 
mostly from urine samples. Susceptibhty to the following antibiotics was 
tested: ampicillin, amoxicillin/clavulanic acid, piperacillin, piperacildtazo- 
bactam, cefoxitin, cefotaxime, ceftazidime, cefepime, aztreonam, imipenem 
and meropenem. MICs of the antimicrobials were determined by the agar 
ddution method and interpreted according to the NCCLS recommendations. 
Results: The highest percentage of P mirabilis resistance was observed for 
ampicillin (70%), followed by piperacillin and amoxicillin/clavulanic acid 
(50%), cefoxitin, cefotaxime, ceftazidime (40%) and piperacillin/tazobactam 
(20%). The rate of the Pmirabilis resistance to most of the antibiotics 
mentioned above increased by about 30% between 1997 and 2000. Resistance 
to piperacillin/tazobactam raised nearly by 11% during the same period. 
Cefepinie, aztreonam, meropenem and imipenem were the most active 
antimicrobials. However, the imipenem MICs were relatively high for about 
50% of susceptible strains (MICs, 2 4  mg/L). 
Conclusions: Resistance of I? mirabilis to many 8-lactam antibiotics that are 
commonly used in the empirical therapy is very fi-equent in Poland. Among 
these, only cefepime, aztreonam and carbapenems showed high antimicrobial 
activity in vitro. The increase of I? mirabilis resistance to @-lactams over the last 
years seem to be an emerging problem in Poland. 
[p10581 Antimicrobial susceptibility of 
fnterobacteriaceae involved in urinary tract infections in 
Crete, Greece 
S. Maraki, A. Georgdadakts, E. Mavromanolakis and Y. Tselentis 
Heraklion, GR 
Objective: To investigate the prevalence of Enterobactetiaceae causing urinary 
tract infections and to determine their in v im susceptibility to antimicrobial 
agents. 
Methods: We studied 1105 consecutive strains of Enterobdcteriaceae isolated 
h m  patients with urinary tract infections in the period fiom January to 
December 2000. Urine cultures were performed by standard method and the 
isolates were idenhfied to the species level using the API 20E system 
(BioMerieux). Susceptibility testing to antimicrobials was done by the disk 
rfifision method based on the NCCLS guidelines. Double-dlsk a s i o n  
method was performed for the detection of extended-spectrum 8-lactamases 
(ESBL) . 
Results: E. coli was the predominant species representing 76.6% of the isolates, 
followed by Protew spp. (8.6%), Klebsiella spp. (8.4%), Enterobacter spp. (3.7%), 
and other species of the family Entembacferiaceae (Cifrobacter spp., Morganella 
morganii, Providencia spp.. Senatia marcescens, Salmonella spp.) (2.7%). The most 
common urinary pathogens E. coli, Prateus spp., and Kkbsiella spp. showed 
the following susceptibility rates (%) to antimicrobial agents tested: ampicil- 
lin 56.3/69.5/0.0; amoxicillin/clavulanate 62.9/79.0/66.7; cefuroxime 
79.8/85.3/65.6; cefotaxime 98.6/98.9/82.8; gentamicin 94N92.6181.7; 
conimoxazole 67.4/85.3/60.2; nitrofurantoin 96.3/6.3/49.5; nalidixic acid 
90.8/79.0/89.2; norfloxacin 93.5/98.0/92.5; ciprofloxacin 93.3/95.8/94.6. 
ESBL producers were found among E. coli isolates (1.3%), among Klebrielh 
spp. (16.1%), and among Enterobacter spp. (9.8%). 
Conclusions: E. coli is the most common uropathogen in our hospital. Local 
surveillance data that provides information about antimicrobial susceptibility 
of pathogens causing UTIs are necessary in order to select the appropriate 
antibiotic treatment. 
m1 Occurrence and transferability of Elactam and 
aminoglycoside resistance in dinical isolates of 
En terobacteraceae 
M. Kettner, D. MichaIkova-Papajova, K. Smetanova, J. Balaz, 
L. Perdochova and D. Rovna 
Bratislava, SK 
Objectives: To study the occurrence of resistance to 15 antimicrobial agents: 
ampicillin (AMPI), cefoxitine (CFOX), cefotaxime (CTAX), ceftazidime 
(CTAZ), ceftriaxone (CIAX), cefepime (CEPI), azthreonam (AZTR), mer- 
openem (MERP), gentamicin (GEN), tobramycin (TOB), netilmtcin (NET), 
amikacin ( M I ) ,  isepamicin (ISE), ofloxacin (OFL), ciprofloxacin (CIP), 
transferability of b-lactam and aminoglycoside resistance and production of 
8-lactamases in a set of 20 clinical isolates of Enterobucteriuceae - five Ki'e&&[la 
pneumoniae (25%), five Enterobacfer cfoucae (25%), one Enterobactw aerogenes 
(5%), three Citrobacferfreundii (IS%), three Esclretichia coli (15%), and three 
Serrafia mnrcescens (15%). The isolates were obtained in the years 1999-2000 in 
Hospital Ruzinov, Bratislava from skin infections and were selected as resistant 
to 8-lactams. 
Methods: The level of resistance was determined by standard method 
NCCLS 2000. Production of 8-lactamases was detected by niaocephin 
method. ESBL producers were identified by double-difision test. Transfer- 
ability of 8-lactam and aminoglycoside resistance was studied by bacterial 
conjugation. 
Results: A total of 16 isolates were resistant to AMPI (80%), 19 to CFOX 
(95%), 15 to CTAX (75%), 16 to CTAZ (SO%), 13 to CIAX (65%), 13 to 
CEPI (65%), 19 to AZTR (95%) and 7 to MERP (35%), 17 to GEN (85%), 
12 to TOB (60%), 2 to NET (lo%), 11 to AM1 (55%), 7 to ISE (35%), 11 to 
OFL (55%) and 7 to CIP (35%). Thirteen isolates (65%) produced 
8-lactamases and I t  isolates (55%) were identified as producers of ESBL. 
Resistance to all 8-lactam and aminoglycoside antibiotics, with only one 
exception ofMERP, was transferable by bacterial conjugation to the recipient 
strain Escherichia coli K-12 31 10. 
Conclusions: Occurrence of resistance to all 8-lactam antibiotics tested and 
the production of 8-lactamases and ESBL were very frequent. The most 
efficient P-lactam was the carbapenem MEW. The occurrence of resistance 
to aminoglycosides and fluoroquinolones was very high, too. The most 
efficient arnonoglycoside was NET. Thirty-five percent resistance to ISE is 
interesting, as this aminoglycoside has not been used in clinical practice in 
Slovakia yet. The transferability of resistance to 8-lactams together with 
aminoglycoside resistance by bacterial conjugation points to its plasmid 
determination and to the alarming situation in the spread of resistance in 
the mentioned hospital, so the further more d e d e d  studies are indispensable. 
(p10601 The PEARLS study: determining incidence of 
extended-spectrum plactamase (ESBL)-producing 
fnterobaderiaceae, vancomycin-resistant E. faecium (VREF), 
and methicillin-resistant 5. aureus (MRSA) in 16 centers from 
10 European countries 
B. Johnson, S. Bouchillon, D. Hoban, J. Johnson. M. Dowzicky, D. Wu 
andK.Focht 
Rollifif Meadows, St.  Davids, USA 
Background Resistant isolates found in the hospital environment continue to 
increase and are of great concern. This study is part of an ongoing study 
examining resistance determinants in pathogens. The current incidence of 
ESBL producers in selected Enterobacteriaceae, VREF and MRSA were 
measured in 16 investigative sites fkom 10 European countries. The informa- 
tion gathered h m  The Pan-European Antimicrobial Resistance Using Local 
Survedlance (PEARLS) study will be us& in determining selective pressures 
that influence the increasing incidence of resistance. 
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Methods: Each site collected consecutive isolates consisang of the following: 
50 Enterocom faecium (EF), 50 Entnobacw cloacae (EC), 50 Enterobum 
aerogenes (EA), 75 Escherichia coli (EsC), 75 Kkbsiella pneumoniae (KP), 25 
Acinetobacter spp. (As), 25 Pseudomonas aerugimsa (PA), 25 Serratia marcescens 
(SM), 25 Staphylocoms aureus (SA). All isolates were tested in a central 
reference laboratory using broth microdilution following manufacturer’s 
instructions and NCCLS guidelines. 
Results: The overall incidence of VREF and MRSA was 8.8 and 35.2%, 
respectively. Following are the ESBL rates for Enterobacteriaceae: EC 
(23.2%), EA (27.6%), EsC (4.3%), KP (18.9%) and SM (37.7%). The total 
ESBL rate for all Enterobacteriaceae was 16.3 and 23.7% without EsC 
included. The highest rates of ESBL occurrence per country without EsC 
included were Portugal (32.0%); Italy (26.4%); Austria (26.6%); Greece 
(25.0%); Spain (23.0%); France (21 3%); Germany (19.7%); the Netherlands 
(17.8%); Switzerland (8.3%) and Belgium (0.0%). The hghest occurrence of 
VREF was in Portugal (44.4%) and the lowest with no occurrences ofVREF 
in France, Greece and the Netherlands. MRSA rates varied with a hgh of 
87.5% in Portugal, whereas the Netherlands had no occurrences of MRSA. 
Conclusion: Resistant rates are affected by many factors including patient 
population, prior antimicrobial therapy, formulary changes and regional 
dtfferences, among other factors. The rates of these three determinants of 
resistance are consistent with current literature for VREF, MRSA and ESBL 
in Europe but vary greatly by region. These data wdl serve as a baseline for 
determining selective pressures that influence resistance rates. 
Emergence of multiresistant Gram-negative 
bacteria in the nursing-home setting 
N. HaIume, E. Stephan, D Sharara, M. Abou Chawareb and 2 Daoud 
Betrut, LBN 
Objective: The epidemology, chical presentanon, and natural hstory of 
many lnfechons are unique m the nusing home semng. In this study, our aim 
was to reme the emergence of extended-spectrum /?-lactamase (ESBL)- 
producmg strains of the f d y  Enterobnctenaceae among the popdahon of a 
nursing home m Bemt. 
Material and methods: In this retrospechve study, all the mcroblologc data 
of the Samt George nursing-home populahon consutmg of 57 males and 
female was collected and compded. The anhbionc suscepnbhty teshng (AST) 
of the isolated germs was exammed and recorded for ESBL producnon. These 
strains were idendied by usmg the standard techmques and/or the API 20E 
system (BioM&rieux, Marcy Etode, France) and AST were performed as 
recommended by the NCCLS. ESBL producnon was detected by the double- 
&c method and confirmed by synergy between third generanon cephalos- 
porms synergy with clawlanate. The isolates mcluded were those collected 
from Werent pahenu or those from the same p wth  Wemt suscept- 
ibdmes. 
Results and discussion: Among the 19 males and 38 females who form the 
population of the nursing home, 30 (52.63%) had suffkred at least one 
symptomahc or asymptomahc UTI durlng the past 18months. Flve ofthese 
pahents (16.6%) were infected wth  ESBLpmducing strain of Enrerobacter- 
iaceae. Results are shown m Table 1 
Table 1 Frequency (%) of the different lsolated s t r a m s  of ESBL-producing Enrembacfer- 
iaceae 
K.pncurnoniae E. roli C.frewndii (p10611 A 2001 multicenter, multicountry surveillance 
study identifying antibiotic resistance to extended-spectrum Frequency (%) ESBL among 5 (12.8) 2 (5.1) 2 (5.1) 
fl-lactamase-producing Enterobacteriaceae, vancomycin Entmbarteriareae 
Total number of Entnobacrenmm 39 39 39 
Frequency (%I ESBL among the genus 5 (41.7) 2 (11.1) 2 (100) resistant E. faecium and methicillin-resistant 5. aureus 
isolates: the PEARLS study Total number 12 18 2 
B. Johnson, S. Bouchillon, D. Hoban, J. Johnson, M. Dowzicky, D. Wu 
and K. Focht 
Rolling Meadows, St. Davids, U S A  
Background The increase of extended-spectrum B-lactamase (ESBL), van- 
comycin-resistant Enterococcus faecium (VREF) and methicillin resistant Sfa- 
phylococcus aureus (MFLSA) isolates worldwide has been reported in recent 
studies. The impact of high cephalosporin use may significantly affect the 
increased incidence of these organisms. The Pan-European Antimicrobial 
Resistance Using Local Surveillance (PEARLS) Study compares susceptibihty 
results of various antimicrobials in Europe, the Middle East and South Afiica. 
Methods: A total of3850 isolates were evaluated from 33 investigative sites in. 
Austria; Belgium; Egypt; France; Germany; Greece; Italy; Lebanon; Portugal; 
Saudi Arabia; South Africa; Spain; Switzerland; the Netherlands and Turkey. 
Each investigator collected the following selected species: 50 Enlerocoaus 
faecium (EF); 50 Enterobacter cloacae (EC); 50 Enreroba6er aerogenes @A); 75 
Escherichia coli (EsC); 75 Klebsiella pneumoniae (Kl’); 25 Acinetobactw spp. (As); 
25 Pseudomonas aeruginosa (PA); 25 Senaria marcescens (SM); 25 Staphylococcus 
aureus (SA). The following antimicrobials: amoxicdlin/clavulanic acid (MC); 
cefepime (Cfp); cefotaxime (Cft); ceftazidime (CG); cefrriaxone (Ctx); 
ciprofloxacin (Cip); gentamicin (Gtm); imipenem (Imp); levofloxacin 
(Lev); piperacillin/tazobactam (P/T) and vancomycin (Van) were evaluated 
following manufacturer’s instructions and NCCLS guidelines. 
Results: ESBL Enterobacferiaceae isolates, includmg EsC, showed the lowest 
level of resistance to Imp at 3.1%. Average cephalosporin resistant rates for 
ESBL Enterobacteriaceae, including EsC, ranged from 5.0 to 30.0% and varied 
from country to country. Among the /l-lactams/p-lactamase inhbiton (i.e. 
P/T and A/C) the resistant rates averaged 18.4% vs. 73.8%. Lev and Cip were 
at 37.9 and 11.17% susceptible, respectively, for non-VREE CEz had the 
highest percent resistance to MRSA at 93.3%. Vcm demonstrated the hi&& 
percent susceptible to MSSA at 99.6% and MRSA at 99.3%. 
Conclusions: Imp, P/T and some cephalosporins demonstrated good activity 
against Enterobacteriaceae including ESBL producers. None of the antimicm- 
hi& tested did well against VREE All antimicrobials tested had high resistance 
percentages to MRSA except Vcm. More studies are needed in order to 
monitor the impact-specific antimicrobials may have in the hospital environ- 
ment. 
The tsolated germs were: 2 Hebsrella pneumaniae, 18 Eschenchra cob, 7 h t e u s  
spp., 2 Citrobaderfreundti, 1 Burkholdena cepacia, 1 Aunerobacter baumanri, 1 
Pseudomom spp., and 6 Enterocmus faecalrr Our results show an uqortant 
percentage of ESBLproducing strains s h m n g  sirmlar pattern to those 
isolated III the k n t  George Hospital located m the p r o m t y  of the nursmg 
home and that are mcreasmg yearly The challenge for the future is to 
rmmmze mfecaon in the nursmg home, wMe hmnng the emergence 
and spread of annrmcrobial resistance w t h  ophmal cost-effecnve care. There 
is an urgent need for c h c a l  studes to evaluate strategtes for the prevennon 
and management of mfecnons ~fl the nursmg-home pahent. 
[p1063) Qfepime in vitro activity against 
Gram-negative rods 
A. Samet, L. Naumiuk and M. Bronk 
Gdansk, PL 
Objectives: To determine cefepime (FEP) in vitro activity against Enterobac- 
teriaceae, Pseudomonas aenrginosa and Arinetobacter baumannii isolated over 
6months. 
Methods: Antibiotic sensitivity was done by duc-diffusion method according 
to NCCLS guidelines. Non-replicate bacterial isolates were obtained &om 
clinical material collected from January 2001 to June 2001. ESBL production 
was determined by double-disc method. 
Resuk. During the study period, 1675 isolates from 20 species were 
obtained. Majority of them were as follows: Escherichia coli 556, Pseudomonas 
aenrginosa 391, Enterobacter cloacae 174, Klebsiella pnarmoniae 169, Proms 
mirabilis 140, A .  baumannii 73. FEP was most active against E. coli and 
l? mirabilis - 99%. E. cloacae - 94%, K.pneumoniae - 89%. The highest 
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resistance was noted in A. baumannii - 59% and Pamginosa - 9%. These 
species were also intermediate susceptible to FEP 11 and 21%, respectively. 
ESBL phenotype was found in 1 17 isolates, 66 of them being K .  pneumoniae. 
Seventy-four percent of ESBL-producing isolates were sensitive to FEP, 19% 
intermediate and 7% resistant. 
Conclusion: Overall sensitivity of bacteria to FEP reached 87% independent 
of the species, Ninety-six percent of En@robactm'uceae and 63% of nonfer- 
menting rods were sensitive. Because ESBL positive isolates constituted 10% 
of Enterobacfm'mae, FEP should be, then reported as resistant regardless of the 
in vitro result. Urinary tract isolates can be the only exception. FEP was least 
active against A. baumannii. 
ml Synergistic action of ceftazidime with serum in 
the bactericidal action on E. cob isolated from blood of 
patients with bacteremia 
Wroclaw, PL 
G. Mokracka-Latajka and B. Krzyzanowska 
Objectives: Purpose of this work was determination and comparison of the 
minimal bactericidal concentration (MBC) of ceftazidime (CAZ) in depen- 
dence of cooperation or without cooperation with bactericidal factors of 
normal human serum (NHS) against E. coli strains isolated from blood of 
patients with bacteremia. 
Methods: Following E. coli strains were studied sensitive to the bactericidal 
action of NHS, resistant to NHS and strains for which the NHS was 
bacteriostatic. All studied strains were susceptible on CAZ. Values of 
MBC were determined for CAZ alone and CAZ combined with NHS. 
Results: For killing of E. coli strains sensitive to the bactericidal action of NHS, 
the MBC was 32 times smaller for the CAZ combined with NHS in 
comparison to the bactericidal action CAZ alone. On the other hand, the 
value of MBC of CAZ alone or CAZ combined with NHS was exactly the 
same for strains resistant on NHS or for strains for which the action of NHS 
was bacteriostatic. 
Conclusions: It is shown that the cooperation between CAZ and NHS in the 
bactericidal action against E.coli strains sensitive to the action of NHS. 
Moreover, the cooperation between the antibiotic and NHS in the bacter- 
icidal action results in 32 times less than the value of MBC of antibiotic. 
Conclusions: Cooperahon of CTX and NHS in bactericidal action against 
K. peumortiae and E. closcae strains sensitive to the action of NHS results in 
si&icant decrease of MBC of the antibiotic. 
jP1066 
release 01 
Influence of moxifloxacin on endotoxin 
Escheridria coli 
M. Tiautmann, C. Scheibe and A. Moricke 
Ulm, D 
Objectives: To examine whether moxifloxacin, a new fourth-generation 
fluoroquinolone, causes endotoxin (LPS) release from Escherichia cofi and to 
compare its degree of LPS-releasing capacity with that of the drugs belonging 
to other antibiotic classes. We used imipenem as a representative of drugs 
known to cause low-LPS release, and ceftazidime as a drug known to induce 
large amounts of LPS. 
Methods Escherichia coli 018:Kl:H7 was grown in Mueller-Hinton broth in 
the absence and presence of 2x ,  1 0 ~  and 5 0 ~ .  The minimal inhibitory 
concentration (MIC) of mo&oxacin, imipenem and ceftazidime. At 0,2,4, 
6 ,8  and 24 h, bacterial concentrations in the suspension were determined by 
plate counts, and supernatant samples were taken for determination of free 
(soluble) LPS. The LPS was quantified by enzyme-linked immunosorbent 
assay using two monoclonal antibodies specific for diifeent epitopes of the 
side-chain region of E. coli 018 LPS. The biological activity of antibiotic- 
induced LPS was examined by measuring the release of tumor necrosis factor 
alpha (TNFa) from a CD14positive monocytic tumor cell line, MonoMac6, 
in response to LPS challenge. 
Resub. h4ICs (mg/L) were 0.06 mg/L for modoxacin, 0.25 mg/L for 
imipenem, and O.l25mg/L for ceftaadime. The time course of bacterial 
lulling was comparable between the three drugs. LPS concentrations were 
sigtllfcantly lower in cultures containing modoxacin or imipenem com- 
pared to the ceftazidime and controls. For example, a t  10 x MIC and 4 h 
exposure time, LPS (ng/mL; mean + SEM) concentrations were 73 + 11.9 
for modoxacin, 35.2 + 4.4 for imipenem, 590+ 183.1 for ceftazidime and 
7866.7 + 2150.8 for controls. Corresponding TNF levels @g/mL) were 
50.5 + 3.5 for moxifloxacin, 44 + 3.6 for imipenem, 292 + 78.7 for ceftazi- 
dime, and 712 + 129.5 for controls. 
Conclusion: Moxifloxacin induced sipficantly less endotoxin release com- 
pared to cefEazidirne-containing and control cultures, and s m h l y ,  low levels 
compared to imipenem. Low-endotoxin release may be regarded as a favor- 
able property regarding the future use ofparenteral moxifloxacin in abdominal 
infections. 
IP1065) Cooperation of cefotaxime with serum in the 
bactericidal action on Klebsiella pneumoniae and 
Enterobacter cloacae strains isolated from blood 
G. Mokracka-Latajka and B. Krzyzanowska 
Wroclaw, PL 
Objectives: Purpose of this work was determination and comparison of 
minimal the bactericidal concentration (MBC) of cefotaxime (CTX) in 
dependence of cooperation or without cooperation with bactericidal factors 
of normal human serum (NHS) against Mebsiella pnecrmoniae and Enterobarter 
cloacae isolated fiom blood of patients with bacteremia. 
Methods: Following K.pneumoniae and E. cloacae strains were studied sensi- 
tive to the bactericidal action of NHS, resistant to NHS and strains for which 
the NHS was bacteriostatic. Moreover, all studied strains were susceptible on 
CTX. Values of MBC were determined for CTX alone and CTX combined 
with NHS. 
Results For killing of K. pneumoniae strains sensitive to the bactericidal action 
of NHS the MBC was eight times smaller for the CTX combined with N H S  
than for the CTX without NHS. Siiarly,  for killing of E.cloacae strains 
sensitive to the bactericidal action of NHS the MBC was 32 dmes smaller for 
the CTX combined with NHS than for the CTX alone. On the other hand, 
the amount of MBC of CTX with or without NHS was exactly the same for 
K. pneumoniae and E. cloacae strains resistant on NHS or for strains for which 
the action of NHS was bacteriostatic. 
I P1068 I Effect of subinhibitory concentrations of 
gentamicin and tetracyclin on hemolytic activity of 
uropathogenic Escherichia coli 
A. Rezaee, F. Mirfakhraee and M. Sattari 
Tehran, IR 
Objectives: Hemolysins are a major virulance factor for some pathogenic 
strains of Escherichia coli. The aim of this study was to evaluate of effect of 
subinhibitory concentration of gentamicin and tetracyclin on hemolytic 
activity of uropathoganic E.  coli. 
Methods: We isolated desirable strains from patients with urinary tract 
infections. The hamolytic activity of these strains was measured by a smdard 
method. By using th is  method. the effects of iron and calcium on hemolytic 
activity of the s t r a i n s  were investigated. Minimum inhibitory concentrations 
(MIC) of gentamicin and tetracyclin for these strains were determined and the 
effect ofsubMIC ofgentamicin and tetracyclin (1/29 1/4 and 1/8), alone or in 
combination, on the hemolytic activity was evaluated. 
Results: The results showed that after elimination of free iron ions of the 
medium by caco3 hemolytic activity was reduced. Addition of calcium in the 
medium to concentration of l o w ,  induced a six-fold increase in hemolytic 
activity of the strains. Experiments showed that only subMICs of tetracyclin 
significantly reduced the hemolytic activity. 
Conclusion: This study shows that tetracyclin (1/2 & 1/4) can sigdcantly 
reduced hemolytic activity. Also, the combination of subMICs of gentamicin 
and tetracyclin (118 MIC) reduce the hemolytic activity. 
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Mechanisms of resistance in Gram-negative bacteria 
Assessing neutrality in an in vitro competition 
model of paired mutator-nonmutator P. aeruginosa clinical 
isolates from cystic fibrosis patients 
M. Morosini, R. Canton, A. Oliver, M. 11. Baquero and E Baquero 
Madrid, E 
Objective: A simple model to investigate the factors favoring selection of 
mutator strains in cystic fibrosis patients is proposed. The objective of this 
work is to establish the conditions for neutrality in the absence ofselection of 
different mixtures of paired isolates fiom the same patient exhibiting either a 
mutator (M) or nonmutator (NM) phenotype. 
Methods: Three paired M and NM l? aeruginosa strains from three ditferent 
patients were selected. Mutation fiequencies were determined on 300 pg/mL 
rifampin LB-agar plates. Clonal relatedness among clinical isolates was 
determined by using PFGE-XbaI technique. One colony from each isolate 
grown on LB-agar plate was suspended in 5 mL of LB-broth and incubated 
overnight at 35 “C under strong agitation. Cultures were adjusted to the same 
OD (when necessary), and colony counts were performed for inoculum 
control. Simultaneousb, an aliquot of individual cultures was mixed render- 
ing, in the final volume, the following proportions (M : NM): 10 : 90; 25 : 75; 
50 : 50; 75 : 25; 90 : 10. Then, 100 pg/mL of each mixture were placed onto a 
nitrocellulose filter which in turn was placed on the surface of an LB-agar 
plate. After 18 h at 35 “C, the fdter was removed, re-suspended in 1 m of 
saline, vortexed and the resulting suspension was diluted for plating on LB- 
agar plates. Afl-er overnight incubation, 100 colonies were re-streaked on LB- 
agar plates with and without 300 pg/mL of rifampin to analyze if initial 
proportions were maintained. 
Results: Initial proportions of paired M and NM I! aeruginosa strains in the 
different assayed mixtures were maintained in repeated independent experi- 
ments. However, in one pair of strains tested, a prolonged (48 h) incubation 
period was necessary to ascertain this observation owing to the slower growth 
of the M partner strain. 
Conclusions: These conditions should allow the evaluation of the in vitro 
behavior of M and NM l?aeruginura strains when competing in Werent 
proportions under various environmental challenges. 
/p10701 Aminoglycoside resistance mechanisms in 
Entembacteriaceae and Pseudomonas aeruginosa isolated 
from different hospitals in Bratislava and western Slovakia 
T Macickova, M Kettner, A Zakova and M Bagova 
Brahslava, SK 
Mdhple anabioac resstance m pathogens has become a major problem in 
nosocomd infechons m many countnes Ammoglycoside anhbioacs re- 
a nwnstay m the treatment of serious bactenal dechons and m combmahon 
therapy they are commonly recommended to treat 1nfeChOnS owing to the 
noninducible Gram-negahve pathogens The mam m e c h s m s  of annno- 
glycoside remtance are productlon of ammoglycwde-modng enzymes 
(AGME) and permeabhty changes In our study, we followed producnon of 
AGME, transferabhty of resistance and occurrence of plasnnd DNA m 42 
ceftazidune-resistant c h c a l  isolates of Enterobactm’aceae, whch were high 
reslstant also to of five ammoglycosides (57-94%) The second group was 
presented by 22 gentarmcin (GEN), tobramycin (TOB) and nehlnucm (NET) 
- reslstant chmcal isolates of Pseudomoncu aeruginosa whch were also resistant 
of d a c m  (AMI) and iseparmcm (ISE) Isolates were origmahng tiom 
dlfferent hospitals m BratlslaM and western Slovaha. In all the Entembaner- 
iaceae isolates testedufiusoglycoside rastance was owing to the productlon of 
AGME. In the Pseudomonas isolates, only two cases of non enzymatic 
mechamsm of remtance were obsetved Presence of AGME was exannned 
hectly by a ra&oenzymahc assay. The most frequently encountered combi- 
nahon in Enterobactenaceae isolates was the producnon of AAC(6’)-I (82%), 
causmg reslstiulce to AMI, TOB and NET wth  APH(2”) (73%), conferring 
resistance to GEN and TOB. In Pseudornonas ~solates presence of AAC(6’)- 
111, causmg reastance to GEN, TOB, NET, AM1 and ISE in 77%, APH(2”), 
codemng resistance to GEN and TOB 111 64% and APH(3‘)-VI, causlng 
resstance to AMI and ISE ~ 1 5 5 %  ofisolates. A fkquency ofresrstance transfer 
by bacterial conjugahon to recipient Esdierichza coli 3110 was found in hmits of 
10-2-10-9 m Entmbucteriaceae isolates and 10-2-10-7 in Pseudomom isolates. 
The aminoglycoside resistance was transferable by bacterial con~ugadon with 
exception of ISE as transconjugants donors were ISE-sensitive, although 
presence of ISE-inactivating enzyme APH(3’)-VI has been detected in them 
(Pseudornonm). In donors and transconjugants plasmid DNA m the range of 
36-57h4Da (En&robact&wae) and 55-75 MDa (Psmabmom) was observed. 
Resistance to ISE which has not been introduced into therapy in Slovakia yet 
IS interesting and evidently another substrate of this enzyme - AMl, was 
responsible for hemination of this resistance mechanism. 
/p1071/ A clinical strain of Burjwolderia ps-fllei 
lacking a wrolideaminoglycoride efflux-pump 
T. Schiilin and H. Grimm 
Nijmegen, NL; Bmg, D 
B. pseudomalla is the causative agent of melioidosis. Typically, these bactena 
are multidrug resistant, mcluding annnoglycoslde resstance, which is owing 
to an efflux m e c h m .  In the laboratory, mutant saains law this efttux 
pump, thus being aminoglycoside susceptible, have been genented Inter- 
estingly, these strains are also susceptible to macrolide. Very rarely, those 
suscephble phenotypes also appear in c h c a l  smm. (three out of >3000 
lsolates in one report). Here, an aminoglycoside and macrolide susceptible 
strain is presented, which was isolated together with two other strains of 
B.psewdomallei from sputum of a pahent with cysnc fibmsrs. The history of the 
pauent has been published earlier. He has undergone mdhple courses of 
antibiotic therapy for relapsing pulmonary melioidosis. Far into his c w m ,  
three different phenotypes, a mucoid, a rough and a smaU colony variant of 
B. pseudumaller were isolatedhm sputum. The sd-colony variant exhibited 
gentamicin susceptibility. Lack of an efflux pump was suspected as the 
underlying mechanism and MICs for other aminoglycosides and macrolides 
were tested by the E-test method. MICs (in mg/L) of the small colony variant 
for efythromycin A (S), clarithromycin (4), gentamicin (0.25), streptomycin 
(4), netilmicin (l), tobramycin (0.5), and amikacin (2) were well below the 
MIC of the other phenotypes. The strains were identical by molecular 
fingerprinting. The Iack of the efflux pump has not been confirmed by 
molecular tesung. Diflkrent phenotypes of Pseudomom aenfginosa with 
ditferent resstance patterns in CF patients are a well-recognized phenom- 
enon. This has been explained by heavy antibiohc use in this population with 
subsequent forming of resistant suhpopulations. Also, small colony variants 
have been described, bemg usually more resistant than the parent s t r a m .  This 
is also true for described s m a l l  colony variants of B.pseudomallei. Our case 
shows, that also more susceptible subpopulations may be generated III vivo. It 
is important to test all phenotypes of strains occurring under therapy or in 
relapsing disease to choose the most adequate regunen of antibiotics and to 
detect unusual resistance patterns. 
m] Evidence for additional regulatory system for the 
MexXY efflux pump in aminoglycaside-resistant 
Pseudomsnasaeruginose strains 
S. Islam, S. Jalal and B. W r e h d  
Stockholm, S 
Objectives: The Pseudomom aenrginosa efflux pump MexX-MexY pumps 
out aminoglycosides, fluoroqumolones and other anhbiohcs. It IS negaavely 
regulated by mexZ. This efflux pump lacks an outer membrane protein, but 
can use OprM &om the MexA-MexS-OprM pump. Because resistance to 
ammoglycosides and other anhbiohcs 1s common among stram from cystic 
fibrosis (CF) paoents, we have stuhed the role of MexXY pump in ami- 
noglycoside resstance in CF s t r a m s .  
Methods: Twelve ammoglycoside resismt stram (MIC tobramycin 
4-16mg/L, mkacin 32 to >256mg/L) were used. Stram PA01 and two 
aminoglycoside sensihve CF s&s were used as control. Genomic DNA was 
amphfied by PCR for mexZand the operator region between mexZand merX 
and sequenced 111 ABI 310 Genetic Analyzer. Total RNA was punfied f h m  
the Pseudomonas cells. Single-strand cDNA was prepared from RNA by 
reverse transcriptase. The amount of cDNA for the pump protein mexY 
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was determined quantitatively by real-time PCR in the Lightcycler using 
SYBR Green. As a standard for the amount ofcDNA in each preparation, we 
used the parC gene (topoisomerase i.v. subunit C). 
Results: Mutations were found in 9 of 12 resistant in mexZ, leading to 
fi-ameshift or amino acid substitutions. A mutation was found in one of the 
sensitive CF strains (Leu4 to Pro), probably not significant. Mutations were 
also found in the operator region in four strains. The amount of mRNA for 
MexY (pump protein) wassigntficantlyhigher (>lo0 x PAOl) in three ofthe 
resistant strains but also in one strain, hlly sensitive to aminoglycosides, 
ciprofloxacin and other anti-Pseudomonac antibiotics. We found no mutations 
in mexZ or operator region in one resistant strain with over-expression of 
mexk: 
Conclusion: Overproduction of the efflux pump MexXY cannot be the only 
explanation for resistance to aminoglycosides in Pseudomom strains fiom CF 
patients, because increased mRNA for the pump protein MexY was detected 
in three of 12 strains only. The sensitive s t r a i n  with over-expression ofMexY 
may have a nonhnctional efflux pump. Also, because no mutations in m a Z o r  
operator region were found for one strain with over-expression of m e r x  we 
must assume that there are additional regulatory functions for the mexX-mexY 
genes. 
1 P10731 Partial characterization of a transposon 
containing the tetA gene in an Acinetobacter baumannii 
clinical isolate 
A. Ribera, I. Roca, J. Ruiz, I. Gibert and J. Vila 
Bareha, E 
Objective: The objective of this study was to analyze the molecular mechan- 
isms of resistance to tetracycline in one clinical isolate of A. baumannii. 
Methods: To achieve this aim, a genomic library of the afore-mentioned strain 
was obtained. Briefly, genomic DNA was relieved and partially digested with 
an enzyme of a high fiequency of cut (Sau3AI). Fragments ranging fiom 4 to 
9kb were cloned into an expression vector @BSK) which was further 
transformed in DH5-a Escherichia coli strain, susceptible to a great variety 
of antibiotics. Resistant strains were selected with Mueller-Hinton plates 
supplied with 18 mg/L of tetracycline. The resistant clone was characterized 
and the whole insert was then sequenced. Moreover, the MICs oftetracycline 
in both the wild-type and the transformed E. coli strains were performed by 
E-test. 
Resub One clone resistant to tetracycline was obtained. The clone con- 
tained an insert of 5859 bp which was thoroughly characterized. It was found 
that the resistance to this antibiotic was owing to the f e d  gene which encodes 
for a tetracycline efflux pump. Together with the f e d  (1 199 bp), tetR (650 bp), 
the tetA repressor, was cloned. Moreover, the partial sequence (2019 bp of a 
total of 2972 bp) of a transposase gene, fnpA, and 1340 bp corresponding to an 
IS similar to that of Salmonella typhi (IS4321) which included an IR and 
another tranisposase, were found. The activity of the gene responsible for 
tetracycline resistance in the E. roli strain was demonstrated by calculating the 
MIC ofthis antimicrobial agent. Whereas the MIC oftetracycline in the wild- 
type strain w a s  0.75 mg/L, the MIC in the transformed strain was 256 mg/L. 
Conclusion: In this work, the presence ofthe tetA gene (encoding for an efflux 
pump, and responsible for tetracycline resistance) is located in a transposon 
carried by an A. baumannii clinical isolate. Moreover, owing to the high 
homology, almost of 100%. among the genes found within the insert and 
those described in other Gram-negative bacteria, an horizontal transference is 
suggested. 
JP1074) Chloramphenicol sensitivity of some Escherichia 
coli cat-expressing strains 
J. Potrykus and G. Wegnyn 
Gdansk, PL 
Objectives: Esrherichia coli CM2555 strain was recently shown to be sensitive 
to chloramphenicol when expressing cat, the chloramphenicol resistance 
gene. A functional resistance protein, chloramphenicol acetyltransferase 
(CAT), was synthesized in this strain. The stra in  phenotype seemed to be 
linked to the CAT mechanism of action - acetylation of chloramphenicol 
with a simultaneous de-acetylation of acetyl coenzyme A (Acetyl CoA). In 
the course of genetic mapping experiments we discovered that the CM2555 
strain carries a nonsense mutation in MA, a gene encoding a component of 
ucrAB-TolC efflux system. The goal of this study was to investigate the impact 
of the mutation on chloramphenicol sensitivity of the cat-cartying CM2555 
Strain. 
Methods: anAB and anEF deletion strains were generated using P1 general- 
ized transduction. Plasmids carrying the MA, ME and anEFgenes (analogs of 
anA and acrAB, respectively) were constructed from pUC19 cloning vector. 
lntracellular acetyl coenzyme A levels were determined by a spectrophoto- 
metric assay. 
Results: Introduction of MA, anE and anEFgenes on multiple copy plasmids 
into the cat-carrying CM2555 strain reversed the sensitivity phenotype. 
Earlier we have shown that the level ofAcetyl CoA decreases in cat-carrying 
CM2555 strain after the addition of chloramphenicol to the growth medium. 
When the strain carried efflux pump genes on a plasmid, the decrease in 
Acetyl CoA levels was not observed. The acrAB deletion rendered CM732 
(CM2555 parental strain) and C600 cat-expressing strains sensitive to &or- 
amphenicol. The sensitivity phenotype was accompanied by a decrease in 
levels of Acetyl CoA in the presence of chloramphenicol. The phenotype was 
reversed by introduction ofwEFon multicopy plasmid. The deletion did not 
affect cat-mediated chloramphenicol resistance of MG1655 and MC1061 
strains. Deleting mEF had no effect on the resistance phenotype of either 
strain. 
Conclusions: The a d  gene product seems to Sec t  the chloramphenicol 
sensitivity of CAT producing CM2555 strain by influencing intracellular 
Acetyl CoA levels. The deletion of acrAB might sensitize some other cat- 
carrying E. cdli strains, such as C600, to the antibiotic. In this case, over- 
expression of both efflux-pump components is necessary to reverse the 
phenotype. Further investigation is needed to determine molecular basis 
of this phenomenon. 
[=I Physiological alterations associated with fusidic 
acid resistance cost 
M. Macvanin and D. Hughes 
Uppsala, S 
Objectives: To explain the reduced virulence of fusidic acid-resistant (FUR) 
mutants. To elucidate the costs associated with bacterial resistance to fusidic 
acid in vim. To create a synthetic mehum that mimics the in vivo conditions 
relevant for the cost of fusidic acid resistance in S. typhimurium. 
Methods Fitness measurements (growth rates, competitive ability and sur- 
vival) of FusR mutants in synthetic media. Fitness measurements invivo in B6 
dd-type and n-fox mice. Quantification of catalase and ppGpp levels in 
FusR mutants. 
Results: Fusidic acid resistance is caused by mutations in a component of the 
protein synthesis machinery, elongation factor-G (EF-G). These mutations 
reduce the affinity of the antibiotic for its target. Observed phenotypes of 
FusR mutants of S. typhimurium include avirulence in a mouse infection 
model. In this study, hydrogen peroxide is identified as the major factor that 
imposes this fitness cost on FusR mutants in vivo. Co-sensitivity to superoxide 
or nitric oxide is not observed. Catalase levels are reduced in FusR mutants 
and this can account for their reduced survival in the presence of hydrogen 
peroxide in vitro and in macrophage. 
Conclusions: The results suggest a direct link between FusR mutations and 
transcriptional regulation of catalase levels. This transcriptional effect is 
mediated via a ribosomally synthesized global transcription factor ppGpp. 
The reduced levels of catalase produced in FusR bacteria can explain their 
decreased ability to survive and proliferate in the intracellular environment in 
which they are exposed to an oxidative burst that generates hydrogen 
peroxide. 
IP1076J Analysis of penA gene in Neisseria meningitidis 
isolates with reduced susceptibility to penicillin 
l? Stefanelli, C. Fazio, G. La Rosa, M. Muscillo and F? Mastrantonio 
Rome, I 
Objectives: The aim of this study was to analyze the penA sequence, which 
encodes the penicillin-binding protein 2 (PBPZ), in 28 N. mmingitidis clinical 
isolates, 24 with decreased susceptibllity to penicillin (MIC > 0.06 H / ~ L ,  
pen9 and four susceptible (MIC < 0.06 pg/mL,penS) used as control, in order 
to assess the relationship between alterations in the gene and reduced 
susceptibility to penicillin. 
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Methods: Meningoccoccal strains sent to the Reference Laboratory of 
the lstituto Superiore di Saniti were serotyped and tested for 
susceptibility to penicillin by E-test. MICs between 0.06 and 1 pg/mL 
indicated strains with decreased susceptibility to penicillin. The p e a 4  gene 
was amplified by PCR using already known oligonucleotides. The 2.1 Kb 
amplicons were analyzed by RFLP using different restriction enzymes and 
were sequenced. 
Results: Among the 24 penI N. meningitidis isolates, 12 showed nucleotide 
alterations, in particular in the region codingfor the transpeptidase domain of 
PBP2, caused by horizontal transfer ofDNAhmother commensal Neisreriae. 
In particular, N. cinerea was the most k u e n t l y  found (8/12); N.perJlavu/siuu 
was recovered at the 3'-end of the gene and in four strains N.@vescm was 
found. In one strain, without tramlocations, a duplication of 54 nucleotides 
was found at the 3'-end of the gene. These polymorphism were analyzed by 
investigating restriction endonuclease patterns of the penA gene. The penl 
strains showed nine Werent patterns whereas two patterns were found among 
the pens as well as among the penl strains without any DNA aanslocations. 
Conclusions: Modifications in PBP2 that may affect the affinity for penicillin 
result h m  changes in p e d  gene. This gene has been already reported to be 
polymorphic in meningococcal penl strains. Ths study on 24 strains with 
decreased susceptibility to penicillin suggests that the penlphenotype does not 
correspond to a single p " A  genotype. A decreased susceptibihty to penicillin 
is only partially related to translocations in the gene from corresponding DNA 
regions of commensal Neissm'ue. The polymorphism of this gene is not 
suficient to characterize all the penl meningococci and other targets should 
be further investigated. 
In vitro activity of various drugs 
1 P1077 I Moxifloxacin: determination of the in vitro 
activity against bacterial isolates from the skin and soft 
tissues to assess its value for clinical use 
0. Deppe and T. Rieger 
Oberhuusen, D 
Objectives: Aim of the project was to determine the range of pathogens in 
wound swabs from skin and soft tissues on a patient basis, to ascertain the in 
vim susceptibilities of the isolated bacteria and to assess the value of 
moxitloxacin for clinical use. 
Methods: Bacterial isolates from 100 wound swabs (skin and soft tissues, 
nonsterile, patients >15 years) were tested for resistance with the microdilu- 
tion-method. Additional Moxifloxacin susceptibility-testing with E-test. 
Online collection of clinical data to assess the infectious status and the renal 
function of the patients. 
Results: Isolation of 179 bacterial strains (S.  uureus 26%/n=47, Saurtw 
(MRSA) 3% (n= 5), coagulase-negative staphylococci (CNS) 13% (n=24), 
enterococci 16% (n = 29), streptococci 7% (n = 12). corynebacteria 3% 
(n = 6) ,  Enterobacteriaceae 20% (n = 35), Psrudornonar spp. 8% (n = 14). Adne- 
tobucter spp. 4% (n = 7); strictly anaerobic organisms were not considered 
within this study). The overall susceptibility for m d o x a c i n  was 89% as well 
for the Gram-positive as for the Gram-negative strains (95% excluding 
Pseudomonar spp.). A total of 53 swabs showed growth of 1 strain, 47 of at 
least 2 strains (up to 5). Wounds h m  which only one saain was isolated were 
more often associated with S. aureus than wounds with at least two strains, i.e. 
foot or decubital wounds with mean values of 2.4 strains per swab. A total of 
43 isolates (18 cases) were from these two locations. 38 (88%) of them showed 
susceptibility against modoxacin. Patients were 17-93yem old, about the 
half(52%) had a reduced renal function. A total of 64 ofthem needed systemic 
antibiotic treatment. 
Conclusions: Considering the suitable properties of moxifloxacin as wide 
range of efficacy, high oral bioadability and very high tissue-penetration 
infections of the skin and soft tissues seem to be another area for use of 
moxifloxacin. This is confirmed by the results ofthe present susceptibility tests 
for leading staphylococci, streptococci and Enferobacteriuceae. Even chronic 
wounds like 'diabetic feet' or decuhiti, often starting point of systemic 
infections, seem to be an indication for a moxifloxacin-regime in antibiotic 
therapy. 
1 PI078 1 Streptidine is released from streptomycin by 
enzymatic hydrolysis in the human serum 
0. Granados, G. Men and N. Barba-Behrens 
Mixico, h4EX 
Objectives: It has been speculated in the past whether streptomycin (STP) acts 
hy complete or broken down the damaged hair cells of the mner ear. 
Therefore, its hydrolysw by human-serum components was lnvesngated by 
incubating STP in it, and separating the resultmg compounds by hgh  
performance liquid chromatography. 
Methods: In vitro enzymatic hydrolysis was performed by incubation of STP 
0.1 rn in serum at 37 "C for 24 h. The serum was then deproteinized wth  
20% trichloroacehc acid, and the supernatant was analyzed usmg a paned-ion, 
reversed-phase chromatography m combinahon wth  a &ode detector. 
Resub: We found that after ~fl mtro mcubatlon of STP m the presence of 
human serum, the presence of a metabohte that matched the peak of the 
strephdtne (STD) porhon ofthe molecule of STP h k e d  to it -a and a- 1,4- 
glycosidx bond was observed The InId  concentrahon of STP before 
incubaaon was of 0 1 m~ and after lncubauon tlus concentrahon decreased 
to 0.079 m, the STD signal from a standard curve was 8-8.5 p ~ .  Control 
samples consisted of 0.1  in^ of STP soluhons, in phosphate buffer (50 rn, pH 
6.8). 20% trichloroacehc acid soluhon and the supernatant of deproteinlzed 
serum The three soluhons were incubated m the same condIhons as the 
expermental sample. In all the controls, were found 0.099 + 0.002 m~ of 
STP. Except for the b d e r  controls, in whch a Concentrahon of 2 ~ V I  of STD 
was detected. 
Conclusions: Armnoglycoside anhbiohcs, such as STP, can be vulnerable to 
suffer some metabohc changes in contact w t h  blood. Ths  fact refutes the idea 
that these h d s  of anhbiohcs are ellrmnated fiom the orgamsm wthout 
suffering any land of degradatmn, and saesses the nohon that its metabohtes 
mtead of the complete saucture, may be the actual ototomc compounds. 
With thls dlscovery, new fionaea of research in the veshbular tome effects of 
STP are openmg 
1 PI079 1 In vitro activity of moxifloxacin against bacteria 
isolated from odontogenic abscesses 
I Sobortka, G Cach-, E StArenburg, M. 0 Ahlea and D. Mack 
Hamburg, 1) 
Objectives: Odontagemc abscesses are caused ma& by myred tnfechons 
owmg to fadtahve anaerobes and anaerobes. Mox1l3oxacm (MXF) 1s a new 
8-methoxyqmolone with a broad actimty agamt a wde  range of mcro- 
orgamm mcludmg streptococci and anaerobes. The aim of our study was to 
analyze the III mtro achmty of m d a x a c m  m odontogemc pathogens in 
order to estunate the hypothezed role of MXF m aeaanent of odontogenic 
abscesses. 
Methods: In a prospechve study we evaluated the anarmcrobial suscepubhty 
of all pathogens lsolated from 41 swabs of 37 panents wth  odontogeruc 
abscesses. The mid idubitory concentrations (MICs) of all bacterial 
isolates for pemcdh (PEN), amoxycdldclavulmc acid (AMX/CLA), 
chndamycm (CLI), doxycydtne POX), levofloxaun (LYX), and MXF were 
d e t e m e d  mth  E-test. Ad&honally, as a pharmacodynarmc parameter the 
raho of the peak serum level C, to the MIC was calculated for all annbiotics 
tested C,/MIC values of >8 are predicave for climcal efficacy especdy 
among fluorochmolones 
Results: In total, 90 bacterial pathogens were wolated ofwhch 87 pathogens 
(51 facultahve anaerobes and 36 anaerobes) could be subculhvated for MIC 
deternunahon The most prevalent bacteria were dfferent wndans saepto- 
cocci mth  38 isolates and Prwotella sp mth 31 isolates Considenng all 
bacterd isolates the lowest MIC90 values were obwned for MXF and AMX/ 
CLA (OSmg/L each) followed by LVX (2mg/L), PEN (8mg/L), DOX 
(16mg/L), and CLI (256mg/L) Accordmg to recent NCCLS breakpomt 
criteria 98% of the isolates were suscephble to MXF and LVX. Comparable 
actimty was observed for AMX/CLA wth 95% suscepable isolates, whereas a 
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lower activity was observed for DOX, CLI, and PEN with only 76, 75, and 
6Yh susceptible isolates. The highest C-/MIC& values as predictive for 
clinical cure were calculated for MXF and W C L A  (nine and seven) in 
contrast to the lower Cm,/MICw values for LVX, PEN, DOX, and CLI 
(2.9, 0.8, 0.2, and <0.1). 
Conclusions: Modoxacin provides superior in vitro activity and promising 
pharmacodynamic properties in odontogenic pathogens compared to usually 
employed antibiotics. Thus, moxifloxacin may be an alternative for anti- 
microbial therapy of odontogenic abscesses that should be evaluated in clinical 
trials. 
I P1080 1 Antimicrobial susceptibility and causative 
agents of hospital- and community-acquired urinary 
tract infections (UTI) 
R. Paberza, A. Zilevica, M. Paberzs, L. Luzbinska, S. Hromova, 
A. Majore and B. Bandere 
Riga, LV 
Objectives: To establish the causative agents of hospital acquired and com- 
munity acquired UTI and the antimicrobial susceptibility of isolated urinary 
pathogens. 
Methods: Between November 2000 and October 2001, all urine isolates &om 
hospitalized patients in Latvian Infectology Center and Hospital of Trauma- 
tology and Orthopedics were collected and also &om community 
acquired patients. Cultures of urine samples were performed by isolation 
method of CHROM agar Orientation. Isolates were identified to the species 
level using the SCEPTOR and Crystal systems. Antimicrobial susceptibility 
tests to more then 20 antibiotics were performed using the disk ditrusion and 
SCEPTOR MIC method. p-Lactamase activity was tested using cefinase 
disks. 
Results: A total of 1015 isolates &om urine cultures were analyzed. There 
were three groups of causative agents: (I) Gram-positive cocci- 496, &om 
them E.faecalis- 233, E.Jaecium -38, E .  durans- 1, S.  epidermidis group - 137, 
S. saprophytim - 45, S. aureus - 20, S. sciuri - 3, S. n’mulaur - 2, Streptococas 
agalucfiue - 15, Streptococcus canis - 2; (2) Gram-negative rods: the family 
Enterobucteriuceae- 452, &om them E. coli- 314, K l e b s i e l f ~ E n t e r o b u c t e ~ ~ ~ a f i a  
(KES) group - 92, Citrobucterfreundii- 13, Protew vulgnris-8, Profeus mirabilis- 
17, Provideruiu retfgm’ - 3, Morganella morganii - 4, Hafniu alvei - 1; (3) Gram- 
negative noniermenters - 67 &om them: Pamginosa - 37, Pputida - 6, 
Acinetobacter baumunii - 14, Acinetobacter lw@ - 10. The antimicrobial 
susceptibility of UTI causative agents: 254 strains (40.1%) of hospital patients 
and 56 strains (14.7%) of community patients were polyresistant. In hospi- 
talized patients strains polyresktance was mainly registered of genus Pseudo- 
monus - 86.2%. of KES group - 55.196, of genus Staphylococcus - 35.2%. In 
community acquired U T I  patinets, polyresistant st ra ins  prevailed in genus 
Pseudomonac- 85.7% in KES group - 34.8%, in genus Staphylococcus - 29.5%. 
Conclusion: The most common pathogen isolates &om urine cultures in both 
the examined two hospitals and community acquired UTI were Escherichia 
coli, Enterococcus faeculis, coagulase negative Staphylococci and KES group. 
Polyresistance in rhe hospitals was higher than in community acquired 
UTI, except genus Psardomonus. 
Jp1081] In vitro activity of piperacillin/tazobactam and 
comparator antibiotics against bacteria from hospitalized 
patients in the British Isles 
R. A. Walker, S. Mushtaq, D. James, M. Warner and D. M. Livermore 
London, UK 
Objectives: Piperacdlidtazobactam is a j-lactam/j-lactamase inhibitor com- 
bination active versus clinically important Gram-negative and Gram-positive 
bacteria. We assessed its comparative in vitro activity versus contemporary 
isolates from hospitalized patients in the British Isles. Results were compared 
with those of a similar survey run in 1991, immediately before launch of 
piperacillin/tazobactam. 
Methods: Twenty-seven British and Irish hospitals each collected up to 200 
consecutive, clinically sigruficant isolates. The organisms were identified by 
standard laboratory methods or with MI kits, according to the species. Disc- 
susceptibility tests were performed at the collecting laboratories by the British 
Society for Antimicrobial Chemotherapy’s method. For quality control, a 5% 
sample of the isolates, plus those with key resistance, were subjected to MIC 
tests centrally. 
Results: Compared with the 1991 survey and based on the first 2500 
isolates, S. aureus was more prevalent (36% of all isolates cf. 25%). Much 
of this increase reflected the dramatic emergence of MRSA (16.4% of all 
isolates in 2001, cf. 0.7% in 1991). F! amginosa was also more prevalent (9.3% 
in 2001 15 6.2% in 1991), whilst E. coli was less so (17.7% in 2001 cf. 26.6% in 
1991). As in 1991, >95% of the isolates of Pamginosa, Bucteroides spp., 
Streptococci, Pneumocoui and E.faecalis were susceptible to piperacillin/tazo- 
bactam, as were 87% of Acinetobacter spp. and >85% of Enterobacteriaceae. 
Nevertheless, more resistance to piperacillin/tazobactam was seen in E. coli 
than in 1991 (11% cf. 4%) and Klebs ie fh  (16% cf. 5%), but not in the 
Citrobacter, Enterobacter, Morganella, Serratiu group (17% in both years). 
Amongst the comparators meropenem remained the most potent against 
enterobacteria, with near universal activity. Ceftazidime and gentamicin were 
similarly active as in 1991, but the activity of ciprofloxacin had been 
compromised vs. enterobacteria (86% susceptible in 2001 cf. 96% in 
1991). 
Conclusions: The main difference between the surveys in 1991 and 2001 was 
the dramatic rise in of S. aureus in general and MRSA in particular. This 
indicates a major shift in the patterns of infection. Other changes in resistance 
were subtler. Although there was some increase in piperacillin/ 
tazobactam resistance amongst E .  coli and Klebsieffae, the combination remains 
a potent antibiotic with a broader spectrum than any other noncarbapenem 
agent. 
P I  082 1 Checkerboard and time-kill methods for analysis 
of polymyxin B with second antibiotic combinations 
W. Grzybowska, S. Tyski and A. Ochman 
Warsaw, PL 
Objective: Polymyxin B with other antibiotic combined in some composed 
topical preparations exists on Polish market. Such rnultiantihiotic drugs might 
be active a@st different microorganism: Gram-positive as well as Gram- 
negative. In this situation different targets in microbial cells are under focus 
and antibiotics could change their physical structure and biochemical proper- 
ties e.g. ribosomes - aminoglycosides and tetracyclines as well as cell 
membrane - peptide antibiotics. Checkerboard and time-kill methods are 
the most widely used techniques to assess interaction between two agents. The 
aim of this study was to analyze the activity interactions of polymyxin B with 
the other antibiotics (neomycin, framycetin and oxytetracycline) combina- 
tions on standard bacterial strains used for the drug control and on some 
clinical isolates. 
Methods: Using checkerboard technique, serial dilutions of two antibiotic 
standards were prepared and combinations of six concentrations proportional 
to the MIC values (&om 1/4 x MIC to 2 X MIC) of the both drugs were 
analyzed. 
Standard strains: B .  bronchiseptica ATCC 4617, M .  luteus ATCC 9341, S. aur- 
eus ATCC 6538P, B.subtilis ATCC 6633, B.cereus ATCC 11778 and 
B. pumifus ATCC 14884 as well as clinical isolates of E. coZi, P aeruginosa, 
K. pneumoniae, Salmonella sp., and S. aureus (MRSA and MSSA) were under 
investigation. Fractional Inhibitory Concentration (FIC) indexes for combi- 
nations of two antibiotics were also calculated from the checkerboard 
data. 
Results: Investigating all standard strains, synergism for 33.3% of combina- 
tions was observed. However, additive effects were the predominant (47%), in 
three cases inmerence effect was also noticed. No inhibition effect was 
detected when polymyxin B with each of three antibiotics was analyzed. In 
case of standard strains, S. aureus, B. cereus and M .  luteus synergy was observed 
in each polymyxin B combinations. The lowest - 0.12-0.18 FIC values 
were present in case of polymyxin B and oxytetracycline combinations. 
Time-kill method was used for synergy analysis of polymyxin B with 
neomycin, hmycetin and oxytetracycline combinations, against M .  iuteus 
ATCC 9431 strain. Effect of antibiotics combined in concentrations: 
1 X MIC, 0.5 x MIC, and concentrations calculated from FIC indexes, 
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after 1, 2, 4, 8, and 24 h incubation on nnmcoccal growth, was analyzed. 
Synergy effect detected by checkerboard method was confirmed by time-kill 
assay. 
Ip1os3/ Interaction of neomycin and the other antibiotic 
combined in multiantibiotic drugs 
S. Tyski, W. Grzybowska and A. W6jcik 
Warsaw. PL 
Objective: Antimicrobial combinations are used most frequently to provide 
broad-spectrum empirical coverage in the treatment of bacterial infections. 
However, combination of two antibiotics may not influence their activity, 
may lead to synergy or antagonism in the activity. Neomycin is combined 
with one of the following antibiotics: ampicillin, procaine penicillin, poly- 
myxin, lincomycin, oxytetracycline, erythromycin, gramicidin and bacitracin 
in some human and veterinary multiantibiotic drugs marked in Poland. The 
aim of this study was to analyze the activity interaction of neomycin with 
other antibiotic combination on standard bacterial strains used for drug 
control and on some clinical isolates. 
Methods: Checkerboard technique was used. Serial dilutions of two drugs 
were performed using six antibiotic concentrations proportional to MICs 
(&om 1/4 x MIC to 2 x MIC) of the drugs being tested. 
Standard strains: B. bronchiseptica ATCC 4617, M .  luteus ATCC 9341, S. aur- 
ew ATCC 6538P, Bsubtilis ATCC 6633, B.cereus ATCC 11778, 
and B.  pumilus ATCC 14884 as well as clinical isolates of E. coli, P aeruginosa, 
K.pneumoniae, Salmonella sp., and S.aureur (MKSA and MSSA) were 
under investigation. Fractional inhibitory concentration (FIC) indexes for 
combinations of two antibiotics were also calculated f b m  the checkerboard 
data. 
Results: Analyzing growth of particular bacterial strains in the presence of 
different neomycin concentrations combined with each of eight other 
antibiotics, additive effect was observed in 57.4%, indifference in 29.8% 
and synergy in 12.8% of combinations. Greatest synergy was observed when 
aminoglycoside - neomycin was combined with peptide antibiotics - poly- 
myxin B (FIC=0.31) and gramicidme (FIC =0.19) and analyzed with the 
application of M. luteus strain. Also, in case of B. cereus, synergy was observed 
in neomycin/bacitracin (FIC = 0.31) and neomycin/gramicidm (FIC = 0.5) 
combinations. Analyzing results of all standard strains, lack of interaction or 
only additive effect was observed, when neomycin was combined with 
ampicillin, procaine penicillin, oxytetracycline and erythromycin. No any 
synergy was noticed when B. bronchiseptica and B.pumilus strains were ana- 
lyzed. In case of neomycin and other antibiotic combinations against clinical 
isolates, no synergy effect was observed. Most often additive interaction was 
noticed. In few cases (resistant strains), determination ofh4IC and calculation 
of FIC values showed to be impossible. 
In vitro susceptibility of Bartonelle spp. against 
telithromycin and other newer antimicrobial compounds 
C. Dorbecker, T. Schiilin, K. Oberle and A. Sander 
Freibq ,  0; Nqmegen, NL 
Macrolides are first-line antibiotics in treating diseases caused by Bartonella 
spp., based on clinical grounds. Only limited susceptibility data are avdable, 
owing to the fastidious nature ofthese microorganisms. We tested the MICs of 
31 strains of Bartonella spp. (21 B.  henselae, 2 B. quintana, and one of  each 
B. elizabethae, B. rribocomm, B. alsatica, B. vinsonii spp. vinsonii, B. vinsonii spp. 
ampemis, B. sckoenbuchii, B. doshiae and B.grahomii) against telithromycin, a 
new ketolide antibiotic, four macrolides (erythromycin, roxithromycin, 
clarihmycin, azithmycin), three fluoroquinolones (ciprofloxacin, levo- 
floxacin, moxifloxacin), five aminoglycosides and &pin. Agar-dilution was 
performed on chocolate-agar with a final inoculum o f  lo6 &/spot, incubated 
MIC (mg/L) 
hnribiorrrm n <0.002 O.Nl2 0.004 0.W8 0.015 0.03 0.06 0.12 025 0.5 1 2 4 8 16 
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29 
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8 1 5 4 3  
1 1 1 3 6  3 I 
I i i i n i i 2  
8 1 4 6  1 
1 1 1 0 7  7 
3 I 6 6  1 
2 7 1 6 2  
1 1 2 1 1  
1 5 I 9 4  
1 4 7  8 1  
at 37 "C in 5% COz. Results were read after 3-4 days of incubation and wefe 
as shown m the table above. Telithromycin was the most active agent 
ehbiting the lowest MICs. All strains had macrolide MICs lower than 
0.25 mg/L. M d o x a c i n  was the most potent fluoroqutnolon tested. Cat- 
scratch disease is the most fiequent c h c a l  presentation of Bartadla infections 
and is usually a self lirmting disease. In immunocompromised patients 
(especially HIV-patients) infections caused by these agents may persist for 
a longer m e  and a lifelong treatment or prophylaxis may be indicated. 
Although the climcal value ofin vltrosusceptibility testing for Banonella saainS 
remans uncertain, these data may be useful for therapeutic intemnhons in 
these diseases as well as for monitoring development of resistance m some 
isolates. 
I P1085 I Antibacterial properties of propolis (bee glue) 
against aerobic filamentous bacteria (Nocardla) 
S. Eshraghi and S. Valafar 
Tehran, IR 
One of the most useful products of the beehtve is 'propolis', a resinous 
substance that is collected by bees firom buds. Propolis has been usedin ancient 
time for the treatment of malignant tumors and injuries. These observations 
attracted the attentions to the antibacterial properties of this substance. The 
effect of propolis on bacteria could be related to its high percentage of 
flavonoid content and also the presence of caffeine acid esters. In regard to 
important role of infectious disease in treating the life of people, and also 
inaccessibihty to useful drugs with minor side-effects, we decided to consider 
the ability of ethanol extract of propolis in preventing the growth of bacteria. 
For this purpose, we chose two strains of Nocanfia (N. aszeroides and N. brasilinrsis) 
as o r i d  bacteria and other six species (I? aeroginosa, S.  aureus, K .  pneumoniae. 
E. coli, E. ~lowae,  andS.peXenery) as elective organisms. Because oftheduence 
of propolis in the treatment of both cutaneous and respiratory disorders, the 
effication of propolis on these bacteria has been studied. After pre- 
paring seven concentrations of ethanol extract of propolis in 80?? Methanol, 
and culturing the organisms in their spedic culture media, we tempted the 
antibacterial properties of propolir by means of four methods of distribution in 
agar (Drop-plate, Disk-pkte, &-plate- and cylinder-plate). Aher the distribu- 
tion of propolis extract in agar, the diameter of the cleat zone formed has been 
measured, whtch is related to the ability of extract to prevent the growth of 
bacteria. In according to the results, which is insert in tables, N astwoides and 
N. brosiliensis, has nearly shown the same susceptibility to various concentrations 
ofpropolis extract, and the complete clear zones reveal that this effect has been 
completed. As for other bacteria, the effect ofpropolis was complete in two cases 
(S. aumrsandE. colt) and for theotherfour bacteria the effectwas the same andas0 
less than the two mentionedbefore. In addition, we came to this conclusion that 
zones formed by Amikacin 50mglmL in each four routs of distribution in agar 
was equal to that of5% concentration ofpropolis, and that the potencyofpropolis 
is 80% of Amikacin potency. (Whlch is the most effective antibiotic against 
Nocardia) . 
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I PI086 1 Studies of the selection of resistant 
Streptococcus pneumoniae by benzylpenicillin in an in vitro 
kinetic model 
I. Odenholt, E. Lowdin, 1. Gustafsson and 0. Cars 
Uppsala, S 
Introduction: Little is known about the selective effect ofdgerent antibiotic 
concentrations on a mixed culture of bacteria with Werent degrees of 
susceptibdities. Dosing regimens should be optimized to obtain maximal 
efficacy and reduce the risk for emergence of resistance. 
Objectives: The aim of the study was to investigate the selective effect of 
different concentrations of benzylpenicillin (Pc) in a culture of Strrptococcus 
pneumoniae containing 90% of sensitive (PSP) (MIC = 0.01 5 mg/L), 9% of 
intermediate (PIP) (MIC=0.25mg/L) and 1% of resistant (R) PRP 
(MIC = 4 mg/L) using an in vitro kinetic model. 
Methods: The culture was exposed to Pc at C,, of 0.33, 1.5,2.9, 10.2 and 
53.5 mg/L, respectively, in order to obtain different T > MIC for the included 
strains. Samples were withdrawn at 0,3,6,9, 12 and 24 h and seeded on blood 
agar plates containing penicillinase, 0.062 mg/L Pc and 1 mg/L Pc. 
Results: Maximal growth was obtained at 9 h and all controls had by then 
increased 3 log 10 cfu. At 24 h, PIP had decreased fbm 10 to 1% of the total 
amount and PRP from 1 to 0.1%. At C, of 0.33 mg/L, T > MIC were 67,6 
and 0% for PSP, PIP and PRP, respectively. At this concentration, PSP and PIP 
disappeared after 6 h. However, a re-growth of PIP was seen at 24 h. At C,, 
of 1.5 mg/L, T > MIC for PSK PIP and PRP were 100, 38 and 0%. PSP 
disappeared after 3 h and PIP after 6 h. At this concentration, PRP increased 
7.2 log 10 ch/mL at 24 h. At C, 2.9 mg/L, T > MICswere lOO,54 ando%, 
respectively. PSP and PIP disappeared after 6h, whereas PRP increased 
steadily during the 24 h. At 10.2 mg/L, T > MIC were 100, 83 and 18%. 
All strains disappeared at 6 h but a re-growth was noted at 24 h for PRP. At the 
highest concennation with T > MIC of 100, 100 and 56%, respectively, all 
strains disappeared already a t  3 h. 
Conclusion: A selection of the non-susceptible strains of S.pneumoniae 
occurred in the in vim kinetic model when the bacterial population was 
challenged with Pc except for the highest concentration. In our experiments 
T > MIC of approximately 38-56% was required to obtain efficacy against the 
populations with decreased susceptibility to penicillin. Sub-optimal antibiotic 
dosing regimens may be a risk factor for the emergence of resistance in the 
normal flora or at infection sites with pre-existing resktant subpopulations. 
JP10871 Investigation of the effects of ranitidine and 
sucralfate on the bioavailability of ABT-773 in healthy 
volunteers 
M. 
H. Lode 
Berlin, D 
Objectives: ABT-773 is a new ketolide antibiotic which has potent activity 
against penicillin- and macrolide-resistant Gram-positive bacteria. Conco- 
mitant administration of ABT-773 with ranitidine or sucralfate might lead to 
delayed or reduced absorption in the upper gastrointestinal tract, through 
insolubility at increased pH (ranitidine) or formation of chelate complexes 
(sucralfate). 
Methods: The pharmacokinetics (PK) and interaction of ABT-773 and its 
metabolite M-1 were assessed in a crossover trial with 12 healthy volunteers 
(age: 32 f 5.7yean. weight: 79.0 k 11.2 kg, creatinine clearance: 
121.5f25.5 mL./min/1.73m2) receiving 150mgofABT-773 alone or con- 
comitantly with ranitidine or sucralfate. Plasma samples obtained at merent 
h e  poinu were analyzed by liquid chromatography-mass spectrometry. 
Urine recovery was measured by validated bioassay. Statistical and pharma- 
cokinetic analysis including estimation of the 90% confidence interval w a s  
performed by WinNonlin Pro 2.0. 
Results: The PK data of a single oral dose of ABT-773 alone were as follows 
(arithnieticmeans*SD): C,=: 318f161ng/mL.at1.79f0.5h(T&; fl,*: 
5.66 & 00.77 h; AUCO-E: 1662 f 907 ngh/mL; total urine recovery (24 h): 
13.67 & 4.7%. The C, and AUC were statistically significantly reduced by 
25.7 and 15.8% respectively, and T,,, and tIf2 were prolonged, owing to a 
Pletz, V. Preechachatchaval, M. AUewelt, 0. Burkhardt and 
delayed and decreased absorption when ABT-773 was co-administered with 
ranitidine. Statistical analysis revealed no impact of sucralfate on the bioavail- 
abhty of ABT-773. 
Conclusion: In conclusion, in our study there was a sigruficant interaction 
between ABT-773 and ranitidme but not between ABT-773 and sucraEate. 
m] Examination of antimicrobial activity of selected 
nonantibiotic drugs 
H. Kruszewska, T. Zartba and S. Tyski 
Warsaw, PL 
Objective: Avariety ofpharmaceutical preparations, whch are applied for the 
treatment of noninfectious diseases, have shown in vitro some antimicrobial 
activity. These drugs are called ’nonantibiotics’. The aim of this study was to 
detect and characterize the antimicrobial activity of nonantibiotic drugs 
selected from the preparations analyzed during the state control performed 
in the Drug Institute in Poland. 
Methods: About 100 pharmaceutical preparations were randomly chosen 
from different groups of drugs. The surveillance study was performed on 
standard microbial strains used for drugs contral: S. aureus ATCC 6538P, E .  coli 
ATCC 8739, Pamginosa ATCC 15442, and C. albicans ATCC 10231. The 
sterile blotting-paper discs were soaked with 10% (v/v or w/v) solution of 
tested drug in 0.08 M phosphate buffer pH 7 and placed onto Mueller- 
Hinton 2 Agar plates, inoculated with standardized cells suspension (0.5 GMC 
Farmland scale) of suitable strain. The inhibition of bacterial growth was 
observed as a halo around the disc containing the tested compound. MIC was 
calculated for the most interesting cases. 
Results: It was shown, that the drugs listed below inhibited growth of at least 
one of the examined strains: acyclovir (awirol 100mg), butorphanole (buta- 
midor 10 mg/mL, amp.), emadastine (emadine 0.05% eye drops), fluvastatine 
(lescol 40 mg), ketamine (kecamidor lo%, amp.), clodroniate sodtum (sin- 
dronat 400mg, caps.), levocabastine (histimet 0.5mg/mL, eye drops), oxa- 
prosine (reumax 600mg), oxymethazoline (nasivin 0.05%, nose drops), 
proxymetacaine (alcaine 0.5%, eye drops), rutozidewith ascorbic acid (cerutin 
20+200mg), tegaserole (zelmac 50mg), telmitamne (pritor 20mg), tra- 
madole (tramundin 1 0 0 4 ,  tropicamide (tropicamidum 1%. eye drops). 
Sraphylococcus a u m s  was susceptible to most of the drugs listed above. 
Levocabastine and emadastine inhibited growth of this microorganism in 
concentration 0.02 mg/mL and tegaserole - 0.08 mg/mL. Fluvastatine 
showed activity against S. aureus and C. abicans in concentration 0.4 mg/mL, 
oxymetazoline showed activity against S.  aureus and E. coii (MICs: 0.005 and 
0.025 mg/mL, respectively). Growth of E. coli was also inhibited by butor- 
phanole (MIC - 0.9 mg/mL) and oxymethazoline (MIC - 0.025 mg/mL). 
Pseudomonac aeruginosa was sensitive to oxaprozine, clondroniate sodium and 
tramadole (MICs: 60, 63, and 43mg/mL,, respectively). 
I PI089 1 Pharmacodynamic studies in an in vitro kinetic 
model of a new pharmacokinetically enhanced formulation 
of arnoxicillin against Streptococcus pneumoniae with 
different susceptibilities 
E. Lowdin, 0. Cars and I. Odenholt 
Uppsala, S 
Objectives: The e5cacy of a m o x i c h  (AMX) is mainly dependent on the 
time that the free concentration stays above the MIC (T > MIC). However, 
the exact hction of the dosage interval during which this concentration 
should be exceeded for optimal efficacy is not known. The aim of the present 
investigation was to study the pharmacodynamic effects of a new formulation 
of AMX against difFerent strains of Streptocows pneumoniae in an in vitro 
kinetic model. 
Methods: Four clinical isolates of S.pneumoniae with MICs of 1, 2, 4 and 
8 mg/L, respectively, were exposed to AMX simulating the concentrations 
obtained in humans of the new formulation of AMX containing 1125 mg 
(immediate release) and 875 mg (slow release). Doses were given at 0 and 12 h. 
Bacterial counts were followed for 24 h. 
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Results: The T > MIC values for the investigated strains were 75,64,56 and 
48%, respectively. AMX exerted a complete bactericidal effect after the fmt 
dose against the strain with a MIC of 1 mg/L. Against the strain with a MIC of 
2 mg/L, re-growth was noted after the fint dose but no re-growth was seen 
after the second dose. For the strains with MICs of 4 and 8mg/L and 
T > MIC values of 56 and 48%. respectively, re-growth was seen after both 
the first and second dose. However, at 24 h the log(l0) du/mL of the strain 
with a MIC of 4mg/L was only 1O2-1dcfu/mI, compared with 
106-107 cfu/mL for the strain with a MIC of Smg/L. 
Conclusion: In ths  model, the new formulation of AMX with a prolonged 
T > MIC was effective against S. pneumoniae with MICs up to 2 mg/L when 
given twice daily and resulted in signhcant killing of strains with a MIC of 
4 mg/L. Further studies of this formulation of AMX in animals and clinical 
studies are warranted. 
The demonstration of in vitro antagonism among 
fusidic acid and quinolones 
M. Ertek, H. Yazgi, S. Erol and U. Altoparlak 
Erzutum, TR 
Objectives: Fusidic acid is an antibiotic which is active against staphylococci 
and some other bacterial pathogens. It is used in the treatment of staphylo- 
coccal infections, usually in combination with other agents. Report of the 
effects of antimicrobial combinations containing fusidic acid have been 
somewhat inconsistent. The aim of OUT study was to indtcate the in vitro 
antagonism among hsidic acid and quinolones, and to be warning for clinical 
studies. 
Methods: In our study, 26 Sfaphylocorcus strains (15 coagulase-negative 
staphylococci and 11 coagulase-positive staphylococci) isolated from various 
clinical samples were used. All of these strains were found sensitive to fusidic 
acid, levofloxacin, ciprofloxacin, ofloxacin and moxiiloxacin in sensitivity test 
carried out with the method of disc ditfusion. In vitro antagonism among 
fusidic acid and quinolones was investigated. After detecting the inhibition 
zone-diameter of these five antibiotics for each strains, interaction among 
them was investigated with dtsc-approximation test. Quinolones and fusidic 
acid discs were placed on Mueller-Hinton agar plaques such a way that the 
distance between the disc would be 2 mm shorter than the total ofboth zone 
diameters. The fact that there was narrowness at  the side ofhsidic acid in zone 
diameter round quinolones was evaluated as in vitro antagonism. 
Results: In all the staphylococci strains investigated, zone diameter of 
quinolones in Mueller-Hinton agar plaque had been narrowed at the side 
of fusidic acid. In all of 26 strains, quinolones and fusidic acid were antagonkt 
in vitro. 
Conclusion: Fusidic acid is used commonly in combined treatments of 
staphylococcal infections. Spectrum of quinolones in clinical use is more 
common. Fusidic acid and quinolones be used usually in combination 
with other agents in the treatments of chronic osteomyelitis and some 
Respiratory pathogens: in vitro studies 
other infections. Unfortunately, there are in vitro antagonism among fusidic 
acid and quinolones. The reason for this antagonistic effect and its clinical 
implications are not known. So, we are opinion of that clinicians should be 
more careful in combined treatment with quinolones and fusidtc acid. 
\ P1091 I Microbiological outcomes and pharmacokinetics 
of oritavancin in patienb with Gram-positive bacteremia 
A. de la Peria, J. Chien, J. Geiser, T. Brown, D. Farlow, G. Weerakkody 
and M. Wasdewski 
Indianapolis, USA 
Objectives: To evaluate the multiple-dose efficacy and pharmacokmetics (PK) 
oforitavancin (Ly, a glycopeptide antibiotic with bactericidal achvity against 
Gram-positive (G+) pathogens, including resistant strains, m patients with 
Gf bacterema; and to exanune the relationship between PK and efficacy 
endpomts. 
Methods: Patients: (n = 27) were 18 years or older, weighed at least 37 kg and 
must have had true or probable G+ bacteremia from blood specimens 
obtained within 4days prior to enrollment. Each patient received one of 
three dose regunens (loading doseldaily maintenance doses): 3/2mg/kg 
(n=5), 4/3mg/kg (n=5), or 5/4mg/kg (n= 17) for 7-lodays. Bacteno- 
logic outcome was measured at the primary efficacy endpoint (first follow-up 
visit, 5 days after end of therapy). Efficacy analyzes were based on 10 qualified 
patients h m  the LY 5/4 group who met pre-specified criteria. Plasma 
samples collected over appromnately 60 days were assayed for LY concentra- 
tion using LC/MS/MS; aIl plasma concentration data were analyzed using 
population PK modelmg. Relevant clinical and demographic patient factors 
(e.g. age, weight, and dose) were evaluated for their d u e n c e  on the 
disposition of LY. The relationship between plasma exposure and clinical 
endpoints was evaluated. 
Results: Favorable bactenologc response was observed in 9 of 10 qualified 
patients in the LY 5/4 group. Plasma exposure appeared to he a predictor of 
response; bactenologc failure may be associated with subtherapeutic expo- 
sure to LY The 27 patients contributed 313 plasma concentrations for PK 
analym. The LY CL, Vc, and Vp estimates for a typical bactererma patient 
were 0.841L/h, 6.50L. and 22.0L. respectively. The inter-patient coeffi- 
cients of variation on CL and Vc were approximately 40%. Plasma f,,2 
estimated during a dosing period was approximately 40 h. No pahent factors 
appeared to significantly influence the disposition of LY; however, an 
effect of weight could not be excluded. No serious adverse events were 
observed. No rehhonship was identifiable between adverse events and plasma 
exposure. 
Conclusions: Oritavancin 5/4mg/kg for 7-lodays was effectiw and well 
tolerated in 9/10 patients with G+ bacteremia. Slmilar or higher doses may be 
efficacious in patients with G t  bacteremia. Based on this s m a l l  exploratory 
analysis, no dosage adjustment for LYappears to be necessary owing to paaent 
factors. Pharmacokineacs was linear in the dose range tested. 
1 P1092 1 Macrolide and ketolide susceptibility of 
5. pneumonhe isolates collected in Austria during 
2000-2001 
C. Jebelean, C. Luger, L. Binder, R. Watschinger and M. Mittermayer 
Linz, A 
Background: Macrohde resstance m pneumococci is Increasing in many 
European countries Tehthromycin 1s the first member of the ketohde f a d y  
of antimcrobials mth achvloj agamst pneumococci ~ncludmg those mth 
acqured reststance to erythromycm. 
Objective: To invesugate the acavlty of tehthromyan and various macrohdes 
on S.pneumoniae strams collected m Austrla. 
Methods: A total of 401 s t r a m  of S.pneumow lsolated dunng the last year 
&om cbddren (206 snayl~) and adults (181 strains) from Merent regoons ofthe 
country were tested for susceptibhty to tehtbmycin, erythromycin (E), 
roxlthromycin (R), clarithromycin (C), authromycm (A), hndamycln (Cl), 
penicillin (P), and tetracycline (T) using an agar dilution method. E-resistant 
strains were bther investigated for the presence of macrolide resistance genes 
(meJ erm and m7R) using a PCR-based method. 
Results: Overall the P, E, C1, Tresistance was 10, 10.4 and 10% respectively, 
with higher prevalence in children (16, 10,5 and 14%) and lower prevalence 
in adults (5,7,4 and 7%). (In a similar investigation on strains collected during 
1999-2000 the P, E and Tresistance was 6.10 and 7%). The respective MIC50 
and MIC90 ofthe antibiotics testedwere: telithromycin <0.015 and 0.03 mg/L; 
E 0.03 and 1 mg/L; R 0.06 and 2 mg/L; C <0.03 and 0.5 mg/L; A 0.12 and 
2mg& Cl<O.O6 and <O.O6mg/L. Resistance to E was exhibited by 43 
strains, 21 of them harboring erm and 22 mefgenes. Telithromycin showed the 
lowest MICs and retained its good activity also on saains containing ery- 
thromycin-resistance genes; the range of MICs for those strains was from 
<0.015 to 0.5 mg/L. 
Conclusions: The macrolide resistance prevalence of pneumococci isolated in 
2000-2001 was similar to that found in 1999-2000. Telithromycin w a s  highty 
active against isolates of S. pneumoniae collected during the last 2 yeam in 
Austria. 
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m1 The influence of the e m  and mef genes on 
telithromycin resistance in Streptococcus pneumoniae 
E Walsh, J. Willcock and S. Amyes 
Edinburgh, Kent, UK 
Objectives: To investigate the effects of the presence of em and mefgenes on 
the ability to select for telithromycin resistance in Srreptococcuspneumonia. 
Methods: The S.pneumoniae strains chosen for investigation were 02J1095 
containing the em, gene, 02Jl175 with the mefgene and a macrolide-sensitive 
strain NCTC 13593. Mutants were selected from plates containing telithro- 
mycin at the MIC or twice the MIC and subcultured twice on agar plates 
containing telithromycin. This procedure was repeated for each generation 
until telithromycin resistance occurred or successive generations resulted in 
the same MIC. The e m  and mefgenes from the parent and the mutant strains 
were amplified using PCR and sequenced to investigate changes in the gene 
sequences &om parent to mutant. 
Results: The strains 0251095 and 02J1175 were both sensitive to telithromycin 
although they were resistant to macrolides owing to the presence of the erm 
and mefgenes, respectively. Telithromycin did not select for resistance in the 
macrolide-sensitive NCTC 13593 strain after four generations of mutation. 
However, resistance to telithromycin occurred in both 02Jl095 and 02Jl175 
mutants. Second generation 02J 1095 mutants had high-level telithromycin 
resistance whereas the highest telithromycin MIC was 8mg/L after four 
mutant generations of 0231175. There were no nucleotide differences 
between the em genes from the parent (02J1095) and the corresponding 
mutant strains. The mef genes from each of the four mutant 02J1175 
generations also showed no changes to the parent 0251 175 mefgene. 
Conclusions: Therefore, these results suggest that telithromycin does not 
select for resistance in strains lacking the erm or mefgenes, but will select for 
resistance in strains containing either gene. Thus in order to select for 
telithromycin resistance the strain must first be macrolide resistant owing 
to an em or mefgene. Also, high level resistance to telithromycin is selected 
with fewer generations in S. pneumoniae containing the erm gene rather than 
the mefgene. 
Strain Telithromycin MIC (mg/L) Mutation kequency 
02J1175 (m& 
M I  
M I1 
M 111 
M N  
NCTC 13593 
N I  
N I1 
N I11 
NIV 
0.06 
1 
32 
0.5 
2 
4 
8 
8 
0.016 
0.032 
0.12 
0.5 
0.5 
Parent 
1 x 
Parent 
1 x 10-3 
2 x 10-4 
3 x 1 0 - ~  
3 x 
2 x 10-2 
3 x 
Parent 
3 x 
6 x lo-' 
2 x 
using light or fluorescent microscopy (with a vital dye) followed by measure- 
ment of bacterial viability by culture techniques. The kinetics of intracellular 
killing varied amongst the test strains but was not correlated with their 
antibiotic susceptibility pattern. 
Results: Addition of moxifloxacin at  concenhations ranging h m  1/2 to 
4 x MIC resulted in enhanced killing of all the bacterial strains notwith- 
standing their resistance to penicillin, erythromycin or ciprofloxacin. Moxi- 
floxacin pretreated cells induced at least a 50?? loss ofviability within 2 h 0774 
cell lines) or  1 h (monocytes) as compared to control cells to which no 
modoxacin had been added. Inaacellular staining with fluorescent vital dye 
clearly demonstrated that the loss of viability occurred intracellularly and that 
any increase in intracellular killing could be attributed to treatment with 
moxifloxacin. 
Conclusion: The results demonstrate that moxifloxacin is bioaaive intracel- 
lularly against antibiotic-resistant strains of Streptococcus pneumoniue, thereby 
augmenting innate cellular defense mechanisms. 
1 PI095 1 Susceptibility to selected antibiotics of 
Streptococcus pneumoniae strains isolated from patients 
with respiratory tract infech'ons 
E. M m r ,  J. Niedzwiadek, J. Ligisza, Z. Hencner and 
M. Koziol-Montewka 
Lublin, PL 
Objectives: In recent years a number of studies have addressed the frequency 
of antibiotic resistance among respiratory pathogens, including Streptocms 
pneumoniae, and an increased resistance has been reported for commonly used 
antibiotics. The aim of our study was to evaluate the susceptibility to selected 
antibiotics among Streptococcus pneumoniae strains isolated from patients suffer- 
ing f b m  respiratory tract infections. A total of 52 Streptocorms pneumoniue 
strains, isolated h m  patients with sinusitis, bronchitis, and pharyngitis, have 
been examined. 
Methods: Susceptibility to penicillin, erythromycin, tetracycline, and van- 
comycin has been evaluated using Sceptor Streptococcus MIC/ID panels 
(Becton Dickinson) accordmg to manufacturer's instructions. 
Results: In our study, we have observed high penidin (S=23, 1=26, 
R=3), tetracycline (S=23, 1=13, R=16), and erythromycin (S=33, 
I= 13, R= 6), resistance rates among Sh~ptococcus pneumoniae strains. A total 
of 12 s t r a i n s  have been fully or moderately resistant to erythromycin and 
tetracycline - 8 of them have been also rully or intermediateh resistant to 
penicillin. As a total, 19 strains have appeared to be multiresistant and have 
been M y  or intermediately resistant to two or three antibiotics (penicillin, 
erythromycin, tetracycline). All examined strains have been susceptible to 
vancomycin. All strains have been also susceptible to optochine. 
Conclusions Increasing resistance of Streptococm pneumonia strains to com- 
monly used antibiotics indicates the necessity of performing antimicrobial 
susceptibility test in every case of infection with t h ~ ~  pathogen. 
lntracellular survival kinetics of Streptococcus 
pneumoniae in J774 cells and human blood monocytes: 
effect of moxifloxacin 
C. Gemmell and C. McCreadie 
Cla(~our UK 
Introdudon: As a member of the fluoroquinolones, moxifioxacin and 
exhibits antibacterial activity against several Gram-positive species and is 
known to concentrate intracellularly. In this connection, it seemed appro- 
priate to determine whether the drug displayed intracellular bioactivity 
against various strains of Streptococcus pneumoniae with differing antibiotic 
susceptibilities and different capsular polysaccharide serotypes. 
Methods: A number of clinical isolates with raised MICs towards penicillin, 
cipmfloxacin and/or erythromycin were selected. Their susceptibility to 
complement mediated phagocytosis by activated J774 macrophages was 
measured. J774-cells were pre-activated with phorbolmyristare acetate 
(0.16 p ~ )  and interferon gamma (10 units) and keshly isolated blood mono- 
cytes were isolated &om human blood donations using Histopaque 1077 
(Sigma) with greater than 95% purity and viability. Phagocytosis was assessed 
Ip10961 In vitro bactericidal activity of new 
fluoroquinolones against vancomycin-tolerant pneumococci 
L. Gualco, E. Tonoli, G. C. Schito, E. A. Debbia and A. Marchese 
Genoa, I 
Objectives: The incidence ofpenicillin-resistant and multiple-resistant pneu- 
mococci has increased worldwide at an alarming rate. A further threat is 
representedby the recent descriptions ofvancomycin tolerant strains. The aim 
of this study was to evaluate the in vitro activity of new fluoroquinolones 
against vancomycin tolerant S. pneumoniae strains. 
Methods: The bactericidal activity of levoflowin, gemifloxacin, modox-  
acin, trovafloxacin, clinafloxacin and vancomycin was assessed by the time-kill 
curve method described by N o d  et al. (Nature 339: 590-593,1999) in nine 
multiresistant, vancomycin tolerant S. pneumoniae strains previously described 
(Marchese et al. 40th ICAAC, 2000 (Abstract 1778)). The reference-sensitive 
strain R6 was used as control. 
Results: Time-kill tests confiimed tolerance to vancomycin and showed a 
pronounced bactericidal activity of all fluoroquinolones tested. In particular, 
after 4 h of exposure the initial inoculum was reduced by ckdoxacin fTom 
99.9 to >99.999%, by levofloxacin and trodoxacin from 99.9 to 99.999% 
and by gemifloxacin and moxifloxacin &om 99.3 to 99.99% depending on the 
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strain. After 6 h of exposure, the initial inoculum was reduced to 0.01 or to 
<0.001% for all fluoroquinolones and no re-growth was observed after 
further incubation. 
Conclusion: New fluoroquinolones active against Gram-positive pathogens 
retain bactericidal activity against multiresismnt vancomycin-tolerant pneu- 
mococci. Approved molecules of this class endowed with appropriate phar- 
macokinetic properties may represent effective therapeutic options for serious 
pneumococcal infections, including meningitis, sustained by these diflicult- 
to-treat strains. 
m\ Antibiotic sensitivity of Streptococcus 
pneumoniae isolates from Hungary 
0. Dobay, E Rozgonyi and S. Amyes 
Edinburgh, UK; Budapest, HUN 
Objective: Streptocorn pneumoniae is the major cause of community-acquired 
pneumonia and has become increasingly Wicult to treat as it has acquired 
resistance to penicillin and other antibiotics. Hungary and Spain have reported 
the highest incidences ofpenicillin resistance in Europe, and therefore they are 
each a demanding environment for testing the efficacy of new antibacterials. 
This study examines recent Hungarian isolates to determine their sensitivity 
to the new antibacterials. 
Methods: One hundred and twenty non-repeated Streptocom pneumoniue 
strains were collected by the diagnostic laboratories of the Semmelweis 
University in Budapest between January and June 2000. The strains were 
transported to the UK and their identity confirmed. Antibiotic disc-&ion 
tests were performed on 13 antibiotics and their sensitivity determined, where 
appropriate, according to NCCLS guidelines. Sensitivity to antibiotics not 
listed in the guidelines was determined by comparison with established 
antibiotics or disc contents of the BSAC guidelines were used. 
Results: The rates of resistance and intermediate sensitivity (where appro- 
priate) were extremely high to oxacillin, clindamycin and cotrimoxazole. No 
intermediate resistance was found for the macrolides though the resistance 
rates were high at around 36%. Amoxiclav, imipenem and cefotaxime 
sensitivity was hgh. Vancomycin tolerance has recently been observed in 
the US and Sweden, and five strains in this cohort showed evidence of the 
same in Hungary. Full sensitivity to levofloxacin and ciprofloxacin was found 
in only approximately two-thirds of the population but a much higher 
proportion were fully sensitive to moxifloxacin. 
Conclusions: Against this very exacting population of bacteria moxilloxacin, 
amoxiclav and telithromycin showed a remarkably hgh  level of efficacy. 
Percentage 
Antibiohc Disc content (pg) Sensitive Intermediate Resistant 
Oxacillin 
Imipenem 
Amoxiclav 
Cefotaxhe 
Vancomycin 
Erythromycin 
Clarithromycin 
Levofloxacin 
Cipmfloxacin 
Modoxacin 
Clindamycin 
Co-nimoxazole 
Telithromycin 
1 
10 
3 
5 
30 
15 
15 
5 
5 
1 
2 
25 
15 
36.4 
99.2 
94.1 
99.2 
95.8 
63.2 
63.2 
59.7 
68.9 
88.6 
27.6 
7.4 
91.0 
4.2 
0 
0.8 
35.5 
23.8 
39.7 
14.8 
7.4 
63.6 
0.8 
5.9 
0.8 
36.8 
36.0 
4.8 
7.4 
11.4 
32.8 
77.9 
1.6 
I Pl098 1 Bactericidal activity of moxifloxacin and other 
antibiotics against Streptococcus pneumoniae 
H. Drugeon, M. Juvin and P. Arvis 
Nantes, Puteaux, F 
Objectives: To evaluate the in vitro bactericidal activity of moxifloxacin 
(MXF) against SP strains with different resistance phenotypes: penicillin S, 
penicillin R, arnoxicillin R, erythromycin R PRY-R)- ermB -low and high 
level, ERY-R me$?. 
Methods: 12 SP s t r m s  (2 smns for each phenotype) were stucfied by using a 
kdhg curve method. Seven antibiotic concentrations were used fiom 0.25 to 
16 mg/L by follomng a two-fold dilution. Viable counts were measured at 
TO, T3, and T6 h by using agar plates m t h  mhibitors to prevent antibiotic 
carry-over Tested anhbiotics were moxifloxacm (MXF), levofloxacin 
(LEVO), amoMcillin (AMX), ceftriiaxone (CRO), pyostacme (PYO). AU 
saa ins  were susceptible to m, LEVO and PYO. 
Results: At T3 h a decrease of2 log 10 cfu/mL was observed for 10 shams wth 
MXF 2 2 mg/L, at T6 h, a decrease of 3 log 10 cfu/mL was observed with 
MXF 2 2 mg/L for 9 strains and a decrease of 2 log 10 &/mL for the three 
others stmns. At T3 h, a decrease of 210g 10 &/mL was observed for seven 
s t r m  mth LEVO 2 4 mg/L, at T6 h, a decrease of 3 log 10 &/mL was 
observedwithLEV0 2 4mg/Lformnestramandadecreaseof2log lO&/mL 
for the three others straios (the same strains as with MXF). At T3 h, a decrease 
of 210g 10 &/mL was observed for one s t r a m  (me@ strain) with AMX 4 mg/ 
L and for three strains for AMX 16mg/L. At T6h, a decrease of 210g 
10 &/mL was obtarned for five strains and a decrease of 3 log 10 &/mL for 
three strains by AMX 4 mg/L. The bactericidal activity was not related to the 
penicdhn and amoxidin resistance phenotype. At T3h, a decrease of 
> 1 log 10 ch/mL was observed wth CRO 1 mg/L for only one strain (mefE 
strain) and at T6 h, with CRO 16 mg/L a decrease of 3 log IOcfu/mL was 
observed with one strain and a decrease of 1 log 10 &/mL for nine strams. At 
T3 and T6 h, a decrease of3 log 10 &/mL w a s  observed with PYO 2 1 mg/L 
for four of 6 ERY-S smns  and three of 6 ERY-R strains (one of four m B  
s t r m s ) .  
Conclusions: The bactericidal actimty of MXF and LEVO was observed h m  
T3 h and was similar for both drug but was obtamed with 2 mg/L for MXF 
and with 4 mg/L for LEVO. PYO exhibited a rapid and intense bactericidal 
activity with s h a m  mthout m B  gene. But, it had a weak bactericidal effect 
agdlnst ERY-R-mB strains. The bactencidal activity of AMX was obtained 
at T6h only For CRO, the kdhg rate was very slow, even at high 
concenhlthons. 
lplossl In vitro activity of rokitamycin against 
well-characterized macrolide-resistant Streptococcus 
pneumonhe strains 
E. Tonoh, M. Bozzolasco, L. Gualco, M. Dolcmo, A. Marchese, 
G. C. Schto and E. A. Debbia 
Genoa, I 
Objectiws: The level of suscephbhty to macmhdes (M). streptognmin B 
(SB) and hcosarmdes Q m S.pneumoniue depends on the expression of 
&rent genetic detemnants. For t h ~ ~  reason certain molecules belongtng to 
the above menhoned groups may be actlve against S. pneumonrae possemng 
either ennB or mefA genes. The aim of ths study was to evaluate the in vim 
acnmty of the 16-member macrohde rolatamycin towards well-charactenzed 
macrohde-resistant pneumococci. 
Methods: A total of 40 erythromycm-resistant S.pneumoniue strans (20 
showmg a constitutive MLSB phenotype, and 20 belonging to the M-type) 
and 20 fully suscepnble pneumococci were stuhed. m B  and &A genes were 
amplhed by PCR. Mtnunal dubitory concentranons (MICs) of mk~tamy- 
cm, erythromym, awthromycsn and danthromycin were assessed by the 
mcrobroth ddutlon method (NCCLS, 2000) 
Results: Rohtamycin and clarithromyc~n were the most potent drugs in 
terms of MIGO (0 015 mg/L) agamst macroltde-suscephble pneumococci 
For these two drugs MICs were generally 1 or 2 dduhons lower than those 
&splayed by erythromycin and azithromym (MIC9,, 0.06 mg/L). Rokita- 
mycin was also the most active drugagamst M-type strams (MICw: 0.06 mg/L), 
wh t  a potency m excess of 130-fold compared to erythromycin, darithro- 
mycm and awthmmycin (MI% values rangmg f b m  8 to 16mg/L). S. pneu- 
mniae carzymg the emtB gene were less sllscephhle to all drugs: MICw were 
128 mg/L (rohtamycm and clarithromycm) and >256 mg/L (authromycm 
and erythromycm) However, rohtamycln showed a bunodal dismbnhon of 
Conclusion: In countries where m@A cfictated remtance is dormnant 16- 
membered macrohdes may represent mtereshng therapeutic ophons. 
MICS (1-4 and 32-128mgIL) 
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m] Telithromycin is highly active against 
community-acquired respiratory tract infection (CARTI) 
pathogens collected from patients in Germany (PROTEKT 
1999-2001) 
R.  Reinert and E. Halle 
Aachen, Berlin, D 
Objectives: PROTEKT is a global longitudinal surveillance study with good 
representation throughout Europe. The study is aimed at determination of 
resistance of key pathogens responsible for CARTI. 
Methods: Within Germany, isolates were collected h m  eight centers during 
the winter season of 1999-2000 and 12 centers in 2000-2001 (preliminary 
data). MICs of 26 antibacterials were determined centrally by NCCLS broth 
microdilution methods and interpreted using available NCCLS breakpoints. 
Results: Prevalence of resistance to penicillin G and erythromycin A (EryR; 
MIC 2 1 mg/L) among isolates of S. pneurnoniae during 1999-2000 (n = 325) 
was as follows: penicillin G intermediate (PenI, MIC 0.12-1 mg/L), 20 
(6.2%); penicdh G resistant (PenR, MIC 2 2mg/L), 7 (2.2%); EryR, 51 
(15.7%). Corresponding data for 2000-200l(n= 219) were: PenI, 10 (4.6%); 
PenR, 7 (3.2%); EryR, 37 (16.9%). ModeMIC, MIGO andsusceptibdity data 
for a selection of the antibacterials tested against S. pneumoniae are presented in 
Table 1. 
Table 1 In vitro acnvity of 11 anubacterials against S.pneumoniae (199?-2000) 
Antibacterial Mode MIC (mg/L) MICw (mg/L) % Susceptible 
Telithromycin 
Penicillin G 
Cefuroxime 
Erythromycin A 
Azithromycin 
Clarihmycin 
Co-trimoxazole 
Levotloxacin 
Linezolid 
Teicoplanin 
Quinupristin/daifopristin 
0.008 
n.015 
0.03 
0.06 
0.12 
0.03 
0.25 
1 
1 
0 06 
0.5 
0.03 
0.06 91.7 
0.12 97.5 
> 64 84.3 
164 84.9 
>32 84.3 
8 82.2 
1 99.7 
2 100 
0.12 100 
1 98.5 
- 
'NCCLS breakpoint not yet available. 
Telithromycin was the most potent ofthe agents tested, having a mode MIC, 
MICSo and MICB" of 0.008,0.008 and 0.03 mg/L, respectively, in both study 
years. Importantly, telithromycin retained potent activity against pneumo- 
cocci resistant to other antibacterials. Telithromycin was also highly active 
against isolates of S. pyogenes (1999-2000: mode MIC, 0.015 mg/L; MK&, 
0.03 mg/L; 2000-2001: mode MIC, 0.015mg/L; MICw, 0.03mg/L), 
H. injuenzae (1999-2000: mode MIC, 1 mg/L; MIC9,,, 2mg/L; 2000/ 
2001: mode MIC, 1 rng/L, MICw,, 1 mg/L) and M. cafurrhalis (2000 and 
2001: mode MIC, 0.06mg/L; MIC90, 0.12mg/L). 
Conclusions: The PROTEKT surveillance study confirms the increasing 
prevalence of macrolide resistance among pneumococci in Germany. Teli- 
thromycin was highly active against isolates of the major bacterial pathogens 
implicated in CARTIs, includmg macrolide-resistant strains. 
1 P I  101 I Telithromycin is highly active against blood 
isolates of 5. pneumoniae, 5. pyogenes and H. influenzae 
collected from patients with community-acquired 
respiratory tract infections (CARTIS; PROTEKT 1999-2000) 
D. Felmingham 
London, UK 
Objectives: PROTEKT is a global longitudmal surveillance study (69 centers 
in 25 countries) initiated in 1999 to track the spread of antibacterial resistance 
among bacterial pathogens implicated in CARTIs. We present here the 
comparative activity of the new ketolide telithromycin against blood isolates 
collected during the first year of the study. 
Methods: As part of PROTEKT, blood isolates of S.pneumoniae (n =213), 
S. pyogenes (n = 29) and H. influenzae (n = 20) were collected fiom outpatients 
with CARTIs. MICs of 26 antibacterials were determined centrally by 
NCCLS broth microdilution methods and interpreted using avahble 
NCCLS breakpoints. 
Results: Mode MIC, MICw and suscepabhy data for a selecnon of the 
anabacterials tested against S pneumoniae are presented HI Table 1 
Table 1 In nt ro  aChvlty of test anhbactenals a w t  S peumwuae 
Ambacterial Mode MIC (rng/L) MI&, (rng/L) % Suscephbhty 
Telitbmmycin 
Penicillin G 
Erythromycin A 
Azithromycin 
Clarithromycin 
Co-trimoxazole 
Levotloxacin 
Lmezolid 
Quinupristin/dalfopristin 
0.00s 
0.015 
0.06 
0.12 
0.03 
0.25 
1 
1 
0.5 
0.12 
2 
8 
16 
16 
8 
1 
2 
1 
- 
78.4 
81.2 
81.2 
81.2 
69.0 
100 
100 
98.6 
"NCCLS breakpoint not yet available. 
O n  a weight basis, telithromycin was the most active of the agents tested, 
having mode MIC, MICm and MICw of 0.008, 0.008 and 0.12mg/L, 
respectively. The prevalence of high-level penicillin G resistance 
(MIC 2 2 mg/L) among pneumococci was 12.20?, with a further 9.4% of 
isolates being penicillin G intermediate. Erythromycin A resistance was 
18.8%. Importantly, telithmycin retained potent activity against these 
resistance phenotypes. Telithromycin was also highly active against invasive 
isolates of Spyogenes (mode MIC, 0.015; MIC9", 0.03mg/L) and H. in& 
enzae (mode MIC, 1 mg/L; MIC9,,, 2 mg/L). 
Conclusions: This subanalysis of the PROTEKT surveillance study confirms 
the potent activity of telithromycin against invasive isolates of bacterial 
pathogens implicated in CARTIs, irrespective of resistance phenotype. These 
data are consistent with the high ciinical success rates and bacteriologic 
eradication rates that have been reported with telithromycin in patients with 
CAP-associated bacteremias. 
ml Telithromycin is highly active against 
community-acquired respiratory tract infection pathogens 
collected from patients in Spain (PROTEKT 1999-2001) 
E Baquero 
Madrid, E 
Objectives: PROTEKT, initiatedin 1999, is a globallongitudinal surveillance 
study of antibacterial resistance among bacterial CARTI pathogens. Data are 
now available for isolates collected in Spain during two consecutive winter 
seasons: 1999-2000 (2000) and 2000-2001 (2001; preliminary data). 
Methods: Isolates were collected from two centers in 2000 and seven centers 
in 2001. MICs of 26 antibacterials were determined centrally by NCCLS 
broth microddution methods and interpreted using available NCCLS break- 
points. 
Results. Prevalence of resistance to penicfin G and erythromycin A among 
isolates of S. pneurnoniae during 2000 (n = 133) was as follows: penicillin G 
intermediate (PenI, MIC 0.12-1 mg/L), 15 (11.3%); penicdlin G resistant 
(PenR, MIC 2 2mg/L), 56 (42.1%); erythromycin A resistant (EryR, 
MIC 2 1 mg/L), 38 (28.6%). Corresponding data for 2001 (n = 199) were 
as follows: PenI, 28 (14.1%); PenR, 66 (33.2%); EryR. 76 (38.2%). Mode 
MIC, MICgo and susceptibility data for a selection of the antibacterials tested 
against Spneumoniae are presented in Table 1. Telithrornycin was the most 
potent of the agents tested, having a mode MIC, MI& and MICgo of 0.008, 
Table 1 In vitro activity of test antibacterials against S.pneumoniae (2000) 
Antibacterial Mode MIC (mg/L) (mg/L) 
Tehthromycm 0.008 0.03 
Penicillin G 0.015 2 
Cefuroxime 0.03 8 
Erythromycin A 0.06 >64 
Azithromycin 0.12 >64 
Clarithmmycin 0.03 >32 
Co-aimoxazole 0.25 16 
Levotloxacin 0.5 1 
Linezolid 1 1 
Teicoplanin 0.06 0.12 
Quinupristin/dalfopristin 0.5 1 
"NCCLS breakpoint not yet available. 
% Susceptibility 
- 
46.6 
50.4 
71.4 
70.7 
71.4 
45.1 
100 
100 
100 
99.2 
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0.008 and 0.03 mg/L, respectively, in both study years. Importantly, telithro- 
mycin retained potent activity against pneumococci resistant to other anti- 
bacterials. Telithromycin was also highly active against isolates of S. progenes 
(2000 mode MIC, 0.015mg/L; MIC9(>, 0.25mg/b 2001: mode MIC, 
0.008 mg/L; MI%, 0.5 mg/L), H. it$uenrue (2000 and 2001: mode 
MIC, 1 mg/L; MICRO, 2mg/L) and M. cutarrhulis (2000: mode MIC, 
0.06 mg/L; MICw, 0.06 mg/L; 2001: mode MIC, 0.06mg/L; MICRO, 
0.12 mg/L). 
Conclusions: The results of the PROTEKT surveillance study in Spain 
between 1999 and 2001 confirm the high prevalence of b-lactam, macrolide 
and cotrimoxazole resistance amongst pneumococci, and the potent activity 
of telitbmmycin against such isolates and other CART1 bacterial pathogens. 
I P I  103 1 In vitro activity of telithromycin and macrolides 
against clinical isolates of Streptococcus pneumoniae from 
patients with community-acquired respiratory tract 
infections 
L. Hagberg, M. Rangaraju and S. Jenkins 
Gteborg,  S; Romuinville, F; Bridgmufq USA 
Objectives: The worldwide increase in antibacterial resistance among respira- 
tory pathogens has prompted the need for new agents that retain activity 
against resistant pathogens and have a low potential to induce, or select for, 
resistant strains. Telithromycin is the first of a new class of antibiotics, the 
ketolides. Telithromycin displays potent in vitro activity against common and 
atypicalhtracellular respiratory pathogens, including resistant strains. We 
report here an analysis of the in vitro activity oftelithromycin versus macrolide 
comparators (clarithromycin [CLA] and azithromycin [AZI]), against clinical 
isolates of Streptococcus pneumoniae collected during Phase 111 clinical studies 
with telithromycin. 
Methods: A total of 394 clinical isolates of S. pneumoniue were obtained fiom 
adult patients with community-acquired respiratory tract infections @new 
monia [n = 2501, acute exacerbation of chronic bronclutis [n = 281 and acute 
maxillary sinusitis [n= 1161) who took part in one of 11 multicenter clinical 
trials. Tentative breakpoints used to determine in vitro susceptibility to 
telithromycin were: susceptible, 51.0 mg/L; intermediate, 2.0 mg/L; resis- 
tant, 24.0mg/L. NCCLS breakpoints were used to determine susceptibdity 
to CLA and MI. 
Results: AU isolates (n = 394) showed intermediate or full susceptibility to 
telithromycin (mode MIC 0.015mg/L), whereas 58 (14.7%) and 61 (15.5%) 
strains were resistant to CLA and AZI, respectively. All 47 pneumococcal 
strains that were resistant to penicfin G (MIC 2 2.0 mg/L) remained sus- 
ceptible to telithromycin (mode MIC 0.03 mg/L). These isolates showedhigh 
levels of cross-resistance to both CLA (63.8%, n=30) and AZI (68.1%, 
n=32). A total of 58 strains (14.7%) were resistant to erythromycin A 
(MIC 2 1 .O mg/L). Nearly all of these strains were also resistant to both 
CLA and AZI (98.3%, n = 571, yet none were resistant to telithromycin (mode 
MIC 0.03mg/L). 
Conclusion: Compared with CLA and M I ,  telithromycin provides excellent 
coverage against clinical isolates of S. pnwrnoniue, includmg penicillin G- and 
erythromycin A-resistant strains. 
ImI Telithromycin is highly active against isolates of 
5. pneumnim from pediatric isolates collected in the 
PROTEKT Surveillance Study (1999-2000), irrespective of 
penicillin G or erythromycin A resistance 
D. Fehngham 
London, UK 
Objectives: The rapid evoluhon of drug-resistant Spneurnoniae in the 
pediatric population is of parhcular concern, We present here the results 
of a subanalysls performed on the first year's data &om the PROTEKT 
su rvehce  study to assess the prevalence of antibacterial resmance among 
pedlatnc Isolates of Spneumonia, and the activlty of the new ketohde, 
teltthrornycm, agamst such mlates. 
Methods: S. pneumonrue isolates were collected during the 1999-2000 respua- 
tory season from cMdren (aged <12 years) wth  commumty-acquired respua- 
tory tract infecnons (CARTIS). In total, 69 centers in 25 countries 
contributed data for 1999-2000. In vitro suscephbhty of isolates to 26 
anhbactenals was determned by NCCLS broth mcrodduhon at a central 
laboratory and interpreted using NCCLS breakpomts, where avadable. 
Suscephbihty data were analyzed by culture source and age range. 
Results: In total, 368 isolates of S. pneumoniue were collected from the 4 man 
culture sources (sputum, nmpharyngeal, ear and blood). Among these 
isolates. the overall p d e n c e  of pemcibn G resistance (PenR, 
MIC22mg/L) was 26%. and of erythromycm A resstance (EryR 
MIC 2 1 mg/L) was 38%. Isolates reustant to erythromycin A were also 
cross-resistant to clarithromycin and authromycin. The hghest rates of 
resistance were recorded for chddren aged 1-2years ( P e a ,  44%; EryR, 
51%), and for isolates fiom the nasopharynx ( P e a ,  30%; EryR, 57%). Rates 
of EryR by age and culture source are summarized m Table 1. 
Table 1 Prevalence of EryR among S.pneumoniae by age and culture source 
'Aee (Years) 
Culturesource 5 1  >1-52 >2-<8 >8-<12 
Sputum 19/56 (34%) 316 (50%) 14/40 (35%) 4/12 (33%) 
Nasopharyngeal 27/49 (55%) 7/12 (5%) 24/39 (62%) 2/6 (33%) 
Ear 16/54 (3%) 7/13 (54%) 6/24 (25%) 1/8 (13%) 
Blood 1/27 (4%) 4/10 (40%) 3/12 (25%) 
Total 63/186 (51%) 21/41 (51%) 47/115 (41%) 7/26 (27%) 
Overall, tehthromycin had an MICm/m of O.OlS/O.lZmg/L. Agamt PenR 
and EryR S. pneumonia, tehthromynn had MICSO/W of 0.06/0.25 -A. and 
0.06/0.5 mg/L, respectively. 
Conclusions: The hgh prevalence of EryR and P e a  among pneumococci 
wlaked &mcM&en mth  CAKTIs is a cause for concern, and highhghrs the 
need for new anubactenals such as the ketolide telihomycin, which shows 
excellent activity agamst isolates of S.pneumonrae from pediatric pahents, 
lrrespeChVe of p e m c h ,  macrohde or mulhple resstance. 
IP1105) Bactericidal activity of amoxicillin alone and in 
combination with clavulanic acid against Streptococcus 
pneumoniae isolates with reduced susceptibility to 
amoxicillin 
T Moore, N. Niconovlch, S Rttenhouse and J. Poupard 
CoNegevtlle, USA 
Objectives: Tnne-lull studies were performed to evaluate the antibacterial 
aChvlty of a m o x l c h  alone and in combination wth  clavulatllc acid against 
StrrptococMs pneumoniue isolates wlth reduced suscephbdity to amoxlcdhn 
Included were two Isolates ulth amoxicdh MICs of 2 mg/L, three isolates 
mth MICs of 4 rng/L, three isolates with MICs of 8 mg/L and one isolate 
mth  a MIC of 16mglL. 
Methods: Isolates were mcubated m the presence of amoxtclllin z t  c lavuhc  
acid at 0.25, 0.5, I,  2 and 4 hmeS the MIC. Viable counts were conducted at 
2-h intervals for 8 h and agam at 24 h. 
Results. No notable Merences m rate of lull were observed between 
amondhn and amonch/clavulatuc acid. A bactermdal e5ect 
(>2log[lO] decrease fkom the imhd test moculum) was ob5erved at con- 
centrahons at or above the MIC, mth some strains showing a reduced growth 
rate at 0.5 mnes MIC. At these concentrations, the ndubitory effect was 
shown to be hme dependent through 8 h. 
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Conclusions: Overall. these results indicate that at or above the MIC, 
amoxicillin and amoxicWclavulanic acid produce a time-dependent bac- 
tericidal effect against S.pneumaiae isolates with reduced susceptibility to 
amoxicillin. The rate of kill seen with these isolates is sirmlar to that reported 
for isolates that are considered highly susceptible to these agents. 
2mg/L), in blood 42% 0.12mg/L, MI%: 1 mg/L), in CSF 8.2% 
(IvlICw: 0.06 mg/L, MICw: 2 mg/L) and in others 86% (MICso: 1 mg/L, 
MICw: 4mg/L). The penicillin-resistant strains coming from sputum and 
tracheal aspirate revealed susceptibility to the following antibiotics: Amx 
(loo%), Amc (loo%), Ctx (90%), Cip (89%) and showed resistance to: Sxt 
(89%), Em (64%), Kz (34%). Cla (29%). Cef (27%), Cm (26%). No resistant 
strain to vancomycin was found. The following Serotypes were resistant to 
penicillin: 6 (30%), 19 (22.3%), 7 (17.3%). 23 (14%). and 8 (14%). 
Conclusions: The most efficient drugs against penicillin-resistant pneumo- 
cocci were: Amx, Amc, Ctx and Cip. Clarithromycin was more active than 
erythromycin. There is an urgent need to implement a network in Romania 
for the surveillance of the antimicrobial usage and a stronger partnership 
between clinical medicine and public health. 
I P1106 I Combination therapy with vancomycin and 
levofloxacin for severe bacterial pericarditis due to 
penidllin-resistant Streptococcus pneumoniae (PRSP): 
feasibility in a disease refractory to ceftriaxone, vancomycin, 
and quinupristinldalfopristin (QPIDP) 
A. S d h ,  R. Talwani. M. Sheldon and R. W. Tribble 
Columbia, USA 
Objectives: Bacterial pericarditis is rare, and optimal therapy for life-threa- 
tening complication owing to PRSP is uncertain. 
Results: A 29-year-old healthy black man presented with acute respiratory 
distress, fever (38.5 "C), and severe chest pain. Lingual consolidation on chest 
radiograph, and EKG indcated acute pericardial inflammation. Echocardio- 
graphy showed moderate efhsion and diastolic equalization of pressures, 
cardiac ramponade. The laboratory results are as follows: WBC 10.4K/pL, 
ALT 546U/L, AST 491 U/L, and ESR 11Omrn/ h. An emergent pericar- 
diocentesis catheter was placed and 360 cc of brownish, turbid effiision with 
several intragranulocytic Gram-positive diplococci was removed. Streptococcus 
pneumoniae was isolated &om pericardtal fluid (PF) and blood cultures, 
antimicrobial susceptibility (MIC) as follows: penicillin 4 pg/mL, ceftriaxone 
3 pg/mL, erythromycin >21 mm, rifampin >19mm, vancomycin >17mm, 
levofloxacin > 17 mm, linezolid 28 mm, and QP/DP 18 mm. Vancomycin 
(2 g daily) was added to ceftriaxone (4 g daily) 2 days later. Day 5, QP/DP 
(7.5 mg/kg every 8 h) was substituted for ceftriaxone as fever rose to 39 C, 
WBC 16.1k/pL, and PF drainage increased to 120cd24h. Day 9, he 
developed septic shock, WBC 31.8k/pLLL, fever 40 C, and in pericardial 
fluid intragranulocytic diplococci persisted. Levofloxacin (750 mg daily, IV) 
was started and QP/DP was discontinued. The following day patient under- 
went surgical de-bridement and pericardectomy. Assisted ventilation was 
discontinued 96 h following surgery. He was discharged on day 23, and 
completed 4 weeks of antibiotic therapy. 
Conclusions: Early surgical intervention is critical in patients with severe 
bacterial infection of the pericardiurn. High-dose levofloxacin in combina- 
tion with vancomycin appears to be well tolerated and may provide an 
alternative in refractory infections owing to PRSP. 
m/ Study of antibiotic-resistant pneumococci 
isolated in Romania from January 1999 to December 2000 
M. Pana, M. Ghita, 0. Dorobat, R .  Papagheorghe, N. Popescu, 
M. Andrei, V. Ungureanu, S. Iacob and S. Botea 
Bucharest, RO 
Objectives: To study the antibiotic resistance in pneumococci isolated in 
Romania between January 1999 to December 2000. 
Methods: Two hundred 42 strains of Streptococcus pneumoniae coming &om 
sputum or tracheal aspirate (N= 107), blood (N= 52), CSF (N= 23), pleural 
fluid (N= 4), and others (N= 56): ear fluid, sinus, pharynx, were collected 
between January 1999 and December 2000 at the National Reference Center 
for Streptococcus. The specimens fiom pharynx came h m  47 patients with 
HIV. The isolates were serotyped and analyzed for susceptibility to the 
following antibiotics: penicillin (Pc), erythromycin (Em), clarithromycin 
(Cla), cefazolin (Kz), cefuroxim (Cet), cefotaxim (Ctx), cotrimoxazole 
(Sxt), chloramphenicol (Cm), ciprofloxacin (Cip), amoxocillin (Amx), amox- 
icdhdclavulanic acid (Amc) ,  vancomycin (Va) by standard agar dilution MIC 
testing. 
Results: Interpretative criteria were used according to NCCLS 1999. During 
the study period penicillin-resistant strains of S.pneumoniae were noted as 
follows: in sputum and tracheal aspirate 67% (MEso: 0.25mg/L, MICgO: 
Ip11081 Current antimicrobial susceptibilities of 
pneumococci and other Streptococcus spp. from France, 
Germany, Italy and the USA using TSN@ data 
M. E. Jones, J. A. Karlowsky, L. J. Kelly, C. Thornsberry and D. F. Sahm 
Hilversum, NL; Herndon, Fmnklin, USA 
Objectives: Because &lactams and macrolides are used to treat infections 
attributable to Spneumoniue (SP), S.pyogenes (Spy), S. aguldiae ( S A g )  and 
viridans group streptococcus ( V S ) ,  we present current susceptib 
these species to these antimicrobial classes as reported to physicians following 
routine test procedures by cluncal laboratories. We also review the impact of 
the new 2002 NCCLS (M100S12) ceftriaxone (CRO), cefotaxime (CTX) 
and cefepime pneumococcal breakpoints for non-meningeal isolates. 
Methods: We reviewed data @nuary 1999-September 2001) &om The 
Surveillance Network@ (TSN) Databases in France (Fr), Germany (Gy) Italy 
(It) and USA, to determine current susceptibilities from routine test results. 
We used 2001 NCCLS breakpoints, except for Fr data, for which CA-SFM 
(2001) criteria are used. To apply the revised 2002 NCCLS M100-S12 
pneumococcal non-meningeal CRO/CTX breakpoints, we re-interpreted 
available quantitative MIC data. 
Results: For SF', penicillin (PEN) and erythromycin (ERY) non-susceptibility 
(NS)was72.6,2.9,8.4,and56.4,and54.4, 15.0,34.4and37.7%forFr, Gy, It 
and USA, respectively. Rates of CRO/CTX NS were 23.6/28.4% (Fr), 7.3/ 
1.5% (It) and 23.1/29.2% (USA). For SF'y or SAg, no isolates were reported as 
resistant to PEN. In contrast, 41.6 (Fr), 1.3 (It) and 25.3% (USA) of VS were 
PEN-resistant. ERY NS in Spy, S A g  and VS, respectively, were 14.4/16.4/ 
45.9% (Fr), 10.8/11.5/not tested percentage (Gy), 27.6/18.4/20.0% (It) 
and 12.6/24.5/40.0% (USA). Where TSN data was available for non-SP 
species, >99% of isolates remained susceptible to CRO except for 9.3% 
(CRO) and 10.4% (CTX) NS among VS &om the USA. Interpreting 
CRO MICs for non-meningeal isolates of SP using 2002 NCCLS criteria 
showed the percentage S to be 97.8% (Fr), 100% (Gy), 98.1% (It) and 94.7% 
Conclusions: Macrolide resistance (or non-susceptibility as discussed above) 
has emerged in all streptococcal species reported. PEN non-susceptibility for 
SP and VS varied notably by country. Among non-SP species, CRO or CTX 
were not routinely tested in European clinical laboratories, despite showing 
high activity when they were tested. Current levels of susceptibility to CRO 
or CTX among non-meningeal isolates of pneumococci will increase con- 
siderably when 2002 NCCLS M100-Sl2 breakpoints are introduced. 
(USA). 
Antimicrobial susceptibilities of H. hfluenzae and 
M. catarrhalis causing lower respiratory tract infections: 
SENTRY Antimicrobial Surveillance Program, Europe 2000 
E. Loza, R. Canton, M. Morosim, R.  Jones and E Baquero 
The SENTRY Pattrapants Group 
Objective: To study the occurrence of different B-lactam resmance pheno- 
types in H rnjuenrae (HI) and M. catarrhah (Mc) Isolates and the resistance 
profile to other antlmcrobials. 
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Methods: A total of 681 Hi and 285 Mc isolates were recovered 
in 16 laboratories &om 12 European countries. Susceptibility was 
centralized (Univ. of Iowa) and performed as recommended by the NCCLS. 
Analysis of both organisms was made using NCCLS criteria for Hi 
(M100-Sll). 
Results and conclusions: The proportion of p-lactamase producers in Hi and 
Mc were 11.7 and 95.7%, respectively, 'The B-lactamase positive rate in Hi 
isolates from different laboratory sites ranged fkom 0 to 30%, verrfjmg that 
these isolates were not recovered during the Sentry Antimicrobial Surveil- 
lance Program in all European geographic areas in 2000. Only 1% of Hi 
isolates were intermediate (2 isolates) or resisrant (4 isolates) to ampicillin in 
the absence of B-lactamase production. With the exception of one of these 6 
Hi isolates, all showed a reduced susceptibility to amoxicillin/clawlanate 
(4-8 pg/mL) and cefuroxime (8->8 pg/mL) and displayed higher MICs 
to ceftriaxone (O.O3pg/mL) than that obtained in other Hi irrespective 
of B-lactamase production (<O.OOsO.Ol  pg/mL). Within 8-lactamase- 
producing Hi isolates, no amoxidin/clavulanate or cefuroxime-resistant 
isolates were obselved. All isolates of Mc and all but 3 of Hi were inhibited 
by 0.06pg/mL of both ciprofloxacin and the new desfluoroquinolone 
BMS284756 compound. Clarithromycin resistance was uncommon in Hi 
(1.1%) and was not detected in Mc. Chloramphenicol, tetracycline and 
rifampicin resistance rates in Hi were 1.2, 0.7, and 0.7%. respectively; the 
corresponding values in Mc were 0,3.9, and O%, respectively. Cotrimoxazole 
resistance was only present in Hi (16.5%) and was randomly distributed 
among different sites. 
vl National in vitro susceptibility of cornrnunity- 
acquired respiratory tract pathogens (SEPRA) 
S. Mannelli, S. Andreoni, E Bistoni, G. Fadda, E. Maghano, G. Nicoletti, 
A. Nanetti, G. Pal&, M. Tufano, E. Varaldo and G. Schito 
Genoa, Novara, Pmgia ,  Rome, Milan, Cafania, Bologna, Padua, Naples, 
Ancona, I 
Objective: To evaluate Italian susceptibility data of antimicrobial agents 
against community-acquired respiratory tract pathogens. 
Materials and methods: This multicenter, comparative antimicrobial in v im 
susceptibility study included 10 Italian sites that have contributed to collection 
of clinical isolates from blood or sputum cultures. The broth microdilution 
method (Sensititre -Trek Diagnostic System) was used to determine the MIC 
of each of the study isolates, according to NCCLS guidelines (2001), and 
adequate analysis controls were utilized. 
Results: Prehmmuy results on MICw (mg/L), MIC ranges and susceptibility 
rates (%) of the most common respiratory tract pathogens, collected during 
2000 and 2001 are shown in Table 1. 
Table 1 
1 P1110 1 In vitro activity of levofloxacin and other 
antibiotics against respiratoty tract pathogens isolated in 
France during 2000-2001 
H. Drugeon, N. Moniot-Ville, A. Bensalah and M. E. Juvin 
Nantes, Paris, Lmallois Perret, F 
Objectives: The objective of this study was to evaluate the in vitro activity of 
levofloxacin (LVX) against recent respiratory tract pathogens (RTP) in France 
in comparison with other antibiotics. 
Methods: A total of 1694 French clinical strains of adult respiratory tract 
infections were isolated fiom November 2000 to April 2001 in 30 participant 
centers. MICs of LVX, penicillin (PEN), a m o x i c h  (AMX), amoxiclav 
(AMC) and erythromycin (ERY) were determined by the agar dilution 
method in a central laboratory. Susceptibhty rates were calculated according 
to the recommendations of the Comit6 de I'Antibiogramme de la SociktC 
Franpise de Microbiologie. 
Results: MICs 50% (mg/L)/MICs 90% (mg/L)/percentages of susceptibility 
for each species are presented below: Streptococnrs pneumoniae (SP): Overall SP 
strains (n=675): LVX: 1/2/99; PENI: 0.12/2/49; AMX: 0.06/2/72; ERY 
0.5/64/52.3; PEN susceptible strains (PSS) (n = 331): LVX: 1/1/99.7; AMX: 
0.015/0.03/1OO; ERY 0.03/16/84; PEN intermediate strains (PIS) 
( n =  191): LVX: 1/2/98.4; AMX: 0.5/1/74.3; ERY 32/64/27.7; PEN- 
resistant strains (PRS) (n = 153): LVX: 1/2/98; AMX: 2/4/8.5; ERY: 64/ 
64/14.4. Haemophilus infuenzae (HI) (n= 751): LVX: 0.03/0.03/99.9; AMC: 
0.5/2/98.8. Moraxella cuturrhalis (MC) (n =268): LVX: 0.06/0.06/100; AMC: 
0.03/0.12/100; ERY 0.12/0.25/99.6.LVX shows a good activity against SP 
whatever the susceptibility to PEN. PEN non susceptible strains are dwided in 
55.5% of intermediate strains and 44.5% of resistant strains. Susceptibility of 
PRS to AMX is low and 17% ofthese strains shows a high level of resistance to 
AMX (MICs 2 4 mg/L). Resistance rates of SP to ERY are h&, especially 
among PIS and PRS. About 33.2 and 92.1% of HI and MC isolates, 
respectively, are 8-lactamase producers. Among the drugs tested, LVX has 
the best activity. 
Conclusions: The results of this study show that LVX has a good activity 
against the most fiequent RTP, and that resistance rates of SP to this antibiotic 
remain very low, whatever their susceptibility to penicillin. Resistance to 
penicillin and macrolides is high among SP strains. High level of AMX 
resistance becomes frequent among PRS of SP. Production of b-lactamase 
concern one-third of HI isolates and almost all MC strains. In conclusion, 
LVX appears to be a drug of choice for the treatment of respiratory tract 
infections. 
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Conclusions: These results demonstrate that the major community-acquired 
respuatory tract pathogens in Italy are susceptible to new fluoroquinolones, 
such as m o x i f l d n ,  and confirm that these antimicrobials are an excellent 
option for empirical treatment. 
I P1112 I Alexander Project 2000 Europe: comparative 
in vitro activity of 17 nonquinolone antimicrobials against 
3380 adult community-acquired RTI (CARTI) isolates 
D. Felmingham and R. Gruneberg 
London, UK 
Objectives: The Alexander Project has collected adult CARTI 
isolates, including Haemophilus infuenzae (HI), Sfreptococnrs pneumoniae 
(SP), Moraxella catarrhalis (MC) and Streptococcus pyogenes (SPY), since 1992 
in order to determine reliable surveillance data for use in guidmg empirical 
therapy. 
Methods: MICs and percentage susceptibilities of isolates collected in 
Europe in 2000 were determined against a range of nonquinolone antimi- 
crobials according to strict NCCLS methodology and quality control 
procedures. 
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Results: Susceptibihty patterns varied for individual countries. Data for 
Europe are summarized in the table. 
Mode MIC. MIC'XI (mvL) md M 
HI (1439) SP (1707) MC (145)' SPY (RY) 
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%S, percentage susceptibility; amox/clav, amoxicillin/clavulanic acid. 
'No NCCLS breakpoints defined for MC. 
bSusceptibility based on penicillin. 
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Figure 1 
Conclusions: AmoxicMclavulanate was the only antmicrohid to which 
>90% of both SP and HI isolates were susceptible. Overall, the most potent 
antimicrobial (MIC[90] 5 2 mg/L) against the four CARTI pathogens was 
amoxicillidclavulanate and the least potent were the macrolides and 
cefaclor. 
The Alexander Project in Europe: decreased 
susceptibility of isolates of Streptococcus pneumoniae to 
macrolides 1992-2000 
D. Felmingham and R. Gruneberg 
London, UK 
Objectives: The Alexander Project has collected adult community-acquired 
respiratory tract infection (CARTI) isolates for 9 consecutive years in order to 
determine reliable survedlance data for use in guiding empirical therapy. 
Centers in five European countries have participated throughout the period 
1992-2000: France, Germany, Italy, Spain and UK. 
Methods: MICs were determined agamst erythromycin, clarithromycin and 
azithromycin according to strict NCCLS methodology and quality control 
procedures. 
Results: Changes in the MIC of erythromycin for Sfreptocouwr pneumoniae 
isolates collected between 1992 and 2000 in France, Germany, Italy, Spain and 
UK are shown in the Figure 1. Resistance to erythromycin (MIC 2 1 mg/L) 
has increased from 9.6% in 1992 to 30.6% in 2000. Resistance to clarithro- 
mycin (MIC 2 1 mg/L) and azithromycin (MIC 2 2 mg/L) increased from 
9.0% (1992) to 30.6% (2000) and from 9.1% (1992) to 30.6% (2OOO), 
respectively. Changes in erythromycin resistance for individual countries 
were, from 1992 to 2000: France, 25.4-58.6% Germany, 1.@8.3%; Italy, 
1.4-31.4%; Spain, 9.7-28.7% and UK, 2.4-11.9%. 
Conclusions: Resistance to macrolides has increased significantly throughout 
the lifetime of the Alexander Project. Phenotypically, the increased MICs are 
indicative ofMLS (B) resistance. T h  makes the continued use ofthese agents 
in the empirical treatment of CARTI doubtful. 
I PI114 I In vitro activities of gemifloxacin and four other 
fluoroquinolones against contemporary respiratory tract 
pathogens recovered from outpatients in Germany 
M. Kresken, S. Bagel, J. Brauers and K. Machka 
Bonn, Munich, D 
Objectives: Gemifloxacin is an enhanced-affinity fluoroquinolone with 
potent activity against both Gram-negative and Gram-positive organisms 
that cause community-acquired respiratory tract infections (CARTI). We 
compared the in vitm activity of gedoxacin  with that of moxifloxacin, 
levofloxacin, gatifloxacin, ciprofloxacin and seven other licensed antimicro- 
bials against Streptocorns pneumoniae (SP), HaemqhiIur injuenzae (HI) and 
Moraxella catarrhatis (MC). 
Methods: Organisms were recovered &om outpatients in eight geographic 
areas in Germany between October 2000 and April 2001. A total of 158 SP, 
135 HI and 86 MC isolates were recovered. Susceptibilities were determined 
by broth microdilution, according to NCCLS standards, in a central labora- 
tory. 
Results All SP isolates were susceptible to penicillin. Macrolide resistance was 
detected in 4.4% ofSP isolates. All HI isolates were susceptible to amoxicillin. 
Penicdlin resistance was evident in 95.3% of MC isolates. MIC50,w values 
(mg/L) and percent susceptibihties (%S) are given in the table. 
SP (n=158) HI (n=135) MC' (n=86) 
Anurmmbd MICm MI% %S M E w  MICw %S MICW MICW %S 
Among the fluoroquinolones tested, gedoxacin  was the most potent agent 
against S.pneumoniae. The rank order of potency (MICy" [mg/L]) was 
gemifloxacin (0.06) > moxifloxacin (0.25) > gaidoxacin (0.5) > levofloxacin 
>ciprofloxacin (2). Gedoxacin  also showed excellent in vitro activity 
against HI and MC (MICs for all strains 50.03 mg/L). 
Conclusion: The excellent in vim potency of gemifloxacin suggests that it 
would be a beneficial therapeutic option for the treatment of CARTI. 
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/p1115j In vitro emergence of spontaneous and multistep 
resistance in S. pneumoniae, Moraxella catamha/& and 
H. in fluenzae 
S. Schubert, U. Ullmann and A. Dalhoff 
Ktel, Wuppertul, D 
Objectives: In vitro study to mvestigate the spontaneous emergence of 
remtance in Streptococcus pneumontae, Moraxella catarrhah and H. tn$uenzae 
to faropenem (FAR), amoxycfin (AMX), amoxycdhdclavulanate (AMC), 
cefkomme (CFX), and clarithromycm (CLA) 
Methods: 
Spontaneolis emergence .f resistance: Resistant variants were elicited by 
spreading an inoculum of 10’-10’ C W ~ L  over BHI agar plates supple- 
mented with 5% bovine blood (S. pneuinoniae, M .  catarrhah) or HTM agar 
pIates (H. injuenzae) and addmg the test drugs: at 2 x MICs for each test 
organism [H. injuenzae (n = 4, AMX and AMC-resistant strains included), 
S. pneumoniue (n = 6, penicillin and quinolone-resistant strains included), 
M. catanhuh (n = 3, B-lactamase positive strains included)]. Following an 
overnight incubation at 37 “C the number of colonies growing on the 
drug-containing plates was counted. The frequency of resistant variants was 
calculated as the ratio of resistant variants arising after overnight incubation 
to the number of cfu originally inoculated. 
Muhistep emergence of resistance: Bacteria were grown overnight in BHI or 
Fildes broth containing two-fold dilutions of the antibiotics. After an 
overnight incubation a second set of serial drug dilutions was performed 
using an inoculum &om the test tube containing the highest drug con- 
centration permitting visible growth. The transfer was repeated daily over a 
total Deriod of 7 dam. 
Results: Following exposure of the indicator organisms, the following 
remtance mutation frequencies were observed. 
Orgrniirn FAR AMX AMC CFX CLA 
Faropenem h d  not induce mulhstep resistance in the test s t m m  (except for 
one strain of AMC-resistant H mJuenzue) 
Conclusions: Overall, the spontaneous emergence of drug resstance to 
faropenem was smilar to comparator drug However, for cermn strams,  
comparator drug mduced resistance mutahons up to 1000-fold more fre- 
quently than with faropenem In general Faropenem &d not induce mulhstep 
resiStance 
ml Telithromycin is highly active against isolates of 
5. pneumoniae and H. Influenme from pediatric isolates 
M. Nonoyama, K. Shimada, T. Oishi and K. Sunakawa 
Sagamihara, J P  
Objective: To investigate susceptibility oftelithromycin (TEL) against S. pneu- 
minim including resistance to penicillin (PRSP) and erythromycin (ERSP) 
and H. intuenzue isolated from pediatrics. 
Introd-. The emergence of resistant strains of S. pneumonioe and H. infu- 
enzae, which are the primary pathogens of pediatric community-acquired 
respiratory tract mfections (RTIs), to existing antibiotics has become an 
important treatment issue. In Japan, particularly, the rate of macrokle- 
resistant strains of S.pneumoniae has been growing rapidly. TEL, a novel 
ketolide with enhanced antibacterial activity, was developed by changing the 
structure of the macrolide clarithromycin (CAM), Owing to its unique 
structure, TEL demonstrates high in vitro susceptibility to PRSP and ERSP 
and also demonstrates good c h c a l  efficacy agamst commwty-acqulred 
RTIs caused by S. pneumoniae in adults 
Methodslresults: The suscephbility of 60 isolated strams of S. pneurnonioe and 
56 isolated strauls of H. itzzuenzue to macrohde antibiohcs and TEL, rsolated 
h m  children in Japan, was investigated. TEL demonstrated high suscept- 
ibility to remstant S.pneumoniae including PRSP and ERSP. The MIC5dw 
and MIC range for TEL against S. pneumonw was 0.03/0.063 pg/mL and 
<0.01-0.25 pg/mL, mpe&wly, versus >128/>128 pg/mL and 50.01- 
>128 pg/mL, respecuvely, far chthromycm (CAM), >128/>128 i$g/mL 
and 10.01->128pg/mL, respectidy, for anthromycin (AZM) and 
1/>128 i$g/mL and 0.063->128 pg/mL, respectively, for rokitamycin 
(RKM). TEL demonstrated good suscepablhty to macrolide-reustant 
H. inJuenzae mcludmg BLNAR (B-lactamase-negative ampicillin-resutant 
H. tntuenzae). The M I C ~ O / ~  and MIC range of TEL against H. intuenzue 
was 2/4 and 0.25-4pg/mL, respectively, versus 8/16 and 2-16pg/mL, 
respecnvely, to CAM, 1/2 and 0.125-4~1g/mL, respectively, to AZM and 
16/32 and 2-32 pg/mL, respectively, to RKh4. 
Conclusion: TEL showed good suscephbhty to Japanese pediatric isolates 
includmg PRSP, ERSP and macrohde-resistant H.inJuenzue. TEL can, 
therefore, be expected to demonstrate good clinical efficacy for the treatment 
of pediatric community-acquired RTIs in Japan. 
Ip1117j Evaluation of in vitro activities of oral 
macrolides and plactam antibiotics against respiratory tract 
pathogens 
c. Oplustil 
C. Mendes, S. Sinto, A. Hsiung, W. Francsco, C. Kiffer, R. Nunes and 
So0 Raulo, BR 
The ‘~tl vitm’ actiwhes of azhromycm, clarithromycin, amwdhn. amox- 
iclllin/clavularuc acid, cefprozil, and cefaclor were evaluated against 597 
strains isolated fbm upper and lower respuatory specimens h m  outpatients 
wthout age restriction &om September 1999 to July 2000. The analyzed 
samples were as f o k  247 H. inJwnzue, 147 S. o u m ,  114 S. pneunronioe, 51 
S. pyogenes, and 38 M. cafanhalis. The Mmimum Idubitory Concentration 
(MIC) was determmed by E-test methodology and interpzeted f o l l m g  
NCCLS crirena. Of 247 H. inj?wwue, 9.7% were posinve for fi-lactamase 
producaon. Among the hlactzmase producers, all (100%) were suscephble to 
amoxxclllin/clavulan~c acid and cefaclor, 98% to cefprozd, 96% to ulthro- 
mycin, and 90% to clarithtomycm. Of 147 S. o u w  analyzed, 100% were 
suscepuble to oxaclllin, amcuacdlm/clawlanic acid, cefprod, and cefaclor, 
71% to c l a r i h y c i n ,  and 68% to azithromycin. Among the S. pneunumiae 
(n= 114), full resistance to pemcfin was not obsermd, whilst 14 (12.3%) 
presented intermehate resrs-nce to penicillin. O v e d  100% were suscep- 
hble to amoxd in  and amoxinllin/clavulanic acid, 99% to cefpmd and 
cefaclor, 88% to authromycin, and 86% to clulthromycm. Among the 
pneumococcal isolates with mtermdate MIC to penidm, 21.4% were 
reslstant to azithromycin and 28.6% to clarixhromycin. Among the 51 
S.pyogerpps, 8% presented resistance to azithromycin and clarithromycm, 
and all M. catankalis were found to be B-lactamase producers. 
Ip11181 Antimicrobial susceptibility patterns of 
Haemophilus influenzae 
M. Kanellopoulou, N. Skarmoutsou, M. Mansoukou, H. Fakir;, 
V. Bournazou, G. Kanderakis, 1. Triandaphdou and E. Papafrangas 
Athens, CR 
Objectives: To determine the susceptibility of 467 Haemophilus inJuenzue 
strains isolated fiom sputum/bronchid secretions during a period of 3years 
(1999-2001) to 13 antimicrobial agents. 
Methods: The susceptibilities to antibiotics were performed by microdilution 
method according to NCCLS guidelines. H.inpUenzae ATCC 49247 
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and H.injuenzae ATCC 49766 were used as internal quality control 
S t r a i n s .  
Resub: The MIC50/MIC& (mg/L)  appeared, respectively: ampicillm 0.25/1, 
amoxidlin/clawlanic 0.25/1, cefaclor 2/8, c b x i m e  0.5/2, ceftriaxone 
<0.015/<0.015, ciprofloxacin 0.008/0.015, levofloxacin 0.015/0.03, gabflox- 
acin 0.008/0.015, azithmmycin 212, clarithromycin 16/16, tetracycline 0.511, 
trimethoprim/subnethoxazole 0.12/8 (resistance 28%). ImipenemO.12/0.25. 
A percentage of 7% of strains produced /?-lactamase (range of MICs 2->16). 
Conclusions: (1) The production of/?-lactamase was responsible for the 7% of 
resistant H. influenzae strains. (2)  H .  injuenzae were highly sensitive to qui- 
nolones (MIC 0.008-0.03 mg/L) and imipenem (MIC 0.12-0.25 mg/L). (3) 
Azithromycin seems to be more effective than clarithromycin to the tested 
isolates. (4) The behavior of H .  influenzae isolates to trimethoprim/suIfa- 
methoxazole was very encouraging (sensitivity 72%). 
m) Antibiotic resistance amongst ocular isolates of 
Haemophilus influenzae from outpatients in an eye hospital, 
Riyadh 
A. Adlan, A. Snelling, A. Al-Rajhi, J. Fletcher and T. Issa 
BmclJoord, UK; Riyadh, SA 
Objectives: Haemophilus infuenzae is a renowned respiratory pathogen. 
International surveillance studies show the prevalence of antibiotic-resistant 
isolates is increasing, but very little is known about resistance in strains causing 
eye infections or isolated as commensals from normal eyes. The aim of this 
study was to investigate the prevalence of resistance to 10 antibiotics in ocular 
isolates of H .  injuenzue. 
Methods: Two groups (pathogen and commensal) of ocular isolates of 
H .  injuenzae were collected during a 7-month period (November 1999 to 
May 2000) b i n  patients presenting with eye mfection and from healthy 
employees at the King Khaled Eye Specialist Hospital. The pathogen group 
(n = 85) yielded 100 discrete ocular isolates of H .  inzuenzae. The commensal 
group (n = 80) yielded 18 isolates. Susceptibility testing was by agar dilution 
and the E-test (AB Biodisk). Nitrocefin was used to detect /?-lacramases. 
Polymerase chain reaction was used to serotype strains and genotype 
j-lactamase positive isolates. Biotyping (pathogen group), was by API NH 
strips (BioMerieux). 
Results: By NCCLS criteria all 118 isolates were susceptible to five anti- 
biotics: ceftazidime, cefuroxime, ciprofloxacin, ofloxacin, and amoxicillin/ 
clavulnic acid. E-test results were comparable to agar dilution. Resistance 
(% strains) was detected to the other five antibiotics: ampicillin (27%); 
tetracycline (19%), chloramphenicol (14%). clarithromycin (2%); and ery- 
thromycin (1%). All isolates were non-capsulated. A total of 31 isolates 
produced TEM-1 type /?-lactamase; the majority of these, 20/31 (65%) were 
biotype II,4/31 (13%) were biotype 111, and 4/31 (13%) were biotype IV, and 
3/31 (13%) were from the commensal group. 
Conclusion: In marked contrast to respiratory infections, capsulated H .  inpu- 
enzae were not isolated from eye infections. fl-lactamase positive strains were 
common and there was a sigtuficant level of resistance to tetracycline and 
chloramphenicol when compared to nonoccular reports. Further studies are 
recommended to characterize the subgroup of H.  injuenzae causing eye 
infections to determine optimum treament as data from respiratory isolates 
may not be applicable. 
sites. The MICs of 10 antibiotics were determined by the broth microdilution 
test. The serotype was performed by the slide agglutination test. 
Resulo: The incidence was very low, 1.6/100.000 population aged less than 
15 years. The majority cases (95%) less than 5-year-old, and 7% cases less than 
2-month-old. The characteristic of the diseases showed 63.9% was meningitis, 
16.4% was pneumonia, and 12.3% was sepsis. The smtype revealed 82% w a s  
type b, 3% was non-type b and 15% was nontypeable. The 8-lactamase 
production rate was 65.8%. The antibiotic sensitivity revealed the resistance 
rate for ampi&, amoxicWcla&te, clarithromycin, chloramphenicol 
and tetracycline were 65.8,2.6,15.8,36.0 and 46.5%, respectively. All strains 
sensitive to the second and the third cephalosporins. 
Conclusion: Extremely hlgh ampicillin resistance of invasive H. infuenzae 
were isolated from pediatric patients in Taiwan. The low incidence and low 
rate of type b strains were dXerent &om western countries. 
vl Antimicrobial susceptibility of Haewnophilus 
influenzae clinical isolates collected from four European 
countries, 2000-2001 
R. S. Blosser-Middleton, I? A. Hogan, J. A. Karlowsb, I. A. Critchley, 
C. Thornsbeny, D. E Sahm and M. E. Jones 
Herndon, New York, Franklin, USA; Hilwrsum, NL 
Objectives: Haemophilw influenzae (HI) is a common respiratory pathogen in 
adult and pediatric patients worldwide. Empiric treatment of patients with 
respiratory infections is often a /?-lactam, macrolide, or fluoroquinolone, 
however, the prevalence of /?-lactamase (BL) production in some counmes 
has often eliminated /?-lactams such as ampicillin and amoxicillin as potential 
therapies. We examined current levels of antimicrobial resistance among HI 
recently isolated in four European countries. 
Methods: During 2000-2001,840 isolates of HI were isolated from patient 
specimens collected in hospitals in France, Germany, Italy, and Spain and 
submitted to our central laboratory for antimicrobial susceptibility testing. 
The identification of each isolate was confirmed and each was tested for 
susceptibility to ampicillin (AMP), amoxicillin-clavulanate (AC), cefaclor 
(CFL), cefuroxime (FUR), azithromycin (MI), clarithromycin (CLR), 
roxithromycin (ROX), ciprofloxacin (CIP) and levofloxacin (LEV) by broth 
microdilution (NCCLS, M7-A5). MlCs were interpreted using the NCCLS 
2000 published breakpoints, where available. BL production was tested using 
the chromogenic substrate nitrocefin. 
Results: Overall, BL production was 18.8%. By country, BL production was 
8.1% (rang., 4.8-11.9% per site) in Germany. 8.6% (range, 2.4-19.0% per 
site) in Italy, 23.8% (range, 11.9-42.9% per site) in Spain, and 34.8% (range, 
28.6-44.4% per site) in France. All isolates were susceptible (S) to AC, CIE 
and LEV. Among the mamolides tested, AZI was the most active (MIGO, 
2 mg/L; 99.0-100% S), followed by CLR (MI%, 16mg/L; 76.7-82.9% S) 
and ROX (MIC90, 16mg/L; no interpretive criteria). All of the macrolides 
tested were equally active against both BL-positive and BL-negative isolates. 
By age, BL production was highest among patients 514years in France 
(41.6%), Spain (29.3%), and Germany (9.1%), and among patients >65yean 
in Italy (7.1%). BL production among isolates collected &om respiratory 
sources ranged from 6.0% in Germany to 34.0% in France. The activity ofthe 
macrolides in all countries was consistent, regardless of age, specimen source, 
or BL production. 
Discussion: BL production among HI varied si&icantly between countries. 
In all countries, HI remained highly susceptible (>99%) in vim to AC, FUR, 
CIF’, LEV, and AZI. 
1 Pf12d 1 Epidemiological studies and antibiotic 
susceptibility of invasive Haemophilus infl uenzae infection 
in Taiwan 
C. C. Wag,  M. L. Chu, C. M. Yu and C. L. Lee 
Taipei, TW ROC 
Objectives: To determine the epidemiological data and antibiotic suscept- 
ibility of invasive H. injuenzae infection in Taiwan. 
Methods: From 1996 to 2000, 148 patients’ general data were analyzed and 
114 H .  influenzae strains isolated fiom pediatric patient’s blood, CSF or stenle 
(p1122) Azithromycin, clarithromycin and roxithromicin: 
in vitro efficacy and cross-resistance among Haemophilus 
influenzaleisolates in Finland 
P. Kirp2noja and H. Sarkkinen 
FIN 
Objectives: The consumption rates of azithmmycin, clarithromycin and 
roxithromicin in FinIand in the year 2000 (DDD per lo00 inhabitantdday) 
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were 0.76, 0.43 and 0.69, respectively (National Agency for Medicines 
and KELA. 2000: Finnish Statistics on Medicines) and have slightly 
increased in recent years. Seventy-seven percent of macrolides are 
prescribed for upper respiratory tract infections (otitis, sinusitis and acute 
bronchitis) (http://www.mikstra.fi), which is nonoptimal according to the 
Current Care guidelines Olttp://www.duodecim.fi/english, Current 
Care). According to Nissinen et al. (1995) the in vitro efficacy of erythro- 
mycin against Haemophilus iniuenzae isolates in Finland was mar@ in 
1988-90 (11.6% ofthe nontypeable strains from middle ear were susceptible). 
However, during the past few years the new macrolides (azithromycin, 
chlarithromycin and roxithromicin) have replaced erythromycin in 
clinical practice but the degree of resistance among these macrolides in 
Finland is not known. In the present study the in vim efficacy of the 
macrolide group against Haemophilus influenzae was evaluated by analyzing 
their activity and cross-resistance among consecutive clinical isolates in 
Finland. 
Methods: The strains (n=376) were collected &om seven clinical micro- 
biology laboratories in Finland. The MIC-values were determined using the 
E-test method Piodisk, Sweden) and HTM-agar. The disc a s i o n  method 
and the breakpoints used for SIR-interpretations are based on the most recent 
NCCLS-guidelines or previously published data in case of roxithromycin 
(Erwin and Jones, 1993). The results were analyzed using the WHONET5.1- 
computer program. 
Results and conclusions: Accordmg to the E-test results, 98% of 
the isolates were susceptible to azithromycin, 87% to clarithromycin 
and 97% to roxithromicin. On the basis of the MIC frequency distri- 
bution curves azithromycin was the most potent drug among the 
isolates included in this study. Clarithromycin and mxithromycin were less 
active. The E-test results also indicate that clarithromycin can be used as a 
representative of the macrolide group for Haemophilus injuenzae, because no 
false susceptible results for azithromycin and roxithromicin are detect- 
ed. When the disc diffusion method is used, chlarithromycin also predicts 
the susceptibility of azithromycine (no false-resistance results), whereas 
the use of azithromycin would not reveal 1% of chlarithromycin-resistant 
isolates. 
1 PI123 1 E f f e c t  of moxifloxacin on bacterial virulence 
mechanisms in comparison with amoxicillin, clarithromycin 
and ceftriaxone 
L. Drago, E. De Vecchi, M. Valli, L. Nicola and M. R. Gismondo 
Milan, I 
Objectives: To compare modoxacin (MFX) actimty mth  that of amoxlcdhn 
(AMX), darithromycm (CLR) and ceftrtaxone (CRO) agamst Gram-poslnve 
and Gram-neganve bacteria, and effect\ of subMICs on bacterial wrulence 
factors. 
Methods: In wtro anarmcrobd achvlaes agamt Stmptococcur pneumoniae, 
Staphylococcus a u w ,  Morarella catanhalis, Haemophtlus injuenzae, Eschenchia 
colt, Roteus mirabrh and Pseudomoms aougtnosa were evaluated by broth 
m c d u n o n  method. The effects of subMICs (1/4 and 1/8 x MIC) of 
annbioacs on bactenal adhesion to epitheld cells and fibrobhsts were stuhed 
by mcubatmg S. pneumonrae, M catarrhalu, S. aurew and H. rnsuenzae, pre- 
viously exposed to annbiotics, mth  either human oral cells or MRC-5 
monolayers. Adhesion was determmed by counhng bacterm adhered to 
100 cells by scannmg electron mcmscopy (SEM). Alteranom in bacterd 
morphology induced on S. aureus, H. injumzae and I? aerugrnosa by growth 
wlth subMICs (fbm 1/4 to 1/32 x MIC) of anabioacs were also evaluated by 
SEM. 
Results: The MICs confirm that MFX has a marked acnwty agamt Gram- 
positwes, whde remnmg potency a-t Gram-neganve orgausm. 
Although simdar actlvltles were observed for MFX, CRO and AMX agam~t 
S.pneumoniae strains, none of the comparators were as effective as MFX 
against S. aureus. Among Gram-negative bacteria, MFX was mostly active 
against EnterobacreriaEeae with the exception of E! mirabilis, showing marked 
potency against H .  inzumzae and M .  catanhalis. Only CRO exhibited a similar 
or slightly greater (F  mirabilis) or lower (E! amginma) activity against Enter- 
obateriaceae, H. inzuenzae and M. cakmhalis. Pre-incubation with subMICs of 
the antibiotics sigtllficantly decreased the number of adhering bacteria in a 
generally dose-dependent manner. Buccal cells bearing low numbers of 
M. catanhalis and S. pneumoniae were more frequently found in MFX-treated 
bacteria (1/8 x MIC) than in the other groups. Moreover, MFX strongly 
reduced the number of S.pneumoniae adhered to MRC-5 cells, when 
compared with the other drugs. MFX induced cellular elongation in 29% 
of H. i n j u m a e  at 1/4 x MIC and amentation in 33, 27 and 13% of 
Paeruginosa at 1/4, 1/8 and 1/16 x MIC, respectively. 
Condusiom: MFX, by interfering with some bacterial pathogenic 
factors, di5plays a remarkable antimicrobial profile, representing a potentially 
advance in chemotherapy against Gm-positive and Gram-negative 
bacteria. 
/p11241 In vitro activity of empenem against 
community-acquired respiratory pathogens 
L. Gualco, E. Tonoli, G. Dho, A. M. Schito and A. Marchese 
Genoa, I 
Objectiie: The in wtro efficacy of ertapenem, a new klactam drug, agamst a 
large number (over 500) of community-acqwed respiratory pathogens was 
studied. 
Methods A total of 180 S. pneumoniae (including 50 penicillin-intermediate 
pen-I] and 30 penicillm-resistant [Pen-RD, 100 Spyogencs, 70 H. intuenzae 
(20 B-lactamase posinve [bl+]), 70 M. catmhlis (50 bL+), 100 methicillin- 
suscepnble S. aureus (MSSA) and 30 K.pneumonrae were analyzed. With 
ertapenem, p e m c h ,  a m p i c h ,  amoxicillm, coclavulanate, cehx ime ,  
cefotaxime, ceftriaxone, dulthromycin, anthromycm, clindamycin, cipro- 
floxacin, levoflwcin, gentamicin, amzkacm, vancomycm, tetracyche, 
chloramphemcol and rifampin were tested on the appropriate orgamsms. 
MICs were detemned by a broth microddunon method (NCCLS, 2001). 
Bactericidal activity of ertapenem alone (4 x MIC) and in combmanon mth  
gentamicin, vancomycin, danthromycin, nfampm and levofloxacm 
(0.5 x MIC) were assessed agamst 15 S.pneumoniae. 
Results: Agamt Pen-S S.pneumoniae, ertapenem displayed a potent actiwty 
( M E w  0.03mg/L). Ertapenem showed MICw of 0.5 and 2mg/L aga1n5t 
Pen-I and Pen-R strams, respectively, mth  MICw values f b m  two- to four- 
fold lower than those of other betalactams. S. pyogenes, irrespectively of their 
erytbromycm-resistance phenotype, were inhibited by ertapenem at an 
MICw value of <O.OlSmg/L and by the other drugs (range of 
MICw 5 0.015->64 mg/L). Agamst fl-lactamase-negative (bl-) and 
bl+ H. injuenrae ertapenem showed WC,=O.12 and O.Smg/L, respec- 
nvely. MICw of the other drugs Eanged from 50.0075 (cipmflmracin) to 
>16 mg/L (ampicillin). Toward bl+ and b!- M. catanfialis ertapenem demon- 
strated MICw of 0.03 and <0.0075mg/L. The orhcr antibiotics showed 
MICw values ranpng from 0.015mg/L (rifampin) to 8mg/L (anpclum). 
Aganst MSSA ertapenem was one of the most potent drug (MI% 0.5 mg/L) 
together mth  nfampin, qumolones and tetracycline (MICw ranging 
&om <0.03-0.5mg/L). Time-lull curves showed a bacterladal actiwty 
of ertapenem against al l  pneumococa tested (>3 log m24 h). The combina- 
tion of ertapenem with the other drugs revealed prevalent synergistic effect 
and only three cases of mhfference were noted. No case of antagomsm was 
found. 
Conclusion: Ertapenem, showmg a potent in wtro broad-spectrum acnvity 
against the most common bacterd respiratory pathogens, may be useful in the 
treatment of c o m m ~ ~ t y  acquired respiratory infections. 
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In vitro evaluation of antiseptics 
-1 Evaluation of selected antiseptics effectiveness 
using a novel plate suspension test 
V. Krasnova, G. Afinogenov and A. Domorad 
St. Pe&&tg, RUS 
Objectiveis To assess reduction factors (RF) of selected antiseptics using a 
novel plate suspension test. 
Methods: Four antiseptics (D) 1% dioxydine (quinoxaline); (CHX) 0.05% 
chlorhexidine digluconate; (P) 1% poviargole (silver colloidal soh- 
tion + PVP); and (K) 1% katapole (Ouats + PVP) were tested against S. auras 
ATCC 6538, E. coli ATCC 25922, l? a q i n o s a  ATCC 15442, and C. nlbicanr 
ATCC 10231. In the test, metal cylinders (about 2.0cm3 capacity) were 
placed individually onto blood agar Petri plates and 0.9 mL of an antiseptic to 
test was carefilly pipetted into the cylinder correspondingly, then an inocu- 
lum of lOOYl fkom bacterial suspension (108cfi/mL) was added to antiseptic 
per cylinder. After each specified exposure period (5,15,30,60 min and 3 h), 
a volume of 0.7 mL of reaction mixture was removed away, and the 200 Yl of 
neutralizer was added to the rest. In 5 min, the cylinder was removed from 
blood agar and the neutralizer-reaction mixture poured was inoculated on 
the same agar plate by surface-plating technique. The cfu was counted after 
18-24 h overnight incubation and the RF of each preparation was calculated. 
Resufts: All the antiseptics listed were revealed to demonstrate a fair effec- 
tiveness. From investigated four antiseptics, K possessed relatively higher 
activity. MeanKRF was5.7 (2.3 to >6), foUowedbyD4.9 (1.9 to >6), C M  
4.6 (1 to >6) and P 3.1 (1-5.2). It was established that all the antiseptics to be 
effective in the first 5-15 min, reducing microbial cell counts by 2.5-6 log and 
more. The investigated compounds showed various R F  values towards Gram- 
positive and Gram-negative strains studied. The most effective antiseptics 
were: K (RF mean 6.2). CHX (5.5) against S. aureus; D ( 7 9 ,  K (6.0), CHX 
(5.9) against E. mli;D (5.3). K (4.9). andCHX(4.8) against i?nerugimsa. Pgave 
the relatively lower activity (2.7-4) against test bacteria used. The lower RF 
average values of 4.3,2.7,2.1, and 1.7 were demonstrated against C. albicans 
by K ,  P, D and CHX, respectively. 
Conclusions: Our experience demonstrates the plate suspension method to be 
convenient for routine biocide testing. All the examined antiseptics were quite 
effective to decrease considerably microbial cell count within 5 min-3 h. 
Ip1126/ Efficacy of two different disinfectants against the 
spores and vegetative cells of Bacillussubtilis 
H. S. Kasgar and A. Cotuk 
Istanbul, TR 
Objectives: Bacterial spores are highly resistant to inactivation by physical and 
chemical agents. Chemical sterilization agents are used in the healthcare 
setting to disinfect many medical instruments. Since Baciilus species has been 
noted to cause serious infections in hospitalized patients, the aim ofthe study 
is to investigate the effects of two traditional disinfectants Sirafan (quaternary 
ammonium compound) and sodium hypochlorite against the spores and 
vegetative cells of Bacillus sub& 
Methods: The efficacy of these disinfectants was assessed by using a suspension 
test (DGHM), whereas the effects of these disinfectants on biotilm cells of the 
same strain on silicon disks were determined by conducting a carrier test 
method. Then the findings were compared. A 0.1,0.5,1 and 3% Sidan, and 
0.005, 0.01, 0.02, 0.03 and 0.04% sodium hypochlorite were applied. The 
eradication was evaluated in regards to the concentrations ofdsinfectants and 
time of exposure. The effect of disinfectanB on the suspended spores and 
Vegetative cells of B. subrilis was investigated between 1 and 30 min, whereas 
the samphg was done between 1 and 60min for biofilms. 
Results: The suspended vegetative cells of B. subtilis were eradicated by 0.5% 
Sirafan within 20 min and spores within 30 min. The biofilm of spores and 
cells of B.subri1is were eradicated by 0.1% Sirdan within 60min. The 
suspended vegetative cells of B.subtilis were also killed by 0.01% sodium 
hypochlorite within 10 min and spores within 30 min by 0.02%. The biofilm 
of cells were eradicated by 0.01% sodium hypochlorite withm 45min, 
whereas the spores in b i o h  form were eradicated within 60min. 
Conclusions: The results yielded from the suspension and carrier tests reveal 
that the eradication of biofilm-forming cells and spores demands for higher 
concentrations of dlsinfectants and longer time of exposure. These fmdings 
suggest the necessity to count on biofilm test results concomitant to suspen- 
sion tests for reliable consideration. 
I PI127 I In vitro antimicrobial activity of Greek 7Bymus 
bee-honeys 
E. Chinou, N. Aligiannis, S. Karabournioti, A. Skaltsounis and 1. Chinou 
Piraeus, GR 
Objectives: As a part of a systematic research on the chemical composition 
and on biological activities of the famous, through antiquity, Greek honeys, 
and as it has been observed an increasing interest in its use in traditional 
Mediterranean food; we report in this study the antimicrobial activities of six 
Greek Thyrnw bee-honeys samples produced in six Herent regions of Greece 
as well as of a pure isolated compound (a trlhydroxy ketone) which was found 
to characterize the Greek thyme honey. 
Methods: Our six thyme-honeys samples were studied microscopically 
(pollen analyzes) and predominant plants found were of Thymus species, 
ranging from 41.28 to 83.79%. From the five out of six examined samples, a 
trihydroxy ketone was isolated and identified by modern spectral means (14 
2D NMR) as E-4-(1’,2’,4’-mhydroxy-2‘,6’,6-trimethylcyclohexyl)-but-3- 
en-2-one (1). The antimicrobial activities in all the studied samples and of 
pure isolated compound were determined, using the diffusion technique, by 
measuring the MIC of them against two Gram-positive bacteria: S. aureus and 
S.  epidermidis, four Gram-negative bacteria: E. coli, E. d o m ,  K .  pneumoniae 
and l? aemginosa and three pathogenic fungi Candida albirans, C. tropicalis and 
C.glabrata, all ofthem were strains of ATCC. Standard antibiotics were used in 
order to control the sensitivity of the tested organisms. 
Results: Through the antimicrobial screening, the thyme honeys as well the 
characteristic trio1 (1) isolated, &om five out of six studied samples, proved to 
be sigruficantly active against all six tested bacteria as well as the tested fingi 
(MIC values: 0.04-2.1 mg/mL.). 
Conclusions: The results of our studies suggest that the activity of the thyme 
bee-honeys can be attributed, to a considerable degree, to the existence of the 
isolated kihydroxy ketone, which appeared to possess strong activities against 
all tested microbia. Besides, as this compound appears to occur only in thyme 
honeys, hence may be served as proof of floral source for these honeys which 
command considerable market premiums in Greece. 
ml Activity of selected disinfectants against clinical 
strains of €nterococcus spp. 
J. Dlugaszewska 
Poznatf, PL 
Objectives: The ability of enterococci to prolonged survival on hands and 
environmental surfaces is a critical factor for transmission of these micro- 
organisms &om a person (patient or hospitals@ to the environment and then 
to another person. Thus, routine disinfection of environmental surfaces and 
handwashmg with an adequate agent is mandatory. The aim of this study was 
to asses the activity of common antiseptic/disinfectant agents used against 
E n t e r o c w  spp. strains isolated fiom hospitalized patients. 
Methods: Aldewir (glutaric aldehyde: 4.0g; ethanol: 26.0g; isopropanol: 
6.0 g), ftaloxid (magnesium monopetoxyphthalate; organic and inorganic 
acids; ammonium surfactants), terralin (akyldimethylbenzylammomium 
chloride: 20.0 g; phenoxypropanol: 35.0 g), chlorhexidine gluconate, ethanol 
and isopropanol were tested against five strains of E.faecalis and five strains of 
E.faedurm. The tests were carried out in accordance with European Standards 
(EN1040197). The reduction factor (RF) of the bacteria counts exposed to 
the agents was determined. 
Results: According to the European Standards, product shall demonstrate at 
least a 100 OOOlog ( R F  2 5) reduction in viable counts of bacteria. It was 
found that aldewir, ftaloxid, terralin at the concentration and time recom- 
mended by the manufacturer as well as ethanol and isopropanol at the 
concentration of 70% (v/v) and time of 60 s reduced all enterococcal strain 
cell counts by over 100000 (RF > 5). The activity of these agents did not 
decrease when they were tested at the lowered concentration of 20%. A 
4% (v/v) aqueous solution of chlorhexidine gluconate produced a >5 log 
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cell reduchon only for three of the 10 usmg strains Addihonally, the 
chlorhexldme gluconate was signtficantly less acme at the lowered determ- 
nahon concentrahon of 20%, RF for all tested st rams was <5 
Conclusion: Thus, it can be concluded that the dlsdectant based on glutaric 
aldehyde, magnesium monoperoxyphthdate, quaternary ammonium com- 
pounds as well as ethanol and lsopropanol show the required bactericidal 
achwty against china1 strains of enterococci, whereas aqueous soluhon of 
chlorhexldme gluconate have the achvlty lower than requned. 
I P I  129 I Old and new antiseptics against epidemic 
MRSA - are they effective? 
D. Morrison, Z. Al-Doori, B. Cosgrove, G. Edwards and C. Gemmell 
Glasgow, UK 
Objectives: Various antiseptic regimens are used to treat patients colonized 
with MRSA, however, treatment is not always successful. The objectives of 
Chts study were to determine whether treatment failure was due to reduced 
susceptibility to commonly used antiseptics and to investigate the effectiveness 
of two novel antiseptics. 
Methods: The MIC for triclosan and chlorhexidine of a collection of 232 
MRSA (72 EMRSA-15, 73 EMRSA-16 and 87 isolates of various other 
clones) isolated between 1997 and 2000 in 30 Scottish hospitals were tested 
using NCCLS criteria. The bactericidd activity of two commonly used 
antiseptic preparations, aquasept (2% triclosan) and corsodyl (1% chlorhex- 
idine), was compared with that of two 'novel' antiseptics, Tea Tree Oil 
(Thursday Plantation) and Topro Aloe Vera (Alliance Products) against 
EMRSA-15, EMRSA-16 and six other Scottish MRSA (SMRSA) clones 
using a quantitative suspension test method based on the European Standard 
EN1040. 
Results: The MICqo of triclosan and chlorhexidine was 0.06 and 2 pg/mL, 
respectively, for EMRSA-15 and 0.03 and 2pg/mL, respectively, for 
EMRSA-16. The majority of other Scottish MRSA clones were relatively 
sensitive, except for SMRSA99 (Iberian clone) and SMRSA117 which had 
triclosan MICgo of 1 and 4 pg/mL, respectively, and chlorhexidine MICgo of 
4mg/mL. In quantitative suspension tests, aquasept and coaodyl antiseptics 
gave complete kill of all eight clones at 30s contact time. The bactericidal 
activity of Tea Tree Oil varied between Merent clones, however, complete 
kill (5 log reduction) was acheved for all clones after 30 min of contact time. 
Topro Aloe Vera gave a 2 log reduction at 30 s contact t h e ,  however, no 
further reduction was observed over a period of 6 h. 
Conclusion: These results indicate that the antiseptics commonly used in 
hospitals have excellent activity against epidemic MRSA clones and that the 
'novel' antiseptics, although not showing the same level of effectiveness, may 
be useful alternatives. 
[p11301 In vitro susceptibility to antimicrobial agents 
and disinfectants of group G streptococci 
A. Coli, G. Brigante, V Orlandi, R .  Belloni, G. Lombardi and 
A. Toni010 
lhrese, I 
Objectives: Group G streptococci (GGS) are isolated from different body 
sites, most commonly oro-pharyngeal, respiratory tract, and wound infec- 
tions. Over the last year, GGS accounted for the 8.4% of strains isolated from 
skin lesions at the Center for Wound Infections of Varese, Italy. Due to the 
increase of severe infections caused by GGS, we evaluated the in vitro 
susceptibility of these microorganisms to several antimicrobial agents and 
disinfectants. 
Methods. Over a 1-year period (November 2000-0ctober 20011, we 
collected 20 GGS clinical isolates. Particularly, strains were recovered from 
wounds (lo), oro-pharyngeal swabs (3, urinary tract (2), blood (2), and nasal 
swabs (1). Nine antibiotics, including ampicillin, vancomycin, ciprofloxacin, 
levofloxacin, chloramphenicol, erythromycin, clindamycin, cefotaxime and 
tetracyclines, were tested by means of both disk difhsion test and micro- 
dilution broth panels (Sceptor, Becton Dickinson, Sparks, MD). In addition, 
the strains isolated from wound infections were tested against five topic 
disinfectants, including chlorhexidine gluconate, merbromine, povidone 
iodine, silver nitrate and toluen-p-sulfochloramyde. 
Results: All strains were susceptible to ampicillin, vancomycin, ciprofloxacin, 
levofloxacin, chloramphenicol, erythromycin, clindamycin and cefotaxime. 
On the contrary, only 8/20 GGS showed fkll susceptiblltty to tetracyclines. 
Among tested drugs, penidin, ampicillin, cefotaxime, and clindamycin 
showed the lowest MIC9" with values of 0.06, 0.12, 0.25, and 0.25mg/L, 
respectively. Tetracycline was the least-active drug, being characterized by a 
MICw of 8mg/L. Susceptibikty to disinfectants showed high variabihty, 
MBC9Os ofchlorexydine gluconate, silver nitrate and merbromine were 0.01, 
0.01, and 0.02 g/L, respectively. MBC90s of povidone iodine and toluen- 
psulfochloramyde were 9.4 and 6.3 g/L, respectively. 
Conclusions: Our study demonstrates that various antimicrobials and disin- 
fectants are available for the treatment of tolerant organisms like group G 
streptococci. However, some patients resulted repeatedly positive for GGS 
regardless of an appropriate therapy. This finding suggests difticulties in 
eradicating infections, perhaps because these drugs fail to reach therapeutic 
levels at the site of infection. Finally, since few isolates were from blood 
cultures, an epidemiologic survey for GGS is very important in order to avoid 
spreading of drug resistances. 
Ip1131/ Antimicrobial activity of A//iumsativum L. 
M. Cuciureanu, A. Poiata, R. Cuciureanu and C. Tuchilus 
lasi, RO 
Introduction: Traditionally, garlic was used for centuries for dietary and 
medical properties. Organosulfur compounds and other secondary metabo- 
lites of garlic may by responsible for therapeutic effects. 
Objectives: To investigate the antimicrobial activity of fiesh garlic juice, 
aqueous and alcoholic extracts against different microbial species. 
Methods: Antibacterial activity of garlic was tested by diffusion method in 
Mueller-Hinton agar. Different Gram-positive and Gram-negative strains, 
sensitive or multiresistant to antibiotics, were included in the study. Plates 
were inoculated with bacterial inocula according to the standard antibiogram 
procedure. Garlic samples were poured into the holes and the diameters of 
growth mhibition were measured after 24 h ofincubation at 37 "C. The active 
substances were analyzed by gas chromatography and mass spectroscopy. The 
compounds were identified by comparing the mass spectra and retention 
indices with those in the literature. 
Results. Garlic juice showed antimicrobial activity against all tested strains 
with the exception of Pseudomanas uenrginosa. The diameters of zones inhibi- 
tion (mm) are followed Staphylococcw a u w  ATCC 25923: 40; Saro'na lutea 
ATCC 9341 : 34; Bacillus cereus: 30; Escherichia coli ATCC 25922: 25; E. coli and 
Salmonella spp., extended-spectrum 8-lactamase producers: 24 and 25, respec- 
tively; Candidaalbicans: 45. These values are sigtllficantly more hgher that 
those obtained with both aqueous and alcoholic extracts. 
Conclusions: Garlic juice exhibits a broad antimicrobial activity against Gram- 
positive and Gram-negative rods. Organisms that are multiresistant to anti- 
biotics are susceptible to garlic. Among tested strains, only Z? amginosa showed 
resistance to garlic. 
w] A new procedure for the complete removal and 
the prevention of regrowth of biofilms in 
hemodialysis machines 
K. Ferey, M Pasmore, G Husson and J Costerton 
Pans, F, Bozeman, USA 
Introduction: Bacteria are known to attach to surfaces and create biofilms 
B i o h  have been found in flmd pathways of hemodlalysis systems, mostly 
inside slltcone tubmg of dlalysis machmes These biofilms release bacterial 
pyrogens that can cross the ddysls membrane and induce chromc d a m -  
matory disorders to pahents in dlalysis 
Objectives: Each of the pharmaceuhcal firms producing ddysis machines 
recommend a Werent cleatung procedure and the lack of hterature about 
their achon on biofilms led us to perform research studles to d e t e m e  thelr 
efficacy on remomg exlshng blofilms and on prevenmg further growth in 
order to gve scien&ic arguments to dlalysis area pmfwionals. 
Methods: The eight most commonly used cleanmg procedures were tested on 
b i o h  that were grown on s h o n e  tubing m a reactor system that m c s  
dlalysis machmes The first biofilm was grown wth  the addmon of supple- 
mentary numents. The second biofilm was thinner and was p m  wthout 
addihonal nutrients. The efficacy of the cleaning procedures was assessed on 
biofh-fouled tubing samples in a close recirculahng cleanmg model. To 
study the preventlve efficacy of those procedures, another model was set up m 
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which a contaminated media circulated for 4 h through the tubing and was 
then replaced by the cleaning chemicals every 4 h, until a mature biofilm 
develops on the control samples. Biofilm analyses were performed using 
staining methods and confocal microscopy, allowing the calculation ofbiofilm 
thickness and coverage. Then, the biofihn was removed using a mechanical 
scraper, the number of culturable bacteria was evaluated by plate counts on 
M A  medlum and the endotoxin level was measured using the LAL assay. 
Results The most efficient cleaning procedure was a citric acid pretreatment 
followed by the autoclaving of the tubing. However, of the Merent 
procedures tested, none led to the complete removal of the biofilms. For 
this reason, we performed a screening of about 70 combinations of 13 other 
chemicals that led to the development of a very promising new cleaning 
procedure, allowing the complete removal of the biofilm and an excellent 
prevention of regrowth. 
Conclusions: Further studies will improve and vhdate this new procedure in 
order to allow its marketing. That way, the microbiologic quality of dialysis 
liquids might be improved, increasing their biocompatibility and therefore the 
quahty of life of dialyzed patients. 
1 In vitro activity of topical disinfectants against 
bacteria isolated from wounds and diabetic ulcers 
V Orlandi, A. Bettaccini, A. Endimiani, G. Brigante, A. Coli and 
A. Toni010 
Varese, I 
Objectives: The choice of topic dismfectants to treat skin lesions is an 
important option of the infection control team. In order to help clinicians 
in choosing the most appropriate treatment, we wanted to assess: (i) the 
incidence ofmicroorganisms isolated &om wounds and habetic ulcers: (ii) the 
activity of topic disinfectants against infecting bacteria; (iii) the relation 
between efficacy of disinfectants and resistance to antimicrobial drugs. 
Methods: Bacterial identification and antimicrobial susceptibility testing were 
performed by the Sceptor System (Becton Dickinson, Sparks, h4D). Suscept- 
ibility to topic disinfectants was assayed by homemade broth microdilution 
panels. Particularly we studied the activity offive compounds as representative 
of dfierent classes, including chlorhexidine gluconate (CG), povidone iodine 
(PI), toluen-p-sulfochloramyde (TS), merbromine (M), silver nitrate (SN). 
Minimum bactericidal concentration (MBC) was determined in 96-well 
plates, ranging fkom undiluted concentration (CG, 5 g/L; PI, 75 g/L; TS, 
25g/L; M, 20g/L; SN, 3g/L) to 12 two-fold dtlutions. 
Staphylococcus aureus 
Results: Over a 1-year period, 146 specimens gave a positive result; of them, 
66 showed two or more infectious agents for a total of220 isolates. The most 
prevalent species were Staphylococcus aureus (n = 62, 28%), Psardomonacam- 
ginosa (n=46,21%), Droteusmirabilis (n=29, 13%), and group G streptococci 
(n = 18,8%). The resultingMBC90 (g/L) forthe threemajor pathogens were, 
respectively: for S. a u m  (CG, 0.16; PI, 9.4; TS, 6.3; SN, 0.2; M, 0.08); for 
I? aefuginosa (CG, 0.31; PI, 37.5: TS, 6.3; SN, 0.0015: M, 0.01); for I! mirabilis 
(CG, 2.5; PI, 19; TS, 3.1; SN, 0.02; M, 0.08). Resistance to oxa& was 
detected in 47% of S.  uureuc isolates. Resistance rates of I? Aemginosa were as 
follows: gentamicin, 27%; ceftazidime, 27%; imipenem, 10%; and amikacin, 
10%. Finally, i? rnirubilis strains showed resistance to gentanlicin in 38% of the 
cases, but maintained full susceptibility to ceftazidime, imipenem, and 
amikacin. A few cases showed both a multidrug-resistant phenotype and 
resistance to three disinfectants. 
Conclusions: Our study demonstrates that merbromine has the highest in 
vitro activity against all tested bacteria, but silver nitrate is a valuable option. 
Finally, high resistance rates to antibiotics suggest an appropriate antibiotic use 
in order to adequately treat skm lesions. 
Antimicrobial activity of betadine disinfectant 
agent against multiresistant nosocornial pathogens 
A. Samet, M. Bronk, J. Kur and L. Naumink 
Gdansk, PL 
Objectives: Antimicrobial activity of the betadine disinfectant against the 
clinical multiresistant strains was examined. The 27 isolates, Staphy~ococ~s aur- 
eus (three MRSA), E n @ ~ ~ ~ ~ c c ~ s f a e ~ a l i s  (three HLAR), E.faecium (three VRE), 
Pseudomonac amginosa (three), Acitzetobucter baumannii (three), EnterobactercJou- 
cae (3), Serratia mawcens (three), MehielIapneumoniae (three ESBLf), 
Eschericha coli (three ESBL+), were tested for antimicrobial effectiveness in 
the standardized betadine solution. 
Methods: Antimicrobial effectiveness was examined by a suspension method. 
The initial suspension containing 108 &/& were prepared with tryptose 
soy broth and added to a disinfectant sample. In the assay, the disiiectant 
activity was arrested by neutralization after 1 min contact time. Disinfectant is 
considered to be bactericidal when a >5 log reduction is achieved. 
Results: The initial suspensions of all strains and the reduction achieved by 
disinfectant were (1.12-2.78) x lo7 and (0.275-1.92) x 10Zch/mL. The 
reduction achieved a >5 log. 
Conclusion: Betadine bactericidal effectlveness against multiresistant clinical 
bacterial strains is high and species independent. 
The clonal spread among Swedish children of a 
Staphy/ococcus aureus resistant to fusidic acid 
A. Osterlund, T. Ed&, B. Olsson-Liljequist. S. Haeggman and 
G. Kahlmeter 
Nine microbiological laboratories in Sweden 
Objectives: 
1 To investigate the epidemic spread of a S. aureiu resistant to fusidic acid in 
2 To investigate the clonality of fusidic acid resistant S.uureus-isolates in 
3 To investigate the use of fusidic acid in ointments in Sweden over time. 
Methods: 
1 A retrospective survey using data from laboratories in eight Swedish 
2 A prospective study using PFGE to fingerprint fusidic acid resistant 
3 A retrospective analysis of the sales of ointments containing fusidic acid in 
Results: In all counties with available laboratory data, S. aureus resistant to 
hsidic acid were more common among strains isolated &m patients in the 
age group 0-12 years than those &om older patients (Table 1). The resistant 
S. aureuc seemingly appeared in the county ofBlehge  first, and subsequently 
(1998 or later) spread to other parts of Sweden. PFGE-patterns indicate the 
domination ofa single clone. During the period 199%2000, theyearly sales of 
superficial infections among cM&n in Sweden. 
superficial infections among Swedish children. 
counties. 
S. auras-isolates &om the different counties. 
Sweden during the period 1993-2000. 
ointments containing hsidic acid increased from 4 to 12g per 1000 inha- 
bitants in the age group C-12 years and M g  in the age group 13years and 
older. The sales varied considerably among the counties. 
1997 1998 1999 2000 
Skine county 
Blekinge county 
Krotioberg contry 
Kalmar county 
JGnkoping county 
Vastra Goraland county 
Dalarna county 
Norrbotten county 
Proportions, in percentage, of s. i u w  isohtes &om patients G12years resistantG 
fusidic acid in eight Swedish counties. Numbers in brackets are the corresponding 
figures &om the age group 13yem and older. 
Conclusions: The apparent clonal spread of a S. aureus resistant to fusidic acid 
among children throughout Sweden is described. Irrespective of whether the 
increase in the use of fusidic acid ointments was caused by the epidemic per se 
or by the concomitant withdrawal h m  the market of a major alternative 
drug, the increase in the use of fusidic acid to which the clone was resistant 
facilitated the epidemic. 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 259 
Ip11361 Typing of Staphy/ocmcus aumus isolates from 
bovine mastitis by coagulase serotying and coagulase gene 
polymorphism (PCR-RFLP) 
F A Abdul-Salam, R A. Cheema and E E Udo 
Safat, K W T  
Objectives: To type S aureus isolates &om bovme rnashhs m Kuwat by 
coagulase serotyping. and PCR-RFLP of the coagulase gene 
Methods: One hundred and sutteen S. aweus lsolates were collected from mdk 
of mashtic cows m 12 h r y  farms in Kuwatt and studied for their relatedness 
usmg coagulase serotyping and coagulase gene polymorphsms Coagulase 
serotyping was performed using coagula?e antisera (Denka Selken) accordmg 
to the manufacturer’s instruchons. The coagulase (coa) gene polymorplusms 
was determmed by the amphficahon of the 3’ end regon of the coa gene by 
PCR usmg COAG2 and COAG3 primers followed by AluI restrichon 
endonuclease dtgeshon and analysis of the restnchon fiagment length poly- 
morphsm (RFLP) patterns of the amphfied products by agarose gel electro- 
phoresis. 
Results: S x t y  (51.7%) ofthe isolates were nontypeable by any ofthe coagulase 
antlsera However, 56 (48 3%) isolates were dtfferentuted mto seven coagulase 
serotypes. Coagulase serotype VI was the commonest serotype and was 
detected 30 (25 9%) isolates. Coagulase serotypes 111 and V were detected 
in STX isolates (5 2%) each and coagulase serotype VII was detected m seven 
(6%) isolates. Coagulase serotypes I, I1 and N were less frequent and none 
belonged to coagulase serotype VIII PCR arnplhcaaon of the coil gene gave 
PCR products of 714, 825, 861 and 987 bp m size. Five coa gene RFLP 
patterns One RFLP pattern 1 was domnant and was detected m 101 (88%) 
isolates in all 12 farms The rest belonged to four RFLP patterns 
Conclusion: Results of coa gene typing suggested that the majonty of the 
S aureus isolates from all the farms had a common origm. However, there was 
no correlanon between results of coagulase serotypmg and coa gene typmg. 
The coagulase serotypmg was not use& as a typing tool for studymg S. nureus 
of a n d  orign PCR-RFLP represent5 a valuable typing tool for assessmg 
the relatedness of bactenal lsolates 
Ip1137/ Antimicrobial susceptibility of Staphylococcus 
aureus strains isolated from 16 patients with a PFGE 
confirmed relapsed bacteremia 
0 Oregom, T. Fosse, C. Gmud-Moriii, E Bernard and V. Blanc 
Nice, Antibes, F 
Objectives: To idenhfy anmcrobid suscephbhty changes between meal 
and second episode stmns isolated from S. a u w  bactererma wth a relapse 
confirmed by pulse field gel electretrophoresis (PFGE). 
Methods: From 1997 to 1999, we idenafied retrospechvely 40 pahents w th  a 
recurrent S aureus bactererma Patlent file records were analyzed and PFGE 
was performed on isolates &om both episodes PFGE bandmg patterns were 
idenhcal m 16 paoents, consistent wth a relapsed mfecnon. Anubiograms 
were performed by the &ion method M e t h l c h  resistance was screwed 
by the oxascreen test and confirmed by the latex h4RSA or m e 4  PCR. 
Screemng for hGISA and GISA ( s t r a m  wth reduced suxephbhty to 
Vancomycin) was done by culture of strains on plates containmg 6mg/L 
of vancomycm and MIC E-test determnanon. 
Results: Ilutlal stratns demonstrated the follonrlng annbioac reslstances (N, 
%) pemcdhn (16, loo%), oxacdhn (7, 44%). gentarmcln (1, 6 2%), erythro- 
mycin (7,44%)), fosfomcm (2,12 S%), pefloxam (6,37.5%). No resBtance to 
cotrimoxazole, rifampin, fusi&c acld and glycopephdes was observed The 
second s a a m  was isolated 11-137 days afrer apparent resoluhon of the first 
epaode. Acqwed resistance was observed for seven patlents 
resistance to rifamp1an for one pahent and to fusidic aad for another 
low level pefloxacin resistance (MICs 2-4 mg/L) for two pahents wluch 
change m glycopephde suscephbhty for three paaents (1 MSSA/2 R?RS& 
Most pahents presented risk factors for early relapses such as mdwelhg 
foreignbady (14,87.5%), excessive tune to imhal anhbiohc therapy (5,31%) 
and hemodldysu dependence (5, 31%) 
panent, 
received only a 2-day Buoroqunolonc treatment; 
MICs 6 8  mg/L) afier ltutlal glycopeyude treatment. 
Conclusion: These results suggest that early relapse S. aureus bacterema could 
be associated with an antimicrobial susceptibility changes without initial 
treatment failure. ParhCUlar attenhon should be focused on low level resis- 
tance to g€ycopephdes and fluoroqumolones. 
(p11381 investigation of vancomycin resistance among 
Staphylococcus aureus isolates at a university hospital 
H. Arslan, A Azap, F Ergm and E Kuru Inci 
Ankara, 77t 
Objective: To evaluate vancomycm resntance among Staphybcocm aureuz 
lsolates obkuned f b m  n o s o c o d  lnfechons at a uversity hoqxtal. 
Methods: One hundred forty-five isolates collected over a penod of 
lomonths in 2001 were exarmned. M e h d h n  semhwty was detected mrh 
1-pg-oxacdhn dsk. Of the isolates tested, 67 were methciUm-resntant. In- 
house-prepared bmn heart h i o n  agar (BHIA) plates contaming 6pg of 
vancomycm per mL. were used for screemg. Plates moculated mth 10 pL of a 
suspension of each mlate equvalent m demty M a 0.5 McFarland standard 
and mcubated at 35 “C were exarmned for mwtb after 48 h. Entenuoms 
faecnhs ATCC 51299 (vancomycm resistant) and S . a u w  ATCC 29213 
(vancomycm suscephble) were mcluded as quahty-control orgamsms. 
Results: Thrty-four of the 145 S. aureus lsolates were blood nolates, 26 were 
respiratory system Isolates, 18 were conhnue ambulatory peritoneal ddysate 
isolates and 18 were urinary system isolates. No growth other than E.faecalrs 
ATCC 51299 was detected on BHI agar plates conmmng 6 pg ofvancomycin 
per mL. 
Conclusion: Baskent Umversity Hospital is a 300-bed, terhary care hospital 
with most of its paaents are on hemoddysis or conhnue ambulatory 
pentoneal Qalyus (CAPD) program because of renal Mure and at whch 
appro-tely 80 krdney transplantations are performed annually. Annual 
vancomycln consumpaon at the hospital is 5000 g. Despite large amount of 
vancomycm use m high-nsk pahent p u p ,  no vancomycm resistant S a u 7 m  
isolate was detected. As these results demonstrate vancomycin resistance of 
S aureus lsolates IS not yet an important problem for our hospital. 
v1 The biological cost of antibiotic resistance from 
the perspective of Staphylococcus aureus 
T. A. Wichelhaus, B. Boeddinghaus, S. Besier, V. Schaefer, V. Brade and 
A. Ludwig 
Frankfurt am Main, D 
Introduction: Antibiotic resistance due to chromosomal mutations that cause 
structural modifications in the cellular target of the drug can be associated 
with a fitness burden. 
Objectives: This study was aimed at analyzing (i) the biological cost of RNA 
polymerase (tpoB) mutations conferring rifampicin resistance on S. sureus (ii) 
the relationship between the cost of ‘ ~ o B  mutations and the level of mistance 
to rifampicin (iii) the distribution of rpoB mutations in vivo in view of the 
possible fitness burden associated with resistance. 
Methods: A total of 54 S. aureus isolates was analyzed including 30 rifampicin 
resistant in vitro mutants derived from a single susceptible isogenic reference 
st ra in  as well as 23 rifampicin resistant in vivo isolates obtained 
f b m  six countries revealing 19 different PFGE genotypes. Mutations con- 
ferring rifvnpicin resistance were determined by partial DNA sequencing 
of the rpoB gene includmg resismce cluster I and 11. The relative fitness of 
the dampicin susceptible parent strain and the evolved rifampicin 
resistant in vitro mutants was determined from pair-wise competition experi- 
ments. 
Results: With respect to invitro mutations conferring r ibp ic in  resistance 18 
Nerent rpoB genotypes could be identified. Only one genotype H481A 
showed no fitness burden whereas the other mutants were associated with a 
loss of fitness. A relationship between the cost of rpoB mutations and the level 
ofresistance to rifmpicin could not be demonstrated. Interestingly, 23 in vivo 
strains exhibit only seven Merent rpoB genotypes with mutation H481A, 
demonstrably not associated with a cost of fitness in vim, being prevalent in 
91% of isolates. 
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Conclusions: In vivo S. aureur adapt to the burden of resistance by the 
selection ofmutations with little or no cost to their fitness. This phenomenon 
possibly is responsible for stabilizing the resistant bacteria in a population. 
IP1140] Nationwide laboratory surveillance for 
Staphyrcoccus aureus with reduced susceptibility to 
vancomycin in South Korea 
Y. S. Lee, S. U. Kwon, S. H. Jeong, J. K. Lee, J. I. Yoo, H. B. Kim and 
K. W. Lee, B. S. Kim 
Seoul, KOR 
Background and objectives: More than 70% of S, aureus isolated in tertiary 
hospitals in Korea were reported to be methicillin-resistant. And so glyco- 
peptide antibiotics has been increasingly used for the treatment ofmethicillin- 
resistant S.aureus (MRSA) infections. To evaluate the current status of 
S. aureus with reduced susceptibility to vancomycin, we have done labora- 
tory-based surveillance. 
Methods: During the period from April 2001 to May 2001, 3746 MRSA 
isolates from 27 tertiary participant hospitals were screened on brain-heart 
infusion agar containing 4 pg/mL of vancomycin (BHI-4 agar). The mini- 
mum inhibitory concentrations (MICs) of vancomycin were determined 
by agar diiution, broth ddution and E-test methods. To detect the 
strains heterogeneously resistant to vancomycin (hetero-VRSA), population 
analysis and growth on BBL(R) MU 3 agar (Becton Dickinson, Japan) were 
done for the isolates grown on the BHI-4 agar. PFGE (Pulsed-field gel 
electreophoresis) was performed for molecular epidemiological analysis of 
isolates. 
Results: Total 100 (2.7%) isolates grew confluent on the screening agar. None 
of them showed resistance to vancomycin. and vancomycin MICs for 15 
isolates revealed 4 pg/mL by above mentioned methods. In these 15 isolates, 
only four contained resistant subpopulations similar to Mu3 strain, firstly 
identified hetero-VRSA. In 16 isolates, however, were suspected to be 
hetero-VRSA on BBL(R) MU 3 agar. Among 100 isolates, 40% differed 
h m  AMC 11094, first VRSA h m  Korea, by only one to three band on 
PFGE . 
Conclusions: Despite high prevalence of MRSA in Korea, none of S. uureur 
isolates were resistant to vancomycin and less than 1% (4-16/3746) were 
heterogeneously resistant to vancomycin. But PFGE analysis suggested the 
possibility of re-emergence of VISA in Korea. This alerts us to the possibility 
emergence of VISA/VRSA and to need of necessary to periodic surveillance 
for VRSA. 
I P11411 Antimicrobial resistance of Staphy/ococcus 
aureus clinical isolates from a Greek hospital during 
a 3-year period 
M. Pouyiouka, V. Karabassi, V. Scandami, M. Toutouza, A. Petrohilou. 
M. Miari and C. Kontou-Castellanou 
Athens, CR 
Objectives: To study the antibiotic resistance of Staphylococcus uureus (SA) 
isolated from a Greek major hospital within a 3-year period. 
Materials and methods: During a 3-year period (1998-2000) a total of 599 
clinical isolates of Sfaphylocmus aureus were collected from patients treated in 
our hospital. The strains were isolated from blood cultures (22%). catheter tips 
(8.5%), bronchial cultures (15%) and from other sources (liquids, wounds, 
etc.) (54.5%). Of these isolates 75 (12.5%) were derived from the Intensive 
Care Unit (ICU) and 504 (87.5%) fiom the rest ofthe hospital. Isolates were 
identifed as SA by a positive catalase test, a positive coagulase test and a 
positive nuclease test. Susceptibility to antibiotics was detected by the 
diffusion method according to NCCLS guidelines. 
Results: Of the strains tested 252 (43.5%) were methicillin susceptible (MSSA) 
and 327 (56.5%) were methicillin resistant (MRSA). The percentages of 
resistance to antibiotics (except 8-la.t.mS and glycopeptides) for MRSA and 
MSSA were, respectively: Gentamicin (GM) 80-10%. Amikacin (AN) 73- 
17%. Ciprofloxacin (CIP) 80-6%, Erythromycin (E) 82-18%, Chdamycin 
CM 767%. Of SA from ICU 93% were MRSA while h m  the rest wards 
51% were MRSA. The percentage of resistance for MRSA s h s  derived 
&om ICU and from the other wards were, rmpectively: GM 99-75%, AN 99- 
67%, CIP 97-76%, E 9&79%, CM 96-70%. 
Conclusions: It is worth notmg that: MRSA isolated from ICU were much 
more resistant, with the exception ofglycopeptides than MRSA from the rest 
of the hospital. The prevalence of Methirillin resistance and associated 
multiresstance in SA has increased s~pficantly during the 3-year study 
period. AU isolates were sensiuve to vancomycin. 
[p1142/ Antibiotic susceptibility of staphylococci 
(including MRS) isolated from hospitalized children 
J. Ruczkowska, I. Doha, B. Kowdska-Krochmal and I. Choroszy-Khl 
Wrodaw, PL 
Objectives: The aim of present study was the analysis of drug susceptibility of 
staphylococci (including MRS) isolated from children hospitalized in two 
pediatric clinics in 1998-2000. 
Material and methods: Antibiotic (n = 9-10) susceptibility of 501 staphy- 
lococcal strains isolated h m  various clinical materials was determined by the 
disc a s i o n  method (NCCLS). Among tested strains there were 277 isolates 
(107 S. aureus and 170 CNS) h m  pediatric surgery (S) and 224 (43 S. aureus 
and 181 CNS) from pediatric nephrology (N) patients. 
Results: All staphylococci were susceptible to vancomycin and teicoplanin 
(strains from urine also highly to nitrofurantoin). S. aureus strains were more 
susceptible than CNS to: erythromycin, clindamycin, gentamicin and cotri- 
moxazole. There were also differences in antibiotic susceptibility of the staph 
isolates from S and N, especially to erythromycin, clindamycin, doxycycline, 
gentamicin, cotrimoxazole and fluoroquinolones. Penicillim was practically 
ineffective. A t o d  of 209 (42%) out 501 were MRS strains (62% b m  S and 
38% fiom N). MRSA and MRCNS strains from S versus N constituted 23 
and 62% versus 19 and 39%, respectively. MRS strains from S and N were 
susceptible to glycopeptides ( l W ? ) ,  highly resistant to erythromycin (85 and 
75%), clindamycin (a 74%), gentamicin (68% S), cotrimoxazole (60 and 61%) 
and less resistant to doxycycline (38 and 45%). gentamicin (38% N) fluor- 
oquinolones (43 and 23%). 
Conclusion: S. aureus in comparison to CNS strains were more susceptible to 
the majority of 10 antibiotics. MRS strains (constituting 42%) were isolated in 
prevalence &om children in S. Only glycopeptides were active against 100% 
MRS strains, while against over 60% fluoroquinolones and gentamicin (strains 
from N) and doxycycline (strains from S ) .  
Ip11431 Clinical implications of ~taphy/ococcus aureus 
with reduced susceptibility to vancomycin 
H. B. Kim, S.  U. Kwon, Y. S. Lee, B. S. Kim, M. Oh and K. W. Choe 
Seoul, KOR 
Objectives: Rapid evolution of antibiotic resistance in S. aureur, including 
recent emergence of vancomycin-intermediate S. aureus (VISA), has been a 
serious concern. Infections of VISA and S. aureus with vancomycin MIC 
(minimum inhibitory concentration) of 4pg/mL were reported to be the 
causes of treatment failures. To understand the clinical characteristics of 
infections with these strains, we reviewed the clinical characteristics of the 
patients infected with S. uureus with reduced susceptibility to vancomycin. 
Methods: Clinical isolates of S. aureus were screened for reduced susceptibility 
to vancomycin. One hundred isolates of possible VISA, which grew con- 
fluently on brain-heart infusion agar containing 4 pg/mL of vancomycin, 
were referred to the National Institute of Health for confirmatory testing 
during the period h m  April 2001 to May 2001. Out of 100 isolates, 15 
revealed vancomycin MIC of 4 pg/mL by agar dilution, broth dilution or E- 
test methods. Among them, four isolates were ascertained to be colonizers, 
not pathogens. The clinical characteristics of the 11 patients were analyzed 
retrospectively. 
Results: The median age of the patients was 52 (11-74) years, and nine were 
male and two were female. Types of S. aureus mfection included six chronic 
osteomyelitis, two postsurgical infections, one pneumonia, one intra-abdom- 
inal infection, and one catheter-related infection. While one case had no 
history of prior exposure to glycopetides, 10 were exposed for a prolonged 
period of time, ranging from 7 to 432 days. Despite adequate treatments, site 
of infections became culture negative in only one case. Two patients died of 
S. aureus mfections. 
Conclusions: Chronic osteomyelitis was the most common type of S. aurercr 
infection with reduced susceptibility to vancomycin. Most infections due to 
S. artreus with vancomycin MIC of 4 pg/mL were not successfuuy treated. 
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Prolonged exposure to glycopeptides was associated with the emergence of 
S. aureus with reduced Susceptibility to vancomycin. 
CIP and LEV. MIC90 to CIP and LEV were the same. However, MOX and 
LEV had a reduced activity against nonsusceptible to CIP MRSA isolates. 
v/ In vitro antimicrobial susceptibility of S. aumus 
in suspensions, biofilms and resuspended biofilms 
T. Kanchanapoom, S. Starks, W. Jackman and N. Khardori 
Springtield, USA 
Objectives: Device-related infections are difEcult to treat and can become 
persistent infections because of the b i o f h  mode of bacterial growth. Once 
b i o f h  dislodge and enter the bloodstream, they can cause systemic infec- 
tions. Diagnostic microbiology laboratories test and report susceptibilities of 
bacteria in suspension (planktonic bacteria). However, the susceptibilities of 
the biofilms are not done. 
Methods: We tested the susceptibilities ofthe b i o f h  of 10 clinical isolates of 
S. aureus to oxacillin, synercid and vancomycin. The suspension bacteria were 
tested using broth microdilution technique (NCCLS, M7-A5). The b i o f h  
were grown in 96-well mimtiter plates by culturing 1 x lo6 to 2 x lo6 du/mL 
in 200 pL of TSB for 24 h. Plates where then washed twice with PBS and 
100 pL of TSB was added. 100 pL of the antimicrobial agents were added at 
concentrations of 50,500 and 1000 pg/mL and at the MICw. The microtiter 
plates were incubated for 24 h to allow interaction between the antimicrobial 
agents and the bacterial biofilms. Colony counts on serial dilutions were used 
to calculate percent viability. In parallel experiments, the b i o f h  were 
resuspended (disrupted) prior to the addition of the antimicrobial agents. 
Results: The MIC90 of oxacillin, synercid and vancomycin in suspension were 
0.25,0.5 and 8 pg/mL, respectively. The mean percent viability of biofilms in 
the presence of oxacdin at 0.25,50, 500, 1000 pg/mL were 25.8,35.7,43.0 
and 23.5%, respectively, compared to 39.7,7.04,45.4 and 8.37%, respectively, 
for resuspended b i o f h .  The mean percent Viability of biofilms in the 
presence of synercid at 0.5, 50, 500 and lOOOpg/mL were 17.6, 4.9, 22.6 
and25.1%, respectively, compared to 12.7, 19.2,0.79 and 25.5%, respectively, 
for resuspended b i o f h .  The mean percent viability of b i o f h  in the 
presence of vancomycin at 8, 50, 500 and l000pg/mL were 100, 53.3, 
15.3 and 7.43%, respectively, compared to 100, 15.2, 22.3 and 22.3%, 
respectively, for resuspended b i o f h  
Conclusion: The routine susceptibility testing using bacterial suspensions 
(planktonic mode ofgrowth) does not predict susceptibilities ofbacteria in the 
biofilms (sessile mode of growth). 
ml Comparative activity of old and new quinolonss 
against nosocomial Sraphykmcus aureus 
V. Kretchikov, A. Dekhnich and L. Stratchounski 
Smolensk, RUS 
Objectives: To compare in vitro activity of an old quinolone-ciprofloxacin 
(CIP), which is known to have a deficient activity against Gram-positive 
bacteria with new quinolones-levofloxacin (LEV) and moxifloxacin (MOX), 
which combine good Gram-negative activity with enhanced Gram-positive 
activity. 
Methods: Overall, 140 S. aureus isolates obtained from hospitalized patients in 
Smolensk (Russia) were studied. MICs to CIP, LEV, MOX and Oxacillin 
(OXA) were determined by agar dilution method. Interpretation of results for 
OXA, CIP and LEV were pefiormed according NCCLS recommendations 
(2001). Intermediately resistant and resistant strains were considered as non- 
susceptible. The S. aureus ATCC 29213 was used as a control strain. 
Results: Among 140 isolates tested, 77 (55%) were methi&-resistant 
(MRSA). MOX was the most active agent with MfCw=0.125mg/L 
compare to O.Smg/L for CIP and LEV. The MICsO, MiC90 and MICs 
ranges are shown in the table. The MICs of tested quinolones for methicillin- 
susceptible strains (MSSA) and MRSA were the same with the exception of 
for MOX-0.125 mg/L for MSSA and 0.06 mg/L for MRSA. Against 
ciprofloxacin-susceptible MRSA the following MICgo (MICs ranges) were 
observed 0.5 (0.125-0.5) for CIP, 0.25 (0.125-0.5) for LEVand 0.06 (0.03- 
0.06) for MOX. Against nonsusceptible to CIP MRSAstrains (10.4%) MICw 
(MICs ranges) were: 1 (0.5-4) for LEVand 0.25 (0.125-2) for MOX. Among 
all isolates only one strain was intermediately resistant to LEV (MIC = 4 mg/L), 
resistant to CIP (MIC = 16 mg/L) and had MIC = 2 mg/L for MOX. 
Condusions: According to the above data MOX is a potent agent against both 
methicillin-susceptible and -resistant S.  aureus. MOX was more active than 
Antimicrobials MI650 (mg/L) MI% (mg/L) MIC range (mg/L) 
MSSA (N=63) 
CIP 0.5 0.5 0.25-1 
LEV 0.25 0.5 0.125-0.5 
MOX 0.06 0.125 0.03-0.25 
MRSA (N= 77) 
CIP 0.5 0.5 0.25-16 
LEV 0.25 0.5 0.125-4 
MOX 0.06 0.06 0.03-2 
Rapid detection of S.aureus from blood 
culture specimens 
C. Palomares, M. J. Torres, J. Aznar and J. C. Palornares 
Seville, E 
Objectives: To evaluate a new rapid method based in red time PCR for the 
direct detection of Staphylocms aureus in blood culture specimens. 
Methods: One hundred S. aumus isolates and 90 diverse bacterial species were 
studied. DNA stock was prepared by phenol/chloroform extraction method. 
Seventy-five clinical blood samples were also used for direct detection of 
S. a u m s  extracted using a commercial method (Qiagen). PCR amplification 
was carried out using primers directed against a sequence of the nucA gene. 
Detection of the product was done by using a pair of probes that hybridize 
with an inner sequence of the amplicon (FRET assay). 
Results: AU the S. aums st ra ins  tested positive in the FRETassays and none of 
the other bacterial species used, showing a sensitivity and specificity of 10050. 
The assay was not aEected neither by blood inhibiton or exogenously added 
microorganisms. The detection limit was 20cfi1 per assay. All the blood 
samples, that grew Saureus, gave a positive PCR results but none of the 
samples, which grew other bacteria. 
Conclusion: The nu& FRET-PCR assay described is extremely sensitive and 
specific for S. aureus direct detection in blood cultures specimens. 
Ip11471 Long-term outcome of patients with 
Staphylococcus aureus bacteremia 
G. Fatkenheuer, M. Preuss, B. Salzberger and H. Seifiert 
Cologne, D 
Objectives: Staphylococcus aurew bacteremia (SAB) is a leading cause of 
nosocomial infection and sepsis. While intravenous antimicrobial therapy 
for 214 days is thought to be crucial for prevention of secondary complica- 
tions, little is known about long-term prognosis. We studied outcome and risk 
factors for death in a large cohort of patients with SAB including all 
departments of a tertiary medical center. 
Methods: AU patients with documented SAB from January 1997 to Decem- 
ber 2000 at the university hospital of Cologne were included in this retro- 
spective analysis. C h c a l  data were obtained by chart review and were 
available in 229 out of 284 identified cases (81%). For information on 
long-term outcome a questionnaire was sent to general practitioners and 
registration offices, and data were available in 202/229 patients (88%). 
Statistical analysis was performed using SPSS 6.1. 
Results: A diagnosis of= was established in 153 male and 76 female patients 
(mean age 56 * 18years). Predisposing factors were present in 91% with 
surgery (n = 77) and cardiovascular diseases (n = 70) being the most prevalent 
conditions. Venous catheters were the most fkequent source of SAB with 48 
definite (21%) and 32 probable cases (14%), and in 95 persons (41.5%) the 
origin of SAB remained undefined. Most patients had nosocomial SAB (177, 
77%). Sepsis developed in 168 (73%) and septic shock in 36 (16%) patients. 
Complicated SAB with organ infection was diagnosed in 45 persons (2Ph). In 
13 cases (6%) MRSAwas present. After 1-year, 123 persons (54%) were alive, 
79 (345%) had &ed (46 within 30 days) and 27 (10.5%) were lost to follow-up. 
Risk factors for shorter suMval were age >60years ( P =  0.04). a diagnosis of 
pneumonia ( P <  0.001). malignant disease ( P <  0.001). neutropeaia 
(P= 0007), immunosuppressive therapy (P < 0.001), and source of bacter- 
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emia unknown (P=O.OOl). Mortality rates were highest in patients with 
neutropenia v7%), immunosuppressive therapy (62%) and malignant disease 
(58%). All deaths n = 11,65%) in patients with pneumonia (n = 17) occurred 
w i h  30 days. 
Condu~iom: Patients with SAB have a substantial riskofshort- andlong-term 
mortality. The crude mortality rate after 1 year in our cohort was 39% (79/202). 
Prospective studies are needed to assess the s p e d c  mortality of SAB and to 
evaluate strategies for a more favorable outcome. 
I PI 148 1 ~tap~yloco~cus a mus septicaemia in non- 
neutropenic adult patients: a retrospective clinical and 
microbiological analysis 
M. Falcone, l? Carfagna. €? Baiocchi, E. Pistella, M. Cassone, F? Serra and 
M. Venditti 
Rome, I 
Introduction: S.  uureus is one of the leading agents of nosocomial infection 
among adult patients. 
Purpose: To determine predisposing factors and secondary complications of 
S. aureus septicemia (SAS) in non-neutropenic patients, as well as predictors of 
outcome in non-neutropenic patients with SAS. 
Patients and methods: We performed a retrospective study of 56 patients 
who developed S. aureus sepsis (SAS) from January 1997 through June 2001 
hospitalized in medical wards at Policlinico Umberto I-University of Rome 
‘La Sapienza’; we excluded &om the study surgery patients and Intensive care 
unit’s hospitalized patients. 
Results: Median age was 61.9 years (24-89), male sex 29 (51%). infection was 
nosocomial acquired in 83.5%. More fiequent underlying diseases were high 
blood pressure (37.5%), diabetes mellitus (26.8%). cirrhosis (26.8%) and 
malignancy (26.8%); SAS was intravascular device-related in 32%, mucocu- 
taneous-infection in 16%, respiratory tract in 8.9% and unidendfiable focus- 
related in 43%. Metastatic infections were found in 12 patients (21.5%), with 
six (10.7%) developing infectious endocarditis; the rate of SAS relapse was 
8.Yh; Methicillin-resistance was found in 30.3%; most common empirical 
therapy was ceftriaxone (33.9%) and piperacillin f tazobactam (19.6%) with 
addition of vancomycin or teicoplanin in 39.2% of cases. Overall mortality 
was 41% and attributable mortality 28.5%. Twenty-nine patients that devel- 
oped metastatic infections or died for sepsis were compared with 27 patients 
that did not develop complications. Factors associated with an increased 
incidence of metastatic infections and SAS related mortality were: delay to 
adequate antibiotic therapy (2.46 gg vs. 1.15 gg, P= 0.02). a 72-h surveillance 
blood culture positive (3.56ggvs. 1.51 gg, P =  0.01). high rate ofseptic shock 
(58.6% v 3.7%, P =  0.00001), bacteremic pneumonia (17.2% vs. 0, P=O.O2) 
Antifungal drugs 
as source of bacterema and maJor severity of dness at the onset of SAS 
evaluated wth  ILLNESS SCORE (4.2 vs. 2.1 P=0.002). 
Conclusion: SAS in non-neutropemc panents IS associated with sipficant 
morbidity &om htgh rate of metastahc infectxous and with a considerable 
related m o d t y  Delay to adequate anubiotxc therapy, 72-h survedance 
cultures posmve, sepac shock, bacteremtc pneumoma as source ofbacterernta, 
major severity ofdness at the onset of SAS were all premchve of a comphcated 
course and a poor prognosis 1 ~ 1  term of morbidq and mortahty. 
Influence of nasal mupirocin on the incidence of 
S. aureus (SA) infections in children undetgoing peritoneal 
dialysis (PD): a doublcblind, placebo-controlled multicentre 
study 
H. von Baum, J. Oh, G. Klaus, E. Wuehl and F. Schaefer 
On behuffof the European Pediatric Peritoneal Diulysis Study Group 
Objectives: Nasal SA colonization is a major risk factor for catheter-related 
infections in continuous peritoneal dialysis (CPD) patients, including chil- 
dren. Patients or their caretakers may be the SA carriers and therefore the 
source for infection. The objective of our study was to investigate the 
eradication of SA by intranasal mupirocin of patients and caregivers and its 
efficacy on the reduction of SA site infections. 
Methods: In a randomized, double-blind, placebo-cont-rolled multicentre- 
study, after screening (nasal and exit site) for SA carriers (children and/or 
caregivers) were randomized to mupirocin or placebo treatment for 5 days bid 
every 4 weeks. 
Resub Overall, 122 patients and their caretakers from 18 centers were 
included. Meman follow-up time: 7.8 months. In 58 families, both patient 
and caretakers remained SA negative. In 40 families, the patient but not the 
caretakers carried SA and in 24 families, at least one caretaker but not the 
patient was a carrier. All positive family members received nasal prophylaxis. 
SA infection within 12 months occurred in 20% of PD patients of families 
with at least one SA carrier but in only 5% ofpatiento of noncarrier families. 
The number of infections was significantly reduced in the mupirocin arm 
during the first treatment year (1 vs. 5 infections; 11-month infection-free 
intervak 96% vs. 84% P<O.O5). However, two additional SA infections 
occurred during the second year, associated with SA recolonization of the 
caretaker in one case. Mupirocin sigolficantly reduced carrier rates in children 
during the first treatment year (P< 0.002) but not in caretakers, which might 
be related to selective noncompliance in caretakers. 
Conclusions: Nasal mupirocin appears to be effective in reducing SA infec- 
tions in chddren on CPD. However, it should be emphasized that decolo- 
nization of SA in chddren alone is not sufficient if caretakers are colonized. 
m] Early determination of in vitro resistance of 
filamentous fungi to antifungal drugs based on growth 
curves 
J. Meleaadis, J. Mouton, J. Meis and l? Verweij 
Nijmegen, NL 
Objectives: Early and objective determination of the in vitro susceptibility of 
filamentous fungi may be critical for initiation of antifungal therapy. In this 
study, a new methodology for testing the resistance of hlamentous fungi to 
three antifimgal drugs was developed based on the first detectable growth by 
spectrophotometer. 
Methods: A broth microdilution method (NCCLS guidelines, M-38P) was 
used in order to test the susceptibility to itraconazole (ICZ), amphotericin B 
(AB) and terbinafine (TB) of Rhiropusoryzae PO), Aspq’I[lusfumigntus (AF) 
and Sedosporium proltjkanr (SP) using two-fold serial dilutions. Microtiter 
plates were incubated at 37°C for 24h and growth curves obtained by 
measuring the optical density (OD) of each well by spectrophotometer @t3, 
Anthos) every 1 O m i n .  The time to the first detectable growth (ODO) was 
determined for each drug-containing well and drug-free well. The OD0 was 
then correlated with the MIC scores (0 ,1 ,2 ,3  the iowest drug concentration 
with absence of growth, slight growth, prominent and slight reduction of 
growth, respectively, or 4 the highest drug concentration showing no 
reduction of growth compared to growth control) at each concentration 
for each drug-organism combination. 
Results: The OD0 of the growth control of RO, AF and SP was 5.4,7.7 and 
9.9 h of incubation, respectively. The ODOs increased concordantly with 
increasing drug concentrations. As an example, the OD0 at the MIC-2 
occurred 4 h later then the growth control for ICZ (i.e. 9.3 h for RO and 
11.7 h for aF) and for TB (i.e. 11.5 h for AF and 14.4 h for SP). Using the 
ODO, a distinction could be made between susceptible strains and resistant 
strains. 
Conclusions: The use of a continuous monitoring system by a spectm- 
photometer permits discrimination ofsusceptible strains h m  resistant strains. 
This method may be useful for early determination of resistance in molds. 
Ip11511 ~esensitization to fluconarole in patients with 
human immunodeficiency virus infection: case report and 
review 
A. Del Arco, J. L. Prada, J. De La Torre and L. Romualdo 
Murbellu, E 
Introduction: HN-infected patients suffermg from meningihs by Cryptococ- 
cus neofomuns, fluconazole is the preference treatment both after imtial therapy 
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with amphotericin B as in secondary prophylaxir. Even though this drug is 
usually well tolerated, sometimes can eve adverse effects. Procedures for 
desensitization have been developed. We present 3 case attended in our unit 
and a review ofthe literature. A 32-year-old man, old intravenous drug abuser, 
was suffering from HTV infection for 7years. He had been treated with 
M T ,  but he had left it 1 year ago. His last CDe lymphocyte count was 
5cells/mm3. The viral load was 1200OOOcopies/mL. Four days before 
admission, he suffered from fever, headache and meningeal symptoms. 
CSF culture yielded C. neoformans. Amphotericin B was used as induced 
treatment, then the patient was switched to fluconazole (400mg/day) to 
complete 8 weeks. After this time, the dose was decreased to 200 mg daily as 
secondary prophylaxis. By his own choice, the patient left the treatment. One 
month later, he came to our external-patients unit, and we encouraged him to 
take the prophylaxis with fluconazole. When it was restarted, he sdered fever 
and pruritic rashes. These symptoms resolved withm a few day after 
discontinuing fluconazole and treating with antihistaminic. Five days later, 
the patient again suffered fever and severe headache. A new CSF analyas 
revealed relapse cryptococcal meningitis. A new induction with amphotericin 
B was indicated. At this moment, we elected to test dose and desensitize the 
patients using the procedure described by Craig beginning with 0.2 mg each 
day until 15days, with excellent results. Now after 3months. the patient 
remains free of symptoms. 
Discussion: Though fluconazole is usually a well-tolerated drug, adverse 
effects are described. The skin lesions reported spread &om a &se rash to a 
complete severe Stevens-johnson syndrome. Our case sdered &om serious 
skin lesions and general symptoms (fever) closely related with fluconazole. In 
our case, we contemplated the Craig’s procedure because of the itraconazole 
failure and the major recidive possibility with weekly amphotericin B. During 
all this time, our patient remained without symptoms. In our opinion, this 
method is safe and can be funaional in patients with fungal infection, 
especially cryptococcal, suffering from Buconazole hypersensitivity. 
I P1152 I Effects of 5-hydroxytryptamine on several 
Aspegillus and Candida species in vitro 
A. Mayr, M. Ledochowsky, M.-P. Dierich and C. Lss-Florl 
Innsbruck, A 
Objectives: In humans, selective serotonin reuptake inhibitors (SSRIs) mod- 
lfy the concentration of 5-hydroxyqptamine (5-HT) and lead to an increase 
of 5-HT during therapy with SSFUs. Recently, we found that sertraline, a 
typical SSRI, has in vivo and in vitro antifungal activity. Therefore, we 
investigated the direct d u e n c e  of 5-HT against clinical isolates of ApqiZlus  
flaws, A.fumigafus, A .  t e r m s ,  C. albicans (CBS) and C. parapsilosic (ATCC 
22019). We examined the effects of 5-HTwith regard to viability, morphol- 
ogy and physiology on the diEerent species. 
Methods: To determine the viability, a broth microdilution method was used. 
For morphological studies, examination by light microscopy and electron 
microscopy were performed. The red-fluorescent nucleic acid-binding dye 
Propidium-Iodid, whch is impermeable to live cells, was applied to inves- 
tigate the membrane integrity. In addition, the enzymatic activity of C. albi- 
cans for production of phospholipases was investigated by egg-yolk agar. 
Resultr: 5-HT was fungicidal towards the tested fungi, at  which Candida spp. 
seemed to be the most sensitive h g i .  A. ferreus represented the most resistant 
species with the MFC ranges of 25-50 mg/mL.. The MFC ranges were for 
C. albirans 3.12-6.25mg/mL and for C.parapsi1osis 0.7&1.56mg/mL. The 
application of light microscopy showed shrinkage of the cytoplasm and 
damage of the fungal organelles. By using the Propidium-Iodid staining 
method, a massive destruction of the plasma membrane was detected. A 
significant decrease (P < 0.05) on phospholipase activity of C. albicans at S-HT 
concentrations of 0.19 m g / d  was observed. 
Conclusion: In conclusion, we showed that 5-HT has antifungal activity. 
Further studies are required to evaluate the potential role of 5-HT in 
antifungal host defense. 
Fungal colonization in neutropenic patients: a 
randomized. double-blind study comparing itraconazole 
solution and amphotericin B solution 
C. Lass-Florl, E. Gunsil~ur, A. Petzer, M. Dierlch and G. Gasd 
Innsbnuk, A 
Objectives: The impact of prophylaxs w~th  itraconazole soluaon and 
amphotericin B soluhon for fungal colomzation &om oropharynx and rectum 
was assessed m a randormzed, double-bhd study among 115 pahents mth  
hematologml malignancies and neutroperna. 
Methods: In the begmmng of chemotherapy, paclents were allocated ran- 
domly to receive itraconazole (5mg/kg  of body weight m c e  a day) or 
amphotenan B (lo00 mg three tunes a day) until neutrophd recovery. Fungal 
sunredance cultures were obtanedbefore, during and after neutroperna w c e  
a week. 
Resulti: A total of 59 pahents received itraconazole, and 56 received 
amphotencm B. At the m e  of adrmssion, Candrda colotllzahon m orophar- 
ynx and rectum occurred m 53 (46%) and 37 (32%) of the pauents. 
Candtdaalbrcans, C.glabrata and C .  h e t  were the most common isolates. 
During neutropenia, fungal COlONZahOn in oropharynx occurred in 12 (19%) 
and 24 (42%) pahents, m rectum occurred m 11 (18%) and 23 (41%) pahents 
m the itraconazole and amphotenan B recipients ( P <  0 01). mpeChVely. Of 
these pahents, 1.7% m the itraconazol p u p  and 5 1% in the amphotericm B 
group had superfiaal fungal lnfechans (P< 0.01). Invasive canLdLasis devel- 
oped m 3 (5.1%) patients, mvap~e aspergilloss occurred m one patlent m the 
amphotericin B group (P< 0.01). The inndences of suspected fungal infec- 
tton were not Merent between the groups. 
Conclusions: Itraconazole soluaon reduced sigrulicantly Candrda colotllza- 
hon and decaon  in neutropemc pahents compared to amphotencin B 
solutton 
In vitro and in vivo release of clotrimazole from 
ear drops formulation 
S. L. Braha, A. Poiata, E. Braha, M. Vasdescu and I. Oita 
last, RO 
Objectives: Clotrimazole (CLT) has an antimicotic activity and it is also active 
against Gram positive bacteria. In regard to th is  data three formula eardrop 
contaming 1.2% CLT was formulated. The products have been tested both 
physico-chemcally and regarding the availability of CLT, using microbiolo- 
gtcal deternunation. We made also a clinical evaluation by treating some otitis 
and otomicosis cases. 
Methods: We prepared three eardmps formulations: 
1.2% CLT suspended in 1% tween 80 with solvents (2Wo propilenglycol, 
0 1.2 CLT suspended in 20h PVP-water with 2% benzylalcohol and 20% 
1.2% CLT dissolved m 2% benzylalcohol and PEG300. 
The products were characterized physico-chermcally by measuring some 
parameters: pH, the electric conductivity and viscosity. The availability of 
CLTwas assessed by microbiological tests, &metric methods. The bioava- 
ibdity was clinical evaluated on 63 patients with otomicosis and otius. 
Result% The products’ pH varies between 5.06 and 6.40. The elecmcal 
conductivity is indirectly proportional to the values of pH. The viscosity 
varies between 2.93 and 7.45mF‘as. The biggest viscosity has the third 
preparate with PEG300, respectively, 7.45 mPas. The microbiological tests, 
umg Sabouraud agar medium, reveal that the CLT included in products is 
achve against Candida albiram, Sadna lutea, Bacillus subtiZis, Staphylococcus 
aureus. The clinical data revealed the efficiency against external, 
medium otitis and otomicosis of second and third preparates, leadmg to their 
healing. 
Conclusion: Although, the mimbiological testes proved a higher achvity 
for the third preparate (solution). We can note also a good efficiency for the 
second preparate (with a macromolecule that increases the contact m e ) .  
2% benzylalcohol) and water; 
propyleqlycole; 
1 P1155 1 Promotion of mycelium formation by propofoi 
A. Gonplves Rodngues, R Araujo, S. Costa-de-Ohveira and 
C Pina-Vaz 
Porto, P 
Introduction: Fungal agents are b e c o m g  increasingly responsible for noso- 
c o d  mfecbons, pamcularly in the sethng of the ICU umt Hypha and 
mycehum formation IS assumed to be an unportant wulence factor by 
prOmOhng adherence to host ceb  and for m e  hvauon. Propofol, admuus- 
tered m a hpid emulsion, is a mdely used anesthehc and sedatlve agent m 
Crlhcd care pahents 
Objective: To evaluate the effect of propofol upon hypha and mycehum 
formahon by Candida and Aspergllus. 
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Material and methods: Clinical isolates of C. albiurm (3 strains), Afrrmigahrs 
(2 strains) and A.@vur (2 strains) were incubated with plain and with serial 
ddutions of propofol, in RPMI 1640 cell culture medium (Sigma). After 
incubation for 2 h at 37 "C, samples (200 cells) were hourly checked for 
budding and germ tube formation by blastoconidia or germination of spores 
in case of Candida and Aspergillus, respectively, up to 8 h. 
Resultr: Propofol induced hypha formation both by Aspergillus and Candida, 
although much faster in the latter. After 2 h, an extensive rate of germ tube 
formation and of cell division @udding) by C .  albicans was found, also in plain 
propofol. Similar results were found for Aspergillus regarding spore germina- 
tion and hypha formation, although noticeable only after 5-6h and parti- 
cularly with A.fi(m&aatrrs. 
Conclusions: Propofol is potentially associated to a high risk of nosocomial 
primary hngemia, particularly by Candidu spp., due to its high potential of 
contamination even when infused shortly after its use. Additionally, by 
promoting mycelium formation, seriously enhances the invasiveness and 
pathogenesis by Candida and Aspergillus organisms, promoting the establish- 
ment and progression of deep-seated fungal infections. 
Evaluation of the E-test for susceptibility testing 
of clinical yeasts to amphotericin B, flucytosine, 
ketoconazole, fluconazole and itraconazole 
L. Alcali, T. Peliez, I? Mutioz, M. S. Diaz-Infantes, M. Marin-Arriaza 
and E. Bouza 
Madrid, E 
lntroductlon: The E-test is a diffusion method consisting of a strip with a 
gradient of drug concentrations that permits easy and rapid reading of MICs. 
Although this method had showed excellent results for numerous bacteria its 
yield for yeasts is still being studied. 
Objective: To evaluate the E-test for susceptibility testing of clinical yeasts to 
amphotericin B, flucytosine, ketoconazole, fluconazole and itraconazole. 
Methods: We compared the correlation of MICs of amphotericin B, flucy- 
tosine, ketoconazole, fluconazole and itraconazole by the E-test with those of 
the reference method (M-27 A, NCCLS, supplemented with 2% glucose). E- 
test was performed according to the manufacturer's recommendations. Three 
incubation times were evaluated for E-test 24, 48 and 72 h. A total of 312 
yeasts were tested: 56 C. albicans, 55 C. parapsilosis, 49 Cglabrata, 52 C. 
tropicalis, 49 C. krusei, and 51 Cryptocwcus n e o f m a m .  
Results Overall, the best performance for E-test was obtained after 48 h of 
incubation (89% correlation vs. 75% at 24h and 84% at 72h). At this 
condition, 53% of species-antifungal pairs had a correlation greater than 
95%. The pairs with lower agreement were flucytosine-C. knrsei (10%) and 
flucytosine-C. neoformans (60%). For the remaining species-antifbngah pairs 
the range of correlation was of 79-93%. The agreement by species were 96 
(C. albicans), 94 (C.parapsilosis), 92 (C. tropicalis), 92 (C.glabrata), 77 ( C .  kruset] 
and 83% (C. neoformans). The agreement by antifungals were 92 (amphoter- 
icin B), 78 (flucytosine), 91 (ketoconazole), 95 (fluconazole) and 90% 
(itraconazole). 
Conclusions: In this study, optimal agreement with standard susceptibility test 
was obtained at 48 h of incubation. At this time, good results were obtained 
except for flucytosine when tested with C. krusei and C .  neojomum. E-test is a 
ready-to-use method that represents an alternative for the antifungal suscept- 
ibility testing in the clinical laboratory routine. 
v1 Antifungal susceptibility testing of yeast 
bloodstream isolates 
M. Kolackova, I? Hamal, M. Kolar, E. Faber and V. Raclavsky 
Olomouc, C Z  
Objectives: To determine in vitro activities of systemic a n t i f i d  against 
clinical yeast isolates causing nosocomial bloodstream infections. 
Methods: A total of90 yeast isolates, including 10 yeast species, were obtained 
from blood cultures of 69 patients. Most frequently, Candida parapsilosis was 
identified (n=45), followed by C. albicans (a= 19) and C. tropicalis (n= 10). 
Standardized microdilution method according to M27-A document of 
NCCLS was used for the determination of the minunal inhibitory concen- 
trations (MICs) of amphotericin B (AMB), flucytosine (FCZ), ketoconazole 
(KET), itraconazole (ITR), fluconazole (FLA) and voriconazole (VOR). 
Reading of results was done after 24 h of incubation at 37 'C with exception 
of C. parapsilosis strains, which were evaluated after 36 h. 
Results: MIC ranges and most frequent MICs (in parentheses) in p&mL were 
for C. Parapsilosis: AMB 0.125-1.0 (0.5). FCZ 0.062-0.5 (0.259, KET 0.031- 
0.5 (0.25), ITR0.031-0.5 (0.25), FLA0.25-4.0(0.5) andVORO.031-0.125 
(0.062). for C. albicam: AMB 0.325-0.5 (0.5), FCZ 0.062-0.125 (0.062), 
KET 0.031-0.25 (0.031), ITR 0.062-0.5 (0.25). FLA 0.062-2.0 (0.5) and 
VOR 0.015-0.125 (0.015) and for C .  tropicalis: AMB 0.125-0.5 (0.25), FCZ 
0.062-16.0 (0.062), KET 0.031-0.25 (0.031), I T R  0.031-0.5 (0.25), FLA 
0.062-1.0 (0.5) and VOR 0.015-0.125 (0.015). MICs of all isolates were 
verified by repeated testing. According to NCCLS interpretive guidelines for 
AMB, FCZ, ITR and FLA, none of the isolates was evaluated as resistant. 
Significant changes in the MICs among the isolates of the same species 
obtained subsequently firom individual patients were not observed. 
Conclusions: The majority of our bloodstream isolates have law MIC values 
indicating susceptibility to systemic antifungals. Results of microdilution 
method used in our study were easily readable and, moreover, they showed 
very good reproducibility in repeated experiments. 
Acknowledgments: This workwas supported by grants NI6190-3 (IGA MH 
CR) and MSM 15120004 (ME CR). 
/p11581 PLD-118. a novel antifungal compound 
tolerability, safety and pharmacokinetics after multiple oral 
dosing in healthy male volunteers 
A. Schroedter, A. Bischoff, K. Oreskovic, J. Knoeller, W. Schoenfeld and 
J. Peterson 
Neuss, D; Zagreb, HR 
Background PLD-I 18 is a novel oral antihngal compound, primarily active 
against Candida spp., including azole-resistant strains. 
Objective: Double-blind, randomized, placebo-controlled, sequentially 
ascending dose study was performed to assess tolerability, safety and pharma- 
cokinetics of PLD-118 after multiple oral dosing in healthy male volunteers. 
Methods: A total of 32 subjects, divided into four groups and randomized in a 
3 : 1 ratio for active treatment and placebo, received multiple oral doses of 
50mg (tid), IOOmg (tid) or 150mg (bid or tid) PLD-118. Each volunteer 
received a single dose on the first day, followed by a 72-h wash out period, 
multiple doses for 7 days, and a single dose on the last dosing day. Plasma 
samples were collected over 72 h at Day 1 and Day 1 1, as well as prior to and 
1 h after the morning dose at Days 4-10. Urine samples were collected up to 
72 h after the last dose. 
Results Mean pharmacokinetic data are summarized in the table below. 
Dose (mg) 
50mg (tid) 100% (tid) 15Omg (tid) 15Omg (bid) 
Study day 1 1 1  1 11 1 11 1 11  
C, (pg/mL) 1.6 2.4 3.2 5 6  4.5 5.9 4.7 6.0 
AUC,d 8.7 14.4 19.6 39.8 27.4 46.9 24.5 38.6 
L a x  01) 0.67 0.67 0.84 0.67 0.67 1.5 0.67 0.67 
t l / Z  01) 7 4 6.8 7.4 7 9  7.0 7.2 7.4 7.5 
Ae,Z (% ofdose) 81 142 83 158 82 140 85 127 
(m x h / W  
PLD-118 was well tolerated. The most fkeequent adverse event was dry mouth, 
occurring in five subjects. EEG abnormalities were detected in two subjects 
receiving PLD-118 and in two receiving placebo, suggesting normal biolo- 
gical scatter. There were no clinicaIly significant drug-related changes of vital 
signs, ECG parameters or laboratory findings. 
Conclusion: Presented results suggest good tolerability and favorable phar- 
macokinetic proftle of PLD-I18 in man, supporting further clinical devel- 
opment of the compound. 
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Neutropenia and related infections 
Staphylococcus haemo/yticus bacteremia in 
patients with hematological malignancies 
A. Micozzi, M. Cassone, M. Raponi, F. Taghetti, M. Venditti and 
P. Martino 
Rome. I 
Objectives: We describe 22 cases of methicillin-resistant S. haernolyttinrs 
(h4RSH) bacteremia occurred in a 7-month period in a hematological ward. 
From August 2000 to February 2001. 220 episodes of bacteremia have been 
observed in our pts with heinatological malignancies. Out of these 123 (56%) 
were caused by coagulase-negative staphylococci and 22 (10%) by MRSH. 
Methods: Predisposing factors, clinical characteristics, antimicrobial treat- 
ment of these 22 cases were compared with a control group of pts with 
Staphyfmcnrs aurew (SA) bacteremia. There were no differences in sex, age, 
underlying HM and intensive antineoplastic chemotherapy in the two groups 
of pts. More pts with MRSH were neutropenic at the onset and during 
bacteremia (P= 0.0003) and had a CVC in place (P= 0.04) Prophylaxis with 
quinolones was given in 17 and 11 pts with MRSH and SA, respectively 
( P =  0.05). Previous and/or ongoing antibiotics, including glycopeptides, 
were administered in a similar percentage in the two groups. 
Results: All MRSH and SA isolates were inhibited by 4mg/mL Vanco 
concentrations. On the other hand, Teico concentrations >8mg/mL were 
required to i h b i t  11 (50%) MRSH (up to >16mg/mL to inhibit three 
MRSH isolates); all SA were inhibited by Teico concentrations <8 mg/mL. 
Crude mortality rate was 23% and 18% in MRSH and SA pts, respectively; 
attributable mortahty was 4.5% in both groups. Duration of bacteremia was 
longerthan48hin 15MRSHptsvs. 6SApts (P=O.003). CVCwasremoved 
in five MRSH pts and three SA pts. Only 14 out of 22 MRSH bacteremias 
were treated with glycopeptides (10 Teico, 4 Vanco). No cases of endocarditis 
have been observed. 
Conclusions: MRSH bacteremia is a frequent complication in pts with HM; 
as compared to SA bacteremia, is more frequently associated with neutropenia 
and CVC, despite poor susceptibility to antibiotics, associated morbidity and 
mortality appear neghgible. 
Ip1161j Changing of empiric antibiotic regime to prevent 
Enterococcus infection in febrile neutropenic patients 
E. Hajdh, T. Bicskay, K. Piukovics, Z. Borbknyi, E. Nagy and G. Varga 
Szeged, HUN 
Objectives: To analyze the preventing effect of changed empiric antibiotic 
therapy on the occurrence of severe Enteroroms spp. infections in febrile 
neutropenic patients. 
Methods: 197 febrile neutropenic periods of 131 patients were treated 
between 01 January of 2000-30 June of 2001. 68 patients suffered 
from non-Hodglun lymphoma, 56 from acute leukemia, 7 from other 
hematological diseases such as aplastk anemia or drug-induced agranulory- 
tosis. Thirty-seven cases were treated with high dose of cytostatic drugs. 
The absolute granulocyte (G) count was <0.1 x G/L in 59 cases, 0.1-0.5~ G/ 
L in 70 cases and 0.5-1.OX G/L in 68 cases. Blood cultures and relevant 
microbiological samples were examined during febnle periods. Eighty infec- 
tious periods were clinically documented, 42 infectious periods were clini- 
cally and microbiologically documented and FUO were seen in 75 cases. 
Despite the fact that only one Enteroroms faecium sepsis could be detected 
between 1995 and 1999 in febrile neutropenic patients, in 2000 seven 
bacteremia ceased by multidrug-resistant Enferococnrsfaecium and three caused 
by Enteroroms faernlis was observed. In two cases. Enterocmsfaedum caused 
urosepsis. The third-generation cephalosporin f aminoglycosid empiric anti- 
biotic therapy was changed either to piperacillin/tazobactarne or in some 
cases to carbapenems from December of 2000 to prevent selection of 
enterococci. 
Results After changing empirical antibiotic regime in the hematological 
department only one Enterocoaus faen'um sepsis aanuary of 2001) and two 
Enterocoawfadum urinary tract infections (January of 2001 and April of2001) 
were detected between January and November of 2001. 
Conclusion: Changmg empiric antibiotic therapy in the hematological 
department has stopped increasing of the multidrug-resistant Enmoccus 
faecium infections in the fever neutropenic patients can interrupt. 
Ip11601 Septic shock in neutropenic patients 
E. Karabatsah, M. Agiannitou, P. Tsiodra, S. Hini and A. Efstratopoulos 
Athens, GR 
Objective: To study the characteristics of septic syndrome in neutropenic 
patients. 
Methods: We studied 94 septic episodes in 86 neutropenic patients (absolute 
number of polymorphonuclears <500/cm3), owing to toxicity from che- 
motherapy. The majority of the patients (75.6%), suffered h m  hematological 
malignancies. The data analyzed included clinical characteristics, laboratory 
findings, duration of hospitalization and outcome. 
Results: In one-third of the septic episodes, there were blood cultures found 
positive for either Gram-positive bacteria (45%. predominately S. aureus and 
Staph. coagulase-negative), or Gram-negative bactetia (48%, Predominately 
E. coli and Pseudomonnc aeruginosa). In 20% of the cases, there were more than 
one pathogens isolated &om the blood cultures (polybacteremia). The most 
prevalent manifestation of sepsis in neutropenic patients was fever, present in 
90% of the septic episodes. Evidence of severe sepsis (hypoxemia, oliguria, 
metabolic acidosis, DIC) was present in 18% of the septic episodes and 8.5% 
were in septic shock. Mortality was 14%. Prolonged neutropenia was 
associated with prolonged length of hospitalization and adverse outcome. 
The duration of hospitalization was shorter in patients with positive blood 
cultures (12.8f7days) than in patients with negative blood cultures 
(22.3 3~ 5.4 days) (P < 0.05). 
Conclusions: Positive blood cultures in neutropenic septic patients lead to 
timely administration of appropriate antimicrobd therapy and therefme 
decrease the length of hospitalization. Fever is the main manifestation of 
sepsis in neutropenic patients. Prompt increase of the total number of 
polymorphonuclears in these patients, improves the outcome and shortens 
the length of hospital-stay. 
I P I  162 Betadine influence on colonization of 
nasopharynx of patients with leucopenia after 
chemiotherapy 
A. Samet, E. Arlukowicz, A. Sledzinska, E. Ddemaszkiewicz, 
A. Hellman and W. Prejzner 
Gdansk. P 
Introduction: Betadme solutlon 1s an iodxde anmeptx wth  broad spectrum of 
a n m c r o b d  activity (it has only local use). Apphcation of ths agent on slun 
or mucosa elmmates at least 85% mcroorgamms, whch makes it one of the 
most effemve anOSephCS. 
Objectives: Estunaaon of betadme aCtIMty on nuuoorgamsms coloruzmg 
nosopharynx of panents treated mth  chemiotherapeutm 
Methods: We exarmned 25 patients (pts) (22 with acute leukema and 3 wth  
lymphoma d g n u m )  who demonstrated leucopema after chemotherapy 
Those pts were treated in Hematologcal Ward 12 pts had to gargled betadme 
3 tunes a day and 13 pts were a control group (they used rmxed soluaon wth  
anhbacterd, anhfkngal, etc. mgredlents). All of them had bacteriologd 
examnahons (nosopharyngeal swab and sahva) before they started usmg 
betadme and on 7th. 14th, 21th day of exammanon The m n  purpose of 
the test was to check the level of mcroorgamm h n a b o n  from the 
nosopharynx Samples were idennfied by standard methods and ~LSC - 
dtffusion suscepnbhty tesnng was done accordmg to NCCLS 
Result% The pauents were exammed from 30 March 2001-15 November 
2001 270 bacteriologcal tests were done. They mcluded 86 nasal swabs, 84 
pharyngeal swabs and 100 d v a  samples. We nouced presence of pathogens 
taken before the treatment in 15 cases. There lsolates were as followed: yeast 
(68 isolates; 49 3%), Gram-negahve rods (52 isolates; 37.7%), Gram-posluve 
coca (18 isolates, 13%) We cultured only common, multlsuscephbbe swns .  
Results are presented as follows 
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Betadine Conuol group 
Number of microorganisms (nr of patients) (nr of patients) 
Decrease about 103 &/mL 3 (25%) 
Increase about 103 c h / d  2 (16.6%) 
No change 7 (58.3%) 
1(7.6%) 
2 (15.4%) 
10 (76.9%) 
We did not observe correlation between garghng with antiseptic and the 
number of microorganisms in nasal samples. 
Conclusions: We conclude that betadine is an effective disinfectant and in 
83.4% examined patients prevented superinfections. 
Ip11631 Infectious complications in acute leukemia 
patients in a Korean university hospital between 
1998 and 2001 
D. H. Shin, J. H. Park, J. J. Lee, I. J. Chung, H. J. Kim, J. H. Shin and 
S. J. Kim 
Kwangju, KOR 
Objectives: The purpose of this prospective study was to determine the 
spectra, frequency and their resistance pattern of pathogens that cause 
bacteremia and pneumonia in patients with acute leukemia. 
Methods: The anatomical sites of infection was determined as a culture- 
positive site or a clinically evident site of infection, with the isolation of 
bacterial strain &om either a sterile or a non-sterile body site, according to 
CDC definitions. Susceptibility of organisms was studied using a disc-&- 
sion technique according to NCCLS methods. 
Resulk: Over the 3-year period, 360 febrile episodes, attributable to infec- 
tion, were documented. The frequent sites of infection observed were: blood 
st ream 122 (33.8%), lung 117 (32.5%), oral mucosa 114 (31.6%), gastro- 
intestinal tract 97 (26.9%). perianal area 44 (12.2%), soft tissue 43 (11.9%), 
indwelling venous catheter 33 (9.1%), and paranasal sinus 23 (6.3%). A total of 
162 organisms were isolated in the 122 bacteremic episodes. Overall, 86 
Gram-positive bacteria (GPB) (53.0%), 73 Gram-negative bacteria (GNB) 
(45.0%) and 3 hngi (0.18%) were isolated. The most frequently isolated 
organisms were coagulase-negative staphylococci (23.4%), E. coli (16.6%). 
K.pneutnoniae (1 l.l%), Enterococci (10.4%), Viridans group streptococci 
(9.8%). E. cloacae (8.6%) and S. aureus (7.4%). Seven (41.1%) of enterococci 
were VRE. In addition, 15 (20.5%) of GNB were the extended spectrum beta 
lactamase-producing organisms. Twenty percent of GPB were susceptible to 
cefotaxime, the extended spectrum beta lactams commonly used for empiric 
therapy, whereas 55.5% of G N 3  were susceptible to piperacillin, 56.1% to 
cefotaxime, 61.6% to ceftazidune and 75% to ciprofloxacin. Ninety-two 
organisms were isolated in the respiratory specimen cultures from 64 patients 
with microbiologically documented pneumonia; 57.6% were GNB, 30.4% 
GPB, 7.6% M. tuberculosis and 4.3% fungi. Antimicrobial susceptibility 
among the organisms that cause pneumonia was comparable to that of the 
same species for bacteremia. Overall, 50 patients (13.8%) died during or after 
360 febrile episodes and 29 (8.0%) died of infectious complications. 
Conclusions: Our results show that GPB are the major pathogens of 
bacteremia and the rates of resistance among bloodstream or respiratory 
pathogens are increasing. Greater consideration must be given to carbapenems 
and glycopeptides in empirical therapy for infections in patients with acute 
leukemia. 
Ip11641 Staphy/ococcus aureus bacterernia in 
neutropenic and non-neutropenic patients: a retrospective 
case-control study 
P. Carfagna, A. Micozzi, E Taghetti, M. Falcone, €? Serra, €? Ma~tino and 
M. Venditti 
Rome, I 
Background: Bacteremia owing to S. aureus is an increasing problem for the 
widespread use of intravascular devices in c h c a l  practice. Few data are 
presently available in the International Medical Literature about this infection 
in neutropenic patients @a). 
Aim of the study: To define the clinical sigmficance of S. aureus bacteremia in 
neutropenic pts. with hematological malignancies. 
Methods: Cases of S. aurew bacteremia were identified by review of micro- 
biology laboratory records and defined according CDC criteria by review of 
pts. clinical charts. To determine the clinical impact of S. aureus bacteremia in 
neutropenic pts. a case control study was performed with cases of S. nureus 
bacteremia in non-neutrupenic pts with similar age and with bacteremia 
occurring during the same period. 
Results: Two groups of 39 neutropenic and non-neutropenic pts could be 
analyzed in the study, with similar median age (55.5 vs. 51.8year, respec- 
tively), similar male to female ratio (25 : 14 vs. 21 : 18, respectively), and 
simdar rate of methcillin-resistance (26% vs. 28%, respectively). Neutropenic 
pts. showed an higher frequency ofmucositis (P=  O.oOOOl), less days offever 
(P=0.05), less days of bacteremia (P=0.007), less days to an adequate 
antibiotic treatment (P=O.O02), less days of antibiotic therapy (P=O.O09). 
In neutropenic pts. were observed no metastatic infection (P= 0.002) and a 
lower related mortality (5.1% vs. 28.5%, respectively, P =  0.006). Relapse was 
observed in 4 (10%) neutropenic patients vs. 2 (5%) non-neutropenic ones 
( P =  0.3). 
Conclusion: Bacteremia owing to S. auws in neutropenic pts. seems to be a 
low-inoculum bloodstream dection associated with low morbidity and 
mortality rates if adequate antistaphylococcal therapy is promptly adminis- 
tered. 
ip11651 Use of daptomycin in febrile, neutropenic 
patients with vancomycin-resistant Enterococcus faecium 
WREF) bacteremia 
D. R. Snydman, K. Miller, B. Britigan and D. D. Poutsiaka 
Boston, Iowa, USA 
Objective: It is known that vancomycin-resistant enterococcal bacteremia in 
the neutropeuic patient is associated with poor outcome. In a series of six 
prospectively followed bone marrow transplant recipients with VREF, mor- 
tality at 30 days was 100%. Daptomycin is an investigational lipopeptide with 
excellent bactericidal activity against VREF. 
Methods: We examined the microbiologic and clinical outcome in patients 
with fever, neutropenia and bacteremia with VREF who were treated with 
daptomycin in an open label, emergency-use trial. We analyzed those patients 
who received more than one dose of daptomycin. 
Results: There were 10 patients with 11 comes offever and neutropenia with 
VREF bacteremia who received >1 dose of daptomycin, five were BMT 
patients, six had acute leukemia. Median age was 58 years. Eight patients were 
male, two females. Daptomycin dose was 6 mg/kg/day i.v. with doses adjusted 
for renal insufficiency. Median number of days of daptomycin treatment was 
14 (range 3-18days). Ten of 11 coulses were complicated by persistent, 
profound neutropenia. Five of 11 courses (45%) had clinical and micro- 
biologic cure, 3 of 11 (27%) relapsed, 1 had persistence and 2 could not be 
evaluated. Mortality 1 month postdaptomycin treatment use was 5 of 10 
(50%). 
Conclusions: Compared to the historical experience of bacteremia with 
VREF in fever and neutropenia in BMT, use of daptomycin in t h ~ s  population 
shows promise with micmbiologic cure rates of 45% and suMvd of 50% 
(P  = 0.09). However, VREF bacteremia in fever and neutropenia is still a very 
poor prognostic marker. 
1p11661 Randomized pilot phase trial of once-daily oral 
monotherapy of neutropenic fever 
T. Wicke, M. Schwonzen, D. Reichen, U. Bethe, G. Fatkenheuer and 
0. A. Cornely 
Coiogw, Mesckede, Oldenbq, D 
Objectives: Intravenously administered antimicrobial agents have been the 
standard choice for the empirical management offever in patients with cancer 
and neutropenia. If orally administered empirical monotherapy were not 
inferior to intravenous therapy, it could offer advantages such as improved 
quality of life and lower cost. 
Methods: We perform a prospective randomized multicenter trial in the 
treatment of neutropenic fever, comparing efficacy and safety of i.v. piper- 
acillin/tazobactam 4.5 g tid with oral levofloxacin 500 mg/day. 
Core inclusion criteria are: oral temperature at least 38.5"C once or 38°C 
twice within 24 h, neutropenia <500 pL, expected to last shorter than 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 267 
10 days. Patients are stratified for autologous stem-cell transplantation. Pri- 
mary endpoint is defined as defervescence on day 4 followed by at least 7 
debrile days. Secondary endpoints are time to defervescence and toxicity. 
Results: A total of28 episodes of23 patients (m = l2J= 11; age 2049years; 
median 46 tears) have been included up to now. According to ISDA criteria 
fever of unknown origin accounted for 20 episodes (71%), microbiologically 
defined infection for 5 (18%). clinically defined infection for 3 (11%). 
Treatment was successful without the need of modification in 85% in the 
intravenous-therapy group treated with piperacillin/tazobactam and 73% in 
the oral monotherapy group treated with levofloxacin. The medtan time to 
defervescence was 3days (range 14days each). One patient in the oral- 
therapy group died with septic shock without isolation of a causative 
pathogen. There were no adverse effects hke diarrhea, nausea or vomiting. 
Conclusion: Oral levofloxacin 500 mg/day does not seem to be inferior to 
intravenous piperacilldtazobactam tid in the empirical treatment of neu- 
tropenic fever in patients with low risk. Recruitment into the study continues 
in order to warrant a solid statistical analysis. This interim evaluation was 
intended according to the protocol. 
1 PI167 1 Recurrent Brevibacterium bacteremia: 
role of long-term catheter 
I. Beukinga, H. Rodriguez-Villalobos. A. Deplano, E Jacobs and 
M. J. Struelens 
Brussels, B 
Objectks: Brevibacierium spp. is a rare cause of bacteremia in compromised 
hosts with intravenous devices. The need for catheter removal in these cases 
has been suggested, although information on the efficacy of a conservative 
catheter antibiotic therapy is limited. We describe two cases of recurrent 
bacteremia owing to Brevibacferium casei associated with a long-term infected 
intravascular access. 
Patients and methods: Two cases of Brwibacterium bacteremia were rew- 
spectively studied over a two years period. Species identification was per- 
formed using API Coryne (Bio Merieux) and complementary biochemical 
tests. Susceptibility was performed by disc &&ion on Mueller-Hinton agar 
with 5% sheep blood. Culture isolates were typed using amplified tkgment 
length polymorphism analysis of genomic DNA. 
Results: The fmt patient, a 43-year-old woman, suffered from Crohn’s disease 
with chronic enteru-cutaneous fstulae. She had a totally implanted port for 
infusion of total parented feeding. A first episode of bacteremia owing to 
B. casei was treated with a 15-day course ofvancomycin. Blood cultures were 
negative after treatment. Five months later, she became neutropenic and 
developed a second episode of bacteriemia with the same pathogen. Despite 
catheter removal and another course of vancomycin therapy, the patient 
developed sepsis and died. The second patient, a 31-year-old man, had a 
Hickman’s catheter used for chronic hemodialysis after kidney transplantation 
failure. Following a first episode of bacteriemia with B. wei, the patient was 
also treated by a 15-day course of vancomycin. Control blood cultures were 
negative at the end of therapy. Two months later, the patient became septic 
again and the organism was re-isolated from blood. He received another 15- 
day course of vancomycin while the catheter was not removed. At two 
months follow-up, this patient’s examination was unremarkable and conwl 
blood cultures remained negative. All isolated strains had the same antimi- 
crobial-susceptibility profile. 
Conclusions: These cases of catheter-related B. w e i  bacteriemia 
illustrate the relapsing nature of these infections aker transient cure by 
antibiotic therapy with the catheter left in situ. Catheter removal may be 
the preferred therapeutic option for eradication of this device-associated 
infection. 
/p1168j Microorganisms from blood cultures in a 
hematology unit from 1999 to 2001 
A. Samet, E. Dziemaszkiewicz, E. Arlukowcz, W. Prejzner and 
A Hellmann 
Gdansk, P 
Objectives: To analyze the results of blood cultures m pahents suffenng from 
malignant hematological dlsease. 
Methods: We obmned blood cultures from 381 pahents hospitalized in 
hematology ward from 01.01.1999 to 30.10.2001. 
Two systems were used. Bact/Alert (Organon T e M a )  and Vital 
(bioMeneux) . 
R@sults: We cultured 1170 mcmorgaolsms from our pahents. POSihve rate 
was 22.2%, 91 were polyrmcrobial cultures. The madence ofEnterobadenaceae 
was 147 isolates (12.5%) with only 5 (0.4%) ESBL-producmg Isolates. Non- 
fermentmg rods conshtuted 9.5% (112) of all mcmorgdlllsm. The most 
prevalent were staphylococc~, coagulase negative (CNS) - 535 isolates 
(45.7%), Stnphpfocoauc aurew 47 lsolates (4.1%) and MRSA 2 aolates. There 
were 79 (9.1%) enterncocci wth 30 lsolates of them VRE. Candida spp. was 
lsolated with the &quency of 5.9%. 
Conclusion: Gram-positive coca are most prevalent rmcroorgmwns Isolated 
h m  blood cultures wth VRE bemg multuemtant. There was a @cant 
increase m fichendrra coli, Pseudomonas ampnosu and Sttnotrophomonas mal- 
tophrfta isolation rate over Jyears, &om 4 to 8%. 1.1 to 15% and 1.5 to 6%, 
respechvely. 
Ip1169j Acinetobacter baumannii strains isolated 
from oncologic patients 
E. Chmou, E. Tsiganou, A. Georgouh, 2. Chiolou, N. Trobouki and 
N. Golemati 
Rraeus, GR 
Objectives The aim of the study was to detetrmne the chnical usefulness of 
bIotyplng and anhbiohc resistance patterns m epidemiologd mveshgation of 
Annetobucter sp. infechons. 
Methods: We performed a retrospectwe s t u d y  to evaluate the episodes of 
A. baumannii mfeaions during the last 1.5 years. The aolates were identified 
by the MI 20 NE system. Suscephbility to anarmcrobial agents was deter- 
mined according to NCCLS by the MIC and disc-&son methods. 
Resulis: During the period from01 January 2000 to 30 June 2001,101 snains, 
from clinical material, were collected. The sources of isolates were as follows: 
respmtory specimens n = 42, wounds n = 23, urine n = 19, catheters n = 14 
and other specimens n=3. Repeat isolates from the same patient were 
excluded. Fe-five lsolates were collected h m  paaents hospitalized at 
ICU, 35 isolates h m  surgery wards and 11 lsolates h m  the other wards. 
By the API 20 NE b e  diEerent biotypes were identified. The API profile 
0001073 dominated (76%). Most of the A h e t o b u m  baumannii isolates were 
sensitive to imipenem (loOo/o), meropenem (9003). ampicdlidsulbactam 
(60%) and gentamicin (37%). 
Conclusions: In our study, A.  baumannii mostly isolated at the m t e m e  care 
umt and surgery wards and it predominately caused respiratory tract infec- 
tions. In OUT experience inupenem remains the treatment of choice in 
A .  baumannii infections 
1 P I  170 The dinical spectrum of infections in patients 
with primary humoral immunodeficiency: a clinical survey of 
patients from Iranian Primary ImmunoDefkiency Registry 
N. Rezaei, A A g h a m o h d ,  A. Farhouh, M. Moem, 2. Pourpak, 
K Abohaah, M. Movahd, M. Gharagouzlou, B. h e e d  Ghazi and 
M. Mahmoud~ 
Tehran, IR 
Background Prmary Humoral ImmunoDefiaencies (PHID) are currently 
increasmgly rec-ed, thanks to novel advances m the muno logy  and its 
laboratory techques Paaenu with PHID fkquently show idechous com- 
phcahons, which are often the fint madestahon of dIsease and the major 
cause of their morbdty and mortahty. 
Objectives: To determne the spectrum of mfechous Comphcabons JII 
chddren wth PHID 
Methods: We have renewed the data from the climcal files of patienti unth 
PHID, dtagnosed accordmg to standard cntena, who were enrolled in Incuan 
Prlmary fmmunodefiaency Reptry. 
Results: We analyzed 125 pahents (84 males), wth the dugnoses of pmnacy 
anhbody deficiency mcludmg common-vanable mmunodefiaency (64 pts), 
x-hked agammaglobuhema (29 pts), IgA deficiency (20 pa), IgG-subclass 
deficiency (8 pu), and hyper-IgM syndrome (4 pts) The mean age of the 
pahents at the ame ofstudy was I1 years. Acute and recurrent infectlolls were 
found mall of our pahents A hundred and twelve paaents out of 125 have had 
some form of respmtory system ifechons. Followmg the respmtory system 
was gastrointesnnal tract involvement, seen m 77 paaents; The rest of organs, 
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in descendmg order offrequency is musculoskeletal system in 21 patients, skin 
infections in 20, and central nervous system involvement in 18 patients. The 
majority of patients (92 pts, 73.6%) had pneumonia prior to dqposis. The 
other infections were diarrhea (73 pts), otitis media (68 pts), sinusitis (61 pa), 
conjunctivitis (17 pts), bacterial meningitis (16 pts). oral candidiasis (14 pts), 
cutaneous abscesses (14 pa), septic arthritis (13 pts), urinary tract infections 
(13 pts), and osteomyelitis (5 pts). Also we had 24 patients with bronchectasis, 
12 with giardiosis, 6 with tuberculosis and 5 patients with Dneumorystis carinii 
infection. As the first presentation, 86 patients were presented with respiratory 
tract infections. Pneumonia was the most fiequent presentation, with the 
frequency of 37.6% (47 pts). The rest of organs, involved as the first 
manifestation of primary immunodeficiency were gastrointestinal tract, skin 
and CNS. Sepsis was also seen in three patients as the primary manifestation. 
Conclusions: Based on th is  study, we suggest that hypogammaglobulinemia 
should be considered in any patient with a history of recurrent infections in 
Merent organs, and such patients should have a full assessment of immune 
system. 
I P I  171 ] The clinical spectrum of infections in patients 
with primary phagocytic disorders: a clinical survey of 
patients from Iranian Primary ImmunoDeficiency Registry 
K. Abolmaali, A. Aghamohammadi, M. Moein, A. Farhoudi, 
Z. Pourpak, N. Rezaei, M. Movahedi, D. Mansouri, A. Babaei Jandaghl, 
N. Shahnavaz and J. Bakhshaei 
Tehran, IR 
Background Primary phagocytic disorders, although not very common, 
comprise one of the challenging tasks ofthe infectious specialists. This group 
can be divided into those of deficient cell numbers and those with insufticient 
phagocytic function. Chronic granulomatous disease, being the most com- 
mon disorder in t h i s  group, results f?om a defect in the oxidative burst of 
neuwphils. 
Objective: To determine and compare the c h i d  spectrum of mfections in 
patients with primary phagocytic disorders. 
Methods: We had extracted data &om the clinical files of patients with the 
diagnoses of primary phagocytic disorders, according to the standard criteria, 
who have registered in the Iranian primary immunodeficiency registry. 
Results: We have reviewed 65 patients (42 males), with the mean age of 
10.7 years at the time ofstudy. They were all diagnosed as primary phagocytic 
deficiency including chronic granulomatous disease (38 patients), leukocyte 
adhesion defect (11 patients), hyper IgE syndrome (8 patients), Chedia- 
Higashi syndrome (4 patients), and Schwacbman syndrome (4 patients). In 43 
of our patients, the parents were fmt-degree relative. The leading infections 
were in the form oflymph node involvement (40 patients), abscess formation 
(37 patients), and pneumonia (35 patients). Abscesses have mostly occurred in 
the skin (31 patients), followed by liver abscesses (6 patients), pulmonary 
abscess (3 patients), and perianal (2 patients). The other sites of abscess 
formation were in the breasts, paravertebral, eyes, neck, and the teeth. 
The causative organism in most ofthe cases was S. auras. The other infections 
were otitis media (21 patients), diarrhea (21 patients), oral candidiasis 
(16 patients), tuberculosis (12 patients), cellulites (10 patients), sinusitis 
(10 patients), septic arthritis (8 patients), and osteomyelitis (8 patients). We 
also had 6 cases with disseminated BCGosis and three patients with asper- 
gdlosis. Most of these infections were caused by catalase-positive organisms. 
On the whole, respiratory system was the leading site of involvement. 
Conclusion: Phagocytic disorden should be considered in any patient with 
recurrent abscess formation in different organs of the body especially in the 
lymph nodes and the skin. Thus, any patient with a hstory of recurrent and/ 
or unusual abscesses should have a full assessment of the immune system. 
m] Dysregulation of myeloperoxidase level and 
life-threatening Candida infection in subjecb receiving 
cancer chemiotherapy 
A. Tokarz, M. Koziol-Montewka, B. Gabczynska, E. Staroslawska, 
E. Kosior and J. Oles 
Lublin, P 
Background: Systemic fungal infections are a great problem in patients 
receiving cancer therapy. In those patients profound neutropenia following 
chemiotherapy is a serious risk factor for opportunistic fungal infections 
associated with high risk of mortality. Phagocyric cells represent tbe first line 
ofdefense in the conml of Gndidu infection. Those ceUs are able to kill yeast's 
cells by activation of the respiratq burst and the dominant mechanism 
involves the myeloperoxidase-dependent pathway. 
Objective: Evaluation the connection of MPO level with frequency of 
colonization and invasive Candida infections in patients undergoing che- 
miotherapy. 
Methods: The clinical samples were obtained from 31 women with carci- 
noma ovariorum after the third come of treating with aggressive specimen 
Tax01 and cisplatin, without symptoms of systemic &gal infection. They 
were examined for fungal colonization of mucosal membranes and presence of 
Candida antigens in bloodstream. For antigen detection we used Platelia 
Candida. The level of MPO wa3 determined using ELISA method. The 
control group consisted of 21 healthy persons. 
Results: Routine culture on Saburaud agar and biochemical identification of 
Candida species demonstrated that five patients were colonized on two or 
three sites. 4 ofthose persons were also positive for antigen presence in 
bloodstream. The mean level of h@O in persons colonized with Candida was 
5.9ng/mL (range (n9.5). In patients with no Candida infection, the mean 
level of MPO was 33 ng/tnL. and in control group: 1691 ng/mL. 
Conclusions: The results indicate that in the group of patients with drastic 
decreased level of MPO, there was frequently Candida invasion observed. 
Generally decrease of MPO level in oncologic patients is a predisposing risk 
factor for invasive Candida mfectiou. 
/p11731 Continuous infusion of ceftazidime for patients 
with breast cancer and multiple myeloma receiving 
high-dose chemotherapy and peripheral blood stem-cell 
transplantation 
G. Egerer, C. Harter and A. D. Ho 
Heidelberg, D 
Objectives: This prospective study was performed to examine the safety and 
efficacy of a continuous infusion ofceftazidime in neutropenic febrile patients 
after high-dose chemotherapy (HDCT) and peripheral blood stem-cell 
transplantation (PBSCT) and to determine if the underlying disease would 
represent a risk factor for infectious complications. 
Methods: From September 1995 to May 2000,55 patients with breast cancer 
(BC, group I, 54 females, 1 male) and 32 patients with multiple myeloma 
(MM, group 11, 10 females, 22 males) were included in this study. The febrile 
patients received 2 g  intravenous bolus of ceftaudime, followed by a 4-g 
continuous infusion per 24 h using a portable infusion pump. If the fever 
persisted for 72 h, a glycopeptide antibiotic was added. 
Results The me&an age was 42 years (range 22-59) in group 1 and 52 years 
(range 35-63) in the group 11. A total of 35 BC patients (64%) and 20 MM 
patients (63%) responded to the monotherapy of ceftazidime. After combina- 
tion with a glycopeptide antibiotic, 11 patients vs. 10 patients became afebrile. 
The causes of fever in group I were: fever of unknown origin (FUO) in 49 
patients, microbiologically documented infection (MDI) in 5 patients and 
clinically documented infection (CDI) in 1 patient. The causes of fever in 
group 11: FUO in 22 patients, MDI in 8 patients and CDI in 3 patients. 41 
fever episodes of the BC patients (75%) were success~y  managed by out- 
patients treatment, vs. 22 episodes in the MM patients (69%). Sigmiicantly 
more episodes of MDI and CDI occurred in patients with MM (P=  0.05). 
Conclusion: Continuous infusion with ceftazidime is efficacious in both 
treatment groups. This study showed that patients after HDCT and PBSCT 
with BC and MM could be treated as outpatients. A close monitoring by a 
physician is essential to assure the safety. The outpatient treatment contributes 
a better use of health care resources. 
1 P I  174 I Immunosuppression after experimental stroke 
causes severe lung infections 
K. Prass, C. Meisel, J. Braun, I. Viktorov, C. Hoefich, K. Ruscher, 
J. Priller, T. Wolf, E. Halle, H. D. Volk, U. Dimagl and A. Meisel 
Berlin, D; Moscow, RUS 
Objective: Extensive epidemiological studies have demonstrated the high 
incidence of severe stroke related infections and their prominent role for 
morbidity and mortality in stroke patients. 
Methods: We subjected mice to an experimental regional cerebral 
ischemia (stroke) by occlusion of the middle cerebral artery (MCAO) for 
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durations from 30 min to permanent occlusion. Fourteen hours, 2, 5, 14 or 
42days after experimental stroke the N m a l s  were killed and blood, 
the thymus, and the spleen were harvested. We analyzed the tissues 
with FACS for the leukocyte subpopulations CD3+, CD4+, CD8+, 
CD45R+, DX5+, and CDII+ 0. We measured the proportion of apoptotic 
leukocytes by annexin-V-staining. We further performed functional testing of 
monocytes (TNF-GI) and lymphocytes (IL-4AFNa) with stimulation by 
C o d  and LPS, respectively The lung, thymns and intestines were examined 
histologically. Thymus histology included TUNEL-staining. Thymus-DNA 
was tested electrophoretically for laddering. Microbiological assessment was 
based on cultures ofblood, bowel, and lung tissue of animals killed 3 days after 
stroke. 
Results The FACS-analysis demonstrated an early onset and long-standing 
reduction of circulating lymphocyte population, predominantly of NK- T- 
and B-cells. With annexin staining, we found a massive apoptosis rate of 
immature CD4+8+ thymocytes and of splenocytes. The apoptosis of 
thymocytes corresponded with a macroscopic atrophy of the harvested thymi. 
Beyond the demonstrated lymphopenia we observed a pronounced monocyte 
and lymphocyte dysfunction. The microbiological blood and lung tissue 
cultures of animals 3 days after stroke displayed a high bacterial load (mainly 
E. colI). This corresponded to the clinically observed septicemia and pneu- 
monia. 
Conclusion: Experimental stroke leads to an early onset and long-lasting 
lymphopenia as well as a significant dysfunction ofthe remaining lympho- and 
monocytes. The immunological organs thymus and spleen are not spared. 
Ths immuno-suppression syndrome provides the hasis of a high vulnerabhty 
for mainly pulmonary Gram-negative infections. Our findings warrant the 
evaluation ofspecific immuno-modulatory and antimicrobial strategies in the 
adjuvant therapy of strokes. 
vl The risk factors for candidemia in lung cancer 
patients after surgery 
M. Koziol-Montewka, A. Miroslaw, K. Buczynski, A. Chndnicka, 
A. Tokarz, A. Sidor-Wojtowicz and S. Jablonka 
Lublin, P 
Background: Invasive candidemia is a life-threatening complication especially 
in hospitalized cancer patients because of surgical operation. Early diagnosis 
and evaluation of the range of risk-factors leading to the better prognosis and 
prophylactic chemotherapy of those patients are still a major challenge. 
Candida colonization, dysfunction of humoral and cellular immune system 
and prolonged periods of hospital staying are considered as the high-risk 
factors of invasive candidemia development. 
Objectives: Rate of Candida nasopharyngeal colonization at the first and last 
day ofhospitalization, number of invasive Candidu infection after surgical lung 
operation and relationship to immune factors (TNF-a, IL-12, C-reactive 
protein and myeloperoxidase concentration) and term ofhospital staying were 
studied in 108 patients with lung cancer. 
Results: Forty-three (39%) ofhospital admitted patients were colonized with 
Candida in nasopharynx and additional 12 patients were colonized during 
hospital-stay. Pneumonia and wound infections were observed in 15 patients 
and 10 of them (66%) had been colonized with Candida at the fjrst day of 
study Candida albicans as the only pathogen was isolated from three patients. 
There was some relationships between colonintion and infection by Candida 
and tested immune factors but significant relahOnShipS between candidemia 
and myeloperoxidase concentration (13.1 ng/nlL vs. 170 n g / d  in healthy 
persons) were observed. 
Conclusions: Our study confirmed that patients suffered from lung cancer are 
at high risk of infections with pathogenic Candidu species that at high 
percentage colonized those patients in mucosal membranes of pharynx. 
Colonization is a progressive process during hospital staying and decreased 
immune factors might predisposed to infection incidence. 
Ip11761 Frequency and clinical significance of Esrhericbia 
w/i bacteremia caused by ESBL-producing strains in 
neutropenic patient 
A. Micozzi, E Tagherti, P. carfagna, E Brandimarte, M. Falcone, 
M. Venditti and E? Martino 
Rome, 1 
Introduction: Over the last 15 years, numerous outbreaks of infection with 
organisms producing extended-spectrum beta-lactamases (ESBLs) have been 
observed world-wide. The advent of these pathogem has represented a great 
threat to the use of many c k e s  of antibiotin, particularly cephalosporins, and 
an associated mortality ranging from 42 co lW?. 
Aim of the study: Retrospective evaluation of the frequency and clinical 
significance of ESBL-producing E. coli bacteremia in neutropenic patients at 
Department of ‘Biotecnologie Cellulari ed Ematologia’ Policlinico Umbeno I 
University of Rome ‘La Sapienza’. 
Methods All E. coli blood isolates from January 2001 to October 2001 were 
idencifted as ESBL producers strains according to NCCLS criteria. 
Results During the study period, 4 (lG??) out of 42 E. coli blood isolates were 
found ESBL producers. Review of clinical charts revealed the urinary tract as 
the source of infection in two cases and failure of ceftriaxone plus amikacin 
therapy in dl septicemic patients with ESBL-producing strains. Piperacib- 
azobactam was used as a second line therapy in all these patients and cure was 
obtained in three. The remaining patient eventually improved with mer- 
openem theram. 
Conclusion: Our preliminary data confiim poor efficacy of third generation 
cephaiosporins and suggfft a potential role of piperacillinazobactam a p h t  
serious infection caused by ESBL-producing E. coli. 
Tuberculosis and related infections 
1 P I  177 I Epidemiologic and clinical features of 
tuberculosis: a review of 139 cases reported from 
19% to 2000 in a general hospital in Pis, Italy 
Ital,: I 
M. Bonadio, C. Gigh, M. Meini and L. Carnegha 
Objectives: To describe epidemiological and clinical features of tuberculosis 
(tbc) cases identified recently in the hospital of Pisa (Tuscany, Italy). 
Materials and methods: We performed a retrospective study of all cases of tbc 
notified to the Public Health Service in Pisa during January 1996-December 
2000. The diagnosis of tbc was made following the criteria of the WHO. 
Results: A total of 139 pts (83 males and 56 females) atrected by tbc were 
identified. Diagnosis was microbiologically proven @ositive culture for 
M. tuberccrlosis) in 81 pts. Mean age was 53.8 + 20.5 SD year (range 16-87). 
Thirty-five pts were extra-European community citizens (mostly &om 
Africa). The incidence of tbc (N/lOOOOO) was 8.4 in 1996 and 6.8 in 
2000. Sixty-eight percent of pts had puhnonary tbc, 24% extrapulmonary 
and 7% mixed tbc. Extrapulmonary tbc w a s  more fIequent in extra-European 
community citizens than in Italian ones. Seven pts (5%) were presenting also 
advanced HIV infection. Microscopic examination for acid fast bacilli in 
spurn.  or bronchial secretion resulted negative in 17.4% of proven pulmon- 
ary tbc (positive culture for M. t u b ~ l o s i s ) .  The chest X-ray showed pleural 
effision in 19 pts and cavity formation in 42 pts (more fiequently recognized 
at CT imaging). Fever was not present in 42.4% of the pts at the moment of 
diagnosis. About 3.8% of the isolated strains of M. tubercltlosis were in v im 
multidrug-resistant. 
Conclusions: The data presented showed an important rate of tbc in Pisa, 
similar to the incidence of tbc reported by other studies carried out on a 
national scale. We have yet to understand if the decreased rate observed in 
2000 represents a new trend as reported in other north American counmes. 
The isolation rate of multidrug-resistant strains of M. tuberrulosis in Pisa seems 
to be sirmlar to the rates reported in other areas of Europe. 
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(p11781 Tuberculous meningitis in non-HIV children 
S. Florescu, E. Ceausu, P. Calistru, 0. Dorobat, 0. Cotrut and L. Paun 
Budrarest, RO 
Obieaives: To analyze clinical features, laboratory findings and prognosis of 
TBM in non-HIV children. 
Methods: A total of 51 children with TBM admitted in our department in last 
6  yea^ were retrospectively studied. 
Results: T3M in children represented 27.8% &om all patients @ts) with TBM 
recorded in above-mentioned period of time. Age distribution was: <1 years: 
5 cases; 1-3years: 9 cases; 4-6years: 13 cases; 7-l0years, 8 cases; and 14- 
16 yeas: 8 cases, with limits between 7 months and 16 year of age. A total of 
24 pts (47%) were refereed &om rural areas. F d y  exposure to TB infection 
was documented in 20 cases (39.2%) and 11 pts (21.5%) had personal history 
of TB. Twenty children (39.2%) had concomitant active pulmonary TB. 
Meningeal signs dominated clinical presentation in all cases; 13 pts (29.4%) 
had cranjal nerves palsies, 7 pts (13.7%) -pyramidal signs, 6 pts (11.7%) had 
acute urinary retention, and seizures were noted in 7 children (13.7%). Coma 
was recorded in 14 cases (27.4%). Mean CSF cells count was 482 cells/mm3, 
with significantly lower values in group under 7 years of age (n = 30) versus 
children >7 year (n = 21) (304/mm3 vs. 586/mm3, P <  0.05); lymphocytic 
predominance >90% was found in 82.3% of cases. Protein level in CSF was 
greater than 1 g/L in 78.4% of pts. Direct CSF smem revealed AFB in 21 cases 
(41 -1%) and CSF cultures were positive for Mycobocten’um tubenulocis in 14 pts 
(27.4%); both CSF-sediment staining and CSF cultures were positive in three 
pts (5.9%). Five pts with coma eventually died. Neurological sequelae were 
noted in 12 pts (28.5%). Nine pts died (17.6%) and seven cases ofthem were 
<7 years. 
Conclusions: TBM in children represents a high proportion of all TBM cases 
admitted in our clinic. Most of the cases are recorded in children less than 
I0 year of age. Most of the children had history of TB or exposure to TB. 
Mortality and neurological sequelae remain high. 
(p11791 Tuberculous meningitis in 
children - epidemiological, clinic and biologic aspects 
E. Nicoara, D. Stanescu, V. Musta, N. Nicolescu, V. Lazureanu and A. 
Dragulescu 
Timicoara, RO 
Objectives: To study the epidemiological, clinic and biologic aspects of 
tuberculous meningitis in children. 
Methods: Retrospective analysis of20 cases hospitalized in our clinic with the 
diagnosis of tuberculous meningitis between 1994 and 2001. 
R e s u b  The following results were obtained: the highest incidence was 
noticed in the preschool age group (50%), the disease afEecting more the 
girls (60%) and the patients of urban origin (65%). Only, in 20% of cases 
there was evidence of contact with an infected patient. Seventy percent of 
cases had no other determination of the infection, 15% of cases were severe 
forms with encephalitic component. The extent in time of the debut 
varied tiom 1 week to Zmonth, the hospitalization period being extended 
up to 60 days for 15 patients. The spinal fluid at the admission was clear in 70% 
of patients, in 14 cases the cell count results were under 300cells/m3 
and only in seven cases there were 100% lymphocytes. Most tuberculous 
meningitis (85%) had low level of glucose, elevated proteins up to 2 g/L and 
low chlorine levels in the spinal fluid. The diagnosis was established on 
positive acid-fast stain (75%) and/or cultures on Lowenstein-Jensen medium. 
Six patients developed hydrocephaly and three patients presented brain 
abscesses. 
Conclusions: The recrudescence of tuberculosis noticed in the last 
decade is associated with the increase of the number of bacluary meningitis 
and meningoencephalitis. Nervous system tuberculosis is a severe 
form of infection with high risk of complicatiom and not favorable 
evolution. 
Ip11801 Concomitant occurrence of bronchopleural and 
pleurocutaneous fistula from Mycobacterium tubemhsis 
pulmonary infection 
C. Papahtathiou, S. Mchaelidis, M. Zoumberi, A. Damianos and 
G. Kouppari 
Athens, GR 
Objectives: The presentation of a rare case of concomitant existence of both 
bronchopleural and pleurocutaneous fistula h m  M. tubenulocis infection in a 
patient with a history of past pulmonary tuberculosis. 
Methods: The samples were examined for the presence of Mycobactm’urn spp. 
All samples were cultured on two Loewenstein-Jensen and smears were 
examined after Ziehl-Neelsen staining for acid-fast bacilli (AFB). Identifica- 
tion and susceptibility testing of isolate was carried out by the National 
Mycobacteria Reference Center. A 78-year-old woman was admitted to 
hospital owing to a growing right-sided subcutaneous tumor-like lesion on 
her an teda ted  chest area, during the past 2 months. In her past history she 
reported having pulmonary tuberculosis (diagnosed 30 or more years ago) 
which was incompletely treated. The patient had been well until 2 months ago 
when the cutaneous lesion started to develop but no other symptoms were 
present. On examination, there was a rather soft bulslng cutaneous mass, 3 cm 
in diameter with a fistula of 2.7 cm on its surface which was located over the 
rlght anterior d a r y  line at the fifth intercostal space. No signs of inflam- 
mation were detected over the lesion but a whitish pus-like fluid could be seen 
oozing h m  the fissure. Chest radiography revealed extensive calcified right 
fibrothorax, but no signs of parenchymal lesions. By the use of methylene- 
blue dye which was injected into the fissure of the cutaneous lesion, the 
existence of both bronchopleural and brochocutaneous fistula was established. 
Samples of sputum and cutaneous lesion fluid were collected for direct AFB 
smear and cultures while biopsy was obtained &om the cutaneous lesion. 
M .  tubenuloris was grown f b m  cultures (sensitive to rifambicin, ethambutol, 
isoniazid and resistant to steptomycin) while histological findings in biopsy 
were typical oftuberculous granulomas. The patient was given a standard anti- 
TB regimen and surgical intervention followed for dramage of pleural 
empyma and management of fistula. The patient was discharged from hospital 
in a good condition with appropriate instructions. 
Conclusions: Coexistence of bmnchopleural and pleurocutaneous tubercu- 
lous fistulas is a rare but recognizable complication of reactivated past 
pulmonary tuberculosis. Radiological signs of extensive pleural involvement 
and history of incompletely treated past pulmonary TB infection can facilitate 
the dmgnostic work-up in these cases. 
Ip11811 Selection of a Mycobacterium tuberculosis strain 
after dissemination in patients co-infected with two 
different clones 
M. Marin, D. Garcia De Viedma. J. Martin, M. S. Diaz, L. Alcala, 
M. J. Ruiz and E. Bouza 
Madrid, E 
Objectives: Single episodes of tuberculosis (TB) can be caused by co-infection 
with more than one clone of Mycobactedum tuberculosis (MTB). Polyclonal 
infections can also be found in cases of disseminated TB, but it has not been 
established whether both strains are present in the diEerent body sites or 
whether a clonal selection (compartmentalization) could occur in the dif- 
ferent body locations. 
Methods: Three patients with documented co-infection with merent MTB 
strains in two independent body sites (respiratory and extrarespiratory) were 
studied. Isolates b m  each body location were plated onto solid medium to 
obtain isolated colonies. Ten colonies were picked from each sample and 
molecular fmgerprints were obtained by spoligotyping and double-repetitive- 
elements-PCR (DKE-PCR) . 
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R e s u b  In two patients, the colonies analyzed were all identical for the same 
sample but different when comparing respiratory and extrarespiratory sam- 
ples. In the third patient, two different typing patterns were obtained for the 
colonies selected &om the respiratory sample but only one ofthese two strains 
w a s  detected in the analysis of the extrarespiratory sample. 
Conclusions: A clonal compartmentalization is observed in the dissemination 
ofTB. The selection of a specific clone for dissemination in one of the patients 
suggests that this compartmentalization is mediated by selective events. These 
findings must be considered in the management ofptients with disseminated 
tuberculosis. 
1 P I  1821 Mycobacterial infections in a general hospital 
during a 2-year period (November 1999-Nowmber 2001) 
C. Papaefstathiou, M. Zoumberi, S. Nikolaou, S. Anagnostou, 
C. Kostopodos and G. Kouppari 
Athens-Chalandri, GR 
Objectives: To determine the incidence ofmycobacterial infections in general 
hospital during 2-year period and the drug-resistance pattern of isolated 
Mycobacferia. 
Methods: Over 2-year period, 2058 consecutive respiratory and extrapul- 
monary samples kom 1144 patients (25-88years old), were examined for the 
presence of Mywbactm'um spp. Respiratory and urine specimens were pm- 
cessed according to the standard CDC NALC/NaOH method. All samples 
were cultured on two Loewenstein-Jensen solid media and smears were 
examined by microscopy after Ziehl-Neelsen staining. Cultures were incu- 
bated at 37 "C for 6 weeks. Identification and susceptibility testing of isolates 
were carried out by the National Mycobacteria Reference Center in Athens. 
The Amplified Mycobacterium tuberculosis Direct Test (AMTD 11, Gen-Probe, 
bioMerieux) was applied to 64 respiratory and nonrespiratory specimens 
collected h m  60 patients. The MTD-technique was pelformed in samples 
after decontamination. 
Results: A total of 29 Mycobacrerium spp. were isolated fiom the cultures of 
samples, obtained from 29 patients (2.5%). Of these patients 10.3% were 
immigrants. Of the isolates, two were from urine, tsm fiom gastric fluid, 21 
&om respiratory specimens (sputa, bronchial washings), one from peritoneal 
fluid, one h m  pleural fluid, one &om pus of pleurocutaneous fistula and one 
h-om biopsy. Of these, 20 were new cases of tuberculosis and 9 chronic or 
relapses. Smear microscopy for acid-fast bacilli was povitive in 18 samples 
(62.1%). Mycobucten'um tuberculosis complex (MTBC) strains detected in 
samples from 21 patients. Mycobateria other than Mywbacterium tuberculosis 
(MOTT) were detected in eight cases. Of64 examined with MTD samples, 
56/64 were true negative (negative-culture and one w a s  M. avium) (87.5%) 
and 2/64 were false-negative (3.1%) (one gastric fluid, one biopsy). Of the 
M. tuberculosis isolates 9.5% were resistant to streptomycin, 4.wo to isoniazid, 
0% to rifampicin and to ethambutol. Mortality rate in cases of mycobacterial 
infections was 10.3%. 
Conclusions: The incidence oftuberculosis was 2.5%. Multiresistance was not 
recorded in M. tuberculoris isolates. Of the patients, 69% were new cases of 
tuberculosis and 31% chronic or relapses. Mortality rate in cases of myco- 
bacterial infections was 10.3%. 
Ip1183) Tuberculous meningitis clinical features and 
outcome in 27 patients 
B. A. Besirbelhoglu, A. Acar, A. F. Aydin, U. Dizer and A. Pahsa 
Ankara, TR 
Objective: To study the clinical features and outcome in adults with tuber- 
culous meningitis. 
Patients and methods: Twenty-seven patients (24 male and 3 female; ages 
ranged 19-68 years old) of tuberculous meningitis were reviewed retrospec- 
tively. The cases had been diagnosed at Gulhane Medical Military Hospital 
(Ankara, Turkey) between 1997 and 2000. The clinical manifestations and 
outcome for each case were analyzed and included in the study. 
Results: The clinical symptoms and signs on the admission were fever, neck 
stiffness, and headache in 27 (100%) patients; alteration in consciousness and 
focal neurological signs in 15 (55.5%). hemiplegia and seizures in one (3.7%). 
Fourteen patients were in the 1Erst stage of the disease (rational, no focal 
neurological signs or hydrocephalus), 12 in the second stage (confusion OF 
focal neurological deficit), and one in the third stage (stuporous or dense 
paraplegia or hemiplegia). A b n o d  chest X-ray were found in three (1 1 .l%) 
patients ( d a r y  pattern in two patients. pleural effusion in one). Cranial CT 
showed hydrocephalus in eight (29.6%) patients, tuberculomas in four (14.8). 
All the patients were treated with antituberculous drug and steroids. The 
overall mortality for all of the patients was 14.8% (four cases). Permanent 
neurological sequelae were shawn in nine patients (33.3%). Fourteen patients 
(51.8%) recovered completely. 
Conclusion: Tuberculous meningitis continues to be an important problem in 
developing countries, including Turkey. The disease has significant mortality 
and morbidity rate. Therefore, it should be considered in the differential 
diagnosis in any patient presenting with fever, headache or neck stifkess; early 
diagnosis must be performed and specific therapy must be started without any 
delay. 
(p1184( Mycobacterium kansasii infections in patients 
with cancer 
M. V. Leal, M. J. Unzaga, E Garcia, V. Bustamante, J. Garms, 
J. A. Crespo, R. Shchez and R. Cisterna 
Bilbao, E 
Objective: The aim of this study is to know epidemiological features of 
M .  kansasii infection in patients with cancer. 
Patients and methods: We reviewed the medical records of all patients with 
cancer who were cared at our hospitals from which M .  kanrasii was isolated. 
First, we applied ATS diagnostic criteria for nontuberculous mycobacterial 
duease to the cases and then, patients were further classified according to 
modifted criteria into: definitive disease (all ATS criteria), possible disease, 
probable-definitive disease, pulmonary/gastmintestinal colonization, indefi- 
nite and disseminated disease. 
Results: M. kansasii was isolated i b m  16 patients with cancer which were 
cared for at Basvrto and Santa Marina hospitals from 1998 to 2ooo. Nine 
patients had lung neoplasm, two ofthem with metastasis and anothex one with 
laryngeal neoplasm. Seven patients had the following localization of neo- 
plasm: two laryngeal, one Kaposi's sarcoma, one testicle, one stomach, one 
prostate, and one non-Hodkmg lymphoma. Fifteen patients (93.8%) were 
male. Mean age was 65.93yem (range, 25-81 years). Four were HIV-positive 
and 12 HW negative. The most common symptoms were weight loss 68.8%. 
cough 56.3%, sputum production 37.5%. fever 31.3%, dyspnea 31.3%, and 
chest pain 12.5%. The predisposing factors were COPD (62.5%), hepatopathy 
(25%), and gastrectomy (25%). Acid-fast bacillus smears were positive in 25% 
(4/16). No patient had dmeminated disease. A total of 16 patients yielded 
pulmonary isolates, eight (50%) of them were classified as having definitive 
disease as met all ATS criteria, one (6.3%) as possible disease, five (31.2%) as 
colonization and two as indefinite. Four of the nine patients with pulmonary 
disease (definitive and possible) according to our criteria, did not receive 
ancimycobacterial agenrs (two died before culture results were available). In 
the group classified as pulmonary colonization, two HIV-positive patients 
started treatment and none of the two H W  negative. The only patient with 
gastrointestinal colonization was HIV positive and was treated too. The 
ancimycobacterial regimen included isoniazid, ethambutol, and rifampicin 
after M. kansasii was confirmed in culture. 
Conclusions M. kamasii causes dlsease and is a colonizing agent in cancer 
patients. In our area of Bilbao, M .  kansarii disease has recently shown to be 
frequent in patients with cancer and should be suspected. 
Ip1185j Mycobacferium kansasii disease in Bilbao, Spain 
M. V. Leal, M. J. Unzaga, F. Garcia, V. Bustamante, J. G d s ,  R. Shcbez, 
J. A. Crespo and R. Cisterna 
Bilbao, E 
Objective: The aim of this study is to know the clinical significance of the 
isolates and the epidemiology of the infection. 
Patients and methods: We reviewed the clinical records of all patients with 
M .  kansasii isolated from culture specimens at the Basurto Hospital from I998 
to 2000 and at the Santa Marina Hospital from 1998 to June of 1999. First, we 
applied ATS diagnostic criteria for nontuberculous mycobacterial disease to 
the cases and then, were further classified according to modified criteria into: 
definitive disease (all ATS criteria), possible disease, probable-definitive 
disease, pulmonary/gastrointestinal colonization, indefinite and diswminated 
disease. 
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Results: During the 3years study period, M .  kmrsarii was isolated h m  96 
patients: 30 HIV-positive and 66 HIV-negative patients, with male predo- 
minance (5/1) and a mean age 53.51 (range, 25-90years). The mean age of 
HIV-negative patients was 20 years older than the H N  positive. There were 
two HIV-positive patients with disseminated disease. The geographic analysis 
was restricted to the area ofBilbao that contributed to 83% of patients and one 
was excluded because of homelessness. The peripheral districts of Bilbao 
showed higher incidence. The predisposing fictors were COPD (33.3%), 
hepatopathy (22.9%). gvtrectomy (13.5%) and neoplasia (19.4%). There was 
higher frequency of COPD in HIV negative (P< 0.05) and greater propor- 
tion of hepatopathy between HIV positive (P < 0.05) The respiratory symp- 
tom were cough (61.6%), dyspnea (28.1%). hemoptysis (18.8%). and chest 
pain (17.7%). Fever was more frequent in H N  negative (P< 0.05). Chest X- 
rays showed infiltrates (38) or cavity lesions (35). HIV-positive and -negative 
patients did not differ significantly in chest X-rays. The predominant 
pulmonary presentation was unilateral and in the right upper lobe. 
Chest X-rays didn’t show abnormalities in seven patients, four of them 
were HIV positive. Multidrug regimen containing isoniazid, rifampicin 
and ethambutol was initiated or previous therapy was changed when M .  kaa- 
snrii was recovered in 67.7% of patients, 24 HIV positive and 41 HIV 
negative. Only 57.28% patients met strict ATS criteria but according to 
our criteria 70% had M .  kansasii related disease. Positive isolates also appeared 
in pulmonary colonization in (12.5%) and gastrointestinal colonization in 
(2.08%). 
Conclusions: ATS criteria, with their requirement for multiple positive 
specimens may be excessively strict for clinical purposes. 
I P I  187 1 Risk factors for a bad outcome of patients with 
tuberculosis in a pneumological intensive care unit 
K. Oettel, R. Erbes, M. RafTenberg, H. Mauch and H. Lode 
Berlin, D 
Objectives and methods: Until recently, just a few studies focussed on risk 
factors contributing to a bad outcome among patients with pulmonary 
tuberculosis in ICU-treatment. We reviewed the clinical records of63 patients 
being admitted for pulmonary tuberculosis in our pneumological intensive 
care unit within the last 11 years. 
Results: Among the patients were 58 with tuberculosis and 5 with atypical 
mycobacteriosis. Flfty patients were males and 13 females. Mean age was 
48yem (15-84years). The w e d  in-hospital mortality rate was 23.8%, none 
of the patients with atypical mycobacteriosis died. Six patients had a positive 
HIV-testing, but AIDS did not correlate with a bad outcome. Factors 
associated with a bad outcome ( P <  0.01) were proven chronic pancreatitis 
in the patients history, as well as development of nosocomial pneumonia, 
acute renal failure, ARDS, bacterial septicemia and ventdator-associated 
pneumonia under therapy. The need for mechanical ventilation was also 
associated with a bad outcome. 
Conclusions: We conclude, that preexisting chronic pancreatitis, the need for 
mechanical vendation as well as complications under therapy like develop- 
ment of ARDS, acute renal failure, nosocomial pneumonia, ventilator- 
associated pneumonia and bacterial septicemia are strongly associated with 
a bad outcome among patients being treated for tuberculosis or atypical 
mycobacteriosis in an ICU. 
Jp1186] Clinical and epidemiological characteristics of 
tuberculosis among Italian and foreign-born patients in 
Ip11881 Molecular epidemiology of tuberculosis in 
Eauatorial Guinea 
Brescia. Italy 
G. R. TudB, M. Obama, J.-M. Espasa, J.-R. Rodriguez, I? Franco, . .
J. S m o  and M. G o d e z  
Barcelona, E; Bata, GQ I. El-Hamad. C. Scolari, M. Pezzoli, S. Tedoldi, S. Casari, S. Caligaris, 
L. Scanmuzza and G. Boschi 
Brescia, I 
Background Tuberculosis (TB) is an emerging problem among foreign born 
persons who recently immigrated into I+. The definition of clinical and 
epidemiological characteristics of TB in this population is important in order 
to define specific interventions for prevention and care. 
Objectives: To describe and compare clinical and epidemiological character- 
istics of TB among Italian and foreign patients in a hospital setting. 
Methods: We have systematically included in this analysis all TB cases 
observed at the Institute of Infectious and Tropical Diseases of the University 
ofBrescia during the period 199U-1999. TB diagnosis has been based on TB 
culture isolation in all cases. We have retrospectively reviewed the clinical 
charts to collect information on age, gender, origin, skin reactivity to 
tuberculin, HIV serology, site of the disease, sputum results, drug-suscept- 
ibility pattern. 
Results: This analysis include 187 cases. The annual incidence has shown 
an increasing trend during the study period fbm 15 cases in 1990 to 39 
cases in 1999, representing 0.94 and 3.54% of all hospital admission in the 
infectious disease unit in 1990 and 1999, respectively. The increasing 
trend was highest for foreigners and for HIV-negative patients. Male repre- 
sented 77.5% of the cases, the mean age was 36.4 years. The site ofthe &ease 
was pulmonary in 35.3%, extrapulmonary in 37.4%, and pulmonary 
and extrapulmonary in 27.3%. H N  co-infection was diagnosed in 43.9% 
of the cases, more commonly among Italian patients (70.5% vs. 20.5%, 
P =  0.001). Extrapulmonary disease was more frequent among foreigners 
(46.7% vs. 28.4%, P =  0.035); disseminated disease was more eequent among 
HIV co-infectedpersons ( 3 9 % ~ ~ .  18.1%, P =  0.001). Sputumsmearpositivity 
was similar in Italian and foreign patients (60.3% vs. 63.4%) and among HIV- 
positive and HW-negative cases (56.2% vs. 66.5%). More foreigners had a 
positive tuberculin skin test ((76.7% vs. 54.5%, P =  0.028) and HIV-negative 
persons (78.8% vs. 44.4%, P =  0.001). 21.7% ofTB isolates were resistant to at 
least one drug, with similar rates among Italians and immigrants (23.7% vs. 
20.3%) and HIV infected and non infected (20.4% vs. 22.7%). Resistance rates 
to rifampin and isoniazid were 3.1 and 12.4%, respectively. 
Conclusions: We observe an increase in TB rates, in particular among foreign 
HIV-uninfected persons. 
Objective: To study the molecular epidemiology of tuberculosis (TB) in 
Equatorial Guinea. 
Methods: Restriction kagment length polymorpbisrn (RFLP) analysis asso- 
ciated with IS6110 was used to study M. tuberculosis isolates obtained from 
1999 to 2000 from five districts of Equatorial Guinea. Patients whose isolates 
had identical patterns were grouped into clusters. Clinical, epidemiological 
and demographic data were reviewed to iden* risk factors for TB transmis- 
sion. 
Results: Five hundred and six patients were dugnosed as having TB (47.8% 
with positive culture). A total of 185 (77.5%) of the 239 culture-positive 
pulmonary TB patients were available for RFLl? DNA fingerprinting iden- 
tified 21 clusters: one cluster with 25 isolates, two with 15, one with 8, two 
with 6, three with 4, three with three, and f d y ,  9 with two isolates. Of all of 
the isolates of the positive cultures, 18.8% were resistant to one or more 
antituberculous drugs. Most of these resistant isolates were from among the 
largest cluster and were isoniazid resistant. Univariate analysis showed that 
resistance to antituberculous drugs was a factor observed significantly more 
frequently among patients infected with a clustered isolate. 
Conclusions: The level of clustering (61.6%) observed in this study suggests a 
high degree of recent transmission or the scarce polymorphism of the isolates 
because of the high prevalence of TB in a country with 47.7% of the study 
population living on an island. 
I P I  189 1 Clinico-microbiologic particularities of 
extrapulmonary tuberculosis (1 997-2000) 
h r ,  RO 
Objectives: The aim of this study is analysis of the cases of extrapulmonary 
tuberculosis and the particularities of M .  tuberculosis resistance to antituber- 
culous drugs between 1997 and 2000. 
C. Luca, T. Turcu, V. Luca, C. Dorobat, R. Scum and L. Ghibu 
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Methods: Retrospective study on 132 patients with extrapulmonary tuber- 
culosis (meningitis, renal, bone, &on tuberculosis, tubeiculosis pericar- 
ditis and generalized tuberculosis) at the hospitalized patients in the Clinic of 
Infectious Diseases of Iasi, Romania, between 1997 and 2000. They were 
analyzed fiom the clinic, microbiologic and therapeutic point of view. 
Isolation and identification of M. tuberculosis were realized by conventional 
method. 
Results: The 132 patients with extrapulmonary tuberculosis presented 116 
meningitis (11 with VIH infection); eight cases - generalized tuberculosis 
(three cases - polyserositis, two cases - granulia, two cases - meningitis with 
granulia), three cases presented ganghon tuberculosis, three cases - bone 
tuberculosis, one case - ovarian tuberculosis pericarditis. We observed the 
prevalence of the male sex with 62.12% cases, the age of patients varied 
between 5 months and 71 years old, with the prevalence of the young adult. 
The testing of antibiotic sensitivity was effectuated on 68 s h i m  of M. tuber- 
culosis, to isoniazid, streptomycin and rifampin; 60.20% strains being sensible 
to isoniazid, 20.8% to streptomycinand 14.7% to rifampin; the multiresistance 
being to 29.4% M. tuberculosis strains. The evolution under therapy with 
quadruple association of antituberrulous drugs was favorable in 91.6% the 
lethality being of 8.3%. 
Conclusion: Multiresistance of M .  tuberculosis represents a problem of tuber- 
culosis therapy, in some cases of being necessary the association of fluor- 
oquinolons, as the fifih anti-tuberculous drug. 
(p11901 Gammadelta T lymphocytes in the peripheral 
blood of tuberculosis (TB) patients with and without 
HIV co-infection: a prospective study 
A. Cmalho, A. Matteelli, S. Tedoldi, <:. Casalini, L. Scaramuzza. 
S. Pirovano, S. Caligaris, M. Gulletta and P. Airz, 
Bresda, I 
Objective: To compare the profile of gammadelta T cell population in the 
peripheral blood of TB patients with and without HIV infection at the time 
TB diagnosis is established (time 0) and at the end of a 6-month anti-TB 
treatment (time 6). 
Methods: From December 97 to October 01 consecutive TB patients f h m  
the Department of Infectious Diseases, Spedali Civili, Brescia were e n d e d  in 
the study. CD4+, CD8+ and Vdeltal and Vdelta2 T cell counts were 
analyzed at time 0 and time 6. Lymphocyte surface membrane expression 
was evaluated with the FITC-TCRgammadelta, -Vdeltal , -Vdelta2 and PE- 
Vdeltal monoclonal antibodies (mAbs). 
Results A total of 107 patients (73% male, 78% foreign born, 33% HIV +) 
were evaluated at time 0 and 41 reviewed at time 6. Median percentage 
(range) of total lymphocytes, CD4f , CD8+ , total gammadelta T cells and 
deltal and delta2 subsets among TB patients according to HIV serostatus at 
time 0 and time 6 are presented in Table 1. 
Table 1 Mema percentage (range) of total lymphocytes, CD4+, CDS+, gammadelta-T 
cells and deltal and delta2 subsets (time 0 and time 6) among TB patients according to 
HIV serostatns 
W H W +  TBHlVf  W W +  TBHHTV+ 
n tulle 6 tulle 0 -6 
ceu pouvhon " = 33 n=33 P-due' n=72 "=?a P&C' 
'Wilcoxon's rank test. 
Conclusions: Our results suggest a redistribuhon of lymphocyte population 
among HIV-seronegative TB patients after anh-TB therapy, with an incre- 
ment of total lymphocytes percentage and Vdelta2 cells but wth a reduction 
of TCD4 lymphocytes and Vdeltal subset. Among HIV-sempositve TB 
patients we observed a tendency to total lymphocytes increasing without 
signlficant changes among the other subsets. 
1p1191) Altered expression of phagocyte Fcg receptors 
in active tuberculosis: effects of therapy 
P. RUE, F. J. M o h ,  S. P. Rometo, J. A. Bernal, A. A. Garcia-Egido, 
C. Rwera and F. Gomez 
Cadiz ,  E 
Background: Macrophage and granulocyte recepton for IgG (FcgRs) are 
important in host defense against infechon. 
Objectiws: We have studied the expression of FcgRs by peripheral blood 
monocytes (M), rnonocym cultured for 72h (M/M0), and granulocytes (G) 
in patients w th  active Tuberculosis (TB), during antituberculous therapy 
(anti-TB-Rx) and, after compehaon of anti-TB-Rx. 
Methods: The surface expression of the three type of FcgRs, FcgRI, FcgRII 
and FcgRIII, on M, W M 0  and G were ana lyd  by flow cytometry in 37 
HIV-negative patlents vvlth TB (33 men and 4 women), at diagnosis of TB, 
and monthly thereafter until competition of anti-TB-Rx. FcgRs e x p w o n  
was assessed on reshng M, M/M0 and G, and on these cells after stimukhon 
by culture m the presence of IFNy. 
Retultr: The expression of FcgN and FcgRIII by M, M/M0 and G was 
ugtllficantly enhancedin patients wth achve TB by: 43 f 4% and 22 f 2% for 
M, respectively (P < 0.001), 58 3~ 6% and 42 f 4% for M/M0, respectively 
(P<O.OOl) and, 139f9%and37f3%for  G, respechdy (P<O.OOl). The 
expression of FcgRII by M, M/M0 and G was slgfllficantly decreased by 
respechvely. These dterahons of pbagocyte FcgRs expression returned to 
n o r d t y  after 8 weeks of effeChve anti-TB-Rx and, r e w e d  normal unul 
the end of TB treatment, The expression of the three types of EcgRs, FcgFLI, 
FcgRII and FcgRIII by M, M/M0 and G from patients with TB was 
sipficantly increased by culture rn the presence of IFNy (P<O.OOl). 
Nevertheless, the expression of FcgRII by M, M/M0 and G from patients 
after effechve anti-TB-Rx was not sigdcantly increased by culture m the 
presence of IFNy. 
Conclusions: Macrophages and granulocytes from HIV-negahve patients mth 
active tuberculosis exhibit an mcreased expression of FcgRI and FcgRIIl and, 
an Impaxed expression of FcgRII. These alterations of phagocyte FcgR 
expression during active tuberculosis disappear after effechve anhtubercdous 
therapy. 
-36+1% (P=O.O2), -473~3% (P<O.OOl),  and - 2 9 f 1 %  (P=0.002), 
Childhood tuberculosis in the indigenous Warao 
population in Venezuela 
C. Ferdndez de Larrea, C. Fandiiio, D. Lbpez, B. del Nogal, 
N. Rodriguez, J. Convit, Z. Araujo and J. de Waard 
Caracas, VE 
Objectives: A definite dqnosis of childhood Tuberculosis is difficult in rural 
areas that do not have access to a large hospital. The Warao people ofthe Delta 
Amacuro State, Venezuela, have a very high prevalence of adult TB, and we 
suspected that the Warao children would also have a high prevalence, almost 
entirely undiagnosed. 
Methods: We applied a simple methodology to select chddren suspicious for 
tuberculosis that is based on a rating system using clinical criteria, reactivity to 
tuberculin and intradomicilliary contact. 
Results: Of the 502 children less than 15-year-old that were evaluated with 
this rating system, 27 were determined to be suspicious and further evaluated 
with a chest X-ray. Radiological confinmation ofTB was found in 16 ofthe 27 
suspicious children (60%). Of these 16, 13 were PPD positive and 7 patients 
had additional confirmation; 3 were positive by culture or smear examination 
and 5 were positive using a serologic TB diagnostic test. The prevalence of 
chddhood tuberculosis in this population studied was 3.3%. 
Conclusions: This methodology proved to be highly efficient in diagnosing 
childhood tuberculosis in this population, and should also be useful in other 
rural populations with a high prevalence of adult TB. 
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vl Immigrants are becoming the majority of TB 
cases in Milan metropolitan area 
L. R. Codecasa, M. Ferrarese, G. Besozzi, C. Lacchini and V. Penati 
Milan, I 
Objective To evaluate the incidence of immigrants among TB cases in Milan. 
Methods: We retrospectively analyzed our TB cases survey h m  January 1990 
to November 2001 (461 1 pts). Patients ranged yearly between 346 and 420; in 
2001 (January to 15 November) were 356. 
Results A total of2877 subjects (62.4%) were Italians or from E.U. countries, 
while 1734 (37.6%) were immigrants from developing countries (IDC). In 
1990, IDC represented 21% of the survey while in 1995 and 2000 were, 
respectively, 35 and 55%. In 2001,215 LDC (60.4%) were diagnosed. Among 
the Merent ethnic groups, PhiIipinos and North Afirican Arabs were, 
respectively, 45 and 3wo in 1990, and decreased to 14 and 12% in 2001, 
while East Europeans and PeruviadEcuadorians increased in the same years 
&om, respectively, 4 and 3% to 9 and 34%. Lkewise, West Atkans and 
immigrants from Indian Subcontinent increased from 5 to 13% and f h m  0 to 
8%. 
Conclusions: In the considered period, the number of TB cases seen per year 
at our Center remained substantially stable. However, Italians continued to 
decrease while IDC constantly increased, becoming the majority of cases since 
year 2000. This phenomenon has not yet been observed at national level, but 
is similar to what has already happened in other European Countries. Among 
IDC, while some groups remained stable in absolute numbers, others 
continued to increase in absolute and relative numbers, mostly because of 
a more recent immigration in our area. 
v] lroniazid preventive treatment (IPT) in children: 
a 443 case Italian survey 
L. R. Codecasa, M. Ferrarese and G. Besozzi 
Milan, I 
Objective: To evaluate adherence, tolerability and effectiveness of IPT in 
children <14years old. 
Methods: A total of 443 children, 225 Italians (It) and 218 immigrants from 
developing countries (IDC) received the recommendation of IPT (November 
199SDecember 2000). as recommended by WHO/IUATLD. IPT consisted 
of isoniazid 10 mg/kg (max 300 mg daily), usually for 6 months; 227 children 
were close contacts ofcontagious TB cases (124 It, 103 IDC), ofthese 100 had 
an initial negative Mantoux test and IPT lasted 2months until a second 
Mantoux w a s  performed. 
Results: A total of367 subjects (190 It, 177 IDC) completed the treatment; 15 
of them reported adverse reactions (AR) that did not cause IPT discontinua- 
tion (three increased AST/ALT, one vomiting, three gastritis, two headache, 
two unrest, one cramps, two itchmg). Flfty-five children did not complete 
IPT. five because of AR (two sight disturbances, two headache, one liver 
intolerance); 12 interrupted IPT spontaneously, 15 refused IPT before 
starting, 22 were lost to follow up. Twenty-one patients are still under 
treatment. So far, only one case of active TB occurred in a ‘close contact’ 
child. 
Conclusions: IPT confirmed to be a well-tolerated treatment in children 
(4.5% overall side-effects incidence). IDC children completed IPTas often as 
the Italians, while in the adults it has been observed a laver adherence. In our 
experience, IPT proved so far to be effective in preventing the development of 
active TB disease &om recent infection. 
v] A systematic review of the adjunctive use of 
systemic corticosteroids for pulmonaty tuberculosis 
N. Ahmed and R. Smego 
Karachi, PAK 
Objective: To determine the safety and benefit of adjunctive systemic 
corticosteroids in the management of pulmonary tuberculosis. 
Methods: A systematic review of 10 placebo-controlled clinical trials invol- 
ving the use of prednisone, prednisolone, and/or adrenocorticotropin 
(ACTH) m conjunchon with standard anhtuberculous chemotherapy. A total 
of 1769 steroid-treated pauents were anaiyzed, most ofwhom had moderate- 
to-severe &ease and cavitahon. The mean dady predrusone or predrusolone 
dose was 32 mg (range lHOmg) ,  and the mean M y  ACTH dose was 40 
umts The mean duranon of steroid therapy was 87 days (range 30480 days). 
C h c a l ,  mcrobiologc, and radiographx outcome measures included tune to 
defervescence, weight gun, normahahon of serum alb- level and 
erythrocyte sedmentanon rate, length of hospitaluatlon, rate and raptd~ty 
of sputum conversion, and radiograptuc regression of pulmonary intiltrates 
and camhes 
Results: Corticosteroid therapy resulted m broad and slgg;iplficant chmcal 
benefits in all studes remewed, and more rapid radIographc resohhon of 
pulmonary infiltrates and, to a lesser extent, closure of cavihes (for the latter, 
especially in the first 4 months but extending up to 1 year after uuhahon of 
treatment) Steroids did not have any appreaable effect on the speed or rate of 
sputum conversion. Detrimental side-effects attnbuted to stemd therapy or a 
hgher rate of bactenologrc relapse were not observed 
Discussion: The adjunctlve use of systemc corhcosterold therapy can safely 
provtde si&~cant early and prolonged chn~cal and radiographic benefits to 
panents with advanced pulmonary tuberculosis 
Ip11961 Sporotrichoid Mycobacterium fortuitum infection 
in a healthy woman during pregnancy 
A. Safdar 
Columbia, USA 
Introduction: Infections owing to the rapidly growing mycobacteria (RGM) 
have emerged as an important though idequent cause of morbidity in 
patients with defects in cellular immune system. In noncompromised indi- 
viduals, these infections may occasionally present as refkctory prosthetic 
surgical device infections. Suppression of cellular immune responses during 
and immedlately after pregnancy are understood, albeit, opportunistic infec- 
tions owing to RGM are seldom seen in this setting. 
Results A painless red nodule developed on the right lower extremity in a 
34-year-old HW-seronegative primigravida during early third trimester 
of normal intrauterine pregnancy. M e r  giving birth to a I11-term healthy 
child, crops of lesions on the proximal lower leg spread caudally. Three 
distinct clusters of excoriated, nodular lesions with an erythematous, indu- 
rate base were present along the anterio-medial aspect of tibia. Otherwise, 
her physical examination was normal. Laboratory studies showed: WBC 
6.6k/pL, platelets 277k/~L, AST 19U/L, ALT 16U/L, antinuclear anti- 
bodies <1: 40, RF < 25 IU/mL, Aqgotensin-1-Converting Enzyme 23 U/L, 
TSH 2.62 pIU/mL, and ESR 20mm/h. Underlying facial compartments and 
bone were normal on three-phase 25.0mCi technetium radionuclide bone 
and MRI scans. Biopsy of the right-leg lesion showed extensive necrotizing 
granulomas in the deep reticular dermis, and abundant superficial and deep 
dermal infiltration with neutrophils and lymphocytes. No microorganism was 
identified. In 2week5, RGM was isolated h m  skin biopsy specimens. 
Treatment with oral clarithromycin and ciprofloxacin (500mg twice daily) 
was initiated. The DNA sequencing of RGM confirmed genetic relatedness to 
~ y ~ b ~ ~ u ~ ~ o ~ u ~ f u ~  and results f antimicrobial susceptib&ty (MIC pg/mL) 
are as follows: amikacin 0.25, cefoxitin 8.0, ciprofloxacin 0.06, clarithromycin 
2.0, doxycycline 0.12, erythromycin 0.25, and imipenem 0.25. Nine months 
following antibiotic therapy her lesions resolved completely. 
Conclusions: Pregnancy is associated with suppression of T cell-mediated 
immunological responses and may rarely lead to opportunistic infections. De 
novo cutaneous and subcutaneous infections owing to RGM are extremely 
rare, and sporotrichoid lymphatic spread has been observed. In my patient, 
response to oral combination antibiotic therapy lead to an excellent clinical 
response. 
[mi Tuberculosis in dialysis patients 
H. Arslan, E Oner-Eyuboglu, F. Ergn, S. Akcay, S. Taymaz and 
N. Ozdemir 
Ankara, TR 
Background: Immunocompromised patients w t h  chronic renal failure have 
an increased risk of tuberculosis and extrapulmonary mvolvement is reported 
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to be predominant in this group of patients. The aim of this study was to 
determine the incidence and clinical presentation of TB in hemodialysis 
patients (HP). 
Methods: We evaluated retrospectively the incidence, clinical characteristics, 
thoracic and extrathoracic involvement of TB in 510 HP during a 4-year 
period. (between October 1998 and October 2001) 
Results The overall incidence was 3.6%. The infection was limited to 
intrathoracic cavity in 38.4% of the patients, a single extrapulmonary side 
in 54.8%. It  was disseminated in 6.8% of the cases. In patients with extra- 
pulmonary TB, lymph node involvement was predominant with a ratio of 
35.6% in all TB patients followed by peritoneum (6.8%), bone (5.5%), kidney 
(4.2%), muscles (2.7%). The most common symptom was fever, which was 
observed in 76.7% of the patients. 1% of the patient gave a h to ry  ofprevious 
exposure. PPD skin test was anergic in 63%, >10 mm in 26%. < l o r n  in 
11% of the cases. TB diagnosed by sputum smear (7.5%), and or culture or 
tissue biopsies which presented caseating granulomas and acid-fast staining 
bacilli. All of the patients were treated with four-drug therapy regiment. The 
success rate was 87.8%, 6.8% ofthe patients did not complete the therapy and 
5.4% of the patients died during therapy because of disseminated TB. 
Conclusions: 
The incidence of TB is higher in HP than general population; 
Extrapulmonary involvement was higher in these groups of patients; 
Because there was a high rate of energy, these patients require further 
clinical evaluation for TB. 
1 PI198 1 Vitamin D deficiency is highly prevalent among 
immigrants with tuberculosis in London 
A. Ustianowski and R. Shaf€er, R. N. Davidson 
London, UK 
Objectives: Vitamin D is known to be important in the host defense against 
tuberculosis, both in vim and in vivo. We previously showed, in a case- 
control study, there was significant Vitamin D deficiency in our Gujrati Indian 
patients, who are vegetarians. We, therefore, extended our observations to 
assess the overall prevalence of Vitamin D deficiency amongst all patients 
diagnosed with tuberculosis in our infectious diseases unit. We could then 
relate the Vitamin D levels to ethnic origin, religion, type of tuberculosis, sex, 
age, time in U K ,  and month of Vitamin D estimation. We analyzed all cases of 
tuberculosis, diagnosed between June 1998 and June 2001, who had routinely 
measured plasma 25-OH-vitamin D levels. 
Results: Ofthe 210 patients, 76% of patients were Vitamin D deficient (25- 
OH Vitamin D less than 22m/L), with 56% having undetectable levels. 
About 68/79 Indian, 23/27 East African Indian, 29/34 Somalian, 7/12 
Pakistani, 7/7 Afghani, 216 African and 15/21 Sri Lankan patients were 
deficient (with 56, 16, 23, 5, 4, 1 and 6 having undetectable levels, 
respectively). In contrast only 0/6 whte Europeans and 1/8 South-east 
Helicobacter pylori I 
Asians had decreased 25-OH Vitamin D levels. Muslims, Hindus and Sikhs 
all had equivalent rates of Vitamin D deficiency. The greatest proportions of 
deficiency were found in patients with miliary, CNS, bone and pleural 
tuberculosis, and the lowest proportions among those with pulmonary TB. 
Among immigrants, Vitamin D deficiency was si&icantly correlated with 
the duration of residence in the UK. 
Conclusions: Vitamin D deficiency is a major feature of patients with TB 
among alI ethnic groups apart from white Europeans and South-east Asians. 
Religion (and therefore a vegetarian diet) appem to play only a minor role; 
possibly lack of exposure to sunlight is a more important determinant of 
Vitamin D deficiency. We consider it probable that Vitamin D deficiency 
contributes to the very high rate of reactivation oflatent TB infection among 
immigrants to the UK. 
/p11991 A comparison between disk diffusion and 
microdilution for susceptibility testing of Mycobctefium 
fortuitum complex 
J Esteban, I. Gadea, M. V Torres, E Cabria, E. RoEn, 
E Santos-O'Connor and R. Ferhdez-Roblas 
Madnd, E 
Objectives: We compared a dssk d&&ion method w t h  the broth mcro- 
ddnhon techmque for suscephbhty tesMg ofMycobactenum forruitum complex 
orgamsms. 
Methods: Nmety-four c b c d  isolates (M.forfurtum (48). M. chelonae (24), 
M mucogenuum (4), M perepnum (12) and M.abscessus (6)) were tested 
together mth  the type saains of the five species. Broth mcroddution was 
performed accordmg to standard techmques. Disk diffusion techmque was 
performed onto Muller-Hinton agar plates mcubated at 30°C during 
3-4 days. Anhbiotics tested were tetracyche, clanthromycm, anthromycm, 
erythromyun A, armkacin, levofloxacm and ciprofloxacm. 
Results: All the strams grew on the Midler-&ton agar plates. SIXIY s t r a m  
grew at 72 h and the other 34 st rams were read at 96 h. Global results showed 
good CorrehhOn for all antunicrobids except for danthromycm and azi- 
thromycm (R> 0.7, P <  0.05). However, when the results were analyzed by 
species, correlahon was poor except for a few anwcrobials. These data can 
be expimed by the polarizahon ofMIC result? for M. chelonae (qumolone- 
resutant and mamhde-suscephble) and M forrutturn (qumolone-susceptible 
and macrohde-resstant) and the fact that 74.7% of the strains tested belonged 
to these species. The analysis of the results for resistadsusceptible results was 
good for all the anumicrobials tested except anthromycin and erythromycm 
Conclusions: The dtsk-&&sion techmque could be useful as a screening 
techmque for some anhnncrobials, except for anthromycm and e r y h m y -  
cm, and perhaps all the bactenostahc anhbiohcs, but the results must be 
confirmed by wing an accepted reference techmque. 
-1 Evaluation of the Oxoid creaFAST(R) H-Pylori 
Combi-Kit for the identification of clarithromycin-resistant 
Helicobacterpylori in gastric biopsies 
F. Lew, D. Cross, P. Quirke, P. Moayyedl and M. MetcaKe 
Leeds, Bariqsloke, UK 
Objecthres: A recent application of in situ h y b n b h o n  is a rapid screemg 
method to idenhfy bacteria m formalin-fixed paraffin embedded specimens. 
The method explain the fact that there are mulhple copies of rRNAmthn a 
bacterial cell, the sequences of which can coIiftrm spenes idenhty, allowing 
development of simple and rapid in SIN hybridization methods. One apphca- 
tion of thls method is the detechon of annbiotic-resistant strams of Helicobacter 
pyfm' m gastric biopsies. Resistance to the macrohdes and in particular, 
clanthroqcin, an antibiotic used extensiveky to treat H. pylori infechon, is 
conferred on bacteria by the presence of three defined mutations within 23s 
rRNA. An in situ hybridmanon method, the Oxoid creaFAST(R) H-Pylori 
Combi-&t, is capable of detechng the macrohde-resistant strains of H. pylon 
in formalin-fuced paraffin embedded gastric biopsies. The method util~zes a 
-re of fluorescent labeled olrgonucleoade probes - fluorescein labeled 
probes specfic for a 16s rRNA H.pylori spec& sequence and Cy3-labeled 
probes specific for the 23s rRNA sequences that confer macrolide resistance. 
A large sample of archival biopsy specimens, h m  UK patients with known 
outcome for clarithromycin based proton pump dubitor triple therapy, was 
investigated to evaluate the spedcity and rehabdity of the method. 
Methods: Eighty-five biopsw were selected from the archive fbm patients 
with clarihmycin-sensitiw strains of Rpylori that had successful or 
unsuccessful eradication therapy and from paaents with clarithmmycin- 
resistant strains of H.pylori. The 4-pm sections were subjected to in s ih l  
hybridzahon as detailed m the ht wth mmor modification. Visualization of 
the hybrid products by fluorescence microscopy using a combined gmenlred 
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filter disclosed both the chkhromycin-sensitive and -resistant strains present 
in each biopsy. 
Results: Identitication of the clarithromycin-resistant strain of H .  pylori by in 
situ hybridization showed close correlation with antimicrobial sensitivity 
testing by disc &ion, defined as no inhibition around a 2-pg clarithro- 
mycin disc. The method was also capable of identifying the presence of 
coccoid forms of H.pylori in the biopsies. 
Condudons: The method illustrates the exceptional specificity of non- 
isotopic in situ hybridization for the identification of macrolide-resistant 
and -sensitive strains of H. pylon'. 
sections in which Helicobacterpylori infection was confirmed by biochemical 
tests and by histological and histochemical examination. 
Results: HBV-DNA was found in all five HBcAg positive liver biopsies of 
Helicobacter spp. The 16s rDNA was detected in all five biopsy specimens of 
gastric mucosal and in none of liver specimens from patients in all groups. 
Conclusions: Our data suggest that Helicobacfer species were not involved in 
the pathogenesis of virus-related HCC and chronic hepatitis or of liver 
metastatic carcinoma. 
m) Identification of H.py/oti directly from biopsy 
specimens by UreC PCR without culture and comparison 
with bacteriological methods 
S. A. Tabibian and SA. Fazely 
Isfaahan, IR 
Introduction: Helicobacter pylori is a microaerophilic Gram-negative fastidious 
bacterium. It has been associated with chronic gastritis, peptic ulcer and 
gastric carcinoma. 
Methods and materials: In the present study by UreC PCR directly without 
culture 79 biopsies were studied and compared with bacteriological methods 
including Gram stain, rapid urease test and culture. 
Results: Sixty-four cases were positive on PCR at sensitivity 91.4% and 
specifity 100%. Seventy-three cases were positive on rapid urease test at 
sensitivity 100% and spechty 66.7%. A total of 71 cases were positive on 
Gram stain at sensitivity 88.9% and specifity 100%. Forty cases were positive 
on culture at sensitivity 57.1% and specifity 100%. 
Discussion: Based on the results obtained by UreC PCR we can iden@ 
H.pylon' directly without culture on biopsy specimens. In comparison with 
bacteriological tests, UreC PCR enjoys a higher degree of sensitivity and 
specifity. In addition to idenafylng the bacterium, we can use methods such as 
RFLP with restriction endonuclease on products of PCR to determine 
genotyping, re-infection, infection with new strain, re-crudesence or drug 
resistance. Also, by using this method we can study in mahgnant cases embed 
tissues including MALTand the role ofH. pylori in the diseases as retrospective 
study. 
/P1202j Lack of detection of Helicobacter spp. in the liver 
of patients with viral chronic hepatitis and hepatocellular 
carcinoma or metastatic liver carcinoma 
N. Coppola, G. de Stefano, A. Giorgio, E Scarano, C. Marrocco, 
L. Tarantino, C. Scolastico and P. Fllippini 
Naples, I 
Objective: To test the hypothesis that Heluoborfer species play a role in the 
enhancement of liver necro-inflamma tion and fibrosis and in the develop- 
ment of hepatocellular carcinoma (HCC), we searched DNA sequences of 
Hetirobacrer species in liver specimens &om patients with viral-related chronic 
hepatitis and HCC or liver metastatic carcinoma. 
Methods: We enrolled 28 consecutive patients with ultrasound evidence of 
hepatic nodule(s) on their first liver biopsy: 21 had a histological evidence of 
HCC (19 males and 2 females; median age 68years, range 4678; Group I) 
and 7 of metastatic liver carcinoma (4 males and 3 females; median age 
69years, range 48-81; Group 11). In the same period we observed 27 
consecutive patients with chronic hepatitis on their first liver biopsy (18 
males and 7 females; median age 52years, range 31-66) (Group 111). Heli- 
mbacter sequences were searched by PCR using primers for the 16s rDNA of 
Helicobacier spp., designed to amplitj a 400-hp fiagment and detected by 2% 
agarose gel hybridization with a specific biotymlated probe. We used, as 
positive controls for the DNA extraction from liver tissue, hepatic-biopsy 
sections in which HBV infection was confirmed by the positivity for HBcAg 
and in which we amplified HBV-DNA by specific primers; positive controls 
for the amplification of Helicobacter spp. were obtained h m  gastric-biopsy 
1 P1203 1 Detection of Helicobacter py/on' cagA gene by 
polymerase chain reaction in gastric biopsies and fecal 
samples 
K. M. Bindayna, W. Al-Baker and G. A. Botta 
Manama, BH 
Objective: The polymerase chain reaction (PCR) has been used successfully 
to detect He[icobacfm pylon f h m  gastric biopsies and gastric juice. However, 
results using feces as biological samples for PCR are conflicting, largely owing 
to PCR inhibitor(s) usually found in stool. Aim of the study was to 
characterize H.pylori genotype in faecal sample using specific primes for 
the cagA gene. To overcome the problem of PCR inhibitors new DNA 
extraction kit was used. 
Methods: One hundred antral biopsies and 40 fecal samples were obtained 
6om symptomatic patient undergoing upper endoscopy. Biopsies were 
cultured using standard H.pylori method. PCR was used to detect cagA- 
positive H.pylori &om both biopsies and stool. 
Results The cagA gene was detected in fecal and biopsy sample of 10/40 
(25%) and 61/100 (61%), respectively. Duodenal ulcer and/or antral erosions 
were observed in 9 of 12 cagA-positive patients (75%) and in 3 of 12 (25%) 
cagA-negative patients. 
Conclusions: Our results indicate that using DNA extraction techniques to 
remove PCR inhibitor will make faecal sample a more suitable for the 
detection of UtgA status in H.pyZori. Moreover, they confirm the existence 
of a sigmficant relationship between UtgA status and duodenal ulcer. 
The evaluation of nested PCR, PCR, culture, 
staining and histopathological results for the detection of 
H. py/ori in gastric biopsy specimens of symptomatic adults 
0. Kisa, A. Albay, R. Mas, B. Celasun and L. Doganci 
Ankara, TR 
Objectives: Infection &om Helicobacter pylori plays a role in several gastro- 
duodenal diseases. Different tests are available for diagnosing H. pylon' infec- 
tion. Polymerase chain reaction (PCR) is a rapid, sensitive and accurate 
method for the specific detection of H. pylon' h m  gastric biopsy specimens. 
The aims of this study were to compare nested PCR, PCR, culture, Giemsa 
staining, and hstological findings and to assess the diagnostic value of these 
tests. 
Methods: In our study, 104 gastric tissue specimens from symptomatic adult 
patients were examined by nested PCR, PCR, culture, Giemsa staining, and 
histological methods for detection of H.pylon'. The infection state was 
considered as positive or negative when the results of at least two of the 
five tests agreed. In this respect, sensitivity, specificity, positive and negative 
premctive values of all groups were determined, and statistical comparisons 
between the results were made with kappa test by using SPSS for Windows 
10.0. 
Results Accodng to our results, positivity was achieved in 24% (25/104) 
with Giemsa staining, 34% (36/104) with histopathology, 36% (38/104) with 
PCR and 41% (43/104) with nested PCR, respectively, whereas H.pylori was 
isolated in only 33% (35/104) of the cultures on the biopsy specimens. Both 
the sensitivity and the positive predictive value of the nested PCR method 
were loo%, and both the specificity and negative predictive value were 98%. 
Only the results of the nested PCR method were in agreement with our 
definition of H.pylori infection state (n=44, P >  0.05). 
Conclusions: As a conclusion, our results suggest the nested PCR as a hghly 
valuable method in the detection of H. pylon' with a reasonably high sensitivity 
and specificity. 
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I PI205 I Detection of anti-Caga antibodies in patients 
with H.pylori gastric infection 
S. Mavrea, I? Douroumani, A. Adamopoulos, D. Alepopoulou and 
E. Anasmakou 
Athens, GR 
Objective: To evaluate the role of detection of anti-Caga antibodies in patients 
with H.pylori (H.P.) gastric infection with dugnosed ulcer of the duodenum 
and chronic superficial gastritis. 
Material and methods: Our study consisted of 80 adult patients with H.P. 
gastric infection. A total of 68 of the patients were diagnosed with duodenal 
ulcer and 12 with chronic superficial gastritis. The diagnosis of H.P. infection 
was based on gastroscopy (two samples of the gastric mucus). The presence of 
H.P. in biopsies was detected microbiologically (microaerophil conditions). 
For the detection and classlfcation of IgA and IgG anti-Caga antibodies were 
used Helicobacter p120 (Caga) ELISA test (VIVA Diagnostica). 
Results: In al l  the patients with duodenal ulcer IgG antibodies anti-Caga 
were found (average optical density 1.12&0.62), when only in 36 
patients were positive IgA antibodies anti-Caga were found (average optical 
density 0.90 * 0.52). Six of the twelve patients with chronic superficial 
gastritis were positive in anti-Caga antibodies (IgG and IgA). Five patients 
had only IgA anti-Caga and the last patient was negative for anti-Caga 
antibodies. 
Conclusion: The presence of IgG anti-Caga antibodies is strongly correlated 
with duodenal ulcer in the course of H.P. infection. This fact is a strong 
indication that Caga antigen plays an important role in the pathogenesis of 
duodenal ulcer. 
(p1207/ A semiquantitative measurement of Heficobacter 
pylori antigen in stools 
R. Monno, E. lerardi, M. Margiotta, A. Costi, L. Marcuccio and 
C. Panella 
Bar& Foaia, I 
Objective: To cordate a semiquantitative measurement of Helicobacter pylon' 
antigen amount in stools with delta value of 13C-urea breath test (UBT) . This 
value has been used to predict the severity of gastric damage and outcome of 
H. pylon' treatment. 
Methods: Fifteen dyspeptic patients with H. pylon infection confirmed by 
positivity to histology, rapid urease test, UBT and stool antigen (Hpsa) 
detection were studied. In a fint stage we tested Hpsa with known amounts 
of H. pylon' (from 0.2 to 2 millions cfu/mL.) both alone and mixed with stools. 
In this way we have obtained a curve of saturation in both cases, even if the 
presence of feces (owing to protein content) increased bacterial concentration 
required to obtain test positivity and saturation point. For the Hpsa measure- 
ment we applied the principle of 'standard points' to the numerical value 
expressed by the absorbency units. 
Resultr: Our measurement of the Hpsa correlated with Delta UBT for each 
patient using Pearson r-test fr= 0.77; P <  0.01). In addition, by Student's t-test 
a significant correlation with the CagA stares was observed for either Delta 
UBT and Hpsa higher values (P< 0.01). 
Conclusions: Our data suggest that an estimation of H.prlm' antigen can- 
centration in stools is feasible and similarly to that reported for Delta UBT 
may represent a semiquantitative determination of H. pylon' load. 
1 Pl206 1 Determination of the antigen in stool for 
diagnosis of H. py/ori infection and value of this method in 
the post-treatment follow-up of H. pylon' eradication 
B. Kocazeybek, R. Memisoglu, N. Memsoglu, S. Aritiirk, A. Ordu, 
Y Tufan and C. Demiroglu 
Istanhi, TR 
Aim: To compare the determination of antigen in stool for diagnosis of 
H.pylori with other invasive methods in cases diagnosed as gastritis and 
duodenal ulcer in terms of etiopatholcgy and to evaluate the effect of this 
method in H. pylon eradication in the post-treatment follow-up. 
Methods and materials: E+ty patients who had been admitted to gastoen- 
terobepatology policlinics of two Merent centers with dyspepsia were 
prospectively included in this study. Endoscopy was performed and they 
were diagnosed as chronic gastritis or gastritis and duodenal ulcer. Four tissue 
samples were obtained during endoscopy for culture, urea determination, 
pathological investigation and PCR studies. In addition to these, HPSA 
investigation of all patients were performed with HPSA E A (Meridian 
Diagnostic, USA) test kit. H.pylori was considered as positive when only 
culture was positive or two out of three invasive test methods were positive. 
HP(+) cases were treated with three antibiotics (omeprazol + amoxich  + 
claritromicin) for 15days. Forty-five patients which could be followed 
1 month after treatment were evaluated a&&. 
Results: Out of 50 HP(+) cases according to the criteria of this study, in 
46 (92%) HPSA were detected positive (sensitivity 92%). Out of 30 HP(-) 
cases, in 27 HPSA were found negative (specificity 90%). Out of 45 HP(+) 
cases which had follow-up after treatment, in 37 (86.1%) infection was 
eradicated. Thirty-five (94.6%) of these 37 cases had HPSA results negative 
whereas in seven cases out of eight having infection HPSA was detected 
positive (HPSA sensitivity after therapy 82.5%, HPSA specificity after therapy 
Conclusion: This study emphasizes that HPSA test in stool samples is an 
accurate and a simple method for identification of H.pyfori infection. In 
addition to this it is also indicated that in the post-treatment follow-up of 
bacteria eradication, HPSA test has more advantages in comparison to 
invasive methods. 
94%). 
Comparison among different laboratory methods 
for the determination of Helicobacter py/ori infection 
M. C. Medori, M. L. D'Annibale and D. Crotti 
Pcrugia, f 
Objective: The aim of this study was to assay two Werent commercial 
methods, for the direct search of H.p. in stools, in comparison with the 
culture, Hurease test, direct identification of the bacterium, in dyspeptic 
patients. Serological tests for identifcation H.p. antigens and CagA cytotoxin, 
were performed on all specimens. 
Materials and methods: Each of 36 specimens was tested by the following 
methods: 
Culture, Hurease test, Bacterial direct identification, Search for the antigen 
All samples with positive culture and/or bacterial direct identification were 
All samples with negative cultme and bacterial direct identification were 
Results: By using the above mentioned criteria we were able to identify 18 
negative and 18 positive specimens. 
in stools with (Meridian H.p. SA, Helory AST Eurospital). 
considered positive; 
considered negative. 
Meridian H.p. SA Helory AST Eumspital 
Negative 18 
Negative specimens 13 
Specificity (%) 72.2 
Positive specimens 5 
Positive specimens 18 
Negative specimem 0 
Sensibility (Yo) 100 
Positive 18 
14 
4 
77.8 
18 
0 
100 
Conclusions: The two commercial methods for the direct search of H.p in 
stools showed 100% sensibility, the Eurospital test showed lugher specificity, 
however, all false-positive samples obtained with both methods were low 
positive. 
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m] Immunaiiagnosis of wicobacter pylori infection 
by femtolab in dyspectic patients 
M. Rosell6, M. Quesada, I. Sanfeh, E Salceda, A. Montserrat, E. Brullet 
and X. Calvet 
Subadell-Barcelona, E 
Intnwluctian. Helicobe pylon' (Hp) is a common human pathogen impli- 
cated in chronic inttammatory process, which may ultimately lead to the 
development of peptic ulcer &ease or gastric carcinoma. Hp antigens can be 
measured in human stools with an enzyme immunoassay (Em) and this could 
turn into a valuable noninvasive diagnostic tool. 
O w v e :  To evaluate the usefulness of a new monoclonal EIA for detecting 
Hp antigens in dyspeptic patients' feces (FemtoLab H. pylon Cnx, Martins- 
ried, Germany). 
-.Gastric biopsies were taken &om 76 dyspeptic patients undergoing 
endoscopy (50 men, 26 women, age range 17-84, mean 52k16.5) for 
histology (H) (haematoxylin and eosin, Giemsa staining) and rapid urease test 
(RUT). The presence of Hp in stool specimens was determined by HpSA 
(Platinum Premier HpSATM Meridian Diagnostic Inc., Cincinnati, USA) and 
Stick H. pyl (OPERON S.A, Zaragoza, Spain). FemtoLab also investigated 
Hp antigens in feces at three d6erent times, which uses a monoclonal anti- 
If. pylon capture antibody absorbed in microwells. Hp status was estahlkhed by 
a minimum concordance of three reference tests (H, RUT, HpSA or Stick 
pyl). Sensitivity, specificity, positive- and negative-predictive values (PPVand 
PNV, respectively) of each determination were calculated. Concordance 
between determinations was estimated by Kappa statistics. 
Re~ults: According to the reference methods the sensitivity and specificity of 
FemtoLab immunoassay ranged &om 98 to loOO? and 84-90%, respectively 
(F'PV. 84-90%, PNV. 94-100%). Correlation coefficients ranged from 0.85 to 
0.92. 
Conclusions: FemtoLab stool test is a highly sensitive and specific test. At the 
same time, the new stool assay was a reliable and easy-to-perform tool for 
diagnosis of Helirobacter pylori infection. 
v] Non-invasive post-treatment assessment of 
H.py/ork a comparison between monoclonal and polyclonal 
stool tests 
M. Zanetti, 1. Luui, M. Gomez Miguel, R. Vendramin and 
0. Pieramico 
Merano, Rome, I 
Introduction: Stool antigen test and urea-broth test are the most accurate and 
widely used techniques for noninvasive assessment of H .  pylorr' (HP) infection. 
A new second-generation stool antigen test based on monoclonal antibodes 
anti-HP has been proposed. 
Aim: The comparison of two different stool antigen tests for post-treatment 
assessment of HP 
Patients and methods: Ninety-seven patients (53 F, 44 M, age 17-73yem) 
have been included. Each patient was treated with standard triple-therapy 
regimen for 1 week. Post-treatment evaluation was performed between 4 and 
loweeks after therapy by means of urea breath-test (UBT) or endoscopy, 
Atherosclerosis: Chlamydia and others 
depending on climcal situation of patient. HP status was assessed by means of 
rapid urease test (RUT), histology (H) and culture (C). HP lnfection was 
conf i ied  XUBT, C or both RUT and H were positive. HP was considered 
absent ifUBTwas negative or, in case ofgastroscopy, all the three invastve tests 
(RUT,C,H) were negaave. Stool specimen were collected, stored, h z e n  
(-20°C) and then tested with two difGerent stool tests (Prermer Platinum 
HpSA Meridan; Ferntolab Connex) accordmg to the manifactures protocol. 
Results: Shown in the following table: 
Tests TP FN FF' TN Sensibility Specificity PPV NF'V 
Ferntolab 42 4 4 55 91% 93% 91% 93% 
HpSA 35 10 2 62 78% 97% 95% 86% 
Conclusions: Both stool tests are easy to perform and results clearly evaluable. 
Owing to the high sensibility and specificity they can be recommended for 
noninvasive evaluation of HP infection after therapy. 
Detection and identification of Helicobacter 
py/ori in gastric biopsy and resection specimens 
T. Babic, H. Basic, V. Katic and M. Otasevic 
Nis, W 
Objectives: To compare the sensitivity of detecting H. pylm' in gastric biopsy 
and resection specimens using traditional detection methods (haematoxyh 
and eosin (HE) stain, modifled Giemsa stain) with immunohistochemistry 
using a commercially available anti-H. pylon' antibody (Dako, Denmark). 
Methods: Gastric a n d  biopsy specimens showing chronic gastritis (28 cases) 
together with tissue blocks h m  gastrectomy specimens for duodenal ulcer 
were histology reviewed. The p& sections were stained with classical 
histological HE and modified Giemsa and immunoenzymatic by alcaline 
phosphatase antialkaline phosphatase (APAAP) method for the identification 
of H .  pylon'. 
Results: The HE, modified Giemsa and immunoenzymatic treated sections 
were carehlly examined for the presence of H.  pylm'. HE-stained H. pylon' 
appeared as slightly basophilic, spiral-shaped organisms attached to the apical 
surface of the surface mucus cells. However, curved bacteria were only 
detected when found in great numbers. Using a modified Giemsa stain, 
the spiral-shaped bacteria of H. pylon' stained blue, were attached to the brush 
border of the gastric foveolar epithelial cells and inside gastric pits. In some 
cases masked bacteria hidden within mucus were obwous only in immunos- 
tained preparations (red deposits). H.pylori was identified in 36.6% sections 
stained with HE, but it could be identified with greater &equency in sections 
stained with modified Giemsa (78.3%). It could be detected at a still greater 
frequency in staining with APAAP (90%). Immunohistochemistry was posi- 
tive in all cases in which H. pylon was detected by other methods. 
Conclusion: Immunoenzymatic staining of tissue sections by the APAAP 
procedure is a highly sensitive and easy to use method for detecting H. pylon in 
gastric biopsy and resection specimens. 
w/ IL-12 and IFN-y serum concentrations in 
abdominal aortic aneurysm (AAA) patients with persistent 
Chlamydia pneumoniae infection 
J. Niedzwiadek, E. Mazur, A. Wolski, J. Michalak and 
M. Koziol-Montewka 
Lublin, PL 
Objectives: The aim of our study was to evaluate the frequency of persistent 
C.pneumoniae infection and its activity in AAA paaents by measuring 
C.pneumoniue specific I&, Igh4 and IgA levels and the concentrations of 
IL-12 and IFN-y in patients' serum. A total of 28 patients operated for AAA (5 
E 23 M, mean age 68.5 years) and 20 control subjects matched for age and sex 
(4 16 M) wthout c h c a l  s w s  and symptom of cardtovascular and 
pulmonary hsease took part iu our stu*. 
Methods: Mmomunofluorescence method was apphed to evaluate the 
level of ana-C pneumoniaa I&, IgA and IgM (C pfieumoniue MIF test, 
Labsystem) The concentrahons of cytolunes were evaluated using ELISA 
method (optELA set, Pharrmngen). The results were evaluated by means of 
Student's t-test and considered stahshcdy slgtllficant when P< 0 05 
Result% Serologx marken of persistent C. pumonrue lnfechon have been 
detected in 25/28 (89.3%) paaents and in 6/20 (30%) healthy controls In 40% 
(10/25) of pahena w~th serologic markers of penistent C pneumoniae mfec- 
hon hgh hters of speclfic IgG (over 1:1024) and IgA (over 1.64) mdxated 
active mfechon-reinfecaon or exacerbaaon of chromc infecaon Mean 
concentraaons 0fK-12 (3.86pgImL) and IFN-y (6 86pg/mL) in thu group, 
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lower than in the rest Ofpahents (IL-12 = 24.94pg/ml, IFN-y = 3 6 . 9 W d )  
and m healthy controls (IL-12 = 17 55 pg/mL, IFN-y = 41 82 pg/mL), can 
lndxate lack of protechon against intracellular pathogens. 
Conclusion: Since all pahents wth achve C.pneumoniae infection were 
&posed as havmg symptomahc AAA, we suggest that achve mfechon 
can exacerbate lnflammahon m the AAA wall. Paaents wth s m a I l  AAA and 
achve mfectlon may be can&dates to antimcrobial treatment, w h h  can slow 
down the progression of the &ease. 
ml Chlamydia pneumoniae-specffic Ig t  and IgA 
antibodies in patients suffering from ischemic ulcerations of 
the legs 
J. Chylak, M. Paul, Z. Cybulslu and W Majewslu 
Poznan, PL 
Objectives: Serum samples taken from 49 pahents (ranging in age from 30 to 
70yean, mean 52.lyears) suEermg from lschemic ulcers of the legs were 
exammed to determme the seroprevalence of IgG and Ig f i  speclfc anhbodm 
agamt C.pneumoniae. Twenty-three healthy blood donors m s& age 
(P=O.43) conshtuted the control group. 
Methods: Specific IgG and IgA anhbodm were determined 111 sera by the 
enzyme munoassays (Labsystems, Fmland, H e l s k ) .  Sera c o n w n g  anti- 
C. pneumoniae IgG anhbodies mth hten of 45 EIU or hgher and IgA mth 
hters of 12 EIU or hgher, were considered pOSlhve 
Results: The results are presented in table The SerOpOSihVIty rate of IgG and 
IgA anhbodm in sera of exammed pahents nras slgmf~candy hgher 
(P< 0.00001) than in the control group 
I& and I&+ Only IgG+ Only IgA+ IgG and IgA- 
Anabodies n % n % n % n %  
Patients (n=49) 29 59.1 8 16.3 5 10.2 7 14.3 
Control (n=23) 9 39.1 5 21.7 2 8.7 7 30.4 
The coexistence of spec& IgA and IgG antibodies was more fkequently 
detected in the patients with ischemic ulcers than in the healthy donors 
(P< 0.00001) 
Conclusions: The higher seroprevalence of anti-C. pneumoniae-specific IgG 
or IgA antibodies may indicate that persistent infection caused by C.pneu- 
moniae occurs more often among patients suffering from ischemic ulcers of the 
legs than among healthy people. 
[m] Infection of chlamydia pneumniae increased of 
serum level of interleukin-l/?, but not interleukin-8 during 
atherosclerosis 
S. Fedorov and L. Glushko 
Ivano-Frankivsk, UKR 
Objectives: Atherosclerosis is a major cause of stroke, coronary heart disease, 
peripheral vascular disease, and aortic aneurysm. Because of the prevalence 
and importance of these diseases. atherosclerotic lesions within arteries have 
been extensively studied. While many risk factors have been identified, the 
mechanism by which the lesions are formed remains unknown. The most 
popular concept is that the endothelium lining the lumen of the artery 
becomes damaged. This damage alters the properties of the endothelium and 
leads to a cascade of events culminating in fibrosis, necrosis, lipid accumula- 
tion, and eventually calcification. There have been several candidates for- 
warded as putative initiators of endothelial injury including microorganisms. 
Recent studies have shown an association between an obligate intracellular 
bacterium, Chlamydia pneumoniae, and atherosclerosis. 
Object and methods: A total of80 patients with stable angina pectoris, FC 111, 
aged fium 44 to 77years and 30 persons of control group were examined. 
Immunoglobulin G (I@) antibodies to C. pneumoniae were measured using 
the ELISA method. Levels ofinterleukm-la (IL-1s) and interleuh-8 (IL-8) 
m serum were measured by ELISA. 
Results: IgG antibodm to C. pneumoniae were found m 48.75% patients wth 
stable angina pectons versus 15.38% persons from control group. Level of IL 
18 111 serum Of SerOpOSihVe to c. pneumoniae patients was 56.03 f 2.25 p g / d  
versus 39.55 f 3.89pg/mL in smnegative patients (P< 0.01). We revealed a 
strong correlation between t i t tes  of anti-C.pwmoniae IgG and ILlg serum 
level (r= 0.96; P<0.05). Lewl of IL-8 in serum of seropositive paaents was 
0.842fO.O52ng/d and in serum of seronegative pahents was 
0.845 f0.042 (P>O.O5). 
Conclusion: The results of' rhis study showed that chronic C pneumontae 
lnfecaon is an independent nsk &tor for the development of coronary heart 
disease. This mfection increases the level IL-lg but not lL-8 m serum. 
Infection of C. pnerrmoniae inc~ases of level IL-10 but not IL-8 in serum of 
patients with stable an& pectorzs. F~nal verificahon of a pathogenetic role of 
chrotllc chlamyd~al infechon in the development of coronary heart disease is 
s a l l  lackmg. 
Ip12151 specific antibodies against ch/myttia 
pneumonlae in patients with advanced atherosclerosis 
M. Karynski, €? Slowinski, I? Gnesiowski, E. Podsiadly, W. Staszkiewicz 
and W. Hrymewicz 
Warraw, PL 
Introduction: Number of studies pointed the association between chronic 
Chlamydia pneumoniae infection and atherosclerosis. The presence of specific 
antibodies in serum is one of the important indicator of the infection. 
Objective: To determine IgA, I@ and IgM specific antibodies against 
C. pneumoniae in patients undergoing carotid endarterectomy due to advanced 
atherosclerosis. 
Materials and methods: The study group consisted of 32 patients aged 45- 
88years (mean age 66years). All patients were undergoing carotid endarter- 
ectomy due to advanced carotid athemsclerotic lesions. The control group 
consisted of 28 children aged 1-3years. Sera were stored at -20°C until 
serological tests were performed. Au sera were analyzed by the EIA test 
(C.pneumoniae IgM EIA, C.pneumoniae IgG EIA, C.pneumoniae IgA EM, 
Labsystems, Finland). 
Results: All tested sera from the study group were negative for antibodies 
against C. pneumoniae in IgM, but positive in IgG of 75% and in IgA of 68.7% 
cases. In control group, 100% of cases were negative for antibodies against 
C. pwmoniae in IgM and IgG, and 86% in IgA. Differences between study 
and control groups were statistically significant (Table 1). 
Table 1 The prevalence of serological markers C. pneumontoe infection in study group 
in cornpartsou mth control group 
Control group Study group 
n % n % P (Fisher tst) 
0/32 0 0128 0 NS' 
24/32 75 0128 0 <O.ooOol* 
22/32 68.7 4/28 14.3 O.Ooo1" 
IgG 
IP 
'NS: not sigdcant. 
Condudon: The results indicated sqguficantly high frequency of m e d  levek 
of C.pneumoniae IgG and IgA antibodies in sera of patients with advanced 
atherosclerosis. 
Is there any link between the presence of 
Chlamydia pneurnoniae (CP) antigen in pharynx, anti-CP 
antibodies in sera and inflammatory markers in patients 
with coronary heart disease? 
I. Choroszy-Ul, J. Ruczkowska, J. Gajek and D. Zysko 
Wroclaw, PL 
Objectives: In 1988 Saikku et al. presented serological evidence of an 
association of Chlamydia pneumoniae with chronic coronary heart disease 
280 Abstracts 
and acute myocardd idarction but still there are controversies in 
causative relation and the pathogenic pathways. The aim of our work 
was to examine the presence of CP antigen in pharyn.., anti-CP antibodies 
in sera and some inflammatory markers in patients with coronary heart 
disease. 
Material and methods: Our study compromised 47 patients (32 men and 15 
women, aged 40-79) hospitalized in 2000-2001 in Clinic of Cardiology 
because of angina peaoris (n= 35) or acute myocardial infarction (n= 12). 
WE measured level of C-reactive protein (CRP), fibrinogen, IgG and IgA 
antibodies against CP in blood samples and examined pharyngeal swab 
specimens for CP antigen. Serologic testing for CP was performed by 
SeroCP-IgG and IgA ELISA test (Savyon Diagnostic Ltd., Israel) while 
test C.pneunroniae-Antigen IFT (Medac, Germany) was used for detection 
CP-elementary bodies (EB) in pharyngeal swab specimens. As a control 
group, we examined 15 age and gender-matched subject, without cardio- 
vascular disorders. 
Results: Antichlamydd IgG and IgA response (>l.l) was found in 39/47 
(82.9%) and 24/47 (51%), respectively, in the control group in 9/15 and 6/15. 
CP-EB in pharyngeal swab specimens were found in 6/47 (12.7%) of the 
examined patients and 2/15 in the control group. CRP levels were positively 
correlated to plasma fibrinogen (r= 0.37, P< 0.05) but were not correlated to 
CP serology and the presence of CP antigen in pharynx. 
Conclusions Higher prevalence rate of IgG- and IgA-specific anti-CP 
antibodies in patients with coronary heart disease than in control group 
may suggest the specific anti-CP immunization in this group of patients. In 
both groups there was no strict association between high seropositivity for CP 
and the presence CP-EB in pharyngeal swab specimens. 
[p1217) Serological study of cytomegalovirus (CMV) and 
Chlamydia pneumoniae (C.pn.) infections in patients with 
coronary artery disease 
E. Chatzoum, E. Logothetis, E. Baimakou, E. Eleftheriou, 
S. Konstantopoulou, 1. Lymperopoulos, K. Kostopoulos and 
E. Kouskouni 
Athens, GR 
lplzlsl Characterization of the cytokine response to 
Chlamydia pneumoniae and Chlamydia trachoma tis 
C. Herrnann, K. Gueinzius and T. Hartung 
Constance, D 
Objectives: Infections with Chlamydia attract increasing interest, since there is 
emerging evidence that Chlamydia pneumoniae (Cp), a common respiratory 
tract pathogen, and C. trachomatis (Ct), a sexually aansmitted urinary tract 
pathogen, are associated with chronic diseases like atheroscIerosis, multiple 
sclerosis and arthritis. All these Chlamydia-associated manifestations involve 
inflammatory reactions, however, not much is known about recognition and 
activation of the immune system by these pathogens. The aim of this study was 
to characterize the cytokine profile released from leukocytes after stimulation 
with Cp or Ct. 
Methods: Human whole blood or murine bone marrow macrophages were 
incubated for 24 h in the presence of f06/mL viable Cp, Ct or I00 pg/mL 
Lipopolysaccharide (LPS, Salmonella abortus equi (S.a.e.)) and cytokine release 
w a s  determined by ELISA. 
Results Both, Cp and Ct induced a distinct cytokine profde, 
Werent from the one induced by LPS. Ct induced similar amounts of 
the pro-inflamma tory cytokines TNF-a, ILl-B and IL8, as well as twice as 
much IFN-y, compared to stimulation with LPS, but less anti-inflammatory 
IL-10. In conrrast, Cp induced significant less of the pro-idammatory 
cytokines and failed to induce any IFN-y, but led to a stronger induction 
of the anti-infiamma tory IL-10. The same results were obtainedwith W- and 
heat-inactivated Cp and Ct. In the presence of a blocking anti-CD14 
antibody, the Cp- and Ct-induced cytokine release was not reduced, while 
the action of LPS was blunted, suggesting that leukocyte activation is 
independent of CD14. Incubation of bone marrow macrophages obtained 
&om C3H/HeJ and TLR2-/- mice revealed that both TLR4 and TLR2 are 
important for the release of murine IL-6 and TNF-a in response to 
Chlamydia. 
Conclusions: Taken together, stimulation of infiammatory responses by 
Chlamydia appear to be only partially dependent on their LPS. Although 
carrying the same LPS, Cp compared to Ct or LPS (S.a.e.) induced a 
predominantly anti-idammatory cytokine pattern, what might be due to 
the involvement of different receptor combinations. 
Objective: To evaluate the possible relation between coronary artery 
cLsease and serological evidence for Chlamydia pneumoniae and CMV infec- 
tions. 
Methods: A total of 272 sera samples were collected and investigated for the 
presence of IgG, IgA and I g M  antibodies against C.pn@umoniae (C.pn.) as well 
as IgG and IgM antibodies against Cytomegalovirus (CMV). A total of 172 
sera samples derived from hospitalized patients (of mean age 
63 f 12years) affected by C O I O M ~ ~  aaery disease (CAD), angiographically 
documented and 100 sera samples fiom healthy subjects (control group) 
with the mean age 5 7 f  10 years, not affected by CAD. Antibodies against 
CMV and C.pn. were performed by ELSA methods, levels of C-reactive 
protein (CRP) by nephelometry and levels of total cholesterol, HDGcho- 
lesterol and triglycerides by an automated biochemical analyzer (enzymatic 
methods). 
Resub In the CAD group, the presence of specific IgG antibodies 
against C.pn. was 79.07%, IgA 74.22% and IgM 4.65% while in the 
control group was 30, 7 and 0%. respectively. Specific I g G  antibodies 
against CMV were detected in the 97.68% of the CAD group and 
IgM antibodies in the 4.65% of them. The percentages in the control group 
were 8.5 and PA, respectively. High CRP values were detected in the 61.63% 
of patients with CAD while in the control group, were found normal values. 
Conclusions: Higher levels of CRP, IgG, IgM and IgA antibodies against 
C.pn. as well as IgG and IgM antibodies against CMV were found in CAD 
group of patients than in control group. According to the results above, it 
appears that there is a possible relation between CAD and chronic infection by 
C.pn. and CMV 
1 P1219 1 Are fungi involved in the atherosclerosis process? 
E. Moahc, J . 2  Elkaim, J. Mansourah, I? Gouny, I.. Doucet, J.-J. Blanc 
and A,-M. Le Flohic 
Brest, F 
Objectives: There is growing evidence of a relationship between some 
infective agents (Chlamydia pneumoniae and cytomegalovirus) and athero- 
sclerotic process. We sought to determine a similar implication between fungi 
and atherosclerosis. 
Methods: We studied atherosclerotic arterial fkgments from 30 patients 
(24 M) undergoing peripheral vascular surgery (aorta, carotid, h o d  and 
iliac arteries) and 30 fragments of nonatherosclerotic internal mammary 
arteries kom patients undergoing coronary artery bypass surgeey (27 M). 
Each fragment was separated to two pieces: one for mycological analysis and 
the other for direct microscopy examination and culture in specific mediums. 
All fragments were handled with strict cautions in order to prevent any 
external contamination. 
Results: Ten (16.6%) fragment cultures showed fungal growth 9 fragments 
originating from atherosclerotic lesions (9/30) and only one from an internal 
mammary artery (1/30, P<0.05). Three fungal species were identified 
Aspergiliur, Cludosporium and Trichodma. No correlation was found between 
the presence of fungi and atherosclerosis risk factors. 
Conclusion: Thls study shows a significantly bigh afhity of some fungi 
species to atherosclerotic arterial intima. Further investigations are needed to 
clarrfy fungal involvement in atherosclerotic process. 
Clinical Microbiology and Infection, Volume 8, Supplement I ,  2002 281 
Gynecological infections 
(p12201 Study of group B Streptococcus (GBS) 
colonization in pregnant women with gestational 
age over 2Oweeks in an Iranian hospital 
S Rabiee and R Yousefimashouf 
Hamadan, IR 
Objectives: To determne the rate of GBS colomzation in the pregnant 
women during 20 weeks and more gestational age m one referral Gyneco- 
1ogdObstetrics center rn Hamadan, we t  of Iran 
Methods: A total of 544 pregnant women selected randomly and two vagmal 
cotton swabs were taken, one for Gram’s s-g and the other for culture. 
The second sample streaked on blood agar medium and incubated at 37 “C. 
After overnight, the colomes were observed for B-hemolysis, then Bantrann 
test was done on 8-hemolysis colomes The Na-hypporate hydrolysls test was 
done on Barifracrn resstant colomes. The posinve hydrolyss for Na-hyppurate 
was considered as GBS posinve. 
Results: A total of 145 women (26 7%) were colomed by GBS There was 
not correlanon and women’s age, gestatmnal age, panty, sexual acnvmes, and 
prevlous contracepnon method 
Condusion: We concluded that GBS colomzaUon m &IS popdahon 1s hgher 
than normal rates mennoned m the text references Because of remarkable 
rate of GBS colonuanon in this area, we recommend doing prophylaxu by 
pemcfin G in GBS-colomzed women that they have a risk factor for 
pregnancy-related mfecnons 
wj A study of risk factors of vaginal colonization 
with group B streptococci, in pregnant women, Trujillo. Peru 
S. Benites Castillo, C. Romero Goicochea, R. Guzman Villa and 
M. Chavez Castillo 
Ttjillo, PE 
Objective: Colonization with group B streptococci (GBS) at any time during 
pregnancy is an important risk factor for neonatal sepsis. We s t u d y  442 
pregnant women to determine the principal risk factors to colonize with GBS 
and we associated with higher or lower colonization rates. 
Methods: We evaluated an instrument made specially for this purpose; 
previously we made a pilot study to determine the validity of this instrument. 
It consisted in questions related to the principal factors in accordance with the 
literature revised, such as social characteristics investigated (age, profession, 
residence, marital status, education, and ochers). 
Results We determined the influence of a previous pregnancy with pre 
presence of GBS. 27.8% were primiparas; 28.Vh smokers; 2.Th with a history 
of alcohol use; 0.9% with a hstory of sexually transmitted disease; 33.5% 
unmarried. No statistically signiftcant differences were found in regard to age, 
weight, marital status, history of drug use. 
Conclusion: The influence of the number of previous pregnancies proved to 
be significant. Pregnant women with two or more previous pregnancies 
tended to be more fkequently colonized than primigravidae or secundigra- 
vidae women. These findings are discussed in relation to the possible reservoir 
of the microorganisms and the route of infection. 
1- Recurrent neonatal invasive group B 
streptococcal disease in Denmark 1984-1999 
K. Ekelund and H B. Konradsen 
Copenhagen, DK 
Introduction: Group B Streptocorns (GBS), is one of the most fcequent causes 
of mortality andmorbidq m neonates. In Denmark, the vast maJority of GBS 
st~?111s tsolated fmm panents ulth mvasive infechon is sent to Statens Serum 
Insutut for survehnce of type dstrihution. 
Objective: Our ann was to esnmate the fcequency of recurrent GBS mfechons 
in neonates (0-90 days of age) m Denmark from 1984 to 1999 and to describe 
the c h c a l  features of these infechons We wanted to put the recurrent GBS 
infecnons in the perspechve of the total GBS mfecnons in neonates received 
m the same period m the Streptococcus Umt 
Methods: Serotypmg of GBS isolates was performed by the Lancefield 
capaary-precipitahon method 
Results: In the period 1984-1999, 402 cases of invasive GBS-dsease m 
neonates (0-90 d a y s  old) was regstered at the Streptococcus Umt. A total of 
221 (55%) of these cases were among boys and 171 (43%) were ~n girls. In 10 
(2%) the sex was not stated The mcidence was 04/1OOO hve births and 
mcreased from 0.1/1000 hve buths m 1984 to 0.8/1000 hve buth in 1995. 
The Streptococcus Umt received 432 GBS isolates from blood or CSF from 
the 402 neonates (0-9Odays of age) 111 the study period. A total 311 (72%) 
were h m  blood and 91 (21%) were h m  CSE The most kequent serotypes 
were serotype I11 (59% (41-83%), Ia 16% (0-32%), Ib 8% (&20%), NT 7% 
(0-33%) and I1 6% (0-15%). Recurrence ofneonatal GBS 1nfeChOn occurred 
mfour (1%) ofthe 402 cases in Denmarkin the period 1984-1999. Three out 
of the four were boys. The mean ages of the cMdren at the first and second 
episode of the mvasive GBS dtchonS were, respecbvely, 5 5 days (0-13 days) 
and 27.8days (2631 days). The mterval ulth no anbbiohc therapy between 
the two episodes varied between 2 and 7days. None of the patient died. 
Isolates fiom three of the patlents were serotype 111 both at first and second 
episode. The isolates kom the remmng patients two episodes were serotype 
la. 
Conclusions: Inwive neonatal GBS Infechon IS shll a fcequent problem m 
Denmark. The lncidence was 0.4/1000 live births in the penod h m  1984 to 
1999. Recurrent GBS d e m o n  occurred only m 4/402 cases (1%). The 
mterval mth  no anubionc therapy between the two episodes vaned from 2 to 
7days In all four cases, the seroty-pe idenafied at both the first and the 
recurrent episode were ~denhcal. Serotype In IS the dommatmg serotype both 
in mvmve neonatal GBS d e m o n  m Denmark 1984-1999 and m the 
recurrent episodes 
m2231 Direct latex agglutination testing of selective 
broth for the detection of Group B streptococci (GBS) in 
pregnant women 
C. Guerrero, A. Menasalvas, R. Cesteros, J. Martinez, T. Rodriguez and 
M. Segovia 
Murcia, E 
Objectives: To determine the value ofthe direct latex agglutination testing of 
selective broth for the rapid detection of Group B streptococcal colonization 
in pregnant women. 
Material and methods: Vaginal and rectal specimens from pregnant women 
were inoculated onto Columbia with colistin and nalidixfc acid agar 
(CNA) and a selective broth (Todd Hewitt supplemented with gentamicin, 
nalidixic acid and 5% blood). After 24h of incubation in 5% COZ all 
negative CNA cultures were incubated for an additional 24 h and all selective 
broth were subcultured onto CNA. In addition, latex testing for GRS was 
performing according to the manufaaurer’s protocol on the selective broth 
after 24h of incubation. Antimicrobial susceptibility by disk Husion 
testing was performed directly fiwn selective broths positive by the latex 
method. 
Results: A total of 114 specimens &om 67 pregnant women with GBS 
colonization and 120 specimens from 66 pregnant women with no coloniza- 
tion were evaluated. Of the 114 positive specimens, the direct latex method 
detected 91 (80.7%). In 23 cases, the direct latex method was negative. Of 
those, there were 11 specimens in which GBS was isolated h m  initial CNA 
but subcultures of the selective broths were negative. Of the 120 specimens 
negative for GBS in only one case the latex method was positive. In this case, 
presence of GBS in the broth was confirmed by inoculation of the broth onto 
a Merent selective solid medium (Granada agar). Autirnicmbial susceptibility 
testing was performed in 96 samples, of those in 68 (70.8%) results were 
available. 
Conclusions: The direct latex test of selective broth is a rapid method for 
detecting GBS colonization but it cannot replace the traditional subculture 
method. 
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I P1224 I A &year seroepidemiological screening for 
C W ,  rubella and Toxoplasma infections among women 
of child-bearing age 
M. E. Alexandrou, E. Zagotzidou, A. Voyatzi, S. Katsigaraki, 
C. Iconomidou, A. Peppa and V. Petrocheilou 
Athens, GR 
Objectha: The aim of the study was to determine the seroprevalence of 
Rubella virus, Cytomegddrus (CMV) and Toxoplasma gondii antibodies in a 
population ofpregnant women in Greece. Findings of the survey will provide 
empirical data on immunization coverage and will help to prevent congenital 
infections. 
Material and methods: During a 4-year period (1997-2000) (A) 1872 Greek 
women (67%) and (B) 922 immigrants form East Europe (32.9%), were 
screened for IgG and IgM antibodies to rubella virus, CMV and Toxopllacma 
gondii. IgG antibody titers to rubella were determined by hemagglutination 
inhibition (Rubeokit, Bio-Rad, F'asteur, France), to CMVand Tmoplasma by 
indirect immunofluorescence (Merifhor CMV IFA, Gull-Meridian And 
Toxo Spot IF, Biomerieux, France, respectively). Enzyme Immunoassay 
method has been used for the detection of IgM antibodies (IMX System 
Abbott lab. Illinois, USA). 
Results: The findings of this study showed that approximately 21.4% of 
screened Greek women and 20.4% of immigrants were seronegative to 
rubella. Values between 50 and 200IU/mL of IgG antibodies were detected 
in 65.2 and 62.9% of both groups A and B, respectively. Increased levels of 
rubelk IgG antibodies (>200 IU/mL.) were found in 15.8 and 13.3% among 
the women of child-bearing age. Seropredence of Toxoplasma IgG antibodies 
(>200 IU/mL) was determined in 2.4 and 3.3% of population A and B. One 
thousand four hundred twenty-two (76%) women and 697 (75.5%) were 
susceptible - IgG antibodm <25 IU/mL) - to Toxoplama. CMV IgG anti- 
body titers (20-80) were found in 1191 and 636 of the 2794 women, while 
626 (33.4%) and 246 (26.6%) were seronegative. Finally. high CMV IgG titers 
("0) were determined in 0.96 and 1.2% of the screened population. 
Seropositive rate of rubella IgM antibodies 0.9%, Toxopllacma 0.9% and 
CMV 2.3% was found in women tested. 
Conclusions: (1) A substantial number of women that were susceptible to a 
primary infection with CMV (about 26-33%), rubella virus (21%) and 
ToxopIatmagondii (76%) was found. (2) The results did not show a statistically 
sigmficant Merence between the two groups of populations examined. (3) 
rubella immunization strategy should be reconsidered for women of child- 
bearing age. 
[m The persistence of antirubella antibodies in 
woman of child-bearing age 
T. Wysokinska, W. Janaszek, B. Bucholc, P. Gonka, G. Gniadek, 
M. Fiejka and J. Slusarczyk 
Warsaw, PL 
Objectives: Introduction of monovalent and conjugated vaccines against 
measles, mumps and rubella helped to decrease sipficantly the morbidity. 
Therefore, World Health Organisation and USA Childhood Immunisation 
Initiative introduced the program of measles and rubella eradication. Rubella is 
a mild disease, usually without consequences and complications. Clinically 
serious is congenital rubella, when nonimmunized pregnant woman is 
infected with rubella virus during first month of pregnancy. The main aim 
of vaccination is associated with elimination of congenital rubella. In Poland, 
the vaccination of 13 old girls was introduced in 1989. The current data on 
serologic status of rubella antibodies in women in reproductive age are 
lacking. The aim of the study was an evaluation of antirubella antibody 
levels in women 15-3Oyears old. It was thought that such data might be of 
value in view ofplanned introduction to the NationalVaccination Program of 
additional vaccination against rubella of woman immediately after delivery. 
Methods: To establish the level of antibody the test kit ETI-RUBEK-G Plus 
Kit Diasorin was used. The method for quantitative determination of specific 
IgG to rubella virus is an immunoenzymatic assay, based on ELISA techmque. 
Results: The total of 865 serum samples has been tested. In 767 sera (88.7%) 
the protective titers of antirubella antibodies were detected. The decrease of 
antirubella antibodies titer together with increasing age of tested women was 
observed. The geometric mean titer of rubella antibody was 158.7 I U / d  
among women at age of 15 years, and 66.8 IU/mL in the age group of 
30 years. Among investigated women 11.3% had no protective antirubella 
antibodies. 
Conclusion: The decrease of antirubella antibody titer together with increas- 
ing age of tested women was observed. It is necessary to take into considera- 
tion possibility of introducing additional dose of vaccine for women in 
reproductive age. 
[p12261 In vitro and in vivo antibacterial activities of 
telithromycin (TEL) against gynecological pathogens 
(33, J p  
Objective: To evaluate in vitro and in vitro antibacterial activities of TEL 
against gynecological pathogens. 
Methods and results: In vim: the antibacterial activity of TEL against recent 
clinical isolates (isolated in 2000) of S. agalactiae (33), E.faecalis (22), Ngomr- 
rhoeae (30). Z? anaerobius (20), E rnagna (20), B.jagilis (25) and I! bivia (30) was 
compared with those of erythromycin A, clarithromycin, azithromycin, 
ampicillin and levofloxacin. TEL inhibited more than 50% of clinical isolates 
of S. &ache, E.f~euzlis, N.gonorrhoeae, I? anaerobius, E magna, B.jagilis and 
Z? bivia at the concentration of 0.016. 0.063, 0.063, 0.032, 0.032, 0.5 and 
0.25 pg/mL, respectively. TEL inhibited more than 90% of clinical isolates of 
S .  agalactiae, Efaecalis, N.gononhoeae, P anaerobiuc, E magna, B.jugilis and 
P biuia at the concentration of 0.016, 4, 0.125, 0.063, 0.063,4 and 1 pg/mL, 
respectively. In vivo: The efficacy of TEL was evaluated using experimental 
intra-abdominalabscessinmicecausedby B.frogilir (MICofTEL: 0.016 pg/mL). 
TEL inhibited the abscess formation and significantly decreased the viable cell 
counts in abscess in comparison with the untreated group. 
Conclusions: These results suggested TEL would be also useful for the 
treatment of anaerobic infections concerning in vitro and invivo antibacterial 
activities. 
H. Mikamo, X. H. Yin, Y. HayasakiandT. Tamaya 
jp1227/ Prevalence and antifungal susceptibility patterns 
of yeasts from women with vulvovaginitis 
F. Zara, R. Mighavacca, C. Terulla, E. Giorgetti, E. Nucleo, M. Spalla, 
R. Brerra, R. Daturi, C. Matti, A. Spinill0 and L. Pagani 
Pavia, I 
Introduction: The number of life-threatening fungal infections observed 
worldwide has increased significantly. The major agents are Candida species 
and C.albicans is the predominant pathogen. The therapeutic choice is 
restricted to a fav agents; among these azoles have been more extensively 
used, but resistance to such drug agents is emerging. 
Objectives: To evaluate the incidence of Candida spp. and other yeasts and 
their resistance to anhfungal agents among patients with vulvovaginitis. The 
relatedness of the isolates h m  patients with recurrent vaginitis was also 
investigated. 
Methods: The population of this study included patients with symptomatic 
vaginitis attending the Department of Obstetrics Gynecology, University 
Hospital of Pavia, Italy. Vaginal and vulvar swabs were collected and cultured 
on Cromo Albicans Agar (Biolife). The fungal isolates were idensled by use 
of the YBC card (Vitek systemBioMCrieux) and confirmed by API-Candida 
(BioMCrieux). Antifungal susceptibility testing was carried out by a broth 
microdilution test YeastOne (Sensititre) and the E-test (AB Biodisk) using 
RPMI 1640 glucose agar plate. Quality control strains included were 
according to the manifactureer. Genotypic characterization was performed 
by the pulsed field gel electrophoresis of genomic DNA using the reagent kit 
four (Bio-Rad). 
Results: A total of 39 specimens &om 36 patients were cultured. The 
identification ofisolates revealed a prevalence of C. albicans (52.9%). followed 
by C. knrsei (17.6%) C.glabrata (11.8%), S. carevisiae (11.8%), and C.parapsilosis 
(5.Wo). The concordance of results obtained with the two identification 
methods used was high (99.8%). C. albicans resulted always sensible to 
amphotericin B, Buconazole, 5-Auqaine and rarely resistant to itraconazole 
and ketoconazole (2%). C. krusei isolates were sensible to amphotericin B, 
itraconazole and 5-flucytosine, resistant to ketoconazole and showed an 
intermediate level of resistance to fluconazole. C. glabrata, S. cerevisiae, and 
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C.pnrapsilosis resulted sensible to the tested drugs. In 26.5% of the cases, the 
results of the two antifungal susceptibility tests were incongruous. 
Conclusions: It seems there may be an increasing trend of nonalbicans species 
in vulvo vaginitis. Further studies are needed to make a surveillance of the 
reifections by the above species because in three patients with recurrent 
vaginitis the latter isolates developed m b c e  to itraconazole and ketoco- 
nazole. 
m( Antifungal activity of the 'paracymeno' 
on Candida species 
C. Pina Vaz, A. G. Rodrigues, S. Costa-de-Oliveira, C. Tmares, E. Pinto, 
A. Martinez-de-Oliveira, L. Couto, C. Cavaleiro and 
J. Martinez-deOliveira 
Porto, Coimbra, P 
Introduction: Vulvovaginal candidosis (VVC) is one of the most common 
gynecological infections. The reduced number ofavailable antifUngals and the 
increasing resistance urged the search of alternative therapy. Previous research 
of our team demonstrated the antifungal activity of some essential oils (1). 
Paracymeno is a component of the essential oils Thymus vulgaris and Thymus 
Objectives: To determine the: (1) antifungal activity of paracymeno, esti- 
mated as the minimal inhibitory concentration (MIC) on commonly patho- 
genic Candida species; (2) effect upon germ tube formation by C. albicam; (3) 
the chemical composition of the essential oil; (4) mechanism(s) of activity by 
flow cytometry (FCM) using two fluomcrom FUN-1(2) and propimum 
iomde (3) .  
Matertals and methods: Ten clinical strains (five C. albicutzs and five non- 
albicans) and two ATCC strains (C.albicans 10231 and C.kmsei], either 
sensitive or resistant to classic antifungds. MIC was determined according 
the NCCLS protocol M 27-A. The ability to form germ tubes was assessed in 
a germ tube formation assay. The composition of the essential oils was 
investigated by gas-chromatography and gas-chromatography/mass spectro- 
metry. The mechanisms of activity were elucidated by flow cytometry using 
propidium iodide (PI) to evaluate Iesion of the membrane and FUN-1 to 
study metabolic disturbance with different concentrations of the oil, after 
serial times of incubation. 
Results: MIC was 1/32 for all tested strains, except for C. krusci which was 
1/16. Dilutions well above MIC concentrations totally inhibited germ tube 
formation. The concentration of paracymeno was 11.7 and 21.2% of essential 
oil of Thymus vulgaris and Thymus zygis, respectively. The ddutions associated 
to an extensive rate of killing induced a permeation to PI, related to a direct 
damage of the cytoplasmic membrane. In a kinetic study assaying the MI€ 
concentration, 15 min were sufficient to produce killing of 57.4% of the cells 
in the suspension. Lower concentrations, unable to produce lesion of 
membrane, induced metabolic disturbance as shown by FUN-1 staining. 
Conclusions: Paracymeno demonstrated a potent andfungal activity, due 
mainly to direct damage to the cytoplasmic membrane of Candida species. 
The essential oil shows however, greater antifingal activity than its compo- 
nent paracymeno. Our results support the we ofparacymeno in the treatment 
of mucocutaneous candidosis, namely W C ,  in case of being devoided of 
toxicity and side-effects. 
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Gardnerella vaginalis and other microorganisms 
from women in reproductive age with colpitis 
A. Samet, E Arlukowcz, J Emerich, W Baranska-Rybak, A. Sledzmska 
and M Kochowska-Bronk 
Gdatzsk, PL 
Objective: Cardnerella vagimlls (GV) is an euological factor of colpitis, a 
sexually transmtted dsease (STD) . The most common symptoms are: v a g d  
i t c h  and discharges wth foul smell and codortIess copdahon. 
Methods: We tested 420 samples  h m  womens' genital tracts. They had 
symptoms of colpihs. They were heterosexual age 24-50. From all of them 
cervical and vapal  swabs were taken Samples were cultured on d&erent 
plates to evaluate aerobes, anaerobes and fungi 
Results: We obtamed 538 bacterial Isolates fiom gemtounnary tract in 
2000years. The most frequent were aerobic: Eschetichta colt (22.9%), Enter- 
ococnrsfaecahs (20.4%) and anamblc: Gmdnerella vaginalts (17.1%), Pqtostrq- 
tococcus sp. (4.1%), Prrvorelh sp. (3.9%). GV was suscephble fo p e m c h ,  
chdamycm, tetracyclme, daxycyche, metromdazde (MET). In spite of 
suscepubhty in vitro to MET we observed some cases chmcally reststant to 
t h s  anhbionc. Successful outcome was obtamed after chndamycm treatment. 
Conclusions: GV is the most common pathogen isolated &om colpihs-Be 
infections (17.1%). We observed that it&ctions* caused by GV had more 
troublesome symptom and were more d&icult to treat than colpitis caused by 
others pathogens. 
Ip123oj The association between bacterial vaginosis, 
cervicovaginal IL-6 level and preterm delivery 
S. Djukic, B. Vranes, N. Opavski, V. MJac, L. Ranin, M. Pervulov and 
M. Bujko 
Belgrade, Podsorica, YU 
Objectives: Bacterial vaginosis (BV) is the most prevalent cause of vapid 
symptoms among women of child-be- age. Several studes have been 
pubIished during the last fav years that suggest that women with BV tend to 
have a higher incidence of preterm labor and premature rupture of mem- 
branes than women with normal flora. An increased level of cytokmes has also 
been found in the vaginal fluid of women with abnormal vaginal flora. The 
a m  of our study was to determine the possible association between BY 
cervicovagmal IL-6 levels and preterm delivery. 
Methods and results Vi5lgUral samples for BV diagnosis and IL-6 analysis were 
taken h m  56 unselectedpregnant women. By using Nugent criteria, BV was 
diagnosed in 35.7%, intermediate flora in 7.1% and n o d  vaginal flora in 
57.1% of exanuned pregnant women. The IL-6 levels m cervicovaginal fluid 
ofpregnant women with BV were higher (median 128.15pg/mL) than those 
in pregnant women with normal vaginal flora (median 118.05pg/mL) 
( P <  0.01). Medcln value of cervicovaginal IL-6 was statistically significantly 
higher among pregnant women with BV who delivered preterm compared 
with pregnant women wth  BV who dehvered at term (P< 0.01). 
Conclusion: Our results show that pregnant women wth  BVand h~gh levels 
of cervicovagml IL-6 deliver more often preterm compared with pregnant 
women wth BV and low levels of ceMcovagIMI IL-6. 
Molecular epidemiological study of vertical 
transmission of vaginal Lectobacillus spedes from mothers 
to newborn infants 
N. Kato and Y. Matsumiya 
Gqu, JP 
Objectives: Lactobacilh may act as probiotics providq  beneficial effects to 
the host by improving the balance of colonic bacteria. Meanwhile, there is 
liale information available re&g how and when infants became colonized 
with lactobacilli in their gut. We investigated mother-to-newborn infant 
transmission of ~ o b w " I h  species in Japanese. 
Methods: Vaginal swabs were obtained fiom the anterior and posterior 
vaginal fornices of pregnant women and the spontaneously defecated stool 
was collected hxn their newborn infmts. All infants were born by uncom- 
plicated vaginal delivery and basically fed breast milk. All specimens were 
cultured anaerobically on LBS agar. Lactobacilli were identified by a two-step 
multiplex PCR to the species level. hcfobadlrrs strains were fingerprinted by 
arbitrarily primed polymerase chain reaction (AP-PCR) using ERIClR and 
ERIC2 primers. 
Results: Of 86 pregnant women tested, 71 (82.6%) were positive for vaginal 
lactobacilli. At 5 days after birth, 24 (33.8%) of the 71 infants whose mothen 
were lactobacilli positive had fecal lactobacdli while only one (6.7%) ofthe 15 
d i n t s  delivered from the vagIMI lactobacilli-negative mothers was lactoba- 
cillipositive ( P <  0.01). Lactobacillus crispatus was the most prevalent species 
as vaginal lactobacilli in mothers and fecal lactobacilli in infants at 5 days of age 
whereas Lactobaciflusgasseri was the most commonin &ts at 1 month ofage, 
followed by L. crikpafus. Identification to the species level followed by M- 
PCR typing demonstrated that 23.3% of the 86 infants were likely to be 
colonized in the intestine by vaginal lactobacilli of their mothers and that only 
two infants ofthem retained the same vaginal lactobacilli until 1 month of age. 
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Conclusions: These results suggest that approximately one-fourth of infants 
acquire vaginal lactobacilli of mothers at birth and that the acquired lacto- 
bacilli do not last in the intestine of the infant for long-term but rather are 
replaced by ones from milk or unknown sources after birth. AP-PCR with 
primers ERIClR and ERIC2 is suggested to be a potential tool for typing of 
lactobacdi. 
The possible influence of H202-producing 
lactobacilli on asymptomatic cervical shedding of Herpes 
simplex virus 
A. Knezevic, S. Stepanovic, M. Cupic, M. Stanojevic and T. Jovanovic 
Belgrade, W 
Objectives: Antimicrobial activity of H202-producing lactobacilli in female 
genital tract represents an important nonspecific mechanism of local host 
defense in the prevention of STDs. The aim of this study was to examine the 
prevalence of H20z-producing lactobacilli and asymptomatic cervical shed- 
ding of Herpes simplex virus type 1 and type 2. 
Methods: The study population consisted of 67 asymptomatic women of 
reproductive age. Vaginal lactobacilli were isolated and identified to the genus 
level by colony morphology, characteristic Gram’s stain and catalase-negative 
test. The abihty of lactobacilh to produce H202 was tested by tetramethyl- 
benzidine (TMB) plate method. Herpes simplex virus types 1 and 2 were 
detected in endocervical smears by the test of &ect immunofluorescence 
with type speclfic monoclonal FITC labeled antibodies. 
Results: Lactobacilli were isolated and identhed &om 54 of 67 (80.6%) 
women. Among the isolated strains of lactobacilli the percentage of H202- 
producing strains was 66.67%. Asymptomatic cervical shedding of Herpes 
simplex virus types 1 and 2 was detected among 4 of 36 (1 1.12%) women with 
H202-producing lactobacilli and among 4 of 13 (30.77%) women without 
isolated lactobacilli. 
Conclusion: The results of this study suggests the lack of correlation between 
the presence of asymptomatic cervical shedding of Herpes simplex viruses and 
the presence of Hz02-producing lactobacilli. 
Hybrid capture based human papillomavirus 
typing in cervical specimens compared to cytology 
(Pap test) and colposcopic biopsy 
l? Petasecca, J. Gaido, S. Votano and A. Fusco 
Rome, I 
Introduction: Human Papillomavirus (HPV) infections are related to several 
cutaneous and mucosal dysplasias, including both benign and malignant 
lesions. recent developments in HPV DNA detection techniques have shown 
that HPV infections in female genital tract are common but the progression of 
the disease may require several facton such as the persistence of the infection, 
the viral load, co-infection with the presence of immunodeficiencies and 
probably the presence of other cofactors. 
Objectives: The utility of a molecular assay for the detection of HPV in 
cervical smears was evaluated. 
Methods: A total of 114 women aged between 21 and 69years (36 median) 
with normal cytology, with atypical squanious cells of undetermined sig- 
nificance (ASCUS), with low (LSIL) and high (HSIL) grade squamous 
intraepithelial lesions in cervical cytology, were studied. In a l l  women with 
ASCUS, LSIL and HSIL, a colposcopically directed biopsies wereperformed. 
hybrid capture (HC It) testing for 14 human Papillomavirus types (digene 
hybrid capture I1 system) were tested on all 114 women. 
Results: Based on cytology results, 40 patients showed normal cytology, three 
ASCUS, 53 LSIL and 18 HSIL. With the molecular assay, HPV D was 
detected in 651114 (58%) patients. the high-risk HPV types was present in 
46/65 (70%) patients, the low-risk HPV types in 9/65 (14%) patients; in nine 
(16%) women was present high and low-risk HPV types. The sensitivity of 
hybrid capture for colposcopic biopsy was 90% (47/52) and a specificity 50% 
(12122); the corresponding values for Papanicolaou smears were 76% (54/71) 
and a specificity 77% (31/40). All the colposcopic biopsies evocative of 
invasive carcinoma, were positive for high-risk HPV presenting a pap smears 
of HSIL lesions. 
Conclusion: HPV detection with the HC I 1  assay represents an easy test for 
routine use, in molecular biology laboratory. In our experience, its sensitivity 
for the detection ofHPV DNA is Iugher than classic cytological smears, 90% 
versus 76%, when compared with ‘gold standard’ of biopsies. This sensitivity 
makes this assay highly recomendable for routine detection of high and low- 
grade lesions, in association with cytological examination. 
Detection of women at risk of developing 
vulvar cancer 
A. Saez, P. Benavides, M. E Sevilla and C. Lozano 
Madrid, E 
Background: The strong association of Human Papillomavirus (HPV) and 
cervical cancer makes important the study of these viruses in vulva, in women 
with HPV high risk (HR) in cervix. 
Methods: We have made a cross-sectional study in 2338 cervical samples, in 
the last 3 years from women with any cytologic and/or colposcopic alteration. 
The DNA-HPV detection tests were: (1) a-PCR-based assay using the 
MY09-MY 11 consensus primers. (2) Hybrid Capture I1 HPV microplate 
assay. The tests were performed without knowledge of the cytologic diagnosis 
and other clinical data. 816 patients had a positive results to HPV HR. In 515 
of them, we made detection of HPV in vulva (Group I). We studied further 
100 women without clinical symptoms (cytology and colposcopy negatives) 
and we have made detection of HPV in vulva (Group 11). 
Results: The positive rates were: Group I: 54.4% ( n  = 280) and Group 11: 12% 
(n = 12), P < 0.001. The rate of positive HPV and the oncogenic risk, high 
risk (HR) and low risk (LR), in each group is shown in Table 1.  In the Group 
I, coincident results between cervix and vulva were obtained in 242 patients 
(86.4%). The most frequent HPV HR was type 16 (31.5%) P < O . O l  and 
successive types were 31 (14.8%) and 61. We have made an OR = 5.6 to the 
patients exposed to HPV H R  in cervix. 
Conclusions: The presence of HPV in d v a  in women with HPV HR in 
cervix was sigdcantly higher (P< 0.001) than in the group without clinical 
symptoms, as the types of HPV HR. In our s t u d y ,  we met 5.6 times more 
HPV in vulva in those patients exposed to HPV HR in cervix. 
Oncogenic risk HPV(+), HPV(+) HPV(+) 
of HPV n (46) HR, n (%) LR. n (%) 
Group I (n= 515) 280 (54.4) 236 (84.2) 44 (15.7) 
Group I1 (n = 100) 12 (12) 5 (41.6) 7 (58.3) 
1 P1235 I Human papilloma virus testing in cervical cancer 
screening: results from a pilot experience in Italy 
V. Ghisetti, S. Franceschi, P. Snijden, A. Gigho-Tos, G. Marchiaro, 
N. Segnan and G. Ronco 
Turin, I; Lyon, F; Amsterdam, NL 
Objective: Estimating HPV prevalence and type distribution in a study group 
representative of the population of Turin, ltaly. In Italy no previous popula- 
tion-based study of HPV prevalence has been available so far. 
Methods: From 699.5 women enrolled in a population based screening 
program for cervical cancer in Turin, Italy, under informed consent (6556 
women) a further cervical sample for liquid-based cytology was collected and, 
after slide preparation, the specimen was stored at -20 ‘C. A random study of 
1048 samples, stratified by age, history of screening and screening unit was 
tested for HPV by PCR, in collaboration with IARC and the Free University, 
Amsterdam. Cytology was evaluated according to the Bethesda System. 
Samples were first prescreened by a B-globin PCR to check DNA quallty, 
then HPV was detected by PCR with general consensus primers GP5+/ 
GP6 + 0. Enzyme immunoassay was used to type high risk (HR) fiom low 
risk (LR) HPVwith two specific cocktail probes. Final typing- achieved by 
a dot-blot hybridization test with specific probes complementary to the most 
common HR/LR HPV Preliminary data are available for 727 samples (720 
B-globin positive). 
Results: HPV DNA was found in 571720 (7.9%) samples. The majority of 
samples were HR positive (42157 = 73.7%). while LR HPV was present in 9/ 
57 (15.8%) and double HR and LR infection was detected in 6/57 (10.5%). 
HPV 16 was the most representative type (37.5% of H R - W  infections). 
The prevalence ofHR HPVinfection was 8.72,9.90,3.80,4.24 and 6.94% in 
age classes 25-34,35-44,45-54,55-64 and >65, respectively. The majority 
of HPV infections (37/57 = 65%) were detected in women with normal 
smears. 
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Conclusions: HPV prevalence was consistent with available data f b m  other 
Western European countries. Since the majority of HPV infection have been 
detected in cytological normal smears, the hypothesis of mo-g the 
primary screening strategy by including HPV test is under evaluation. 
lp12361 Detection of papilloma virus infection in 
progressive cervical neoplasia by in situ hybridization 
M. Niakan, 2. Jamali, M. Izadi, 2. Eftekhar, M. R. Jalali and S. Faghih 
Zadeh 
Tehran, IR 
Cervical cancer is one of the most frequently found cancers in women and 
appears to have a viral etiology. Since HPVs now comprise more than 100 
different HPV types, the in situ hybridization (ISH) has been the preferred 
methodology for virus identification and typing on isolated DNA. We 
examined three groups of patients &om Tehran region. Aged 21-27years. 
The first group comprised 12 females with squamous cell carcinoma (SGG), 
the second group included six females who suffered from cervical intrae- 
pithelial neoplasia (CTN) and two dysplasia. Fonnalin fixed, parafin 
embedded tissue specimens representing 20 cases of gynecology, oncology 
imam and mirza hospitals stage 2 and 3 were used. HPV DNAwas detected by 
ISH with DNA probe kits (ENZO Inc.). All 18 carcinomas were positive for 
HPV6/11 11(6101%), HPV 16/18,10 (55.5%) and31/33/51 14 (77.7%). In 
two patients (10%) HPV types could not been fuaher classified and these cases 
were therefore categorized as HPVX. These findings are consistent with the 
hypothesis that HW infection is the primary cause of cervical neoplasia. 
Furthermore, they support HPV vaccine research to prevent cervical cancer 
and efforts to develop HPV DNA diagnostic tests. 
/p12371 Chronic genital infection and antisperm 
antibody production 
A. Mirshafiey, M. H. Salari, N. Badami and A. Razavi 
Tehran, IR 
Objectives: Our aim was to determine the prevalence and clinical sigdcance 
of genital mfection in antisperm antibody (ASA) production. 
Methods: ASA production using capillary tube agglutination test was inves- 
tigated in 126 women presenting with chronic genital infection and 120 
healthy controls in IVF center of Yazd province-Iran. 
Results: 31.8% of women presenting with genital infection showed Urea- 
plasma urealyricum, 23.5% Chlamydia trachomatis, 21.8% Mycoplama hominis, 
19% Lisferia, 2.2% E. coli, 1.1% Cardrnella vaginalis and 0.6% Mebsiella 
pneumoniae infection. The percenrage of isolation of ASA pathological titer 
(1/16 and >1/16) in patients compared with healthy controls were 74.8 and 
0.8%, respectively. 
Conclusions: These data suggest that chronic genital infection could increase 
ASA production level in patients compared with healthy controls. 
/p1238j Occurrence of Ureaplasrna urearyticum and 
Mycoplasma hominis in patients with genito-urinary tract 
infections in Gdansk, Poland 
A. Samet, M. Kochowska-Bronk, M. Bronk and J. Komarnicka 
Gdansk, PL 
Objectives: To evaluate the incidence and antibiotic susceptibility of U. urea- 
lyticum and M. hominis in outpatients with genitourinary tract infections h m  
January to August 2001. 
Toxoplasmosis 
Methods: Mycoplasma Duo I(lt @to-Rad) and Mycoplsama IST (bioMer- 
ieux) were used to cu l tw U urealyhnrm and M .  hominrs. Anhbiohc suscept- 
ibhty to ofloxacine, tetracyckne, doxycycke and erythromycm was 
dete-ed wth  SIR Mycolasma (Bio-Rad) and Mycoplsama IST (bioMer- 
ieux). Ciprofloxacin achvity was evaluated by broth macrodduhon method. 
Results: A total of 512 specimens were o b m e d  from 382 pahents, 286 
females and 96 men, from 14 to 68years old. The c h c a l  material was as 
follows: 152 cervical swabs, 131 vagmal swabs, 112 urethral swabs, 89 urme 
and 28 semen. U. urealyfhm was isolated &om 80 specimens and M. hominis 
6om 13. From76posihvepatients,60werefemaleand 16men. AUM. hominis 
were suxephble to ciproflmcm, ofloxacme, tetracychne and doxycyclme, 
only 50% to erythmmycm. Dmrycychne was the only umformly achve agent 
apns t  U. urealythm. There was 48% resistance rate among other agents 
agamt U. urealyrtcum. 
Conclusion: U. urealyricum and M hominis were cultured from 20% of out- 
pahens suffering f b m  genitourinary tract mfechons. Doxycyche proved to 
be the most active agent in vltro. Other anhbiohcs were less acuve dependmg 
on the orgamm and the agent. 
New perspectives of povidoneiodine used for 
prophylaxis against Ophthalrnia neonatown 
A. Kramer, H. Below, W. Behrens-Baumann, P. Rudolph, P. Wutzler and 
K. Reimer 
Creijbald, Magdeburg, Jena, Limbug D 
Objectives: In central Europe, neonate conjunctivitis is mainly caused 
by staphylococci, E. coli and chlamydia, whereas N. gononhoeae mfections 
occur rarely. With neonate keratitis nosocomial pathogens predommate, 
the mam ones being I? aeruginosa. Prophylaxis against Opkthalmia neonatonrm 
1s s t i l l  necessary since it reduces the risk of infections that can impair vision 
and even lead to blindness. However, silver nitrate as the former agent of 
choice should be replaced because of the local miranon potential after 
msullatian and the lack of antimicrobial efficacy against chIamydia. Povi- 
done-iodine (pvp-I) was evaluated as possible agent of choice for the Credk 
prophyhs. 
M h o d S :  The bactencidal efficiency ofPVP-I (Bet;usodona(R) soluhon) was 
measured m a quantitative suspension test according to the guidehes of the 
German society for hygene and microbiology The antichlamydial 
aChvity was determined by the reduction of inclusion bodies in McCoy cell 
monolayers detected with immunofluorescence microscopy. The local toler- 
abdity was assessed u m g  the HET-CAM (chorioallantois membrane) test as 
well as the tissue explarit test carried out on the pentoneum of neonatal rats 
PI .  
Results: 1.25% PVP-I has a bactencidal e&ct in vitm wtlw 30s with a 
reduction factor of >5 lg against N.gononhoeae, S. aureus, E. coli, I! amginosa 
and C. harhomatis. By contrast, 1% sdver nitrate and 0.1% eryrhromycin had 
no e&ct at all in 30 s against C. frachomatic. In the HET-CAM test and in the 
explant test the relevant PW-I concenaations were found to be well 
tolerable. With healthy volunteers, 2.5% PVP-I SOhhOn caused pronounced 
b-g; a 1% solution w a s  tolerated without pain. 
Conclusion: Because of the antimicrobial efficacy and the tolerability 1.25% 
PVP-I can be currendy considered as remedy of choice for the prophylaxis 
against ophthalmia neonatorum. 
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I P1240 I Toxoplasmosk serologic control in 
pregnant women 
T. Juncosa, C. Latorre, C. Muiioz-Almagro, A. GenC and 
A. Gonzilez-Cuevas 
Esplugues-Banelona, E 
Introduction: Toxoplasmagondii is an obhgate intracellular parasite of universal 
dmribution. It may be the cause of subclinic infechon m healthy individuals, 
of congenital toxoplasmosis and of severe infections in immunocompromised 
patients. Oral and transplacental routes used to be the most fkquent mechan- 
isms of transmission. Primoinfection is related to low avidity of specific I@. 
Objectives: To know the prevalence of infection in pregnant women in OUT 
population and to evaluate the usefulness of avidity of IgG for the detection of 
primoinfection. 
Methods: All 2754 pregnant women attending our hospital during 1999 were 
screened for toxoplasmosis. First line test was anti-Toxoplasma I&, and, in case 
it was positive, a specific IgM determination was also performed. If these 
antibodies were positive, a test for avidity of specific IgG was then done 
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(positive IgM were previously evaluated in order to eliminate possible residual 
cases). A second sample of serum obtained 3-4 weeks after the first one was 
studied in order to know the evolution of IgG titer. Both I& and IgM 
antibodies were determined by means of a MIA test by the Axsym system 
(Abbott). Tests for avidity of IgG were performed at the National Reference 
Center at hhjadahonda (Spain). 
Results: A total of 679 IgG tests were positive (prevalence: 24.6%). Only 22 
out of these 679 sera had positive IgM (0.7Yh). Three of these patients with 
positive IgM were excluded because they had positive values in previous 
pregnancies, which discarded a recent infection. The remaining patients with 
positive Igh4 had high avidity of specific IgG, except one of them who showed 
a low avidity in her last control of a twin’s pregnancy. Previous controls had 
been at 8 and 11 weeks (these two determinations were carried out in another 
center) and the third and positive one was at 32 weeks. IgG titers were 315, 
322 and 198 IU/mL. 
Conclusions: The prevalence of gestational infection was 0.03% in our 
population (one primoinfection every 2754 pregnancies). As our seropreva- 
lence is 24%, strict prophylactic hygienic and alimentary measures are re- 
commended in order to prevent infections in seronegative women. The test 
for avidity of specific IgG is usefd in order to discard infection in suspected 
pregnant women (those with positive IgM), eliminating useless doubts. It is 
also a tool for beginning treatments in case of proven primoinfection. 
Congenital toxoplasmosis: incidence and 
consequences in a prospective cohort of 1460 pregnancies 
monitored in Lyon, France 
M. Wallon, M. Al Kurdi and E Peyron 
Lyon, F 
Objectives: Estimate the incidence and consequences of congenital toxo- 
plasmosis in a cohort of 1460 pregnancies with proven Tdvoplasma infection. 
Methods: Pregnant women and their children were managed between 1988 
and 2000 according to a standardized protocol. Dates of maternal infection, 
types and duration of maternal treatments, results of prenatal, neonatal and 
posmatal work ups and postnatal treatments, prospectively collected, were 
available for all patients. 
Results: Out of the 1460 pregnant women with proven Toxoplasma infection, 
602 (41%) were infected in the first trimester, 473 (33%) in the second and 385 
(26%) in the third. Prenatal treatment consisted of spiramycin alone in 1060 
(73%) women, pyrimethamine-sulfadiazine alternating with spiramycin in 
203 (14%). pyrimethamine-sulfadiazine alone in 94 (6%), and 103 (7%) were 
not treated. Out of the 51 nonlive births, 25 fetus spontaneously aborted or 
were stillborn, 12 fetus were terminatedwithout proofoffetal infection, seven 
were terminated due to hydrocephalus or ventricular dilatation on ultrasound 
scan and seven after positive analysis of the amniotic fluid despite the lack of 
ultrasound lesions. Among the 1409 live born children, 1327 (94%) were 
followed up until infection was ruled out (987; 74%) or in (340; 26%). Based 
on live born children, the overall riskoffetalinfectionrangedthm 24 to 30%, 
with estimates ranging &om 3 to 10% in the first trimester, 21-26% in the 
second, and 5843% in the third. All mfected children were treated 
posmatally. At their last examination (mean age: 71mouths; range: 
12-169), 252/340 (74%) were free of any lesions. The remaining 88 children 
had intracranial calclfication (29 cases), chorioretinis (69). hydrocephalus (two 
cases) or microphthahia (two cases). None, but one child who dled 
immediately afrer birth, had neurological impairment. Only two chddren 
with bilateral ocular lesions had sigruficant visual impairment. 
Conclusion: In our experience ( a n t e d y  treated pregnant women), the 
consequences of congenital toxoplasmosis are less severe than generally 
admitted. This information should be clearly gwen to future parents. Termi- 
nation of pregnancy is only warranted in the event of fetal lesions on 
ultrasound scan. Follow up during the first year of life is crucial to exclude 
or prove congenital toxoplasmosis. Life-long surveillance of dected children 
is equally essential for secondary and temary preventions. 
-1 Evaluation of the new Platdia Toxo IgM TMB 
test kit 
J. Franck, C. Masson, N. Lambert and M. H. Guindre 
Matseifle, Mama La Coquette, F 
Objectives: Toxoplasmosis, caused by Tdvoplacmagondii and usually benign, 
can be severe following transplacental contamination (congenital toxoplas- 
mosis) and m munocompromsed pahents Serologic tesnng IS the pnrmry 
tool for toxoplasm& screemg and dagnoss. The a m  of ths  study is to 
compare sensihwty and spedcity of Plateha Toxo I@ TMB to the VIDAS 
Toxo IgM test in the CondIhonS of use of a hospital laboratory. 
Methods: Prospechve study. 607 samples destined to be done rouhnely were 
smultaneously tested when received, all the samples coming from either 
pregnant women, newborns or immunocomprohed paaents. Retrospective 
study 262 samples were analyzed, 100 samples h m  w e n t  mfechons, 48 
samples &om 14 seroconversions and 100 cord blood samples. Dlscrepant 
results are resolved wth  ISAGA Toxo IgM The tests have been performed 
followng the manufacturers’ recommendanons. 
Results: Prospective study: no false posihve sample was observed that con- 
firmed the spechcity of 100% SenSIhVIty study gives a good result of 92%. 
Among the four plateha false negahve samples: m three cases, IgM detected by 
ISAGA were residual IgM, whde in one case IgM were n o n s p d c .  These 
results were d d a t e d  on a second sample. The predictive positive value of the 
test is 100.0% for a confidence mterval of 95% (90.4-100.0) and the predlcave 
negahve value 99.3% for a confidence interval of 95% (98.1-99.8). Retro- 
spechve study 
0 Samples &om recent mfechons’ no h e p a n t  result was observed. 
0 Seroconversions: four samples gwe dmxepant results. 
The Plateha results, nearer to the ISAGA than VIDAS results show a rapid 
dynamx of plateha durmg seroconversions, unth a precocious detectton of 
speclfic IgM, but also a f&t decrease when followed up. Cord blood samples: 
no mscrepancy was observed III the 100 samples taken fiom healthy newborns 
(mother w th  negahve serology), all samples bemg found negahve. Out of the 
14 samples &om dected newborns, four of them found posihve or doubtful 
wth plateha are found negahve w t h  VIDAS, but posinve by ISAGA. The 
results obtamed mth  plateha are idenhcd to those obtained w t h  ISAGA and 
show the very good senslhnty of Plateha Toxo IgM TMB for the screenmg of 
chddren mth congmtal toxoplasmosis. 
Conclusion: T ~ I S  test, along wth  Plateha Toxo IgG TMB, is perfectly 
appropnated for toxoplasmosis screening and dngnosis. 
I P1243 I Evaluation of the new Platelia Toxo IgG TMB 
test kit 
J. Franck, C. Masson, N. Lambert and M. H. Guindre 
Marseille, Marnes La Coquette, F 
Objectives: Toxoplasmosis, caused by Toxoplasmagondii and usually benign, 
can be severe following transplacental contamination (congenital toxoplas- 
mosis) and in immunocompromised patients. Serologic testing is the primary 
tool for toxoplasmosis screening and dngnosis. The aim of this study is to 
compare sensitivity and specificity of Platelia Toxo IgG, to the IMX Toxo IgG 
test in the conditions of use of a hospital laboratory. 
Methods: Prospective study: 787 samples destined to be done routinely were 
simultaneous tested when received, all tbe samples coming fkom either 
pregnant women, newborns or immunocompromised patients. Retrospective 
study: 162 samples were analyzed, 48 serums fiom 14 seroconversions, 14 cord 
blood samples &om infected newborn and 100 cord blood samples &om 
healthy newborn whose mothers had a negative serology during the preg- 
nancy. Discrepant results were resolved with dye test. The tests were per- 
formed following the manufacturers’ recommendations. 
Resuk. Prospective study: no false positive sample on 787 random samples 
was observed, that confirmed the specificityof 100%. Sensitivitystudy gives a 
very good result of 98.2%. The predictive positive value of the test is 100.oo/o 
for a contidence interval of 95% (98.3-100.0) and the predictive negative 
value 99.0% for a contidence interval of 95% (97.5-99.6). Retrospective 
study: 
Seroconversions: in some cases, we observed a delay on specific IgG 
detection compared to IMX technique. This delay is less than 1 month 
in four cases and between 1 and 2 months in two cases. This weakness is 
compensated by the precocity of detection of specitic I g M  with Platelia 
Toxo IgM TMB, a very recent contamination being confirmed on all these 
samples by the high titer ofspecific IgM. The choice of a positive cut off at 
9 W/mL and of a gray zone &om 6 to 8 IU/mL seems to be perfectly 
justified. 
0 Cord blood samples: no discrepancy was observed on the cord blood 
samples &om healthy newborns, all samples being found negative 
with Platelia Toxo IgG TMB, nor on the ones fkom newborns with 
congenital toxoplasmosis, all being found positive with PlateIia Toxo 
IgG TMB. 
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Conclusion: This test, along with Platelia Toxo I g M  TMB is perfectly 
appropriated for toxoplasmosis screening and diagnosis. 
Low incidence of Toxoplasma infection during 
pregnancy and in newborns in Sweden 
B. Evengard, K. Petersson, M. Engman, S. Wiklund, S. Ivarsson, 
K. Tear-Fahnehjelm, M. Forsgren, R. Gilbert and G. Malm 
Stockholm, S 
Objectives: To estimate the burden of disease due to congenital toxoplasmosis 
in Sweden, the incidence of primary infections during pregnancy and birth 
prevalence of congenital toxoplasmosis in 40 978 children born in two regions 
in Sweden was determined. 
Methods: Women possibly infected during pregnancy were identified based 
on: (1) detection of specific IgG based on neonatal screening of the PKU card 
blood spot followed by retrospective testing of stored prenatal samples to 
detect women who acquired infection during pregnancy and follow up of 
their children to 12 months; (2) detection of specific IgM on the PKU blood 
spot. 
Results: The birth prevalence of congenital toxoplasmosis was 0.73/10.000 
(95% CI: 0.15-2.14). The incidence ofprimary infection during pregnancy 
was 5.1/10.000 (95% CI: 2.6-8.9) susceptible pregnant women. The ser- 
oprevalence in the southern part was 25.7% and in the Stockholm area 14.0%. 
Conclusions: The incidence of infection during pregnancy was low, as the 
birth prevalence of congenital toxoplasmosis. Neonatal screening warrants 
consideration in view of the low cost and feasibility. 
[-I Serum profile of IgG and IgM antibodies towards 
Toxoplasma gondii in reproductive-age women: a laboratory 
view, 1995-1999 
E Farrarak~, E Spiridalu. E Athousalu, I Tsapala, A. PeAoti, 
A Papwanah and V Liakou 
Heraklron, Crete, GR 
Introduction: Toxoplasrnosls, a dlsease of global drspersion, is caused fiom 
protozoan Toxoplasmagondu. With the normal transrmsslon through placenta 
- fiom the pregnant woman to the embryo - causes congerutal toxoplasmosis 
mth  con results, polymorph and is often fatal for the embryo. 
Aim: The detecaon of speclfic IgG and IgM abs towards Tgondri 111 18-40- 
year-old women who were exammed m our laboratory before and during 
pregnancy (there was no dimcal picture of toxoplasmosls in any of the cases). 
Also there was no pahent w th  AIDS, neither under chemotherapy or 
munorepressive therapy. 
Material and method: We exammed serums fiom 8100 women for IgG and 
IgM abs towards Tgondu wth ELISA and mrect agglutmahon and under 
suspicion of acute toxoplasmosis and for IgA anh-Toxoplasma 
Results: See table. 
5.151 2.850 97 2 
63.59% 35.18% 1.2% 0.03% 
Conclusion: Although in our samples, an lmportant percentage of women 
have been infected fiom ths parasite, the small percentage (1.2%) that 
corresponds m recent mfecaon is of great importance, because of the serious 
consequences for the embryo. Therefore, there is a necessity of control dunng 
pre-pregnancy period 
IgG avidity in acute symptomatic toxoplasmosis: 
multicenter evaluation of the reliability of five commercial kits 
R. Vezzo, W Buffolano, H. Pentimak, A S e m ,  D. Marcheth, 
G. Guazzotti and R. Rescaldam 
Monza, Naples, Rome, Perugta, Bologna, Krcelli, I 
Objective: Primary toxoplasmosis m gestahon poses a hazard as it can be 
transmtted to the unborn chdd with severe sequelae. Gestahonal age (GA) at 
contamination is a critic factor, as there is a shlft in transmission rate after h e  
10th week towards increasing incidence, while clinical severity decreases with 
GA. IgG avidity is reported a~ a usefid test to date maternal contamination 
when seroconversion cannot be documented; furthermore, interassay varia- 
bhty among commercial kits is far to be defined. The clinical usefulness of 
five commercial kits in differentiating acute fiom latent toxoplasmosis has 
been assessed in a multicenter study. 
Methods: Overall 131 serum samples were obtained from 54 patients with 
clinical and serological dqnosis of acute symptomatic toxoplasmosis and 49 
control patients with clinical and semlogical diagnosis of chronic or latent 
toxoplasmosis according to routine confirmatory tests in collaborating cen- 
ters. All of them were retested for IgM presence and absence, respectively, by 
using MEIA IgM Abbott, Vidas ELFA IgM BioMerieux, IF1 IgM BioMer- 
i ew  and for IgG pattern by time by using ELFA IgG, BioMerieux. IgG 
avidity test has been carried out by R.V. by using BioMerieux, Bouty, Dasit, 
Diesse and Radim commercial kits according to manufacturers' instructions 
in a single session. 
Results: All but one (Radim) of the commercial tests seemed comparable in 
defining latent phase of the infection; in fact, high IgG avidity has been found 
in 98-100% chronic phase patients. False low IgG avidity results were shown 
in 0-1 of 49 control patients. Unfortunately, worse concordance has been 
shown among test kits in discriminating acute phase patients, as 64.3-1Wh of 
the tests carried out displayed low. 
Conclusions: Most of commercial kits to carry out IgG avidity 
against Toxoplasmagondii showed comparable clinical usefLlness to exclude 
a contamination occurring less than 3-4months before the sample has 
been taken. Unfortunately, clinical effectiveness of low IgG avidity in 
discriminating acute infection seemed questionable, at least using some 
commercial kits. 
ml Use of IgG avidity analysis versus IgA-specific 
detection for serodiagnosis of toxoplasmosis 
E Touafek, L. Paris and M. Danis 
Paris, F 
Objectives: The ability to discriminate between recently acquired Toxoplasma 
gondii infection and infection that occurred prior to pregnancy is crucial 
during the first trimester of pregnancy. As IgM antibodies may remain for 
more than 1 year after initial infection, it is necessary to use other methods to 
determine when the infection occurred. Detection of acute stage specific 
antigen is useful, but the reagent is not commerciahed. Detection of specific 
IgA more or less IgE and IgG avidity analysis are possible in a not specialized 
laboratory. In the first part of this work, we assess IgG avidity analysis on sera 
with specific IgG and IgM. In the second part, we compared the ability of IgG 
avidity versus specific IgA detection to discriminate recently and ancient 
acquired toxoplasmosis. 
Methods: A total of 220 routinely sera studied with Platelia Toxo IgG and 
Platelia Toxo IgM (Biorad) with specific antitoxoplasmosis IgG and IgM were 
classified as chronic (170 sera) or recent (50 sera) toxoplasmosis and IgG 
avidity analysis done with an adaptation of Platelia Toxo IgG. For 174 of these 
sera, the detection of specific antitoxoplasmosis IgA was made by immuno- 
sorbent agglutination assay (personal antigen). 
Results: The study of the 220 classified sera showed that an avidity index of 
0.45 or more was inconsistent with recently acquired toxoplasmosis. A total of 
139 sera (82%) fiom the 170 classified as chronic toxoplasmoi had an avidity 
index more than 0.45. For the 174 sera with data of IgA and avidity, 75 sera 
(43%) are IgA-negative, considered as chronic toxoplasmosis (but two are 
fmm acute toxoplasmosis, without IgA); 110 sera (63%) have an avidity index 
more than 0.45, considered as chronic infection. In our data, 58 sera with 
specific I g A  are chronic infection. 
Conclusions: IgG avidity analysis is easily done with the Platelia IgG Toxo 
(Biorad). For sera with specific IgG and IgM at screening, IgG avidity is more 
contributive than IgA-specific detection to assess the patient as chronic 
toxoplasmosis. In our laboratory, we wdl change our algorithm, doing first 
avidity for pregnant women with specific IgG and IgM. IgA detection will be 
done in second intention for sera with low avidlty. Further studies are 
necessary to simplify the avidity protocol which, actually, requires many 
dilutions for one serum. 
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Comparison among different strategies for 
microbiological diagnosis of Toxoplasmagondii infection in 
pregnant women, fetuses and newborn infants 
A. Sensini, R. Castronari, M. C. Angelici, S. Cherchi, E. Frezzato and 
E Bistoni 
Pmfia, Rome, I 
Objectives Case definition of maternal or congenital toxoplasmosis is 
still problematic. Chemotherapy during pregnancy may modlfy the 
serological status and a t k t  the detection of parasites in body fluids. The 
aim of this study was to evaluate the different strategies for microbiological 
diagnosis of Toxoplasma infection in pregnant women, fetuses and newborn 
infants. 
M e t h o d s  Eighty-three pregnant women, two HIV positive, and their new- 
borns were evaluated from 1996 to 2000 for suspected Toxoplarma infection. 
Specific I$, I@, I@ and IgG avidity were detected in maternal Serum 
samples at different times during pregnancy. In newborns, specific IgG, IgM, 
IgA were evaluated at birth and monthly until negativization. A total of 54 
amniotic fluids, 9 placentas, 32 cord blood samples and 15 urine samples &om 
neonates were assayed by PCR for detection of Toxoplarma DNA B1 gene. 
Thirty-one biological samples were assayed at Istituto Superiore di Saniti 
(Rome, Italy) for parasite culture and DNA detection by PCR-targeting P30 
gene and rDNA. 
Results: Six newborns with congenital infections, c1assAed as definite 
accordmg to the Lebech et al. classification system, were identilied; two 
were horn HIV-positive mothers. All newborns were asymptomatic, but one 
manifested chorioretinitis. Serological markers of congenital infection were 
not detectable at birth when the mother had undergone chemotherapy during 
pregnancy, but serological rebounds were observed when the postnatal 
treatment w a s  interrupted. In contrast, IgM and IgA were positive in infected 
newborns of untreated mothen. In one case, %xoplasma DNAwas detected in 
cord blood the mother was HIV positive. All other biological samples (cord 
or peripheral blood, urine, placenta) resulted negative, even in presence of 
congenital infection. The mothers of infected newborns seroconverted 
during pregnancy, while no case of congenital infection was observed when 
stable titers of IgG and high or intermediate values of I& avidity were 
obtained. 
Conclusions: Treatment of mother and newborn improves the outcome of 
infection with increased asymptomatic congenital toxoplasmosis. This study 
supports the validity of serological and molecular strategies for diagnosis of 
Tomplasma infection in pregnant women, but it points out the complexity of 
neonatal diagnosis. Serological monitoring of the newborns up to 1 year of 
age appears the most reliable procedure in the absence of suitable, not invasive 
biological samples. 
m1 Diagnosis of toxoplasmosis on spontaneous 
abortion by immunohistochemistry 
U. Sukriahyadi 
Yogyakarta, ID 
Objectives: To evaluate immunohistochemistry method for diagnosis of 
spontaneous abortion caused by toxoplasmosis based on Sensitivity and 
specificity. 
Methods: The study was conducted as a cross-sectional study at the Depart- 
ment of Obstetric and Gynecology, Sardjito Hospital, Yogyakana, Indonesia, 
during May 1999 till April 2000. A total of 70 pregnant women with 
spontaneous abortion were included in this study. The inclusion criteria 
were as follows: the women had risk facton of toxoplasrnosis during the first 
or second trimester and were willing to participate by putting signed in inform 
consent. An amount of 1 mL of each subject had been taken for detection of 
antibodies. The presence of IgM and IgG antibodies were detected by Toxo 
ISAGA and Toxo Screen-DA kit (BioMerieux), respectively One gram of 
abortion tissues were collected from each subject and processed by standard 
methods, also subsequently embedded in low-melting paraffin. Sections of 
approximately 6 microns in thickness were cut and stained by immunohis- 
tochemistry using monoclonal antibodies against RH-strain of Twoplasma 
gofidii. Data were analyzed using sensitivity and specificity of Herrman 
formulas (1995). 
Results: The results of detection of antibodies showed t h t  eight (11.4%) out 
of 70 subjects had both IgM and IgG in their sera, and 33 (47.1%) had only 
IgG. The results of detection antigens by immunohistochemistry showed that 
35 (50%) out of 70 subjects had positive antigens in the abortion tissues. 
Thirty-three (47.2%) out of 70 subjects had positive antibodies in the sen and 
positive antigens in the abortion tissues. Eight (11.4%) subjects had positives 
antibodies in the sera, but negative antigens in the abortion tissues. Two 
(2.8%) subjects had negative antibodies in the sera, but positive antigens in the 
abortion tissues. The sensitivity and specificity of immunohistochemistry 
diagnostics were 80.5 and 93.1%, respectively. The positive predictive value 
and negative predictive value were 94.3 and 77.1%. respectively. 
Conclusions: Immunohistochemistry method has a high sensitivity and 
specificity, therefore semlogd diagnosis for spontaneous abortion caused 
by toxoplasmosis must be confirmed with immunohistochemistry. 
Bordetella 
(p1250-1 The sero-epidemiological survey of immunity 
against pertussis in adult population in Poland 
J. Walory, P. Grzesiowski, B. Bukowska and W. Hryniewicz 
warsalv, PL 
35-50years (31.8EU/mL). The highest titer of IgA-PTAb was found m 
persons above 35yean of age. Detailed results are shown in the Table 1. 
Table 1 GMT of antibody against pertussis toxin IgG-TTAb and I&-PTAb in study 
population 
Introduction: In Poland during 1997-2001 an unexpected increase of 
pertussis incidence was observed with the lughest numbers UI older ctuldren 
and adults Immumty after primary vaccmatlon lasts only few years There is 
no effechve currently avadable vaccine agamst pertussis used for booster in 
adults In the first step of the program, base-he serologcal status against 
Bordetelfa pertussis should be assessed. 
Objective: To evaluate the semlog~cal status of healthy adult populauon 
measured by anhbody hter agamst pertussis t o m  I@-PT and IgA-PT. 
Materials and methods: Blood samples from healthy adults were collected 
after mformed consent. Pertussis antltoxm IgG and IgA were tested in total of 
184 blood samples by ELISA calibrated by the WHO standard. 
Results: The hghest percentage of persons wth IgG-PTAb < 50EU/mI 
(70?h, 42/60) and the lowest GMT for I&-PTAb was observed in group of 
Age 
GMT pU/ml] 19-34 years 35-50years >50years 
39.4 31.8 3 5 . T  
IgA 76.8" 124.8" 130.9'* 
Ins: NOT significant. 
"P< 0.05. 
Conclusions: In individuals above 35 years ofage high IgA-PTAb with rather 
low IgG-PTAb antibody titen were observed. These findings could reflect 
natural contacts with Bordetellapenursis. It  suggests that booster immunization 
in adults should be considered. 
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Relative role of pertussis among acute 
respiratory infections in adults 
M. Riffelmann and C. H. Wining von Konig 
Krefeld, D 
Objective: To assess the relative proportion ofinfection with Bordetellaperfussis 
and BordefeNa parapertussic in prolonged coughing in adults aged more than 
18 years. 
Methods Patients were recruited fiom sentinel physicians (general praai- 
tioners) in Krefeld, Germany. The main inclusion criterion was coughmg for 
more than 7 days. Clinical information was gathered by questionnaires. For 
diagnostic purposes, nasopharyngeal swabs, pharyngeal washings, and per- 
ipheral blood were sampled from every patient. Direct detection of antigen or 
nucleic acid (PCR) was done for B. pt~tussis, B. parapertussis, adenovirus, 
influenza virus A and B, parainfluenza viruses, and respiratory syncytial virus 
(RSV). IgA/IgM and IgG antibodies against B.pertussis antigens. adenovirus, 
Chlamydia pneurnoniae, coxsackie virus, ECHO-virus, in5uenza virus A and B, 
Mycoplusrna pneumoniae, parasuerma viruses, and RSV were measured by 
ELISA. 
Results: 143 patients were recruited, with a continuous age distribution 
between 18 and 80yean; 58% were female and 42% were male. They were 
coughing for a mean of 24 days. Positive laboratory results were obtained in 
27% for adenovirus, 25% for influenza virus A/B, 20% for RSV, 11% for 
Bordetellae, 10% for parainfluenza viruses, and 10% for C. pneumoniae infec- 
tion. Signs for infections with more than one agent were frequent, and 
serological diagnosis of M. pueumoniae infection was hampered by polyclonal 
stimulation. 
Conclusions: Bordefella infections were one of the frequent causes for pro- 
longed coughing in adults in t h  German population. 
I P1252 1 Investigation of the population structure of 
Bordete//a pertussis in the UK a comparison of pre- and 
post-vaccination strains 
S .  Neal, N. Fry, T. Harrison, E. m e r ,  R. Matthews and R. George 
London, Manchestq UK 
Objectives: To investigate the dynamics of the UK B.pertussis population 
using IS1002-based restriction fragment length polymorphism (RFLP), by 
comparing pre- and post-vaccination isolates. 
Methods: A total of 47 UK clinical isolates isolated between 1940 and 1999 
were analyzed. The number of isolates, grouped by decade was as follows: 
1940s (12). 1950s (12), 1960s (12), 1990s (11). Primers targetingthe IS1002 
were used to generate digoxigenin-labelled PCR products. Genomic DNA 
was digested usmg SmaI and the products separated by field-inversion gel 
electrophoresis together with molecular size markers. DNA was transferred 
onto nylon membranes and probed with the labeled PCR products. Immu- 
nological detection of hybridized products was performed using the DIG 
DNA Detection Kit. Developed Southern blots were scanned and analyzed 
using BioNumerics (Applied Math). 
Results: ISlO02-RFLP analysis of all 47 isolates resulted in the detection of 4, 
5 or 6 bands. The 47 strains produced 15 distinct RFLP patterns, 4 ofwhich 
were present in more than one decade. Six different patterns were seen in the 
1940s and 1950s, seven in the 1960s and four in the 1990s. RFLP pattern 1 
dominates the B.pertussis population, occurring in 21/47 isolates, is seen in 
2/12 of the 1940s strains, 7/12 in the 50s. 5/12 in the 60s, and 7/11 of the 
1990s. 
Conclusions: Previous studies in the Netherlands indicate that genetic 
diversity has decreased after vaccination was introduced in 1953, reflected 
in the reduction of frequency of RFLP types over time. Our preliminary data 
can neither suppott nor refute that this has occurred in the UK. However, 
since the introduction of vaccination in the UK in 1953, the predominant 
RFLP pattern 1 has increased in the B.perfussis population &om 2/12 in the 
1940s to 71’1 1 in the 1990s. This RFLP pattern, also found in Germany and 
North America, has increased in the Dutch B. pertussis population foUowiq 
vaccination. This clonal expansion of B. pertussis strains is suggested to be due 
to vaccine-driven evolution. It has also been hypothesized that clonal 
expansion of B. pertusris strains that are antigenically d8erent f b m  the vaccine 
strains is responsible for the occurrence of pertussis epidemics. IS1002-RFLP 
and other methods allow the analysis of the population structure of B.perfussis 
over time, and may give warning or aid in the investigation of epidemics and 
outbreaks. 
(p1m1 Bod.te//a pertussis adenylate cyclase toxin: a 
potential epidemiological marker and diagnostic tool for 
pertussis infection 
E. Packard, R. Parton, J G. Coote and N K. Fry 
Glasgoq London, UK 
Background Adenylate cyclase toxm (ACT) is an essential wulence factor of 
B.perfussis and a protecnve anngen in mouse models ofpertussis mfecnon. As 
well as bemg a possible component of future acellular pertussis v ~ ~ i n e ~ ,  it is 
also bemg investigated for its use m mdhpurpow vaccines, as a vehicle for 
mtracellular delivery offoreign epitopes to antigen presenting cells. Before the 
t o m  can be used in such apphcations its properties should be fuuy char- 
acterized, includmg its potential for anhgeruc vananon. The presence of the 
AC enzymic acnvlty m c h c d  speumens f b m  pereussu,-mfemd mdmduals 
has been used m &agnosis of pertussis. Conventlond assays for AC use 
radioisotopes and are time-consuming and expenswe. A novel conductunetric 
assay that is rapid and mexpensive has been developed to detect AC enzyrmc 
acnwty. 
Objectives: To determine possible sequence variation in the region of the 
cyaA gene encodmg the C-terminal region of ACTof B. pertussis and develop 
a rapid conductmetric assay of AC enzymic actiwty for pertussls diagnosa. 
Methods: Twenty clmcal isolates of B.pertusm were selected from the period 
1920-1999. Oligonucleotide primers were designed to target two areas of the 
cyaA gene encodmg the unmunogeruc C-terrmnal regon of the protemv and 
PCR products of 570 and 620 bp were produced. Nucleohde sequences were 
determmed usmg an automated DNA sequencer (CEQ 2000 XL Beckman 
Coulter). Conducumetric assay mvolving a pyrophosphatase-coupled reac- 
tion and a simple apparatus for measuring changes in the associated electrical 
conductance have been developed. This assay has been optimized for the 
detechon of low levels of recombinant AC enzymc activity. 
Results. Amplified products of expected s1ze were obtained with all 20 chmcal 
lsolates and reference stram. No sequence varlanon was evident in the two 
regions exammed compared to the available sequence data. Sunulated clinical 
samples with different numbers of B. pertussis added (wild-type strain 18323 
and BP348 p-1 were used), different lysls methods for release of AC 
enzyme, and the need for an ennchment step prior to assay have been 
mvvestigated. 
Conclusions: Preliminary results indicate that there is htde or no variation m 
the cyaA gene of B.pertussrr isolates and thus it d not be a useful target for 
genotypmg t h l s  orgamm. The potential of the conductmetric assay as a 
dngnostic tool will be reported. 
vl Native and genetically inactivated pertussis 
toxins are potent inducers of human moncKytederived 
dendritic cell maturation and secretion of type 1 cytokiner. 
implications for induction of protective immune responses 
C M. Ausrello, G. Fedele, E Urbani, R. Palauo, F. Spewen and 
A. Cassone 
Rome, I 
Objectives: Pertussis toxm (PT) is a critically protective anhgen present in d 
perturns vaccmes, but the immunological mechanisms underlymg protection 
have not yet been elucidated. Smce dendritic cells (DC) exert a crucial role in 
the mduchon and regulation of immune response, we inveshgated the 
capacity of PT to induce maturanon and function of human monocyte- 
derived DC and to act as adjuvant in LPS induced DC maturahOn. 
Methods: Immature DC were obtained by colturing monocytes in presence 
of IL-4 and GM-CSF for 6 days. DC maturation was studied by cytofluoro- 
metric analysis and antigen presentaaon ability in MLR. The cytokine 
producnon was assessed by quantitahve RT-PCR, ELISA, cytometric bead 
array, and intracellular staming. Thl/Th2 polamation was studied by using 
naive cord blood T cells 
Results: Both the nanve (nPT) and a genehcally de toded  (dF’T), but not a 
heat-inactivated PT, efficiently promoted the expression on DC of CD80, 
CD86, HLA-DR and CD83 markers, the alloreacnve anugen presentation 
and the cytolune producnon. In pamcular, both nPT and dPT, whde not 
affecting IL-10 production by LPS-shmulated DC, strongly s y n e z e d  with 
LPS for IL.-12 production. DC stimulated by PT plus LPS secreted soluble 
factors fostermg IFN-gamma but not IL-4 and IL-5 producnon by naive T 
cells. Ths  Thl polanzanon, as wen as the ahreacdw anhgen pre6entahon. 
was markedly mhibited by ann-IL-12 mAb. 
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Conclusion: Overall, the fmdmgs support the notion that nPT is a potent Thl 
adjuvant, and that dPT has fully preserved this adjuvanticity. The synergic 
interaction between F'T and LPS in IL-12 production might be relevant for 
the mechanisms of pertussis vaccine-induced protection. 
)p1255/ Isolation of Bodetella pertussis and B. holmesii 
from blood cultures of three patients in the UK and 
identification using SSU rRNA gene sequencing 
N. K. Fry, S. Neal, K. Herrity, H. Malnick, M. Noone, S. T. Chapman, 
R. Wall and T. G. Harrison 
London, Stockton on Tees, Newport, Middlesex, UK 
Background Bacterial isolates from blood cultures obtained &om three 
patients were referred for identification. patient 1 was a 75-year-old immu- 
nocompromised female; patient 2, was a 53-year-old male with endocard&, 
fever and rigors; and patient 3, was a 39-year-old female with fever and 
abdominal pain. Preliminary tests indicated that all isolates belonged to the 
genus Bordetella. 
Objectives: To obtain a definitive idendfication of the three isolates. 
Methods: Isolates were subcultured onto blood charcoal, Columbia blood, 
MacConkey, and nutrient agar plates and Gram stains were performed. Fatty 
acid analysis was performed using the Sherlock Microbial Identification 
System (MIS). Genomic DNA extracts were prepared, PCR performed 
using primers targeting conserved regions of ribosomal DNA (rDNA) and 
amplicons cloned and sequenced. Sequence data was assembled, aligned 
manually, and phylogenetic analyses performed. 
ResulW All three isolates grew on blood charcoal, Columbia blood and 
nutrient agar and were small Gram-negative coccobacilli. Only two isolates 
(&om Patients 2 and 3) grew on MacConkey agar. Fatty acid results yielded 
scores of 0.698, indicating identification as B.pertursis (patient l), 0.496 
(patient 2) and 0.263 (patient 3) indicating idendfication as B. avium &om 
the latter. DNA sequence analysis confirmed the identity of isolate from 
patient 1 as B.pertussis (100%) and those &om Patients 2 and 3 as B. holmesii 
(99.9-1 00%). 
Conclusion: Definitive identification of all three isolates was achieved using 
SSU rRNA gene sequencing. In all three cases, the contribution of Bordetella 
spp. in causing disease cannot be determined. However, further investigation 
of the role of Bordetefla spp. in &ease, particularly when isolated &om 
nonrespiratory sites, is clearly warranted. Preliminary studies using PCR 
have shown that B.pertussis maybe carried by asymptomatic people. The 
prevalence of B. holmesii carriage is unknown, although in one study active 
surveillance for B.perfussis by culture resulted in an increase in isolation of 
B.  holmesii. B. holmesii is capable of causing severe infection in both immu- 
nocompromised and inmunocompetent hosts. B. holmesii has been previously 
isolated from patients with splenectomy or endocarditis. In this investigation 
patient 2 has endocarditis and patient 3 had previously had a spenectomy, 
indicating that these conditions may predispose to infection with this 
organism. 
/p1256J Detection of BodeteIIa pertussir virulence 
factor pertussis toxin gene variants using LightCyclerTM 
real-time PCR and fluorescence resonance energy transfer 
hybridization probe melting curve analysis 
J. Makinen, J. Mertsola, M. K. Viljanen, H. Arvilommi and Q. He 
Turku, FIN 
Objectives: Anagenic variahon m two unportant virulence factors of Borde- 
tefla perturcrs, pertactin and pertussis toxm (PT), has been reported The 
polymorphsm in the PToperon IS m a d y  found m the gene encodmg the S1 
subunit Four alleles have been descnbed, namely SlA, SlB, S1D and S1E 
Most of the recent isolates represent SlA. So fa ,  the only method to 
determine these alleles has been PCR-based sequencmg, a rehhvely hme- 
consuming and expensive method Here we describe the rapld detechon of 
PT gene vanants by L@tCyclerTM real-hme PCR and fluorescence reso- 
nance energy transfer (FRET) hybridizahon probe meltmg curve analyw 
Methods: A total of 57 Fmmsh c h c a l  isolates, two vaccine strains and one 
reference s tmn (18 323) represenhngPT SlA, B, D andE alleles were tested. 
Bacterial genomc DNA was used The pruners and probes were destgned on 
the basis of the pubhshed sequences and synthehzed by TIB Molbiol, B e r h  
The probes QJ 3 BDE and QJ 4 BDE are spec& for alleles SIB, S1D and S1E 
The probes QJ 5 E and QJ6  E are spec& for StE and thus Merenhate S1E 
from SIB and SID. To each run a negahve control, plnthout template DNA 
was mcluded To the run?. usmg the QJ 3 BDE and QJ 4 BDE probes, DNA 
extracted from strams representmg $1 A, B, D and E was included. To the runs 
usmg QJ 5 E and QJ 6 E probes. DNA b r n  s t r a m  represenhng S1E was 
mcluded. The amphfkahon reachons and the FRET hybrihzaaon probe 
melhng curve analym were carried out m LightCyclerTM (Roche Diaposacs 
GmbH, Mannheim). 
Results: The probes QJ 3 BDE and QJ 4 BDE correctly hybndrzed to and 
gave signal for the PCR products denved &om s t r a m  harbormg SIB, SlD 
and SlE alleles The probes QJ 5 E and QJ 6 E hybnhed to and gave signal 
for the PCR products derived b m  the stratns representmg SlE allele. The 
speclfic mean of melhng temperature (T,,,) for QJ 3 BDE and QJ 4 BDE was 
66.43 "C (SD 0.41). The speafic mean of T, for QJ 5 E and QJ 6E w a s  66,43 
(SD 0,17). All mtra- or mterassay variahons of T, for both sets of probes were 
low GO 29 "C) 
Conclusions: The assay correctly idenhfiied the PT gene variants The assay 
was smple, rapid (both assays can be camed out wthm 2 h) and rehable when 
compared to sequencmg and is therefore swtable for large scale screernng of 
B pertussis c h c a l  isolates. 
/p12571 Isolation and characterization of Bordetella 
bronchisepfica strains from clinical health workers 
M. Rosales, G. Barcenas-Morales and J. Montaraz-Crespo 
Mexico, MEX 
Bordetella bronchiseptica is a common pathogen ofthe upper respirarory tract in 
many animals species and causing diverse illnesses. In humans this micro- 
organism has been isolate b m  immunosupressed individuals or with other 
pathologies but in each case the individuals had been in touch with domestic 
animals. So, the aim of this work was the isolation of B. bronchiseptica strains 
from healthy people who had no contact with domestic animals for at least 
6months prior to the studies. 
Methodology: Pharyngeal swabs from individuals with the characteristics 
described above and b m  dog breeders were grown onto MacConkey agar. 
Biochemical and serological tests with antiserum against B. bronchiseptica, 
B.pertussis and B.pampertussis were employed. The PCR technique was used 
in order to idennfy B. bromhkeptica with DAL 1 and DAL 3 as primers. After 
B. bmtuhiseptica strains were identified we probed for antibiotic resistance and 
the assay of crystal violet stain was usedin order to identlfy ifthe strains were in 
phase I or not; red blood ceUs were also used from bovine, equine and sheep in 
blood agar 5% for hemolysis test. Dermonecrotoxin was detect in guinea pigs 
with raw extract of the bacterial suspension; and for pertactin detection 
immnunoelectrohansfer was used with two monoclonal antibodies (BB07 
and BB05). 
Results: We isolated four B. brotuhkeptuu strains from c h c a l  health inhvi- 
duals, three strains from people without animal contact and 1 strain from dog 
breeder. The four strains were idenhfied by biochemical, serological and PCR 
methods. The isolated strains were not in phase I. Neither expressed 
dermonecrotoxin or pertactin; also they had no lysed red blood cells from 
bovine and the antimicrobial susceptibility assay were s im i la r  among the 
strains. 
Conclusions: Conditions settled for this work reduced the number ofpossible 
candidates to examine, mevde1ess we isolated three stains &om three 
individuals with the mentioned characteristics. It is important to say that 
titer antibodies of these three individuals were lower than dog breeders who 
did not yield B. bronchiseptica. 
Isolated s t r a i n s  showed less pathogenicity, because they did not 
remain in phase I; also some virulence factors were not expressed and 
titer antibodies were low. These results show the possibility that B. bmmhi- 
septica remained in the respiratory tract for a long time and when the 
individual suffered immunological abatement this microorganism came into 
view 
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Tissue protozoans and Pneumocystis 
1- Prevalence of plasmodium among travelers and 
immigrants in a Madrid hospital 
M Martinez, R. de J d i n ,  S de Mguel, N Cannno, M Baquero and 
M Subiraa 
Madnd, E 
Objectives: Study of the prevalence of imported malaria concerned 111 
travelers and -grants coming from endemc areas. 
Methods: We studed 720 indmduah from January 2001 to October 2001. All 
patients came h m  countries w th  hgh inndence m the dsease (mainly 
Equatorial Gumea). The &agnosis w a s  realued by mtcroscopy unth Field- 
stamed thck and thm blood smears 
Results: We found 58 cases posihves of malaria (8%). We obtamed 47 cases of 
Pfalnpanrm (81%), 7 cases of P ouale (12%) and 4 cases ofR nuax (7%). None 
case of P malanae was seen. The geographcal d~smbunon was the following 
Pfalnpanrm (46 &om Equatonal Gumea and 1 from Conakry Gumea); I! wale 
(6 from Equatord Glunea and 1 fiom Cameroon); P mum (2 f b m  Indra, 1 
fiom Papua New Guinea and 1 from Ecuador) 
Conclusions: As a result of the arise of travelea found m the last years, an 
increase between the cases of malaria has been observed. The result of our 
study show a prevalence of 8% of cases ofimported malar~, therefore, we due 
to consider when a person has traveled to a zone wth  malana and to make the 
correct diagnosis and later processmg 
[ P1259 I Imported malaria at an infectious disease 
unit in Vienna, Austria: a review of 332 cases between 
1990 and 2000 
H. Laferl, E Walhs, M. Szell, R. Fossler, N. Soleman, B. MBhr and 
H. Pichler 
Vienna, A 
Objectives: To study the epidemolopal. clinical and laboratory features 
in imported malaria, and thus mcreasmg physician awarenes of the 
variabhty in its presentahon and improve chnical management and health 
outcomes. 
Methods: M e d d  records were renewed for pahents with mcroscopically 
confirmed malana diagnosed at our department between 1990 and 2000. 
Pahents wth relapsing or recrudescent infechons were counted ody  once 
Results: Of a total of 332 cases, 208 were caused by Pfhpanrm, 94 by P v i m ,  
13 by P malarrae, 5 by P ovafe, 11 pahents had dual infechon, and m 1 case 
plasmodia were unspenfied. 78% of the panents were male, me&an age was 
36yean (range, 14-79). 16% were classified as havlng severe falciparum 
malana accordng to WHO criteria There were 5 fatal cases, 4 of them 
were female. 94% of falciparum cases were acquired in subsaharan Afnca, 6% 
in Asia, and 1 case in the Americas. P ucvux lnfechon was acqulred m Asia, 
Africa and the Americas m 62, 21 and 17%, respectively. 33% of the 
falci- cases were Imrmgrants, most of them r e t u r w  &om a journey 
to thelrcountryoforign 61%ofpahentswithfdcipmmalar1a, and5Phof 
the vlvax cases had taken no chemoprophylms at all. 100% ofvlvax cases, and 
99% offalciparum panents gave a hsmry of fever 1 1%, however, were afebrde 
at the nme of their presentanon W e  85% of the falciparum cases fell 111 
wthin 2 weeks after their return to Austria, and none later than 2 mouths, 
51% of the vivax cases developed symptoms later than 2 months after thew 
return. Other commonly reported but unspecific symptoms were headache, 
shakmg GUS, and myalp. Thrombocytopema (<140000/mm’) was the 
most promment laboratory feature occurrmg m79% of panentr w th  counts 
<100000/mm3 m 63%. Hemoglobm level5 below 12 g/dL were observed in 
41%, a subnormal Quick‘s test (<70%) in 65% Leukopenia (<4000/mm3) 
was noted in 46%, leukocytosls m 9%. 64% of the paaents had an elevated 
LDH (>240U/L), GPT (ALT) was elevated (>22U/L) m 52% 10% of the 
falciparum cases had hyperparasitema, 13 of these panents had chmcal 
jaundice, 11 cerebral malam (sensu lato), 7 showed signs of ARDS, 6 acute 
renal fdure, 5 had DIG and 5 MOE 12 pahents w th  falaparum makna 
requued treatment at the ICU. 
Conclusion: Malarra has to be ruled out or proven promptly in any spp to -  
mahc pahent w t h  a history of travel to a malana-endemc area. 
Presumption of malaria infection by using the 
Cell-Dyn 4OOO hematology analyzer 
M Mamnez Padd, M Submts, M Lago, S Puente, S Crespo, 
G Palacios and M Baquero 
Madnd, E 
Objective: Malana mortahty in  nonendemc areas of the world, where malaria 
is a relanveh rare &ease, 1s almost always due to a mssed or late dugnous 
Chicians may not m h d y  consider malarla as part ofthe ddferennal dngnosis 
of pyrema (especially if the ClimcaUtravel hlstory IS inadequate) and may only 
insntute general screemg tests such as a Full Blood Count A number of 
reports were received about unusual patterns of dots in the automated 
leukocyte dlfferenhd plots ohtamed on the Cell-Dyn 4000 analyzer (Abbott 
Diagnbncs, Santa Clara, CA) from patients w th  malaria The purpose ofour 
work was to go to h potential method for dagnosu of &a. 
Methods: We stumed peripheral blood samples, collected on EDTA tubes, 
&om 40 pahents who had KnVe &a Samples are processed in parallel 
uung Field s t a m  of thck and dun smears as reference method and by the Cell- 
Dyn 4000 hematology analyzer. The three principles used by the C e l l - w  
4000 (impedance, hght scatter and fluorescence) allow to have a complete cell 
count of whte and red blood cells, includmg rehdOcyteS (via R N A  
detechon) and leukocyte vlabhty index obtained by DNA detechon 
Results The mam abnormal patterns of greatest relevance to malaria were 
when ather populations ofpurple and/or blue leukocyte events (represenhng 
neutrophdes on normal samples) depolanze hght, or when the green-coded 
depolarizmg events fall outside of the normal eosinophd ‘footprmt’. Other 
hdmgs consist on DNA material detemon not associated to any cell hgdity 
phenomenon and a reticulocyte dutribuaon showmg a small peak corre- 
rpondmg to dected rehculocytes. 
Conclusion: Due to the increasing flow of travelers and unnngrants comng 
from endemc areas wth  malaria, cytometnc methods should be considered as 
a prormslng tool in malana dlagnosr.. Thus, it can be very sigdicanve m those 
nonendemc areas where climcians are not aware of t h s  dmease and the 
diagnosis could be delayed or even mssed 
(p1261( Status of malaria in lranshahr county (Sistan and 
Baluchistan province, south-eastern of Iran) in the past 
decade (1991-2000) 
K Akbarzadeh, M. Nateghpour and H. Vatandoost 
Tehran, IR 
Malaria is a pubhc health problem today in more than 90 countries, inhabited 
by a total of some 2400 mllion people-40% of the world’s populahon 
Malaria is one ofthe 10 most prevalent and deadly dwease m the world. About 
30G500 d o n  c h c a l  cases occur every year w th  over 1 2-1.7 d i o n  
deaths. Relahve risk of acquiring malana m Iran 1s below 1.50 000 Over the 
past 80years m Iran, numerous researchers have worked on malaria The 
dtsease has become well connolled m the most of the country only m the 
south-eastern corner of Iran. Ths area includes provmces of Sistan and 
Baluchlstan, Hommzgan, the tropical areas of Kerman, and 1s charaaenzed 
by ‘refkctory malaria’. Iranshahr county has a high morbidity of this dsease an 
Lran. A retrospectwe study on malarla cases ofthe last decade was conducted in 
order to definite the status ofthe dsease in Iranshahr county Accordmg to the 
results ‘API’decreased from 85 73 in 1991 to 29 11 m 1994, followng a peak 
about 67.80 in 1995 decreased agam to 10.14 in year 2000. Trend of ‘ABER’ 
after a relanve ulcrease in the years of 1993-1994, decreased fiom 145 56 in 
1991 to 19.35 in the year 2000 Except decreases m the years of 1993-1994, 
‘SPR’ had a relahvely constant trend and reached from 5.89 m 1991 to 5.24 in 
year 2000 Annual Plasmodiumfalnpanrm Index ‘AFI‘ and Annual PZmmodrum 
V L V ~  Index ‘AVI’ had no much dfferences, but m the last 2 years of 1999- 
2000 thls difference was hgher. Nomthstandmg the effecme acUWIes of the 
pnmary health care system that provoked notable reducnon in trend of 
malana cases, the dlsease conml programs have not acheved thew goals m &IS 
area. The followmg factors are considered responsible for b s  fdure: 
1 The paI’hdy exophhc habits of the mam common vector of m h a -  
Anopheles cultnfaanes 
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2 hs tence  of four secondary vectors (A. d’thali, A. puviatilis, A. superpictus, 
3 The great dispersion of villages. 
4 Low socioeconomic/health status of local communities. 
5 High illiterzcy rate. 
6 Socialization of local communities with Pakistani neighbors. 
7 The most %ban immigrants (over 1 out of 6 of over 360 000 population 
A. stephemi) m addition of A. pukchm’mus as a doubtful vector. 
number of Iranshahr). 
wl Visceral leishmaniasis: difficult on treatment 
D. Kraja, N. Como, K. Pano and E. Cani 
Tirana, AL 
Objedves: The recognition of frequency and cause of Micult leishmaniasis 
to be treated. 
Methods: Eighty patients of age 18-56years were studied and observed 
during 1987-2001. 
The treatment Glucantimdl cases, 80 mg/kg/die i.m. for 15 days; Lomi- 
d i n i 4  cases, 7 doses; Mopurinol-10 cases 25 mg/kg/die for 4 weeks and 
Glucantimi + Allopurin0&5 cases. The end of treatment was decided by 
parasitological criterion. We identified the frequency and cause of difficult 
cases for treatment and mortality rate. 
Results The dificulty of treatment was related to: (a) the etiological treat- 
ment. It failed on nine cases with Glucantime: four immediate deaths, one 
febrile vasculitis and four severe myocardiopathie; five cases with Allopurinol: 
five severe vasculitis; two cases with Lomidini: one death and one hypotension 
and renal insufficiency; 1 case with Glucantime + Allopurinol: severe 
vasculitis. The fever was normalized on the third day of treatment in 
2.5%; on the fourth day 10% on the fifth day 32.5% on the sixth day 
20%; on the seventh day 13.7%; on the elghth day 5% of the cases and after 
that in 13 cases 16.25% (the last resulted leishmania-like pathologies with 
leishmania in bone marrow aspiration). Continuing the follow up on 65 cases, 
we noted parasite presence after the h t  cycle in 7.46%. after second cycle in 
20% and after third cycle its disappearance. (b) The necessity of supportive 
treatment on 15% of cases (antishock, antianemic, antiseptic). The mortality 
rate was 6.25%. 
Conclusions: We did not seen leishmaniasies resistance toward etiological 
treatment, but a delay of its action after 6 days on 18.75% of cases. The 
Leishmaniasies ‘difficult’ to be treated were identified in 36.25%. 
Epidemiology of cutaneous leishmaniasis 
(reservoir hosts and human infection) in Jarghooyeh rural 
district, lsfahan county, central Iran 
R. jafari, M. R. Yaghoobi-Enhadi, A. R .  Zahraii-Ramazani and 
A. A. Akhavan 
Yazd, Tehmn, I$han, IR 
Objectives: This study was carried out to determine the reservoir hosts and 
human infection of cutaneous leishmaniasis in jarghooyeh rural district, 
southeast of Idahan county. 
Methods: This study was conducted over a period of 12 months (&om 4 April 
1997 to 20 March 1998) in Jarghooyeh rural district, 60km &om south-east 
Isfahan county, central Iran. To study the characteristics of the human disease, 
four villages were selected, in each ofwhich all the inhabitants were examined 
by house to house visit. The number and the places of scars and sores 
were noted for each individual. In each case with Cutaneous lesion, scraping 
were taken h r n  the sores and examined for the presence of L&hmania 
parasites. Rodents were caught in 20 live traps, l5day intervals. After 
capturing of rodents, smears were prepared fiom the edge of ears. All smears 
were stained by Giemsa by routine methods and examined under a light 
microscope. 
Results: In four viI lages of the Jarghooyeh rural district, two species of rodents 
(Rhombomys opimus and Men’ones libyas) were identified. R. opimus was the 
predominant species and its leishmanial infection rate was 6.6%. Study of 
prevalence among 5237 inhabitants showed a rate of 3.87% for ulcers and 
42.84 for scars. Based on number of scars, 51.56% of previously affected 
people had only one scar, 22.5% had2 scars, 10% had 3 scan and 15.94% had 4 
scars or more. Hands, legs and face were the affected parts of the body, with 
44, 33.8 and 13.8% of the active lesions, respectively. 
Conclusion: These investigations showed that ZCL is endemic in this area. 
Active disease 1s usually found in chddhood, and older people usually have 
scars of old lesions. The w e s t  and least infection rate were observed in fewer 
than four and over 25-year-old age groups. respectively. There is a non- 
sigmficant difference in disease based on sex (P< 0.05). 
/p1264 Recurrent visceral and disseminated cutaneous 
leishmaniasis caused by Leishmania infanium Mon-I during 
HIV infection 
L. Cab,  R. Marhedi and E Chiodo 
&JbgUQ, I 
Introduction: Leishmaniasis is emerging as a common and serious opportu- 
nistic disease in patients with human immunodeficiency virus (Hnr) infection 
in endemic areas, such as southern Europe. In HIV-infected patients this 
protozoan disease can occur with various clinical presentations, ranging h m  
typical visceral forms to asymptomatic or atypical cases. A 32-year-old i.v. 
drug abuser male patient, with advanced HIV infection was first hospitabzed 
owmg to persisting hyperpyrexia, weight loss, asthenia, systemic lymphade- 
nopathy, hepatomegaly, splenomegaly, pancytopenia, and hypergammaglo- 
bulinenlia. His CD4+ lymphocyte count was 101 cells/mm3, while plasma 
HIV viral load was 3000 cop ie s /d  ongoing antirewvird therapy included 
zidovudme, lamivudine, and nelfmavir since 25months. High titer (1:8192) 
anti-leishmania donouani antibodies were detected by an indirect immuno- 
fluorescence assay, but our patient refused both bone marrow and liver biopsy. 
On the ground of a strong suspicion ofvisceral leishmaniask, therapy with i.v. 
liposomal amphotericin B was administered for 21 days, leading to a complete 
clinical remission. Thirteen mnths  Later, our patient developed a fuced, 
nonevolving rash involving the chest, back and abdomen, with disseminated 
nonulcerate, nonscabby, maculo-papular lesions, painless and not pruriginous, 
approximately 3-8 mm in diameter. The histopathologic study, May Grun- 
wald-Giemsa staining and culture of a slun biopsy specimen prompted a 
diagnosis ofcutaneous leishmaniasis, and the zymodeme Mon-1 ofLeishrnunia 
infantam complex was identified by an isoenzymatic characterization. A novel 
28-day attack course of liposomal amphotericin B was adrmnistered, leading 
to a partial reduction of cutaneous lesions. Three months later, in spite of a 
secondary prophilaxis with the same drug associated with oral itraconazole, 
disseminated maculo-papular cutaneous lesions appeared again with initial 
features. Therapy with i.v. pentamidine isethionate was started and continued 
for 8 weeks, leading to a complete resolution of cutaneous rash. 
Conclusion: Zymodeme Mon-1 of the Leishmania infnfum complex is the 
most common causal agent of HW-associated visceral leishmaniasis in the 
Mediterranean basin, and it could also rarely be responsible for localized 
cutaneous forms. However, disseminated cutaneous leishmaniasis sustained by 
Mon-1 zymodeme described in our HN-infected patient is an exceedingly 
uncommon presentation. 
Jp1265j A successful control program for soonotic 
cutaneous leishmaniasis in a new focus of disease, Ardakan 
county, Yazd province, central Iran 
Y , d ,  I 
Objectives: An epidemic focus of zoonotic cutaneous leishmaniasis (ZCL) 
caused by Leishmania major has established in Ardakan county, Yazd province, 
central Iran, during 1998-1999. Because of its public health importance, and 
the high risk of disease transmission to the other parts of the province or the 
country, which are susceptible for disease establishment, we decided to control 
ZCL with assistance of Yazd province public health center in 2000. 
Methods: The control program was conducted in two phases: rodent control 
via poisoning with Kletat, and indoor residual spraying with Pmpoxur 50% 
WP 2g/m2. 
Results: Our findugs show a five-fold reduction in disease incidence in 
treated area, meanwhile we observed a 1.3 time increase in this rate in control 
area. The decrease of ZCL incidence was sigmficant in treated area 
(P<O.OOOl). In addition, incidence rate of disease in control area was 
sigmficantly greater than that of the treated area (P<O.Ot). 
A. A. Hanafi-Bojd, A. A. Dehghani-T& and R. Jafari 
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Conclusion: Based on t h s  study and other gimilar surveys, the rodent control 
seem to be an effective method for ZCL control. Although, indoor residual 
spraying can help the reduction of cases in epidemics. 
Ip12661 Cutaneous and visceral leishmaniasis in Aydin, 
Turkey, January-November, 2001 
S. Ertug, N. Aydin, B. Gultekin and E. S. Doyuran 
Aydin, TR 
Objectives: Cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) are 
endemic in the western and south-eastern parts of Turkey. The aim of this 
study was to determine clin~cal and demographic characteristics of VL and 
CL. 
Methods: The records of patient with VL and CL of Central Healthy Service 
of Ayd* and Adnan Menderes University Medical Faculty have been 
evaluated retrospectively. 
Results: Forty-five patients were found infected with CL and four patients 
had VL in Aydjm. Rate of sex in patients' who had CL was in female 57.8% 
and male 42.2%. CL was more ftequent in the age p u p  of 0-19years 
(40%) (range 1-81 years). Four patients' who had VL ages ranged from 1 to 
12 years. When the number and localization of CL lesions evaluated, it has 
been found that 21 (46.7%) cases had one lesion, 11 (24.4%) cases had two 
lesions and 13 (28.9%) cases had three or more lesions. The face was the most 
fiequent site of involvement (53.3%). The incidence rate while minimum in 
August to November (2.2%), increased to maximum of 84.4% in January- 
April. 
Conclusion: Interestingly, there was both of VL and CL in Aydjm area and 
leishmaniasis may still continue as endemically. For a successfd fight against 
Leishmaniasis, it is necessary to control vectors and reservoirs also to detect 
and record the cLnicd and demographic characteristics carefully. 
1p1267) Field trial for the control of zoonotic cutaneous 
leishmaniasis in Badrood, Iran 
M. R. Yaghoobi-Ershadi and A. A. Akhavan 
Tehran, IR 
Objectives: Due to the rewrgence of zoonohc cutaneous leishmanlass (ZCL) 
in some nonendemc areas of Iran, extensive studles have been conducted on 
the epidemology of the dlsease m Werent parts of the country m recent 
years The objechve of this study w a s  to deterrmne the effects of rodent 
control on the reduchon of the lncidence of ZCL in an endemc area m 
Badrood, Iran. 
Methods: A survey was carried out in two dages,  in a a c l e  around the 
d a g e s  durmg Apnl 1997-January 1999 The control strategy adopted m 
1997 consisted ofdestrucnon the colomes ofgerbfine rodents by dlggmg in a 
radlus of 500m fkom houses m the intervention area Opened burrows 
were bated w t h  nnc phosphtde One d a g e  was kept as control Evaluaaon 
was made ln 1998 and no other control measures was carried out m the area. 
Case findmg was done by house-to-house msit once m every season 
durmg 1997-1998 and al l  of the lnhabitants of the selected &ges were 
exammed 
Results: The average reducaon of rodent holes was calculated 87.4% 1 year 
afrer the fmt baitmg m the mtervenhon area Changes in the number of 
rodent holes and the mcidence of the &ease in the mtervenhon and control 
villages were stahshcdy signtficant (P-value < 0 000001) 
Condushr: Our eduahon demonstrated that, the program reduced the 
incidence of ZCL 12-folds m treated d h g e  when compared with that of the 
control one at the end ofthe first year ofoperahons and more than one-fifth of 
its orignal Ievel through '2 years The results show that, the method IS very 
effechve for destroymg rodents and reduclng the incidence of ZCL in a small 
scale and special arcurnseances 
F 2 i M  Investigation of meumocystis carinis 
trophoroites and cysts and Cryptosporidium parvum 
oocysts in respiratory tract specimens of patients with 
pulmonary disorders 
A S Kantarcioglu, S Erturan, Y Bagdath and M Yaman 
Lctanbul, TR 
P cannii 1s a uI l lcehh  eukaryohc organum causing senous opportun~stic 
pneumoma 111 munosuppresed hosts, speually mth  AIDS and m cancer 
and transplant pauents. F'uhmnary colonmuon m HIV-negahve paaents and 
carriage in mununocompetent pauents wth underlymg pulmonary &ease 
may also east C. parvurn is a protozoan of serious pathogemcity, the cause of 
gastromteshd and ewarntesunal mfechons mvolvmg lungs, bde ducts, 
pancreas in lmmunocompromsed pahents includmg AIDS, cancer and 
-plant paaents who are recexvmg munosuppresszve therapies and also 
rarely m munocompetent hosts. Asymptomanc carriers are considered to 
have an important role III establdmg mfecaon We mvesagated the presence 
of P cannu trophozoites and cysts and C pawurn oocysts m bronchal lavage 
(n = 50) and sputum speclmens (a  = 69, total n = 119) from patients (n = 90) 
with pulmonary dmrders between 28 June and 28 November 2001 Defined 
major symptom mcludes chronic cough (6). fever (Z), dyspnea (3), hemop 
tysls (6). sputum secrehon (75). Rdological abnord t ies  were found m all 
pahents The pauents tlld not receive anhfimgal and/or anti-l? mm: pro- 
phylams or treatment before ob- the speumens. Direct rmcmcopical 
e x m a u o n  was performed from fkesh speclmens usmg acid fast (Ziehl- 
Neelsen and Kmyoun) and Giemsa stauung. Direct unmunofluorescent 
annbody detecaon (Medour Fneumocystis can#n; Merihan Diagnosacg, 
Inc.) pmcedure w a s  also used m sputum speclmens and the results were 
assessed under fluorescent mcroscope The underlymg dlseases and predw 
posmg factors were lung and other organ cancen (n=69), past or aChVe 
tuberculosis (n = 9) Hodgkm lymphoma (n = 1) rheumatoid artrim (n = 2), 
BehGet's dsease (n = 1) Pamphigus uw&ans (n = 1) long-term and large spec- 
trum anhbiohc usage (n = 37) coracosteroids (n = 13) Age range waslG85, 
medlan age was 66. Neither P cunnii trophozoites and cysts, nor C. pawurn 
oocysts were found ln the present study. Ths result is in parallel with the very 
low P cannit frequency found m two prevlous study and one pulmonary 
cryptococcosls case reportedm Turkey. PneumocystosiP and cryptosporidosis 
have become emerging Me-threatemng iofechons m unmunocompronused 
mdmduals They can be detected wth  rouane techmques used for idenh- 
ficahon of mycobacteria and fung m respmtory secrehons and lavage 
specimens so their lnve?.hgahO!l may be useful in pahents at risk. 
lp12691 Pneumocysts mtfi pnwmonia in HIV 
seronegative oncologic patients 
A. Georgouh, E. Chinou, A Slskou, Z Cholou, N Troboulu and 
P Golemah 
Araeus, CR 
Objectives: To assess the incidence and the pretllsposmg factors of Pneumo- 
cysyshs canntr pneumonia (PCP) m oncologx pahents wthout the acqwed 
immunodeficiency syndrome. 
Methods: Bronchoalveolar lavage PAL) or mduced sputum specnnens from 
131 Consecuhve oncologc, HIV SerOnegahve pahents (55 M, 76 F of mean 
age 53 years) were studled for the detechon of P cannil cysts and trophozoites, 
using a dlrect immunofluorescent procedure Hematolop mahgnancy m 72 
(55%) and sohd tumors in 59 (45%) of our pahents were the underlying 
dgnancies .  Ninety out ofthe 131 pahents were undergomg chemotherapy 
dunng the last 6 months 
Results: PCP was magnosed m 30 (22.9%) out of 131 of our pahents. There 
was no ugdcant  dfference in the incldence of PCP between the paaents 
mth  hematolopc mahgnancy (20 8%, 15/72) and those wth sokd tumors 
(25 4%. 15/59) All 30 of our paaents with PCP had undergone chemother- 
apy dunng the last 6 months but 24 paaents @P?) were also receivmg long- 
tern therapy vvlth corncostemids at the tune of dlagnosa (mean duraaon 3 
months). All but one of our patlents w t h  PCP had a successful outcome mth  
a trnnethoprime-sulfamethoxazole treatment. 
Conclusions: PCP is quite fiequent m oncologc paaents. Chemotherapy and 
long-term treatment wth  coracosteroids are the mam factors pretllsposlng to 
this dectlon 
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Intestinal parasites 
lm/ Antiamoebic in vitm activity of pefloxacine 
F. Riccardo, R. Binazzi, M. Bavastrelli and S. Sanguigni 
Rome, I 
Objectives: Amebiasis is a disease caused by the intestinal protozoan Enfu- 
moeba hittolyticn. It has a worldwide &mibution decting 100? of the world 
population and has become more and mole common also in non tropical 
areas. Metronidazole remains the first choice treatment but various SNdieS 
have demonstrated that cure rates with this drug do not reach 100% moreover 
the lack of a comparable drug to use as alternative treatment significantly 
narrows the therapeutic options in people who cannot take metronidazole 
due to side-effects and allergic or idiosincrasic reactions. For these reasons the 
identification of new amebicidal drugs is important, and ths is made all the 
more evident by the growing sciendic interest on the topic. In this study, we 
examine the antiamebic activity of pefloxacine in vitro. A quinolone was 
chosen because, similarly to metronidazole, it is effective against anaerobe 
bacteria and acts primarily against DNA interfering with its synthesis. 
Methods: Xenic cultures on Robinson's media of a s t r a i n  of E. histolytica, 
isolated in May 1997 from a symptomatic carrier coming from Ruanda and 
cryo-preserved, were used. Pefloxacine was tested at the doses of 10; 15; and 
5 pg/mL, that correspond to the therapeutic concentrations in vivo and its 
effect on parasite growth was compared to that of cultures of the same strain 
and of comparable initial amebic density that were either drug-fiee (negative 
control) or exposed to 10 p g / d  of mewnidazole (positive control). 
R m k .  As seen in Fig. 1, metronidazole showed a marked effect between the 
48 and the 72 h, with parasitic clearance. The drug-free test did not show 
s i m c a n t  modifications of the normal growth rate in cultural condrtions. 
Pefloxacine, in all the concentrations examined, determined a gradual 
decrease of the parasite density throughout the experiment, showing an 
enhanced amebicidal activity between the 48 and the 72 h. 
Perfloxacine activity on xenic coltures of 
Entamoeba histolytica 
-- 
time (hrs) 
Figure 1 
Conclusions The promising in vim activity of pefloxacine against E. histo- 
lyrica confirms the activity of quinolones against amebic infection and is a good 
starting point for further in vivo randomized studies of these drugs in the 
treatment of symptomatic amebiasis. 
hours by vomica with discharging of brown, chocolate-like pus. The native 
microscopical examination of the bronchial aspirate and of the expectoration 
shows extremely frequent clusters ofvegetative, magna forms, ofE. histolytua. 
Abdominal echography and computer tomovaphy confirm the presence of a 
splenic abscess, without involving the liver and the central nervous system. 
There were either epidemiologic argumentations nor other cases of infections 
with E. histolytiur in the territory. 
Results: After two cycles of treatment with the combination hidroxiclor- 
oquine + metronidazole, the author succeeded the sterilization of the pul- 
monary abscesses with the tendency of normalization of the radiologic aspect 
and the disparition of the splenic abscess. 
Conclusions: Extraintestinal amebiasis is nowadays not any more only a 
tropical disease and physicians can be c o h n t e d  with diagnose difficulties, 
if a s&ar case appears in Central Europe regions. 
Outbreak of Cyctospora cayetanensis 
gastroenteritis associated with consumption of imported 
Thai Basil, Vancouver, British Columbia, May 2001 
L. Hoang, J. Harb, C. Ong and M. Fyfe 
Vancouver, CAN 
Objectives: Cyclospora cayefanensis, a coccidian parasite, is a recently identified 
cause of protracted and recurrent gastroenteritis associated with certain fresh 
produce. In May 2001, an outbreak of C.cqetmensis gastroenteritis was 
identified in British Columbia (BC). By June 15, a total of 17 cases were 
reported to the BC Center for Disease Control by the respective health 
authorities. A majority of these patients were either of Vietnamese origin or 
had 6equented Vietnamese restaurants in the Greater Vancouver area. This 
report presents the findings of the outbreak investigation. 
Methods: We conducted a casecontrol study involving a total of 17 case 
patients that were identified and reported for positive C. cayefanensis on stool 
microscopy. We interviewed patients using a structured questionnaire about 
symptoms and dietary habits within the 2-week period before the onset of 
symptoms. Controls were asymptomatic volunteers nominated either by the 
patients or their physicians. Controls were asked using the same questionnaire 
about the same 2-week period as their matched case patient. Both patients and 
controls with a travel history in the 4-week period prior to developing 
symptoms were excluded from this study. 
Results: 17/17 (100%) of patients were exposed to Thai Basil, an essential 
ingredient in popular Vietnamese cuisine, either at home or at a restaurant, 
compared to 3/17 (18%) ofthe controls ( P =  0.004). Fresh bean sprouts were 
also implicated (P= 0.04). Although incomplete to date, our trace-back 
investigations revealed chat the Thai Basil was imported via Hawaii while 
bean sprouts were locally grown. 
Conclusion: This outbreak in Canada is the first documented sporadic 
outbreak of cyclosporiasis linked to Thai Basil. As there is h t e d  knowledge 
of the pathogenesis and modes of transmission of C. cayetanensis, this outbreak 
provides the opportunity to increase our understanding of this 
emerging pathogen and to improve on our prevention and control of future 
outbreaks. 
[m Extraintestinal amebiasis-an emerging infection 
C. Manuela 
Timisoara, RO 
Objectives: Clinical presentation of extraintestinal amebiasis, with several 
pulmonary abscesses and splenic abscess. 
Methods: The author present the clinical case of the patient M.P., 56years, 
t?om the district of Arad, Romania, with the following symptoms of drsease: 
abrupt onset with shivering and septic fever, cough with muco-purulent 
expectoration and, occasionally hemoptysia, wasting syndrome (15 kg weight 
loss), respiratory impairment and toxemia. The radiologic examination s h o w s  
several opacities with large dimensions in both lungs. After antibiotic therapy 
with third generation of cephalosporines. the clinical signs and the radiologic 
aspects are unmodified. The performed bronchoscopy is followed in few 
I PI273 1 Genotyping of human isolates of Giardia lamblia 
from Portugal 
M C. Sousa, A Donato and J. Poiares-da-Sdva 
Coirnbra, P 
Genehc charactermhon of a total of 28 Gurdia lamblra isolates &om cysts and 
from axemc cultures were performed by polymerase cham reachon to amphe 
segments of gene encodmg the enzyme triosephosfate isomerase (tpi), 
coupled wth  the detechon of resmchon-fkagment-length polymorphisms 
(PCR-RFLP). DNA extrachon for cysts was performed from whole faeces 
and from samples concentrated using two methods. (1) the cyst samples were 
suspended in resuspension soluhon (500m Trs-HC1, l o r n  EDTA and 
lOOmg/mL Rnase A) and cell lysis sohhon (0 2M NaOH and 1% SDS) 
provided in the Wizard Plus Mmpreps DNA pUlficahOn Systems (Promega) 
and were treated for 2 m n  m a am-Beadbeater (Stratech SCienhfiC) usmg 
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0.5mm zirconium beads. DNA was purified from the lysate using the 
procedure provided in the kit; (2) the cyst samples were mechanically 
disrupted in the presence of 1 0 ~  guanidinium thiocyanate in 0.1 M Tris- 
HCl ( p H 6 . 4 ) 4 . 2 ~  EDTA (pH8.0)-2% Triton X-100 together with 
0.5 mm zirconium beads and isoamyl alcohol. DNA was purified fiom the 
lysate using coane activated silica. Genomic trophozoites DNA was extracted 
in vitro by axenic cultures in log late phase using TBE buffer (1Omm Tris- 
HCl, 1 m EDTA), lysis buffer (8% triton X-100, 0.25 M sucrose, 50 u w  
EDTA, pH 8.0) and proteinase K. DNAwas purified from the lysate using the 
Prep-A-Gene DNA purification Kit (Biorad). Two sets of primexs were used 
to a m p 4  segments of gene encoding the enzyme triosephosfate isomerase 
(pi), and the amplified PCR products were cut by XhoI and HidIII. lsolate 
Portland 1 (ATCC 30888) (assemblage A, group l), B-36 (assemblage A, 
group 2) and Ad-28 (assemblage B) were used as genotype standards. The 
present methodology identified genotypes belonging to the two previously 
described human genetic groups and is the first molecular characterization of 
G. lamblia &om Portugal. The sensitivities of PCR procedures increased with 
the increasing numbers of cysts as observed by fluorescence microscopy. Our 
results point that human G. lamblia isolates &om Portugal were typed to the 
two genetic groups: assemblage A 90% (Nash group 1 and group 2) and 
assemblage B (Nash group 3) 10%. There were no sigtuficant Werences in the 
distribution of the genotypes by G. menic cultures and cysts. 
I PI274 I Giardia lamblia. a re-emerging infectious disease 
in the child population of Crete, Greece 
S. Maraki, H. Michailidou, M. Antoniou, E. Tsapaki, G. Sakellaris, 
E. Galanakis and Y Tselentis 
Heraklion, GR 
Background: Giardiasis has been considered to be uncommon in the child 
population of Crete, Greece, however, more recently several cases have been 
observed. The present study was undertaken to review the epidemiology and 
the clinical manifestations of Giardiu infection in children seen at the Uni- 
versity General Hospital of Crete. 
Methods: Medical and microbiologic records of all children with stool 
specimens and serology positive for Ginrdia were retrospectively reviewed 
during the 8-year period 6om January 1994 through October 2001. 
Results 559 stool specimens were examined for the presence of Giardia 
lamblia during the study period. In seven chddren cysts of the parasite were 
demonstrated and the diagnosis of giardiasis was serologically confirmed. All 
children were diagnosed during the last 3 years of the study period (1999- 
2001); not a single specimen was found positive before 1999. The children 
were aged 6-1 1 years. Six were boys, all belonging to immigrant families and 
born m other Balkan countries. The remaining child was a girl born in Crete, 
without a history of travels abroad. AJI children had presented with recurrent 
abdominal pain. Two children had undergone appendectomy and further two 
were investigated for failure to thrive. Following the diagnosis of giardiasis, all 
were treated with metronidazole and had a full recovery. 
Conclusions: Giardiasis is a re-emerging infectious disease for the children of 
Crete. This re-emergence seems to be related to the recent migration of 
families to the island. Giardia infection should be included in the differential 
diagnosis of children with chronic recurrent abdominal pain even in areas 
where the disease is considered to be eradicated. 
lp1275/ Prevalence of certain Enteropathogens among 
apparently healthy children in a slum area of Istanbul 
S Karavehoglu, L Arslan, N Molla, D Tansuker, M. Sungur, I. Barlan, 
M. Balur and U Over 
Istanbul, TR 
Background: A prospectwe study was carried out to lnVeShgate the prevalence 
of c e r m  medd ly  nnportant protozoa, hehnths,  and bacterial agents in an 
apparently healthy c u d  population wth  4-12years of age &om a slam of 
Istanbul during summer period of 2001. 
Methods: Stool samples from 1069 chddren were collected and processed for 
parasitic and bacterial exammahon. Ethyl-acetate sehentahon techmque 
was used for parasihC e d o n  m stool samples. Cell-tape method was also 
carried out for the detechon of Enterobrus vt-rmiculans Bacterial exammauon 
was performed by standard methods for the Isohhon and idenhfkahon of 
Sdrnonella spp and Shgellu spp from stool samples. 
Results: Five hundred twenty (48.6%) chddren had one or more mteshnal 
parasites. E uermrnrlans and Blattucystrs hominrs were found m high rates (24%). 
followed by Giardia lamblsa (11.8%). In 109 (10.2%) of children, more than 
one parasite were present The mcidence of the other mtestrnal parasites 
(A. lumbncoides, H. nand, ?: fnckrura, T suginafa vaned between 1 and 3%. 
Bacterial pathogens mndudmg Salmonella spp. and Shgella spp were found m 
0.6% of ctuldren. 
Conclusion: The hgh prevalence of E. vermrculans, G lambha and B hominrs 
m the apparently healthy chddren was the most sigdcant result of ths study. 
In addthon to the hgh prevalence of G. lamblur and B horninis, the occurrence 
of Salmonella spp. and ShigeNa spp., even 111 low mcidence among apparently 
healthy populanon may be Indtcahve for poor hygiemc condihons of water 
supphes and food sources in h s  regon of Istanbul Memopoh wth  poor 
hvmg standard 
1 P1276 I The rate of Oxyuris vermicularis infection and 
vulvitis in children 2-5 years of age in Sari kindergarten, Iran 
M. Shanfand H. Ziaee 
Sun, LR 
Objective: 03cyuriF vevmiorlaris I one of the mam hygetuc problems causing 111 
the world specdy in ciuldren under 2 years of age. Over 40 million 
Amencans specially children are lnfected by 0. verminrlmic. One of the 
complicahons of paraUte is it’s role rn causing vulmtis. Smce the parasite is 
more prevalent in glrls than boys, ths study was conducted to show the 
prevalence rate of 0. venninrlaris infection and wlmtis in chddren between 2 
and 5 years of age in Sari townshp. 
Methods: Samples were collected by scotch tape method from all chtldren of 
2-5 years of age. Vulva of the children were examned by a rmdwfie under the 
supemnon of a specialist. Informahon about I t c h ,  edema, erythema and 
vulvar i t c h ,  vaginal excretion, puritis and bed wetting were recorded in a 
questionnaire. Other informattons hke age, education, occupation of parents, 
family members, the number of siblings, the number of cM&n in each c h  
and their baby sicten., cleanliness of 4, beds and their informa hablr~, 
hathing, disinfection of fomitres and bed sheets, the presence ofphysicians in 
kinder garden, hygemc cud for baby sitters and the children infected with 
0. uminrlatk were recorded 111 a queshonnalre and the children d e e d  to 
0. verminrlaris were exarmned by scotch tape method. 
Results: From the t o d  number of 216 children under study, 64% were 
mfected to O.verntimh, 38 (13.5%) persons had &tk, and 13 (6%) 
persons bad vulvltls along with 0.wmtirulOris. There was no sigfuficant 
relahonship between 0.uemuulanr and vulvitis by X stadstlcal anaIys~. 
34.2% who had nrlvltt, were mfected to 0,vmiculans too. There were 
ngmfkant relatronshp between the age and 0.vemricularis mfection 
(P< 0.001), between vulmtls and age p u p  (P< 0.051, between 0. m i c u -  
lark and using fomtier, (P< 0.01) and between d m h s  and itching of anus 
( P <  0.05). 
Conclusions: Regardmg the prevalence of 0. vmniCUlariZ infechon and its role 
in vulvlhs and the h t a t i o n  of the studes in this field, it is necessary to have a 
proper planrung for the improvement of health and the agents of causing 
dmhS.  
[p12771 Simultaneous Enterobius and Toxocara infection 
in a closed collective: some immunological findings 
L. Vina, V. Sondore and B. Rozentale 
Riga, LV 
Objectives: The aim of this study was to define the peculiarities of immune 
status of patients with Enterobious + Tojocara infection. 
Patients and methods: A total of 135 young men closed collective were 
involved in study. Enterobious ova were found in anorecd scrapings. Sera were 
tested for Toxocuru canis antibodies by ELISA. Total, T-, B-lymphocyte, CD4, 
CD8, total NK counts and helper/suppressor (H/S) ratio in peripheral blood 
were measured by laser flow cytometry. 
Results: Enterobiosis alone was found in 17 patients, toxocarosis alone in 6, 
Exocara carriers-19; 7 of patients were infected with both Enterobius and 
Exocara. A tendency to increase of H/S ratio was observed in patients v&h 
simultaneous Enterobius and Toxocara infection (1.42 f 0.21) if compared with 
enterobiosis alone (1.15 & 0.01, 70% <P< 80%) and Toxocara carrying 
alone (1.14jz0.08, 70% <P<80%).  A tendency to decrease of NK-lym- 
phocyte count was registered in simultaneous enterobiosis and toxocarosis 
(272 zk 45 cells/mm3) if compared with enterobiosis alone (355 * 47 cells/ 
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mm3, 70% < P <  80%). No sigtllficant differences were observed amongst 
these p u p s  for total T-, B-lymphocyte, as well as CD4 and CD8 counts. 
Obtained data revealed increasing of total B-lymphocyte counts (325 31 52 
cells/mm3) and H/S ratio (1.28 * 0.18) in patients with toxocarosis if 
compared to Toxoura carriers (246 f 22 and 1.14 & 0.08 cells/mm3, respec- 
tively; 8Wh < P < 90?? and 50% < P <  60%, respectively). 
Conclusions: Immunosuppression in so-called aggravated groups of patients 
(enterobiosis + toxocarosis, toxocarosis alone) is not so expressed as in patients 
with enterobiosis or Tojcorara carrying alone. This finding was confirmed too 
by higher antibody level to Tunis in simultaneous enterobiosis and toxo- 
carosis, as well as in toxocarosis than in Toxocura carrying alone. 
1 PI278 1 The treatment of hymenolepiasis 
D. Kraja, N. Como and E. Cani 
Tirana, AL 
Background: Hymenolepiasis is the most frequent taeniasis in Albania. Its 
complete cure is not always immediately realized. The aim is the recognition 
of the real efficacy of its current etiological treatment. 
Methods: We studied 150 patients with hymenolepiasis of age 10- 
62years. accumulated during the period of 1986-2000. We separated 
them in two groups. Group 1-100 patients were treated with 
Niclosamide vomesan, Radeverm]: first day 2 g/die, followed by 1 g/die 
for 6 additional days. Group 11-50 patients were treated with Praziquantel 
pdhycini, Cesol] 25 mg/die in a single dose. The parasitological control was 
executed 15, 30 and 60 days after treatment. The positive cases resulted by 
coproparasitological examination were treated up to three cycles as above 
mentioned. 
Results: In the first group, with niclosamide, we identified Taenia nana 
elimination in: 73% out of 100 patients after the fmt cycle; 62.9% out of 
17 patients after the second cycle and 60% out of6 patients after the third cycle 
with niclosanlide. Totally, f b m  100 patients, the niclosamide purified 96% of 
them using on cases without effect up to three weekly cycles treatment. In the 
second group with praziquantel were identified purification after the first 
cycle; 78% out of 50 cases treated after the second cycle, 72.7% out of 8 
patients treated and after the third cycle 66.6% out of 3 patients using the 
antiparasitic drug. We cured 98% of 50 cases using three cycles of para- 
ziquantel treatment. It is obvious that the efficacy of niclosamide and 
praziquentel on hymenolepiasis treatment is very high, but not absolute. 
The remaining of a sensible positive percentage, repeated after each cycle 
treatment with those drugs, indicates that reaching the complete cure on 
hymenolepiasis is not easy. We think that except the therapeutical factor, there 
should intervene other factors related to self-infestation or Taenia nana 
circulation in the patient Me environment. 
Conclusions: The etiological treatment of hymenolepiasis is easier to be 
realized with praziquantel because of its comfortable application; niclosamide 
remains a very good alternative. 
Reinfection rate of Ascaris lumbricoides in the 
rural areas of Hamadan, West Iran: report of one year 
follow-up 
M. Fallah, A. Mirarab, F. J d a n  and A. Ghaderi 
Hamadan, IR 
Objectives: This study was carried out to determine the post-treatment re- 
infection rate (RIR), for evaluating the infection pressure that used in the 
control programs. 
jP12801 A rnulticentre retrospective study of domestic 
intestinal parasitosis in Italy in the 19905 
D. Crotti, E Bernieri and A. Ragho 
On behay of the Association of Italian Clinical Microbiologists, Committee of 
Parasitology (AMcLI-CoSP), Milan, I 
Objective: To focus the attention of Microbiologists on home intestinal 
parasitosis, following specific indications provided with previous ‘ad hoc’ 
Courses and the distribution of a preliminary Manual of Diagnostic Para- 
sitology. For this study, eight Laboratories of Clinical Microbiology were 
recruited, of whom the responsible guaraiiteed a standardized stool para- 
sitological investigations. 
Methods: The data of31 years, between 1990 and 1999, were collected, with 
a total of 18.182 subjects for standard stool parasitological examination, 2.151 
for cellophane-tape test, 1.106 for C. pawurnacid fast stain (only three Labs 
per 18years), 411 for S. stercoralis-Baermandlarvae culture methods (only 
one Lab per the last 5 years), 545 for D.jagilis4iemsa stain (only one Lab 
per the last 2 years). Five Labs were of north Italy, two of middle ItaIy, one of 
south Italy. Two Labs supplied data of the last year, two Labs of the last 2 years, 
one Lab of the last 3 years, one Lab of the last 5 years, one Lab of the last 7 
years, one Lab of 10years. 
Results: Helminths ova were reported only in 0.6% of subjects, with pre- 
valence of Taenia spp. (0.3%). No pathogen trematodes were observed; among 
nematodes only A .  fumbricoides (0.05%) and T frichiura (0.05%) were observed 
(also very few casula larvae of S. stercorulis and eggs of E. vermicularis were 
reported); among cestodes very few cases ofH. nma, H .  diminuta and D. latum 
(all in 0.005% of cases) were observed too. Forty cases of S. stercoralis (9.7%) 
and 256 cases of E.  uennicularis (11.9%) were instead reported when speci- 
fically investigated. Protozoa were reported in 3.2% of subjects: G. intestinalis 
in 1.9%, other not pathogens (B.hominis included) in 1.3%. C.purvum 
prevaded in 0.7% of investigated cases, D.jagi2is in 2.1%. 
Conclusions: AMCLI-CoSP concludes that few Labs are s t i l l  organized for 
good fecal diagnostics and are available to perform adequate data collection. 
Anyway, faecal parasites and particularly helminths are very rare in Italy; so, 
the investigation for these pathogens could be reserved to organized Labs. 
Moreover, more Labs must investigate for D.jagiIis and other protozoa using 
at least a Giemsa stain, must research specifically S.rtercoralis when at risk 
factors are present, many stool specimens must be analyzed for excluding 
G. intestinalis. 
Methods: A total of 187 indmduals rendered Ascans egg negahve by drug 
treatment were used m the re-infechon study done 3-monthly for 12 months. 
Stools from 187 indmduals, horn Merent d a g e s  dstributed in the all 
provinces level, were exanuned to d e t e m e  post-treatment re-infechon rate 
for Ascans AU posihVe cases treated with albendazole and stool e m n a t i o n  
follow-up was done during 5-7days after treatment Those who were 
rendered negahve by treatment and those ongmally negahve were included 
in the RIR study 
Results: Re-infechon rate at the 3-month mtervals were 5.5, 3 2, 6.15 and 
6 4% for first, second, thrd and fourtb period of follow-up, respechveh. 
Commulahve RIR was 21% Most of mfected mdwiduals (48%) passed 
unfedzed eggs. 
Conclusions: Because t h s  study was done after a mass treatment program, the 
infechon pressure changed to an acceptable level and considered as a good 
guide index for sunredlance of ascariasls III the control program area. On the 
basis of results of tius study, we recommend kequency of mass treatment only 
one m e  a year for next 3 years 
Methods: A total of 122 patients (pts) infected by genotype 1, 4, 5 or 
pretreatment viral load @DNA 2.0, Chiron) >3 Meq/mL, with no previous 
treatment, received 6mU IFN during 12months (M). Ribavirin was 
given with IFN after 3rnonths therapy, for 9months in pts with 
detectable RNA (Cobas Monitor 2.0, Roche; Quantiplex HCV-RNA 
3.0, Bayer). Viral load was expressed as log(iLT/mL) and HCV Ag as 
Results: Sustained response (SR) was obtained in 400? ofthe pts, relapse (RR) 
in 18%, non-response (NR) in 42%. Flfty-two pts had detectable R N A  at M2. 
(p12811 Ortho total HCV core antigen assay can aid early 
prediction of response in patients treated with interferon/ 
ribavirin 
F. Lunel, €? Veillon and C. Payan 
Angers, F 
Objectives: To evaluate the predictive value of Total HCV Core Antigen 
Assay and viral kinetics in patients with chronic HCV 
log(pg/mL x 10000). 
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Pre-treatment Ag values were correlated with viral load (? = 0.779). The 
HCV Ag level was significantly lower in SR (n = 32) than other groups (5.47 
vs. 6.07, P <  0,001). We observed a rapid decrease ofAg (5.2logpg/mL) and 
viral load median (5.1 logIU/mL) after M1 in SR. In pts who relapsed after 
IFN alone (n = 20), the fall was less (2.6 logpg/mL, 3.6 logIU/mL) during 
MI. In SR (n =29) and RR (n= 10) two-combination therapy, the decrease 
ofAgandviralloadmedianatM1 were, respectivety(Ag: 1.2andl.4logpg/mL; 
RNA: 2.4 and 1.5 logIU/mL). Ribavirin increased the fall ofAg and RNA 
load to undetectable levels for SR and RR at M4 and M6, respectively. We dld 
not observed significant variation of Ag and viral load in N R  (31). The 
negative predictive value of HCV-RNA and Ag after M1 of treatment was 
100%. and positive predictive values were 81 and 82%. After one month of 
IFN alone, it was hghly predictive of SR, correlated with RNA negative and 
early reduction of HCV-RNA (>2log). 
Conclusion: Early measurements of total HCV core antigen are useful to 
predict tong-term response to treatment. 
Genetic variability of EVE2 regions of HCV 
genotype 4 
C. Argentini, S. Dettori, D. Di Paola, C. Gandin, M. Angelic0 and 
M. Rapicetta 
Rome, I; Alexandria, ECY 
Six genotypes ofHCV have been identified that show different geographical 
distribution. High heterogeneity was found, from our studies performed in 
Africa for genotypes 2 and 4. This latter genotype is highly prevalent in Egypt. 
The present work was aimed to characterizing viral variants of HCV genotype 
4, &om 141 hepatopatluc patients in Egypt (141) by the analysis ofEl and E2 
genome regions. These regions are relevant for future vaccine development. 
Thirty-six isolates were studied by phylogenetic analysis (DNA DIST and 
Neighbour Joining methods). Twenty were assigned to subtype 4a, whereas 
four new subtypes were characterized, to which, respectively, 4, 2, 1 and 1 
isolates were assigned. High heterogeneity was observed among isolates of 4a 
subtype in both genome regions (mean variability >lo% range between 14 
and 30%). The analysis of similarity (nucleotide and protein sequences, 
Simplot program) and secondary prediction on protein sequences (Antheprot 
Package) demonstrated that also few amino acid changes could induce protein 
modifications of antigenic presentation. In conclusion, the high intra- and 
inter-subtype variability, both in nudeotide and protein sequences were 
observed for genotype 4 isolates. These findings, relative to genome regions 
applied for vaccine development, may be relevant for HCV prophylaxis 
particularly in highly endemic areas. 
Ip12831 Genotype distribution to identify the source of 
HCV infection in Moroccan HD patients 
H F. S. Souad, E Hanaa and 0 Bennura 
Casablanca, MA 
Hepahhs C w u s  (HCV) infection is hghly prevalent and represents a major 
problem in hemodalysis patients (HD) worldwde Little is, however, known 
about this high-risk group in Morocco The principal objechve ofthe present 
study was to determme the genotype dlstribuhon and to idennfy the source of 
HCV infection in Morocco HD pahents Our results show that 46 3% of the 
615 screened HD pahents, collected from dfferent Moroccan nnes are 
posihve for HCV antiboches by ELISA Our results also show tbat the 
frequency of HCV-posmhve HD panents decreased after 1994, the date at 
whch the screemng of Moroccan blood-donon started, mdlcanng that 
screemng of blood-donon’ results m a decreased of HCV traansrmsslon in 
HD pahents. However, the percentage of HCV mfecnon in both transfused 
and untransfused HD panents renmned elevated after 1994. These results are 
in favor a nosocormla ldeChOII as the man came of HCV transmuson in HD 
panents. HCV-RNA was detected by re>erse transcripnon-polymerase cham 
Ieactlon (RT-PCR) in 108 sera of the 172 HCV-posihve pahentS tested 
(63%) HCV genotypes were exanuned usmg the hne probe assay. Subtype lb  
was predomnant (75%). whereas, subtypes 2a/2c, l a  and 3a were less 
common (13.9, 3.7 and 09%, fespechvdy). T h ~ s  genotypmg data strongly 
suggest a transfusional and nosocormal pathways of lnfecnon in h s  hgh-risk 
group in our country. 
/p1284/ Evaluation of ortho total HCV core antigen assay 
in assessment and follow-up of patients treated for chronic 
HCV 
P Vedlon, F Lunei and C Payan 
Angers, F 
Introduction: Pretreatment viral load and response to IFN/ribavmn are 
correlated. An assay to quanntate ‘Total’ HVC core anhgen m serum or 
plasma, m the presence of anh-HCVannbo~es, has been developed by OCD 
The test is an ELISA reqmmgpretxatment with denaturing solunon at 56 “C 
for 30 s to dlssociate Immune-complexes and mtact mions. Free Ag capture is 
wa a MWP coated wth  two anh-HCV Mabs, each directed to a &shnct 
region of the protein Detecaon is wa a dlaerent par  of anacore Mab’s 
conjugated to poly-kIRp To& Core Ag assay is theorehdy capable of 
measuring wenua, and may reflect vlral load. 
Objectives: We evaluated HCV Ag w t h  two qUanhtahVe assays for HCV- 
RNA bDNA 2.0 or 3.0 payer) and Momtor 2.0 (Roche). 
Methods: We stu&ed 191 samples from untreated pahents and 237 from 144 
pahents wth chromc HCV treated with IFN or IFN/ribavlrin, at 1 month 
(Ml), M2, M3, M4, M6 and M12. 
Results: Correlanon of& and quantltahve assays was hgh (r= 0.85 and 0.83, 
respechvely), and we dld not find any Merence between the levels of R N A  
and Ag among HCV genotypes (r= 0.82-0.96). In untreated RNA posiave 
pahent samples (n = 144), HCV Ag was under the cut-off m exht pahents. 
bDNA 2 0 and Momtor 2 0 fded  to detect 5 and 1 samples, respectively. Ag 
values, before treatment, were sigmficantly lower m summed responders thaa 
in other groups (5.4pg/mL vs. 6pg/mL, P <  0.001). In panents treated w~th 
IFN or combinahon therapy, we found very good correhhon between 
decrease or negahve of Ag and wral load 2logIU/mL decline of HCV- 
RNA after M1 of mtederon was sigtllficantly correlated with the negahve of 
HCV Ag and response. A number of 38/41 of susmned responders had a 
RNA load decrease >2 log IU/mL and 39/41 had a negahon of HCVAg after 
M1. 
Conclusion: Total HCV Core Ag appears to be a new tool for momtormg 
pahents with HCV lnfechon 
lp12851 Efficacy and tolerability of interferon-a and 
ribavirin in the therapy of patients with chronic hepatitis 
type c 
T Mach, U Janas-Skulina, M. ZeJc-Bajsmmcz and 
I Sobczyk-Krupiarz 
Cracmq PL 
Objectives The combmation of mtefiemn-a and ribavlm 1s the current 
strategy of treatment of pahents wth chromc hepaaas type C The aun of our 
study was to evaluate the efficacy and tolerabhty ofmterferon-a plus nbavinn 
combination therapy m pahents wlth C ~ I O N C  hepahhs type C .  
Methods: Eighty-four pahents aged 2 0 4 5  years were enrolled to th~s pro- 
spechve study, there were 54 m v e  pahents, and 30 relapses after lneffectlve 
inte&eron-a monotherapy. Panents were anti-HCV(+), HCV-RNA(+} by 
PCR (cut o& 200 copies/mL) wth  hstologcally confiimed chromc hepahhs 
and abnormal achvity of ammotransferases lashng at least 6 months before the 
star t  of therapy Panents were treated wnh interferon-a 2b (Schermg-Plough, 
3 m u  thrice weekly) plus ribavmn (Schenng-Plough, 1 0-1.2 g/day). Blood 
morphology and biochermcal tests were performed every month, HCV-RNA 
was assessed at b a s h e  and after 24 and 48 weeks of therapy. HCV-WA(-) at 
24 weeks was defined as early response (ER), at 48 weeks as end of treatment 
response (ETR). 
ResuEts: After 24 weeks of treatment 31 pahents (72%) elammated HCV - 
acheved ER. Twenty-me of pahents (67% of d pahents) were sall negahve 
for HCV-RNA after 48weeks and acheved ETR, two pahents (5%) had 
detectable serum HCV-RNA again. Hemoglobin decreased h m  14.2 to 
122g/dL (P<O05) after 24weeks, then increased to 12.9g/dL. after 
48weeks Leukocytes count decreased ham 5.25 x 109/L to 3 7 x 109/L 
( P  < 0 05) after 24 weeks and increased to 4 36 X 109/L after 48 weeks. 
298 Abstracts 
Conclusion: The study confirms that interferon-a and RIBA combination 
therapy was effective in patients with chronic hepatitis type C as estimated at 
the end of treatment and was well tolerated. 
-1 Induction therapy with interferon alpha-2b in 
nalve chronic hepatitis C patients 
H. Leblebicioglu, M. Sunbul, B. Aygen, E Sirmatel, Y. Ersoy, K. Aydin 
and I. Dokmetas 
Samun, Kqseri, Gariantep, Malaya, Trabzon, Siuas, TR 
Objectives: Hepatitis C virus infection is a major health burden affecting 
estimated 200 million people worldwide. Interferon is the fint drug shown to 
be effective in patients with chronic hepatitis C (CHC). Current data suggest 
that daily administration of interferon-a in CHC is more effective than the 
thrice weekly (tiw) scheme. The aim of the present study was to evaluate the 
efficacy of induction therapy in CHC patients. 
Methods: A total of 56 naive biopsy proven CHC patients (25 males, 31 
females) with ALT levels > 1.5 x IU and positive HCV-RNA in serum were 
included. The therapy was administrated 5mU INFa 2b every day for 
1 month, followed by a maintenance period of 11 months with the same 
dose tiw. 
Results: At the completion of the induction period, 37 of 56 (66.1%) patients 
had partial virological response. Among the patients studies, the virological 
response with clearance of HCV-RNA was achieved in 39.2% and the 
biochemical response with normalization of ALT in 44.6% at the end of 
12-month therapy. Overall, sustained response rate was found as 37.5%. 
Interferon treatment was well tolerated without sigolticant side effects. 
Conclusion: Daily administration of 5 mU INFa 2b for 1 month, followed by 
a maintenance period of 11 month with the same dose tiw in CHC is 
associated with high rate of sustained response. 
1 P1287 1 Side-effects of double therapy (interferona plus 
ribavirin) in chronic hepatitis C 
D. Delic, l? Nikolic and Z. Nesic 
Belgrade, W 
The double therapy interferona and ribavirin is the much more effective then 
therapy with interferon alpha only. Between 1996 and 1999 we realized a 
prospective, open, pilot study of efficiency and tolerability of double therapy 
in 29 patients with chronic hepatitis C: 21 males (72,41%) and 8 females (27, 
59%). For this purpose, we conducted the double therapy during 24 weeks 
and followed patients 24 weeks more. All patients were treated with interferon 
alpha 3mU, three timedweek and ribavirin 1200mg/day divided in two 
doses. Based on maintaining HCV-RNA in serum (PCR method) and serum 
aminotransferase activity before, during and after the therapy, patients were 
divided in two groups: 
0 SRP (sustain responders): 13 patients (44, 83%) with fast sigolticant decrease 
and elimination of HCV-RNA in serum and normal levels of serum 
aminotransferase activity during therapy and following, and; 
0 RRP (relapse responders): 16 patients (55, 17%) with significant decrease 
HCV-RNA in serum and normal levels of serum aminotransferase activ- 
ities only during therapy. 
Interferon-cr plus ribavirin is generally well tolerated therapy. Side-effects are 
generally reversible. The most 6equent side-effects of double therapy in our 
patients have been ‘fly-like syndrome’ (fever, headache, arthr+a, myalgia) 
during first 2 weeks of therapy in 13 patients (44, 83%) and ‘late syndrome’ 
(arthraIgia, myalgia, nausea, fatigue and insomnia) in 16 patients (55, 17%). 
Our patients tolerated these side-effects well and therapy was not changed. 
Leukopenia (under 3.0 x lo9) was observed in three patients (10, 34%); 
anemia (hematocrit under 30) in eight patients (27, 59%); leukopenia and 
anemia in four patients (13, 79%); depression in one patient (3, 45%) and 
suicidal ideas in one patient (3,45%). All these side-effects required the change 
of therapy regime (reduction of doses or therapy break during 2 weeks at 
least). Early termination of the therapy was not necessary in any patient. 
Conclusions: Side-effects of double therapy in our study were fiequent but 
not dangerous. In all patients, side-effects have been solved by reduction of 
doses or by temporary break of the therapy. 
1p12881 Viral kinetics in Lithuanian patients with chronic 
hepatitis C virus infection during induction vs. standard 
interferon-a therapy 
A. Ambrozaitis, L. Balciuniene and 0. Weiland 
Vilnius, LIT; Stockholm, S 
Objective: To evaluate viral kinetics during induction and standard three 
times a week (tiw) dosing with interferon-a (Realdiron, Lithuania) for 
treatment of patients (pts.) with chronic hepatitis C virus (HCV) infection. 
Methods: Thirty-six pts. with mean age of 37 years were entered consecu- 
tively to three treatment groups: standard IFN treatment 3mU/tiw for 
48 weeks (group I), induction IFN treatment with standard follow-up dosing 
6mU/day for 10 days followed by 3mU/tiw unal Week 24 (group 11) and 
high follow-up dosing 6 mU daily for 10 days followed by 6 mU/tiw until 
week 24 (group 111). All pa. were HCV-RNA-positive in serum at inclusion, 
and had had raised liver enzymes for more than 6 months (mo). Sixreen pts. 
had genotype 1 and 20 - genotype no. 1. HCV-RNA levels were analyzed at 
baseline, week 4,8,12, end-of-treatment and at follow-up the 24 weeks after 
treatment stop. A liver biopsy was performed in aU pts. within 6 months prior 
to entry and at treatment stop. Histological evaluation was performed 
according to Ishak scoring system. 
Results: Induction IFN mono-therapy followed by standard or high-dose tiw 
dosing of IFNa used as mono-therapy was not better then standard tiw 
treatment &om onset in achieving a decline in HCV-RNA levels week 4,8 or 
12 during treatment. Patients with HCV genotype 2 or 3, on the other hand, 
had a much more pronounced decline in HCV-RNA levels, irrespective of 
treatment schedule, than genotype 1 pts.. reflected by a mean 3 log and 1 log 
decline of the HCV-RNA levels already week 4, respectively. No patient 
treated with induction and a low follow-up IFN dose during only 24 week 
achieved sustained virological response (SR), whereas pts. treated with 
induction and a high follow-up dose achieved SR in 36%, a difference which 
nearly reached significance, P=0.067. Pts. treated with standard scheme 
during 48 weeks had an overall S R  of42% not significantly different fIom the 
result in the combined induction groups 17%, P=O.1. Adverse events were 
the commonly noted with IFN treatment. In the induction high-dose follow- 
up group nearly half of pts. had trombocytopenia (175 x 109/L). 
Conclusion: Genotype no. 1 infections respond with a much more pro- 
nounced decline in viral levels early during treatment than genotype 1 pts. and 
that a shoa-induction period does not translate in a higher sustained response 
rate. Adverse events were sigmfkantly more common in pts. treated with 
high-dose IFN therapy. 
1 PI289 1 Daily interferon in chronic hepatitis B patients: a 
multicenter study from Turkey 
I. Koksal, R. Caylan, F. Sumatel, Y. Ersoy, B. Aygen and M. Sunbul 
Trabron, Guriantep, Malapa, Kayseri, Sumsun, TR 
Objectives: Chronic hepatitis B (CHB) infection is a major health problem in 
Turkey. HBsAg positivity varies h m  3 to 12.5% in Turkish population. In this 
study, response to the daily interferon treatment was evaluated in chronic 
hepatitis B patients. 
Methods: The treatment consisted of interferon alpha-2b (5 mU/day) for 
24 weeks. Patients were evaluated as to the clinical response and side-effects 
during and 1 year after termination ofthe treatment. Inclusive criteria for the 
study population were determined as such; HBsAg positivity for a minimum 
of 6months prior to treatment, increased ALT levels, HBeAg or antiHBe 
positivity and HEW DNA positivity. Liver biopsy was performed prior to the 
treatment and evaluated according to Knodell scoring system. A total of 60 
patients (fedelmale = 21/39) were included into the study. Mean age was 
33 f9.2 (17-55). Four patients were discarded 6om the protocol because of 
side-effects of the therapy. 
Results: At the end of the 6months. the following responses were noted 
biochemical 71.4%, ViTologic 46%, complete response (biochemical and 
virologic response) 41%, HBeAg negativity and antiHBe positivity 44%. 
One year after the treatment the following responses were noted biochemical 
44.6%. virologic 39%, HBeAg negativity and antiHBe positivity 50%, 
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sustained response (biochemcal and wolog~c response) 33.9%. Loss of 
HBsAg was determned in 3 5% of pahents. 
Conclusion: Daily admt ra t ion  of 5 mU interferon alpha-2b for 6 months in 
CHB is associated wth hgh rate of sustained response 
1 PI290 1 Viral dynamic of hepatitis C in patients treated 
with pegylated interferon-a plus ribavirin 
M. C. Nogales, S. Bernal, M. Romero Gbmez, L. Grande, 
M. C. Serrano, R. Claro, M. Ramirez and E. M d n  Mazuelos 
Sevilla, E 
Objective: To study the influence of HCV genotypes, basal viral load, and 
viral dynamics as predictive factors in early viral response (EVR) in patients 
treated with pegylated interferona-a plus ribavirin (PEG-IFN + RBV). 
Patients and method. Thirty-four patients with chronic hepatitis C treated 
with PEG-IFN + RBV were studied, 16 males and 18 females. The average of 
age was 43 years. We used a PCR technique (Monitor, Roche) to determinate 
the viral load at baseline, at 48 h, and 2,4, 12 and 48 weeks. Genotypes were 
determined by reverse hybridization using InnoLIPA genotyping kit (Inno- 
genetics). we defined three phases: (I) changes on viral load at 48h; (11) 
changes at 4weeks; and (111) changes between 48 h and 4weeks. EVR is 
defined as negation of RNA HCV viremic or decrease of 2 logs on viral load 
from baseline to 12 weeks. 
Results: Twenty-one patients showed EVR. Genotypes no. 1 were associated 
with EVR (52% ofpatients infected by genotype 1 versus 100% ofinfected by 
no. 1 genotype) but no viral load at baselme. The phase I1 of viral dynamics 
showed a higher decrease in responders than non-responders (3.88 log f- 2.47 
vs. 0.611og&0.5, P<O.OOl). Also, the phase I1 was statistically different 
according to genotypes (decrease of 2.3log&2.2 in genotype 1 vs. 
5.3logf1.9 in no. 1 genotype, P<O.OOZ). 
Conclusions: HCV genotypes and phase I1 of viral dynamic, but no viral load 
at baseline were associated with EVR. Also, no. 1 genotype showed a deeper 
decrease ofHCV-RNA in phase I1 ofviral dynamic. On the other hand, phase 
I1 were associated with the viral genotype. Therefore, the d u e n c e  of 
genotype in EVR should be explained by a different viral dynamic. 
jp1291( Factors predictive of response to interferon-cz 
(IFN) plus ribavirin in patients with chronic hepatitis C 
non-responders to IFN alone 
G. De Santis, A. Gramoni, E. Mancardi, G. Cariti and G. Di Perri 
Turin, Z 
Objective: The aim is to assess if HCV genotypes, HCV-viral load, and 
pretreatment liver histology may be prognostic indicators in the therapy with 
IFN plus ribavirin ofpatients with chronic hepatitis C non-responders to IFN 
alone. 
Methods: Thirty-two patients were studied. In all, individuals were evaluated 
the histological activity index (HAI), the HCV genotype and the HCV viral 
load. HA1 was scored according to Ishak et al. Serum HCV-RNA was 
determined by qualitative (Amplicor-Roche) and quantitative (Amplicor 
Monitor-Roche) methods. HCV-genotypes were identified by Inno-LiPA 
HCV 11-(Innogenetics). Biochemical response (normalization of serum 
alanine aminotransferase concentrations) and virological response (undetect- 
able serum HCV-RNA) were evaluated at the end of therapy and after 
6 months of follow-up (sustained response-SR). 
Results: 19 patients were infected by genotype 1 ,2  patients by genotype 2,4 
patients by genotype 3 and 7 patients by genotype 4. Virologic SR was 10.5% 
in genotype 1,50% in genotype 2,003 in genotype 3, and 14.2% in genotype 
4. The table shows the mean HAI score and the mean viral load among 
ddTerent genotypes in patients responders and non-responders (see following 
table). 
Mcan HAI score (gradmb-rtagmg) M a  v m l  load 
P m e m  No of 
( F W ’ P ~ )  Patlens Raponden Nan-rapanden Responders Non-responders 
~~ 
1 19 (594%) 7-1 62-1.9 200000 700WO 
2 2 (625%) 8 4  8-4 200000 312000 
4 7 (21.87%) 8-2 53-53 1OOOM)O 740750 
3 - 265 250 4 (12.5%) - 6 45-2 
Conclusions: HA1 score was not slpficantly Werent among responders and 
not responders. A high response rate was acheved in genotype 2, whereas 
genotypes 3 and 4 showed poor response. No patient w th  genotype 3 had a 
susmned vlrolog~c response. Another factor that may be predichve of 
response is the viral load before treatment (200 000 copies/mL vs. 700 OOO 
copies/mL, in patients with genotype 1). These results mght be useful to 
determine the best cost-effectme thenpeunc strategy in patients with chronic 
hepahhs C nou-responder to IFN. 
I P1292 1 InterFerona plus ribavirin combination therapy 
in patients with chronic hepatitis C, non-responders to 
interferon afone: response rates in different genotypes 
A. Gramom, G. De Sanus, E Mancardl, G. Cariti and G. Di Perri 
Twnn, I 
Objective: To assess the efficacy of therapy with interferun-a (IFN) 
plus nbawin in pauents infected wth  dflerent genotypes of HCV now 
responders to IFN alone 
Methods: In 1999-2000, we treated 11 1 naves pahents wth IFN alone. 
Sustained biochemcal and vmlogx response was achieved m 12 7% of 
pahents w t h  genotype 1, 54 5 and 32.4% in pahents infected by genotype 
2 and 3, respechvely. All pahents w th  genotype 4 were non-responders to 
IFN alone. We studied 32 pahents non-responders to prevlous treatment w t h  
IFN >5 mU three tmes weekly for at  least 3 months. All pahents had posihve 
serum HCV-RNA as well as biochemcal and h t o l o g d  evldence of chromc 
hepatlas. HCV genotype 1 was found m 19 pahents (59.4%). and genotypes 2, 
3 and 4 have been detected m 2 (6.25%). 4 (12.5%) and 7 (21.87%) patients, 
respechvely. Pahents were treated wth  IFN 3 m u  three hmeS weekly plus 
ribavirin 1-1 2 g d d y  for 6 months. Biochemcal response (normahahon of 
serum alanine ammotransferase concentrahons) and vmlogic response (unde- 
tectable serum HCV-RNA) were evaluated at the end of therapy and after 
6 months of follow-up (susmed response). 
Results: The follmng table surmnatlzes response rates among dfferent 
genotypes. 
Response at end therapy (46) Susmed mponse (%) 
Genotypes 
(no. of 
pahents) Biochemcal Virologic Biochemical Virologic 
1 (19) 47.4 86.8 15.8 10.5 
2 12) 100 100 50 50 
3 (4) 75 75 50 25 
4 (7) 14.2 14.2 14.2 14.2 
Conclusions: Re-treatment with IFN plus ribavirin is effective in about 20% 
ofpatients with genotypes 1 and 3 non-responders to IFN alone. Patients with 
genotype 2 are the only ones that show a high response rate to the 
combination therapy. Genotype 4 is more common than previously reported 
in Italy (7.3% vs. 3%). and shows no response to IFN alone; in patients with 
genotype 4 is mandatory the combinahon therapy IFN plus ribavirin. 
ml Quasi-species in hepatitis C virus and their 
implications in antiviral therapy 
B. Fernindez, M. Basaras, S. Blanco, S. Sinchez, E. Arrese, 
B. de las Heras and R. Cisterna 
Bilbao, E 
Introduction: Interferon-a eliminates hepatitis C virus (HCV) in only 15- 
30% of chronic idected patients. The aim of this study is to evaluate the 
relationship between the hypervariable region 1 (HvR1) quasispecies of 
hepatitis C vims and the evolution of therapy to determinate the significance 
of genetic complexity as a predictor fictor of the responsiveness to interferon 
therapy. 
Patients and methods: A total of 12 patients divided into three p u p s  were 
analyzed (three patients with sustained response, three patients with transient 
response and six non-responders patients). Patients were infected with 
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genotypes l a  (one patient), lb  (seven patients) and3a (fourpdtients). The vi+al 
quasispecies were detected by nested RT-PCR by using primers flanking 
HVRl mediated single-strand conformation polymorphism (SSCP) assay. 
The bands were visualized by silver staining. 
Results. Two different genetic complexity patterns were obtained. The 
patients with sustained response showed a low quasispecies genetic complex- 
ity. In three non-responders patients and in one patient with transient response 
the genetic complexity pattern was high and all of them were l b  genotype. 
Into the rest of patients with transient response the appearance of new bands 
was detected. These patients were 3a genotype. The high genetic complexity 
pattern was detected only in patients infected with subtype Ib. 
Conclusions: These results suggest that the presence of a low genetic 
complexity pattern at the beginning of the interferon therapy is necessary 
to achieve a sustained response. Similarly, a high genetic complexity pattern 
could be related with the lack of a positive response to the treatment. The 
presence of this pattern only in patients infected with genotype Ib may 
explain the poor response to the therapy. A high genetic complexity pattern 
could be an independent predictive factor to genotype, as we have obtained in 
transient responden infected with genotype 3a. Because ofthe low number of 
patients involved in this study, prediction of response to interferon based on 
the genetic complexity pattern was not possible. Large-scale studies are 
urgently needed. 
Methods: The effect ofinterferon alpha-2b on 20 panents were evaluated. Of 
these pahents 11 pauents (55%) had chromc hepatltts B and m e  patzents 
(45%) had chromc hepahtis C. In pahents w t h  chromc hepahas B, IOmu 
Interferon alpha-2b was admsttated subcutaneously three m e s  a week for 
16weeks, in chromc hepahhs C patients 3mu Interferon alpha-2b was 
Injected subcutaneously three tunes a week for 24week.s. Regardmg the 
interferon comphcauons (bone m w  suppresson) the plhents were exam- 
med in the h t ,  second, fourth weeks and then monthly after b e p n m g  the 
treatment Before begmnig of the treatment, WNS markers (H85 Ag, Hbe 
Ag, HBV DNA, HBC Ab, HCV Ab, HCV-RNA) and hver enzymes (Ast, 
Alt, Ap) were recorded and hver btopsy were taken m all paaents. These 
expements were repeated after treatment too and the results were analyzed 
by student t-test. 
Results H~stolog~cd findmgs in pahents w th  chromc hepants B showed 
response m four pauents (36.3%) fow pahents (36.3%) unthout any changes, 
three pauents (27.3%) progression of the dmase. In pahents vvlth c h r o ~ c  
hepahas C, the response was (33.3%), without any changes was (33.3%), 
progression was (33 3%). Btochemcal response (decreased Alt level) before 
and after treatment was compared m chromc hepahhs B and C panents The 
results corresponded mth cytologxcal hdmgs 111 chromc hepams B paaents 
(36.3%) but m chromc hepaam C pahenls, biochemcal response (44.5%) was 
hgher than cytolog~cal response. 
1. Elefiiniotis, I. Glynou, C. Mavrogiannis, M. Simou, D. Papadeli, 
E. Georgakopoulos, H. Kada and G. Karvountzis 
Athens, GR 
Objective: Lamivudine is an oral nucleoside analogue with a potent antiviral 
effect on hepatitis B virus (HBV) due to inhibition ofviral DNA-polymerase. 
B2-microglobulin (B2-m) constitutes a sigdcant part of HLA class I, which 
plays a critical role in the T-cell immune response mechanism against viral 
infections. The aim of this study was to evaluate serum B2-m levels in 
HbeAg(-)/HBV-DNA(+) patients with chronic hepatitis B (CHB) before 
and after 6-month lamivudine monotherapy and to compare the results with 
those of healthy control subjects (HS). 
Methods: Serum fiom 29 CHB patients [ages: 44 + 2years, ACT = 188.7 + 
104 IU/L, HBV-DNA (2.4 + 2.3) x lo6 copies/mL, HAI = 6.9 + 2.8, stage 
3.2 + 1.3)] was obtained prior to and after completion of 6-month lamivudine 
monotherapy, as well as serum &om 26 HS of similar age and gender. Serum 
B2-m levels were determined by ELSA (IMX-Abbott). All the subjects were 
fiee of other acute or chronic illness and had not previously received any 
medication for hepatitis. All patients displayed normal liver function tests were 
HBV-DNA(-) (<400 copies/mL, Amplicor, Roche Monitor) after the end of 
the 6-month therapy Statistical evaluation was based on Wicoxon-test 
(P-value < 0.05). 
Results: Serum B2-m levels in CHB patients after the end lamivudine therapy 
were 1966.05 + 341.48 IU/L, significantly higher than those prior to therapy 
(1765.75 + 405.1 IU/L, P=0.001). The correspondingserumB2-mlevelsin 
the HS were 1419.5 +307.36IU/L and remained in similar levels after the 
6-month period (1407.5 + 295.45 IU/L, P >  0.05). 
Conclusion: Six-month lamivudine monotherapy results in a sigdicant 
reduction of viral load and possibly enhances the HLA class I mediated 
immune response, thus implying a possible indirect immunoregulatory effect 
of this primary antiviral drug. 
in dialysis 
N. Grinberg, M. Khoury, M. Pksano, E. Olivera, J. Lercari, 
E. Sanguedolce, M. Lopez, L. Gasparotti and C. Lavorato 
Buenos Aim, AR 
Objectives: To know the hepatitis C (HCV) prevalence and to identify 
factors related to higher risk of semconvenion for HCV at Dialysis Units 
@u). 
Methods: 155DU have been surveyed by the Infectious Control Team of 
CADRA, fiom 1/2/1998 to 7/30/1999 on field. Compliance with standard 
precautions, d e s  and procedures, prudent use of Vancomycin, cleanliness, 
reuse process, sterilization and disinfection, transfusions, pathogenic waste 
management, were surveyed. Relationship between these markers and HCV 
seroconversion is analyzed. In order to identify independent markers, stepwise 
logistic regression (SLR) was used. 
Results: HCV prevalence was 27.8% in this survey. DU with anti-HCV (+) 
patients represented 58.7% in ttus survey, and 34.8% of them registered 
seroconversions (SC+) during the last 2 years before the visit. According to 
the model identified by SLR, a predictive score was made. When the 
characteristic was present, the following scores were given: Transfusions: 
2.5 points, absence ofRight Dialyzers ID: 2 points, vancomycin prophylaxis. 
1.5 points. The probability of seroconversion w a s  predicted by adding the 
score accumulated at each DU. DU with no scoring had 1.5% probabilities of 
seroconversion. DU with 6 points (maximum score) had 89.3% probabllities 
of seroconvenion. 
Conclusions: A pattern has been identified which allows to predict the risk 
of seroconversion at each DU. The continuous surveillance of dialysis 
practices, educational programs and supervised use of antibiotics are essential 
in order to improve quality of care and reduce the impact of nosocomial 
infections. 
1 P12951 The effect of interferon therapy on patient with 
chronic active hepatitis B and C 
H. Kalantari and M. Jalali 
Isfaahan, IR 
Objectives: Many drugs have been used for treatments of hepatitis but 
they were not effechve. Interferon is an effective drug and causes 
response to 40 and 25% chronic hepatitis B and C, respectively, in the 
USA. The aim of present study was to evaluate the effect of interferon in 
Iranian patients. 
sc+ (n=54) Variables 
Decontanunauon clamps 
Tmshions’ 
Sohd soap 
Abundant sink (HD mom) 
No surk (HD room) 
fight waste management 
Proper disposable 
Bad clemg procedures 
fight Dialyzers ID‘ 
Vancoinycin prophyhs’ 
*Independent markers in SLR. 
19 (35.2%) 
50 (92.6%) 
28 (51.8) 
19 (35.2%) 
11 (20.4%) 
6 (11.1%) 
20 (37.0%) 
13 (24.1%) 
33 (61.1%) 
7 (12.9%) 
No SC (n= 101) 
66 (65.4%) 
53 (52.5%) 
31 (30.7%) 
38 (37.6%) 
9 (8.9%) 
47 (46.5%) 
25 (24.8%) 
16 (15.8%) 
80 (15.8%) 
13 (12.9%) 
P 
0.0003 
<0.0001 
0.01 
0.001 
0.0001 
0.001 
0.04 
0.003 
<0.0001 
<0.0001 
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(p12971 Risks of hepatitis C among Jordanian population 
H. &el 
Zarqa, JOR 
Objectives: To study the seroprevalence positive of hepatitis C among 
Jordanian population. 
Meth0ds:Srrrdypopultion: recruitment to the study was conducted at various 
primary health care centers and various governmental and private hospitals in 
Jordan. 7866 sera were collected (December 1996 through December 
2000). A questionnaire was completed for subject concerning personnel 
and epidemiological data relating to hepatitis C. Apart from demographic 
data, such as age and sex, the questionnaire asked for details of the home 
environment, previous contact with jaundice, external environments and 
travel abroad. 
Test method a sample of blood (3-1OmL) was taken from each 
subject and stored at 20 "C prior to serological analysis. Serum samples were 
analyzed using ELISA kit (Modified HCVab, Abbott Laboratories), a sample 
being considered positive for HCV IgC titer result was lOmIU/mL or 
greater. 
Statistical analysis: the results were expressed as the proportion of subjects 
in each group or subgroup, positive for HCV with a 95% confidence 
interval (CI). AU data were summarized using SPSS (Version 10). Confidence 
intervals were not calculated for subgroups of less than 10 subjects. 
Evaluation of the relationship of each variable with HCV status was deter- 
mined using the chi-squared or Fisher's exact test. Statistical significance w a s  
assumed at the conventional level of P< 0.05 and all quoted D-value are two- 
sided. 
Results and conclusions: The prevalence of anti-HCV antibody among 
Jordanian population was tested at c h c s  and hospitals. A blood sample 
was taken to test the presence of IgG (indicating past mfection) and a 
questionnaire concerning personnel and epidemiological data relating to 
hepatitis C was completed. In total 7866 samples for persons aged <10 
and <60years were suitable for the analysis. There were 2007 subjects who 
positive for HCV (25.5%). The proportions of subjects positive varied 
sigruficantly with age (P= 0.001); 32.9% in the <35 yem were positive 
compared with 25.6% aged 35 and below. There was a sigmficant association 
between a positive-HCV test and social level (P=0.004), with a higher 
proportion positive in the low social level. Persons with jaundice, live with 
infected persons, infected mother during pregnancy, blood transfusion or 
travel abroad were significantly more likely to be HCV positive (P=O.001, 
P= 0.004, P =  0.020, P= 0.001, respectively). 
[ P1298 I Hepatitis C virus patient serotyping in Belgium 
L. De Cock and R. Vranckx 
Emssds, B 
Objectives: Given that both pathogemcity and the response to treatment are 
associated with HCV serotype, it would seem serisible to establish the 
prevalence of the Merent HCV types in Bellpum. The HCV serotypes 
were determmed in Belgian patients and possible associations with age and sex 
were investigated. 
Methods: The serotype was idenhfied in 68 HCV-RNA pC5ihVe 
samples. 
Results: In 55 of the 68 samples (80.9%), anhboches were identified 
with serotype 1 (58.8%) and serotype 3 (19.1%) shswing the hghest pre- 
valence. Seventeen samples contamed several serotypes with serotype 1 being 
detected in 82.4% of cases. There was no significant difference m the 
distribution of HCV types in relation to sex. Serotype 1 was detected among 
older patiena compared with serotype 3 (P< 0.01) and serotypes 2 and 4 
(P=0.05). 
Conclusion: Serotypes 1 and 3 are the most prevalent types in Belgan patients. 
The data suggest that serotype 1 spread earher than serotypes 2 ,3  and 4. Thu 
corroborates previous European stuches. 
)p12991 Endogenous levels of mRNA for type 1 and I1 lFNs 
and IFN-related genes in liver biopsies of patients with 
chronic HCV infection 
I. Abbate, M. Romano, R. Longo, G. Cappiello, 0. Lo Iacono, V Di 
Marco, A. Ursith, A. Span6 and M. R. Capobianchi 
Rome, I 
Objective: To measure endogenous expression of type I and 11, IFNs, IFN 
receptor (IFNAR-I), IFN-stimulated genes (IRF-1 STAT-1, PKR, and 
oligoA-S) as well as ICE and IL-18 in liver biopsies of naive patients with 
chronic HCV infection and in patients affected by non-infectious liver 
pathologies. 
Methods: Liver biopsies from 24 HCV-infected chronic patients negative for 
HEW and HIV infection, and &om six patients with NASH and one with 
autoimmune hepatitis were analyzed. Histological evaluation was performed 
by Knodell score. Gene expression was measured at mRNA level by semi- 
quantitative RT-PCR, and normalized to B-acdn. 
Results: In liver tissue &om HCV-infected patienu mRNA levels of Type I 
IFN were decreased, while those of IFN-y, IFNAR-1, IRF-1, and IL-18 
were up-regulated as compared to tissues from non-infectious hepatitis 
patients. In HCV-infected patients IFN-y was positively correlated with 
IFNAR-I, IRF-1 and IL-18. No correlation was observed between viremia 
and the other parameters. ACT levels were correlated with IFN-y, but not 
with IFN type I expression. Liver fibrosis was absent or mild (FO-1, n = 13) in 
the biopsies with higher IFN type I mRNA levels, while it was moderate or 
severe (F3, n = 11) in those biopsies with lower IFN mRNA levels ( P =  0.024 
for IFNa and 0.047 for IFNB). 
Conclusions: Several genes acting downstream the IFN pathway are up- 
regulated in the hepatic tissue from patients with chronic HCV infection, 
as compared to non-infectious hepatic diseases. Therefore, it is likely that 
this phenomenon is determined by virus-driven mechanisms. The degree 
of tissue damage, in terms ef fibrosis, seems to be counteracted by 
the expression of endogenous type I IFN, which is, in turn, down-regulated 
in HCV-infected patients. Because HCV has evolved escape mechanisms 
against the IFN system, our observation can have pathogenic implications. 
Long-term follow-up of a newborn with 
immunotolerance to HCV infection 
R Bemto, M Gram, J. Gil, E L6pez-Franco and M C Rubio 
Zaragoza, E 
Objective: We presented the long-term follow-up of a vemcally HCV- 
infected, seronegative but RNA-posihve d a n t  
Methods: Sera markers of HCV were determmed m a baby, born to an anti- 
HIV-neganve intravenous drug-user proshtute aged 28yem. Baby was born 
by vagnal dehvery at 38weeks of pregnancy. Hts mother was anti-HCV- 
posihve wlth REJA bands for NS4(2+) and c33c(2+). His aunt was ako anh- 
HCV-posihve and presented the same RIBA profile than the mother Serum 
antl-HCV was detemned by u m g  MEIA (AXSYM HCV 3 0 Abbott), 
whose anngen mcludes 4 recombmant protem related mth structural and 
nonstructural regions of wus genome (HCr43, ~200 ,  c100-3 and NS5) 
Serologrcal resdts were confirmed by RfBA 3.0 (Chron) whch includes 5 
pepades, 2 recombinant (c33c and NS5) and 3 SynthehC (~100, 5-1-1 and 
c22), the first four bemg nonstructural protem and the fXh a core protem of 
virus. V d  RNA w a s  assayed by RT-PCR (Cobas Amphcor HCV Momtor 
V2.0, Roche). HCV genotype was determmed mth a hne probe assay 
(InnoLE'A HCV 11, Innogeneacs) 
Results: Idant sera results are expressed m the table Infant was anh- 
HIV-negahve during all follow-up No munodeficiency was detected 
and his response to measles, mumps and rubella vaccmes, ahmstered at 
18months, was POSihVe, mth appearance of anhbomes awnst three 
viruses (I@ EIA indexes 3.4, 2 6 and 2.6, respechvely) Pahent presented 
hepatomegaha durmg follow-up w~th  elevated AST and ALT levels, but no 
mcrease of serum bhrubm level was detected The infant was also tested 
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to exclude other infectious, metabohc or immunological causes of 
chronic liver diseases. Liver biopsy was refused. Mother HCV-RT-PCR 
was positive (2.4 x 10SUVmL). Infant, mother and aunt were HCV 
genotype 4 
h a - H C V  RIBA3.0 
*F RT-PCR AST ALT 
(mQnths) Rcsdk Index Resole NS4 c33c c U  NS5 (IU/L) (UIL) (u/L) 
Binb 
3 
5 
8 
I I  
16 
21 
25 
33 
Pos 59.4 POS 
POS 18.7 POS 
POS 4.9 POS 
POS 1.1 NEG 
NEC 0.2 NEG 
NEG 0.2 NEG 
NEG 0.2 NEG 
NEG 0.2 NEG 
NEG 0.2 NEG 
4+ 4f - - NEG 
4+ 3f - - 5 . 6 ~  lo5 27 26 
3+ 2+ - - 4.8X105 41 48 
f f - - 2 . 6 ~  lo5 102 179 
>8Sx Id 192 303 
_ - - _  2 . 3 ~  lo5 205 270 
2.6x lo5 85 117 
_ _ _ -  
2.6 x lo5 _ - _ _  
_ - - _  
>8Sx 105 78 82 _ - - _  
Conclusions: Passively acquired maternal antibodies were negative before 9th 
month. Infant developed a chronic HCV infection with elevation of ALTand 
AST levels and high viral load. HCV specific antibodies were absent as result 
of an S m t  immunotolerance to viral antigens. 
I P1301 I Clinical, virologic characteristics and liver 
histology of anti HCV-positive subjects according to 
arninotransferases levels 
A. Hristea, J. Bach, C. Popescu, R. Hristea, G. Popescu, S. Spiridon and 
D. Banica 
Bucharest. RO 
Objective: The aim of the study was to find out if the clinical and virologic 
findings and liver histology in patients with increased ALT levels are different 
as compared with patients with normal ALT levels. 
Material and methods: We retrospectively studied 81 anti HCV-positive 
patients, HIV seronegative for which the hepatic biopsy was perform in 
addition to the serum HCV-RNA detected by PCR. Most of patients 
were women (55.6%). the mean age being 44.7f11.9yem. We excluded 
concomitant infection with HEW, an autoimmune cause of hepatitis and 
hepatotoxic drug intake. The persistence of normal ALT values (in 22 
patients, 27.2%) was documented by repeated testing with at least three 
values taken over a 6-month period. We used Ishak score to appreciate liver 
histology. Data were analyzed using Epi-Info version 6, the sigfllficance level 
being 5%. 
Results: We did not find any statistically sigNficant difference between men 
and women with normal ALT levels {22.2%, respectively, 31.1%). Surpris- 
mgly we found an oider average age in persons with elevated ALT levels, but 
the mean age was under 50 years for both groups (39.7 & 12.2 years in normal 
ALT group and 46.6 f 11.3 years in elevated ALT group). The fiequency of 
symptoms was similar in anti HCV-positive patients with normal ALT levels 
than in those with elevated levels (72.7%. respectively, 76.3%). Consumption 
of alcohol was sigmficantly greater in the elevated ALT levels group than in 
patients with normal ALT levels (49.2% vs. 9.1%, OR 9.67, P<0.05). 
Biochemical features were not different in the two groups as well as virologic 
characteristics of patients with chronic hepatitis C. The genotype 1 was 
predominant in the two groups. The histological Gndings (staging and 
grading) in normal ALT level group were mild (20122, respectively, 
21/22) and severe staging or cirrhosis was rare. The fibrosis was slgtllficantly 
greater in patients with elevated ALT (P < 0.05), while the necro-damation 
was significantly greater when ALT level was superior to two fold the normal. 
We did not found any statistically significant Werence between the severity of 
hwtological characterlshc and the presence of symptom, either with con- 
sumption of alcohol. 
Conclusion: An important number of patients mfected with VHC have 
normal ALT levels despite having detectable HCV-RNA in serum. It seems 
mportant to evaluate the response rate to IFNa as well as the long-term 
outcome without treatment in these paaents. 
Cryoglobulinemia in Greek patients with chronic 
HCV infection and association with liver histology 
D. Siagris, M. Christofidou, K. Thomopoulos, A. Lekkou, 
A. Tsamandas, C. A. Gogos and C. Labropoulou-Karatza 
Patras, GR 
Objectives: To determine the prevalence of cryoglobulinemia and to idennfy 
any association between cryoglobulinemia and liver histology in HCV- 
infected Greek patients. 
Patients and methods: 80 HCV-RNA-positive patients (44 males, 36 
females, mean age 50.1 f 16.6yem) were studied. The presence of cryoglo- 
bulins was assayed by collection and coaguIation of blood at 37 "C, centri- 
hgation and incubation of serum at 4 "C for 7 days. Liver biopsy samples were 
evaluated according to the staging and grading system described by Ishak et al. 
Results: Cryoglobulins were detected in 22/80 (27.5%) patients. Only two 
patients presented an unmistakable cryoglobulinemic syndrome (vasculitis, 
glomeluronephritis, arthralgia). When croglobulinemic patients were com- 
pared with non-ctyoglobulinemic patients, grading of necro-inflammatory 
activity (6.27 f 2.21 vs. 5.84 f 2.48, NS) and staging score (3.41 f 1.62 vs. 
3.29 41 1.92, NS) were not found Merent. 
Conclusions: The prevalence of HCV related CrpglobuIinemia was 27.5% in 
our patients, although only two patients d e s t e d  a clear clinical syndrome 
of cryoglobulinemia. There was no association between the severity of the 
hwtological lesions and cryoglobulin presence. 
IP1303) Prevalence of cryoglobulinemia in HCV-infected 
Greek patients on chronic hernodialysis 
D. Siagris, M. Christofidou, K. Thomopoulos, A. Lekkou, D. Goumenos 
and C. Labropoulou-Karatza 
Pahas, GR 
Objectives: To determine the prevalence of cryoglobulinemia and assess the 
fiequency of auto-antibodies in HCV-infected Greek patients on chronic 
hemodialysis. 
Patients and methods 73 HCVAb(+) patients (49 M, 24 F, mean age 
57.8 f 13 years) on maintenance hernodialysis were studied. Serum HCV- 
RNA was detected by RT-PCR. The presence of cryoglobulms was assayed 
by collection and coagulation of blood at 37 "C, centrifugation and incuba- 
tion of serum at 4 "C for 7 days. Rheumatoid factor (RF), antinuclear (ANA), 
antimitochondrial (AMA) and anti-smooth-muscle antibodies (ASMA), were 
detected in serum. 
Results: Cryoglobulins were detected in 22/73 (30.1%) patients but the 
cryocrit value was very low: 2.4% in two patients, 1.4% in one, 1% in two and 
<1% in 17. HCV-RNAwas detectedin 56/73 (76.7%) patients. Rheumatoid 
factor was found in 21/73 (28.8%) patients, ANA in 16/73 (21.9%), AMA in 
1/73 (1.4%) and ASMA in no one. There was no association between the 
presence of cryoglobulins and patients' age, sex, RF, ANA or HCV-RNA 
positivity. 
Conclusion: This proportion of cryoglobulinemic patients was not different 
from that found in a Greek report of 87 HCV patients without renal disease. 
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Cryoglobuhnema is quite fkquent m HCV pauena on mamtenance hemo- 
dialysis but cryocrit values are exceptionally low. On the contrary to what IS 
known for HCV pahents with normal r e d  function, no correlation was 
found between cryoglobulinemia and age ot RF positivity. 
Results: Out of 232 patients, 27 (1 1.6%) were HCV posihve, 17 were males 
and 9 were females, the mean age was 49 (SD 15.6 years). HCV infection was 
more prevalent among older patients (>50 years vs. <50yean, P= 0.001) and 
those who stared hem More implementation of routine HCV 
screemng in 1993 (P= 0.001). Gender and transfusion history was not found 
as a sigtllficant risk factor. Seven pauents (26%) had rmxed HCV infection and 
16 had nona-nonb genotype 2 infection. The table below shows the 
genotypic profile of our study population. 
w/ Prevalence, genotypic profile and risk factors for 
HCV infection in a population of Lebanese hemodialysis 
patients 
N. Hakune, H. Samaha, W. Karam, M. Abou Jaoude, J. Mokhbat, 
J. Khabout, R. Najem and E. Nassr 
Bernrt, LBN 
Objective: Hemoddysis pahents are considered at hlgh risk of developing 
HCV mfection. The aim of t h ~ ~  study was to determine HCV-genotype 
Istribuhon and to analyze the risk factors for HCV infechon in t h l s  group of 
pahents. 
Methods: Two hundred and hty - two pahents on m t e n a n c e  hemoddysa 
were rouhnely screened for HCV Ab by h4EIA HCV 3 0 (AxSym, Abott). 
The HCV-posihve samples were further analyzed using nested RT-PCR, 
followed by hybridrzahon to HCV subtype core regon-specific bionnylated 
oltgonucleotide probes immobhzed onto a n d n  coated wells DNA/probe 
hyhnds were detected by DNA enzyme nnmunoassay (DEIA). An analysis of 
the risk factors including transfusion history and date of starhng hemodlalysa 
was pe6ormed. 
H BV 
Single genotype lnfecaon n = 20 (74%) 
Genotype l a  l b  2 2a 2b 3a 4 5 6 Mixedinfection 
Nb 1 1 1 6 0 0 2 0 0 0  7 
% 3.7 3.7 59.2 0 0 7.4 0 0 0 26 
Conclusion: The prevalence of HCV infection in hemodialysis patients in our 
study population remains within the m g e  usually reported (1 1.6%). The fact 
that the majority of cases (59.2%) were infected with nona-no& HCV 
genotype 2 suggests a nosocomial transmission of HCV before implementa- 
tion of routine HCV screening in 1993; however, further subtypmg by duect 
sequencing is necessary to confirm this pathway. 
m) Effect of IL-12 and 11-18 on anti-HBcAg 
response of Th lymphocytes in children with chronic 
hepatitis B 
A. Szkaradkiewicz, A. Jopek, J. Wysocki and I. Malecka 
Poznari, PL 
Objectives: The typical lymphokme pattern in chron~c hepatihs B (CHB) was 
charactenzed by a weak or absent anhgen-specific IFN-), producuon. The 
aun of t h s  work was to evaluate effects of IL-12 and LL-18 on the secretory 
anti-HBcAg response of peripheral blood Th lymphocytes m chddren mth  
CHB. 
Methods. The studies mcluded 12 cllddren, aged 5 1 6  years with documen- 
ted diagnosrs of chronic active type B hepatitis. T CD4 lymphocytes were 
isolated from peripheral blood using the biomagnetic techmque (Dynal) and 
rHBcAg shmulated cytokme production (IFN-y, IL-4, I L 5  and IL-lo), 
estimated by ELISPOT assays (Mabtech) in 24 h cultures. In parallel, cultures 
of TCD4 lymphocytes were set up. stimulated with rHBcAg in presence of 
IL-12 and/or IL-18 
Results: In response to rHBcAg, IFN-) producing cells were not 
observed or very weak IFN-y produchon was dlsclosed, mth  preserved 
secretion of IL-5 and IL-10. In turn, IL4  producing cells could not be 
detected. After costimdahon wth IL-12 and rHBcAg a signhcant number 
of IFN-y producmg cells was detected w t h  no sigdicant changes 
m secrehon of the remaimng cytokmes A most pronounced increase 
m the number of IFN-y producmg cells was observed following 
rHBcAg shmdahon of Th lymphocyte cultures in presence of IL-12 and 
IL-18. 
Conclusion: IL-12 and IL-18 synergicdy achvate a strong, anbgen- 
spechc EN-y producuon m Th lymphocytes of CHB-afTected children. 
Cellular gene activation by HBV integration in or 
close to chromosomal regulative elements: a hypothesis 
from the WHV/Woodchwck model 
R. Brum, U. Villano, E. D'Ugo and R. Giuseppetti, C. Argentnu, 
M. Rapicetta 
Rome, I 
Aim: In the WHV/Woodchuck model for HBV-induced HCC, the N-myc2 
proto-oncogene can be activated by WHV integrahon either close to the gene 
or in the b3n and win noncoding lon located 10 and 150 kb downstream, 
respechvely. A matrix attachment region (MAR) IS located in b3n. MARS are 
noncoding regulative elemenm of chromosomal DNA. Aim 6f t h ~ ~  work was 
to i d e n ~ a n d  characterize further cases ofWHV insertion in b3n in naN& 
occurred HCCs to better clad$ the posible inwhremenr of the M 
element m mediating N-mycZ achvation. 
Methods: Search for integration in b3n was carried out by Southern blotting/ 
hybridzanon. Integrahon was characterized by PCR and sequencing. 
N-myc2 transcription was assayed by Northern blothng. 
Result% Fifteen Woodchuck tumors were screened for integrahon in b3n. 
One tumor showed an additional, WHV posihve, hgment. Sequencing 
showed WHV insertion to be located a few nucleotides adjacent to the MAR, 
closer than previously described mtegrations. Tumor-specific N-myt2 tran- 
scripts mca ted  activaaon of the gene. 
Conclusions: The data remforce the hypothesis that N-myc2 achvation 
by mtegrahon in b3n might be medated by deregulanon of the 
noncoding MAR element located nearby WHV insemons. Ths  mechanism 
has never been inveshgated in human HCC. Several HBV insemom 
occur m noncodmg regions, whose funChOn(S) cannot easily be investigat- 
ed because suitable approaches are unavailable. Clarification of the 
mechatusms mvolved in N-my62 achvahon by WHV insertion m the b3n 
and win noncodmg loci may sigolficandy contribute to elucidate basic 
mechamsms for better understandmg the role of HBV integration in HCC. 
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)p13071 Peginterferon a-2a (40 kD) (PEGASYS) therapy for 
HBeAg-positive chronic hepatitis B (CHB): &week end of 
follow-up results and evaluation of the prognostic factors of 
response 
W. G. E. Cooksley, T. Pmtvisuth, Y.-J. Wang, V Mahachai, Y.-C. Chao, 
T. Tanwandee, A. Chutaputti, W Y. Chang, F. E. Zahm and N. Pluck 
Brisbane, ACJS; Songkla, TH; Taipei, TW; Bangkok, TH; Kaohsiung, TW; 
Basel, CH; Welwyn Garden City, U K  
Background Recipients of peginterferon a-2a (40kD) have recently been 
shown to exhibit improved 24-week end of treatment responses compared 
with patients given standard interferon (Roferon A). (Cooksley WGE et al. 
Hepatology 2001; 3 4  349A. Abstract 710.) 
Objectives: To assess the 48-week end of follow-up responses following 
24 weeks’ treatment with peginterferon a-2a (40 kD) or Roferon A, and to 
evaluate of the prognostic factors of response, in the treatment of HBeAg- 
positive CHB. 
Methods: A total of 194 adults, who had not previously been treated with 
interferon-a or had received <6 months of nucleoside analogue therapy in the 
preceding 6 months were enrolled into a Phase 11, multicenter study. All 
patients were serum-positive for HBsAg, HBeAg, HBV DNA and demon- 
strated biopsy-proven CHB with ALT > 2x ULN. They were randomized 
(1:l:l:l) to receive Roferon A (4.5MIU tiw) or peginterferon a-2a (40kD) 
(90, 180 or 270pg qw) for 24weeks and followed-up for an 
additional 24weeks. Efficacy was assessed by measurement of HBeAg 
and HBV DNA (AMPLICOR HBV MONITOR test), but the study was 
not powered to assess the effects of the individual doses of peginterferon a-2a 
(40kD). A logistic regression model was used to estimate the effects of 
baseline HBeAg, HBV DNA and serum ALT on response rates at 48 
weeks. 
Resub An HBeAg positive response (defined qualitatively as ‘negative’ or 
quantitatively as ‘<0.280peiu/mC‘) occurred at 48 weeks in 25.5, 36.7, 34.8 
and 29.2% of patients given Roferon (4.5MIU tiw) and peginterferon 
a-2a (40 kD) (90. 180 or 270 pg qw), respectively. The greatest drop in 
HBV DNA was produced by peginterferon a-2a (40 kD) 180 pg qw; log 3.5 
at the end of treatment. Preliminary analyzes suggest that certain prognostic 
factors associated with standard interferon therapy such as baseline ALT may 
be less important with the use of peginterferon a-2a (40kD). 
Conclusion: Peginterferon a-2a (40kD) at doses of 90 and 180pg qw, 
demonstrated similar sustained responses that were substantially higher than 
those produced by Roferon A (4.5 MIU tiw). However, peginterferon a-2a 
(40 kD) dosed at 180 pg qw produced the greatest drop in HBV DNA and 
quantitative eAg during treatment period. The reasons for the si&icant 
improvement in efficacy in the use of peginterferon a-2a (40kD) over 
standard interferon in chronic hepatitis B will be discussed. 
I P1308 1 Differential immunogenicity of a recombinant 
hepatitis B vaccine in Iranian neonates: influence of 
ethnicity and environmental factors 
E Shokri and A. Jafarzadeh 
Tehran, IR 
Objectives: To compare immunogenicity of a recombinant hepatitis B (HB) 
vaccine in two p u p s  of neonates born in two cities of Iran with di6erent 
geographic and ethnic backgrounds. 
Methods: Ten micrograms of a recombinant HB vaccine (Heherbiovac) was 
administered under field condition to Iranian healthy neonates at 0, 1.5 and 
9months intervals. The subjects consisted of two groups of 290 and 231 
neonates selected h m  two cities located at north-west (Uromia) and south- 
east (Kerman) of Iran, respectively. The level of anti-HBs antibody was 
quantitated in serum 2-4 weeks after administration of the last vaccine dose, 
by sandwich ELISA. 
Results: A higher seroprotectionrate (anti-HBs > 10 IU/L) (98.3% vs. 96.1%) 
and significantly increased serum anti-HBs antibody titer (1 1869 vs. 
6104 W/L) (P< 0.001) were induced in vaccinated neonates from Uromia 
city, compared to those born in Kerman. 
Conclusion: These findings suggest contribution of ethnic and/or environ- 
mental factors in the antibody response to recombinant HB vaccine in 
human. 
[p13091 Revaccination with a single low dose of a 
recombinant hepatitis B vaccine induces protective antibody 
response in the majority of healthy nonresponder neonates 
A Jafarzadeh and E Shokri 
Rafsanjan, Tehran, IR 
Objectives: To evaluate the influence of supplementary vaccmahon with a 
smgle dose of 2 . 5 5  or 10 pg of a recornbmant hepath B (HB) vacane m 
healthy nonresponder neonates to pnmary vaccination. 
Methods: Three different doses (2 5, 5 and 1Opg) of a recombinant HB 
vaccine (Heberbiovac) were a h t e r e d  i m at 0, 1 5 and 9 months of age to 
three large groups of healthy Iraruan neonates. Serum samples were collected 
2 4  weeks after complehon of vaccmahon and anQ-HBs was quantitated by 
sandulch ELISA Immedlately, the fourth vaccine dose of the same con- 
centrahon was admuustered to nonresponder neonates and anh-HBs was also 
measured in their serum 
Results: Admuustrahon of fourth vaccme dose mduced seroprotechon 
(anh-HBS > 10 IU/L) m 10112 (83%), 10112 (83%) and 21/24 (88%) of 
nonresponder neonates in 10, 5 and 2.5 pg groups wth geometric mean hter 
of 8012, 4421 and 1850W/L, repedvely. 
Conclusion: These results mhcate that a sigruficant propomon of non- 
responder neonates can be induced to develop a protechve anh-HBs response 
folloulng admnistranon of a s~ngle supplementary dose 
Long-term investigation of new-borns of H8sAg 
positive mothers vaccinated against hepatitis 8 
L. Roznovsky, I. Lochman, L. Lukacova, A. Sulakova, A. Zjevikova, 
I. Orsagova, L. Pliskova, A. Kloudova and J. Chovancik 
Ostrava, Hradec fialove, CZ 
Objectives: Protective titers of anti-HBs antibodies after immunization, 
vanishing of anti-HBs in long-term period and breakthrough infections after 
immunization were investigated in 533 neonates of HBsAg-positive mothers 
vaccinated against hepatitis B. 
Methods: Combine passive-active immunization was commenced in 
1988. The number of immunized chddren gradually increased and 
the group included 533 new-borns in November 2001. All mothers were 
HBsAg-positive during pregnancy, 27 of them were also HBeAg 
positive. The children received hepatitis B immunoglobulin at birth 
and three 10 pg doses of plasma-derived or recombinant vaccine at interval 
0, 1 and 6months (only 18 children of HBeAg-positive mothers at 
interval of 0, 1 and 2 months). The immunization schedules were completed 
in 497 children, serologic investigations after immunization were 
performed in 478 children. Blood samples were obtained after completion 
of immunization schedule, at 2 years of age, and biennially thereafter. Samples 
were tested by ELISA for HBsAg, anti-HBs, anti-HBc, anti-HBe and anti- 
HBcIgM. 
Results: Anti-HBs antibodies were tested in 354 children during 2 months 
after immunization. Protective titres of anti-HBs were proved in 335 of 354 
children (94.6%). Vanishing of protective anti-HBs antibodies were detected 
in 137 of 478 children (28.7%) with serologic investigation after immuniza- 
tion. Disappearance ofanti-HBs was observed in 7.9,16.5 and 23.6% children 
during second, fourth and sixth year of Me. Only one child suffered &om 
rmld, acute hepatitis B in the beginning of the second year of his life. 
The child was infected with variants of HBsAg with substitutions at residues 
137 and 139. Asymptomatic infections with presence of anti-HBc antibodles 
were observed in four children since fourth till seventh year of 
life. The increase of anti-HBs without revaccination was observed in 54 
children. 
Conclusions: Protective titers of anti-HBs after immunization in 
94.6% cMdren, vanishing of protective anti-HBs during 8 years in 28.7% 
children, one hepatitis B and 4 asymptomatic infections were proved in 
533 children vaccinated against hepatitis B during 14-years monitoring. 
Grant support: Ministry of Health, Czech Republic, IGA No. NI6047-3. 
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I P1311 I Vaccination of patients with chronic renal failure 
against hepatitis B 
L. Roznovsky, A. Sulakova, I. Orsagova, A. Zjevikova, L. Lukacova, 
I. Lochman and A. Kloudova 
Ostrava, CZ 
Objectives: Anti-HBs antibodies response after imauniZation against hepa- 
titis B and breakthrough infections were investigated in 540 patients with 
chronic renal failure fiom 4 dialysis units and their out-patients departments. 
Of these patients, 182 died during investigation. 
Methods: Active immunization against hepatitis B was commenced in 
1988. The number of immunized patients gradually increased and the 
group included 540 patients in November 2001. The vaccination schedule 
was 0, 1, 2months for dialysis patients and 0, 1, 6months for predialysis 
patients. Plasma-derived or since 1990 recombinant vaccine were adminis- 
tered intramuscularly, each vaccine contained 40pg of HBsAg, but for 
predialysis patients only 2Opg till 1998. The immunization schedules were 
completed in 367 patients. Blood samples were obtained after third or next 
dose of vaccine and biannual thereafter. Samples were tested by ELISA for 
HBsAg, anti-HBs, anti-HBc, anti-HBe and anti-HBcIgM. The patients 
without protective anti-HBs level after vaccination were once or twice re- 
vaccinated. The patients with vanishing of anti-HBs antibodies were also re- 
vaccinated. 
Results: Anti-HBs antibodies after vaccination were investigated in 309 
patients. Protective anti-HBs level were proved in 152 of 309 
patients (49.2%) after immunization and in 184 (59.5%) or 206 (66.7%) 
patients after fourth and fifch dose of vaccine. The new HBsAgpositive status 
was proved in 28 dialysis patients, most of them suffered from acute 
hepatitis B. These breakthrough infections were more keequent after 
initiation of vaccination program, the latest breakthrough infection was 
proved in 2000 and previous four infections in 1994. Asymptomatic infections 
with new appearance of anti-HBc antibodies were proved in nine 
patients. The increase of anti-HBs without revaccination was observed in 
38 patients. 
Conclusions: Vaccination of patients with chronic renal failure is not satis- 
factory, only 66.7% of patient developed protective anti-HBs level after five 
doses of vaccine, but long-term vaccination considerably reduces hepatitis B 
incidence in this group of patients. 
Grant support: Ministry of Health, Czech Republic, IGA No. NI6047-3. 
m1 Seroprevalence of hepatitis B and D in rural 
Egypt: a prospective study 
E. Mohareb 
New York, USA 
Introduction: The consequences of acute and C ~ O N C  hepahhs B w u s  (HBV) 
infection represent a major health problem in Egypt. Indmduals wth chromc 
HBV 1nfeChOns are prdsposed to an mcreased rlsk of developing hepato- 
cellular carcinoma In 1992, HBV vaccme was mtegrated mto the mfant 
immufllZahon schedule throughout Egypt. 
Objectives: We describe a prospecuve study done m the summer of 1999, in 
two dages,  one m Qena governorate, Upper Egypt (1462 mdmduals IXI 235 
f a d e s )  and the other m Sharquya governorate, the Nde Delta (1273 
mdmduah m 279 f a d e s ) ,  to evaluate the prevalence of HBV and HDV 
and to assess associated risk factors 
Methods: Sera collected from both cohorts were tested by ELISA for total 
anh-HBc and HBsAg Posinve HBsAg sera were tested for anti-HDV lgM. 
All tests were performed usmg commercial kits. 
Results: There is an age-dependent increase in anh-HBc anhbodes wth  an 
overall seroprevalence of 42.5% (n =621) and 18.2% (n = 232) for Qena and 
Sharqurya, respecavely. However, chromc decuon rate as measured by 
posinve sera for total anh-HBC only, showed prevalence rates (PR) of 32.7 
and 16.5% (Qena and Sharquiya, respecavely). Overall, semprevalence of 
HBsAg was 11 6% (n = 170) in Qena and 2.8% (n = 36) m Sharquya. Camer 
rate, however, as mmcated by posihve HBsAg alone was 1.9% (n = 28) and 
I.l%(n= 14) forQenaandSharquiya,respectwely.ThePRforann-HBcand 
HBsAg were 8.5% (n = 11) and 7 7% (n = 10) m Qena and 2.4% (n = 3) and 
1.6% (n=2) in Sharquya. There wa8 no slgmficant Merence for both 
markers between chddren who have or have not received vaccinahon 
An&-HDV PR, for HBsAg positwe sera, was 16.5% (n=28) and 5.5% 
(n = 2) for Qena and Sharqluya, respectively. None of the mdwiduah with 
both HBV markers reportedjaundce signs Among the f d e s  surveyed in 
Qena and Sharqmya, 4% (n = 50) and 24% (n = 14) of these f d e s  had 
more than one HBsAg positive indmdual. Cornpanson between HBsAg 
POSihVe and neganve mdrvlduals for potennal risk factors, emphasize the role 
of blood transfusion in HBV trammssion m both sites (P= 0 0001) when 
compared to injechons, surgenes, dental work and shavlng ( P =  0.35, 0.20, 
0 45, 0 22, respecavely) 
Conclusion: Although chromc and/or past infechon rates for HBV are 
hgh lu both study commmbes, these results suggest that acme trammsion 
is ongomg and prevennon and control measures should be strictly 
enforced. 
[p13141 Ten year stue of histological variation of liver 
and laboratory findings in 100 healthy hepatitis B carrier 
H. Kalantan and M. Jakli 
Isfaahan, IR 
Objectives: Hepatis B (HBV) IS the most common cause of chronic hepatias 
worldwide. One of the potential dangers of healthy HBV carriers, a part &om 
a c t m g  others IS the emergence of C ~ N C  hepatitis and eventually h e r  
cmhosis, liver cancer and, the resultant death. The objective of this study was 
to mveshgate the variations of liver histology along wth  other laboratory 
findmgs. 
Methods: In a descripnve study 100 healthy HBV carriers whose positive 
HBsAg was longer than bmonths were stuhed. First they underwent 
h e r  Enzymes, sonography and biopsy. If the tests were normal, the 
pahents underwent repeated tests except for hver biopsy, every 6months. 
In the event of an increase in hver enzymes or a-phetoprotein, and 
sonographc changes, they underwent liver biopsy and the results were 
recorded. 
Results. thuty percent of the healthy HBV carriers experienced no specific 
laboratory c-es in penodic rests in 10 years. Seventy percent of the patients 
did experience lab changes consisting of an increase m ALT and AST and 
blluubm and three cases of increase in a-phetoprotein and some sonographlc 
changes hke h e r  coercing. Nodule formation and in one case, liver mass were 
reported. The aforementioned patients underwent h e r  biopsy. In t h ~ s  
group 30 persons under 5 years and 40 persons over 5-10 years expenenced 
lab changes. The results of their hver biopsy are as follows. In 30-subject 
group: 5 persons (16%) aBcted with C.EH Grade 1, 15 persons 
(50%) a c t e d  with mild C.A.H Grade 3, 7 persons (23.3%) a c t e d  with 
moderate C.A H. Grade 3, 3 persons (1Wo) had no abnormal histological 
variations. In 40-subject group: 25 persons (62.2%) a c t e d  with sewre 
C.A.H. Grade 4,2 persons (5%) a c t e d w i t h  C.P.H. Grade 1,2 persons (5%) 
aftlicted with early cirrhosis stage 3, 1 person (2.Wo) &cted with heptoma, 
10 persons (25%) &cted with mdd C.A.H. Grade 2 
Conclusion: With regard to the fact that healthy HBV carriers can potentially 
endanger others in the society and cause high costs for talang care of such 
patients, and vain attempts to cure them, the best h u g  to do is to train people 
how to prevent the disease and how to avoid passing the virus to others. 
AWicted people are recommended to undergo clinical and paraclinical tests at 
least every 6months so that the progression of the hsease towards chronic 
hepatins, cirrhosis and liver cancer can be checked. 
Seroepidemiological study on hepatitis B 
infection prevalence in Bulgaria 
M. Kojouharova, P. Teoharov, N. Vladnmrova, S. Zlatev, I. Haydushka, 
M. Atanasova, M. Sredkova, V. Gngorova, P. Sotrrova, H. Q e m ,  
B. Dimtrova, V Rusev and L. Ivanova 
Soh, Plovdiv, Pleuen, Sara Zagora, Virtu, BG 
Introduction: Bulgaria is a country wth intermedate endemciry of hepahhs 
B nral (HBV) infechon. As a result of the uxuversal infant m u m t i o n  
program successfully mplemented since 1992, the incidence rate of acute 
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hepatitis B in the targeted children age group was dramatically reduced. 
However, in the older age groups and especially in adolescents and young 
adults, the annualincidence rate ofacute clinically manifested cases retainedits 
constantlevelvaryingbetween45.4and63.2/100000in theage group 15-19 
and between 32.9 and 42.3/100000 in the age group 2C29 in the recent 5 
years. 
Objectives: To perform a seroepidemiological analysis of the HBV 
prevalence in the general population of 14-6Oyean of age and to 
evaluate the HBV burden on that part of the population unprotected by 
vaccination. 
Methods: A multicentre study was conducted in the biggest cities in Bulgaria: 
Sofia, Plovdiv, Varna, Pleven and Stara Zagora in the period 1999-2000, 
comprising a total of 11 597 healthy nonimmunized persons distributed in 5 
age groups: 14-19; 20-29; 3G39; 4 W 9  and 5G59years of age. After an 
informed consent, blood samples were obtained and tested for HBV markers: 
HBsAg, anti-HBs and anti-HEk using commercially available enzyme immu- 
noassay (Sorin Biomedica). 
Results: Seronegative for HBV markers were 72.54% &om a total of 
1 1  597 persons. HBsAg carriage was proven in 3.86% on the average, 
varying from 1.96 to 5.26% in the different study sites, and w i t h  
significantly broader limits in the Se ren t  age groups (1.52 to 5.72%). A 
total of 27.46% of the tested subjects showed evidence of previous or present 
HBV infection (from 17.77% in Sofia to 38.57% in Plwdiv), and &om 8.48% 
in the 14-19 age group to 40.70% in the 40-49 age group, results corre- 
sponding to the surveillance data of the annual incidence rate of acute HBV 
cases. 
Conclusions: The results obtained confirm the data of previous observations, 
which proves that the HBV endemicity in Bulgaria is characterized by an 
intermediate prevalence of HBV The distribution of HBV infection is 
unequal in the different areas of the country as well as in the different age 
groups. 
Hepatitis B in Catalan adopted or immigrant 
children 
C. Latorre, T. Juncosa, C. Muiioz-Almagro, A. GenC, A. Gonzilez- 
Cuevas and V. Fumad6 
Esplugues-Barcelona, E 
Introduction: Hepatitis B is an important public health problem in many parts 
ofthe world. About 300 million people (5% ofworld population) are infected, 
which allows an endemic maintenance of the virus. More than 10% of south- 
east Asia and tropical Africa mbabitants are viral carriers. A great number of 
children born in these areas attend our hospital, whch is a Reference Center 
for Pediatric Imported Diseases in Catalonia, after arrival to our country. In 
our community, systematic hepatitis B vaccination is carried out during the 
early adolescence since 1990. 
Objectives: To know the prevalence of hepatitis B infection in adopted or 
immigrant children attending our hospital, as well as their infective 
Methods: Two hundred and seventy-five adopted or immigrant children aged 
one month to 13 years (16.3% less than I-year-old and 57% with ages between 
1 and 2years) were controlled at the Pediamc Imported Diseases Unit from 
January 2000 to October 2001. Hepatitis B surface antigen (HBVsAg) was 
determined in all them as a screening test. In case of positivity, hepatitis 3 e 
antigen (HBVeAg) and hepatitis B e antibody (HBVeAb) were also studied. 
All tests were performed by MEIA methodology in an Axsym System 
(Abbott). 
Results: HBVsAg was positive in 15 patients (5.45%). aged 11 months (one 
patient), 1-2-year (12 patients), 3years (one patient) and 4years (one more 
patient). All of them had positive HBVeAg but negative HBVeAb. Chddren 
came from India (nine &om Calcutta, one from Bombay and one fioni New 
Delhi), China (one), Ukraine (two) and Ivory Coast (one). There was none 
declared case of acute hepatitis B in children less than 5-year-old in Catalonia 
during 1999 and four cases in children aged 5-19years. 
Conclusions: There was a high infection rate in the studied pedi- 
atric population compared to that of Spanish children in a similar age 
range. The presence of HBVeAg in all cases demonstrates their infectivity. 
The introduction of chddren at risk of transmission of hepatitis B among 
our autochthonous population, which is not systematically vaccinated at 
Status. 
early or adult ages, is a reason for vaccmation of close contacts of these 
children. 
I P I  31 7 I Prevalence of HBsAg, anti-HBs, anti-HBc total, 
anti-HBc IgM, anti-HW and anti-HAV lgG in hernodialysis 
patients 
A. Kadanali and S. Pirimoglu 
Erzurum, TR 
Objective: To investigate the prevalence of HBsAg, anti-HBs, anti-HBc total, 
anti-HBc IgM, anti-HCV and anti-HAV I& positivity in hemodialysis 
patients. 
Methods: The positivity of HBsAg, anti-HBs, anti-HBc total, anti HBc 
IgM, anti-HCV, anti-HAV IgG were determined in 59 patients undergoing 
hemodialysis (the average age 4 7 . 2 f  16.9, 31 men and 28 women). 
Results: The positivity of HBsAg, anti-HBC total, anti-HBs, anti-HCVand 
anti-HAV were percentage 6.8,45.8,62.7,81.4 and 94.9, respectively. W h i l e  
all patients with HBsAg positivity have anti-HBc total positivity, no anti-HBc 
IgM positivity was determined. Co-positivity of both HbsAg and anti-HCV 
were found in four patients (6.8%). The average duration ofhemodialysis was 
7.3 months (1 month-5 years) in 11 anti-HCV negative patients. The average 
duration between the beginning of hernodialysis and positivity ofmarkers was 
22.3 months (2 months-3 years). Anti-HBs positivity was due to seroconver- 
sion in 22 patients and vaccination in 15 patients. 
Conclusion: High semprevalance of hepatitis markers were found in hemo- 
dilaysis patients. Hepatitis markers must be checked regularly in hemodialysis 
patients and infection control protocols should be strictly used in hemodialysis 
units. 
Ip13181 lntrafamilial transmission of hepatitis B virus 
S. Erol, Z. Ozkurt, M. Ertek and M. Tasyaran 
Erzurum, TR 
To determine the possible route of hepatitis B virus (HBV) transmission 
among family members, 240 family members (42 spouses, 32 ofliprings, 34 
mothers, 35 fathers, and 97 siblings) of 84 HBsAg carriers, and 384 healthy 
indwiduals (control group) were screened for HBV markers by ELISA 
method. The median age was 33*14.62 in the study group, and 
35.0 k 10.08 in the control group. The xz and Fisher’s exact tests were used 
for statistical analysis. The prevalences of HBsAg and seropositivity among the 
family members (29.6 and 43.8%, respectively) were significantly higher than 
the control group (9.6 and 29.7%, respectivelx P< 0.05). Seropositivity was 
observed to increase by age. The prevalences of HBsAg and seropositivity 
were higher among the spouses (70.0 and 90.0%, respectively) and ofliprings 
(66.7 and 100%) of female index cases, and siblings (40.2 and 49.5%) of all 
index cases than the other family members. Among the 37 ofiprings of the 14 
farmlies with an HBsAg positive father, 16 (43.2%) were HBsAg, and 3 (8.1%) 
were anti-HBs positive. Among the 21 offiprings of the five families with an 
HBsAg positive mother, 9 (42.8%) were HBsAg and 1 (4.8%) was anti-HBs 
positive. However, in the five families with both parents HBsAg positive, 4 
(44.4%) of9 offsprings were HBsAg, and 4 (44.4%) were anti-HBs positive. A 
total of 23 siblings of the index cases who both parents negative, 7 (30.4%) 
were HBsAg-positive and 4 (17.3%) were anti-HBs positive. These data 
suggest that transmission of HBV to oaprings was very high in case both of 
the parents were positive, but there was no difference in case only mother or 
father was positive. As well as mother, HBV infection of the father had 
increased the prevalence of HBsAg. Despite a high HBsAg prevalence in the 
offsprings of female index cases, HBsAg and anti-HBs prevalences in the 
mothers of index cases were not higher than the control group ( P >  0.05). 
According to these data, mother alone has not a considerable role to acquire of 
HBV infection. In addition to these results, a high seropositivity rate among 
siblings of index cases suggested that both parents-to-child and sibling-to- 
sibling horizontal transmission might be the main route of intrafamilial spread 
of HBV infection. The number of HBeAg positive patients (four index cases, 
and three family members) was not sufficient to determine the role of HBeAg 
in the intrafdial  transmission. 
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[p13191 Economic evaluation of preventive therapy in 
neonates from HbsAg seropositive mothers 
I. Glynou, H. Salvanos, M. S i o u ,  H. Kada and €? Papathanasiou 
Athens, GR 
Introduction: Human-HBIG is adrmnistered to neonates, born from HbsAg 
seropositive mothers, in order to achieve passive immunization against HBV 
infection. The Human-HBIG preparation used was packed in 5.0 mL bottles. 
The dose given once to every mother carriers’ newborn is 0.5 mL. If no other 
Human-HBIG is needed for another case, the 4.5 mL of Human-HBIG is 
rejected for safety reasons (Company’s recommendation). 
Objectives: The purpose of our study was to evaluate the cost of preventive 
HBV therapy in neonates &om HbsAg positive mothers. 
Methods: In ‘Elena Venizelou’ Maternity Hospital all women in labor are 
tested for hepatitis B whether they were tested during pregnancy or not. The 
method we used to test the serum samples for HbsAg, was Abbott micro- 
somatic ELISA. In the total of neonates from HbsAg seropositive mothers, 
who were born from 1/1/1997 until 31/8/2000 were determined (a) The 
total number of 5 mL bottle of Human-HBIG used. @) The total quantity of 
administered Human-HBIG. (c) The total quantity of rejected Human- 
HBIG. (d) The total cost of the administered Hum-HBIG quantity. (e) 
The total cost ofthe rejected Human-HBIG quantity, based on the medicine’s 
price (90.815 GDR per bottle for the year 2000). 
Results: In our hospital during the period &om 1/1/1997 to 31/8/2000, 
20.064 births took place. 691 births were &om HbsAg seropositive 
mothers (3.44%). From the above-mentioned seropositive women were 
born 685 babies, 10 twin and a stillborn child.595 bottles of Human-HBIG 
were used in total. (Five bottles for the 10 twin, 95 bottles for 190 babies born 
in the same day and 495 bottles for the 495 babies.) The total administered 
quantity of Human-HBIG was 347.5mL. The total rejected quantity of 
Human-HBIG was 2.6275mC. The total cost was 54034925 GDR 
6311 643 GDR (11.68%) was the value of the administered quantity and 
47723281 GDR (88.31%) was the value of the rejected quantity of the 
medicine. 
Conclusion: Strategy to reduce these costs should be directed at using 
smaller package of Human-HBIG (since 1 mL bottle is available), in order 
Hepatitis 
to achieve passive immunization in neonates born h m  HbsAg-carrier 
mothers. 
Effects of interferon-a therapy on cardiac 
functions in patients with chronic hepatitis B infection 
M. K. Erol, S. Erol, M. Koruk and M. Ertek 
Enunrm, TR 
Various types of cardiovascular complications, such as myocardial infarction, 
ventricular fibrilladon, cardiomyopathy, myocarditis and atrioventricular 
block, attributed to interferon therapy, had been reported previously. The 
aim of this study was to evaluate the cardiac effects of interferon-a therapy in 
patients with chronic hepatitis B (CHB) infection. Forty-five patients with 
CHB (42 male and 3 female; mean age 34.2 f 11.5 years) were included in the 
study, and l0wU intederon-a-28 was administered three times a week for 
6 months to these patients. The cardiac evaluation (detailed medical history, 
physical examination, electrocardiography and systolic, diastolic functions 
parametets by the echocardiography) was performed at the beginning and 1st. 
3rd and 6th months of the therapy. No patient had any cardiac symptoms 
before and during interferon therapy. Systolic and diastolic blood pressures, 
heart rate were not sigtllfcantly a c t e d  during therapy (P  > 0.05). None of 
the patients revealed cardiac rhythm disturbance on electrocardiography 
before and during therapy period. No sigruficant changes were detected in 
systolic (ejection hction, hctional shortening, preejection period, left 
ventricular ejection time, the ratio of pre-ejection period/ejection time, 
Q-V peak) and diastolic (E peak, A peak of transmitral Bow velocity, E/A 
ratio, deceleration time, isovolumic relaxation time by the conventional 
echocardiography, and E peak, A peak, deceleration time of E wave at the 
medial and lateral corners of mitral annulus by tissue Doppler echocardio- 
graphy) left ventricular function parameters between at the beginning and at 
the lst, 3rd, 6th months. The results of tlus study suggest that interferon-cc 
therapy do not sigtllficantly deteriorate cardiac functions in patients with 
CHB infection, and it may be used safely in patients who have not previously 
cardiac disease. 
(p13211 Changing seroepidemiological patterns of HAV 
infection in Konya, Turkey between 1998 and 2001 
D. Findik, 0. Ural and U. A r s h  
Konya, TR 
Objective: The seroepidemiology of hepatitis A virus (HAV) was assessed 
among the patients with prediagnosis of viral hepatitis. 
Methods: Between the period of 1998 and 2001, 9638 sera h m  the 
patients with the prediagnosis of viral hepatitis were tested for the 
presence of anti-HAV total antibodies and 9519 sera for the presence of 
anti-HAV IgM by using ELISA method (DiaSorin s 
Results: Between the period of 1998 and 2001 anti-HAV IgM seropositivity 
was 12.9, 10.2, 6.5 and 5.9%, respectively. Infection rates decreased sigrufi- 
cantly with years h m  1998 to 2001 (P<O.O5). It was observed that the 
majority of acute HAV infections were taking place between the months 
October and March. Anti-HAV total seropositivity was 71.9, 79.8, 82.5 and 
88.5% during the years 1998-2001. Anti-HAV antibodim rates increased 
signtficantly with years from 1998 to 2001 (P< 0.05). NQ M a e n c e  in the 
incidence rates for anti-HAV antibodies found between males and females 
(P> 0.05). 
Conclusion: These observations indicate that HAV infection is endemic in 
Konya in Turkey It is also observed that the incidence rate of anti-HAV Igh4 
antibodies is decreasing and the incidence rate of anti-HAV total antibodies is 
increasing with years &om 1998 to 2001. The increasing incidence of anti- 
HAV total antibodies may be related to active immunization against HAV 
infection and decreasing incidence of anti-HAV IgM antibodies may be 
Italy). 
related to sanitary “nprovements and also active immunization in recent years. 
Ongoing vaccination of chddren may prevent hture outbreaks. 
Ip1322j 
cohort 
M i n e  of maternal HAV antibodies in a neonatal 
V. Terulla, S. Zucca, E Zara, R. Mighavacca, A. Brerra, M. Spalla, 
E. Nucleo, L. Pagani, F. Polatti, A. De Silvestri and C. Belloni 
Pavia, I 
Introduction: The anti-hepatitis A virus (HAV vaccination in infants would 
guarantee the control of infection. The vaccine is safe and well-tolerated in 5- 
month-old babies. However, the immunogenicity of the HAV vaccine in 
infants could be impaired by the presence of passively acquired maternal HAV 
antibodies. 
Objectives: In the present study, we evaluated the prevalence of HAV 
antibodies in women at delivery in a low-endanicicy area and the decline 
of passively acquired maternal HAVantibodiesin the fiist year oflife inishts 
born by HAV-positive mothers. 
Methods: We enrolled 103 women at delivery and evaluated their babies in 
the first year of life (at birth, 3,6,11 and 12 months), after obtaining informed 
consent. Anti-HAV antibody levels were determined by MEIA test 
(HAVAEi 2.0 Abbot Italia). Anti-HAV levels >10 mIU/mL were considered 
protective. 
Results: Eighteen out of the 103 enrolled mothers (17.5%) had anti-HAV 
serum level >lOmlU/mL. At birth infants exhibited anti-HAV antibody 
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levels that were similar to the levels oftheir mothers. In the 18 positive infants, 
the anti-HAV levels declined after birth during their first year of life. The 
geometric mean diminished &om 1388.9mIU/mL at birth down to 
15.3mIU/mL at 12months. Anti-HAV level was still >lOmfU/mL in 6 
out of6 infants, in 12 out of 13 and in 11 out of 18 babies, respectively, at 3,6 
and 12months. Two out of 85 dants born hy anti-HAV-negative mothers 
and negative at birth, were found positive at 5months of age (210 and 
2480 mIU/mL.) and remained positive until 12 months (12 and 42 mIU/mL, 
respectively). 
Conclusion: There seems to be no reason for not including anti-HAV 
immunization in childhood vaccination programs, even in low endemic 
HAV areas. We propose to screen all women at deIivery for anti-HAV 
antibodies: children born by anti-HAV-negative mothers could be vaccinated 
early during the first year of life, children born by anti-HAV-positive mothers 
could procrastinate vaccination, if necessary. 
-1 Hepatitis A virus infection and coronary artery 
disease 
H. Yazgi, S. Erol, M.K. Erol and M. Ertek 
Erzurum, TR 
Over the past decade, awareness of possible association between athero- 
sclerosis and infections has steady increased. Specific organism that have 
been implicated include Chlamydia pneumonia, Helicobacter pylori, herpes 
simplex virus, cytomegalovirus, and hepatitis A virus (HAV). However, 
several prospective seroepidemiological studies failed to demonstrate an 
association between these infections and atherosclerosis. The aim of t h i s  
study was to evaluate an association between HAV infection and coronary 
artery dsease (CAD) by using serologic tests. A total of 360 individuals 
undergoing coronary angiography, included in the study. Two hundred and 
smy-four patients who had angiographic evidence of atherosclerosis included 
in CAD group, and 96 patients who had no angiographic evidence of 
atherosclerosis included in control group. Serological status of the cases 
was assessed by ELISA test measuring IgG antibodies to HAV. Risk 
factors for CAD (age, sex, smoking, diabetes, dyslipidemia, hypertension 
and C-reactive protein (CRP) levels) were analyzed. Association of 
HAV infection with CAD, risk factors, and other characteristics were 
investigated using &test, ,y*-test. and regression modeling. Mean age was 
56.9 (range, 35-89years) in CAD group, and 54.4 (range, 37-74) in control 
group. Two hundred and sixty-three (99.6%) of the 264 subjects in 
CAD group, and 94 (97.9%) of the 96 subjects in control group had IgG 
antibodies. There was no difference between the groups in respect to HAV 
seropositivity (P< 0.05). The odds ratio was 0.18, and 95% CI; 0.016-1.99. 
Due to a very high seroprevalence, we could not perform further 
analysis for seronegative and seropositive individuals. There was a higher 
prevalence of smoking, diabetes and hypertension in CAD group than in 
control group (P<O.O5). In addition, mean LDL (132.1 &31.6mg/dL vs. 
92.3+31.9mg/dL, P<0.001), and CRP levels (1.15f3.2mg/dL vs. 
2.41 * 5.24mg/dL, P <  0.01) were higher in CAD group than in control 
group. Smoking, elevated LDL, tryghceride and total cholesterol levels were 
also associated with increased levels of CRP (P< 0.05). However, no 
significant association were found berween CRF' levels and HAV seroposi- 
tivity (P > 0.05). 
In conclusion, it is impossible to evaluate the possible association between 
HAV infection and CAD by using the seroepidemiological method, especially 
in the population who have high seroprevalence rates. 
Trends in the epidemiology of acute hepatitis in 
northern Greece during the 1990s 
F. Kamaria, E. Zambaoglou, K. Papanastasiou, I! Mamasi, 
D. Kolokotroni, L. Sideropoulos and A. Papachristou 
Thessaloniki, CR 
The objectives ofths retrospective study were to present and analyze the acute 
hepatitis cases admitted to the Medical Clinic of Infectious Diseases Hospital 
of Thessaloniki, Greece during the last decade. 
Methods: In this study, 1898 adult patients with acute hepatitis (man age 
[mean f S.D.]: 31.16 & 13.0year), 1244malesand654females were included. 
Type ofhepatitis, gender, age, duntion ofhospitalization and disease outcome 
were recorded and estimated during a period of 10 years. 
Results: (1) As to the type of hepatitis: HAV infection represented 21.6%. 
HBV 60.6%. HCV 6.06%. acute HBV superimposed on chronic HCV 
2.64%, acute HCV on chronic HBV 0.93%, acute HAV on chronic HBV 
infection 1.2%, and HDV 0.50%, while of unidentified type 6.4%. (2) As to 
the gender, in the females, as compared with the males, the pmpomon of 
hepatitis B and the unidentified type was greater (P<O.Ol and P<O.O5, 
respectively). On the contrary, men had hepatitis C at a higher ratio 
(P< 0.01), as well as coinfections (P< 0.001). (3) As to the age, elder people 
(>&year), as compared with the younger ones, had a longer duration of 
hospitalization (P=O.OOO), much higher mortality (P<O.001), in a much 
hgherratio hepatitisB (P<O.OOl) andofunspecifiedtype (P<O.001), butin 
amuchlesserproportion hepatitisA (P< 0.001) andcoinfections (P< 0.001). 
(4) As to the year of admission, during the 2nd 5-year period (1996-2000) a 
signifcant decrease in the total hepatitis cases was observed, in comparison 
with the 1st period (1991-1995) (871 vs. 1027, z = 3.514, P<0.000). This 
was mainly due to the decrease of hepatitis B cases (P < 0.001), while an 
increase in hepatitis A cases and comfections was indicated (P< 0.01 and 
P < O . O O l ,  respectively). (5) As to the outcome, there were 55 severe 
(fulminant + subacute) hepatitis cases (2.89%), out of which 40 succumbed 
(72%), the unidentified cases having proportionally much higher mortality 
rate (P< 0.001). 
Conclusion: HBV infection still remains at the top ofthe list, with preference 
to the females and the elder people, while HAV infection is more common at 
the younger ages and HCV infection in the males. During the 2nd 5-year 
period of the 1990s, a reduction in HBV infection was noticed, due 
presumably to the vaccination schedule. On the other band, the increase 
in the HAV cases during the same period, could be attributed to the rise of the 
susceptible elder individuals, after the continuously improving sanitary con- 
ditions in our country. 
[p1326/ Five-year prevalence of viral hepatitis B and C 
E. Kalogeropoulou, E. Karabatsaki, M. Agiannitou, P. Tsiodra and 
A. Efstratopoulos 
Athens, GR 
Objectives: To assess the prevalence of infection with viral hepatitis B and C 
agents in the patients of a medical deparnnent of a tertiary hospital in a period 
of 5 years. 
Methods: Retrospective study of the notes of all patients admitted in our 
department in the last five years, during which all patients were screened for 
hepatitis B and C. The HBV marker used was HbsAg, detected by third 
generationELISA and HCVantibodies were detected with a third generation 
anti-HCV ELISA, followed hy immunoblotting (RIBA 3) if the test was 
positive. 
Results: Anti-HCV positivity was found in 1.8% of the patienu and 2% were 
positive for HBsAg. There was no difference in prevalence of hepatitis B or 
hepatitis C between males and females. In multivariate analysis, the variables 
significantly associated with HCV seropositivity were age older than 40 years 
and history of blood transfusion. A decline in anti-HCV prevalence was 
observed in patients over 85years of age. Seropositivity of both HBsAg and 
anti-HCV was strongly associated with a history of intravenous use of illegal 
substances. PrevaIence of HBsAg was sigdkantly higher (20.4%) among 
patients who were immigrants. 
Conclusions: The higher prevalence of both chxonic HBV and HBC in a 
hospitalized population than the estimated prevalence below 1% in the general 
population through studies on blood donors and army recruits, is due to the 
increased age of the patients admitted in m e d d  departments. 
ml A hospital outbreak of hepatitis E in Karachi, 
Pakistan with possible parenteral transmission 
A Siddqu, S. Majeeb, A Khan, A Saleem, M. Bibi, F. ul Haq, 
R. Jooma and R. Smego 
Karachi, PAK 
Objective: To inveshgate a nosocomal outbreak of hepatms E mvolvmg 
6 serologically confirmed and 12 presumphve cases that occurred on a 
neurosurgery ward at a pubhc teachmg hospital 
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Methods: A casecontrol study. Health care practices were assessed 
by mtemews of ward staff, and selected laboratory mveshgahons were 
performed on patients, health care workers (HCWs), and water samples. 
Age-matched controls were randomly selected h m  pahents adnutted 
for more than 2weeks to the ward dunng October 2000-February 
2001 
Results: Water samples &om ward sources (n = 10) were free of fecal coh- 
forms. Due to a shortage ofnunmgstaff, the prachce ofsharlng an mtravenous 
admrtllstration set among panents was reported for dexametbasone and 
manmtol infusions Females were more l~kely to develop hepaum E than 
males (OR 2.8; 95% CI, 0.96-5 ZO), and a cluster of cases occurred in one 
corner of the female sectlon of the ward. Mean length of hospital stay for cases 
was 42 days versus 27 days for controls ( P =  0.0009); death rates among cases 
and controls were 5/18 (28%) and 6/75 (So/,), respectively. None of the 
HCWs reported illness or clinical signs of jaundice. Cases more frequently 
received i.v. dexamethasone (61% vs. 19%, respectively; OR 4.6; 95% CI, 
1.4-15.9); P=0.0001), i.v. mannitol (100% vs. 49%, respectively; OR 3.8; 
95% CI, 1.6-18.9). and blood transfusions (OR 2.67; 95% CI, 0.61-10.64; 
P <  0.01) than conttuls. 
Discussion: In conclusion, i.v. dexamethasone and mannitol infusion 
and blood-component therapy were sigdcant risk factors for the develop- 
ment of hospital-acquired hepatitis E on this neurosurgical ward, and 
parented transmission via sharing of i.v. administration sets could be an 
explanation. 
Molecular diagnostic methods II  
(p1328) PCR on microchip: development of a multiplex 
PCR-based microchip assay for identification of clinically 
relevant bacterial species 
M. Becker, M. Weizenegger, A. Harim, H. Holz, B. Remmel and 
H. Voss 
Heidelbey, D 
Objectives: Speed coupled with accuracy i s  of greatest importance in 
diagnostics of infectious diseases. PCR-based methods offer the potential 
to meet these goals, however, individual target amplification is usually 
performed in separate reactions to identify and characterize bacterial species. 
Microchip-based technologies allow to parallel numerous assays by assigning 
specific targets to elements on the microchip. As a proof of principle, we 
showed that bacterial species can be identified accurately from blood cultures 
using isolated bacterial genomic DNA directly without pxamplification in a 
smgle multiplex PCR reaction on a microchip. 
Methods: On the basis of own sequence data of suitable regions of the 
bacterial genome &om clinically relevant in-house strains, specific primers 
were designed for the identification and characterization of 15 Merent 
chcally relevant bacterial species. Additionally three group-specitic primers 
detecting the major groups of Gram-positive bacteria, enterococci, staphy- 
lococci and streptococci, as well as primers i d e n e n g  antibiotic resistance 
genes llke the MecA-gene of staphylococci were implemented. Amino-linked 
primers were immobilized in pairs (fonvard and reverse) per spot onto glass- 
slides. Solid phase amplification assays were carried out in a sealed micro- 
chamber by using bacterial genomic DNA isolated from positive blood 
cultures (BACTEC, Becton Dickinson, Heidelberg). During PCR reaction 
genomic DNA anneals to immobilized primers. The subsequent primer 
extension and incorporation of fluorescence label into the captured PCR 
product is used to detect the presence of a specific DNA sample. The PCR 
process was performed in an in situ block cycler. The slides were analyzed via a 
confocal fluorescence scanner. 
Results and conclusions: M e r  careful evaluation of many parameters 
effecting specificity and sensitivity (chemistry support, design of 
primers, PCR conditions, sample preparation, etc.), we developed an accurate 
multiplex PCR-based microchip assay which allows precise, specific enzy- 
matic amplification and species detection for all investigated strains within 3 h 
after sample preparation fium positive blood cultures. Due to its high 
discriminatory power the assay has the potential to address the demands 
in molecular diagnostics for rapid and sensitive bacterial differentiation 
today. 
I PI329 I Automated and generic nucleic acid extraction 
using magnetic silica particles 
Boxtel, NL 
P. van Deursen, A. Verhoeven, P. de Bit: and H. Kreuwel 
Objectives: The bioMCrieux is developing a new system for nucleic acid 
extraction in the clinical laboratory. The mtrument uses generic Boom 
chemsmy m combinahon wrth magnenc shca parhcles. In contrast to probe- 
based methods, it does not use target specific reagents. The objective of t lus 
study is to validate the mtrument in combinahon with five NAD assays. 
Methods: The following c h c a l  apphcaaons were validated: (i) HIV-1 RNA, 
(II) HBV DNA, ( ~ )  CMV mRNA, (iv) Enteroms RNA, (v) M p b a a e n ~ m  
fuuberculosis rRNA. These targets were recovered &om plasma, serum, whole 
blood, stool and spnnun samples, rapectively. Detection of the isolated 
nucleic acld was performed with NuchSens EasyQ HIV-1, NuchSem EasyQ 
HBV, NuchSens CMV pp67, and NuchSem BWC Kit. 
Resulti. All targets were recovered very e&aently firom their relevant chical 
specimen, which illustrated the system; potenhd as a universal sample 
preparation module for NAD teshng. Furthermore, the automated magnehc 
shca method resulted in an improved m e  to result compared to alternative 
isolahon methods. Typically, 48 sample preparations were completed withm 
90 m. 
Condusions: Ths study demonstrates that the new nucleic acid extraction 
instrument can be used as a flemble, fast and general frontend module for a 
variety of NAD assays. 
Ip1330] DNA mkroarray as a diagnostic tool for 
viral CNS infections 
Y. Boriskin, P. Rice, R. Stabler, J. Hinds, H. Al-Ghusein and 
P. Butcher 
London, UK 
Objectives: To develop a DNA microarray for rapid diagnosis 
specific pathogen identification in patients with merungitis 
and 
and 
Lncephabhs Iru&ly developed for viral pithogens, once the u&G has been 
assessed, the array can be extended to nonviral pathogens causing CNS 
infechons 
Methods: A DNA mcroarray was constructed comprismg 39 umque 
gene sequences for 14 vlral causes of meugIhs and encephahhs, namely, 
cytomegalom (CMV), herpes simplex vl~us types 1 and 2 (HSV-1 and 
HSV-2), human herpesviruses 6A, 6B and 7 (HW-6 and HHV-7), varicella- 
zoster vms  (VZV). Epstem-Barr w u s  (EBV), papovavmses BK and JC, 
measles, mumps, Coxsache B and ECHO muses. PCR-ampkfted and 
purtfied wal probes repraenhng a mean of three (range 1-5) mfferent 
regons of the viral genomes were printed on glass shdes and arranged to 
create an easlly recogruzable wus-spechc pattern. CSF samples h r n  pahents 
with vlral CNS syndromes, dqposed prevlously by nested PCR and 
gel electrophoresis detechon, were subjected to DNA and R N A  extrachon 
followed by smgle round of mdhpiex DNA PCR or RT-PCR, respecnvely. 
Amphfied DNA was purified and enzymahcdy labeled using random 
primers and the Cy3 fluorescent dye As an mternal conaol, m every reaction 
the mxture oforiginal DNAprobes was labeledwth the Cy5 fluorescent dye. 
A copurified two-dye target mMture was hybridzed to the array and 
the fluorescence ermtted by bound labeled DNA was measured m the 
control and sample channels By supenmposing the two dternahvely 
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labeled images the pattern of spots appeared characteristic for a speciftc virus 
found in the specimen. All positive targets were validated by direct sequen- 
cing. 
Results: To date, all CSF samples diagnosed previously as CMV, HSV-2, 
HHV-6A and 6B, HHV-7, VZV, EBV, JC, Coxsackie and ECHO viruses 
were confirmed as such by the microarray. Although not every target within 
the viral genomes was amplified, at least one target per virus yielded a specific 
pattern. 
Conclusions: This pilot DNA microarray is capable of detecting at least 14 
different viruses in a single test and is as sensitive as nested PCR. 
1 PI331 I Sequencing and comparative analysis of 
the partial structural protein gene of two human parvovirus 
B19 Chinese isolates 
H. Cao, L. Jiang and W. Zhang 
Cuangzhou, CHN 
Objectives: To determine the partial structural protein gene of two 
human parvovirus B19 (PVB19) Chinese isolates AF221904, AF221905 
and to compare them with other PVB19 strains as well as to analyze 
the relationships between strain’s genetic diversity and the clinical manifesta- 
tion. 
Methods: The partial structural protein region gene (2809-3806nt) of 
two PVB19 strains isolated, respectively, from a child with acute 
leukemia (AF221904) and an adult with active hepatocirrhosis and aplastic 
crisis (AF221905) were ampIified by re-polymerase chain reaction (re-PCR). 
Then cloned into pGEM-T vector and sequenced. The nucleotide 
variability and phylogenetic trees were analyzed by DNASTAR and CLUS- 
TAL W. 
Results: Compared with standard strains, the nucleotide changes of the two 
isolates were 10 (AF221904) and 32 (AF221905), and the amino acid changes 
were 1 and 6, respectively. On the phylogenetic tree, AF221905, U38506 
(isolated from a child with aplastic anemia in Xian, China in 1993), U38507 
(isolated &om a child with erythema infectiosum in Xian, China in 1992). 
U38509 (isolated &om blood donor in Japan in 1983) assembled in one 
cluster. The strain (AF221904) and some isolates from Europe, America and 
Korea assembled in another cluster. The similarities both in nucleotide and 
amino acid levels between the two clusters were lower than those w i t h  one 
cluster. 
Conclusions: The genetic diversity of virus strains can be used to examine 
whether a virus strain causes a speclfic clmical manifestation. Our studies 
suggested that PVB19 strains with different molecular characteristics disse- 
minated widely in China, and that no particular genotype of PVBl9 was 
associate with the distinct clinical symptoms. 
I P I  332 I The development of multiplex PCR assay for 
investigation of ‘high-risk’ HPV type prevalence 
0 Shpulina and G. Shlpultn 
Moscow, RUS 
Objectives: The ‘hgh-risk’ HPVs (14 types) is associated wth  greater than 
95% cervical cancers The PCR mth  consensus pruners that amp@ a regon 
of the L1 gene (MYll/MY09 and GPS+/GP6+ pruners) allows to detect 
more than 40 anogemtal types, but it reqwes the a a h o n d  strategies for type 
idenuficahon The aim of ths study was to develop a techmque for the 
detection of ‘hgh-nsk’ types of HPV, to compare the developed technique 
with other PCR-assays and to estnnate the prevalence of 10 ‘hgh-nsk’ HPV 
types among women in Moscow. 
Methods: The cemcal swabs &om 397 women were invesagated in t h ~ s  tudy. 
The presence of 10 ‘hgh-risk‘ HPVs DNA were tested in two mulnplex 
PCRs wth  genotype-specfic pruners. The various HPV genotypes gave 
amplification products of different size. In the first PCR-test the DNA of 18, 
39.45 and 59 types were amplified giving amplification products of 240,340, 
475 and 455 bp, respectively. In the secondPCR-test, the DNA of 16,31,33, 
35, 52, 58 types were amplified giving amplification products of 325, 520, 
227, 280, 360 and 242 bp, respectively. The results were compared with 
those obtained by ‘nested’ PCR with MY11/MY09 as outer primers and 
GP5+/GP6+ as inner primers. 
Results. Among 397 samples 210 where negative in both MY-GP 
and multiplex PCR-tests. 187 where positive, 182 (45.85%)-in MY-GP 
PCR and 107 (26.96%)-in multiplex PCR. Five samples (1.26%) where 
positive only in multiplex PCR-test (three of them contained HPV 39 type, 
one sample contained HPV 45 type and one sample contained HPV 52 
type). The HPV 16 detected in 40 (10.08%) samples, HPV 18-in 10 (2.52%), 
HPV 31-in 18 (4.54%), HPV 33-in 20 (5.04%). HPV 35-in 5 (1.26%). 
HPV 45-in 7 (1.77%), HW 39-in 6 (1.52%), HPV 59-in 18 (4.29%), 
HPV 52-in 10 (2.52%), HPV 58-in 2 (0.51%). Single types were 
detected in 83 cases, double types-in 19 cases and triple types-in 5 
cases. 
Conclusions: We propose one-step procedure for simultaneous detec- 
tion and typing 10 ‘high-risk‘ HPV types. The developed method is simple, 
rapid and sensitive. Next modifkation ofthis approach will allow to detect all 
of the 14 ‘high-risk‘ HPV types. The prevalence of 10 ‘high-risk‘ HPV 
types among Moscow women, estimated by the developed technique was 
26.96%. 
[p1333/ Genetic heterogeneity of calicivirus infection 
in Moscow, Russia 
A. Mukhina, G. Shipulin and S. Yatcishina 
Moscow, RUS 
Objectives: Calicivirus is recognized as one of the most important viral cause 
of acute gastroenteritis and outbreaks. The aim of the present study was to 
investigate the role and heterogeneity of CV in structure of acute gastro- 
enteritis in Russia using in-house RT-PCR method for detection of these 
viruses in stool samples. 
Methods: We designed a set of primers for separate detection of NLVl, 
NLV2, SLV. Conservative regions of polymerase (ORFl) and capsid (ORF2) 
genes were selected for two sets of primers for each of three types of 
caliciviruses. For nucleic acids purification h m  feces, we used the silica- 
guanidiniumthiocyanate method described previously by Boom with our 
minor overpatches. To investigate the variability of the strains of caliciviruses 
detected in the study, the amplified with primers to the capsid region 322 bp 
products were sequenced and alignedwith known sequences, published in the 
GeneBank. All the nucleotide sequence data had been submitted to the 
GeneBank. 
Results: A total of 123 cases of acute sporad~c gastroenteritis in children were 
tested for the presence of viral and bacterial agents. Caiiciviruses were 
detected in 81123 (6.5%) cases. AII viruses isolated during 2-year period 
were shown to belong to the NLV2 and none of the eight isolated caltciviruses 
were related to the NLVl and SLY. All isolates showed high rate of variability 
between each other (75100%)). The maximum rate of homology (98-99%) 
was detected between four isolates which were closely related to the NLV2 
strains isolated in Japan (homologs to the reference strain Hu/NLVZ/Hiling- 
don/1990/UK). The rest three isolates were more variable, one of them was 
related to the Hu/NLV2/Grimbsy/l995UK and two others (homology 96%) 
were related to the Japan strain-Hu/NLV2/Chita/1996/JP. In one case 
primers to the capsid gene did not amplify cDNA of NLV2, and the positive 
RT-PCR result was achieved with primers to the polymerase gene. The 
190 bp PCR product was sequenced and aligned to the known sequences. 
This isolate was related to the reference strain NLV2 Hu/NLV2/Melksham/ 
1994/UK. 
Conclusion: This study presents the first experience of detection and genetic 
analyses of human cahciviruses in Moscow, Russia. The rate of sporadic cases 
of calicivirus diarrhea was 6.5%. The clear predominance of NLV2 confirms 
the prevalence data of the NLV2, demonstrated in numerous studes. The 
sequence data shows heterogeneity of NLV2 circulated during two winrer 
periods in Moscow. 
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-1 Real-time detection and quantification of HBV 
DNA using a sensitive DNA NASBA assay covering a dynamic 
range of at least 6 log 10 
B. Deiman, 1. Berghuis, D. van Strijp, I. Frantzen, S. Vermeer, 
L. van Kerkho& D. Pijnenburg, B. van Gaal and W. Schippers 
Boxtel, NL 
Objectives: Worldwide, over 340 million people are persistently infected with 
hepatitis B virus (HEW). A sigrufcant minority develops chronic hepatic 
insficienq, cirrhosis or hepatocellular carcinoma, resulting in about 
1 million deaths per year. Viral loads up to 10l1 copiesJmL have been 
registered. The aim is to develop a sensitive assay for the quaneification of 
HBV DNA covering a broad dynamic range. 
Methods: A nucleic acid sequence-based amplification (NASBA) assay was 
developed for the quantification of HBV DNA. NASBA is originally 
designed for detection of RNA targets. However, with some important 
adaptations, NASBAwas shown also to be a functional tool for the amplifica- 
tion of HBV DNA. The most important adaptation is the inclusion of a 
restriction enzyme digestion. To assure detection of all different genotypes, 
the conserved restriction sites XbaI and BssSI, both located in the S gene of 
HBV DNA, have been selected. Both restriction enzymes are included in the 
test. Primers and a molecular beacon probe were selected in the region 
adjacent to the restriction sites. HBV DNA is isolated fkom serum or 
plasma samples using the NucliSens Extractor (Organon Teknika/bioMCr- 
ieux). The minus strand ofHBV DNA is used as template. Amplification takes 
place during 1 h. The amplification product is detected real-time with 
molecular beacon technology. An internal calibrator is included for quanti- 
fication. 
Results: It is shown that a 100-1000-fold increase in sensitivity is obtained due 
to the restriction enzymes included in the test. Using a two-step approach, a 
dynamic range &om -lo2 to > I d  WHO copies/mL can be detected 
without the need to dilute samples. Data 6om analytical performance testing 
will be presented. Correlation with other HBV tests that are commercial 
available will be shown. 
Conclusions: A sensitive quantitative HIIV DNA test covering a dynamic 
range of at least 6 log 10 is developed based on NASBA and molecular beacon 
technology. 
Evaluation of ‘end point‘ and ‘real-time’ 
molecular-based assays for amplification and detection of 
influenza viruses 
A. Rahman, D. Westmoreland and J. D. Fox 
Curd8 UK 
Objectives: Molecular assays provide some advantages over culture and 
antigen methods for diagnosis ofRNA respiratory txact infections, particularly 
where acellular samples are taken for surveillance or where a sensitive, rapid 
diagnosis will greatly assist patient management. The aim of this study was to 
develop and evaluate NASBA and ‘real-time’ RT-PCR for diagnostic detec- 
tion of influenza A and B viruses in clinical samples. 
Methods: Respiratory samples previously tested for influenza A, influenza B 
and other respiratory infections by culture and antigen-based procedures, 
together with in vitro synthesized RNAs and titrated reference viruses, were 
used for development and evaluation of the molecular-based assays. Primers 
and probes for the assays were designed within the influenza nudeoprotein 
region. Influenza A and B were targeted separately and the assay for influenza 
A was d e s F d  yo d,etect all subtypes. NASBA was undertaken using the 
NucliSens Basic &t (bioMCneux) with detection of amplicons using ‘end- 
point’ and ‘real-time’ procedures. Reverse transcription was undertaken in a 
separate step prior to cDNA PCR amplification using the Lightcycler (Idaho 
Technologies). ‘In tube’ detection of amplified PCR products utilized Cy5 
labeled probes. 
Results: The feasibility of using rapid molecular-based assays for detection of 
influenza A or B genomic RNA in respiratory samples was confirmed. The 
NASBA procedures picked up a lower RNA copy/virus control input than 
the RT-PCR but both methods correctly identified clinical samples positive 
by conventional procedures. 
Conclusion: The influenza A and B molecular assays will provide important, 
rapid diagnostic information allowing consideration of the use of antiviral 
therapies in those at most risk &om severe iafluenza infection and avoiding 
inappropriate antibiotic use. 
I P1336 1 Diagnosis of parainfluenza virus infections using 
NucliSensm Basic Kit NASBA with ‘end point‘ and 
‘real-time’ detection 
S. Hibbitts, A Rahman, D. Westmoreland and J. D. Fox 
Curdg UK 
Objectives: Outbreaks of human p d u e n z a  virus (HPIV) infections have 
been reported wth potenhdy severe disease in the very young and m u -  
nocompromsed. The auns of tlus study were to develop assays based on 
NuchSensTM Basic IClt NASBA for magnosis of HPIV infechon and to assess 
the posslble advantages of usmg such molecular approaches in a hospital 
environment. 
Methods Krt-based reagents were u t h e d  for eXrraChOn, amphficahon and 
detechon of amphfied products (NucliSensTM B ~ K  f i t , bioMCieux). 
Pruners and probes were based on the HN p r o m  (separate assays for HPIVs 
1-3) or P protem (HPIV 4a and 4b combined assay). Detechon of amplified 
products was by electrochemilurmnescence (ECL, ‘end-pomt’ detectlon) or 
by use ofmolecular beacons (‘real-tune’detechon). Titrated reference vuuses, 
syntheac RNA (prepared by clorung of the target and m vltro transcription) 
and a range of &agnoshc respiratory specmens (n = 50 to date) were utihzed 
to evaluate the assays, Feasibhty ofmulaplexing primers and probesm a mgle 
reachon was assessed umg a combmed HPIV1 and HPIV3 assay as a model 
with ‘real-me’ and ‘end pomt’ detection. 
Resultr: The assays w g  ECL detecaon proved to be very SenSlhve and 
speclfic. Typic*, less than or equal to 100 R N A  copies or 1 TCIDso mput 
was detectable w t h  no cross-reacuon wth other respuatory viruses. Results 
for &cal samples were concordant w t h  those obtained by ‘convenhonal’ 
procedures. ‘Real hme’detection uthzed probes spec& for either HPIVl or 
HPIV3 with sinular performance characterlstics to the assays w t h  ‘end point’ 
detechon. The combined HPIVl and HPIV3 mdhplex assay gave good 
results for ECL and molecular beacon detection on control material and 
c h c a l  samples. 
Conclusion: Bmc Kit NASBA IS a smtable dugnostlc molecular amplification 
method for rapid detechon of HPIVs m a range ofspecmen types. T h  assay 
d allow a speclfic magnous to be made in a me-fiame relevant to pahent 
management and to haspital infechon control. 
Development and evaluation of ‘real-time’ 
molecular amplifkation assays for diagnosis of respiratory 
syncytial virus infection 
A. Rahman, D Westmoreland and J. D. Fox 
Curd& UK 
Objectives: Respiratory syncyaal wrus (RSV) has been associated with severe 
respiratory tract symptomology and complications in the very young, the 
elderly and lmmunocompromised mdmduals. The ;urns of this study were to 
develop and evaluate molecular assays based on NucliSensTM Basic Kit 
NASBA and ‘red-hme’ PCR for magnosis of RSV infeaton and to assess 
the possible advantages of usmg such molecular approaches in a hospital and 
community semngs. 
Methods: PrImen and probes were designed wthm the RSV fhsion protem 
regon whch allowed amphficahon and detechon of both RSV A and B 
sua ins  by NASBA and RT-PCR. NASBA was undertaken using the Nucli- 
SensTM Basic f i t  (bioMineux) wth  detection of amphfied products by 
e l ec t rochdmescence  (ECL) or ‘real-tune’ usmg a molecular beacon 
Reverse transcription was undeaaken m a separate step prior to cDNA PCR 
amplification umg the Lightcycler (Idaho Technologes) Detechon of 
amplified PCR products utihzed Cy5 labeled probes. Sensihvlty and speci- 
ficity of the molecular assays were assessed usmg respuatory samples (n = 1 12 
to date) and ntrated reference w e s .  
Results: The molecular assays had a considerable advantage above culture- 
based procedures because of the rapld turn-around tune for results. Direct 
anhgen detection was relahvely insensitive on swab material The NASBA 
assays wth ECL or molecular beacon detechon gave eqwdent 
results and proved to be very sensitive and spec& Typically, less than or 
equal to 0.01 TCIDC,~ RSV input was detectable by NASBA wth no cross- 
reachon w t h  other respiratory viruses. The senslhwty of the NASBA vsay 
was found to be 100-fold hlgher than the RT-PCR on cultured materd and 
the latter procedure mssed some culture and or duect anhgen p 0 S i h w  
samples. 
Conclusion: Molecular amphficahon methods d Impact on sumedance of 
RSV infechons and patient management. Basic &t NASBA 1s a suitable 
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hagnosac method for rapld detecaon of RSV in a range of respiratory 
samples. The assay will allow a speclfic dngnosis to he made in a time-fixme 
relevant to patient management and to hospital infection control. 
(p13381 Molecular analysis of human parechovirus 
type 2 (formerly echovirus 23) 
F. Ghazi and G. Stanway 
Tehran, IR; Colhester, UK 
Picornaviruses have been divided into five genera until recently, when a sixth 
genus, Parechovirus, was defined. Human parechovirus type 1 (HpeV1; 
formerly echovirus 22) was the first recognized member of this genus and 
preliminary sequence analysis of echovirus 23 [now renamed human par- 
echovirus type 2 (HPeV2)] suggested that it is also a parechovirus. Here we 
describe the complete nucleotide and predicted amino acid sequences of 
HpeV2, which indicate a close relationship to HpeVl throughout the 
genome. Sequence covariance in the five unmanslated region allows a 
prediction of the secondary structure, which indicates that these parecho- 
virusm have a type 2 internal ribosome entry site, most closely related to that 
of cardioviruses. Overall, HpeV2 has 87.9% amino acid identity with HpeVl , 
most divergence being seen in regions of the capsid proteins that probably 
define antigenic sites. The N-terminal sequence extension to W3, seen only 
in parechoviruses, is highly basic in both viruses, but has a variable sequence, 
suggesting that it dose not have a sequence-specific role. There is an RGD 
motif near the C terminus of VP1, in an analogous location to that in 
HpeVlwhich is believed to be functionally sigm6cant. The results confirm 
that both viruses are parechoviruses and give insights into the molecular 
features of this genus. 
11113391 Multiplex RT-PCR for diagnosis of human 
picornavirus infections 
P. Joki-Korpela, P. Laakso, M. Maaronen and T. Hyypia 
Helsinki, FIN 
The best known picomaviruses are enteroviruses which cause meningitis, 
encephalitis, poliomyelitis, myocarditis, respiratory infections and rashes. 
Khmoviruses are the major cause of common cold while hepatitis A virus 
(hepatovirus) infection affects liver. Of the two recently established picorna- 
virus genera, parechoviruses appear to cause mainly gastroenteritis and 
respiratory infections, and Aichi virus (a kobuvirus) has been detected in 
oyster-associated gastroenteritis cases in Japan. The aim of our work was to 
develop an RT-PCR test which would detect all human picomaviruses in a 
single assay. For the purpose, we designed primers from the 5’ untranslated 
region of the viral genome which give rise to 116-260 nt long amplicons and 
combined the reactions as multiplex RT-PCR. Furthermore, we developed a 
liquid hybridization assay where one of the primers in each reaction is 
biotinylated to mediate binding of the amplicons to streptavidin-coated wells. 
The product was then detected with digoxigenin-labeled oligonucleotide 
probes and the results measured by chemiluminescence. We have further 
optimized the amplification and liquid hybridization reactions which cur- 
rently allow detection approximately 25 cDNA copies of the viral genome. 
The assay enables simultaneous identification of enteroviruses, rhinoviruses, 
parechoviruses, hepatitis A virus and Aichi virus. The method is currently 
used for analysis of clinical samples including CSF, serum, stool and naso- 
pharyngeal specimens. In particular, we are interested in the clinical outcome 
of infections caused by the currently poorly known human picornavirus 
groups, parechovinises and Aichi virus. 
Nuclisens@ Basic Kit NASBA including internal 
control and molecular beacons for reliable ‘real-time’ 
diagnosis of enterovirus infections 
M. Jacobs, H. Foolen, M. Peeters, J. Fox, I? Haima and €? Sillekens 
Boxfel, NL; Cardfi  UK 
Objective: Enteroviruses are among the most common viral pathogens of 
humans and are responsible for a wide range of clinical symptoms. The aim of 
this study was to enhance diagnostic detection of enterariruses in a range 
of clinical specimens. 
Methods: Based on the 5‘ noncoding region of the enterovirus genome 
primers and an enterovirus speclfic internal control (IC) to monitor assay 
fidelity at the individual sample level were developed. Standard reagents from 
the Nuclisens@ Basic Kit were used for automated nucleic acid extraction and 
subsequent RNA amplification and simultaneous detection. Diflerently 
labeled molecular beacons were used for detection of enterovirus and IC 
RNA amplicons during the amplification process. Reference viruses, clinical 
samples and quality control specimens were analyzed. 
Results: Introduction of molecular beacons enabled the detection of both 
enterovirus RNA and 1C RNA amplification Simultaneously over time. In 
this way, performance validity could easily be assessed for each individual 
sample while detecting the presence of enterovirus RNA. The analytical 
sensitivity of this ‘real-time’ NASBA assay was approximately 1000 copies of 
synthetic RNA in the isolation-ampEcation reaction for a wide range of 
enteroviruses. Analysis of reference strains showed a specificity of almost 100% 
(with the exception of HRV 45) and a sensitivity of 0.1-1.0 TCIDso. 
Specificity and sensitivity of the ‘real-time’ NASBA assay were confirmed 
hy the results obtained from the EUCA panel that were similar to those of 
three reference laboratories. The newly developed ‘real-time’ NASBA 
appears to be user-friendly and results are available withm one working day. 
Conclusion: The internally controlled ‘real-time’ pan-enterovirus NASBA in 
Nuclisens@ Basic Kit format is a very reliable assay and applicable for rapid 
clinical diagnosis of a wide range of viruses. The approach of a closed tube 
system by using molecular beacons enlarges the utility of the assay in a routine 
diagnostic setting. 
Molecular diagnosis of periodontitis 
D. De Vito, D. Rizzi, S. Loner0 Baldassarra and G. Fanonato 
Bari, I 
Objective: It is generally accepted that periodontitits is initiated by the 
establishment of a specific subgingival bacterial flora. A number of marker 
organism, namely Actinobarillus actinomycetemcumifans, Pff~~y~f fmon~g i~g i~a l j s ,  
Preuotella intermedia, Bacteroidesforsythus and Trponema denticula have attracted 
particular attention because exotoxins produced by these organisms were 
associated with continuous idammation and tissue degradation. About 1Ck 
15% of all periodontitis cases exhibit an aggressive progress indicating 
microbiological testing, for example forms of early onset periodontitis, as 
the preadolescent, the juvenile and rapidly progressive periodontitis. In 
adhtion, severe forms of the adult generalized periodontitis, the refiactory 
and the therapy-resistant periodontitis as well as infection of osteointegrated 
implants represent indications for microbiological testing. 
Materials and methods: It’s very difficult to use traditional methods of culture 
because the organisms responsible for periodontitis are anaerobic and their 
vitality is reduced in the subgingival sample. Than we have utilized a 
commercial molecular test that allows the fast and easy identification of five 
periodontopathogenic bacterial species. DNA isolated from subgingival 
samples is used to ampkfv a specific gene fkgment Gom each species. 
Biotinylated amplicons are subsequently identified by a reverse hybridization 
assay. We have used a casecontrol study and examined 25 patients affected by 
periodontitis and 50 healthy controls. 
Results: The results evidenced that in all the patients with periodontitis are 
present alone or in association the five periodontophatogenic bacteria 
investigated. The first detected is T denticola (20%) and the following B.for- 
sythus (12%); frequently the association of T denn‘cola with B.fonythus (24%). 
The bacterial concentration present in a healthy sulcus lead to a negative result 
in all the controls. 
Conclusions: The speclfic and sensitive detection of periodontopathogenic 
bacteria from subgingival pockets allows for the quick identification of risk 
patients and gives valuable information when choosing an effective theram. 
p w l  Detection of community-acquired pneumonia 
pathogens in lower respiratory specimens using the 
BDProbeTecm ET System 
T. Brink, D. Wolfe, K. Thornton, J. Price, D. Yursis, T. Hellyer and 
J. Wood 
Spark, USA 
Objectives: (1) To develop strand displacement amplificaaon (SDA)-based 
assays for use on the BDProbeTecTM ET System to detect three ofthe leading 
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causes of community-acquired pneumonia (Legionella pneumophila, Myco- 
pfasma pneumoniae and the Chlamydiaceae firmly) &om a single processed 
lower respiratory sample. (2) To assess the efficacy of a universal sample 
processing method for lower respiratory specimens including sputum and 
bronchial washings: (a) Evaluate the effect on the internal ampMication 
control (IAC), (b) determine analytical sensitivity in spiked processed speci- 
mens. 
Methods: Performance of the IAC for each of the three assays w a s  
evaluated using 119 lower respiratory specimens (97 sputum samples and 
22 bronchial washings). All samples were processed according to a customized 
Qiagen DNA extraction protocol and assayed using a universal buffer 
system and dried amplification reagents. To determine the analytical sensi- 
tivity for each assay, serial dilutions of the three organism were seeded all 
together into a negative lower respiratory specimen pool, then processed and 
assayed. 
Results: For the 119 lower respiratory samples examined, the LAC, an 
indicator of SDA reaction inhibition, showed an indeterminate rate for the 
L. pneumophila and C. pneumoniae assays of 1.8 and 5.4%, respectively. All of 
the inhibited samples were sputum specimens. The analytical sensitivity using 
a processed lower respiratory specimen pool was determined to be 1092 
colony forming units/mL for L. pneurnophila and 1092 elementary hodies/mL 
for C. pneumoniae. Performance of the BDProbeTecTM ET M .  pneumoniae 
Assay is currently being investigated. 
Conclusions: The BDProbeTecTM ET community-acquired pneumonia 
assays offer the potential for highly sensitive detection of L. pneumophila, 
M.  pneumoniae and the Chlamydaceae f a d y  from lower respiratory speci- 
mens. All three assays employ a common, rapid and straight-forward sample 
processing protocol that provides for efficient recovery of DNA and removal 
of potential assay inhibitors. 
/p1343/ Evaluation of PreservCytG solution (Cytyc@) for 
the detection of Chlamydia trachomatis by PCR on COBAS@ 
Amplicor 
J.-L. Pauzk, M.-C. Mottiez, F. Joris and 0. Pkter 
S o n ,  CH 
Objectives: The aim of this study w a s  to evaluate the convenience of cervical 
samples in C p @  medium for the detection of Chlamydia trachomafir by PCR 
on COBAS Amphcor. 
Methods: Cervical specimens collected in Cytyc medium were 
obtained from women for a cervical cytological screening. A total of 110 
samples were randomly chosen, 55 in a group of specimens without 
particular cytological findings and 55 among specimens presenting 
atypical squamous cells of undetermined sigdcance (ASCUS) or low grade 
cervical lesion (LSIL). Samples were prepared by centrifugation and a 
single washing step in Phosphate-sucrose bufler prior to standard 
procedures for PCR preparation on cervical swabs. In addition, five women 
with a C. trachomatis infection detected by PCR or direct immunofluores- 
cence and for whom a Cytyc sample was available, were also included in this 
study. 
Results Out ofthe 110 Cytyc specimens, 2 (1 3%) were found positive for C. 
trachomatis and the five Cytyc samples Gom infected women were also found 
positive. Five out of these seven samples were classified in the ASCUS-LSIL 
group. Cytyc solution of specimens positive for C. trachomafis conserved at 
room temperature were still found positive by PCR on COBAS Amplicor 6- 
12months later. Negative specimens were negative. No inhibition was 
observed with the procedue used for preparation of the samples Gom Cytyc 
medium. 
Conclusion: PreservCyt solution (Cytyc) is a highly stable medium for PCR 
detection of C. trachoma& on COBAS Amplicor. It appears to he particularly 
well adapted for cytological examination, as well as for detection ofpathogens 
like Human papillomirus, C. tracbomds . . ._ Detection of ASCUS-LSIL 
may help for the selection of women at risk for C. truckomatis infections. 
Samples in Cytyc medium are well adapted for retrospective epidemiological 
study on C. trachomafis. 
1813441 K R  diagnosis of invasive disease caused by 
Neisseria meningitidis and direct multilocus sequence typing 
of PCR products 
J Kalmusova, J. Felsherg and €? Kruova 
Prague, CZ 
Objectives: The polymerase cham reacnon (PCR) for nonculture dugnosis of 
mvasive memngococcal dlsease was introduced to increase the percentage of 
laboratory confumed cases The multdocus sequence typlng (MLST) ofPCR 
products was introduced wlth the a m  to reveal sequence types (STs) from 
pahents wlth suspected mvasive memngococcal &ease. 
Methods: The PCR method was ophrmzed on N mentngrtrdts and sensiuvlty 
and spenficity of the PCR detecaon of N mentng~fidrs Gom cerebrospmal 
flwd (CSF) were assessed m 195 samples &om patients wlth the folloulng 
diagnoses. invasive memngococcal dsease, bacterial nonmemngococcal 
memnphs and vlral memphs  DNA was extracted from the CSF by 
IsoQuick km (ORCA Research Inc , USA) MLST was made accordmg 
to the method developed at the Umversity of Oxford. 
Results: The followmg parameters of the PCR detechon of N mentngthdts 
Gom the CSF were calculated. sensiavlty = 0 85, spechcity = 0 95, posinve 
predichve value = 0.88, negabve pr&dve value = 0 93. Under our condl- 
hons, PCR gave laboratory confrrmahon 111 nearly 50% (47.4%) of paaents 
wth  mvasive memngococcal dlsease where the ehology was not confirmed by 
classical methods MLST performed duectly &om cerehrosplnal fluid revealed 
STs in all PCR products. 
Conclusion: The PCR method for nonculture hagnosis of masive memn- 
gococcal &ease and h4LST typing of N. meningttrb duectly h m  c h c a l  
matenal were mtroduced in the National Reference Laboratory for Merun- 
gococcal Infecnons m Prague. These molecular methods unprove laboratory 
dlagnosn of mvasive memgococcal dlsease. 
Acknowledgments: Thls s t u d y  was supported hy research grant NV6882- 
3 of the Inrernd Grant Agency of the htmstry of Health of 
the Czech Repuhhc and made use of the Multi Locus Sequence 
Typing website (http://nrnseria.mlst net) developed by Dr Man-Suen 
Chan, nted at the Umvemty of Oxford and funded by the Wellcome 
Trust. We thank Dr. K Jolley (Ur~ver~lty of Oxford, UK) for kxnd e&tmg 
of the text 
1813451 Development and comparison of two 
PCR-based methods for the detection of serogroup 
A Neissma meningitidis 
E. K. Girvan, M. A. Diggle and S. C. Clarke 
Wishaq Gimgow, UK 
Objectives: The diagnosis ofmeningococcal disease (MD) is usually based on 
clinical presentation, and is ideally confirmed with the isolation of Neisseria 
meningifidis h m  a patient source. With the introduction of the meningo- 
coccal serogroup C vaccine (MenC), there is a need for enhanced surveillance 
ofother serogroups within the population. The gene cassette, requiredfor the 
biosynthesis of the nonsialic acid capsular polysaccharide of N. meningifidis 
serogroup A, has been characterized. The cluster contains four genes: m y d ,  
my&, mynCand mynD which are specific to N. meningifidis serogroup A. The 
aim of this study was to develop, and evaluate both a conventional gel-based 
PCR detection system and a new dual-labeled end-point fluorescence PCR 
system (DEF-PCR) for the detection of mynA. 
Methods: A conventional PCR for serogroup A detection was developed 
and evaluated for specificity and sensitivity using a total of 88 
isolates (comprising 13 serogroup A meningococci; 26 ‘other’ meningococcal 
serogroups and a variety of 49 nonmeningococcal isolates). A novel 
PCR method was developed for serogroup A detection, using primem 
labeled with reporter and quencher dyes. The chemistry results in the 
production of fluorescent emissions, which can be detected on a standard 
fluorescent reader. 
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Results: The sensitivity of the DEF-PCR method was greater, compared 
to the conventional method. The DEF-PCR also allowed a high 
throughput (by giving a digital fluorescence value), eliminating the 
subjective visual reading of gels. An appropriate cut-off value could be 
calculated to ensure straightforward interpretation. Both PCR methods were 
found to be highly specific, for the detection of N meningitidis serogroup A. 
However, a small percentage of false positives could not be eliminated fiom 
the cut-off values created with the DEF-PCR. This could be attributed to the 
very high sensitivity, highlighting small amounts of contamination within 
some samples. 
Conclusion: It appears that the DEF-PCR method can provide an excellent 
eacient screening method for the detection of N. meningifidiis serogroup A. 
Advantages include its high throughput capacity, documented speclficity and 
high sensitivity. However, further evaluation studies are required before this 
method is used routinely as a detection system. 
I P1346 1 Comparison of detectability of Mycopasma 
pneumoniae infections in children, using PCR-test and 
serological methods: indirect irnmunofluorescence and 
immunoenzymatic assay 
B. Maczyfiska, K. Matusiewicz, J. Chiciak, M. Stankiewicz, 
B. Sozariska and A. Boz&ki 
Wmdaw, PL 
Objectives: Mycoplasma pneumoniae is an important cause of community 
acquired infections of upper and lower respiratory tracts in children, mainly 
atypical pneumonia. The aim of our study was the comparison of the 
serological procedures used in routine diagnostic (enzymatic- and fluores- 
cence assays) with the polymerase chain reaction (PCR) which is currently the 
most reliable and sensitive method applied in M .  pneurnoniae diagnostic. 
Materials and methods: The materials Gom 100 children hospitalized in 
Pediatric and Alergology Department ofMedical University ofWroclaw were 
analyzed. The PCR assay using M.pneumoniae Diagnostic Kit Venor Mp 
(Minerva, Germany) was performed to amplify the gene encoding the PI 
adherent protein. PCR was used to examine the presence of M .  pneumoniae in 
throat swab specimens. The level ofIgM and IgG antibomes were evaluated in 
sera samples using two immunoenzymatic tests: with membrane PI  protein 
(ELISA DiaSorin, USA) and with whole cell mycoplasma antigen (ELISA 
Euroimmun, Germany) and indirect immunofluorescence test with Biochip 
technique-fibroblastic cells infected by M .  pneumoniae (Euroimmun, 
Germany). Swabs and sera were taken from cNdren in acute infection. 
Results: Fifty-two percent throat swabs from children investigated by PCR 
were positive. Depending on serological test used, Werent percentages of 
positive results (IgM or both IgM and IgG antibodies) were detected in sera 
samples-30% using ELISA &om DiaSorin, 27% in fluorescence test and 1OOh 
in ELISA from Euroimmun. Additional in fluorescence test 10% of samples 
were considered as the positive on the basis of the high titer (>200) of IgG 
antibodies. In 15% of cases, positive results in PCR were negative in all 
serological methods. 
Conclusions: Detectability of M.pneumoniae was highest with PCR test 
applied. In serological test used in routine diagnostic, the false negative results 
could be obtained. The indirect fluorescence test was considered as the most 
reliable and sensitive in comparison with PCR assay. 
[p13471 Detection of Legioneiia pneumophila, 
Mycopiasma pneumoniae, and the Ctrlarnydiaceae family 
from a single throat swab using the BDProbeTecm ET 
System 
L. Kohler, S. Finn, J. Price, S. Joshi, S. Wang and T. Hellyer 
Sparks, USA 
Objectives: 
1 To develop a panel of strand displacement amplification assays for 
the detection of community-acquired pneumonia pathogens (Legionella 
2 
3 
pneumophila, Mycoplasma pneumoniae, and Chlamydiaceae family) from 
a single dry throat swab (stored without transport media) using the 
BDProbeTecTM ET System. 
To determine analytical sensitivity, specificity, and specimen stability for all 
three pathogens. 
To evaluate asymptomatic individuals to rule out the potential of a carrier 
state in otherwise healthv individuals. 
Methods: Analytical sensiawty was determmed for each assay by tesmg serial 
Cwutlons of orgamsms and a cloned target nucleic acid sequence. Speclficity 
was evaluated by challengmg the assays with a vanety of potenhal cross 
reactants, including genetlcally related bacteria To deterrmne whether a 
carrier state ensts for the target orgasms, approxunately 100 throat swab 
specimens were collected Gom asymptomauc volunteers The stabhty of dry 
throat swab specunens was detemned by teshng a second panel of swabs 
obtamed from aSymptOmahC indmduals that were seeded w t h  organisms and 
stored at various temperatures. All specimens were processed and assayed using 
a uversal buffer system and dried amphficatlon reagents. 
Results: The analyhcal sensittwty of the three assays usmg cloned target 
nucleic acid was 160, 131, and 1 I0 copies per test for L. pneumopfula. M .  
pneumoniae, and C. pneumoniae DNA, respecavely The analyhcal sensitiwty 
usmg seeded orgamsrm was 44 and 10 orgamsms per test for L pneumophtla 
and M pneumontae, respectlvely, and 38 elementary bodes per test for C. 
pneumoniae No cross-reachwty was observed. Dry throat swab specimens 
were found to be stable for 3 days at 2-8 "C and at least 7 days at -20 "C. 
Eduahon of ambient temperature stabhty 1s ongomg. No fdse-posihve 
results were observed in testmg of throat swab specmens Gom asymptomatlc 
mdlvlduals. 
Conclusion: The BDProbeTecTM ET L pneumophila, M pneumoniae, and 
Chlamydaceae tvlllly assays offer the potenhal for hghly sensiave and 
spec& detechon of these pathogens All three assays may be performed 
from a single swab specunen usmg a s t r e d n e d  workflow 
lp13481 Development of a multiplex real-time 
quantitative TaqMan assay to detect Chlamydia 
pneumoniae, Legionella pneumophila and Mycoplasma 
pneumoniae in respiratory tract secretions 
M. Welti, J. Bille, M. Altwegg, R .  Sahh, A. Wenger and K. Jaton 
Lmsanne, Zurich, CH 
Objective: Atypical pathogens such as Chlamydia pneumoniae, Legionella 
pneumophih and Mycoplacma pneumoniae are an important cause of 
community-acquired pneumoniae. The available detection methods either 
lack sensitivity or give only a retrospective diagnosis. In order to improve 
detection and identification of these pathogens, we developed a quantitative 
real time multiplex PCR for the simultaneously diagnosis of C. pneumoniae, L. 
pneumophila and M. pneumoniae in respiratory samples. 
Methods: Real-time PCR using the ABI Prism 7700 Sequence System 
(Applied Biosystem) was performed. Primers and probe were selected fiom 
hghly conserved sequence of the PST-1 fiagment of C. pneumoniae, the MIP 
gene of L. pneumophila and the PI protein gene of M. pneumoniae). Three 
plasmids containing the respective target genes were constructed to allow 
quantification and used as positive controls. 
Results: This multiplex PCR was able to detect simultaneously one copy of 
C. pneumoniae, L. pneumophila and M .  pneumoniae genome per 10 pL extracted 
DNA. CoampMication of two target genes without loss of sensitivity was 
demonstrated. The specificity was assessedusing 35 reference or clinical strains 
of bacteria and respiratory viruses. The comparison of multiplex real-time 
PCR and single conventional PCR assay for the 73 respiratory specimens 
analyzed so far showed an overall agreement of 98.3% corresponding to 95.8, 
100 and 100% for C. pneumoniae, L. pneumophila and M .  pneumoniae, 
respectively. Clinical application of this multiplex PCR was performed up 
to now on 38 respiratory samples from 36 patients with respiratory tract 
infections. Of 15 patients with positive serology, 12 were confirmed to be 
positive with the multiplex PCR for one of the three pathogens. All patients 
with negative serology were negative with multiplex PCR. In addition, the 
multiplex real-time PCR was found to be more sensitive than L. pneumophila 
culture. 
Conclusion: The multiplex PCR is a rapid, sensitive and specific method for 
the detection of C. pneumoniae, L. pneumophila and M .  pneumoniae and can 
thus, contribute to adequate clinical management. 
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Pharmacological issues 
lp1349) Cellular accumulation and membrane-binding 
properties of ester prodrugs of ampicillin (pivaloylarnpicillin 
[PIVA], phthalirnidomethylampicillin [PIMA]) 
H. Chanteux, E Van Bambeke, M. P. Mingeot-Leclercq, E. Sonveaux 
and P. M. Tulkens 
Brussels, B 
Objectives: The /?-lactam do not accumulate in eucaryotic cells which 
contributes to their poor activity against intracellular infection. This feature 
is due to the presence of a free carboxylic function on the molecule. PIVA and 
PIMA, in which the carboxylic function is masked and are therefore weak 
organic bases, accumulate in cells (Biorg. Med. Chem. 2001; 9: 493). The aim 
of this work is to study the mechanisms governing their cellular accumulation. 
Methods: All experiments were performed onJ774 mouse macrophages. We 
measured the kinetics of accumulation and efflux at 37 and 4 "C as well as the 
influence of a variation of the extracellular concentration (5-200 p ~ )  or ofthe 
pH of the medium (6-8). Bindmg to phospholipids was determined by 
equilibrium dialysis against liposomes. Chloroquine [CQJ and azithromycin 
[AZ], two weak bases known to be sequestrated into acidic compartment by 
proton-trapping, were examined in parallel. 
Results: Both prodrugs accumulated to a hgh level (cellular to extracellular 
concentration ratio [Cc/Ce] = 40 and 35 for PNA and PIMA, respectively) at 
37 "C as well as at 4"C, and were rapidly released ( f l / z <  5min) at 
both temperatures. Accumulation was not affected by variation of the 
extracellular pH, but was saturable at concentration of >5 p. Equihbrium 
dialysis experiments demonstrated a high binding to phospholipids 
( & = 4 5 p ~ ) .  This behavior was in sharp c o n a t  to that of CQ and 
A2 (accumulation at 37 "C with marked decrease at acid pH, no accumula- 
tion at 4 'C; slow release at 37 "C ( t l l r  2 h and 30 min) and no release at 4 "C 
(t112 > 24 h); lack of saturation at concentration of <80 p ~ ;  low binding to 
phospholipids). 
Conclusion: The mechanism by which PIVA and PIMA accumulate in cells is 
very different from that described for CQ and AZ. We may suggest that the 
prodrugs mainly bind to the pericellular membrane, perhaps because of their 
property of cationic amphiphile. 
Pharmacokinetio of cefepirne in experimental 
acute necrotizing pancreatitis 
D. Papagoras, M. Kanara, E. J. Giamarellos-Bourboulis, 
N. Kostomitsopoulos, G. Antzaklis, P. E. Karayannacos and 
H. Giamarellou 
Athens, GR 
Objective: To determine tissue penetration of cefepime since it may be a 
candidate of prophylaxis in acute necrotizing pancreatitis. 
Methods: Acute necrotizing pancreatitis was induced 6 days after the intra- 
peritoneal injection of DL-ethionine when three doses of 50mg/kg of 
cefepime were administered intramuscularly at 8 h time intervals. Thnty-five 
rabbits with acute necrotizing pancreatitis and 33 controls were sacrificed and 
concentrations ofcefepime were determined in serum and pancreas at regular 
time intervals by a microbiological assay. 
Rerults: Respective mean (fSD) pancrextic concentrations in rabbits with 
acute necrotizing pancreatitis and in controls were 22.3f6.9 and 
12.7ft5.4pg/g at 60min, 9.3&1.2 and 8.5&0.8pg/g a t  90min, 
5 .7 f1 .3  and 5.5*0.4pg/g at 120min and 2 .3f0 .4  and 2.8&0.6pg/g 
at 180min h e r  the last dose of cefkppime. Respectivz mean (-+SD) serum 
concentrations in rabbits with acute necrotizing pancreatitis and in controls 
were 46.1 zk21.5 and 45.2+16.6pg/mL at 60min, 40.159.4 and 
48.5 f 21.5 p g / d  at 90 min, 38.7 f 9.7 and 33.9 f 4.3 p g / d  at 120min 
and 24.8f2.7 and 17.3f21.5pg/mL at  180min after the last dose of 
cefepime. Tissue/serum ratio of cefepirne was found to be 0.48, 0.23, 
0.15 and 0.09 at 60, 90, 120 and 180min. respectively, after the last dose 
of cefepime in rabbits with acute necrotizing pancreatitis and 0.28,0.18,0.16 
and 0.16, respectively, at  60, 90, 120 and 180min in controls. 
Conclusions: Tissue penetration of cefepime in acute necrotizing pancreatitis 
is adequate over the first 120 min after the administration of the last dose of 
cefepime, resulting in tissue levels much higher than the MICs ofthe common 
pathogens of pancreatic superinfection. 
I P1351 1 Cefepime and nonconvulsive status epilepticus 
(NCSE) in renal failure (RF) patients 
M. Michels, B. De Keulenaer, P. Zachk, D. Schepens, R. L. Lins and 
R. Daelemans 
Antwq,  B 
Objectives: A retrospective analysis of seven cases of NCSE in patients (pat.) 
with renal failure (RF) treated with the fourth generation cephalosporin 
cefepime. 
Methods: As a result of an increased incidence of NCSE in our end-stage 
renal disease (ESRD) pat., the suspicion of an association with the use of 
cefepime and the recently published data on NCSE and cephalosporins, we 
reviewed the records of the pat. with RF and NCSE treated with cefepime 
between March 2000 and May 2001. 
Results: NCSE developed in seven pat. Six pat. were known with ESRD, 
requiring dialysis. One patient had acute renal failure (ARF). Creatinine 
clearance varied from 5.5 to 24.5 mL./min (mean 12.7 f 7 . 2  mL./min) on the 
day NCSE was diagnosed. The daily administered dose of cefepime was 2 g in 
five dtalysis pat., one patient developed NCSE after receiving only one dose of 
2 g, and the patient with ARF received 6 g after 24 h. All pat. presented with 
change in mental status with confusion, apathy or agitation, without con- 
vulsions. In all, EEG recordme were compatible with status epilepticus. The 
interval between the start of cefepime and the diagnosis of NCSE varied &om 
2 to 9days (mean 4.32k3days). NCSE persisted despite the use of anti- 
convulsants in four pat. where cefepime was continued. They all died. In three 
pat., cefepime was stopped and NCSE disappeared withm 24-48 h. They 
survived. Serum cefepime levels were available in three patients and were 
high, ranging &om 14.4 to 78.1 MmL. (mean 53.5 f 34.2 pg/mL). We also 
looked for other causes of NCSE. One patient was HIV positive and had a 
viral meningitis, another had a ventriculoperitoned drain. However, the 
serum cefepime levels in these two pat. were very high (68 and 78.1 &/I&). 
The causality between the presence of NCSE and the use of cefepime is 
considered as probable (WHO criteria) because of the temporal relationship, 
the lack of other causes in five out of seven pat. and the positive dechallenge in 
three pat. 
Conclusion: Treatment with cefepime, in pat. with RF, can result in NCSE. 
When changes in mental status or encephalopatby occur during treatment 
with cefepime, NCSE must be considered. In EEG-confirmed NCSE, 
cefepime should be stopped. Prognosis appears to be good after discontinua- 
tion. Although, the mechanism is unknown and the relationshp with the 
dose unclear, dosage adjustment accordmg to RF should be rigorously 
applied. 
m1 Lack of interaction between faropenem daloxate 
and warfarin in healthy vdunteers 
B. Voith, 1. Rossouw, M. Potgieter, J. Botha, J. Nagelschmitz, U. Voigt 
and J. Kuhlmann 
Wuppertal, 0; South Ajhcn, ZA 
Objectives: Faropenem daloxate (FD) is a new oral antibiotic with a penem 
structure unique f?om carbapenems and other avadable /?-lactams. FD is 
rapidly hydrolyzed in vivo to fkropenem (F), the active moiety. In vim, F has 
a targeted spectrum of antimicrobial activity against Gram-positive and 
-negative bacteria. FD is being clinically investigated for the oral treatment 
of community-acquired infections. Concomitant administration of FD with 
warfarin (W) could potentially lead to an interaction by protein displacement 
ofW or by Vitamin K deficiency due to changes in the normal gastrointestinal 
flow as a result of antibiotic treatment. Thus, the potential influence of the 
coadministration on pharmacokinetics and blood clotting was investigated in 
Methods: The study was conducted in a randomized, double-blinded, two- 
way cross over design. Twenty-four healthy male subjects, 18-45yeaxx ofage, 
were included. After a priming dose of 25mg W sodium (16days before 
treatment start), FD (corresponding to 300 mg F) or placebo were given bid 
for 8 days, with a concomitant single dose of 25 mg W sodium on day 5. Safety 
and tolerability were evaluated by momtoring of adverse events, vital signs, 
ECG and clinical laboratory parameters. Pharmacokinetic parameters were 
determined through analysis ofplasma profiles for R- /S-dar in  and for E In 
this study. 
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addition, prothrombin time (PT) and clotting factors 11, VII and X were 
determined for evaluation of a pharmacodynamic interaction. 
Results: No changes in AUC (0-96 h) for PT and the clotting facton 11, VII 
and X were seen, and all 90% confidence intervals were within the predefined 
equivalence ranges of 9 ~ 0 5 %  (forPT) and 90-110% (for factors 11, VII and 
X). The study treatments were safe and well tolerated, without any clinically 
relevant changes in vital signs, ECG, and laboratory parameters. The 90% 
confidence intervals for C, and AUC for R-/S-warfarin and F were all 
within the conventional equivalence range of 80-125%. 
Conclusions: No pharmacokinetic or pharmacodynamic interaction between 
FD and warfarin was observed in this study. The coadministration of FD and 
W was safe and well tolerated in healthy volunteers. 
[p13531 Postantibiotic effect of high dose AmBisome 
(AmBis) 3 weeks after treatment 
J. Olson, R. Pronltt and J. Adler-Moore 
Pomona, USA 
Objectives: Previous preclirucal reports of amphotericin B in tissues of 
-is-treated animals (5-2Omg/kg), 1 week after termination of treatment, 
suggested that AmBis may have some postantibiotic effects. Since, fungal 
infections are difficult to eradicate from tissues, prolonged activity ofthe drug 
would probably help to produce fungal clearance at these sites. 
Methods: To study this, we injected C57B1/6 mice with phosphate buffer 
(control) or 20 mg/kg AmBis i.v., three times per week, for 1 or 3 weeks. 
Kidney homogenates were prepared (three mice per time point) 48 h after the 
first week and third week of treatments, and again 3 weeks later. Homogenates 
were mixed with 1.0, 2.0 or 3.010g10cfu of Cnndidaalbicam and 
plated immediately or incubated overnight at 30°C prior to plating onto 
Sabouraud dextrose agar. For comparison, exogenous AmBis or hngizone 
(Fz) (10 pg/mL) was added to some homogenates from buffer-treated mice. 
Results: When the homogenates h m  drug-treated or control mice were 
plated immediately, there was no inhibition of fungal growth (e.g. 
2.0 loglo cfu of yeast incubated with homogenates yielded 2.0 loglo cfu on 
plates). However, overnight incubation of untreated control homogenates 
with 1.0, 2.0 or 3.0 loglo cfu yielded 5.0, 6.4 and 7.310glo cfu, respectively. 
Homogenates from mice treated with drug for 1 week showed marked 
inhibition of yeast growth (two- to five-fold log reduction) after overnight 
incubation compared to growth in homogenates h m  untreated mice. 
Inhibition was 100% when yeast were incubated overnight with homogenates 
&om mice given 3 weeks before treatment and mice tested 3 weeks post- 
treatment. Exogenous addition of Fz or AmBis to control homogenates also 
showed 100% inhibition, but only after overnight incubation. 
Conclusions: A carry-over effect from tissue containing AmBis was not 
observed if the tissue was plated soon after homogenization, although 
antifungal activity of the drug in the kidneys, even 3 weeks after treatment, 
was observed when the homogenized tissue was incubated overnight with a 
yeast challenge. Thus, a postantibiotic effect probably occurs with hgh-dose 
AmBis treatment of mice. 
. 
I P1354 I Ex vivo synergy of arachidonatesnriched serum 
with ceftazidime and amikacin on multidrug-resistant 
keudomonas aeruginosa 
D. Plachouras, S. Skiathitis, I. Dontas, A. Dionyssiou-Asteriou, 
P. E. Karayaxmacos, H. GiamareUou and E. J. Giamarellos-Bourboulis 
Athens, GR 
Objective: Multidrug-resistant Pseudomonas amginosa (MDPA) may become 
in viuo susceptible to ceftazidime and amikacin in the presence of arachidonic 
acid (AA) [l]. The present study aimed to the ex vivo effect of mchidonate- 
supplemented serum on MDPA isolates. 
Methods: An emulsion ofAAwas administered i.v. at a dose of 25 mg/kg over 
10 min by the left jugular vein of 10 rabbits and blood was sampled at 15-min 
intervals by catheters inserted in the left carotid and in the hepatic veins. Blood 
was centrifuged and 1 n L  of serum separately was added in 9 mL of MueUer 
broth containing a 5.6log-phase inoculum of each of the two MDPA blood 
isolates. Isolates were resistant to ceftazidime, imipenem, amikacin and 
ciprofloxacin. Cekid ime and armkacin were already added in broth at 
16 p.g/mL each, i.e. tbei  mean serum level. Bacterial growth was counted 
after 3, 5 and 24 h of incubation at 37 "C. Synergy was defined as more than 
21oglO decrease of viable counts compared to the effect of serum sampled 
before lnfusion of AA and to controls g r o w  with ancimicmbials. 
Results: Synergy was achieved for both isolates only after 5 h of incubation. At 
that time, mean decreases of viable cells compared to the effect of serum 
sampled before the idusion of AA were 1.39, 2.09, 2.51 and 1.50 after 
incubation in the presence of antimicrobials and sera sampled fiom the hepatic 
veins 15,30,45 and 60 min after infusion ofAA, respectively. Mean decreases 
were 3.71, 2.28, 2.57 and 1.64 after incubation in the presence of anti- 
microbials and sera sampled &om carotid artery 15, 30, 45 and 60min after 
lnfusion of AA, respectively. 
Conclusions: Ex vivo incubation of sera from rabbits intravenously adminis- 
tered AA may act in synergy with ceftazidime and amikacin on MDPA. The 
presented data may be applied for the therapeutic management of infections 
by multidrug-resistant nosocomial isolates in animal models. 
Reference 
1 Giarmrellos-Bourbodk cc al. AAC 2000. 4 4  2187. 
1 P1355 1 Pharmacodynamics of moxifloxacin in fibrin clots 
A. Dalhoff, M. Heid-, S. Schubert and U. Ullmann 
Wuppeml, Kid, D 
Background: Fibrin has pleiotropic functions: it plays a major role in tissue 
repair; it is one of the main constituents of the inAamma tory response 
associated with most infectious processes; it is an integral component of 
intravascular thrombi, and it provides a protective environment for bacteria as 
fibrin clots serve as diEusion barriers for antibiotics that permit bacteria to 
develop resistance. Therefore, the penetration of modoxacin into fibrin 
clots, its antibacterial action and its propensity to permit resistance develop- 
ment were studied. 
Methods: A modified method according to Bergeron et al. was used. Fibrin 
clots were infected with Spneumoniae, S.  aureus (MSSA), MRSA/B-lactamase 
negative, MRSA bla pos. and E.roli. Infected fibrin clots were placed in 
dialysis tubings and placed either into a one-compartment in vitro model 
simulating human serum kmetics of moxifloxacin following doses of 200 and 
400 mg or were implanted subcutaneously into NMRI mice; animals were 
treated with 100mg/kg i.v. every 6h. Bacterial counts and moxifloxacin 
concentration within the fibrin clots were quantitated and compared to viable 
counts of nonentrapped bacteria exposed to moxifloxacin under the same 
experimental conditions. 
Results: Penetration of modoxacin into the clots was rapid and was not 
different from the surrounding medium or serum. Viable counts of all four test 
organisms declined dose-dependently. In vitro E.  roli was eradicated within 
2 h, S. pneurnoniae in 3 h, MSSA in 7 h, and both MRSA strains in 12 h &om 
the infected clots. Analogous results were obtained in vivo. MICs ofpre- and 
postexposure isolates were not Merent. Nonentrapped controls were elimi- 
nated from the test systems within the same time periods. 
Conclusions: Fibrin clots did not constitute a penetration barrier for moxi- 
floxacin. The antibacterial action was not impaired due to the protective 
environment of a fihrin clot, and resistance did not emerge. These data suggest 
that modoxacin would provide &cient tissue penetration and clinical 
efficacy in serious infections. 
Omidazole-induced liver damage 
E Tabak, R. Ozaras, Y. Erzin, A. Celik, A. Mert, R. Ozturk, 
H. Senturk and Y. Aktuglu 
Istanbul, TR 
Introduction: Ornidazole is used in the treatment of infections caused by 
anaerobic bacteria and protozoa. It is generally well tolerated. Only two cases 
ofhepatotoxicity have beenreported. We here describe the three patients who 
developed hepatitis after ornidazole use. 
Case 1: A 38-year-old woman was initiated fluconazole and ornidazole for her 
vaginitis. Nine days later, she was admitted with fever and diarrhea. The stool 
revealed Entnmoeba hktolytica cysts, and ornidazole 1 g/day was used for 4 days, 
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but she felt worse and was readmitted the third day. She had jaundiced scleras 
and hepatomegaly (HM) (3cm). ALT was 977U/L, AST 1288U/L, t. 
bilirubin 32mg/dL (d. 19), ALP 1062U/L (64-306), HBsAg, anti-HBc 
IgM, anti-HCV, ASMA, and IgM Ab. against HAY EBV-VCA, CMV, and 
HSV were negative. MR chohgiography was normal. Biopsy: prominent 
cholestasis, acute cholangitis, moderate fibrosis. Ornidazole was discontinued 
and in 1 month, laboratory returned to normal. For the past 1 year, she is 
doing well. 
Case 2 A 50-year-old woman presented with jaundice, dark urine 
and weakness for 7days. Three weeks ago, she was prescribed ornidazole 
(1 g/day for 3 days) for vaginitis and used it for 3days. Four days after 
discontinuation, the symptoms began. She reported an acute hepatitis after 
ornidazole use of 7 days, 10 years ago. She had jaundiced skin and scleras and 
HM (2 cm). ALTwas 3042 U/L, AST 1665U/L, t. bilirubin 47.9mg/dL (d. 
19.3), AP 422U/L, HBrAg, anti-HBc IgM, anti-HAV IgM, anti-HCV, 
HCV-RNA, anti-HEV, anti-LKM, ASMA, FANA, and IgM Ab. against 
CMV and EBV VCA were negative. An abdominal USG was n o d .  Liver 
biopsy: focal and bridging necrosis, 52days after laboratory returned to 
normal. For 8 months, she is healthy. 
Case 3 A 25-year-old woman was initiated ornidazole (1 g/day) for vaginitis. 
Three days later, was readmitted with nausea and the drug was discontinued. 
Fifteen days later, she presented with jaundice, dark urine, and vomiting. She 
had jaunhced scleras. ALT was 116OU/L, AST 790U/L, t. bilirubin 
IgM,  Anti-HCV, HCV-RNA, anti-HEV, and IgM Ab. against CMV and 
EBV-VCA were negative. MR cholangiography was normal. Biopsy: pro- 
minent cholestasis, acute cholangitis, moderate fibrosis. Laboratory returned 
to normal in 1 month. For the past 1 year, she is doing well. Ornidazole is 
commonly used and may lead to hepatic toxicity. Cholestasis, cholangitis, 
fibrosis or necrosis may be seen. Clinicians should be aware of the hepato- 
toxicity of the drug. 
lO.lmg/dL (d. 8.7), AP 431U/L. Anti-HAV IgM, HBdg, anti-HBc 
/p1357j Inhibitors of P-glycoprotein increase the 
accumulation of azithromycin and other macrolides in 
macrophages 
C. Seral, J. M. Michot, H. Chanteux, M. P. Mingeot-Leclercq, 
P. M. Thlkens and E Van Bambeke 
Brussels, B 
Objectives: Macrolides (M) accumulate in J774 macrophages. These cells 
express P-glycoprotein (Pgp), an efflux pump transporting basic drugs. We 
have examined the influence ofPgp inhibitors on accumulation (Ci/C,) ofM 
and intracellular activity of AZM. 
Methods: Wild J774 macrophages were exposed simultaneously to M and 
Pgp inhibitors. Cell-associated M was measured by microbiological assay. 
AZM activity towards intracellular Staphylocoau aureus (ATCC25923; MIC 
0.5 pg/rnL) was evaluated by 13% counting after 20-h incubation with AZM at 
C, ranging &om 0.05 to 10 pg/mL. 
Results: Accumulation data is shown in the table. 
% of control 
Drugs' c,/ce Cyclosporin Verapamil GF120918 
(time) control ( 2 0 ~ ~ )  (20 w) (250 mi) 
AZM (3h) 21 f 4  352 f 77" 339 & 52** 218 f 46" 
ERY (2h) 3f0 451 f19"' 336 f 11"' 238 f 7'* 
TEL (1 h) 25+1 172 f 6." 139 f 5"' 146 f 6"' 
CLR (1 h) 46&4 125 & 15' 81 &6* 112f9' 
Rob (1 h) 2 6 1 3  150 f 18' 1 0 6 i l l '  131 i 14* 
YPg//mL for all hut ERY (50pg'mL); bmxithromycin; 'not signiticant vs. controt 
***P<O.OI; **P<O.Ol; 'P<O.O5. 
We tested the effect of verapamd on AZM lntracellular achvity. Verapamd 
enhanced the activity of AZM (0.4logcfu decrease over controls) only at 
suboptimal M M  C, (0.5-1 pg/mL). 
Conclusion: Pgp may play a key role in regulating the accumulahon of AZM 
and ERY, and, to a lower extent, of other M. Increased C,/ C, of A Z M  appears 
however, oflimited chemothempeuhc value, probably because its intracellular 
activity is largely concentration-independent. 
I P1358 1 Effect of voriconazole on the pharmacokinetics 
of sirolimus 
S. Abel, R. Allan, A. Eel-, N. Wood and D. Nichols 
Sandwich, Canterbury, UK 
Objectives: Voriconazole is a second-generation triazole agent for the treat- 
ment of severe hngal infections and has a potential inhibitory effect on 
CYP3A4-mediated metabolism. Sirohus is an immunosuppressive 
agent largely metabolized by CYP3A4. Immunosuppressed patients are 
susceptible to fungal infections and therefore coadministration ofsirolimus 
and voriconazole may be clinically important. The objectives of this study 
were to determine the effect of steady-state voriconazole on the pharmaco- 
kinetics (PK) of single-dose sirolimus, and to investigate the safety and 
toleration of a single dose of sirolimus during coadministration with vor- 
iconazole. 
Methods: This was a single-blind, randomized, placebo-controlled, two- 
period crossover study in 16 healthy men aged 1943years. All subjects 
received voriconazole orally on days 1-9 (400mg/day/l2h on day 1; 
200mg/day/12h on days 2-9) or placebo (per day/l2h on days 1-9). 
Single-dme sirofimns (2 mg, p.0.) was administered on the morning of day 
4. Log-transformed maximum plasma concentrations ( C d ,  area under the 
plasma concentration-time curve to infinity (AUC) and untradormed time 
to C, ( T d  for s i r o h u s  were subject to an analysii of variance (ANOVA) 
that allowed for variation due to sequence, subject, period and treatment. 
Results: Mean C, and AUC of sirolimus were increased by concomitant 
administration of voriconazole. The means for C,, and AUC were approxi- 
mately 11.1- and 6.6-fold higher, respectively (see table). 
Sirohus + Sirohus + 
Parameter voriconazole placebo Comparison 90% CI 
AUG (ng h/mLy 1242 112 1114% 987, 1258 
cm (n%/W' 53.6 8.2 656% 573, 752 
c m  (h) 1.26 0.85 0.41 0.22, 0.59 
'Geometric mean; comparison is ratio (%) of means. 
bArithmetic mean; comparison is difference between means. 
Treatmenc-nlated advem events (AEs) were reported by eight subjects (13 
events) durlng voriconazole treatment, 10 subjects (15 events) during UT- 
ohnus + voriconazole treatment, three subjects (ax events) during placebo 
treatment and six subjects (nine events) duringsirohnus + placebo treatment. 
The majority ofAEs were rmld or moderate. One subject dwontinued due to 
an AE which was not regaTded as treatment related. 
Conclusions: Exposure to shlimus is increased sqpf~cantly when coadmi- 
nistered with voriconazole. Coadministration of voriconazole and simlimus 
was well tolerated. Mean PK parameters of sirolimns were obtained on day 4 
sirolimus (S), voricoaazole 0, placebo (P). 
ml In vitro antimicrobial activity of the essential 
oils of Greek propolis 
E strahs, 0. Kretsi. E Chmou and I Chnou 
Pirams, GR 
Objectives: Propohs (bee-glue) IS a complex ~IXNIV of beeswax, small 
amounts of sugar and plant exudates collected by honey-bees (A@ mel@m) 
&om various trees, shrubs and herbs. It has been known as a remedy smce 
anaent tunes and is shll used m folk mehcine, in 'bio-cosmeacs,' 'health 
foods' and beverages mended to m a m m  or mprove health. As a part of a 
systemaac research on the chermcal composihon ofpropoh, we report 10. t h ~ s  
study the antunmobial achvlhes of the essenaal o h  and of pure d a t e d  
compounds of Greek propob, whxh, to our knowledge, have nexer been 
studled before 
Methods: The anamcrobial acmhes of the essenhd ods and of pure isolated 
compounds of Greek propoks were d e t e m e d ,  u q  the dduhon techque, 
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by measuring their MIC against two Gram-positive bacteria: S. ~ureus, and 
S. epidermidis, four Gram-negative bacteria: E. coli, E. cloacne, K. pneumoniae 
and Z? amginosa, and three pathogenic fungi, Candida albicans. C. tropicalis and 
C.glabrata, all are strains of ATCC. Standard antibiotics were used in order to 
control the sensitivity of the test organisms. 
Results: Through the antimicrobial screening, the oils proved to be active 
against all six tested bacteria as well as the tested fungi (MIC values 
0.5-8.75 mg/mL). The chemical composition of the oils have been studied 
by GC-MS and fium the 105 identified constituents, the major compounds 
(a-pinene, junipene, a-eudesmol, a-cedrol and manoyl oxide) have been 
isolated and were tested on the same cultures, under identical conditions, to 
compare their activities with those of the oil. 
Conclusions: The results ofthe assays suggest that the activity of the oils can be 
attributed, to a considerable degree, to the existence of a-pinene and 
manoyl oxide which appeared to possess strong activities against all tested 
microbia. 
P1360 I A model using Staphy/ococcusauft?us and HEp-2 
cells for evaluation of the intracellular pharmacodynamics 
of antibiotics 
B. 0. Lesko, E. Tan0 and 0. Cars 
Uppsala, S 
Objectives: Some bacteria, although not obligatory intracellular (IC) patho- 
gens, can have an IC habitat. Such facultative IC distribution might reflect a 
pathogenic mecharusm that may have to be taken into account when treating 
patients. IC location of Staphylococcus aureus (SA) could, e.g. in endocarditis 
New drugs II 
cause treatment failure and relapse after antibiotic regimes. Pharmacodynamic 
studies of antibiotics in vitro are mostly performed in acellular systems. Few 
models exist for studies of nonprofesional phagocytm and the ef€ect of 
antibiotics on facultative IC bacteria. HEp-2 cells can harbor IC pathogens 
such as HeZbbacterpybri, StrepfococcuspVogenes and staphylococcal species. We 
have adapted a HEp-2 cell model to look at IC kihng of SA with IC active 
antibiotics. 
Methods: S. aureus s t r a i n  type 42 D was used; MIC was 0.03125mg/L to 
rifampicin (Ibfa) and 0.5 mg/L to levofloxacin (Levo). HEp-2 cells (ATCC 
CCL 23) were cultured to a confluent cell layer and inoculated with challenge 
doses of SA. Ditferent exposure times were tested. Electron microscopy (EM) 
photographs were taken. Methods to remove remaining extracellular (EC) 
bacteria were studied. Infected cells were treated with study antibiotics @da 
20-200 x MIC or Lev0 50 x MIC). EC antibiotics were removed. Viable 
count on IC bacteria was done. 
Results: The number of IC bacteria increased during the fitst 2 h of exposure. 
To reach the intended IC bacterial concentration of 105/mL, a final con- 
centration of -1 x 10’staphy1ococci/mL in the exposure medium was 
needed. IC location of bacteria was confirmed by EM. Gentamicin was 
the most efficient method for removal of EC bacteria. When treating with 
Rifa or Levo, the most prominent IC lulling of SA occurred during the hrst 6- 
9 h. IC bacteria were less efficiently killed than bacteria in the EC medium. 
Conclusion: The time for bacterial challenge and control of postexposure EC 
bacteria showed to be important factors for quantification of IC effects. The 
study antibiotics, although known to have IC accessibility, primarily aEected 
EC bacteria. Complete IC killingwas not achieved at the concentrations used. 
Further antibiotic studies on facultative intracellular pathogens, also including 
dynamic models, are warranted. Future and more efficient IC-active anti- 
biotics could have an important clinical application in preventing treatment 
failures and relapses of potentially dormant IC infections. 
I P1361 I The ketolide antibiotic telithromycin inhibits the 
in vitro secretion of IL-la and TNF-a by human monocytes 
stimulated with lipopolysaccharide 
E G. Araujo, T. Slifer and J. S. Remington 
Palo Alto, USA 
Objectives: A number of antibiotics have been shown to have sigmficant 
immunomodulatory properties both in vitro and in animal models. Although 
it remains unclear whether such properties are clinically relevant, immuno- 
modulation by antibiotics may have sigdicance in the dammation caused 
by infection and in septic shock. Ketolides are semisynthetic derivatives 
of clarithromycin. representing a new class of antibacterials witbin the 
macrolide-lincosamidestreptogramin group. Our previous demonstration 
that the macrolides clarithromycin and azithromycin modulate in vitro 
cytokine production by human monocytes prompted us to examine the 
new ketolide antibiotic telithromycin for similar activity. 
Methods: Purified human peripheral blood monocytes, obtained from eight 
healthy adult volunteers, were stimulated with 100 ng/mL of Eschridzia roli 
lipopolysaccharide (LPS) and exposed to either 0.5, 1, 2, 5 or lOpg/mL of 
telithromycin. These concentdons of telithmmycin were not toxic for the 
monocytes as determined by the 3-(4,5-dimethyIthiazol-2-yl)-2,5-drphenyl- 
tetrazolium bromide cytotoxicity assay (MTT assay). At 3, 6, and 24h of 
incubation, the amounts ofinterleukin (1L)-la, IL-16, IL-6, IL-10 and tumor 
necrosis factor (TNF)-a were measured in the supernatants of the monocyte 
cultures using enzyme-Med immunosorbent assay. 
Results: Stimulation with LPS alone significantly increased secretion of each 
of the cytokines examined. Treatment of LPSstimulated monocytes with 
each of the concentrations of telithromycin sign&antly inhibited ( P <  0.01) 
secretion of IL-la and TNF-a by monocytes of each of the eight volunteers. 
A clear dose-response was noted with the most remarkable effect observed at 5 
and 10 pg/mL of telithromycin. Secretion of IL-lB, IL-6 and IL-10 was not 
significantly inhibited in monocytes from any of the donors. 
Conclusion: Telithromycin has immunomodulatory effects through its capa- 
city to alter secretion of IL-la and TNF-a by human monocytes. 
lp13621 Efficacy of telithromycin in the treatment of 
community-acquired pneumonia (CAP) caused by resistant 
pneumococci 
L. Hagberg, M. Rangaraju and S. Jenkins 
CofeboE, S: Romainvilk, F; Bridgwute& USA 
Objectives: Telithromycin, the first ketolide antibacterial to be approved for 
c h c a l  use, has been specifically designed to offer the ideal spectrum of 
activity for upper and lower respiratory tract infections, including those 
caused by resistant strains, with a short, well tolerated treatment regimen. The 
clinical and bacteriological efficacy of telithromycin were assessed in patients 
with CAP caused by Sfreptococnrs pneumoniae resistant to penicillin G (PEN) 
and/or erythromycin A FRY). 
Methods: Adult patients with a diagnosis of CAP (radiologically confirmed) 
received telithromycin 800 mg orally once daily for 7-10 days in one of six 
phase I11 clinical trials (n = 1373), or telithromycin 800 or 600mg once daily 
for 7days in a phase I1 study (n=96). Patients with S.pneumoniae as the 
causative pathogen were identified, with particular focus on those infected 
withPEN-and/orERY-resistantstrains (MICs/2.0and >l.Omg/L,respec- 
tively). Per-protocol (PP) clinical and bacteriological outcomes were assessed 
at a post-therapy visit (Days 17-21 in the phase 111 studies or at the end of 
therapy (Day 7) in the phase I1 study. 
Results: Of 191 patients with documented S. pneumoniae infection (single and 
mixed infections), 32 (16.8%) were infected with PEN- and/orERY-resistant 
strains. All isolates were susceptible to 5 l.Omg/L telithromycin. Patients with 
CAP due to PEN- and/or ERY-resistant S.pneumoniae showed high rates of 
clinical cure (87.5% [28/32]) and bacteriological eradxation (90.6% [29/32]). 
Corresponding clinical cure and bacteriological eradication rates for all 
pneumococci isolates were both 94.8% (181/191). A total of 9/47 patients 
with pneumococcal bacteraemia had PEN- and/or ERY-resistant mfections, 
with seven of these nine patients clinically cured with bacteriological 
eradication. 
Conclusion: Telithromycin is a highly effective empirical treatment for 
patients with CAP caused by PEN- and/or ERY-resistant pneumococci. 
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I P I  363 I Five-day therapy with telithromycin has good 
bacteriological efficacy against key respiratory pathogens in 
acute maxillary sinusitis (AMS) 
K. Roos, M. Rangaraju and S Jenlans 
CoteboT, S, Romainmlle, F, Bndgewater, USA 
Objectives: Telithromycin (TEL) is the first member of a new class of 
anttbacterials - the ketohdes - to undergo chmcal development and to be 
approved for c h c a l  use. It  has been spedically deagned to offer an 
optmal, well balanced spectrum of coverage m the treatment of respmtory 
tract infections, includmg those caused by resistant s t r a ~ ~ ~ s ,  wth  a well 
tolerated, short and rehable treatment r e p e n .  A pooled analysis of 
bactenologcal efficacy ofshort-course therapy wth  TEL agamst key respua- 
tory pathogens m panents wrth AMS from three phase 111 c h c a l  tnals is 
reported 
Methods: Adults (aged 213 years, n = 980) w t h  clmical signs and symptoms 
of AMS (radolwcally confirmed) received 5- or 10-day TEL 800 mg once 
dady (n = 608 and 372, respechvely) CaUSahVe pathogens were lsolated from 
sinus secrehon cultures PP bacteriologrcal outcomes were assessed at a post- 
therapy wit (Days 16-24) and classified as sahsfactory if the causahve 
pathogen was eradcated or presumed erahcated at thls wsit. 
Results: A total of 324 causahve pathogens for 5- and 10-day TEL (n = 225 
and 99, respechvely) were isolated &om 253 pahents m the bacteriologrcal PP 
populahon The most frequently isolated pathogens were S pneumoniae 
(n= 91), Haemophrlus intuenzae (n= 64) and Morarella ratanhalts (n = 18). 
The overall bacteriological eramcation rate was 196/225 (87.1%) for 5-day 
TEL and 90/99 (90 9%) for 10-day TEL Bactenal et;l&CahOn rates by key 
pathogen for 5- and 10-day TEL, respechvely, were 56/61 (91.8%) and 27/30 
(90%) for S pneumoniae; 14/16 (87 5% ) and 617 (85 7%) for S pneurnoniae 
wth  reduced suscephbhty to pemcdhii and/or erythromycin A 42/48 
(87 5%) and 14/16 (87.5%) for H injuenzae, 7/9 (77.8%) and 2/2 (100%) 
for b-lactamase POSihVe H rn$mzae, 13/14 (92.9%) and 3/4 (75.0%) for 
M cntanhalis, 19/19 (100%) and 4/4 (100%) for Staphy~ococcur a m s ;  2/2 
(100%) and 3/3 (100%) for Streptococcus pyogew.  
Conclusion: Short-duration therapy wth  TEL (800 mg) once dady for 5 days 
is effechve at eralcatmg key respuatory pathogens m AMS, mcludmg 
resstant strams. 
1 P1364 I Utility of an 800-mg dose of telithromycin for 
CAP caused by extracellular pathogens: a preliminary 
assessment by pharmacodynarnic modeling and Monte Carlo 
simulation 
G. L. Drusano and S L Preston 
Albany, USA 
Objective: Our objechve was to evaluate the frequency with whch an 800 mg 
once d a y  dose of tehthromycin attamed target AUC/MIC n h O S  for 
orgamsm eradlcahon and good clinical outcome 
Methods: A total of 354 panents w t h  CAP who had one or more plasma 
concentrahons determned for tehthromycm served as the populahon for a 
pharmacohehc analysis using BigNPAG A two-compartment open model 
w t h  a lag hme and wrth first-order input to and clearance h m  the central 
compartment was employed. Classlfcauon and Regression Tree (CART) 
analysis and logshc regression were employed to Irk exposure to outcome in 
a subset of CAP pahents wth a defined extracellular pathogen and outcome 
(nncrobiologcal outcome [MO], n = 72; c h c d  outcome [CO], n = 78). as 
well as an MIC to tehthromycm. A 2500-subject Monte Carlo simuhhon was 
performed with ADAPT 11. MIC &tribuhons for H inzuenzae (n = 276), S. 
pneumoniae (a = 337), and MornrCello catmhalrs (n = 102) were o b m e d  &om 
the PROTEKT database. 
R e s u k  The mean, median, mode, and $tandard dewahon values for serum 
clearance normahzed to b1omdabhty were 81.7, 63.6, 43.4, and 53.7L/h, 
respecavely After the MAP-Bayesian step, the observed-predcted plot 
demonstrated a best-fit h e a r  regression wth  an r of 0 88 (? = 0.77). CART 
analysis demonstrated breakpomt values for AUC/MIC of 2.93 for MO and 
4.25 for CO. These exposure variables were included in the final logshc 
regression models for both chntcd and mcrobiologd outcome. Monte 
Carlo sIm&hOn wth  expectation over the MIC dmmbuhons for the target 
pathogens demonstrated target atmnment rates (MO/CO) of >99.9/94.4% 
(H.  inauenzae), >99.9/>99.9% (S.pneumoniae), and >99.9/>99.9?/0 
(M. cataddis). 
Conclusion: Using Monte Carlo simdahon modehg, telithromycin at a dose 
of 800 mg once dady generates high probabilities for good mcrobiological 
and chical outcomes for common extracellular respiratory pathogens. These 
results will be bolstered by hamg an increased number of patients added to 
the analysis. 
Ip13651 Antimicrobial susceptibility of 1213 H. influenzae 
isolates against cefditoren and 10 other antimicrobials. A 
multicenter international study in South Europe (ARISE 
Project) 
F. Soriano, J. J. Granizo, P. Coronel, M. Gmeno, E. Rodenas, M. Gracia, 
C. Garcia and R .  Fernandez-Roblas 
Madrid, E 
Objective: A multicenter and international study to asses the in via0 
susceptibility of H. injuenzae against cefditoren, a cephem antibiotic, and 
10 other antimicrobials was carried out in South Europe (ARISE Project). 
Methods A total of 1213 H. injumzae strains were collected 607 &om Spain, 
448 from Italy, 129 from Portugal and 29 &om Greece between September 
2000 and March 2001 h m  adult patients (217 years) with respiratory tract 
infections (respiratory tract and blood samples). All the isolates were sent to a 
central Laboratory (Fundaci6n Jimtnez Dim, Madrid, Spain) where suscept- 
ibility test was performed by broth microdilution (Sensititre) following 
NCCLS recommendations. 
Antibiotic 
Pemcdhn 
Amonnhn 
Amox-clav 
Cefidtorea 
C e f a d r d  
Cefpuduame 
Cefiuuxnne 
Cefotaxlme 
Erythromycin 
Clarithmmycin 
Lev05oxacin' 
MIC range 
<0.0>28 
<0.12-232 
50.069 
~0.03-o.lz 
50.25-264 
50. 12-1 
50.12-16 
<0.OM.5 
<0.&216 
5 O . O i W  
<O.O&l 
0.5 
0.5 
025 
50.03 
16 
50.12 
0.5 
50.03 
2 
4 
<_0.06 
No. (%) susceptible strain 
3 
8 
1 
10.03 
32 
50.12 
2 
50.03 
4 
8 
20.06 
N.E. 
977 (80.5) 
1210 (99.8) 
1213 (100) 
N.E. 
N.E. 
1203 (99.2) 
1213 (100) 
N.E. 
1157 (95.4) 
1212 (loo) 
'Levofloxacin MIC was not correctly measured in one strain. 
Resultr: The results are shown in the table. Data are expressed in pg/mL.. 
Breakpoint is not estabhhed (N.E.) for penican, cefditoren, c e f a h d  and 
erythromycin. 
Conclusions: Cefdicaren mhibited 1206 (99.4%) s t r a m  by a concentration 
<0.03 pg/mL and 236 (19.5%) s t r a m s  were nonsusceptible to amoxicillin. 
Susceptibilty to clarithromycin was similar in Italy (95.8%), Greece (%.6%)), 
Spain (95.2%) and Portugal (94.6%). 
jP13661 In vitro susceptibility of 309 isolates of 
methicillin-susceptible 5. aureus (MSSA) against cefditoren 
and 10 other antimicrobials. A multicenter international 
study in Southern Europe (ARISE Project) 
R. Fernbdez-Roblas, J. J. Granizo, €? Coronel, M. Gimeno, 
E. Rbdenas, M. Gracia, E Santos and E Soriano 
Madrid, E 
Objetive: A multicenter and international study to asses the in vim suscept- 
ibility of MSSA against cefditoren, a cephem antibiotic, and 10 other 
antimicrobials was carried out in South Europe (ARISE project). 
Methods: A total of 709 SAMS strains were collected, 406 from Spain, 155 
from Italy, 74 each from Portugal and Greece between September 2000 
and March 2001 from adults patients (217 years) with respiratory tract or 
skin/soft tissue infections. All the isolates were sent to a central Laboratory 
(Fundaci6n Jimtnez Diaz, Madrid, Spain) where susceptibility test was 
performed by broth microdilution (Sensititre) following NCCLS recorn- 
mendations. 
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Results: Results are shown in the table. Data are expressed inpg/mL. 
Breakpoint IS not established (N.E.) for cefditoren and cefadroxil. 
in Italy (61.2%) and Spain (63.4%) than in Greece (70.6%) and Pomgd 
(84.3%). The prevalence oflevofloxacin resistance was low and occurred only 
in Spain (2.6%) and Italy (0.3%). 
Antibiotic Range of MIC MICIO MICw No. (%) susceptible strain 
Penicillin 50.03-28 28 2 8  70 (9.9) 
AmoxicilLin 50.12-232 8 232 54 (7.6) 
Amox-clav. 10.06-4 0.5 1 709 (100) 
Cefidtoren 50.03-2 0.5 0.5 N.E. 
Cefadmxil cO.25-32 4 4 N.E. 
Cefpodoxime 50.124 2 2 671 (94.6) 
Cefuroxime 50.12-232 1 2 708 (99.9) 
Cefotaxime 10.03-28 2 2 709 (100) 
Erythromycin <0.06-216 0.25 216 563 (79.4) 
Clarithromycin 20.062256 0.25 2256 573 (80.8) 
Levofloxacin jO.06-8 0.25 0.5 683 (96.3) 
N.E. not established 
Conclusions: All strains were inhibited by a cefditoren concentration of 
2pg/mL. No resistance to Amox-clav. and cefotaxime was detected. 
Resistance to macrolide antibiotics was similar (around 20%) and resistance 
to levofloxacin, cefjodoxime and cefuroxime was unusual (less than 
6%)). however, resistance to amoxicillin and penicillin were high (more than 
90%). 
[p13671 In vitro activity of cefditoren and 10 other 
antimicrobials against 877 5. pneumoniae strains isolated in 
Southern European Countries (ARISE Project) 
E Soriano, R. Fernindez-Roblas, €? Coronel, M. Gimeno, E. Rbdenas, 
M. Gracia and J. J. Granizo 
Madrid, E 
Objective: In order to describe the susceptibility of Spneumoniae against 
cefditoren, a cephem antibiotic, and 10 other antimicrobials, a multicenter 
study in South Europe was carried out. 
Methods: A total of 877 S. pneumoniae strains were collected, 459 &om Spain, 
312 from Italy, 89 from Portugal and 17 &om Greece between September 
2000 and March 2001 from adult patients (217 years) with respiratory tract 
infection (respiratory tract samples and blood cultures). All the isolates were 
sent to a central Laboratory (Fundacibn JimCnez Diaz, Madrid, Spain) where 
susceptibility test was performed by broth microdilution (Sensititre) following 
NCCLS recommendations. 
Results The results are shown in the table. 
Antibiotic MIC range MICm 
Penicillin 50.02-28 50.03 2 
Amoxicillin 50.12-16 - <0.12 2 
Amox-clav. 10.06-216 50.06 2 
Cefidtoren 50.03-4 50.03 0.5 
Cefadroxd <0.25-264 2 264 
Cefuroxime 50.12-232 50.12 8 
Erythromycin 50.06-216 50.06 216 
Clarithromycin $0.06-2256 50.06 2256 
Cefpodoxime 50 12-232 50.12 2 
Cefotaxime <0.0>>8 50.03 I 
Levofloxacin 10.06-216 1 1 
Data are expressed in pg/mL. Breakpoint is not established (N.E.) for 
cefditoren and cefadroxil. 
Conclusions: Cefditoren was the most active antibiotic tested (MICg0 = 
0.5 pg/mL), followed by levofloxacin and cefotaxime (MI%= 1 pg/mL). 
Penicillin susceptibility was lower in Greece (35.3%) and Spain (52.9%) than 
in Portugal (83.1%) and Italy (84.3%). Erythromycin susceptibility was lower 
m] In vitro susceptibility of 590 isolates of 
S. pyogenes against cefditoren and 10 other antimicrobials. 
A multicenter international study in Southern Europe (ARISE 
Project) 
J. J. Granizo, R. Fernadez-Roblas, €? Coronel, M. Gimeno, E. Rodenas, 
M. Gracia and E Soriano 
Madrid, E 
Objective: A multicenter and international study to assess the in vitro 
susceptibility of S.pyogenes against cefditoren, a cephem antibiotic, and 10 
other antimicrobials was carried out in South Europe (ARISE project). 
Methods: A total of 590 S.pyogenes s t r a i n s  were collected, 286 From Spain, 
278 &om Italy, 13 each from Portugal and Greece between September 
2000 and March 2001 h m  adult patients (>17 years) with pbaryngitis or 
sofz tissue infections. fill the isolates were sent to a central Laboratory 
(Fundacibn JimCnez Diaz, Madrid, Spain) where susceptibility test was 
performed by broth microdilution (Sensititre) following NCCLS recom- 
mendations. 
Results: The results are shown in the table. Data are expressed in pg/mL. 
Breakpoint is not established (N.E.) for Amox-clav., cefditoren and 
cefadroxil. 
Antibiotic Range of MIC 
Penicillin - <0.034.06 
Amoxlcillin 50.12-50.12 
Amox-clav. 50.06-<0.06 
Cefidtoren 50.03-<0.03 
Cefadroxd 5 0 . 2 5 4  
Cefpodoxime <O. 12-50.12 
Ceiiuoxime 50.12-50.12 
Cefotaxime 10.034.1 2 
Erythromycin <0.06->16 
Clarithromycin 20.06-1256 
Levofloxacin 0.12-2 
N.E. not established. 
M G o  
50.03 
50.12 
50.06 
50.03 
50.25 
50.12 
50.12 
50.03 
50.06 
50.06 
0.5 
MICw 
50.03 
50.12 
50.06 
50.03 
50.25 
50.12 
50.12 
50.03 
216 
16 
1 
No. (%) susceptible strain 
590 (100) 
590 (100) 
N.E. 
N.E. 
N.E. 
590 (100) 
590 (100) 
590 (100) 
461 (78.1) 
461 (78.1) 
590 (100) 
Conclusions: All strains were inhibited by a cefditoren concentration 
<0.03 pg/mL. No resistance to penicillin and levofloxacin was detected. 
Resistance to macrolide antibiotics was detected in Italy (32.0%), Greece 
(23.1%) and Spain (12.9%) but not in Portugal. 
In vitro activity of ketolide ABl773 against 
Listeria monocyrogenes and Coryneform bacteria of clinical 
interest 
L. Martinez-Martinez, M. C. Conejo, A. Pascual, A. I. Suirez and 
E. J. Perea 
Sm'lle, E 
Objectives: To evaluate the in vim activities of ketolide Al3T 773 (ABT), 
ampicillin (AMP), cefuroxime (CUR), ciprofloxacin (CIP), clindamycin 
(CLD), cotrimoxazole (SXT), erythromycin (ERY) and vancomycin 
(VAN) against L. monoqfogenes and coryneform bacteria strains isolated &om 
c h c a l  samples. 
Methods: Two hundred and eleven strains were evaluated, includmg: L. mono- 
qfogenes (15), Corynebacterium amycolatum (40), C. jeikeium (40), C. minutissi- 
mum (14), C.pseudodiphteriticum (12). C. strialum (40), C. urealyticum (40), and 
Rhodococcus equi (10). Organisms were idencified using API CORYNE strips 
and additional phenotypic tests when necessary. A microdilution assay using 
cation-adjusted Mueller Hinton broth (with 0.5% Tween 80 for C. jeikeium 
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and C. urealyticum was used. Plates were incubated aerobically at 35 "C for 24 h 
or in the case of C. jeikeium and C. urealyticum) for up to 48 h. 
Results: MIC50/MIC90 (mg/L) values against all 21 1 tested strains were 0.25/ 
>32 (ABT), 2/>64 (AMP), >128/>128 (ERY), >64/>64 (CLD), 4/>64 
(CUR), >16/>16 (CIP), >16/>16 (SXT) andO.S/l (VAN). MICW/MICw 
against L. monocytofmes were 0.015/0.015 (ABT), 0.5/1 (AMP). 0.25/0.5 
(ERY), 212 (CLD), >64/>64 (CUR), 1/4 (CIP), 0.015/0.03 (SXT) and 1/1 
(VAN). For the remaining species. MICSO/MIC~ of ABT, ERY and CLD 
were: 0.125/0.5, 16/128 and >64/64 (C. amycolatum), 1/>32, >128/>128 
and >64/>64 (C.jeikeium), 0.03/>32, 32/>128 and >64/>64 (C. minu- 
tiuimum), >32/>32, >128/>128 and >64/>64 (C.pseudodiphteriticum), 
0.125/>32, 8/>128 and >64/>64 (C. striatum), >32/>32, >128/>128 
and >64/>64 (C. urealyticum), and 0.03/0.5, 0.5/>128 and 4/>64 (R. eqrri]. 
Conclusions: All strains tested were inhibited by vancomycin at 2 mg/L. ABT 
773 was the most active compound of those herein evaluated against 
L. monocyfogenes. ABT was also the most active compound against C. amyco- 
latum and R. equi. ABT was more active tlm erythromycin and chdamycin 
against C. jeikeium, C. minutissimum, and C. shiatum. 
I P1370 I Synthesis and studies of bacteriostatic activity of 
5-aminothiazole 
T. Sakalova and N. Kravchenia 
G7Odn0, B L R  
Earlier we have synthesized diamides of dicarboxylic acids, amide components 
of which are 5-nitrothiazole on the one hand, and urea, biuret, benzolsul- 
phamides, triazol, on the other hand. All the above compounds exhibit 
bacteriostatic activity towards certain microorganisms (Khimicheskii i 
Farmakologicheskii Zhurnal, Vestsi AN Belarusi., 1993, no. 4, s. 61-63). 
For further studies of bacteriostatic activity qf amides and diamides of 
dicarboxylic acids, as well as for determination of structure-activity' relation- 
ship, we have synthesized a range of monoamides of 5-nitro- or 5-sulpho-2- 
aminothiazole; that of monoamides of 2- or 4-aminopyridines; as well as that 
of diamides of dicarboxylic acids, with their amide component being 5-nitro- 
or sulpho-thyazole-2-yl on the one hand, and 2-or-4-pyridyl on the other 
hand. Antimicrobial activity of the synthesized compounds was studied in 
vitro with the use of the method ofdouble series dilution in a liquid broth. For 
this purpose, approximately 50 various Gram-positive and Gram-negative 
microorganisms: S .  aureus, Badllw subtilis, Senatia marrhescens, E. coli, Proteus 
morganii, Micrococcus lisodeicticus, Staphylococctrs epidermidis, Shigella sonnei and 
others. These included strains obtained fbm patients (E. coliO26, S. aureuc 877 
st, S. epidermidis 994). Minimum inhtbitory concentration was expressed in 
mkg/mL. Nitazole was used as a comparison substance. The obtained data 
demonstrate that diamides of dicarboxylic acids containing a pyridine cycle 
possess at least the same bacteriostatic activity as nitazole or have a wider 
activity range. They inhibit growth of all microorganisms in concentrations 
30-240mkg/mL, diamides of azelainic acid turned out to be stronger 
bacteriostatics than nitazole 103 mkg/mL. All mono-(5-nitrothiazole-Z-y1) 
amides of dicarboxylic acids did not exhibit any more antimicrobial activity 
than nitazole in relation to all the microorganisms under study with the 
exception of E. coli K-12 240 mkg/mL. At minimum inhtbitory concentra- 
tion of less then 1000 mkg/mL, monopyridilamides proved to be inactive. All 
similar mono- and diamides of 5-sulpho-2-aminothiazole proved inactive 
too. Analysis of the obtained results makes it obvious that heterocycles 
function inadditively in the studied diamides. The diamides' bacteriostatic 
effect is due to synergic activity of heterocycles of thiazole and pyridine. 
Diacyl radical, too, provides insigdlcant effect. 
lm1 Comparison of daptomycin and vancomycin MIC 
results by DIN, NCCLS, SFM and SRGA methods for 297 
Gram-positive organisms 
L. Koeth, R. Leclerq and B. Olsson-Liljequist 
Westlake, USA; Cum, F; Solnu, S 
Objective: Daptomycin is a novel lipopeptide antibiotic with potent bacter- 
icidal activity against Gram-positive strains. Broth containing physiologic 
levels of free Ca2+ (50 pg/mL) is recommended for daptomycin MIC testing 
(a higher Ca2+ level than is used in most MIC methods. Validation of MICs 
using calcium supplemented broth or agar by various MIC methods is 
necessary. 
Methods: Daptomycin and vancomycin susceptibiltty of 297 Gram-positive 
organisms [50 each of S. auneus (SA), S. epidermidis (SE, Enferococnrsfaecium 
(EM), Enterococnssfaecalis (ES), S. pneumoniae (SP) and 47 viridans Sfreptococas 
(SV)] was determined by DIN using Isotonic broth (instead of Isosensitest 
broth), by NCCLS using Mueller Hinton broth, by SFM using Mueller 
Hinton agar fbrn three merent manufacturers and by SRGA using PDM 
agar. All media was supplemented to 50 pg/mL Ca2+, except for SFMl which 
was supplemented to 25 pg/mL Ca2+. Lysed horse blood was added to the 
media for all methods for streptococcus testing. NCCLS recommended QC 
organisms were tested on each day of testing. 
Results: All Q C  results were within expected NCCLS ranges. All vancomycin 
mean MICs were within f l  doubling dilution of one another. Daptomycin 
mean MICs (pg/mL) appear in Table 1. 
Table 1 
NCCLS SFMl SFM2 SFM3 SFM4 SRGA DIN 
SA 0.26 0.54 0.23 0.22 0.12 1.95 0.34 
SE 0.28 076 0.35 0.27 0.22 1.13 0.33 
EM 2.91 3.84 1.69 0.76 1.56 3.89 2.23 
ES 1.67 1.79 0.68 0.50 0.30 2.71 1.36 
SP 0.1 0.46 0.21 022 0.12 0.47 0.16 
SV 0.35 1.08 0.44 0.42 0.29 0.78 0.43 
ALL 0.49 1.06 0.45 0.40 0.27 1.44 0.54 
Conclusions: Isotonic broth, used in the DIN, is a valid aiternahve to 
Isosensitest broth for daptomycin testing. Modification of i n o d u m  prepara- 
tion for enterococci testing and additional calcium supplementation of lysed 
horse blood containing media may be required in order to accurately assess 
daptomycin MICs using SFM methods. Additional calcium supplementation 
of PDM agar used in the SRGA method is also recommended. 
/p13721 Ramoplanin is active against E. galrinarum 
isolates from neutropenic patients expressing van4 vanS 
and vanC resistance to vancomycin 
D. Jabes, A. Bulgheroni and R. Goering 
Gerenzano, I; Omaha, USA 
Objectives: Ramoplamn is an investigational agent for the prevention of 
bloodstream infechon due to vancomycm resistant enterncocci (VRE). Ths 
study reports on the prevalence and resistance genotypes of E galZimrurn from 
neutropemc pahents, and the comparahve achvlty of ramoplarun and gly- 
copepmdes. 
Methods: In an ongomg study, pahents expected to be profoundly neutro- 
pemc for at least 10 days are screened for the presence of VRE rn stools prior 
to enrolment. We report on 16 panents h m  7 study centen found to be 
colonised wth  E.gaZtiMnrtn. The isolates f b m  these paaents were genotyped 
(for u a d ,  B, C and 0) by mdhplex PCR and subjected to chromosomal 
hngerpnnang by puked field gel electrophoresis. 
Results: Various combmahons of van genes were found seven isolates had 
both van A and uanC genes present, two had both uanB and vanC, two had 
uanC only and two had uanA, vanB and uanC genes Three remam uni- 
denhfied The vancomycm MlCs for these orgatllsm ranged fbm 4 to 
128 mg/L, the hghest value being recorded for one of the two lsolates wth  
the uanB, uanC genotype. All lsolates of the uanA, uanC genotype had 
vancomycm MIC of 8 or 16mg/L, and those w t h  u a d ,  uanB and VanC 
had MIC of 8 mg/L. PFGE analysis showed panent-to-pahent transmssion of 
one genotype (mrul, uanC) at one study center. All tsolates oEE.gallmatum 
lsolated to dare were suscephble to r a m o p h  and as0 to teicoplamn. 
Conclusions: WMst ths study confirms that E . g a l l i m r n  can harbor and 
express vancomycin resistance genes other than uanC, the climcal relevance of 
h s  species in causing bloodstxean mfectlon m at-nsk pahents re- to be 
elucidated. 
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lp1373( Evaluation of the phannacokinetid 
pharmacodynamic (PWPD) features of 58-264128, a novel 
Pleuromutilin antibiotic, in rodent models of infection 
A. Gozzi, A. Parazzoli, P. Bianchi, R. Broggio, A. Zanoncelli, S. Braggio, 
B. M. Marturano and E. Di Modugno 
Verona, I 
Objectives: SB-264128 is a novel Pleuromutilin derivative characterized 
by good in vitro antimicrobial activity against respiratory tract 
pathogens such as S.pneumoniae (Sp) and H .  influenzae. The objective of this 
study was to investigate the pharmacodynamic activity of SB-264128 and to 
assess which PWPD parameter best correlates with in vivo antimicrobial 
efficacy. 
Methods: Single dose pharmacokinetics of SB-264128 were determined 
following subcutaneous (SC) dosing of 10, 50 and 200mg/kg in immune- 
competent mice (IC), and 50 mg/kg in immunosu pressed mice (IS). Thigh 
infection in mice was induced by injecting 2 x 10 cfu of Sp ATCC 10813 
into both thighs. Two hours post-infection ( p i )  SB-264128 was administered 
SC at dosages ranging from 10 to 400 mg/kgper day. Thigh bacterial load was 
determined 24 h p.i. Nonlinear regression analysis was used to idenhfy the 
PK/PD parameter that best correlates with cfidthigh at 24 h pi .  Pneumonia 
in IC mice was induced by intranasalinstillation of 5 X lo6 c h  ofSp BG1. SB- 
264128 was given SC over a dosage range of 10-400rng/kg per day starting 
6 h p.i. Lung bacterial load was assessed 24 b p.i. 
Resub SB-264128 was highly and rapidly absorbed after SC administration 
in uninfected IC mice, with C,, values of2486 and 12 453 ng/mL (0.25 h at 
10 and 50mg/kg, respectively, and 39018ng/mL (0.5 h at 200mglkg. PK 
profiles appeared linear within the dose-range tested. Calculated apparent 
half-lives were 1.1, 1.5 and 1.4h at 10, 50 and 200mg/kg, respectively. No 
s id icant  difference was found between the PK parameters of IC and IS 
mice. In an experimental thigh infection model, the antimicrobial activity of 
SB-264128 was found to be highly correlated with the time (fkee drug 
concentration) >MIC (Tf>MIC). Bacteriostatic effect was attained at a 
T,> MIC value of 9 and 30% in IC and IS animals, respectively. SB-264128 
also proved to be highly efficacious in a pneumonia model, with complete 
bacterial clearance at a Tf> MIC value of 25%. 
Conclusion: Dosing fkequency of SB-264128 was the major determinant of 
efficacy against Spneumoniae both in thigh and pneumonia infection models 
in mice. Consistently, TF> MIC was the PK/PD parameter that showed the 
best correlation with in vivo activity of SB-264128. Collectively these results 
suggest that the efficacy of SB-264128 is affected by the duration ofbacterial 
exposure to the drug rather than its concentration. 
P 
1 PI374 1 Comparative efficacy and safety of 
pharmacokinetically enhanced amoxicillin/clavulanate b.d. 
versus amoxicillin/clavulanate 875/125 mg t.d.s. in CAP 
J. Garau, M. Twynholm and E. Garcia-Mendez 
Barcelona, E; Harlow, UK; Madrid, E 
Objectives: The pharmacokinetically enhanced formulation of amoxkillin/ 
clavulanate (AMX/CA 2000/125 mg) was designed to achieve high levels of 
amoxicillin over the dosing duration to eradicate isolates of S. pneumoniaewith 
amoxicillin MICs up to and including 4mg/L. This study compared the 
clinical and bacteriological efficacy and safety ofAMX/CA 2000/125 mg b.d. 
vs. AMX/CA 875/125mg t.d.s. in the treatment oftypical CAP in adults. 
Methods: This was a randomized, double-blind, double-dummy, multi- 
center, parallel-group study conducted in Spain and Italy. Patients received 
eitherAMX/CA2000/125mgb.d. orAMX/CA 875/125mgt.d.s. orally for 
7 or lodays. 
Results: A total of 319 patients aged 18-94years received AMX/CA 2000/ 
125mg (158) or AMX/CA 875/125mg (161). At test of cure (TOC), Days 
1&39, clinical success in the clinical PP population (primary efficacy end- 
point) for AMX/CA 2000/125mg was 94.7% (108/114) vs. 88.8% for 
AMX/CA 8751125mg (1031116) (treatment ae rence  5.9; 95% CI -7.1, 
13.0). Clinical efficacy at end of therapy @OT, Days 8-17) in the clinical PP 
population was 96.0% (121/126) for AMX/CA 2000/125mg vs. 92.2% 
(1181128) for AMX/CA 8751125mg (treatment Merence 3.8; 95% CI 
-1.9, 9.6). Bacteriological success in the bacteriology PP population for 
AMX/CA 2000/125mg was 85% (17/20) at TOC and 91.3% (21/23) 
at EOT vs. 77.3% (17122) and 80.8% (21/26), respectively, for AMX/CA 
875/125mg. At TOC, three patients (includmg two with bacteremia) 
in the AMX/CA 2000/125mg group and one patient in the AMX/CA 
875/125 mg group with penicillin-resistant S. pneumoniae isolated at screening 
were clinical and bacteriological successes. Both agents were well toierated, 
with the fkequency of adverse events similar for AMX/CA 2000/125mg 
(62.0%) and AMX/CA 8751125 mg (57.8%); only 7.0 and 6.2% of patients, 
respectively, had adverse events lea- to withdrawal. 
Conclusions: AMX/CA 2000/125 mg b.d. was at least as effective clinically as 
AMX/CA 875/125mg t.d.s. in the treatment of CAP, with a safety profile 
similar to that of other M / C A  formulations. 
I P1375 1 Efficacy of a pharrnacokinetically enhanced 
formulation of amoxicillin/clavulanate against experimental 
respiratory tract infection in rats caused by H. influenzae 
V. Beny, C. Singley, J. Satterfield and G. Woodnutt 
Collegeville, USA 
Objectives: The efficacy of a novel pharmacokinetically enhanced formula- 
tion of amaxicillin/clawlanate (AMX/CA 16 : 1) was studied in experi- 
mental respiratory tract infection (RTI) in rats against H. infuenzue (BLA + 
and BLNAR). 
Methods: Rats were infected intrabronchdy. Therapy began 24 h later to 
simulate in the rat serum levels following human oral dosing of AMX/CA 
2000/125mg (16 : 1 b.d.), M I C A  875/125 mg (7 : 1 t.d.s., b.d.), AMX/CA 
1000/125 mg (8 : 1 t.d.s.), azithromycin (AZI) 1000/500 mg (0.d.) and 
levofloxacin (LEV) 500 mg (0.d.). Therapy continued for 3 days; 14 h after 
therapy the rats were killed and the lungs removed for bacterial enumeration. 
Results: AMX/CA 16 : 1 was highly effective against RTI caused by H .  
influenzae HI28 @LA+, M I C A  MIC 1.0/0.5 mg/L), reducing bacterial 
numbers by 41og compared with controls (2.0f0.7 vs. 6 .4 f  0.610g[10] 
cfu/lungs, respectively; P I  0.01. The effect achieved with AMX/CA 16: 1 
was sunilar to AMX/CA 7:1 b.d., AMX/CA 8 : l  t.d.s., AMX/CA 7 : l  
t.d.s., AZI and LEV (2.0f0.8, 2.1&1.0, 2.8f1.3, 3.2f1.7 and 
<1.710g[10] cfu/lungs, respectively; 02 0.05. Following infection with 
H. influenzae Chesterfield (BLNAR, AMX MIC 4.0mg/L), AMX/CA 
16: 1, AMX/CA 7: 1 t.d.s. and AMX/CA 8 :  1 t.d.s. produced a marked 
effect, reducing bacterial counts by 3log compared with controls (3.1 f 0.9, 
3 .6 f  1.1, 3 . 8 f  1.3 vs. 6.7 fO.6log[lO] cfdlungs, respectively; P< 0.01). 
AMX/CA 7: 1 b.d. was less effective (5.1 f0 .9 ;  PsO.05 vs. controls; 
P <  0.01 vs. AMX/CA 16 : 1). AZI produced a marginal effect with bacterial 
counts 1-1.5 log lower than controls, even though the AZI MIC was 2 mg/L 
for this strain (5.8fl.llog[lO] cfu/lungs; PsO.05). AMX/CA 16: 1 
showed sigdcant improvements in efficacy compared with AZI ( P S  0.01). 
Conclusions: These data indicate the potential benefit ofAMX/CA 16 : 1 b.d. 
compared with existing therapies and support a susceptible breakpoint for this 
formulation of 24.0 mg/L. 
lp13761 XOB: a novel, orally absorbed, inhibitor of Class 
A and C plactamases 
C. E. Jamieson, I? A. Lambert and 1. N. Sipson  
Birmingham, Cambridge, UK 
Background: jf-lactamase production is the principal mechanism of resistance 
to penicillins and cephalosporins. Existing jf-lactamase inhibitors are generally 
ineffective against Class C f&lactamases and/or are not orally available. 
Oxapenem XOB has the potential to fill this clinical niche. 
Methods and results XOB inhibited all 8 (TEM-1, TEM-10, SHV-5, P99, 
S2, S & A, OXA-1 & OXA-5) cell-tiee j?-lactamases (spectrophotometric 
may), with values of <0.001~.003mg/L, whereas ICsos for clavulanic 
acid were >3mg/L against Class C and D jf-lactamases. In MIC tests 
(NCCLS guidelines) against 36 nonfastidious isolates many producing high 
levels of Class A, C or D jf-lactamases. XOB enhanced ceftazidime activity 
against all species tested except E aemginosa and E.fuecafi5. XOB possesses little 
intrinsic antibacterial activity (MICs > 8mg/L) against nonfastidious species 
but, at 8 mg/L, causes filamentation in E. coli. XOB exhibited similar DHP 
stability to meropenem (>95% stability over I h at 37 "C),  and peak serum 
levels of 5.3 and 16.2 mg/L following oral and SC administration at 50 mg/kg 
in mice. 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 323 
Conclusion: XOB has the potential to become the first B-lactamase inhbitor 
to be developed for oral and parenteral admhstration agamst organism 
producing Class A, C and D B-lactatnases. 
Contributions to the study of cellular activity of 
some polyacetate carbohydrates 
T. Oita, I. Oita and M. I. Lazar 
hi, RO 
Objectives: Latest 20yean are characterized by the introducing in therapy of 
many new molecules. Polyacetates carbohydrates such as a-D-glucose pen- 
taacetate, D-sorbitol hexaacetate, 0-mannitol hexaacetate are chemically well 
known, but their cellular properties are less known. We intended to v+ if 
these substances possess bacteriostatical or bactericide properties against some 
microorganisms and also we intended to study if these substances possess 
mutagenic properties. 
Material and method In our study, we used following substances: 
a-D-glucose pentaacetate 99% &om Aldrich; 
D-sorbitol hexaacetate 97% from Aldrich; 
D-mannitol hexaacetate from Aldrich; 
four series of mannitol hexaacetate we synthesized, and characterized from 
All reagents were European Pharmacopoeia or USP grade. In order to vellfy 
microbiological properties we tested the activity of substances mentioned 
above on following microorganisms: E. coli (IP52166), S. aurew (ATCC 
9144), I! aeruginosa (IP5842), B. subtilis (ATCC 6633), C. albicans (IP 
4872), S. cereuisiae (ATCC 2601) and Aspegillw niger (ATCC 16604). We 
added the substances as microtablets and we measured the inhibition zone. 
Mutagenic activity was tested using Fedgen method. We colored in violet red 
the genetic material &om Secale sp. with Schiff reagent. The Secale sp. seed 
were incubated with different concentrations ofsubstances mentioned above. 
As a blank we used distilled water. After young plants raised, we roped 1 cm 
&om the superior regions of leaves and first prefixed and then we fixed the 
coloration of genetic material. In order to assure the maximum spirallyzation 
of chromosomes we kept some samples at 4 "C between 12 and 24 h and some 
we treated with a colchicine solution 2 h. We have fixed the color 5 min with 
Bataglia solution (a mixture of ethanol, chloroform, glacial acetic acid and 
formaldehyde solution in a 5 : 1 : 1 : 1 : 1 ratio). After that we washed the 
samples 5 min at room temperature with a normal solution of hydrochloric 
acid, and we hydrolyzed the samples 10-12min with a 50% solution of 
hydrochloric acid. The color of chromosomes was obtained by immersing in 
Schiff reagent at  room temperature. 
Conclusions: The tested substances have some microbiological properties and 
have no mutagenical properties against the DNA &om &ale sp. 
purity point of view. 
Lp1378/ AM-112 (PFOB): chemistry and biological activity 
of a novel, broad spectrum, plactamase inhibitor 
I. N. Simpson, C. J. Urch, C. E. Jamieson and P. A. Lambert 
Cambridge, Birmingham, UK 
Introduction: Current 8-lactamase inhbitors are effective against B-lactam 
resistance mediated by Class A but not Class C 4-lactamases. This report 
describes the chemistry and biological activity ofAM-112, an oxapenem with 
potent activity against both Class A and Class C B-lactamases. 
Methods and results: AM-I 12, prepared using a convergent 7-step synthesis. 
Its stability to hydrolysis by porcine dehydropeptidase is similar to merope- 
nem. AM-112 inhibits cell-&ee Class A, C and D 8-lactamases (TEM-1, 
<0.001-0.003 mg/L. AM-1 12 possesses antibacterial activity (MIC against 
S. aureus (0.5-2 mg/L), penicillin-susceptible Spneumoniae (<0.5 mg/L) and 
M .  catanjUrlis (<0.5mg/L). AM-I12 synergises with cephalosporins, mark- 
edly enhancing their activity against Enterobacteriaceae isolates producing 
htgh levels of characterized 1-lactamases and producing unexpected synergy 
against j3-lactamase negative enterococci. Following i.v. administration at 10, 
50 and 100 mg/kg, AM-1 12 exhibits similar pharmacohetics to ceftazidime 
in mice and rats. in animal models of infection, AM-112 complements 
ceftazidime activity against S. aureus and enhances ceftandime activity against 
E. cloacae P99 and E. coli SHV-5. 
Conclusion: AM-112 has the potential to markedly increase ceftazidime 
efficacy in the treatment of serious mfections (Fig. 1). 
TEM-10, SHV-5, P99, S2, S & A, OXA-1 & OXA-5) with ICSo value of 
Figure 1 
I P1379 1 Clearance of moxifloxacin during continuous 
hemofiltration in vitro 
K. Itmer, G. Roth, M. Bucher, H. Grobecker, E Kees and K. Taeger 
Regembug, D 
Backgroundlaims: Moxifloxacin is a new 8-methoxy-Buoroquinolone with 
broad-spectrum Gram-positive and Gram-negative activity. Mean renal 
clearance was between 24 and 53 mL/min after administration of both the 
single oral and i.v. formulations. [l] The clearance of moxilloxacin was 
unaltered in the presence of renal insufficiency following single oral doses in 
one study, [2] suggesting lack of need for dose adjustment. However, 
moxdloxacin has not been studied during continuous hemofiltration. Aim 
of this in vitro study was to determine the clearance of moxifloxacin during 
continuous hemofiltration. 
Methods: Continuous hemolkration with the following condxtions: 
1000 mL of human blood (600 mL) washed human erythrocytes, 200 mL 
human albumin 20?/0, l O O m L  Ringer solution, 100 mL NaHC03, pH 7.35, 
hematocrit 41 was enriched with 8% m d o x a c i n  and was hemofiltrated 
(blood pump: HF Edwards BM 11, post-dilution hemofiltration system with 
SH-Bic 35 filtration solution, hemoflter: Hospal Multdow 100, blood flow 
100mL/min, turnover 2000mL/h); samples before filter, after filter, filtrate 
(min): 0, 5, 10, 15, 20, 25, 30, 40, 50, 60; determination of moxifloxacin: 
HPLC; determination of clearance, sieving coefficient: Excel 7.0. 
Results: Under these hernofiltration conditions in vim we found a clearance 
of 20 d / m i n  and a sieving coefficient of 0.9. 
Conclusion: During continuous hemofiltration in vim with a blood flow of 
100 mL/min and a turnover rate of 2000 mL/h we found a nearly normal 
clearance. This finding would suggest a lack of need for dose adjustment 
under these hemofiltration conditions and a normal hepatic function. The 
high sieving coeficient would suggest that moxifloxacin is filtered nearly as 
bee as creatinine and therefore independently of the blood protein 
concentration. Following investigations with variations of hemofiltration 
conditions, protein concentrations and real clinical situations have to prove 
this hypothesis. 
References 
1 S w  H. Kubma D. Pharmacohnetics and elimination of rnodtloxacin &cr o d  and inuavcwur 
2 Balfour ]A, Whernan LR, Moxifloxacin. Dugs 1999, 57 (3): 36S73. 
admiiiirnation in mn.j.  Antiminob Cl-the 1999; 43 (Suppl. B): 8590. 
Lp13BoI safety update of oral moxifloxacin: a review of 
worldwide post-marketing surveillance 
H. Lode, R. Kubm and C. Reiter 
Bnlin, Wuppevtal, D 
Introduction: Modoxacin (MXF), a new 8-methoxy fluoroquinolone, has 
been shown to be effective and safe for the treatment of respiratory tract 
infections in controlled clinical studies. Recently compiled safety data f b m  
oral post-marketing surveillance are reviewed. 
Methods: An analysis of one large phase IV safety study and of two large post- 
marketing safety observational studies (PMOS) was performed for the 
incidence of adverse drug reactions (ADR), and to put this in perspective 
to the data generated during preauthorization clinical trials. Data are also 
reported for the >7.2 million patients as of August 2001 who have been 
prescribed MXE 
Results: Post-marketing safety surveillance studies and clinical trial AD% and 
serious ADRs (SADRs) for oral moxifloxacin were as in the table. 
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Tnals No. %. ADR SADR Most ti'equentADR3 
30 Cliniczl vailr 7368 25% 0.5% 7% Nausea, 5% diarrhea. 3% dizziness 
Phase IV study (USA) 18374 14.3% 0.1% 5.3% Nausea, 2.2% diarrhea, 2.096 dllzlnsr 
PMOS cornunity 16007 2% 0.2% 0.5% Nausea. 0.4% diarrhea, 0 2% dizziness 
PMOS hospital 2188 3% O.% 1% Dimhea, 0.296 rash, 0.1% nausea 
(Germany) 
(Germany 
The ADR frequency in the post-marketing studies conducted under'real 
world conditions was much lower than in the controlled clinical trials. There 
was no evidence for significant cardiac events potentially related to QT 
prolongation in the safety surveillance studies involving 36 569 patients. As of 
August 2001, Bayer has received from worldwide sources a total of 1979 
spontaneous ADRs on the background of 7.2 million patients exposed. There 
were three confirmed cases of Torsades de Pointes (TdP) reported for these 
7.2 million patients, all confounded by multiple arrhythmogenic factors (e.g. 
coexisting heart disease, electrolyte disturbance and concurrent medications). 
The incidence of 2.1 cases/100000 patient years TdP seen with M X F  
treatment is similar to the background rate (four cases/lOO 000 patient years). 
Only rare (<O.OOl%) reports ofMXF-induced tendon rupture, convulsion or 
severe hepatic events have been noted. No new ADRs have been detected 
from the post-marketing safety data unknown to the class of newer fluor- 
oquinolones. 
Conclusion: MXF is as safe and well tolerated as other commonly prescribed 
antibiotics. 
I P1381 I Moxifloxacin lung penetration after repeated 
oral and i.v. administrations of 400mg once daily dose 
D. Bredh, J. Jougon, M. Munck, D. Ducint, J. Veuy, V. Landreau, F'. Arvis 
and M. Saux 
Bordeaux, Puteaux, F 
Objectives: Pharmacokinetic of moxi9oxacin in plasma and lung tissue at 
steady state (400 mg) 0.d. was studiedin 48 patients (24 i.v. and 24 oral) subject 
to lung surgery for bronchial carcinoma. 
Methods: Mean (fSD) characteristics of the patient population were: 
age= 67.14 (f7.87) years, weight =75.45 (f12.63) kg and creatinine 
clearance = 68.34 (3~10.65) mL/min. Plasma samples (two for each patient) 
and lung samples (one for each patient) were obtained and analyzed by a 
validated HPLC assay with UV detection. To determine lung/plasma con- 
centration ratios, one plasma sample was drawn simultaneously with a lung 
sample. In total, 12 groups, 6 for i.v. and 6 for oral were made according to the 
time of sampling after the last administration (fifth) of moxifloxacin to obtain 
pharmacokinetic steady-state: 1 h (n = 4). 2 h (n = 8). 3 h (n = 8). 8 h (n = 4), 
9 h  (n=4), 12h (n=4), 24h (n=8) and 36h (n=8). 
Results: Results are presented for i.v. and oral administrations. respectively. 
The lung/plasma concentration ratios were calculated in each group and 
ranged tiom 1.32 to 3.31 and h m  2.64 to 5.96. The mean (fSD) lung/ 
plasma ratios were 1.97 (k0.74) and 4.33 (f1.35). Minimum mean (fSD) 
steady state lung concentrations were 1472 (k447) ng/g and 1731 (+636) 
ng/g. Mean (fSD) maximum steady state lung concentrations were 7706 
(3~2435) ng/g and 14965 f 2704 ng/g and were reached rapidly, 1 and 3 h 
after last administration. Respective mean (fSD) maximum steady state 
plasma concentrations were 6754 (f2416) ng/mL and 2919 (f550) ng/mL. 
Times to obtain these concentrations were 01.52 and 3h. The terminal 
elimination half-lives in lung tissue were 10 and 12 h during the periodof 12- 
24h. Mean concentrations ratios are time dependent and interindwidual 
variabdity is higher for oral than i.v. administration. 
Conclusions: These results indicate that a dosage regimen of 400mg moxi- 
floxacin given once daily provides excellent lung penetration as evidenced by 
the minimum steady state lung concentrations and steady-state moxifioxacin 
concentrations @ung/plasma) ratios and moxifloxacin therefore is a good 
choice for the treatment of lower respiratory tract infections. 
I P1382 1 In vitro release of moxifloxacin from a new type 
calcium phosphate bone cement (Norian) 
K. Athanassiou, F! Grecka, I. Lazaretos, G. Koratzanis, 
K. Kanellakopoulou and H. Giamarellou 
Athens, GR 
Objective: Norian skeletal replacement system (NSRS) is a novel injectable 
calcium phosphate cement proposed for the structural augmentation of 
regions of cancelous bone after hctures (Elder et al. 1 Orthop Trauma 
2000,14: 386). The present study aimed to the in vim release of moxifloxacin 
f b m  NSRS in order to investigate its enrichment with modoxacin as a 
means to surgical prophylaxis. 
Methods: Five grams of NSRS was mixed by 1003 ratio to modoxacin at 
room temperature. After solidification it was placed in the bottom of a 
cylindrical vial. Five replicates were prepared. One mL of Mueller Hinton 
broth was added over the kee surface of the mixture and left to 37 "C. Broth 
was replaced daily for 1 month (Days 1-28). Concentrations of moxiflomcin 
in broth were determined by a microbiological method using B. su6tilis 66 633 
as an indicator strain. 
Results: Mean concentrations of modoxacin of five vials after 1 h was 
173.5pg/mL, after 1 day 168.2pg/mL.. The latter concentration ranged 
between 81.3 and 98.4 pg/mL on days 2-5, between 10.9 and 19.6 pg/mL on 
days 6-9, between 18.6 and 37.4 p g h L  on days 1G20 and between 38.8 and 
55.8 pg/mL on days 21-28. Highest means of 98.4 and 55.8 pg/mL were 
detected on days 2 and 21, respectively. 
Conclusions: Enrichment of NSRS with modoxacin is accompanied by 
its slow release over 28 days at concentrations adequately above the MICs of 
the commonest Gram-positive cocci implicated in bone infections. Supple- 
mentation of NSRS with moxdoxacin may be proposed in surgical 
prophylaxis. 
Faropenem 
1 PI383 1 Comparative activities of faropenem and 19 
antimicrobials against 200 penicillin-susceptible and 
-resistant streptococcus pneumoniae isolates recovered 
from two Spanish hospitals 
J. Lmares, M. Morosim, E Tubau, E. Loza, M. Dominguez, R. Martin, 
E Baquero and R. Canton 
Barcelona, Madnd, E 
Objectives: (1) To compare the activities offaropenem, an oral penem, to that 
of 19 antimicrobials against 102 invasive and 98 non-invasive clinical 
isolates of S. pneumoniae consecutively obtained from adult patients from 
October 2000 to June 2001 in two Spanish hospitals. (2) To characterize 
the macrolide-resistant phenotypes. (3) To analyze the serotypes most fre- 
quently isolated. 
Methods: The in vitro studies were performed by microdilution method 
(SensititreTM). The genes ermB, ermTR and mefA were detected by PCR. 
Results: MIC,, and MIC9" (pg/mL) of 20 antimicrobials against 200 isolates 
and percentage ofresistance (R) according to NCCLS criteria were: p e n i c h  
(PEN) <0.03/4 (15% I, 25% R), ampicillin <0.25/4 (NC=no criteria), 
amoxicillin-clavulanate <0.5-0.25/4-2 (5% I, 7% R), cefuroxime <0.5/8 
(2% I, 30% R), cefotaxime <0.06/1 (17% I ,  7% R), cefepime <0.5/>2 (12% 
I, 16% R), imipenem <0.12/0.5 (18% I, 9% R), faropenem <0.03/0.5 (NC), 
erythromycin (ERY) <0.25/>32 (29%R), azithromycin <0.5/>4 (29% R), 
josamycin <0.5/>2 (NC), clindarnycin (CLI) <0.25/>1 (28%R), quinu- 
pristin/dalfopristin <1/<1 (0% R), tetracycline (TET) <2/>4 (2% I, 
33%R), chloramphenicol (CHL) <2/>8 (14%R), cotrimoxazole (SxT) 
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<0.5-9.5/>2-38 (15% I, 35% R), vancomycin 0.5/0.5 (O?? R), teicoplanin 
<0.25/<0.25 (0% R), ciprofloxacin 1/2 (NC) and levofloxacin 1/1 (0.5% I, 
1% R). The percentage of antibiotic R was hlgher in non-invasive than in 
invasive pneumococci: PEN 50% versus 30%, ERY 38% versus 23%. CLI 35% 
versus 22%. TET 44% versus 26%, CHL 18% versus 10% and SxT 54% versus 
46%. No antibiotic susceptibility differences between the two hospitals were 
found. Among all isolates studied, 58 (29%) were positive for ermB gene and 
resistant to all macrolides and CLI (MLS-B phenotype), and one s t r a i n  (0.5%) 
showing M phenotype was positive only for mefA gene. The most frequent 
serotypes found among invasive strains were 14 (12%), 19 (ll%), 9 V (8%), 
3 (7%), 1 (7%), 4 (7%), 7 (5%), 8 (5%) and 6B (5%). 
Conclusions: In recent years, 40% of strains in Spain have decreased suscept- 
ibility to penicillin and 29% have shown resistance to >3 antimicrobials. The 
majority of multiresistant strains were positive for ermB gene. Faropenem was 
the most active p-lactam studied, inhibiting 96.5% ofstrains at  concentrations 
less than or equal to 0.5pg/mL. This antimicrobial could be effective in 
treating infections caused by pneumococci including those with acquired 
macrolide resistance. 
for the presence of p-lactamase before MICs were deterrmned for faropenem 
(FAR), ampicdm (AMP), amaxy&n/clavulanate (AMC), clarithromycin 
(CLA) and levofloxacm (LEV) using the NCCLS rmcrobroth ddution 
method. 
Results: The vast majority of the isolates (95%) were nontypeable. Of the 
remauung encapsulated bacterta, the majonty were either serotype b (1.7%), 
serotype f (1.2%) or serotype a (1.1%). The predormnant biotype was biotype 
I1 (46.8%), followed by biotype 111 (27 0%) and biotype I (14.6%). 
B-Lactamase was present m around 20% of the H. rnjuenzae AU 8-lacta- 
me-posihve lsolates were reastant to AMP but suscephble to AMC. FARs 
acnvlty was unaffected by the presence of 8-lactamase. The achvity of each 
anhbmtic remamed fauly constant urespechve of biotype or serotype 
(although assessment of the less-common biotypes and semtypes was &cult 
because of low numbers) A summary of the aChylhes of the test anhbiotics 
aganst all 1122 isolates 1s shown m the table 
)p13841 Comparative in vitro activity of faropenem 
against community-acquired respiratory pathogens 
E. Tonoli, G. Dho, A. M. Schito, E. A. Debbia and A. Marchese 
Genoa, I 
Objectives: The increasing prevalence of antibiotic-resistance among respira- 
tory pathogens documented worldwide, poses major therapeutic problems. 
The purpose of the present study was to evaluate the in vitro activity of 
faropenem, a new oral carbapenem, against a large collection (600) of well- 
characterized respiratory pathogens circulating in Italy. 
Methods: A total of 360 S. pneumoniae (including 50 penicillin-intermediate 
and 40 penicillin-resistant) 100 S. pyogenes, 70 H. injuenzae (20 8-lactamase- 
positive) and 70 M. catarrhalis (50 j3-lactamase-negative) have been studied. In 
addition to faropenem, ampicillin, amoxicdin, coclavulanate, cefador, cefur- 
oxime, clarithromycin, azithromycin, clindamycin, levofloxacin, tetracycline, 
cloramphenicol and rifampin have been tested on the appropriate pathogens. 
MICs have been obtained by a broth microddution method (NCCLS, 2001). 
Results: Against penicillin-susceptible S. pneumoniae, in term of MIC90, 
h p e n e m  was the most potent drug tested (MICw O.O15mg/L). The 
MICw values of the other compounds ranged horn 0.03 mg/L (amoxicillin) 
to 32 mg/L (azithromycin). Faropenem showed good activity against peni- 
cillin-intermediate (MI&, 0.25 mg/L) and penicllltn-resistant (MICW 1 mg/L) 
strains, with MIC values h m  4- to >64-fold lower than amoxicillin, 
coclavulanate, cehroxime, cefaclor, clarithromycin, tetracycline and chlor- 
amphenicol. Towards erythromycin-resistant S. pyogenes. showing MLSB, 
iMLSB and M phenotype, faropenem 0.03mglL) was the most 
active drug followed by ampicillin, levofloxacin, chloramphenicol, and 
tetracycline (MIC9, values ranging h m  0.06 to >64mg/L). Against 
/?-lactamase-positive and -negative H. in$14enzae, fampenem showed MICW 
of 1 mg/L, whereas of the other drugs ranged fiom O.O6mg/L 
(levofloxacin) to 32 mg/L (cla&hromycin). Agamst p-lactamase-negative 
and positive M.cafanhaiis, faropenem showed MICgo of 0.03 and 
0.5mg/L, respectively, the MICw of the other antibiotics varying h m  
0.015 mg/L (dampin) to 16 mg/L (cefaclor). 
Condurion: Faropenem confirms a broad and potent in vim activity against 
all major respiratory pathogens analyzed, irrespective of their resistance 
patterns, and may therefore play a role in the treatment of comunity- 
acquired infections. 
I PI385 I The activity of faropenem and other oral 
antibacterial agents against biotyped and serotyped recent 
clinical isolates of Haemophilus influenzae 
I. Momssey, D. Farrell, A. Leakey, L. Vdjoen and D. Fehngham 
London, UK 
Objectives: Faropenem is a new oral penem anhbiohc currently bemg 
inveshgated for the treatment of community-acqulred respiratory tract mfec- 
hOnS In h s  study, we inveshgated the m wtro actmty of faropenem and other 
oral anhbacterd agents awnst H in@w-tzae. 
Methods A collectlon of 1122 recently Urculamg c h c a l  lsolates 
were used. These lsolates were fully biotyped and serotyped and assessed 
MIC (mg/L) F A R  AMP AMC CLA 
MIC5o 0.25 0.25 0.5 8 
MI& 1 >16 1 16 
MIC range 0.0- <0.12->16 <0.12-8 <0.12->64 
Conclusions: FAR showed good activity against H. injuenzae with MIC 
values similar to AMC. CLA activity was borderline with MICSO just at the 
susceptible NCCLS breakpoint (8 mg/L). These data confirm the potential 
role of FAR in the treatment of respiratory tract infections. 
Ip1386j In vitro activity of faropenem against Gram- 
negative pathogens 
A. Bauernfeind, I. Schneider and A. Dalhoff 
Munich, ffippertal, D 
Background: Treatment of Gram-negative bacterial infectom with oral 
8-lactams may be impaired by resistance due to hydrolysis by class A and 
class C 8-lactamases. Faropenem daloxate is a novel penem antibiotic, which is 
rapidly hydrolyzed after oral administration to the active drug constituent 
faropenem (FAR). 
Objective: To determine the in vitro activity of FAR against a variety of 
Gram-negative pathogens including strains producing defined 8-lactamases. 
Material and methods: A totaI of 1282 clinical isolates were analyzed for their 
MICs by an agar dilution procedure following NCCLS standards. 
Results: The organisms are grouped by their MICw (mg/L) for FAR: 
MICw 5 1: E. coli AMP 5 8, E. coli AMP > 8,  K. pneurnoniae CAZ < 2, 
K. oxytoca CAZ < 2, Shigella spp., Salmonella spp., X enfmcolitica, A. hydm- 
philia, Rpickeffi i ,  C. jejuni, H .  pylon', B. ratanhalis AMP > 0.25 (producing 
BRO-1 or BRO-2). N.gonodoeae PEN < 4, N.gononhoeae PEN > 8, 
H. injuenzae AMX < 8; MICw = 2-4: E. coli CAZ > 2*, K .  pneumoniae 
CAZ > 2'. K. q t o c a  CAZ > 2' ('producing defied Extended Spectrum 
or AmpC type p-lactamases), E. mgenes, I? agqlomeranr, C.freundii, C. divs, 
H. alvei, I? mirabilis, I? vulgaris, I? retfgm", I? sfuarrii, M. morganii, H. injuenrae 
AMX > 8; MI% = 8-32: E. cloacae, S. mamcens, S.  liquejkiens, A. xylosox- 
idans, B .  cepacia complex; MICw = 2 256: l? aemginosa, P~uorescens, Ppulida, 
Psfutzeri, S. maltophiliu. FAR is active against pathogens producing broad 
spectrum, extended broad-spectrum and Amp C type j3-lactamases. 
Conclusion: Given the in vim activity of F A R  against Gram-negative 
pathogens and its marked j3-lactamase stability, we conclude that FAR 
warrants further investigation for the treatment of community-acquired 
infections. 
In vitro aahrity of faropenem against Gram- 
positive pathogens 
I. Schneider, A. Bauernfeind and A Dalhoff 
Munich, Wupperfal, D 
Background: Therapy of infechons caused by Gram-posihve organisms with 
oral 8-lactams is impared by low &mty to pemcillin bmdmg protems or by 
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penicillinases. Faropenem daloxate is an oral penem, which rapidly hydrolyzes 
in vivo to the active drug constituent faropenem (FAR). 
Objective: To explore the potential spectrum of activity of FAR against 
Gram-positive pathogens including penicillin and oxacillin-resistant 
strains. 
Material and methods: A total of 676 clinical isolates were analyzed for their 
MICs by an agar dilution procedure following NCCLS standards. Drugs 
studied FAR, penicillin (PEN), oxacdlin (OXA). 
Results: The table above contains organisms (no. of strains tested), stran 
characteristics and concentrations of FAR at which at least 90% ofthe strains 
were inhibited. The majority of organisms were susceptible at MI& of 
0.25 mg/L or below; MICw of 0.5 or 1 mg/L were found only for Liste~ia spp. 
or PEN-resistant S,pneumoniae. FAR resistance was detected only for OXA- 
resistant staphylococci and enterococci. 
FAR MICw, (rng/L) 
0.5 64 
PEN50.06 !Alma 'pp. (14) S. eppldenntda (20) OXA > 4 
1 256 
S.pnemanwe (15) PEN >0.5 S ~UILUI (35) OXA > 8 
OXA > 8 S k a n d y i i m  (18) 
OXAS2 4 >256 
OXAS2 Efim/;s  (100) E /&"In (40) 
om52 
om52 
om52 8 
OXAS2 S.nlpwphylimr(17) OXA>2 
OXAS2 
PEN 0.1M.5 
Conclusion: The in vitro activity of FAR against Gram-positive pathogens 
suggests that FAR warrants clinical investigation as an oral treatment for 
community-acquired infections. 
Lp1388/ Comparative in vitro activity of faropenem, a 
new oral penem, against recent respiratory tract isolates 
recovered from outpatients in Germany 
M. Kresken, S .  Bagel and J. Brauen 
Bonn, D 
Objectives: Faropenem (FAR) is a novel oral antibiotic with a penem 
structure, unique from carbapenems and other avdable fl-lactams. It is 
characterized by potent antimicrobial activity against both Gram-positive 
and Gram-negative bacteria, including 8-lactamase-producing strains. We 
have evaluated the current susceptibilities of respiratory-tract isolates from 
outpatients to FAR in comparison to 11 other commonly used antimicrobial 
agents. 
Methods: Organisms were recovered in five geographic areas in 
Germany during October 2000-April 2001. Minimal inhibitory concentra- 
tions were determined using the broth microddution method according to 
NCCLS in a central laboratory. The antimicrobials studied were: FAR, 
telithromycin (TEL), penicillin (PEN), amoxicillin (AMX), coamoxiclav 
(AMC), cefuroxime (CXM), cefaclor (CEC), moxifloxacin (MOX), levo- 
floxacin (LEV), azithromycin (AZM), clarithromycin (CLR), and roxithro- 
mycin (ROX). 
Results: A total of 369 isolates were tested. The table below shows MICcm 
values (mg/L) and percentages of susceptible isolates (%S) for S. pneumonia 
(SP), S,pyogener (GAS), H.  inzuenzae (HI), M .  catanhalis (MC), and S. aureus 
(SA). FAR had potent activity against all species tested. The highest MIC 
observed was 0.125 mg/L. 
SP(n=100) GAS(n=63) HI(n=Y2) MCS(n=8O) SA(n=34) 
______________ 
MIC,, %S MICm 'hs MICw %S MIC, %S MI& %S 
FAR 5006 50.06 0.125 n a  0.1% g . 0 6  ".a 
TEL 50.06 100 50.06 iw 2 17.4 50.06 ion 4 676 
PEN 5006 100 50.06 100 0.25 n a  216 25 4 14.7 
AMX 50.06 IMi 50.06 lWb 05 100b 4 113b 4 oh 
AMC 50.06 100 5006 0.25 loo o 125 ion I 100 
CXM 50.25 ion 50.25 0.5 loo I inn 2 97 I 
CEC 505 too 50.5 4 100 I 100 2 ion 
MOX 0.125 iw 0.125 0.06 100 no6 n a  006 "a .  
LEV 0.5 IM) 0.5 100 50.06 100 50.06 ion 0.125 IW 
AXM 50 125 95 0 2 5  92 1 100 50.125 IM 216 58.8 
CLR SO25 95 0.5 90.5 8 973 SO25 100 264 58.8 
ROX S0.25 n.a. 5025 na. 16 n . ~  50.25 n.i. 264 n.i 
"Break points cap) for S. awlem were applied. %p of ampicillin; ma., no NCCLS by 
available. 
Conclusion: FAR possesses significant potency and antimicrobial profile 
compared to marketed antimicrobials suggesting that FAR may be a valuable 
future option for the treatment of community-acquired respiratory tract 
infections. 
jp1389/ Analyses of in vitro activities of faropenem 
against Gram-positive bacterial isolates resistant to 
levofloxacin 
E J. Scbmitz, S. Mayer, S. Mayer, M. Boos and A. C. Fluit 
Dtisselrlod 0; Wed Haven, USA 
Objective: Faropenem daloxate (FD) is a novel penem antimicrobial agent 
intended for oral administration. FD is rapidly hydrolyzed in vivo to far- 
openem, the active moiety. The purpose ofthe presented study is to evaluate 
the in vitro activity of faropenem against genetically characterized Gram- 
positive isolates resistant to levofloxacin. 
Methods: The strains tested have either been collected from clinical speci- 
mens or derived kom resistance selection experiments with different quino- 
lones. The following isolates were tested 97 mettucillin-susceptible 
levofloxacin-resistant S. aureus isolates, 93 levofloxacin-resistant S. pneumoniae 
isolates, 48 levofloxacin-resistant S. pyogenes isolates, and 44 levofloxacin- 
resistant viridans streptococcal isolates. All isolates have been characterized for 
alterations within the gyrase and topoisomerase enzymes using PCR and 
sequencing of the target genes, gp4, gyrB, grlA, grlB or parC and parE, 
respectively. MIC values were determined using NCCLS criteria for levo- 
floxacin and faropenem. 
Results: Faropenem demonstrated good activity with MIC9o values of 
1 mg/L for methicillin-susceptihle, levofloxacin-resistant staphylococci, levo- 
floxacin-resistant S. pyogenes and viridans streptococci tested. The MI& 
value for levofloxacin-resistant S. pneumonia isolates was 0.5 mg/L. In 
total, only 7 out of 282 (2.5%) isolates displayed MICs for faropenem of 
>2 mg/L. 
Conclusions: Based on its in vitro activity against levofloxacin-resistant 
Gram-positive cocci and given its oral bioavailability, faropenem daloxate 
appears to be a promising new antimicrobial agent for the treatment of a 
variety of infections due to Gram-positive cocci and warrants further clinical 
investigation. 
I PI3901 The influence of protein binding on the effect of 
faropenem against H. influenzae 
I. Gustafison and 0. Cars 
Uppsala, s 
Objectives: Faropenem daloxate (FD) is a novel ester pro-drug of faropenem 
sodrum. Serum protein binding (PB) of 80-95% has been reported. We 
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studied the influence ofhuman albumin and serum on the pharmacodynamics 
of faropenem (F) against 14 clinical strains of H. i n z z a e .  
Methods: PB was determined by centrifugation-filtration at 757 g for 1 h in 
the following media: 50% human serum in broth, and 20g/L albumin in 
broth. The concentration of F was 2mg/L, as determined by a standardized 
biological method. The killing effect of F was studied in broth, broth with 
20g/L albumin and broth with 50% active human serum and inactivated 
serum (56,30 min). The killing was determined by measuring viable count for 
24 h. 
Results: PB of F in both media was 91-92%. A climcal strain 
(MIC = 0.125 mg/L) was exposed to F at a concentration of 2 x MIC. A 
reduction of 4 log 10 cfu/mL was seen in broth (mean of three experiments). 
To obtain similar results in broth supplemented with 20g/L albumin, the 
concentration had to be 5 0 ~  MIC. Two other strains, MIC 0.5 and 2 mg/L, 
were exposed to F at a total concentration of 12mg/L, corresponding 
approximately to the C,, obtained in patients following 300mg of FD. 
The medium consisted of 50% inactivated human serum. Thus, the free 
hction of F was approximately 1.2 mg/L. At 24 h the strain with the MIC of 
0.5 mg/L was reduced by 4.3 log 10 cfu/mL. For the strain with a MIC of 
2 mg/L, re-growth occurred by 1.210g 10 c f u / d .  Similar exposure were 
performed in 50% active serum, which showed a fast bactericidal effect for 
both strains. A further 12 climcal strains (MICs &om 0.125 to 0.5 mg/L) were 
investigated for the abdity to grow in the presence of active serum. Half of the 
strains grew, and they were further studied by exposure to F at the total 
concentrationsof3,6 and 12mg/L. Areductionof5loglOcfu/mlwasnoted 
for all strains at the concentration of 6 and 12 mg/L. At 3 mg/L, three strains 
were not completely lulled at 24 h. The findings were expected, because the 
free concentration was approximately 0.3 mg/L, and the concentration w a s  
not sufficient to exceed the MIC. 
Conclusions: Our study showed that it is the free fraction of faropenem in 
serum that has antibacterial effect against H.  injuenzae. Active human serum 
had bactericidal effect for 7/14 investigated strains. Further studies are needed 
to clarlfy the potential synergistic effects of F and human serum in systems 
mimicking human kinetics. 
Faropenem daloxate vs. cefuroxime axetil in 
the treatment of acute sinusitis 
R. Siegert, 0. Berg, P. Gehanno, A. Leiberman, J. Martinkenas, 
I! Nikolaidis, €? A r v i s ,  M. Alefelder and I! Reimnitz 
Recklinghausen, D; Stockholm, S; Paris, F; Beer Sheua, IL; Vilnius, LlT 
Thessaloniki, GR; Puteaux, F; Leuerkusen, D 
Objectives: To compare the efficacy and safety of faropenem daloxate 
( F m ) ,  300mg twice daily for 7days, with cefuroxime-axed 
(CEF), 250mg twice daily for 7days, in the treatment of acute bacterial 
sinusitis. 
Methods: A total of 561 patients with acute bacterial sinusitis (ABS) 
diagnosed by the presence of three or more clinical signs or symptoms of 
acute sinusitis and conf i ied  by sinus X-ray were enrolled in this multi- 
national, randomized, double-blind study. A sample was obtained for culture 
by either sinus puncture or middle-meatus swab. A total of 452 patients 
(80.6%) were valid for the per protocol efficacy (PP) analysis, 228 FAR and 
224 CEF; 136 (30.1%) were microbiologically valid, 71 FAR and 65 
CEE 
Results: Clinical cure rates at 7-16days post-therapy (test-of-cure) were 
equivalent: FAR 89.0%, CEF 88.4% (95% CI: -5.2%, 6.4%). The most 
kequently isolated organisms were: S. pnarmoniae (47.1%), H .  inauenzae 
(30.1%), S. aureus (14.7%) and M. catanhalis (8.8%). Bacteriological 
succes at test-of-cure was observed in 91.5 and 90.8% of FAR- and 
CEF-treated patients, respectively (95% CI: -9.2%, 9.5%). Eradication/ 
presumed eradication was detected for 97.3 and 96.3% of S.pneumniae, 
85.0 and 90.5% of H. &$enme, 88.9 and 90.9% of S. aureus, 100.0 and 83.3% 
of M. catarrh& in FAR and CEF recipients, respectively. At 28-35 d a y s  
post-therapy, continued clinical cure rates were 92.6 and 95.0% of 
FAR- and CEF-treated patients, respectively. Both drugs were well tolerahxk 
the most 6equently reported drug-related adverse events were diarrhea (2.2% 
vs. 2.9%), nausea/vomiting (1.5% vs. 0.7%), abdominal pain (0.7% vs. 
1.5%) and skin feactions (1.5% vs. 1.1%) in FAR and CEP recipients, 
respectively. 
Conclusions: In this study, FAR was an effective and well-tolerated therapy 
for ABS with high clinical and bacteriological success rates. 
I PI392 1 Bactericidal activity and post-antibiotic effect of 
faropenem against anaerobic pathogens 
A. Speciale, I. Milazzo, K. Musumeci, E Caccamo, A. M. Lo Bue and 
G. Blandino 
Catania, I 
Objectives: Periodontal anaerobic bacteria can be involved in systemic 
infections such as bacteremia, endocarditis, brain abscesses, urogenital infec- 
tions, skin and soft tissue infections. Faropenem is a unique oral penem 
antibiotic with a broad spectrum of activity against Gram-negative, Gram- 
positive and anaerobic bacteria. This study tested the antibacterial activity of 
faropenem, in conlparison with that of amoxiciUin/cla+te, by time-kiU 
kinetics and post-anthiotic effect against various anaerobic bacteria supposed 
to cause systemic infections. 
Methods: One strain of Porphyromonas gingiuafij, one strain of Baneroides 
ureolyticus and one strain ofActinomyces sp. were tested to evaluate the time-kill 
kinetics and the post-antibiotic effect of both faropenem and amoxkillin/ 
cladanate. 
Time-kill kinetics: A closed system using incubation of bacteria in the 
presence of MIC, 4 x MIC and 10 x MIC concentrations of faropenem, 
and MIC and 4 x MIC concentrations of amoxicillin/clavulanate was used; 
viability counts were performed at 0, 8, 12 and 24 h. Killing curves were 
performed according to the he-kil l  protocol described for anaerobic 
bacteria by Rosenblan in 'Antibiotics in Laboratory Medicine' (edited by 
Lorian, 1986). 
Post-antibiotic effect (PA€): The PAE of faropenem was determined by the 
viable plate count method of Craig and Gudmundsson, against all the three 
isolates of anaerobic bacteria. The PAE was calculated with the following 
equation: PAE (time) = T- C, where T is the time required to increase by 
1 log a h  the count (du/mL.) observed immediately after completion of the 
same procedure on the culture after drug removal. 
Results: Time-kill kinetics: killing curves of faropenem against Rgingiualis 
showed that 4 x MIC and 10 x MIC concentrations caused a bactericidal 
effect with a 99.9% reduction of bacterial inoculum (three log decrease) in 
12 h against B. ureolyticw a three log reduction was obtained in 24 h at 
10 x MIC concentration; whereas for Actinomyces sp., faropenem showed a 
bactericidal effect only at 10 X MIC in 12 h. The PAE was 02.60 h for 
Pgingivalis, 01.50h for B. u r e o l y h  and 1 h for Adinomyces sp. 
Bactericidal activity of faropenem (FAR) and 
amoxycillin (AMX) investigated in the presence and absence 
of serum 
J. Andrew, F! Boswell, J. Ashby and R. Wise 
Birmingham, UK 
Objectives: The effect of 700h heat inactivated human serum on FAR and 
AMX time kill kinetics (protein bmding 95 and 20%, respectively) was 
compared for a total of 12 isolates, 4 M. ratanhalis (2 B-lactamase-producing 
strains), 4 H. injluenzae (2 8-lactamase-producing strains), 2 Group A strep- 
tococci and 2 S. pneumoniae. 
Methods: Concentrations ofFAR a n d M  equivalent to 2,5 and 10 x MIC 
were added to logarithmic cultures (-105 and 107 c f u / d )  in Iso-Sensitest 
broth (ISB) and 70% ISB/human serum (v/v) both supplemented with 5% 
lacked horse blood, 20mg/L NAD and 20mgK hemin. Antibiotic-& 
controls were included at both inocula. Viable counts were determined at 0,2, 
4, 6 and 24 h on supplemented Columbia agar following appropriate serial 
dilution in phosphate-buffered saline. Bacteria were enumerated after 48 h 
incubation at 35-37 "C in air enriched with 4 4 %  COz. 
Results: See Table 1. 
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Table 1 Range of bactericidal rates (change in log 10 &/mL from 0 to 6 h) at an 
inocdum of 105cfu/ml at 10 time MIC 
Organism Absence of serum Presence of serum 
No. FAR AMX FAR AMX 
M. camhalis 4 (4) 111 
(1) 111 
Number strains: T increase or 1 decrease in viable counts by up to 1 log 1, 1-2 logs 11.2 
to L3logs 111. 
Conclusions: FAR and AMX exhibited similar time-dependent lane- 
tics. In ISA, in the absence of serum FAR and AMX were bacteriostatic 
(i.e. less than 99.9% kill) after 4 h with x5 and 10 MICs on M. catarrhah, 
H. injuenzae and Group A streptococci and bactericidal for S. pneumoniae. 
In 70% serum FAR was bactericidal against M. catarrhah, H. injuenzae 
and one suain of Spneumoniae. Despite sigdicant Werences in protein 
binding both FAR and AMX were more active in serum. The higher protein 
binding of FAR did not have a significant effect on its pharmacodynamic 
properties. 
1 PI394 1 The bactericidal activity of faropenem and other 
&lactam antibiotics at peak serum concentration against 
Streptococcus pneumoniae with reduced susceptibility to 
penicillin G 
I. Morrissey, D. Farrell, J. Shackcloth, L. Williams, R. Ellis, 
D. De Rubeis, M. Robbins and D. Felmingham 
London, UK 
Objectives: To assess the effect of penicillin G (PEN) resistance on the 
bactericidal activity of antibacterial against S. pneumoniae (SP). 
Methods: Five recent clinical isolates of SP were incubated with antibacterial 
agents at peak serum concentration (value after standard oral dosing except 
ceftriaxone (CEF) where iv data was used) at 35 "C in brain heart inhsion 
broth supplemented with lacked horse blood (5%, v/v) and in the same 
medium either with 20% (v/v) complement active or with 200h (v/v) heat 
inactivated human serum added. Viable counts were made after 1 ,2 ,3 ,6  and 
8 h. Reduction in log 10 viable count was plotted against time and the area 
under the curve (AUC) calculated. 
Results: No difference in kdl was observed in the thee media, indicating that 
the SP were not serum sensitive. To compare the test agents, average results for 
the three media were used to calculate time to reduce viabllity by 99.9% 
(TYY.~) and AUC. These results are shown in the table (AM0 = amoxycillin; 
FAR = faropenem; NA =not achieved). 
SP24(1) 3.3h 24.7 3.3h 24.6 5.3h 18.2 2.0h 27.2 
SP06 (2) 5.6h 17.2 5.2h 18.7 8.0h 12.2 3.0h 23.3 
SP40(4) 5.4h 18.1 5.0h 19.9 8.0b 13.9 2.4h 25.2 
SP75 (6) 6.6h 15.7 NA 5.4 NA 12.7 4.6h 21.0 
SP56 (8) NA 6.3 NA 0 NA 8.9 5.4h 18.1 
Conclusions: FAR was more bactericidal than the other fi-lactams tested. In 
addihon, FAR was less aEected by reduced PEN susceptibility than PEN, 
AM0 or CEE 
m] The impact of protein binding of faropenem on 
its antibiotic activity 
C. Fuhst, A. Barger, 1. Wiegand and B. Wiedemann 
Bonn, D 
Objectives: The aim of h s  study was to compare the antibiotic activity of the 
new oral penem Faropenem (F) in presence and in absence of 40 g/L human 
serum albumin. Faropenem is bound to plasma proteins to 96%. To study the 
effect of protein binding on the antibiotic activity, we determined kill curves 
of three S. pneumoniae strains and H. inzuenrae. 
Methods: H. injuenzae [MC F: 0.5 mg/L] and three strains of S. pneumoniae 
(penicillin resistant [MIC F: 0.25mg/L], peni&n intermediate [MIC F: 
0.0625 mg/L] and penicillin susceptible [MIC F: 0.0625 mg/L]) were used. 
We simulated concentration-time curves by using Uerent modified in vitro 
models. The human phannacokinetic ofa 300-mg dose of F with and without 
40 g/L of human serum albumin was simulated during a time period of 24 h. 
For H. injuenzae we determined the kill kinetics also in a batch culture for 6 h. 
Bacterial counts were performed by preparing 10-fold dilutions ofthe samples 
with 0.9% saline, then plating a 0.05-mL altquot on an appropriate agar. 
Colony forming units (cfu) were read after 24-48 h incubation of 37 "C in an 
C 0 2  incubator. 
Results: For S.pneumoniae we did not find any difference between the 
antimicrobial activity of F with or without the addition of albumin in the 
in vitro model (reduction of the bacterial count was at least 5-6 orders of 
magnitude). The simulation of a 300-rng F dose plus albumin for H. injwnzae 
results in an bacteriostatic effect over 24 h. The same concentration without 
albumin shows a decrease of2 log cfu for H. infienzae. This Merence of the 
antibiotic effect is concentration dependent. To elucidate the impact of the 
protein binding of F on the antimicrobial effect ofH. infruenzae we studied the 
kill kinetics with increasing constant concentrations. The data (Table 1) 
demonstrate that the merence between the effect with and without protein 
decreases with increasing concentration of F. 
Table 1 
logDif. cfu (after 6 h) 
Concentration of faropenem Without albumin With albumin AlogDif. cfu 
2 x MIC - 1.72 2.14 3.86 
4 x MIC -1.7 0.42 2.12 
8 x MIC -1.65 -0.03 1.62 
16 x MIC -1.9 -0.33 1.57 
Conclusion: As the protein binding of F is 96% the actual concentration 
available at C,, (1 1.8mg/L) for a 300-mg dose is -0.5 mg/L. For strains 
with MIC below this concentration the antimicrobial effect is not at all 
impaired, whereas for bacteria for which the MIC is in the range of the 
concentration of F in the 6ee fiaction, the protein binding has to be taken into 
consideration. 
(p1396] The effect of protein on the bactericidal activity 
of faropenem against Spneumoniae and H. influenzae 
using serum bactericidal tests 
K. Bowker and A. MacGowan 
Bristol, UK 
Objectives: Faropenem is an oral penem with in vitro activity against a wide 
range of pathogens including S. pneumoniae, H. injuenzae and M .  catanhalir. 
Protein binding of faropenem is approximately 95%. This series of experi- 
ments was designed to investigate the effect of protein on the activity of 
faropenem against S. pmumoniae and H. infruenzae using simulated serum cidal 
titers. 
Methods: Media was spiked with faropenem concentrations of 5.5, 11.0 and 
20mg/L with 0, 35 and 70% added human serum. Serum was either heat 
treated or not and one strain each of S. pneumoniae and H. intuenzae (both 
MIC 0.12 mg/L) were employed. 
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Results: The serum cidal titers are shown in the table. 
Cidal titer [faropenem concentration (mg/L)] 
% Serum 5.5 11.0 20.0 
S. pneumoniae 0 16 64 64 
(serum not heated) 35 4 4-8 8-1 6 
70 2 4-X 4-1 6 
H. infuntzae 0 2 16 64 
(serum not heated) 35 4 8 X 
H. infuenzae 0 8 16 64 
(serum heated) 35 2 4 4 
70 <2 2 2 
70 >1024* >1024* >1024* 
'Also no growth in anabiouc-Gee control. 
The effect of serum on faropenem activity against S. pneumoniae and H .  inju-  
enzae differed. Adhtion of serum had the effect of reducing the in vitm 
activity offaropenem against S.pneumoniaeat all ratios and concentrations and 
heating the serum had no eEect on the activity of faropenem. In contrast 
against H .  injiuenzue serum increased faropenem activity at some ratios and 
this effect was absent with heat treated serum. Although serum at higher ratios 
was bactericidal against H. injiuenzae on its own, almost certainly related to the 
presence of complement as this effect was elinunated by heat treatment at low 
ratios a positive interaction of faropenem and serum appears to have occurred. 
Conclusions: The results indicate a potentially positive interaction of far- 
openem with serum and H.intuenzae.  However, due to variability in 
performing serum cidal tests and the use of doubling dilutions to define 
endpoints, it is a c u l t  to precisely define the roles of the antibacterial effects 
of complement and faropenem against H. injuenzae under these experimental 
conditions. Further studes are required to elucidate the interaction in more 
detail. 
mj Targeted recombinant B-lactamase in prevention 
of antibiotic-induced changes in gut microflora 
J. Harmoinen, P. Koski, K. Lindevall, K. Vaali, P. Heino and 
E. Westermarck 
Helsinki, Espoo, FIN 
Objectives: Broad-spectrum p-lactam drugs cause selective pressure on 
colonic microflora. Disturbed colonic ecology may lead to decreased colo- 
nization resistance and increased formation of resistant bacteria. The present 
concept was developed to overcome these untoward effects. The efficacy of 
the new treatment modality was investigated on intravenous ampicillin- 
induced changes in gut flora. 
Methods: j-Lactamase of Bacillus lichen$ormis was overproduced in Bacillus 
subtilis using a bacillar secretion vector. The purified enzyme was released in 
the small bowel from a controlled-release formulation with a pH-dependent 
release. Fistula-operated beagle dogs (n = 6) were treated BID with either 
20 mg/kg ampicillin (i.v.) +placebo (p-o.), 20 mg/kg ampicillin 
(i.v.) + TRBL (p.0.) or only placebo (i.v. + p.0.). Stool was collected at days 
4 and 10. Fecal samples were quantitatively cultured for total and main groups 
of aerobic and anaerobic bacteria and yeast. Temperature gradient gel 
electrophoresis (TGGE) w a s  used to separate the ribosomal RNA genes. 
Computer analysis of the TGGE profiles of the samples generated similarity 
percentages between the individual samples. 
Results: Ampicillin + placebo group had clearly decreased counts of both 
aerobic and anaerobic bacteria d10 and d14, whereas ampicillin+TRBL 
group had only minor overall changes and some occasional changes by single 
species. Intravenous ampicillin decreased the fecal similarity percentage to 
60% when 16 S rRNA fingerprints taken before treatment were compared to 
values taken during treatment. The similarity percentage during treatment 
with ampicillin + TRBL did not differ from that of placebo (86 vs. 81%). 
Conclusions: According to our preliminary results the effects of TRBL are 
reflected in a virtually unchanged microflora of the gut. This stability was 
detected by both 16s rRNA fingerprints and conventional culturing. These 
results indicate that TRBL is a promising novel approach for overcoming 
ecological damage to gut flora caused by j-lactam antibiotic agents. 
I PI398 1 High prevalence of nosocomial Escherichia coli 
and Klebsiella pneumoniae producing CTX-M-type extended 
spectrum &lactamases (ESBLs) in Russian hospitals 
M. Edelstein, M. Pimkin, I. Edelstein, A. Narezkma and L. Stratchounski 
Smolensk, RUS 
Background and objectives: ESBLs of a CTX-M-type represent rapldly 
emerging group of j-lactamases. On the basis of sequence stmtlarity all 
enzymes of this group can be distributed into four subtypes epitomized by 
CTX-M-1, CTX-M-2, CTX-M-8 and CTX-M-9. The aim of our study 
was to investigate the prevalence of Werent subtypes of CTX-M ESBLs 
among nosocomial E.  coli and K .  pneumoniue strains in Russian hospitals. 
Methods: Consecutive nosocomial isolates of E. coli (n = 494) and K.  pneu- 
moniae (n=410) were collected in 28 Russian hospitals during 1997-1998. 
ESBL production was detected by double-disc synergy test. All ESBL- 
producing strains were screened for CTX-M b-lactamases by PCR with 
primers specific to the conserved regions of the coding genes. A PCR was 
followed by RFLP analysis with PstI and PvuII restriction enzymes permitting 
the ditferentiation of the CTX-M subtypes. The E. coli strains producing the 
known CTX-M B-lactamases were used for quality conml. 
Results: The ESBL phenotype was observed in 71 (14.4%) and 239 (58.3%) 
E.  coli and K.  pneumoniue isolates, respectively. Among the ESBL producers 24 
(33.8%) E.  coli and 77 (32.2%) K. pneumoniae were found to possess genes for 
CTX-M j-lactamases. The majority of these strains (92.1%) produced the 
CTX-M-I-related ESBLs. The CTX-M-Zrelated enzymes were detected in 
eight E. coli strains 6nm a smgle hospital only. Neither CTX-M-8- nor CTX- 
M-9-related enzymes were found in this study. The CTX-M-producing 
strains were detected in 17 of 28 surveyed hospitals and predominated over the 
strains expressing all other types ofESBLs in the medical centers located in the 
areas of Ural and Siberia. In two hospitals the relative frequency of CTX-M- 
type ESBLs ranged up to 93 and lOoO/o, respectively. 
Conclusions: We conclude that the CTX-M-type f3-lactamases represent a 
significant and rapidly spreading group of ESBLs in Russia. 
ESBLs producing K. pneumoniae and E. coli 
isolated in 2001 
0. M. Dorobat, T. Biolan, E. Ceausu, l? Calistru and D. Sohnie 
Bucharest, RO 
Objective: To evaluate the prevalence of ESBL in 21 1 K .  pneumoniae and 658 
E. coii isolated in 2001 h m  inpatients and outpatients. 
Methods: Susceptibility tests were done by disk di&sion method according 
with NCCLS guidehes. Screening for ESBL production was made by (1) 
disk diffusion test with ceftazidime (CAZ), cefotaxjme (CTX), aztreonam 
(AZT); (2) double disk synergy test; (3) E-test ESBL screen strips (CT/CTL 
and TWTZL); and (4) ATE3 Expression System BioMerieux. 
Results: Sixty K. pnt-umoniae (57 isolated from inpatients and 3 from out- 
patients) and 30 E.coli (27 inpatients and 3 outpatients) produce ESBL. 
Between ESBL-producing K .  pneumoniae there were 27 h m  urine (24 &om 
inpatients, 3 from outpatients), 21 from lower respiratory tract (all h m  
inpatients), 6 from blood and 6 from another specimens. ESBL-producing K.  
pneumoniae were resistant 66.6% to gentamicin, 48.3% to netilmicin and 40% 
to ciprofloxacin. From ESBL-producing strains E.  coli 90% were resistant to 
ciprofloxacin, 86.6% to gentamicin and 60% to netilrmcin. ESBL-producing 
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E. mli were isolated 18 from urine (14 &om inpatients and 4 from outpatients), 
4 from lower respiratory tract, 3 from blood and 5 &om another clinical 
specimens (all inpatients). 
Conclusions: The overall prevalence ofESBL-producing st ra ins  was 28.4% for 
K .  pneumoniae and 4.5% for E. coli. The kequency of ESBL was higher for 
strains isolated from inpatients, 30.4% in K. pneumoniae and 5.4% in E. coli 
versus 12.5% in K. pneumoniae and 2.5% in E.coli for the strains f b m  
outpatients. Resistance to quinolones and aminoglycosides is often associated 
with ESBL production. 
I PI400 I Concentrationdependent selection of 
cefotaxime resistant E, coli in an in vitro kinetic model 
S. Olofsson, I. Gustafsson and 0. Cars 
Uppsala, S 
Objectives: DifFerent antibiotic dosing regimens may va'y in their capacity to 
select pre-existing mutants. In previous static experiments by Negri et al. 
(2000). a concentration-dependent selection oflow level cefotaxime resistant 
genetic variants was described. Selection occurred primarily at low concen- 
trations between MIC values of the strains, called a selective window (SW). 
Our aim was to extend these experiments using an in vitro kmetic model. 
Methods: Isogenic E.coli were used, REL606 expressing the TEM-1 
j-lactamase enzyme, and REL607 expressing the higher-level resistant 
TEM-12 enzyme. The strains differ in their ability to use L-arabinose, and 
form Merent colors on tetrazolium-arabinose (TA) indicator plates. A 
competition assay was performed in an in vitro kinetic model where the 
bacteria were kept in a closed system and the elimination rate of the antibiotic 
was varied. The populations were n ~ e d  99:l of TEM-l/TEM-12. The 
bacterial mixture was exposed to cefotaxime for 24 h. The initial concentra- 
tions of cefotaxime and the elimination rate in the kinetic model were 
adjusted to give SWs of 1, 2, 4 and 8h. The time that concentrations 
exceeded MIC (T>MIC) was also varied. Samples were withdrawn at 
Merent time points, and treated with #?-lactamase before appropriate dilu- 
tions were plated on TA indicator plates. The grade of selection after 24 h, the 
selection coefticient, was estimated from R24-RO h, where R is the natural 
logarithm of the ratio of TEM-12 and TEM-1 densities. 
Results: The MIC ofTEM-1 and TEM-12 producing E. coli was 0.0156 and 
0.0625mg/L, respectively. When a SW of 1 h was used with T>MIC of 
2/3 h for TEM-12 and TEM-1, respectively, the selection coefkient was 7.0. 
A SW of 2 h with T> MIC of 2/4 h gave a selection coefficient of 7.6, and a 
SW of 4 h at T> MIC of 216 h gave a coefficient of 9.0. A SW of 8 h was also 
tested where T> MIC was 4/12 h, the selection coefficient then was 11.9. By 
increasing T> MIC, the selection coefficient was changed. When T> MIC 
for TEM-12 was 12 h, selection was highly variable and unpredictable. In 
some experiments TEM-12 was completely eliminated. 
Conclusions: The selection coefficient in the in vitro kinetic model was 
dependent on T >  MIC for the two s t r a i n s  as well as on the length of the SW 
Selection was less likely to occur when T> MIC approached 12 h for TEM- 
12. Pharmacodynamic studies of antibiotics should include the capacity of 
different dosage regimens to select resistant subpopulations. 
inoculum and by 32 times witb the higher, with the only exception of the 
meropenem MIC in the strain transformed with IMP-1 which increased by 
64 and by 128 times with the low and high inoculum, respectively. The MICs 
of both imipenem and meropenem were even lower in the OmpC-OmpF 
mutant-transformedwithVIM-1, but not in that transformedwith IMP-1. As 
opposed to the results previously obtained with the CphA enzyme of 
Aeromonas hydrophila, the parent strains transformed with either VIM-1 or 
IMP-1 had carbapenem MICs noticeably higher than the nontransformed 
strains, mostly as regards meropenem and IMP-1. However, the results 
obtained with all the porin-deficient mutants did not significantly differ 
from those previously obtained with CphA. 
I P1402 1 Effect of siliconited latex urinary catheters 
(SLUC) on the activity of carbapenems against isogenic 
strains of P. aeruginosa with different expresion of 
AmpC-j-lactamase, OprD and MexA-MexB-OprM 
M. C. Conejo, L. Martinez-Martinez, 1. Garcia and A. Pascual 
Seville, E 
Objective: We have described a decreased activity of carbapanems against I? 
aeruginosa (Pae) in the presence of SLUC, related to the loss of an OprD-like 
protein and the expression of a new outer membrane protein. In order to 
understand the underlying mechanism of this phenomenon we have studied 
the effect of SLUC on the activity of imipenem (IP) and meropenem (MP) 
against isogenic strains of Pae. 
Methods: Isogenic strains producing or not AmpC-#?-lactamase PL),  OprD 
porin and MexA-MexBOprM system were studied. The activity of IP and 
MP was determined in cation-adjusted Mueller-Hinton broth (MHB) and in 
eluate &om SLUC incubated in MHB (four segments of 1 cm/mL; 37 "C; 
24 h). The activity of several quinolones was also studied. OMP profiles and 
BL activity of the strains grown in MHB or eluate were determined by SDS- 
PAGE and spectrophotometric assay, respectively. 
Results: The activities of IP and MP in eluate from SLUC decreased by 8-16 
and 4-8 times, respectively, against strains of Pae expressing all OprD, BL 
(either inducible or constitutive) and normal mdtidrug eWux system MexA- 
MexE-OprM. IF', but not MP, had the same activity in MHB as in eluate 
against all but one strains lac- BL activity but expressing OprD. MICs of IP 
and MP against OprD deficient strains were the same in both MHB and 
eluate. MICs of MP, but not of IP, were consistently one dilution lower in 
MHB than in eluate against strains with defective MexA-MexB-OprM. 
Activities of quinolones against all the strains studied were similar when tested 
in either MHB or eluate. Strains expressing OprD in MHB lost it when grown 
in eluate, and expressed a new OMP ofabout 50 kDa when growing in eluate. 
No differences in BL activity were detected when strains were grown in either 
MHB or eluate. 
Conclusions: Resistance to IP in I! "uginosa grown in eluate from SLUC is 
mainly due to both loss of OprD and expression of BL. For MP this 
phenomenon is related to both loss of OprD and integrity of the MexA- 
MexB-OprM system. The role of the 50 kDa OMP expressed by Pae grown 
in eluate is unknown, but seem not to be related to any of the currently 
described Pae e3lux systems, since its expression is not associated with 
decreased quinolone activity. 
I P1401 1 Role of permeability in carbapenem resistance of 
porin-deficient E. coli producing metallo-j-lactamases 
A. Mazzariol, A. Degola, L. Xiaokang, J. D. Docquier and G. Cornagha 
Verona, I; Chengdu, CHN 
To assess the influence of different permeability defects on  carbapenem 
susceptibility, we used E. coli K-12 derivatives in which the OmpF and/or 
the OmpC structural genes had been inactivated by the insertion mutation 
element Tn5, or in which the regulatory locus ompB had been mutated. The 
parent strain and its porin-deficient mutants were transformed with two 
dfierent constructed vectors (namely pAx22 and pPAh4) carrying the VIM-1 
and IMP-1 metallo-a-lactamase genes. Both B-lactamases caused a two- to 
four-fold increase in the MICs ofimipenem and a four- to eight-fold increase 
in the MICs of meropenem for the nonporin-deficient strains. Only minor 
increases were observed in the OmpC-deficient strains when the lower 
inoculum was used (104ch per spot). whilst when the higher inoculum 
was used (1O'ch per spot) both j-lactamases caused a two- to four-fold 
increase in the MIC of imipenem but a 32-fold increase in that ofmeropenem. 
In the OmpF-deficient strain all the MICs increased by 8 times with the lower 
w] Antimicrobial susceptibility to plactams 
and /&lactamares production among clinical isolates of 
Gram-negative nonfermentative rods 
R. Franiczek, M. Fleischer M. Grabowski, 0. Bortkiewicz and 
K. Fleischer 
Wroclaw, PL 
Objectives: To study the antimicrobial susceptibihty to /l-lactam antibiotics, as 
well as the production of extended-spectrum P-lactamases (ESBLs) and 
inducible P-lactamases (IBLs) in clinical isolates of Gram-negative non- 
fermentative bacteria. 
Methods: Flfcy-three recent clinical isolates including Pseudomonas spp. 
(n = 23). An'netobacter baumannii (n = 20) and Stenofrophomonas malrophilia 
(n  = 10) were examined. The strains were isolated from ICU and identified 
by the automatic ATB system (BioMerieux). ESBLproducing strains were 
detected using the double disk (DD) test according to Jarlier and the oxoid 
combination disk method. IBL activity was detected by the two-disk test 
according to Sanders. The MICs of piperacillin (PIP), aztreonam (ATM), 
Clinical Microbiology and Infection, Volume 8 ,  Supplement 1,  2002 331 
ceftazidime (CAZ), cefotaxime (CTX), cefviaxone (CRO), imipenem (IPM) 
and meropenem (MEM) were determined by an agar dilution method 
according to NCCLS criteria. E .  coli ATCC 25922 and E! aenrginosa ATCC 
27853 were included as quality control strains. 
Results: DD test results were positive for eight strains (two for Pseudomonas 
spp., and six for S .  malfophifia). However, none of the inves!igated strains 
displayed an ESBL activity in the oxoid combination disk method. The abdity 
to produce IBLs was detected in 24/53 straifis. ESBLpositive isolates showed 
high resistance to typical oxyimino-~-lactam (third-generation cephalospor- 
ins and aztreonam). In addition, ESBL-producing Pseudomonas spp. strains 
were resistant to imipenem (MIC 512-1024mg/L) and meropenem (MIC 
64-256mg/L). A .  baumannii and S .  maltophifia isolates were uniformly resis- 
tant to PIP (MIC 128-1024mg/mL), ATM (MIC 64-1024mg/mL) and 
CRO (MIC 12&1024mg/mL.). 
Conclusions: Our results confirm the need of reliable methods for the 
detection ofESBL producers among Gram-negative nonfermentative strains. 
The DD test was more sensitive to ESBL screening than the axoid combina- 
tion disk method. The majority of the strains exhibited multiresistance to 
8-lactam antibiotics, including carbapenem. 
w1 Resistance mechanisms to aminoglycosides 
and /?-lactams of Stenorrophomonas maltophiria strains 
from Greek hospitals 
C. Masgala, I. Galani, M. Souli, Z .  Chrysouli and H. Gianiarellou 
Maroussi, CR 
Objectives: Stenotrophomonar maltophilia is an important emerging pathogen 
causing a variety of nosocomial infections. Being inherently resistant to many 
antibiotics, ths species poses a therapeutic challenge to the clinician. The 
main objective of this study was to elucidate the mechanisms of S.  rnottophifia 
rendering resistance to aminoglycosides and rx-lactams. 
Methods: A total of 28 nosocomial isolates from five Greek hospitals, 
collected during the period April 1998 to May 1999 were studied. Suscept- 
ibility tesnng was performed by the agar a s i o n  (Kirby-Bauer) test and 
E-test, using the National Committee for Chical Laboratory Standards 
guidelines (M7-A5, Vol. 20, No. 2, 2000). Epidemiologic relatedness 
between the isolates was assessed by pulse field gel electrophoresis (PFGE) 
of SpeI-restricted genomic DNA. Aminoglycoside resistance mechanism 
were determined using the aminoglycoside resistance patterns method 
(AGRP) and the DNA probe analysis. fi-Lactamases were determined by 
isoelectric focusing (IEF). 
 result^ All strains showed resistance to the carbapenems such as imipenem 
and meropenem. Ceftazidime was active against 60% of the isolates tested. 
Relatively few isolates were susceptible to the combination of piperacillin/ 
tazobactam (25%) and only one was susceptible to aztreonam. Amikacin 
showed the lowest level of resistance of all aminoglycosides tested inhibiting 
46% of S. maltophilia strains of our study. PFGE revealed 27 diflerent 
genotypes. All isolates possessed several different a-lactamases with alkaline 
pl values greater than 8.2 that hydrolyzed imipenem. The majority of the 
strains harbor also other enzymes with PIS of 5.4-7.9 but only four of the 
isolates were able to hydrolyze imipenem with one ofthese enzymes. None of 
the isolates possessed any aminoglycoside modifying enzymes so that resis- 
tance due to impermeability wa.s concluded according also to AGRP method. 
Conclusions: No clear correlation appears between MIC of a-lactams, PI of 
extracted a-lactamases and genotype of the clinical isolates of S. rnultophitia 
tested. The resistance of S. maltophilia is extremely complex and hrther work 
is required to clarify the mechanisms behind the wide phenotypic variations 
observed. 
1 PI405 1 Resistance to /?-lactam antibiotics 
in Aeromonas caviae 
2 Gonzalez-Lama, P Lupiola, J Martm, M Gonzalez and T Tejedor 
Las Palmas de Gran Canana, E 
Objectives: The contnbuhon of 8-lactanme producuon to j3-lactam anu- 
biohcs reslstance was exarmned m an Acnurae mutant stram (AC7m), 
selechoned in vltro by cefotamme denved fiom its wlldtype s t r a m  (AC7) 
isolated m our laboratory fiom crude sewage 
Methods: Anhbiohcs suscepabhty test were performed by serd two-fold 
dllunon m Mueller-Hmton Broth. Nitlocefin was used for 8-lactamase 
detechon on mtact c& and crude enzyme preparauons. A modficahon 
of a spectrophotometer aadmetlic method was used for stu&es of substrate 
and mhibitor profiles IEF was performed m PAGE pH: 3.5-9 5 Cefoxmn 
(0.5 pg/mL) was used for B-lactamase mduchon. 
Results: Both strams produced j?-lactamase. AC7m. in contrast to AC7 that 
was mducible by cefostm, produced 8-lactamases consntuhvely AC7m was 
regarded as a derepressed mutant from AC7, whch overexpressed 8-lacta- 
mase. AC7 was suscephble to most of b-hctam anhbiohcs tested, being 
resistant to m o p e m & ,  firsr generahon cephalosporlns and ammcllhn 
plus potassium clawlanate. AC7m was rewtant to arrunopenich and its 
combinaaons wth 8-lactamase h b i t o r s ,  carboxlpenicillins, ureidopenid- 
lins, and cephalosporms. T h s  stram remamed suscephble to ceftandune, 
mpinem and aztreonam. A c o r n o n  major 8-lactamase band at PI 6 5 
shared AC7 and AC7m. 
Conclusion: /3-lactamase produmon by AC7 and AC7m was mvolved in 
p-lactam anhbiohcs rewtance Based on substrate and dubitor profdes 
deterrmned m somc extracts for AC7 and AC7m, the enzymes &played 
on IEF at PI 6.5, were assigned to chromosomal group 1 blactamases 
Irmpenem may be the appropiate choice for therapy of ifecuons caused by 
stable derepressed mutants of A caurae producmg group 1 /?-lactamares 
I PI406 I First isolation of a carbapenem-hydrolyzing 
/?-lactamase in a Pseudomonas aemginosd in Spain 
G. Prats, L P o d ,  E. Muo, B. Mueh, S .  B e h s  and P. Nordmann 
Barcelona, E; b-Kremlin-13uAtre, F 
Objectives: A retrospechve analys~s of susceptibdity to 8-lactams was con- 
ducted in the Pseudomom aerugrnosu isolates from a Barcelona hospital to 
search for carbapenemase producers. Indeed, carbapenemases (of the IMP and 
VIM series) have been already reportedhm Italy, Greece, and France One of 
the s t r m s  was analyzed m deeds for its 8-Iactamase content 
Methods: Prekrmnary 8-lactam suscepnbhty testmg was performed wth  52 
mpem- and ceftazidme-resistant P amgrnosa strams that had been isolated at 
San Pau hospital m Barcelona 6om January 1996 to June 2001 A 8-lactamase 
extract of culture of one of the s t r a m  (Ka 209) was prepared for detechon of 
carbapenem hydrolysB Usmg genomc DNA of Ka 209 as template, PCR 
experment were performed with primers spec& for detechon of IMP and 
VIM genes and class 1 mtegrons. Clomng of a PCR product m pPCRScript 
in E roll was followed by sequencmg of the lnsert. Plasmd extnchon, 
conjugahon and electrotransformahon m E cob and P aenrgrnosa reference 
strams, and hybndizauon mth an mternal probe for blaVIM-2 were then 
performed. 
Results: Out of 52 E! aenrgrnosa strams, one of them, Ka 209. was reslstant to 
mipenem, to ceftyidune and suscephble to aztreonam This anhbiohc 
resistance phenotype agreed w t h  the presence of an Ambler class B carba- 
penemase (metallo-enzyme). 8-Lactamase extracts of culture of Ka 209 
hydrolyzed carbapenems PCR and sequencing expenments idenhfied the 
blaVIM-2 gene It was located onto a class 1 integron. The blaVIM-2-posihve 
plasrmd of SO kb was not conjugative but was able to rephcate 111 E roll. 
Conclusion: Currently, VIM-2 1s the carbapenemase most often lsolated m 
Europe T h ~ s  work constitutes a forewarning of the probable dlssemnanon of 
plasnnd-encoded carbapenemases at least in Southern Europe. 
I PI407 1 Molecular characterization of E. coli HBlOl 
harboring blaTEM1 gene after exposure to ceftazidime and 
ceftibuten 
M. Penlh, B. Segatore, M. M. Tavlo-Perez, D. Setacci, A. Pensa, 
G M Rossolmi and G Amtcosante 
L'Aqutla, I ,  Jk Palmas de Gran Canana, E; Srena, I 
Objectives: Exposure to expanded spectrum 8-lactam antibiobcs In Enter- 
obacterlaceae harboring blaTEM-1 or blaSHV-1 genes results 111 the appear- 
ance of new enzymes wth  extended spectrum of achvlty and reslstanCe 
to the above compounds The a u n  of the present study was to charactenze 
the emergence of reslstence and the m e c b m s  mvolved m E.rolr 
HBlOl 
Methods: E colt HBlOl contaming the blaTEM-1 gene (pBR322) was 
exposed to increasing concentranom of ceftazi&me (range 1-256m/mL) 
and cefnbuten (range 0.25-16 pg/mL). The grown colomes were screened 
for the presence of TEM-1 gene by PCR and duect sequencmg Outer 
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membrane protein (OMP) profiles were studied according to the procedure 
previously reported [l]. 
Results: E. coli I-Lt31Ol with plasmid containing the TEM-1-encodmg gene 
was exposed to Merent concentrations of ceftazidime and ceftibuten. E. coli 
HBlO1 carrying a mutated allele encoding the TEM-12 ESBL was obtained 
after exposure to the following cefeazidime concentrations: 32, 64 and 
128pg/mL, while exposure to sirmlar concentrations of ceftibuten did 
not result in selection of TEM-1 ESBL variants. The low level of 
resistance in both ceftazidime and cefiibuten selected mutants was associated 
with the loss of an OMP with an electrophoretic mobility similar to E. coli 
OmpE 
Conclusions: In the present study, ceftazidime and ceftibuten were able to 
select resistant mutants of E. coli HBl0l containing the blaTEM-1 gene at 
different levels and by means of different mechanisms. Ceftazidime was able to 
select mutants either producing the TEM-I2 ESBL or to repress OmpF 
expression whereas ceftibuten only selected mutants that were deficient in 
OmpF. These results show a different effect of ceftazidime and ceftibuten in 
the selection of resistant mutants. 
Reference 
1. Tam0 MM.. J. V h .  J. Ruir, J. Ruir, A.M. Mamn-Sanchez. M.T. Jim6ncneZ de Anu 1999. 
Mechannm involved in the development of resl~rance to Buoroqumoloner in E. mlr stmns 
J Anrimimlr Clieniodter. 44: 735-742. 
(p1408/ Activity of 8-lactam antibiotics against 
Enterobacteriaceae with different 8-Iactamases patterns, 
including extended-spectrum enzymes 
B. Segatore, D. Setacci, M. Per&, M. -R. De Massis, L. Franchino, 
N. Franceschini, G. -M. Rossolini and G. Amicosante 
L'Aquila, Milan, Sienu, I 
Objectives: Extended-spectrum /Hactamases (ESBLs) are widely dlffused in 
nosocomid isolates of Enterobacteriaceae, where they can be found alone or 
in various combinations with merent enzymes (e.g. AmpC-like). In the latter 
case, the complex 8-lactamase pattern may result in a peculiar resistance 
phenotype. The aim of this study was to evaluate the activity of several 
antimicrobial agents against Enterobacteriaceae with different 8-lactamase 
patterns includtng various TEM- and SHV-type ESBLs. 
Methods: The study was carried out on 103 ESBL-producing clmical isolates 
OfEnterobacteriaceae. The B-lactamase pattern was investigated by analytical 
IEF, and the nature of the ESBLs by direct sequencing of the blaTEM 
and blaSHV alleles. The ESBLs repertoire included TEM-12, TEM-15, 
TEM-72, TEM-87, SHV-2a. SHV-5, SHV-11 and SHV-12. An AmpC- 
f i e  enzyme was present in 26 cases. MICs were determined by an agar- 
dilution procedure using two different inocula (5 x lo5 and 5 x 1O8c& per 
Results: Susceptibility rates were as follows: meropenem, 100?? 
imipenem, 98%, cefotetan, 94%; piperaciUir-tazobactam, 93% amikacin, 
85%; levofloxacin, 66%. A si&icant inoculum size effect was observed 
with several compounds, including imipenem, piperacillin-tazobactam, cefo- 
tetan, and cefepime (susceptibility rates decreased to 83, 68, 88 and 31%, 
respecnvely). A relationship of susceptibility patterns with bacterial 
species and with production of different TEM or S H V  ESBLs was also 
observed. 
Conclusion: Carbapenems, and meropenem in particular, were the most 
active against ESBL-producing Enterobacteriaceae, and retained full activity 
also in the presence of complex 8-lactamase patterns including AmpC-like 
enzymes. However, in the presence of high bacterial inocula, cefoteran and 
anukacin also appeared to be a good alternative for chemotherapy of infections 
caused by ESBL-producing Enterobacteriaceae. 
TEM-I 9, TEM-20, TEM-24, TEM-26, TEM-43, TEM-52, TEM-60, 
spot). 
[ PI409 I Occurrence of extended spectrum 8-factamase in 
clinical isolates of K. pneumoniae 
S Wongwaruch, M Kusum, C Dhiraputra and P Pongpech 
Nonthaburr, Bangkok, TH 
Objectives: To deternune the occurrence and anhmcrobd suscephbdity of 
extended-spectrum B-lactamase (ESBL) produmg K pneumoniae in patlents 
attending Siriraj hospital in Bangkok during August 2000 to January 
2001. 
Methods: ESBL-producing isolates were screening with disk a s i o n  
according to NCCLS guidelines. Confirmation of suspected ESBL- 
producing isolates was performed with E-test (CT/CTL or TZITZL). 
Antimicrobial susceptibility testing were determined by a microdilution 
automatic method (VITEX system, BioMeriew). 
Results: Out of 22 178 clinical specimens, 400 (1 A%) were culture positive 
for K. pneumoniae; 26% (104/400) of all isolates were ESBLproducing 
strains. Rates of detection of ESBL-producing K. pneumoniue were 18.7, 
30 and 25.9% for blood, sputum and urine samples, respectively. Susceptibility 
testing has revealed that all 70 tested strains including 53 isolates 
fiom blood and sputum and 17 isolates from urine samples were sensitive 
to imipenem (MIC 4 mg/L). None of the tested isolates were sensitive to 
piperacillin/tazobactam and amoxicillin/clavulanic acid or aztreonam. 
Rate of resistance to ciprofoxacin, levofloxacin, gentamicin, tobramycin 
and trimethoprim/sulfamethoxazole were 60,64,28,9 and 51%, respectively, 
for isolates from blood and sputum; 71, 71, 18, 6, and 35% for urinary 
isolates. 
Conclusions: A high rate (26%) of the clinical isolates of K. pnerrmoniae 
were ESBL-producing strains. Imipenem was highly active against ESBL- 
producing K. pneumonia. In contrast, reduced activity was observed with 
fluoroquinolones, aminoglycosides and trimethoprim/sdfamethoxazole. 
Further idenh6cation of ESBLproducing stlains requires molecular techni- 
ques for specific control interventions. 
I P1410( The antimicrobial susceptibility pattern and ESBL 
production of common Gram-negative bacteria isolated 
from nosocomial infections in a Turkish hospital 
P. Zarakolu, G. Guven, G. Hasceiik, M. Akova and S. Unal 
Ankara, TR 
Objectives: To determine the antimicrobial susceptibility pattern and ke- 
quency of production of extended-spectrum fi-lactarnases (ESBL) in certain 
Gram-negative bacteria isolated from nosocomial infections seen in medical 
and surgical wards and intensive care units of an University adult hospital 
against commonly used antimicrobials were evaluated. 
Methods: The isolates collected between January 2000 and July 2001 and 
included in the study were causes of nosocomial infections. The antimicro- 
bials tested were meropenem, imipenem, ciprofloxacin, piperacilhn + tazo- 
bactarn, tobramicin, cefotaxime and cefepime. The susceptibilities were 
determined by E-test (Biodisk, Sweden) which was applied according to 
the manufacturer's instructions and the results were evaluated accorchng to the 
NCCLS 2001 recommendations. The ESBL production was tested by E-test 
and accepted to be present ifthe ratio ofceftazidime/ceftazidime + clavulanic 
asid is >8. The bacteria consisted of Preudomunas uetuginosa (n = 69), E. rooli 
(n = 71). Iclebsiella sp. (n = 37). Acinetobacter sp. (n = 53). 
Results: The susceptibility pattern of the bacteria to the agents were sum- 
marized in the table. 
ESBL 
IMP IP CI P + T  TOB CT CE production 
P Aenrginosa n=dP 43% 34% 38% 59% 26% 17% 40% 15.9% 
Acinetobocter sp n=53 43% 45% 19% 26% 66% 10% 32% 5.6% 
E. coli n= 71 100% 99% 61% 77% 86% 80% 89% 15.5% 
Klebsiella sp n=37 100% 97% 78% 60% 73% 46% 78% 37.8% 
MP: Meropenem, I P  Imipenem, CI: Ciprofloxacin, P + T Piperacillin + tazobactam. 
TOB: Tobramicin. C T  Cefotaxime. CE: Cefepime. 
Conclusion: Among the most common Gram-negative pathogens 
isolated &om nosocomial infections, the ESBL production was found 
to be the highest for Mebsiellu sp.The most effective antmicrobial for I? 
amginom was piperacillin + tazobactam and for Achetobarter sp. tobramicin. 
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For the rest of the pathogens tested, carbapenems were found to be highly 
effective. 
/p14111 Nalidixic acid and ciprofloxacin susceptibility of 
ESBL-producing and nonESBL-producing Enterobaderiaceae 
K. Przedpelska, A. Samet, L. Naumiuk and B. Rybak 
Gdansk. PL 
Objective: To determine and analyze naIi&c acid (NA) and ciproffoxacine 
(CIP) susceptibllity among Enterobacteriaceae ESBL-positive and ESBL- 
negative. 
Materials and methods: The disc diffusion for zone diameten and agar 
dilution for MIC determination to NA and CIF’ methods were used for 200 
ESBL positive and 200 ESBL negative isolates. All isolates was collected over 2 
years from 1999 to 2000. 
Results: The overall sensitivity to NA and CIP was 68 and 80%, respectively. 
Three patterns ofsensitivity were obtained: 272 CIP and NA-S (68%), 79 C P  
andNA-R (20%) and 48 NA-R, CIP-S (12%). Ofthe latter group 105% were 
ESBL positive and 135% were ESBL negative. Only 45% of ESBL positive 
isolates were CIP-R and 7% NA-R, comparing to 14 and 24% of ESBL 
negative, respectively. There was a good correlation between MICs of NA and 
CIP and lnhibition zone diemeters; 29 ESBL negative and 91 ESBL positive 
isolates obtained from children were more sensitive to NA and CIP than the 
isolates &om adults (P< 0.005). 
Conclusions: The reason for the decreased NA and CIP resitance 
among ESBL positive isolates can be linked to the high percentage of 
ESBLs in pediatric wards. Fluoroquinolones are rarely used to treat 
infections in chddren; 12% oftested isolates were NA-R being s t i l l  susceptible 
to CIP which can lead to increased risk of resistance development to 
CIF’. We found NA susceptibility testing by drsc diffusion as good as agar 
dhtion method for assesing the risk of ciprofloxacin resistance in Enter- 
obacteriaceae. 
W) Antimicrobial agent susceptibility of ESBL- 
producing E. coli and K. pneurnoniae isolated in a regional 
hospital, Poland 
T. ZaGba, D. Stankiewicz and S. Tyski 
Warsav, PL 
Objectives: Extended-spectrum fi-lactamase (ESBL) producing clinical 
strains have became a major problem in hospitals, causing severe, difficult 
to treat infections. ESBL enzymes occur predominantly in K. pneumoniae and 
E. coli. Detection of ESBL expression has proved to be difticult in routine 
susceptibility testing, because using in vitro tests of resistance to cephalospor- 
ines and aztreonam at the NCCLS breakpoint for susceptibility may not be 
determinate. The occurrence of prevalence of ESBL among E. roli and K. 
pneumoniae strains isolated from inpatients during 2 months time-period this 
year, was noticed. 
Methods: The bacterial isolates were collected at the Microbiology Depart- 
ment in ’Brodnowski’ regional hospital in Warsaw. Species identification was 
performed by ID32 GN ATB System (BioMerieux) following the manufac- 
turers recommendations. A double-disk diasion method (DDT) was applied 
to detect extended-spectrum fi-lactamases with amoxicilline/clavulanate (201 
10 pg), ceftaddime (30 pg), cefotarcime (30 pg) and additionally aztreonam 
(30 pg) discs. Minimum inhibitory concentcltions (MIG) were determined 
by an agar dduhan techque  usmg MuelleeHmton agar accordmg to 
NCCLS. 
Results: T W - o n e  ESBLs posihve nonrephcated isolates of E mlr (4) and K 
pneumonfae (27) were collected The most of isolates were obmned from 
respmtory tract (mtratracheal tubes, tracheal swabs and sputum) and unne 
The majority ofwlates showedreduced Senslhvlty to ceftazldlme, whde were 
hghly resistant to cefotaxune due to the expression of cefotaxlmaze-type 
enzyme. The suscephbhty to cefoxlhn (cephamycin) was common All but 
one lsolates were resistant to amoxyche/clavularnc acid when tested by 
DDT One-thd isolates were rewtant to ammoglycosides, almost 3003 to 
ciprofloxacm and only 25% to tetracyche. The increase of ciprofloxacin 
resxstance among K. pneumoniaeis observed m compmson to respechve study, 
performed by us 2 years ago. All E colt strains were reslstant to menhoned 
anhrmcrobid agents. The MICs of carbapenems not exceed 0 12 mg/L value, 
except seven isolates wth MICs range of lrmpenem 1-4mg/L. Further 
inveshgahons would be necessary to charactenze type of ESBLs and the 
epidermology of s t r a m .  
In vitro activity of cefoperaz ndsulbactam 
vs. amoxicillin/davulanic acid and piperaciilin/tazobxtam 
against extended-spectmm plactamase 
(ESBL)-producing strains of E. col; and K. pneumoniae 
L Stratchounsh, I. Edelstem, A N a r e b ,  M. Edelstein and M Punlon 
Smotensk, RUS 
Objectives: To compare m yltm achvlty of the most commonly used 
pemch-&bitor combinahons (amoxlcdldclavulac acid AMC), piper- 
acllkn/tazobactam (PTZ)) and cefoperazone/sulbactam (CPS) agamst noso- 
comal ESBL-producmg isolates of E colt and K pneumonm. 
Methods: A total of 209 ESBL-producmg isolates of E colt (n = 49) and K 
pneumonrae (n= 160) collected m 21 Russian hospitals during 1997-1998 
were included m h s  study. The presence of an ESBL was detected by E-test 
ESBL strips. Suscephbhty to AUC @/I), PTZ (4mg/L fixed tam- 
bactam concentrauon) and CPS (1/1) was de termed wng E-test and 
results were mterpreted accordmg to the current NCCLS gudehnes The 
suscephbhty to CPS was determmed on the basis of cefoperazone MIC 
breakpoints. 
Reruk The results of suscephbhty tesMg are summanzed m the table. The 
pemcfin-dubitor combmahons were not acnve m mtm apns t  a ngmficant 
proporhon of ESBL producers and the MIC90 values of both AMC and PTZ 
exceeded the restance levels advocated by NCCLS At the same m e ,  CPS 
was actwe awnst the majority of strams with the excephon of smgle K. 
pneumoniae wlate (0.5%) explesslng a hgh level of resxstance (MIC 96 mg/L) 
and 12 (5.7%) mtermedlately resistant stram. 
AMC PTZ CPS 
% I + R  MICw % I + R  MICW % I + R  MICw 
E .  coli 85.7 48 36.7 256 2 12 
K. pneumoniac 81.9 64 48 1 256 6.9 16 
Au s ( T m  82.8 64 45.5 256 5.7 16 
Conclusion: Among all fi-lactam-itdubitor combmahons tested CPS revealed 
the highest activity against ESEL-producing organisms. Its superior activity 
probably attributed to the improved stability of cefoperazone and to the high 
concentration of the inhibitor component (sulbacram). 
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Resistance in nonfermenting Gram-negative bacteria 
[p14141 cmtxpenem-resistant ~ e u d ~ m o n a s  eruginosa 
in patients with and without carbapenem treatment 
L. Naumiuk and A. Samet 
Gdansk, PL 
Objectives: To study carbapenem-resistant Pseudomonar am@nosa (CRPA) 
incidence in patients with concurrent imipenem or meropenem therapy. 
Meth& We analyzed clinical and microbiological data of patients with 
meropenem (MEM) and imipenem (IPM) resistant I? aenrginosa isolates over 
l0months @mmry4ctober 2001). 
Results: During the study, 1092 P m g i n o s a  isolates were obtained 
h m  412 patients, CRPA being isolated 224 times h m  43 patients. 
Majority of CRPA were h m  respiratory tract specimens 27.5%, 
wounds 25% and blood 23%. Patients were h m  ICU (50%), hematology 
(18%). surgery (14.5%) and general medicine (6.5%). Eighteen patients 
received P M  and 10 MEM during or just before CRPA isolation. They 
suffered h m  polymicrobial mfections. DifTerent phenotypes IPM-S, MEM- 
R and IPM-R, MEM-S were recovered h m  other 23 and 6 patients, 
respectively. However, seven and three of them also possessed IPM-R, 
MEM-R isolates. 
Conclusions: CRPA are isolated &om 10% of patients with Pamginosa 
idectiodcolonization in our hospital. A t a d  of 28 patients (65%) received 
carbapenems during or before CRPA isolation. Phenotypes with difFerent 
IPM, MEM sensitivity can be cultured h m  the same patient. We have not 
suspected cross-infections among CRPA positive patients. Careful adminis- 
tration and patients selection should decrease the risk of carbapenem resistance 
during treatment in P aeruginosa. 
ml Epidemiology and antibiotic susceptibility of 
imipenem-resistant Pseudomonas aeruginosa 
V. Skandami, A. Xanthaki, M. Toutouza, M. Poujiouka, A. Tsiringa and 
C. Kontou-Castellanou 
Athens, GR 
Objectives: To study the frequency and antibiotic susceptibility ofimipenem- 
resistant Pseudomonas aeruginosa isolates &om clinically sigmlicant samples. 
Methods: All isolates were h m  clinically sigtllfcant samples and only one 
isolate per patient was included. Strains were isolated from bronchial secre- 
tions (25.2%). urine (20%), blood (11.8%), ear secretion (8.7%). sputum 
(8.3%). pus (7%). central catheter (5.1%), drainage (3.6%) and others (4.4%). 
Antimicrobial susceptibility testing was pedormed by the disk difhsion 
method according to NCCLS. 
Results: During the study period (January 1999-June 2001), 771 strains of 
Pseudomonas amginosa were isolated h m  clinical samples in our microbiology 
laboratory. Imipenem-resistant strains were collected From 21 3 (27.6%) 
patients. Of them, 114 were from the intensive care units, 50 general surgery 
units, 25 pathology clinics, 8 urology, 7 other surgery units, 5 cardiology, 4 
outpatients. The antibiotic susceptibility rates for imipenem-resistant and 
imipenem-susceptible strains were, respectively: ticarcillin (18-77%), ticar- 
cillin/clavulanate (2140%). piperacillin (24-80%), aztreonam (2&65%), 
amikacin (21-72%). netilmicin (22-720/0), gentamicin (1&51%), tobramycin 
(23-76%), piperacillin/tazobactam (27-85%), cefepime (2242%), ciproflox- 
acin (2945%). ceftazidime (26-89%), colistin (97-97%). We distinguised 
more than 30 resistant phenotypes and the most strains were multiresistant. 
The prevalence of multiresistant isolates difFered greatly between different 
wards. 
Conclusions: Imipenem-resistant Pseudomow amginosa is becoming an 
increasing therapeutic problem in our hospital and especially in intensive 
care units. Many isolates exhibit multiresistant phenotype. Of the antibiotics 
tested, the most effective proved to be colistin, ciprofloxacin, piperacillin/ 
tazobactam and cefepime. 
I PI416 I Analysis of prognostic factors in Pseudomonas 
aeruginosa bacteremia 
M. Alcktara, J. Gbmez, B. Martinez, J. Ruiz, E. Simarro, J. A. Herrero, 
M. Canteras and M. Valdb 
Murcia, E 
Background Pseudomonus aeruginosa causes infections with a high mortality 
rate, despite the availability of antimicrobials active against the microorganism. 
Objective: To identify prognostic factors in Pamginoza bacteremia (PAB). 
Methods: We prospectively analyzed 21 1 consecutive cases of PAB during a 
7-year period. Cultures, isolation, and antimicrobial sensibility were per- 
formed by standard methods. Death was considered related with the infection 
when it w a s  active at this moment. The variables analyzed were: sex, age 
(> 60, <60), acquisition (nosocod ,  community), baseline diseases 
(McCabe I, 11, 111), severity at first evaluation (accordulg to Winston low, 
medium, high, very high), with the blood cell (WBC) count (>12000, 
5-12000, <5000/pL), origin, presence of shock, administration of active 
antimicrobials. For the statistical analysis bivariant and logistic regression tests 
were used. 
Results. Overall mortality was 28% (59/211). Death was more frequent in 
patients with McCabe I (21/27,78%), and I1 (34/156,28%) than in subjects 
classified as McCabe I (4/27,15%) P< 0.02. Critical initial clinicalsituation at 
the first evaluation also was significantly related with the mortality (medium 
4/31-13%, high 34/147-25%, very high 21/33-64%). The presence ofshock 
also was related with mortality (58/72,81% vs. 11139 < 1% P <  0.0001). The 
poorest prognosis was detected in patients with a PAB of pulmonary origin 
(28/62, 45%), followed by those with unknown origin of the bacteremia 
(24/81, 300/0), compared with other sources (7/68, 10%) P<O.01. F d y ,  
patients who did not receive an adequate treatment also had ahigher morrality 
rate (14/21, 67% vs. 45/190, 24%) P<O.01. 
Conclusions: PAB has an overall high mortality rate. The prognosis of PAB is 
worse in patients with severe baseline diseases, critical condition at presenta- 
tion, development of shock, in bacteremias of pulmonary origin and in those 
not adequately treated. 
Ip14171 Comparative in vitro activity of carbapenerns 
against Acinetobacter baumannii and Pseudomonas 
aeruginosa isolates from the intensive care unit 
M. Fleischer, R. Franiczek, 0. Bortkiewicz, M. Stankiewicz, 
M. Grabowski and K. Fleischer 
Wfociaq PI. 
Objectives: The aim of this study was to compare the in vitro activity 
of imipenem and meropenem against AcinetDbmter baumannii and 
I? aerudnosa isolates recovered fiom patients hospitalized in the intensive care 
unit (ICU). 
Methods: A total of 158 nonduplicate isolates of A. baumannii (n= 93) 
and I? C W ~ ~ ~ ~ U S Q  (n = 65) were isolated fiom Variety of specimens obtained 
h m  patients hospitalized in ICU during the period 2000-2001. The 
isolates were identified by the automatic ATB system (bioMeriew). The 
minimal inhibitory concentrations (MICs) of imipenem and meropenem 
were determined by the agar dilution method according to NCCLS recom- 
mendations. 
Results: In vitro activity of imipenem against I? aeruginosa strains, expressed as 
MICSO/MIC%, ranged h m  4/32 mg/L in 20004/64mg/L in 2001. The 
MICw/MIC& values of meropenem were 4/32 mg/L in 2000 and decreased 
in 2000 (2116 mg/L). Imipenem activity against A. baumannii strains isolated 
in 2000 and 2001 were 4/16 and 4/32mg/L, respectively. In contrast to 
I? aenrginosa, meropenem was less active against A. baumannii s t r a i n s  isolated in 
2001 (MICso/MIC90= 16/64mg/L) in comparison with those isolated in 
2000 ( M I C S ~ / M I C ~ ~  = 8/32 mg/L). 
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Conclusions: The MIC50/MIC90 values of imipenem increased moderately 
among P aeruginosa and A. baumannii isolates during the period 2000-2001. 
It was found out that meropenem was more active against Pamginosa 
isolates. 
I P1418 I Risk factors in Pseudomonas aeruginosa 
bacteremia in a medical department of a tertiary-care 
hospital 
E. Karabatsaki, M. Agiannitou, F! Tsiodra and A. Efitratopoulos 
Athens, GR 
Objective: Our aim was to define the factors associated with increased 
mortality in bacteremias fiom Pseudomonas aeruginosa. 
Methods: We studied 50 episodes of bacteremia due to P aeruginasa. Logistic 
regression was used for the identification of possible clinical and laboratory 
risk factors for fatal outcome. The subjects studied were 49 patients, 26 males 
and 22 females, of a mean age of 64.6*8.2years, all hospitalized in the 
medical department of a tertiary hospital. 
Results: Eight of the 50 cases of P amginosa bacteremia were polymicrobial 
(16%). Crude mortality was 30%. The variables significantly and indepen- 
dently associated with an increased risk of death, were: (1) temperature 
<38.5"C (OR 5.3, P<O.Ol); (2) chemotherapy (OR 6.4, P<O.OOl); (3) 
pneumonia (OR 3.8, P<O.O5); (4) shock (OR 8.6, P<O.OOl) ;  (5) poly- 
microbial bacteremia (OR 6.8, P <  0.001); and (6) severe underlying disease 
(OR 7.4, P< 0.001). 
Conclusion: Pseudomonas aeruginosa bacteremias represent 13% of the total 
number ofiacteremias in our medical department. Clinical data easily assessed 
at bedside and few laboratory data can distinguish patients into high or low 
risk of death fiom Paeruginosa bacteremia and therefore lead to prompt 
installation of proper antibiotic therapy. 
/p14191 E f f e c t  of extracellular lipase activity of three 
Pseudomonas aeruginosa strains isolated from human 
infections on chemiluminescence reaction of human 
peripheral blood neutrophils and monocytes 
M. Hajartabar 
Tehran, IR 
Effect of extracellular hpase achvtty of Pseudomonas aerugtnsa EF2, ATCC9027 
and ATCC19660 s t r a m  isolated &om human mfechons on chermlurmnes- 
cence reachon of the penpheral blood neutrophh and monocytes investl- 
gated. Human penpheral blood neutrophtls and monocytes were 
premcubated wth  vanous concentration of hpases at 37 "C for 60 min After 
preincubanon, the cells were shmulated mth chemotacac pephde (F-Met- 
Leu-Phe 1C-5 M). A Beckman L 8000 scinhllatlon counter placed under ar- 
conmhoned thermostat-controlled 21 & 1 "C contllhons was used. Chenu- 
lummescence hnchon of the cells was assayed in mtro and performed m 
duphcates Appropriate controls were mcluded m each experiment. haChVa- 
non of the hpases were performed at 100 "C for 10 mm. Results were gwen as 
percentage of control cells response premcubated wth  buffer. Heat treatment 
of lipase at 100 "C for 10 mm almost abohhed the dubitory efEect on 
neutrophli and monocyte chermluminescence, whde hpases at concentrahons 
of 8 U I / d  inhibited neutrophd and monocyte chemtlummescence 
responses by approxunately 22 and loo%, respechvely. Also, premcubahon 
of neutroplvls wth the hpases at concentraaon of 4,2 and 1 UI/mL. resulted 
in appmmmately 12,5 and 4%. respechveiy, whde premcubated of monocytes 
with the same Concentrahons resulted ui 95, 48 and 3203, respechvely, of 
c h e d m e s c e n c e  response of control cells (premcubated mth buffer). The 
results showed that monocytes chemtlummescence response IS considerably 
more SensihVe to the lipase than the same response of the neutrophh. Also the 
results showed the inhlbitory effect of the extracellular llpase f h m  EF2 s t m m  
was lugher than the two other st rams used Since monocytes are one of the 
most nnportant cells of the host defense system, hpase achvlty of Pseudomonas 
mginosa may conmbute to the pathogenesis of infections caused by ths 
Gram-negahve bacterium 
m1 Significance of Pseudomonas aeruginosa 
colonization of the gastrointestinal tract 
T. Ohara 
Minamikawachi, JP 
Objectives: This s t u d y  was conducted to determine both the association 
between gastrointestinal (GI) colonization and the development of invasive 
Pseudomonas aeruginosa infection, and risk factors for acquisition of I? aeruginosa 
colonization of the GI tract. 
Methods: A prospective cohort study was undertaken. All stool specimen sent 
to microbiological examination were cultured for I? amginosa for 3 years. 
Colonization was defined as the isolation of I! aeruginosa fiom two consecutive 
cultures in the absence of infection. 
Results Stool specimens of 207 patients over 3 years were investigated. Ofthe 
207 patients, 87 were identified as l? mginosa-colonized. Forty-five patients 
had undergone previous iwasive procedures and 83 bad been prescribed 
antibiotics within 1 month prior to the isolation of P aeruginosa. The most 
common organisms isolated h m  stool with l? amginosa were Staphylococcus 
auras, coagulase-negative staphylococci, and Candida. In colonized patients, 
P amginosa were isolated from the following body sites in addition to the GI 
tract: respiratory tract (3Yh), skin (16%). urinary tract (15%), throat (13%), 
and nose (10%). Fourteen distinctive P m g i n o s a  infections developed in 13 
patients. Infection associated with GI colonization included four cases 
of pneumonia, four of urinary tract infection, three of skin infection, and 
three of bacteremia. No statistically significant correIation were observed 
between the acquisition of infection and age, gender, underlying disease, 
previous invasive procedure, or duration ofhospitalization. Ofthe 87 patients, 
12 were diagnosed with ileus and three underwent gaswstomy when 
colonized. 
Conclusions: Approximately 15% of GI-colonized patients develop invasive 
infection. Age, gender, underlymg disease, previous invasive procedure, and 
duration of hospitahtion are not risk factors for the development of invasive 
P aeruginom dections in colonized patients. Gastrointestinal disorders, and 
obstruction and surgical interventions in pamcular, are important factors in 
GI tract colonization by I? amginosa. 
I P1421 I Levofhxacin in the treatment of Pseudomonas 
aeruginosa in patients with nosocomial pneumonia 
J. Kahn, M. Oross, A. Tennenberg and B. Wiesinger 
Raritan, USA 
Objective: A recently completed trial comparing levofloxacin (L) 
750mg i.v./p.o. and imipenem/cilastatin (IC) 500-1OOOmgi.v. per every 
6 h  followed by oral ciprofloxacin 750mgbid in patients with nosocomial 
pneumonia (NP) demonstrated no statistically sigmficant differences in 
clinical efficacy (L 58.1% and IC 60.6%) or microbiological eradication 
(L 66.7% and IC 60.6%) between the two arms. A more detailed, patho- 
gen-specific, analysis has recently been undertaken and features interesting 
Merences in how the regimens compared in term of their likelihood of 
eradicating I? amgfnosa and being associated with superinfections due to those 
organisms. 
Methods: Patient populations in the two groups were evaluated with a 
variety of potential severity stratification including length of hospitalization 
prior to onset ofW, requirement for intubation, initial oxygenation, number 
of co-morbid factors, and overall APACHE I1 scoring. As per protocol, 
adjunctive therapy was encouraged when Pamginosa was proven or sus- 
pected: ceftazadime or other antipseudomonas B-lactam or an aminoglycoside 
were to be added to the (L) or (IC) arm, respectively. 
Results: Of a total of 438 patients enrolled, 187 were microbiologically 
evaluable: 93 in the (L) arm and 94 in the (IC) arm. Microbiological 
eradication rates for select pathogens of interest are displayed in the table. 
Pathogen N No. eradicated N No. eradxated 
S. a u m  21 14 (66.7) 19 13 (68.4) 
I! aeruginosa 17 10 (58.8) 17 5 (29.4) 
S. marcescenr 11 9 (81.8) 7 2 (28.6) 
E.  coli 12 10 (83.3) 1 1  7 (63.6) 
K. pneumoniae 11  9 (81.8) 7 6 (85.7) 
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An analysis of superinfections showed dSerences between (L) and (IC). 
S.aureus superinfections were seen in roughly the same in number and 
distribution of infection types; there were five s.+eulh infections on (L) 
but only 1 on (IC). On the other hand, there were 16 cases of infections 
caused by pseudomonads (nine I! ueruginosa, seven S. maltophilia) on (IC) and 
only 4 (two Pamginosa, two S. maltophilia) on (L). 
Conclusions: It seems hkely, given the overall comparability of risk factols in 
the two arms, that these ditferences are accounted for on the basis of 
microbiologic properties of the two agents and strengthen the argument that 
serious infections like NP should be treated with at least two antimicrobial 
agents h m  difierent classes. 
1 PI422 1 B-Lactam, aminoglycoside and fluoroquinolone 
resistance in Pseudomonas aeruginosa clinical isolates 
obtained from a hospital in Bratislava. Slovakia 
M. Kettner, D. Michalkova-Papajova, A. Zakova, J. Balaz, L. Perdochova 
and D. Rovna 
Bratislava, SK 
Objectives: The set of35 Pseudomonas aeruginosa isolates selected as resistant to 
clinically used B-lactam antihiotics were collected in different wards of 
Hospital Ruzinov, Bratislava. The aim was to study the occurrence of 
resistance to selected 8-lactams: ampicillin (AMPI), cefoxitine (CFOX), 
cefotaxime (CTAX), ceftazidime (CTAZ), ceftriaxone (CIAX), cefepime 
(CEPI), azthreonam (AZTR), meropenem (MEW); aminoglycosides: gen- 
tamicin (GEN), tobramycin (TOB), netilmicin (NET), amikacin (AMI), 
isepamicin (ISE); and fluoroquinoloues: ofloxacin (OK), ciprofloxacin 
(CIP). Transferability of aminoglycoside and b-lactam resistance, production 
ofb-lactamases and ESBL and the presence ofplasmid DNA in clinical isolates 
were studied, too. 
Methods: Resistance was tested by standard agar dilution method (NCCLS 
2000). Nitrocephin method was used for the detection of clinical isolates that 
produce /I-lactamases. Production of ESBL was detected by double diffusion 
test. Transferability of resistance was tested by bacterial conjugation using 
Pseudomom aeruginosa 1008 as a recipient strain. The plasmid DNA was 
isolated by alkaline lysis and its molecular weight was determined by agarose 
gel electrophoresis. 
Results The occurrence of resistance was: 97.1% to AMPI; 100.0% to 
CFOX 77.1% to CTAX, 48.6% to CTAZ; 54.3% to CIAX; 28.6% to CEPI; 
54.3% to AZTR 11.4% to MERP; 82.9% to GEN 80.0% to TOB; 80.0% to 
NET; 0.0% to AMl; 80.0% to ISE; 82.9% to OFL and 85.7% to CIP. 85.7% of 
clinical isolates were identified as 8-lactamase producers, but none of the 
isolates produced ESBL. Resistance to all 8-lactams and aminoglycosides was 
transferable by bacterial conjugation. The &equency of transfer was &om 
1.4 x 10-6-2.3 X lo-'. From the selected isolates and their transconjugants 
the plasmid DNA with molecular weight ranging &om 60 to 73 MDa was 
isolated. 
Conclusions: The kequent occurrence of resistance was determined in the 
case of all antimicrobial agents tested, with exception of aminoglycoside AM1 
to which all isolates were susceptible and carbapenem MEW to which only 
four isolates were moderately resistant. Transferability of B-lactam together 
with aminoglycoside resistance by conjugative plasmids may contribute to 
spread of multiresistant Pseudomonas aeruginosa clinical isolates in the hospital. 
Study of plasmid DNA have pointed to the occurrence of nosocomial 
plasmids with the same molecular weight about 65MDa in many dinical 
isolates. 
lp1423) Evaluation of Sensidisc diffusion method for 
synergy qualitative screening of Gram-negative 
nonfermentative (GNF) clinical isolates 
L. Piccoli, I. Erbetti, M. B. Marturano and F. Marchetti 
Erona, I 
The antibiotic combination therapy is often required in the treatment of GNF 
nosocomial infections, to increase antibacterial activity and broaden the 
bacterial spectrum. Nevertheless, synergistic effect of an antibiotic combina- 
tion is strain dependent and the checkerboard and killing curves methods are 
not easily performed in routine laboratory work because labor-intensive 
and time-consuming. For this reason, an easier and cheaper method for 
qualitative screening of synergism is desirable. In h s  study, we compared the 
checkerboard in broth and the disc di&sion method to determine synergistic 
&ect of levoflmcin (LVX) and cehid ime (CAZ) in combination, against 
31 I? aeruginosa isolates, 13 S. maltophilia and 12 Acinetobacterspp. Disc diffusion 
method (Ml) was performed placing the discs containing each antibiotic at 
three fuced distances among them, established on the basis of the susceptibility 
breakpoints. Combination was considered synergistic if an enhancement or 
bridging was observed at or near the junction of the two zones of inhibition. 
In addition, the effect of LVX/CAZ Combination against I! aeruginosa isolates 
was investigated placing the discs one close to each other (MZ). lo this case, 
combination was considered synergistic ifan enhancement of inhibition zone 
was observed compared with those of the single drugs. Results obtained by 
checkerboard and M1 were in agreement for 64, 69 and 500h against 
l? aeruginosa, S. maltophilia and Acinetobdr spp.. respectively. Most of the 
disagreement cases concerned the combinations that were declared additive 
with checkerboard method but gave profles closer to synergistic or indifferent 
effect with the disc diffusion method. The results of combination in M2 
against I? aemginosa isolates were in agreement for 58 and 80% with those 
obtained with checkerboard and M1 method, respectively. In conclusion, 
both CLsc a s i o n  methods here reported look promising for qualitative 
scleening of in vitro synergy test, even though a larger number of strains and 
dserent antibiotic combinations have to be investigated. 
I PI424 1 In vitro development of resistance to B-lactam 
antibiotics in P. aeruginosa 
l? Bildstein, M. Blasko, U. Frank and F. D. Daschner 
FreibuE, D 
Objdves: To investigate whether stepwise selection of resistance in Psm- 
domonar aeruginosa reflects exposure to antibiotics in the clinical setting. 
Methods: Five isolates of Pseudomom aetuginosa were obtained h m  the 
culture collection ofthe National Reference Centre (NRC) study (EurJ Clin 
Microbiol Infect. Dis 2000; 19 888-91) and five isolates h m  patients 
suffering from cystic fibrosis. The 8-lactam antibiotics tested were piper- 
acillin, ceftazidime, cefepime, imipenem and meropenem. In addition the 
aminoglycoside amikacin was investigated. The minimal inhibitory concen- 
trations (MIC) were determined by microdilution technique according to 
NCCLS-guidelines. Development of resistance was investigated by up to 30 
serial passages on blood agar plates contahmg subinhibitory concentrations of 
the respective antibiotic. Antimicrobial resistance was defined as a four-fold 
increase in the MIC with stability after 10 serial passages on antibiotic-fke 
media. 
Results: After 10 passages 74.5% ofthe l? aemginosa isolates isolates had already 
acquired phenotypic resistance against the b-lactam antibiotics. Upon ter- 
mination of the test series a sieufcant increase in b-lactam resistance had 
developed in 110 of 120 (91.7%) of the isolates and resistance proved stable in 
95 (86.4%). Of the NRC study isolates 86.7% (52 of 60) acquired stable 
/3-lactam resistance, whereas only 66.7% (33 of 50) of the mucoid z? aeruginosa 
isolates &om cystic fibrosis patients. For the aminoglycoside antibiotic 
amikacin stable resistance was acquired by 60% of the organisms. 
Conclusions: From our in vim study, we can conclude that the rate of 
development of resistance in I! aeruginora against b-lactam antibiotics appears 
to be lower in mucoid I? ~ruginos~ trains kom cystic fibrosis patients. 
-1 Assessment of incubation times for testing 
antibiotic combinations against multiply resistant isolates 
from cystsic fibrosis patients by E-test 
F. M. MacKenzie, K. E. Milne and I. M. Gould 
Aberdeen, UK 
Objectives: It is not clear why E-test methods state incubation times of 48 h 
for both MIC and synergy testing of non lactose fermentors. Standard 
NCCLS MIC methods and checkerboard synergy testing recommend 24 h 
incubation. The objective of this study was to compare 24 and 48 h incubation 
times for E-test MIC and synergy testing with standard methods. 
Methods: A total of 114 MICs were carried out by NCCLS broth micro- 
ddution (24 h) and E-tests (24/48 h). 100 synergy tests were carried out by 
microdilution checkerboard (24 h) and E-test (24/48 h) methods. Eleven 
isolates of Pseudomom aeruginosa, 10 Burkholderia cepacia, five Stenotrophomonas 
maltophilia and two Alaligews ~~losoxidans were tested and eight antibiotics 
were used. Fractional inhibitory concentration indices (FICIs) were 
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calculated and antibiotic combinations interpreted as follows: synergy 
(FICI < O S ) ,  additive effect (FICI > 0.5-1.0), indifference (FICI > 1.0- 
2.0) and antagonism (FICI > 2.0). 
Results: MICs by E-test (24 h) gave better agreement (95%) with NCCLS 
methodology than E-test 48 h (93%) although there were marginally more 
majorerrors (15%) at24 hthan48 h (13%).E-test (24 h) comparedwithE-test 
(48 h) gave 92% agreement with 8% major errors. E-test synergy testing at 
both 24 and 48 h gave 43% agreement with the standard checkerboard 
method. E-test (24h) however, resulted in fewer major errors (10%) than 
E-test (48h) (13%). Poorest agreement of MIC resulu was found for the 
isolates of S.  maltophilia [NCCLS vs. E-test 24 h (70%) and 48 h (54%)] and the 
best agreement was found with the A. xylosmidans isolates (89% NCCLS vs. 
E-test 24 and 48 h). Poorest agreement of synergy results was found for the 
Pseudomonas species [NCCLS vs. E-test 24 h (31%) and 48 h (34%)] and best 
agreement between synergy methods was found for the S .  maltophilia [check- 
erboard vs. E-test 24 h (78%) and 48 h (H9%)]. 
Conclusions: Our results provide no evidence to support manufacturer’s 
recommendations that E-test MICs and synergy testing be carried out with 
48 h incubation of nonlactose fermentors. 24 h incubation ofE-test MIC and 
synergy tests was found to compare as well as 48 h incubation when compared 
with standard NCCLS MIC and checkerboard methods. Some inter-species 
variation in results was found. 
/p1426/ Resistance development of P. aeruginosa to 
fluoroquinolones and aminoglycosides 
K. Kirst, M. Blasko, U. Frank and F. D. Daschner 
Freiburg, D 
Objective: To explore the development of stable resistance of 10 I? aeruginosa 
strains in vitro to fluoroquinolones and aminoglycosides. 
Methods: Five isolates of Paerugiirosa were obtained from the 
culture collection of the National Reference Centre study (Eur J Clin 
Microhiol Infect Dis 2000; 19 888-91) and five isolates from 
patients suffering from cystic fibrosis. The fluoroquinolones tested were 
ciprofloxacin, levofloxacin, moxdoxacin, gatifloxacin and the aminoglyco- 
sides were tobramycin and netilmicin. Minimal inhibitory concentrations 
(MIC) were determined by microdilution technique according to NCCLS 
guidelines. Development of resistance was investigated by up to 30 serial 
passages on blood agar plates containing subinhibitory concentrations of the 
respective antibiotic. Antimicrobial resistance was defined as a four-fold 
increase in the MIC with stability after 10 serial passages on antibiotic-fiee 
media. 
Results: A significant increase in resistance developed in 108 of 118 (91.5%) of 
the I? amrginosa isolates. Resistance was stable in 81 (75%) of the isolates. A 
total of 87.5% of the isolates developed resistance to quinolones (i.e. gati- 
floxacin 88.2%, and moxifloxacin 83%). while 75% remained stable. All the 
strains tested acquired phenotypic resistance to aminoglycosides, which in 
73.7% remained stable. 
Conclusions: If exposed to subinhbitory concentrations I? amrginosa quickly 
develops resistance to fluoroquinolones and aminoglycosides. 
included in t h s  study. In the period between January and December 2000, 
35.5% ofthe strains were obtained h m  surgery clinics, 31.5% intensive care 
unit, 22.5% bum unit and 10% internal medicine clinics. The 
dstribution of the strains according to the isolation sites were as follows: 
46% of the strains were obtained horn wound and abscess, 22% respiratory 
tract, 7.8% blood, 1.3% ear and 10.5% miscellaneous. The in vitro activity of 
cefoperazone, amikacin, ciprofloxacin, aztreonam and imipenem to Z? aenr- 
ginosa were examined by microdilution broth test according to NCCLS-M7- 
A4. The resistance pattern was as follows: 48% to cefoperazone, 22% to 
amikacin, 33% to ciprofloxacin, 54% aztreonam, 18.5% to imipenem. 
Twenty-one percent of the total strains (182 strains) were found as multiple 
resistance strains which were isolated from burn unit (69%) and intensive care 
units (31%). Resistance to cefoperazone, ciprofloxacin and aztreonam of 
I? amrginosa strains in our hospital were very high. This can be explained as the 
strains are mostly isolated &om burn and intensive care units, also inappropri- 
ate antibiotic administration and not obeying to hospital infection control 
procedures. 
lp14281 Antibiotic-resistance pattern of clinical isolates of 
Pseudomonas aeruginosa in a university hospital, 1996-2001 
S P&ez-Ramos, J. L6pez-Barba, M -I Soho-Ocaiia, 
I Jeshs-De-La-Cde and M. Rodriguez-Iglesias 
Duerto Real, E 
Objective: Descnphon of resstance pattern of Pseudomonar aerupnosa (Ps.a), 
in chmcally significant samples of pahents rermtted to the Laboratory of 
Mcrobiology during a 6-year penod (1996-2001). 
Material: The samples rermtted have been evaluated for study durmg the 
period understood between 1996 and 2001 The samples have been processed 
for the lsohhon of Ps a The idenhficahon and suscephble to anhbiohcs has 
been performed u1 automated system McroScan(c) DadeBehnng(c) 
through panels Combo Neg 61 (1997-1998) or panels Combo Neg 1s 
(1999-2001). The data were processed by the StahStiCd system Statgraphics 
Plus 4.1. 
Results: During the period of study has been isolated 1897 Ps.a. The 
percentages of isolates hom samples was. respiratory samples 27.9%, umary 
samples 264%, s k i n  lesions 1622%. wound 10.1%, ear Qscharge 8.2??, 
blood 3.3%, abscess 3% and other samples 4.88%. The resfitance is shown 
in Table 1 
Table 1 
a Aug As Cpc Cfe Cft Cnr Cp For Om Imp Mm 08 PIT R TI To TIS h p l u  
19% 4 99 27 * 54 U 15 29 22 * * ‘ ’ 24 20 4 % 289 
1997 5 100 22 * 88 13 13 67 23 ’ * . 24 I I  4 93 315 
1998 S 98 25 13 100 91 I2 15 65 22 14 4 24 9 12 14 6 95 328 
iw9 4 99 27 1s PI 92 14 15 74 24 17 in 24 8 11 IS 3 95 287 
ZWO 9 IW 35 20 1W 89 17 16 75 28 IS 10 M 12 14 I6 9 95 323 
2001 15 99 27 26 100 91 19 22 79 M 19 10 34 12 14 16 10 95 355 
Keys antibiotics: Ak=amikacin; Aug=amoxicillin/clavulanic ac.; Azt=aztreonam; 
C h  = cefazolin, Cpe = cefepime; Cfe = cefkime; Cft = cefotaxime; C& = cefoxitin; 
Caz = ceftazidime; Cp = ciprofloxacin; Fos = fosfomycin; Gm = gentamicin; Imp = 
irnipenem; Mer = meropenem; Ofl = ofloxacin; PIT = piperacilinltazobactam; Pi= 
piperacillin; Ti = t i c a r m  To = tobramycin; T/S = trimethoprimlsul. (% of resistance 
for antibiotic and year). 
I P1427 I The antibiotic sensitivity of Pseudomonas 
aenrginosa isolated from various clinical specimens 
S .  Kursun, S. Aksaray D Tezeren, E Guvener, N Balaban and V Yetener 
Ankara, TR 
The number of Pseudomom aeruginosa isolates in both from hospital and 
commumty acqlured lnfeChOnS are mcreasmg. The increasmg resistance raho 
of the anhbiohcs and the emtance of the mdhple reslstance are serious 
problems. The goal of h s  study was to find out the mdhple resistance 
l? amrgtnosa strains isolated from various chmcal materials and the anhbiohc 
resstance pattern A total of 182 strams lsolated fiom various chmcs was 
The resistance of Ps.a have showed an important increased against 
Fos (50%), Cft (37%). Cpe (~WO), Ak (11%) and (lo??). A less 
increased have at Gm (8%), Caz (7%), Cp (7%), To (6%) Mer (6%) and 
Imp (5%). The rest of antibiotics have stayed in constant Ievels during these last 
years. 
Conclusions: The isolates of Ps.a in the area of the university hospital 
have shown a significant increased in the resistance to cephalosporins 
11 th-generation, aminoglycosides and fluorquinolones. The increase in 
resistance pattern against this antimicrobial agents and cephalosporins 
third-generation is a very important event that requires of a strict surveillance 
in the microbiology laboratory. 
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exposition I! aemginosa becomes progressively resistant to several classes of 
antimicrobial agents. An increasing incidence of S. maltophilia isolates has been 
reDorted m some CF centers. Ths oreanism is hi& resistant to many 
wl Comparison of intravitreal ceftazidime and 
merpenem in treatment of experimental pseudomonal post- 
traumatic endophthalmitis in a rabbit model 
G. M. Ay, S .  Akhan, S. Erturk, S. Aktas, N. Kir and Y. Caglar 
Kocaeli, Irtanbul, TR 
Objectives: We developed an experimental model of post-traumatic pseu- 
domonal endophtalmitis in rabbits to compare the efficacy of intravitreal 
cefiazidime and three doses of meropenem. 
Materials and methods: A penetrating eye injury was made in the right 
eyes of 35 rabbits. 0.1 mL from 104cfu /d  of Pseudornonus aeruginosa 
ATCC 27853 were inoculated in the midvitreous body. Most animals 
showed the first signs of e n d o p h h t i s  in 14-16 h after inoculation. The 
animals  were examined chically at 2,4,12 and 22 h after surgery using slit- 
lamp biomicroscopy and indirect ophthalmoscopy. Rabbits were divided into 
five treatrnentgroups. Seven rabbits received 0.1 mL intravitreal injection of 
ceftazidime (22.5 g/L); seven rabbits received 0.1 mL intravitreal injection 
of meropenem (0.5 g/L); seven rabbits received 0.1 d intravitreal injection 
of meropenem (1 g/L), 7 rabbits received 0.1 mL intravitreal injection of 
meropenem (2 g/L) and seven rabbits received 0.1 mL of normal saline. At 2 
and 24 h, two 100 pL vitreous samples were taken for high-pressure liquid 
chromatography analysis and colony counting in culture. 
Results: At 2 h, vitreous levels of ceftazidime were above the two doses (0.5 
and 1 g/L) of meropenem (P< 0.05). At 24 h, vitreous levels of ceftazidime 
were above the three doses of meropenem (P  < 0.05). Culture results showed 
no difference between treatment with ceftazidime or three doses of mer- 
openem. Clinical and bacteriological examinations revealed significantly less 
idammation in rabbits treated with ceftazidime and meropenem than saline 
control groups. 
Conclusion: Intravitreal antibiotic treatment both with cefiiidime and 
meropenem appears effective. 
" " I  
antibiotics. The aim of this study was to investigate the activity of the newer 
fluoroquinolones; levofloxacin, m d o x a c i n  and gedoxacin in compar- 
ison with ciprofloxacin and ofloxacin against these two groups of multiply 
resistant bacteria obtained tiom CF patients. 
Methods: Thirty-four multiply resistant I! amginosa isolates and 17 S. mal- 
tophilia strains obtained h m  respiratory specimens of 16 CF patients between 
1997 and 2001 were included in this study. Susceptibilities of the strains to 
various fluoroquinolones were studied by the agar dilution procedure, 
according to the recommendations of the NCCLS. 
Result The table shows the results of the in vitro activity of the fluoroqui- 
nolones tested, 
MIC (mg/L) 
Microorganism 
(n*) Quindone Range MIC,o MICgo S% I% R% 
l? aemginosa (34) LEV0 0.25-128 4 16 21 32 47 
OFX 0.5-128 8 32 21 12 67 
CIP 0.0&64 2 4 15 38 47 
MXF 0.0&>128 8 32 15 15 70 
GEM 0.12->128 2 8 12 - 38 
2 100 - - 
OFX 0.5-4 2 2 88 12 - 
CIP 0 . 2 5 4  2 4 18 35 47 
1 100 - - MXF 0.06-1 0.5 
GEM 0.03-2 1 2 35 - 65 
S.  maltophilia (17) LEV0 0.252 0.5 
S: sensitive, I: intermediate sensitive, R: resistant. 
Conclusions: We conclude that the newer fluoroquinolones are not a good 
choice for the treatment of respiratory tract infections of CF patients with 
multiply resistant E! aeruginosa strains, but levofloxacin and moxifloxacin 
display potent and superior activity to those of other fluoroquinolones against 
S. maltophilia and could be considered a good option for the treatment of 
infections sustained by this bacteria in CF patients. 
m] Old drugs for new use: in vitro activity of 
polimixins against Gram-negative bacilli 
M. Martino, L. Pistori, R. Cruz, S .  Cely, A. Navarini, L. Mimica and 
I. Mimica 
SZo Paulo, B R  
Introduction: Polimixins are a group of cyclic basic polypeptides. Only 
polymixins B and E (colistin) are available for therapeutic use in humans. 
Emergence of resistance in many genera of Gram-negative bacteria emerged 
quickly and it is now found worldwide. In Brazil, this fact have not different 
aspects and in some cases we do not have any standard antimicrobial available 
to be used. 
Objectives: Evaluation of antimicrobial activity of polimkin B and colistin 
against Gram-negative bacilli resistant to cefalosporin and sometimes even 
imipenem. 
Methods: Susceptibhty testing was performed by using the E-test (AB 
BIODISK, Solna, Sweden) and following NCCLS procedures. The 
MICw and M E w  were determined with both antimicrobial. Thirty strains 
-1 Antimicrobial activities of gatifloxacin, 
sulfamethoxazole against nosocomial isolates of 
Stenotrophomonas maltophilia 
levofloxacin, ciprofloxacin a d trimethoprim- 
were analyzed and MICSO and MICw. 
Results: MIC50 and MICgo against Gram-negative bacilli, in mg/L, were 
respectively: politnixin B, 1.5 and 3.0 (range from 0.75 to 4.0); colistin, 1.0 
and 1.5 (range h m  0.38 to 2.0). 
M. Giovanakis, I. Agorio, C. Bondulich, L. Canteros and M. Visser 
Buenos A i m ,  AR 
ConclusionsiPolimixh B and Colistin was found to be effective against most 
strains of Gram-negative bacilli. Although polymixins are very toxic, it could 
be reserved for serious infection due multiply resistant organisms. 
LP1431 1 In vitro activities of ciprofloxacin, ofloxacin, 
levofloxacin, moxifloxacin and gemifloxacin against 
multiply resistant Pseudomonas aemginosa and 
Stenotrophomonas maltophilia strains obtained from cystic 
fibrosis patients 
Z .  Aktas, M. Salcioglu and Z .  Erturan 
Istanbul, TR 
Objectives. Aggressive antibiotic therapy is one of the main reasons for the 
improvenient in life expectancy among CF patients. Due to repeated drug 
Introduction: Sfenofrophomonus muftuphiliu (Sm) is a nonfermentative Gram- 
negative bacillus that is now emerging as one of the leading causes of 
nosocomial infection, especially in intensive care units. This organism usually 
affects immunocompromised, mechanical ventilated, use of intravascular 
devices, broad spectrum antibiotic prophylaxis and prolonged hospitalization 
patients. Management of Sm infections can be difficult due to its inherent 
multidrug resistance. 
Objective: The purpose of this study was to evaluate in vim activities 
of gatifloxacin (G), levofloxacin (L), ciprofloxacin (C) and trimethoprim- 
sulfamethoxazole (TMS). 
Methods: Organisms were identified according to Manual of Chical 
Microbiology Murray, 7th edition and conf i ied  by API 20 NE (bioMerieux). 
We determined MIC by agar dilution method with Mueller Hinton against 63 
Sm isolated from 23 blood cultures (11 from venipuncture; 12 through 
catheter), 15 respiratory tracts, 4 urine, 21 other samples. Agar p1ate.s were 
incubated aerobically a t  35 "C for 24 h. MICs were interpreted according to 
NCCLS 2001 guidelines criterium for Pseudornonar aeruginosa and other 
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non-Enterobacteriaceae. MICs break points used for G were: 5 2  pg/mL 
susceptible, 4 pg/mL intermediate and 28 g g / d  resutant (this breakpomt 
apphes to isolates &om the urmary tract only). Pseudomonas mginosa  ATCC 
27853 and Escherichia cofi 25922 were used for quality control. 
Results: Out of 63 tested strains: 1 to G, 2 to L, 4 to TMS, and 36 to C were 
resstant (see table). 
Drug Range 50 90 Break pomt Susceptibdity isolate (%) 
Gatdoxacin 0.06-4 0.5 1 1 2  98.42 
Levofloxacin 0.0- 0.5 1 5 2  96.23 
TMS 0.25-16 0.5 1 52/38 93.66 
Ciprofloxacm 0.5-32 2.0 8 11 42.86 
Conclusion: These results showed that G and L were more active in vitro than 
TMS (drug of choice) and C was the least effectwe against Sm. 
I PI433 1 In vitro synergy of colistin with rifampin and 
cotrimoxazole on multidrug-resistant Stenotrophomonas 
maltophilia 
L. Karnesis, E. J. Giamarellos-Bourboulk and H. Giamarellou 
Athens, GR 
Objective: Nosocomial infections by S. maltophilia are managed with difKculty 
due to the limited number of therapeutic options. Interactions of cohtin with 
rifampin and cotrimoxazole were investigated as probable candidates active on 
that species. 
Methods: Twenty different isolates were exposed over-time to the in vitro 
interaction of 1 x and 4 x MIC of colistin with 2 pg/mL of rifmpin and 2/ 
38 p g / d  of trimethoprim/sulfamethoxazole, i.e. concentrations represent- 
ing mean serum levels. All isolates were resistant to ampicillin/sulbactam, to 
rifampin (MIC > 64 pg/mL) and to cotrimoxazole (MIC > 4/76 p g l d ) .  
Antibiotics were added with a 6log-phase inoculum of each isolate in 
Mueller-Hinton broth and bacterial growth was determined at standard time 
intervals during incubation at 37°C. Synergy was defined as any more or 
equal to a 2 log 10 decrease of viable cell counts compared to the most active 
single agent. A total of 180 time-kill curves were performed. 
Results. Synergy between 1 x MIC and 4 x MIC ofcolistin and rifampin was 
found in eight (55%) and 10 (55%) isolates, respectively, after 4 h of growth, in 
11 (55%) and 11 (55%) isolates, respectively, after 6 h of growth and in 11 
(55%) and 13 (65%) isolates, respectively, after 24h of growth. Synergy 
between 1 x MIC and 4 x MIC of colktin and cotrimoxazole was found 
in one (5%) and four (20%) isolates, respectively, after 6 h of growth and in 10 
(50%) and 10 (50%) isolates, respectively, after 24h of growth. 
Conclusions: Colistin interacts synergistically with rifampin and to a lesser 
extent with cotrimoxazole on a considerable number of S. maltophifia isolates. 
That interaction occurs over the first hours of bacterial growth so as to 
become promising for the therapeutic management of nosocomial infections 
by these isolates. 
I PI434 I In vitro activity of aminoglycosides on 
Stenotrophomonas malthophilia virulence factors 
V Majtin and L Majtinovi 
Bratislava, SK 
Objectives: The a m  of study was to mveshgate the effect of aminoglycosides 
(adac in ,  gentamcm, netllrmcin, tobramycin, streptomycm) at the subin- 
hbitory concentrahons (sub-MICs) on the cell-surface hydrophobiclty, hpase 
actmty and monltty of S malthophtfta strain isolated 6om tonsd ofpanent wth 
tumor duease 
Methods: The cell-surface hydrophobicity was evaluated by the method of 
bacterial adherence to hydrocarbon-xylene (BATH) and by the method ofsalt 
aggregahon wlth ammomum sulfate (SAT). The hpase achnty was measured 
spectrophotomerncally in the culture filtrates by the use of polyoxyethylen- 
sorbitane (Tween 60). The mothty assay was performed on the semsohd 
swarmmg agar mehum (0.35%). 
Results: The highest inhibition of adherence to xylene caused by both 
gentamicin and amikacin at 1/4 of the MIC was 68.6 and 69.9??, respectively. 
These data correlated with the results of salt aggregation test. AII antibiotics 
tested at sub-MICs expressively inhibited the lipase production. Amikacin 
caused the total inhibition of this enzyme within the whole concentration 
range. Exposure ofthe bacterial cells to sub-MICs ofaminoglycosides resulted 
only in moderate inhibition of motihty of the saain tested compare to the 
unexposed cells. 
Conclusions: The results obtained indicate the interference of aminoglyco- 
sides with pathogenic potential of S. malf~oph~~ia  at sub-MICs of aminoglyco- 
sides, namely gentamicin and amikacin. 
I PI435 I Stenotrophomonas maltophilia (SM) in an 
ambulatoty patient population 
E. Pearlman, S. Butala, L. Bilello and J. Stauffer 
Long LFfand City, USA 
SM has become an important nosocomial pathogen in hospitalized, immu- 
nocompromised patients and has been noted to colonize the respiratory tract 
of patients with cystic fibrosis (CF) [J Hosp Infect 1995: 3 0  4531. Little 
appears to have been written about SM in the non-hospitalized population. 
CLS is a large fkestandmg clinical laboratory in New York City serving an 
exclusively ambulatory population. Over a 7-month period (9/1/1999-4/1/ 
2000), 30 patients had positive cultures for SM. Culture and identification of 
the organism used standard procedures [ASM Manual of Clinical Micro- 
biology (7th ed.), 19991 and Vitek instrumentation (BioMerieux; Hazel- 
wood, MO). Antibiotic sensitivity studies used E-test strips (AB BioDisk; 
Piscataway, NJ). The positive cultures were approximately equally distributed 
by gender (17F) and appeared to come mainly from older adults with 22/30 
(73%) h m  individuals 252 YO and 18/30 (60??) patients 262 YO. Two 
patients however, were 5 and 7 YO. Culture sources included sputum (14), 
mucocutaneous/soft tissue (9), genital (4). urine (2), ear (1). With respect to 
the sputum specimens 8/14 (58%) were from patients 262 YO. Associated 
conditions included cancer (3) [prostare, breast, non-Hodgktn’s lymphoma], 
sarcoidosis (2) and COPD (1). The 9 cultures from mucocutaneous/sofi 
tissues included 8 foot ulcers, 7 ofwhich were fiom patients 272 YO, and 1 lip 
pustule (F, 7 YO). The four genital cultures included one case in which there 
had been a recent termination of pregnancy and one case of prostate cancer 
treatedwith radiation. One of the two urine cultures was associated with BPH 
and recent catherization. None of the patients had a hwtory of CF. Sensitivity 
data indicated that 29/30 cultures were susceptible to trimethoprim/sulfa- 
methoxazole (MIC 5 2/38 pg/mL), 27/30 to ticarcillin/clavulanic acid 
(MIC 5 16 Fgg/d), 17/30 to Ciprofloxacin (MIC 5 1 pg/mL) but only 
3/30 to Aztreonam (MIC 5 8 p g / d ) .  Of the 30 cultures, 27 were sensitive 
to at least two drugs but the remaining cultures were susceptible only to 
trimethoprim/sulfmethoxazole. Although the number of specimens was 
smal l ,  our study suggests that positive SM cultures occur mainly in older 
outpatients. Its role in soft tissue infections has previously been noted [Ann Int 
Med 1994; 121: 9691. There is a suggestion that the organism may colonize 
or infect the respiratory tract of older adults. Occasionally multidrug resistant 
organisms may be seen. 
An epidemiological analysis of 
Stenotrophomonas maltophilia strains 
R. Caylan, N. Kaklikkaya, K Aydin, E Aydin, G. Y h ,  K. Cubukcu, 
B. Ozgiimub and I. Koksal 
Trabzon, TR 
Objectives: S. maltophilia has recently emerged as an important cause of 
nosocomial infection. In this study, we aimed to determine whether there 
is a genotypic relationship between clinical isolates of S. maltophilia strains 
obtained h m  hospitalized patients. 
Methods: S. maltophifia was isolated by standard microbiological methods 
using blood and EMB agar, and idenhfied was with automatized Sceptor 
system. This identification was confirmed by PCR using SMl and SM2 
primers directed 23s rRNA of S. maltophilia. Forty-four clinical isolates from 
41 patients were tested for antibiotic susceptibility and genotyped by entero- 
bacterial repetitive intergenic consensus sequences PCR (ERIC-PCR). 
Susceptibility to antibiotics were evaluated by disk difksion method and 
by E-test strips. 
340 Abstracts 
Results: Isolates from the first five patients were identical. Identical pattern 
was observed in two isolates &om two Werent patients in the same clinic on 
the same day. Furthermore, the DNA binding patterns of five isolates were 
also identical. 
Conclusion: Three nosocomial outbreaks were determined by S. maftophilia in 
our hospital using ERIC-PCR. These findings provoke new insights into 
occurrence of cross-contarnination. 
/p14371 Is Stenotrophomonas maltophilia an emerging 
pathogen? Epidemiology and resistance to antimicrobials in 
a general hospital 
S. Cercenado, E. Cercenado, 0. Cuevas and E. Bouza 
Madrid, S 
Objectives: To determine the prevalence and the susceptibility to antimi- 
crobials of clinical isolates of S. maltophilia in a general hospital over a 5-year 
period. 
Methods: From January 1996 to December 2000 all S.  maltophilia recovered in 
our microbiology laboratory were studied. The isolates were identified using 
the MicroScan system and confirmed by the AF'I 20 NE system. Over the 
entire study period, susceptibdity testing was performed by the broth 
microdilution method using the MicroScan system. Antimicrobials evaluated 
were: piperacillin, cefrazidime, cefepime, gentamicin, amikacin, tobramycin, 
cipmfloxacin, imipenem, meropenem, and cotrimoxazole. 
Results: A total of 690 S. maltophilia were isolated &om clinical samples. 
S. malrophilia represented 1.8% of the total of Gram-negatives recovered over 
the study period and 10% ofthe total ofnonfermenters. The origin ofisolates 
was: lower respiratory tract (227), wounds (184), blood (101), urine (69), 
sterile fluids (47) and miscellaneous (62). The 690 isolates belonged to 42 
merent wards. A total of515 corresponded to adult patients (75%), and 175 
to children (42 isolates were &om newborn patients). The number of isolates 
per year (n) and the percentages of resistance to antimicrobials are shown in 
the table. 
1996 1997 1998 1999 2000 
(n=120) (n=112) (n=160) (n=163) (n=135) 
Piperachn 41 62 71 52 55 
C e fta z i d un e 63 61 61 63 56 
Cefepune N / A  N / A  N / A  90 90 
Gentarmcin 89 79 85 79 76 
Tobramycin 89 79 84 74 67 
A I l l l k a C l n  88 78 84 75 70 
cIprofloxacln 49 54 58 51 49 
Cotrmioxazole 8 3 5 4 0 
Inupenem 100 100 100 100 100 
Meropenem I on 100 100 100 100 
Conclusions: S. maltophilia is an important cause of nosocomial infection. In 
our hospital, resistance rates ofthis microorganism to Merent antimicrobials 
have remained stable over the years. Small percentages of resistance to 
cotrimoxazol have been detected, however, this antimicrobial remains the 
treatment of choice for S. maltophilia infections. 
Methods: The NHS susceptible rods were treated by merent serum pre- 
parations: NHS with blocked one of the pathways of complement (C) 
activation, with removed lysozyme or with blocked one of the activation 
pathway without lysozyme. 
Results: Flfty percent of studied Stenotrophomonns maltophilia s u a i n s  
were sensitive to the bactericidal action of NHS. For 15 studied S. maltophilia 
strains five difTerent variants of the bactericidal action of complement and 
lysozyme were found. Eight strains was sensitive to the action of serum in 
which the C was activated via classical pathway without lysozyme or 
alternative pathway with lysozyme as well as simultaneously by both 
pathways without the participation of lysozyme. Three other strains were 
sensitive to the C activated via classical or alternative pathways with participa- 
tion of lysozyme or to the C simultaneously activated by both pathways 
without the lysozyme. Two strains were killed by the C activated via the 
classical pathway with presence of lysozyme. One strain was killed by the C 
activated via alternative pathway with lysozyme and another one strain by the 
C activated via classical or alternative pathway always with participation of 
lysozyme. 
Conclusions: Diversity of the mechanisms of bactericidal activity of 
serum is probably due to the diEerent antigenic structure of studied 
bacteria. 
m1 In vitro activity of new sulbactam combinations 
against aerobic and anaerobic bacteria: results of a German 
multicenter study 
S. Bagel, M. Kresken, A. Schmalreck, G. Beck and D. Pfriinder 
Bonn, Munich, Karkruhe, D 
Objectives: Sulbactam is a 8-lactamase inhibitorwhich is used in combination 
with j?-lactams. In the present study the in vitro activities of sulbactam plus 
penicillin (PES), sulbactam plus cefuroxime (CFS) and sulbactam plus cefta- 
zidime (CAS) against aerobic and anaerobic bacteria were compared to those 
ofthe three 8-lactams alone (PEN, CFX, CAZ) as well as the commonly used 
antimicrobials piperacillidtazobactam (PIT), imipenem (IMP) and metro- 
nidazole (MTK). 
Methods: Between May 2000 and May 2001, a sample of 1934 clinical isolates 
(Gram-positive cocci, Enterobacteriaceae, Arinetobacter spp., anaerobes) 
recovered hom hospitalized patients fiom 11 geographic areas in Germany 
was collected. Minimal inhibitory concentrations (MICs) using the broth 
microdilution method were determined according to DIN 58 940. Sulbactam 
was added to PEN, CFX, and CAZ at a constant concentration of 8 mg/L. 
Results: The table shows MIC5" and MIC9" values for selected groups of 
bacteria (mg/L). 
IIolalcl (") MIC PEN PES CPX CFS CAZ CAS PIT IMP MTR 
AU ecembc isolate (1529) 50 32 2 4 1 0.5 I125 1 50.12 ".I. 
W 225b 2256 t256 2256 2256 2256 16 1 n.t. 
90 2256 2256 2256 32 32 4 64 0.25 n.t. 
S oumurlnrl MUSA (364) 50 8 50 12 I 0.5 8 4 I 50.12 n f .  
90 128 8 128 64 64 64 8 I nl. 
AU m m b c  1soIatec1 (405) 50 8 50 12 16 50.12 8 50.12 5 0  12 n . ~  0 5 
Bdmid~rrFp.(248) 50 8 50.12 M 50.12 64 5U.12 0.25 n.f. 1 
90 64 0.25 128 I 2256 2 2 n.t. 2 
A boumonnn (35) 50 42 50 12 32 50.12 2 50.12 50.12 50.12 n.t. 
90 64 50.12 128 1 128 2 2 ".L 2 
mvotrlla spp. (71) 50 1 50.12 z 50 12 I 5 n . u  5 ~ 1 2  n.t 0.5 
n.t., not tested. 
yo 32 ~0.12 64 50.12 64 o s  0.25 2 
1 P1438 ] Bactericidal activity of human serum against 
Stenotmphomonas maltophilia isolated from blood 
G. Mokracka-Latajka and B. Krzyzanowska 
Wroclaw, PL 
Objectives: Purpose of this work was determination of all factors necessary to 
killing Stenotrophomona maltophilia rods sensitive to the treatment of normal 
human serum (NHS). 
The addihon of sulbactam enhanced the activity of 8-lactams to varymg 
degrees. Sulbactam/pemcAn G showed hgh achvlhes against S aurews 
(MICs comparable to PIT and better than the cephalosporins), anaerobes 
(MICs better than metromdazole) and A baumannu (MICso 5 0.125 mg/L) 
Combmed mth  cephalosporins, the effect of sulbactam was most pronounced 
in anaerobes (MICs comparable to metromdazole) and in A .  baumannri, but 
there was only a moderate increase m the acnvlty against other aerobic species 
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Conclusion: The combination of sulbactam plus p e n i c h  G represents a 
valuable addition to the arrnamentarium of approved sulbactam combina- 
tions. Pencillin G plus sulbactam is an interesting option primarily for the 
treatment of mfections caused by S. aureus and anaerobes. 
synergy: All antimicrobials were bactericidal against the strain B, reachmg a 
bacterial concentration <2 &/I&; IMP (MIC) was also bactericidal against 
the strain C. The following combinations were synergistic: IMP(M1C) + SB 
(MIC) for the strain A, IMP(MIC)+CL for the strains A and C, 
IMP(C& + CL for the strains B, C and D, MRP + SB(MIC) for the strain 
A, MRP + CLfor thesh.ainsA, C andD, SB(M1C) + CLfor the st~ainsB and C. 
Conclusions: The carbapenems plus sulbactam are synergistic against selected 
strains of mdtiresistant A .  baumamzii. Also, the combination of colistin to 
carbapenems and sulbactam is synergistic against most of the strains of 
multiresistant A. baumannii. These results suggest that these combinations 
may be useful in the treatment of infections caused by this agent 1-1 Problems in interpretation of carbapenem 
susceptibility results with Arinetobacter baumannii in 
automated systems 
€? Della-Lam and V. LaBombardi 
New York, USA 
Objectives: A. baumannii is a multidrug resistant pathogen ofien only 
susceptible in vitro to carbapenems and colistin. Inasmuchas they cause 
nosocomial infections associated with high mortality rates, accurate results 
by in vitro methods are essential to the administration of appropriate anti- 
microbial therapy. Although the MICs of A. baumannii to imipenem and 
meropenem have been shown to be similar using microbroth techniques, we 
observed differences using two semi-automated systems. This study (1) 
measures the extent of MIC discordance with the semi-automated 
systems when testing A. baumannii to these carbapenems, using the micro- 
broth method as a gold standard (2) determines the impact on interpretation 
and (3) offers recommendations to improve accuracy of carbapenem report- 
ing. 
Methods: Carbapenem MIC results of 136 clinical isolates h a m  patients 
at Columbia Presbyterian Medical Center were obtained by the 
Microscan Walkaway SI (Dade Behring, IL) with neg combo 27 panels, 
the Vitek 2 (bioMerieux, MO) and microbroth (PML Microbiologicals, OK) 
systems. 
Results: With the Microscan Walkaway, the strains were 54% susceptible to 
imipenem and 27% to meropenem and the susceptibility with the Vitek 2 
system was 52 and 31% for imipenem and meropenem, respectively. 
Conclusions: Discordance of meropenem with imipenem was observed in 
27% of isolates using the Microscan Walkaway and 21% with Vitek 2. Broth 
microdilution confirmed that discrepancies occurred most often in the MIC 
range of 4-16 with both systems. It is recommended that breakpoint panels 
should not be solely used to determine susceptibility to carbapenems and 
reconsideration of breakpoints for these antibiotics with A .  baumannii might 
be warranted. 
1 PI441 I Bactericidal activity and synergy against 
multiresistant Acinetobacter baumannii 
C. Pichardo, M. Jimenez, D. Martin, M. Pachon-Ibaiiez, M. Bernabeu, 
A. Llanos, A. Garcia-Curie1 and J. Pachon 
Seville, E 
Objectives: The purpose of this study was to know the bactericidal activity 
and synergy of imipenem (IMP), meropenem (MRP), sulbactam (SB) and 
colistin (CL) against four strains of mularesistant Acinetobacter baumannii 
representing the four more fkequent clones isolated in our center. 
Methods: MIC and MBC were performed using microdilution method 
(NCCLS). Time-kill curves were used to evaluate the bactericidat activity 
and synergy of antimicrobial combinations (IMP + SB, IMP + CL, 
MRP + SB, MRP + CL, and SB + CL) against the multiresistant A .  bauman- 
nii strains A, B, C and D. For the time-lull curves antibiotics concentrations 
were equivalent to MIC of each of antimicrobial agents and the C, of IMP 
and SB obtained in mice (IMP 30 mg/kg and SB 60 mg/kg). Antibiotics were 
considered to be bactericidal against A .  baumannii when there was a reduction 
of the origmal inoculum >3lagcfu/mL during the 24h of incubation. 
Synergy was defined as 221og decrease in &/mL when using the drug 
combination, relative to the most active component alone. 
Results: MIC/MBC IMP (32/32mg/L), SB (32/32mg/L), MRP 
(8/16mg/L for strains A and C, and 16/16mg/L for s t a i n s  B and D), CL 
(0.5/2 mg/L for the strains A and C, 0 5 8  for the s t r a i n  B, and 0.5/1 for the 
strain D). C-: IMP (16.9mg/L), SB (81.5mg/L). Bactericidal activity and 
vl Novel OXA-type carbapenemase in endemic 
carbapenem-resistant clones of Acinetobacter baumannii 
from Bilbao, Spain 
E Lopez-Otsoa, L. Gallego, K. Towner, L. Tysall, D. Livermore and 
N. Woodford 
Bilbao, E; Nottingham, London, UK 
Objectives: To characterize a collection of carbapenem-resistant Acinetobacter 
baumannii isolates obtained h m  a single hospital in Bilbao over the course of 
1 year, and to investigate their relationship with other strains of A. baumannii 
associated with worldwide outbreaks of nosocomial infection. 
Methods: A total of 82 clinical isolates ofA. baumannii obtained fmm patients 
with chronic bmnchiectasis attending a single hospital in Bilbao over a I-year 
period, were identified by tDNA fingerprinting. MICs were determined by 
the broth microdilution method and interpreted according to NCCLS 
criteria. Carbapenem-resistant isolates were examined for the presence of 
carbapenemases with phenotypic disk synergy tests, followed by PCR 
analysis and sequencing of PCR products. RAPD fingerprinting with 
DAF4, ERIC-2 and M13 core primers was used to study the population 
structure of the Bilbao isolates and their relationship with other worldwide 
nosocomial isolates of A .  baumannii. 
Results: Determination of MICs revealed that 49 (60%) and 39 (4%) of the 
A .  baumannii isolates were resistant to imipenem and meropenem, respec- 
tively, at the NCCLS breakpoints and also showed multiple resistance to other 
main antibiotic classes. RAPD fingerprinting of carbapenem-resistant isolates 
revealed two major clusters (I and 11) of isolates, of which cluster I could be 
further subdivided into a number of related subclusters depending on the 
precise W D  primer used. One of these subdustets was related to two 
carbapenem-susceptible isolates found previously in Barcelona, Spain, and 
Trieste, Italy, but this was the only close relationship found amongst a 
collection of 48 A. baumannii isolates associated with worldwide outbreaks 
of nosocomial infection. Phenotypic disk synergy tests indicated the presence 
of carbapenemase activity in the isolates fbm Bilbao. PCR analysis followed 
by sequencing detected a novel integron-associated OXA-type carbapene- 
mase in both major clusters. 
Conclusions: The study revealed that two major clones of carbapenern- 
resistant A. baumannii isolates were endemic in a single Bilbao 
hospital. Resistance was associated with the presence of a novel i n t epn-  
associated OXA-type carbapenemase that has spread between the different 
clones. 
I PI443 1 Aeromonas spp. an emerging enteric pathogen? 
M Martsoukou, M Kanellopoulou, N Skarmoutsou, E Mylona, 
A. Charalambopoulou, K. Pavlou, A. Zervogmm and E. Pap- 
Athens, GR 
Objectives: To lnveshgate the role of Aeromonas spp in adults gastrointestmal 
mfechons 
Methods: Durmg a 3-year period stools h m  587 (1999 190, 2000 192, 
2001 : 205) pahents were mvesttgated for Aeromonas spp. The samples were 
plated m blood agar plus a m p d m  3 Omg/L and mcubated m ambient ax for 
48-72 h The tdentlficahon and suscephhhty to anhbioha were pefiormed 
by the commercial ID/MIC panel (Pasco, Difco). 
Results: T h  retrospemve study revealed an mcidence of 1% (1999), 5.2% 
(2000), 6 3% (2001). Aerornonas hydraphifa 17/25 (68%) was the most common 
isolated species followed by Aeromonus camae 6/25 (24%) The c b c a l  fearures 
were. dlarrhea 20/25, abdormnal d~scomfort 18/25, vormtmg 17/25, fever 
5/25 in pahents who were suffenng from diabetes mefitus, chromc renal 
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failure, alcoholism, intestinal malignancies. All the strains were susceptible to 
Ciprofloxacin and Tiimethoprim/sulEunethoxazole. 
Conclusions: (1) The isolation rate of Aeromonac species, as responsible 
pathogen of the intestine, showed an increasing trend. (2) Arromonas hydrophila 
was the predominant species. (3) Diarrhea, abdominal discomfort and vomit- 
ing were the main symptoms, since fever was rather rare. (4) The most 
common used antimicrobial agents, Ciprofloxacin and Cotrimoxazole, 
showed a remarkable in vim activity (100%) in these infections. 
I PI444 I Pulsed-field gel electrophoresis analysis of 
Aetvmonas vetvnii isolated from a patient with sepsis 
A. Mencacci, 11. Mazzolla, M. Vitali, S. Farinelli, E D'Al6, E. Cenci and 
F. Bistoni 
Pmgia, I 
Objectives: Gram-negative bacilli of the genus Aeromonas are widespread in 
aquatic environments and are responsible for different human infections. In 
contrast to the recognized association of these bacteria with immunocom- 
promised hosts, recent data indicate that Aeromonas spp. may also be primary 
causes of human infections in immunocompetent hosts. In recent years, 
Fungal infections 
Aeromonas extra-intestinal infections have been reported in growing frequen- 
cies. Nevertheless, Aeromonas bacteremia remains an uncommon finding, 
often associated with different underlying hepatic diseases and usually related 
to the species A. h ~ d r ~ h i ~ a .  To date the etiologic roIe of A. veronii has been 
rarely described. Here we report a case ofA. veronii sepsis associated with acute 
suppurative cholangitis in a patient with chronic hepatitis B. 
Methods: The Sceptor (Becton Dickinson, Milan, Italy) and the API 20E 
(bioMCrieux, Rome, Italy) systems were used to identify the bacteria 
recovered h m  peripheral blood and bile. The clinical isolates were analyzed 
by pulsed-field gel electrophoresis (PFGE) using the Chef Mapper System 
(Bio-Rad, Milan, Italy) after DNA digestion with Spe 1 and Xba 1 restriction 
enzymes (BioLabs, New England, USA). DNA fingerprinting gels were 
compared using the Molecular Analyst sohare  for Macintosh (Bio-Rad). 
Results: The two clinical isolates h m  blood and the isolate from bile were 
identified as A. veronii. PGFE analysis revealed their genetic homogeneity, as 
they were characterized by indistinguishable PFGE patterns, in spite of the 
different antibiotic susceptibility showed. The PFGE pattern was comparable 
to that of the 35624 ATCC A. veronii strain. 
Conclusions: A. veronii, together with A. hydrophila, can be responsible for 
Aeromow sepsis, associated with biliary tract infection and PGFE analysis can 
be an useful tool to demonstrate the genetic homogenicity of Aeromonas 
clinical isolates. 
1-1 Candidernia in a Greek hospital: 7-year 
analysis 
H. Belesiotou, E. Platsouka, A. Lazou, N. Nitsos, S. Spanou, 
S. Constantoulalu and 0. Paniara 
Athens, GR 
Objective: Candidemia is a serious cause ofblood stream infection resulting in 
a mortality rate of nearly 40%. In this study, we determined the rate of blood 
isolation of merent Candida species firom hospitalized patients. 
Methods: Between 1995 and 2001, 150 clinical strains of Candida spp. were 
isolated &om blood cultures specimens (one isolate per patient). Identification 
of Candida was performed with Becton-Dickinson (BACTEC NR 9240) and 
BioMerieux fyeast API 32ID) systems. The in vitro activity of amphotericin 
B, fluconazole, itraconazole, 5-fluorocytocine, ketoconazole and miconazole 
against Candida bloodstream isolates was tested by determination ofminimum 
inhbitory concentration (MIC) using Sensititer panels. 
Results: Candida spp. were idennfied as: Candida albicans 43.3%, C .  parapsilosis 
14.6%, C.gfabrara 13.3%, C. fropicalis 12.6%, C. kncrei 8%, C. pseudofropicah 
4.6% and C.famafa 3.3%. The majority of Candida species was susceptible to 
amphotericin-B and fluconazole and moderate susceptible to other tested 
antifungal agents. The patients with candldemia were immunosuppressed 
patients of specific units 46.7%. medical wards 29.3% and surgical wards 
24.0%. 
Conclusion: In our hospital, Candida albicans was the yeast most frequently 
isolated &om blood followed by C. parapsilosis, C.glabrafa and C. tropicalis. The 
approved antifungal agents were generally active against Candida spp. The 
majority of candidemia cases were in high-risk patients with 32.6% mortality 
rate. 
Fungal colonization of upper gastrointestinal 
tract in HIV-infected patients 
P. Skwara, T. Mach, G. Biesiada and A. Kalinowska-Nowak 
Cracow, PL 
Objectives: The aim of the study was to analyze fungal strains cultured 60m 
oral and esophageal swabs as well as h m  gastric juice in HW-infected patients 
(pa) in relation to CD4 lymphocyte count. 
Methods: Mycological cultures h m  oral and esophageal swabs, and 
gastric juice were analyzed in 45 HIV-infected patients of whom 25 had 
CD4 < 200/mm3 (group 1) and 20 had CD4 > 200/mm3 (group 2). Samples 
were taken during gastroscopy performed in year 2001 because of dyspeptic 
symptoms. Fungal resistance to antimycotic drugs was estimated. Control 
group consisted of 21 non-HIV-infected patients (group 3). 
Results: Significant fungal growth was found in oral swab cultures: in 14 pts 
(56%) in group 1, in 10 pts (50%) in group 2, in 3 pts (14%) in group 3; in 
esophageal swab cultures: in 1 1 pts (44%) in group 1, in 10 pts (50%) in group 
2, in 6 pts (28%) in group 3; in gastric juice cultures: in 12 pts (48%) in group 
1, in 7 pts (35%) in group 2, in 6 pts (28%) in group 3. Mycotic stomatitis was 
present in 14 pts (56%) in group 1 and in 6 pts (30%) in group 2. Fungal 
esophagitis was present in 10 pts (40%) in group 1 and in 2 pts (1 0%) in group 
2. There was no symptomatic mycosis found in group 3. The following fungal 
strains were isolated in group 1 : Candida albicans in 52% pts, C .  glabrata in 8% 
pts, C .  ktuzei in 4% pts, C. tropicalis in 4% pts, C. inconspicua in 4% pts; in group 
2 C. albuans in 55% pts, C.gla6rata in 15% pu, C. tropic& in 5% pts, 
C. lusitaniae in 5% pts, Geotrirhum in 5% pts; in group 3: C. albirans in 47% 
pts, Geotrichum in 5% pts. The antimycotic drug-sensitivity of fungal strains 
in HIV-infected patients was as follows: clotrimazole (loo%), nystatin (98%), 
ketoconazole (98%), miconazole (85%), fluconazole (72%). There were fewer 
drug-resistant fungal strains isolated h m  non-HIV-infected patients, among 
them all were sensitive to clotrimazole, nystatin and fluconazole. 
Conclusion: Fungal colonization of upper GI tract mucosa is significantly 
more frequent in HIV-infected patients and is related to cellular immunity 
deterioration measured by CD4 lymphocyte blood count. There are often 
coexisting clinical symptoms of fungal infection. Candida albicans appeared to 
be predominant f h g u ~  cultured fiom all groups of patients. Drug resistance 
(especially to fluconazole) is more frequent in HIV-infected patients. 
Investigation of Candida dubliniensis and 
identification of andida spp. in orophatyngeal swabs of 
cancer patients 
A. Tekeli, I. Dolapci, S. Cesur, E. Tekeli and E Icli 
Ankara, TR 
Objectives: To investigate the presence of C. dubliniemis; a novel Candida 
species, and other fungal pathogens in cancer population. 
Methods: The oropharyngeal swabs of 543 cancer patients were collected 
during their visit to oncology clinic in 9-month period. Samples were 
obtained with a sterile swab, which was immediately used to inoculate 
and streak on  Sabouraud dextrose agar (SDA) plate for isolation. Cultures 
were incubated at 37 "C for at least 48 h in aerobic condition. Among Candida 
isolates, phenotypic characteristics of Candida dubliniensis was investigated by 
analysis of germ-tube formation and chlamydospore production, growth at 
42 "C and 45 "C, colony morphology on Staib agar and intracellular beta+- 
glucosidase activity. The carbohydrate assmilation patterns were studied using 
the API 20C AUX system. 
Results: Totally 209 Candida species were isolated. Ofthe isolates 147 (70.3%) 
were C. dbicans. The other species were C. parapsihis, n = 16 (7.6%); 
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C. tropicalis, n =  13 (6.2%); C.glabrata, n = 10 (4.7%); Cguillermondi, n = 5 
(2.3%); C. krusei, n = 4  (1.9%); C. k&, n = 3  (1.4%); Cfarnata, n = 3  (1.4%); 
S. cereuisiae, n = 2 (0.9%); C. pelliculosa, n = 2 (0.9%)); C. utiles, n = 1 (0.4%); 
C. Neofmans, n =  1 (0.4%); H. Polynrorphn, n = 1 (0.4%); and no C. dubli- 
niensis was isolated. 
Conclusions: Although colonization with Candida does not indicate 
clinical candidiasis, it may be the cause of candtdemia with increased 
morbidity and mortahty. Among Candida spp., C. dubliniensis is gaining 
significant importance because of its misidentification as C.albicans by 
routine protocols like germ-tube formation and chlamydospore production 
and its resistance to antimicotics like fluconazole. In our study, C. dubliniensis 
was not isolated in oropharyngeal specimens of the cancer patients. Further 
studies are needed to reveal the incidence of C. dubliniensis in various patient 
populations. 
I PI448 1 Trends in hospitalizations with candidiasis 
diagnoses in Australia, 1995-1999 
M. Slavin, I. Sukarom, S. Crowley, G. Davies and J. Fastenau 
Emf Melbourne, A U S ;  Whitehouse Station, U S A ;  South Granville, AUS; 
Brue B ~ N ,  USA 
Objectives: Mycoses due to Candida are important causes of morbidity and 
mortality in hospitalized patients. This study examined the trends in hospi- 
tdzations with candidiasis diagnoses (CD) in Australia during the period 
Methods: Data were extracted &om the National Hospital Morbidity Data- 
base. A hospitalization with a CD was defined as any acute hospital-discharge 
diagnosis of: disseminated candidiasis (ICD-9-CM: 112.5); invasive candi- 
diasis (ICD-9-CM: 112.4, 112.81, 112.83, 112.85, 112.89, 112.9, 771.7); or 
noninvasive candidiasis (ICU-9-CM: 112.0, 112.1. 112.2, 112.3, 112.82, 
112.84). Costs of hospitalizations with a CD were estimated by multiplying 
length ofhospital stay (LOS) by the average DRG cost per hospital day (1998 
Austrahan dollars). Logistic, Cox, and linear regrestion models were used to 
examine the impact of different candidiasis diagnoses on mortality, LOS, and 
costs adjusting for age, gender, year, insurance, hospital type, and principal 
reason for admission. 
Results: A total of 57758 hospitalizations with a CD were identified 
(disseminated: 533; invasive: 1 1 885; noninvasive: 45 340). Hospitalizations 
with a CD increased annually by 3% from 1995 to 99. During this period 
hospitalizations with a CD accounted for 757 714 bed days and an estimated 
$520 million in hospital costs (dissenlinated: 16 361 days, $17 million; inva- 
sive: 198 421 days, $154 million; noninvasive: 542 932 days, $349 nlillion). 9% 
of hospitalizations had candidiasit coded as the primary diagnosis (dissemi- 
nated: 16%; invasive: 9%; noninvasive: 9%). In-hospital mortality was higher 
for hospitalizations with disseminated CU (OK 4.1, 95% C1 3.2-5.3) and 
invasive CD (OR I . l ,  95% Cl 1.0-1.2) as compared to hospitalizations wlth 
noninvasive CD after adjusting for co-variates. The risk of being discharged 
was significantly lower for hospitalizations with disseminated CD (HR 0.39, 
95% C1 0.35-0.44) and invasive CD (HR 0.78, 95% CI 0.764.80) as 
compared to hospitalizations with noninvasive CD. Hospitalizations with 
disseminated CD and invasive CD as compared to hospitalizations with 
noninvasive CD had increased hospital costs of 185% and 39%, respectively. 
Conclusions: Hospitalizations with different CD were associated with differ- 
ences in measured outcomes. Among hospitalizations with CD, disseminated 
CD occurred infrequently, however, had significantly greater burden with 
respect to in-hospital mortality, LOS, and costs. 
1995-99. 
have been analyzed Candtda albtcnns was the thlrd cause ofmfection (10 6%), 
204 fungal species were detected in 123 pahents, often Candida albicans. In 49 
pahents, Candzda were cultured from several specimens About 17.8% of the 
infechon were found m pahents with inhmnatory bowel dtseases, 15 4% m 
pahents wlth perItonIhS, 13.8% mth acute panCreahhS, and 12.2% wlth 
neoplasms of upper gastminteshnal tracts, 13.8% neoplasms of colon, 12 2% 
neoplasms of bhary tract and m 8.1% m t h  neoplasms of pancreas, the rest 
6.5% mcluded other c h c a l  dugnom. From peritoneal cavlty Candtda was 
rased in 48.2%, €rom-mfected wounds in 17.9%, resplratory tract in 17.9%. 
unne m 5.4%, vascular catheten m 7.1% and blood in 3.6% It had been called 
attenhon for the frequency of emtence risk factors. broad spectrum anh- 
biohcs ( l W ? ) ,  poor health state (66.7%). invasive monitormg (65.0%). 
neoplasm (46.3%), cfiabetes (20.4%), steroid medxahons (16 2%) More than 
three nsk facton rn all the analyzed group were in 76 4% (941123) and m 
group mth I e W t y  m 91.0% (51/56) (n.s.). In all the groups the lethahty has 
been stated as 45.5% and mgmup mth posihve blood cultures &om 85 7%. Ln 
p u p  mth mdhple posihve cultures 35 pahents (71.4%) dted, and m group 
mth slngle cultures - 21 paaents (28.4%) ( D <  0,OOOl). C h c a l  symptoms 
were generally unspecific. From all the serologx studtes performed markmg 
of anh-candrda anhbodtes by induect unmunofluorescency 1s worth attenhOn 
(1.160), although serolog~c smdm m systemc myCOhC mfections and the= 
interpretaaon are ddticult. On the basis of kerature and our own stud~ea we 
have accepted the rules of the ant&ngal systemc and early ernphcal systemc 
treatment offered by h i e  and Solomluna. 
Conclusions: Mycohc lnfecnon IS related to considerable rnodty,  that rises 
in pahents mth co-morbidtty and those subjected to mtensive care. For takmg 
rahond measures, the awareness of the risk, adequate dtagnoshcs and mom- 
tormg of the mfections in the hgh-ruk groups, are mdspensable. 
IP1450/ Molecular epidemiology of Candida blood 
isolates in a university hospital during a 6-year period 
M. Bakir, R. Barton, N. Cerikcioglu and A. Yagci 
Istanbul, T; Leeds, UK 
Objective: Candida species currently are the second most conunon nosoco- 
mial pathogen in Marmara University Hospital, Istanbul with a significant 
increase in the rate of candidemia from 12 to 26% of all blood stream 
infections during the last 3 years. An epidenllological analysis of 148 Candida 
blood isolates between 1994 and 2000 was performed in order to check for 
clonality of the most profound Candida species. 
Methods: Candida blood isolates were identified in the species level by 
standard methods. The DNA of C. albicans and C. tropicdis was digested with 
EcuRI, and that of C. parapsilusis with both EcoRl and SalI. The products were 
separated by electrophoresis in agarose gel and blotted onto a nylon membrane 
by standard methods. As the species specific probe, lambda-phage clones Ca3, 
Cp13-3, and Ct14 were used for C. albicans, C. parapsiloris, and C. tropicalis, 
respectively. The fingerprint patterns were analyzed using the Bionuinerics 
software. 
Results: C. albicans, C. parapsilosis, and C. tropicalis comprised 40, 31, and 12% 
of all isolates, respectively. Levels of clonality varied among three Candida spp. 
Of the 60 C. albicans isolates, there were six clear incidences of two or more 
different patients with isolates having identical fingerprints. Thirty of 42 
C. parapsilosis isolates could be grouped into six clusters of strains that were 
indistinguishable, including 12 different isolates with the identical fingerprint 
in a cluster. Eleven of 17 C .  tropicalis isolates clustered in groups of two or 
more identical strains. 
Conclusion: In all, Candida species analyzed there was evidence of ndsocomial 
transmission and this was at a higher level for C. parapsilmis and C. mipiralis 
than C. albicans. 
1 PI449 i Candida infections in high-risk patients in 
abdominal surgery 
R. Marciniak, M. Drews and Z. Adamski 
Pornnri, PL 
Candidemia: an emerging nosocomial infection in 
the non-immunocompromised host 
Candida species are increasingly important nosocoinid pathogens. The aim of 
the study was an analysis of the results of nlicrobial cultures in patients who 
bad been operated during the last 6years. The usefulness of laboratory 
diagnostics (traditional laboratory methods and serological ones performed 
on some of the patients) has been valued. The risk factors for iiiycotis spread 
S. K. Aganval, s. Anuradha, A. [jrakasll, N.  p. Sin& alld I\. Kaur 
N~~ ~ & i ,   IN^ 
Objectives: Nosoconlial infections contribute significantly to increased 
morbidity, mortality, prolonged hospital stay and escalation of treatnient 
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costs. The present study evaluated the prevalence, clinical profile and outcome 
of candidemia in immunocompetent hospitalized patients. 
Method% Non-neutropenic, immunocompetent hospitalized patients (with 
absolute neutrophd count >1500 cfu/mm) were screened for Candidemia in 
the presence of fever (>38.4 "C for >48 h) and/or hypotension and altered 
mental status. Blood cultures were drawn in brain-heart infusion and 
BACTEC media and were observed for the growth of Candida species. 
Additionally, sites suspected as serving as portal of entry like intravascular and 
urinary catheters, other indwelling lines and swabs were also cultured for 
Candida. All the patients found positive for candidemia received intravenous/ 
oral fluconazole or itraconazole for a period till 14days after resolution of 
signs and symptoms. 
Results: Seven of the 91 patients screened over a 12-month period had 
candidemia incidence of 7.6%. Six (four female and two male) of these were 
evaluated in de td .  All of them had prolonged fever (mean duration-32 days) 
which could directly be attributed to candidemia. Prolonged intravascular 
devices, urinary catheters, procedures hke tracheotomy, parented antibiotics 
and bedsores were identifed as the possible sources of entry for Candida in all 
the patients and Candida species were cultured &om these in all the patients. 
Hospital stay was prolonged by a mean duration of 28.7 days in these patients. 
All the patients successfdly cleared Candida from their blood on treatment 
with antifungal therapy. Although four ofthe six patients died, candidemia did 
not contribute directly to the death of any patient. 
Conclusions: Candidemia is a remediable cause for prolonged hospital stay 
and morbidity in hospitalized immunocompetent patients and should be 
actively sought for and treated. 
Randomly amplified polymorphic DNA in the 
genotyping of Candida albicans 
Z. U. KhCni, S. Ahmdd, A. S. Mustafa and Z. Khan 
S<!/itf, Kl27 
Objective: To genotype the Cmrdidn nlhicms isolates from blood and other 
body specimens by rdiidondy amplified polymorphic DNA (RAPD). 
Methodology: Three oligonucleotide primers were used in the RAPD 
analyzes. Initidly grnoniic DNA froin six standard strains was used as 
teuiplate for the ILAI'D and thr amplified products were resolved by agarose 
gel rlectrophorew. After various parameters wcrc optimzed to obtain the 
m,iximinii number ofdiscreet bands with the standard strains, the method was 
'ipplied to six C. nlbin~ris iwlates obtained from blood cultures and other body 
sites offour patients in  a hospital ICU and 1 1 C. olbimis strains isolated from 
hand\ and tiiouths of iiui-ses working in their vicinity A total of 24 blood 
culture isolates obtained from various hospitals around Kuwait were also 
Results: The blood culture profiles of C. dlrinrrrs isolated from two ICU 
piitirnts diffrred from those ofthe nurses by at least one band. The genotypic 
pcitterns with primer AP3 obtained with isolates from one patient in the ICU 
iii.itched esactly with '1 mouth isolate profile of a nurse. However, profiles of 
these isolates obtained with primer CARAPDl were dissimilar. The 24 
clinical C. d k m r  isohtes gave a distinguishable pattern using the CAKAPD 1, 
AP3 and CT5 .is primers, though CTS was less discriminatory Considering 
sin&-band differences to be significant, 22 patterns could be discerned from 
the 24 isoldteq tested. Interestingly. amplification patterns of the two isolates 
ilom thr saiiie individual were considerably different with both primers 
\ug(ge\tins tli.it .it l es t  two different strains were infecting a t  the same time. 
Conclusions: This study dcrnonmates that RAPD IS a simple and rapid 
trt-hniqur t& the typing of C. a/!wnm5 and thus has an applicntion in the 
nioleculx cp ide in io lo~~ of nosocomial candidiasis. 
typed. 
m, Epidemiology of fungal organisms isolated and 
identified at a tertiary-care reference mycology center in 
northern Italy: a 12-month survey 
Bo/~l~pl~l, I 
li. Mnnfrrdi, A. Nanrtti, R.  Vhit i i i i ,  1. Calza and F. Chiodo 
Objective: To perforiii a prospective surveillance study of fuurigal organisms 
cdtured in J I -year period from inpatients and outpatients referring to our 
university hospital. 
Methods: Among 27 959 clinical specimens submitted for fungal search, 3781 
(13.5%) proved positive. Samples bearing to a single patient @) sent in the 
same day were regarded as 1 submission. 
Results: Candida spp. largely prevailed over all other fungi: 3645 isolates of 
3781 (96.4%). Although C. ulbicuns still accounts for the great majority of 
cultured strains (2638 cases of 3645: 72.4%), the emerging of C.glubrata (286 
episodes: 7.8%). C. parapsilosis (70), C. ke j r  (36), and C. krusei (21 cases) was 
notable, as well as the appreciable number of  C. lusitaniae, C. mgosa, C.guii-  
liermondii, C. coiliculosa (5-13 isolates each), and C. dubliniensis, C. incospicua, 
C.peZliculosa, C.famata, C. liplytica, C. pseudotropuulis, and C .  pukhcrrima (1-4 
episodes each), while untypeable Candida spp. were cultured in the remaining 
429 cases. Fungi other than C d i d a  spp. included A p g i f l u s  in 55 cases 
(1.5%) (A.fumigatr*c in 32 episodes, A.ftauus in 15, and A.n@ in 8), 
Saccharumyces rereuisiae in 53 cases, Tlchosporon spp. in 10 p (1: askai and 
7: inkii in 8 and 2 cases, respectively), and Geotrichum spp. in 10 p (G. capitatum 
in 6 cases, G. candidurn in 1, and Geotrichum spp. in 3 cases). The isolation of 
Cryptucuccus neoformans (4 cases), Rhodotomla spp. (3), and Penica'llium spp. 
(1 episode), proved remarkably rare. 
Conclusion: Although takmg into account the &culty to distinguish 
invasive d e c t i o n  from trivial colonization according to isolation only, and 
the sigdicance attributable to the diflerent isolation sites, underlying 
disease (if any), inpatient/outpatient origin, and concurrent antimicrobial 
administration, the large prevalence of Candidu spp. over other fungal 
pathogens remains a major issue, with a rising hequency of some nonalbicans 
strains, which usually show unpredictable in vitro susceptibhty to most 
imidazole antimycotic compounds, and a prominent association with con- 
current illnesses, immunodeficiency, prolonged hospitalization, insuumenta- 
tion, use of prosthetic devices, and parenteral nutrition. A quite stable 
number of Aspergillus spp. organisms is isolated predominantly from neutro- 
penic hosts, while Saccharomyces spp. is an emerging colonizer and pathogen of 
the genital tract. The decline of Cryptutocci~s and Penicillium spp. is attributable 
to the sharp drop of frequency involving all AIDS-related opportunistic 
pathogens 
Real-time detection of Aspergillus spp. using 
nucleic acid sequence-based amplification (NASBA) and 
molecular beacon detection 
C. Ginocchio, I? Sillekens, J. Loemer and P. van Aarle 
L a k e  Sirrress, 1JSA; Boxtel, NL; Tibinyen, D 
Objectives: lnvasivr aspergillosis is a leading cause of morbidity and mortality 
in trancplantation, cancer, siirgical, and burn patients. The development of 
molecular based methods for both the diagnosis and preemptive monitoring 
of patients at risk for invasive aspergillosis will permit the early detection of 
fungal disease and the prompt initiation of antihigal therapy to improve 
survival. 
Methods: Initial work by Loeffler et al. described a nucleic acid sequenced- 
based amplification (NASBA) method combined with electrochernilt~m~i~e- 
cence (ECL) end-point detection for the ident~fication of Aspergillus qp. in  
whole blood samples. We have modified the assay for 'real-tinie'detection by 
replacing ECL detection with molecular beacon technology. Nucleic acids 
from fungal cultures were isolated using a freeze-thaw procedure followed by 
silica-based extraction. Nucleic acid extraction and NASBA amplification 
were performed by using NucliSens Basic Kit reagents (Organon Teknika/ 
bioMCrieux, Boxtel, The Netherlands). Isothermal (41 C) amplification ofa 
18s ribosomal R N A  region and molecular beacon fluoresence detection were 
periormed simultaneously using a single-tube closed system. Continuous 
monitoring of emitted fluoresence was performed using a NucliSens EasyQ 
Analyzer. 
Results: Specificity studies indicate the assay can eRiciently detect all clinically 
relevant species of Aspergillus, cvith minimal cross reactivity with lion-Asper- 
pllrrs fungal isolates. Aspexillrrs sp. KNA can be detected as early nr 31) min 
after the initiation of the amplification reaction. The sensitivity of tbr  assay iq  
in the range of 10-100 conidia per aiiiplificatiori reaction. 
Conclusions: This assay has significant potential for the detection of invasive 
aspergilloris. Benefits of the assay over the original format include rapid and 
sensitive detection, significantly less technical time aiid a ringle-tube format 
that greatly reduces the risk of sample cross-ContaiiiinatiUn that can lead to 
false-positive results. Additional studies are being conducted to optimize assay 
conditions, restrict cross reactivity and enhance assay sensitivity. 
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-1 Prospective comparison between the Nuclisens 
Basic Kit NASBA and a PCR-ELSA for the detection of 
Aspergillus spp 
J. Loeffler, C. Dorn, H. Hebart, P. Cox and H. Einsele 
Tibingen, D 
Objectives: Invasive aspergdlosis is a major cause ofmorbimty and mortality in 
immunosuppressed patients. Early diagnosis is mandatory for appropriate, 
successful therapy. In this study, a prospective comparison between a Nucli- 
sew-nucleic acid sequence based amplification (NASBA)-based assay (detec- 
tion of Aspergillus-RNA) and a previously published protocol for the 
amplification of fungal DNA by PCR-ELISA was performed. Blood samples 
from patients (n = 21) receiving an allogeneic stem cell transplantation (SCT) 
were analyzed twice weekly by both assays. 
Methods: Serially diluted Aspergillus fitmigatus conidia were used for 
sensitivity testing ofthe new molecular-based method. Primers and a specific 
probe were designed within the fungal 18s rRNA gene region. Blood 
specimens ( n  = 245) from SCT recipients were compared subsequently hy 
PCR and NASBA assays. Isothermal amplification combined with electro- 
chemiluminescence were performed by using NucliSens Basic Kit reagents 
(Organon Teknika, bioMhieux, Boxtel, the Netherlands) as described pre- 
Results: The NASBA assay showed a detection limit of 1 cfu/mL blood 
(PCR 10cfu/mL). Thirteen patients were positive by both assays, 3/21 
negative by both assays whereas 5/21 showed a positive result only by the 
NASBA test. Two patients suffered from documented invasive asperflosis. 
They were both NASBA-positive over 3 weeks prior to radiological doc- 
umentation of pulmonary mfiltrates and remained positive for up to 31 days. 
In contrast, PCR remained positive only for 4 days. In patients with pul- 
monary infiltrates or amphotericin B therapy (n = lo), a mean number of 6.4 
NASBA tests (range 1-13 tests) was positive, compared to 2.3 NASBA- 
positive tests (range 1-5 tests) in patients with febrile neutropenia only (n = 6). 
Conclusion: The NASBA Basic Kit technology is a hghly sensitive tool for 
the detection of Asp~gilh-RNA in blood specimens of immunosuppressed 
patients. 
viously. 
I P1456 I Rapid identification of medically important 
yeasts by a multiplex PCR method 
Y. L. Li, J. H. Chen, S .  N. Leaw and T. C. Chang 
Tairhung, Tainan, TW 
Objectives: Yeasts are emerging as important etiological agents of nosocomial 
infections. The identification of yeasts by conventional morphological and 
metabolic characteristics may require from 2 to several days .  The aim of this 
study was to evaluate a multiplex PCR method for the identification of 
Cryptococcur neofonnans and Candida spp. that are 6equently isolated from 
clinical specimens. 
Methods: A total of 220 yeast strains were used in this study, These strains 
included the following species (strain number): C. albicans (94), C. tropicalis 
(38), C.parapsilosis (30). C.glabmta (28), C. krurei (9), and Cryptocoms neofr- 
mans (21). Nine primen were designed to ampllfy the internal transcribed 
spacer regions 1 and 2 (ITS1 and ITS2) of the above yeast species that are 
commonly isolated in the hospital. The PCR products amplified from 
different species varied in size and could be effectively separated by disc- 
polyacrylamide gel electrophoresis. In addition, 49 st ra ins  of other yeast 
species, 22 strains of molds, and 13 strains of bacteria were also tested by the 
multiplex PCR method. The negative and positive controls were run in 
parallel with test samples. 
Results: The precise lengths of the amplicons obtained &om the six yeast 
species were as follows: C.glabrata (280 bp), C. albicans (254 bp), C.parupsiloris 
(189bp), Cryptocom neofomans (161 bp), C. tropicalis (127 bp), and C. kmei 
(1 17 bp). Of the 220 strains ofyeasts tested by the multiplex PCR, all strains of 
C. albicans, C. tropicalir, Cglabrata, C. k m e i ,  and Cryptococncr neofrmans were 
correctly idennfied. However seven out of the 30 strains of C.parapsilosis 
produced no PCR product and these strains were not identified. The overall 
sensitivity of the multiplex PCR method was 96.8% (213/220). All strains of 
other yeast species, molds, and bacteria produced negative results. The 
specificity of the method was 100% (84/84). 
Conclusions: The multiplex PCR method had a hgh sensitivity (96.8%) and 
specificity (100%). The method could be completed within 8 h and is simpler 
than any previously reported molecular methods for the identification of 
yeasts. 
[p14571 Epidemiology of fungal urinary tract Infections in 
a pediatric hospital in Greece during a five-year period 
E. Lebessi, G. Stamos, A. Zaphiropoulou, E. Bozavoutoglou, 
A. Velegraki, N. J. Legakis and M. Foustoukou 
Athens, GR 
Objectives: To evaluate the frequency, the causative agents and the main 
epidemiological characteristics of fungal urinary tract infections (UTIs) in 
children. 
Methods: We retrospectively reviewed all cases offungal UTIs during a 5-year 
period in a 500-bed pediatric hospital (1996-2000). The urine cultures were 
performed in the microbiology laboratory. Appropriate guidelines were 
followed for the specimen collection and transport. Isolation and identifica- 
tion of culture isolates were made by conventional methods and the minimum 
inhibitory concentrations of yeasts to antifungal agents (amphotericin B, 
fluconazole, itraconazole, ketoconazole and 5-fluorocytocine) was deter- 
mined by the Alamar colorimetric method (Sensititre). The interpretation 
of results was based on (cfu/mL.) counts of isolates, the presence of leukocytes 
in urine and additional clinicd information. 
Results: Thirty-two out of 3093 UTI episodes were caused by Candida species 
in 29 patients, aged 30days to 14years old (16 males, 13 females). All cases 
were considered as nosocomial infections. Candida albicans comprised 78% of 
fungal isolates, C. tropicalis 12.5%, C.parapsilosis, C.glabrata and C. sake 3.1% 
each. Most yeast isolates were found sensitive to all antifungal agents, while 
100% were sensitive to amphotericin B (AB). All patients received antifingal 
therapy according to the results of the sensitivity testing (nine received AB; 12 
fluconazole (FZ); five AB and FZ, two ketoconazole (a); one nystadn (NS); 
1 NS and KZ; one FZ and 5-fluorocytocine; one FZ and KZ). The main 
predisposingfacton for fungal UTIs were: antibiotic administration (10oo/o of 
patients), invasive procedures (22/29, 76%), abnormalities of urinary tract 
(14/29, 48%), preceding surgery (8/29, 27.5%), malignancy (5/29, 17.2%) 
and renal failure (3/29, 10.3%). The highest incidence of candidal UTIs 
was noted in intensive care unit (ICU) (12/32,37.5%) and in pediatric wards 
(1 1/32,34.3%). The remaining cases occurred in surgical wards (4, 12.5%), in 
neonatal ward (2, 6.2%), in hemodialysis unit (2, 6.2%) and in oncology unit 
(1, 3.1%). Fungemia was diagnosed in six cases, all in patients of the ICU. 
Conclusions: Candida species are important causative pathogens of nosoco- 
mial UTIs in children, 6equentIy complicated by fungemia, especially when 
specific predisposing factors are present. 
/p14581 Fungi - isolated pathogens from hospitalized 
patients with diarrhea 
E. Swoboda-Kopec, M. Wroblewska, E. Krawczyk, B. Sulik-Tyszka, 
E. Stelmach, A. Rokosz and M. Luczak 
Warsaarsaw, PL 
Objectives: Analysis offungal isolations f b m  the stool Gom the patients with 
diarrhea hospitalized on different hospital wards (1998-2000). 
Methods: Fungal strains were cultured from the stool and swabs of the anus. 
The culture was done accordmg to standard mycological procedures and 
commercially available tests (bioMerieux, Sanofi Diagnostics Pasteur). Sus- 
ceptibility to antifungal agents was tested using Fungitest (Sanofi Diagnostics 
Pasteur). 
Results: In a total of 299 specimens, among them 234 h r n  the internal 
medicine wards and 65 from the surgical wards, were tested. From these 
specimens, 336 fungal strains were isolated, including 266 isolates &om the 
internal medicine wards. The most common species were C. albicans - 164 
strains (48.8%) and C.glabrata - 93 strains (27.7%). Fungi were found in 
specimens mainly f?om the hematological ward C. albirans - 73 strains 
(21.7%) and C.glabrata - 59 strains (17.6%). 
Conclusions: 
1 Fungi were isolated from the patients with marrhea more often flom the 
2 Diarrhea caused by fungi is observed mainly in hematological ward. 
internal medicine wards than from the surgical wards. 
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3 The most commonly isolated fungi from the patients with diarrhea are: 
C. albicam and C.g/abrafa. 
1 P1459 I Frequency of isolation of fungi from clinical 
specimens 
A. Samet, J. Nalewajska and M. Bronk 
Gdansk, PL 
Objectives: To determine the spectrum of fungi in clinical specimens !?om 
patients in our hospital. 
Methods: The study.involved the clinical specimens recovered from patients 
hospitalized at the Public Hospital no. 1 in Gdansk f h m  January 2001 to 
September 2001. A total of 1435 fungi isolates were recovered 6om respira- 
tory secretions, blood, pus. wounds, urine, vaginal swabs, stool and other 
miscellaneous clinical specimens. The idenafication of fungi was done with 
the VITEK system (bioMerieux) YBC card and Chromagar ID (ABS Graso, 
Poland). 
Results: We analyzed 32 014 clinical specimens recovered from Intensive Care 
Unit, Hematology Unit, Surgery, General Medicine and Pediatric Unit 
patients. We isolated 1435 fungal strains. 38.8% strains were isolated from 
respiratory secretions, 24.1% f h m  urine, 13.2% h m  wound, 2.4% - blood, 
16.6% - stool, 3.7% - peritoneal fluids, 0.6% - vaginal swabs, 0.6% - 
catheters. The frequency of isolation was as follow: Candida albicuns 
56.0%; C.glabrata 22.9%; C. k m e i  4.2%. C. tropicalis 3.2%, C. parapsilosis 
1.5%; Aspergillus spp. 1.8%. C. lrrritaniae 0.6%, Muror spp. 0.5%; and other 
Candida spp. 9.4%. The majority of isolates fungi were from: Intensive Care 
Unit (413) -28.8%; Surgical (311) -26.8%; Hematology Unit (241) - 16.8%, 
Pediatric (85) - 5.9??, and Internal Medicine (385) - 26.82%. 
Conclusion: Candid0 albicam is the most common yeast in our patients. Molds 
were never so ofien isolated from clinical material. 
I P1460 1 S. boulardii fungemia in three intensive care unit 
patients not receiving 5. boulardii therapy 
M. Cassone, S. Scafetti, F. Mondello, G. Pavoni and M. Venditti 
Rome, I 
Objectives: Suuharomyces boulardii is a biotherapeutic agent widely used in the 
prevention of antibiotic-induced diarrhea in intensive care units (ICU). In 
humans, there are 17 cases of S. boulardii fungemia reported in the literatnre, 
almost invariably associated with oral administration of 6eeze-dried S. bou- 
lardii. The objective of the study is to describe the largest outbreak of 
S.  boulardii fungemia in a single medical ward in patients that were not 
receiving S. boulardii (three immunocompetent ICU patients). 
Methods: The three patients were on enteral nutrition, and had a central 
venous catheter (CVC). They had multiple blood cultures positive for 
S. boulardii; in one case, CVC tip was also cultivated and was positive. The 
two available strains and a strain h m  the commercial sample available in the 
ICUs pharmacy were identified as S. boulardii by biochemical tests and lack of 
spore formation. Mithocondrial DNA-restriction profiles analysis was carried 
out by pulsed field gel electrophoresis (PFGE). 
Results: The fungal isolates were identifed as S.  boulardii. PFGE demonstrated 
that they were genotypically identical to S.  boulardii obtained from the 
commercial sample stored in the ICU's pharmacy. The patient were cured 
with fluconazole therapy (200 mg bid) administered for 2-3 weeks, or by 
CVC removal. 
Conclusions: CVC contamination was the probable source of fungemia for 
the three study patients. The inabihty ofthe routine identification methods to 
Merentiate it from Saccharomyces cermiiue has probably led to an under- 
estimation ofthe real number of cases of fungemia in the literature. They can 
take place even in immunocompetent patients, and in patients not receiving 
S. boulardii therapy, by CVC contamination; it has been previously demon- 
strated that after opening a packet of freeze-dried Sarrharornyces boulardii, 
aerosolized viable yeasts persist in the air and on room surfaces, and that they 
persist on undressed hands of operators even aker vigorous hand washing. 
Colonization of CVC via aerosol dispersions must be prevented by preparing 
the biotherapeutic agent in a dedicated room separated h m  patients room. 
S .  boulardii must be considered a potentially dangerous microorganism: two 
studies documented septic shock in the presence of positive blood cultures 
that yielded S. boulardii as the unique isolate. All cases described in the 
literature and our patients had a rapid response to therapy. 
1p14611 Infection due to Crvptoeoccus naofocmdns in 
Romanian adults 
S. M. Erscoiu, 0. Dorobat, D. Ispas, M. Homos, P. C&hu and 
E. Ceausu 
Bucharest, RO 
Objectives: To analyze the clinical aspects, the treatment and the evolution of 
infections owing to Crvptococnrs neoformans in Romanian HIV-infected adults. 
Methods: The study involved the patients hospitalized in HIV Depamnent of 
our hospital, between November 1999 and October 2001. Neurological 
changes were retrospectively analyzed. To establish the cause ofthe hsease and 
the immunological status of the patients, clinical and laboratory investigations 
were performed. The classic India ink test h m  CSF smear, cultures &om CSF 
and blood cultures were performed using BacT/Alert System, Auxacolor and 
ATB Expression for identification of yeast and hngi test or E-test to 
determinate the sensitivity of them. 
Results: Among 318 hospitalized patients, 18 (5.66%) had cryptococcal 
meningoencephalitis. There were 7 males and 11 females, aged 1646years. 
Classic meningeal symptoms occurred in 8 patients, AU atients were HN +, 
class C (average value of CD4 = 68 lymphocytedmm ) at the moment of 
cryptococcosis. One patient had cryptococcal skin lesions and some of them 
had pulmonary symptom before or after diagnosis of CNS disease. The India 
ink test from smears of CSF was positive in aU patients, cultures from CSF 
were positive in 15 patients and five had fungemia. CT/MRI were performed 
in six patients (four patients with intracerebral cryptococcomas). Patients were 
treated with three different regimes: flucowole, 10 patients; itraconazole, 
five patients (after the detection of fluconazole resistance); and three patients 
with combined treatment. Intermittent maintenance therapy was done in six 
patients. Six patients began an antiretroviral treatment before the onset of 
meningitis, three ofthem stopping it because of adverse events. Mortality was 
registered in 12 patients. The average time of survival was 5.6 months(range 
4 days to 23 months).Two patients were lost from follow-up. Sixteen patients 
had simultaneous opportunistic mfections (toxoplasmosis, septic shock, HIV 
encephalopathy and tuberculosis). Persistently elevated intracranial pressure 
(13 patients), relapses of the disease (nine patients with mean three episodes) 
and coma complicated the disease. Just one patient treated by fluconazole and 
receiving HAART for H N  infection is alive with negative CSF cultures at 
13 months &om the onset of the illness. 
Conclusions: Because some of the prognostic factors in cryptococcal menin- 
gitis can be corrected, early diagnosis, early use of appropriate antifungal 
treatment, ARV treatment are important in management. 
x 
lp14621 Disseminated cryptococcosis in an 
immunocompetent woman 
M. Samarkos, T. Kontopoulou, P. Fanourgiakis and E. Vaidakis 
Athens, GR 
Introduction: Most patients with cryptococcosis have an underlying disease, 
though it does occur in patients who are not apparently compromised but 
much less frequently. We report a case of cryptococcosis in an immunocom- 
petent patient which involved the lungs, CNS, eyes, skin and bones. A 53- 
year-old female patient was admitted to our hospital because of fever lasting 
for 45 days, and reaching 39 "C the last 10 days. The patient also reported 
nonproductive cough, a slight back pain and a mild headache. An early chest 
radiograph had revealed a well-defined, non-calcified, single lung nodule 
measuring 1 cm. Her medical history included scleroderma (CREST) for 
which she was taking ciapride and omeprazole. Upon admission, except for 
the skin signs of scleroderma, there were also difFuse rosy spots on the trunk. 
Nuchal rigidlty and focal neurological symptoms were absent. Radiographic 
examination showed no change in the aforementioned lung nodule (chest 
radiograph and CT scan). A bone scan showed an osteolytic lesion of the 
right-arm. The eye examination revealed papilledema and a significant loss of 
visual acuity in the left-eye. An Indian ink preparation of spinal fluid showed 
yeast cells with capsules, characteristic of Cryptocwus. Antigen of Cryptococcus 
neofmanswas detected both in serum and in spinal fluid. The patient with the 
diagnosis of cryptococcosis was adnunistered liposomal amphotericin and 
flucytocine for 4Odays. She was discharged in excellent condition, with 
restored visual acuity and with a significant reduction in the size of the 
lung nodule. She was subsequently given antifungal prophylaxis for 1 year. 
No cause of immunosuppression has been found, despite a thorough inves- 
tigation. 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 347 
Discussion: The described case is a dmermnated cryptococcosis in an 
unmunocompetent woman w t h  c h c d  d e s t a h o n s  &om central nervous 
system, lungs, skm, bones and eyes. Although our paha t  had a history of 
scleroderma neither the disease itselfnor its treatment premspose to m u -  
nosuppression The lung is the portal of entry and md site of &chon for 
Cryptococrus neojiormans, whch may subsequently cllssemnate to other sites, 
w t h  preddection to the central nervous system. Although c h c a l  mamksta- 
tions tend to overlap between immunocompronused and immunocompetent 
hosts, a dlssemnated disease does not usually characterize cryptococcoss ln 
nnmunocompetent hosts 
lp14631 Rhinocerebral zygomycosis 
G. Margaritis, Z. Psaroudaki, A. Argyropoulou, P. Agelidakis, 
D. Karakalos, E. Perivoliotis, A. Manoussou, S. Constantoulalu and 
0. Paniara 
Athens, GR 
Introduction: Rhmocerebral zygomycosis is often found in patients with 
diabetes mellitus, particularly in the presence of acidosis. The most useful clue 
is the black necrotic eschar either in the nasopharynx or on the palate. This 
eschar or material sloughing from it may be mistaken for clotted blood. This is 
a case ofrhinocerebral zygomycosis in a 39-year-old diabetic man, admitted to 
the emergency room after a car accident with hemopneumothorax and 
multiple rib fiactures. Ten days later, he developed nonspecific neurological 
symptoms, mental status dysfunction, fever and epistaxis. Brain CT-scan 
revealed an in6act on the right-bregmatic area and ultrasonography showed 
occlusion of the right-interior carotid. The para-nasal cavities appear normal. 
Over the following days, he developed an acute exophtalmus of the left-eye 
and full ophthalmoplegia in both eyes, which evolved into blindness. An 
angiography confirmed the carotid occlusion and a new CT-scan revealed 
opacities in all para-nasal cavities. At the time the patient was presenting 
bloody epistaxis and a black necrotic eschar had been formed on the palate. 
Nasal specimens and cerebrospinal fluid (CSF) were sent to the laboratory. 
Direct KOH wet preparation of the nasal material showed wide ribbon-like, 
hyaline, predominantly aseptate hyphae with wide-angle branching. Culture 
on common growth media allowed the growth of Mucor spp. The CSF count 
was 90 WBC/mm with lymphocyte predominance and the culture yielded 
Mutor spp. High-dose liposomal amphotericin-B was introduced. The patient 
died 20 days later. 
Conclusions: Communication between physicians and the clinical micro- 
biologists is essential. Specimens need to be accompanied by clinical details. 
Demonstration oflarge aseptate, twisted hyphae in the correct clinical setting 
constitutes strong evidence of zygomycosis. The rapid progression seen in the 
zygomycotic infection allows no delay in diagnostic efforts. 
/p1464) Dermatophytosis: a retrospective study 
M. Chratofidou, V. Stamouh, E Dmtrakells and G. Dmtracopoulos 
Pafras, GR 
Objectives: To determme the prevalence of dermatophytosis and the causanve 
agents of &IS superfiud infechon 111 outpahents of our hospital, the last 
10 years. 
Patients and methods: Durulg the penod fiom 1991 to 2001 a total of 3269 
chcally suspected cases of dermatomycoses were exanuned for CauSahve 
fun@ Skm scrapings, hairs and nails were collected h m  relanve anatonucal 
sides mth c h c a l  signs of infection After a direct mcroscopic exammahon 
the specmens, were cultured on a Sabouraud dextrose-agar plate wth  
chloramphemcol for the isolation of yeasts and on a second plate wth  
chloramphemcol and cyclohexlmde for the isolahon of dermatophytes 
Results: According to t h ~ s  retrospechve malys~s, 821 pahents had posihve 
cultures for fung~. Among them 235 (29%) cultures were posihve for yeasts 
and 586 (71%) cultures were POSihVe for dermatophytes. M tanis was isolated 
in 340 (58%) cases, T rubrum 111 207 (35%) and T mentagrophyfes in 25 (4%). 
E.Jotcosum, 'I: violaceum and T. tomurans were isolated from four cases each 
one. M. gypseum was isolated from two subjects. 
Conclusions: Dermatophymsis (71%) was the most fiequent superficial 
infection of dermatomycoses. M. ranis (58%) and ?: rubrum (35%) were the 
most prevalent species of dermatophytes which were isolated fiom cultures of 
outpanents w th  dermatophymm. 
Etiological agents of cutaneous mycoses in 
Bilbao (Spain) for 7 years 
P. Liendo, J Sinchez and R. Cisterna 
Bilbao, E 
Objectives: Knowledge of superficial mycoses epidemology in our hospital 
The hospital of Basurto is a prmary and ternary care, teachmg hospital that 
provldes care in the urban area of Bdbao (Span). 
Methods: We carried out a retrospective study of skm lesions suspicious of 
mycological enology, received ul OUT hospital between 1995 (September) and 
2001 (November). Samples were observed for direct mcroscopy exanunanon 
wth  30% KOH and cdhvated m Sabouraud + chloramphenicol/ciclohex- 
m d e  agars for 15days at room temperature. Moulds and dermaaophytes 
ldenhficahon was based on mcmscopic and macroscopic characterishcs. For 
yeast identification, germ-tube test and Api C aux (bioMeneux) were 
performed. 
Results: We received 2634 samples of 1827 paaents, age range 2Omontbs to 
90 years old. A total of 1120 (42.52%) samples of 775 pahents were scales of 
glabrous skm lesions, 1433 (54.40%) n a i l s  of 1010 pahents and 81 (3.07%) 
hairs of 42 panents We isolated 356 fung: 
1 58 14% dermatophytes, 
2 36.51% yeast, and 
The most frequent isolated h n g  was Trubrurn (31.61%), followed by 
C. albicans (16.01%), M canis (14.60%), C.parapsilopsis (10.96%) and Tmenta- 
gophyres (5.05%). M. canis was mainly isolated in pahents less than 20 years old 
(65.38%) and T rubrum between 21 and 60yean (73.39%). Yeasts were the 
most fiequent lsolahon (70.54%) 111 patients older than 41 years In-hand 
onychomycoses yeasts were the mcroorganistm more fiequently isolated 
(98.04%), whereas m feet a d s  supposed 15.73% oflsolahons In ths sample, 
T rubrum was predominant (44.94%) followed by Sopulariopsts spp. (21.34%) 
which was only isolated in this localizahon 
Conclusions: We observed: 
1 a global predominance of dermatophytes; 
2 anthropophilic dermatophytes mcidence was hgher than zoophilic; 
3 usually 111 hand nads only yeasts were isolated; 
4 in Tinea rapitis M.  cants was predormnant; 
5 lncrease in T rubrum incidence; 
6 not increase in Af?ican endemic dermatophytes despite unmigration. 
3 5.33% scopularopsis spp. 
Clinical, mycological and epidemiological 
characteristics of toenail onychomycosis in Estonia 
H Jam, S. Kaur, M Eisen, l? Naaber and H Sllm 
Tnrtu, EST 
Objectives: Stuclles dunng the recent years show an increase in the incidence 
of fungal nad dlsorden The a m  of our study was to evaluate the chmcal 
features, pred~sposing factors and pathogens of toenall onychomycosis in 
Estoma. 
Methods: Between January and May 2001, 436 panents (173 men, 263 
women) wth  dnucal ugns  of onychomycosls were mtemewed and exarmned 
by dermatologst in a l l  counaes of Estoma Specmens were collected by 
dermatologst for dxect mcroscopy 111 25% KOH with glycerol and cultures 
Results: Totally, 436 persons had 2344 lnfected toenads (mean number of 
affected toenah for one pahent 5 4) At the hme of inveshgahon, 70% of 
patients had the signs of Tineapedlr Higher age was risk factor for coniblned 
infechon of skm and nads in both genden Other foot dlseases (psonasis, 
eczema, wa l  warts, etc.) were magnosed m 17% ofpahents. The coexlstence 
of toe- and fingernail onychomycosis occurred in 14%, concomtant tmea 
manus was dmgnosed in 6% and nnea crurls m 4% of pahents. The factors 
assouated wth  d lnfechons were prolonged anhbionc or nnmunosupresive 
therapy, diabetes, obesity, and mpmed cIrC&hOn. The most common 
subjechve symptoms were embarrassment and d~scomfon of wahng. The 
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diagnosis of fungal infection was confirmed by positive microscopy in 259 
(59%) and by positive culture in 186 (43%). Of these positive samples, 23% 
cases were found to be positive by microscopy and 6% by culture only. Thirty- 
six percent specimens were positive by both methods. Eighty percent of 
isolates were dermatophytes. Yeam were isolated in 11% (3% confirmed by 
distinctive microscopy) and non-dermatophytic moulds in 8% of the cases (2% 
contimed by distinctive microscopy). T tubrum was most common pathogen, 
followed by T menragrophyres, T inferdigitale, Minospoturn canis, 7: violaceurn and 
Epidmophyton jlo~osum. Candida albicam and C. parapsihis were agents of 
toenail candidosis. 
Conclusions: Predisposing factors for onychomycosis are the diseases 
that impair the circulatory system, and concomitant creatment with antibiotics 
or immunosupressive drugs. The most flequently isolated pathogens 
were similar to the pattern in whole Europe. Our data show high prevalence 
of progressive onychornycosis and suggest the need for education of our 
patients. 
Animal models and experimental treatment 
(p14671 The synergism between quinupristin4alfopristin 
(Q-D) and fi-lactams against methicillin-resistant 
Staphylococcus aureus (MRSA) requires blockage of 
bacterial penicillin-binding proteins (PBP) 
J. VouiUamoz, J. M. Entenza, F? Majcherczyk, M. Giddey and 
F? Moreillon 
Lausanne, CH 
Background: Although not a cell wall inhibitor, subinhibitory concentrations 
of Q-D result in the production of a structurally and biochemically abnormal 
peptidoglycan in MRSA and enterococci. This might be the basis of the 
synergism between Q-D and several B-lactams that was previously demon- 
strated in vitro and in rats with experimental endocarditis (EE). However, the 
mechanism of this synergism is not known. 
Methods: To evaluate the requirement for PBP blockage in this interaction 
we compared the effect ofQ-D combined with either cefepime or aztreonam 
against a well characterized MLSB-resistant MRSA (strain P8). Cefepime 
blocks the normal staphylococcal PBPs, but not the low-afhity PBP2A of 
MRSA. Therefore, it is effective against methicillin-susceptible staphylococci 
but not MRSA. Aztreonam, on the other hand, blocks neither of 
the staphylococcal PBPs, and thus is ineffective against both methicillin- 
susceptible staphylococci and MRSA. 
Results. In vim, the minimal inhibitory concentrations in broth were 0.5 mg/L 
ofQ-D, 32 mg/L ofcefepime and > 1000 mg/mL ofaztreonam. On agar plates 
containing increasing drug concentrations, M A  colonies grew on up to 
500 mg/L of cefepime and >5000 mg/mL of aztreonam. In the presence of 
subinhibitory concentrations of Q-D (1/4 x MIC), these value decreased to 
32 mg/L for cefepime, but were not af?ected for aztreonam. In vivo, rats with 
aortic EE were treated for 5 days (starting 12 h after inoculation) and received 
either a low dose of e D  (7 mg/kg bid) alone or combined with human-like 
kinetics of2 gofcefepimebidor2 gofaztreonamqid Controlswerekilledatthe 
startoftherapy. Theresultswereasinthetable (infectedratdtotalrats [medianlog 
cfu/g ofvegetation]). 
the function ofPBP2A. The results provide a rationale for further studying the 
basis of such potentially useful interaction. 
m1 Failure of escalating doses of vancomycin WAN) 
in the treatment of experimental endocarditis (EE) due to 
glycopeptide-intermediate Staphylococcus aureus (GISA) 
J. Vouillamoz, P. Moreillon, K. Sieradzki, M. Giddey, M. I! Glauser and 
J. M. Entenza 
Lausanne, CH; New York, USA 
Background: It is generally agreed that the emergence of GISA is of clinical 
concern. Yet most isolates of GISA have minimal inhibitory concentrations 
(MIC) of VAN (8-16mg/L) that can be achieved in the plasma during 
intravenous (i.v.) theram. Therefore, it was proposed that VAN might still 
successfdy treat GISA infections provided that appropriate amounts of the 
drug are delivered to the patient. 
Methods and results We tested t h i s  hypothesis in rats with aortic EE infected 
with either a Susceptible-susceptible methicillin-resistant S. aureus (MRSA 
217; VAN MIC = 2 m@L), or three consecutive clinical isolates of MRSA 
(MRSA P2, P3 and P3 ) with increasing levels of VAN resistance (MICs of 2, 
8, and 16 mg/L, respectively). Although resistant to methicillin, all isolates had 
rather low MICs of amoxicillin/clavulanate (AC) (MIC< 16mg/L), due to 
the intrinsic & i t y  of amoxicillin for penicillin-binding protein 2A (as 
previously demonstrated). Treatment started 12 h after inoculation and lasted 
for Sdays. Rats received human-like kmetics produced by either l g  i.v. 
VAN/12h (bid), or continuous VAN infusion producing constant plasma 
levels of 20 and 40mg/L. Control treatment was A/C (2.2g every 6h). 
Results were as in the table (infected rats/total rats [median log cfu/g of 
vegetation]). 
9-D Cefepme Q-D plus Aztreonam Q-D plus 
Control bid bid cefepme qid aztreonarn 
8/8 [7 91 7/7 [9.1] 818 [9.0] 8/13 [3.6]* 10/10 [9.3] 10/10 [9.0] 
*P< 0 05 compared to q D  or cefepme used alone. 
Conclusion: Aztreomam, which does not block S.nureus PBPs, did not 
synergize with Q-D. In contrast, cefepime that blocks the normal S. nureus 
PBPs interactedpositively with Q-D. This suggests that some PBP blockage is 
required for synergy. Most /?-lactams block the normal set of S. aureus PBPs. 
During such treatment MRSA are believed to use their low-affinity PBP2A to 
assemble the cell wall. Thus, the beneficial effect of Q-D on B-lactam-treated 
MRSA might result &om some direct or indirect interference of Q-D with 
VAN20 VAN40 
Isolates Controls VAN hid (mg/L) (mg/L) AC 
217 VAN-S) loll0 17.51 0/12 [2.0] - - - 
Pc-2 @re-GISA) 6/6 [7.6] 818 [9.2]+ 2/9 [2.0]+ - 4/13 [2.0] 
PC-3 (GISA) 717 [6.82] 414 [9.0]+ - 7/9 [9.0]+ - 
PC-3' (GISA) 10/10 [5.8] 7 / 8  [8.l]+ - - 1/13 [2.0] 
+Groups in which isolates with a fimher increase in Vanco MICs were selected. 
Conclusion: VAN bid was only active against MRSA 217. Constant 
levels VAN were active against the pre-GISA PC-2, but failed against the 
most resistant GISA isolates. Moreover, VAN selected for variants with 
increased resistance (VAN MICs up to 16mg/L) in all isolates of the PC 
series. In contrast, AC therapy was effective. These results contradict the 
optimistic view that high-dose VAN treatment may still be effective against 
severe GISA infection and highlights the need for developing alternative 
therapies. 
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lp14691 Risk of pneumococcal resistance induction by 
short-term ciprofloxacin (CIP) or moxifloxadn (MXF) 
treatment in a bacteremic mouse model of pneumococcal 
pneumonia 
C. CheGon, B. Veber, N. Frkbourg, M. Caron and J. E Lemeland 
Rouen, F 
Objectives: MXF is a new quinolone with good activity in v im and in vivo. 
Older quinolones such as CIP are well known to generate bacterial resistance, 
particularly when given in low doses. This capacity to induce bacterial 
resistance is a major impediment to use of quinolones as single-drug therapy. 
The aim of this study was to compare the in vivo ability of CIP and MXF to 
increase the minimal inhibitory concentration (MC) against Pneumocms in 
an experimental pneumonia model. 
Methods: Female Swiss mice were infected with 1 000000 cfu of a d e n t  
Streptococcus pneumoniae (SP) strain (4241) by the intratracheal per oral route 
after general anesthesia. A 50-mg/kg dose of either antibiotic was given 18 h 
post-infection, followed 24 h later by a second dose. Controls were infected 
but not treated. After 48 h, the last antibiotic dose, lung cultures were done on 
blood agar containing the administered antibiotic in concentrations of 1/2 
MIC, MIC, 2MIC, or MIC. The cultures were read after 24 and 48h 
incubation in COz at 37°C. 
Results: SP MIC before treatment was 1 mg/L for CIP and 0.25 mg/L for 
MXF. All the controls died, with no change in MICs oflung SPs (no growth at 
the MIC). In the CIP group, a mean of 25 cfi~ were found in the 1 mg/L agar, 
while cultures in the free CIP agar showed a mean of 100 000 cfullung, for the 
same mice. In contrast, with MXF, no growth occurred in the 0.25 mg/L agar. 
These results were confirmed by two successive experiments. 
Conclusion: In t h i s  model of pneumococcal pneumonia, after only two doses, 
CIP selected resistant mutants, as shown by bacterial growth in agar contain- 
ing CIP at the MIC. In contrast, MXF did not change the MIC of 
Pneumocoaus. These results require codirmation in humans. 
I P1470 I Efficacy of levofloxacin (LEVO) in a murine 
pneumonia model by H. influenzae in comparison with 
moxifloxacin (MOXI) and azithromycin (MI) 
M. B. Marturano, A. Zanoncelli, V. Andreetta, L. Piccoli and 
E. Di Modugno 
Verona, I 
Background H.  inzuenzae is an important pathogen of upper and lower 
respiratory tract infections (RTI), including acute otitis media, sinusitis, 
bronchitis and pneumonia. Levofloxacin and moxifloxacin are two fluoro- 
quinolones with good activity against RTI pathogens, including Haemophilus 
spp. Azithrornycin is a macrolide antibiotic extensively used to treat com- 
munity RTI. 
Objectivas: The aim of this study was to evaluate LEVO activity in an 
experimental pneumonia model of H.  inyuenzae and to compare it with that 
of two other antibiotics used to treat RTI. Dosing regimens were chosen 
taking into account the PK/PD values linked to clinical efficacy in the 
literature (AUC/MIC > 100 for fluoroquinolones and AUC/MIC about 30 
for AZT). 
Methods: Bacterial inocula were prepared by harvesting H. inzuenzae 
ATCCl02ll from chocolate agar plates and suspending it in saline solution. 
Ten-fold dut ions were prepared into cooled molten nument agar. Mice 
(C57BL/6 J, Harlan) were anaesthetized injecting i.p. 0.2 mL of a ketamine- 
xylazine solution and infected by intratracheal instillation of50 pL ofbacterial 
suspension (approximately 106 cfdmouse). A single dose of antibiotics was 
administered orally 4 h post-infection. After 24 h, the start of therapy, lungs 
were removed and homogenized to determine viable bacterial numben. 
Results: MIC values were: 0.03 pg/mL for LEVO, 0.06 pg/mL for MOXI 
and 2 pg/mL for AZT. All animals developed a pulmonary infection 4 h after 
inoculation (about 5 x 106 &/lung). Followingadmhstration of LEVO (5, 
0.5mg/kg), MOXI (10, lmg/kg) and AZT (100, 200mg/kg) bacterial 
counts were reduced to the lunit of detection at the highest dosa and 
remained close to start of therapy at the lowest ones. These results showed 
that LEVO and MOXI were effective in eradicating H. inJhlgfzde at doses 
corresponding to AUC/MIC values fir lower than predicted while AZT 
behaved a. expected. 
Conclusion: A mouse model of pneumonia caused by H. mjuenxae was 
developed and v&dated by testing three andbiohcs already on  the market 
to treat RTI. In this experimental model LEVO showed to be more effective 
than predicted hom PK/PD panmeters m treating a pulmonary infection 
caused by H. injuenzae pathogen. 
ml Therapeutic effect of antibiotics within oxidative 
stress in acute septic peritonitis - a new rat model 
R Muttersands H o f h n n  
Marbutg, D 
Objectives: Most ammal models of sepfic peritomas use cecal hgahon and 
punchwe or muapentoneal mjechon of fecal mocolum. Ths  may cause 
problems due to the mabhty to quanhtate loadmg doses and a random 
combinahon of bacterial species involved The purpose of our study was to 
establsh a new anunal model reflechng the Situahon in human SephC 
peritomhs, whch would combine systemc intlammatory response with 
chromc mtra-abdomal lnfechon and abscess-formahon 
Methods: E. colr, BactenodesJragilrs and B thetaiotaomicron were cultivated in 
BHI. A dose-dependent mortl ty of 50% was found at injecuon of 
5 x 108 &/kg BW. We inveshgated the models response to one  lacta tam 
(piperachtazobactam) and two qumolones (levofloxacm, modoxam) .  
The release of free oxygen rachcals by nlacrophages a descrlbed as a 
pathogeruc factor rn lethal sephc perltOnihS. To smdate dm OXIdahve s m s s  
(0s). ozomzed oxygen was mjected mtraperitoned. Ozone and anhbiohc 
were given 1 h after bacterial mocdahon alone and m combmhon. Further- 
more, immuno-hstochemcal analyzes ofpro-idammatory cytolunes (TNFa 
mRNA, IL lB  *A) were inveshgated by m situ hybridnahon of the rats 
spleen. 
R e s u b  We could show a ngdicant hgher mortahty m amnals exposed to 
0.5 All anhbioacs had a beneficid effect on m o d t y  The combinahon of 
anhbioacs and OS led to a hilgher morrahty m two cases Only moxlfloxacin 
M not reduce its beneficial effect on mortahty in combination wth  OS in 
situ hybridrzahon showed a hgh expression of TNFa mRNA and IL-lp 
mRNA in the spleens of the control groups. The expression of the cytolunes 
was even hgher in the B-lactam group and sigmficant lower m the qumohne 
group 
Discussion: Our standarkzed a d  model a smtable to mveshgare the 
pharmacologx and pathophysiologx mterrelaaons m human lethal sephc 
pentomhs. The mrtalIty rate was mcreased w t h  piperacdbn-tazobactam 
under OS, maybe due to LPS-hberahon by destruchon ofbactenal cell walls. 
Probably because of thev mode of achon and a therefor lower and delayed 
LPS-release the qwolones were more effechve in ths a m a l  model As 
expected, 0 s  msed mortality m the levofloxacm group A higher release of 
prodammatory cytokmes could be the reason. The effect of modoxacm 
was not modlfied by the presence of ozoruzed oxygen m the peritoneum 
1814721 The effects of Saccmmyces boulardi on bacterial 
translocation in rats with obstructive jaundice 
M. E Geydc, M. Aldemir, 0. Kokoglu, C. Ayaz, S. Satilmis, 
H. Buyukbayram and S. Hosoglu 
Diyarbakir, TR 
Background The developing of bacterial translocation following obstructive 
jaundice (OJ) & an important cause of sepsis. Bacteria location has been 
consistently demonstrated in experimental models of OJ. 
Objectives: The aim of this study was to investigate effect of Sarcromyces 
boulardi treatment on preventing bacterial translocation in an OJ animal 
model. 
Method: Sixty Sprague-Dawley adult rats were included in the study by 5 
groups. Group 1 was the control group. In Group 2, 3, 4 and 5 common 
bile duct ligation was performed and either saline, ampicillin-sulbaktam 
(50mg/kg/day), S. boulardi (100 mg/day) or ampicillimulbaktam plus S. 
boulardi via enteral catheter were given, respectiveIy, for a 7 days of period. 
Biochemical and mi&obiological analyzes were performed from blood, 
mesenteric lymph nodes, liver and spleen samples. Histopathological exam- 
inations of terminal ileum specimen were also performed. 
Resula: The bacterial translocation rates were Wo in group I, 83% in-group 2, 
42% in-group 3, 42% in group 4 and 33% in group 5. Bacterial translocation 
rate was significantly higher in-group 2 than groups 3, 4 and 5 (P< 0.05). 
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There was not a sigmficant difference among groups 3, 4 and 5 for bacterial 
translocation rates. Serum bilirubin level, M, ALT, and ASTwere sigfuficantly 
elevated in groups 2, 3 , 4  and 5 compared to group 1 (P< 0.001), however, 
there was no significaat difference among groups 2, 3, 4 and 5 (P>O.O5). 
Histopathological examination of ileum specimens revealed a sig&cant 
decrease in the height of villi in group 3 when compared with the groups 
4 and 5 (P=  0.001). 
Conclusion: S. boulardz was effective in the successful control of translocation 
and improvement of intestinal barrier function. 
I P1473 1 Lipid peroxidation by multidrug-resistant 
Pseudomones aeruginosa in the pathogenesis of nosocomial 
sepsis 
S. Skiathitis, S. Hatziantoniou, K. Demetzos, I. Dona,  G. Karatzas, 
A. Dionyssiou-Asterioy H. Giamarellou and E. J. GiamareUos-Bourboulis 
Athens, GR 
Objective: Concentrations of polyunsaturated fatty acids (PUFAs) are 
increased in serum during acute inflammation. Elevated levels of malono- 
dialdehyde (MDA) as a result of the peroxidation of PUFAs have been found 
in the blood of patients with sepsis (Goode et al. Crit Care Med 1995: 
23646). In order to investigate whether peroxidation may be triggered by 
multidrug-resistant l? aeruginosa (MDPA), one isolate was ex vivo exposed to 
sera derived &om animals intravenously administered y-linolenic acid (GLA). 
Methods: An emulsion of GLA was administered iv at a dose of 25 mg/kg 
over lOmin by the left jugular vein of seven rabbits and blood was sampled 
at 15-min intervals by catheters inserted in the left carotid and in the 
hepatic veins. Blood was centrifuged and 1nL of serum was added in 
9 mL of Mueller broth containing a six log-phase inoculum of one MDPA 
blood isolate. The applied isolate was resistant to ceftazidime, imipenem, 
amikacin and ciprofloxacin. During 3, 5 and 24h of incubation at 37 "C 
ahquots were sampled for estimation of viable cell counts and for treatment 
with trichtoroacetic acid. Sera were then centrihged and MDA was deter- 
mined by the thiobarbiturate assay. Levels of acids in blood samples were 
measured by GC-MS. 
Results. Added sera did not have any effect on MDPA growth and mean viable 
counts were 6.4, 8.0 and 9.0 log of &/mL after 3, 5 and 24 h of incubation, 
respectively. Mean MDA after 3 h of growth in the presence of sera sampIed 
from the hepatic veins before infusion of GLA and 15,30,45 and 60 min after 
&ision of GLA were 604, 564, 1450, 465 and 870 mM, respectively, and in 
the presence of sera sampled from the carotid artery 590, 887.5,935, 1256.7 
and 23057 mM, respectively. These concentrations decreased considerably at 
5 and 24 h of growth. In blood samples, GLA was found metabolized to 
arachidonic acid at concentrations ranging between 18.6 and 30.6 mh4 whch 
are within those detected in sepsis (Falconer et al. Br J Cancer 1994; 69: 826). 
Conclusions: Lipid peroxidation of sera supplemented with PUFAs occurs ex 
vivo over the first hours of rapid growth of MDPA, so as to implicate lipid 
peroxidation triggered by h4DPA as a probable pathogenetic mechanism of 
nosocomial sepsis. 
1 P1474 Incidence of renal infarcts in Pseudomonas 
experimental endocarditis in rabbits 
P. Fanourgiakis, T. Argyrakos, S. Hatzianastasiou, M. Samarkos, 
A. Vasdeki, T. Kontopoulou, D. Rontogianni, G. Chalevelakis and 
G. Saroglou 
Athens, GR 
Introduction: Kidneys are usually affected during che course of infective 
endocarditis. Glomerulonephritis, infircts and abscesses are the most usual 
types of pathologic processes, but clinical or biochemical evidence of renal 
involvement may be lacking in spite of the presence of such a pathology. 
Autopsy studies demonstrated infarctions in about half of the cases. 
Objectives: The present study was conducted in order to evaluate the 
fiequency of renal infarcts during the course of experimental Pseudomonar 
umgirzo5u (PA) endocarditis in a rabbit model. 
Materials and methods: Forty four surviving rabbits with left sided PA 
endocarditis were sacrificed on day 8 (10 controls, 14 receiving cef-tazidime 
plus tobramycin (TOE), 10 ciprofloxacin, 11 irnipenem plus TOB). The 
kidneys were excised and sent to the pafhology laboratory. The specimens 
were fixed using buffered formalin. Hematoxylin and eosin sections were 
examined under light microscopy. Special histochemical stains such as d-PAS 
and Gram were performed in selected cases. 
Results: 39/45 (86.6%) of cases showed single or multiple unilateral or 
bilateral wedge-shaped white (anemic) septic infarcts with the apex of the 
wedge pointing towards the focus of vascular occlusion. The infarcts were 
visible macroscopically as sharply demarcated pale, yellow-white areas with 
the base against the cortical surface and the apex pointing towards the 
medulla. Microscopically they were accompanied by calcification of the 
surrounding cells. 
Conclusions: Renal infarcts are almost a constant feature of PA experimental 
endocarditis in rabbits. This surprisingly high tendency for embolization of a 
distant organ emphasizes the need for early initiation of antibiotic therapy and 
early valve replacement when it is indicated. 
)p14751 Protective effect of lactobacilli in experimental 
model of satmondlosis 
H. Tamm, P. Naaber, T. Kullisaar, K. Zilmer, A. Rehema, 
R.-H. Mikelsaar, M. Zilmer and M. Mikelsaar 
Ertu, EST 
Introduction: Several smcLes have shown immunomodulative effect of lac- 
tobacik in infections and their antagonistic activity against pathogens. Still 
there are few data about protective effect of lactobacilli against oxidative stress 
in case of salmonellosis. 
Objectives: The aim was to determine microecologically, morphologically 
and by means of oxidative stress parameters the influence of several strains of 
lactobacilli on experimental salmonellosis. 
Methods: NIH mice (n = 47) used in this study were divided into four groups: 
(1) S. typhimurium-challenged mice (n = 16), (2) lactobacilli (L. ucidophitus and 
L.fprmenfum) administered mice (n = lo), (3) salmonella-challenged mice 
pretreated with lactobacilli (n= 14) and (4) control group (n=7). After 
sacrification the counts of salmonella were estimated in intestine and blood, 
biochemical and pathohistological changes (scores: 0 =no changes to 
5 =severe changes) were evaluated in distal part of ileum. 
Results: Mortality rate and the intestinal and blood salmonella counts didn't 
differ in groups 1 and 3. Pathohistologically in group 3 intestinal lymph node 
hyperplasia w a s  less expressed than in group 1 (medians 1 vs. 1.5, P <  0.01). 
Suppurative lymphadenitis was found in group 2 animals but not in group 3 ones 
(medians 1.1 vs. 0, P<O.Ol). Oxidative stress parameters were more 
expressed in group 1 than in 3 concentration of intestinal lipid peroxides 
(LPO) was higher in group 1 (mean 297pmoWmg prot) comparing With 
group 3 (224, P<O.Ol), aSo the free iron and saturation of iron-binded 
proteins were higher in salmonella group (medians 2 2 . 5 1 ~  and 31.5%) vs. 
group 3 (13 and 22%). 
Conclusion: Although administering of lactobacilli does not reduce salmo- 
nella concentration in intestine nor decrease mortality rate, it s t i l l  express 
protective effect against mucosal inflammatory injury and oxidative stress. 
lp14761 Kinetics of ceftaridime and pro-inflammatory 
cytokines in neutropenic mice during E. coli sepsis 
J. Buijs, A. S. M. DofferhoK J. W. Mouton and J. W. M. van der Meer 
N+negett, NL 
Objectives: During sepsis cytokines are produced by the host, in response to 
endotoxin (LPS). LPS is liberated from bacterial cell-walls during lysis. 
Ceftazidime (Cz) is a 8-lactam-antibiotic with a dose-dependent pattern 
of binding to penicillin-bindmg-proteins (PBPs). At low dose-levels PBP-3 
binding occups, leading to filament-formation. During fdament-formation 
large amounts of LPS are incorporated in the cell-wall. At higher concentra- 
tions Cz binds to PBP-1 , leadmg to a quick bacterial lysis. We compared the 
effects of dosing-schedules of Cz on morphology, growth and the pro- 
inflammatory response. 
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Methods: We studied kinetics of Interleukin-6, TNF-a and Cz in 
ueutropenic Swiss mice during sepsis, treated with Cz (N=18) or 
saline (N=10), during the first 4h  of treatment. On t = O  mice were 
challenged with 107 cfu E. coli ATCC 25922 in thigh muscles. After 2 h, 
they were treated with 2 mg Cz (80 mg/kg), intravenously, either as bolus- 
injection or continuous infusion. On f = 3,4, 5 and 6 h mice were sacrificed 
for collection of plasma-samples, bacterial counts and morphological studies. 
Kinetics of IL-6, TNF and Cz were also measured in mice without infection 
(N= 10). 
Results: During continuous infusion only rods were seen, whereas after bolus- 
injections massive filament-formation occurred. In both groups, a sigmficant 
reduction of cfus in thgh muscle was measured compared to controls 
(P= 0.006). In continuously treated mice a peak-level of TNF was reached 
1 h after start of the mfusion, sigmficantly higher than bolus-treated animals 
(P=  0.018) and controls (P= 0.004). The bolus-group also produced sig- 
nificant higher TNF, compared to controls (P=OO19). I L 6  showed a fast 
decrease in untreated mice fiom 2916 to 336pg/mL, whereas in continuous- 
treated mice continuous high levels were measured (2026-1717pg/mL). 
After bolus-injections a decrease occurs, comparable to controls. In septic 
mice plasma-Cz-levels were lower and clearance was slower, compared to 
controls. In mice without lnfection IL-6 and TNF were below detection- 
limits at all time-points. 
Conclusions: During continuous infusion of 80 mg/kg Cz filament- 
formation is prevented. This leads to bacterial lysis and LPS-production, 
which is reflected as high cytokine-responses during the first hours of 
treatment. After bolus-injections filament-formation occurs. This results in 
the risk of a postponed, but much higher LPS-release and therefore should be 
prevented. 
v1 Penetration of moxifloxacin (MXF) into the 
vitreous humor in an endophthalmitis rabbit model 
S. Bronner, G. PrLvost, J. D. Peter, M. C. Ploy, C. Renault, l? Arvis, 
H. Monteil and F. Jehl 
Sfrasbourg, Limoga, Puteaux, F 
Objective: Bacterial endophthalmitis is a serious complication of ocular 
surgery and of penetrating eye trauma. Leading causative organisms are 
Gram-positive pathogens, i.e. Staphylococcus aureus and Staphylococcus epider- 
midis. Treatment remains difficult because most antibiotics show poor ocular 
penetration when administered by systemic route. MXF is a new fluoroqui- 
nolone, with enhanced activity against Gram-positive organisms including 
Staphylococcus spp. 
Methods: The penetration of MXF into the vitreous humor (vit) of normal 
and 24-h S. aurelrs infected eyes of New Zealand albino rabbits was evaluated, 
following an IV adrmnistration of two doses (5, 20mg/kg). MXF MIC and 
MBC for the S. aureus V8 strain used were 0.125 and 0.250 pg/mL, respec- 
tively. 
Results: A good intravitreal penetration of MXF was observed whatever the 
doses in infected and uninfected eyes. For the 5-mg/kg dose, the mean vit 
AUC 0.5-5 h (area under curve) was 1.73 f 0.37 pg h/mL and the mean ser 
AUC 0.5-5 h was 5.40 4~ 3.26 pgh/mL in uninfected rabbits (n = 5). At the 
same dose in infected rabbits (n=6), the vit AUC 0.5-5 h was 
2.38 f 0.74 pg h / d  and the ser AUC 0.5-5 h was 8.55 f3.72 pg h/mL. 
The penetration ratios determined by vit AUC 0.5-5 h/ser AUC 0.5-5 h 
were 0.32 and 0.28 for uninfected and infected rabbits, respectively (no 
siwicant dfierence). For the 20-mg/kg dose, in uninfected rabbits (n = 5). 
the mean vit concentrations (0.5 h = 1.56 f 0.39, 1 h = 1.67 f 0.17, 
2h=1.66&0.33, 3h=1.48+00.22, 5h=1.113~0.23) resulted in a mean 
vit AUC 0.5-5h of 6.64+0.76pgh/mL, the mean ser AUC 0.5-5h 
was 19.43&11.16pgh/mL. The mean vit AUC 0.5-5h increased 
to 9.12 f 1.81 pgh/mL (concentrations: 1.75f0.52, 2.03 f 0.64, 
2.50 f0.67, 2.02f 0.44, 1.54 f 0.35) in dected rabbits (n = 8) while the 
mean ser AUC 0.5-5 h was unchanged. The penetration ratio was then 0.34 
for umnfected rabbits and was sigmficantly improved for infected rabbits 
(P<O.O2), reaching 0.47. The ser AUIC was 152.48m/mL/h for the 
2O-mg/kg dose and 63.92 pg/mL/h for the 5-mg/kg dose. The vit AUIC 
of 68.48pg/mL/h for the 20-mg/kg dose was associated with a 3.5-log 
decrease of viable bacteria in the vitreous. The vit AUIC of 14.56 pg/mL/h 
for 5-mg/kg dose was associated with a 1.6-log decrease. The vit I L  
(C-/MIC) were 20 and 5.44, respectively. 
Conclusions: The penetration of MXF in the vitreous of rabbits is high, and 
MXF concentrations are higher than the MICs against major pathogens, 
including meti-S S. B U ~ J S  strains. 
I P1478 I Experimental model of ~bphy/moccus aureus 
conjunctivitis in the rabbit efficacy of netilmicin solution 
and gel 
A. Marino, A. Blanco, M. Mazzone, 0. Peri, L. Lombardo, V Alonzo 
and V Enea 
Mesina, Cafania, I 
Objective: To set up a reproducible rabbit model of Staphylococncc aureur 
conjunctivitis and evaluate the efficacy of Netilmicin in two ophthalmic 
formulations. 
Methods: Animal model An abrasion along the inner surface of the lower 
lid and a radial 4mm incision near the medial canthus was effected on 
both conjunctivae of 15 white New Zealand rabbits. Two 50 pL. dmps 4 a 
1 x 10s/mL suspension of an ocular isolate of S. a u m  were admmistered in 
the cul-de-sac of both eyes at 2 h intervals for a cod of three applications. 
Clinical evaluation of the infected eye was performed with a slit lamp, and 
clinical signs were monitored daily for 5 days. Groups of three rabbits were 
sacrificed with Tanax, at 2448-72-96-120h after injury and infection, and 
their conjunctivae removed to determine the bacterial load. Efficacy test: The 
experimental model described above was used to test the efficacy of a new gel 
formulation containing xanthan gum, sodium hyaluronate and Netilmicin 
sulphate versus Neulmicin sulphate eye drops. Both formulations contained 
the equivalent of 0.3% Netilmicin base. At 24 h after the infection 30 rabbits 
with evident clinical signs were randomly distributed in two groups and 
treated. The right eye of each animal was treated three times a day for 2 days 
with 50 pL ofNetilmicin eye drops (group 1) or Netilmicin gel (group 2). The 
left eyes were treated with vehicles. 
Result.% At 24 h fiom the injury S. nureus caused in the rabbit a conjunctivitk 
that persisted for the 5-day period of ocular observation. Hyperemia and 
purulent discharge were the most pronounced scored signs. Analysis of the 
bacterial burden at 24,48,72 and 120 h yielded a mean f standard deviation 
of 4 . 9 f  0.089; 3.6 f 0.504; 3.2 f 0.103; 4.2 f 0.971 log colony forming 
unitslg of tissue, respectively. Statistical analysis (t-test) of the treatment 
groups confirmed that the two pharmaceutical formulations, administered 
three times a day for 2 days, were equivalent, both producing a 98% reduction 
of the bacterial load. 
Conclusion: We have established a rabbit model of S. nureus conjunctivitis 
with persistence of the infection and relative clinical signs over a 5-day period. 
This animal model was useful to test topical ophthalmic formulations against 
the most common pathogen of the eye surface. The highly sigdicant f-values 
found for both treated groups c o n f i i  that the antibiotic is equally active in 
both formulations. 
Experimental group B streptococcal arthritis: role 
of interleukin-10 
M. Puliti, C. von Hunolstein, E Bistoni, G. Orefici and L. Tissi 
Perugia, Rome, I 
Objective: Septic arthntis is one of the clinical manifestations of group B 
Streptococcus (GBS) infection in neonates and is often associated with age and 
serious underlying diseases in adults. Intravenous inoculation of CDl mice 
with type IV GBS results in high incidence ofddfuse septic arthritis, associated 
with high systemic and local production of ILls and IL-6. Aim ofthis study 
was to assess the role ofthe anti-inflammatory cytokine IL-10 in the evolution 
of GBS systemic infection and arthritis. 
Methods: CD1 mice were inoculated intravenously with arthritogenic strain 
1/82 oftype IV GBS. Mice were administered intraperitoneally with anti-IL- 
10 monoclonal antibodies (1 mg/mouse) at the time of infection, or with 
exogenous murine IL-10 (400,200 or 100 ng/mouse) for 5 days, starting 1 h 
after bacterial challenge. Mice were monitored daily for survival and arthritis. 
In a subsequent set of experiments, mice were N e d  at selected times for 
examination of cytolune production, bacterial clearance and joint histo- 
pathology. 
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Results: Detectable levels of IL-10 were evident in sera and joints of GBS- 
infected mice as early as 4 h afier challenge, and a peak value was reached on 
day 4, followed by a progressive decrease in the subsequent days. Neutraliza- 
tion of endogenous IL-10 by administration of anti-IL-10 antibodies 
(1 mg/mouse) a t  the time of infection resulted in worsening of articular 
lesions and 60% monality, associated with early sustained production of IL-6, 
IL-is and TNF-a. Treatment with exogenous IL-10 had a beneficial effect on 
GBS arthritis, with a clear-cut dose dependence. The decrease in pathology 
was associated with a significant reduction in IL-6, IL-lP and TNF-z 
pmduction. Histological findings showed a limited periarticular inflammation 
and a few cell influx in the articular cavity of IL-10-treated mice, confirming 
clinical observations. 
Conclusion: This study provide the fmt evidence of a regulatory role for 
endogenous IL-10 in GBS disease and calls attention to the potential 
therapeutic use of this cytokine in GBS arthritis The beneficial effect of 
exogenous I L l O  on GBS arthritis appear to be associated not only with its 
ability to suppress cytokine production, but also with its effect on leukocyte 
recruitment at joint level. 
jp14801 Efficacy of moxifloxacin and cotrirnoxazole in the 
experimental pneumonia caused by Srenorrophomonas 
maltophilia 
D. Martin-Lozano, C. Pichardo, M. Jimenez, M. Bernabeu, 
M. Pachon-Ibafiez, M. Rodriguez-Hernandez, A. Garcia-Curiel, 
J. Pachon and M. Herrero 
Spvilfe, E 
Objectives: To compare the activity of moxifloxacin (MX) and cotrimoxazole 
(TS) in monotherapy and in combmation in an experimental pneumonia 
murine model caused by S. maltophilia. 
Mycobacteria: diagnostic methods 
Materials and methods: In vitro studles: nine Merent isolates from bacter- 
emias were used. The following parameters were determined MICs, MBCs, 
C, in serum, bactericidal activities and synergy (checkerboard, time-kill 
curves). In vivo studies: two strains (A and B) were used; strain A was 
susceptible to both antimicrobials, and strain B was susceptible to TS and 
intermedlate to MX. An experimental pneumonia model in mice with an 
intratracheal inoculum of 50 pL was developed. Two types of experiments 
were carried out: mortality study (treatment during 72 h and evaluation ofthe 
survival) and study of bacterial clearance from lungs (treatment each 2 h 
during 12 h and sequential sacrifice of three mice each 2 h). In the mortality 
study, the animals were grouped in CON (controls, no treatment), MX 
(40mg/kg/day), TS (40mg/kg/day), and MX + TS. In the clearance study, 
the groups were: CON, MX (20mg/kg/2h), TS (lOmg/kg/2h), and 
MX + TS. Variables: mortality and bacterial clearance from lungs. Statistical 
analysis: Fisher, x2. ANOVA, and post hoc Tukey and Dunnett tests. 
Results: In vitro: eight out of nine strains were susceptible to TS (NCCLS 
2000), with a MBC range of 3.2/64-6.4/128; for MX MI% was 16mg/L 
(range 1-16), with a MBC range of 16-64. In serum mice C,,, of MX and 
TS were 6.84 and 3.27(62.1) mg/L, respectively. For both strains, only MX 
showed bactericidal activity and, besides, synergy was found using MX + TS 
combination to concentrations equal to C-. In vim: mortality studies: only 
the combined therapy decreased the mortality respect to CON (strain A 
13.3% vs. 86.6% and strain B: 0% vs. 93.3%, P=O.OOO), being better than 
monotherapies (P<O.Ol); bacterial clearance: as in mortahty study, the 
combination was the only treatment that cleared the lungs respect to 
CON (strain A: 4.98 vs. 8.44 log &/mL, P=0.037, and strain B: 6.16 
vs. 8.37 log cfu/tnL., P=0.008). Comparing treatment groups, MX was 
better than TS in monotherapy for strain A (P=  0.000). and combination was 
better than monotherapies for both strains ( P < O . O l ) .  
Conclusions: MX shows bactericidal in vitro activity against S. maltophilia. 
The association of MX to TS improved the in vivo survival and the bacterial 
clearance from tissues in a model of severe experimental murine pneumonia 
caused by S. maltophilia. 
Detection of Mycobaderium using a laser 
scanning cytorneter 
C. Pina-Vaz, A. GonGalves Rodrigues, S. Costa-de-Olivein and 
C. Tavares 
Porto, P 
Introduction: In the last decade, the reemergence of tuberculosis has empha- 
sized the importance and the need of implementing and maintaining effective 
public health approaches to prevent transmission of the disease. A quick 
diagnosis is essential for an effective treatment and reduction of transmission. 
Direct detection methods, although very quick, suffer fiom the drawback of 
low sensitivity and of being too time consuming. Cultivation still remains a 
delayed method for diagnosis. The laser scanning cytometer (LSC) (Com- 
pucyte Corporation) is a new technology, which to our knowledge was 
hereby used for the filst time in microbiology. LSC is a new apparatus similar 
to flow cytometer but with considerable advantages regarding clinical and 
research applications. 
Objective: To develop a method of detection ofMycobacterium using acridine- 
orange and an LSC. 
Material and methods: Five hundred smears &om clinical samples (198 
positive and 302 negative), were stained in parallel by Kinyoun acid-fast stain 
(the method routinely used in our laboratory) and by acridine-orange 
fluorescent stain. Smears stained by Kinyoun were analyzed by light micro- 
scopy, as usual, and smears stained by acridine-orange were maintained in the 
dark until cytometric analysis, according an optimization protocol. Discrepant 
results were re-tested and if disagreement still persisted, data were compared 
with the results of the culture. 
Results: Smears Kinyoun positive were all positive on LSC, even those 
showing scarse bacilli. F@ smears Kinyoun negative (4.96%) were positive 
by LSC but only 11 became positive on culture. Only four (1.32%) were 
considered false positive. 
Conclusion: Observation of Kinyoun stained smears is time consuming, needs 
considerable observer experience and shows low sensitivity, although with a 
high specificity. LSC analysis is automated, allowing the observation of a l l  the 
cells present in the smear, in real time or later on, due to the available software. 
Fluorescent staining proved to be more sensitive than Kinyoun staining. We 
believe that the detection of Mycobacten'um by LSC is an important new 
methodology that needs further improvement. 
A new serological test for tuberculosis diagnosis 
R. P. M. van Gijlnvijk, A. van Poucke, L. ter Stege, B. Dalla, 
M. Ghiradelli and D. Marchem 
Amsterdam, NL; Bologna, I 
Objective: We have evaluated a new serological test for tuberculosis (TB) 
diagnosis. It  is an enzyme linked immunosorbent assay (ELISA) which detects 
the presence of TB-specific immunoglobulin G (IgG) antibodies. It uses a 
mixture of protein- and glycopmtein antigens obtained kom culture super- 
natant of Mycobartetiuni tubmulogis. We have evaluated if serological detection 
of TB is beneficial in case of sputum-negative TB patients, e.g. extrapd- 
monary TB and chldren TB. 
Methods and results: The study was performed using 1332 sera &om which 
489 were found positive for TB by culture. The TB-positive sera were 
obtained from the World Health Organization of which 39% (n= 190) were 
testedpositive for HW. All negative sera were from Dutch origin and included 
554 healthy blood donor sera and 279 sera h m  patients found positive for 
other infectious diseases than TB (sick, non-TB). Using a cut-off set at 
spechcity of 95%. the sensitivity for the HW-negative, TB-positive panel was 
80% and positive predicted value (PPV) is 83% and negative predicted value 
(NFV) is 93% (prevalence TB + is 26%). No difference was found with 
respect to specificity when healthy and sick, non-TB sera were compared. 
The sensitivity of the HIV- positive TB sera was 52% at a lower cut-offwhich 
allows a specificity of 90%. We compared ELISA data w t h  results obtained 
fiom Ziehl-Neelsen (ZN) stained sputum smears (accordmg to DOTS). A 
sensitivity of 72% at a specificity of 95% was found for ZN-negative patients. 
This means that ar an average sensitivity of 70% for Z N  on sputum smear, a 
combined analysis of patients using ZN and ELISA results in a sensitivity of 
92% and a specificity of 95% (see table). 
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Positive in culture 
ZN positive ZN negative 
Positive in ELISA 58.4% 21.6% 
Negative in ELISA 12.3% 7.3% 
Conclusion: The described ELISA test for the serological detechon of TB has 
a sigrufcant added value m the hagnosis of TB especdy for ZN-negahve 
pahents. 
PI483 1 Value of repeated sputum &cimens sent to the 
laboratory in the diagnosis of pulmonary tuberculosis 
0. Kisa, A. Albay, 0. Baylan and L. Doganci 
Ankara, TR 
Objectives: The presumptive diagnosis of active disease depends on the 
demonstration of acid-fast bacilli by microscopy, with definitive diagnosis 
by subsequent culture. How many sequential sputum specimens are really 
necessary for the diagnosis of tuberculosis? To answer this question, we 
retrospectively evaluated the results of 6844 respiratory specimens sent to our 
laboratory between 1998 and 2001. 
Methods: All of the specimens were tested by acid fast bacilli (AFB) smear and 
BAdTEC 460 culture system and then we examined the laboratory records of 
the patients. 
Results: A total of 785 (11%) specimens of 353 patients were positive for 
Mycobacterium tuberculosis complex. For 76% (270/353) of these patients the 
organism was detected f?om one or more sputum specimens. Of the patients 
with sputum specimens submitted to the laboratory, 16% (42/270) had only a 
single specimen sent for examination, 11% (29/270) had two specimens 
collected, and 74% (199/270) had at least three specimens sent to the 
laboratory. The AFB smear was found as positive for 55% (23/42) of patients 
of whom only a single sputum specimen was sent whereas the AFB was 
detected at least once for 55% (16/29) ofpersons who had two specimens sent 
to the laboratory. AFB smear was positive for 69% (137/199) of the patients 
who had three or more sputum specimens collected, M .  tuberculosis was 
isolated in the first, second and third samples of the majority (98%, 195/199) 
of the patients of whom three or more sputum samples were sent to the 
laboratory. Our results indicate that the diagnostic value of four or more 
Sputum specimens submitted to the laboratory was very low (2%) and we 
could carry out M.tubernrlosis isolation in the first, second and third sputum 
samples of the overwhelming majority (98%) of the patients. 
Conclusions: We recommend that at least three sequential sputum specimens 
be collected for all patients suspected TB, which is necessary for definitive and 
cost-effective dugnosis of pulmonary tuberculosis. The examination of four 
or more specimens is an insufficent use of laboratory resources and will 
increase the hospital expenses. 
ml Evaluation of FAST PlaqueTB test for the rapid 
diagnosis of M. tuberculosis 
A. Albay, 0. Kisa, 0. Baylan and L. Doganci 
Ankara, TR 
Objectives: Acid fast bacilli (Am) smear and culturing the organism 
are conventional methods for diagnosis of mycobacterial infections. FAST 
PlaqueTB is a rapid test utilizing bacteriophage amplification technology for 
the detection ofviable Mycobarteriurn tuberculosis in clinical specimens. This test 
can detect 100-300 bacilli/mL and the results are available in 24h. We 
evaluated the performance of the FAST PlaqueTB test by comparing with 
BACTEC 460 TB culture system, polymerase chain reaction (PCR) and AFB 
smear methods. 
Methods: All of the specimens were evaluated by AFB smear, BACTEC 460 
culture system, polymerase chain reaction (PCR) and FAST PlaqueTB test. 
Results We investigated 74 sputum specimens sent to our laboratory. Twenty- 
two AFB smear positive specimens were also positive by FAST PlaqueTB test, 
BACTEC 460 TB culture system and PCR method. Twenty-three of 52 
specimens that were negative by microscopy were positive by BACTEC 460 
TB culture system and 20 of 52 specimens were found as positive by FAST 
PlaqueTB test and 18 of 52 specimens were positive by PCR. One specimen 
was evaluated as positive only by PCR whereas one specimen was positive 
only by FAST PlaqueTB test. One of the specimens was found as positive by 
BACTEC 460 TB culture system and FAST PlaqueTB test. The sensitivityof 
AFB smear, PCR and FAST PlaqueTB test were 48.9%. 86.7% and 88.9%, 
respectively, when we accepted BACTEC 460 TB culture system as gold 
standard. 
Conclusions: We concluded that FAST PlaqueTB test has a good potential for 
rapid diagnosis of M.tubmculosk as a result ofthe evaluation ofthese three tests 
according to BACTEC 460 TB culture system. 
Ip1485j Isolation of nanobacteria from kidney stones 
J. M. Fernandez Fernandez, M. A Bratos, J Rrvera, B Hernandez, 
J Martln Gd, P Guherrez, A Ordufia, E Fernandez del Busto and 
A. Rodriguez Torres 
Klladolid, E 
Introduction: Nanobacterla were observed by Robert Fok in 1990 in Italy 
whde studyng mneral samples. The size of these mcroorgamuns is 0 . 1 4  5 
pm and they are not able to grow m common bacteriologcal meha They are 
included in the alpha-2 subgroup of Proteobacteria as well as Brucella and 
Bartonella. The= pnnciple charactensnc is the capabhty of formng apahte 
crystals at neutral pH and m phyxologcal calcium and phosphate concentra- 
nons Their tmphcaaon m several pathologes has been suggested, all of them 
being pecuhar due to the calcdicahon of merent structures, such as III the 
case of kidney stones, etc. 
Materials and methods: From February to August 2001, 21 stones 
from pahents of the Urology Servlce were collected The extracted stones 
were tnturated in a sterile glass mortar, and whenever possible, part of the 
sample was preserved for chermcal analysis, and the rest was d e m m e h e d  by 
means of HCl 1 M The resultant matenal was filtered through 022-p 
pore filters and culhvated at 37°C rn DMEM supplemented wth  FBS 
gamma-madated M e r  6-8weeks of mcubanon, the tube bottom was 
scraped wth  glass beds and the sedment were inoculated in tubes and 
cultured as descnbed The result of this culture was dried and shaded wth 
gold for analysts by transmsnon (TEM) and scanmg electron mcroscopy 
(SEM). 
Results: Twenty-one stones obtarned horn pahents, 52.4% belongmg to men 
and 47 6% to women. Accordmg to the age hstnbuhon, there was no age 
group especially sigdcant m number The mean age was 57.09yem The 
chermcal composihon of the stones was, in most cases, rmxNres of calcium 
phosphate and calaum oxalate. After 4-6 weeks of culture, m seven of the 
imhally moculated tubes appeared a whhsh precipitate whch was dehcately 
granulated and firmly adhered to the tube walls. The use of Gram, Ziehl- 
Neelsen, and acridme orange smns to m u h e  this precipitate gave neganve 
results In the subcultures the precipitate appeared III a shorter penod of hme 
and hgher quanaty, and where analyzed by TEM and SEM, showed parhcles 
wth  a thck cellular wall and a capsule wth  variable hckness, w th  
pleomorphc sizes and shapes. The cellular wall and the capsule are clearly 
separated structures. The total thickness varies h m  20 to 200 nm. The X-ray 
analysis gave a composiaon of the structure formed by Si, Au, P, Ca, and K. Si 
corresponds to the glass support, and Au to the shadys 
lp14861 A rapid test for detection of Mycobacterium 
tuberculosis in body fluids and aspirates 
G. Revathi, D. Patel, H. Gatu and K. Radia 
Nairobi, K E N  
Introduction: The Aga Khan Hospital, Nairobi has a large number of 
immunosuppressed patients admitted with extrapulmonary tuberculosis pos- 
ing diagnostic challenges. 
Objective: To evaluate the sensitivity and specificity of performance of Fast 
Plaque TB assay (Biotec) with body.fluids and aspirates (excluding sputa). 
Methods: Since June 2001, 112 bo uids consisting ofCSF (21). pleural 
bronchoalveolar lavage (16). and various other aspirates including bone 
marrow were subjected to Fast Plaque TB assay following the manufacturer's 
instructions. All the specimens were cultured by Bactec 460 and on con- 
ventional Lowenstein Jensen's slopes. Cultures were followed upto 16 weeks 
on solid media and 12 weeks in liquid media. 
Results: T h q - o n e  specimens were tested positive by Fast Plaque TB assay. 
Only 6 of these were ZN smear positive. Twenty-nine of these specimens 
grew MTB in culture. Eight specimens grew nontubercular mycobacteria in 
fluids (32), ascitic fluids (5). lymph 3" de aspirates (6), tracheal aspirates 0, 
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culture. None of t h ~ s  tested poslhve with Fast Plaque TB assay. Three of them 
were ZN smear posmave. A false poslhve assay rate of 6.4% IS observed in the 
results so far. 
Conclusion: Almost the same false posltlve assay rate (6.25%) was observed III 
our earher study mth  sputa samples Obmously wtth body flu& a large sample 
sue IS necessary for any reahshc mpresslons. Our study is going on 
(p14871 Evaluation of mycobacteria growth indicator 
tube (MGIT) for susceptibility testing of Mycobacterium 
tuberculosis 
L. Alcali. C. Pkrez-Fernhdez, M. J. Ruiz-Serrano, D. Garcia de Viedma, 
M. Marin-Arriaza, M. S. Diaz-Mantes and E. Bouza 
Madrid, E 
Introduction: Mycobacteria growth indicator tube (MGIT) is a nonradio- 
metric broth-based culture system suitable for susceptibility testing of M. 
tuberculosis. However, the absence of antimicrobial agents in the MGIT 
medium can cause, in some cases, the repetition of the test due to bacterial 
or hngal contamination of the medium. 
Objectives: To evaluate MGIT for susceptibility testing of M .  tuberculosis to 
streptomycin, isoniazid, rifampicin and ethambutol using PANTA (poly- 
myxin B, amphotericinB, nalidixic acid and azlocillin) as inhibitor ofbacterial 
and fungal growth. 
Methods: We selected for the evaluation a total of 102 clinical isolates of M .  
tuberculosir and the reference s t r a i n  H37Rv. The propomons method (PM) 
was used as the reference method (NCCLS, M24-T2) with the following drug 
concentrations (pg/mL): S (2 and lo), I (0.2 and l), R (1) and E (5 and 10). 
MGIT susceptibility testing was performed according to the manufacturer’s 
recommendations except for the use of PANTA as inhibitor of bacterial and 
hngal growth. For analysis purposes, strains were considered as intermediate 
to one drug when resistant to the low concentration and susceptible to the 
high concentration, and susceptible or resistant when susceptible or resistant 
to both concentrations, respectively. 
Results: There were 43 intermediate or resistant s m s  to a t  least one drug by 
PM. MGIT system had a mean time-to-result of 6.8days (5.1-11.3days). 
Agreement between both methods was of98.0% (S), 99.0% (I), 100% (R) and 
96.1% (E). Discordant strains for S were two PM-susceptible and MGIT- 
intermediate, for I one PM-intermediate and MGIT-resistant, and, for E four 
PM-intermediate and MGIT-resistant. During the test, no MGIT-tubes were 
contaminated. 
Conclusions: MGIT is an excellent and rapid method for the susceptibility 
testing of M. tuberculosis. The use of PANTA can avoid bacterial and fungal 
contamination without affecting the validity of the method. 
I P1488 I Evaluation of MBlBact medium, Middlebrook 
7H11 medium and Lowenstein-Jensen medium for isolation 
of mycobacteria from drinking water 
V. Quintana, E Alcaide, F! O h ,  P. Berlanga, M. A. Benitez and 
R. Martin 
Barcelona, E 
Objective: To evaluate three different culture methods for isolating non- 
tuberculous mycobacteria (NTM) from water in a geographical area with a 
hgh incidence of clinical NTM isolates. 
Methods: Drinking water samples (5 L) from 8 public distributions systems 
were weekly collected between April and October 2001. The specimens were 
filtered (0.2 mm) and the membranes were mixed with 10 mL ofphysiological 
serum for 24 h. The suspensions were decontaminated and concentrated with 
the N-acetyl-L-cysteine-NaOH procedure, and the sediment were used for 
acid-fast staining and for inoculation into MB/BacT (MB) bottle, Middle- 
brook 7Hl l  (7Hll) medium, and Lowenstein-Jensen (JJ) medium. All 
isolates were identdied by biochemical tests, specific DNA probes, and 
PCR-RFLP of the hsp65 gene. 
Results A total of 26 NTM (12%) were isolated 6om 216 water specimens 
studied 20 M. gordonae (MGOR), 1 M. chelonae (MCHE), and 5 M.forfuiturn 
(MFOR). The table summarizes the mycobacteria recovery rates from each 
medium alone or in combination. 
MB+ MB+ 7 H l l f  
NTM Total MB 7Hll LJ 7Hll LJ LJ 
MGOR 20 14 3 5 17 17 8 
MCHE 1 1 0 0 1 1 0 
MFOR 5 0 3 2 3 2 5 
Total (“A) 26 (100) 15 (57.7) 6 (23.01) 7 (26.9) 21 (80.1) 20 (76.9) 13 (50) 
AU specimens were smear negative for acid-fast bacteria. Rates of contam- 
ination for MB, 7Hl l  and LJ were 0.46%. 4.63%. and 2.31%, respectively. 
Conclusion: The MB medium shows the highest sensitivity for recovery of 
NTM 6om water samples, except for MFOR. Therefore, an additional solid 
medium should be used in combination to improve NTM recovery. 
1 P1489 I SDS-PAGE for identification of species belonging 
to the Mycobacterium fortuitum complex 
J. Esteban, E Cabria, M. V. Torres, E. Rollh, I. Gadea and M. S. Jiminez 
Madrid, Majadahonda, E 
Objectives: We performed a study to determine the usefulness of SDS-PAGE 
of whole cell proteins for characterization of species of rapidly growing 
mycobacteria that belongs to the Mycobaaeriurn fortuifurn complex. 
Material and methods: Tested strains were 37 M.fortuiturn, 32 M. chelonae, 10 
M .  peregrinum, 5 M. abscessus and 3 M .  mucogmicum. Eight collection strains 
(includmg type strains of the five species) were also included in the study. 
Identitication of the strains was achieved by common biochemical tests. SDS- 
PAGE was performed according to the common protocols and the gels were 
stained with Coomasie blue, photographed and scanned for comparison with 
the Scion Image sohare.  The average s W i t y  between patterns were 
calculated by using the Dice coefficient. 
Results: All strains yielded between 44 and 58 bands in the elecmphoreto- 
grams. Intraspecies similarity showed Dice coescients higher than 95%, with 
only one strain of M .  fortuifum with 6-band difference (Dice coefficient 
87.75%). However, interspecies similarity was always below 75%, the s i m -  
larity being higher between M .  forfuitum and M .  peregrinum (75,51%) and 
between M. chelonap and M. abscessus (54.9%). Visual examination of the 
electrophoretograms was enough for species characterization when type 
strains are included in the test. 
Conclusions: SDS-PAGE of whole cell proteins is a useful technique for 
identification of isolates of the M.fomifurn complex, and is easy to perform 
without the need of complex or expensive equipment. 
Rapid identification of mycobacteria species by 
automatic sequence analysis of hsp65 gene 
F. Brunello 
Verona, I 
Objective: The purpose of this study was to evaluate the partial hsp65 
sequencing for the rapid identification of mycobacteria species. 
Methods: Thrty-four clinical isolates used in this study were grown in a 
liquid medium (MEVBact system; Organon Teknika Corp., Durham, NC) or 
on Lowenstein-Jensen medium (Biotest, Heidelberg, Germany). Nine strains 
were from the American Type Collection (Rockville, h4D). Bacterial DNA 
was prepared as described by Van Soolingen and a segment of the hsp 65 kDa 
heat shock protein gene (hsp65) was amplified as described by Telenti. The 
PCR product was purified with silica gel columns (Qiagen; M-Medical- 
Genenco, Florence, Italy). Sequencing reactions were done by a standard 
sequencing method with a DNA sequencing kit (Deaza Dye Primer Kit - 
Visible Genetics Inc.) with the fluorescent primers Cy5.0-Tbll e Cy5.5- 
Tb12 on a Opengene Long Read Tower sequencing system (Visible Genetics 
Inc., Toronto, Ontario, Canada). The sequences were analyzed hy using our 
Gen-library. This database was obtained by alignment with Gene Base 
software Version 1.0 (Applied Math-Bebum). A phylogenetic tree of the 
mycobacteria was constructed by using the same program. 
Results: The strains analyzed were identified correctly and each species had an 
unique sequence. Nucleotide differences were found along the length of the 
amplified hsp65 fragment but were particularly fiequent in 4 regions: positions 
122-125,218-224,287-292 and 355-359 which represent the hypervariable 
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regions of the hsp65 gene and possible species-specific regions. Among 
isolates classified as the same Mycobacterium species the analysis identified 
hsp65 allelic diversity. For example, 28 isolates of Mycobactm'um tuberculosis had 
6 distinct hsp65 alleles. The phylogenetic analysis based of hsp65 gene 
confirmed the phylogenetic analysis of the genus Mycobacterium obtained 
with 16s rRNA sequencing. 
Conclusions: Automated hsp65 sequencing is a rapid and reliable method for 
the identification of mycobacteria; allelic diversity within hsp65 does not 
preclude the use of this target as the basis for recognition of medically 
important subspecies strain group. 
v1 Molecular typing of Mycobacterium avium 
strains isolated from HIV-positive patients 
L. Franzin, D. Cabodi and A. Sinicco 
Turin, Z 
Objective: M. avium is an important cause of opportunistic mfection in HIV- 
positive patients with low CD4 cells count (< 100 x lo6 cells/L). The aim of 
the study was the molecular typing of M. auium strains isolated from these 
subjects. 
Methods: Forty-two strains of M. avium (identified by biochemical tests and 
Accu Probe) isolated fiom difterent samples (blood, sputum, brochoalveolar 
lavage, feces) of 16 HIV-positive patients were examined. DNAplasmids were 
extracted by alkaline lysis (after growth with o-cycloserine and ampicillin), 
analyzed by electrophoresis in 0.7% agarose gel and visualized by ethidium 
bromide. The strains were also typed by RAPD-PCR (random primer 
amplified polymorphic DNA) using three primers (Leg 1, A 1245, B 1245); 
the amplified products were analyzed by electrophoresis on polyacrylamide 
gel and silver staining and by electrophoresis in 2% agarose gel. 
Results: Two strains isolated from different samples of each two patients 
showed one small (< 30 kb) plasmid, while four strains isolated from different 
samples (blood, sputum, bronchoalveolar lavage, feces) of one patient showed 
smal l  and large (> 150 kb) plasmids. Interpretation of RAPD-PCR patterns 
of difterent patients st ra ins  was sometimes d&cult. Isolates of the same patient 
showed the same profile by RAPD-PCR. Strains analyzed with B 1245 
primer showed the same profile in nine subjects and three Werent patterns in 
plasmid carrying strains of three patients. 
Conclusions: M. avium isolates belonging to a patient had same molecular 
profile (RAPD-PCR and plamids), suggesting that disseminated infection was 
caused by the same strain. As some isolates of different patients shared the same 
profile, suggesting a common source, relatedness between strains and patients 
need to be further investigated. 
w/ Integrated procedure for mycobacteria and 
corynebacteria identification in clinical specimens 
V Nickolaevsky, Y Bazhora, V Kresyun and A Asmolov 
Odessa, UKR 
Introduction: Nowadays one of the urgent problems of chmcal mcrobiology 
is a problem of idenhficahon of atypical microorgatusms, causmg lnfechons in 
human beings Recently a lot of cases of tuberculosis, mycobactenoses, 
diphtheria and dlphthena-hke dlseases have been reported to be caused by 
atypical bacteria like nontoxlgemc corynebacteria and nontuberculosis myco- 
bacteria, etc , mostly in immunocompromsed persons Most part of these 
cases were not hagnosed at early stages beLause of absence of adequate c h c a l  
laboratory methods 
Objective: To develop a smple, mversal and reproducible method of 
identlficahon and Merenhahon of Mycobactenurn and Cqnebactenum 
species m c h c a l  samples hke sputum, pharyngeal washes, mucous scrapes, 
etc 
Material and methods: Specunens of sputum from 50 smear-ponhve and 38 
Smear-negahVe pahents, mdudmg those 111 whlch anhtuberculosis therapy 
was not effechve, specunens h m  mucous membranes of genitaha of 23 
panents mth gemtal tuberculosis, pharyngeal washes from persons with 
dlphthena, tonsdhus, a n p ,  reference strams of mycobactena and coryne- 
bacteria. Mycobacter~ isolahon from sputum probes was carrled out by 1ts 
absorpuon on magnehc corpuscles mth  polyclond anhbohes and concen- 
tnhon III s m a l l  volume. Then we extracted DNA by detergent processmg. 
Pam ofspec& prmers to these mycobactena and corynebactena species and 
umversal primers (UP-PCR, RAPD) were used 
Results: We established a high correlation between bacteriological methods 
and PCR in identification of Mycobactm'um tuberculosis in smear-positive 
specimens of sputum. Spec& DNA fragments of Mycobacrm'um tuberculosis 
were found in 83.5% of smear-negative specimens, that approximately twice 
exceeds the effectiveness ofbacteriological methods. Additionally in 12.8% of 
smear-positive and in 18.7% of smear-negative patients nontuberculosis 
mycobacteria were found. In specimens with nontoxic corynebacteria 
15.6% of other corynebacteria species were found out. Alternative method 
includes mycobacteria cultivating on Lowenstein-Jensen agar or corynebac- 
teria cultivation followed by UP-PCR for species differentiation. Mathema- 
tical data treatment was made by special programs, which allow comparing 
and clusterizing PCR patterns. This PCR procedure is an effective method 
for revealing agents in clinical samples decreasing time expenditure with 
higher effectiveness and sensitivity. 
I P1493 I Identification of mycobacterial species isolated 
from patients suspected of pulmonary tuberculosis based on 
the 165 rDNA sequence analyses 
B. Wen 
Beijing, CHN 
Objectives: To iden@ the mycobactenal specles isolated from the patients 
suspected of hamg pulmonary tuberculoss. 
Methods: A polymerase cham reacnon (PCR) was estabhshed for ampuca- 
hon of 5'-end fiagnents (-680 bp) of 16s rRNA genes of nontuberculous 
mycobacterial strams lsolated f b m  the sputum specmens ofpahents chmcally 
suspected of having pulmonary tuberculosts in the pu lmo~ry  hospital m 
Chongqing of China. The 16s rDNA fragments were directly sequenced by 
dideoxynucleotide methods with an automatic DNA sequencer. Phylogenetic 
analyses were made based on the 165 rDNA sequences. 
Results: In 165 rDNA sequence comparisons of 23 stmns of the present study 
mth the known mycobactertal speaes, the sequences offive scams (22?h) were 
i d e n t d  to that of M. gordonae and the sequences of four strains (17%) 
idenacal to that ofM.juoroanthenivorans. However, the sequences of other 10 
strains were mostly similar to that of M. kansasii, M .  j7avenccens. M. W h ,  and 
M. monamenr, respectively. The sequences of other 4 s t r a m  were unique and 
higher divergent (>4%) from that of the known mycobactenal species, 
indlcahng that they may be new species of genus Mycobactm'um. 
Conclusion: The phylogenetic analysis on the b a s  of 16s rDNA sequences 
reveals that at least 4 new species of Mycobacferium are found in human 
pulmonary ifechon. The species of nontuberculous mycobacteria causing 
pulmonary infecfion of humans in Chongqing area are different fiom that 
reported in other areas. The analysis of 16s rDNA sequences is a quick and 
accurate way to idendfy mycobactenal species isolated from the pahents. 
v] Role of gene amplification methods in the 
diagnosis of patients infected with Mycobaderium 
tuberculosis 
G. M~raghotta, R. Del Prete, A. Mosca, G. Barra Parsi, R. Antoneth and 
A. Di Taranto 
Bari, Fogq'a, Z 
Objectives: The purpose of the study was to evaluate two gene amplification 
methods for Mycobactenum tuberculosis (MTB) detection m both pulmonary 
and extrapulmonary chical samples. 
Methods: Bghty-one clmcal spemens (71 respiratory and 10 extrapul- 
monary) from 80 pauents suspicious of being infected mth  MTB were tested 
by mcroscopy/smear (Ziehl-Neelsen, ZN), culture (Bactec. 9120 System, 
Becton Dichson, USA), polymerase cham reachon (PCR, Roche Diag- 
nostic System, USA), and Gen-Probe Amplified Mt Dmxt Test (AMTD, 
Gen-Probe, USA). All respmtory and unne samples were decontarmnated 
mth  sohum dodecyl (lauryl) sulfate (SDS)-NaOH prior to teshng. The 
results obtamed by gene amphfkahon were compared mth those by tradi- 
nonal methods. 
Results: About 11/81 c h c a l  specunens were POSIhM. In parhcular, 
8/11 specmens were posihve for all the tests performed but one negative 
for Bactec culture and two negahve for Z-N/Bactec culture, respechvely. Of 
the remander three samples, two were Bactec poSihVe and Z-N/PCR/ 
AMTD negahve, and one was PCR posihve and Z-N/Bactec/AMTD 
negahve. 
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Conclusions: Results show that both nucleic acid amplification methods 
appear highly sensitive and specific for the detection of MTB. Moreover, in 
the presence of smear-and culture-negative samples, AMTD which is based 
on rRNA testing might represent in the presence of positive PCR a useful 
means in clarifying patient response to antimicrobial therapy. 
m) Analysis of a 7-year experience with 
‘Mycobacterium tuberculosis Direct Test‘ (MTD) on 
respiratory and nonrespiratory specimens 
R. Riva, M. Carcheri, R. Cozzani, G. Lacitignola, C. Zanin and 
R. Capuzzo 
Genoa, I 
Objectives: In our hospital, since January 1994 we have been using the 
‘Mycobucterium tuberculosis Direct Test’ (MTD test), manufactured by Gen- 
Probe Inc. (San Diego-CA), a rapid diagnostic test for cases of doubdul 
positive specimens for M .  fuberculosis. This test was introduced to make up for 
the extremely long growth times of mycobacteria. Before the introduction of 
this test, the only rapid test available was a microscopic exam, which, 
unfortunately offers a low sensitivity, allowing the detection of about 
5 x lo4 bacilli/nL in the case of staining with Ziehl-Neelsen or 200& 
10000 bacilli/ml with a fluorescent stain. This brings the percentage of 
positivity to 6675% in the best case scenario, a value too low considering 
the elevated infectivity of M .  tuberculosi for which 50% of the infective dose is 
<10 bacilli. Thus, the innoduction of a rapid diagnosis using molecular 
biology based on ampliftcation of RNA ribosomal fkctions. We analyzed the 
results obtained over a period of7 years on about 2500 specimens to verify the 
validity and economic impact on our hospital. 
Methods: Using the MTD test, we tested various specimens: sputum, 
bronchial aspirates, pleural fluid, urine, seminal liquid, sterile body fluids, 
gastric aspirates, tissue specimens such as endopleuric fiber, etc. Particular 
attention was given to pretreatment of the various materials in order to have 
ideal specimens for amplification. Testing was performed using the manu- 
facturer’s directions. In admtion to the amplification procedure, all specimens 
were cultured on solid media and in broth media. A microscopic exam was 
also performed. 
Results: From the results obtained from about 2500 MTD tests performed, 
we found a high correlation with culture methods. In another 100 cases of 
bacterioscopic examination negative or doubtful, the MTD test provided an 
immediate diagnosis or exclusion of TBC without waiting for the culture 
results.We were also able to follow some cases of recidive indicated by the 
MTD test before the microscopic exam became positive. 
Conclusion: The analysis of the results obtained over a 7-year period confirm 
the validity of the MTD test fbm specimens of different origin. It seems that 
the Amplified MTB Direct Test could be useful both for the positive effect on 
the patient, thanks to the rapid diagnosis and initiation of therapy as well as for 
the cost savings afforded the hospital through reduced length-of-stay. 
94”C, 1 min at 36°C and 2min at 72°C; this was followed by lOmin of 
extension at 72 “C. The amplification product was loaded onto 2% MS-8 
agarose gel and the fi-agments were visualized by ethidium bromide staining 
and UV light. 
Results: Twenty isolates and the control strains were used in the initial studies 
to develop optimal conditions for performance of the RAPD-PCR. With the 
9 primers tested in this study, 7 produced satisfactory amplicons with all tested 
isolates. Two primers (MPTR-1 and INS-2) generated the best ampElication 
patterns and produced more Werent patterns with the best reproducible 
results. These primen were used thereafter. Both primers produced three 
Werent patterns: the MPTR-1 produced three patterns which were named 
as A, B and C. The INS-2 primer produced three patterns which were marked 
as 1,2 and 3. Five clusters were identified Al, B1, A2, A3 and C1. The cluster 
A1 was formed by the majority of the isolates (87 isolates) and by the type 
strain CECT3030T. The second cluster (Bl) was formed by 30 isolates. The 
cluster A2 was formed by 4 isolates. The pattern A3 was produced by only one 
isolate. The pattern C1 was produced by the control strain provided tiom the 
institute of Pasteur, and none of our collection produced the same pattern. 
Conclusion: The RAPD-PCR technique appears to be simple and rapid 
compared with many complicated molecular typing methods 
I PI497 I Restriction fragment length polymorphism of 
gyr6 for the diagnosis of dysgonic Mycobactenum 
tuberculosis complex strains 
I. Nahimana, J. Bille and G. Prod’hom 
Lausanne, CH 
Objective: The aim of the study was to apply the PCR Restriction Fragment 
Length Polymorphism ofgyrB recently described by S. Niemann et al. (J Clin 
Microbiol 2000; 38: 3231-3234) for the discrimination of dysgonic Myco- 
bacterium tuberculosis complex (MTBC) strains. 
Methods: Eighteen dysgonic MTBC strains and four ‘classical’ M tuberculosis 
strains previously isolated &om human clinical specimens and identified by 
biochemical and genetic tests were studied.The gene gyrB (1020bp) was 
amplified by PCR using primers: MTUBf (5’-TCG GAC GCG TAT GCG 
ATA TC-3’) and MTBUr (5‘-ACA TAC AGT TCG GAC TTG CG-3’). 
Polymorphism o f p B  was analyzed using RsaI, TaqI and Sac11 according to 
the previously described algorithm (Niernann et al.). 
Results: Sixteen of the 18 dysgonic MTBC strains were correctly discrimi- 
nated using the analysis ofgyrB (3 M. bovis (pyrazinamide resistant) N= 7; (ii) 
M. uficanum N = 8; (iii) M .  microti N = 1. For to2 M. azcanum strains 
(resistant to thiophen-2-carboxylic acid [TCHI), PCR-RFLP pattern was 
similar to the unique pattern of the ‘classical’ M. tuberculosis strains (N= 4). 
Conclusion: The analysis ofthegyrBpolymorphism by PCR- RFLP is a rapid 
and simple technique to identify the majority of dysgonic M.  tuberculosis 
complex strains. However, M .  ufricunum subtype I1 (resistant to TCH, more 
frequently seen in West Afiica) could not be distinguished fbm M. tuberculosis. 
Randomly amplified polymorphic DNA PCR for 
comparison of strains of type I Mycobacterium kansasii 
lp14981 Assessment of a rapid molecular method for the 
identification of Mycobacterium tuberrulosis 
A. Gaafar, M. J. Unzaga, C. Ezpeleta, G. Martin, M. V. Leal, E Calvo and 
R. Cisterna 
Bilbao, E Pavia, I 
R. Mighavacca, E Zara, E. Nucleo, M. Spalla, R. Brerra, A. Cardillo, 
E. Giacobone and L. Pagani 
Objectives: We studied the feasibility of using RAPD-PCR for comparison 
M .  hnsasii type I strains. This included development of optimal PCR 
conditions and primers. RAPD-PCR was tben applied to 122 clinical isolates 
of M .  kansasii type I, previously typed by PCR-RFLP. 
Methods: Isolates: 122 clinical isolates of M. kamasii. Identification was 
performed by DNA probe (AccuProbe). Molecular typing was performed 
by PCR-FLPofthe Hsp65gene. The type strain M. katzsasii CECT3030Tand 
one strain belonging to genotype I (provided by Dr V. Vincent, Institute of 
Pasteur, Paris) were used as control strains. DNA was obtained as follows: One 
loopful of bacteria was suspended in a mixture of TEN buffer and phenol:- 
chlorofor1n:isomyl. subjected to sonication for 15 min and precipitated with 
isopropanol and sodium acetate. The concentration and the purity of the 
samples were determined by spectophotomerry. 9 random primers were 
chosen for evaluation (MPTR-1, MPTR-E INS-2, IS986-+, R-4, P-2, 
Pntb-1, Pntb-2 y RISK-1). The amplification included 40 cycles of 1 min at 
Eight million people contract tuberculosis every year, and one-third of the 
world’s population is infected with M. tubemloris. Annually tuberculosis 
causes 3 million deaths. The main cause of dissemination is the absence of 
early diagnosis and prompt medical attention. Probes and DNA-amplification 
procedures, represent new technologic developments in clinical microbiol- 
o m  
Objectives: We evaluated the specificity and sensitivity of a rapid method for 
the direct detection of microrganisms in clinical samples proposed for 
laboratory diagnosis of M. tuberculosis vs. standard procedures. 
Methods: In the period between February and November 2001 we inves- 
tigated for the presence of M.tubmfosis, 154 biological specimens, collected 
from patients recovered in medical and surgical wards at the University 
Hospital of Pavia (northern Italy), using both molecular and traditional 
methods. Each sample was submitted to a decontamination/dygestion by 
using the BBL MycoPrep kit. Fast extraction of mycobacterial DNA was 
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successively performed by using the 'Mycnbacterium gene releaser' (Euroclone 
Ltd., UK) kit. The method is based on a nested PCR. Each sample was also 
examined after Ziehl-Neelsen stain to detcvt and estimate the number of acid 
fast bacdh and cultured in double on Lowenstein-Jensen Medium W c o  
Laboratories, USA); incubation was performed at 37 "C. The cultures were 
examinated firstly after 10-14days and then every week until a total of 8 
weeks. 
Results: The samples were from: respiratory tract 75%, urine or other 
urogenital tract specimens 19.7%, pus or &om other sources 5.3%. Two of 
154 specimens processed for the presence of Mmberrulosis provided positive 
result with both molecular and cultural methods, while they were not with 
microscopic examination. The remaining 152 samples always resulted nega- 
tive with all procedures. The assessed molecular method showed high 
specificity (100%) and sensitivity (100%). 
Conclusions: Because of their high specificity, sensitivity, simple applicabllity 
and high velocity, the molecular methods are a wise investment and should be 
routinely considered for the detection of M.ttrberculosis in clinical laboratory, 
especially in the management of patients with active disease to evaluate the 
effectiveness of antituberculosis treatment. 
v1 Rapid detection of Mycobacterium tubeKulosis 
resistance mutations in sputum samples by LyghtCycler PCR 
A. C. Llanos, M. Ruiz, M. J. Torres, A. Criado, A. Arroyo, 
J. C. Palomares and J. Aznar 
Seville, E 
Objectives: To evaluate a new rapid method based on real-time PCR for the 
detection of mutations in the TOB and katC genes in sputum samples. 
Methods: One hundred s i x t y  sputum samples with documented auramine 
counts, obtained from 69 patients diagnosed as having tuberculosis attended at 
the H.U.V. del Rocio in S d e  were studied. DNA was extracted from the 
samples using DNA IV method (Unipath SA). The extracts were amplified 
with the Lightcycler system, using two primers and two short oligonucleo- 
tide probes (fluoresceinated anchor and Red640 sensor labeled probes). For 
the FOB gene we used two pairs of probes, one covering the region spanning 
codons 526 and 531, and a second one covering codons 513 and 518. The 
katG gene probe covered the region containing codon 315. All the samples 
were decontaminated by NALC-NaOH method, and inoculated onto 
Lowestein-Jensen media and a MGIT tube. Susceptibility testing was per- 
formed in clinical isolates from 33 patients by the Bactec MGIT 960 method. 
Results: One hundred fifty-five (96.8%) samples were positive by PCR with 
both pairs of primers. Six samples had a mutation in the rpoB gene, two at 
position 531 and four at position 516. There was 100% agreement between 
phenotypic and genotypic susceptibility tests for RMP. In the case of INH, all 
the 10 genotypic resistant strains showed phenotypical resistance, while one 
phenotypic resistant strain could not be detected by PCR (false negative). 
Conclusion: This is a rapid, sensitive and highly specific method to detect 
mutations at the FOB and katC genes of M.fubenulosis directly in acid fast 
positive clinical samples, allowing discrimination between susceptible and 
resistant strains in less than 3 h. 
I P I  500 ] Comparison of the Roche Amplicor 
Mycobactetium assay and BD Probe Tec system for the 
detection of Mycobacterium tuberculosis in respiratory 
specimens 
W. H. E Goessens, P. de Man, J. G. M. Koeleman, A. Luijendijk, 
R. te Witt, H Endtz and A. van Bekum 
Rotterdam, NL 
amplification techniques. The results of the amplification methods were 
compared with the reference, i.e. liquid culture by BACTEC or MGIT 
technique. 
Results: Of the 398 clinical specimens, 47 specimens h m  13 patients were 
culture positive for M. tubmlosis.  Of these 47 specimens, 31 were smear 
positive, 33 were positive by the Roche Amplicor Mt test and 39 by the BD 
Probe Tec. Of the 351 culture negative specimens, five were positive by the 
auramine staining, six were positive by the Roche Amplicor Mt test and 11 
were positive by the BD Probe Tec. After discrepancy analysis and review of 
the patients' clinical data, 58 specimens kom 13 patients were considered as 
'true-positive' specimens, meaning that two of five culture-negative smear 
positive specimens, six of six culture-negative Roche Amplicor Mt test 
positive specimens and nine of 11 culture negative BD Probe Tec positive 
specimens were diagnosed as 'true-positive' specimens. These data compared 
with the number of 'me-positive' specimens resdts in the following sensi- 
tivities:micmscopy, 56.9%; for Roche Amplicor Mt test, 67.2% and BD Probe 
Tec, 82.8%. The specificities were 99.1%. 100% and 99.4%. respectively. 
Conclusions: Both amplification techmques give rapid results and are very 
specific for the detection of Mt complex in respiratory specimens. The BD 
Probe Tec technique detects more 'true-positive' specimens than the Roche 
Amplicor Mt test, but the differences are not significant. 
v1 Isolation of Mycobacterium nucleic acids 
(RNA & DNA) from sputum and cultured strains using 
magnetic silica particles 
P van Deursen, M Rodngue, C Zm&m and H Kreuwel 
Boxfel, NL, Many "Etorle, F 
Objectives: bioMerieux is developmg a novel isolahon procedure that uses 
Boom chemstry in combmnon wth magneac shca pamcles In pnnciple, 
the lsohhon procedure is genenc and can be apphed for a broad range of 
dfferent sample matnces The objecave of ths study was to vahdate the 
method for the recovery ofMycobactenum nucleic acids from dlfferent samples 
Methods: In total, 19 AFB-smear posihve sputum samples were used for 
RNA study. Sputum samples were decontarmnated wth  NALC-NaOH and 
mcubated for 20 m at 95 "C to inacnvate the bacteria Next, 1 mL of lyss 
buffer was added to the samples Control RNA was splked to the lysed sampks 
to momtor isolahon effichency Mycobactnurm ruberculosis nbosod RNAwas 
detected with the NuchSens Basic kt. Control RNA was detected m a 
separate amphfiicatxon reachon usmg real m e  NASBA and a molecular 
beacon probe. Adhhonally 10 AFB-smear POSihVe sputum samples and 10 
Mycobarterrurn s t r a m s  (Tb complex and MOTT) isolated on LJ slants were also 
tested for DNA extracnon. Same protocol was apphed on all samples 
Sensiavity study was also performed on genomc DNA. All DNA samples 
were PCR amphfied and detected on DNA chp 
Results: Mycobactmum tubenulosir R N A  was detected m 18 samples (95%). 
One sputum sample scored negahve for Mycobacten'um tuberotlosis. However, 
m ths pamcular sample also the control RNA was not detected. This sample 
contamed a large amount of cell debns, whch was not removed adequately 
during sample pretreatment. Incorporabon of a simple extra step, clanficahon 
by centrhgahon, resulted in a more robust extraction of nucleic aads from 
sputum samples All DNA samples (either &om sputum or stram), and 
whatever the stram mvolved, were well idenhfied on chp. Furthermore 
sennhvlty was shown to be at least 50 copies of gDNA per assay. 
Conclusions: The new nudac acid extraction method was apphed successful 
for the detechon of Mycobactmum species m AFB-smear pOSlhVe sputum 
samples or cultured stmns. However, an extra step in the pretreatment 
procedure seems necessary for efficient nucleic acld recovery from sputum 
samples. 
Objectives: Retrospective evaluation oftwo amplification techniques in their 
capacity to detect organisms ofthe M. tuberculosis (Mt) complex in respiratory 
specimens. 
Methods: Three hundered ninety-eight sputum, bronchoalveolar lavage and 
bronchial and tracheal aspirate specimens from 297 patients were tested for the 
presence of Mt complex by auramine fluorochrome staining, strand displace- 
ment amplification technique (Probe Tec, Becton Dickinson) and PCR 
(Roche Amplicor Mt test). All specimens were decontaminated and digested 
with 2% NaOH in 0.5% N-acetyl-I-cysteyne and concentrated by centrifuga- 
tion. Pellets were resuspended in 2mL PBS and divided for culture and 
1 PI502 I Four years' experience using MTD2 test as an 
amplification method for direct detection of mycobacteria 
E. Vasconi, C. Agrappi, M. Barzani, L. Bertinotti, P. Clerici, 
L. Marinoni, P. Melloni and E. E Viganb 
Legnano, I 
Objectives: The purpose ofthis study was to evaluate results using MTD2 test 
(Gen-Probe Inc.) obtained &om 1997 until now for the diagnosis of tuber- 
culosis. 
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Methods: Since 1997, diagnostic protocols for detection of mycobacteria 
provided direct smear examination by staining with Auramine-Rhodamine, 
and culture in liquid (MGIT-BD) and on solid powenstein-Jensen) media; 
the MTD2 test was used since there was a specific requirement for t h i s  type of 
test by clinicians in suspicious cases of tuberculosis or by the laboratory on all 
positive smear samples (in order to confirm the presence of M.tuberculosis 
complex). 
Resulk From April 1997 until November 2000 M .  tuberculosis was isolated by 
culture techniques h m  63 patients (49 cases of pulmonary tuberculosis and 
14 cases of extrapulmonary tuberculosis). Microscopic examination was 
positive for 34/63 patients (53.90h): for respiratory samples the sensitivity 
was 59.2% and for other sample types it was 35.7%. MTD2 test was performed 
on 46/63 cases having a positive culture and it was positive in 41 cases, 
demonstlating a global sensitivity of 89% (91.9% in respiratory specimens and 
77.8% in other specimens). In our analysis the average time to have a positive 
result using culture techniques was 12.3 days (4-34 days) in smear-positive 
samples (Auramine-Rodhamine staining) and 27.3days (10-62days) in 
smear-negative samples. Considering the lengthy times to obtain results using 
culture methods, it is important to verlfy the MTD2 sensitivity in patients 
with smear-negative results: during these 4 years, out of 10 patients with a 
negative smear and positive culture, for which an amplification test was done, 
seven resulted positive with the MTD2; this allowed a faster diagnosis. Finally 
we analyzed the use ofMTD2 test during the year 2000: out ofa total of 1123 
detection tests for mycobacteria, MTD2 was required 275 times, about 24.5% 
of the total cases. In addition ths analysis demonstrated that MTD2 test was 
required on the 50% ofpatients who had culture positive results, showing the 
appropriateness of the use of the test. 
Conclusions: Our analysis confirms the effectiveness of amplification test 
employment for direct detection of mycobacteria in selected patients, as 
suggested by others. 
-1 Diagnosis of extrapulmonary tuberculosis: 
traditional methods and molecular biology 
M. C. Screm, €? Lanzafame, A. Bertolissi and E. Pitzus 
Udine, I 
Objectives: To evaluate the reliabdity of PCR related techniques in diagnosis 
of tuberculosis in extrapulmonary samples. 
Methods: Fifty-seven cases of extrapulmonary tuberculosis were collected 
and analyzed in our institute from 1991 to 2201. Twenty-one patients were 
females and 36 were males. Age ranged &om 22 to 89years (mean value 
62.3 years, median 70years). The samples examined were lopus, 10 biopsies, 
8 urines, 5 swabs and 24 biological liquids (18 pleural etbions, 1 blood, 2 
liquors and 3 synovial or peritoneal fluids). All samples were cultured in 
Lowenstein Jensen medium; 36 were assayed by acid-fast bacilli stain and 23 by 
molecular test (Transcription Mediated Amplification TMA, Gen Probe and 
Ligase Chain Reaction LCx, Abbott). 
Results: All samples had positive cultures (Gold Standard), 16 (44%) of the 
microscopical examinations and 16 (70%) of the PCR assays were positive. 
PCR and microscopy showed the same sensitivity (100%)for detecting 
M.tubercuhsis in pus saniples, but PCR was more sensitive than microscopy 
in biopsies (75% vs. 50%, respectively) and urines (100% vs. 28%, respec- 
tively). Sensitivity of PCR and microscopy is lower in swabs and liquids 
(0% vs. 20% and 25% vs. 0%, respectively) than in pus, biopsies, urines 
but in pleural easions the sensitivity of PCR reached 66.7% vs. 0% of 
mcroscopy. 
Conclusions: M.tuberculosis is a very fastidious microrganism because micro- 
scopical observation is not a sensitive and specific assay and culture takes 
several weeks. PCR assay is a more sensitive and rapid test. Actually it is 
evaluated both in clinical trials of pulmonary and extrapulmonary tubercu- 
losis. Nevertheless, the commercial kits are generally not standardized for 
biological samples other than respiratory fluid or urine. Our study indicates 
that PCR is a rapid and a very good tool for diagnosis of empulmonary 
tuberculosis in pus, biopsy, urine and pleural effusion. The lack of sensitivity 
in swabs and liquids other than pleural efision is probably due to a casual 
reparhtion of the very small number of tubercular bacilli (below 10 colonies) 
in the tested samples. 
I P I  504 1 Combined use of BACTEC MGIT 960 System and a 
PCR assay, for the detection and identification of 
Mycobacterium tuberculosis from clinical specimens 
E Kontos, E. Petinaki, G. Giti, C. Kostopoulos, S. Anagnostou, 
I. Tselentis and A. Maniatis 
Larissa, Heraklion, Athens, GR 
Objectives: Evaluation of the combined use of the BACTEC MGIT 960 
System and a polymerase chain reaction assay for the detection and identifica- 
tion of Mycobactm'um tubernrlosis in a routine clinical laboratory. 
Methods: Seven hundred and s u t y  specimens (539 sputum samples, 29 
bronchial washings, 76 body fluids, 8 gastric fluids, 96 urine, 6 tissue biopsies, 
1 lymph node biopsy, and 5 other specimens) submitted to the mycobacterial 
laboratory, were processedwith the NALC-NaOH method recommended by 
CDC, stained and cultured in parallel on the Bactec MGIT 960 system and on 
Loewenstein-Jensen medmm. The pedormance of two culture systems has 
been compared. In positive MGITs, the presence of mycobacteria was 
confirmed by Ziehl-Neelsen stain, and a PCR assay was applied for the 
identification of Mycobactm'um tuberculosis. DNA extraction and PCR con- 
ditions have been performed as described previously. The results of PCR assay 
have been compared with those obtained by classical biochemical identifica- 
tion for mycobacteria tests. 
Results: Eighty-two mycubacterial isolates - 51 Mycobatetiurn tuberculosis and 
32 MOTT (mycobacteria other than tuberculosis) - have been detected. All 
of them were detected in MGIT (100% sensitivity) while 5 six (68% 
sensitivity) on Loewenstein-Jensen medium. The mean time of detection 
of Mycobacterium tuberculosis by BACTEC MGIT 960 System was 9.4 days 
while 20.5 days for Loewenstein- Jensen medmm. The PCR assay identified 
all Mycobacterium tuberculosis isolates (100% sensitivity) while gave rise negative 
results for the remaining MOTT (specificity 100%). 
Conclusions: The study indcates that the sensitivity and the detection 
time of mycobacteria in BACTEC MGIT 960 system were higher than that 
of Loewenstein- Jensen medium. The identification of Mycobactetiwi fuber- 
culosis by PCR assay was in excellent concordance with that by the 
classical biochemical tests. We propose that PCR assay is faster, easier and 
cheaper for identification of MycobacMium tuberculosir in a routine clinical 
laboratory. 
I PI505 M. genavense directly identified in stool 
specimen with HPLC 
M. A. Sempere Alcocer, M. MLI~IOZ, I? Coll and A. Shnchez Porto 
Marbella, E 
M. genavense is a slow-growing fastirnous mycobacteria wich has been 
reported to cause disseminated infections in patients with advanced HIV 
infection. The identification of M. genavense is a challenge for the myco- 
bacterial laboratory due to its failure to grow in conventional solid media and 
its long incubation time to grow in liquid media. HPLC Mycolic acid analysis 
is a rapid, standardized, and economic system, which identlfjr a wide 
mycobacteria species by their characteristic mycolic acid pattern. Although 
idendfication of M .  genavme has been documented in culture media, to our 
knowledge this is the first report in which identification of M. genavense is 
performed in a stool specimen by HPLC. We present a case of 26-year-old- 
patient with AIDS with abdominal pain, diarrhea and wasting syndrome. A 
year ago he was previously diagnosed of disseminated mycobacteriosis with- 
out microbiological confirmation. Initial antimicobacterial therapy was 
effective and continued with secondary prophylaxis (ethambutol and clari- 
thromicin) during one year. In a new admittance abundant small clumped 
acid-fast coccobad were seen in the stool samples &om this patient. 
DifTerent decontaminations methods were used for repeated culture in solid 
and liquid meka, however, mycobacteria failed to grown and contamination 
by other bacteria was encountered. HPLC with fluorescence detector was 
used in order to identify directly the mycobacteria in stool specimen. Stool 
specimen (1OmL) was cleaned by means of two washes with s h e  solution. 
Sediment obtained by centrifugation was subjected to sapodication and 
derivatised to 4-bromomethyl-6,7-dimethoxycoumarin derivatives. A linear 
gradient of chloroform/methanol was used in the HPLC analysis. To confirm 
the HPLC identification, PCR-restriction analysis was performed in 0.25 mL 
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of dduted stool specimen. With HPLCand fluarescence detector we obmned 
a triple cluster of mcolic acid characteruhc of M genavense and the pahent 
was hagnosed of dissermnated mycobacterial mfecbon wth  enterihs by 
M .  genavense. On the other hand PCR-restrichon enzyme analys~ (PRA) 
revealed the presence of the characterishc pattern asslgned to M. genuuense 
Infections and medical devices 
(two DNA restriction & p e n t  of 325 and 15 bp for BsfEII and two of 140 
and 105 bp for HaeIII). This result indicate that HPLC with fluoroscence 
detector could be used in stool in direct identification of fastidious myco- 
bacteria as M. genavense or M. avium that produce disseminated infections 
whose reservoir for this bacterium seem to be the gut. 
Ip15061 Clinical interest of the type of bacteremia 
inpatients with permanent endocardial pacemakers 
B. Soperla, J. de la Fuente, D. Cid, M. Rubianes, A. Nodar, M. Seijas and 
C. Martinez-Vazquez 
Vigo, E 
Background: Bacteremia inpatients with permanent endocardial pacemaker 
(PEP) is a serious problem. Literature is scarce and agreement about manage- 
ment does not exist. 
Methods: The files of the 1182 PEP implanted between May 1987 and 
January 1999, were revised. The criteria for bacteremia was two positive 
blood cultures for the same microorganism. Patients with one positive blood 
culture were included if the same microorganism was recovered &om the 
system. Bacteret.uk were chd ied  as early onset (EOB) occurring within the 
frst 6 months after implantation and late onset (LOB) occurring thereafter. 
The source of the bacteremia was recorded. 
Results: Twenty-six cases of bacteremia inpatients with PEP were studied. 
Eighteen bacteremias were PEP-related, the other eight, the source was not 
the pacemaker. The prevalence of PEP-related bacteremia in our hospital was 
1.52%. EOB (n = 6) and LOB (n = 12) disclosed differences in diagnostic 
dificulty: All EOB had local signs of infection versus 27% in LOB group 
(P<O.OOl).  S. n u m  caused 83.3% ofEOB and 16% of LOB (P<O.O05). 
Mortality was h&er in EOB patients (50% EOB vs. 0% LOB). Among 
patients with LOB 45% had been previously diagnosed of pneumonia. 
Endocarditis was diagnosed in 75% (9/12) with LOB. In the two groups, 
total extraction of the system was necessary. In any case of bacteremia arising 
outside the PEP, the system became involved. 
Conclusions: EOB and LOB are difXerent in the type of microorganism, 
diagnostic difficulty, and prognosis. Extraction of the pace-system is necessary, 
except in nonstaphylococcd bacteremias arising out of the system. 
I P1507 I Conservative management of early vascular 
prosthesis infections 
C. Martinez-Vazquez, I. Oliveira, B. Sopeiia, J. de la Fuente, A. Lopez, 
B. Gimena and A. Nodar 
Vigo, E 
Background The use of synthetic vascular prosthesis has supposed an 
important advance in vascular surgery. However, infection of these prosthesis 
is a serious complication with high morbidity and mortality and, for most 
authors, complete extraction of the vascular graft plus parented antibiotic 
treatment are needed for cure. 
Methods: We prospectively studied all patients with infected vascular pros- 
thesis attended at our hospital since May 1998 until November 1999. 
Prosthesis was considered infected when spontaneous drainage though the 
surgical wound was observed, plus a CT-scan showed a periprosthetic 
collection. Only patients with patent prosthesis and without septic shock 
were included. We tried a conservative approach keeping the prosthesis in 
place, with surgical or radiological guided drainage plus antibiotic treatment. 
Results: Fourteen patients with early prosthesis infection haw been included 
(one of them with periaortic infection, and the others with extracavitary 
infection). All patients, except one, presented fever and spontaneous purulent 
drainage. Microorganisms were recovered fiom the pus in 10 patients. 
(definte infection) Only one microarganism was isolated in seven patients 
(S. epidmidir (n = 4). S. aweus, E. coli and B. -'a) and mixed flora in the 
other three patients (Streptormu simsclans + E.fmlis; S. epideimidir + E.faecalb 
and S p'dmnidist PIoteus mira&iiis}. After two years of follow-up without 
antibiotic treatment, complete clinical, radiohgical and analytical cure was 
achieved in 11 patients (78.6%) and in other three (11.6%) the conservative 
management M e d  (under anhbiotic treatment in two of them and one year 
after antibiotics were mthdrawn in the other). 
C o ~ l u ~ i o n :  Most patients with early vascular prosthesis infections, can be 
cured without surgical extraction of the prosthesis. 
IP1508j Successful treatment of a VA shunt infection 
complicated by shunt nephritis with linezolid a case report 
A. M. Wechsler-Fordos, C. Pramer, G. Perneczky and M. Kanzler 
Wennu, A 
Although the mcidence of shunt mfechon has decreased thls complication is a 
constant source of concern. m e 1 3  shunt nephrihs can result as a sequela of a 
C ~ K O N C  infechon In August 2001 a 40-year-old-woman was adrmtted 
because of seizures. Few days later she developed fever and mental detenora- 
hon Blood cultures ylelded methlcdlm-resistant coagdase-negahve staphy- 
lococci wthout any evident source. The pahent also suffered from 
detenorahon of her renal functaon, edema and severe hypertension. The 
pahentb medlcal h t o r y  was unevendul unhl October 1998 when she had a 
subarachnoidal hemorrhage due to an aneurysm Three months after chpping 
a VP shunt was Implanted. The pentoneal had to replaced by an a t r d  part 
2 weeks later. Now the pahent h d  not lmprove m spite of adequate therapy. 
The hypothew of shunt nephnhs was generated though there was no 
evldence of shunt malfunchon on the CT scans at admmion. Pleocytom, 
elevated protein and decreased glucose were found in the lumbar tap, but no 
bacteria. Complement factors C3 and C4 were decreased, cuculatmg immune 
complexes and proteinase-3 antibody were elevated. Consequently the 
complete shunt system was removed. S. eprdmrdis was cultivated h m  a l l  
intraoperatlve materds. With respect to the superb penetrahon of lmezohd 
into the CSF flwd and the mpared renal funchon the antmucrobd treatment 
consmed of lmezohd 600mg bid and lOmg vancomycm admmstered 
mtraventncularly. Immediately after surgery the pahent's neurological con- 
hhon improved. Two weeks later hydrocephalus developed. CSF flud to 
momtor therapy pnor to the inserhon of a new shunt could only be gamed by 
a suboccipital tap Pleocytom and hypoglycorrhachla had resolved, protein 
was normal, there was no bac ted  growth. Thus a ventnculopentoneal shunt 
was mserted. Sur weeks after removal of the shunt creaamn has decreased &om 
4.5 to 2 mg/&, the complement factors C3 and C4 are m h  the normal 
range, circulating m u n e  complexes and protemse-3 antibody are decreas- 
mg In conclusion, lmprowment in renal function after removal of the 
contamnated shunt is the rule and occurred also in h s  pauent, therefore 
no renal biopsy was performed. Therapy of bacterial meningitis due to 
resistant enterococci wth  linezohd was successhl recently Lmezolid therapy 
for 4 weeks was also effechve and well tolerated m t l u s  case of shunt infection 
and shunt nepbrxtis. 
I P I  509 1 Colonization/infection of ventriculoperitoneal 
shunt (VPS) by Propionibacteriurn acnes a frequent cause of 
VPS failures 
M. E. JImknez-Mejias, E J. Mirquez-&vas, R. Terrones, 
J. Palommo-Nick, F Rodriguez-Burgos and J. Pachbn 
Seuille, E 
Background: Study of cases of repeated ventnculopentoneal shunt (ws) 
fdures and shunt colotuzahon by Propiombactenum acnes. 
Methods: Inchion criteria: adult pahents wth  VPS and mdhpk cerebrosp- 
mal flwd shunt fadures and €? acnes CSF isolahons We have stuhed number of 
shunt rewsions, intervals between revlsions, symptoms, ChaacteKYShCS of CSF, 
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microorganisms isolated of CSF, and treatment of I? ucws VPS colonizations. 
All CSF were immediately processed and cultivated in aerobic and anaerobic 
media. 
Resub l? acnes was isolated fiom 11 patients with multiple VPS failures. 
Numbers of revision: 4.4 (r 2-8). 
Time of VPS fatlure: 4-46months. 
Preoperative lagnosis: sterile VPS nialfunction (100%). 
There are a progressive shortening of the intervals between revisions. 
Clinical presentation: Eight patients showed clinic of valve malfunction 
(headache, somnolence), and five abdominal pain. No fever. CSF showed 
no a b n o d t i e s .  All patients were treated with intravenous penicdin (50.000 
UUkg q4h) during 15-21 days, removal of WS, placed an external ventri- 
cular dramage device, and a new VPS implantation. No relapse or 
VPS maknction were observed during a monitoring time of 30months 
(rr 12-46111). 
Conclusions: 
1 This results suggest that the colonization of VPS by I! acnes is associated 
2 In this cases CSF cultures in aerobic and anaerobic media are warranted. 
3 Replacement of the all shunt components and appropriate intravenous 
with multiple W S  failures. 
antimicrobial treatment are necessary. 
(p15101 Safety of heart-lung machines during prolonged 
stand-by 
A. Witschi, A. Widmer, B. Jaussi Schnider, H-R. Zerkowski, J. Wehrle 
and E Bernet 
Basel, CH 
Objectives: Heart-lung machines (HLM) are increasingly used ‘off-pump’ in 
open heart surgery. The tubes are discarded after every single operation even 
when the HLM has not been used. This represents a loss of $1500 for the 
disposable mbes and a loss oftime for HLM installation. A prolonged stand-by 
period for HLM would therefore save time and money. We investigated 
whether the fluid circulating in the tubes remains sterile up to 72 h. 
Methods: Samples ofintratube fluid were taken under aseptic conditions after 
0, 12, 24, 36, 48 and 72 h. Samples from the fluid bags were also taken. 
Microbiological testing was performed using a combined method of dxect 
inoculation and membrane fdtration (Steritest System, Millipore@). Endo- 
toxin levels were measured in order to rule out any contamination. 
Results: Four machines of the type S A R N S  9000 were examined. Within an 
incubation time of 14 days, no (0%) bacterial growth was observed in the 44 
samples taken from the tubes. The endotoxin results are pending. 
Conclusion: HLMs can be kept in stand-by for up to 72 h, given aseptic 
assembly and handhng of the tube system. The prolonged use of HLMs d 
save time and considerable amounts of money. 
I P I  51 1 1 Micro-organisms from peritoneal dialysates 
inpatients with continuous ambulatory peritoneal dialysis 
M. Kochowska-Bronk, A. Samet, M. Bronk and L. Nanmiuk 
Gdansk, PL 
Objectives: To evaluate the frequency of microorganism isolated h m  
peritoneal fluids patients with continuos ambulatory peritoneal dialysis 
(CAPD) 
Methods: From CAPD patients with peritonitis symptoms 137 peritoneal 
fluids samples were collected. The specimens were inoculated on solid media 
after 10-min centrifugation. Aerobic, anaerobic and broth cultures in B a d  
Alert (Organon Teknika) were started. The pellet was Gram stained. 
Results: In the period from January to November 2001, 49 fiom 137 
dialysates were positive (37.5%), six of the positives were polymicrobial. 
Following microorganisms were obtained Staphylococm epidermidis (20), 
Enferobacter cloacae (3) .  S. aureus (3), S. viridans (3). Mebsiella oxyfoca (2), 
Acinetobacter sp. (2), Pseudomonas sp. (2). Enteroroms faecalir (2), E.fuecium 
(1). Pseudomonas aeruginosa (l), Senatia marcarens (l), Citrobacter braakii (I), 
Morganella motgannii (1). Proteus mirubifis (1). S. agalactiae (l), Aeromom sp. (l), 
Bacteroides ovatus (l), Fusobactm’um nucleaturn (l), Candida albicans (4) C. tro- 
pinriis (3). In polymicrobial infection: two S. epidemidis (doxycycline resistant 
and sensitive), S. epidemidis + S. aureus, K. oxyfou + S .  agalactiae, S. marces- 
tens + C. tropicalis, E.faecium + C. albicans. 
Conclusion: The most prevalent etiologic agents of peritonitis inpatients with 
CAPD were S. epidemidis (20), C. albicans (4), S. aweus (3). S. viridanc (3) and 
C. tropicalis (3). Utilization of d ~ e r e n t  solid and broth media enabled good 
recovery of various microorganisms and approprlate antibiotic therapy based 
on microbiologic results. 
m1 Analysis of microbial causes of peritoneal 
dialysis-related peritonitis 
H. Arslan, F. Ergin, A. Azap, E. Kuru Inci and N. Ozdemir 
Ankara, TR 
Background Peritonitis remains a common and serious complication ofPD. 
Because of the increasing antimicrobial resistance of isolated microorganisms 
some authors emphasize that current andmicrobial therapy procedures needs 
to be revised. In this study, we evaluated the microbial causes ofperitonitis in 
our PD program and analyzed their antibiotic susceptibilities. 
Methods: During a 22-month period 186 positive cultures, isolated from 152 
patients’ periton dialysate samples, were evaluated by means of microbial 
agents and their susceptibility patterns. 
Results: The culture positive peritonitis rate was 0.66%/patient/year. There 
were 198 microorganisms isolated h m  186 positive samples. The rate of 
infections caused by multiple pathogens was 6.4%. The ratio of Gram- 
positive, Gram-negative and fungal pathogens were 71.7, 26.2, and 2.1, 
respectively. S. ep idmid i s  and S.  aureus were the most common causes of 
peritonitis isolated in 47.7 and 12.6% of culture positive cases. I? aeruginosa, 
E .  coli, Klebsiella spp. and Enferobacter spp. were the most common causes of 
Gram-negative peritonitis identified in 6.5, 5.0, 4.5, and 4.0% of culture 
positive cases, respectively. Methicillin resistance to S. auras and S. epidemidis 
were 8 and 35%, respectively. All m e t h i c h  resistant strains were sensitive to 
vancomycin and 70% of them were sensitive to gentamicin. All Enterobac- 
teriaceae strains isolated were sensitive to imipenem. Cefepime, ceftriaxone, 
cefoperazone, cefazoline susceptibilities ofthese isolates were: 85,78,74, and 
52%, respectively. Also 85% of the isolates were sensitive to ciprofloxacin and 
92% to gentamicin and amikacin. None of the I? amginom isolates were 
resistant to ceftazidime, cefepime, imipenem and piperasilin tazobactam. One 
strain was resistant to aminoglycosides (amicasin, tobramycin, netilmicin), and 
another to ciprofloxacin. 
Conclusions: Our data showed a sigdcantly low rate of antimicrobial 
resistance in the strains isolated &om peritonitis patients compared to the 
nosocomial isolates. According to what we have found we insist on the 
ampiric intraperitoneal administration of a cephalosporin and aminoglyco- 
side, inspite of combinations including vancomycin in the management of 
peritonitis unless the previous profile of the microbial distribution and 
antimicrobial susceptibility patterns of peritonitis are known. 
I P I  51 3 I Biofilm-producing pathogens isolated from 
patients affected by metabolic disorders 
M. Dolcino, E. A. Debbia, A. Piazzi and A. Berio 
Genoa, I 
Objectives: Patients afEected by metabolic disorders are easily infected by a 
wide range of opportunistic pathogens causing severe c h c a l  symptoms. In 
many cases these bacteria are resistant to antibiotics and produce b i o f h ,  
factors that might increase the risk of a therapeutic failure. In this study, we 
have analyzed the pathogens isolated &om patients affected by different 
metabolic disorders (hyperaminoaciduria, hypercholesterolemia, sugar intol- 
erance, cystinuria, hyperlactacidemia, gammopathy, homocystinuria, calcu- 
losis). 
Methods: the presence of microorganisms in the urine of patients dected by 
metabolic disorders was explored and the biofrlm production was verified in 
Congo Red agar plates, according to the method described by Freeman. 
Results: among 18 patients studied, 10 demonstrated bacterial growth of one 
or more species &om urine samples. The microorganisms isolated showed in 
five cases the presence of biofh-producing organisms, they were: Mebsiella 
ornithinolytica, Proteus mirabilis (two strains), Alcaligenes faecalis, Staphylococcus 
epidermidis, Escherichia coli, S. simulans, S.  haemolyticus, S.  epidemidis. Consider- 
ing their metabolic disorders, four patients resulted afXected by impaired sugar 
metabolism and one suffered hypercholesterolemia. B i o f h  production was 
observed in one or more species isolated h m  the same patient afEected by 
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these latter metabolic disorders. Ln no case, we detected b i o f h  producing 
and non producing strains &om the same patient. 
Conclusions: The present findings indicate that patients affected by 
disorders in sugar metabolism are more easily infected by biofh-producing 
pathogens, while inpatients with other metabolic diseases, microorganisms 
involved did not produce slime. Further studies to detect factors that 
facilitate the colonization of these patients by biofilm producing strains are 
under way. 
/p15141 Ventilator associated pneumonia in 
intensive care units 
H. Erdogan, N. Baykam, D. Albayrak and B. Dokuzoguz 
Ankara, TR 
Introduction: The aim ofthis study was to evaluate the incidence, risk factors, 
etiologic agents, antimicrobial susceptibility, source of agents and mortality 
rate of ventdator associated pneumonia (VAP) in ICU. 
Methods: The adult patients who received more than 48 h ventilatory support 
in four intensive care units of government hospital were evaluated prospec- 
tively. Among the consecutive 100 patients who had received ventilatory 
support, 25 were excluded 6om study as they died or separated from ventilator 
in 48 h. VAP was defined according to presence of CDC criteria. Etiologic 
agents were detected by quantitative culture of endotracheal aspirate and 
antimicrobial susceptibility tests were performed by &sk a s i o n  test. Age, 
sex, accompanying dtseases (such as COPD, DM), surgical procedures, 
nutritional status, antibiotic usage, APACHEE 11, approach to gastrointestinal 
protection, period of ventilation were evaluated as the risk factors for VAP. 
Cultures were taken fiom each ventilator to detect the source of infection. 
Student’s t, Mam-Whitney Uand Kaplan-Meier log range tests were used for 
statistical evaluation. 
Results: VAP was diagnosed in 26 of 75 patients (32%). There were no 
statistical dserence between age, sex and APACHEE I1 of VAP(+) and 
VAP(-) patients. Relevant risk factors were surgical procedures, usage of 
H2 receptor blocker, duration of mechanical ventilation (P< 0.001). Etio- 
logic agents of VAP were polymicrobial in 46% of patients and Acinetobacter 
spp. isolated in 27.5%. Pseudomonas spp. in 20%. MRSA in 22.5% and 
Klebsiella pneumonia in 10% of aspirate cultures. Gram-negative bacteria 
were multiresistant at the rate of 85%. Any contaminated ventdator was 
detected for being the source of these agents. MortaIity rate of patients with 
VAP (100%) was sigtllficantly hgher than that of VAP(-) patients (85%) 
( P  < 0.05). 
Conclusion: VAP is the most important complication of mechanicd ventila- 
tion in ICU and the role of VAP on mortality rate is important. Surgical 
procedures, usage of H2 receptor blocker, duration of mechanical ventilation 
are the risk factors ofVAP. Multiresistant Gram-negative bacteria and MRSA 
are the main problem microorganisms in VAP in ICU. It was concluded that 
the education of healthcare workers on hand washing and contact isolation 
precautions will help to decrease the incidence of VAP in ICU. 
I PI515 I Ventilator associated pneumonia (VAP) in a 
university hospital 
F. Ergin, H. Arslan, A. h a p ,  G. Yapar and 0. Dikmen 
Ankara, TR 
Objective: To evaluate the rate of vennlator associated pneumonia (VAP) in 
the four intensive care unit (ICU) and determine causative pathogens and 
their susceptibility patterns. 
Methods: Baskent University Hospital is a tertiary care hospital having 23 
beds in ICU. All patients intubated in four ICU (neurology-neurosurgery, 
internal medicine, surgery-reanimation, and cardiovascular surgery) during 
one month surveillance period were enrolled. We used diagnostic criteria of 
CDC for diagnosis of VAE? Samples of deep endotracheal aspiration taken 
6om patients cultured quantitatively in serial dilutions of 10-5 mL.. Antibiotic 
susceptibility testing was performed by disk diffusion method according to the 
NCCLS standards. 
Results: During the study period 43 patients were intubated in four ICU. Ten 
of them developed VAP. VAP rate was 43.2 per 1000 ventilation days. Four of 
the patients with VAP have other accompmying infections (two urinary tract, 
1 surgical site, 1 necrodzing fadis).  VAP developed at mean 6.9 & 5.3 days 
after intubation (median 7). In infected group 80?? of patients had 
one or more underlying chronic disease such as dtabetes mellitus, 
cerebrovascular disease and transplantation while this percentage was 
39.3% in nonidected patients. Mean APACHE score was 9.60f5.02 in 
infected group and 6.88f4.14 in noninfected group. There was no 
APACHE score and mean age difference between infected and noninfected 
groups ( P >  0.05, Mann-Whimey U-test). Isolated pathogens were Acineto- 
bacter spp.(4), E. aerogefies (2), Pseudomonus (2), Morexella spp. (1). MRSA (1). 
We observed that three of four Acinetobacter spp. were resistant to meropenem, 
amikacin, ciprofloxacin, ceftazidime, piperacilliwtazobactam and susceptible 
to cefepime and sulbactam-cefoperazone and one ofthe two Pseudomonus was 
resistant to all tested antibiotics. Both of E. aerogenes were resistant to cipro- 
floxacin, amikacin and cefcazidime. Mortality rate attributable to VAP was 
30%. 
Conclusion: Reported rate ofVAP commonly 10-1 5 cases per 1000 ventilator 
days based on a study population. We detected higher rate of VAP. Although 
there was no difference in APACHE score between the groups, high rate of 
underlying disease in mfected group might have contributed to t h i s  high rate 
of VAI? We also observed a very high antibiotic resistance. 
I P I  516 1 Quantitative cultures of bronchoalveolar lavage 
fluids (BAL) in mechanically ventilated patients 
S. Konstantopoulou, E Vapa, F! Karle, E. Lympempodos, L. Mtsi, 
H. Savmdou, E Vigla and M. S a d a  
Athens, GR 
Objective: The purpose of thu study was to perform quanhtaave bacterial 
cultures on bronchoalveolar lavage fluids obtamed from mechanically vent]- 
lated pahenu from Intensive Care Umt. 
Methods: Two hundred bronchoalveolar lavage specmen from paaents (20- 
60 years) reqwmg mechamcal ventdanon for 3-32 days, were qUantItahVely 
cultured for aerobic, anaerobic mcroorgamsms and fun@ in order to confirm 
any speclfic infecnon of lower respiratory tract. Concentranon lo4 c f ~ / m ~  
was considered as a posinve culture. Anhbiouc suscepnblltty tesnng was 
performed by my-Bauer disk ddbsion method accordmg to NCCLS 
guidelines. 
Resultr: From 200 BAL cultures a percentage of 39% were sterde. From 
posinve cultures a percentage of 20% grew Annetobacter anitratus, 12% 
Pseudornonas spp. 18% Enterobarterraceae (17 specimens Mebsiella pnatmoniae, 
five Escherichia colt, eight Enterobacter spp , SIX Senatia spp ), Wo Entemcococs spp., 
5% Staphylococcus aureus and 4% Candida spp. (eight specunens Candida albicans 
and two C glabrata) The 78% of the strams of Annetobacter anitratus and 
Pseudomonas spp , were susceptible to ammoglycosides and 50% to ammo- 
glycosides and pexms. hnty-e i# t  percent of Gram(-) bacteria were 
suscepbble to ammoglycosides and penems and 55% of the St~phylococnrs 
aureus stram were suscepbble to teicoplanin-vancomycm Seventy percent of 
the S anreus st rams were reslstant to me th lch .  
Conclusion: The infections in ICU pahents are caused by mulhresistant strains 
and the mortahty xs hgh Therefore, the idenuficanon of lower respiratory 
tract lnfechons by bronchoalveolar lavage flwds has A great dlagnosnc 
value 
I P1517 I lnhaled ampidllinlsulbactam against 
A. baumannii in bronchial secretions of ICU patients: 
a preliminary report 
M. Horianopoulou, M. Kanellopoulou, I. Paraskevopoulos. 
V. Harizopoulou, K. Sakayianni and S .  Lambropoulos 
Athens, GR 
Introduction: Acinetobacter baumannii is an important cause of nosocomial 
pneumonia, particularly in the intensive care unit (ICU) setting. Ventilator- 
associated pneumonia (VAP) caused by A. baumannii carries a high (43%) 
attributable mortality. 
Objectives: The aim of this study was to assess the effectiveness of aerosolized 
ampicdldsulbactam in ICU patients with multiresistant A .  baumannii colo- 
nization of the respiratory tract. 
Methods: Eleven intubated patients on mechanical ventilation participated in 
the study Multiresistant A.  baumannii, sensitive only to ampi&n/sulbactam, 
was isolated &om the bronchial secretions (107-10scfU/mL). All 1 1  patients 
were subsequently treated with intravenous ampicillin/sulbactam, whereas 
eight of them were also given the same antibiotic in aerosolized form. 
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Quantitative cultures ofbronchial secretions, routine blood chemistry, as well 
as chest radiographs were obtained on a daily basis. 
Results: A decrease ( h m  10' to 102cfu/mL) in the number of A. baumannii 
colonies was observed, following 2 to 4days of combined treatment 
with both intravenous and inhaled ampicillin/sulbactam. None of the 
eight patients developed VM. In the three patients who only received the 
antibiotic intravenously, a decrease from 10* to lo5 or 1 0 4 c ~ / d  was 
observed after 7days of treatment. One of the three patients developed 
VAI? 
Conclusions: Our results suggest that the administration of aerosolized 
ampicillin/sulbactam represents an effective means of preventing vendlator- 
associated pneumonia caused by A. baumannii. 
Catheter-related infections 
Ip15181 Impact of antiseptic impregnation on central 
venous catheters: the rate of microbial colonization of 
antiseptic impregnated catheters 
G. Hinterberger, C. Lass-Florl, W. Hasibeder and M.-P. Dierich 
Innsbruck, A 
Objectives: Prospective trials have shown that antiseptic impregnation of 
central venous catheters reduce the incidence in catheter associated infections. 
The aim of this study was to investigate the microbial colonization-rate 
between a nonimpregnatedcatheter (ARROW-HOWSTM, Crosstec; type A), a 
silver-submicron impregnated central venous catheter (SICURISTM, 
Siemens; type B) and a new catheter with s m a l l  amounts of silver-sulfadicin 
and chlorhexidine on its surface (ARROW gard BlueTM, Crosstec; type C). 
Methods: After removing the catheter, the distal segment was cut to a length 
of about 3-4cm under aseptic conditions. The microbioIogical treatment 
consisted of quantitative analysis of colonization from the catheter-outside 
and qualitative analysis including the whole tip. 
Results: A number of 400 catheters were investigated during a period of 
18 months. By comparing the rate ofcolonization ofthe three catheters (A, B, 
C) sigm6cant ditferences were found (P< 0.05). Types A and B catheters 
represented the maximum-rate of microbial colonization (type A 32/125; 
typeB 41/146). Type C appeared to be the catheterwith thelowest numberof 
colonization (14/129). Microbiological investigations showed coagulase- 
negative staphylococci with a rate of 71% of isolates followed by Gram- 
negative rods with 15%, Staphylococcus uureus with 7% and yeasts representing 
7%. 
Conclusion: The results of this study demonstrate that impregnation with 
silver-sulfadicin and chlorhexidine appear to protect the catheter *om 
bacterial contamination. 
Fl Retrospective study on microbial colonization of 
central vessel catheters in pediatric ICU patients 
A. Makri, T. Panagea, I. Varzakakos, Z. Sarri, L. Sianidou and 
E. Papavasileiou 
Athens, GR 
Objectives: Our targers were to determine the isolation rate of microorgan- 
isms which were recovered from central vessel catheters from ICU patients 
aged between 15 to 18 years, as well as their resistance to antibiotics. 
Materialsand methods: A total of276 samples of central vessel catheters &om 
ICU patients were sent for culture to our laboratory during the last decade 
(1991-2000). Catheters were removed h m  patients S15days after their 
introduction. Culture was performed by the Maki semiquantitative method 
and all samples, after enrichment in cooked meat broth, were subcultured on 
selective media. All microorganisms were identified by classical microbiolo- 
gical methods and susceptibdity to antibiotics was tested according to NCCLS 
instructions. 
ResulU: A total of 114 cultures were positive (41.3%) and 162 were negative 
(58.7%). One microorganism was isolated in 87 samples (76%), two micro- 
organisms in 19 samples (17%) and three or more microorganisms in eight 
samples (7%). The microbes most commonly isolated were the following: 
Staphylococcus co (48%), Cundida spp. (17%), Acinetobarter spp. (6%), Hebsielh 
spp. (5.5%). Enterobacter spp. (5%) and EnterDEornrs spp. (5%). Resistance to 
antibiotics of Staphylococcus was as follows: erythromycin (55.5%), oxac& 
(52.8%), clindamycin (45.8%). gentamicin (43%), nefilrmcin (30%), cipro- 
floxacin (27.8%). amikacin (18%), rifampicin (ll%), and temacycline (4%). 
Increased resistance to several antibiotics was also observed for An'netobacter 
spp. isolates. 
Conclusions: CNS and Candida are still the commonest microbes colonizing 
central vessel catheters from ICU pediatric patients. The high colonization 
rate found in these patients might be due to the dificulty to replace catheters. 
Regular replacement of central catheters may contribute to the decrease of 
blood infections indiiced by catheters. 
I PI520 I Bacterial species isolated from central venous 
catheter-tips and the susceptibility to antibiotics 
M. Papadaki, 2. Roussou, I. Melas, E. Merkouri, S. Polyzos, C. Mathas, 
T. Kyriakopoulos, C. Nikolaou, C. Kyriakopoulos and S. Kitsou 
Athens, GR 
Objectives: To determine the bacterial species isolated &om central-venous 
catheter tips in a 3-month period &om ICU patients of the hospital. The 
resistance pattern also was studied. 
Materials and methods: A total of415 catheter tips &om ICU patients were 
investigated by the semiquantitative (Maki) method. Identification and 
susceptibility testing (MIC) were performed by semi automated system 
(Pasco, Difco Laboratories). For resistance determination of staphylococci 
and enterococci to glycopeptides E-test was used. 
Results: A total of 200 (48.2%) clinical strains were isolated (see table). 
Gram-positive cocci 85 Gram-negahve bacilli 115 
Coag. neg. staphylococci 56 A. baumani 29 
S .  epidermifis 13 K. pneumonioe 17 
Enteroroms spp. 10 S. maltophiiio 15 
S. sums 9 I! mirabilis 13 
C. violaceum 12 
I! shhigelloider 8 
E.  cloarae 7 
I! aeruginosa 7 
l?Jluomcem 3 
C. violaceurn and S. rnaltophifiawere the most resistant. GISA/GISE strains have 
not been isolated. Imipenem and vancomycin remain the more effective 
antibacterials against Gram-negative and Gram-positive pathogens, respec- 
tively. 
Conclusion: The percentage of bacterial colonization of venous catheters in 
ICU is high. The increasing resistance of the bacteria to antibiotics is the 
major problem of ICU in spite of restricted policy use of antibiotics in our 
institution. 
Reduction of central venous catheter-related 
infection (CRI) in cancer patients 
M. Karthaus, S. Zenz, H. Ruschulte, A. Osthaus, B. Juttner, G. Heil and 
K. Jaeger 
Bielefeeld, Hannouq D 
Background Central venous catheters (CVCs) impregnated with chlorhex- 
idine and silver-sulfadazine (CH-SS) CH-SS have recently been introduced 
for the prevention of CRI. The purpose of this study was to assess the etticacy 
of CH-SS impregnated CVCs (ARROW gard Blue PlusTM) to prevent CRI 
in patients with hematological malignancies undergoing chemotherapy fol- 
lowed by severe neutropenia (<lOO/pL). Proven CVC-related blood stream 
infection PSI) was defined as the isolation of the same species from peripheral 
blood culture and CVC-tip (>15 cfu Maki technique). 
Methods: A randomized, prospective clinical trial was carried out in con- 
secutive cancer patients to compare CRI using an CH-SS impregnated CVC 
(n = 51) with that using a standard uncoated triple-lumen CVC (n = 55) 
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between March and October 2000 Panents were treated for leukema 
(n = 92), lymphoma (n = lo), myeloma (n = 3), and myelodysplashc syn- 
drome (n= 1) 
Results: Study groups were balanced regardmg to sex, age, underlymg 
Asease, inserhon site, and durahon of severe neutropema The CVCs 
were m-situ a mean of 14 3 (SD 8 2) d in the study group versus 16 6 
(SD 9 7) d m the control arm CVC hp colonuation was observed less 
frequent in the study group (7 panents vs 17 pahents, P=0035) CVC- 
related BSI were sigmficantly less kequent m the study group (1 pahents vs. 8 
paaents; P =  0.02) AU CVC-related BSI lnfecnons were related to Staphy- 
Conclusion: In panents mth severe neutropema, CH-SS lmpregnated CVC 
yleld a sigillficant annbacternl effect agamst Sfupliylouxnrs spp. Resultmg m a 
sigruficantly lower rate of CVC tip colomzanon as well as CVC-related BSI. 
lococcus spp. 
11)15221 Taqman quantitative PCR as a promising tool for 
the diagnosis of staphylococcal catheter infections 
S. J Vandecasteele, J. Van Eldere, R Merckx and W E. Peetermans 
Leuven, B 
Objectives: Coagulase negaave staphylococci (CNS) are the mam cause of 
catheter related bloodstream lnfechons Quantitahve catheter culture (QCC) 
is the gold standard for magnosing catheter infections. The current study 
compares the rehabhty of QCC and a newly developed method based on 
quanhtahve PCR (QPCR) in the dmgnosis of catheter infecaon. 
Methods: One hundred and two catheter segments were moculated m vltro 
with S. epidermidis and implanted subcutaneously m rats. After 2 weeks, all 
catheters were removed QCC of 56 catheters was performed after somcation 
of the samples as prevlously descnbed Cultures were counted after 1,2 and 
5days Instant RNA and DNA isolanon was performed for the other 56 
catheters using a FastPrepTM based protocol Both the gmk (guanylate b a s e )  
and 165 gene were quanhfied on the RNA (translated m cDN& to check for 
vlable bacteria) and genomc DNA (gDNA) sample wth  Taqman quannhve 
PCR. The theorencal detechon h t  was 20 c h  for QCC and 750 copies of 
gDNA for QPCR. 
Resub. QCC ylelded an average of 1.4 x LO5, 2 2 x lo5 and 3 x lo5 cfu after, 
respectively, 1, 2 and 5 days of mcubanon QPCR yielded an average of 
1.8 x lo7 copies of gmk gDNA at the day of catheter explantanon. These 
Merences were significant (P<O 0001; Kruskall-W&s test). When com- 
paring QPCR and QCC, QPCR had hgher yleld (Dunns Mdhple Com- 
paruon; P< 0.001) and a lower vanabhty (Bartlett test for equal varrances; 
P<O.OOl) than QCC When usmg QCC, 22, 19, and 5 catheters were 
Ciostridium difficile 
negative after, respecnvely, 1,2 and 5 days. When usmg QPCR,just 1 catheter 
was neganve for both gmk RNA and DNA. There was no RNAlgDNA 
nnsmatch m the QPCR group. Slgruficantly more catheters were negahve 
wtth QCC counted after 1 and 2days than mth  QPCR (ch-square; 
P <  0.001). 
Conclusion: QCC has an only moderate rdabhty in the ckagnosts ofcatheter 
mfecnons, especially when plates were just cultured for 1 or 2 days, or when 
hgh duhons were used Instant nucleic acid extraCQOn w t h  QPCR IS a 
promslog method for the d~agnosts of catheter mfechons, w t h  a htgher 
SeWhvlty, a hgher yleld, and a smaller lntersample variabhty. The c h c a l  
usefulness has however, yet to be estabhshed. 
Successfully treated Candida CVC-related 
pneumonia in an immummpromised patient 
M. Giacchmo, C Scolfaro, G Donato, L Lazier, M Pultrone, 
A Versace, F Garofdo and P A Tovo 
Tunn, I 
Objectives: C .  albicans and C. tropicuhs are common agents of sepsis and 
secondary hematogenous pulmonary mvolvement even m unmunocompro- 
msed pahents, but Candidupneumonia is unusual. Imdazole annhngal agents, 
such as ketoconazole, fluconazole, itraconazole and voriconazole, have been 
successhlly used m s m a l l  senes agamt some Candida species. Here, we 
describe a p e c h  case of primary mycoac pneumoma m an m u n o c o m -  
pronnsed pahent. C h c a l  care: L.V., Caucasran male aged 14, atfected by a 
metastasised EBV-related rhynopharyngeal carcmoma. After apphcaaon of a 
Central Catheter he was m t e d  wth  chemo and radlotherapy. He developed 
bone marrow aplasia, under prophylacnc treatment wlth fluconazol and 
nevertheless he had a mucosal colonmaon due to a Candida ufbicans and a 
C cruzn An episode of FUO was successfully treated wlth cehzdune, 
armkacin, teicoplarun Three days later, fever wth chds reappeared. Cen td  
and peripheral blood cultures were positive for Candida albicanr and crusei, 
resistant to Fluconazole. An X-ray film showed a bllateral pneumoma The 
CVC was removed and Ampho B plus Flucitosme were started. After 15 days 
chca l  and X-ray pictures were unchanged. Antib1oncs were stopped and 
treatment was replaced wth Vonconazole, 4 mg/kg/day. Fever Asappeared 
after 5 days and gradually the rad~olog~cal picture Improved Two weeks later a 
new CVC was apphed and CT started agam. Vonconazole was conanued 
orally and the panents defitlltely Improved. 
Conciusions: CVC-related mycoac lnfecnons m aphhc oncologc paaents 
may show a good response to the treatment lfit is appropriately and quickly 
started, and If the source 1s removed. 
PCR-ribotyping of clinically important 
Clortridium difficie strains from Hungary 
E. Urbin, J. Brazier, J. Sbki, E. Nagy and B. Duerden 
Szeged, HUN; Card8 UK 
Objectives: Detection of the source of toxin-producing Clostn’dium d w l e  
strains is of great importance for the control of the nosocomial spread of this 
microorganism. Many Werent techniques have been employed to help to 
determine genetic relationship among hospitally acquired C. d@le isolates. 
Methods: Isolates of C. d@ik originated &om difkrent hospital wards of 
University Hospital of Szeged were typed by PCR amplification of rRNA 
intergenic spacer regions (PCR ribotyping). The aim of our study was to 
determine: (1) whether isolates are genetically similar to C .  dwte isolates 
collected in United Kingdom, Anaerobe Reference Unit, CardiEduring an 
international surveillance; (2) which are the most common ribotypes of 
C. d w e  in our hospital. 
Results: A total of 15 different ribotypes were detected among the 65 isolates 
tested. The most predominant PCR ribotype in the Hungarian survey of 
these isolates was 087, which accounted 39% of all isolates in contrast with 
international typing study where the the most common type was ribotype 
001. We found two nontoxigenic C. dijiciie st ra ins  showing the same pattern, 
which were distinct h m  all the ribotypes previously described, suggesting a 
new type. 
/p15251 Clindamycin resistance (em@, toxigenicity and 
genotype of Clostridium diffide strains isolated from 
patients with antibiotic associated diarrhea (AAD) 
H Pituch, A van Bellcum, N van den Braak, P. Obuch-Woszczatynsh, 
H Verbrugh, F Meisel-Mlkolajczyk and M Luczak 
Warsaw, PL; Rotterdam, NL 
Background: H ~ g h  level resistance to chndamycm is related to the presence of 
the ermB genes We observed that isolated C d&le strams hghly resistant to 
clxndamym are belongmg to Merent tomnotypes The aun of the study was 
to defke the relanonshp between chndamycin resistance, tomgemcity and 
genotype od C d&le strains solated from AAD. 
Material and methods: Thtrty-five C d@le strauls isolated f b m  pahents 
wtth AAD hospitaltsed y1 five umts of the academe hospital have been 
stumed. For comparaave reasons we used C d@le reference strams Tox- 
igemcity of the isolates was detemned by means of EM, cytotonclty assays 
and PCRs for the detecaon the nonrepeaang sequences and repeatmg 
sequences of toxin A and B genes. Suscephbhty to chdamycln was Itlves- 
hgated using the E-test Detecaon of the ermB gene was performed by PCR 
using the 2980/2981 primer pan Fbbotypmg was performed by PCR 
amphficahon of rRNA mtergemc regon spacer. 
Results: Among 35 s t r a m  of C. d@le isolated from panents wth AAD 
26 strams belonged to tomnotype A+B+and m e  smns  belonged to 
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toxinotype A - B+ 0. P C R  ribotyping generated 13 different ribotypes. 
W i t h  isolates A - B+, two Merrent types of C. d&le strains were defined: 
eight strains of ribotype A and one strain of ribotype E. W i t h  toxinotype 
A + B+, we observed high di6erentiation among ribotypes A-M. Among 35 
strains of C.dt@cile 22 were high level resistant to clindamycin (63%). 
Interestingly most strains representing highly resistance to clindamycin 
belonged to ribotype A. All strains A-B+ were hgly resistant against 
clindamycin. All strains resistant to clindamycin harbored ermB gene. 
Conclusion: Different toxinotypes od C. dfici le  strains were observed among 
clindamycin resistant strains. Among clindamycin resistant strains a single 
ribotype dominates. 
[p15261 Evaluation of immunoassay methods for 
detection of Clostridium difficile toxins 
A. Benavente, A. Andreu, C. Juste, J. Brazier and R. Bartolorn6 
Barcelona, E; Card8 UK 
Objectives: To evaluate four commercial enzyme immunoassay methods 
(EIA) and the culture for the diagnosis of C. d@le associated dlarrhea 
(CDAD) . 
Methods: The detection oftoxins in the stools was performed in 114 samples 
fiom 103 patients by 4 E L k  CdTOXA OIA (n = 114); Vidas C. dfici le  Toxin 
AII (n = 114); Premier Toxins A and B (n = 89); Immunocard Toxin A 
(n = 23). The reference assay was the demonstration of stools toxicity (ST) 
in cell lines Hep2. The stool culture (n = 114) was carried out on cycloserine- 
cefoxitin-fructose agar and the toxigenicity of the isolated strains was deter- 
mined by the reference assay (strain citotoxicity-SCT) andEIAVidas. Toxin A 
and B genes were examined by PCR method (n = 28). P C R  ribotyping was 
also performed in 28 strains. 
Results: Reference assay (ST) was positive in 28 (24%) of the samples and 36 
(31.6%) were positive in some ofthe 4 EIAs. Sensitivity (S) and specificity (SP) 
of ElAs were, respectively: CdTOX A, 82 and 95%; Vidas: 89 and 96% 
Premier, 84 and 95%; Inmunocard, 76 and 100%. The percentage of false- 
positive and false-negative were, respectively: CdTOXA, 14.8%and 5.7%; 
Vidas, 11 .1  and 3.5%; Premier, 12.5 and 6.1%; Immunocard, 0 and 23.1%. 
C. d w l e  was isolated &om 31 (27%) specimens (S: 89%; S P  94%). The mean 
correlation between the culture and EIAs was 83.5% (range: 72348%). In the 
four EIAs, the mean percentage of samples with negative result and positive 
culture was 16.6% (range 9.3-30.7%). The mean percentage oftoxigenicity of 
these strains was 61.4% (range 44.4-75%). In 26 (92%), C. dficile strains toxin 
A and B genes were detected and none were detected in the remaining two. 
Thirteen Werent  ribotypes were detected, 43 percent corresponding to types 
1, 20 and 78. Two ribotypes had never been described before and they were 
assigned as new types 126 and 127. 
Conclusions: Except for Premier, EIAs were sensitive, rapid and easy to use for 
the diagnosis of CDAD. The culture and demonstration of strain toxigenicity 
in cell lines have improved dagnosis of the samples with false negative results 
of EIAs. 
I PI527 1 MLSB-resistance in Clostridium difficile is 
associated with resistance to moxifloxacin 
G. Ackermann, L. E Kircher, K. Tischendorf, R. Schaumann and 
A. C. Rodloff 
Leipzk, D 
Objectives: C. dficile remains the leading cause of nosocomia-acquired 
diarrhoea. C. d f i i l e  usually exhibits resistance against B-lactan-antibiotics, 
whereas susceptibility to others may vary. This study investigated whether 
antimicrobial susceptibility of C. dficile has changed in a defined time frame. 
Methods: C. dficile strains (n=  178), recovered h m  patients in two Uni- 
versity hospitals in Germany between 1986 and 2001, were investigated for 
their susceptibility to erythromycin (ERY), clindamycin (CLIN), moxiflox- 
acin (MXF), vancomycin (VAN), and metronidazole (MET) by E-test. The 
genetic background for resistance was investigated using PCR and DNA- 
sequencing. One hundred fifty-six isolates were toxigenic strains, determined 
by PCR amplifylng fragments of tcdA and tcdB. 
Results: All strains were susceptible to VAN and MET. Resistance rates to 
ERY, CLIN, and MXF at different times are shown in the table. AU but three 
strains exhibiting resistance to antimicrobials were toxigenic strains 
1986-1995 (n=46) 1996-2000 (n = 83) 2001 (n = 41) Z 
Only MILS& 14 (30.4%) 39 (47%) 21 (051%) 74 
MLSB+MXl-R 0 10 (12%) 9 (22%) 19 
Only MXF-R 2 (4.3%) 11 (13.2%) 9 (22%) 21 
According to DIN recommendations resistance was defrned as foUow. 
CLIN, >8 pg/mL; ERY, >8 p g / d  M; recommendations do not exisr for 
MXF, the MIC value published for trovafloxacin is >4 pg/mL. 
Conclusion: (A) The results indicate that prevalence of resistance against 
MLSB- and fluoroquinolone-antibiotics in C. d&le is increasing. (B) Fluor- 
oquinolone resistance is associated to resistance against MLSB-antimicrobials. 
(C) Antimicrobial resistance might be related to toxigenicity. Due to the low 
number of nontoxigenic strains included in this study further analysis of 
nontoxigenic strains are required to prove t h ~ s  hypothesis. 
Toxin A-negative toxin B-positive Clostridium 
difficile strains as aetiologic agents in antibiotic associated 
diarrhoea (AAD) among children hospitalised in a 
haematology unit 
H. Pituch, A. van Belkum, N. van den Braak, P. Obuch-Woszczatynski, 
A. Sawicka-Grzelak, H. Verbrugh, E Meisel-Mikolajczyk and M. Luczak 
Warraw, PL; Rotterdam, NL 
Purpose: We report cases of antibiotic associated diarrhoea (AAD) due to 
A-B+ Clostridium d&!e strains in a hematologic unit and discuss the 
implications of diagnostic testing in suspected cases of C. d@icIe-associated 
AAD. 
Material and methods: Stool samples of 19 children (hospitalised between 
1999 and 2000), suspected for C. dijicife associated diarrhoea were investi- 
gated. For direct detection of toxin A in faecal samples and in isolated strains, 
the EIA ‘Culturette Brand Toxin CD’ TCD (Becton-Dickinson) was used. 
The cytopathic effect examined by bacterial culture supernatants on McCoy 
cell line was used for detection of toxin B. P C R  for detection nonrepeating 
and repeating sequences toxin A gene and nonrepeating sequences toxin B 
gene was used. 
Results: Directly in feces toxin A was detected in three cases by using EIA and 
16 sapmles were toxin A negative. Any other enteric pathogens as Salomonella, 
Shi.qella, enteropathogenic E .  coli and rotaviruses were not detected in these 
stools. Nine strains of C. d@de were isolated. O f  these strains, three were 
toxin A positive as demonstrated by the TCD test. The remaining six toxin A 
negative strains demonstrated cytopathic effect on McCoy cells. The non- 
repeating regions of both toxin genes were detectable in all strains. The PCR 
product obtained upon amplification of the repeating unit of DNA isolated 
from A - B+ strains was the same the product derived from the reference 
strain A - B+ GAI 95601 (700 bp). By P C R  ribotyping we distinguished 
four Merent  types among nine C. di@e strains. Within A - B+ strains we 
distinguished two ribotypes (A and E). 
Conclusion: A - B+ C. dficile strains are capable to cause AAD in children of 
hematology unit. Clinical laboratories which use test for detection only toxin 
A need to be aware that results may be falsely negative. 
v] Detection of Clostridium difficile strains with a 
variant pathogenicity locus 
P. Spigaglia and F? Mastrantonio 
Rome, I 
Objectives: The genes for toxins A and B (tcdA and tcdB) of C. dij’iale are part 
of a 19.6-kb genetic locus that includes 3 additional open-reading frames 
(ORFs), tcdD, tcdE and tcdC. The acquisition of this pathogenicity locus 
(PaLoc) is a prerequisite for virulence. C. dficile strains, variant for the 
pathogenicity locus, have been already described. Despite the modified 
PaLoc, these strains can st i l l  be associated with clinical diseases, but few 
epidemiological data have been reported. The difficulty in the identification 
of variant C. d e i l e  strains is due to the inabiljty to recognise these strains by 
the commonly used clinical tests. Infact,with the exception of few strains, 
both toxin A and B produced by variant strains react with commercial hts for 
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toxin detection. Therefore, PCR-based methods seem the most appropriate 
approach to identify C. d&le strains with a variant PaLoc. 
Methods: In this study we analyzed 49 toxinogenic C. dificile strains to 
identify variant strains for the pathogenicity locus and to investigate this 
genetic unit. C. dfici le  strains were examined by three PCR-based methods: a 
PCR multiplex assay detecting the three accessory genes tcdD, tcdE and tcdC 
together with cduZ and cdd3 that are located upstream and downstream the 
PaLoc; a RFLP-PCR differentiating C. d@le strains according to changes in 
their toxin genes when compared to the reference strain VP 110463; a specific 
PCR assay for the detection of the genes encodmg the enzymatic (cdtA) and 
the binding (cdtB) components of the binary toxin, an actin-specific ADP- 
rybosyltransferase recently found in the majority of variant strains. 
Results and conclusion: We identified nine (18%) C. d@de strains with a 
variant PaLoc and seven of these strains, variant for the toxin A and B genes, 
could be classified in already known toxinotypes: four belonged to toxinotype 
Vand three to toxinotype VI. One of the other two strains was variant only for 
the tcdC gene and the other for the tcdC gene plus some minor modifications 
in the toxin A and B detected by the RFLP-PCR. This last strain may 
represent a new toxinotype. All the strains with variations in toxin A and B 
genes produced also the binary toxin suggesting a vicarious role for the latter. 
-1 Multicenter typing analyzes of Uostridium 
difficle isolates from geographically diveme hospitals in 
Japan 
H Kato and N Kato 
Tokyo, Cfu ,JP  
Objectives: Clostrrdtum d@tlels well known as the prmciple pathogen causlng 
nosocomal marrhea Recent reports have documented par~cubr types of 
C. d@le are associated with active diseases. We investigated isolates from 
C. dficile-associated dlarrhea (CDAD) in geographically diverse hospitals in 
Methods: A total of 183 C.d@ile from six hospitals epidemiologically 
unrelated were examined. Toxigenicity of isolates was screened by PCR 
detecting the toxin A and B genes and determined by enzyme-linked 
immunosorbent assay for toxin A production and cell culture assay for toxin 
B production. Two typing systems, PCR amplification of rRNA intergenic 
spacer regions (PCR ribotypmg) and pulsed-field gel electrophoresis (PFGE), 
were used to type C. d@le isolates. 
Results A single PCR ribotype, type s m z ,  accounted for 47% of the total 
isolates and was predominant at all six hospitals examined in the range of 31 to 
65%. AU isolates typed as PCR ribotype s m z  were not typeable by PFGE 
because of DNA depdation. Although 14 isolates which were idendfied as 
PCR ribotype gr correspondng to the type endemic in US and UK, were 
recovered fiom five ofthe six hospitak, this type did not predominate at any of 
the hospitals examined in Japan. Of the 183 isolates tested, 30 isolates 
were identified as toxin A-negative, toxin B-positive (A-BS). A-B+ 
isolates were recovered at all six hospitals, and accounted for 3, 4, 8, 11, 18, 
and 39?/0, respectively. At the hospital with the highest prevalence of A - B+ 
isolates, the 19A-B+ isolates represented two types by PCR ribotyping, 
types fr and trf. All 12 isolates which were typed as trfwere classified into the 
same major PFGE type (defined by three or fewer than three fiagment 
differences), but the remaining seven fr isolates displayed different seven PFGE 
patterns. 
Conclusions: These typing results indicate the endemic strain (PCR ribotype 
smz)  may have specific p o t e n d  for nosocomial infection in Japan. 
A - B+ C. di&ile was recovered h m  the all six hospitals, indicating isolation 
of A - B+ h m  CDAD patients is not rare. In addition, typing analysis by 
PFGE suggests that there was a nosocomial spread of a clone of A - B+ at a 
hospital. 
Japan. 
Bacterernia and endocarditis 
I PI531 1 Blood cultures at a teaching hospital 
from 1997 till 2001 
V. Tomic, R. Erzen and E. Music 
Golnik, SLO 
Objectives: The aim of the study was to review and compare the results of 
blood cultures performed manually from 1997 until mid 1998 and auto- 
matically with Bactec 9120 (BD, Cockeysde. MD, USA) from mid 1998 
onwards, and to determine any advantages of continuous blood culture 
monitoring in a laboratory manned only 8 h/day. 
Methods: In 1997, all blood culture bottles were routinely subcultered after 
24 h and 5 days on enriched blood agar, chocolate agar and Bnrcella agar plates 
and incubated at 37 "C in ambient air, with added 5% C 0 2  and anaerobically, 
respectively. Blood culture bottles that were flaged positive by Bactec 9120 
were subcultured using the same protocol as above. Also Gram stain was 
pedornied. 
Results: In 1997, we determined 54 positive from 1126 blood cultures drawn. 
&om 1998 till the end of October 2001 there were 118 117 105 and 100 blood 
cultures positive from 1318, 1385, 1315 and 1266 drawn, respectively. The 
positive rate has been constant (7-9%). The most common isolates have been 
Sfrqfococnts pneumoniae (n = 112) and Escherichia coli (n = 139) followed by 
coagulase-negative staphylococci (CoNS) (n = 69) S. QUZUS (n =SO), enter- 
obacteria (n =44). Ninty-eight percent of first positive blood culture 
bottles were detected by 17h after insertion into Bactec 9120. Most 
(78%) of the presumed contaminants were detected after more than 17h 
of incubation. 
Conclusions: With automated, continuous blood culture monitoring system, 
we determined more positive blood cultures than manually and time interval 
to detection has shortened. Number of presumed contaminating bacteria 
(CoNS, Corynebacterium sp., Propionibacterium acne4 increased in first year of 
employing automated system, but have come down again after auditing the 
blood drawing procedures. 
/p15321 Moraxdla lacunata bacteremia in elderly patient 
with chronic obstructive pulmonary disease 
C. Papaetitathiou, S. A. Michaelidis, M. Zoumberi, A. Damianos and 
G. Kouppari 
Athens, GR 
Objectives: The presentation of an unusual case of M. lacunato bacteremia in 
an elderly patient with aspiration pneumonia and chronic obstructive pul- 
monary disease. 
Methods: Blood CUIN~~S were carried out by BACTEC system (Becton 
Dickinson). The identification of microorganism was performed by standard 
methods and API ID 32GN system. Susceptibility testing was performed by 
disc diffusion method. A 85-year-old woman was admitted to hospital due to 
an acute onset febrile episode (39°C) with chills, general weakness and 
lethargy. Her past medical history included chronic atrial fbnllation, chronic 
obstructive pulmonary disease, vascular encephalopathy and recent myocar- 
dial infarction. On physical examination there was a supraventricular arrhyth- 
mia, low intensity bilateral wheezes over both lungs and mid-inspiratory 
crackles over the right lung base. Auscultation of the lungs also revealed a 
uniform diminution of normal breath sounds. No other abnormal physical 
signs were revealed except for several superficial decubitus ulcers over the skin 
of her lower back. Based on clinical and radiological findings a presumptive 
diagnosis of aspiration pneumonia was made. Laboratory tests showed mild 
leukoqtosis (WBCs 11800/pL with 78% neutrophils) and hyponacremia 
(Na = 127 mEq/L). M. lacunafa was repeatedly isolated h m  blood cultures 
obtained pn day of admission. The strain was sensitive to penicillin, cefalos- 
porins, aminoglycosides, tetracycline, ciprofloxacin and trimethoprim/sulfa- 
methoxazol. The pulmonary infection was treated with intravenous 
adrmnistration of cefoxitin (1 mg x 3). netilmicin (150 mg x l), metronida- 
zole (500mg x 3) for 11 days and ciprofloxacin (200mg x 2) for the next 
9days. The patient had a gradual recovery and was discharged in a good 
general condition without fever afier 19 days of hospitalization. 
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Conclusion: M.facumta which is an unusual cause of infections may be 
considered as one of the rare pathogens causing bacteremia in elderly and 
debilitated patients with other underlying diseases such as chronic obstructive 
pulmonary disease. 
lp15331 Brevundimonas vesicularis bacteremia in an 
elderly patient with underlying diseases 
C. Papaefstathiou, M. Zoumberi, C. Christopoulos, A. Diakakis, 
I? Economopoulos and G. Kouppari 
Athens, GR 
Objectives: The presentation of an unusual case of Brwundimonas vesicularis 
bacteremia in an elderly patient with underlying diseases. 
Methods: Blood cultures were carried out by BACTEC system. The 
identification of microorganism was performed by standard methods and 
API ID 32GN system. Susceptibility testing was performed by disc diibion 
method. A 93-year-old woman was admitted to hospital with a 5-day history 
of productive cough and a 2-day history of pyrexia and general malaise. Her 
past medical history included mild chronic renal failure, cerebrovascular 
disease and cardiac failure. On physical examination she was pyrexial 
(38 C) and tachycardic and had signs of an upper respiratory tract infection. 
The radiological image raised a great suspicion of infection in the area of the 
lower left lung. Laboratory tests at admission showed WBCs 5300/pL with 
87% neutrophils, Ht 33%. platelets 65.000/pL, creatinin 1.7/dL, Na 
145mEq/L, K 5.2mEq/L, SGOT 238U/L, SGPT 123U/L, LDH 
642 U/L, biluubin 2.4 mg/dL, CPK 408 U/L (CPK-MB 34 U/L). Cefur- 
oxime (750 mg x 3, i.v.) was administered to the patient. On day 3 the clinical 
picture was aggravated and netilrmcin 300mg x 1 i.v. was added. Based on 
newer clinical and radiological findings a diagnosis of pneumonia was made. 
The hematological and biochemical picture were considered compatible with 
septicemia. Breuundimonnr vesinrlaris was isolated from blood cultures obtained 
on day of admission. The strain was sensitive to amoxi&n/clavulanic, 
cefalosporines, aminoglycosides, aztreonam, tetracycline and trimetho- 
prim/sulfamethoxazol. The patient on day 6 died because of septic shock. 
Conclusions: B. vesicularis is an unusual pathogen, which rarely involved in 
human mfection. This is the first case report ofB. vesicularis fatal septicemia in 
Greece. B. vesicularis may be caused rarely fatal septicemia in elderly patients 
with other underlying diseases. 
I P1534 I Bacteremia in nonagenarians 
E. Espejo, E. Anoro, R. M. Borrallo, M. A. Morera, E. Garcia Restoy 
and E Bella 
Tenam, E 
Objectives: To evaluate the characteristics of bacteremia in nonagenarian 
patients. 
Methods: Prospective study of all episodes ofsigdicant bacteremia in patients 
over 90-year-old adnutted to a 320-bed general hospital f b m  1983 to 2000. 
The mortality in this group of patients was compared with the mortality in 
other age groups in the same period. The functional status was assessed using 
the Barthel index in 70 patients. 
Results: We studied 87 consecutive episodes ofbacteremia in 93 nonagenarian 
patients (31% males, 69% females). A rapidly or ultimately fatal underlying 
disease was present in only nine cases (10%) and five patients had a solid or 
hematologic malignancy. A sigtllficant cognitive deficit (Reisberg scale >4) 
was present in 36 cases (41%). The Barthel index was <60 in 48%. The 
bacteremia was hospital-acquiredin 27%, nursing home-acquired in 13%, and 
community acquired in 60% of cases. The main sources of bacteremia were: 
the urinary tract (41%), the respiratory tract (22%), the billary tract (14%) and 
the skin-soft tissue (9%). The portal ofentry was unknown in 7% of cases. The 
main causative agents were: E. coli (45%), S.pneurnoniae (13%), S. aums (lO??), 
E.fmcalis ((7%). I? mirabilis (7%), I? amginosa (6%), and Kpneumoniae (5%). 
Thirty percent of patients presented with altered mental status, 20% with 
shock and in 22% of cases the a&ry temperature was <37.5 "C. The crude 
mortality was 18% and the mortabty related to bacteremia was 14%. In a 
multivariate analysis, the presence of acutely altered mental status, shock, and 
S. QUWUS were the variables independently associated with a higher mortality. 
When the crude and bacteremia-related mortality in this age group was 
compared with the mortality in other age groups the figures were as follows: 
<65year: 11 and 8%; 65-8Oyear: 21 and 15% 81-9Oyear 24 and 19%, 
>90year: 18 and 14%. 
Conclusions: (1) The ~lliun sources of bacteremia in nonagenarians were the 
urinary tract, the respiratory tract and the bhary tract. (2) Severe underlymg 
diseases were relatively infrequent in these patients. (3) The presence of 
acutely altered mental status, shock, and S. aurarr were risk factors indepen- 
dently associated unth a kgher mortality. (4) The mortality in nonagenarian 
paaents is not hgher than the mord ty  m pahents aged 65-90. 
I P1535 I Erysipelothrix rhusiopathiae bacteremia and 
cellulitis in an adult 
G. Kouppari, M. Zoumberi, A. Papakyriakou, K. Papaefstathiou, 
I. Korakianitis and P. Economopoulos 
Athens, GR 
Objective: A case of Erysipelolhrix rhusiopathiae bacteremia and cellutitis in an 
adult is presented. 
Methods: Blood cultures were performed by Bactec system (Becton Dick- 
inson), the identification of Erysipelothrix by API Coryne (bioMerieux), 
biochemical reactions and Gram stain. The susceptibility testing was carried 
out by disk diffusion method. A male patient aged 18 years was admitted to the 
hospital because of allergy after an insect bite and fever 38 "C. The bite was on 
the smal l  finger of the left hand which had a localized ceUulitis developing 
around the bite. The lesion w a s  violaceous and painfid, indurated with edema 
and clearly delineated at the border. On day of admission WBC count was 
28200/pL with 92.6% neutrophils and from blood cultures Erysipelothrix 
tusioparhiae was isolated. The strain was resistant to aminoglycosides, vanco- 
mycin, rifampicin, trimethoprime/sulEunethoxazole and susceptible to peni- 
cillin, amoxicillin/clavulanic acid, cephalosporins, clindamycin, tetracycline, 
imipenem, chloramphenicol. erythromycin and fluorocinolones. Augmentin 
i.v. and antiallergic treatment were administered and the patient became 
afebnle. He was discharged from the hospital in good condition after 3 days of 
admission. 
Conclusion: The disease was contracted through an insect bite on  the patient's 
hand. 
lp15361 Group B streptococcal bacteremia in 
nonpregnant adult 
J. de la Fuente, C. Lopez Jato, A. Nodar, M. Alvarez, P. Lamas, 
B. Sopeiia, C. Martinez and D. Cid 
Vp, E 
Objective: To determine the clinical characteristics, antibiotic susceptibility 
and evolution of group B streptococcal bacteremia (GBSB) in nonpregnant 
adults. 
Patients and method We retrospectively reviewed the clinical charts of 
patients with group B streptococcus isolated in blood cultures in a period of 
105 months (January 1993-September 2001). Study protocol included demo- 
graphic data, underlying comorbid conditions, associated infectious foci, in 
vitro susceptibility antibiotic tests, and outcome. 
Results: Seventy-one GBSB were documented 39 (55%) in early and late 
neonatal period, 11 (15.5%) pregnancy-related and 21 (29.5%) in nonpreg- 
nant adults. In the later group, the mean of age was 58yean (18-93). and 12 
(57%) accounting in women. GBSB were community-acquired in 17 (81%) 
and monomicrobial in 20 (95%) cases. Underlying conditions were present in 
16 (76%) patients: diabetes (38%), malignancy (30%), liver cirrhosis (15%). 
surgery (15%), urologic dlsease (5%) and HIV (5%). An associated foci of 
infection was present in 17 cases: skin and soft tissue infections (24%), 
osteomyelitis (19%), genitourinary (9.5%), pneumonia (9.5%), prosthetic 
(9.5%), endocarditis (5%) and arthritis (5%). Group B streptococci were 
uniformly susceptible in vitro to penicillin (4.2% peniciIlin tolerance), 
ampicillm, amoxicillin, cefalotin, vancomycin, clindamycin and c e f o h e .  
Resistance to erythromycin and gentamicin occurred in 16 and 33% of 
isolates, respectively. Directly related GBSB fatality occurred in one patient 
(5%) and GBSB was a contributor condition in two additional subjects (9.5%). 
Conclusion: Group B streptococcal bacteremia in nonpregnant adults is 
ffequently associated to underlying conditions and concomitant infectious 
foci, mostly cutaneous and osteoanicular. Penicillin continues to be the 
treatment of choice. 
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I P I  537 1 Bacteremia due to /?-hemolytic streptococcus 
group G: increasing incidence and clinical characteristics of 
patients 
A. Yinnon, N. Sylvetsky, D. Raveh, Y. Schlesinger and B. Rudensky 
Jerusalem, IL 
Objectives: To describe the epidemiology and features of patienu diagnosed 
with bacteremia due to group G Streptococlus (GGS) during one decade (1990- 
1999). 
Methods: Retrospective review of patients with bacteremia due to GGS and 
group A Streptococrus (GAS) during 10 years, with calculation of annual rates of 
bacteremias due to these organisms, expressed as percentage of all positive 
patient-specific blood cultures (excluding obvious contaminants) and as 
ratios/lOOO adrmssions. Records of patients with GGS and GAS were 
retrieved and clinical data compared. 
Results: During the decade 1990-1999, 741 f 228 blood cultures were 
annually positive, for a total of 7415 organism. Of these, 327 (4.4%) were 
8-hemolytic streptococci, includmg 109 (33%) group A, 99 (30%) group B, 
49 (15%) group G, and 70 (22%) other types. The annual rates per 1000 
admissions showed a relatively stable incidence of GAS bacteremia, and a 
sigmficant, recent increase ofthat of GGS. The respective annual incidences of 
GGS and GAS bacteremias have converged to 3r0.35 cases/1000 admissionsin 
1999; each currently constitutes f1.2% of all positive blood cultures. Of49 
patients with GGS, 40 records were retrievable and compared with those of a 
random sample of 46 patients with GAS. Of patients with GGS, 62.5% were 
>75 year, compared to 30% of patients with GAS (P < 0.01); 80% of patients 
with GGS were male, compared to 39% of patients with GAS (P< 0.001). 
Alcoholism and mahgnancy were not risk factors for GGS; however, 40% of 
patients with GGS had peripheral vascular disease, compared to 4% only in the 
GAS group (P< 0.001). The source of GGS bacteremia was askin infection in 
77.5% of cases, compared to 46% in patients with GAS (P< 0.001). The 
mortality of the cohorts was 15% and 19.5%, respectively (NS). 
Conclusions: GGS bacteremia has occurred with increasing kequency in the 
last decade in our hospital, currently surpassing GAS. If confirmed by others, 
this could indicate a change in epidemiology of serious infections due to 
B-hemolytic streptococci. Elderly patients, admitted because of community- 
acquired skin infections and diagnosed with GGS bacteremia should be 
treated with penicillin without need for additional imaging unless clinical 
features suggest malignancy or localized infection. 
/p15381 Acute nonrheumatic perimyocarditis associated 
with group A streptococcal tonsillitis 
C. Garzoni, R. Monotti and G. Mombelli 
Locarno, CH 
Introduction: Acute rheumatic hearth disease is a well-known immune 
mediated complication of a tonsillar infection with group A B-hemolyhc 
Streptococci (GAS) and usually occurs some weeks after the infection in the 
context of rheumatic fever. Less recognized is the presentation of acute 
perimyocarditis, whch occurs 2-7 days after the onset of infection. 
Case report: A 45-year-old man presented to the emergency room because of 
intermitting left-sided chest pain radiating to the left shoulder. Three days 
before admission because of fever, sore h a t  and a positive rapid strepto- 
coccus test (Strept-A-test) the diagnosis of streptococcal tonsillitis was made 
and oral cefpodoxim was started. On admission he was afebrile. Exudative 
tonsilhtis was present. Examination ofthe heart was normal. ECG showed ST 
elevation in I, 11, aVL, V3-V6 without Q waves. Myocardial necrosis was 
documented by the presence of elevated enzymes (CK 424 U/L, CK-MB 
97 U/L). Inflammatory markers were also elevated (CKP 234 mg/L). He was 
treated for a (sub)acute non-Q myocardial infarction and a coronary angio- 
gram was performed 3 days later, which showed normal coronary vessels. We 
revised the diagnosis of acute nonrheumatic streptococcal perimyocarditis. 
GAS infection was also documented by an increase of Anti-streptolysin-0- 
titer 4 weeks later. 
Discussion: Some weeks after a GAS pharyngitis, immunological mechanisms 
cause the clinical picture ofrheumatic fever. Multiple organs are damaged and 
the entire heart is involved giving rise to a pancarditis. There is a small number 
of reports of a less known acute nonrheumatic perimyocarditis that occurs 
2-7days after the acute tonsillitis. As in viral perimyocarditis the clinical 
presentation is nonspecific and can range h m  asymptomatic ECG changes to 
acute coronary syndrome mimicking myocardial infarction like in our patient. 
The pathogenesis is not clear but it is supposed to be tom-mediated, some 
bacterial exotoxins and cellular components of GAS have toxic properties. 
Mononuclear infitrates pmdominate histologically like in mral infection. It 
has typically a benign course and pmgnosls and most of reported patients 
recover completely. 
Conclusion: Pericarditis can give the picture of an acute coronary syndrome 
with STelevation andin face ofa concomitant GAS pharyngms, which can be 
easily demonstrated, it’s important to consider the presence of an acute 
nonrheumatic streptococcal perimyocardihs. 
1 PI539 1 Infective endataditis: report of cases due to 
unusual community-acquired pathogens 
J. Benes, M. Kabelkova and 0. Dzupova 
Prague, CZ 
Of the group of 117 patients suffering h m  community-acquired i n f ~ t ~ v e  
endocarditis (IE) who were hospiralizedin our department during years 1990- 
2000, several cases were caused by unusual pathogens: 
1 A 59-year-old woman developed mitral LE due to Strq?rococcus pyqmer A 
after taking care of a child with scarlet fever. The disease was complicated 
mth  early embohm to the left retmal artery leading to the loss of the eye. 
2 A 69-year-old woman mth  a mitral biopmsthesis developed endocarditis 
due to Listeria monocytogenes. Because of penicillin allergy and renal failure, 
she could not be given standard therapy. She was cured with teicopla- 
nin + rifampicm + conimoxasol. No immunosuppressiVe condition was 
found in this patient. 
3 Gemella morbillorum endocarditis was diagnosed m a 31-year-old man with 
Fallot’s congenital cardiac defect. The patient had undergone S.mitis 
endocarditis 4 months ago. 
4 A 37-year-old man having suffered from fever and urticarial exanthema was 
diagnosed as IE due to Neisreria meningitidis B predisposing condition was 
bicuspid aomc valve. 
5 A 84-year-old man developed N&s& meningitidis B endocarditis localized 
on the sclerotic aortic valve. The disease was complicated with shock and 
multiple organ system failare (MOSF) and he died 15 h after admission. 
6 A 24-year-old man with a bicuspid aortic valve who arrived from Belarus 
developed pseudomembranous tonsillitis caused by Cmyncbactm’um 
diphtheriae. The disease was complicated with IE involving all cardiac valves 
and MOSE Despite mtensive therapy he died 6 weeks after the onset of the 
disease. 
7 A 48-year-old man with a bicuspid aortic valve developed endocarditis due 
to Haemophilus injuenzae b. The disease was complicated mth  early onset 
MOSF and subvalvular abscess formation. The patient died despite mten- 
sive therapy including cardiac surgery. 
v1 Infective endocadis cases in a general hospital, 
Milan, in the years 1999-2000 
M. C. Moioli, C. A. Orcese, G. R. Ciliberto, G. Tare&, G. Ortisi 
and M. R. Villa 
Milan, I 
Objective: Analysis of Infective Endocardids (IE) incidence in our Hospital by 
means of collectable data. 
Methodx We studied the record-card of 56 patients (14 in 1999,42 in 2000) 
for which IE was diagnosed in accordance to the Durack‘s criteria modified 
per the latest Duke University indications. Beyond age and sex, we collected 
information of each patient, about predisposing heart condition, etiolom, 
echocardiographics evaluation, localization, particular clinical scene and 
mortality. 
Results. We observed a trend towards a higher age (60.7% over age 50year) 
and prevalence ofmale (34 patients). Thuty-two percent o f E  occurs without 
known cardiopathy, 20% in patients with prosthetic valve, 12% in patienw 
with various types of cardiopathy; in 36% of the patients a previous valvular 
heart disease on the native valve (mainly m i d  - 12 patients) was identifed. 
The etiology was identified only in 36 patients; of the remaining ones, 13 had 
negative blood culture because of previous antibiotics therapy. In 17 patients, 
IE was caused by Streptocoma spp. (four oral, eight intestinal, five others), in 15 
by Stuphilococcus spp. (five amus, seven coagulase-negative, three o the~~) ,  in 
four by other microorganisms. Transthoracic echocardiography was per- 
formed in 51 patients, with positive result in 44 (86%); transesophageal 
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echocardiography was performed in 31, with positive result in 30 (97%). In 
80%, IE occurred on a native valve; in 51 patients the localization was on a 
slngle valve (25 m i d ,  19 aortal, six tricuspid, one pulmonar), in 5 on two 
valves. In 47% of single valve LE and in 60% of two-valve cases, patients 
underwent surgery within 30 days from the diagnosis. Although the belief that 
a higher risk of embolus derives from hgh volume or mobile or increasing 
volume vegetation, particularly if m i d ,  of the 15 patients with mobile 
vegetation of more than 10 mm in diameter, six underwent embolus and five 
of these had a m i d  valve-originated embolus. Several were the ‘special cases’: 
24 aged people, two children, three drug addicts, nine nosocomial IE and 10 
“slight” patients. Mortality was 14%. 
Conclusions: tE incidence did not decrease in the last years, its mortality rate 
approaches 15% and all this despite the significant progresses in the diagnostic 
and therapeutic fields. This failure should foster a closer cooperation among 
infectious diseases clinician, microbiologist, cardiosurgeon, echography clin- 
ician and pathologist, in order to optimize the diagnostic strategy. 
I P1541 1 Pulmonic valve endocarditis: case report and 
review of the literature 
M. Tariq, R. A. Smego, N. Islam and A. Soofi 
Karachi, P A K  
Objectives: To present a case of pulmonic valve infective endocarditis 
involving a structurally normal heart, and review the epidemiologic, clinical, 
and laboratory features of this rare condition. 
Methods. Case report and review ofthe English language literature from 1960 
to 2000. 
Results: We identified only 38 cases of isolated pulmonic valve endocarditis 
occurring on structurally normal hearts. Patients with pulmonic valve 
infection tended to be young and male, and the vast majority of infections 
were community-acquired. Predisposing factors included iv drug abuse 
(28%), alcoholism (13%), sepsis (7%). central line (7%) or other catheter- 
related (5%) infection, and dental extraction, bowel surgery, liver or renal 
transplantation, and colonic angiodysplasia (2.6% each). No predisposing 
factor was identified in 28% of cases. Fever, shortness of breath, and pleuritic 
chest pain predominated and radiographic and laboratory evidence kequently 
demonstrated multiple pulmonary emboli. Pulmonic regurgitant murmurs 
were present in about one-half of subjects. Causative organisms included 
Staphylococcus aureur (44%), Streptocorn species (13%), S. bovb (5%), Pseudo- 
monas aenrginosu (5%), E. mli (5%). Candidu albicum (So/,)), gonococcus @%), 
and Baaeroides jagitis, H. injuenzae, and Enterococnrs faecalis (2.6% each). 
Transthoracic echocardigraphy detected pulmonic valve vegetation in 29 
CNS infections 
of38 (76%) cases. Twenty-five patients were treatedmedically with antibiotics 
alone (seven died) and 13 required surgical intervention (zero deaths) 
Discussion: Pulmonic valve endocarditis is an extremely rare infection that 
shares epidemiologic, clinical, radiologic, microbiologic, and prognostic 
features with tricuspid valve endocarditis. 
(P=0.07; 95% CI, 0.1-18). 
-1 Changing patterns of infective endocarditis (IE) 
in a tertiary care teaching hospital 
M. BoM~~o,  A. Cioppi and C. Gigli 
Fisa, I 
Aim of the study: To evaluate some current epidemiologic, microbiologic 
and diagnostic aspects of IE in a tertiary care teaching hospital in comparison 
with the data obtained from a similar study performed in the same institution 
during the 1982-1988 period. 
Methods: AU cases of LE occurred at Pisa General Hospital in the 19962000 
period were retrospectively investigated. Patient medical charts and micro- 
biologic records were evaluated. 
Results: Sixty-nine patients with IE were recognized accounting for 0.26% of 
all patients admitted to the Pisa hospital. In according with the Duke criteria 
58 cases of IE were definite and 11 possible; 67% of the patients were males; 
mean age was 60.9+ 17year (range 19-86). The site of E was as follows: 
pacemaker in 26% of patients; native valve in 62.3% prosthetic valve in 
10.2%; native and prosthetic valve 1.5%. An history of i.v. drug abuse was 
present in six patients; 28 patients (40.6%) had no previously known heart 
disease. Blood cultures were negative in 10 patients (14.2%) or not available in 
seven patients. The remaining causative microorgasisms were distributed as 
follows: staphylococci 42% (S. aureus 11, CNS 18) streptococci 24.5% (S. boob 
6), enterococci 4.5%; other pathogens 4.5% (including two Gram-negative 
rods). Embolic complications occurred in 19 patients (27.5%). A positive 
echocardiographic criterion of IE was present in 60 out off 69 patients. 
Transoesophageal approach was more sensitive than transthoracic in detecting 
the site of IE, especially in patients with pacemaker IE. Valve surgery or 
removal of infected pacemaker was performed in 36 patients (47.8%). In 
hospital, mortality was 17%. 
Conclusion: As compared to the previous study performed in the same 
institution, several new trends were recognized (1) increased mean age of 
patients with IE; (2) increased frequency of pacemaker IE; (3) 
increased frequency of IE caused by staphylococci and S. bovis; (4) increased 
number of patients with IE undergoing valve surgery or removal of infected 
pacemaker. 
Antibiotic-resistant Haemophilus influenzae 
meningitis: patient characteristics and clinical outcome 
during a &year period that included the introduction of 
H. influenzae type B conjugate vaccine 
B. Olowokure, I. Blair, J. I. Hawker and N. J. Spencer 
Birmingham, UK 
Objective: To determine the characteristics of children less than 5 yean of age 
admitted to hospitals in the West Midlands region of the UK with Huemo- 
philusinjhenzae (HI) meningitis resistant to antibiotics, and to examine 
whether meningitis due to antibiotic-resistant HI resulted in different clinical 
outcomes compared to nonantibiotic-resistant HI. 
Methods: Cases were identified over a 4-year period using a passive labora- 
tory-based survedance system supported by several other overlapping sur- 
veillance systems. During the final 2 years ofsurveillance, HI type B conjugate 
vaccine was introduced into the UK immunization schedule. Case notes were 
reviewed to obtain sociodemographic, clinical and microbiologic data. Cases 
were included if HI had been isolated f k m  a sterile site. 
Results: During the study period, 165 cases of HI meningitis were identified 
and 147 clinical isolates were andyzed. Thirty of the 147 (20%) isolates were 
found to be ampicillin or amoxycillin resistant, 24/30 (80%) antibiotic- 
resistant isolates were identified by the passive surveillance system alone. 
Resistance to either ampicillin or amoxycillin or both was associated with 
nontypable HI organisms (P= 0.044), being the youngest sibling (P=0.042), 
being aged less than 18months (P=0.004) and having postmeningitis 
sensorineural hearing loss (P= 0.033). Significantly more (P= 0.036) chil- 
dren &om socially deprived areas with antibiotic-resistant organisms had 
sensorineural hearing loss, despite children b m  more affluent areas having 
a greater proportion of antibiotic-resistant organisms. Duration of hospital 
stay, previous hospital admission and mortality were not associated with 
antibiotic resistance. There was a nonsignificant increase in the proportion 
ofisolates that were antibiotic resistant &om 19% (22/117) in the first 2years 
of the study to 23% (7130) in the last 2 years, the period that conjugate vaccine 
was introduced. 
Conclusions: HI meningitis infections resistant to antibiotics are associated 
with higher morbidity than infections with antibiotic-susceptible strains. 
Children from deprived areas and young infants with siblings are at greatest 
risk. These results may have implications for antibiotic therapy in these key 
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patient groups, particularly with regard to empirical antibiotic therapy and the 
public health management of this disease. 
w1 Epidemiologic features of pneumococcal 
meningitis 
C. Aspichueta, M. J. Unzaga, B. Amezua, A. Martinez, C. Ezpeleta and 
R. Cisterna 
Bilbao, E 
Objectives: To identify the epidemiologic characteristics of pneumococcal 
meningitis in our hospital that is a 800-bed, primary and tertiary care teaching 
hospital that provides care to urban area of Bilbao. 
Methods: A retrospective study of pneumococcal meningitis cases was 
conducted during a 6-year period, &om 1995 to 2000. 
Results: The microorganism was isolated from 23 CSF with the following 
distribution along years: 1995 (three), 1996 (four), 1997 (six), 1998 (four), 
1999 (two), 2000 (four). The highest age-specific incidence ofpneumococcal 
meningitis was observed in children <5years of age and in elderly of 
>55years of age. There were no HIV subjects. There were eight cases in 
children, four males and four females (6 months-7 years). S. pneumoniae was 
recovered from blood cultures in six (75%) patients, and three showed otitis 
media. The treatment was started with a third-generation cephalosporin and 
vancomycin (62.50%) and dexamethasone (75%). The elderly group had 15 
subjects (55-91years), seven males and eight females, the organism was 
present in blood cultures in nine (60%) patients, and in otic exudate in three 
(20%), although three more patients presented otitis media. Mortality until 
discharge was 20%. The treatment was started only with a third-generation 
cephalosporin in all of the patients, except in one in whom imipenem and 
vancomycin was aggregated. Dexamethasone treatment was not used as 
primary therapeutic measure. 
In both groups: Gram stain showed Gram-positive diplococci in 11 (47%). 
The peripheral WBC count was increased in 47%, only one showed 
leukopenia and died. CSF glucose, protein and white blood cell count 
were consistent with bacterial meningitis. Global penicillin resistance was 
30% (26% with MIC between 0.1 and 1 pg/mL and 4% with MIC > 1 pg/mL). 
Cefotaxirne M I C L I  pg/mL was found in 2 (15%) of 13 tested 
patients. 
Conclusions: (1) S.pneumoniae meningitis is greatest among the very young 
and the very old. (2) The high fatahty in our patients is in elderly. (3) Hlgher 
penicillin-resistance rate w a s  in pediatrics patients 50% versus 20%. 
/p1545) Bacterial meningitis in Poland from 1997 to 2001 
A. Skoczyuska, A. Klarowicz and W. Hryniewicz 
Warsaw, PI. 
Objectives: The aim ofthe study was to characterize major etiologic agents of 
bacterial meningitis in Poland during 5-year activity of the National Refer- 
ence Centre for bacterial meningitis. 
Methods: Strains isolated from cerebrospinal fluid or/and blood &om patients 
with meningitis or meningococcal septicemia were identified by standard 
methods. Meningococcal serogroups and H. inauenzae serotypes were deter- 
mined by slide agglutination, whereas meningwwcal serotypes and serosub- 
types by whole-cell ELISA method. Serotypes of S.pneumoniae were 
settled by the Quellung reaction. Susceptibihty testing was performed for 
N meningitidis, H. inauenrue and S. pneumoniae according to the NCCLS 
guidelines. 
Results: During 1997-2000, altogether 460 strains were collected. The most 
frequently identified was N. meningitidis (n=  189, 41.1%), followed by 
H. inzuenzae ( n =  113, 24.6%) and Spneumoniue ( n =  104, 22.6%). Other 
species were isolated sporadically. Most of the N. meningitidis and H. influenzue 
strains were isolated from children below 5yean of life, with the highest 
incidence under the age of two. S. pneutnoniae was responsible for cases in all 
the age groups. Out of rneningococcal strains, almost 85% belonged to 
serogroup B, 11.6% to serogroup C and 3.7% to W135. The most kequent 
serotype was 22. Most meningococci were highly sensitive to penicillin, only 
5.8% of them showed decreased susceptibility to this antibiotic. More than 
93% of H.inzwenzae isolates belonged to serotype b (Hib). The seven 
remaining isolates were noncapsulated. A total of 11.5% strains were resistant 
to ampicillin via production of b-lactamases. Broad distribution of serotypes 
was found among pneumococcal strains of which the most common were 
serotypes 3, 8 and 19E Pemcb-nonsuscephble strams consatuted 10 6% of 
all pneumococcal isolates. Results &om 2001 \rill be added at the end of thls 
Year 
Conclusions: The most common eaologtc agent of laboratory-confirmed 
bacterial m e q h s w a s  N. menmnptidrs, mostly serogroup B, bemg responsible 
for more than 40% of cases. Hzgh percentage of menmghs in Poland caused 
by H inauenzae s t m s .  mostly serotype b, results h m  the lack of mass 
vaccinahon a p s t  Htb. 
(p1546/ investigation of preadmission antibiotic 
treatment in patients with meningococcal disease 
L. Roznovsky, V. Smtncova, V. Dostal, S. Plisek, E. Gal, I. Burget, 
l? Chalupa, P. K r h ,  P. Dlouhy and J. Svejda 
Ostrava, Plzen, Hradec Kralove, Bmo, Prague, Usti nad Labem, CZ 
Objectives: Early recognition, immediate antibiotic treatment and aggres- 
sive treatment ofseptic shock can reduce mortality ofmeningococcal disease. 
Methods: Investigation of preadmission antibiotic treatment was performed 
in 146 patients (65 females, 81 males) with hvasive meningococcd disease, 
who were treated at five university hospitals in the Czech Republic fbm 
January 1996 to November 2001. Meningococcalmeningiris was proved in 30 
patients, septicemia in 42 patients and meningitis/septicemia in 74 patients. 
Twelve patients died, nine of them suffered by septicemia and three of them by 
meningitdsepticemia. The highest morbidity and mortality were in the age 
groups Myears (55 children, six deaths) and 15-19yean (43 patients, five 
deaths). The serogroups C andB were absolutely predominant, new emerging 
C.2a:P1.2, P1.5, ET-15/37 was the most &equent 
strain. Statistical analysis was performed using Fisher’s exact test. 
Resub Preadmission antibiotic treatment was used in 106 patients before 
transfer to special intensive care units, only seven of them (6.6%) died. Forty 
patients were not treated before admission to special intensive care units and 
five of them (12.5%) died. Preadmission treatment was used in 26 of the 42 
patients with septicemia (six treated patients of nine deaths), in 60 of the 74 
patients with meningitidsepticemia (one treated patient of three d a b )  and 
in 20 of the 30 patients with meningitis (zero death in this group). The 
mortality ofpatients with and without preadmission antibiotic treatment were 
1.7 and 14.3% for meningitidsepticemia, identically 23.1% for septicemia 
and 0% for meningitis. The diflerences were statistically insignificant for all 
patients (P=O.202) and also for patients with sepsis/meningitis (P=O.OW). 
The antibiotic cheapy was started usually in local hospitals before patient’s 
transport to special intensive care units. General practitioners and physicians of 
out-patients departments started antibiotic therapy sporadically, only in 14 
patients. 
Conclusions: Appreximately three quarters of patients with meningococcal 
disease in the Czech Republic received preadmission antibiotic treatment. 
The mortality of patients with preadmission antibiotic treatment was almost 
twice lower then in patients without treatment (6.6% vs. 12.5%), but 
statistically sigrufcant Merences were not proved. 
Grant support: Grant Agency Czech Republic No. 310/96/K102. 
(p1547] Bacterial meningitis in children: a 10-year study 
G. Kuli-Lit0 and N. Jani 
Tirana, DUN~S, AL
Objectives: To show the epidemiologic data and trends ofpediatric bacterial 
meningitis during the study period, and to compare the outcome of menin- 
gitis before and after the use of third generation of cephalosporins as routine 
treatment of infection. 
Methods: The study is based on retrospective analysis of medical charts of 403 
children with bacterial meningitis, aged 1 month- 14 years, hospitalized to 
the Pediatric Department of University Hospital Center of Tirana, during the 
period June 1990-June 2000. The diagnosis of bacterial meningitis was 
established on cytochemical characteristics of CSF and positive Gram stain 
and/or CSF blood cultures. The epidemiologic data included in the study 
were: age, sex, origin, sex seasonality, complications and case fatality rate. The 
etiologic data and antibiotic combinations used were taken into consideration. 
Results: During the last 10 years, 403 children with bacterial meningitis were 
admitted to our clinic. The distribution of the cases had approximate values 
except during 1997-1998, when a slight elevation of incidence was notified. 
The increase was related with the social events and the demographic 
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movements towards Tirana, in this period. Fiftyfour percent of the cases had 
urban origin and male patients dominated with a rate of 1.4 times more. The 
most affected age was 0-1 year, which included 46.5% of the cases towards 
26.5 and 27%. which belonged, respectively, to the age groups 1-4 and 5 
14 years. The infection was more frequent at the first and second trimester of 
the year. The positivity ofbacterial cultures resulted at 67%. The bacteriologic 
agents according to the fkequency were: N meningitides: 36%; S. pneumoniae: 
34%; H .  inyuenzae: 20.4%; enterobacter: 2.6%; others: 7%. During the period 
199C-1995, 67% of the cases were treated by the combination of ampicil- 
lin + chloramphenicol. The complications such as hydrocephalus, mental 
retardation, epilepsy, and deahess were noticed in a value of 13.7% and case 
fatality rate was 7.4% for this group. At the second quinquennial, 61% of the 
patients were treated by a cephalosporin (cefotaxime or ceftriaxone), where 
the case fatality rate and complications were found much lower, respectively, 2 
and 7.4% ( P <  0.002). 
Conclusions: Bacterial meningitis still remains a serious infection of pediatric 
age. Cephalosponns of third generation had decreased the m o d t y  and 
improved the course of the disease. 
vl Latex agglutination for bacterial antigens and 
meningococcus PCR two useful tools in legal autopsies 
A. Fernindez-Rodriguez, J. A. Vhquez, M. I? Sulrez-Mer, B. Aguilera, 
L. De la Fuente, G. Vallejo and M. Sancho 
Madrid, E 
Objectives: In legal autopsies, microbiology is sometimes needed as a 
complementary tool for pathologists. However, postmortem bacterial cd -  
tures are often contaminated or difficult to interpret. The aim ofthis study was 
to assess the usefulness of latex agglutination test for bacterial antigens in 
postmortem samples fium legal autopsies in which an infectious disease had to 
be ruled out or established as a cause of death. Moreover, since 2000, specific 
meningococcus PCR was performed when meningococcal septic shock was 
strongly suspected. 
Methods: Bacterial antigen detection of Neisseria meningitidis (serogroups A, 
B, C, Y and W135), Haemophilus inpuenzae type b, Strepfococcuspneumoniae and 
group B Streptococcus was performed with the Directigen Meningitis Combo 
Test (Becton Dickinson Microbiology Systems) in 34 samples (28 sera and six 
CSF) according to instructions of the purchaser. Detection of genetic material 
h m  N. meningitidis by PCR with primers designed to a m p q  the specific 
regions ofthe meningococcus ctrA and mgA genes was performed in three sera. 
Posterior serogrouping was done by amplification of the pup-specific syaD, 
B, C, Yand W135genes. 
Results: Directigen-positive results were obtained in a 20.6% (7/34) of the 
samples. Latex agglutination was positive for N. meningitidis in six sera (five 
serogroup C and one serogroup B) and one serum was positive for H. in&- 
enzae type b. The six CSF analyzed were negative. Two of the N. nzeningifidis 
serogroup C-positive sera were also positive for specific group C PCR. On 
the other hand, one serum in which the latex agglutination could not be 
performed, yielded a positive PCR for meningococcus. These results allowed 
us to confrm the suspicion of meningococcemia in eight cases of sudden 
death. Pathologic findings and clinical history were always consistent with 
positive results. 
Conclusions: In postmortem samples in which a bacterial culture is not 
recommended, antigen-detection tests can be a useful strategy when a 
fulminant infection by N meningitidis or H .  irguenzae is suspected as a cause 
of death. Positive results provided a rapid, presumptive diagnosis that per- 
mitted early prophylaxis of contacts. In our opinion, this technique should 
always be run in conjunction with meningococcus PCR to confirm menin- 
gococcemia. 
Reemergence of meningococcal disease in 
Taiwan: identification of a major clone serogroup W135 
P-R. Hsueh 
Taipei, TW 
Objectives: To determine the epidemiology of meningococcal disease invol- 
ving the 2001 outbreak in Taiwan. 
Methods: Antimicrobial susceptibilities, serogroups and genotypes of isolates 
recovered from the 2001 outbreak were determined. 
Results: The annual incidence rate (per 100 000) of meningococcal disease 
(meningitis and septicemia) in Taiwan was 0.63 in 1964 (78 cases), declined to 
0.01 in 1986 and to 0.001 in 1990, and was zero during the period b o r n  1991 
to 1995. It reemerged with a 0.075 incidence rate in 1996 and a 0.068 rate in 
2000. From January 2001 to June 2001, a remarkable increase in the number 
ofcases ofmeningococcal disease (31 cases, 0.14/100000) was noted. Among 
the 71 patients with a diagnosis of meningococcal disease during the period 
fiom January 1998 to June 2001.12 patients (16.9%) died. During this period, 
the disease occurred most commonly during February-May and predomi- 
nantly in patients aged less than 1-year-old and fium 11-30-year-old. The 
majority of the 71 isolates recovered h m  the 71 patients belonged to 
serogroups B (42.3%) and W135 (32.4%). In 1999, serogroup B isolates 
accounted for 84.6% of all isolates (11 out of 13 isolates), but during the 
period &om January to June 2001 this prevalence decreased remarkably 
(22.6%), while the prevalence of serogroup W135 (35.5%) increased. Agar 
dilution susceptibility of 32 preserved isolates of Neisseria meningitidis (31 &om 
the 31 patients treated &om January to June 2001, and one in 1998) to 15 
antimicrobial agents showed that one isolate (3.2%) had intermediate suscept- 
ibility to penicillin (MIC, OSYmg/L) and was B-lactamase negative. All 
isolates were susceptible to rifampin, fluorquinolones and macrolides, and all 
were resistant to trimethoprim-sulfamethoxazole (MICs, d4/76 Ymg/L). 
Molecular typing of the 32 isolates by arbitranfy primed PCR using three 
random oligonucleotide primers revealed 23 clones with a major clone (clone 
IV, serogroup W135) whch was isolated from six padents b m  four different 
regions of Taiwan. 
Conclusions: The recent reemergence of meningococcal disease in Taiwan 
may be partly due to the wide dissemination of several clones of N. meningi- 
tidis. Trimethoprim-sullamethoxazole should not be considered as the 
drug of choice for management for meningococcal disease or carriage in 
Taiwan. 
ml Diversification in Neisseria meningitidis genome 
correlates with transition from carrier state to invasive 
disease 
A. Skoczynska, E. Sadowy, R. Konior and W. Hryniewicz 
Warsaw, Cracow, PL 
Objective: The aim of the study was to investigate epidemiologic situation 
withm a famdy where two cases of invasive meningococcal disease were 
diagnosed. 
Methods: Meningococcal isolates were sent to the National Reference 
Centre for Bacterial Meningitis (NRCBM), where they were reidentified 
and serotyped by whole-cell ELISA method. MICs of the following anti- 
microbial agents were evaluated by E tests: penicillin, ceftriaxone, cefotaxime, 
rifampin and ciprofloxacin. Molecular typing was performed by randomly 
amplified polymorphic DNA method (RAPD) with three ditlerent primers, 
pulsed-field gel electrophoresis (PFGE) of bacterial chromosomal DNA 
digested with BglII, NotI and SpeI restriction enzymes and multilocus 
sequence typing (MLST). 
Results: In June 2O0lI5.5-year-old boy was admitted to a hospital with severe 
symptom of bacterial meningitis without any skm changes. Next day, his 8- 
year-old brother reached the hospital with symptom of septicemia (high 
fever, septic shock and purpura fulminans). N. meningitidis was isolated &om 
cerebrospinal fluid (CSF) of the first boy. Blood culture ofthe second boy gave 
negative results, but Wellcogen latex test was positive for antigens of 
N meningitidis A, C, Y, W135. The first boy was treated with cefotaxime 
and the second one with ampicillin and amikacin. After recovery, nasophar- 
yngeal swabs were taken from the whole family, including the youngest 4.5- 
year-old brother and parents. Meningococci were isolated from the first boy 
and parents. AU four meningococcd isolates were susceptible to antimicrobial 
agents tested. They belonged to serogroup C, serotype 2h and serosubtype 
P1.2.5. Molecular typing by RAPD and PFGE using NotI and SpeI showed 
identity of the isolates. On the contrary, PFGE performed with BglII 
restrictase Merentiated the isolate from CSF by three bands fiom those 
fiom nasopharynx. MLST identified all four isolates as representatives of 
sequence type 66 (ST 66) according to the Oxford MLST database (http:// 
www.mlst.net). 
Conclusions: By using a set of molecular typing techniques, we were able to 
detect differences between the meningococcal isolate that caused meningitis 
and those involved in carriage in the same patient and  IS family. Such changes 
reflect the rapid diversification of N. mening genome and may be con- 
nected with a shf t  in biologic properties. 
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w1 Development of venous sinus thrombosis and 
Clostridium abscess after Proteus vulgaris meningitis: a case 
report 
R. GoziikiiGiik, A. Colpan, H. Bodur, E. Akinci, H. Esener, 
M. A. Cevik and N. Balaban 
Ankara, TR 
Gram-negative bacilii are rare cause ofbacterial meningitis in adults, but they 
have become particularly important in patients with chronic mastoiditis, otitis 
media, head trauma, neurosurgical operations, and impaired host defenses. A 
19-year-old woman was admitted to the hospital with headache, fever, 
vomiting, aural pain. She had a history of previously chronic otitis media. 
The cerebrospd fluid evaluation demonstrated purulent meningitis caused 
by Proteus vulgaris. She was treated with 6 g/day intravenous ceftazidime and 
1 g/day intravenous amikacin. Initial cranial magnetic resonance imaging 
(MRI) scanning showed meningeal contrast enhancement, mastoiditis and 
otitis media at the right side and sigmoid-transverse sinus thrombosis secon- 
darily to local dissemination of infection. Mastoidectomy was performed 
on the patient in the department of otolaryngology. Five days later, 
control cranial M R I  demonstrated abscess formation along the trombosed 
venous sinuses. The abscess evacuation was performed in the department of 
neurosurgery. Clostridium spp. has been kolated h m  intraoperative culture. 
An amount of2 g/day metronidazole was added to antibiotic treatment and it 
was continued for 6weeks. She recovered with medical and surgical 
therapy. As a conclusion, persistent infection and local complications may 
occur in Gram-negative bacilli meningitis. When severe complications 
develop, surgery should be performed in addition to the medical treatment, 
if necessary. 
1p1552/ Infectious meningitis:  years of experience in a 
general hospital 
J. De La Torre, J. L. Prada, A. Del Arco, F. Galeas and I. Lopez 
Murbella, E 
Objectives: To study the clinical and epidemiologic characteristics of the 
infectious meningitis (IM) in our area. 
Methods: This is a retrospective study which described all the cases of IM 
diagnosed in the Costa del Sol Hospital &om January 1994 to December 1999. 
Our center is a general hospital attendmg to an area of 250 000 habitants in the 
south of Spain. 
Results: Total admissions during this time were 59329; 77 patients were 
diagnosed with IM: 43 males (55.8%) and 34 females (44.2%). The mean age 
was 22f23yean (1-78); 17 patients (22%) were less than 1-year-old; 
between 1- and 14-year-old in 27 cases (35%); and more than 14years in 
33 cases (43%). Patients were admitted in the following units: Pediatric Unit: 
43 cases: Internal Medicine (M): 12 cases; Intensive Care Unit (ICU): four 
cases; Otorhinolaryngology Unit: one case; ICU+M: 16 cases; and 
ICU + Pediatrics: one case. In 10 patients, Haemophiiur inj7uenzae was isolated 
(13%). in seven Streptocorcuspneumoniue (9%), two cases of Lisferia monocyto- 
genes, Criptocows neojormans, Staphylococcus aureus and Streptocwus group C, 
and one case of S. agalactiae, S. epidermidis, Escherichia coli, Mycobaderium tuber- 
culosis and Rickettsia conorii. The causal agent was not determined in 47 cases 
(61%), in those patients CSF has lymphocyte prevalence in 17 (36%). Our 
patients suffer from associated problems in 27 cases (35%): otorhinolaryngo- 
logic diseases (seven cases), HIV infection (four cases) and in smaller number 
of cases hepatopathy, small-for-date baby, diabetes, hematologic diseases, 
neoplasm and previous IM. Sequels were developed in 11 cases (14%): 
epilepsy in three cases, permanent dyshnction of the central nervous system 
in three cases, hydrocephalus in two cases and one case was diagnosed of 
chronic migraine post-IM. About the outcome: four patients died (5.2%). 
three adults and one child. The length of stay was 10 days, 6.61 days in the 
pediatric patients (<14years) and 14.52days in adults. 
Conclusions: In our area, IM is present in more than two-third parts in 
patients smaller than 14years. The causal microorganism is not isolated in 
more than half of the cases neither by culture nor serology. Our cases are 
predominately patients without predispose factors; this rules out preventive 
sanitary actuation over the population, In adults, this infection causes an 
elevanon in the length of stay and a h i o n s  in ICU, and an mportant rate 
suffer Gom serious sequels. 
Meningitis by Geme!lamorbi/lorum with 
associated pituitary apoplexy 
E. Vdlegas, J. de Otero, L. Ferrer, B. Oms and F. Ferrer-Ruscalleda 
Barcelona, E 
GemeZla morbillorum is a c o r n e d  microorganism of the human gastroin- 
testinal, respiratory, and genitourinary tracts. The spectrum of disease is very 
similar to that caused by S. viridans, although the microorganism seem to be 
rarely associated with infections other than infective endocarditis and bacter- 
emia. We report a case of meningitis due to C. morbilfomm followed by 
hypophyseal hematoma with pituitary apoplexy and secondary panhypopi- 
tuitarism. A 56-year-old man was admitted to our hospital with a 5-day 
history of severe headache and vomiting. Two days before admission, he 
developed fever (39-40"C) and mal;use. The initial exploration showed very 
bad status, slight conhion and nucheal rigidity. A canial CT scan was 
normal. Cerebrospinal fluid (CSF) analysis showed pleocytosis, hyperprotei- 
uorraquia and normal level of glucose. The Gram stain was negative. 
Intravenous therapy with cefotaxime was started. A week after admission, 
the patient acutely developed an impairment of headache and clinical status, 
with left hemianopsia. The MRI showed acute hypophyseal hematoma, with 
optic chasm compression and lateralization, compression of cavernous sinus, 
and m;uollary, sphenoid, ethmoid and bnta l  sinus occupation, suggesting the 
diagnosis ofpansinusitis. Laboratory tests confirmed a panhypopituitarism and 
therapy with dexametasone was started. CSF culture revealed growth of 
C. morbillorum and antimicrobial treatment was changed to benzilpenicfin. 
ceftazidime and clindamycin. After 2 days, the general condition and neu- 
rologic status improved greatly. Antibiotics were administered for 15 days and 
the patient was discharged in good condition. No relapse was observed. 
Human infections caused by C. morbillomm are extremely rare. In fact, only 
two previous cases of meningitis by this microorganism are reported in the 
literature. Furthermore, our patient suffered a pituitary apoplexy, a very 
unusual complication ofsepsis and meningoencephalitis. Despite its rarity, our 
case suggests that the pathogenicity of G. morbillonrm should not be under- 
estimated. 
Acute bacterial meningitis in elders: risk factors 
concerning mortality 
D. Leca, E. Miftode, T. Turcu, C. Dorobat and V. Luca 
h i ,  R O  
Objectives: The purpose ofthe study is to point out the risk factors leading to 
death in acute bacterial meningitis in elders. 
Material and methods: A retrospective study was conducted on 73 elderly 
patients (54.8% male and 45.2% female) admitted in our clinic during a 7-year 
period (1994-2000). 
Results. The organisms isolated were Streptocowspneumoniae in 21.9%, 
Neisseria meningitidis in 8.2%, Listeria monocytogenes in 5.5%, Staphylococncs awr- 
eur in 4.1% and unknown etiology in 60.3% of cases. In 20 cases (27.39%), 
bacterial meningitis was nosocomially acquired (posmeurosurgical proce- 
dures). The overall case fatality was 26%. The factors related to mortality were 
male gender (68.42% of death cases), evolution time before admission >48 h 
(death in 43% ofcases), coma (death in 100% ofcases), seizures (death in 62% 
of cases), altered immune states (death in 56% of cases), causative organism 
(mortality rate was 56.25% for pneumococcus, 33.33% for staphylococcus and 
20.45% for unknown etiology), pleyocimsis <lo00 ceIl/mmc (death in 100% 
of cases), high albumin CSF level (death in 84.2% of cases), nosocomial 
acquisition (47.36%). 
Conclusions: Bacterial meningitis has a severe evolution in elderly patients 
with late admission, neurologic impairment, nosocomial acquisition, altered 
immune states, low pleyocitosis, increased albumin values in CSF, pneumo- 
coccal and staphylococcal etiology associated to high mortality. 
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I P1555 I Lirteriamonocytogenes meningitis complicated 
by granuloma formation in cerebellar pedincule 
R. Caylan, K. Aydin, 0. Bayraktar, G. Aktoz, I. Koksal and A. Sari 
Trabzon, TR 
Meningitis caused by Listeria monocytogenes is a rare disorder, especially in an 
immunocompetent adult. A 41-year-old woman was admitted with the 
complaints of high fever, severe headache and nausea and vomiting. She 
was mentally alert hut her body temperature was 38.7 "C and also had a s t 8  
neck. Lumbar puncture revealed increased CSF pressure, purulent appearance 
and leukocytes 1200/mm3 (75% PNL and 25% lymphocytes), protein 
269 mg/dL, glucose 55 mg/dL. Gram stain of CSF was negative. Ceftriavon 
4g/day was initiated empirically however, lack of clinical improvement 
prompted a control LP at the 48th hour of the treatment and revealed the 
following CSF findings; 2200 leukocytes/mm3 (80% lymphocytes and 20% 
PNL), protein 456 mg/dL, glucose 71 mg/dL. CSF culture yielded diphter- 
oids which arouse a suspicion of L. monocytogenes as the probable etiologic 
agent. Motility test, catalase test and animal inoculation tests all confirmed 
L. monocyrogenes. Antibiotherapy was altered to ampicillin + gentamycin. On 
the third week of the treatment, the patient developed diplopia, severe 
headache and ptosis of the left eye, dysartria and somnolance. h4RI scans 
showed minimal signs of hydrocephalus. In addition, in the left cerebellar 
peduncle a contrast-enhanced area with 8mm diameter was diagnosed as 
granuloma formation. At the end of 6weeks of antibiotic treatment, the 
control MRI scam showed disappearance of the granuloma. The patient was 
discharged and in the follow-up period of 6 months after the discharge, the 
patient was normal. 
[ P1556 1 Epidemiology of Listeriamonocytogenes and 
L. innocua using multilocus enzyme electrophoresis 
M. Jalah and H. Kalantari 
I$ahan, IR 
Objectives: Listeria monocytogenes is considered an ubiquitous food-borne 
pathogen whch can lead to serious infections, especially in newborns and 
elderly, pregnant, and immunocompromised people. L. innocua is a closely 
related nonpathogenic species of Listeria, which has been suggested as an 
appropriate epidemiologic marker for L. monocytogenes. Little information is 
available on the comparative epidemiology and molecular biology of L. mono- 
cytogenes and L. innoma. The purposes of the present study were to employ 
MEE: (1) to determine the genetic diversity amongst isolates of L. innocua and 
L. monorytogenes from a number of Australian sources; (2) to employ informa- 
tion on that diversity to: (a) increase understandmg ofthe origins of and means 
of transmission of Listetia yla poultry as human foods, (b) and contrast poultry 
isolates to clinical and other isolates. 
Methods: United States Department of Agriculture method of isolation used 
to isolate 168 strains of Lisreriu mainly from poultry production environments, 
foods and human cases. Multilocus enzyme electrophoresis was applied to 
analyze ancollected strains. 
Results It was shown that L. innocua maintains 1.9 alleles per polymorphic 
loci and a genetic diversity of 0.12 compared with 2.9 alleles and a genetic 
diversity of0.48 in L. monocyfngenes. The number ofelectrophoretic type (ET) 
found in isolates obtained from two poultry production plants in Sydney, 
Australia also varied with 54 ETs in 73 isolates of L. monorytogenes and 10 ETs 
in 95 isolates ofL. innocua. There was one common ET (67%) in L. innocua but 
no common ET in L. monocytogenes, where 79% ofETs were represented by a 
single isolate. Nine isolates obtained from episodic human cases oflisteriosls in 
Australia represented nine Merent ETs and there was no evidence of a 
disease-specific strain. 
Conclusions: The marked difference in the level and distribution of genetic 
variation in L. innoma compared to L. monocytogenes raises serious doubts as to 
the validity of using it as a marker surrogate for L. monocytogenes. 
m1 Cerebrospinal fluid ferritin: a new diagnostic tool 
in CNS infections? 
F. Kamaria, E. Chaidouli, Z. Fika, H. Psillaki, A. Kansouzidou, 
L. Sideropoulos and A. Papachristou 
Thessaloniki, CR 
Differential diagnosis of CNS infections becomes often troublesome, neces- 
sitating more laboratory support. As such ferritin could be used as an acute 
phase protein measured in the CSF. The objectives of this paper were the 
appraisal of CSF ferritin in the dierentiation of CNS infections, since 
relevant reports are so far scarce in the literature. 
Methods: Seventy-six adult patients with miscellaneous CNS infections, as 
well as 20 healthy subjects (control group) were included in the study. Ferritin 
levels in the serum and the CSF specimens, as well as CSF leukocyte count, 
protein, glucose and lactate values were assessed and interrelated. For the 
measurement of ferritin levels, a microparticle enzyme immunoassay (I&- 
Abbott) was used. 
Results: CSF ferritin values (mean*SE) were 7.5& 1.9ng/mL in the 
controls, 10.85f 1.81 in the 42 persons with aseptic meningitis, 
38.5 x t  32.14 in the six patients with encephalitis, 40.43 f 8.87 in the seven 
with meningitis of specific etiology (TBC, brucella, mycoses), and 
72.14 f 16.23 ng/mL in the 21 individuals with bacterial meningitis. There 
was a statistically significant difference between: (a) the controls and the 
patients with bacterial meningitis and specific infections (P=O.OOO); (b) 
aseptic meningitis and all the other infections (P= 0.000 for the bacterial and 
the specific meningitis, and P =  0.029 for the encephalitis). On the contrary, 
between bacterial meningitis on one hand and specific meningitis or ence- 
phalitis on the other, as well as between encephahtis and specific infections, no 
difference was observed. CSF ferritin values correlated significantly: in the 
sum of patients with CNS infection with their corresponding serum values 
( r =  0.316, P =  0.005) and in addition with all dammatory CSF parameters: 
cells (r=0.315, P=O.O06),protein (r= 0.573, P=O.OOO), glucose (r=0.344, 
P=0.002), and lactate (r=0.616, P=O.OOO); in the bacterial meningitis 
group, values were in correlation with CSF protein (r=0.510, P=0.018), 
glucose (r=-0.406, P= 0.068), as well as withlactate (r=0.507, P =  0.023), 
whereas in the other cases of meningitis, no such correlation was found. 
Conclusion: Measurement of CSF fetritin may contribute to the Nerential 
magnosis of the various CNS infections, mostly in the distinction of aseptic 
&om bacterial or specific infections. There is, undoubtedly, need for further 
studies in which a higher number of patients, chiefly with specific infections 
and encephalitis, have to be included. 
(p15581 Performance of the Gram stain in the bacterial 
meningitis diagnosis 
D. Fontanals, M. Barroso, E. Morante, E Salceda, J. Hernindez and 
B. Sola 
Sabadell-Barcelona, E 
Objectives: To evaluate the performance of the Gram stain in the diagnosis of 
the cerebrospinal fluid (CSF) infection. 
Methods: During 2000 and 2001, we analyzed 626 CSE We processed the 
Gram stain following an established protocol and using as a culture an 
enriched chocolate agar plate and a thioglycolate broth. The culture has 
been considered as the gold standard and we compared the Gram-stain result 
to the culture result. In case ofdisagreement, we checked to see ifthe patient 
had received antimicrobial therapy prior to lumbar puncture, the clinical 
diagnosis, and the result of the blood culture. The established protocols were: 
(1) leukocytes count of at least 10/mm3 with predominant polymorpho- 
nuclear; (2) predominant lymphocytes with glucose below 40mg/dL and 
protein above 50mg/dL; (3) suspicion of sepsis or meningitis; (4) immuno- 
deficiency; (5) when the physician asked for it. The data were analyzed with 
the statistical program SPSS 10.0. We calculated the sensitivity (S), the 
specificity (SP), the positive predictive value (PPV), and the negative pre- 
dictive value (NPV). 
Results: We analyzed 626 CSF. Only 190 (30.4%) reached the established 
protocol for realizing the Gram stain. We obtained 23 (12.1%) CSF with 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 373 
culture positive: 10 (43.4%) Neissen'a mcningitidis, 10 (43.4%) Streptoma 
pneumoniae, 1 (4.4%) S. agalm'ae, 1 (4.4%) Haemophilus intuenzae, and 1 
(4.4%) Listeriu monocytogenes. We found S = 87%. SP = 98.8%, PPV = 91%, 
and NPV = 98.2%. 
Conclusions: The Gram stain is a simple, rapid, accurate and inexpensive 
method to fvld out the etiologic agent in approximately 80% of the bacterial 
meningitis. We have found good S, SP, PPV and NPV in comparison to the 
bibliography. 
I P1559 1 Bilateral thalamic abscesses: a case with full 
recovery 
C kva ,  C Scolfaro, F Papaha, F Giordano, L. Lazier, M Pultrone, 
A Versace, F Garofalo and P A Tovo 
Tunn, I 
Objectives: Cerebral abscesses may arise h m  cerebral or facial idecuons or 
trauma or bacterenua Here we describe a pecuhar case of bdateral thalamc 
abscesses in an immunocompetent boy 
The care: A healthy Caucasm male at the age of 14years developed a 
pharyngm. wth  fever (T. 39 "C), CMS and severe asthema, that resolved after 
5 days of a first-generanon kephalosporm Fifteen days later, fever reappeared 
wth  headache and asthema. After another week of anabiohc treatment, a 
Brucellosis 
confusional state developed, associated wth  signs of meningitis, isocoric 
mydriatic pupdlae, and normal fundus oculi. CT and MR scans showed 
two thalamic, bilateral lesions 4-5cm of diameter. The analysis of CSF 
showed 6800 cellslml, mainly granulocytes, glucose: 43mg/dL, proteins: 
170mg/dL., C1: 123meqlL. CSF cultures and coagglutination assay were 
negative. The patient was treated with meropenem (120 mg/kg/die), 
vancomicin (40 mg/kg), fluconazole (8 mg/kg/die), and desamethazon 
(0.8 mglkgldie). There was a progressive improvement on clinical and TC 
controls. Twelve days later, apparently after missing one single dose of 
meropenem, a second-stage coma arose: on TC scan the abscesses showed 
a new sigmficant enlargement. They were drained and a Gemella spp. grew on 
the cultures of the brownish, thick, purulent-like material. Based on the 
sensitivity tests, meropenem was kept, for 2 months, associated with vanco- 
micin and then chloramphenicol for 40 days. A new progressive clinical and 
CT improvement followed. Two months later, the general condition of the 
patient was good, neurologic signs had disappeared apart &om a slow pupillar 
reflex left, a CT scan showed two hyperdense scars in place of the abscesses. 
Meropenem was stopped. The boy was sent home and treated with i.v. 
teicoplanin for 25 days, followed by oral chloramphenicol for 25 more days. 
He is at the moment in good condition, apparently M y  recovered. 
Conclusion: This  case indicates that in the deep cerebral abscesses surgical 
drainage plus prolonged specific antibiotic treatment are necessary. By the 
way, bilateral thalamic abscesses due to an opportunistic agent in an immu- 
nocompetent patient are a very rare event. 
I PI560 1 Dixovertebral infection in brucellosis 
H. Bodur, M. A. Cevik, C. Erbay, E. Akinci, A. Colpan and A. Erbay 
Ankara, TR 
Diskovertebral involvement in brucellosis occurs approximately 2&50% of 
cases. In this report discovertebral infection in 11 of 47 patientr with 
brucellosis were presented. The age of the patients were between 29 and 
73 (average 55). Eight of the patients had intervertebral disc bulgmg symp- 
toms. Diskovertebral infection and paravertebral abscess was detected in one 
patient at the same time. Infection was localized at C X 4  level in one case, 
L5-SI level in two cases, L3-L4 level in three cases, L2-L3 level in two cases, 
L4-L5 level in two cases and T12-L1 level in one case. Bnccella spp. was 
yielded &om the blood cultures of the eight patients. Wright agglutination test 
was positive (>1/800) in all ofthe cases. Diskovertebral infection was showed 
in magnetic resonance imaging. No pathologic finding was detected on X- 
ray. Eight patients wete treated with streptomycin (20-40 g), doxycycline and 
rifampin. One patient did not tolerate doxycyche and instead they were 
given trimethoprim-sulfamethaxazole. One patient developed allergic reac- 
tion to all of the antibiotics used and treatment had to be stopped at the end of 
the fifth week. Antimicrobial therapies were continued for 4-6 months except 
this one patient. At 2-lomonth follow-ups, no recurrence was observed at 
any patient and surgical intervention were not needed in any case. 
rh561  I Osteoarticular changes in patients with human 
brucellosis 
Pn'lep, M K  
M. Zezoslu 
Objectives: To evaluate features of osteoarticular involvement in pauents w th  
human brucellosis. rates, types and numbers. 
Materials and methods: A total of 768 new pahents w th  human brucellosls 
between 01.1991 and 11.2001. Four hundred forty-six of them, 58%, were 
wth some osteoarticular changes. Diagnosls was made usmg standard clinical, 
biochenucal, serologcal (BAB. Wnght, COOMB, S, RVK, 2-mercaptoetha- 
nol, ELISA igM and IgG) analysis. Also, we made standard radiopphs. 
Results: M u  changes ~fl al  patients were: hgh temperature in 96%, s w e h g  
m 83%. osteoarhc~ar changes in 58% (307 males and 139 females). In 69 
patients, osteoarticular changes were the only sign of the disease. Sacroileitis 
was found in 263 patients (179 bilateral), peripheral arthritis in 145 and 
spondylitis in 38. Polyarticular changes were in 62.1% and monoarticular in 
37.9%. In treatment, we included SMC, cotrimoxasol and doxyciclin or 
rifampicin, cotrimoxasol and oxytetraciclin plus diclofenak in all of them. In 
72 patients disease relapsed. 
Conclusion: OsteoarticuIar changes are frequent in patients with human 
brucellosis and could be diagnostic dilemma when are presented as the only 
sign of the disease, especially out of the endemic regions. 
lp15621 Detection of Brucella spp. in a tertiary Greek 
hospital 
A. Lazou, M. Anagnostopoulou, K. Fountoulis, H. Belesiotou, 
N. Nitsos, E. Platsouka and 0. Paniara 
Athens, GR 
Objedves: Brucellosis remains a common infectious disease in many parts of 
the world, notably in Mediterranean countries and the Middle East. In this 
study, we present the laboratory detection of Bnuella spp. in our tertiary 
hospital between 1994 and 2000. 
Methods: The samples included blood and bone marrow for culture and 
serum for detection of Brucefla IgG, IgM and IgA antibodies by immuno- 
fluorescent assay, Wright tube test and Rose Begal test. BACTEC NR 660 
and recently BACTEC NR 9240 bottles were incubated for 20 days f b m  
patients with suspicion of clinical brucellosis. Gmwth time of Brucella w a s  
approximately within the second to fourth day (range 36 b-14days). 
Results: We found 66 patients, 40 males and 29 females, mean age 57 f 2 with 
positive blood cultures. The yearly distribution of Brucella spp. between 1994 
and 2000 was 6,4, 8, 9, 5, 13, 21 cases, respectively. In two cases Bnuella spp. 
was ako isolated h m  bone marrow culture and in one case in synovid fluid. 
Positive titers of Bnrcella antibodies, Wright tube and Rose Begal test were 
present in 59 tested out of66 blood culture positive cases. All but one patients 
were cured with antimicrobial treatment (mainly rifampicin plus tetracycline 
or quinolone plus rifampicin) . 
Conclusion: Brucellosis remains a public health problem in Greece. Blood 
culture system (BACTEC) is as effective as serologic routine tests. The 
prevention of the disease requires animal testing and education of high risk 
population. 
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Ip1563J Bfuce//af Sdcroliitk evaluation of 41 cases 
A. S. Inal, Y. Tasova, N. Saltoglu, T. Selu and I. H. Diindar 
Adana, 7'R 
Objectives: Sacroiliitis, a common involvement of brucellosis, is the main 
cause of the back pain. In this study, clinical and laboratory characteristics of 
patients with brucellosis were retrospectively evaluated. 
Methods: Clinical features and laboratory findings of 41 patients with 
sacroiliitis due to brucellosis followed and treated at Infectious Diseases 
D e p m e n t  were investigated. Diagnosis of brucellosis was made consistent 
symptoms and on serum titers >1/40 standard agglutination test and/or 
isolation of Bmcella melitemis. Sacroihtis was investigated by spot X-ray, Tc99 
scintigraphy or magnetic resonance imaging (MRI). 
Results. Forty-one patients whose mean age was 38.8 & 18.3years were 
evaluated. Thirteen (31.7%) of those were male. Sacroiliitis was detected 
by X-ray in 27 (65.8%), scintigraphy in 8 (19.5%), X-ray + scintigraphy in 4 
(9.8%), scintigraphy+MR in 1 (2.4%), and MR in 1 (2.4%). Sacroiliac joint 
has been involved unilaterally in 21 (51.2%) and bilaterally in 20 (48.8%). 
Symptoms and clinicaf examination findings of patients were as follows: 
arthromyalgia (n = 36; 87.8%). fever (n = 34, 82.9%). cMs  (n = 25, 61 .O%), 
weight loss (n = 2, 4.9%), diarrhea (n = 1, 2.4%), hepatomegaly (n = 14, 
34.1%), splenomegaly (n=7, 17.1%), spondylitis (n=7, 17.1%), arthritis 
(n =7, 17.1%), lymphadenopathy (n=3, 7.3%), orchitis-ophoritis (n =2, 
4.9%). osteitis ( n =  1, 2.4%). On laboratory investigations, erythrocyte sedi- 
mentation rates (ESR) were found high levels, but 9 (27.5%). Mean value of 
ESR was 45 f 2 9 .  Titers of SAT were 31/160 in 39 (92.7%) patients. All 
patient were given as combination of at least two antibiotics. Cure rate was 
97.6% by minimum 6-week therapy. The only case whose complaints were 
not lessened despite 6-week therapy, was determined he had also spondylo- 
disciitis by MR and treated for 6 months. 
Conclusions: In this study majority of patients with sacroiliitis were women. 
The considerable point is almost equal rates of undateral and bilateral 
involvement of sacroiliitis in brucellosis. 
(P1564J Chronic hepatosplenic abscesses in brucellosis: 
clinico-therapeutic features and molecular diagnostic 
approach 
J.-D. Colmenero, M.4. Queipo, J.-M. Reguera, M.-A. Suarez, 
S. Martin, M.-A. Garcia-Ordoiiez, C. Juarez and €? Morata 
Md'hga, E 
Objectives: To describe clinical, radiological and histological features of 
chronic hepatosplenic abscesses (CHSA), and define the contribution of 
new molecular techniques for diagnosis, and our experience with treatment 
of this unusual complication of brucellosis. 
Methods: From January 1982 to July 2001 we studied prospectively 832 
patients with brucellosis. Diagnosis was established according to isolation of 
Bwella spp. in blood or other body samples or a compatible clinical picture 
with specific antibodies at significant titers or seroconversion. Liver and 
splenic samples of patients with CHSA were studied by a PCR technique 
consisting of the amplification of a 223-bp fi-agment fiom the gene coding for 
the synthesis of a membrane protein of B. abortus (BCSP31). All patients were 
treated and followed homogenously. 
Results: Eight patients (0.96%) had CHSA, six men and two women, aged 
57.6 + 16.6years (range: 39-80). Their localization was hepatic in five cases 
and splenic in three. The duration of the symptom was 6.7 + 9.2 months 
(range: 1-24). Blood cultures were negative in seven cases, SAT titers were 
diagnostic in three (37.5%) and Coombs' in seven (87.5%). Culture of the 
samples of tissue or pus was positive in one (16.6%) of the six cases in which it 
was performed, whereas the PCR assay was clearly positive in all these 
samples. Abdominal CT showed poorly defined heterogeneous lesions with 
large central calcifications, surrounded by a hypointense area. Conservative 
therapy with or without percutaneous drainage failed in all six cases 
attempted. One patient received surgical treatment initially, and one patient 
refused splenectomy. All excised pieces showed the presence of necrotizing 
granulomas. After a followup of 35.8 + 14.4months (range: 14-61) six of the 
surgically treated patients remain asymptomatic. 
Conclusions: (1) CHSA are a rare but severe complication of brucellosis. (2) 
Their diagnosis is Wicult with conventional microbiological techniques. (3) 
Molecular techniques appear to be a very powerhl diagnostic tool. (4) 
Combined medical and surgical therapy should be recommended. 
lp15651 Bfuce//a endocarditis: clinical experience with 11 
cases 
A. Alarcbn, J. M. Reguera, M. Fernindez-Quero, E Miralles, E. Caiias, 
C. Juirez and J. D. Colmenero 
Seville, Md'laga, E 
Background: Brucella endocarditis (BE) is a rare complication of Erucelh 
infection but nevertheless responsible for the majority of deaths related to 
this illness. 
Methods: Descriptive study of BE in a prospective cohort of 1000 patients 
with brucellosis diagnosed between January 1985 and December 2000, in two 
tertiary hospitals in the South of Spain. BE cases were defined according to the 
Duke criteria. 
Results: We observed 1 1 cases of BE which represents the 1 .l% of all cases of 
brucellosis, and the 3.5% of the left-sided infective endocarditis diagnosed in 
the period of study. Ten patients were male and the mean age was 
42f14yean (range: 21-69). The average time to diagnosis was 142days 
(range: 15-365). A pie-existent val& &ease was present in 5 (45%) 
patients: rheumatic valvular disease in four and one patient with bicuspid 
aortic valve. The aortic valve was infected in nine (82%) patients and the mitral 
valve in two (18%). Ten (91%) patients developed left ventricular failure (LVF) 
and two patients had severe embolic complications. The echocardiographic 
s t u d y  showed vegetations in all cases. Blood cultures were positive in seven 
(65%) patients. Cardiac surgery was performed during the active endocarditis 
in eight (72%) patients with aortic valve infection because of hemodynamic 
instability, and annulus abscess was observed in three of them. Antimicrobial 
treatment given was doxycyclme plus rifampin for 3 months plus streptomy- 
cin the three first weeks. One patient (999) died and the others were 
asymptomatic and without relapses after 2 years of fonow-up. 
Conclusions: (1) The incidence of BE remains a life-threaning complication 
of brucellosis, even in the last years; (2) the &agnostic delay would enhance 
the valve damage; (3) cardiac failure is the major reason for valvular replace- 
ment; (4) combined rnedtcal and surgical treatment is still necessary in most of 
cases. 
I P1566 1 Epididymborchitis and spondylitis due to 
Brucela mellitensis 
E. Magira, S. Papandreou, T. Gounaris and E. Sioula 
Athens, GR 
A 65-year-old Greek farmer was admitted to the hospital because of painful 
scrotal swelling, hepatosplenomegaly, lumbar pain that was radiated to the 
lower limps and low-grade fever accompanied by profuse sweating. His 
medical records were unremarkable while his life style included occupational 
animal exposure ingestion of raw milk and millc products. The leading 
symptom were vertebral pain that was started 6 months ago and gradually 
impaired his functional status requiring bed rest and analgesics, along with the 
scrotal pain. No neurological deficits were noticed. The liver function tests, 
the hemoglobin level, the ESR and the rest of the laboratory data were within 
the normal ranges. Focal hypoechoic right testicular lesions, swelhng of the 
concurrent e p i d i h s  along with an increase in the vascularity of the right 
testis were seen on a Doppler examination. These findings were consisting in 
unilateral epididymo-orchitis. A CT scan of the lumbar spine area was also 
performed and showed a decrease of the signal intensity localized in the 
anterior aspect of L5 vertebral body at the discovertebral junction involving 
the subchondrial parts of the L5 and S1 vertebrae. These focal spondylitis 
lesions were also demonstrated on the technetium bone scanning (increase 
uptake at the aEected area). Standard tube agglutination test was positive for 
antibodies to B r u ~ t l l ~ ~  rnellitensis (titer >1/1280) and the Coomb's test revealed 
titers of antibody to Bmcella of >1/320. Cultures of blood specimens were 
positive for Bmcella mellitensis. The patient was placed on a combination of 
antibiotics with doxycycline, streptomycin and r i h p i n .  A remarkable 
improvement of his clinical condition was showed 2 weeks later. This case 
illustrates the following points: In areas in which brucellosis is endemic when 
scrotal abnormalities are seen the possibility of genitourinary tract complica- 
tions of BnrceNa should be considered. Epididymoorchitis is a focal form of 
human brucellosis described in 2-2003 of patients with Bnrcellu. Therefore, 
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BmceEu must be placed in the differend diagnosis of orchitis. Focal spondy- 
litis may coexist and the patient evolved to diffise disease. A high index of 
suspicion along with the proper m e d d  treatment is recommended to 
complete resolution. 
1 P1567 1 Relapsing Brucella aborhrs epididymo-orchitis 
E. Akinci, H. Bodur, C. Erbay, A. Colpan, M. Deveer, S .  S. Eren and 
M. A. Cevik 
Ankara, TR 
B m d a  abortus rarely causes epididymmrchitis. In this report a case of 
Bnrcella abortus epididymoorchitis relapsing 4 months later was presented. A 
47-year-old male was admitted to the hospital with fever and right testicular 
pain and swelling. Four months earlier, he had been hospitahzed in our clinic 
and treated for brucellosis associated with left epihdymo-orchitis. He had 
taken rifampin plus doxycyclme for 6 weeks and completely recovered. None 
ofthe risk factors for reinfection was detected in this case. Brucella abortus was 
yielded h m  his blood cultures. Testicular ultrasonography showed right 
epididymoorchitis. He was given streptomycin plus doxycycline and non- 
steroidal anti-%tory drug. At the fourth day of the treatment fever, 
testicular edema and pain were disappeared; but aspermia was detected in his 
spermogram. Antimicrobial treatment was planned to be continued for 
8 weeks and he was discharged. What interesting for this case was relaps of 
BmceNu epididymmrchitis and involvement of the both testisses. 
(p1568( A case of brucellosis presenting with severe 
thrombocytopenia 
C. Erbay, E. Alunci, H. Bodur, A. Colpan and M. A. Cevik 
Ankara, TR 
Thrombocytopenia is one of the rare hematologic complication of brucel- 
losis. Herein a case ofbrucellosis with severe thrombocytopenia was reported. 
The patient was admitted to hematology service with epktaxis, ecchymoses, 
fever, thrombocytopenia (0.6 x 103/L) and anemia. His initial diagnosis was 
idiopathic thrombocytopenic purpura. Corticosteroid treatment was started 
and erythrocyte and thrombocyte suspensions were transfused. Despite this 
treatment clinical symptoms and laboratory disorders were not improved. No 
significant pathology was detected in the examination of bone marrow 
aspiration. On the seventh day, Brucella abortus was yielded h m  his blood 
cultures. Steroid was stopped and rifampicin plus doxycycline started. His 
clinical symptom w e e  disap eared and laboratory findings improved 
(thrombocyte count: 205 x 10 /L) at the second week of the antibiotic 
treatment. It was thought that thrombocytopenia was related to immune 
destruction of thrombocyte in the peripheral blood. This case was interesting 
showing us that thrombocyte count might decrease to very low levels in 
brucellosis. So that. especially in the endemic areas, brucellosis should be kept 
in mind for the etiology of fever and thrombocytopenia. 
P 
lp15691 Breast abscess caused by Brucella melitensis 
E. Trikka-Graphakos, N. Charalampakn and 2 Salem 
Athens, GR 
Brucellosis has been signhcantly decreased worldwde, but shll remaws a 
problem m some regions of Greece. Early hagnosis of focal forms of 
brucellosis is especially important for the prognosis and treatment of the 
&ease Cutaneous and soft hssue leslons are uncommon manIfestahons of 
brucellosis. Though breast mvolvement m a n m d  brucellosls is not uncom- 
mon, involvement ofthe breast in human brucellosu is very rare. We report a 
case of breast abscess m a 55-year-old female caused by B mditenns. The 
pahent was admtted to the internal medmne d e p m e n t  of our hospital, 
with fever, chJls, malase and weight loss. Dunng physical egarmnahon a 
palpable mas was found ln the left breast. Ultrasonography and mammo- 
graphy revealed findmgs suggestive of abscess. B melttenm biotype I1 was 
lsolated from blood and soft tissue culture. Rose Bengal and Wr&t were also 
poslhve. Surgical dramage of the abscess was performed. Combmation of 
rlfampicln and doxycyclme for 3monchs resulted m h c a l  cure. In con- 
clusion, although breast involvement m human brucellosis is extremely rare, 
one should be aware of the diagnosis, especially where this zoonosis is 
endemic. 
Hematological manifestations of brucellosis 
M. A. Yetkm, H. Smek, N. Tulek and L. Doganci 
Ankara, TR 
Objectives: To determme the hematologd manifestahons of brucellosis 
observed durlng the course of achve dection. 
Methods: One hundred and thirty-two patients who were followed-up with 
brucellosls m our c h c  between February 1999 and October 2001 were 
rewewed retrospectively. The diagnosis was based on clinical fmdings and 
serologic results and/or blood culture confirmations. Durahon of compkts  
physical exarmnation and laboratory findings were noted. Ail these 132 
pahents were dwided in three groups due to the duration of their complaint 
(acute, <8 weeks; subacute, 8-52 weeks; chronic, >52 weeks) to assess the 
rate of their hematological complications. 
Results: The mean age of patients was 42.2 years. The female and male rah0 
were 57/75 (43.2-56.8%, respechvely). Anemia was detected in 201132 
(15.2%) patients. Thrombocytopenia was found in 8/132 (6.1%) patients. 
A mdd thrombocytopenia ((100-150) x 109/L) was detected in four of them 
where as a severe ((5-90) x 109/L) form noted in others Leukopenia w a s  seen 
in 6/132 (4.6%) pahents. Pancytopema occurred in 2.3% (3/132) of cases. 
One ofthe pancytopenic pahent had deep thrombocytopenia (5 x 109/L) and 
leukopem (1.1 x 109/L). No clinically detectable bleedmg occurred. Hema- 
tological complications of brucellosls observed mostly in acute brucellosis 
cases. Thrombocytopenta and leukopenia were resolved rapidly wth treat- 
ment of the Btucella spp. infection. 
Conclusions: Patients with Bnuelln spp. infechon occasionally manifest 
hematological abnormalities includmg Pancytopenia especially in acute cases. 
Though these hematological complicahons might be severe, all could be 
disappeared following successfd antimicrobial therapy. Brucellosis may be 
considered in patients whose blood picture reveals leukopenia, trombocyto- 
penia or Pancytopema particularly when the disease is epidemiologically 
suspected. 
I P1571 I Brucellar orchiepididyrnltis as a clinical 
manifestation of human brucellosis 
E Dimtmvska, D Rmevska, V Malevska, D Galovska, R Dmtrovslu 
and R. Petkovska 
Bttola, SbpJe, M K  
Objectives: Human brucellosis IS endo-epidemc dsease ln our country 
among the cattle and people. In our study we present our experience w t h  
brucellar orchiepiddynuhs in our r q o n  during a period from 1980 unhl 
2000 as a part or the only c h c a l  madestahon of brucellosu. 
Material and methods: Durmg the period of 20yean, 31 pahents were 
treated of unrlateral or bdateral orchiepi&dyrmtls out of total number (502) 
patients lnfected wth  brucellosls memmg that 6,1% of the panents had gen~tal 
mvolvement Ages were among 13-59years. D~agnosis was obmned using 
standard d ~ c a l ,  biochermcal and serologcal (Rose-Bengal, Wright, 
Coombs, RVK. ELISA) hVeShgahOnS. 
Resub. Our pahents were dlsmbutedm two groups accordmg to h u g  place: 
19 pahent hved rn surroundmg vtllages and other 12 pahents hved m towns. 
The predormnant syn~ptoms wew fever, mala~se, osteoartlcuhr involvement, 
enlarged lymph nodes, enlarged h e r  and spleen. Twenty-three pahencs had 
orchepidldymas as a part of brucelloszs, and the other elght pahents had 
orchepi&dymtls as the only c h c d  d s t a h o n .  Twenty-five pahents had 
bllateral, and the other SIX had undated orch~epidulyrmns. The affected testes 
were v t q  panful. warm and swollen. The treatment consisted bed rest mth 
immobhzahon of the scrotum, corncostemides m the most refiaetory cases 
for a 7-days and SMC, cotrmoxasol, and doxycyclyne or rlfamplcm cotn- 
moxazole and oxytetmcycllne. AH pahents responded well to the treatment 
w th  completely resolutlon In five patients (16.2??) we had relapse whch 
consequently responded well to the addmonal therapy 
Conclusions: The study is going on to determne whether the infechon 
would have any adverse effect on the f e d t y  m bdateral involvement. We 
confirm that with the fact that two our pahents who had bllateral brucellar 
orchepildyrmhs are being treated from inferhhty for more than 5 years We 
added that human brucellosis is a sipficant health and socioeconormc 
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problem in Macedoma Adequate m e d d ,  vetermary and sanitary Conclusions: Our results suggest that PCR assay of serum specmens can 
measures and care should be exercised in order to put the dect ion under contribute to the rapid and accurate dagnosrs of brucelloss However, it 
control remans to be clanfied whether positwe PCR results are due to Bnrcelld 
bacteremia or to breakdown products that are present during the d e m o n  and 
whether there 1s correlaaon between the DNA detectlon and the presence of 
specific antibodes 
I Pf572 1 In vitro activities of antimicrobials against 
Brucella melitensis isolates 
N. Elaldi, M. Z. Bakici, M. Bakir, I. Dokmetas and H. Erdem 
Sivas, TR 
Objectives: To test the antimicrobial susceptibility of Bmcella melitemis isolates 
to various antimicrobial agents by using Sceptor automatic system. 
Methods: The 21 B. melitensis isolates were collected between 1 January 1998 
and 28 February 2001 h-om blood cultures of individual inpatients with acute 
brucellosis at Cumhuriyet University Hospital. Ten nlillilters of blood were 
inoculated into a Bactec Plus aerobic/F bottle for adult patients and three 
milliliters inoculated into a Bactec Peds Plus aerobic/F bottle for pediatric 
patients. These inoculated bottles were incubated at 35 "C and were mon- 
itored in Bactec 9050 (Becton Dickinson Diagnostic Instrument systems, 
Towson, MD) automatic system. The bottles were kept in incubation during 
21 days, and they were subcultured when the machine detected its growth; if 
not, a blind subculture was performed after 21 days. The isolates were 
identified to the species level by conventional methods, on the basis of 
not requiring CO2 and not producing HIS. All microorganisms isolated were 
B. melitensis. The in vino antimicrobial susceptibilities of the 21 clinical 
isolates of B. melitensis to tetracycline, streptomycin, cotrimoxazole, rifmpi- 
cin, ciprofloxacin and some of the third generation of cephalosporins were 
determined by using Sceptor (Becton Dickinson Diagnostic Instrument 
systenls, Towson, MD) automatic system. 
Results: Antimicrobial susceptibility of B. melitensis isolates was: cotrimox- 
azole, 100%; rifampicin, 81%; streptomycin, 86% and tetracycline, 100%; 
cefotaxime, 100%; cefoperazone, 67%; ceftriaxone, lOG??; ciprofloxacin, 
100%. 
Conclusion: B.  arrthracis isolates are generally susceptible to antimicrobials 
suggested the treatment of brucellosis especially tetracycline and cotrimox- 
azole in our region (Sivas city, which is located in the Middle Anatolian of 
Turkey). 
m1 Detection of Brucella DNA in serum specimens 
from patients with suspected brucellosis 
G. Vrioni, A. Kostoula, H. Boboyanni, C. Papadopoulou and 
S. Levidiotou-Stefanou 
Ioannina, GR 
Objectives and methods: Bnrcellu organisms are intracellular pathogens that 
have the capacity to survive and multiply within the phagocytes of the host. 
Different methods have been described for diagnosis of human brucellosis. 
Among them, peripheral blood PCR assay seems to be a very promising 
technique not only for the initial diagnosis ofthe disease, but also for the post- 
treatment followup and the early detection of relapses. Recently, PCR has 
been applied to detect Brurefla DNA in serum of patients with brucellosis, 
and serum has been proposed as the optimal specimen for the diagnosis of 
brucellosis. In the present study the PCR technique with primers that amplify 
a 223-bp DNA sequence, present in a gene encoding a 31-kDa Bmella abortus 
antigen, wa5 used to detect the DNA of this bacterium in serum specimens 
from patients with suspected brucellosis. Sixty-four serum specimens from 
equal number ofpatients referred as probable cases ofbrucellosis and 50 serum 
specimens &om healthy individuals, as negative controls, were examined. All 
serum samples were also examined using the Rose Bengal Plate test (RBPT), 
the Wright test and an enzyme linked immunoassay (Serion ELISA) able to 
detect specific IgG/lgM/IgA antibodies. 
Results: From 64 sera, Bmella DNA was detected in 25 serum specimens 
(39%). These specimens, except two sera that developed specfic antibodies 
2 weeks later, revealed positive RBPT, Wright test and ELISA for one or more 
antibody classes. The remaining 39 BrucelZa negative DNA sera were RBPT, 
Wright test and ELISA negative. All the control sera were negative for Bmella 
DNA and antibody detection. 
I PI574 I Differences in acute phase reactants and blood 
count in brucellosis 
F. Arabaci, I. Sahin and H. Giidiiciioglu 
Van, TR 
Objectives: The aim of this study is to determine increase of acute phase 
reactants and changes ofblood count in brucellosis. Acute phase reactants are a 
group of protein those are synthesized by liver as a response to infection, 
including haptoglobulin, some protease inhibitors, components of comple- 
ment system, sendoplasmin and fibrinogen. These are early response to 
infection. After days some other changes, including increase in erythrocyte 
sedimentation rate (ESR), C-reactive protein (CRP), decrease in blood iron 
and albumin levels OCCUIS. These are late acute phase reactants and occur as 
response to some cytokin related changes in vivo. In brucellosis diagnosis is 
based primarily on semptoms of patient, clinical findings and seropositivity 
with Wright's agglutination test in routine practice. Acute phase response may 
be used to confirm the diagnosis of brucellosis either is acute or chronice 
illness. 
Methods: Fourty-four patients diagnosed as acute brucellosis were chosen 
and their blood levels of ESR, CRP, antistreptolysin 0 (ASO), rheumatoid 
factor (RF), amhotransferases (AST, ALT), alkaline phosphatase (ALP), 
serum iron, albumin are compared with patients seronegative to brucellosis 
as a control group. Also total blood count of two groups have been compared 
prospectively. 
Results: The increase in blood levels of ESR, C W ,  AST, ALT and ALP were 
found s igdcant  compared to control group (P=  0.000 and 0.001). Although 
no differences were found in blood levels of A S 0  and R F  in both groups. 
Decrease in serum iron and albumin levels were more significiant than control 
group (P=  0,001). According to comparison of blood counts of two groups, 
decrease in white blood cell counts (WBC) and hemoglobin levels were 
significiant. The platelet count was found insignificant compared with 
control group. All findings were proven by statistically with using Student's 
t-test. 
Conclusions: Bnrcella species are an intracelluler organisms so the treatment of 
brucellosis is long lasting and struggling for clinicians. Especially chronic 
patients with relapses have to been treated for longer periods than the acute 
ones. So the determination of the course of illness is a milestone in effective 
treatment. We propose to acute phase reactants especially increased ESR and 
CRP levels as a cooperative tests for a clinician to decide whether the illness is 
acute or not. 
1 P1575 I Thrombocytopenia in acute Brucellosis 
E Albayrak, S. Cesur, H. Kurt, T. H. Sozen and E. Tekeli 
Ankara, TR 
Brucellosis is an intracellular zoonotic disease caused by Brucella spp. which 
involves many systems and organs lead to serious complications in organs 
involved. Different symptoms and clinical findings makes disease to be 
confused with several other diseases such as; rheumatoid, cardiac, dermato- 
logical, neuological and hematological diseases. The hematologic manifesta- 
tions of brucellosis include anemia, leukopenia, thrombocytopenia and 
clotting disorders. Two cases of brucellosis with thrombocytopenia are 
reported here. With the appropriate treatment of brucellosis thrombocyto- 
penia was W y  recovered. Brucellosis is an endemic infection in our country. 
Sometimes, rare complications may be prominent as in our cases. In cases 
going with thrombocytopenia and Pancytopenia brucellosis should be 
included in differential diagnosis. 
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jp15761 A case of primary psoas abscess due 
to brucellosis 
Y. Capar, S. Cesur, 0. Yuksel, T. H. Sozen and H. Kurt 
Ankara, TR 
Objective: Skeletal system involment is relatively common complication of 
human brucellosis. But rarely reported muscular involvement and particularly 
psoas abscess is always secondary to spondylitis. 
Case: A 70-years-old female patient admitted to our clinic with the com- 
plaints of fever, night sweats, pain in the joints of his back and leg for 3 weeks. 
Physical examination revealed a body temperature of 37 "C and pulse rate of 
70 beatdmin. Tenderness on hip and knee joint was present. Joint movements 
was limited due to pain. Complete blood count showed a 7000/mm3 white 
blood cell count with 59% polymorphonuclear leukocyte and 38% lympho- 
cyte. Erythrocyte sedimentation rate was 12 mm/h and rheumatoid factor was 
30 (normal range 0-20). Lumbosacral X-ray showed osteoporosis and 
osteophyte formation in L3-L4 vertebral level. Nuclear magnetic resonance 
(NMR) imaging of the lumbosacral region showed psoas abscess and spon- 
dylitis on vertebral corpus. Wright Agglutination test was positive with 
1/1280 titer. Blood culture for Brucella species yielded negative result. 
Doxycyline 200 mg/day and rifampin 600mg/day therapy together with 
NSAID is started. Antibiotic therapy continued for 6 weeks. Patient was fully 
recovered both clinically and radiologically after 6 weeks treatment. 
Conclusion: Rare complications of brucellosis should be always on mind of 
physicians, since s m a l l  portion of brucellosis cases are capable of developing 
unexpected complications in unusual organs. 
Epididymo-orchitis due to Brucelfa species: 
report of four cases 
S. Cesur, Y. Capar, P. Dernir, H. Kurt, T. H. Sozen and E. Tekeli 
Ankara, 7'R 
Objective: Brucellosis is a zoonotic infection involving many organ systems. 
Involment of genitourinary system especially in young man is a rare com- 
plication with incidence ranging between 2 and 10% of all BruceNa cases. 
Methods: Between 1996 and 2001 years 120 (78 male, 42 female) patients 
hospitalized for brucellosis were analyzed retrospectively for clinical and 
laboratory findings together with complications of brucellosis. 
Results: The most common symptom ofall patients were fever, arthralgia, and 
night sweats on admission. Besides clinical symptoms, laboratory findings 
included mostly leukocytosis, elevated erythrocyte sedimentation rates and 
positive serological tests for brucellosis. Four of 76 (??5, 12) male patients 
admitted with the signs and symptoms of testicular involvement. These were 
tenderness, swelling, calor and rubor of the unilateral scrotum. Diagnosis is 
corrected by serological tests in both patients. Only two patients' blood 
culture yielded positive result for Brucella spp. Ultrasonographic findings of the 
scrotum corrected our diagnosis as epididymoorchitis. Both patients 
responded to the medical therapy and no surgical procedure is needed. 
No genitourinary complication w a s  observed among female patients. 
Conclusion: Epididymoorchitis due to brucellosis is a rare com- 
plication of the disease. Testicular involvement is usually unilateral as it is 
in our cases. Physicians who evaluated a patient as epididiymo-ordntis 
especially in brucellosis endemic areas should include the disease in Merent 
diagnosis. 
/p15781 Isolation and typing of Brucella from blood 
culture of human brucellosis and its determinants in a 
region of Iran 
A. Bahonar and K Holakouie 
Tehran, IR 
Objectives: BruceUosis remams a major zoonosis worldwde. As bacteriolo- 
gical aspects of dsease is the basic knowledge for control and ehmmanon of 
brucellosis, thls study was carned out on human brucellosls m hospitals 
and dmcs  of the provmce m 1999 However, m Iran wth repomng at 
least 15000 cases in each year (incidence rate=25/100000) research on 
biological and biochemcal characterisncs of the causative orgamsms is very 
important. 
Methods: A total of 101 cases w t h  ckntcal and serologcal &agnous of 
brucellosis and any use of annbioucs have answered to 44 quesnons The 
blood sample, approxmately 7-10mL, was taken h m  all of them and 
transferred asephcdy to a Brucella medmm, Castamda If the blood culture 
was positive, typing of isolated Bmcella was perfumed by biotype chssificahon, 
using the techmque recommended by WHO (Alton et al. 1975, Corbel et al 
1978) in Ran Inshtute. 
Results: A total of 52 persons of pahents were the males and others were 
females. From blood culture of34 (33/6%) patients Brucella melitensis biotype 1 
was lsolated and sex raho (de/female) was 20/14. Posihve blood culture 
pahents (first group) are significantly younger than negahve blood culture 
patients (second group) {25 (SD= 1519) and 35/3 (SD = 18/8) years old, 
respechveb, (&value < 0/01)}. From totd of pahents, 22 petsons (21/8%) 
had <15-year-old and 50% of them (11 persons) were m the first group, 
whereas in adult pahentslsohion of Brutella was 29/1% (23 persons). History 
of dwease (brucelloss) in pauents decreases the chance of Bnrcella isolation 
{OR= 0/12 (0/02-0/57), P-due = 0/002} Geometrrcal mean of sero- 
agluhnahon test and 2-mercapto ethanol was not mfferent in two groups 
(11265 and 11132, respechvely, for 84 and 50 pahents. Orchhc sign m the 
males of first group was 36/7% and in second group was 12/1% (P-value= 
0/01). P revalence of exposure mth  arumals and aborted fetus of anunals in 
first group was hgher than other group Variahon of isolahon Bmcella m five 
cities of provmce was f b m  11 to 50% of pahents in each city that is conform 
wth  &stribuuon of exposure wth am& and aborted fetus of m a l s  and 
chromc forms of &ease. 
Conclusion: Bmcella melttensts biotype 1 is the mam species and biotype in Iran 
and age, contact mth  a m d s  and them aborted fetus, incubahon period and 
hstory ofdmase are the mam factors dechng isolahon of Brucella f b m  blood 
culture of patients. 
m] Specific ELISA IgM and lgG antibodies for the 
detection of active brucellosis 
A. Tumturk, M. A. Yetkin, N. Tulek, D. Kilic and L. Doganci 
Ankara, TR 
Objectives: In this study, we analyzed the results of classic serological tube 
agglutination test and IgM and IgG ELISA for dqnosis of active disease; and 
their variations during the clinical come of brucellosis. 
Patients and methods: Eighty-six patients diagnosed with brucellosis who 
were admitted to our hospitals between April 1999 and August 2001 were 
included in the study. The diagnosis of the cases was based on clinical findings 
and on serological and/or blood culture positivity. The Rose Bengal, tube 
agglutination (STA), ELISA for specific IgM and IgG were performed for 
each serum samples on admission and several months after treatment. These 
86 patients were divided in three groups according to the duration of their 
complaints (acute group <8 weeks; subacute group, 8-52 weeks and chronic 
group, >52 weeks), to compare the test results. 
Results: The mean age of patients was 42.7 years. The female and male ratio 
was 38/48 (44.2 and 55.8%). Except for 30 instances involving the IgM ELISA 
and six instances involving the IgG ELISA, all serological tests gave positive 
results at admission. There were 40, 30, 16 patients in acute, subacute 
and chronic groups. At admission, the positivity rate for IgM antibodies 
were, 32/40,16/30 and 8/16 for the groups, respectively. These rates for IgG 
antibodies were as follows; 37140,27/30 and 16/16. These tests were repeated 
in 60 patients who were treated for brucellosis. The positivity rate of 
ELISA IgM and IgG titers for acute, subacute and chronic groups were as 
follows; 5/22,20/22; 3/24,19/24,2/14,14/14, respectively. When ELISA 
I@ levels fiom the beginning of treatment and h m  several months 
later were compared, a statistically sigruficant decrease was observed 
(P < 0,001). For STA titers evaluated after treatment, there was a clear dedine 
in titers, but none of 60 patients did have a negative value. In six patient an 
increase in IgG level was noted but none ofthese six patients had relapse of the 
illness. 
Conclusions: Our results show that ELISA IgM is a better method for 
diagnosis and followup of brucellosis than the other tests. 
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Miscellaneous community-acquired infections 
Antiphospholipid syndrome as a cause of fever 
of unknown origin 
Y. Akhlglu 
R.  Ozaras, B. Mete, R .  Ozturk, A. Mert, F. Tabak, H. Senmrkand 
Litanbul, TR 
Antiphospholipid syndrome is defined as the occurrence of thrombosis, 
recurrent miscarriage, or both in association with persistent antiphospholipid 
antibodies. In veins, deep venous thrombosis is the most common manifesta- 
tion, but involvement ofvisceral veins is well recognized. Due to a wide range 
of its clinical manifestations and laboratory studies, the hagnosis is &cult. 
We describe a patient presented with fever of unknown origin (FUO) and 
found to have the primary antiphospholipid syndrome. A 46-year-old male 
was admitted with abdominal pain, fatigue, anorexia, dark urine, diarrhea, and 
fever of 2days. His past history was noncontributory, elder brother had a 
history of myocardid infarction. During admission, the temperature was 
40 "C, and he had jaundice on scleras. Crackles over the left lower lung was 
sgdkant .  A chest X-ray revealed left lower lung atelectasis. Laboratory 
studies were as follows: hematocrit 36.3%, WBC 13 300/mm3 (granulocyte 
83%. lymphocytes 9%, monocytes 8%). plateleb 140000/mm3, erythrocyte 
sedimentation rate 88mm/h, CRP 219mg/L (normal: &5), total protein 
5.6 g/dL, albumin 3.1 g/dL, ALT 68 U/L, AST 64 U/L, 7-GT 118 U/L (7- 
47), ALP 297 (64-306). T bilitubin 3 mg/dL with a direct fraction of2.2 mg/dL. 
An abdominal US was normal. He was then prescribed ceftriaxone (1 g, twice 
daily) and clarithromycine (500 mg, twice daiiy), regarded as a community 
acquired pneumonia but he did not respond within lodays. A thorax CT 
showed the atelectasis of posterobasal segment of left lower lobe. Broncho- 
scopic examination was normal and BAL fluid remained sterile. Jaundice was 
regressed within 1 week but fever penisted. An abdominal CTrevealed p o d ,  
splenic, and superior mesenteric thrombi. ERCP, lower extremity Doppler 
sonography, cranial MRI, and o p h t h h c  angiography were negative. Lupus 
anticoagulant was negative and protein C level was normal; but anticardiolipin 
IgG was found as 22 GPL (0-8). The test repeated 10 days later resulted as 23.9 
GPL. The fever persisted all 7 weeks. The patient was initiated LMW heparin 
and then oral coumadin. He responded well; no fever was encountered after 
1 week. During follow-up of 4 months, he is doing well.This patient represent 
the first reporr ofantiphospholipid syndrome presented with FUO in Engltsh- 
language literature. Although very rare, antiphospholipid syndrome should be 
considered in dzerential diagnosis of prolonged fever associated thrombosis. 
Ip15811 Evaluation of 80 adult fever cases of unknown 
origin in Turkey 
A. Willke, 0. Ergonul, A. Azap and E. Tekeli 
Izrnil, Ankara, TR 
Objective: To evaluate the fever of unknown origin (FUO) cases in terms of 
their diagnosis and prognosis. 
Methods: A prospective evaluation was performed among the inpatients who 
had been admitted between 1993 and 1999 to Clinical Bacteriology and 
Infectious Diseases Clinic in Ibni Sina hospital with 1100 beds. Fever of 
unknown origin was defined as, at least 3 weeks of fever >38T  prior to 
admission and at least one examination by a physician during this period. 
Results: All patients were > 15 years ofage and 52% was female. The mean and 
median ofthe age were 43.9 and 44, respectively. Prior to admission, 33% of 
the patients was hospitalized in different institutions, 34% of them was 
evaluated in tertiary, 43% in secondary levels of health care system, and 
25% applied to more than one institutions for medical evaluation. Before their 
admission, all patients had at least one course of antibiotic therapy and 
majority of them (65%) was examined by internal medicine specialist. At 
the end of evaluation, in 52% of he cases the etiology was infectious, in 19% 
immunological and in 17% oncological diseases. In 12% ofthe cases the reason 
for high fever couldn't be explained. Among the most common infectious 
diseases, the various forms oftuberculosis (12%), brucellosis (12%), salmonella 
infections (7%) and malaria (5%) were diagnosed. 41% of the patients was 
totally cured, 58% was aansferred to other clinics of the hospital and only one 
of them was recorded as edtus. The mean and median of length of stay were 
20.7 and 17.5, respectively. To detect the underlying diagnosis, the most usell 
tools were serology (19%). pathological evaluation ofbiopsy specimens (17). 
imagmg techniques (14%). and detection ofmicrobiological agents by culture 
(14%) or smear (9%). The consultations fiom various surgcal and medical 
fields were asked for 29% of the patiens. 
Conclusion: To evaluate FUO cases, we used a umque definiaon which was 
relevant for the health care system of our country. Infectious reasons were still 
the leading etiology among FUO cases in Turkey. Microbiological and 
serological techniques were found to be crunal in detection of underlymg 
causes. 
I P1582 I Fever of unknown origin: an evaluation 
of 83 cases 
N. Saltoglu, Y. Tasova, S. Inal, D. Midikli, H. Aksu and 1. Dundar 
Adana, TR 
Objectives: In this study, we reviewed 83 cases with fever of unknown origin 
(FUO) admitted to Infectious Diseases Department of Qkurova Univelsity, 
Medical Faculty Hospital between January 1994 and July 2001. 
Methods: The criteria of Petersdorfand Beeson (Medicine 1961; 40: 1-30) 
were used for definition. 
Results: A total of59 (67%) were male, and 24 were female (median age 38.5, 
range: 14-80). Among the 83 cases included in this study 77 (93%) were 
determined as classic FUO whereas six of them (7%) were determined as 
neutropenic FUO. Infectious Diseases, n: 49 (59%) were the most common 
causes of FUO. Tuberculosis (Primary TB and miliary TB) constitutes the 
most common infectious reason, n: 11 (22%). Other infectious reasons were: 
infective endocarditis, n: 6; abdominal abcess, n: 5, brucellosis, n: 6; visceral 
leishmaniasis, n: 4, salmonellosis, n: 4, atypical pneumonia, n: 4, rhinocerebral 
mucomycosis, n: 3, cerebral toxoplasmosis, n: 1, Cytomegalovirus infection, 
n: 1. Non-infectious reasons of FUO were: I. Collagen vascular diseases, n: 13 
(16%); (SLE, n: 5, Still's disease, n: 3, Behcet Disease n: 1) 11. Neoplasms, n: 12 
(14.4%) (Lymphomas n: 4); 111. Miscellaneous, n: 3 (4%) (tiroihtis, hemo- 
siderosis, granulomatous hepatitis); IV Undiagnosed, n: 6 (7%). 
Conclusions: Infectious diseases especially tuberculosis are the leading diag- 
nostic category of FUO in Turkey. we followed undiagnosed cases with FUO 
(n: 6) during 1 year, five of them (83%) completely recovered and only one of 
them died. 
lp15831 Clinico-epidemiological study of Mediteranean 
fever cases hospitalized in Bucharest between 1999 and 
2001 
M. Podani, C. Sanda, A. A. Iancu, V. Arama, A. M. Briot and 
A. Streinu-Cercel 
Bucharest, RO 
Objectives: To describe the clinical and epidemiological features of the adult 
cases of Mediteranean fever (MF) treated in our hospital 6om 1999 to 2001. 
Methods: Retrospective study of the hospital files of all adult patients 
discharged with the diagnosis of MF during the last 3 years. 
Results: A total of 129 adult cases were recorded at our  institute, with an 
increasing incidence over the time: 21 cases in 1999,36 cases in 2000,72 cases 
in 2001. The mean age was 49.3yem in the majority of cases (69.2%) 
that came &om the urban area. The risk factoa (owing to the dogs with ticks 
and/or manual tick removal) were present in 50% of cases. The mean values of 
the most fiequent clinical and biological featutes in these 3 years are presented 
below: 
Incubation time was 6.5 days; 
Fever was present in 95% of cases; 
The 'button' rush was present in all 129 cases; 
Innoculation eschar was present in 52% of cases; 
0 Leucocytosis was present in 18% of cases; 
Elevated ESR was present in 76.5% of cases. 
Clinical Microbiology and Infection, Volume 8, Supplement 1, 2002 379 
Radlographc signs of pleuropuhnonary mvolvement were noted in 113 of 
pahents. The mean durahon oftreatement was 7.5 days m monotherapy (87%) 
mth  tetracyches (80%) or fluoroqumolones (7%) alone, or their assoclahon 
m 13% of cases. The seroconvemon was documented m 68% of cases. 
The outcome was favorable in the vast mqority of paaents (98.4%) wth 
only one lethal case (generahzed vascuhhs ulth drssermnated mtravascular 
coagulopathy) and one case healed mth sequelae (cerebral vascuhhs wth  
h rchon) .  Comphcahons with favorable outcome were presented 1fl6.2% of 
cases 
Conclusion: We assist to a remarkable increase of MF cases requlring 
hospitahzation durmg 1999-2001: 129 compared to only 23 cases between 
1990 and 1997. We presume that the great number of errant dogs present in 
the urban area that were parhay ‘adopted’ by the city popidahon is the risk 
factor involved m this phenomenon. In 2001 we also noted the first lethal case 
of MF m Bucharest, 53years after the mtroduchon of the hseases m our 
geographc area. 
I P1584 I Acute rheumatic fever (ARF) and long-term 
sequelae of heart disease: a 15-year experience 
E. Minola, G. Rizzo, E Suter, M. Arosio, C. Farina and A. Gogho 
Bergamo, I 
Introduction: Acute rheumatic fever (ARF) is a delayed, nonsuppurative 
sequel of upper respiratory infection by S. pyogener, characterized hy inflam- 
matory lesions involving joints, heart, skin, and subcutaneous tissues. Clinical 
manifestations include polyarthritis, carditis, subcutaneous nodules, erythema 
marginatum and Sydenham’s chorea. 
Objectives: Analysis of carditic manifestations and permanent effects of 27 
acute rheumatic fever. 
Materials and methods: 27 patients (15 women and 12 males) were evaluated 
from February 1986 to May 2001. Age range was 9 4 6  yeas; eight patients 
were aged under 15. In all patients ARF had been diagnosed according to 
Jones criteria (American Heart Association). In eight patients ARF was a 
recurrent episode. Clinical manifestations, epidemiological aspects and 
laboratory features of the patients were evaluated. 
Results: Patients presented fever (96%). arthritis (85%), angina (70%), carditis 
(63%), chorea (4%), anderythemamarginatum (11%). Sixpatientspresenteda 
first degree atrioventricular; 2 an atrial and ventricular escape. Throat culture 
was positive for S.pyogenes in 7/25 patients (28%). 24/27 patients had 
antistreptolysins 0 antibodies titers >400UI/L. ESR was >35mm/h in 
all patients (100%). 11/17 patients with carditis (65%) had mild-to-moderate 
heart disease: long-term sequelae with mild mitral regurgitation and no signs 
of heart failure (4/11); carditis (6/11); initmaortic insufficiency requiring 
surgical valves replacement (5/11). 9/27 (33%) had permanent sequelae. 
Severe carditis and heart failure were associated to later ARF diagnosis. ARF 
was diagnosed in 78% of cases from October to May, and in 33% from April to 
May. The higher incidence was in the young people (mean = 26years). 26/27 
streptococcal pharyngitis had not been correctly treated. 
Conclusions: Data confirm that rheumatic heart disease determine permanent 
and/or severe heart damage, potentially life-threatening requiring cardiac 
surgery intervention. They confirm that ARF presently affects mostly young 
people and that carditis is reported in 63% of cases. The absence ofan adequate 
antistreptococcal treatment is determinant in rheumatic fever development. 
Reduction in ART: incidence in all western countries over the last decades has 
stated new issues. 
I PI585 1 The role of mycoplarmas in rheumathoid arthritis 
in comparison with other arthritis 
M. S d ,  S. Agha~ and M Pourshafie 
Tehran, JX 
Objectives: At the rheumatoid arthritis (RA) pathogenesrs, some genetlc, 
immunologxal and dammatory mstances are nominated, but how these 
nnmunolog~cal and jolnt mbmmahons have come into exlstence is d 
unknown Various mfechous agents mcludmg mycoplasmas have been taken 
mto consideration as a s y n o d  mciter that is followed by unmunologcal 
responses m chroruc arthnhs 
Methods: At the culture of s y n o d  fluxd for mycoplasma in PPLO media 
(mth standard methods) and invexhgahon of some serologd tests such as 
C-P2aChve protein (CW), rheumatoid factor (RF) and cold aggluhmns 
from 100 pahents wth  RA and companng them wth  40 pahents wth  
osteoarthritis and 37 patients with septic arthrihs (as the control p u p ) ,  
followmg results have been gained 
Results: Culture of synovid fluid of RA pahents in seven cases were posihve 
for mycoplasma. Isolated species are M pneumoniae 3, Mfennentans 2, and 
M homrnis 2 cases. Concemng ulth other two groups synovial fluid culture 
was negahve. Other serologcal tests showed no sigmficant hfference between 
these three groups. 
Conclusion: It 1s supposed that the mycoplasma can be considered as a starter 
of mflamation m some c h m c  arthrius such as RA. 
lp15861 Chronic furunculosis - familiar occurrence 
and recurrence 
E Arlukoulcz, A Samet, R Nomch and W Baranska-Rybak 
Gdansk, PL 
Objectives: To analyze f& occurence of furuncles, the rlsk factors of 
infechons and Staphylococcus aureus nasal carriage and anhbiohc suscephbdity 
results 
Methods: We observed 70 paeents from 1998 to 2000, age 2-78, with 
chromc furunculosis. From each pahent purulent dscharge &om furuncle, 
nasal and throat swabs were taken. In some cases of f d a r  furunculosis we 
took only nasal and throat swabs from all f d y  members S aureus was 
idenhfied by standard methods and hsk - a s i o n  suscepabhty teshng was 
done accordmg to NCCLS 
Results: We nohced f d a r  h n c u l o s s  m23  cases (32 8%) 66 pahents had 
reccurent furuncles (943%) (lasang several years). Local symptoms were 
observed m 65 (92.9%) pahents, systemc (fever, discomfort, c w )  in only 
five pahents (7.1%). Among a l l  paaents, three had habetes and one leukerma. 
Nasal carriage was observed in 27 paaents (38.6%). Most pahents were adults 
>21years (41 pts, 58.6%). other adolescent 13-21yean (21 pa, 30%), 
chddren aged 5-12 years (7 pa, lo??) and only one younger than 5 years 
Most of the S. aureus smns were rewtant to pemcdhn (94.1%) and doxycy- 
chne (27.1%), rarely to chdamycm (4.7%), erythromycm (7.1%). trmetho- 
prm/sulfamethoxazole (5.9%) and aprofloxacm (1 2%) 
Conclusions: Furunculosls has tendency to become recurrent and occur in 
f d e s  FamJla occurence 1s often connected ulth nasal S aureus carriage 
Not every carriers suffered h m  furunculosu. Most S aureus in commumty- 
acquwd decdons are reustan& to p e n i d n  and doxycyche whch one 
should bear m rmnd when one wants to prescribe anhbiohcs. 
Ip15871 The correlation of shock categories with infectious 
nosologies 
D. Kraja, N. Como and K. Pano 
Tirana, AL 
Objectives: The recognition of the nosological-etiological structure, shock 
type and its mortality during infectious diseases. 
Methods: The study includes 300 cases with shock manifestation in the 
infectious diseases during 1970-2000. The patients’ age was 14-82 years. 
Results: We distinguished 1 - hypovolemic shock - 146 cases, 48,6% 1.1 - 
hemorrhagic 30 cases, 10% 13 hepatitis; 11 hemorrhagic fever, 1 flu with 
DIC; 2 leptospirosis; 2 typhoid fever; 1 shigelosis. 1.2 - dehydrative 116 cases, 
38.6% :80 cholera; 30 gastroenteri~, 5 Samonellosis; 1 @ask. 2 - 
distributive shock - 118 cases, 39.3% 2.1 septic 95 cases, 31.5% 54 sepsis, 
5 gastroenteritis, 3 salmonellosis, 3 hepatitis with sepsis, 1 leptospirosis, 3 
leishmaniasis with sepsis. 1 typhoid fever, 1 brucellosis, 1 yersiniosis, 1 
meningocoxemia, 1 staphylococcal endocarditis, 1 septic shigellosis, 4 
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anthrax, 2 saeptococcal angina, 2 septic mononucleosis, 1 Landousy typho- 
bacdlosis, 1 hyperpiretic malaria, 2 erisipelas, 1 gangrenous orchitis, 2 necrotic 
fascities, 2 DIP, 1 candidiasis septicopyenua, 2 facial malignant staphylococci. 
2.2 Neurogenic: 12 cases, 4 %  3 rabies, 2 tetanus, 3 poliomyelitis, 2 menin- 
goencephalitis, 2 purulent meningitis. 2.3 microvascular failure 5 cases, 1.6%: 
4 hemorrhagic fever, 1 leisImamasis with lomidine. 2.4 anaphylactic 6 cases, 
2% 1 spontaneous rupture of hepatic echinococcosis, 5 anaphylaxia: 3 by 
penicillin, 1 by ampicillin, 1 by antitetanic serum. 3 - cardiogenic shock 19 
cases, 6.3%: 3.1 myocarditic 7 cases, 2.3%: 1 mononucleosis. 1 flu, 1 typhoid 
fever, 1 diphtheria, 1 murine typhus, 2 leishmaniasis with glucantime. 3.2 
Aritmic 3 cases, 1%: 1 diphtheria, 1 leishmaniasis with glucantime, 1 tetanus. 
3.3 Mechanical obstruction 12 cases, 4 %  3 hemopericardium: 1 leptospirosis, 
1 flu, 1 hemorragic fever; 1 flu exudative pericarditis; 3 pulmonary 
thrombosis: 1 from flu, 1 &om rickettsiosis, 1 from endocarditis; 2 pneumor- 
rhagia: 1 from leptospirosis, 1 h m  flu. In 17 cases, 5.6%, we had so-called 
mixed shock. Total mortahty rate was 71 cases, 23.66%. 
Conclusions: We noticed shock directly related to infectious diseases on 33 
such nosologies. 
lp15881 Danish national survey on MorJxe//J 
(Branhamella) catarrhalis isolated from blood cultures: 
report of 20 cases 
J. J. Christensen and B. Bruun 
Copenhagen, DK 
Objectives: M .  catanhalis seldom causes systemic infections. A nationwide 
survey of M. cararrhalk bacteremia h m  the years 19%-2000 was performed. 
Methods: Reported cases of M. catarrhalis isolated h m  blood from Danish 
Departments of Clinical Microbiology were registered. Isolates were identi- 
fied with either conventional tests for oxidase production, acid production 
from glucose, maltose and sucrose, hydrolysis of tributyrin or by Minibact-N 
(The Statens Serum Institut, Copenhagen, Denmark). p-lactamase produc- 
tion was determined. Serum, ifobtainable, was examined for presence of IgG 
and IgM antibodies towards outer membrane proteins (OMPs) of M. 
catarrhalis. 
Results: Twenty isolates &om 20 patients were recorded. From four patients 
additional bacterial isolates were recovered; from two patients Staphylococcus 
mreus was isolated, whereas in one patient each HaemophiluspurainPuenzap and 
nonhemolytic streptococci were found. Seventeen of the 20 strains produced 
b-lactamase. Fifteen patients were middle-aged to elderly, while five patients 
were 8 years of age (median age in yean (range): 53 (4 months - 74)). Sixteen 
patients presented with febrile episodes either of unknown origin or in 
relation to granulocytopenia (n= 13) and/or with a pulmonary focus 
(n = 11); one patient each had acute otitis media, viral infection, tonsillitis 
with hemolytic streptococci Group A, and gastrointestinal infection. Fifteen 
of 20 patients had predisposing conditions, especially malignant diseases 
(n=8) or chronic bronchitis (n=3) .  All except three patients received 
antibiotics at the time of blood culturing. All patients, except one who &ed 
on the day of admittance, recovered from their infective episode. In patient 
sera (n = 7), IgG and IgM antibodies against OMPs of M. catarrhalis were more 
often present than in serum from blood donors. 
Conclusion: The occurrence of M.catarrhalis in blood cultures plus an 
immunological response attest to the organism's potential of causing invasive 
disease. 
PI589 I First report on Toscana virus circulation 
in Umbrian Italy 
D. Francisci, R. Papili, G. Camanni, N. Ferracchiato, S. Bastianelli, 
M. G. Ciufolini and E Baldelli 
Perugia, Rome, I 
Objectives: To evaluate for the first time circulation and clinical expression of 
Toscana (TOS) virus in Umbria region. TOS virus, which belongs to the 
Bunyaviridae family, Phlebovims genus (sandfly fever group), was isolated 
for the first time in Tuscany in 1971 from Phlebotomus perniciosus. It is 
a neurotropic virus which causes in man lymphocytic meningitis and 
meningoencephalitis during the summer, due to the higher circulation of 
the vectors. Originally, it was thought that the virus was limited to some parts 
of Tuscany, but subsequent reports from another Italian region, Marches, and 
also other Mediterranean Countries (Cypxzs and Portugal) disproved this 
hypothesis. A region of central Italy, Umbria, borders with Marches on the 
east and with Tuscany on the west, and it is extensively visited by tourist 
during the summer, particularly fiDm northern Europe and USA. 
Methods: (a) We retrospectively studied all cases of aseptic meningitis and 
meningoencephalitis admitted in the Clinica di Malattie Infethve of Perugia 
Hospital from January 1989 to October 2001, with negative results concern- 
ing common neurotropic viruses. Clinical data were taken &om the medical 
records. (b) We examined sera from 50 healthy subjects who were residents in 
Umbria, near Trasimeno lake, on the borders with Tuscany. We used an 
ELISA test for both specific IgG and IgM antibodies. A nested RT-PCR was 
performed at the Arbovirus Unit of the Istituto Superiore & Sanid on CSF 
from mengingoencephalitis. 
Results: We examined sera &om 92 patients. Ofthese, 24 (22 meningitis and 2 
meningoencephalitis) were positive for specific I g M  and IgG (26.1%). The 
presence of TOS v d  genome was confirmed in CSF of 1 out 2 menin- 
goencephalitis. Out of 50 healthy controls, 8 (16%) were positive for specific 
IgG. Males (m/f=2.5) and intermediate age (18-65) were more frequently 
affected. The highest incidence of c h i d  cases was during July and August. 
From the clinical point of view, we emphasize that the 2 meningoencephalitis 
showed a particularly severe course. 
Conclusions: Our study showed, for the first time, that also in 
Umbria the TOS virus is an important etiological agent for summary 
lymphocytic meningitis and acute meningoencephahtis. This virus circulates 
among the general population (border zone with Tuscany) and can cause 
asymptomatic infections. We aim at extending our seroepidemiological study 
to evaluate the virus circulaaon in general population living in other parts of 
Umbria. 
Ip1590] Asymptomatic pharyngeal carriage of 
Lancefield's group B streptococci in medical students 
C-L. Mar6di, R-Z. Gabor and E Rozgonyi 
Budapest, HUN 
Objectives: Aim of the study was to test the asymptomatic carriage of GES in 
medical students. 
Methods: Pharyngeal swabs of560 (male: 257, female: 303) healthy, volunteer 
medical students were tested for the presence of GBS. In comparison 30 
clinical isolates of GBS from patients suffering f b m  acute pharyngitis (male: 
22, female: 8) were selected from the collection of the Institute's own 
diagnostic unit. 8-haemolyuc streptococci were subjected to sero-grouping, 
furthermore -if applicable - subgrouping (BI, BII, BIII) by two commercial 
latex agglutination tests. Each GBS has been tested for bacitracin susceptibility 
and by Christie-Atkins-Munch-Petersen (CAMP)-test. The cell surface 
hydrophobicity (CSH) was determined by standardized salt aggregation test 
(sSAT), and hydrophobic interactive chromatography (sHIC). Statistical 
analysis of the sSAT and sHIC results was carried out by using the Student's 
t-test. 
Results (see table). 
Asymptomatic carrien (n=32) Phxyngitir (n-30) 
Male (y = 30) Female (x = 2) Male (y = 22) Female ( x  = 8) 
S.  a g a k i a e  
la, Ib. Ic 
I1 
111 
Untyped 
sSAT [mean (SU)] 
rHIC [mean (SD)] 
s. pomnur 
S,gllifiicance (K-value) 
28 (93 3%) 
0 (0%) 
2 (6.6%) 
8 (26 6%) 
20 (26.6%) 
4 (13.1%) 
3.73 (0.35) 
3.14 (0.26) 
<0.0001 
2 (100%) 22 (10o"A) 8 (100%) 
0 (WA) 17 (n=77.3%) 5 (62.5%) 
0 (W 5 (22.7%) 3 (37.5%) 
3.73 (0.35) 38.10 (4.66) 38.10 (4.66) 
3.14 (0.26) 58.77 (Y.84) 58.77 (9.84) 
0 (PA) 0 (PA) 0 (0%) 
0 (W 0 (0%) 0 (0%) 
2 (100%) 0 (0%) 0 (PA) 
<0.0001 <0.0001 <0.0001 
Conclusions: Higher late of asymptomatic carriage of GBS in males is 
explained by either epidemiological or hormonal factors. Sub-group dis- 
tribution in asymptomatic carriers implies no association with more virulent 
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Ia, Ib, and Ic strams Cell surface hydrophobicity was sipficantly 
hgher m the group of c h c a l  subjects; therefore it can be concluded that 
it may play an important role in the pathomechamsm of mfections caused by 
GBS 
I P I  591 I IS sciatica an infection? 
T. Elliott, T. Worthington, N. Adams, E? Lambert, A. Stirling and 
M. Jiggins 
Birmingham, UK 
Objectives: (1) To determine if low virulent microorganisms including 
Propionibacterium acnes and coagulase negative staphylococci (CNS) are asso- 
ciated with the interveterbral tissue of patients with severe sciatica; (2) To 
determine the serum IgG levels to lipid S, an exocellular Gram-positive 
antigen, in these patients. 
Methods: Two-hundred and seven patients who underwent microdiscectomy 
for unremitting pain, and 27 controls presenting with scoliosis, myeloma and 
trauma, were entered into the study. Clinical samples removed during surgery, 
including intervertebral disc and surrounding soft tissue were cultured for 
microorganisms by direct and enrichment methods. Serum levels of anblipid S 
IgG were determined by ELISA. 
Results: Seventy-six out of 207 (37%) patients yielded positive cultures within 
7 days of incubation (P=  0.001). P ames was recovered in pure culture fhm 
49 (64%) ofthe positive clinical samples ( P =  0.03) and in mixed culture with 
CNS in 8 (11%). Eleven (14%) of patients yielded a pure growth of CNS. 
Microorganisms isolated in pure culture from the remaining samples included 
Propionibacterium granulosum (1%). Corynebactm'um propinquum (1%) and Micro- 
coccus species (1%). Elevated levels of antilipid S IgG were detected in 26 (34%) 
patients with positive CdNIeS. In comparison, Parnes was recovered from 
only 2 out of 27 (7%) control patients, both of whom had scoliosis. Anti-lipid 
S IgG was undetectable in the serum samples of 21 (78%) control patients. 
Conclusion: Low-virulent microorganisms, in particular R acnes may be 
associated with chronic low-grade infection in the intervertebral discs of 
patients with severe sciatica. 
I Pi5921 L' iver abscess due to Bacillus cereus: a case report 
C. Petrogiannopoulos, G. Latsios, A. Zaharof, G. Hartzoulakis, 
C. Flevaris, L. Konddi and K. Bethmouti 
Athens, GR 
It is well known that sacillus cereus is widely recognized as a food-borne 
pathogen that causes a self-limiting gastroenteritis, which requires only 
symptomatic treatment. We describe a case report of a 72-year-old woman 
who was admitted to the hospital because of acute abdominal colic pain. On 
the first day of her admission whole blood and plasma laboratory inveshgations 
were almost normal, with the exception of the liver transaminases, whch 
were only mildly elevated (AST: 48U/L, ALT: 31 U/L). On the second day 
the patient became febrile (39 "C), jaundiced (billirubin: 21.6 mg/dL) and her 
liver function deteriorated rapidly, as shown by the laboratory examinations 
(AST 1988 U/L ALT 953 U/L). The clinical setting deteriorated as well, as 
the colic abdominal pain became worse with the appearance of acute abdo- 
men. Emergency ultrasound and CT investigation of the abdomen was 
performed, whch showed a big abscess (diameter -3 cm) of the right lobe 
of the liver. The patient underwent emergency laparotomy, and the abscess 
was found ruptured to the fiee peritoneal cavity with subsequent g e n e h e d  
peritonitis. The final clinical cLagnosis was acute peritonitis due to a ruptured 
liver abscess. Culture ofthe pus obtavled perioperatively hom the liver abscess 
and the peritoneal cavity isolated Bacillus cereus. 
Conclusion: Bacillus cereus is a Gram-positive organism that usually causes a 
self-limiting gastroenteritis, rarely food poisoning and extremely rarely 
fulminant liver failure. However, no case of liver abscess has been reported 
up to now due to this organism. 
Long-term followup after community-based oral 
azithromycin treatment of hyperendemic trachoma 
J. Schachter, C. R. Dawson, T. M. Lietman and A. Sheta 
San Framico, U S A ;  Alexandria, EGY 
A major part of the SAFE strategy to reduce or eliminate blinding trachoma as 
a major public health problem is broad based treatment with oral azithromycin 
treatment. It is uncertain how long the effects of a single course of such 
therapy will be. T h  is obviously an important issue for the control program. 
In the ACT (Azithromycin in Control ofTrachoma) project a single course of 
therapy (three doses given at 1 week intervals) resulted in 6493% reduction in 
Chlamydia trachomotis infection rates in trachoma endemic areas. The best 
results were obtained in Egypt where the population in the villages was quite 
stable. Relatively good resula (up to 77% reduction in prevalence of infection) 
were also seen in the control villages where a 6-week course of daily topical 
tetracycline ointment was administered. These treatments were begun in 
January of 1995. In early 2002 a follow-up study is planned to assess whether 
beneficial effects of the treatment regimens could still be detected 7 years after 
the treatment. Village wide surveys wd be done assessing clinical status and 
using LCR positivity to diagnose chlamydial infection. Results will be 
compared to the baselme in these same villages prior to treatment in 
1995, and to results obtained 1-year posttreatment. Results will also be 
compared to results seen in adjacent villages where no treatment had been 
done in an effort to assess whether some of the changes that were seen could 
aCNdy be a result of a secular trends rather than the direct outcome of 
treatment. We plan to present the results of the 2002 follow-up survey of 
infection status in preliminary form because of the short period for analysis 
between generation of the data and time of the meeting. 
m) Microbiob@kal examinations of corneal discs 
removed with keratoplastkal surgery 
Z Csukas, B Ban~zs, C Maroh and F Rozgonyl 
Budapest, HUN 
Objective% A total of 100 cornea removed by keroatoplasac surgery were 
mvesitgated for the presence of bacteria, fung or viruses. IndmhOns of the 
operahons were degenerahons of cornea epithehum, dystrophy as well as 
ulcers of cornea. Propronobadenurn acnes was isolated most frequently from 
damagmg of the cornea The possible role ofthe cytotoxlc effect of P acnes was 
investigated 
Methods: One piece of the cornea was cultivated in ifusion-, Schaedler-, 
Sabouraud-broths, respecavely, durmg 10 days. Another part of the cornea 
was tested for the presence of DNA of the herpes- and adenowuses by PCR 
methods. Cytotoxlc effect of the supernatants of R m s  cultures on epithelaal 
hssue cultures (HeLa) m a 96-well plate was e m n e d .  Durmg the mcubahon 
tune of2,6, 10,24,32 and 48 h, cells were subjected to a treatment wth the 
ddution of 1 10 prepared from the supernatants of 5-day Schaedler broth 
cultures. Viabhty of ceUs was detected by means of the tetrazohum-based 
colonmetnc assay (MTT. Sigma). Cytotoxlc effect on epithehal cells was 
lnvestlgated by mcroscopic exammaaons. 
Results: Out of 100 specimens 37 bacterial strains were isolated includmg 
10 aerobic and 27 anaerobic ones No fungus was isolated. Most frequent 
isolates were P acnes (14), Peptostreptococcus sp (7). Sfomatococcus sp (3 ,  Gernella 
sp (l), Clostrrdium bzjermentans (I), Stapkylococnrs sp (3), M~crococcus sp. (l), 
Streptococcus oralis (I), Corynebucrerium sp. (5) DNA of herpes- and adeno- 
vmses could not be detected by PCR method. Exammng 10 P ames strams, 
m each case a sigtllficant, nonlytlc, cytotoxlc effect was detected m HeLa 
a w e  afler 10 h of incubanon After an im~al  perturbaaon effect a concen- 
traaon dependent 3MPk & w e  ~fl the achwty of mtochondrid dehy- 
drogenase was o b w e d  between 10 and 30h of mcubahon m the 
epithehal cells Mmoscopic exarnIMhOn revealed no morphologd changes 
untd 10 h of exposure, in contrast after 24 h, a sllght cytopathic effect could be 
observed 
Conclusion: Only bacterial stram could be detected in corneal assue, of 
which anaerobic species, first of all P acnes was the most frequently isolated 
mcroorgamsm P mnes strams are able to survive under anaerobic condmons 
for 3months or even longer and meanwhde they can produce toxlc 
382 Abstracts 
metabolites. Our results suggest Panes to be harmful for human tissues of 
Merent sites of the body in case of a chronic persistence. 
(m A case of endophthalmitis caused by 
Bacillus cereus 
E. Yam, S. Aksaray, D. Tezeren, E. Giivener, N. Balaban and V. Yetener 
Ankara, TR 
Up to the last years Bacillus cereus has not generally been regarded as an 
important pathogen and is commonly dismissed as a laboratory contaminant 
but nowadays B.rereur infections have been reported with increasing 
hquency. In this report an invasive endophtalrmtis caused by B.cereus is 
mentioned. A 10-month-old gkl had a bilateral congenital cataract operation 
from one eye. After 48 h following the operation endophtalmitis was devel- 
oped. The vitreous liquid was taken and cultured to Blood, Chocolate and 
EMB agar and incubated in 37 "C, 24 h in aerobic medium. Colonies, which 
are M mm in mameter, raised irregular with greyish to greenish hsted-gtass 
appearance, surrounded by a large zone of 8-hemolysis are isolated. In Gram 
staining: Gram-positive, subterminal spore-forming bacteria are taken for 
further identification. The bacteria which are lecithinase positive, penicillin 
resistance and that do not have parasporal toxin crystals are called B. cereus. In 
disc dfision test, the microorganism is susceptible to gentamycin, vanco- 
mycin, and ciproffoxacin and is resistance to penicillin, oxacillin, erythro- 
mycin, clindamycin. As the patient couldn't get response to gentamycin, 
vitrectomy was done. 
Conclusion: Endophthalmitis caused by B. cereus results as irreversible loss of 
vision by the effect of hemolysin B2. So it wdl be very useful to add effective 
antibiotics to the empirical treatment in the traumatic suspicious cases that 
may be caused by B. cereus. 
Helicobacter pylori I I 
lp15961 Antibiotic-resistance of He/kobacter pyiori 
isolated from biopsy of symptomatic patients 
M. Mascellino, A. Covotta, B. Porowska, M. Vergari, M. Manganaro and 
C. Petrucci 
Rome, I 
Objectives: The increasing resistance to therapy is an importimt factor for 
eradication failure of Hehbacfer pylon infection. When metronidazole-based 
therapy is given to a patient infected by a resistant strain, the change of success 
decreases by 20% whereas as far as clarithromycin is concerned, it decreases by 
more than 50%. Generally, treatment is given on an empirical basic. The 
antimicrobial susceptibility testing is reserved for patient not eradicated in 
order to have indication on the choice ofa quadruple therapy. The aim ofthis 
study was to evaluate the in vitro antimicrobial resistance of H. pylon' isolated 
in symptomatic patients previously treated with triple therapy. 
Methods: Symptomatic patients previously treated for H.  pyfori infection 
underwent endoscopy, were included in this study. TWO gastric biopsy 
specimens, from both gastric antrum and corpus, were obtained for the 
culture and for the rapid urease test. A patients was considered H.pylori- 
positive if culture and/or rapid urease test was positive, and H .  pyfori-negative 
when both tests were negative. Antimicrobial susceptibility testing was 
performed by disk ditksion method @by-Bauer modified). All isolates 
were tested for the following antimicrobials agents: metronidazole, tetracy- 
cline and clarithromycin. 
Results A total of 38 patients were investigated (21 females and 17 males). 
Seven resulted H .  pylori-negative and were evaluated as eradicated. In 22 of 31 
not eradicated patients, H. pylon' grew in culture and antibiotics susceptibility 
tests was performed. Four strains were found to be susceptible to all anti- 
microbial agents tested. The resistance rates in H.pylori were as follows: 
metronidazole 60%, clarithromycin 600?, tetracycline 4.5%. The combined 
resistance in H. pylori was: metronidazole + clarithromycin 40%, metronida- 
zole + tetracycline 5%, tetracycline + clarithromycin 5%, tetracycline + clar- 
ithromycin + metronidazole 5%. 
Conclusions: The high rate of resistance to clarithromycin and metronidazole 
observed in this study can explain the eradication failure. The low percentage 
of the resistance of H.  pylori to tetracycline indicates that this antibiotic can be 
used in quadruple therapy. This study support the utility to pefiorm antibiotic 
susceptibility testing of H.pylori isolated in not eradicated patient in order to 
check the susceptibility and to address the physician to a correct treatment. 
w] The importance of Quickstripe (05) H.pylori (HP) 
in differentiating patients with gastrointestinal symptoms 
J. Ristevska, D. Galovska, E. Dimitrovska, V. Malevska, L. Jovanovic and 
E Vuckov 
Bitola, MK 
Objective: The paper aims at demonstrating the role of QS HP in our medical 
practice as a unique available noninvasive test method in detecting of 
antibodies to HF! It also demonstrates the testas correlation to gastrointestinal 
symptoms as a starting point in specific treatment, as well as differentiation and 
further diagnostic ofdiseases associated with HP infection, with more specific 
reference tests. 
Material and methods: In the period 1999-2000, a group of 108 patients 
were observed and antibodies to HP were detected with QS in 57 of them. 
Gastrointestinal symptoms (dyspepsia, epigastr+a, diarrhea) were present in 
all of them. Besides anamnestic and epidemiological data, in making the 
diagnosis, standard biochemical laboratory analysis, bacteriological and para- 
sitological investigations, stomach and duodenum Rtg and endoscopy were 
conveyed. 
Results: The mentioned 57 patients were at the age of 18-73 years; 32 were 
male and 25 female patients. 44 of these patients were at the age of to 45. 
Various gastrointestinal symptoms, including symptoms of gastritis, dyspepsia 
and diarrhea (for which there had been previous negative bacteriological and 
parasitological findings) were present in them. After the obtained positive QS 
test of antibodies to HP, a specific treatment was conveyed (Maritromycin, 
metronidazole and omeprazole) leading to a clinical improvement and 
disappearance of subjective problems. Thirteen patients above 45 years of 
age with a positive QS HP test and with presence of the above mentioned 
symptoms, were recommended stomach and duodenum Rtg and endosco- 
pical examinations for a definite diagnosis with HP infection (with rapid 
urease test) and possible association to duodenal and gastric ulcer or malignant 
disease. 
Conclusion: QS HP as a rapid, immunochromatographical screening test in 
detecting antibodies to HP is the only noninvasive test method avadable in our 
medical practice. It directs as towards starting a speclfic treatment in the 
younger group of patients, which enables accomplishing an obvious clinical 
improvement and disappearance of gastrointestinal symptoms. At the same 
time, it is a significant direction for further diagnosing of ulcer and malignant 
diseases associated with infection to HP in the elder group of patients. We 
expect the application ofmore specific noninvasive reference tests (ELISA) to 
obtain a more exact diagnosis and follow the infection with Hl? 
lp15981 Eradication of He/icobacter py/ork the effect on 
histological lesions of gastric mucosa in a follow-up study 
M. F. Abasiyanik, H. Saribasak, 0. Huten and E. Sander 
Istanbul, TR 
Objectives: Helicobarter pylori eradication heals gastritis and prevents the 
recurrence of peptic ulcers. We investigated the histological changes of 
biopsies obtained from five different regions of the stomach in a 12-month 
follow-up study, compared the results with serology and evaluated the cagA 
Material and methods: A total of 18 patients (10 duodenal ulcer @U), one 
gastric ulcer, seven gastritis) were given lansoprazole 30 mg, amoxicillin 1 g 
and metronidazole 500 mg bid for 2 weeks. Biopsies were collected before and 
at 1 and 12 months after treatment as follows: five biopsies for histology from 
lesser to greater curvatures of the antrum and body and incisura angularis and 
status and variability Using REP-PCR. 
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another three for CLO, PCR and culture. A serum sample was also collected 
at similar dates. Statistical analysis was performed using SPSS 10.1. 
Results: All patients were H.pylori positive by CLO, histology, PCR and 
ELISA before treatment. Histological scores of 0-3 (absence, mild, moderate, 
severe) were done according to the updated Sydney system. H.pylori was 
detected in all five regions ofthe stomach with variable densities being highest 
in the antrum biopsies. Eight patients with atrophy including four with 
intestinal metaplasia. H. pylon eradication was achieved in 39% of patients. 
The score corresponding to chronic gastritis (CG) declined progressively after 
H.pylorieradication, with average values of 1.52, 1.34,1.02 ( P <  0.05) at 0, 1, 
12 months, respectively. The corresponding score for active CG also improved 
progressively after eradication: 1.05, 0.26, 0.47 (P< 0.05). Nevertheless, no 
significant changes were observed regarding atrophy or intestinal metaplasia 
conditions. A 50% decrease in IgG anti-H. pylori titer at 12 months was 
recorded in six patients. RFLP-PCR results showed five difFerent cagA 
positive patterns. A significant correlation was found between the detection 
of ugA gene and DU. 
Conclusions: Eradication of H. pyfori resulted in a histological improvement of 
gastric mucosa that started early and continued for the 12-nlonth period after 
therapy. The improvement in gastritis is observed immediately after eradica- 
tion, however, it is not followed by a sigiuficant improvement in atmphy or 
intestinal metaplasia. The overall improvement in the idammatory compo- 
nent is slow and progressive. 
mj Effect of cytotoxic properties of He/icobacter 
pylon' on different cell lines 
G. Gosciniak, A. Przondo-Mordarska and B. Iwaaczak 
Wroclaw, PL 
Introduction: A number of v d  genes Mering in signal sequence and 
middle-region alleles have been detected in the strains of H.pylori. It has 
also been suggested that the vacA subtype is associated with diEerent cytotoxic 
activities. Some investigators have postulated that the v d  m2 subtype is in 
vitro less active for the HeLa cell line that for the RK-13 cell line or primary 
culture of humans gastric cells. The aim of the study was to determine the 
relationship between vacA genotypes and the activity ofvacuolating cytotoxin, 
which was tested on the following cell hes :  Intestine 407 and RK-13. 
Methods: The v d  genotypes were investigated in 26 H.  pylon' strains isolated 
from patients with duodenal ulcer and in 50 strains from patients with gastritis 
only. The presence of vau4 signal- and mid-region sequences was determined 
by PCR. Vacuolating cytotoxin activity was examined on Intestine 407 cells 
(human embryonic intestine cells) and RK-13 (rabbit kidney cells). The 
results were regarded as positive when at least 50% ofthe cells were vacuolated 
after 24 h. 
Results: Combinations of sla/ml, sla/m2 and s2/m2 were found in 32,43 
and 25% of the tested strains, respectively. Patients with duodenal ulcer 
showed similar proportions of sla/ml 46% (12/26) and sla/m2 46% 
(12/26) vacA genotypes. S 2 / d  genotype was found only in 8% (2/26) of 
the duodenal ulcer patients and in 34% (17/50) ofthe gastritis patients. Using 
Intestine 407 cells, cytotoxin activity was found in 71% (17/24) of the 
H.pylori sla/ml genotype, but only in 24% (8/33) of the sla/m2 genotype 
and in 32% (6/9) ofthe s 2 / d  genotype. With RK-13 cells, cytotoxin activity 
was found in 67% (16/24) of the sla/ml genotype, 36% (12/33) of the 
sla/m2 genotype and in 32% (6119) of the s2/m2 genotype. 
Conclusions: The fiequency with whch the vacuolating cytotoxin produced 
by the H.pylori m2 subtype was detected in Intestine 407 and RK-13 cell was 
similar. To test the expression of the m2 allele it is advisable to use such cell 
lines that are the most specific for subtype B of cytotoxin. 
their possible role in antibiotic resistance by examining associations between 
clarithromycin (CH) and metronidazole (MZ) susceptibilities in v im and 
porin genotype. 
Methods: A total of 142 isolates of H.pylon' with dfferent MZ and CH 
susceptibilities, determined by disc &sion and E-tests, were examined; 49 
fully sensitive, 67 MZ resistant only, 10 CH resistant only and 16 with dual 
resistance. Novel oligonucleotide primer pairs were designed for each hop 
gene, and PCR assays were performed to detect the five genes in all isolates. 
Strains were also genotyped for cagA (presence or absence) and vavl (s and m 
type). 
Results: hopB, C and E were highly conserved in 99% of H. pylori irrespective 
of antibiotic resistance. The hopA primers amplified two products, the 
expected product of 1329 base pairs and a larger product of approximately 
1950 bp. The two prodacts were amplifkd independently and in combination 
from isolates and an amplicon uras observed in 99% of isolates. 5/9 strains 
lacking the expected hopA product were resistant to MZ. Eight strains had the 
enlarged hopA product (1950 bp) ofwhich four were MZ resistant. Both hopA 
products were detected in 48 strains, these comprised 15 (31%) fully sensitive, 
24 (50%) MZ resistant, three (6%) CH resistant, and six (13%) dud resistant. 
For hopQ no expected product was obtained for 24 (17%) ofstrains ofwhich, 
seven (29%) were fully resistant, and 11 (46%) were resistant to M Z  done. 107 
strains were cagA positive and on the basis of combined genotypes (hop type, 
cagA and v d ) ,  the most common strain type was kopA+ (1329 bp), mgA+ 
and vacA slml (34/142). 
Conclusions: Strains were genotypically diverse with respect to the hop and 
other markers investigated irrespective of antibiotic resistance with the 16 
strains that were resistant to both MZ and CH represented by 11 combined 
genotypes. Our results suggest that resistance is not directly linked to the 
absence of particular porins but is more likely to be due to specific mutations 
causing porin protein alterations that &ct outer membrane permeability. 
Infection with H.py/od strains: testing of drug 
sensitivity and genotypes 
E. Andrzejewska, A. Szkaradkiewicz, H. Klincewicz and K. Linke 
Pozna i ,  PL 
Objectives: The s tudy  aimed at genotype analysis and at evaluation of drug 
sensitivity of H.pylori strains, isolated from patients before therapy and 
following ineffective eradication attempts. 
Methods: The studies were performed on 56 patients with established 
diagnosis of duodenal ulcer with presence of H. pylori, treated by the triple 
therapy (PPI + amoxicillin + darithromycin). Control studies were per- 
formed 12months later. Biopsies of gastric mucosa were plated on Colum- 
bia-agar enriched with blood and antibiotics. The cultures were kept in 
microaeropuc conditions for 4-10 days. Sensitivity of strains to metroni- 
dazole, clarithromycin, amoxicillin and tetracycline was determined using 
E-tests. Genotypic analysis of the strains employed PCR-based RAPD 
fingerprinting using a single T7RNAPOL1. 
Results: Following 12months, 10 patients (17.8%) remained H,pylori posi- 
tive. Genotype analysis demonstrated that in seven of the patients the same 
strains were involved before and after the therapy while in three patients 
distinct genotypes of H.pyloti strains were detected following the therapy. 
High fiequency of primary resistance to metronidazole (44.6%) was noted. 
8.9% strains were resistant to clarithnrmycin. 
Conclusion: Relapsing character of H. pylon' - induced pathology may reflect 
both ineffective eradication attempts and re-infection. 
m/ Investigation of porin genotypes as 
possible markers of in vitro antibiotic resistance in 
Helicobacter pylori 
N C Elvis and R J. Owen 
London, UK 
Objedves: The porm are a f a d y  of outer membrane protems involved in 
the transport of molecules into the bacterlal cell and in some bactena, can 
prowde a mechamsm for anhbiohc resistance through changes in outer 
membrane permeabhty. Five porin proteins mth unspeclfied functions have 
been idenafied in H pylon'; HopA, B, C, D and E. Our am was to mvesagate 
1 P1602 Susceptibility to amoxicillin, clarithromycin 
and metronidazole of Helicobacter py/ori strains isolated 
from Turkey 
F. Kolayli, A. Karadenizli, A. Celebi and 0. Senturk 
Kocaeli, TR 
Objective: To evaluate the susceptibility to amoxicillin, clarithromycin and 
metronidazole of Helicobacter pylori strains isolated from Turkey. 
Methods: In this study, a total of 70 strains isolated fiom patients with H.pylm' 
infection were included. Culture was performed using Mueller-Hinton agar 
(selective supplement) with 10% sheep blood. Strains were tested for amox- 
icillin, clarithromycin and metronidazole resistance with Epsilometer test (AEI 
Biodisk, Solna, Sweden) on Mueller-Hinton agar with 100? sheep blood. 
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Result: Of 70 H.pylori strains, nine strains (12.85%) were resistant to 
metronidazole. Four strains (5.71%) were found resistant to two antibiotics 
(Metronidazole + Clarithromycin). In vitro susceptibility testing agamst 
amoxicillin yiekied three (4.28%) resistant strains. These strains were also 
resistant to metronidazole and clarithromycin. 
Conclusion: Although metronidazole resistance was 5@90% in the world, 
especially in developing countries, we found low rates of the resistance to 
metronidazole among H. pylon isolates from Kocaeli, Turkey. Amoxicillin 
resistance was not found in many countries. On the contrary, H. pylori strains 
isolated fiom Kocaeli, Turkey were resistant. 
jP16031 Prevalence of antimicrobial resistance in 
Helicobacter pylori clinical strains 
P. De La Obra Sanz, J. Hernandez, M. J. Martinez, T. Alarcon and 
M. Lopez-Brea 
Madrid, Almeria, E 
Introduction: The objective of this study was to determine the prevalence of 
metronidazole, furazolidone, nitrofurantoin, tetracycline, amoxicillin, and 
clarithromycin resistance in H. pylori clinical isolates. 
Methods: A total of200 clinical isolates, 78 from females and 122 from males, 
were studied. Strains were obtained f b m  antnun biopsy samples following the 
standard methodology. The MIC was determined by an agar dilution method 
using Mueller-Hinton agar supplemented with 7% horse blood containing 
each antibiotic at two-fold dilutions (25&0.008mg/L). Plates were inocu- 
lated with 106cfu/drop and incubated at 37 "C during 2-5days in a C 0 2  
increased atmosphere. The MIC was determined as the lowest concentration 
of the drug inhibiting visible growth. 
Results: Forty-eight H. pylori isolates were resistant to metronidazole (24%. 
95%IC 0.67-0.96). The MICSO and values were 1, and 16mg/L, 
respectively. The dstribution of rnetronidazole resistance was higher in 
H.pylari isolates h m  females than from males (34% vs. 18%, P=0.007). 
Thwty-six H,pylori isolates were resistant to clarithromycin (18%, 95% IC 
0.9&1.14). The MICso and MICgo values were 0.008, and O.O64mg/L, 
respectively. The distribution of clarithromycin resistance was similar when 
H.pylori isolates fiom females and males (14.1% vs. 15.5%, P=O.7) were 
compared. All the strains tested were susceptible to amoxicillin (range 0.008- 
0.5 mg/L), tetracycline (range 0.008-1 mg/L), nitrofurantoin (range 0.008- 
2 mg/L) and furazolidone (range 0.008-2 mg/L). 
Conclusions: Metronidazole resistance was hlgher in women than men. 
Furazolidone and nitrofurantoin may be good alternatives to metronidazole 
for treating H. p y h i  infection. 
I P1604 1 Mutant frequency and mutation rate in 
Helicobscter pylori clinical isolates 
P. De La Obra Sanz, N. Prieto, M. Lopez-Brea and T. Alarcon 
Madrid, E 
Introduction: The objective of t h i s  study was to determine the in vitro 
frequency of spontaneous mutations in H.pyZori that confer resistance to 
metronidazole, Eurazolidone, and nitrofixantoin. 
Methods: Ten H.pylori clinical isolates, as well as the reference s t r a i n  NCTC 
11637 were used in ths study. metronidazole, furazolidone, and nitrofur- 
antoin MIC were determined by agar dilution method (NCCLS, 1999); all 
strains were susceptible to this antibiotics. H.pyIori strains were gown on 
Brain Heart Infusion (BHI) with 10% fetal bovine serum (FBS) at 37 "C under 
microaerobic conditions to late log phase (3 days). This culture was diluted 
10-4 in BHI broth with 5% SFB. 15 aliquots were prepared, which were 
grown for 3 days to obtain parallel and independent cultures. The number of 
resistant mutants that emerged in each culture was determined by plating the 
all culture on BHI agar with 7% horse blood supplemented with 2mg/L of 
nitrofurantoin or furazolidone or 8 mg/L of metronidazole. The total number 
of cells was determined by plating an appropriate dilution (10-5, 104,  and 
10-7) of three cultures on non selective memum. Colonies on both selective 
and non selective plates were counted afker incubation for 4days. The 
frequency of resistant mutants was expressed as the mean number of resistant 
cells divided by the total number of viable cells per culture. The mutation rate 
(a) per cell division w a s  calculated as a = m / N t ,  where Nt is the total cell 
number per culture, and m is the number of mutations that have occurred in 
the culture. 
Results: No colonies grew on plates supplement with fiarazolidone or 
nitrofurantoin. Four strains show spontaneous metronidazole resistance: 
0 HP-1, no. of cells per culture: 4.5 x 10'; resistant bacteria: zero hcaon:  
6/12; mean: 6; fiequenq of mutants: 1.3 x lo-'; and mutation rate: 
0 HP-2, no. of cells per culture: 4.0 x 10'; resistant bacteria: zero fixtion: 
4/12; mean: 18; frequency of mutants: 4.5 x lo-'; and mutation rate: 
0 HP-3, no. of cells per culture: 3.9 x 10'; resistant bacteria: zero fraction: 
8/12; mean: 6; hpquency of mutants: 1 . 5 ~  lo-'; and mutation rate: 
0 HP-4, no. of cells per culture: 5.0 x 10'; resistant bacteria: zero fixtion: 
10/12; mean: 3; frequency of mutants: 6 x lo-*; and mutation rate: 
Conclusions: Furazolidone and nitrofurantoin resistance occurs sponta- 
neously at a much lower frequency than metronidazole resistance. 
1.5 x 
2.25 x 
1.02 x 
4.0 x 
Resistance of Helicobacter pylori isolates to 
metronidarole, clarithromycin, tetracycline, amoxicillin, and 
cefixime in Israel 
Z. Samra, H. Shmuely, G. Dinari, Y. Niv, D. Passaro, J. Bachor and 
J. Yahav 
Petach- Tiqva, IL; Chicago, USA 
Objectives: Antibiotic resistance of Helicobarter pylon differs according to 
geographical area and may have an important impact on the efficacy of 
therapy. The aim of the study was to determine the resistance of H.pylori 
isolates to metronidazole (MET), clarithromycin (CLR), tetracycline (TC), 
amoxicillin (AM) and cefixime (CEF) in Israel. 
Methods: One hundred and thirty-eight isolates of H. pylori were isolated 
from specimens of 138 dyspeptic adults, including 28 patienb previously 
treated for H .  pylori infection. Antibiotic susceptibility was tested by E-test 
method (AB Biodisc). Resistance was defined as follows: MIC 2 0.5 pg/mL 
for AM, 21 p g / d  for TC; 2 2  bg/mL for CLR and CEF; 2 8  kg/mL for 
MET. H.pylori ATCC 43526 strain was used for quality control. 
Results: All isolates were sensitive to TC, MIC 5 0.38 pg/mL; resistance to 
AM was found in one isolate (MIC = 1.5 pg/mL.) sensitive to all other 
antibiotics, recovered f b m  untwated patient. Resistance to CEF was found 
in two isolates h m  each group (P=0.18). The prevalence ofresistance to 
MET and CLR was much higher in the isolates from the treated than the 
untreated patients: 60.7 and 38.2% for MET (P'0.03); 46.4 and 8.2% for 
CLR (P < 0.001). In the treated group all the METor CLR resistant isolates 
were from patients previously treated with METor CLR, respectively. Dual 
resistance to METand CLR were found in 5.5% ofisolates from untreated and 
32.1% of treated patients (P < 0.001). High MIC value of 2256 p g / d  for 
MET and CLR were observed, respectively, in 30 and 5.4% of isolates from 
untreated patients and 42.6 and 25% of isolates from treated patients. 
Conclusions: TC and CEF are potential alternative agents for the treatment of 
H.pylori infection. In vitro susceptibility testing may improve outcome 
especially after treatment failure. 
(p1606] Antibody-dependent cell-mediated activity 
against Helicobacter pylori in mice 
S. Peppoloni, S. Mancianti, G. Volpini, S. Nuti, P. Ruggiero, E. Blasi, 
R. Rappuoli and G. Del Giudice 
Siena, Modena, I 
Objectives: Antibody-dependent cellular cytotoxicity against Helicobacter 
p y h i  (Hp) was assessed using Hp-specific immune s e r u m  and purified 
IgG in an in vim assay in whch peritoneal cells (PEC) were used as effector 
cells. 
Methods: Lymphoid cell suspension was incubated for 2 h at 37 "C with 
bacteria coated with specific antibodies and at the end of the incubation 
period, diluted aliquots of the mixture were plated. Plates were incubated in 
microaerophylic conditions €or 4-7 days and then the colony-forming units 
counted. 
Results PEC possessed some natural antibacterial activity, which was sig- 
nificantly augmented by Hp-specific antibodies in a dose-dependent manner. 
Specificity was shown by the fact that preabsorption ofserum with an excess 
of whole Hp cells sigruficantly decreased the antibody-mediated killing, 
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whereas serum preabsorbed to E.cofi retamed h s  effect These results 
were also conftrmed quahtatively wth Merent Hp strams. The PEC 
populanon was analyzed at the fluorescence-activated cell sorter Most of 
anhbacterial achmty was associated unth ceh that were non adherent, D Z - ,  
CD19-, CDllc-, Thy 1 2-, CDllb+ and CD16/32+, SUggeShng that the 
m n  effector pop&hOn belong to the macrophage lmeage. S m i h  anh- 
bacterial lulling was also observed wth  the macrophage cell ltne GG2EE. 
Conclusion: These results suggest that antibody-dependent anhbactenal 
achmty may be unportant in the effector mechamsms agamst Hp 
/p16071 Morphological changes in upper gastrointestinal 
tract mucosa and He/icobacter py/ori infection in HIV- 
infected patients 
P Skwara, T. Mach and I Sobczyk-Krupiarz 
Cracow, PL 
Objectives: The aim of the study was to evaluate morphologcal changes m 
upper GI tract mucosa and prevalence of Heficobacter pylon' (Hp) d ic t ion  in 
HIV infected patients wtth CD4 lymphocyte count <200/mm3 m compar- 
ison to pauents w th  CD4 > 200/mm3 
Methods: A total of 68 HIV-infected pauents wlth dyspephc symptoms 
(medlan age 34years) were stuhed, among them 36 (53%) had CD4 
Lyme borreliosis, anthrax and tetanus 
lymphocyte<200/mm3 (group l), while 32 (47%) had CD4 lymphocyte 
> 200/mm3 (group 2). During endoscopy, evaluation of GI tract mucosa 
was done and biopsy samples were taken &om corpus and antrum of stomach 
for histological analysis and rapid urease test. 
Results: Basing on gastroscopy, following macroscopic lesions were found in 
group 1: mycotic esophagitis in 13 patients (pts) (36%), reflux esophagitis in 
eight pts (22%), chronic gastritis of corpus in 16 pts (44%), antrum in 35 pts 
(97%). gastric erosions in three pts (8%), duodenitis in 21 pts (58%). duodenal 
erosions and/or ulceration in 4 pts (11%); in group 2: mycotic esophagitis in 
two pts (6%), reflux esophagitis in 10 pts (31%), chronic gastritis of corpus in 
19 pts (59%), antrum in 27 pts (84%). gastric erosions in one pt (3%), 
duodenitis in 19 pts (59%). duodenal erosions in five pts (15%). Histological 
analysis revealed in group 1: chronic active gastritis in corpus in nine pts (25%) 
whde in anhum in 12 pts (33%). chronic nonactive gastritis in corpus in 18 pts 
(50%) while in antrum in 19 pts (53%). It was found in group 2 that: chronic 
active gastritis in corpus was present in nine pts (28%) whde in antrum in 20 
pts (62%), chronic nonactive gastritis in corpus in 18 pts (56%) while in 
antrum in 10 pts (31%). Hp infection was detected in 16 pts (44%) in group 1 
and in 26 pts (81%) in group 2 ( P <  0.05). 
Conclusion: In HIV infected patients with low CD4 count, mycotic eso- 
phagitis and erosive gastritis were more fiequently found, whereas reflux 
esophag~tis was less often diagnosed. Chronic active gastritis with Hp infec- 
tion was si&icantly less fiequent in the group of patients with low CD4 
count. 
IP1608( Borrelibinduced hyporesponsiveness is 
cross-reactive to endotoxin and Toll-like receptor 
(TLR)-Zdependent 
I. Diterich and T. Hartung 
Coplstunce, D 
Objective: If left untreated, infection with Borrelia burgdo@ usually leads to 
chronic Lyme disease. It is s d  unknown, how this pathogen manages to 
persist in the host in the presence of competent immune cells. We recently 
reported that Bonelia modulate the host's immune response, so perhaps 
preventing their elimination. Here, we further characterize Borrefia-induced 
immunomodulation by desensitization experiments. 
Methods: Human PBMC were pretreated and subsequently restimulated 
with Borreliu lysate, heat-inactivated Borreliu or endotoxin (LPS) in 
combinations. TNF-cr and IL-10 release in the supernatant were measured 
by ELISA. Further, the role of TLR2 and TLR4 receptor was tested in 
analogous desensitization experiments, using bone marrow lavage cells Lorn 
C3H/HeJ (TLR4-mutated) and TLR2-knock-out mice in comparison to 
the respective wild-type cells. 
Results: Macrophages pretreated with Boneliu lysate or heat-inactivated 
Bonelia showed significantly reduced cytokine release on restimulation with 
either Borrelia-specific stimulus. In addtion, hyporesponsiveness to a hetero- 
logous, TLR4-mediated stimulus (LPS) could be induced and vice versa LPS 
could induce desensitization to Bonefiu-derived stimuli. Furthermore, in the 
absence of TLR2-recepto1, no cytokine release could be induced by Borrelia 
and no state of hyporesponsiveness to restimulation with LPS w a s  achieved. 
Respectively, no desensitization to Borrelia stimuli could be induced by LPS in 
the absence of a functional TLRCreceptor. 
Conclusion: Borrelia induce a state of desensitization in human PBMC and 
murine macrophage populations, which is cross-reactive to endotoxin- 
stimulation and is TLR2-mediated. Thus, Borrelia-induced hyporesponsive- 
ness represents a possible mechanism enabling the survival of this pathogen in 
the host despite the presence of immune cells. 
jP1609/ Modulation of cytokine release by antibiotics 
used in therapy of borreliosis 
I. Diterich, C. Hermann and T. Hartung 
Constance, D 
Objective: Ten percent of borreliosis paaents are unresponsive to antlbiotic 
therapy, and thus suffer from a persistent infection with Borrelia burgdo@i. We 
recently reported that Borrelia attenuate the host's immune response which 
might prevent elimination and suggested that antibiosis should be supported 
by the reconstitution ofimmune competence in chronic borreliosis. We tested 
whether the antibiotics generally used in borreliosis therapy have stimulatory 
effects on the immune system in addition to their bactericidal activity. 
Methods: Whole blood and isolated leukocyte populations fiom healthy 
volunteers were stimulated with Borrelia-derived stimuli or with endotoxin 
(LPS) in the presence or absence of antibiotics. TNF-a, INF-y and L l O  
release in the supernatant were measured by ELISA. 
Results: Of all the antibiotics used for borreliosis therapy, none showed clear 
pro-inflammatory effects. However, doxycycline exerted a strong inhibitory 
effect on IFN-), release, and simultaneously reduced the release of IL-10 in 
low micromolar concentrations by up to 50%. This inhibitory capacity was 
further characterized by determining the blood cells which were affected: 
lymphocytes were directly influenced by the antibiotic, resulting in reduced 
IFN-7 release. The mechanism of this effect is being investigated further. 
Conclusion: Thus, up to now, we could not identify a candidate antibiotic 
with immunostimulatory properties. However, doxycycline, a commonly 
used antibiotic in borreliosis treatment was shown to have immunosuppressive 
activities which may be less favorable in late-stage borreliosis cases. 
v1 Lyme borreliosis and human granulocytic 
ehrlichiosis in Bulgaria 
I. Christova, L. Schouls and J. S. Dumler 
Sofia, BG; Bithoven, NL; Baltimore, USA 
In recent years, emerging tick-borne infectious diseases are the focus of 
increasing scientific and medical interest. Lyme borreliosis is the most 
commonly reported tick-borne infection in Europe and North America. 
Bulgaria is endemic for Lyme borreliosis. About 400 cases of Lyme borreliosis 
are reported annually (incidence 5/100 000). Borrelia burgdotj% sensu lato were 
isolated &om ticks and patients. Identification of the isolates by serologic and 
genetic methods showed h& cultivation rate of B.garinii (44% ofthe isolates), 
followedby B. burgdotferisensu shicto (35%) and B. afiei (21% ofthe isolates). 
B. buddofi' s.1. were detected in 32% of adult 1. ridnus ticks by PCR. 
B. afzelii was highly prevalent, found in 54% (21139) of the positive samples. 
B. burgdofen S.S. was detected in 8% (3/39) ofthe positive ticks, B.gariniiin 5% 
(2/39), B. vafairiunu in 3% (1139). Double and triple infections were also 
found. Human granulocytic ehrlichiosis (HGE) is recently described zoonotic 
nonspecific febrile illness, which appears to be the second most common tick- 
borne disease in USA. Antibodies to the agent of HGE were detected in 
Bulgarian patients with tick bites in 9.7% of patients with early Lyme 
borreliosis, in 8% of patients with lymphadenopathy, in 20% of those with 
fever, chills, and headache, and in 4% of persons without clinical symptoms 
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after the tick bite. More recently, the fust clinicalky and serologically con- 
ftlmed acute case of HGE in Bulgaria was described. The agent of HGE was 
detected by F'CR in 34% of adult field-collected ticks. Codection with 
B. burgdo@ and the agent of HGE was found in 12.90? 98/62) of Bulgarian 
field-collected I. ricinus female ticks, 14% (7/50) of the male ticks, and 2.2% 
(2/90) of the nymphs. These data show that Lyme borreliosis and HGE are 
widely distributed in Bulgaria and that coinfection with both agents in 
patients is probably not uncommon. 
m] Case study: problems of diagnosing Lyme 
arthritis in a boy with knee-joint inflammation 
A. Chudnicka, M. Koziol-Montewka, J. Krol, B. Mizak and S .  Snela 
Lublin, Pulawy, Rzeszw, PL 
Background: Borreliosis as a multistage infection, especially in the chronic 
form, might be a serious diagnostic problem. One of the distant consequence 
of Boveliaburgdotjki infection is Lyme arthritis. In the presented case of 17- 
year-old boy, the clinical presentations - knee-joint inflammations and 
information of twice bite by tick (9 and 12 years earlier, without arise of 
erythema) were the basis of suspected borreliosis. 
Methods: In the presented case of the boy, there was observed chronic (for 
about 3 years) knee-joint inflammation. During acute periods, there was 
observed fever (above 39°C) with abundant, growing exudation of synovial 
fluid with numerous granulocytes. The microscopic examination of synovial 
fluid in dark field microscope, showed alived spirochetes, with morphologic 
features of Bonelia. Furthermore, staining by Giemsa method showed spir- 
ochetes. There were also performed serologic tests (ELISA) detecting anti- 
bodies in classes IgM and IgG. The results were negative. The confirmation of 
8. bqdogm' infection was performed by PCR method (in synovial fluid, 
blood and urine) using inner primers (N-PCR). Ceftriaxon was used at the 
first stage of treatment. After a few days of improvement, the intense clinical 
symptoms appeared. The microscopic exanltnation of synovial fluid during 
antimicrobial therapy showed that Bonelia transformed to cytoidal form, 
spherical, morphologically noncharacteristic for spirochetes. Then, the 
arthotonly and drainage was performed and treatment with amicacin (7 days) 
and cefotaxime (21 days). 
Conclusions: In the presented case, the crucial diagnostic element was 
detecting Bonelia in synovial fluid using dark-field microscope, simulta- 
neously with negative serologic studies. PCR method confirmed the presence 
of B. burgdorfen'. The fact that during diagnosis of Lyme disease, negative 
serologic results and cases of transforming from normal form of Bowefia to 
cytoidal form are observed during antibiotic treatment, which poses a crucial 
diagnostic dificulty. 
vl Lyme's disease in Arkhangel'sk province of the 
Russian Federation 
N. Tokarevich, N. Stoyanova, N. Chaika, A. Kozarenko, V. Kulikov, 
Y Andreichuk, R. Buzinov and V. Sosnitsky 
Sr. Pefeisburg, Arkhangefik, RUS 
Objectives: The Arkhangel'sk province is located in the northern part of 
the Russia. Ticks Ixodes - vectors of Lyme disease (L.D.) - can be found in the 
southern forest part of the province and are absent almost completely in the 
northern area (polar and tundra). The goal is to s t u d y  the geographical 
distribution of L.D. in Arkhangel'sk province. 
Methods: Almost 150 samples of Ixodespersufcatus were tested with PCR to 
detect vectors infection with B. bupdo@ s.1. and to idenafy the genospecies 
characteristics of the agent. The ELISA kit 'Lymetest-IgG' (Helix, Ltd) with 
mix of recombinant BomJiu proteins was used for detection of IgG antibodies 
to Borrefia. Almost 200 human sera were tested: tot samples from population 
of Nenetsky Autonomous District located in the northern tick-free area of the 
province and 83 samples of persons bitten by ticks in the southern area of the 
province, including 13 patients with clinical diagnosis of L.D. 
Results: During 3years (1999-2001), 5259 persons bitten by ticks and 106 
patients with L.D. were registered. Most cases were diagnosed clinically, 
taking into consideration the epidemiologic data. The morbidity rate was 2.6 
cases per 100000 persons that is two times lower in comparison with the 
average rate for the whole country. The disease developed in 2% of bitten 
persons. Most cases (93%) were registered in May-August. The age dismbu- 
don ofpatients was as follows: children: up to I4year3 of age (5.4%); adults: 
20-60years (45.9%); retired persons: males over 60yean and females over 
55 years (47.3%). There was no correlation between profession of people and 
morbidity rates. Most patients (56.8%) developed disease after being bitten by 
ticks at their private vegetable gardens or in cottage yards. Forty-four percent 
of ticks 1.persukatus were infected with B. burgdorferi s.1. The distribution of 
Borrelia that was found in ticks by genospecies was as follows: B .  af+elii: 73.8%; 
B.gan'nii: 15.4%; the mixture of B .  dzelii and B.garinii: 10.8%. In sera h m  
penons living in the northern area (Nenetsky Autonomous Disaicf), anti- 
bodies to Bonefia were not found. Antibodies were detected in 17 persons 
bitten by ticks in southern areas and antibody titers increased in nine patients. 
Conclusions: L.D. is widely spread in southern regions of Arkhangel'sk 
province. Two genospecies of Boneliu are transmitted in the province - 
B .  afzelii and B.gan'nii. Many cases of L.D. are not diagnosed. It was proved 
with results of IgG detection with ELISA. 
[p1613] Prospective dynamic study on PCR in urine in 
Lyme neuroborreliosis 
D. Picha, L. Moravcov6, S. Lisiiovi and E. Zdkky 
Prague, CZ 
Objectives: Nested PCR technique has been developed for diagnostic of 
Lyme neuroborreliosis. Prehmary  results of prospective dynamic study of 
urine PCR in neuroborreliosis are presented. 
Methods: Two sets ofprimen were used in nested PCR -first one for plasmid 
gene encoding OspC protein and second one for chromosomal gene 16s 
rDNA. P C R  was proved for urine and CSF (CSF data are not presented here). 
CSF/serum antiborrelial antibody index has been established accodng to 
Reiber et al. 
Patients: Till now 41 patients with neurologic involvement in Lyme borre- 
liosis have been enrolled in prospective designed study. All patients were 
examined clinically before and after treatment (3 weeks intravenously admi- 
nistered penicillin) and later after 3 and 6 months. Examinations of CSF and 
serum antibodies and urine PCR were performed in the same periods. 
Laboratory diagnosis was established on positive CSFIserum-specific anti- 
body index (AI), in five cases only on CSF PCR positivity (examined 
elsewhere). Clinical manifestations comprised Bannwarth's syndrome (26), 
acute encephalitis (lo), polyradiculoneuritis (4) and myelitis (1). 
Results: So far, 41 patients have been included. Urine PCR and A1 were 
positive in 23 (56%) patients in the same time, positive A1 and negative PCR 
were in 13 (32%). Only in five cases was DNApositive and A1 negative. Urine 
PCR was positive in 20 patients before treatment, in 18 cases after treatment 
and in four patients on 3months' control. No patient was positive after 
6 months. 
Conclusion: In sum, urine P C R  was positive in 28 (68%) patients. The 
frequency of positivity decreased from 20 (49%) patients at the beginning of 
therapy to 18 (44%) after treatment (3weeks). Four patients (13%) on 
3 months' control were positive and no positive was found out after 6 months. 
OspC primer was positive in eight and 16s rDNA in 22 samples, both of them 
7 times. 
Acknowledgment: This study is supported by grant of Health Ministry C R  
6244/3 and study 11 1 30 0003. 
Ip1614j Cutaneous anthrax as an occupational disease in 
Central Anatolia, Turkey 
M. A. Yetlun, E. Tanyel, N. Tulek and L. Doganci 
Ankara, TR 
Objective: Zoonotic disease, anthrax, has increasing medical attention world- 
wide. Incidence and medical interest of cutaneous anthrax had been markedly 
decreased in developed countries, but it remains a considerable public health 
concern in Turkey, as so in many developing countries. The aim of this 
retrospective s t u d y  is to describe epidemiologic and clinical features ofour 13 
cases of human cutaneous anthrax. 
Methods: All of the cutaneous anthrax cases admitted to the Infectious 
Diseases Clinic of Ankara Hospital between July 1999 and September 
2001 were enrolled in the study. Epidemiologic data, source of the exposure, 
occupation, age, gender, clinical presentations with incubation period, pre- 
vious antibiotic use, previous surgical procedures and other findings and 
laboratory diagnostic works were noted. 
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Results: AU of our patients had occupational exposure; they were middle- 
aged people with low income. Female to male ratio was 3/10, and they were 
all living in the suburban regions of Central Anatolia. Only one patient had 
the typical scar on face (lower eyelid) and all others had their lesions on upper 
extremity. None of the cases had fatal outcome, but one patient had vision lost 
due to cicatricial ectropion ofleft eye. Patients treated 10-21 days accordtng to 
their clinical responses. Total of eight patients had positive smear and two of 
them also had bacteriologic confirmation. Main drug used to treat was 
parented penicillin and ampicillin plus sulbactam combinations and cipro- 
floxacine were used occasionally. 
Conclusion: Anthrax is an occupational disease in our country and occurs 
more commonly in summers. All of the cases in our centers had an occupa- 
tional history. Majority of these patients have been treated with various 
antibiotics elsewhere before the adrmssion to our center. Although, there has 
been no report of a major epidemic neither in human nor in veterinary 
medicine in Turkey, but our findings emphasize that anthrax still remains a 
public health concern in rural areas, and animal products provided from these 
areas may continue to pose a great risk for exposed people. 
I P1615 I Killing of anthrax spores by aqueous iodine 
W. Gottardi and M. Nag1 
Innsbmck, A 
Objectives: Although, the degerming activity ofpreparations containing free 
molecular iodme against nonspodating microorganisms is well investigated, 
only few reliable studies on its sporocidal activity are known. 
Methods: We have examined the action of aqueous iodine (5,10, and 15 ppm 
free iodme) and of  the commercial preparation Betaisodona solution 
standardized against spores of three virulent and one nonvirulent strain of 
Bacillus anthracis compared to spores of B. subtilis and Clostridium spp. 
Results Free iodme in aqueous solution demonstrated a high activity against 
B. anthracis. which manifested in killing times of 1-5 min. 
Conclusions: Because of these results, iodine solutions can be recommended 
as a disinfectant in case of skin contamination with B. anthracis. 
Ip16161 Rapid identification and virulence 
characterization of Bacillusanthracis by 
pyrosequencing 
H. Kling, S. Hjalmarsson, A. Alderborn, C. Fock, I. Muldin, 
U. Eriksson, F. Elgh and L. Engstrand 
Uppsala, Umea, S 
Objectives: Inhalation anthrax is an acute infectious disease caused by the 
spore-forming bacterium Bacillus anthraris. Infection can be prevented with 
antibiotics if administered within the first 2 4 4 8  h after exposure to B. anthra- 
cis. Any delay in treatment reduces chances of suMval if initial symptoms of 
inhalation anthrax are present. Therefore, the ability to distinguish B. anthracis 
from closely related Bacillus species, and to distinguish virulent from avirulent 
strains is of great importance. Virulent strains of B. anthracis harbor two 
plasmids, pXOl and pX02, carrying genes encoding the anthrax toxin, 
and products necessary for encapsulation, respectively. A rapid and reliable 
technique for identification and characterization of B. anthracis is urgently 
needed. Pyrosequencing is a novel sequencing-bysynthesis technique used 
for rapid and accurate analysis of short, specific DNA sequences. Up to 96 
DNA samples can be analyzed within a single, 1-h assay. We investigated the 
use of pyrosequencing for species identification and virulence characteriza- 
tion of B. anfhracis. 
Methods: Plasmids and chromosomal DNA 60m 10 B. anthracii strains were 
extracted. B. cereus and B. subtilis were used as negative controls. PCR primers 
were designed to amplify a 129-bp kagment of the B. anthracis chromosomal 
marker Ba813, a 177-bp fragment of the lefgene encoded on pXO1, and a 
127-bp DNA sequence of pX02. The PCR hgments were analyzed by 
pyrosequencing. 
Results: Nine of the 10 bacterial sirains examined were clearly identified as 
B. anthracis by pyrosequencing analysis of 20 nucleotides ofBa813. B. anthracis 
identity was also confirmed by culture. One sample was excluded due to PCR 
fdure. Sequence analysis determined the presence or absence of pXOl and 
pX02, and thereby the virulence stam. of the bacterial strains examined. 
Seven of the 10 B. aathrads strains were positive for both virulence plasmids, 
whde three strams lacked both or either of them. Accuracy of the sequence 
analysis was between 99.6 and 100%. 
Conclusions: We found that pymsequencmg prowded a convement way 
to rapidly gam informanon on species idenuty and virulence status of 
B. anthrms. 
Ip16171 Anthrax in pregnancy: report of two cases 
A. Kadanali, M. A. Tasyaran and S. Kadanali 
Erzurum, TR 
Objective: The purpose of tlm report is to review the rarely seen anthrax cases 
in pregnancy, its maternal and perinatal complications, and management of 
anthrax in pregnancy. 
Case reports: 
0 Case 1 : A 33-year-old pregnant women with 32 weeks of pregnancy was 
admitted to hospital with a 5-day history of flaying a dead cow. The patient 
had a submandibular eschar with surrounding vesicles that oozed clear 
yellow fluid, extensive edema on the face, neck and upper thorax as to 
embarrass respiratory function and fever (38 "C). Obstetrical examination 
confirmed the 32 weeks of normal pregnancy; the patient had no signs and 
obstetrical findings (without any uterine contraction and cervical dilata- 
tion) ofpreterm delivery at the time of admission. The white cell count w a s  
28 300/mm3. Direct microscopic examination of vesicle fluid revealed 
large Gram-positive bacilli. Penicillin G and prednisolone therapy was 
administered immediately with the presumptive diagnosis of anthrax; the 
isolated organism was later identified as Bacillusanthracii. The signs and 
symptoms of anthrax were disappeared w i h  lodays of therapy, but 
patient delivered a preterm baby on the 13th day of her hospital admission. 
0 Case 2: A 29-year-old pregnant women was hospitalized with a 4-day 
history of swelling of the right arm and weeping lesion at the right elbow. 
The patient was febrile (38.5 "C) and had a 2-cm open sore with surround- 
ing erythema and induration that oozed serous fluid. Obstetrical examina- 
tion revealed 33weeks of normal pregnancy without any findings of 
preterm delivery. The white cell count was 19600/mm3. Direct micro- 
scopic examination of the vesicle fluid revealed large Gram-positive bacilli. 
The patient was treated with procaine penic ih  for 7 days. On the day of 
discharge from the hospital, preterm delivery began which was not 
prevented with tocolytic therapy and the patient delivered a 34 weeks of 
preterm baby. 
Conclusion: Since anthrax in pregnancy is rarely seen, its management in 
pregnancy, maternal and perinatal complications are not entirely known. 
These two cases showed that anthrax in pregnancy can be s u c c e d y  
managed as in a nonpregnant woman. As in progress in our two cases preterm 
delivery may be one of the major complications for perinatal outcome. The 
obstetrician must be aware of the probability of this complication even at the 
end of the anthrax therapy and may consider the early tocolysis in cases of 
anthrax in pregnancy. 
1 P1618 1 Antimicrobial susceptibility of Bari//usanthracis 
isolated from patients with cutaneous anthrax 
M. Z. Bakici, N. Elaldi, I. Dokmetas and M. Bakir 
Sivas, TR 
Objectives: To test the antimicrobial susceptibility of Bacillus anthrm's isolates 
to various antimicrobial agents. 
Methods: The 28 B. anthracis isolates collected between 1992 and 2001 &om 
cultures of the patients with cutaneous anthrax at Cumhuriyet University 
Hospital were tested for susceptibility to various antimicrobial agents by using 
SceptorTM (Becton Dickinson Diagnostic Instrument Systems, Towson, MD) 
automatic system. They were identified by conventional methods. Suscept- 
ibility breakpoints for interpreting minimum inhbitory conceneation (MIC) 
results for B.anthrm> have not been determined by the NCCLS; thus, 
breakpoints for staphylococci were used. 
Results: All isolates were sensitive to penicillin (MIC < 0.03 pg/mL), and did 
not produce 8-lactamase. Although, all isolates were sensitive to cephalothin 
(MIC < 8 pg/mL), ciprofloxacin (MIC < 1 pg/mL), clarithromycin (MIC < 
2 pg/mL), clindamycin (MIC < 0.05 pg/mL), tetracycline (MIC < 4 p.g/mL) 
and gentamicin (MIC < 4 pg/mL), one of the isolates was resistant to 
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ceftriaxone (MIC < 64pg/mL). All isolates were resistant to cefepime 
(MIC > 16 pg/mL) and cotrimoxazole (MIC < 4 pg/mL). The carbapenem 
antibiotics such as meropenem and imipenem, and glycopeptide antibiotics 
such as teicoplanin and vancomycin showed good activity with MICs of 
<4 pg/mL., <4 pgg/d, <8 Bg/mL., and <2 pg/mL, respectively. Suscept- 
ibility of the six isolates was considered intermediate to ceftriaxone 
(MIC = 32 ~g/mL). 
Conclusion: B. anthracis isolates were susceptible to antimicrobials suggested 
the treatment of anthrax such as penicillin, cephalothin, ciprofloxacin. and 
resistant to fourth generation of cephalosporin and cotrimoxazole in our 
region (Sivas city, which is located in the Middle Anatolian of Turkey). 
[ P1619 I The outcome of 43 adult tetanus cases in a 
tertiary hospital in Turkey 
0. Ergonul, A. Erbay, S. Eren and B. Dokuzoguz 
Ankara, TR 
Objective: To evaluate the outcome of 43 patients with their clinical and 
epidemiologic characteristics. 
Methods: Ankara Numune Education and Research Hospital is a tertiary 
hospital with 1100 beds. This is a retrospective study which includes all the 
patients who were diagnosed with tetanus and hospitalized in Clinical 
Microbiology and Infectious Diseases Department between 1990 and 
2OOO. All the patients were treated according to the guidelines, isolated in 
a quiet environment, surgical debridement was performed if necessary, and 
Rickettsiae 
penicillin G i.v., human tetanus immunoglobulin, diazepam, prophylactic 
heparin and supportive therapy were given. 
Results: The majority of the cases were admitted in the first half of the last 
decade (67%). All the patients were >15years of age, 28 (65%) patients were 
male and 15 (35%) were female. The mean and median age was 44.6 and 
51 years, respectively. Most of the patients were h r n  rural Anatolia (77%), 
48.8% of the patients were farmers, 34.8% housewife, 13.9% worker, and 
2.3% unemployed. The most common clinical manifestations were trismus 
(100%). loss of consciousness (loo%), abdominal rigidity (93%), dysphagia 
(81%), risus sardonicus (72%), generalized convulsion (65%). opustotonus 
(63%), nuchal rigidity (63%), fever (37%), tachycardia (33%), sweating (304b), 
respiratory distress (26%). The mortality rate (MR) was higher in patients 
who had tachycardia (79%). The patients with incubation period less than 
10days had sigmficantly higher MR (81%) compared to patients with 
incubation period of more than lodays (19%) (P<O.O01). The MI1 of 
the patients who had wounds on the head and neck or the body (100%) was 
higher than the patients who had wounds at the extremities (55%). The MR 
was >YO% in fmt 1Odays of hospitalization, but decreased to 18% after 
10 days. The most common form of trauma was caused by a piece of metal 
(39.5%) or splinters of wood or thorn (25.5%). In the patient histories 
obtained h m  their relatives, the tetanus immunization was absent or 
inadequate or not known. 
Conclusion: Even though the MR rate of tetanus cases admitted to our clinic 
was declined in the last half of the last decade, the overall MA for 10 years was 
found to be high. One of the major reasons for the high M R  was delay in 
diagnosis and consequently lack of adequate medical aid prior to admission to 
our hospital. The incubation period was a significant predictor of outcome of 
the disease. 
[p162oj Q-fever, human and animal morbidity in some 
regions of Bosnia and Henegovina, 2000 
S. Zvizdic, T. Bajrovic, E. Beslagic, S. Puvacic, R. Velic, J. Maglajlic, 
S. Hamzic, E. Kapic and A. Zvizdic 
Sarajevo, BLH 
Objectives: C. burnetti causes Q-fever, which may present as an acute febrile 
illness with pneumonia or as a chronic infection with endocarditis. C. burnetti 
is an obligate intracellular Gram-negative, small bacterium. C. burnetti is very 
resistant and in nature it is maintained and disseminated by horizontal and 
vertical transmission, by ticks, wild and domestic animals. Reservoir of 
infections may persist for years or even decades. After the war in Bosnia 
and Herzegovina (1992/1996), we had to import cattle, sheep and goats from 
all parts of Europe and it was result of these dramatic changes of different 
infectious diseases. 
Methods: Diagnosis of Q-fever relies on serologic examination. AU sera were 
tested by the chekin-Q-fever enzyme immunoassay (EIA) or indirect immu- 
nofluorescence assay (ELISA-MRL Diagnostics) for the detection of IgM and 
IgG antibodies to C. burneiii phase I and phase 11 antigens. From January to 
December 2000, blood samples were collected from persons with clinical signs 
of Q-fever who living in urban and rural parts of FBiH and fiom 47 621 
ruminants (23 546 cattle, 22 962 sheep and 1103 goats) fiom 67 different areas 
ofBosnia and Herzegovina. Blood samples fiompatients or animals were eked 
and were separated and kept at -200 "C until required. 
R e ~ l t s :  The seroprevalence of the present antibodies in the cattle was 2.17% 
or 512, in the sheep 1.85% or 425, and goats 0.27% or three positive. The 
prevalence of disease was observed in 44 locations of BB. Cases were 
dmibuted throughout all months with peaks during May and June. From 
total investigated human samples, presence of C. burnetii antibodies were 
observed in 153 patients fiom six different canton of BiH. 
Conclusions: The results of this study indicate that prevalence of C. burnetii 
antibodies in serum samples of cattle, sheep and goats is widespread in BH.  
Antibodies to C. burnetii antigen phase I1 were detected positive in serum fiom 
153 persons in six locations of FBiH. H g h  level ofseroprevalence of codosis 
in domestic ruminants is the primary reservoir &om which human contam- 
ination occurs, because human infections were related to contact with 
livestock. 
Ip16211 Coxiella burnetii hepatitis 
D. Kofteridis, M. Koulentaki, A. G h  and Y. Tselentis 
Herukfion, GR 
Objectives: To investigate the hepatic involvement of acute Q-fever infec- 
tion. 
Methods: Patients were identified from a retrospective study of adults 
hospitalized for a febrile illness associated with serologic evidence of acute 
Coxidla burmtii infection. Over a period of 7 years (1989-1996), serum 
samples from 3300 patiena suspected of being infected by C. burnetii were 
assayed for the presence of antibodies against antigen phase I1 of the micro- 
organism, using the indirect immunofluorescence antibody technique (IFA). 
We reviewed the m e d d  records of 131 patients that W e d  the clinical and 
serologic criteria of acute Q-fever infection. Hepatitis was defined as elevated 
liver transaminase enzymes over two times the upper normal value for the 
testing laboratory. 
Results: A total of 53131 patients (40.4%) had hepatitis as defined above. A 
total of 45/53 were male (84.9%). The mean age of the patients was 
3 7 1  11 years. Total 51/53 (96.2%) patients bad fever at admission and 
7/53 (13.2%) patients were presented as hepatitis. The rest of the 46/53 
(86.8%) patients were admitted in the hospital with community-acquired 
pneumonia. Additional clinical features were hepatomegaly in  eight (15%), 
rashes in three (5.6%), splenomegaly in three (5.6%) and meningitis in two 
(3.8%) patients. Ascites were noted in one patient presented with hepatos- 
plenomegaly, hepatitis and pneumonia. At 7f4days  finom the onset of 
the symptoms, the mean serum levels of ALT were 108 f 86.8 U/L (range 
11-396 U/L; normal range: 5-40 UL). Patients with normal ALT levels at 
admission showed a sigmficant increase in ALT levels on day 12 z t  4.4 (range 
5-26days) firom the onset of the symptoms. Overall on day 12, the mean 
serum level ofALTwere 129.6 f 71 U/L. The mean time to normalization of 
ALT level w a s  29 f 5.7 days (range 25-41 days). One patient had a high serum 
bilirubine level, while prothrombine time was within the normal in all 
patients tested. In 10 (18.9%) patients were detected low serum albumin 
levels, mean 3.11 mg/dL (range 2.1-3.4mg/dL). Despite only six (11.3%) 
patients being treated with doxycycline, the drug of choice for acute Q-fever 
infection, all  patients spontaneously recovered. Fever subsided to normal 
levels in a mean time of 10.1 days (range 4-31 days) &om symptoms onset. 
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Conclusion: Our data suggest that hepatitis is a common feature of 
acute C. bunetii infection. The mean time of complete resolution of the 
dlsease was estimated to be up to 30 days. The outcome was favorable for all 
patients. 
jp1622j Treatment of boutonneuse fever with 
doxicyclini, ciprofloxacini and corticosteroids 
D. Kraja and N. Como 
Tirana, AL 
Objectives: The efficacy determination of some therapeutical protocols 
composed by ‘classic’ antirickettsial therapy like chloramphenicol, tetracy- 
clini, and the ‘modem’ ones like doxicycline and ciprofloxacini associated or 
not with corticosteroids. 
Methods: The study includes 50 cases with boutonneuse fever of age 13-61- 
year-old observed by us during the period of 1993-2001. The etiologic 
treatment chloramphenicolO.5 x 4/die (10 cases), tetracyclini 0.5 x 4/die (14 
cases), doxicyclini 0.1 x 2/die (12 cases). The etiologic treatment lasted 
7days. The patients were treated even with antipiretics, like aspirini 
0.5 x 4/die or paracetamol 0.5 x 4/die, or novalgini (1-2) x 1 ampoule/ 
&e until the normalization of the fever and headache. The patients were 
divided in two groups: the fmt group of 20 patients was treated 
with corticosteriodes lprednisolone (2-4) x 25 mg/die or dexamethasone 
( 2 4 )  x4mg/die], and the second group of 30 patients was treated 
without corticosteroids. The comparison of the two groups was based upon 
the course evaluation of these indications: fever, toxicosis, exanthema and 
‘tache noire.’ It also made up the comparison of those indicators for the 
subgroup, treated by different antirickettsials. The Ztest was used for statistical 
elaboration. 
Results: We did not see significant changes of the efficacy between different 
antirickettsials (P< 0.1); doxicyclini and ciprofloxacini were better tolerated. 
Significant variations were seen regarding fever normalization and toxicosis 
improvement in favor ofthe first group (P< 0.001) and concretely - the fever 
in that group was normalized on the first day in five cases, on the second day in 
13 cases, on the third day in two cases. The fever for the group without 
cortisone was normalized - on the first day in zero cases, on the second day in 
11 cases, on the third day in 15 cases, on the fourth day in four cases. No 
substantial changes of exanthema and ‘tache noire’ course were seen between 
the two groups. 
Conclusions: The e6cacy of doxicyclini and ciprofloxacini was equal with 
that of the ‘classic’ antirickettsials. The corticosteroids usage obviously 
shortened the fever and toxicosis but not the course of the skin lesions of 
bouttonneuse fever. 
jp16231 Mourine typhus in childhood: report of 20 cases 
in Chania, Crete, Greece 
A. Kanitsakis, N. Tzagarakk, A. Psaroulaki, E. Mpalomenk, Y. Tselentis 
and A. Gikas 
Chania, Heraklion, GR 
Objectives: To study the clinical, laboratory manifestations and treatment 
features of endemic typhus in childhood in our region. 
Patients and methods: Twenty children with clinical and serologic Ctagnosis 
of murine typhus were studied fkom June to November 2001 in the general 
hospital of Chania on the island of Crete. 
Results: Twelve patients (60%) were boys and eight (40%) were girls. The 
average patient’s age was 9.8 years (1.5-14). Five out of 20 (25%) patients were 
residents of urban and 15/20 (75%) of rural areas. All cases presented with 
fever (loo%), whereas rashes were found in 18/20 pts (90%). Maculopapdar 
rash appeared within 3.78 days (range: 2-5 days) after the omet of the fever 
and lasted for 2 days (range: 1-3 days). Headache was the presendng symptom 
in 12/14 pts (80%), arthralgias in 12/14 pts (85.7%). myalgias in 11/14 
(78.5%), and photophobia in 2/14 (14.3%). Spleen enlargement was found in 
16/20 pts (SO%)), and liver enlargement in 13/20 pts (65%). Five out of 20 pts 
(25%) presented pulmonary, and 3/20 pts (15%) gastrointestinal manifesta- 
tions of the disease. The most prominent laboratory fin- registered were: 
leukopeniain 12/20 pts (60%), anemiain 4pts (21.1%), thrombocytopenia in 
3pts (15.7%). increase ofserum transaminases in 5.5% pts, and blood traces in 
urine in 6pts (30.3%). Nine out of 20 patients (45%) were treated 
with chloramfenicol, 6/20 pts (30%) with vibramycin, 3/20 pts (15%) with 
cotrimoxazole, 2/20 pts (10%) with ciprofloxacin. The mean time elapsed 
until defervescence was 8.73days (4-15). The outcome was favorable for all 
the patients and no relapse was observed. 
Conclusion: Endemic typhus presents in children of our region mainly with 
fever, headache, and rashes. 
I P1624 I Liver biochemical abnormalities in murine 
typhus: a study of 101 cases 
S. Doukakis, D. Triantafillidou, G. Polimili, M. Kastanakis, 
N. Christodoulakis, N. Ghirousis, E. Vittorakis, I. Bompolaki, 
K. Nikiforakis and S. Kastanakis 
Clzania, GR 
The most fkequent biochemical abnormality in murine typhus is a mild 
elevation of AST, but ALT and LDH are often elevated in parallel. A hundred 
and one patients with compatible clinical status of murine typhus and high 
serologic titers of antibodies against Rickettsia 6yphi, were studied by our team 
between January 1993 and December 1998. For the study of their hepatic 
function, three serum samples were obtained h m  each patient. The first 
sample was obtained on admission, approximately 9 days afiter the onset ofthe 
disease. The second sample approximately 2 weeks after the first. The third 
sample, taken h m  halfofthe patients, was obtained 1 month after the second. 
On admission (first sample), 87/101 patients (86.1%) presented an elevation of 
AST, 66/101 patients (65.3%) presented an elevation of ALT and 81/101 
patients (80.2%) presented an increase of LDH. The mean values of AST, 
ALT and LDH were 70.3, 60.5, and 314.6U/L, respectively. Two weeks 
later (second sample), 851101 patients (84.1%) presented an increase of AST, 
73/101 patients (72.2%) presented an increase of ALT and 76/101 patients 
(75.2%) presented an elevation of LDH. The mean values of AST, ALT and 
LDH were 71.2, 70.5, and 288.3U/L, respectively. One month later (third 
sample), 18/48 patients (37.5%) presented an increase ofAST, 13/48 patients 
(27.0%) presented an increase of ALT, and 8/48 patients (16.6%) presented 
an elevation of LDH. The mean values of AST, ALT and LDH were 35.5, 
33.6, and 154.1 U/L, respectively. Our study showed that the time of 
normal restoration of liver hnction was about 2 months after the onset of 
the disease. 
Demographic features of I01 cases of rnurine 
typhus in Crete, Greece 
S. Doukakis, D. Triantafillidou, K. Bambili, M. Kastanakis, N. Ghirousis, 
E. Vittorakis, I. Bompolaki, K. Nikiforakis and S. Kastanakis 
Chania, CR 
A hundred and one patients with compatible clinical status of murine typhus 
and high serologic titers of antibodies against Rickettsia typhi were studied by 
our team between January 1993 and December 1998. Sixty patients were men 
(59.4%) and 41 were women (40.6%). The median age of the patients was 47 
(SDf19.0) years, with a range of 14-80years. A higher incidence of 
infection was noted in the age group 2@29yem with 21 patients (20.8%) 
and in the age group 6M9years with 23 patients (22.7%). The monthly 
distribution of murine typhus cases revealed a higher incidence of infection 
tiom July till November (91 cases, 90.0%). Seventyfour patients (73.3%) had 
a history of contact with animals, mainly rats, dogs, cats, rabbits, sheep and 
goats. Fifty-two patients (51.5%) were registered as residents of rural areas, 21 
patients (20.8%) were staying in semiurban areas and 28 (27.7%) in urban 
areas. In the Province of Kydonia were traced 73 cases (72.3%), in the 
Province of Apokoronas 15 cases (14.8%), in the Province of Kissam06 11 
cases (10.8%) andin the Province ofSelinos two cases (1.9%). No one case was 
traced in the Province of Sfakia. Twenty-nine (28.7%) of the 101 patients were 
farmers, 17 (16.8%) were clerks, 24 ofthe women (23.7%) were housewives, 
eight patients (7.9%) were workers. Furthermore, seven patients (6.9%) were 
merchants, five (4.9%) were students, four (3.Y?) were pensioners and there 
was one nurse and one physician (0.9%) of our hospital. Our study showed 
that murine typhus regards all the Chania County and especially the Province 
ofKydonia. The rural activity and the contact ofrodents represent risk factors 
for this infection. 
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lp16261 The Albanian features of endemic 
exanthematic typhus 
D. Kraja, N. Como, K. Pano and B. Byku 
Tirana, AL 
Objectives: The evidence of the epidemiologic features and laboratory 
findings of murine typhus in Albania. 
Methods: In 150 cases of murine typhus of age 14-72years, observed 
during 1990-2001, confirmed through positivity of Weil-Felix re- 
action (1 : 320-64Cb-1280) or indirect imunofluorescence (1 : 163244) ,  
we determined residence, age group, gender and also laboratoric-clinic 
spectrum. 
Results: The most vulnerable age group was 15-40yean (60,66%), rarely 41- 
72years (39,34%). Year fkequency was irregular: 6 2 4  cases. The domination 
Sexually transmitted diseases 
of rickettiosis was found in the urban areas (110 : 40). The males are more 
kequently infected (102:38). The type and &equency of signs and their 
percentage was as follows: fever: 100 (from 38 to 41.6"C); exanthema: 100 
(confluent in 10.6% of the cases); headache: 100; weakness: 85.3; anorexia: 
60.6; myalgia: 56.6; chills. 54; typhic tongue: 52; hepatomegaly: 50; sple- 
nomegaly: 42; conjuctivitis: 21.3; encephalopathy: 19.3; petechiae: 12; 
epistaxis: 10.6; hypotension: 6.7; meningismus: 6; vomiting: 6; pneumonia 
3.3; icter: 3.3; diarrhea: 3.3; feet flebothrombosis: 2.6; lymphocitar menin- 
gitis: 1.8; pulmonary thromboembolia: 1.3; myocarditis shock 0.6. We have 
seen: leukocitosis: 21.3%; leukopenia: 12% hypertransaminasemia: 10.6%; 
hyperasotemia: 6%; thrombocitopenia: 4% hyperbhbinemia: 3% of the 
cases. According to the gravity, we have distinguished: grave forms: 23.3%; 
medium forms: 64.7%; mild forms: 12%. The resulting mortality rate was 0%. 
Conclusions: Independently of missing mortality, murine typhus appears as a 
serious disease. 
-1 STDs in women addicted to drugs: a 15-year 
study in an STD unit 
T. Hellin, 0. Beniandres and M. Caiiadas 
Madrid, E 
Objective: To study the correlation between drug use and sexually transmitted 
diseases in women patients of a STD Unit in a 15-year time span. 
Methods: Patients of the STD unit between January 1986 and January 2001 
who had a background ofhigh risk activities for STD infection were analyzed. 
High risk activities included drug use (intravenous or otherwise), prostitu- 
tion, trading sex for drugs, homosexual sex, or unprotected sexual contact 
with four or more partners in the last year. The study group was composed 
with the women who were addicted to drugs. A medical history was gathered 
for d of them, as well as a clinical exploration, and a STD screening. 
Results: Out of 702 patients (83%. of which were HIV+), 343 (43%) were 
women addicted to drugs, 295 of these women (86%) were HIV+, 85% of 
them traded sex for drugs. In addition to HW, 50% of the women had two 
other STDs, 23% of them had three or more. The most common infection 
agents were human papilloma virus (HPV) in 280 cases (81%). There were 
190 cases (55%) of vaginitis, 78 of which were caused by 7: vagitialis, 75 by 
Candida sp., and 37 by Cornerella vaginalis. Twenty-five (7.2%) of the total had 
genital herpes, 15 had syphilis (4.5%), 6 Chlamydia trachomatic (2%), 4 Neisseiia 
gononhorae (1%). 1 H. ducyii  (0.2%), and 1 S. scabiei (0.2%). Twenty-seven 
(8%) presented pelvic inflammatory disease. 
Conclusions: HIV infection among women is correlated to drug use, 85% of 
the addmed women ended up prostituting themselves in order to obtain 
drugs. One out offour has three or more STDs associated to HIV In 280 cases 
(81%) these infections are of viral origin, making them difficult to eradicate. 
This increases morbimortality not only in the female population, but also 
among their sexual partners, and the children born to these women. Drug 
addiction in women constitutes a high risk to public health. 
Ip1628j Evaluation of an enzyme immunoassay (EIA) for 
syphilis screening 
E.S. Pearlman, S. Moosa, S. Swiss, J. Stauffer and L. Bilello 
Long Island ci6y, USA 
Because of concern about the lack of sensitivity of the RPR assay (Bectop 
Dickenson; Cockeysville, h4D) in late stage syphilis as well as automation 
potential, CLS switched to an EIA Assay (Trinity; Jamestown, NY) for IgG 
treponemal specific antibodies (TSA) for screening purposes 4 years ago 
[E.S. Pearlman et al. Clin Chem 1998; 44: 17901. The RPR was used as a 
supplemental assay. Recently a Western Blot (WB) assay for TSA has become 
available (PhoenixBio-Tech; Mssissauga, ON). The manufacturer of the WB 
assay also produces an EIA screening assay. We wished to evaluate the WB 
assay in a syphilis-testing algorithm and in a first study we evaluated the EIA 
from Phoenix-Bio-Tech (FAA-new) as a replacement for our current EIA 
(EIA-old). Both EIA assays and an RPR assay were run on all specimens 
(N= 519 consecutive patient samples). Discrepant resolution utilized RPR 
data and results from FTA (Zeus; Raritan, NJ). All assays were performed 
according to manufacturers' directions. Both EIA assays produced results 
based on an optical density ratio (ODR) ofpatient specimen to a low positive 
cutofC We compared results using an ODR of 20.9 as a positive result for 
EIA-old and ODR >1  .O as a positive result for EIA-new. EIA-new produced 
a higher ODR in 509/519 patient samples [P< 0.0001; Sign test] but overall 
agreement in interpretation @ositive/negative) was noted in 5021519 speci- 
mens (96.7%). The 17 discrepant specimens were all EIA-new [+I and EIA- 
old [-I. Of these samples, 10 were RPR [-] and FTA [-I; 5 were RPR [-] but 
FTA [+I while 2 were RPR [+I but FTA [-I. In two specimens strongly 
positive by both EIA-old (initial ODRs = 2.378,2.267) and EIA-new (initial 
ODRs = 4.943 and 6.33) serial dilution resulted in negative EIA-old results at 
1:16 dilution (OD%= 0.534, 0.632) while both specimens remained posi- 
tive usingEIA-new (OD& = 1.000,1.182). The results suggest that there are 
difEculties with any single test used to screen for syphilis and any combination 
of tests will yield some discrepant data. As a referral laboratory patient data is 
not readily available to us, but the presence of5 EIA-new [+I, FTA [+] and 2 
EM-new [+I, RPR [+I samples that were all EM-old [-I, and also the ODR 
and serial dilution data suggest that EIA-new has greater sensitivity than EIA- 
old for detection of IgG TSA. Such increased sensitivity is desirable in a 
screening assay and EIA-new has been implemented at CLS. 
-1 A new approach to syphilis diagnosis 
E. Pealrman, S. Moosa, S. Swiss, J. Stauffer and L. Bilello 
Long Island City, USA 
CLS is a large fieestanding clinical laboratory serving an exclusively ambu- 
latory population. Because of lack of sensitivity of the RPR assay (Becton- 
Dickenson; Cockeysville, MD) in late stage syphilis as well as automation 
potential, CLS switched to an EIA assay for IgG treponemal specific 
antibodies (TSA) for screening purposes 4 years ago [E.S. Pearlman et al. 
Clin Chem 1998; 44. 17901. The RPR was used as a supplemental assay. 
Recently a WB assay for TSA has become available (Phoenix Bio-Tech 
Mssissauga, ON). The same manufacturer also produced an EIA assay for 
screening, which CLS has evaluated and implemented [E.S. Pearlman et al. 
this meeting]. We were interested in evaluating the role of the WB assay in a 
syphilis-testing algorithm and for this purpose did an RPR assay on 519 
consecutive patient samples irrespective of the result of the initial EIA screen. 
Discrepant specimens were further evaluated by WB and where specimen 
quantity was sufficient, by FTA (Zeus; Raritan, NJ). All assays were per- 
formed according to manufacturers' directions. There was result concordance 
between EIA and RPR in 490/519 samples (94.4%). Of the 29 discrepant 
specimens, 28 (96.6%) wereEIA [+I, RPR [-I. Ofthe latter 28 specimens, 18 
were WB [+] and all 18 ofthese samples were FTA [+I. Ofthe 10 EIA [+I, 
RPR [-] and WB [-] specimens, FTA could be performed on nine samples 
and eight of these specimens were FTA [-I. Finally, there was 1 discrepant 
sample which was EIA [-] and RPR [+I. This sample was WB [+I but FTA 
[-I. Overall, there were concordant results in 26 of28 (92.9%) specimens on 
which both WB and FTA had been performed. As the EIA [-I, FTA [-I, RPR 
[+I, WB [+] specimen suggests, it is ditlicult to get completely consistent 
results when multiple serologic tests for syphilis are used. Given the labor- 
intensive character of the FTA and the presence of false [+] FTA reactions in 
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1% of the general population (ASM Man. Clin. Lab. Immunol., 5th ed. p. 
519), CLS has decided to incorporate the new W B  assay into a syphilis-testing 
algorithm. EIA (+), RPR (-) samples are reflexed to WB. These specimens 
are signed out as TSA (+), TSA (-) or TSA-indeterminate (suggest repeat 
testing in 6 weeks) depending on the WE3 result. 
I P I  630 I The re-emergence of syphilis 
A. Afaq, L. A. Jabbar and G. S. Toor 
London, UK 
Introduction: Syphilis is often referred to as a disease which has been 
successfully controlled during the second halfof the 20th Century. However, 
three recent outbreaks in the UK provide an unpleasant reminder that 
infective syphilis is makmg a comeback. 
Objectives: The clinical features of the disease are discussed before describing 
the recent increases in cases in the UK. 
Methods: Literature review of artides &om medline describing evidence for 
the re-emergence of syphilis. 
Results: Recently, three outbreaks of syphilis have occurred in the UK have 
been reported. The first was in Bristol between 1997 and 1998, where a 
heterosexual outbreak occurred largely due to unprotected sex and multiple 
partners. This was followed by an outbreak in Manchester, where 34 cases, 
were seen between 1999 and 2000, compared to a normal of 2 per year. The 
cases in Manchester were mostly homosexual (70%). and of these, nine cases 
were HIV-1 antibody positive, eight were HIV negative, and seven had not 
been tested. The most recent outbreak occurred in Brighton which involved 
homosexual cases. 
Conclusions: Consideration is given to the possible causes of syphilis epi- 
demics, by reflecting on cases in the USA and the former Soviet Union. 
When considering the drive to control syphilis, the problems of HW 
coinfectivity and congenital syphdis are evaluated. Finally, suggestions are 
made to prevent hrther outbreaks of syphilis by improving management, 
particularly by increased awareness and adequate screening. 
1 PI631 1 Fifteen years of syphilis in an STD unit: clinical, 
epidemiological and evolutional aspects 
T. Hellin, A. Sousa and A. Perez Rodriguez 
Madrid, E 
Objective: To study the clinical, epidemiological and evolutive aspects of 
patients diagnosed with syphilis during 15years at the STD center in a 
University hospital. 
Methods: Data was gathered on all prospective patients of the STD unit 
between January 1986 and January 2001. A complete clinical history, a 
physical examination, as well as a complementary battery of laboratory tests 
were obtained for all patients. The syphilis diagnostic was established by 
Eeponemapallidurn detection in the serous transudate ofulcerated lesions using 
an optical microscope with dark field method. Non-treponemic antibodies 
were detected with a VDRL (Venereal Disease Research Laboratory) test. 
Treponemic antibodies were detected using a FTA (fluorescent treponemd 
antibody-absorption) test and hemagglutination of T patlidurn. 
Results: In 15 years 205 cases of syphilis were diagnosed h m  a total of 3606 
patients, 2630 ofwhich had STDs (3% of the total), 8% ofthese were infected 
with syphilis, 72 of the infected patients (35%) were women, 133 were men 
(65%) 33% of the infected men were HIV-t, of which 73% were homosexual. 
The most kequent presentation was latent syphilis (80%). Three of these cases 
had neurosyphilis, one case was congenital. In 66 cases (30%) syphilis 
coexisted with another STD. Clinical evolution after treatment was favorable 
in all cases. 
Conclusions: Syphills has been a relatively rare STD, representing 8% of the 
patients in a 15-year time span; 16% of the cases coexisted with an HIV 
infection, the most affected were patients with homosexual practices. One- 
third of the syphilis patients had at least two other STDs. Evolution after 
treatment was favorable in all cases. 
1 PI632 I Seroprevalence, antibodies to anti-T. pallidurn in 
a cohort study of pregnant women in Buenos Aires, 
Argentina 
E. Rickard, A. Tacone, M. Vilarino, L. Abossio, L. Perez, S .  Figueroa and 
L. Kiatkowsky 
Avellaneda, Buenos Aim, AR 
Background and objectives: Syphilis is a sexually transmitted disease (STD) 
caused by the Spirochete T pallidurn. A pregnancy untreated woman with 
syphilis transfer the infection to her fetus, who give birth to a child with 
serious mental and physical problems, neonatal death, and disorders such as 
deafhess, neurology impairment, and bone deformities. The present study was 
carried out in our hospital to determine the presence of maternal syphilis 
during: the consult in the pregnant, just given birth, or immediately post- 
delivery. This Retrospective Cohort Study, was performed &om October 
1999 to October 2001, fucing the following bias: (A) the patiens must 
authorize the study. (B) They must not have other results, in order to avoid an 
excessive health cost. (C) They have to compromise themselves to complete 
the treatment so as to study the dynamics of infection. Those who were 
positive had to concur for previously established controls to follow up their 
treatment. 
Methods: We included in the present study 3346 pregnancy women who 
accepted our conditions. The average of ages was 26, with a range between 15 
and 42 years. We tested anti-l: Pallidum antibodies titers, screening of infec- 
tion it was made with two nontreponemal test: RPR (Nosticon Distrib. L.A. 
by Org. Tek., Co. Bio-Mkrieux Group) or VDRL (GenCDiag.). The (+) 
samples were confirmed/quantified with a treponemal test: (TPHA- 
Nosticon) or (FAT-ABS). 
Results: From the 3346 pregnancy women studied, we confirmed infection 
in 64 (189%) IC 95% (143-235). All positive samples presented (+) 
treponemal test with titer between 1/80 and W40.960, although the 
nontreponemal had not given us a greater titer than two dilutions in many 
of cases. 
Conclusion: The importance of this epidemiological study made and the 
prevalence of infection reported is that 19% ofpersons which share the same 
geographical zone and the average of age, ignore their (+) condition, 
transmitting silently the STD to the sexual partners and/or her newborn 
by transplacentarial way. We emphasize that all pregnant women were studied 
without discriminating possible risk groups confirming the absence of 
selection bias. The evidence is clear that all people around the world are 
exposed to this infection. That is the reason why everyone should control 
STD. 
I PI633 1 Increasing incidence of gonorrhoea in Israel 
associated with the countrywide dissemination of a 
ciprofloxacin-resistant strain 
P. Yagupsky, A. Schahar, N. Peled, N. Porat, M. Dan, Y. Keness, 
R. Trefler and C. Block 
Beer-Sheva, Holon, IL 
Objectives: At the end of 1999, high-level ciprofloxacin resistant N. 
gonorrhoeae organisms (MIGO: >32 pg/mL), also exhibiting decreased 
susceptibility to penicillin and tetracycline, were isolated in Israel for the 
first time. A study was conducted to investigate possible changes in the 
incidence of gonorrhea in the country related to the emergence of these 
organisms. 
Methods: The incidence rates of male gonorrhea in southern Israel for the 
January 1991 to June 1999 andJuly 1999 to December 2000 period were 
calculated separately, and the number of cases of gonorrhea diagnosed in a 
large Jerusalem hospital during the same period was determined. Isolates of 
N.gomnhea resistant to ciprofloxacin recovered in southern Israel and Jer- 
usalem, as well as in the Northern and Estern areas of the country were typed 
by pulsed-field gel electrophoresis (PFGE) and compared. 
Results: The incidence of male gonococcal urethritis in the south increased in 
1.5-year period hpm 3/100000 to 12/100000 (P<O.O5) as the result of 
increased isolation of ciprofloxacin-resistant organisms. A marked increase in 
gonorrhea was also encountered in Jerusalem where ciprofloxacin resistance 
affected 54.5% of isolates in 2000. PFGE typing of gonococci &om different 
areas of Israel indicated that all ciprofloxacin-resistant isolates belonged to 
identical or related strains 
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Conclusions: Fluomqumolone-remtant gonococcl may emerge and dwe- 
nunate extensively over a short period of ame. Conanuous survedlance of 
anabionc suscepabhty of gonococcal isolates should be performed to guide 
empmc therapy 
[p1634] Evaluation of the VIDAS PROBE 
Chlamydia trachomacis test in males and females 
within a high risk population 
A. E. Hem, D. Fuller, R. Diaz. M. DeBiasio, S. Reilly, K. Kacena and 
C. Rogers 
Rockland, Indianapolis, USA 
Objective: The aim of this study was to evaluate the preclinical performance 
of the VIDAS PROBE Chlamydia trachomatis (CT) test* in “at risk” female and 
male study subjects. 
Methods: The VIDAS PROBE C T  test is an automated assay for the 
amplification and qualitative detection of C. trachomatis 235 rRNA. A 
built-in internal control sequence coamplifies in the presence or absence 
oftarget sequence and monitors the success ofamplification in each indwidual 
sample and control. The system employs the existing VIDAS immunoassay 
instrument for detection and subsequent decontamination of amplified 
product. First void urine (FVU) and female endocervical or male urethral 
swabs were collected from 804 patients (592 female/212 male) attending a 
sexually transmitted disease (STD) clinic or urgent care OB/GYN clinic. 
Study subjects ranging in age from 19 to 67years (average age 28) were 
deemed at risk for chlamydial infection based on several factors including 
promiscuous behavior, recent exposure to STD infection and risk history 
(number of sexual partners, change in sexual partners, and previous positive 
test for C. trachomah). Specimens were tested by the VIDAS PROBE C T  test 
(TMA), polymerase chain reaction (PCR) and/orligase chain reaction (LCR) 
and compared to patient infectivity status which was deemed positive iftwo or 
more of the comparative tests were positive. 
Results: Of the 592 women and 212 men tested, 80 (14%) and 25 (12%), 
respectively, were shown to be infected with C. rrarhomatis. In women, the 
preclinical sensitivity/specificity of the VIDAS PROBE C T  test for endo- 
cervical swabs and first void urine was 99/99?h and 95/99%, respectively. 
Pre-clinical sensitivity/specificity in male urethral swabs and male urine w a s  
961100% and 100/99%. Inhibition, as monitored by internal control ampli- 
fication, was observed in less than 1 .O% (7/804) of all swab specimens and less 
than 3.0% (231804) of all urine specimens tested. 
Conclusions: Results ofthis study suggest that the VIDAS PROBE CT test is a 
highly sensitive and specific test for the detection of C. frachomotis infection in 
at risk male and female study subjects. 
* T h s  product has not been cleared by the Umted States FDA and 15 not yet 
available for commercial use. 
lp1635/ Polycentric analysis of C. trachomatis infections: 
an epidemiological study 
M. A. Latino, A. Sensini, I. Caola, M. L. Modolo, P. Clerici and 
comitato dl studio ist-Amcli 
Turin, Perugia, Trento, Pordenone, Legnano, I 
CT one of the most wide spread sexually transmitted bacterial diseases. 
Published data have already shown that 30-50% of infections start in an 
atymptomatic manner so that it often escapes dagnosis and it is d&cult to 
prescribe a correct therapy. 
Objectives: In this study, we wanted to evaluate the prevalence of CT 
infection in patients that were treated at five Werent centen for sexually 
infectious disease (STD), in the north and center of Italy. Correlation between 
infection and social and behavior aspects have been studied to find possible 
risk factors. 
Methods: From January 1, 2000 to the June 30, 2001, 14619 patients 
(1 1 904 females and 2715 males), coming fiom sexually transmitted infection 
centers were evaluated. C T  infection diagnosis was evaluated using molecular 
biology techniques in 10432 samples, hybridization techniques in 1910, cell 
cultures in 1300 and by immunofluorescence technique in 973 patients. 
Statistical data were analyzed by Chi-square test and Fisher test with 95% 
CI. 
Resultr: In the studied population, the dec t ion  prevalence is 1.95% (1.61% in 
females and 3.43% in males). CTwas the only pathological agent we found in 
54.39% of our patients. CT infection is particularly associated with a 
subjective symptomatology, more kequendy in males (5.62%) than in females 
(1.90%) (P<0.001). Prevalence in cases with symptomatic partners is also 
significantly higher (P< 0.001): (3.87% in females and 4.35% in males) versus 
asymptomatic controls (1.49%). In consideration of the age correlation, as 
published data have largely demonstrated, CT infection has shown a pro- 
gressive decrease beginning with the younger patients (3.71% under 21 years 
of age and 2.38% between 21 and 30 with a P<O.O01 and <0.005, 
respectively) to the older patients (1.67% between 31 and 40years of age 
and 1.63% over 40). Among other possible risk factors we inquired the 
number of sex partners in the last 6 months and the countries of origin with a 
high incidence of STD. 
Conclusion: Infection resulting &om C T  is decidedly more prevalent in men 
than in women, it is accompanied by a more frequent subjective sympto- 
matology and it is more fiequent in younger subjeca. Among the other risk 
factors that have emerged are the elevated number of sexual partners and 
subjects who come from countries with a high incidence of STD. 
HBV-HCV 
(p16361 Influence of HBV-HCV replication on the clinical 
course of chronic dual (B, C) viral hepatitis 
D. Telehin and B. Gerasun 
Lwiq U K R  
Objective: The aim of this study was the investigation of dual chronic HBV 
and HCV infection clinical course. 
Methods: A total of 42 HBsAg and anti-HCV-positive patients with chronic 
hepatitis were studied. Serological markers of dzsease were assayed using 
commercial enzyme immunoassays, HBV-DNA and HCV-RNA in serum 
were detected by means of a polymerase chain reaction (PCR) technique. 
Comparative analysis was done in next patients groups: (1) dual hepatitis with 
HBV-viremia (HBV-DNA+, HCV-RNA-), six patients; (2) dual hepatitis 
with HCV-viremia (HBV-DNA-, HCV-RNA-I+), 19 patients; (3) dual 
hepatitis with HCV-viremia and HEW-viremia (HBV-DNA+, HCV- 
RNA-/+), eight patients; (4) dual hepatitis with no signs of any virus 
replication (HBV-DNA, HCV-RNA) nine patients. 
Results and conclusion: The clinical course of disease was characterized by 
cytolitic (65%), inflammatory syndrome (1 l%), rarely - changes in bilirubin 
metabolism with cholestasis (6%), the rest - subclinical cases (18%). Chronic 
hepatitis kequency with highest activity was the greatest in one (84%) and 
three (79%) groups. In these both groups, the disease activity was associated 
with replication of HBV, however, HCV had no sigtllhcant influence on the 
disease course. Clinic and laboratory changes were less expressed in patients 
with integrative type of the HBV-infection (group 2): the fiequency of 
chronic hepatitis with high activity was 31%. The cases with expressed clinical 
signs of hepatitis were observed also in the four groups of patients, in spite 
of absence of viremia, 7%. Probably, it is connected with hepatic injury 
by other factors, such as autoimmune antibodies, circulating immune 
complexes induced by viruses. Using of the complex analysis of clinical, 
serological dates and viral load was distinguished the following forms of 
chronic dual (€3, C) hepatitis: (1) hepatitis with HBV-HCV-replication and 
high disease activity (HBsAg+ HBeAg+ HBV-DNA+ AntiHCV+ HCV- 
RNA+); (2) monoreplicate forms- clinical changes were less expressed; often: 
HCV-viremia and integrative type ofHBV-mfeaion (HBsAg+ HBeAg- HBV- 
DNA- AntiHCV+ HCV-RNA+); (3) HBV-HCV hepatitis with no signs of 
any virus replication (HBsAg+/- HBeAg- Anr.iHBc+ Hl3V-DNA- Anti- 
HCV+ HCV-F”A-); usually this form was subclinical, rarely observed, 
so-called postviral HBV-HCV induced autoimmune chronic hepatitis. 
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lp16371 Serum iron, total iron binding capacity and 
ferritin levels in chronic hepatitis B and C patients 
S .  Cesur, F. Albayrak, K. Akin, I. Balik and H. Kurt 
Ankara, TR 
Objective: This study has been planned to evaluate if there is any change in 
iron metabolism of chronic hepatitis B and C patients. 
Methods: The level of serum iron, total iron binding capacity (TIBC) and 
ferritin levels together with liver enzymes in 260 chronic hepatitis B and 30 
chronic hepatitis C patients. Control group consists of 80 people. Ferritin 
measurements were held with the Spechia Irma Test based on immunor- 
adiometric assay principles. The levels of TIBC and serum iron were 
determined by DMA iron procedure at Olympus auto-analyzer. 
Results: Patients with chronic hepatitis B have lower serum iron and ferritin 
levels and hgh iron binding capacity when compared to healthy control 
groups ( P <  0.05). But chronic hepatitis C patientshave higher serum ferritin 
and serum iron levels with normal iron binding capacity when compared to 
controls. No significant difference was observed between chronic hepatitis C 
patients and control groups. 
Conclusion: In chronic hepatitis B and C patients, iron metabolism changes 
are reported in the literature. As in our cases serum iron and ferritin levels are 
reported to decrease. In chronic hepatitis C patients, serum iron and ferritin 
levels increase but there is no significant difference. Iron metabolism changes 
should be monitored and when necessary further investigations such as iron 
staining of liver biopsy specimens should be considered. 
/p1638/ Extrahepatic disorders associated with chronic 
hepatitis B and C virus infections. A retrospective analysis of 
435 patients 
F. Albayrak, S. Cesur, K. Akin, H. Kurt and I.  Balik 
Ankara, TR 
Objectives: Chronic B and C hepatitis is a global public health problem in the 
world. The incidence of both infections seem to increase in both developed 
but mainly in developing countries. In Turkey, despite all recommendations 
and preventive controls hepatitis B and C virus infections st i l l  have a 5-7 and 
3% incidence, respectively. Recent studies show a strong suggestion of 
hepatitis B and C can go together with various extra-hepatic diseases such 
as diabetes, autoimmune diseases, etc. We evaluated the incidence of both 
clinical and laboratory findings of extra-hepatic diseases associated with 
chronic hepatitis B and C virus infected patients. 
Methods: In the study, 400 chronic hepatitis B and 35 chronic hepatitis C 
patients followed in outpatients clinic of Ankara University Ibn-i Sina 
Hospital Infectious Diseases Department between June 2000 and September 
2001. Results were evaluated retrospectively. Patients were followed with 
6 months’ intervals for activation of the diseases. The prevalence of rheuma- 
tologic disorders (rheumatoid arthritis, systemic lupus erythematosus, Sjogren 
disease, etc.), hematologic disorders (iron deficiency anemia), endocrinologic 
disorders (diabetes mellitus, hypothyroidism or hyperthyroidism) were exam- 
ined. 
Results: The most common extrahepatic clinical manifestations observed 
frequently in both groups were diabetes mellitus, thyroid diseases, rheumatoid 
arthritis. Iron deficiency anemia and chronic disease anemia was observed 
only in chronic hepatitis B patients. There were no significant difference 
between chronic B and C hepatitis groups. 
Conclusion: The results demonstrates the relationship between extrahepatic 
manifestations of chronic B and C hepatitis patients. These patients need 
further investigations for extrahepatic disorders and ifnecessary they also need 
therapies in order to prevent probable serious complications. 
1 P1639 1 The presence of serum auto antibodies in 
patients with chronic hepatitis B and chronic hepatitis C 
S. Cesur, K. Akin, F. Albayrak, H. Kurt and I. Balik 
Ankara, TR 
Objective: Several auto antibodies can be seen in the sera of patients with 
chronic hepatitis B and C infection. These auto antibodies may be due to 
interferon therapy, accompanying autoimmune disorder and cross reactions 
but commonly due to primary disease itself. We aimed in our study to evaluate 
the presence and the titer of several autoantibodies includmg RF (Rheuma- 
toid Factor), ANA (Antinuclear Antibody), Anti Sm (Smooth muscle), Anti 
LKM (Liver-Kidney-Muscle), Anti cardiolipin (ACA) IgM and IgG, anti 
TPO and Anti Tg in the serum of patients with Chronic hepatitis B and C 
patients. 
Methods: Serum was obtained fiom 300 chronic hepatitis B (1 78 male, 122 
female) and 30 chronic hepatitis C (19 male, t 1 female) patients. The presence 
and titer of serum autoantibodies were detected by IFA and ELSA methods. 
Result: No sigdicant difference was detected between groups with autoanti- 
body positivity. Extrahepatic manifestations and autoantibodies are Geequently 
observed in chronic hepatitis B and C patients. The most frequent immu- 
nologic abnormalities include ACA IgG, ACA IgM, AntiTPO, RF, ANA 
postitivity in chronic hepatitis B group whereas ACA IgG and R F  positivity in 
chronic hepatitis C group. 
Conclusion: Autoantibody positive patients should be closely followed up for 
developing extra-hepatic manifestations such as autoimmune disorders when 
compared with autoantibody negative chronic hepatitis B and C patients. 
Transfusion transmitted virus 0 infection in 
patients with hepatitis B or C 
B. Bucholc, J. Slusarczyk, M. Drop and J. Cianciara 
Warsaw, PL 
Objectives: In 1997, the genome ofa novel DNAvirus, termed TTV, isolated 
&om sera of patients with post-transfusion non A-G hepatitis, and was 
sequenced by representational difference analysis. TTV is an enveloped, 
circular, single-stranded DNA virus and comprises 3852 nucleodites. The 
TTV genome has three possible open reading Games, capable of encoding 
770, 202, and 105 amino acids, respectively. TTV most closely resembles 
members of Circoviridae f d y .  Many studies demonstrated that TTV 
viremia is frequent in general population and that is a lack of significant 
liver damage. On the other hand, TTV sequences were detected in sera and 
liver tissues &om patients with liver disease, suggesting that TTV could be 
responsible for liver disease. We investigated the prevalence ofTTV in patients 
with cirrhosis and/or chronic hepatitis B or C and also in cases of hepatitis of 
unknown etiology. Influence of TTV superinfection on hepatitis B or 
hepatitis C was also analyzed. 
Methods: The sera from blood donors and fiom patients with different form 
of hepatitis were tested for the presence of TTV DNA, HEW DNA and HCV 
RNA by P C R  systems. TTV DNA was detected by seminested PCR using 
primers f k m  open readmg Game 1. HCVRNAwas evaluated by nested PCR 
with primers directed to the highly conserved 5’ noncoding region of the 
HCV genome. 
Results: TTV DNA was detected in sera: 
f k m  5 out of 33 (15.2%) patients with chronic hepatitis B or C; 
6om 3 out of 11 (27.2%) patients with cirrhosis B or C; 
from 1 out of 5 (20%) patients with cirrhosis C or B together with alcoholic 
from 3 out of 12 (25%) patients with hepatitis of unknown etiology; 
the prevalence TTV was comparable with normal blood donors (13.3%)). 
In case of TTV, superinfection in hepatitis B or C cases, mean values of ALT 
were the same as in cases of non-superinfected patients (ALT in patients only 
with HBV infection was 66.6 IU/L; in patients with HBVand TTV infections 
were 90.31U/L; ALT in patients only with HCV infections was 72.8 IU/L; 
and in patients with HCV and TTV infections was 68 IU/L. 
Conclusions: 
TTV does not seem to influence the clinical course HBVor HCV infected 
patients. 
TTV may play a role in the development of acute and chronic liver disease 
of unknown etiology. 
cirrhosis; 
Investigation of chronic viral hepatitis, of HBV 
and HCV and CA 19-9 serum level 
A. Tsiringa, E. Ketikoglou, C. Petrochilou, M. Toutouza, B. Skandanu, 
A. Moulakakis and C. Kontou-CasteUanou 
Athens, GR 
The frequent causes of chronic viral hepatitis are mainly HBV and 
HCV. Several tumor markers have been used for the diagnosis of malignant 
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diseases. False positive results are a common event in many non-neoplasmatic 
diseases. 
Objective: The aim of our study was to investigate the chronic viral hepatitis 
for HCV and HBV and the serum level of tumor marker CA 19-9 in the 
patientr with chronic hepatitis. 
Materials and methods: A total of 51 patients of our hospital with chronic 
viral hepatitis were included in this study. We detected the antibody to 
hepatitis C virus with microparticle enzyme immunoassay (AXSYM, hepatitis 
C virus Encoded Antigen MIA, ABBOTT) and the HbsAg, HbeAg, anti- 
HBc, anti-Hbe, anti-HBs, anti-HBc IgM with microparticle enzyme immu- 
noassay (AXSYM, MEIA, ABBOTT). Additionally, the patients underwent 
liver’s biopsy and we detected the serum levels of tramaminases. CA19-9 was 
detected using microparticle enzyme immunoassay (AXSYM, CA 19-9 
MEIA, ABBOTT). 
Results: Fifteen (29.4%) of5 1 patients had chronic hepatitis B and 36 (70.6%) 
chronic hepatitis C. Liver’s biopsy proved the diagnosis and the levels of 
transaminases were higher than double of the upper normal limit. In 8 out of 
51 patients (15%), the levels of CA 19-9 were raised 2-6 times the upper 
normal limit. Complete examination to detect neoplasmatic disease and 
attendance for a 3-year period, was negative. 
Conclusion: (1) The causes ofthe chronic viral hepatitis are mainly hepatitis C 
and B viruses. (2) Chronic hepatitis B or C can cause false positive results for 
the tumor marker CA 19-9. 
F l  The significance of cryoglobulin levels in patients 
with chronic hepatitis 6 and C virus infection 
S. Cesur, K. Akin, F. Albayrak and H. Kurt 
Ankara, TR 
Objective: One of the extra-hepatic manifestation of chronic hepatitis B and 
C infection is mixed cryoglobulinemia. Typical presentation of cryoglobu- 
linemia consists ofpurpura, neuropathy and arthralgia. Cryoglohulins can also 
be discovered in asymptomatic chronic hepatitis C and B patients with an 
incidence ranging between 11-54 and 15%, respectively. We tried to find the 
importance of cryoglobulin levels in patients with chronic hepatitis B and C 
infection in the study. Association between cryoglobulin levels and clinical 
symptoms is also discussed. 
Methods: A total of 300 cases of chronic hepatitis B (178 male, 122 female) 
and 30 chronic hepatitis C patients (19 male, 11 female) were included in the 
study. Cryoglobulin levels were detected. 
ReruA: The Study showed that cryoglobuh levels are low in both chronic 
hepatitis B and C patients in Turkey when compared with the results in the 
literature. Mixed cryoglobulinemia is more frequent in chronic hepatids C 
patients than chronic hepatitis B group (16.6 and 4.6%. respectively). The 
most common symptoms with cryoglobulinemia were weakness and arthral- 
gia in both groups. 
Conclusion: The presence of positive results is not associated with extra- 
hepatic manifestations in our cases. The clinical signhcance of positive 
cryoglobulin level remains unclear. 
m] Cytornegalovirus coinfection in patients with 
chronic hepatitis type B and C 
B. Postawa-Klosinska, U. Janas-Skulina and T. Mach 
Cracw, PL 
Objectives: The aim of the study was to evaluate the incidence of cytome- 
galovirus (CMV) infections in patients treated for chronic hepatitis type B and 
Methods: Fifty-two patients without any symptoms of CMV infection were 
randomly selected. IgM and IgG anti-CMV were examined in blood serum 
by ELISA tests. Anti-CMV I@(+) was treated as confirmation of the active 
infection. There were no assessment ofthe primary infection or the reactiva- 
tion of a latent one. 
Results: A total of23 patients were infectedwith HBV, 28 with HCVand one 
patient with both HBVand HCV. Twelve patients with chronic hepatitis type 
B were treated with interferon-a (IFN-a) and lamivudine (LAM). Eleven 
patients with chronic hepatitis type B and one with HBVand HBC infections 
did not receive any antiviral therapy. Seventeen patients with chronic hepatitis 
type C were treated with combination therapy of IFN-a and ribavirine; 11 
patients were not treated. Anti-CMV IgM were detected in one treated and in 
two untreated patients with hepatitis type B, and in two treated and in three 
untreated patients with hepatitis type C. Anti-CMV IgG were detected in 
nine treated and 10 untreated patients with chronic hepatitis type B and in 15 
treated and in nine untreated patients with hepatitis type C; it proves the 80% 
incidence of CMV infection in the population. 
Conclusion: The results confirm the frequent infection of CMV (80%) in the 
patients’ population. The incidence of active CMV infection was observed in 
three patients treated due to the chronic hepatitis type B and in five patients 
with chronic hepatitis type C without antiviral therapy. The results of this 
study with the CMV infections should be confirmed will the use of PCR 
techniques. 
type c. 
